data_2l22_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l22 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.212 -0.881 0 N-CA-C 111.682 0.253 . . . . 14.98 111.682 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.15 -42.38 80.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 111.749 0.277 . . . . 15.79 111.749 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.3 t -56.34 -44.11 79.74 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.87 -0.605 . . . . 12.18 110.696 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -37.81 50.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.107 -0.497 . . . . 11.02 111.173 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -40.98 98.46 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 122.895 0.478 . . . . 16.75 109.713 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.68 -38.29 84.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.326 0.584 . . . . 14.46 110.175 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.36 -37.56 60.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.529 -0.759 . . . . 10.71 109.913 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -64.18 -32.4 73.96 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.469 -0.787 . . . . 14.51 110.608 175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -61.81 -48.71 79.37 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.693 0.797 . . . . 16.85 110.931 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p -72.52 -30.54 64.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.081 0.467 . . . . 13.52 110.945 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.33 -52.17 49.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.449 -1.315 . . . . 12.77 107.449 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.69 65.88 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.756 -0.656 . . . . 15.19 111.576 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -31.01 69.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.747 0.308 . . . . 16.26 110.676 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.59 -28.37 60.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.168 0.508 . . . . 15.45 110.402 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.36 -8.25 55.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.697 -0.683 . . . . 16.16 111.522 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 56.54 46.91 19.65 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.563 -1.199 . . . . 20.58 110.255 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.2 t -124.39 164.1 20.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.782 -1.554 . . . . 17.26 108.302 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.96 126.65 60.49 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.697 -1.223 . . . . 20.19 107.697 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 -8.4 23.52 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.945 2.43 . . . . 17.46 114.312 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.46 52.72 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.79 -0.719 . . . . 18.33 111.31 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -83.38 84.04 7.65 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.434 -0.95 . . . . 20.77 108.434 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 tp -142.07 149.02 19.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.135 0.493 . . . . 16.1 110.484 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 -101.79 120.21 40.01 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.76 -1.941 . . . . 19.87 105.76 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -67.83 -17.48 64.52 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 120.945 0.403 . . . . 15.1 111.678 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.45 7.42 61.68 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.484 -0.78 . . . . 15.48 112.953 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 p -66.56 133.35 50.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.794 0.807 . . . . 14.88 110.557 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 34.6 mtp85 -82.84 139.12 33.67 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.096 -0.957 . . . . 17.38 111.183 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -47.26 -43.11 21.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.486 0.585 . . . . 11.99 112.538 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.53 -32.24 71.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.227 1.011 . . . . 14.71 111.904 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.6 -41.64 65.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.522 0.677 . . . . 16.44 109.215 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.67 -21.09 61.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.381 -1.282 . . . . 13.83 111.104 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.34 29.12 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.341 -0.933 . . . . 14.3 112.468 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.78 85.41 7.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.329 -1.36 . . . . 13.04 107.329 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -68.72 154.58 41.69 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.872 -1.058 . . . . 15.67 110.576 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 t -49.57 -41.52 41.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.261 0.624 . . . . 15.49 112.311 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -48.52 85.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.214 0.531 . . . . 16.98 110.66 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.3 -36.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.621 -0.718 . . . . 14.44 109.585 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -59.43 -44.34 92.93 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.377 -0.829 . . . . 12.4 110.727 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -59.93 -46.45 89.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 14.37 110.533 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.27 -44.61 92.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.99 -0.55 . . . . 16.05 111.259 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.426 ' O ' HG13 ' A' ' 48' ' ' ILE . 7.5 t90 -60.13 -48.23 82.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.547 1.139 . . . . 11.7 110.051 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 41' ' ' ALA . 30.3 mm -56.94 -45.73 83.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.895 -0.593 . . . . 11.48 111.03 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 18.8 mmm180 -62.82 -31.07 71.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.429 -0.35 . . . . 17.18 110.97 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.13 -38.11 69.33 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 110.026 -0.361 . . . . 14.15 110.026 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 44' ' ' TRP . 68.7 mt -61.68 -50.77 78.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.327 -0.99 . . . . 10.8 108.327 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -54.59 -39.03 67.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.631 -1.168 . . . . 12.98 112.147 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -85.92 -37.32 19.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.73 1.011 . . . . 17.81 113.73 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -87.61 -24.48 23.96 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.508 1.299 . . . . 15.55 114.508 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.93 -10.45 19.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.004 0.742 . . . . 12.2 113.004 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 63.57 70.72 0.52 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 17.4 112.304 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.1 174.72 13.29 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.734 -1.209 . . . . 12.25 107.734 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.74 105.1 9.04 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 118.565 0.62 . . . . 16.32 111.148 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 74' ' ' VAL . 27.3 mm -72.51 124.23 90.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 O-C-N 121.82 -0.55 . . . . 11.39 111.91 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.05 126.48 14.53 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.471 -2.165 . . . . 13.44 106.471 167.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 2.18 0.55 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 115.792 1.775 . . . . 12.81 115.792 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -97.84 10.96 38.86 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.561 -0.712 . . . . 14.14 110.588 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.45 -55.89 27.52 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 121.373 -0.441 . . . . 10.76 112.242 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.42 -29.02 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.798 0.809 . . . . 11.0 110.858 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.41 -36.56 68.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.485 -0.78 . . . . 16.59 110.627 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 m -84.99 -40.96 16.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.154 -0.475 . . . . 13.72 110.7 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' HE1' ' CE3' ' A' ' 73' ' ' TRP . 68.5 m-85 -111.87 102.45 53.65 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.618 -0.882 . . . . 12.25 108.618 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 89.4 Cg_endo -83.5 4.08 7.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.286 1.991 . . . . 13.57 112.46 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.9 t -123.49 120.9 61.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.388 -1.338 . . . . 13.28 107.388 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -59.21 -32.5 70.0 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.335 0.865 . . . . 11.45 113.335 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -62.45 -46.32 89.06 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.994 0.184 . . . . 14.64 110.822 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.01 67.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.406 0.622 . . . . 11.34 110.986 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.76 -24.26 48.91 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.254 1.022 . . . . 9.05 113.095 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.4 p -60.28 -23.93 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.983 -0.448 . . . . 9.65 112.201 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.59 -29.2 69.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.802 0.81 . . . . 12.14 109.621 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.418 ' CE3' ' HE1' ' A' ' 64' ' ' TYR . 43.6 t-105 -87.32 -24.62 24.24 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.34 -0.845 . . . . 11.26 110.46 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 56' ' ' ILE . 42.6 t -84.0 -53.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.188 -0.46 . . . . 8.3 110.916 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.8 66.63 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.866 -0.606 . . . . 9.58 114.097 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 t -75.75 -17.82 59.76 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.282 -0.54 . . . . 10.46 110.77 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -84.76 -7.81 59.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.45 -0.341 . . . . 10.43 111.332 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.806 -0.442 . . . . 10.97 109.806 178.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 121.516 0.674 . . . . 10.09 110.913 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.85 -46.2 19.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.317 -0.856 . . . . 11.53 110.412 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -54.01 -44.75 71.19 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.0 -0.545 . . . . 11.91 110.879 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -58.28 -47.37 83.86 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.272 -0.877 . . . . 10.19 112.934 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -35.58 60.47 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.681 -0.807 . . . . 10.43 111.353 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.9 m -58.38 -47.98 82.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.095 -0.502 . . . . 10.46 110.858 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.412 HG12 ' CE1' ' A' ' 156' ' ' PHE . 47.0 mt -63.0 -49.62 82.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 O-C-N 123.353 0.408 . . . . 8.37 110.001 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -51.7 -57.07 10.27 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.953 0.783 . . . . 8.76 112.911 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -67.82 -36.43 80.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.796 0.331 . . . . 10.86 111.471 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.39 -36.26 76.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.617 -0.512 . . . . 11.62 109.617 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.37 -39.08 91.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.629 -0.878 . . . . 7.62 108.629 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.95 -45.98 92.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.138 -0.937 . . . . 11.84 110.438 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.97 -32.56 72.23 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.419 -0.355 . . . . 12.03 111.02 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -65.45 -51.51 59.67 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.892 -0.41 . . . . 9.2 109.892 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.4 tp -64.14 -42.84 96.63 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.451 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.14 91.42 Favored Glycine 0 CA--C 1.518 0.227 0 O-C-N 123.146 0.279 . . . . 12.07 113.099 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.25 -45.35 93.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.862 0.839 . . . . 12.38 109.392 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.432 HD22 ' HB ' ' A' ' 144' ' ' THR . 45.2 tp -70.02 -45.99 66.04 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.525 -1.216 . . . . 11.77 110.739 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.3 tp -72.82 -11.0 60.43 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.934 0.894 . . . . 13.52 110.948 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.0 t80 85.97 -34.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.163 1.785 . . . . 17.15 111.665 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.5 tp -165.12 149.81 9.08 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.963 -1.495 . . . . 16.03 106.963 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -86.99 122.03 71.37 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 105.876 -1.898 . . . . 14.35 105.876 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.38 -3.07 12.25 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 122.65 2.233 . . . . 14.18 111.446 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -162.65 -107.6 0.21 Allowed Glycine 0 C--N 1.291 -1.925 0 CA-C-N 114.773 -1.103 . . . . 14.05 110.701 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -155.87 43.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.199 -2.149 . . . . 16.88 105.199 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.0 mt 62.15 -178.21 0.13 Allowed 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.085 -1.416 . . . . 12.55 111.088 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -148.34 146.51 28.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.736 -1.209 . . . . 14.87 107.736 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.8 t -76.23 91.44 3.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 14.56 109.689 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.37 -92.25 0.15 Allowed Glycine 0 CA--C 1.49 -1.511 0 N-CA-C 108.43 -1.868 . . . . 14.2 108.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 68.23 128.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.336 1.454 . . . . 13.0 112.079 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.54 -176.32 3.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.608 -0.724 . . . . 17.02 109.689 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 66.9 m-85 -63.74 -27.35 69.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.532 0.682 . . . . 13.62 109.652 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.28 -25.24 65.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.736 -1.12 . . . . 16.54 111.216 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.32 -7.33 55.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.419 -0.81 . . . . 15.87 110.23 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.1 mt -106.59 9.3 31.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.473 0.654 . . . . 13.65 110.093 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.64 -175.11 15.94 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.584 -0.734 . . . . 14.16 111.774 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 84.7 mtp -107.09 -9.09 16.27 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.604 0.716 . . . . 15.81 109.979 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -118.58 159.97 22.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.292 -0.867 . . . . 13.63 108.92 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.1 p -81.4 -16.34 52.46 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.776 0.798 . . . . 14.06 109.866 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.41 -36.37 77.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.823 -1.08 . . . . 14.08 111.087 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.432 ' HB ' HD22 ' A' ' 121' ' ' LEU . 7.2 p -63.57 -42.44 98.32 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 116.159 -0.473 . . . . 11.82 110.428 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.08 -41.59 70.19 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.536 -0.756 . . . . 10.82 112.554 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.1 p -65.3 -46.64 79.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 117.082 0.441 . . . . 12.55 111.456 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -59.92 -49.53 77.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 12.17 110.389 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.583 ' O ' HG23 ' A' ' 152' ' ' VAL . 13.9 t90 -62.72 -51.83 65.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.567 -0.742 . . . . 9.45 112.121 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.483 ' SD ' HG13 ' A' ' 165' ' ' ILE . 39.6 ttm -63.79 -37.08 86.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.189 0.44 . . . . 9.88 112.189 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -69.43 -29.07 66.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.493 -0.483 . . . . 14.43 110.533 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.31 -42.47 82.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.688 -0.965 . . . . 10.49 110.688 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 148' ' ' TRP . 22.1 t -58.66 -48.31 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.76 -1.2 . . . . 9.27 107.76 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.8 t -57.71 -52.7 64.39 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.187 -1.37 . . . . 11.46 110.906 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -66.35 -44.14 84.12 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.762 -0.654 . . . . 15.5 111.94 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -65.61 -37.77 87.55 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.039 0.755 . . . . 12.39 113.039 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.412 ' CE1' HG12 ' A' ' 110' ' ' ILE . 97.3 m-85 -93.31 9.91 34.27 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.226 0.536 . . . . 11.97 111.894 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 57.39 43.21 23.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.516 1.126 . . . . 14.37 112.355 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -122.17 155.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.391 -0.596 . . . . 13.16 109.391 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -97.91 97.29 8.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.115 -0.698 . . . . 16.91 109.115 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.17 125.68 54.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.491 -0.929 . . . . 12.32 108.491 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.97 136.01 40.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.263 -0.426 . . . . 14.37 111.106 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.86 -11.46 59.99 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 121.774 0.797 . . . . 13.15 110.421 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.98 -12.03 61.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.139 0.971 . . . . 15.68 109.518 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.2 -10.22 55.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.474 -0.785 . . . . 13.1 109.967 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.483 HG13 ' SD ' ' A' ' 149' ' ' MET . 11.4 mt -56.51 -32.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.81 1.244 . . . . 12.16 109.965 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.29 -6.37 59.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.709 -1.132 . . . . 15.41 109.761 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 88.3 m -94.87 -18.34 21.25 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.052 -0.976 . . . . 15.07 109.582 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.573 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.8 m0 -117.78 98.96 52.09 Favored Pre-proline 0 C--N 1.318 -0.793 0 O-C-N 121.927 -0.483 . . . . 12.68 111.003 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.509 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 83.6 Cg_endo -87.12 3.28 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.556 2.171 . . . . 15.04 112.205 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -139.57 143.9 37.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.88 0.848 . . . . 13.26 111.655 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.36 -28.4 68.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.067 1.747 . . . . 10.32 112.949 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.31 -26.72 60.34 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.047 0.451 . . . . 12.75 110.907 -176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -67.1 -44.98 78.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 113.575 0.954 . . . . 11.26 113.575 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.32 -25.85 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.0 -1.08 . . . . 8.53 110.585 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.36 92.78 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.888 -0.596 . . . . 7.7 111.186 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.56 -26.12 32.68 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.008 -0.677 . . . . 10.38 110.61 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.573 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 9.6 tp10 -68.54 -54.13 18.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.543 -0.298 . . . . 11.97 110.802 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.02 -43.82 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 112.718 0.636 . . . . 9.8 112.718 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 -41.92 92.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.994 0.426 . . . . 10.83 111.399 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -71.87 -29.3 64.22 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.019 -0.537 . . . . 13.85 110.338 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 5.4 mmp_? -65.06 -42.74 93.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.021 -0.536 . . . . 15.46 109.946 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.62 -51.9 23.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.19 -0.459 . . . . 13.35 111.217 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 112.293 0.479 . . . . 13.51 112.293 -178.842 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.719 0.295 . . . . 14.98 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.75 -42.69 99.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.278 0.473 . . . . 15.79 112.278 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -58.09 -44.43 87.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.018 0.927 . . . . 12.18 110.01 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.32 72.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.786 -0.643 . . . . 11.02 110.887 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 27.2 tt0 -67.36 -43.82 80.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.016 -0.364 . . . . 16.75 110.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.456 ' HA ' HE21 ' A' ' 12' ' ' GLN . 30.2 t80 -53.78 -39.02 65.05 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.409 1.084 . . . . 14.46 110.933 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 mt -82.05 -39.19 23.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.777 -0.647 . . . . 10.71 110.96 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -64.01 -22.66 67.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.379 0.881 . . . . 14.51 113.379 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 45.7 mt-30 -57.3 -48.42 78.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.727 0.298 . . . . 16.85 111.568 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -75.52 -34.2 60.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.097 0.475 . . . . 13.52 110.589 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.89 -43.7 95.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.562 -0.745 . . . . 12.77 109.973 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.69 80.21 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.159 -0.928 . . . . 15.19 111.042 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.91 -44.82 30.21 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.152 -0.476 . . . . 16.26 110.845 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -70.63 -35.0 72.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.001 -0.545 . . . . 15.45 112.382 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.83 -15.68 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.531 0.681 . . . . 16.16 111.655 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 64.28 45.64 3.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.375 -1.284 . . . . 20.58 109.703 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -125.47 165.37 18.58 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.144 -1.058 . . . . 17.26 108.144 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.11 126.85 55.7 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.796 0.332 . . . . 20.19 110.736 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.413 ' O ' HG22 ' A' ' 25' ' ' ILE . 38.8 Cg_endo -65.76 -22.52 56.91 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.096 2.531 . . . . 17.46 113.387 -174.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.88 67.97 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 121.001 -0.618 . . . . 18.33 112.632 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -100.96 8.43 43.06 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.253 0.549 . . . . 20.77 111.597 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 22' ' ' PRO . 14.9 tt -85.81 119.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.876 -1.157 . . . . 16.1 107.876 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -74.96 144.17 43.32 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.744 -0.662 . . . . 19.87 110.049 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.53 -16.3 23.81 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.642 1.177 . . . . 15.1 113.914 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.2 6.53 26.95 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 121.032 -0.604 . . . . 15.48 112.264 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -71.01 148.57 47.48 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.473 0.654 . . . . 14.88 110.875 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 99.6 mtt180 -110.68 137.23 48.61 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.02 0.914 . . . . 17.38 111.978 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -47.61 -43.58 25.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.315 -1.766 . . . . 11.99 112.827 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -68.97 -29.54 67.78 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.508 -0.314 . . . . 14.71 111.406 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.72 -23.09 34.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.207 -0.664 . . . . 16.44 109.207 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.88 -39.1 66.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.451 -0.795 . . . . 13.83 109.981 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 14.26 1.05 Allowed Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.266 -0.968 . . . . 14.3 112.824 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 168.8 19.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.345 0.593 . . . . 13.04 110.408 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.4 163.08 40.57 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.234 -2.136 . . . . 15.67 105.234 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -67.03 -31.0 71.24 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 119.579 1.081 . . . . 15.49 109.565 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.36 -43.63 80.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.095 -0.502 . . . . 16.98 109.663 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.17 -33.69 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.672 -0.694 . . . . 14.44 109.944 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.92 95.47 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.814 -0.63 . . . . 12.4 109.776 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.99 -22.54 65.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.703 -0.681 . . . . 14.37 111.369 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.52 -50.83 8.93 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.253 0.549 . . . . 16.05 110.383 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -67.33 -35.68 79.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 C-N-CA 124.417 1.087 . . . . 11.7 111.662 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 48' ' ' ILE . 8.8 tp -58.63 -40.28 78.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-O 120.894 0.378 . . . . 11.48 110.377 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 41.7 ttm180 -69.01 -33.79 74.22 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.304 0.574 . . . . 17.18 110.14 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.36 -27.94 47.06 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 112.495 0.554 . . . . 14.15 112.495 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.426 HD13 HD12 ' A' ' 45' ' ' ILE . 29.7 pt -76.37 -29.54 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 119.219 -0.992 . . . . 10.8 109.032 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.13 -40.03 92.27 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-N 115.377 -0.829 . . . . 12.98 110.372 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 26.3 mtpp -65.22 -49.64 68.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.832 -0.622 . . . . 17.81 110.015 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 44.7 m80 -59.64 -43.86 93.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.551 0.945 . . . . 15.55 113.551 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -92.67 -4.79 52.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.162 1.171 . . . . 12.2 114.162 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.11 45.64 20.47 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.044 1.402 . . . . 17.4 108.891 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.6 tp -119.87 165.92 13.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.206 -1.405 . . . . 12.25 107.206 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -127.33 74.51 1.52 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.139 0.495 . . . . 16.32 109.935 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG12 ' OE1' ' A' ' 77' ' ' GLN . 58.4 mt -89.45 126.36 58.57 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.303 -0.999 . . . . 11.39 108.303 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 56' ' ' ILE . 17.6 Cg_exo -67.2 156.31 66.85 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.002 1.801 . . . . 13.44 109.084 171.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.96 -0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.434 1.272 . . . . 12.81 114.434 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.87 -12.04 60.02 Favored 'General case' 0 C--O 1.24 0.554 0 O-C-N 122.453 -0.154 . . . . 14.14 110.943 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.6 62.69 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 121.304 -0.474 . . . . 10.76 113.079 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.02 35.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.115 0.96 . . . . 11.0 108.716 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -85.42 -44.06 13.08 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.38 -0.825 . . . . 16.59 111.657 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -136.0 25.58 3.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.53 0.681 . . . . 13.72 111.434 -174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -123.34 89.92 50.76 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.73 -1.211 . . . . 12.25 107.73 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.8 Cg_endo -82.99 -3.35 11.07 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.286 1.991 . . . . 13.57 115.697 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.41 120.38 64.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 119.381 0.992 . . . . 13.28 109.347 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -61.37 -35.46 77.52 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.55 -0.75 . . . . 11.45 111.93 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.82 -29.98 69.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.523 . . . . 14.64 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.62 33.78 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.821 0.82 . . . . 11.34 109.423 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 50.7 t80 -87.82 -28.02 21.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.301 -0.863 . . . . 9.05 112.04 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 p -63.4 -36.65 84.43 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.612 -0.68 . . . . 9.65 111.723 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -75.34 -23.69 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 12.14 110.264 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.462 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 49.4 t90 -64.05 -47.89 78.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.053 -1.092 . . . . 11.26 108.053 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 90.9 t -69.22 -43.62 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 CA-C-N 115.594 -0.73 . . . . 8.3 109.235 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.76 -43.9 80.49 Favored Glycine 0 C--O 1.238 0.387 0 CA-C-N 115.491 -0.777 . . . . 9.58 113.319 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -67.58 -33.59 75.33 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.93 0.365 . . . . 10.46 111.183 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.493 ' OE1' HG12 ' A' ' 56' ' ' ILE . 3.7 pt20 -89.67 -2.37 58.27 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.767 -1.173 . . . . 10.43 112.563 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 90.6 mt . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.243 0.544 . . . . 10.97 110.07 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 107.3 -1.37 . . . . 10.09 107.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.44 -46.13 26.32 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.549 1.14 . . . . 11.53 113.555 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.91 -46.64 77.54 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.303 0.483 . . . . 11.91 112.303 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -75.43 -30.23 59.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.195 -0.298 . . . . 10.19 110.195 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.59 -46.08 91.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.003 0.521 . . . . 10.43 111.073 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 m -56.54 -38.44 71.89 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.23 0.538 . . . . 10.46 110.145 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.446 HG23 HG11 ' A' ' 178' ' ' VAL . 66.0 mt -73.59 -52.41 21.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.25 -0.887 . . . . 8.37 109.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -54.88 -43.32 73.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.736 0.814 . . . . 8.76 111.693 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.44 -40.93 93.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.088 -0.506 . . . . 10.86 110.397 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.3 -36.53 66.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.669 . . . . 11.62 109.608 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.48 -45.21 95.2 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.151 0.98 . . . . 7.62 108.406 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.83 -45.3 95.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.385 -0.825 . . . . 11.84 110.385 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -65.31 -39.41 92.45 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.142 -0.481 . . . . 12.03 111.056 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -69.08 -37.88 78.71 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.589 -0.278 . . . . 9.2 111.174 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.1 tp -65.21 -48.48 73.23 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.607 -0.516 . . . . 10.06 109.607 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.89 -49.14 77.31 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.79 -0.641 . . . . 12.07 112.148 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -61.36 -38.85 88.45 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 123.457 0.703 . . . . 12.38 111.322 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.9 tp -67.54 -43.05 81.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.977 -0.556 . . . . 11.77 110.012 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.52 -64.34 0.9 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.293 -0.867 . . . . 13.52 110.252 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.0 t80 168.02 -46.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.301 -2.111 . . . . 17.15 105.301 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -168.38 143.94 3.62 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 103.885 -2.635 . . . . 16.03 103.885 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.61 136.37 20.79 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.065 -0.717 . . . . 14.35 109.065 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.07 6.06 5.56 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.305 2.003 . . . . 14.18 112.378 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 33.76 74.6 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 110.354 -1.098 . . . . 14.05 110.354 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -102.7 20.45 17.24 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.383 1.087 . . . . 16.88 109.259 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -96.64 176.27 6.07 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.158 -0.928 . . . . 12.55 108.981 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 73.1 -58.31 0.6 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.468 1.107 . . . . 14.87 110.547 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -89.64 5.12 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.078 -1.453 . . . . 14.56 107.078 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.99 135.0 5.35 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.405 -1.478 . . . . 14.2 109.405 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.449 ' CB ' ' HG3' ' A' ' 172' ' ' LYS . . . -179.66 138.21 0.13 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.988 1.315 . . . . 13.0 107.739 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -170.01 173.9 5.78 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 118.524 -0.751 . . . . 17.02 109.879 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 55.3 m-85 -63.32 -18.87 64.08 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 119.738 1.154 . . . . 13.62 112.534 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.2 -10.08 59.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.06 -0.973 . . . . 16.54 112.373 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.258 14.3 p30 -70.46 -64.95 0.8 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.109 -0.636 . . . . 15.87 112.705 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 pp -87.3 -9.8 53.99 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.687 0.756 . . . . 13.65 109.019 173.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -83.1 70.56 3.17 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.978 -1.01 . . . . 14.16 113.701 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 92.3 mmm -109.06 -65.15 1.17 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.06 -1.459 . . . . 15.81 107.06 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.428 ' CG ' ' HG1' ' A' ' 144' ' ' THR . 5.3 p-10 -139.54 146.01 39.36 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.167 -1.79 . . . . 13.63 106.167 172.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -73.33 -16.56 61.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 113.119 0.785 . . . . 14.06 113.119 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.63 -52.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.021 -0.733 . . . . 14.08 109.021 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.428 ' HG1' ' CG ' ' A' ' 141' ' ' ASP . 40.6 p -63.82 -31.97 73.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.99 -0.55 . . . . 11.82 111.627 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.08 78.27 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.705 -1.236 . . . . 10.82 110.517 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 m -61.39 -45.33 94.82 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.761 -0.829 . . . . 12.55 108.761 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 150' ' ' ARG . 86.1 mm-40 -59.66 -41.16 89.96 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.498 -0.774 . . . . 12.17 111.514 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -65.48 -47.29 76.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.322 -0.854 . . . . 9.45 110.907 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.8 mtp -69.55 -27.35 65.07 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.291 -0.564 . . . . 9.88 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 2.7 tmm_? -59.37 -43.91 92.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.913 -1.144 . . . . 14.43 107.913 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.35 -54.3 20.8 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.364 -0.834 . . . . 10.49 111.474 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.19 -46.85 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.574 0.749 . . . . 9.27 112.385 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 p -64.54 -52.25 58.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.796 0.331 . . . . 11.46 111.864 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -71.95 -38.49 69.77 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.807 0.299 . . . . 15.5 111.807 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -68.75 -31.2 70.07 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.704 0.631 . . . . 12.39 112.704 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -101.38 1.81 38.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.992 0.425 . . . . 11.97 111.845 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 t 60.56 37.2 19.64 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.215 1.006 . . . . 14.37 111.633 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -119.89 138.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.806 -0.813 . . . . 13.16 108.806 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.95 95.66 10.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.607 0.718 . . . . 16.91 110.546 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.64 129.37 54.56 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.928 -1.138 . . . . 12.32 107.928 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.47 56.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.296 -0.631 . . . . 14.37 109.296 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.13 63.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.289 0.566 . . . . 13.15 111.208 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.81 -4.44 58.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.701 -0.682 . . . . 15.68 110.488 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -74.14 0.62 13.33 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.98 0.363 . . . . 13.1 111.98 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.8 pt -64.96 -14.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.885 0.85 . . . . 12.16 109.379 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -103.31 -3.56 25.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.093 -0.958 . . . . 15.41 109.875 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.3 m -99.42 -40.7 7.74 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.236 -0.654 . . . . 15.07 109.236 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -121.37 69.05 20.96 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.663 -0.866 . . . . 12.68 108.663 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' A' ' 135' ' ' PHE . 1.5 Cg_endo -87.12 40.92 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.988 2.458 . . . . 15.04 113.361 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 36.1 p -154.62 143.28 20.74 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 105.227 -2.138 . . . . 13.26 105.227 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.61 -17.02 64.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.356 0.502 . . . . 10.32 112.356 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.449 ' HG3' ' CB ' ' A' ' 133' ' ' ALA . 92.1 mttt -72.41 -44.24 62.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 120.824 -0.351 . . . . 12.75 110.828 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 19.1 m -63.75 -43.93 95.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 123.652 0.595 . . . . 11.26 110.186 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.5 -48.03 71.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.977 -0.556 . . . . 8.53 109.843 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.54 72.81 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.518 0.562 . . . . 7.7 112.518 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 32.8 t70 -83.25 -29.87 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.558 -0.457 . . . . 10.38 111.308 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 173' ' ' SER . 0.2 OUTLIER -57.73 -49.22 77.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.654 0.782 . . . . 11.97 109.906 -177.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.446 HG11 HG23 ' A' ' 110' ' ' ILE . 12.4 p -56.96 -35.95 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.699 -0.682 . . . . 9.8 111.556 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.1 -34.89 79.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.391 0.615 . . . . 10.83 110.314 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 88.8 mtt180 -74.27 -43.72 55.74 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.025 -0.989 . . . . 13.85 108.642 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -64.49 -40.85 96.44 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.396 -1.274 . . . . 15.46 111.192 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 178' ' ' VAL . 34.5 m -84.18 -39.47 14.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 113.196 0.813 . . . . 13.35 113.196 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 120.941 -0.304 . . . . 13.51 111.172 -179.599 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 111.89 0.33 . . . . 14.98 111.89 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.26 -35.88 80.31 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 122.652 0.381 . . . . 15.79 110.423 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.6 m -57.5 -41.57 81.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 120.847 0.356 . . . . 12.18 111.106 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -69.56 -47.39 63.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.049 -0.523 . . . . 11.02 109.633 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.08 -38.33 85.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.739 -0.664 . . . . 16.75 111.85 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.29 -46.2 74.32 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.961 0.41 . . . . 14.46 110.746 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.24 -35.53 78.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.411 -0.359 . . . . 10.71 111.793 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 85.5 mtt180 -61.97 -41.61 98.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 14.51 108.97 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -61.26 -51.18 70.0 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.058 -0.973 . . . . 16.85 110.141 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 t -56.49 -51.48 68.32 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.944 0.778 . . . . 13.52 110.838 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.62 -52.53 65.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 12.77 110.582 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.17 77.3 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.38 0.511 . . . . 15.19 112.38 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.76 78.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.69 0.281 . . . . 16.26 111.026 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 ptm -70.98 -24.5 62.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.5 -0.48 . . . . 15.45 111.865 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.36 0.7 55.69 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.028 0.381 . . . . 16.16 112.028 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 56.73 42.37 26.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.553 1.141 . . . . 20.58 111.813 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.8 m -117.84 174.53 6.13 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.984 -1.007 . . . . 17.26 109.8 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -94.76 124.37 54.95 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.575 -0.739 . . . . 20.19 110.924 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 -17.96 15.91 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.272 2.648 . . . . 17.46 113.501 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.41 43.02 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.143 -1.183 . . . . 18.33 110.143 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.7 69.7 7.73 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.542 0.687 . . . . 20.77 109.395 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.92 153.87 24.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.74 -0.663 . . . . 16.1 109.635 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.63 87.36 2.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 106.762 -1.569 . . . . 19.87 106.762 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.88 -27.57 60.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.399 1.48 . . . . 15.1 113.061 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.96 -11.79 80.77 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.234 -0.984 . . . . 15.48 112.571 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -81.92 144.94 30.59 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.388 0.613 . . . . 14.88 109.723 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 29.5 ptt180 -71.19 146.54 49.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.071 -0.968 . . . . 17.38 110.471 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -48.07 -34.46 9.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.971 1.709 . . . . 11.99 113.144 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.56 -38.24 71.65 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.228 1.011 . . . . 14.71 110.036 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.3 2.41 55.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.565 0.746 . . . . 16.44 110.927 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.6 0.83 56.73 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.113 -0.699 . . . . 13.83 109.113 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.93 11.1 50.92 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.303 -0.862 . . . . 14.3 111.95 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 175.74 5.62 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.084 0.945 . . . . 13.04 111.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -141.51 159.73 41.61 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.984 -1.916 . . . . 15.67 106.828 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -55.9 -42.98 76.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 118.947 0.794 . . . . 15.49 111.111 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.89 -51.42 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.195 -0.911 . . . . 16.98 110.577 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.22 -41.27 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.603 -0.726 . . . . 14.44 110.203 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.44 87.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 12.4 111.174 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.87 -30.42 71.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.191 0.519 . . . . 14.37 111.185 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.6 -43.92 16.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.431 0.634 . . . . 16.05 110.659 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -57.7 -44.04 85.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 124.944 1.298 . . . . 11.7 111.278 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.63 -31.1 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 121.306 -0.158 . . . . 11.48 110.987 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.49 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 1.4 mmp_? -63.1 -39.71 95.51 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.945 -0.391 . . . . 17.18 109.945 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -38.06 79.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.929 0.395 . . . . 14.15 110.356 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.8 -42.33 88.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.966 -0.753 . . . . 10.8 108.966 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' ND2' ' HB ' ' A' ' 56' ' ' ILE . 14.6 m120 -62.01 -36.26 81.0 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.59 -0.732 . . . . 12.98 111.395 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.3 -49.71 13.16 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.738 -0.21 . . . . 17.81 110.725 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -65.27 -42.38 93.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.301 -0.409 . . . . 15.55 111.759 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -85.51 -13.12 50.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.289 0.477 . . . . 12.2 112.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 57.32 38.36 28.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 17.4 109.956 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.6 tp -122.25 138.59 54.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.181 -0.918 . . . . 12.25 110.183 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -70.7 57.67 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.206 1.403 . . . . 16.32 112.573 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' HB ' ' ND2' ' A' ' 49' ' ' ASN . 11.3 mt -88.68 122.85 68.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.583 -0.698 . . . . 11.39 111.43 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -80.38 162.95 22.25 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.138 1.892 . . . . 13.44 108.765 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.31 -6.91 15.68 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.513 0.673 . . . . 12.81 110.617 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 63' ' ' THR . 33.4 t70 -60.99 -27.91 68.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.217 -1.356 . . . . 14.14 111.671 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.86 -48.97 68.97 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 119.945 -1.122 . . . . 10.76 112.776 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -76.01 -28.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.043 0.925 . . . . 11.0 109.422 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 87.3 t80 -64.21 -41.15 97.17 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.809 -1.087 . . . . 16.59 110.832 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 64' ' ' TYR . 11.4 t -94.79 -18.62 21.07 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 120.544 -0.462 . . . . 13.72 111.987 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.52 ' CD2' HG23 ' A' ' 63' ' ' THR . 96.8 m-85 -128.6 96.44 30.12 Favored Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 121.909 -0.494 . . . . 12.25 110.758 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.608 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 86.9 Cg_endo -84.64 4.27 6.97 Favored 'Trans proline' 0 C--O 1.211 -0.831 0 C-N-CA 122.363 2.042 . . . . 13.57 111.922 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.54 122.56 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.917 -1.142 . . . . 13.28 107.917 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -60.92 -40.8 94.58 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.845 0.858 . . . . 11.45 112.345 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.16 -27.4 67.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.933 0.397 . . . . 14.64 111.247 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.25 -31.6 21.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.566 0.698 . . . . 11.34 109.58 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -70.87 -30.69 67.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 9.05 111.794 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -64.09 -28.12 69.56 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.591 -0.693 . . . . 9.65 111.145 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -74.23 -24.98 59.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.709 -0.678 . . . . 12.14 109.83 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.531 ' CZ3' ' HG3' ' A' ' 77' ' ' GLN . 20.6 t90 -64.49 -49.03 72.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.616 -1.253 . . . . 11.26 107.616 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.33 -43.92 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-N 115.079 -0.964 . . . . 8.3 109.536 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.73 -40.63 95.17 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.778 -0.646 . . . . 9.58 112.347 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.2 p -77.18 -8.87 58.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.788 0.662 . . . . 10.46 112.788 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.531 ' HG3' ' CZ3' ' A' ' 73' ' ' TRP . 16.8 mm-40 -93.32 -35.35 13.1 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.051 -0.405 . . . . 10.43 110.316 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--N 1.325 -0.498 0 N-CA-C 108.707 -0.849 . . . . 10.97 108.707 175.199 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.444 -0.736 0 CA-C-O 120.999 0.428 . . . . 10.09 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.19 87.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.843 -0.617 . . . . 11.53 110.898 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.437 ' OE1' ' HB ' ' A' ' 182' ' ' VAL . 8.1 tt0 -54.25 -51.84 63.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.664 0.786 . . . . 11.91 109.08 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.35 -45.99 90.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.928 -1.033 . . . . 10.19 111.811 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.63 -39.38 91.1 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.053 0.454 . . . . 10.43 111.591 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -69.33 -51.43 37.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.014 -0.539 . . . . 10.46 110.262 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.467 HG23 HG13 ' A' ' 178' ' ' VAL . 54.6 mt -70.22 -27.02 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 116.267 -0.424 . . . . 8.37 111.456 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.21 -38.78 80.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.559 0.695 . . . . 8.76 109.551 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.76 -31.08 66.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.178 -0.919 . . . . 10.86 110.639 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -77.5 -35.86 53.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.45 -0.341 . . . . 11.62 110.465 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.8 -47.02 83.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.813 -0.81 . . . . 7.62 108.813 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -52.17 -55.22 22.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.879 -1.055 . . . . 11.84 109.835 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.5 -44.08 95.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 12.03 112.581 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 t -63.35 -44.43 94.86 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.058 0.456 . . . . 9.2 110.475 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.05 -42.99 83.86 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.36 -0.607 . . . . 10.06 109.36 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.05 -19.73 68.2 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 116.154 -0.475 . . . . 12.07 112.743 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -78.62 -38.87 38.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.201 -0.666 . . . . 12.38 109.201 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.4 tp -80.83 -45.4 16.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.705 -0.68 . . . . 11.77 110.748 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -83.03 -19.46 36.88 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.196 -0.911 . . . . 13.52 110.223 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.2 t80 73.22 -43.78 0.57 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.855 1.662 . . . . 17.15 112.209 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.5 tp -159.34 142.74 14.57 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.154 -0.684 . . . . 16.03 109.154 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.78 112.08 27.29 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.25 0.344 . . . . 14.35 110.251 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.53 -9.66 20.11 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.888 2.392 . . . . 14.18 112.336 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.13 69.01 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.582 -1.007 . . . . 14.05 110.582 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 78.27 27.17 0.53 Allowed 'General case' 0 C--O 1.247 0.955 0 C-N-CA 125.008 1.323 . . . . 16.88 110.666 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.0 mt 56.85 73.05 0.47 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.647 -1.615 . . . . 12.55 112.267 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -86.33 151.59 23.45 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.116 -1.402 . . . . 14.87 111.39 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -37.33 67.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.83 -1.077 . . . . 14.56 110.262 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.17 62.65 4.53 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 110.771 -0.931 . . . . 14.2 110.771 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.4 143.79 28.48 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.458 -0.571 . . . . 13.0 109.458 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -137.52 139.75 40.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.979 -0.748 . . . . 17.02 108.979 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 12.2 p90 -63.32 -6.87 5.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.733 0.813 . . . . 13.62 112.806 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.84 -61.05 2.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.172 0.511 . . . . 16.54 110.039 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.63 -20.98 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.087 -0.506 . . . . 15.87 110.344 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.02 14.47 15.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.932 -0.577 . . . . 13.65 111.468 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.42 60.02 4.87 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.957 -0.857 . . . . 14.16 110.957 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.03 152.21 51.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.469 -1.308 . . . . 15.81 107.469 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.25 39.87 18.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.192 0.932 . . . . 13.63 111.175 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 p -77.62 -32.81 53.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.219 -0.9 . . . . 14.06 112.138 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.1 -50.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.383 -0.969 . . . . 14.08 108.383 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -72.18 -16.14 61.96 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.34 -0.846 . . . . 11.82 111.303 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.69 -22.09 77.99 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.216 -0.754 . . . . 10.82 111.216 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 82.2 p -66.82 -45.87 76.96 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.182 -1.044 . . . . 12.55 108.182 175.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -61.75 -38.35 87.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.136 -0.938 . . . . 12.17 110.147 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.45 ' O ' HG22 ' A' ' 152' ' ' VAL . 12.4 t90 -56.09 -54.09 49.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 9.45 110.308 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 164' ' ' ALA . 43.6 ttm -66.76 -30.83 71.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.242 0.339 . . . . 9.88 111.543 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 146' ' ' THR . 23.3 mmm180 -58.4 -50.16 74.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 14.43 109.189 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.52 -44.75 96.49 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.654 -0.579 . . . . 10.49 111.654 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 148' ' ' TRP . 80.4 t -57.29 -48.67 81.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 123.208 0.603 . . . . 9.27 111.136 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.2 p -71.19 -31.14 67.27 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.816 0.341 . . . . 11.46 111.526 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.61 -44.91 63.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.027 0.441 . . . . 15.5 110.37 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -66.44 -48.2 70.74 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.791 0.663 . . . . 12.39 112.791 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -84.41 -0.24 52.01 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.171 0.434 . . . . 11.97 112.171 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.5 p 54.43 33.43 18.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.204 1.401 . . . . 14.37 112.482 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.3 pt -109.61 153.55 11.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.541 -0.754 . . . . 13.16 110.308 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.09 95.53 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.185 0.517 . . . . 16.91 110.46 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.98 120.81 26.72 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.006 -0.738 . . . . 12.32 109.006 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 134.74 38.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.903 -0.777 . . . . 14.37 108.903 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.32 -7.86 21.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.749 0.785 . . . . 13.15 111.661 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.3 -19.96 65.96 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.881 0.872 . . . . 15.68 109.711 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 167' ' ' THR . . . -59.8 -19.46 50.85 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.659 0.985 . . . . 13.1 113.659 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.5 pt -70.03 -2.31 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.764 -0.585 . . . . 12.16 111.822 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -122.53 23.69 9.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.743 0.306 . . . . 15.41 110.647 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 164' ' ' ALA . 10.3 t -147.07 20.75 1.24 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.503 -0.479 . . . . 15.07 111.088 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -134.94 103.54 10.79 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 108.552 -0.907 . . . . 12.68 108.552 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.528 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 17.2 Cg_exo -69.19 -33.09 19.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.801 2.334 . . . . 15.04 113.37 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -97.56 155.7 16.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.476 -0.784 . . . . 13.26 110.938 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -81.79 -32.28 31.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.114 -0.948 . . . . 10.32 111.876 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -78.11 -5.6 52.09 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.751 0.649 . . . . 12.75 112.751 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.8 p -54.28 -35.52 62.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.251 1.02 . . . . 11.26 112.46 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 7.3 tt -60.7 -30.79 70.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.184 0.594 . . . . 8.53 110.22 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.48 59.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.259 -0.428 . . . . 7.7 110.369 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.29 -30.22 30.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.845 -0.428 . . . . 10.38 109.845 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 5.3 mm-40 -57.25 -59.97 4.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 11.97 109.309 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.467 HG13 HG23 ' A' ' 110' ' ' ILE . 7.6 p -63.96 -37.16 79.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.595 -1.184 . . . . 9.8 111.843 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.22 -39.32 86.24 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.397 0.617 . . . . 10.83 110.441 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -74.28 -41.09 61.77 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.967 -1.015 . . . . 13.85 110.078 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 181' ' ' ARG . 3.3 mmp_? -69.18 -52.91 23.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.764 -0.653 . . . . 15.46 112.065 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.437 ' HB ' ' OE1' ' A' ' 106' ' ' GLN . 46.6 t -73.9 -65.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 13.35 109.38 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.872 1.269 . . . . 13.51 112.575 175.913 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 121.079 0.466 . . . . 14.98 111.122 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.04 -34.38 77.57 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.219 0.533 . . . . 15.79 109.628 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.5 m -60.8 -34.07 73.96 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.182 -0.917 . . . . 12.18 110.229 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.34 -48.46 70.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.702 -0.481 . . . . 11.02 109.702 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.05 -42.52 94.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.467 0.479 . . . . 16.75 111.556 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -63.83 -46.42 85.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 14.46 110.684 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.65 -48.66 59.07 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 111.769 0.285 . . . . 10.71 111.769 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.77 -16.67 63.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.959 -0.696 . . . . 14.51 111.293 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -60.84 -49.2 78.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.342 0.401 . . . . 16.85 109.987 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -79.03 -31.5 44.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.868 -0.333 . . . . 13.52 110.111 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.24 -52.9 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.815 -0.809 . . . . 12.77 108.815 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.79 -25.01 62.68 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.078 -0.51 . . . . 15.19 111.741 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.79 63.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.96 0.41 . . . . 16.26 110.88 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 mmt -85.36 -31.25 23.07 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.898 0.38 . . . . 15.45 110.981 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -96.4 -2.61 45.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.216 0.531 . . . . 16.16 111.505 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 60.16 41.07 17.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.007 1.323 . . . . 20.58 111.795 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 t -107.22 -178.92 3.78 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.032 -0.985 . . . . 17.26 108.586 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -97.72 103.08 15.1 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 123.077 0.551 . . . . 20.19 110.271 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -53.53 -40.55 78.51 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 124.26 3.307 . . . . 17.46 115.258 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.89 -11.65 85.2 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 119.971 -1.109 . . . . 18.33 114.043 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -141.77 58.42 1.49 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.241 0.83 . . . . 20.77 113.241 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.2 pt -97.15 -10.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.18 -0.608 . . . . 16.1 110.408 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 73.85 128.05 0.04 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 125.645 1.578 . . . . 19.87 110.607 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 4.4 p-10 -66.34 -23.83 66.42 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.571 1.323 . . . . 15.1 114.571 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.97 5.89 69.06 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 119.901 -1.142 . . . . 15.48 112.66 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.2 m -70.43 151.54 45.04 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 122.024 0.916 . . . . 14.88 112.951 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 48.1 mtm180 -90.12 132.68 35.3 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.08 -1.418 . . . . 17.38 111.267 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 98.5 m-85 -47.0 -52.69 14.17 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 123.741 0.651 . . . . 11.99 112.638 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' LEU . 19.5 tp -56.1 -37.97 70.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 14.71 111.323 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.73 -23.8 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.799 -0.637 . . . . 16.44 110.885 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.26 -13.42 59.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.296 0.57 . . . . 13.83 110.713 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.21 -8.45 15.9 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.762 -0.732 . . . . 14.3 111.444 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 7.4 tt -69.69 134.23 48.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.461 -0.57 . . . . 13.04 109.461 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 18.5 t70 -114.48 161.33 18.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.233 -1.025 . . . . 15.67 108.233 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 118.829 0.741 . . . . 15.49 111.131 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -70.42 -41.47 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.593 0.711 . . . . 16.98 109.501 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 62.3 mt -67.99 -28.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.001 -1.0 . . . . 14.44 110.177 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' HD22 ' A' ' 36' ' ' LEU . . . -61.14 -48.51 81.3 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.587 -0.733 . . . . 12.4 110.438 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.55 96.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.212 0.529 . . . . 14.37 110.326 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.95 -46.15 88.75 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.912 -1.04 . . . . 16.05 111.618 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -71.92 -41.76 67.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 124.748 1.219 . . . . 11.7 110.437 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mm -51.98 -46.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.634 0.774 . . . . 11.48 112.146 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.9 mtm-85 -58.35 -40.01 81.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.482 0.489 . . . . 17.18 110.617 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 51' ' ' HIS . 22.1 mt-10 -74.19 -34.66 63.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 120.145 -0.622 . . . . 14.15 112.154 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.1 mt -59.93 -46.26 94.21 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 108.866 -0.79 . . . . 10.8 108.866 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -59.84 -39.93 86.8 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 114.972 -1.013 . . . . 12.98 110.535 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -79.2 -43.44 23.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.559 0.578 . . . . 17.81 112.559 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 65.0 m170 -64.86 -44.04 91.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.454 0.538 . . . . 15.55 112.454 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -95.74 -10.77 28.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.35 0.87 . . . . 12.2 113.35 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 59.22 52.06 6.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.313 -1.366 . . . . 17.4 107.313 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.4 tp -127.55 135.96 51.04 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.645 -1.161 . . . . 12.25 110.21 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.02 69.11 3.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 16.32 110.68 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.06 119.24 74.63 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.235 -0.439 . . . . 11.39 110.311 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.45 136.44 31.18 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.103 1.869 . . . . 13.44 109.726 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.88 63.45 Favored 'General case' 0 C--O 1.245 0.868 0 C-N-CA 123.684 0.794 . . . . 12.81 112.036 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.68 -12.36 61.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.205 -0.452 . . . . 14.14 112.066 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.5 -22.87 47.04 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 123.233 0.333 . . . . 10.76 113.663 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -115.94 -1.22 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 122.827 1.299 . . . . 11.0 108.16 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -90.63 -47.74 7.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.398 -0.819 . . . . 16.59 109.541 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 t -96.24 -23.15 16.83 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.792 -0.763 . . . . 13.72 111.493 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -100.57 118.25 61.29 Favored Pre-proline 0 CA--C 1.511 -0.541 0 C-N-CA 120.421 -0.512 . . . . 12.25 109.889 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.656 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.5 Cg_endo -94.53 -1.41 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.363 2.042 . . . . 13.57 114.02 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.31 123.15 68.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.19 0.519 . . . . 13.28 109.925 -174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 89.6 t80 -64.85 -37.12 86.56 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.295 1.038 . . . . 11.45 111.311 -174.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 75.3 tttt -63.34 -39.45 94.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.529 -0.759 . . . . 14.64 111.09 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.47 72.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.135 0.493 . . . . 11.34 110.261 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -67.32 -37.51 83.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.7 -0.682 . . . . 9.05 112.638 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -64.03 -35.31 80.29 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.955 -0.698 . . . . 9.65 112.692 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.158 -0.682 . . . . 12.14 109.158 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -60.66 -38.54 85.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.395 -0.821 . . . . 11.26 109.884 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.18 -48.26 49.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.078 -0.712 . . . . 8.3 109.078 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.49 -43.36 94.09 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.345 -0.843 . . . . 9.58 113.231 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -65.73 -28.5 69.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.794 0.664 . . . . 10.46 112.794 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -85.84 -23.59 27.06 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.433 -0.507 . . . . 10.43 111.022 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 CA--C 1.504 -0.821 0 CA-C-O 121.271 0.557 . . . . 10.97 111.592 178.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 121.273 0.559 . . . . 10.09 111.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.57 -49.0 15.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.426 -0.807 . . . . 11.53 109.751 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.47 -43.76 93.17 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.661 -0.866 . . . . 11.91 108.661 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -50.25 -57.64 7.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.186 0.994 . . . . 10.19 111.409 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.14 -40.56 90.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.698 -0.228 . . . . 10.43 111.523 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 t -59.29 -51.06 71.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.661 -0.496 . . . . 10.46 109.661 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.77 -40.46 82.6 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 CA-C-N 116.369 -0.378 . . . . 8.37 110.254 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.04 -44.53 87.44 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.562 0.745 . . . . 8.76 110.602 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.98 -41.87 67.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.725 -0.671 . . . . 10.86 110.783 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -62.68 -40.48 97.22 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.455 -0.339 . . . . 11.62 111.178 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.95 -50.53 66.28 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.871 0.868 . . . . 7.62 109.791 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.8 -46.7 86.99 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.435 -1.257 . . . . 11.84 111.496 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -70.65 -45.91 64.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.184 -0.462 . . . . 12.03 111.195 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.9 t -64.69 -44.03 91.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.809 -0.632 . . . . 9.2 111.065 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.66 -39.94 80.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.127 -0.629 . . . . 10.06 109.903 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.83 -38.94 94.76 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 111.751 -0.54 . . . . 12.07 111.751 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -54.51 -47.2 73.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.335 1.054 . . . . 12.38 110.662 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -86.4 -22.87 26.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.22 0.822 . . . . 11.77 113.22 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.2 tp -84.16 -28.61 27.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.766 0.317 . . . . 13.52 110.614 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 68.69 1.18 2.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.149 1.38 . . . . 17.15 113.803 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -162.92 154.81 18.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.25 -1.389 . . . . 16.03 107.25 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.07 96.49 25.71 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 110.053 -0.351 . . . . 14.35 110.053 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -75.0 -15.61 20.65 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.486 2.124 . . . . 14.18 110.807 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.93 47.69 4.39 Favored Glycine 0 CA--C 1.497 -1.08 0 CA-C-N 114.789 -1.096 . . . . 14.05 112.661 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -121.26 12.51 11.0 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.523 -0.471 . . . . 16.88 111.967 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.4 mt -55.41 -37.11 67.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.42 1.105 . . . . 12.55 111.141 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -98.06 84.68 3.33 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.14 -1.391 . . . . 14.87 111.901 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 m 72.27 -5.22 1.82 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.845 1.424 . . . . 14.56 114.845 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 -34.53 20.68 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 119.496 -1.335 . . . . 14.2 110.559 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.86 95.9 3.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.056 0.942 . . . . 13.0 109.978 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 170' ' ' THR . 46.3 mt-30 -86.89 177.12 7.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.387 -0.968 . . . . 17.02 108.387 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 44.5 p90 -59.98 -23.16 63.4 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.167 0.894 . . . . 13.62 110.111 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.34 -29.91 70.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.888 -1.051 . . . . 16.54 110.35 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.19 -39.19 12.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.84 -0.618 . . . . 15.87 110.08 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.48 -26.86 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 13.65 111.233 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.53 5.08 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.336 -0.459 . . . . 14.16 113.512 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 72.3 mtm -74.81 -29.61 61.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 117.58 0.69 . . . . 15.81 110.594 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.56 ' OD2' HG12 ' A' ' 143' ' ' VAL . 32.6 t70 -149.21 120.5 7.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.25 0.547 . . . . 13.63 111.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 p -75.32 -25.98 58.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.943 1.09 . . . . 14.06 113.943 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 HG12 ' OD2' ' A' ' 141' ' ' ASP . 2.8 p -72.13 -34.98 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.865 -1.161 . . . . 14.08 107.865 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.8 m -60.62 -50.17 74.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.311 -1.313 . . . . 11.82 109.212 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.77 -54.55 27.62 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.613 0.571 . . . . 10.82 113.471 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 6.9 t -62.9 -45.18 93.75 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 112.648 0.61 . . . . 12.55 112.648 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -65.61 -49.31 69.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 12.17 110.951 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -63.72 -42.15 97.96 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.419 -0.809 . . . . 9.45 110.77 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' A' ' 149' ' ' MET . 0.3 OUTLIER -58.81 -54.62 45.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 9.88 111.256 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 146' ' ' THR . 13.5 ptt180 -63.79 -38.66 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.651 -0.25 . . . . 14.43 111.657 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.9 -53.48 44.87 Favored Glycine 0 N--CA 1.443 -0.853 0 O-C-N 123.531 0.519 . . . . 10.49 112.417 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.88 -41.69 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.525 0.203 . . . . 9.27 111.341 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.9 m -60.72 -54.99 38.58 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 116.172 -0.467 . . . . 11.46 111.466 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -69.31 -25.37 64.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.577 -0.738 . . . . 15.5 111.221 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -64.36 -30.77 71.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.872 -0.604 . . . . 12.39 110.878 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' SER . 69.8 m-85 -98.15 -69.69 0.75 Allowed 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.689 -0.804 . . . . 11.97 111.004 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 19.4 t 171.53 17.32 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.278 0.361 . . . . 14.37 110.998 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.5 pt -123.22 168.46 15.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 O-C-N 121.322 -0.861 . . . . 13.16 109.67 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -130.93 118.01 20.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 120.518 -0.473 . . . . 16.91 110.902 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.8 mt -118.71 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.354 -0.839 . . . . 12.32 109.514 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.51 149.28 36.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.115 -0.948 . . . . 14.37 110.147 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.12 0.968 . . . . 13.15 112.695 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.06 1.85 57.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.887 -0.597 . . . . 15.68 111.236 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.437 ' O ' HG21 ' A' ' 167' ' ' THR . . . -66.23 -18.13 65.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.545 0.572 . . . . 13.1 112.545 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . 0.282 2.6 pp -75.93 7.05 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.932 0.716 . . . . 12.16 112.932 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -98.65 -16.03 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.623 -0.717 . . . . 15.41 110.427 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 164' ' ' ALA . 15.2 t -103.34 15.95 27.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.253 -0.579 . . . . 15.07 111.765 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.559 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 13.5 m0 -123.26 119.2 27.58 Favored Pre-proline 0 CA--C 1.501 -0.915 0 O-C-N 121.902 -0.499 . . . . 12.68 110.453 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.424 ' HD2' ' OG ' ' A' ' 173' ' ' SER . 22.7 Cg_exo -63.32 -37.61 49.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.455 2.104 . . . . 15.04 110.261 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 16.5 p -144.24 169.13 18.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.746 -0.661 . . . . 13.26 110.956 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -52.68 -41.31 63.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.166 0.586 . . . . 10.32 111.875 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.86 -22.83 50.11 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.477 0.917 . . . . 12.75 113.477 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 169' ' ' PRO . 14.3 m -69.1 -26.85 65.13 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.033 0.444 . . . . 11.26 110.665 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.483 HD13 ' CH2' ' A' ' 168' ' ' TRP . 23.6 tp -66.82 -46.06 76.35 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.579 -0.897 . . . . 8.53 108.579 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.46 -28.23 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.934 -1.03 . . . . 7.7 111.273 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.72 -40.53 55.46 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.83 -0.348 . . . . 10.38 111.663 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.84 -34.58 66.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.584 0.957 . . . . 11.97 113.584 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.4 -33.66 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.282 -0.567 . . . . 9.8 110.012 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 183' ' ' GLN . 10.6 t70 -60.86 -49.93 75.47 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 109.427 -0.582 . . . . 10.83 109.427 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.6 -29.41 70.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.468 -0.787 . . . . 13.85 112.134 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -85.89 -51.48 6.36 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.193 0.442 . . . . 15.46 112.193 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.92 -36.65 45.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 120.966 0.412 . . . . 13.35 110.913 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.7 mt-30 . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 118.319 -0.848 . . . . 13.51 109.119 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 28.5 t70 . . . . . 0 C--O 1.197 -1.703 0 N-CA-C 110.191 -0.3 . . . . 14.98 110.191 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.04 -39.83 93.65 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.286 0.634 . . . . 15.79 111.142 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.6 t -65.1 -35.26 80.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.322 -0.622 . . . . 12.18 109.322 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.25 57.55 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 116.219 -0.446 . . . . 11.02 111.093 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 26.1 mt-30 -51.73 -50.23 60.99 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.767 0.827 . . . . 16.75 111.446 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -42.39 96.13 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.823 -0.351 . . . . 14.46 111.158 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.88 -37.16 70.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.9 0.381 . . . . 10.71 110.505 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -64.84 -47.43 77.98 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.201 1.001 . . . . 14.51 109.041 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.81 -46.89 83.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.064 0.946 . . . . 16.85 111.153 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -72.94 -38.7 66.68 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.228 0.455 . . . . 13.52 112.228 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.92 -46.57 88.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.692 -1.225 . . . . 12.77 107.692 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -61.7 -44.26 97.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 15.19 111.315 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.81 86.39 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.21 0.448 . . . . 16.26 112.21 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.41 -44.63 51.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.039 0.385 . . . . 15.45 112.039 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.47 -9.77 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.228 0.537 . . . . 16.16 111.986 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 t80 65.96 36.97 5.6 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.627 1.203 . . . . 20.58 108.857 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 14.6 p -107.89 163.4 13.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.736 -1.209 . . . . 17.26 107.736 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -90.92 136.58 27.43 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 120.234 -0.586 . . . . 20.19 111.506 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' O ' HG23 ' A' ' 25' ' ' ILE . 81.9 Cg_endo -74.91 6.88 3.09 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.415 2.743 . . . . 17.46 112.671 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.48 -30.51 18.74 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 111.301 -0.719 . . . . 18.33 111.301 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -94.85 47.15 1.15 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.175 0.988 . . . . 20.77 111.674 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 22' ' ' PRO . 9.1 tp -126.8 131.81 70.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.96 -1.496 . . . . 16.1 106.96 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -136.4 174.04 11.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.974 -0.103 . . . . 19.87 111.194 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 2.8 m-20 -67.52 -45.42 75.83 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.623 0.725 . . . . 15.1 111.33 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.44 7.77 74.65 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.002 -0.999 . . . . 15.48 113.998 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.9 m -59.89 144.97 47.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.292 0.567 . . . . 14.88 112.435 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.469 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 63.4 mtm180 -82.3 102.33 11.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.548 -2.019 . . . . 17.38 105.548 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' O ' HD22 ' A' ' 36' ' ' LEU . 1.3 t80 -45.55 -58.58 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.798 1.239 . . . . 11.99 114.03 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.34 -29.63 47.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.109 0.481 . . . . 14.71 111.404 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 7.1 mm-40 -68.87 -7.03 30.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 16.44 111.73 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -72.66 -5.96 41.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.233 -0.44 . . . . 13.83 111.239 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.05 11.55 4.74 Favored Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.063 -1.065 . . . . 14.3 114.128 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -115.41 152.17 33.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.898 0.849 . . . . 13.04 112.854 -177.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -126.04 167.59 15.13 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.121 -0.945 . . . . 15.67 109.475 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.3 m -38.72 -52.82 1.69 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.598 1.559 . . . . 15.49 114.71 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.8 -46.19 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.94 0.4 . . . . 16.98 111.317 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -66.16 -38.84 82.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 14.44 109.872 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.16 -42.54 96.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.406 -0.815 . . . . 12.4 110.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.11 96.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.759 . . . . 14.37 110.624 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.85 -40.13 94.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.861 -0.609 . . . . 16.05 111.45 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -67.6 -53.51 27.54 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.034 -0.985 . . . . 11.7 111.53 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 58' ' ' ALA . 7.8 tp -60.49 -29.99 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.421 0.629 . . . . 11.48 110.708 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -62.49 -28.41 69.81 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.06 -0.973 . . . . 17.18 109.417 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -86.61 -33.83 20.05 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.887 -0.597 . . . . 14.15 111.713 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.76 -46.46 96.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.495 -0.557 . . . . 10.8 109.495 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -53.11 -39.27 63.3 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.046 -0.979 . . . . 12.98 111.415 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -77.07 -57.98 3.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.93 -0.577 . . . . 17.81 111.159 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -66.94 -27.99 67.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.284 -0.871 . . . . 15.55 113.219 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -103.85 0.84 30.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.879 -0.728 . . . . 12.2 112.625 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 54.24 47.62 22.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.83 1.252 . . . . 17.4 110.522 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 56' ' ' ILE . 92.8 mt -126.4 142.19 51.62 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.218 -0.901 . . . . 12.25 110.089 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.92 36.34 1.56 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.367 -1.346 . . . . 16.32 107.367 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 54' ' ' LEU . 9.4 tt -56.55 132.69 77.36 Favored Pre-proline 0 C--O 1.244 0.812 0 CA-C-N 112.227 -2.26 . . . . 11.39 110.492 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.38 128.47 30.22 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.143 2.562 . . . . 13.44 111.957 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -71.63 -21.2 61.87 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 121.786 0.803 . . . . 12.81 110.03 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -69.04 -6.87 30.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.102 -0.954 . . . . 14.14 111.52 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' TYR . . . -63.35 -17.67 59.84 Favored Glycine 0 C--N 1.355 1.583 0 N-CA-C 112.019 -0.433 . . . . 10.76 112.019 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -99.16 -43.34 11.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.837 -1.171 . . . . 11.0 107.837 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.71 -48.9 69.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 113.816 -1.538 . . . . 16.59 112.0 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.442 HG21 ' CE2' ' A' ' 64' ' ' TYR . 10.0 t -109.63 13.47 23.82 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.464 -0.494 . . . . 13.72 111.745 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 89.4 m-85 -140.73 75.15 26.08 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 109.339 -0.615 . . . . 12.25 109.339 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.33 38.05 0.7 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.054 2.503 . . . . 13.57 113.253 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.52 120.86 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.645 -1.613 . . . . 13.28 106.645 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -58.03 -42.05 84.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.31 -0.859 . . . . 11.45 112.555 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 83.0 tttt -64.98 -46.09 82.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.764 0.316 . . . . 14.64 110.199 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.85 92.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.975 -0.557 . . . . 11.34 111.551 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.35 -33.93 58.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.183 -0.462 . . . . 9.05 111.633 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -71.2 -33.03 69.56 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.624 -0.83 . . . . 9.65 110.762 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 54.2 mt-30 -69.86 -33.6 72.48 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.888 -0.782 . . . . 12.14 108.888 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.509 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 17.6 t-105 -61.82 -49.63 75.54 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.204 -0.907 . . . . 11.26 110.19 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.2 t -63.2 -45.27 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.259 0 N-CA-C 109.913 -0.403 . . . . 8.3 109.913 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.32 -32.31 80.36 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.667 -0.697 . . . . 9.58 113.398 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 t -87.27 -12.61 46.11 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 122.213 -0.581 . . . . 10.46 110.459 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 86.1 mm-40 -88.45 -47.11 8.59 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 122.308 -0.245 . . . . 10.43 110.366 177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 74' ' ' VAL 0.265 1.2 pp . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 122.846 1.308 . . . . 10.97 112.18 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.239 0.533 0 N-CA-C 112.71 0.633 . . . . 10.09 112.71 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.67 65.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.818 -0.628 . . . . 11.53 110.813 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -80.15 -40.19 27.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.6 -0.889 . . . . 11.91 108.6 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -55.33 -40.48 71.25 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 114.991 -1.004 . . . . 10.19 111.225 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -60.32 -53.57 56.1 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.041 0.536 . . . . 10.43 110.106 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -56.88 -49.96 73.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.211 -0.904 . . . . 10.46 109.743 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.447 HG12 ' CE1' ' A' ' 156' ' ' PHE . 52.7 mt -53.35 -48.23 56.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.663 -0.699 . . . . 8.37 110.974 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -47.17 -44.36 21.91 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.448 1.099 . . . . 8.76 112.346 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 18.5 t70 -70.28 -50.42 39.68 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.738 -0.385 . . . . 10.86 111.216 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -62.77 -31.7 72.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.356 0.598 . . . . 11.62 111.558 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.5 -40.87 66.53 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.315 1.046 . . . . 7.62 109.326 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.8 -47.15 61.0 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.693 -0.685 . . . . 11.84 111.076 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 10.8 pt20 -65.44 -32.71 74.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 12.03 111.474 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 p -71.65 -35.76 70.47 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.335 -0.546 . . . . 9.2 110.604 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.28 -45.22 70.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.053 -0.721 . . . . 10.06 109.053 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 -34.03 78.85 Favored Glycine 0 C--O 1.237 0.341 0 CA-C-N 116.202 -0.453 . . . . 12.07 111.999 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.13 -50.44 68.22 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.453 0.701 . . . . 12.38 109.516 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.67 -43.61 72.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.159 -0.928 . . . . 11.77 111.638 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.06 -24.3 55.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.358 0.503 . . . . 13.52 112.358 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 67.49 2.27 2.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.208 1.003 . . . . 17.15 111.109 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -156.95 155.91 32.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.278 -0.267 . . . . 16.03 110.278 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.85 114.48 65.24 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.481 -1.303 . . . . 14.35 107.481 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.22 -20.06 21.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.976 1.784 . . . . 14.18 110.782 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.96 -104.05 0.18 Allowed Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 108.482 -1.847 . . . . 14.05 108.482 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.84 11.37 0.75 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.136 0.493 . . . . 16.88 111.799 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp 67.48 119.29 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.59 1.556 . . . . 12.55 114.456 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -162.33 -72.69 0.05 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.525 -1.216 . . . . 14.87 110.556 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -128.58 -35.21 1.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.158 0.429 . . . . 14.56 112.158 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.93 81.07 1.7 Allowed Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.965 -0.854 . . . . 14.2 110.965 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.37 59.03 1.15 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.027 0.441 . . . . 13.0 110.947 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.459 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 17.6 tp60 -72.32 136.2 46.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.734 -1.58 . . . . 17.02 106.734 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.65 -31.02 63.97 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 124.216 1.006 . . . . 13.62 111.831 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.9 -31.24 72.06 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.247 0.546 . . . . 16.54 111.488 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -82.69 -22.11 34.66 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.194 -0.457 . . . . 15.87 110.165 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 31.4 mt -93.11 -28.04 16.57 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.867 -0.606 . . . . 13.65 110.235 -176.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.61 86.41 0.06 OUTLIER Glycine 0 C--N 1.31 -0.883 0 N-CA-C 109.817 -1.313 . . . . 14.16 109.817 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptp -71.22 -18.9 62.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.09 1.144 . . . . 15.81 114.09 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.26 150.61 22.37 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 118.99 -0.529 . . . . 13.63 111.313 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -53.34 -44.66 68.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 117.858 0.299 . . . . 14.06 111.649 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.94 -48.3 88.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 111.295 0.109 . . . . 14.08 111.295 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 p -60.22 -38.51 83.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.466 0.543 . . . . 11.82 112.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.79 22.97 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.783 -1.198 . . . . 10.82 111.897 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.6 m -65.02 -32.6 74.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.374 0.269 . . . . 12.55 110.851 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.97 -49.55 76.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.557 . . . . 12.17 109.926 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -71.76 -34.81 69.79 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.517 -0.765 . . . . 9.45 111.142 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -45.59 92.65 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.469 -1.308 . . . . 9.88 107.469 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 154' ' ' ARG . 69.9 ttt180 -63.82 -43.03 97.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.861 -1.063 . . . . 14.43 109.659 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.09 -49.22 68.79 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 115.638 -0.71 . . . . 10.49 113.296 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.57 -37.45 74.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 117.267 0.534 . . . . 9.27 111.807 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.7 m -59.83 -43.84 94.35 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.955 0.159 . . . . 11.46 110.957 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 28.6 mtm180 -63.38 -45.36 91.45 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.561 -0.291 . . . . 15.5 110.624 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -53.97 -43.12 69.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.595 0.961 . . . . 12.39 113.595 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.447 ' CE1' HG12 ' A' ' 110' ' ' ILE . 79.2 m-85 -102.97 4.89 37.94 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.238 -0.585 . . . . 11.97 111.681 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.5 m 53.95 44.06 29.94 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.237 1.015 . . . . 14.37 111.339 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.95 161.55 15.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.316 -0.856 . . . . 13.16 108.773 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -113.25 96.75 6.08 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.978 0.418 . . . . 16.91 110.34 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.49 149.51 27.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.649 -0.871 . . . . 12.32 108.649 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.33 134.99 42.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.713 -0.676 . . . . 14.37 111.926 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.75 -22.2 62.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 13.15 110.103 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.06 -17.55 61.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.55 -0.75 . . . . 15.68 110.194 175.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.54 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -72.7 -3.2 23.68 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 112.654 0.612 . . . . 13.1 112.654 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.5 pt -68.27 -13.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.748 0.785 . . . . 12.16 109.298 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -111.2 3.79 18.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.29 -0.868 . . . . 15.41 109.357 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 56.9 m -97.25 -38.55 9.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 15.07 108.66 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.5 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.2 m0 -102.32 115.58 64.29 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.784 -0.644 . . . . 12.68 109.631 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.29 -30.36 3.41 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.28 1.987 . . . . 15.04 113.185 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.9 p -128.99 170.89 12.91 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 109.585 -0.524 . . . . 13.26 109.585 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.42 -22.65 66.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.444 -0.344 . . . . 10.32 111.061 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -61.79 -44.47 96.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.158 0.504 . . . . 12.75 110.423 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 5.7 m -61.02 -37.05 81.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.268 -0.878 . . . . 11.26 110.466 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.84 -42.25 58.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.191 -0.459 . . . . 8.53 110.558 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.09 83.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 7.7 111.639 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 20.4 m-20 -79.27 -33.75 43.19 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.411 -0.516 . . . . 10.38 110.653 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.5 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 7.4 tp10 -61.69 -50.45 72.43 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.136 -0.483 . . . . 11.97 111.012 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 -41.69 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.729 -0.669 . . . . 9.8 111.086 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.67 -41.51 97.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.791 0.436 . . . . 10.83 110.478 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 5.0 mmp_? -68.82 -31.33 70.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.638 -0.71 . . . . 13.85 111.089 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -78.09 -37.68 45.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.144 -0.48 . . . . 15.46 109.99 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.71 -59.85 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.931 -0.577 . . . . 13.35 109.661 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.135 0.897 . . . . 13.51 110.998 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 112.987 0.736 . . . . 14.98 112.987 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.92 -32.71 69.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.369 0.507 . . . . 15.79 112.369 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.487 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 28.9 p -63.83 -37.32 86.94 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 120.103 -0.639 . . . . 12.18 110.441 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 -20.23 61.9 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.088 -0.506 . . . . 11.02 110.259 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.34 -53.08 6.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.995 -0.743 . . . . 16.75 108.995 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.71 -50.18 70.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 115.319 -0.855 . . . . 14.46 112.9 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.6 mt -71.76 -25.7 62.14 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.263 -0.575 . . . . 10.71 111.395 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -70.33 -40.44 74.15 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.041 -0.726 . . . . 14.51 109.041 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -65.63 -44.62 85.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.323 -0.853 . . . . 16.85 109.366 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 t -64.63 -33.77 76.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.742 -0.663 . . . . 13.52 110.693 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.22 -53.31 51.22 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.929 -1.137 . . . . 12.77 107.929 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' CYS . . . -65.37 -33.64 76.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.872 -1.058 . . . . 15.19 111.541 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.84 -33.88 75.64 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.436 0.532 . . . . 16.26 112.436 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' HA ' ' A' ' 44' ' ' TRP . 44.3 mtt -81.27 -21.86 39.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.923 -0.711 . . . . 15.45 111.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 84.2 mt -98.71 -7.34 27.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.175 0.512 . . . . 16.16 110.814 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 64.72 43.67 4.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.224 1.41 . . . . 20.58 111.742 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 6.6 p -126.83 169.91 12.74 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.637 -0.71 . . . . 17.26 111.182 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.09 127.67 78.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 123.061 0.544 . . . . 20.19 111.68 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.5 -9.9 24.19 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.045 2.496 . . . . 17.46 112.314 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.9 -36.18 65.36 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.263 -1.135 . . . . 18.33 110.263 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -83.11 -37.57 23.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.997 -0.742 . . . . 20.77 108.997 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mm -76.38 92.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.828 -1.175 . . . . 16.1 107.828 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.71 155.77 26.59 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.036 -0.984 . . . . 19.87 110.291 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.35 -17.74 64.87 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 114.396 -1.275 . . . . 15.1 111.87 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.52 6.93 39.06 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 120.89 -0.672 . . . . 15.48 112.79 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -68.97 160.81 30.19 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.851 0.834 . . . . 14.88 113.092 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 18.7 ttm180 -97.45 112.46 24.29 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.524 -1.216 . . . . 17.38 109.738 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -39.03 -60.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.831 1.252 . . . . 11.99 113.877 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.63 -32.8 72.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 14.71 111.729 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.64 -17.27 60.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.786 0.803 . . . . 16.44 110.729 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.56 8.31 17.1 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.151 -0.477 . . . . 13.83 111.557 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.21 31.2 12.18 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.813 -0.915 . . . . 14.3 110.813 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.482 HD21 ' HB1' ' A' ' 41' ' ' ALA . 6.5 tt -108.8 135.67 49.64 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.81 -0.811 . . . . 13.04 108.81 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -123.2 164.02 19.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.572 -1.27 . . . . 15.67 107.572 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -49.54 -41.74 42.13 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.609 0.64 . . . . 15.49 111.756 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.57 -49.39 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.928 -0.578 . . . . 16.98 110.675 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.04 -35.72 75.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.996 -0.547 . . . . 14.44 110.438 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.485 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -60.38 -46.81 88.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 12.4 111.395 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.16 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.316 0.579 . . . . 14.37 110.999 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.14 -40.02 71.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.745 -0.661 . . . . 16.05 111.076 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.429 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 9.2 t90 -57.78 -45.53 85.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 124.278 1.031 . . . . 11.7 110.09 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 41' ' ' ALA . 40.3 mm -54.96 -39.34 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 114.935 -1.029 . . . . 11.48 110.072 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -57.43 -35.45 70.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.36 -0.836 . . . . 17.18 111.668 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 51' ' ' HIS . 24.5 tt0 -85.09 -35.72 21.63 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.037 -0.665 . . . . 14.15 110.787 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 45' ' ' ILE . 19.5 pt -68.57 -30.28 46.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 119.912 -0.715 . . . . 10.8 110.83 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.597 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 6.1 m-20 -63.69 -27.31 69.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.334 -0.848 . . . . 12.98 110.498 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -79.96 -46.32 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.177 -0.675 . . . . 17.81 109.177 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 20.8 m-70 -51.58 -56.56 12.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.303 -0.862 . . . . 15.55 112.899 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.487 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 97.0 m-85 -107.18 16.51 24.0 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.471 0.545 . . . . 12.2 112.471 -173.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 42.91 42.94 3.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.655 1.182 . . . . 17.4 112.523 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.24 140.57 52.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.831 -0.622 . . . . 12.25 109.325 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -81.19 72.05 8.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.253 -0.43 . . . . 16.32 110.216 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.597 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 18.2 mm -61.47 125.37 84.22 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-N 115.947 -0.57 . . . . 11.39 111.564 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 59.1 Cg_endo -77.27 125.82 8.05 Favored 'Trans proline' 0 N--CA 1.434 -1.985 0 C-N-CA 121.938 1.759 . . . . 13.44 108.671 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.51 -19.79 40.4 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.926 0.713 . . . . 12.81 112.926 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 57' ' ' PRO . 3.0 p30 -62.64 -16.76 58.37 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.171 0.804 . . . . 14.14 113.171 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.23 78.71 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 120.847 -0.692 . . . . 10.76 114.566 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.45 -34.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.496 0.665 . . . . 11.0 111.55 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -73.55 -28.0 61.63 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.202 -0.666 . . . . 16.59 109.202 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 m -83.13 -43.52 16.12 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.229 -0.896 . . . . 13.72 110.078 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.2 94.31 48.04 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.278 -0.419 . . . . 12.25 110.31 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 93.7 Cg_endo -83.65 4.34 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.62 2.214 . . . . 13.57 112.705 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.38 120.61 62.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.642 -1.614 . . . . 13.28 106.642 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -56.09 -44.69 79.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.835 -1.075 . . . . 11.45 113.488 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -71.71 -21.33 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.442 0.639 . . . . 14.64 110.784 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.91 -31.7 22.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.662 0.744 . . . . 11.34 109.348 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 48.3 t80 -71.85 -34.11 68.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.388 -0.824 . . . . 9.05 111.455 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 p -65.03 -24.32 67.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.141 0.496 . . . . 9.65 111.569 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -74.06 -39.76 63.27 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.175 -1.046 . . . . 12.14 108.175 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 59.7 t90 -59.83 -45.91 90.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.583 -1.19 . . . . 11.26 109.246 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.91 -45.38 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 8.3 109.966 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.83 84.96 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.603 -0.726 . . . . 9.58 114.365 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -71.68 -16.4 62.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 10.46 112.452 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -93.29 -26.48 17.3 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.39 -0.368 . . . . 10.43 110.489 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.516 -0.363 0 CA-C-N 115.943 -0.571 . . . . 10.97 109.915 178.086 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.433 -1.31 0 N-CA-C 108.442 -0.948 . . . . 10.09 108.442 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.72 -28.66 70.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.173 -0.921 . . . . 11.53 112.725 -174.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.475 ' O ' HG13 ' A' ' 110' ' ' ILE . 48.3 tp60 -61.03 -20.92 63.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.027 0.531 . . . . 11.91 111.592 -176.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.489 HH21 ' NE2' ' A' ' 183' ' ' GLN . 10.8 mpt_? -75.05 -31.08 61.2 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.844 0.312 . . . . 10.19 111.844 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 40.1 tt0 -71.88 -43.69 65.0 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.132 0.491 . . . . 10.43 109.984 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -62.48 -21.53 65.54 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.998 -0.546 . . . . 10.46 111.812 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.54 HG12 ' CZ ' ' A' ' 156' ' ' PHE . 55.3 mt -67.07 -54.68 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 108.704 -0.85 . . . . 8.37 108.704 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 13.7 pt20 -64.37 -29.31 70.38 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.937 -0.574 . . . . 8.76 111.751 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.66 -52.2 64.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.618 -0.512 . . . . 10.86 109.618 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -69.41 -37.4 77.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 11.62 110.489 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.28 -42.27 98.36 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.526 -0.916 . . . . 7.62 108.526 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.1 -47.2 87.38 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.596 -0.729 . . . . 11.84 109.404 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.05 -50.37 72.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 12.03 111.705 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.5 m -69.14 -30.45 68.7 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.717 0.266 . . . . 9.2 111.717 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 47.7 tp -68.96 -49.23 59.8 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 108.707 -0.849 . . . . 10.06 108.707 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.32 -22.03 68.93 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.707 -0.759 . . . . 12.07 112.534 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.08 -52.8 8.2 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 122.538 -0.389 . . . . 12.38 110.756 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.56 -18.11 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.732 0.641 . . . . 11.77 112.732 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 118' ' ' LEU . 4.4 mm? -113.42 3.01 15.63 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.035 0.445 . . . . 13.52 110.83 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 70.45 -29.8 0.19 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 17.15 115.596 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.8 tp -136.0 148.76 48.56 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.593 -0.692 . . . . 16.03 111.365 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -84.44 124.25 73.79 Favored Pre-proline 0 CA--C 1.505 -0.784 0 N-CA-C 107.148 -1.427 . . . . 14.35 107.148 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.17 -16.31 12.38 Favored 'Trans proline' 0 C--N 1.33 -0.446 0 C-N-CA 121.848 1.699 . . . . 14.18 113.08 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.15 6.65 87.66 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 110.575 -1.01 . . . . 14.05 110.575 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -99.72 33.22 2.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.666 0.746 . . . . 16.88 110.603 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 68.2 mt -73.34 103.37 4.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.881 -1.054 . . . . 12.55 108.539 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 79.23 1.27 2.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.214 1.406 . . . . 14.87 111.424 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -89.04 -25.35 22.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.604 0.716 . . . . 14.56 109.338 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 157.49 -91.8 0.12 Allowed Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.248 -1.141 . . . . 14.2 110.248 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 63.45 90.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.862 1.265 . . . . 13.0 112.092 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -97.49 136.56 37.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.721 -0.844 . . . . 17.02 108.721 175.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -47.55 -36.45 10.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.21 1.404 . . . . 13.62 114.063 -170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.29 -40.65 96.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.954 0.502 . . . . 16.54 110.926 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.48 -35.27 75.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.009 -0.541 . . . . 15.87 110.434 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.98 -19.52 61.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 13.65 112.076 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.87 20.48 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.439 -1.065 . . . . 14.16 110.439 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.7 ttm -85.98 129.03 34.96 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.547 -0.908 . . . . 15.81 108.547 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.03 176.09 6.93 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.136 -1.061 . . . . 13.63 108.136 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.871 ' HB3' ' HH ' ' A' ' 166' ' ' TYR . 38.6 m -73.73 -48.06 34.72 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.4 -0.92 . . . . 14.06 109.697 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.19 -48.08 88.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 112.012 0.375 . . . . 14.08 112.012 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 p -67.6 -33.93 75.99 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.913 0.387 . . . . 11.82 111.757 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 -25.5 61.86 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 119.971 -1.109 . . . . 10.82 111.116 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.3 m -64.91 -48.34 74.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 12.55 108.705 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -57.13 -53.59 56.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.891 -1.05 . . . . 12.17 109.993 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -53.0 -53.98 42.01 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 9.45 112.743 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.424 ' HA ' ' HE2' ' A' ' 149' ' ' MET . 3.5 tpt -54.76 -54.08 46.66 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.153 0.581 . . . . 9.88 111.425 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -64.62 -37.23 86.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.966 0.413 . . . . 14.43 110.185 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.38 27.89 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.473 -0.785 . . . . 10.49 112.649 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.88 -42.79 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.512 0.325 . . . . 9.27 111.007 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 25.3 m -58.5 -57.15 14.2 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.837 -0.62 . . . . 11.46 110.847 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -64.2 -35.62 81.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.637 -0.71 . . . . 15.5 111.352 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -76.59 -14.84 59.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.036 0.384 . . . . 12.39 112.036 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.54 ' CZ ' HG12 ' A' ' 110' ' ' ILE . 86.1 t80 -95.68 -70.31 0.72 Allowed 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 119.132 -1.027 . . . . 11.97 111.081 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.9 m -178.74 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.79 0.436 . . . . 14.37 112.138 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 27.7 pt -98.84 142.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.268 0.556 . . . . 13.16 111.796 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -91.78 95.75 10.03 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.748 0.785 . . . . 16.91 109.632 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 87.2 mt -101.01 151.23 22.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.288 -0.869 . . . . 12.32 109.25 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.91 45.81 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.393 -1.276 . . . . 14.37 108.763 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.17 -21.18 66.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.444 0.64 . . . . 13.15 110.204 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -82.08 2.94 28.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 15.68 111.009 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.72 61.17 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.905 -0.497 . . . . 13.1 111.685 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.4 pt -67.38 -10.97 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.261 0.553 . . . . 12.16 110.446 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.871 ' HH ' ' HB3' ' A' ' 142' ' ' SER . 27.3 m-85 -106.57 -1.47 22.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 15.41 109.164 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -89.22 -47.0 8.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.106 -0.701 . . . . 15.07 109.106 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.34 141.09 24.79 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 109.223 -0.658 . . . . 12.68 109.223 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 40.5 Cg_endo -97.21 2.26 1.66 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.377 2.051 . . . . 15.04 114.429 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -120.13 144.34 47.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.455 0.909 . . . . 13.26 113.455 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.48 -30.39 71.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.303 -1.317 . . . . 10.32 112.339 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -58.37 -40.1 81.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.534 -0.757 . . . . 12.75 110.674 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -39.59 93.13 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.319 -0.855 . . . . 11.26 110.844 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.55 -50.38 65.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.216 -1.031 . . . . 8.53 108.216 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.04 -32.32 69.65 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.754 0.65 . . . . 7.7 112.754 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.48 -34.2 31.5 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.523 -0.471 . . . . 10.38 111.033 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.98 -47.42 68.61 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.963 0.905 . . . . 11.97 110.118 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.428 HG11 HG23 ' A' ' 110' ' ' ILE . 12.4 p -57.21 -44.29 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.309 -0.86 . . . . 9.8 112.277 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -57.51 -39.45 76.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.023 0.44 . . . . 10.83 111.627 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -80.92 -23.84 38.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.836 -0.62 . . . . 13.85 110.678 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -84.2 -38.67 20.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 15.46 110.276 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.59 -41.78 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.843 -0.617 . . . . 13.35 111.604 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.489 ' NE2' HH21 ' A' ' 107' ' ' ARG . 10.3 pt20 . . . . . 0 N--CA 1.434 -1.229 0 C-N-CA 120.586 -0.446 . . . . 13.51 111.271 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 111.42 0.156 . . . . 14.98 111.42 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.47 -49.27 62.1 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.021 0.928 . . . . 15.79 112.154 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' A' ' 74' ' ' VAL . 52.6 t -61.46 -48.06 82.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 123.467 0.48 . . . . 12.18 111.535 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.7 92.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.614 -0.267 . . . . 11.02 110.759 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -61.72 -46.52 89.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 123.291 0.369 . . . . 16.75 111.378 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.487 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 77.8 t80 -67.96 -33.52 74.81 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.597 -0.274 . . . . 14.46 110.753 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.93 -40.73 75.36 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 120.354 -0.538 . . . . 10.71 110.229 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -59.4 -45.39 91.61 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.795 -0.446 . . . . 14.51 109.795 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.5 -54.47 46.5 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.488 1.115 . . . . 16.85 111.455 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.7 p -68.18 -35.32 77.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.215 -0.448 . . . . 13.52 111.238 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.13 -52.56 62.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 12.77 108.609 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.04 91.06 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.978 -0.555 . . . . 15.19 111.125 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -49.23 71.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.455 0.539 . . . . 16.26 112.455 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.8 mmm -76.66 -36.79 57.13 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.743 0.646 . . . . 15.45 112.743 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.84 -5.83 58.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.989 0.424 . . . . 16.16 111.71 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 61.04 39.51 16.23 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.767 1.27 . . . . 20.58 110.614 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 t -111.79 -173.56 2.27 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 113.135 -1.848 . . . . 17.26 107.553 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.0 136.92 29.16 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.847 -0.797 . . . . 20.19 108.847 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.1 -19.96 19.65 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.68 2.253 . . . . 17.46 113.182 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.65 -45.42 4.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.704 -0.958 . . . . 18.33 110.704 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.46 75.03 9.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.351 0.596 . . . . 20.77 110.748 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -147.54 144.96 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.744 -0.835 . . . . 16.1 108.744 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -88.42 131.23 34.95 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 107.536 -1.283 . . . . 19.87 107.536 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.58 -15.89 63.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 112.381 0.512 . . . . 15.1 112.381 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.21 7.67 54.67 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-N 116.154 -0.476 . . . . 15.48 112.019 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 p -69.0 133.42 48.11 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.817 0.818 . . . . 14.88 111.324 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 16.5 mtp180 -84.05 140.63 31.71 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.92 -1.037 . . . . 17.38 110.371 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 76.3 m-85 -43.75 -48.35 8.03 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 113.617 0.969 . . . . 11.99 113.617 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.87 -15.15 63.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.217 0.451 . . . . 14.71 112.217 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.1 -39.03 9.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.211 -1.403 . . . . 16.44 107.211 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.2 tp -61.02 -29.17 69.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.058 -1.883 . . . . 13.83 111.581 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.05 6.93 1.39 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.273 -1.441 . . . . 14.3 113.924 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.61 151.42 24.51 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 119.133 -1.027 . . . . 13.04 112.667 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.47 159.89 42.0 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 112.375 -2.193 . . . . 15.67 105.709 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -50.51 -48.52 56.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.821 1.045 . . . . 15.49 113.821 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.29 -46.89 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.479 0.657 . . . . 16.98 110.613 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.35 -37.87 72.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.011 -0.54 . . . . 14.44 110.363 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 -42.19 84.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.607 -0.724 . . . . 12.4 110.19 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.02 84.7 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.247 -0.888 . . . . 14.37 110.93 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.66 -47.74 74.51 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.415 -0.812 . . . . 16.05 110.88 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -66.03 -52.1 52.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.874 1.269 . . . . 11.7 111.818 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.24 -37.16 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.297 0.48 . . . . 11.48 112.297 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -66.39 -40.37 89.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.517 -0.473 . . . . 17.18 110.13 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.48 -24.6 64.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 111.828 0.307 . . . . 14.15 111.828 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.2 -55.72 17.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.29 -0.633 . . . . 10.8 109.29 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 3.3 m-20 -63.31 -34.5 77.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 12.98 112.156 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.43 -47.29 17.83 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.476 -0.329 . . . . 17.81 111.857 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -70.66 -40.29 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 112.822 0.675 . . . . 15.55 112.822 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 9' ' ' PHE . 81.2 m-85 -91.42 -8.13 48.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.786 -0.765 . . . . 12.2 113.02 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 53.98 41.46 32.02 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.959 1.304 . . . . 17.4 109.486 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 tp -115.87 143.47 45.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.737 -0.665 . . . . 12.25 110.942 -170.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -69.76 76.06 0.44 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.491 -0.777 . . . . 16.32 110.861 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.439 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 21.7 mm -98.66 113.86 64.77 Favored Pre-proline 0 C--N 1.316 -0.881 0 O-C-N 121.8 -0.563 . . . . 11.39 110.566 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.6 140.46 93.87 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.478 2.119 . . . . 13.44 109.91 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.89 2.33 1.48 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.289 0.848 . . . . 12.81 113.289 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.4 0.03 41.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 118.961 -0.542 . . . . 14.14 112.163 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.708 ' HA2' ' CZ3' ' A' ' 73' ' ' TRP . . . -43.73 -60.92 3.15 Favored Glycine 0 C--N 1.356 1.667 0 N-CA-C 114.758 0.663 . . . . 10.76 114.758 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.92 -21.7 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.889 1.276 . . . . 11.0 112.019 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -93.33 -40.38 10.44 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.209 -0.451 . . . . 16.59 111.064 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.4 m -73.86 -40.38 63.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.396 -0.366 . . . . 13.72 110.956 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -112.56 103.1 55.35 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.098 -1.075 . . . . 12.25 108.098 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 95.8 Cg_endo -79.55 -0.27 10.58 Favored 'Trans proline' 0 C--O 1.209 -0.949 0 C-N-CA 122.311 2.007 . . . . 13.57 112.529 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.59 119.86 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.757 -1.572 . . . . 13.28 106.757 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 21.9 p90 -57.12 -36.48 70.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.411 0.684 . . . . 11.45 112.529 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -63.77 -31.03 72.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.519 0.727 . . . . 14.64 110.424 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.05 26.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.103 0.478 . . . . 11.34 110.262 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 46.1 t80 -77.39 -30.57 53.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.934 -0.575 . . . . 9.05 111.343 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p -67.26 -24.57 65.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.59 0.71 . . . . 9.65 110.309 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -76.93 -28.66 55.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.608 -0.724 . . . . 12.14 109.404 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.708 ' CZ3' ' HA2' ' A' ' 60' ' ' GLY . 1.6 t90 -56.86 -55.24 36.98 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 108.56 -0.904 . . . . 11.26 108.56 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' SG ' ' A' ' 6' ' ' CYS . 71.5 t -65.8 -43.61 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 CA-C-N 115.132 -0.94 . . . . 8.3 110.188 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.01 -34.67 73.23 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.615 0.572 . . . . 9.58 112.459 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.5 m -72.91 -37.28 67.3 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 122.926 0.49 . . . . 10.46 111.377 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.72 -14.73 60.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.384 . . . . 10.43 112.038 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.943 -1.132 . . . . 10.97 107.943 174.298 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 121.525 0.679 . . . . 10.09 109.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.56 -49.2 73.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.947 1.299 . . . . 11.53 112.689 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt-30 -58.95 -58.65 7.71 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.24 0.337 . . . . 11.91 110.277 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 60.0 ttp180 -55.76 -50.33 70.71 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.877 0.736 . . . . 10.19 111.71 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.15 -41.06 95.1 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.349 0.406 . . . . 10.43 111.973 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -70.39 -42.54 71.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.323 -0.551 . . . . 10.46 111.185 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 106' ' ' GLN . 92.4 mt -58.76 -52.96 53.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.944 0 N-CA-C 109.322 -0.621 . . . . 8.37 109.322 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -49.31 -49.0 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.353 1.033 . . . . 8.76 112.688 -175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 34.2 t70 -68.0 -44.82 75.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.81 -0.356 . . . . 10.86 111.872 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -70.16 -35.26 73.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.069 0.396 . . . . 11.62 112.069 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.86 -41.34 97.81 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.724 0.809 . . . . 7.62 109.464 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -61.56 -46.43 89.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 11.84 109.219 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 27.7 mt-30 -57.88 -49.88 75.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.02 -0.536 . . . . 12.03 110.8 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -57.24 -45.3 84.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 124.183 0.927 . . . . 9.2 110.97 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.06 -49.9 75.82 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.972 0.17 . . . . 10.06 110.962 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.94 97.83 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 121.252 -0.499 . . . . 12.07 112.129 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.99 -45.94 91.41 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.316 1.046 . . . . 12.38 111.131 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 148' ' ' TRP . 26.9 tp -72.29 -43.93 63.5 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.137 -0.938 . . . . 11.77 111.26 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.9 tp -82.25 -11.72 58.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.792 -0.64 . . . . 13.52 111.619 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 66.89 32.81 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.525 1.13 . . . . 17.15 109.845 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 tp -99.54 140.21 34.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.117 -0.947 . . . . 16.03 108.609 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.11 124.72 86.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 108.744 -0.835 . . . . 14.35 108.744 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.18 -17.91 27.53 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.36 2.707 . . . . 14.18 114.029 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -75.04 -13.71 82.44 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 120.47 -0.872 . . . . 14.05 111.672 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -86.4 -21.56 27.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.312 -0.625 . . . . 16.88 109.312 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.28 69.9 5.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.127 -0.942 . . . . 12.55 110.606 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -160.37 -61.15 0.06 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.312 -1.736 . . . . 14.87 106.312 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.4 m -83.78 -31.84 25.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.974 -0.75 . . . . 14.56 108.974 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.81 1.04 Allowed Glycine 0 C--O 1.215 -1.067 0 N-CA-C 110.786 -0.925 . . . . 14.2 110.786 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.72 34.6 2.93 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.297 -1.371 . . . . 13.0 107.297 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.47 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.5 tt0 -123.25 123.68 41.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.522 -1.672 . . . . 17.02 108.071 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -57.9 -35.72 71.42 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 124.107 0.963 . . . . 13.62 110.344 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.74 -28.61 66.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.103 -0.953 . . . . 16.54 111.277 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -25.66 28.01 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.766 0.793 . . . . 15.87 110.469 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 79.5 mt -79.19 -11.06 59.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.31 -0.859 . . . . 13.65 111.011 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.07 -135.08 9.81 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.918 -1.673 . . . . 14.16 108.918 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.557 ' SD ' HD11 ' A' ' 165' ' ' ILE . 43.3 tpp -176.41 92.08 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.145 -0.687 . . . . 15.81 109.145 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -134.38 126.39 29.5 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.029 0.442 . . . . 13.63 111.211 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.0 m -80.41 -21.84 41.85 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.733 -0.667 . . . . 14.06 111.646 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.0 -58.64 6.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 120.464 0.173 . . . . 14.08 111.124 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.5 t -71.82 -28.96 63.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.414 -0.587 . . . . 11.82 109.414 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.16 -43.95 88.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.427 -0.806 . . . . 10.82 112.601 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -62.81 -45.34 93.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.59 -0.522 . . . . 12.55 109.59 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.91 -49.97 74.07 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.568 -0.742 . . . . 12.17 111.372 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.477 ' O ' HG21 ' A' ' 152' ' ' VAL . 19.4 t90 -63.89 -51.52 64.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.815 -0.63 . . . . 9.45 111.431 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 161' ' ' ALA . 42.0 tpp -63.61 -40.76 97.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.03 0.206 . . . . 9.88 110.959 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -60.45 -41.82 94.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.61 -0.515 . . . . 14.43 109.61 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.83 -45.91 95.23 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.757 -0.656 . . . . 10.49 111.82 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 148' ' ' TRP . 56.0 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.832 -0.433 . . . . 9.27 109.832 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 23.8 m -61.63 -51.68 67.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 11.46 110.8 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -65.01 -40.1 94.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.604 -0.725 . . . . 15.5 111.151 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -55.89 -46.64 78.28 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.424 0.69 . . . . 12.39 111.117 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -101.54 11.58 38.76 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.73 -0.388 . . . . 11.97 111.929 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 p 51.4 50.72 18.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.831 1.252 . . . . 14.37 113.107 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.3 pt -127.62 167.42 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.812 -0.631 . . . . 13.16 109.575 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -102.85 111.83 24.34 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.433 -0.348 . . . . 16.91 110.941 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 85.7 mt -129.98 154.28 47.54 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 106.886 -1.524 . . . . 12.32 106.886 173.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -95.59 138.89 32.63 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.467 0.651 . . . . 14.37 110.825 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.21 -24.09 66.55 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.265 -0.879 . . . . 13.15 111.726 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.59 17.82 6.03 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.007 0.432 . . . . 15.68 110.489 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.93 -3.76 27.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.205 0.817 . . . . 13.1 113.205 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.557 HD11 ' SD ' ' A' ' 140' ' ' MET . 26.0 pt -67.93 -12.34 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.628 0.728 . . . . 12.16 110.211 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -108.39 -2.21 19.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.862 -1.063 . . . . 15.41 108.72 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.9 m -101.97 -45.19 5.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.589 -0.732 . . . . 15.07 110.252 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.547 ' CZ3' HD12 ' A' ' 174' ' ' LEU . 5.3 m0 -111.7 118.24 47.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.433 -0.951 . . . . 12.68 108.433 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.11 -29.86 9.44 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.22 1.947 . . . . 15.04 112.261 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 24.2 p -134.58 153.91 51.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.551 0.691 . . . . 13.26 110.321 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -14.5 51.54 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.078 -0.965 . . . . 10.32 113.233 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -43.39 92.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.171 -0.677 . . . . 12.75 109.171 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.5 m -62.68 -41.73 99.24 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.133 -0.939 . . . . 11.26 110.365 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.547 HD12 ' CZ3' ' A' ' 168' ' ' TRP . 36.3 tp -68.89 -43.94 74.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.313 -0.403 . . . . 8.53 110.823 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 107' ' ' ARG . . . -57.67 -39.67 77.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 7.7 111.459 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 16.8 t70 -79.24 -36.12 40.47 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.675 -0.81 . . . . 10.38 110.546 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 14.0 tp10 -64.27 -44.53 91.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.168 -0.469 . . . . 11.97 111.604 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 182' ' ' VAL . 10.1 p -55.59 -39.77 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.316 0.385 . . . . 9.8 111.282 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 106' ' ' GLN . 33.7 t70 -69.5 -34.48 74.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 10.83 110.55 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 29.9 mmt180 -72.93 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 13.85 109.95 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.8 mmt180 -83.38 -33.59 25.76 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.319 -0.623 . . . . 15.46 109.319 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 178' ' ' VAL . 85.0 t -74.53 -51.17 23.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 116.008 -0.542 . . . . 13.35 111.298 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 119.576 -0.25 . . . . 13.51 111.157 -178.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 109.808 -0.441 . . . . 14.98 109.808 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.92 -32.15 51.48 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.997 -0.681 . . . . 15.79 109.691 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.41 -35.93 70.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.941 -0.572 . . . . 12.18 109.882 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -62.95 -49.02 76.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.275 -0.639 . . . . 11.02 109.275 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -54.59 -45.6 73.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.893 . . . . 16.75 111.139 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -63.4 -36.22 83.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.69 0.619 . . . . 14.46 110.75 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.18 -38.37 72.13 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.352 -0.385 . . . . 10.71 110.33 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 30.7 mtp180 -63.21 -50.66 69.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.695 -0.483 . . . . 14.51 109.695 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -64.49 -27.43 68.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.93 -0.577 . . . . 16.85 111.829 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.1 m -83.03 -44.27 15.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.241 0.544 . . . . 13.52 110.338 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.36 -41.62 93.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 12.77 111.509 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.947 0.351 . . . . 15.19 111.947 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 -30.04 68.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.529 0.68 . . . . 16.26 109.763 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.7 mtt -83.65 -34.44 25.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 15.45 109.764 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.43 0.44 54.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.735 -0.666 . . . . 16.16 111.217 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.6 t80 59.39 46.74 12.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.462 1.505 . . . . 20.58 110.668 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.63 -176.88 4.92 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.505 -0.77 . . . . 17.26 109.032 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -109.51 140.3 21.98 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.237 -1.023 . . . . 20.19 108.237 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.75 -23.06 70.46 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.729 2.953 . . . . 17.46 113.838 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.74 -6.81 85.56 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.459 -0.877 . . . . 18.33 112.467 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -109.94 16.48 21.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.798 0.666 . . . . 20.77 112.798 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.437 ' HB ' HD22 ' A' ' 34' ' ' LEU . 41.0 pt -106.04 157.37 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 119.366 -0.934 . . . . 16.1 109.904 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 27.2 mmt180 -101.65 94.77 6.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.185 -0.672 . . . . 19.87 109.185 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.81 -22.2 57.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.04 0.936 . . . . 15.1 113.119 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.62 6.51 77.44 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.573 -0.822 . . . . 15.48 112.936 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 57.6 p -115.25 171.03 7.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.337 -0.545 . . . . 14.88 112.38 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 28.7 mtm180 -62.12 147.75 46.51 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.649 0.78 . . . . 17.38 112.277 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -58.44 -32.61 68.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.283 1.033 . . . . 11.99 111.141 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.82 -25.24 67.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.669 -0.696 . . . . 14.71 110.376 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.88 -28.97 27.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.441 -0.577 . . . . 16.44 109.441 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.437 HD22 ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -63.23 -31.74 72.97 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 13.83 110.823 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.31 -0.39 4.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.865 -1.16 . . . . 14.3 113.57 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -99.93 168.39 9.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 117.616 0.708 . . . . 13.04 111.438 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -128.07 161.08 30.05 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.095 . . . . 15.67 108.045 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.154 1.168 . . . . 15.49 114.154 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.67 -41.18 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.115 0.483 . . . . 16.98 110.569 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.31 -36.37 74.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.314 0.578 . . . . 14.44 110.258 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.38 72.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.334 -0.848 . . . . 12.4 110.427 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.58 -30.66 71.69 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.314 -0.857 . . . . 14.37 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.99 -40.69 27.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.506 0.669 . . . . 16.05 110.24 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -62.29 -45.74 91.9 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.582 -1.19 . . . . 11.7 111.5 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tp -59.19 -31.92 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 111.863 0.32 . . . . 11.48 111.863 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 34.2 mmt180 -60.96 -50.01 75.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.804 0.335 . . . . 17.18 110.345 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -27.33 64.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.327 -0.549 . . . . 14.15 112.027 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.8 -47.45 92.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.093 -1.077 . . . . 10.8 108.093 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.13 -37.89 75.46 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.092 -0.958 . . . . 12.98 111.196 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -84.63 -47.22 10.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.788 0.328 . . . . 17.81 111.789 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -68.72 -35.43 77.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 116.384 -0.371 . . . . 15.55 111.655 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.04 -2.48 37.09 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.346 0.593 . . . . 12.2 112.179 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 48.6 47.22 20.79 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.502 1.521 . . . . 17.4 110.066 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -124.9 127.29 46.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.893 -1.049 . . . . 12.25 109.15 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.02 53.57 2.48 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 113.579 0.955 . . . . 16.32 113.579 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.0 mm -70.68 117.99 60.74 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.386 -0.598 . . . . 11.39 109.386 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.4 151.84 65.65 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.912 1.741 . . . . 13.44 108.764 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -20.45 21.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.372 1.069 . . . . 12.81 112.894 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.83 -12.64 61.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 14.14 112.33 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.68 -52.84 48.08 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 120.981 -0.628 . . . . 10.76 112.339 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.71 0.767 . . . . 11.0 109.923 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.47 -35.38 73.26 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.564 -0.744 . . . . 16.59 111.081 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.9 m -88.57 -34.32 17.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.746 0.308 . . . . 13.72 110.721 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.95 92.86 48.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.495 -0.557 . . . . 12.25 109.495 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 74.5 Cg_endo -83.76 1.95 8.57 Favored 'Trans proline' 0 C--O 1.205 -1.145 0 C-N-CA 123.192 2.595 . . . . 13.57 114.323 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.55 133.02 39.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.916 -1.142 . . . . 13.28 107.916 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -63.85 -45.45 89.45 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 114.805 -1.088 . . . . 11.45 111.799 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -69.21 -24.58 64.04 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 111.944 0.35 . . . . 14.64 111.944 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.8 -41.04 53.9 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.54 -0.541 . . . . 11.34 109.54 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -75.93 -37.58 58.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.877 -0.601 . . . . 9.05 112.032 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.1 p -60.78 -34.33 74.32 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.702 -0.399 . . . . 9.65 110.893 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -68.53 -44.44 74.6 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.182 -0.673 . . . . 12.14 109.182 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -54.85 -45.9 74.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.351 1.06 . . . . 11.26 110.625 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.52 -45.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.069 -0.514 . . . . 8.3 110.776 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.1 93.88 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.736 -0.665 . . . . 9.58 113.672 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -68.61 -24.73 64.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.46 0.541 . . . . 10.46 112.46 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.02 -2.5 58.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 113.573 0.953 . . . . 10.43 113.573 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 108.386 -0.968 . . . . 10.97 108.386 176.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 109.749 -0.463 . . . . 10.09 109.749 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.36 94.17 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.667 -0.697 . . . . 11.53 111.441 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.448 ' O ' HG13 ' A' ' 110' ' ' ILE . 51.8 mt-30 -64.62 -48.35 75.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.999 -0.546 . . . . 11.91 109.796 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.78 -45.43 82.14 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.498 -0.774 . . . . 10.19 110.636 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -56.95 -52.35 65.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.333 0.653 . . . . 10.43 111.149 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 t -58.97 -44.26 91.49 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.635 -0.711 . . . . 10.46 111.163 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 106' ' ' GLN . 83.5 mt -64.08 -49.11 82.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 109.881 -0.415 . . . . 8.37 109.881 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -58.13 -43.69 87.41 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.44 0.696 . . . . 8.76 112.665 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 14.8 t70 -62.59 -43.04 99.79 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.164 0.507 . . . . 10.86 110.099 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.836 ' HH ' ' HD1' ' A' ' 155' ' ' HIS . 65.1 t80 -64.75 -44.1 91.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.639 0.733 . . . . 11.62 110.302 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.99 -33.29 75.26 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.284 -0.871 . . . . 7.62 109.281 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 129' ' ' LEU . 56.6 tttm -62.29 -40.45 96.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.865 0.866 . . . . 11.84 109.802 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 61.1 mm-40 -64.99 -48.6 73.38 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.188 -1.041 . . . . 12.03 108.188 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.4 t -56.58 -52.62 64.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.861 -1.518 . . . . 9.2 111.984 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.538 HD11 ' N ' ' A' ' 119' ' ' GLY . 3.9 pp -68.86 -39.26 79.98 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.377 -0.529 . . . . 10.06 111.746 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.538 ' N ' HD11 ' A' ' 118' ' ' LEU . . . -65.99 -39.44 94.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.126 -0.559 . . . . 12.07 111.778 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.64 -44.74 77.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.869 0.366 . . . . 12.38 110.209 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.0 tp -69.08 -46.08 68.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.334 -0.394 . . . . 11.77 110.953 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -72.72 -20.38 61.22 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.481 0.712 . . . . 13.52 111.327 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.0 t80 83.33 -29.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.005 1.322 . . . . 17.15 112.594 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.8 162.12 36.31 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 122.358 -0.214 . . . . 16.03 110.483 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.0 107.27 42.95 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.005 -0.739 . . . . 14.35 109.005 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -91.87 11.35 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.727 2.285 . . . . 14.18 113.425 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.61 50.69 5.19 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.496 -1.041 . . . . 14.05 110.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -107.48 -15.02 14.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.541 -0.464 . . . . 16.88 112.15 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.417 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 90.3 mt -71.23 97.72 1.6 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.13 0.491 . . . . 12.55 111.746 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 71.07 -20.06 0.23 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.207 1.403 . . . . 14.87 114.558 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -76.73 -28.74 55.91 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.725 0.81 . . . . 14.56 111.137 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.73 102.48 0.21 Allowed Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 110.213 -1.155 . . . . 14.2 110.213 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.86 86.6 2.32 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.99 0.367 . . . . 13.0 111.99 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.42 112.06 23.95 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.15 -0.685 . . . . 17.02 109.15 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -62.55 -20.61 64.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.874 -0.603 . . . . 13.62 111.543 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.14 -29.63 69.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.667 0.787 . . . . 16.54 111.586 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.04 -25.88 39.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.34 0.591 . . . . 15.87 110.901 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.58 2.19 49.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 13.65 111.051 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.01 3.99 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 120.794 -0.717 . . . . 14.16 111.37 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.7 tpp 62.11 86.95 0.1 Allowed 'General case' 0 C--O 1.251 1.153 0 C-N-CA 124.794 1.237 . . . . 15.81 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 44.3 m-20 -57.86 118.73 5.64 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.37 -1.345 . . . . 13.63 107.37 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -56.32 -36.15 68.39 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.126 0.97 . . . . 14.06 111.567 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.01 -44.07 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.369 0.604 . . . . 14.08 110.145 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 141' ' ' ASP . 34.2 m -66.62 -37.96 85.93 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.854 -0.612 . . . . 11.82 110.848 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 -32.86 54.11 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.871 -0.604 . . . . 10.82 112.564 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.6 p -69.7 -39.53 76.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.453 -0.499 . . . . 12.55 110.277 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.84 -46.08 81.96 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.795 0.807 . . . . 12.17 109.699 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -62.18 -54.06 46.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.176 -1.375 . . . . 9.45 111.696 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.428 ' HE3' ' HA ' ' A' ' 149' ' ' MET . 4.0 tpt -58.03 -42.07 84.55 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.947 0.499 . . . . 9.88 110.204 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -58.44 -46.41 86.58 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 115.895 -0.593 . . . . 14.43 110.697 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -45.15 95.89 Favored Glycine 0 C--N 1.321 -0.273 0 O-C-N 123.399 0.437 . . . . 10.49 112.787 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.31 -50.14 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 9.27 110.441 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.1 p -65.5 -38.46 89.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.097 -0.502 . . . . 11.46 111.61 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -63.99 -47.09 81.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 15.5 111.186 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.836 ' HD1' ' HH ' ' A' ' 113' ' ' TYR . 16.0 t-160 -67.48 -31.57 71.81 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.787 -0.365 . . . . 12.39 110.983 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -90.92 6.11 45.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.903 0.705 . . . . 11.97 112.903 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.4 m 59.66 33.51 21.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.777 0.831 . . . . 14.37 112.51 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.44 134.81 58.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.267 -0.642 . . . . 13.16 109.267 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -88.24 94.87 9.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.602 0.715 . . . . 16.91 110.669 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.03 148.73 43.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.026 -1.101 . . . . 12.32 108.026 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.58 143.92 48.08 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.075 -1.083 . . . . 14.37 108.075 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.975 -0.557 . . . . 13.15 109.995 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.32 15.6 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.655 -0.702 . . . . 15.68 110.496 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.99 59.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.053 0.39 . . . . 13.1 112.053 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.64 9.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.434 0.635 . . . . 12.16 112.236 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -110.2 -7.04 14.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.587 -0.733 . . . . 15.41 109.587 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.1 m -79.3 -27.89 42.2 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.281 0.562 . . . . 15.07 110.795 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -113.36 137.83 22.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 116.253 -0.43 . . . . 12.68 110.721 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 -16.93 18.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.063 2.509 . . . . 15.04 111.818 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.9 p -135.65 142.86 45.23 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.489 -1.3 . . . . 13.26 107.489 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.3 -24.9 62.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.742 -0.663 . . . . 10.32 110.983 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -62.34 -21.98 65.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.762 -0.654 . . . . 12.75 110.675 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.6 m -65.7 -18.56 65.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.843 -0.617 . . . . 11.26 111.208 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.94 -46.2 68.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.449 -0.575 . . . . 8.53 109.449 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.16 75.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.494 . . . . 7.7 110.968 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 14.6 t70 -74.99 -31.0 61.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.278 -0.569 . . . . 10.38 110.056 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -76.55 -41.87 45.05 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 123.348 0.659 . . . . 11.97 110.351 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 110' ' ' ILE . 7.2 p -64.67 -30.49 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.744 0.783 . . . . 9.8 110.102 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 183' ' ' GLN . 18.8 t70 -66.59 -28.08 68.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.599 -1.182 . . . . 10.83 110.117 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 85.2 mtt180 -84.22 -42.31 16.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.23 -0.895 . . . . 13.85 109.307 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.04 -51.3 59.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.962 -1.017 . . . . 15.46 111.985 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.25 -35.23 17.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.193 0.52 . . . . 13.35 110.77 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 179' ' ' ASP . 9.0 tt0 . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.246 -0.883 . . . . 13.51 109.212 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 110.263 -0.273 . . . . 14.98 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.66 -47.33 86.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.664 0.385 . . . . 15.79 110.774 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 p -62.63 -36.47 82.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.317 -0.401 . . . . 12.18 111.479 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.56 67.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.445 -0.343 . . . . 11.02 110.235 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.04 -48.59 81.1 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.451 0.701 . . . . 16.75 110.694 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -55.6 -42.25 74.59 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.052 0.845 . . . . 14.46 110.123 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.35 -43.52 63.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.106 -0.497 . . . . 10.71 111.609 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -61.28 -40.0 92.5 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.612 0.244 . . . . 14.51 111.147 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.0 -44.62 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 16.85 110.82 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -71.05 -25.23 62.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.885 0.374 . . . . 13.52 111.415 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.98 -55.96 9.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.72 -1.585 . . . . 12.77 106.72 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.34 65.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.685 -1.143 . . . . 15.19 111.554 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.93 85.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.652 0.263 . . . . 16.26 111.464 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -81.48 -26.09 35.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.018 0.437 . . . . 15.45 111.222 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.57 -4.33 44.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.018 -0.537 . . . . 16.16 112.041 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.97 49.09 3.61 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.955 1.302 . . . . 20.58 112.513 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.15 161.81 22.46 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.781 -1.099 . . . . 17.26 108.757 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -92.9 116.38 66.4 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-O 120.631 0.253 . . . . 20.19 111.124 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 -6.97 19.07 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.388 2.725 . . . . 17.46 113.627 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.76 -20.94 78.96 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.381 -0.688 . . . . 18.33 111.381 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -128.73 71.89 1.43 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 122.167 0.984 . . . . 20.77 109.468 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 tp -127.9 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.612 -0.884 . . . . 16.1 108.612 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -88.67 120.63 30.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.0 -0.741 . . . . 19.87 109.0 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 19.8 m-20 -61.79 -26.44 68.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.46 -0.791 . . . . 15.1 112.174 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.44 4.39 86.16 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.02 -0.61 . . . . 15.48 113.677 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.5 p -79.41 140.36 37.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 117.816 0.808 . . . . 14.88 110.273 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 66.1 mtm180 -75.5 148.24 39.14 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 118.356 -0.831 . . . . 17.38 109.479 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -50.38 -40.19 48.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.905 0.86 . . . . 11.99 110.992 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -23.9 66.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.406 -1.27 . . . . 14.71 112.691 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 30' ' ' ARG . 8.9 mm-40 -76.98 -29.28 55.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.796 0.808 . . . . 16.44 109.074 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.82 -31.94 27.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.16 -0.927 . . . . 13.83 108.808 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.0 32.94 3.63 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 114.787 -1.097 . . . . 14.3 112.174 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.0 tp -81.41 98.9 8.43 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.777 -0.823 . . . . 13.04 108.777 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.91 147.74 45.01 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.707 -1.22 . . . . 15.67 107.707 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 p -58.67 -22.8 57.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.923 0.765 . . . . 15.49 112.178 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.24 -50.93 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.494 -0.558 . . . . 16.98 109.494 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.06 -36.71 76.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.891 -0.781 . . . . 14.44 108.891 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.76 70.98 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.169 -0.923 . . . . 12.4 110.77 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.49 -45.84 85.58 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.066 -0.515 . . . . 14.37 109.967 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -60.79 -45.88 92.68 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.4 0.619 . . . . 16.05 110.712 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -59.34 -52.42 65.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.008 1.723 . . . . 11.7 111.684 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 tp -63.56 -31.61 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.857 0.36 . . . . 11.48 111.403 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' ALA . 99.2 mtt180 -66.35 -35.08 79.45 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 120.972 0.415 . . . . 17.18 110.282 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -73.62 -35.1 65.3 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.22 0.533 . . . . 14.15 110.155 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.01 -50.17 81.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 115.146 -0.934 . . . . 10.8 109.85 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.54 -25.12 59.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.035 -0.984 . . . . 12.98 112.847 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 97.7 mttt -75.82 -61.86 1.78 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 116.296 -0.411 . . . . 17.81 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -74.67 -25.09 58.95 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.958 -0.697 . . . . 15.55 112.008 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -94.96 -6.98 41.22 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.427 0.899 . . . . 12.2 113.427 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 47.92 64.27 1.7 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.877 1.671 . . . . 17.4 112.108 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.48 167.72 21.07 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.94 -1.027 . . . . 12.25 108.312 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.32 70.52 0.76 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.387 -1.338 . . . . 16.32 107.387 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.439 HD12 ' HE1' ' A' ' 73' ' ' TRP . 47.0 mm -92.74 119.93 67.58 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.201 -0.666 . . . . 11.39 109.201 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.65 167.72 7.25 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.056 1.838 . . . . 13.44 108.929 171.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -10.16 3.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.733 1.012 . . . . 12.81 113.733 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.39 -19.57 65.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.26 0.467 . . . . 14.14 112.26 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.77 -44.37 96.36 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.742 -1.218 . . . . 10.76 110.129 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.45 -27.64 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.231 1.012 . . . . 11.0 110.869 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -78.25 -31.5 49.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.734 -0.604 . . . . 16.59 112.175 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t -87.69 -32.28 19.28 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.392 -0.923 . . . . 13.72 110.649 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.474 ' CE2' ' HE3' ' A' ' 73' ' ' TRP . 38.6 m-85 -108.72 100.98 41.73 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 109.526 -0.546 . . . . 12.25 109.526 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.06 -0.45 10.29 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.506 2.137 . . . . 13.57 112.366 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 120.47 61.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.609 -1.626 . . . . 13.28 106.609 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 27' ' ' ASP . 49.2 p90 -58.98 -32.23 69.49 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.024 0.75 . . . . 11.45 113.024 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -60.58 -32.09 71.2 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.919 0.888 . . . . 14.64 111.731 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.5 -30.78 21.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.91 0.862 . . . . 11.34 109.928 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 43.2 t80 -70.63 -31.7 68.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.181 -0.918 . . . . 9.05 111.61 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.1 p -66.18 -28.42 68.75 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.726 -0.609 . . . . 9.65 109.49 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -71.21 -32.76 69.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.481 -0.781 . . . . 12.14 109.634 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.474 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 2.4 t-105 -53.91 -55.8 23.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.413 -0.958 . . . . 11.26 108.413 173.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.13 -44.73 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 C-N-CA 124.031 0.932 . . . . 8.3 110.627 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.6 73.74 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.261 -0.427 . . . . 9.58 113.0 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.2 m -80.36 -31.32 37.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 122.525 -0.397 . . . . 10.46 111.073 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -89.24 -21.41 23.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.051 -0.66 . . . . 10.43 112.073 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.316 -0.884 0 N-CA-C 110.096 -0.335 . . . . 10.97 110.096 174.801 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 121.813 0.816 . . . . 10.09 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.25 -35.42 71.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.509 -1.223 . . . . 11.53 109.916 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.17 -44.53 97.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.771 -1.104 . . . . 11.91 109.852 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.442 ' O ' ' HB ' ' A' ' 110' ' ' ILE . 44.1 ttp180 -78.91 -27.46 43.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.875 -0.602 . . . . 10.19 111.17 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.0 -37.05 86.39 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.809 0.337 . . . . 10.43 110.764 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.8 t -64.69 -41.88 95.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.565 -0.902 . . . . 10.46 108.565 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 67.3 mt -57.36 -41.85 79.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 CA-C-N 115.098 -0.956 . . . . 8.37 109.722 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -55.88 -39.64 71.84 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.228 0.611 . . . . 8.76 112.317 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 m-20 -66.83 -40.86 88.13 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.039 0.447 . . . . 10.86 111.129 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -74.57 -35.06 63.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.144 -0.48 . . . . 11.62 111.613 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.72 -43.23 98.12 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.254 -1.387 . . . . 7.62 107.254 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 79.0 tttt -54.66 -48.19 72.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.606 -1.179 . . . . 11.84 110.243 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -70.12 -39.29 75.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.137 -0.483 . . . . 12.03 111.404 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -58.25 -52.8 64.05 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.92 0.888 . . . . 9.2 110.219 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.7 -38.55 58.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.144 -0.48 . . . . 10.06 110.483 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.75 -26.66 67.21 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 116.415 -0.357 . . . . 12.07 112.389 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.92 -32.45 74.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 123.519 0.728 . . . . 12.38 110.296 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.03 -30.95 62.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.577 0.703 . . . . 11.77 109.535 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.87 6.9 46.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.797 -1.092 . . . . 13.52 110.046 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.2 t80 79.96 -48.82 0.35 Allowed 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 127.78 2.432 . . . . 17.15 112.795 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.47 152.62 31.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.904 -0.406 . . . . 16.03 109.904 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.2 112.48 56.47 Favored Pre-proline 0 C--N 1.314 -0.947 0 O-C-N 124.18 0.925 . . . . 14.35 109.401 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -75.91 -37.31 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.223 1.949 . . . . 14.18 112.052 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -116.84 -112.97 2.7 Favored Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 110.118 -1.193 . . . . 14.05 110.118 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -139.29 3.48 2.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.835 -0.215 . . . . 16.88 110.964 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.65 -177.48 0.11 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.38 1.072 . . . . 12.55 112.588 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -150.37 148.53 28.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.691 -1.596 . . . . 14.87 106.691 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 170' ' ' THR . 25.5 m -74.32 -26.57 60.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.562 -0.744 . . . . 14.56 111.251 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.65 3.53 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 111.123 -0.791 . . . . 14.2 111.123 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.08 107.94 15.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.152 -1.055 . . . . 13.0 108.152 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -73.06 118.04 15.53 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.16 -0.473 . . . . 17.02 110.858 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.53 -27.69 67.96 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.375 -0.83 . . . . 13.62 110.178 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.77 -19.79 65.82 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.408 -0.814 . . . . 16.54 111.629 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.3 -52.39 5.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.496 0.554 . . . . 15.87 112.496 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.82 -10.05 20.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.934 0.716 . . . . 13.65 112.934 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.9 140.19 15.73 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.916 -1.135 . . . . 14.16 112.323 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.2 mtm -133.51 24.6 4.08 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.684 -1.599 . . . . 15.81 106.684 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.41 70.32 1.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.409 -1.723 . . . . 13.63 112.225 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.87 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 45.2 t -68.74 -44.72 73.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.116 0.484 . . . . 14.06 109.919 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.32 -57.25 4.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 122.182 -0.324 . . . . 14.08 110.828 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -69.76 -20.47 63.49 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.64 -0.424 . . . . 11.82 111.927 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -78.86 -24.36 62.26 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.741 -1.218 . . . . 10.82 110.184 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.5 m -72.43 -38.22 68.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.602 -0.888 . . . . 12.55 108.602 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.72 -39.99 86.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.683 -0.69 . . . . 12.17 109.181 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.439 ' O ' HG21 ' A' ' 152' ' ' VAL . 25.1 t90 -65.16 -46.5 80.61 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.188 -0.914 . . . . 9.45 110.711 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.454 ' HA ' ' HE2' ' A' ' 149' ' ' MET . 15.3 mmt -54.35 -47.85 72.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.112 0.482 . . . . 9.88 110.097 176.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 36.6 ttm180 -60.87 -41.02 95.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.247 -0.888 . . . . 14.43 110.232 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.85 -53.57 36.75 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.718 -0.673 . . . . 10.49 111.882 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 148' ' ' TRP . 53.5 t -57.61 -40.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.105 0.479 . . . . 9.27 110.064 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.9 t -61.16 -51.9 67.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.334 -0.848 . . . . 11.46 110.584 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 39.1 ptt180 -75.64 -40.05 56.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.784 0.661 . . . . 15.5 112.784 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -68.98 -33.87 74.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 12.39 111.87 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.97 2.22 43.33 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.737 -0.385 . . . . 11.97 112.025 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 t 60.0 37.57 21.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.972 0.909 . . . . 14.37 111.302 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.12 148.52 19.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.818 -0.438 . . . . 13.16 109.818 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -83.05 95.97 8.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.045 -0.354 . . . . 16.91 110.045 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 tp -109.36 133.99 52.38 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.349 -0.982 . . . . 12.32 108.349 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.46 146.7 29.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.007 -0.542 . . . . 14.37 110.219 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.49 -16.83 62.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 13.15 111.846 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.22 1.87 56.89 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.287 -0.415 . . . . 15.68 110.656 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 168' ' ' TRP . . . -61.83 -22.38 65.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.718 0.636 . . . . 13.1 112.718 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.7 pt -67.44 -12.96 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.235 0.54 . . . . 12.16 111.33 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.87 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 28.8 m-85 -103.75 4.05 34.8 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.038 -0.528 . . . . 15.41 110.477 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.6 t -140.09 14.73 2.44 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 119.392 -0.923 . . . . 15.07 112.931 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.504 ' CD1' ' HB1' ' A' ' 164' ' ' ALA . 25.2 m95 -129.51 114.44 18.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.957 -1.127 . . . . 12.68 107.957 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 58.4 Cg_endo -73.12 -44.13 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.765 2.31 . . . . 15.04 115.491 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 131' ' ' SER . 74.8 p -130.45 -175.56 3.68 Favored 'General case' 0 C--O 1.249 1.058 0 N-CA-C 112.696 0.628 . . . . 13.26 112.696 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 6.7 mp -68.12 -26.5 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.711 -0.477 . . . . 10.32 109.711 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -58.66 -49.96 75.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.45 -0.574 . . . . 12.75 109.45 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.442 ' HB2' ' CE3' ' A' ' 168' ' ' TRP . 3.1 p -67.36 -24.13 65.67 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.884 0.698 . . . . 11.26 112.884 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.12 -47.56 23.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.837 -1.171 . . . . 8.53 107.837 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.22 -30.57 71.69 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.794 -0.639 . . . . 7.7 110.832 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -56.71 -34.97 68.0 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.349 0.66 . . . . 10.38 112.316 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -60.24 -58.27 9.25 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.676 0.75 . . . . 11.97 110.998 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.74 -32.12 51.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.908 -1.042 . . . . 9.8 110.899 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.16 -43.64 92.1 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.31 0.644 . . . . 10.83 110.76 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.4 mtm105 -83.06 -38.07 23.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.198 -0.456 . . . . 13.85 112.038 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -66.26 -46.51 76.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.581 0.585 . . . . 15.46 112.581 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.17 -43.33 17.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.883 0.373 . . . . 13.35 111.828 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.753 -0.462 . . . . 13.51 109.753 -178.638 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 121.959 0.885 . . . . 14.98 109.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -61.86 -41.68 98.13 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.66 0.985 . . . . 15.79 113.66 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.87 -58.59 5.61 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.754 0.659 . . . . 12.18 110.678 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.12 80.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.625 -0.716 . . . . 11.02 111.333 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -58.16 -47.62 82.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.824 -0.626 . . . . 16.75 111.826 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.02 -34.72 77.02 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 121.099 0.476 . . . . 14.46 110.766 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.88 -36.14 77.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.145 -0.479 . . . . 10.71 110.528 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.91 -48.1 83.37 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.51 -0.552 . . . . 14.51 109.51 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.35 -43.77 88.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.685 . . . . 16.85 111.364 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -72.99 -43.48 62.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.96 -0.563 . . . . 13.52 112.373 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.49 -38.71 90.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.775 -0.454 . . . . 12.77 109.775 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.662 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -63.99 -34.87 78.97 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.738 -0.664 . . . . 15.19 110.792 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.85 61.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.981 -0.554 . . . . 16.26 111.042 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.9 mtt -85.36 -45.56 11.78 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.304 -0.407 . . . . 15.45 111.74 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.65 -5.64 48.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.27 0.841 . . . . 16.16 113.27 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 67.36 28.81 7.73 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.899 0.857 . . . . 20.58 111.93 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 6.9 p -97.45 -174.85 3.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.873 -1.158 . . . . 17.26 107.873 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -104.39 138.99 19.68 Favored Pre-proline 0 C--N 1.305 -1.354 0 C-N-CA 120.302 -0.559 . . . . 20.19 110.33 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.49 -9.09 14.93 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.15 1.9 . . . . 17.46 111.693 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.82 -76.57 0.88 Allowed Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 111.437 -0.665 . . . . 18.33 111.437 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -85.31 55.71 3.62 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.725 0.774 . . . . 20.77 110.372 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.56 140.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.844 -1.169 . . . . 16.1 107.844 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -81.88 100.23 9.5 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.204 0.526 . . . . 19.87 110.045 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 5.8 p-10 -77.16 -20.34 55.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.936 -0.575 . . . . 15.1 112.283 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.85 7.21 64.97 Favored Glycine 0 C--N 1.307 -1.061 0 CA-C-N 116.024 -0.534 . . . . 15.48 112.639 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.3 p -92.15 166.75 12.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.127 0.489 . . . . 14.88 110.597 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 88.5 mtm180 -91.61 141.93 28.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.331 -0.85 . . . . 17.38 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -50.22 -48.81 54.22 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.266 1.21 . . . . 11.99 114.266 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.298 0.57 . . . . 14.71 111.158 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 30' ' ' ARG . 44.1 tt0 -82.2 -20.36 37.95 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 124.078 0.951 . . . . 16.44 109.293 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.4 -0.79 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.347 -0.842 . . . . 13.83 109.43 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.38 74.74 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.562 -0.745 . . . . 14.3 112.341 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.6 tp -81.91 82.31 7.59 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.348 -0.982 . . . . 13.04 108.348 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.503 ' OD2' HG22 ' A' ' 39' ' ' VAL . 17.6 t70 -66.44 165.87 13.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.345 -1.298 . . . . 15.67 109.819 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -56.58 -36.74 69.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 118.44 0.564 . . . . 15.49 111.479 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG22 ' OD2' ' A' ' 37' ' ' ASP . 1.5 m -57.41 -51.84 64.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.677 0.751 . . . . 16.98 112.509 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mt -67.87 -46.58 81.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.675 -1.148 . . . . 14.44 110.301 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.36 87.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 12.4 112.458 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.41 93.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.397 0.617 . . . . 14.37 111.034 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.08 -43.3 68.02 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.638 -0.71 . . . . 16.05 110.619 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -57.43 -52.96 63.25 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 125.66 1.584 . . . . 11.7 110.425 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 tp -66.29 -33.03 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.369 -0.378 . . . . 11.48 111.028 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -59.95 -36.23 76.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.368 -0.378 . . . . 17.18 110.628 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.88 -40.37 54.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.299 -0.56 . . . . 14.15 109.69 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.39 -48.44 56.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.007 0.523 . . . . 10.8 110.96 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 16.3 m120 -57.88 -35.91 71.65 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.489 0.551 . . . . 12.98 112.489 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -86.22 -56.11 3.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.061 0.458 . . . . 17.81 110.814 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -61.81 -32.57 72.89 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.073 0.949 . . . . 15.55 111.788 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.15 3.2 25.47 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.473 0.654 . . . . 12.2 111.201 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.251 4.0 pt20 39.82 55.7 2.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.964 2.106 . . . . 17.4 114.308 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.35 159.07 23.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.34 -0.846 . . . . 12.25 110.129 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -94.95 26.82 3.42 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.077 0.551 . . . . 16.32 110.487 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mm -53.71 121.92 30.51 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.346 -0.843 . . . . 11.39 111.027 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.47 137.96 48.61 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.657 1.571 . . . . 13.44 108.555 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.56 -19.99 29.13 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.44 0.696 . . . . 12.81 112.267 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.34 -1.88 57.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.024 -0.534 . . . . 14.14 112.207 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.55 72.0 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 121.481 -0.39 . . . . 10.76 112.368 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.91 -26.22 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.408 0.683 . . . . 11.0 111.522 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -103.76 -2.53 26.26 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.643 -0.423 . . . . 16.59 111.921 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 m -69.52 -57.44 5.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.356 -0.979 . . . . 13.72 108.356 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.23 85.2 50.09 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 105.053 -2.203 . . . . 12.25 105.053 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 71.9 Cg_endo -76.15 54.32 4.14 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.836 2.357 . . . . 13.57 115.175 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.3 126.77 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.277 -1.009 . . . . 13.28 108.277 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -50.54 -54.78 19.8 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.382 0.882 . . . . 11.45 113.382 -171.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 63.1 tttm -65.79 -33.29 75.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.501 . . . . 14.64 111.424 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.94 81.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.104 -0.498 . . . . 11.34 111.04 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.0 t80 -79.06 -32.02 44.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.833 0.349 . . . . 9.05 111.618 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.0 p -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.662 -0.649 . . . . 9.65 110.963 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.16 -27.91 57.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.597 -0.274 . . . . 12.14 110.627 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.526 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 2.2 t90 -53.8 -49.15 68.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.461 1.104 . . . . 11.26 109.277 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 86.8 t -62.83 -41.55 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 123.666 0.786 . . . . 8.3 110.365 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.61 93.22 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.76 -0.654 . . . . 9.58 112.378 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 p -75.22 -22.31 58.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.895 0.379 . . . . 10.46 111.618 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.26 -17.16 57.02 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.957 0.408 . . . . 10.43 110.019 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 97.5 mt . . . . . 0 C--N 1.316 -0.882 0 CA-C-O 122.073 0.939 . . . . 10.97 109.383 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.434 -1.262 0 CA-C-O 120.867 0.365 . . . . 10.09 110.079 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.45 69.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.115 -0.493 . . . . 11.53 111.434 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -70.53 -47.28 61.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.806 -0.813 . . . . 11.91 108.806 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -68.98 -40.55 78.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.037 -0.529 . . . . 10.19 110.772 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.8 -41.99 92.42 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.059 -0.519 . . . . 10.43 110.05 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -64.92 -36.53 84.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 120.453 -0.499 . . . . 10.46 111.281 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 178' ' ' VAL . 50.4 mt -59.31 -50.05 81.25 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 109.546 -0.538 . . . . 8.37 109.546 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -60.83 -34.86 75.21 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.536 -0.756 . . . . 8.76 110.114 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 15.0 t70 -63.49 -52.73 60.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.51 -0.768 . . . . 10.86 110.352 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -62.41 -44.72 95.76 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.337 -0.392 . . . . 11.62 109.976 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.91 -47.41 80.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.98 0.912 . . . . 7.62 110.68 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.31 -47.6 85.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.514 -0.766 . . . . 11.84 110.226 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 23.9 mt-30 -66.18 -43.24 87.42 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.879 -0.6 . . . . 12.03 110.717 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.6 t -58.11 -51.81 68.15 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 123.579 0.752 . . . . 9.2 111.803 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.498 HD23 ' CZ2' ' A' ' 148' ' ' TRP . 3.1 tm? -73.46 -40.82 63.87 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.54 -0.541 . . . . 10.06 109.54 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.53 -27.7 72.17 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.074 -0.512 . . . . 12.07 112.47 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.37 -37.94 68.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.369 0.604 . . . . 12.38 109.761 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.545 -0.752 . . . . 11.77 110.033 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.75 -16.68 55.13 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.552 -0.749 . . . . 13.52 110.567 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 72.46 8.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.351 1.46 . . . . 17.15 112.671 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.64 18.39 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.718 0.807 . . . . 16.03 108.99 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.94 126.23 29.48 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.521 -1.288 . . . . 14.35 107.521 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -7.53 21.03 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.76 2.307 . . . . 14.18 112.489 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.01 -73.06 0.39 Allowed Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 120.653 -0.784 . . . . 14.05 112.244 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -124.69 -22.17 4.64 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.821 0.343 . . . . 16.88 111.105 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp 63.5 -154.79 0.32 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 12.55 110.608 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 68.13 -78.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.148 0.979 . . . . 14.87 110.882 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.7 p -97.15 151.25 19.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.544 -0.91 . . . . 14.56 108.544 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.27 64.46 Favored Glycine 0 N--CA 1.47 0.951 0 C-N-CA 119.807 -1.187 . . . . 14.2 110.491 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.5 82.16 1.94 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.181 -1.414 . . . . 13.0 107.181 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.53 124.12 48.72 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.401 -1.272 . . . . 17.02 111.524 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.19 -7.08 51.4 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.086 -0.961 . . . . 13.62 111.372 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.86 -31.64 69.6 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.824 -1.176 . . . . 16.54 107.824 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.91 -51.98 3.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.772 -1.104 . . . . 15.87 110.176 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.18 15.55 2.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.549 0.69 . . . . 13.65 112.113 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.6 61.31 0.41 Allowed Glycine 0 C--N 1.297 -1.591 0 N-CA-C 109.857 -1.297 . . . . 14.16 109.857 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.6 ttm -72.46 -38.5 68.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.201 0.524 . . . . 15.81 110.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.14 143.27 46.63 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.321 -0.854 . . . . 13.63 110.299 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -82.06 -27.34 33.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.431 -0.804 . . . . 14.06 111.945 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.88 -35.96 50.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.204 0.526 . . . . 14.08 109.801 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.1 p -59.15 -48.12 82.77 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.77 -0.65 . . . . 11.82 110.939 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.4 85.14 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 115.499 -0.773 . . . . 10.82 112.726 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.9 t -64.37 -41.84 96.49 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.486 -0.486 . . . . 12.55 111.423 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -66.36 -46.34 77.08 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.891 0.377 . . . . 12.17 111.186 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.498 ' CZ2' HD23 ' A' ' 118' ' ' LEU . 32.8 t90 -64.14 -48.97 73.98 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.878 -0.601 . . . . 9.45 111.789 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 93.6 mmm -60.93 -45.44 94.68 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 123.245 0.34 . . . . 9.88 111.809 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.21 -36.69 80.59 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.026 -0.27 . . . . 14.43 111.187 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.05 -47.97 80.22 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.656 -0.578 . . . . 10.49 111.656 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.26 -42.92 92.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.204 0.526 . . . . 9.27 110.101 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.2 m -62.82 -41.67 99.41 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.342 -0.845 . . . . 11.46 111.23 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -69.71 -41.79 74.9 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.892 -0.595 . . . . 15.5 109.87 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -60.41 -45.14 94.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.856 . . . . 12.39 110.248 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.52 5.9 49.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.473 0.546 . . . . 11.97 112.473 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.2 m 57.26 39.44 28.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.301 1.04 . . . . 14.37 112.887 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.0 149.66 16.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.076 0.465 . . . . 13.16 111.097 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.61 100.04 12.85 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.813 -1.18 . . . . 16.91 107.813 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -103.6 135.44 45.18 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.017 -0.538 . . . . 12.32 109.623 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.34 133.91 39.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.453 0.644 . . . . 14.37 110.573 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.76 64.3 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.683 -0.689 . . . . 13.15 111.487 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.83 -5.17 59.28 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.746 -0.661 . . . . 15.68 111.091 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.21 -8.54 56.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.727 0.775 . . . . 13.1 109.843 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.88 -23.85 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.984 1.314 . . . . 12.16 109.745 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -113.43 16.75 18.8 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.124 -0.944 . . . . 15.41 110.098 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.8 m -101.77 -34.1 9.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.645 -0.707 . . . . 15.07 109.85 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -103.24 107.41 55.48 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.869 -0.419 . . . . 12.68 109.869 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.58 -13.7 9.49 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.155 1.904 . . . . 15.04 113.007 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -129.46 145.29 51.45 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.555 0.693 . . . . 13.26 111.529 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.9 tp -58.17 -35.09 71.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.439 -1.255 . . . . 10.32 111.9 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.84 -25.44 65.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 12.75 111.718 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.4 m -75.88 -20.16 58.28 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.146 0.498 . . . . 11.26 110.5 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.86 -29.75 55.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.578 -0.897 . . . . 8.53 108.578 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.42 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.417 -0.81 . . . . 7.7 109.4 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -62.07 -30.5 71.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 120.804 0.335 . . . . 10.38 111.343 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -59.38 4.58 Favored 'General case' 0 C--O 1.252 1.205 0 N-CA-C 108.583 -0.895 . . . . 11.97 108.583 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.414 ' CG2' HD11 ' A' ' 110' ' ' ILE . 14.9 p -65.49 -35.18 74.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 114.674 -1.148 . . . . 9.8 111.773 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -57.24 -40.9 78.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.59 0.71 . . . . 10.83 110.919 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 34.2 ttp-105 -82.23 -53.22 6.23 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.341 -0.845 . . . . 13.85 111.18 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -75.42 -45.9 36.05 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.895 1.442 . . . . 15.46 114.895 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.98 -31.66 22.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 119.937 -0.705 . . . . 13.35 109.239 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.237 0.41 0 O-C-N 124.9 1.375 . . . . 13.51 111.223 172.776 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 119.721 -0.181 . . . . 14.98 111.078 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.52 -47.16 82.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 121.029 -0.268 . . . . 15.79 110.744 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.7 m -59.68 -42.91 93.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.509 0.195 . . . . 12.18 111.133 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.04 80.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.305 -0.407 . . . . 11.02 110.682 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.81 -39.13 87.61 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.787 -0.642 . . . . 16.75 110.647 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.35 -49.19 78.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.541 0.736 . . . . 14.46 110.289 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.45 -38.08 83.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.422 -0.354 . . . . 10.71 110.683 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -59.74 -43.72 94.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.112 -0.495 . . . . 14.51 109.907 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.25 -41.86 69.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 16.85 110.096 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -57.73 -45.23 86.08 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.098 0.959 . . . . 13.52 111.132 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.48 -48.12 81.83 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.337 -0.616 . . . . 12.77 109.337 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.39 82.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.669 . . . . 15.19 111.831 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.65 86.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.137 0.575 . . . . 16.26 111.725 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.412 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 63.5 mtt -78.11 -42.61 31.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.705 -0.679 . . . . 15.45 111.468 -176.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.16 3.19 52.72 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.869 -0.733 . . . . 16.16 112.083 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 55.56 46.7 22.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.317 1.047 . . . . 20.58 110.187 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.8 m -123.38 -178.47 4.01 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.973 -1.012 . . . . 17.26 109.843 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.0 mp0 -95.64 145.97 30.49 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.462 -1.681 . . . . 20.19 106.462 174.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.01 49.86 3.38 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 121.874 1.716 . . . . 17.46 109.237 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . -51.1 92.54 0.01 OUTLIER Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 127.945 2.688 . . . . 18.33 114.587 -172.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 44.19 29.71 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 127.044 2.138 . . . . 20.77 115.627 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.76 130.31 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.92 -1.141 . . . . 16.1 107.92 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -151.16 0.34 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.243 -1.021 . . . . 19.87 108.243 -173.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.09 -29.63 64.29 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.55 -0.46 . . . . 15.1 111.051 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -53.66 2.45 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.153 -1.022 . . . . 15.48 111.042 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -74.48 108.75 7.45 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.82 -1.178 . . . . 14.88 107.82 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 91.0 mtt180 -89.86 176.43 6.83 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.312 0.856 . . . . 17.38 113.312 -169.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -49.62 -41.17 41.63 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 112.736 0.643 . . . . 11.99 112.736 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.8 mt -60.34 -25.75 66.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 14.71 111.715 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.26 -36.2 79.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.243 0.617 . . . . 16.44 111.213 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.0 mt -88.98 5.22 45.24 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.584 -0.446 . . . . 13.83 112.006 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.79 51.71 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.992 -1.099 . . . . 14.3 112.677 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 41' ' ' ALA . 6.9 tt -75.13 125.12 28.27 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.684 -0.858 . . . . 13.04 108.684 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -117.35 162.18 18.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.953 -1.128 . . . . 15.67 107.953 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 p -48.43 -43.89 34.78 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.401 0.68 . . . . 15.49 112.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.49 -47.66 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.865 -0.607 . . . . 16.98 110.487 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.0 mt -67.16 -34.46 69.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.816 -0.629 . . . . 14.44 110.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB2' HD23 ' A' ' 36' ' ' LEU . . . -59.34 -33.28 70.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 12.4 111.31 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.15 73.52 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.212 -0.449 . . . . 14.37 111.712 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.27 -45.74 14.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.386 0.612 . . . . 16.05 109.711 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.412 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 3.4 t90 -59.34 -40.59 86.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.498 1.119 . . . . 11.7 111.89 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 tp -62.18 -30.64 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.89 0.376 . . . . 11.48 110.872 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -64.96 -41.02 95.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 17.18 109.958 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -31.7 71.67 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 121.191 0.519 . . . . 14.15 111.424 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.409 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 78.5 mt -66.97 -50.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.44 -0.948 . . . . 10.8 108.44 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 90.9 m-20 -62.66 -31.35 72.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.582 -1.19 . . . . 12.98 112.971 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -71.39 -43.13 67.43 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.871 -0.518 . . . . 17.81 110.155 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -74.64 -45.18 46.5 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 113.97 1.1 . . . . 15.55 113.97 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.411 ' O ' HD23 ' A' ' 54' ' ' LEU . 63.9 m-85 -101.64 -1.15 33.36 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.758 -0.777 . . . . 12.2 112.189 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.298 4.0 pt20 48.49 42.71 19.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.242 1.941 . . . . 17.4 116.242 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 52' ' ' TYR . 3.4 mm? -94.51 171.25 8.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.599 -1.259 . . . . 12.25 107.599 171.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -114.12 60.74 0.67 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.506 -0.924 . . . . 16.32 108.506 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 57' ' ' PRO . 62.7 mt -97.4 126.4 41.77 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.35 -0.841 . . . . 11.39 111.0 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.458 ' O ' HG22 ' A' ' 56' ' ' ILE . 74.2 Cg_endo -77.0 169.5 21.51 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.273 1.982 . . . . 13.44 109.186 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.99 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.462 0.648 . . . . 12.81 110.629 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 5.6 m-20 -62.33 -20.09 64.0 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.101 -0.954 . . . . 14.14 112.312 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.07 99.82 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 119.791 -1.195 . . . . 10.76 110.252 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.03 -27.39 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.634 0.73 . . . . 11.0 110.07 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 20.6 m-85 -74.57 -23.47 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.843 -0.536 . . . . 16.59 110.233 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.4 m -87.57 -45.28 10.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.04 -0.527 . . . . 13.72 109.639 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.503 ' HE2' ' CE3' ' A' ' 73' ' ' TRP . 76.0 m-85 -115.74 104.22 53.03 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 120.583 0.23 . . . . 12.25 111.095 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 71.6 Cg_endo -83.13 3.32 7.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.96 1.773 . . . . 13.57 110.842 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -119.97 120.42 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.301 -1.74 . . . . 13.28 106.301 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -63.38 -29.77 71.01 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 113.504 0.927 . . . . 11.45 113.504 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -64.06 -34.25 77.6 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 14.64 111.696 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.16 -29.12 28.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.818 0.818 . . . . 11.34 109.655 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -75.58 -35.85 60.49 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.995 . . . . 9.05 111.377 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -65.02 -30.39 71.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.107 0.48 . . . . 9.65 109.731 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -70.17 -36.75 74.9 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.252 -0.885 . . . . 12.14 109.599 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.503 ' CE3' ' HE2' ' A' ' 64' ' ' TYR . 17.3 t-105 -61.95 -42.29 98.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 11.26 110.606 173.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 79.6 t -68.8 -45.29 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.921 0 N-CA-C 110.087 -0.338 . . . . 8.3 110.087 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.07 87.7 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 116.153 -0.476 . . . . 9.58 113.331 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 p -73.05 -30.18 63.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.053 0.39 . . . . 10.46 112.053 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.48 -19.92 37.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.599 0.714 . . . . 10.43 110.323 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 95.0 mt . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 109.185 -0.672 . . . . 10.97 109.185 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.924 -0.398 . . . . 10.09 109.924 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.08 76.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.435 -0.348 . . . . 11.53 111.8 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -65.47 -40.98 93.81 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.519 0.676 . . . . 11.91 109.659 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -66.22 -36.6 83.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.277 -0.874 . . . . 10.19 112.893 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.68 -38.38 90.14 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 117.921 0.328 . . . . 10.43 110.688 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 t -56.88 -47.72 79.81 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.785 -0.45 . . . . 10.46 109.785 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 110' ' ' ILE . 68.1 mt -68.79 -51.97 39.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.404 -0.591 . . . . 8.37 109.404 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -53.46 -41.38 66.11 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 124.587 1.155 . . . . 8.76 112.126 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 23.8 t70 -63.65 -48.24 78.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.68 0.252 . . . . 10.86 111.68 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.91 -36.06 69.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 11.62 110.413 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.64 -35.99 82.39 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.82 -0.808 . . . . 7.62 108.82 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 25.0 ttpp -61.92 -45.76 92.3 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 11.84 109.472 174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 77.7 mt-30 -56.22 -47.23 78.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.593 -0.73 . . . . 12.03 109.666 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -64.35 -50.98 65.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.111 -0.95 . . . . 9.2 112.124 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 119' ' ' GLY . 3.7 pp -65.09 -34.99 79.71 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.326 -0.549 . . . . 10.06 111.869 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.523 ' N ' HD11 ' A' ' 118' ' ' LEU . . . -66.38 -47.8 68.11 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 111.072 -0.811 . . . . 12.07 111.072 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.37 -38.81 88.34 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.244 1.018 . . . . 12.38 110.624 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 tp -57.39 -44.05 84.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 11.77 110.102 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 86.9 mt -72.96 -63.24 1.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.522 -0.918 . . . . 13.52 108.522 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -179.27 -47.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.654 1.182 . . . . 17.15 109.978 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -162.67 155.3 19.23 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.777 0.322 . . . . 16.03 110.293 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -125.82 127.3 24.82 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.454 -0.794 . . . . 14.35 110.841 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.32 -2.88 12.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.137 2.558 . . . . 14.18 112.213 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.89 41.42 4.38 Favored Glycine 0 CA--C 1.491 -1.469 0 C-N-CA 120.893 -0.67 . . . . 14.05 111.916 173.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -140.34 -72.66 0.36 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.132 -1.027 . . . . 16.88 113.413 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 mp 67.79 141.25 0.03 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.418 1.104 . . . . 12.55 112.044 -166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -83.04 161.91 21.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.879 -1.156 . . . . 14.87 107.879 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.1 m -78.31 17.49 0.64 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.845 0.683 . . . . 14.56 112.845 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.96 -74.83 0.34 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.663 -1.775 . . . . 14.2 108.663 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 62.07 62.43 1.21 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.998 0.919 . . . . 13.0 111.953 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -80.79 104.67 11.46 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.717 -0.674 . . . . 17.02 110.684 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -66.72 -26.81 67.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.255 1.022 . . . . 13.62 109.945 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.16 -24.37 67.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.434 0.635 . . . . 16.54 110.673 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -97.68 -46.27 6.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.157 0.503 . . . . 15.87 109.782 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.03 -26.07 62.94 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 13.65 112.884 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.02 119.68 6.45 Favored Glycine 0 C--N 1.313 -0.729 0 N-CA-C 111.942 -0.463 . . . . 14.16 111.942 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 86.9 mtp -106.18 -23.23 12.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.307 0.575 . . . . 15.81 110.643 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.51 127.44 19.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.344 0.592 . . . . 13.63 110.305 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.716 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 21.7 t -66.87 -37.49 84.53 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.931 -1.031 . . . . 14.06 110.32 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.89 -40.19 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.468 -0.333 . . . . 14.08 111.135 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.7 p -57.56 -35.29 70.16 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.442 . . . . 11.82 111.515 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.36 -32.11 26.19 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.623 -1.275 . . . . 10.82 112.254 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -68.25 -35.6 78.17 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.428 0.614 . . . . 12.55 110.588 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -63.83 -38.72 92.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.116 -0.493 . . . . 12.17 110.334 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -62.4 -44.22 96.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.75 -0.659 . . . . 9.45 110.22 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 149' ' ' MET . 25.8 mmt -60.23 -36.61 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 9.88 110.323 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.614 ' HA ' ' NE ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -67.06 -43.79 81.77 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.946 -0.57 . . . . 14.43 110.426 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.06 71.87 Favored Glycine 0 C--O 1.246 0.873 0 O-C-N 123.692 0.62 . . . . 10.49 112.73 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.34 -33.15 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.45 0.167 . . . . 9.27 110.898 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.4 m -60.58 -47.09 87.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 121.031 0.443 . . . . 11.46 110.124 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -68.83 -50.43 50.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.603 -0.726 . . . . 15.5 111.37 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -66.0 -34.95 79.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.223 0.453 . . . . 12.39 112.223 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.18 5.77 42.81 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.032 -0.667 . . . . 11.97 112.612 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 p 53.16 44.83 29.76 Favored 'General case' 0 C--O 1.247 0.954 0 C-N-CA 124.473 1.109 . . . . 14.37 113.377 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.78 149.07 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.307 -0.861 . . . . 13.16 108.774 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -96.23 95.64 8.25 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.402 -0.962 . . . . 16.91 108.402 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.8 tp -106.12 136.75 45.25 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.943 -0.572 . . . . 12.32 109.7 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.95 134.53 43.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.525 -0.546 . . . . 14.37 109.525 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.5 60.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.734 -0.666 . . . . 13.15 110.763 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.02 -10.85 59.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.436 -0.802 . . . . 15.68 110.573 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 167' ' ' THR . . . -64.61 -11.51 35.76 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.073 -0.512 . . . . 13.1 112.202 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -58.53 -17.61 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 121.445 0.64 . . . . 12.16 111.467 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.716 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 26.7 m-85 -93.38 -6.41 47.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.077 -0.51 . . . . 15.41 112.131 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' ALA . 13.9 t -103.05 8.94 38.76 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.327 -0.949 . . . . 15.07 111.14 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -129.93 99.46 20.12 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 108.98 -0.748 . . . . 12.68 108.98 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.24 -28.78 39.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.742 1.628 . . . . 15.04 110.906 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 27.8 p -121.96 142.4 50.34 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.812 -0.631 . . . . 13.26 109.493 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.16 -30.56 71.69 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.316 1.046 . . . . 10.32 111.622 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -55.23 -27.03 43.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.127 -0.942 . . . . 12.75 111.91 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.7 m -72.16 -19.89 61.69 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.162 -0.472 . . . . 11.26 112.194 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.7 tp -75.68 -29.84 59.18 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.951 -0.7 . . . . 8.53 109.892 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.26 96.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.807 -0.633 . . . . 7.7 111.196 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -82.16 -25.88 33.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.151 -0.62 . . . . 10.38 110.558 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.38 -48.66 69.44 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.163 -0.472 . . . . 11.97 110.408 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 110' ' ' ILE . 9.0 p -59.56 -39.73 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.861 -0.609 . . . . 9.8 110.141 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.88 -44.59 92.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.528 -0.76 . . . . 10.83 111.234 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -70.92 -28.33 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.124 0.488 . . . . 13.85 111.488 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -79.23 -41.98 27.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.624 -0.431 . . . . 15.46 110.806 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.04 -35.25 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.428 -0.509 . . . . 13.35 111.341 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.37 -0.604 . . . . 13.51 109.37 179.198 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 22.7 t70 . . . . . 0 C--O 1.212 -0.891 0 CA-C-O 120.807 0.337 . . . . 14.98 110.668 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.8 -38.11 70.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.889 -0.507 . . . . 15.79 111.708 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.0 p -65.7 -35.13 79.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.533 -0.867 . . . . 12.18 109.757 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.52 -35.0 79.53 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.055 -0.52 . . . . 11.02 110.477 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 28.5 mt-30 -53.36 -45.56 69.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 123.622 0.576 . . . . 16.75 110.636 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.45 -46.54 88.04 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.849 -0.614 . . . . 14.46 110.473 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.6 -36.35 73.47 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.01 -0.541 . . . . 10.71 111.075 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.62 -46.47 85.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.841 0.857 . . . . 14.51 109.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.92 -44.63 96.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.389 -0.823 . . . . 16.85 110.289 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -69.07 -40.4 78.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.407 -0.815 . . . . 13.52 110.847 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.77 -51.01 71.79 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.505 -0.924 . . . . 12.77 108.505 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.642 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -62.38 -39.61 93.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.055 . . . . 15.19 111.662 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.34 88.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.326 -0.397 . . . . 16.26 111.351 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.3 mtt -71.93 -36.62 69.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.789 0.328 . . . . 15.45 111.819 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 81.3 mt -94.73 -2.39 51.18 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.673 -0.411 . . . . 16.16 111.73 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 59.15 36.21 23.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.512 1.125 . . . . 20.58 111.104 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 23.5 p -112.27 164.91 12.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.11 -0.95 . . . . 17.26 108.976 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 52.2 mm-40 -91.28 129.29 43.91 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.091 -0.707 . . . . 20.19 109.091 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.93 -14.35 42.75 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.484 2.789 . . . . 17.46 114.317 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.98 -13.43 69.2 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.855 -0.688 . . . . 18.33 112.659 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 10.6 pt20 -79.56 -20.19 47.63 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.278 0.539 . . . . 20.77 110.472 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 pt -92.94 168.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.688 -1.227 . . . . 16.1 107.688 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -134.6 166.17 23.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 119.191 -0.433 . . . . 19.87 111.053 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.5 -51.17 69.52 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.64 0.588 . . . . 15.1 111.167 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.23 6.72 70.5 Favored Glycine 0 C--O 1.244 0.741 0 CA-C-N 115.962 -0.563 . . . . 15.48 113.918 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -76.29 136.84 39.62 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.74 0.781 . . . . 14.88 110.924 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 82.3 mtp180 -77.54 147.08 35.93 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 114.576 -1.193 . . . . 17.38 108.786 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -58.63 -25.45 62.7 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.176 0.806 . . . . 11.99 113.176 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.01 -21.34 59.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.096 -0.502 . . . . 14.71 109.884 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.39 -18.74 18.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.864 0.866 . . . . 16.44 109.006 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.14 -21.63 58.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.702 -0.681 . . . . 13.83 109.792 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 24.56 8.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.45 -0.796 . . . . 14.3 112.543 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.38 163.54 16.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.924 0.869 . . . . 13.04 112.47 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.35 153.46 51.83 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.039 -1.437 . . . . 15.67 107.31 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -49.43 -55.65 12.36 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 123.741 0.65 . . . . 15.49 112.629 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.55 -44.79 99.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.249 -0.432 . . . . 16.98 110.704 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.78 -37.64 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.246 -0.433 . . . . 14.44 110.574 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.68 85.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 12.4 110.176 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.74 90.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.677 -0.692 . . . . 14.37 110.242 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.16 -42.39 90.63 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.461 0.648 . . . . 16.05 110.887 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.531 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 7.4 t90 -61.64 -55.61 28.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.793 1.637 . . . . 11.7 109.17 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 58' ' ' ALA . 16.6 mm -54.32 -39.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.436 0.695 . . . . 11.48 111.583 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 18.4 tpt180 -72.33 -23.32 61.14 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.995 -0.548 . . . . 17.18 111.802 -175.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -86.56 -32.82 20.48 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 120.086 -0.646 . . . . 14.15 109.725 175.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 45' ' ' ILE . 87.9 mt -55.61 -35.8 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.972 0.909 . . . . 10.8 109.05 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' A' ' 46' ' ' ARG . 14.5 m120 -53.62 -39.77 65.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.836 -1.075 . . . . 12.98 112.411 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -84.86 -43.83 13.77 Favored 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 119.977 -0.689 . . . . 17.81 109.885 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -62.3 -37.05 84.07 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.36 0.874 . . . . 15.55 113.36 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -108.06 7.13 27.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.023 0.749 . . . . 12.2 113.023 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 48.17 52.6 13.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.302 1.441 . . . . 17.4 110.392 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 49' ' ' ASN . 33.1 tp -143.24 137.12 28.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.39 -0.967 . . . . 12.25 108.39 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.61 46.54 1.37 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.579 0.704 . . . . 16.32 109.474 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 54' ' ' LEU . 13.1 tt -53.36 128.42 50.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.141 -1.39 . . . . 11.39 110.823 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.2 147.37 12.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.466 2.11 . . . . 13.44 112.179 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.438 ' HA ' HG13 ' A' ' 45' ' ' ILE . . . -68.4 -17.74 64.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.924 -1.034 . . . . 12.81 111.87 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.48 -9.27 56.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 14.14 111.915 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.27 -29.31 72.71 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.081 -0.808 . . . . 10.76 111.081 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.4 mt -76.79 -25.92 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 CA-C-O 121.414 0.626 . . . . 11.0 109.384 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -85.66 -14.03 46.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.297 -0.561 . . . . 16.59 111.526 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 t -97.03 -34.5 11.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.586 -0.446 . . . . 13.72 110.075 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -130.38 79.71 71.89 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.871 0.367 . . . . 12.25 110.273 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.8 Cg_endo -89.18 36.72 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.422 2.748 . . . . 13.57 112.813 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.0 t -124.43 127.31 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.397 -1.705 . . . . 13.28 106.397 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -52.41 -49.16 65.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.807 0.73 . . . . 11.45 112.82 -170.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 17.5 tptm -70.36 -21.33 62.89 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.16 0.505 . . . . 14.64 111.58 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.28 -29.71 24.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.584 0.707 . . . . 11.34 109.875 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -82.55 -28.12 31.2 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.305 -0.861 . . . . 9.05 111.145 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -68.75 -32.36 72.08 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.16 0.505 . . . . 9.65 110.083 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 68' ' ' LYS . 11.2 mm100 -72.23 -29.45 63.95 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 109.24 -0.652 . . . . 12.14 109.24 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.634 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 3.1 t90 -57.99 -53.87 53.33 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.351 -0.981 . . . . 11.26 108.351 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.52 -39.75 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 C-N-CA 124.153 0.981 . . . . 8.3 110.877 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.1 95.11 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.246 -0.433 . . . . 9.58 112.808 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -76.1 -13.42 60.21 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 122.55 -0.382 . . . . 10.46 111.081 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 75.5 mm-40 -83.64 -18.8 36.89 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.638 -0.875 . . . . 10.43 108.638 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.313 -1.01 0 N-CA-C 108.331 -0.989 . . . . 10.97 108.331 177.178 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.218 -0.578 0 N-CA-C 112.772 0.656 . . . . 10.09 112.772 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.09 -38.86 62.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.599 0.962 . . . . 11.53 113.599 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.01 -41.72 86.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.441 0.638 . . . . 11.91 110.81 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 107' ' ' ARG . 3.5 mpt_? -83.39 -33.71 25.72 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.781 -0.645 . . . . 10.19 110.957 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.155 0.982 . . . . 10.43 110.386 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -60.53 -47.57 85.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.957 -0.565 . . . . 10.46 110.096 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 110' ' ' ILE . 67.1 mt -61.2 -45.53 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.096 -0.705 . . . . 8.37 109.096 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.07 -35.12 68.98 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 114.83 -1.077 . . . . 8.76 111.048 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.87 -37.78 85.81 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.04 0.448 . . . . 10.86 111.47 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -76.37 -44.29 37.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.853 -0.795 . . . . 11.62 108.853 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.8 -41.02 85.77 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.747 -1.115 . . . . 7.62 109.774 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.58 -42.09 74.28 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.318 1.447 . . . . 11.84 110.174 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -81.56 -33.97 31.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 12.03 111.981 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 80.8 p -61.05 -43.92 98.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 121.01 -0.276 . . . . 9.2 111.153 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 119' ' ' GLY . 4.2 pp -75.34 -31.69 60.65 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.531 -0.468 . . . . 10.06 110.659 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 118' ' ' LEU . . . -58.4 -54.94 33.63 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.187 -0.461 . . . . 12.07 111.972 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -60.43 -43.46 96.76 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.825 0.822 . . . . 12.38 110.702 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.59 -45.12 72.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.514 -1.221 . . . . 11.77 111.922 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.1 mt -91.14 -15.33 29.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.341 0.497 . . . . 13.52 112.341 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.1 t80 66.38 33.97 6.63 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.247 -1.39 . . . . 17.15 107.247 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.38 148.73 35.22 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.766 -1.561 . . . . 16.03 108.47 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 12.8 m-20 -67.98 119.91 70.3 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.394 -0.595 . . . . 14.35 109.394 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 16.8 Cg_exo -70.82 32.25 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.858 3.039 . . . . 14.18 114.387 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 125' ' ' ASP . . . -123.13 3.52 9.72 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 108.725 -1.75 . . . . 14.05 108.725 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -106.18 40.59 1.57 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.231 -1.026 . . . . 16.88 108.231 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.88 48.72 0.39 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.612 -1.176 . . . . 12.55 113.168 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -161.51 -44.15 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 125.429 1.492 . . . . 14.87 107.911 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -64.73 -45.42 86.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.265 -0.879 . . . . 14.56 109.023 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.88 30.47 10.35 Favored Glycine 0 C--O 1.214 -1.105 0 CA-C-N 115.387 -0.824 . . . . 14.2 111.047 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.75 -17.99 23.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.487 0.66 . . . . 13.0 109.857 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -87.71 113.63 23.56 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.99 -1.115 . . . . 17.02 107.99 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -64.46 -16.2 62.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.214 0.53 . . . . 13.62 112.218 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.98 -24.51 55.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.118 -0.492 . . . . 16.54 110.618 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -78.22 -27.75 47.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.412 0.625 . . . . 15.87 109.81 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.19 -20.89 66.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.469 -1.241 . . . . 13.65 111.956 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.52 -53.77 4.89 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.843 -0.903 . . . . 14.16 110.843 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.2 mtm -98.1 146.95 25.05 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.305 -1.369 . . . . 15.81 107.305 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -137.39 -68.2 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.776 1.028 . . . . 13.63 113.776 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 t -70.9 -40.19 72.31 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.033 0.382 . . . . 14.06 112.033 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.1 -50.95 53.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.536 0.684 . . . . 14.08 109.733 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -37.97 83.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.036 -0.984 . . . . 11.82 111.143 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.6 98.44 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.653 -0.703 . . . . 10.82 111.522 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.8 m -56.84 -53.26 59.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.682 0.393 . . . . 12.55 110.115 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -64.84 -38.45 91.04 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.316 -0.402 . . . . 12.17 111.894 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.412 ' O ' HG22 ' A' ' 152' ' ' VAL . 10.0 t90 -67.56 -50.9 56.33 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.348 -0.612 . . . . 9.45 109.348 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 mmt -67.63 -26.18 66.11 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.456 -0.793 . . . . 9.88 111.435 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 26.5 tpt180 -62.92 -43.93 97.47 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.405 -0.961 . . . . 14.43 108.405 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.82 91.24 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.144 -0.782 . . . . 10.49 111.144 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 148' ' ' TRP . 97.4 t -61.09 -40.86 87.15 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.465 -0.568 . . . . 9.27 109.465 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 157' ' ' SER . 39.6 m -66.08 -30.13 70.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.751 -0.659 . . . . 11.46 110.821 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 37.6 mmt180 -67.19 -47.74 70.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.56 -0.533 . . . . 15.5 109.56 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -71.53 -55.34 8.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.235 0.828 . . . . 12.39 113.235 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -105.27 -8.35 18.34 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 114.068 1.136 . . . . 11.97 114.068 -170.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 153' ' ' SER . 28.0 m 55.58 38.88 30.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.91 0.884 . . . . 14.37 112.326 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.9 pt -104.23 144.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.333 -0.617 . . . . 13.16 109.333 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -81.98 95.36 7.37 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 123.522 0.514 . . . . 16.91 111.696 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.29 102.39 6.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.577 -0.897 . . . . 12.32 108.577 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.43 175.68 10.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 121.174 -0.21 . . . . 14.37 111.054 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.37 80.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.445 0.641 . . . . 13.15 110.935 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.84 -10.2 45.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.19 -0.914 . . . . 15.68 112.848 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 -13.64 62.33 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 111.675 0.25 . . . . 13.1 111.675 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -66.65 -18.24 23.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 O-C-N 122.107 -0.371 . . . . 12.16 111.729 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -94.02 1.76 56.17 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.933 0.873 . . . . 15.41 110.194 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.5 m -89.32 -9.55 50.1 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.061 -0.972 . . . . 15.07 108.402 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -130.93 149.04 72.58 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.36 -0.978 . . . . 12.68 108.36 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.85 -38.41 2.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.622 2.215 . . . . 15.04 112.317 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.2 p -138.16 162.15 34.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.319 -1.734 . . . . 13.26 106.319 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.17 -1.25 19.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.024 0.44 . . . . 10.32 112.118 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -76.24 -24.34 54.57 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.179 -0.674 . . . . 12.75 109.179 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.2 m -73.88 -2.65 24.69 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.254 -0.885 . . . . 11.26 111.06 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.33 -32.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.464 -0.569 . . . . 8.53 109.464 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.36 68.9 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.299 0.571 . . . . 7.7 111.22 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.37 -24.69 34.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.411 -0.588 . . . . 10.38 109.411 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.63 -60.97 2.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.66 -0.7 . . . . 11.97 110.05 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.2 p -46.14 -52.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 124.053 0.845 . . . . 9.8 113.199 -173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.91 -45.38 93.98 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 111.897 0.332 . . . . 10.83 111.897 -174.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -78.27 -29.76 48.15 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.463 -0.789 . . . . 13.85 110.448 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.25 -39.61 74.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.633 -0.712 . . . . 15.46 109.391 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.0 t -78.39 -60.55 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.692 -0.685 . . . . 13.35 111.658 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 108.664 -0.865 . . . . 13.51 108.664 -173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 112.058 0.392 . . . . 14.98 112.058 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.89 -27.24 65.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.272 0.558 . . . . 15.79 110.206 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' HB2' ' HH ' ' A' ' 52' ' ' TYR . 35.1 m -66.8 -33.46 75.66 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.459 -0.571 . . . . 12.18 109.459 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 -26.68 32.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.157 -0.474 . . . . 11.02 110.543 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -67.47 -33.97 76.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.175 -0.676 . . . . 16.75 109.175 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -68.5 -28.97 67.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.505 -0.771 . . . . 14.46 109.749 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.81 -44.4 96.25 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.379 -0.6 . . . . 10.71 109.379 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.922 -0.581 . . . . 14.51 109.492 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.75 -46.1 73.07 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.495 -0.775 . . . . 16.85 110.131 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 17' ' ' MET . 48.4 t -59.34 -45.59 90.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.573 -0.74 . . . . 13.52 110.365 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.48 -45.44 93.75 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.273 -0.422 . . . . 12.77 111.449 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.53 -22.95 63.53 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.253 -0.43 . . . . 15.19 111.574 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 -24.36 49.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.426 0.631 . . . . 16.26 109.628 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 13' ' ' SER . 26.5 mmt -78.05 -44.22 27.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.619 -0.719 . . . . 15.45 109.197 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.67 5.49 51.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 16.16 112.607 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 53.41 45.61 27.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.237 1.415 . . . . 20.58 113.107 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -125.33 -173.8 2.91 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.345 -0.983 . . . . 17.26 108.345 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -107.32 134.99 19.72 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 107.976 -1.12 . . . . 20.19 107.976 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -66.04 -11.17 29.93 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.233 2.622 . . . . 17.46 112.859 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.78 -3.41 85.91 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.527 -0.629 . . . . 18.33 111.527 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -102.75 175.41 5.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.677 -1.231 . . . . 20.77 107.677 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.422 HG12 ' HG ' ' A' ' 34' ' ' LEU . 1.9 mp 70.96 140.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 123.883 0.739 . . . . 16.1 110.725 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 6.8 mpt_? -75.25 122.77 24.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.738 -0.601 . . . . 19.87 109.577 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.66 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 p30 -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.83 0.678 . . . . 15.1 112.83 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.37 7.4 68.88 Favored Glycine 0 C--N 1.315 -0.614 0 N-CA-C 110.649 -0.98 . . . . 15.48 110.649 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -99.19 171.34 8.06 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.48 0.657 . . . . 14.88 109.54 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 81.8 mtm180 -92.93 160.3 14.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.163 -0.926 . . . . 17.38 110.38 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -58.26 -18.98 30.66 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.595 -1.184 . . . . 11.99 112.423 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -29.38 70.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.965 -0.561 . . . . 14.71 111.609 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.33 -35.45 80.38 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.361 0.6 . . . . 16.44 109.814 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HG ' HG12 ' A' ' 25' ' ' ILE . 4.1 mp -83.43 -8.92 59.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.772 -0.649 . . . . 13.83 110.248 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.78 35.26 73.08 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 114.83 -1.077 . . . . 14.3 111.373 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.04 114.05 8.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.623 -0.51 . . . . 13.04 109.623 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.22 156.34 23.21 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.481 -0.781 . . . . 15.67 109.784 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 t -56.22 -41.47 75.71 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.271 0.357 . . . . 15.49 111.45 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.23 -47.62 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.912 0.387 . . . . 16.98 110.985 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mt -66.03 -39.68 85.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.026 -0.534 . . . . 14.44 109.683 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.62 99.11 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.588 -0.733 . . . . 12.4 110.444 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.48 85.06 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.564 0.745 . . . . 14.37 111.093 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.84 -47.61 44.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.96 -0.564 . . . . 16.05 111.56 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -61.31 -47.28 86.68 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.088 0.555 . . . . 11.7 111.644 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 tp -59.69 -32.94 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 120.892 0.377 . . . . 11.48 110.571 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -66.86 -32.28 73.45 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.053 -0.522 . . . . 17.18 110.521 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.59 -31.97 60.16 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.564 -0.902 . . . . 14.15 108.564 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.49 -35.12 68.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.566 -0.743 . . . . 10.8 109.783 175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.93 -31.04 70.58 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.475 -0.784 . . . . 12.98 110.042 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -80.45 -43.95 20.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.934 -0.575 . . . . 17.81 110.047 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -65.11 -46.3 81.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.65 0.611 . . . . 15.55 112.65 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.517 ' HH ' ' HB2' ' A' ' 6' ' ' CYS . 55.6 m-85 -100.17 -0.03 39.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 112.787 0.662 . . . . 12.2 112.787 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 53.12 45.17 29.24 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.403 1.481 . . . . 17.4 111.702 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 96.0 mt -134.32 142.87 47.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.579 -1.191 . . . . 12.25 109.485 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -77.51 75.69 4.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.72 -0.844 . . . . 16.32 108.72 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mm -94.18 119.95 66.06 Favored Pre-proline 0 N--CA 1.436 -1.135 0 CA-C-N 116.292 -0.413 . . . . 11.39 111.814 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.15 164.21 13.24 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.869 2.38 . . . . 13.44 110.112 173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -2.92 17.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.634 -0.712 . . . . 12.81 112.518 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.49 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 p30 -68.3 -23.6 64.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.936 -0.306 . . . . 14.14 110.957 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.06 -30.62 70.66 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 119.883 -1.151 . . . . 10.76 111.588 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.94 -21.15 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.723 0.809 . . . . 11.0 110.036 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 16.7 m-85 -85.33 -45.86 11.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.384 -0.598 . . . . 16.59 109.384 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -67.54 -44.6 77.94 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.929 -0.578 . . . . 13.72 110.127 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.05 86.72 14.15 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.873 -0.788 . . . . 12.25 108.873 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 84.1 Cg_endo -83.9 14.87 2.28 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.751 2.301 . . . . 13.57 113.275 -174.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.8 t -124.56 120.29 58.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.118 -1.808 . . . . 13.28 106.118 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.66 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.5 p90 -58.72 -31.6 68.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 11.45 114.313 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -69.36 -24.98 63.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.766 0.654 . . . . 14.64 112.766 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.78 16.97 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.644 -0.873 . . . . 11.34 108.644 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 57.2 t80 -62.15 -28.91 69.98 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.748 -1.114 . . . . 9.05 112.262 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 p -70.0 -26.45 64.08 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.471 -0.768 . . . . 9.65 110.716 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -81.44 -28.94 33.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.746 -0.835 . . . . 12.14 108.746 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 66.1 t90 -58.26 -52.27 66.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.476 1.111 . . . . 11.26 108.094 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 54.4 t -67.88 -39.9 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 CA-C-N 115.266 -0.879 . . . . 8.3 110.781 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.73 97.07 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.192 -0.528 . . . . 9.58 112.3 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.2 m -67.99 -35.97 79.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 111.786 0.291 . . . . 10.46 111.786 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 27.6 pt20 -75.78 -18.77 59.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.363 -0.535 . . . . 10.43 110.517 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 116.141 -0.481 . . . . 10.97 111.039 176.799 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 C--O 1.243 0.742 0 N-CA-C 112.922 0.712 . . . . 10.09 112.922 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -42.03 80.88 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.414 0.524 . . . . 11.53 112.414 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -51.72 -48.4 63.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.405 0.682 . . . . 11.91 111.573 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -68.92 -42.82 76.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 10.19 109.951 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.32 -44.48 83.25 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.989 -1.005 . . . . 10.43 111.766 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -59.84 -39.09 83.98 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.639 0.257 . . . . 10.46 111.038 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.501 HG22 HG11 ' A' ' 178' ' ' VAL . 59.7 mt -71.29 -50.95 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.921 -0.4 . . . . 8.37 109.921 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -58.84 -39.94 82.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.109 -0.496 . . . . 8.76 111.139 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 31.0 t70 -67.73 -36.98 81.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 10.86 111.007 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -70.05 -42.55 72.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.316 0.579 . . . . 11.62 109.782 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.6 -41.49 94.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.534 1.134 . . . . 7.62 109.033 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 33.9 ttmt -54.47 -54.3 42.74 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.559 1.544 . . . . 11.84 110.254 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -67.34 -42.75 83.04 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.916 -0.583 . . . . 12.03 111.908 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.4 t -56.75 -53.09 61.73 Favored 'General case' 0 C--O 1.248 1.021 0 O-C-N 123.574 0.546 . . . . 9.2 111.79 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.36 -36.77 74.39 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 120.676 -0.409 . . . . 10.06 110.912 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.7 84.95 Favored Glycine 0 C--O 1.223 -0.546 0 N-CA-C 111.24 -0.744 . . . . 12.07 111.24 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 -44.4 91.52 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 124.423 1.089 . . . . 12.38 110.804 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.0 -49.6 67.23 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.96 -1.018 . . . . 11.77 112.145 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 tp -94.02 4.23 54.21 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.703 -0.681 . . . . 13.52 112.358 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.1 t80 59.78 40.65 19.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.197 1.399 . . . . 17.15 110.187 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -111.49 154.86 24.12 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.78 -1.563 . . . . 16.03 106.78 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.8 117.94 63.88 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 107.577 -1.268 . . . . 14.35 107.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.57 107.89 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.921 3.081 . . . . 14.18 113.033 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 130' ' ' ARG . . . 125.46 -36.31 2.82 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.505 -1.225 . . . . 14.05 111.651 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -86.31 42.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.38 1.086 . . . . 16.88 109.366 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 127' ' ' GLY . 3.5 pp -137.65 -7.07 1.69 Allowed 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.584 -1.644 . . . . 12.55 111.199 -178.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 127' ' ' GLY . 38.5 ptt180 -95.91 -5.95 40.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.94 -0.573 . . . . 14.87 110.081 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -70.22 -33.95 72.29 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 14.56 108.797 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.41 -62.67 0.95 Allowed Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 108.84 -1.704 . . . . 14.2 108.84 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 60.07 26.81 16.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.367 1.067 . . . . 13.0 110.992 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -97.68 139.89 32.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.308 -1.315 . . . . 17.02 109.662 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 14.5 p90 -70.19 -12.88 61.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.276 -0.875 . . . . 13.62 109.43 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.65 -32.12 62.16 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.272 -0.876 . . . . 16.54 110.342 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.17 -42.39 6.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.429 0.633 . . . . 15.87 110.852 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.5 mt -79.66 -22.35 43.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.589 -0.732 . . . . 13.65 110.465 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -102.72 43.79 1.62 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.954 -1.259 . . . . 14.16 109.954 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.7 ttp -60.29 -43.41 96.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.655 0.782 . . . . 15.81 110.551 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -127.34 120.21 28.02 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 107.479 -1.304 . . . . 13.63 107.479 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -62.06 -39.33 92.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.877 -1.056 . . . . 14.06 111.972 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.7 t -68.76 -36.83 76.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 110.146 -0.316 . . . . 14.08 110.146 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.5 m -56.9 -46.61 81.8 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.194 -0.457 . . . . 11.82 109.776 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.96 -22.52 76.67 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 119.677 -1.249 . . . . 10.82 111.87 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 92.5 m -63.81 -48.89 75.05 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.64 -0.504 . . . . 12.55 109.64 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -59.6 -40.24 86.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.57 0.7 . . . . 12.17 110.227 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.4 ' O ' HG22 ' A' ' 152' ' ' VAL . 22.4 t90 -68.5 -53.03 25.89 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.927 -1.033 . . . . 9.45 112.318 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.412 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 32.7 ttm -65.96 -35.06 79.56 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 111.915 0.339 . . . . 9.88 111.915 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -66.4 -35.95 81.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.528 . . . . 14.43 109.576 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.06 -43.54 97.14 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.628 -0.989 . . . . 10.49 110.628 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 148' ' ' TRP . 75.9 t -56.55 -45.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.607 0.763 . . . . 9.27 109.253 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.2 m -59.51 -40.15 86.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.377 -0.828 . . . . 11.46 110.994 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -70.72 -46.96 62.1 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.478 -0.328 . . . . 15.5 111.591 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -68.22 -30.61 69.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.293 0.849 . . . . 12.39 113.293 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -101.56 0.16 35.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.075 -0.65 . . . . 11.97 112.123 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.8 m 56.42 45.94 21.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.638 -1.164 . . . . 14.37 112.308 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.5 156.15 41.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 13.16 109.047 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -88.8 106.58 18.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.221 -1.029 . . . . 16.91 108.221 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.41 110.3 11.38 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.782 -0.451 . . . . 12.32 109.782 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.28 135.92 47.67 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.944 -0.571 . . . . 14.37 110.469 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.46 -8.61 9.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.416 1.086 . . . . 13.15 112.834 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -77.42 -10.75 59.65 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.386 -0.598 . . . . 15.68 109.386 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -63.7 -13.13 40.35 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 116.102 -0.499 . . . . 13.1 112.256 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.8 pt -68.64 -12.32 15.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 121.166 0.508 . . . . 12.16 109.937 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.59 19.32 13.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.548 -0.908 . . . . 15.41 108.548 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 88.8 m -108.24 -26.55 10.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.187 -0.915 . . . . 15.07 109.679 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -122.75 143.67 40.76 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 107.978 -1.119 . . . . 12.68 107.978 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.566 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 68.8 Cg_endo -93.02 -5.73 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.902 1.735 . . . . 15.04 111.897 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.756 -0.656 . . . . 13.26 111.134 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.94 -32.92 71.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.904 -1.043 . . . . 10.32 111.988 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -62.71 -20.36 64.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.172 -0.467 . . . . 12.75 111.187 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.8 m -70.88 -17.65 62.71 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.102 -0.499 . . . . 11.26 111.024 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.72 -44.94 61.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.892 -1.151 . . . . 8.53 107.892 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.02 80.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.471 -0.786 . . . . 7.7 111.39 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.99 -19.75 60.55 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.318 0.488 . . . . 10.38 112.318 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -74.75 -52.61 11.05 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.331 -0.618 . . . . 11.97 109.331 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 110' ' ' ILE . 3.3 p -62.46 -42.64 96.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.578 -0.737 . . . . 9.8 110.497 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.43 -41.87 90.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.401 . . . . 10.83 110.655 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -69.07 -53.24 21.43 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.74 0.816 . . . . 13.85 113.071 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -85.01 -32.47 22.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 115.187 1.551 . . . . 15.46 115.187 -173.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.87 -40.75 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.817 -0.753 . . . . 13.35 110.213 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 120.44 -0.504 . . . . 13.51 110.255 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 C--O 1.223 -0.29 0 CA-C-O 121.051 0.453 . . . . 14.98 110.008 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.501 ' HA ' HE21 ' A' ' 8' ' ' GLN . 42.9 tt0 -65.92 -37.85 87.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 120.842 0.353 . . . . 15.79 111.295 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 p -63.82 -32.15 73.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.069 0.461 . . . . 12.18 111.016 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -75.14 -40.85 59.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.254 -0.43 . . . . 11.02 109.843 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.501 HE21 ' HA ' ' A' ' 5' ' ' GLU . 50.8 mt-30 -54.47 -43.91 72.13 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.8 0.44 . . . . 16.75 110.616 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.1 -41.41 78.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.771 -0.649 . . . . 14.46 111.006 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.32 -36.29 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.365 -0.38 . . . . 10.71 110.753 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 68.0 mtt180 -60.57 -45.64 93.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.763 -0.829 . . . . 14.51 108.763 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 27.9 mt-30 -59.92 -53.83 53.22 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.558 -0.747 . . . . 16.85 110.244 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 m -56.71 -42.85 79.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.123 -0.944 . . . . 13.52 112.681 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.83 -52.15 22.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.455 0.169 . . . . 12.77 110.687 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.71 71.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.39 0.515 . . . . 15.19 112.39 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.32 84.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.656 0.265 . . . . 16.26 111.544 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.3 mtt -75.81 -32.24 59.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.291 0.567 . . . . 15.45 110.893 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.62 -2.36 41.74 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.877 -0.601 . . . . 16.16 112.199 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 57.54 44.05 21.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.548 1.139 . . . . 20.58 111.589 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.57 177.0 4.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.134 -1.061 . . . . 17.26 108.134 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -96.76 133.72 24.09 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 110.47 -0.196 . . . . 20.19 110.47 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.77 20.66 1.19 Allowed 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 122.89 2.394 . . . . 17.46 111.484 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.16 -104.45 1.2 Allowed Glycine 0 N--CA 1.428 -1.89 0 CA-C-N 114.899 -1.046 . . . . 18.33 113.245 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.42 67.63 9.97 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.299 0.852 . . . . 20.77 113.299 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 pt -90.65 163.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.266 -1.012 . . . . 16.1 108.266 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.511 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 62.0 mtm180 -81.33 132.54 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.382 0.611 . . . . 19.87 109.569 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.01 -39.15 59.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.245 1.818 . . . . 15.1 112.475 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.32 7.48 66.46 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.8 -0.636 . . . . 15.48 114.182 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 74.8 m -68.2 119.16 12.32 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.815 0.817 . . . . 14.88 112.302 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 89.6 mtt180 -70.53 157.92 37.03 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.911 -1.495 . . . . 17.38 110.562 176.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -52.27 -48.6 65.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.951 0.405 . . . . 11.99 111.648 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.27 -41.31 84.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.534 0.734 . . . . 14.71 110.584 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.66 -45.14 84.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.854 -0.612 . . . . 16.44 110.463 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.4 -35.58 74.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.984 -0.553 . . . . 13.83 110.925 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.73 22.06 1.33 Allowed Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.194 -1.003 . . . . 14.3 112.983 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 167.18 20.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.533 0.682 . . . . 13.04 110.681 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -131.41 152.24 50.83 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 117.403 -1.284 . . . . 15.67 107.57 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -55.98 -40.32 73.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 119.495 1.043 . . . . 15.49 111.923 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.21 -51.11 51.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.732 -0.667 . . . . 16.98 110.405 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.64 -35.6 73.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.923 -0.581 . . . . 14.44 112.226 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.97 -30.09 70.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 12.4 110.336 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.47 78.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.512 -0.767 . . . . 14.37 110.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.54 -43.22 66.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 120.473 -0.491 . . . . 16.05 109.762 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -55.76 -54.67 41.62 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.605 -1.18 . . . . 11.7 110.823 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -31.69 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.804 0.335 . . . . 11.48 110.882 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.53 -35.25 75.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.386 0.612 . . . . 17.18 109.509 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -70.21 -21.79 62.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.018 -0.537 . . . . 14.15 112.169 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.9 -46.21 92.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.6 -0.889 . . . . 10.8 108.6 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -62.58 -34.59 77.28 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.321 -0.854 . . . . 12.98 110.952 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -79.12 -39.88 32.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.289 -0.414 . . . . 17.81 110.957 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -79.46 -28.09 41.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.404 -0.362 . . . . 15.55 111.962 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -107.88 -4.84 17.61 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.439 1.274 . . . . 12.2 114.439 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 44.32 47.64 7.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.863 1.665 . . . . 17.4 112.854 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.0 tp -145.33 151.8 38.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.901 -1.148 . . . . 12.25 107.901 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.86 129.41 34.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.911 -0.774 . . . . 16.32 108.911 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.97 153.52 71.12 Favored Pre-proline 0 N--CA 1.42 -1.957 0 C-N-CA 122.76 0.424 . . . . 11.39 110.14 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.18 96.35 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.954 1.769 . . . . 13.44 110.983 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.77 66.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.454 0.645 . . . . 12.81 109.849 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.08 -7.99 14.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 114.632 -1.167 . . . . 14.14 111.735 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.7 -35.49 89.87 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 116.017 -0.538 . . . . 10.76 112.184 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 HD12 HG22 ' A' ' 61' ' ' ILE . 39.3 mt -73.68 -28.6 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.973 0.892 . . . . 11.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -85.24 -3.09 58.7 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.184 -0.916 . . . . 16.59 112.197 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -111.04 -73.23 0.69 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 116.356 -0.384 . . . . 13.72 110.705 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -136.82 88.51 18.56 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 122.199 1.0 . . . . 12.25 110.106 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.1 Cg_endo -80.91 62.41 8.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.828 3.019 . . . . 13.57 114.063 -172.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.71 129.56 43.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.709 -1.96 . . . . 13.28 105.709 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.37 -37.82 74.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.353 -0.385 . . . . 11.45 111.723 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.33 -31.94 72.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.458 0.647 . . . . 14.64 110.215 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.2 45.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.461 0.648 . . . . 11.34 109.5 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 73' ' ' TRP . 58.1 t80 -72.44 -32.65 66.48 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.499 -0.773 . . . . 9.05 111.364 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -65.2 -23.78 67.18 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.008 -0.677 . . . . 9.65 111.017 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -78.13 -33.73 50.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.23 -0.655 . . . . 12.14 109.23 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -50.2 -59.55 3.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.058 . . . . 11.26 110.411 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.58 -34.48 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 CA-C-N 115.742 -0.663 . . . . 8.3 110.666 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.43 -38.24 93.2 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 116.068 -0.514 . . . . 9.58 113.234 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -81.17 -20.46 41.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.226 0.536 . . . . 10.46 110.12 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 14.5 mm100 -76.8 -23.37 52.83 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.362 0.601 . . . . 10.43 109.906 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 122.129 0.966 . . . . 10.97 109.385 175.642 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.414 -2.261 0 N-CA-C 108.256 -1.016 . . . . 10.09 108.256 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.61 -56.77 17.57 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.204 -0.907 . . . . 11.53 112.867 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 110' ' ' ILE . 31.3 mm-40 -59.04 -41.66 88.39 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.409 0.623 . . . . 11.91 110.562 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 37.3 ttt180 -66.24 -36.89 84.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.043 -0.981 . . . . 10.19 111.565 -176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.57 -34.51 70.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.877 -0.729 . . . . 10.43 110.851 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 m -62.28 -41.58 98.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.78 -0.822 . . . . 10.46 108.78 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 51.7 mt -56.68 -44.52 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.165 -0.925 . . . . 8.37 110.932 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 107' ' ' ARG . 15.1 mm100 -53.97 -30.74 48.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.45 0.7 . . . . 8.76 112.431 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -71.14 -46.75 60.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.468 0.652 . . . . 10.86 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 96.0 m-85 -74.79 -27.42 60.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.33 0.586 . . . . 11.62 110.258 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -66.03 -42.3 89.8 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.26 -1.015 . . . . 7.62 108.26 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -60.95 -42.18 97.73 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.001 -0.999 . . . . 11.84 109.78 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.89 -20.01 65.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 12.03 112.382 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.4 m -82.63 -46.02 13.79 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.22 -0.659 . . . . 9.2 109.22 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 59.9 tp -63.13 -41.76 99.38 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.554 0.692 . . . . 10.06 109.633 175.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.82 -49.66 76.16 Favored Glycine 0 C--O 1.2 -2.0 0 CA-C-N 114.935 -1.029 . . . . 12.07 112.454 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -63.48 -28.7 70.14 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.004 0.43 . . . . 12.38 111.094 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 118' ' ' LEU . 26.3 tp -61.3 -42.01 97.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.68 -0.691 . . . . 11.77 110.713 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.13 -76.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.128 -0.693 . . . . 13.52 109.128 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -173.7 -46.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.103 2.561 . . . . 17.15 106.662 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.5 tp -168.21 148.7 4.87 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.252 -2.129 . . . . 16.03 105.252 175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 0.9 OUTLIER -95.82 136.07 22.51 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.29 -1.374 . . . . 14.35 107.29 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 2.7 Cg_endo -86.54 29.86 0.5 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.239 1.959 . . . . 14.18 112.929 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.78 57.61 0.78 Allowed Glycine 0 C--N 1.309 -0.924 0 N-CA-C 110.376 -1.089 . . . . 14.05 110.376 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.58 -18.27 20.72 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.526 0.679 . . . . 16.88 110.689 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.8 113.97 5.99 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.097 -0.956 . . . . 12.55 110.538 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 75.84 10.26 3.3 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.261 . . . . 14.87 112.247 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.3 m -103.66 25.89 9.21 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.68 0.752 . . . . 14.56 110.019 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.39 88.78 1.98 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.68 -0.771 . . . . 14.2 111.99 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.58 95.58 4.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.946 -0.761 . . . . 13.0 108.946 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -118.37 146.69 44.2 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.658 0.742 . . . . 17.02 111.305 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -62.14 -14.63 39.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.819 1.248 . . . . 13.62 112.396 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -69.15 -33.1 72.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.372 0.606 . . . . 16.54 109.905 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.51 -44.74 5.77 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.416 -0.811 . . . . 15.87 110.372 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.06 -23.21 64.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.993 -0.549 . . . . 13.65 111.2 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.06 16.15 30.43 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.557 -0.747 . . . . 14.16 111.626 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.7 ttm -77.85 -24.09 48.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.74 -1.207 . . . . 15.81 107.74 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.08 139.91 52.25 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.669 -1.975 . . . . 13.63 105.669 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.9 m -80.78 -22.73 39.87 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.435 -0.95 . . . . 14.06 108.435 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.878 1.271 . . . . 14.08 111.976 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.37 88.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.882 -0.599 . . . . 11.82 111.572 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.8 44.26 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.782 -0.723 . . . . 10.82 111.354 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.6 m -53.28 -50.87 63.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.346 0.658 . . . . 12.55 110.938 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -76.49 -34.37 58.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.404 0.89 . . . . 12.17 113.404 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -69.9 -52.42 24.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.398 -0.521 . . . . 9.45 109.614 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 165' ' ' ILE . 33.1 ttm -69.66 -31.62 69.8 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.345 0.498 . . . . 9.88 112.345 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -64.57 -35.0 79.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.45 -0.574 . . . . 14.43 109.45 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.71 85.79 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.218 -1.153 . . . . 10.49 110.218 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.05 -49.76 80.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 123.748 0.819 . . . . 9.27 110.036 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.3 t -55.98 -49.55 73.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.813 0.845 . . . . 11.46 110.681 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -66.04 -49.6 67.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.754 0.279 . . . . 15.5 111.754 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -63.06 -34.59 77.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.302 0.853 . . . . 12.39 113.302 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 113' ' ' TYR . 88.5 m-85 -101.06 -3.76 28.67 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.952 0.723 . . . . 11.97 112.952 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t 63.63 34.41 12.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.826 0.85 . . . . 14.37 109.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.5 pt -107.47 155.66 8.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.635 -0.711 . . . . 13.16 109.492 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -99.42 96.75 7.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.791 0.329 . . . . 16.91 111.87 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -124.73 118.59 26.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -108.0 168.4 9.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.423 0.63 . . . . 14.37 111.154 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.13 -6.78 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.505 1.522 . . . . 13.15 114.751 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.91 -23.46 17.43 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.516 -0.474 . . . . 15.68 109.948 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.27 0.52 31.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.786 0.803 . . . . 13.1 109.473 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.489 ' HA ' ' SD ' ' A' ' 149' ' ' MET . 5.9 tt -75.11 -14.41 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.899 -1.046 . . . . 12.16 110.46 -172.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -106.4 6.37 30.32 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.224 -0.898 . . . . 15.41 109.46 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.2 m -87.09 -32.11 20.11 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.796 -0.638 . . . . 15.07 110.092 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.45 74.19 77.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.22 -0.659 . . . . 12.68 109.22 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -94.4 37.22 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.837 2.358 . . . . 15.04 112.115 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 p -140.77 163.2 33.56 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 13.26 109.788 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 49.2 tp -67.21 -55.38 14.3 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.916 0.389 . . . . 10.32 110.518 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -61.27 -44.56 97.03 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.409 -0.814 . . . . 12.75 112.856 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -68.24 -30.66 69.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.754 0.252 . . . . 11.26 110.696 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.59 -45.83 61.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.438 -1.319 . . . . 8.53 107.438 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.87 99.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.605 -0.725 . . . . 7.7 111.243 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 7.0 m-20 -62.94 -33.63 75.76 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.68 0.276 . . . . 10.38 110.679 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 24.7 tp10 -69.22 -57.05 5.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.973 -0.558 . . . . 11.97 110.528 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.93 -36.67 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.136 -0.483 . . . . 9.8 111.518 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.93 -38.36 82.16 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.1 0.476 . . . . 10.83 111.19 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 26.6 mmm180 -77.87 -33.26 52.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 13.85 111.481 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 9.7 mmp_? -73.25 -44.5 59.31 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.745 -0.382 . . . . 15.46 111.555 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.18 -51.73 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.22 0.325 . . . . 13.35 111.761 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.395 -0.812 . . . . 13.51 111.284 -177.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 121.219 0.533 . . . . 14.98 109.932 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.09 -35.44 47.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.901 0.704 . . . . 15.79 112.901 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.74 -43.27 99.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.138 0.495 . . . . 12.18 111.046 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.55 81.78 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.099 -0.501 . . . . 11.02 109.872 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -55.58 -52.31 64.2 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.542 0.526 . . . . 16.75 110.094 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -60.48 -45.72 92.73 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.176 -0.92 . . . . 14.46 111.11 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.89 -36.96 78.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.227 -0.442 . . . . 10.71 111.245 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -62.5 -42.65 99.64 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.032 -0.729 . . . . 14.51 109.032 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.65 -49.62 62.0 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.354 -0.839 . . . . 16.85 110.987 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -62.21 -36.01 80.62 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.041 0.386 . . . . 13.52 112.041 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.47 -55.64 19.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.442 -0.947 . . . . 12.77 108.442 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.87 89.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.131 -0.94 . . . . 15.19 112.016 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.6 77.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.895 0.379 . . . . 16.26 111.479 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.486 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 66.1 mtt -73.76 -21.55 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.677 -0.238 . . . . 15.45 111.511 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.02 11.96 25.52 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.277 0.473 . . . . 16.16 112.277 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 60.84 40.78 15.41 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.419 1.104 . . . . 20.58 110.06 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 68.1 m -121.93 155.28 35.83 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.694 -0.854 . . . . 17.26 108.694 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.42 131.3 31.39 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.74 -0.467 . . . . 20.19 109.74 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.62 -21.5 62.87 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.918 3.079 . . . . 17.46 116.006 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.39 -6.2 84.15 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 119.939 -1.124 . . . . 18.33 111.967 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.96 21.84 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.223 0.535 . . . . 20.77 110.785 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.3 153.4 7.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.79 -1.189 . . . . 16.1 107.79 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -108.22 124.98 51.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.401 0.619 . . . . 19.87 111.085 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -73.0 -21.47 60.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.715 -1.13 . . . . 15.1 111.459 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.92 5.29 79.06 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.303 -0.951 . . . . 15.48 112.906 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -91.68 157.29 17.03 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.521 0.677 . . . . 14.88 110.405 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 22.0 mtp180 -82.49 146.87 29.01 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.988 -1.006 . . . . 17.38 111.347 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -54.64 -43.54 72.39 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 118.52 0.6 . . . . 11.99 112.416 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.11 -31.21 72.3 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.017 -0.538 . . . . 14.71 110.942 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.63 -30.06 46.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.581 0.705 . . . . 16.44 109.266 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.0 -28.92 63.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.675 -0.693 . . . . 13.83 110.572 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.03 4.4 7.87 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.333 -0.937 . . . . 14.3 112.773 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 41' ' ' ALA . 7.3 tt -81.93 131.16 35.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.976 0.417 . . . . 13.04 110.084 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.11 166.42 12.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 117.959 -1.019 . . . . 15.67 109.344 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -55.92 -41.53 74.73 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 119.166 0.894 . . . . 15.49 110.949 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.01 -44.98 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.632 -0.713 . . . . 16.98 110.4 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.14 -38.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.935 -0.575 . . . . 14.44 109.946 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 36' ' ' LEU . . . -58.27 -46.31 86.25 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 123.372 0.669 . . . . 12.4 110.973 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.32 71.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.709 0.766 . . . . 14.37 111.251 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -78.43 -47.91 16.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.328 -0.851 . . . . 16.05 110.931 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 7.6 t90 -60.6 -48.81 80.12 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.323 1.449 . . . . 11.7 111.367 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 tp -62.34 -28.41 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.718 0.77 . . . . 11.48 110.519 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.36 -35.05 54.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.211 -0.904 . . . . 17.18 109.637 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -74.29 -31.88 62.67 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.164 -0.471 . . . . 14.15 111.678 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -69.77 -36.79 71.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.603 -0.839 . . . . 10.8 109.412 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.402 ' OD1' HG13 ' A' ' 56' ' ' ILE . 75.1 m-20 -66.73 -27.82 67.92 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.806 0.812 . . . . 12.98 110.417 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.06 -45.54 26.74 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.663 -1.153 . . . . 17.81 110.105 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -70.5 -39.25 74.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.837 0.31 . . . . 15.55 111.837 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.81 -3.9 55.55 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.909 1.077 . . . . 12.2 113.909 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 56.37 47.29 19.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.898 1.332 . . . . 17.4 108.791 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.0 tp -139.0 153.99 48.21 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.46 -1.311 . . . . 12.25 107.46 -173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -114.87 89.17 3.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.874 -0.787 . . . . 16.32 108.874 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.402 HG13 ' OD1' ' A' ' 49' ' ' ASN . 1.5 pp -76.55 147.9 79.22 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 122.243 -0.286 . . . . 11.39 111.717 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -62.65 122.39 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.637 2.225 . . . . 13.44 110.285 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.65 2.34 4.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.798 1.407 . . . . 12.81 114.798 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.43 5.14 46.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.937 -0.477 . . . . 14.14 110.78 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.63 -66.97 2.47 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.088 -0.505 . . . . 10.76 113.871 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.79 -28.08 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 124.436 1.094 . . . . 11.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -75.66 -39.12 58.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.416 -0.811 . . . . 16.59 110.469 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 92.5 m -82.8 -44.0 16.04 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.012 -0.54 . . . . 13.72 110.954 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -113.74 88.36 13.78 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 123.756 0.822 . . . . 12.25 109.093 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.4 Cg_endo -83.56 25.78 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.938 2.425 . . . . 13.57 113.128 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.13 123.69 59.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.614 -1.624 . . . . 13.28 106.614 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.49 -41.32 76.45 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.15 0.98 . . . . 11.45 112.524 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.25 -30.52 71.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.366 0.603 . . . . 14.64 111.081 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.99 -25.01 30.33 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.988 0.423 . . . . 11.34 110.095 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 49.4 t80 -82.58 -31.45 28.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.928 -0.578 . . . . 9.05 110.89 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 p -68.33 -36.97 80.06 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.627 -0.879 . . . . 9.65 108.627 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.6 -41.99 98.28 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.826 -1.079 . . . . 12.14 109.489 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.473 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 63.7 t90 -52.68 -56.01 18.56 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.969 1.308 . . . . 11.26 109.587 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.13 -42.33 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 C-N-CA 123.295 0.638 . . . . 8.3 110.675 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.66 -17.03 66.48 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.343 -0.39 . . . . 9.58 113.454 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.5 m -81.23 -30.12 34.27 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.194 -0.669 . . . . 10.46 109.194 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.85 -43.63 11.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.814 -0.63 . . . . 10.43 110.16 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.837 -0.62 . . . . 10.97 109.86 178.636 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 22.0 m . . . . . 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 10.09 112.403 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.72 -26.41 50.04 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.994 -1.003 . . . . 11.53 111.382 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.441 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 8.2 tp-100 -63.9 -48.08 78.06 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.267 -1.383 . . . . 11.91 107.267 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 176' ' ' ASP . 31.9 ttm180 -51.9 -45.62 64.25 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 114.138 -1.392 . . . . 10.19 111.544 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 104' ' ' SER . 52.6 mt-10 -61.3 -44.08 97.82 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 111.905 0.335 . . . . 10.43 111.905 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -65.06 -46.57 80.65 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 120.792 0.329 . . . . 10.46 110.318 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.81 -43.2 96.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.696 -0.684 . . . . 8.37 111.468 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.71 -34.03 72.37 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.496 0.718 . . . . 8.76 111.34 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.73 -30.37 59.22 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.468 -0.493 . . . . 10.86 110.051 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -71.85 -45.92 59.75 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.307 -0.997 . . . . 11.62 108.307 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.84 -40.25 75.73 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.579 -1.192 . . . . 7.62 108.842 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -55.47 -48.73 74.06 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 124.343 1.057 . . . . 11.84 110.601 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -69.31 -38.76 78.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.391 0.615 . . . . 12.03 110.455 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -63.67 -40.45 96.86 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.337 -0.847 . . . . 9.2 110.054 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.11 -38.93 66.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.997 -0.547 . . . . 10.06 109.92 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.93 -27.07 66.36 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-N 115.705 -0.68 . . . . 12.07 112.844 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.23 -29.13 70.24 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.341 0.591 . . . . 12.38 110.041 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.82 -28.93 17.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.988 -0.551 . . . . 11.77 111.067 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.73 -30.14 24.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.91 0.386 . . . . 13.52 110.901 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 74.78 -38.89 0.4 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.545 1.538 . . . . 17.15 111.621 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.23 137.19 52.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.505 -0.924 . . . . 16.03 108.505 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.43 134.77 54.32 Favored Pre-proline 0 CA--C 1.479 -1.755 0 O-C-N 123.688 0.618 . . . . 14.35 109.666 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.35 -26.16 81.21 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.685 2.256 . . . . 14.18 109.911 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.94 -45.96 1.53 Allowed Glycine 0 CA--C 1.493 -1.334 0 CA-C-N 115.175 -0.92 . . . . 14.05 111.84 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -110.31 -48.64 3.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.396 . . . . 16.88 110.324 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp 63.93 -173.08 0.17 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.311 1.044 . . . . 12.55 110.97 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 72.56 -49.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 14.87 111.352 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 m -90.1 114.61 26.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.013 -1.477 . . . . 14.56 107.013 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.18 51.02 3.27 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 108.736 -1.745 . . . . 14.2 108.736 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.02 18.23 17.8 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.081 -0.559 . . . . 13.0 111.334 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.99 83.55 3.68 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.124 -1.065 . . . . 17.02 108.124 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -80.32 -7.12 58.92 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.652 0.739 . . . . 13.62 110.182 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.0 mt -56.46 -24.91 48.78 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.931 1.292 . . . . 16.54 109.368 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.35 -6.13 52.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.944 -1.025 . . . . 15.87 111.799 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.71 9.24 12.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.374 0.607 . . . . 13.65 111.251 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.62 -97.2 2.22 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.944 -0.571 . . . . 14.16 112.562 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.2 ttm -82.05 66.63 7.71 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.945 1.355 . . . . 15.81 110.057 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -92.71 -46.87 7.36 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.819 -1.537 . . . . 13.63 111.996 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.594 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 4.4 m -60.94 -34.63 75.02 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.186 0.517 . . . . 14.06 111.902 -176.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.43 -52.75 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 14.08 110.568 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.2 t -72.14 -28.34 63.19 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 109.81 -0.441 . . . . 11.82 109.81 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.44 -28.77 73.94 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 116.066 -0.515 . . . . 10.82 111.832 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 93.8 m -61.36 -46.97 87.96 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.901 0.382 . . . . 12.55 110.624 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.82 -49.86 71.21 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.447 -0.797 . . . . 12.17 109.608 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.435 ' CZ3' HD13 ' A' ' 171' ' ' LEU . 79.1 t90 -57.76 -49.26 77.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.252 -0.886 . . . . 9.45 111.911 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 149' ' ' MET . 0.7 OUTLIER -57.28 -47.75 80.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 123.378 0.671 . . . . 9.88 111.255 -176.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -69.68 -35.65 75.31 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.744 -0.382 . . . . 14.43 111.603 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.15 -47.58 79.65 Favored Glycine 0 C--O 1.244 0.756 0 C-N-CA 120.798 -0.715 . . . . 10.49 112.148 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.24 -41.17 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 111.839 0.311 . . . . 9.27 111.839 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 158' ' ' ILE . 36.1 p -62.82 -37.88 88.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 111.543 0.201 . . . . 11.46 111.543 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.51 -25.18 65.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 15.5 111.113 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -78.82 -31.54 45.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.919 0.39 . . . . 12.39 110.284 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -94.97 5.69 51.19 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.375 0.607 . . . . 11.97 110.761 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.4 m 57.62 41.04 26.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.901 1.281 . . . . 14.37 111.58 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 153' ' ' SER . 17.8 pt -131.11 156.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.703 -0.681 . . . . 13.16 109.517 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -102.12 108.63 20.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.291 -0.263 . . . . 16.91 110.291 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.87 124.96 42.03 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.612 -0.267 . . . . 12.32 110.804 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.48 143.54 28.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.772 -0.825 . . . . 14.37 108.772 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -70.84 -12.03 61.31 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.345 0.593 . . . . 13.15 112.134 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.51 -12.84 61.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.465 -0.789 . . . . 15.68 109.99 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.71 -15.83 63.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.435 -0.802 . . . . 13.1 112.334 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 162' ' ' ALA . 24.5 pt -71.75 -4.66 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.777 0.799 . . . . 12.16 110.605 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.594 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 38.3 m-85 -110.06 0.83 18.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.571 -0.74 . . . . 15.41 109.498 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.5 m -96.02 -23.27 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.802 -0.814 . . . . 15.07 108.802 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -124.53 138.33 30.93 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.264 -1.013 . . . . 12.68 108.264 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.68 -15.06 27.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.86 2.374 . . . . 15.04 112.389 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.1 p -137.39 143.77 42.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.003 -0.74 . . . . 13.26 109.003 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.435 HD13 ' CZ3' ' A' ' 148' ' ' TRP . 32.4 tp -69.22 -25.16 64.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 10.32 110.979 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.37 -19.64 62.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 12.75 111.634 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.587 ' HA ' ' OD2' ' A' ' 176' ' ' ASP . 16.7 m -71.1 -12.09 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.044 -0.525 . . . . 11.26 112.137 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -64.86 -42.15 95.1 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.298 -1.001 . . . . 8.53 108.298 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 178' ' ' VAL . . . -65.68 -23.42 66.77 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.475 -0.784 . . . . 7.7 110.979 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 173' ' ' SER . 63.4 m-20 -79.39 -25.84 42.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.971 0.415 . . . . 10.38 111.165 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.36 -33.37 16.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.53 0.681 . . . . 11.97 109.463 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 175' ' ' ALA . 7.2 p -53.66 -34.15 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 114.746 1.387 . . . . 9.8 114.746 -170.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 106' ' ' GLN . 7.9 m-20 -57.85 -50.46 73.22 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.217 0.532 . . . . 10.83 109.799 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -71.95 -24.53 61.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.356 -0.838 . . . . 13.85 111.334 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -84.75 -46.26 11.58 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.082 -0.508 . . . . 15.46 111.199 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.67 -41.17 19.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 112.348 0.499 . . . . 13.35 112.348 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 119.156 -0.45 . . . . 13.51 109.812 -179.055 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.495 0.664 . . . . 14.98 110.948 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -28.79 70.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.884 -0.598 . . . . 15.79 110.479 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 31.6 m -61.5 -53.7 53.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.305 -0.862 . . . . 12.18 109.877 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.28 -43.08 92.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.286 -0.416 . . . . 11.02 111.3 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -57.12 -50.79 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.405 0.441 . . . . 16.75 111.689 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -63.86 -39.2 93.64 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.956 0.407 . . . . 14.46 111.221 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 88.7 mt -68.02 -40.88 82.84 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.218 -0.447 . . . . 10.71 111.167 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -67.39 -40.22 85.65 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.796 -0.446 . . . . 14.51 109.796 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.78 -54.79 42.2 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.051 0.94 . . . . 16.85 111.506 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 p -65.3 -44.42 87.99 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.994 -0.548 . . . . 13.52 111.951 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.07 -44.63 91.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.934 -0.575 . . . . 12.77 110.815 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.58 97.42 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.562 -0.29 . . . . 15.19 110.698 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.23 -49.08 79.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.96 0.41 . . . . 16.26 111.175 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 ptp -68.6 -26.74 65.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.487 0.551 . . . . 15.45 112.487 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.73 6.5 48.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.795 0.331 . . . . 16.16 111.661 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 59.92 43.13 15.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.403 1.081 . . . . 20.58 111.051 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.1 m -129.94 171.82 12.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 17.26 109.698 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -108.37 135.27 19.99 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.802 -0.814 . . . . 20.19 108.802 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.69 -11.87 33.58 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.007 2.472 . . . . 17.46 112.934 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.22 -14.24 60.68 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.626 -0.59 . . . . 18.33 111.626 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -96.78 -43.78 7.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.123 -0.633 . . . . 20.77 112.138 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.96 138.5 21.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 119.469 -0.892 . . . . 16.1 109.567 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.483 ' HG2' ' OG ' ' A' ' 29' ' ' SER . 4.8 ptm180 -95.1 163.57 13.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.822 0.82 . . . . 19.87 112.785 -165.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.38 -10.88 27.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.564 1.546 . . . . 15.1 111.499 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.57 6.37 29.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.689 -0.687 . . . . 15.48 113.04 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.483 ' OG ' ' HG2' ' A' ' 26' ' ' ARG . 71.4 m -70.64 119.01 14.16 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.928 0.864 . . . . 14.88 111.793 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -87.97 149.3 24.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.543 -0.753 . . . . 17.38 111.375 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -48.37 -42.29 31.21 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.245 0.618 . . . . 11.99 112.402 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.33 -37.89 68.02 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.676 -1.147 . . . . 14.71 111.748 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.22 -7.51 41.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.076 0.465 . . . . 16.44 111.427 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.07 -16.77 34.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.434 0.635 . . . . 13.83 110.309 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.39 27.72 47.02 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.269 -0.878 . . . . 14.3 111.592 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.83 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.955 -1.128 . . . . 13.04 107.955 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' OD2' HG21 ' A' ' 39' ' ' VAL . 18.1 t70 -129.87 168.02 17.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 117.866 -1.064 . . . . 15.67 108.548 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 t -56.57 -44.56 81.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.745 0.702 . . . . 15.49 109.981 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG21 ' OD2' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -58.15 -55.2 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.61 0.719 . . . . 16.98 112.311 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.78 -45.91 87.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.394 -1.275 . . . . 14.44 110.546 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.95 91.56 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.845 -0.616 . . . . 12.4 110.847 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.64 78.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.399 0.68 . . . . 14.37 111.479 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.21 -47.36 65.02 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.187 0.518 . . . . 16.05 111.126 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -64.48 -49.15 72.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.723 1.209 . . . . 11.7 112.338 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.41 -36.93 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.063 0.459 . . . . 11.48 110.503 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -73.64 -26.16 60.64 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.292 -0.413 . . . . 17.18 111.92 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -69.62 -36.69 76.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.937 -1.134 . . . . 14.15 107.937 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.42 -49.58 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.116 -0.947 . . . . 10.8 109.348 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.409 HD22 ' CD1' ' A' ' 56' ' ' ILE . 19.1 m120 -59.84 -37.54 79.54 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.369 0.604 . . . . 12.98 111.153 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -67.29 -58.66 4.41 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.63 1.572 . . . . 17.81 111.665 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -85.35 -27.57 25.78 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.796 -0.762 . . . . 15.55 112.869 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -94.36 -0.93 54.55 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.577 -0.849 . . . . 12.2 112.857 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 44.29 43.56 6.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.056 1.342 . . . . 17.4 112.42 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -117.75 125.83 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.124 -0.943 . . . . 12.25 109.124 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -87.73 96.4 10.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.536 0.522 . . . . 16.32 110.063 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' CD1' HD22 ' A' ' 49' ' ' ASN . 2.4 pp -124.88 153.66 70.82 Favored Pre-proline 0 N--CA 1.426 -1.635 0 O-C-N 121.992 -0.442 . . . . 11.39 110.179 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.43 127.28 17.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.123 1.882 . . . . 13.44 109.867 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.85 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.956 0.903 . . . . 12.81 112.522 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -85.91 -5.47 59.23 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.97 0.414 . . . . 14.14 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.1 -13.17 64.08 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.918 -0.583 . . . . 10.76 112.716 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 tt -58.63 -29.61 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 C-N-CA 123.433 0.693 . . . . 11.0 110.865 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.39 0.8 35.78 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.666 0.617 . . . . 16.59 112.666 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -71.83 -25.89 62.16 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.993 0.901 . . . . 13.72 109.499 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -123.16 100.26 39.68 Favored Pre-proline 0 C--O 1.209 -1.056 0 N-CA-C 106.496 -1.668 . . . . 12.25 106.496 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.14 -1.63 7.46 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.859 2.373 . . . . 13.57 113.819 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.45 120.23 64.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.502 -1.295 . . . . 13.28 107.502 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -54.25 -41.99 69.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.679 1.192 . . . . 11.45 113.067 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -74.1 -29.56 61.91 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.621 -0.263 . . . . 14.64 111.543 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.49 -29.58 46.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 11.34 110.598 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -56.39 -23.98 41.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.936 0.895 . . . . 9.05 113.369 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 p -56.25 -23.58 37.08 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 113.053 0.76 . . . . 9.65 113.053 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.516 ' O ' HG23 ' A' ' 76' ' ' THR . 54.5 tp60 -53.04 -35.88 59.95 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 123.672 0.608 . . . . 12.14 110.332 176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -52.79 -58.76 5.81 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 123.724 0.64 . . . . 11.26 111.402 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.7 t -68.23 -45.8 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 CA-C-N 115.282 -0.872 . . . . 8.3 110.394 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.77 -46.88 81.62 Favored Glycine 0 CA--C 1.518 0.262 0 O-C-N 123.744 0.652 . . . . 9.58 113.543 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' GLN . 14.5 t -79.79 -16.81 54.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 120.321 -0.551 . . . . 10.46 111.488 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -90.63 -13.65 33.92 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 119.708 -0.797 . . . . 10.43 111.593 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 96.8 mt . . . . . 0 C--O 1.243 0.757 0 N-CA-C 107.367 -1.346 . . . . 10.97 107.367 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 109.059 -0.719 . . . . 10.09 109.059 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -35.81 73.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.859 -1.064 . . . . 11.53 113.329 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -60.0 -25.78 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.117 0.414 . . . . 11.91 112.117 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -72.37 -48.54 40.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.919 0.39 . . . . 10.19 110.712 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -65.87 -28.18 68.77 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.524 0.678 . . . . 10.43 110.05 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -64.32 -29.58 70.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.155 -0.93 . . . . 10.46 111.646 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 110' ' ' ILE . 56.1 mt -81.28 -33.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.725 -0.843 . . . . 8.37 108.725 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.05 -53.82 53.8 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.759 -1.109 . . . . 8.76 109.985 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -68.38 -35.56 77.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.333 -0.547 . . . . 10.86 111.114 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.97 -46.57 88.99 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.249 0.343 . . . . 11.62 110.308 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.11 -49.71 76.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.959 -0.564 . . . . 7.62 110.31 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.88 -47.39 85.08 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.681 0.613 . . . . 11.84 111.002 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.81 -34.58 73.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 12.03 112.063 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 -28.97 67.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.824 0.345 . . . . 9.2 110.589 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.5 -44.71 67.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.756 -0.461 . . . . 10.06 109.756 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.36 98.13 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.297 -0.721 . . . . 12.07 111.297 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.35 -42.19 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.369 1.467 . . . . 12.38 110.535 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.63 -34.3 23.12 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.967 -1.015 . . . . 11.77 110.918 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 tp -73.18 -29.29 62.73 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.014 0.746 . . . . 13.52 113.014 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 66.1 13.08 8.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.03 0.932 . . . . 17.15 110.741 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.4 171.34 8.4 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.185 -1.783 . . . . 16.03 106.185 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.89 130.2 91.78 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 109.83 -0.433 . . . . 14.35 109.83 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -69.55 0.73 5.07 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.551 2.168 . . . . 14.18 112.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.87 7.23 57.27 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.402 -0.679 . . . . 14.05 111.402 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -75.3 -16.86 60.39 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.172 0.51 . . . . 16.88 110.372 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.6 165.31 18.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.584 0.707 . . . . 12.55 111.723 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -88.14 77.23 8.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.24 -0.891 . . . . 14.87 109.823 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m 70.91 -48.58 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.814 1.646 . . . . 14.56 111.395 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.12 0.06 OUTLIER Glycine 0 C--N 1.308 -0.99 0 N-CA-C 108.704 -1.758 . . . . 14.2 108.704 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -154.32 93.03 1.56 Allowed 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.499 -0.413 . . . . 13.0 111.902 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 136' ' ' LEU . 28.5 tt0 -168.86 132.35 1.4 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 109.632 -0.507 . . . . 17.02 109.632 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -81.35 -7.46 59.58 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.835 1.05 . . . . 13.62 113.835 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.424 ' H ' ' HG2' ' A' ' 134' ' ' GLN . 83.6 mt -80.15 -35.73 36.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 16.54 112.069 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -37.46 21.24 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.48 0.919 . . . . 15.87 113.48 -173.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.77 -17.54 6.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.243 1.571 . . . . 13.65 115.243 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.36 143.61 4.89 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.226 -0.988 . . . . 14.16 112.289 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -99.49 -7.27 26.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.032 0.444 . . . . 15.81 109.958 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -150.09 149.22 29.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.552 0.691 . . . . 13.63 110.858 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -51.45 -34.99 37.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.699 1.999 . . . . 14.06 114.284 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.3 t -57.5 -47.93 84.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 112.461 0.541 . . . . 14.08 112.461 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.6 p -67.35 -35.54 79.57 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.469 -0.332 . . . . 11.82 110.858 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.01 -47.04 56.88 Favored Glycine 0 C--O 1.219 -0.834 0 N-CA-C 111.285 -0.726 . . . . 10.82 111.285 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 85.9 m -58.25 -46.76 85.39 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.533 0.333 . . . . 12.55 111.009 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.32 -38.15 90.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.259 0.552 . . . . 12.17 111.14 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -67.59 -46.42 72.65 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.477 0.711 . . . . 9.45 110.251 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -49.59 71.2 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.669 0.388 . . . . 9.88 111.192 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 146' ' ' THR . 77.8 mtp180 -58.7 -40.99 85.26 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.641 0.588 . . . . 14.43 110.731 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.07 -44.67 96.94 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.93 -0.577 . . . . 10.49 112.657 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.03 -41.93 84.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-O 121.286 0.565 . . . . 9.27 109.522 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.6 t -59.0 -49.54 77.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.928 -1.033 . . . . 11.46 111.51 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -70.94 -20.87 62.41 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.914 0.388 . . . . 15.5 111.832 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.94 -51.21 7.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.432 -0.507 . . . . 12.39 110.472 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -94.03 -2.05 53.55 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.303 0.853 . . . . 11.97 113.303 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.2 m 62.79 38.99 11.25 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.956 0.884 . . . . 14.37 111.267 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.7 pt -113.66 158.57 13.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.769 -1.105 . . . . 13.16 109.063 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.3 106.04 18.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.728 -0.842 . . . . 16.91 108.728 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.2 mt -121.93 112.32 18.16 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.709 0.766 . . . . 12.32 111.76 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.57 152.06 43.28 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.825 -1.534 . . . . 14.37 108.921 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.87 -13.09 62.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.916 0.865 . . . . 13.15 109.989 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.97 -8.04 45.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.508 1.523 . . . . 15.68 111.804 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.717 ' HA ' ' CZ3' ' A' ' 168' ' ' TRP . . . -59.89 -0.61 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.959 1.837 . . . . 13.1 115.959 -173.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 33.2 pt -96.09 2.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 122.002 -0.436 . . . . 12.16 111.558 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -94.15 -76.18 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.813 1.042 . . . . 15.41 113.813 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -78.64 12.64 1.96 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.3 0.571 . . . . 15.07 111.238 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.717 ' CZ3' ' HA ' ' A' ' 164' ' ' ALA . 18.1 m-90 -120.12 90.68 44.88 Favored Pre-proline 0 N--CA 1.412 -2.363 0 N-CA-C 105.676 -1.972 . . . . 12.68 105.676 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.2 -28.42 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.456 2.104 . . . . 15.04 113.496 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 p -126.06 174.28 8.58 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.526 -0.546 . . . . 13.26 109.526 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.09 -22.09 49.5 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.096 0.951 . . . . 10.32 108.548 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -64.14 -34.42 78.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.807 -1.542 . . . . 12.75 110.477 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -62.23 -45.23 94.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.957 -0.565 . . . . 11.26 110.101 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -70.33 -39.67 74.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.167 -0.47 . . . . 8.53 110.14 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.03 71.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.121 0.486 . . . . 7.7 111.431 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.88 -30.11 40.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.022 0.439 . . . . 10.38 110.212 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -81.84 -37.35 27.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.955 -0.566 . . . . 11.97 112.314 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -56.28 -43.73 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.886 0.374 . . . . 9.8 111.203 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.35 -28.12 62.83 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 121.149 0.5 . . . . 10.83 110.729 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -68.41 -26.69 65.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.474 -0.936 . . . . 13.85 108.474 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -83.98 -48.63 9.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.923 -1.035 . . . . 15.46 110.0 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 86.6 t -70.06 -43.53 79.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 N-CA-C 112.511 0.56 . . . . 13.35 112.511 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.028 -0.73 . . . . 13.51 109.028 -176.529 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.535 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 30.1 t70 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.644 0.735 . . . . 14.98 110.045 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.04 -40.19 94.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.982 -0.554 . . . . 15.79 111.578 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 57.6 m -60.9 -43.88 97.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.009 -0.541 . . . . 12.18 110.872 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.93 92.83 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 110.09 -0.337 . . . . 11.02 110.09 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 24.7 mt-30 -57.77 -52.99 63.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.168 0.508 . . . . 16.75 110.696 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.98 -46.59 86.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.508 -0.769 . . . . 14.46 111.381 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.84 -35.46 80.74 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.756 0.65 . . . . 10.71 112.756 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtm-85 -62.91 -46.48 87.6 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 120.881 -0.328 . . . . 14.51 110.217 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.09 -41.21 95.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 16.85 110.983 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -58.31 -59.72 4.89 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.206 1.002 . . . . 13.52 111.592 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 17' ' ' MET . 42.3 tp -69.67 -41.63 75.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.471 . . . . 12.77 111.448 -175.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.285 0.476 . . . . 15.19 112.285 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.87 88.96 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.732 -0.387 . . . . 16.26 110.874 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 19.9 ptp -75.06 -31.12 61.19 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.268 -0.423 . . . . 15.45 111.76 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.37 -11.5 37.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.903 0.858 . . . . 16.16 110.934 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.2 t80 64.2 48.62 2.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.968 1.707 . . . . 20.58 109.886 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 21.3 p -119.84 174.82 6.21 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.374 -1.343 . . . . 17.26 107.374 176.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.33 129.91 35.54 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 112.121 0.415 . . . . 20.19 112.121 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.5 -18.91 33.22 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.414 2.742 . . . . 17.46 113.418 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.29 -36.34 7.6 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.318 -1.113 . . . . 18.33 110.318 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -87.45 70.95 9.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.022 -0.732 . . . . 20.77 109.022 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -140.74 151.79 20.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.943 -1.132 . . . . 16.1 107.943 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -114.4 131.33 56.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.804 -0.813 . . . . 19.87 108.804 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 9.3 p-10 -77.12 -21.89 53.54 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.701 0.401 . . . . 15.1 111.48 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.78 5.88 79.59 Favored Glycine 0 C--N 1.312 -0.8 0 N-CA-C 111.025 -0.83 . . . . 15.48 111.025 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -72.33 137.94 46.98 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.261 0.553 . . . . 14.88 109.724 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 49.3 mtp180 -82.55 142.85 31.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.692 -1.225 . . . . 17.38 107.692 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -57.19 -16.47 8.15 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.424 0.898 . . . . 11.99 113.424 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 mt -70.06 -34.6 73.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.972 -0.751 . . . . 14.71 108.972 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -77.42 -24.8 50.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.002 -0.999 . . . . 16.44 109.131 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.0 mt -74.69 -37.22 62.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.855 -0.794 . . . . 13.83 108.855 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.6 26.21 30.61 Favored Glycine 0 CA--C 1.493 -1.288 0 CA-C-N 115.124 -0.944 . . . . 14.3 114.488 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 ' H ' ' A' ' 36' ' ' LEU . 1.5 pt? -85.68 126.37 33.9 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.565 -0.854 . . . . 13.04 110.903 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.83 161.09 27.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.177 -0.919 . . . . 15.67 110.5 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.67 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 4.1 t -54.36 -36.59 64.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.191 0.451 . . . . 15.49 111.026 -175.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -54.54 -56.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.419 0.525 . . . . 16.98 112.419 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.35 -41.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.32 -0.855 . . . . 14.44 110.571 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.94 88.73 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.019 -0.537 . . . . 12.4 110.756 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.43 82.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.469 0.652 . . . . 14.37 110.697 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -67.39 -51.68 49.0 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.618 -0.719 . . . . 16.05 111.259 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -64.64 -45.16 88.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.165 0.986 . . . . 11.7 111.453 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 ' O ' HG12 ' A' ' 48' ' ' ILE . 10.5 tp -62.5 -35.38 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.5 . . . . 11.48 111.357 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -81.38 -20.27 40.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.732 -0.787 . . . . 17.18 111.546 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -78.36 -31.55 48.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.657 -0.817 . . . . 14.15 111.758 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 45' ' ' ILE . 22.5 pt -67.22 -31.39 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.473 -0.891 . . . . 10.8 108.715 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' ND2' HG13 ' A' ' 56' ' ' ILE . 11.0 m120 -62.14 -42.18 99.0 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 115.196 -0.911 . . . . 12.98 110.422 174.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.33 -47.37 17.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.664 -0.698 . . . . 17.81 110.452 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -66.74 -34.54 78.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.852 -0.613 . . . . 15.55 111.764 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.555 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 69.1 m-85 -101.55 -12.2 18.67 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.626 1.343 . . . . 12.2 114.626 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 57.94 45.85 17.53 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.132 0.968 . . . . 17.4 108.922 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.0 tp -123.37 149.15 45.3 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.879 -1.055 . . . . 12.25 110.719 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -99.64 109.46 21.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.381 -0.97 . . . . 16.32 108.381 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 ' ND2' ' A' ' 49' ' ' ASN . 2.5 pp -124.36 149.63 61.79 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 118.185 0.448 . . . . 11.39 110.765 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.12 105.01 1.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.703 1.602 . . . . 13.44 109.039 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.98 -24.72 25.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.062 1.345 . . . . 12.81 113.145 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.81 -3.26 30.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.428 -0.351 . . . . 14.14 111.453 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.18 -49.3 31.05 Favored Glycine 0 C--O 1.204 -1.756 0 O-C-N 123.656 0.597 . . . . 10.76 113.342 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.53 -31.01 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 11.0 112.209 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.67 ' HH ' ' HG ' ' A' ' 38' ' ' SER . 90.7 m-85 -89.7 -40.11 12.75 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.068 0.396 . . . . 16.59 112.068 -175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -80.36 -35.59 35.21 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.374 0.607 . . . . 13.72 110.457 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -121.64 76.7 36.85 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 124.185 0.994 . . . . 12.25 108.737 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.597 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 4.1 Cg_exo -81.09 37.8 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.165 2.576 . . . . 13.57 113.878 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.53 124.78 60.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.837 -1.542 . . . . 13.28 106.837 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -55.08 -40.36 70.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.167 0.987 . . . . 11.45 113.33 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.4 tttt -64.8 -42.14 95.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 14.64 110.287 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.82 81.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.685 -0.688 . . . . 11.34 110.576 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -71.38 -35.63 71.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.928 0.344 . . . . 9.05 111.928 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 p -65.32 -26.48 68.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.626 -0.83 . . . . 9.65 110.935 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 16.3 mm-40 -77.26 -39.45 48.21 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.022 -0.535 . . . . 12.14 110.051 172.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -62.58 -30.79 71.59 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.54 0.736 . . . . 11.26 111.918 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.75 -44.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.207 -0.664 . . . . 8.3 109.207 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.28 -27.03 73.43 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.417 -0.81 . . . . 9.58 113.991 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -72.9 -16.48 61.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.313 0.557 . . . . 10.46 110.991 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.21 -23.58 32.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.109 -0.701 . . . . 10.43 109.109 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.502 -0.867 0 CA-C-N 115.097 -0.956 . . . . 10.97 110.301 178.9 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 11.3 p . . . . . 0 N--CA 1.426 -1.651 0 CA-C-O 122.755 1.264 . . . . 10.09 108.0 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.84 -24.19 59.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.816 -1.538 . . . . 11.53 110.099 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -66.3 -45.68 79.52 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.822 -1.177 . . . . 11.91 107.822 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.491 ' HB3' ' O ' ' A' ' 104' ' ' SER . 48.0 ttp180 -51.99 -53.01 46.58 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 124.148 0.905 . . . . 10.19 110.219 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.53 -48.27 79.76 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.716 0.635 . . . . 10.43 111.843 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.2 t -60.63 -50.33 73.95 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 10.46 110.971 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.45 -39.54 84.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 CA-C-N 116.469 -0.332 . . . . 8.37 110.929 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -47.48 -42.19 22.27 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 124.742 1.217 . . . . 8.76 112.105 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.0 -29.82 66.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.022 0.439 . . . . 10.86 112.022 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.09 -36.76 16.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.283 0.563 . . . . 11.62 110.186 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.76 -37.36 86.14 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 108.224 -1.028 . . . . 7.62 108.224 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 126' ' ' PRO . 83.6 tttt -51.03 -44.66 61.08 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.248 1.419 . . . . 11.84 110.349 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.69 -44.98 80.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.453 -0.794 . . . . 12.03 110.379 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -66.81 -48.3 69.39 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.557 -0.747 . . . . 9.2 110.968 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 119' ' ' GLY . 4.4 pp -71.38 -34.62 70.58 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.43 0.157 . . . . 10.06 111.147 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.411 ' N ' HD11 ' A' ' 118' ' ' LEU . . . -65.41 -42.64 95.84 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.491 -0.644 . . . . 12.07 111.491 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.17 -44.72 96.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.919 0.866 . . . . 12.38 109.733 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.52 -45.77 78.4 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.509 -1.223 . . . . 11.77 110.956 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.0 tp -76.86 -19.06 57.93 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.518 -0.764 . . . . 13.52 111.073 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.1 t80 62.45 31.71 17.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.862 1.665 . . . . 17.15 109.738 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 125' ' ' ASP . 1.3 tm? -120.27 146.43 46.09 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 105.268 -2.123 . . . . 16.03 105.268 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 16.8 t70 -61.43 122.2 68.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.634 0.584 . . . . 14.35 110.308 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.473 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 15.2 Cg_exo -69.98 6.51 1.36 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.057 2.504 . . . . 14.18 114.787 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.89 1.26 55.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.186 -1.566 . . . . 14.05 109.186 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -125.01 36.8 4.53 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.801 1.286 . . . . 16.88 107.822 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.19 124.04 21.99 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.265 -1.334 . . . . 12.55 110.34 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -63.38 146.32 53.79 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.389 -0.967 . . . . 14.87 108.389 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.5 t -58.3 -61.89 2.24 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 118.765 0.711 . . . . 14.56 111.548 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.12 -57.17 2.71 Favored Glycine 0 C--O 1.247 0.942 0 N-CA-C 110.162 -1.175 . . . . 14.2 110.162 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 71.07 114.57 0.05 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.248 1.419 . . . . 13.0 112.578 176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.82 116.23 6.78 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.542 -0.754 . . . . 17.02 109.555 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.508 ' O ' HD23 ' A' ' 138' ' ' LEU . 17.1 t80 -56.59 -40.07 74.61 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 124.932 1.293 . . . . 13.62 110.961 -177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.0 -2.4 43.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.47 0.915 . . . . 16.54 113.47 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.2 -14.41 61.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.555 0.693 . . . . 15.87 109.993 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -64.77 -14.15 57.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.276 -0.875 . . . . 13.65 112.869 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.81 150.31 6.13 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.295 -0.722 . . . . 14.16 111.295 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.71 -31.49 65.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.806 -0.812 . . . . 15.81 108.806 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.82 125.46 27.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 114.729 -1.123 . . . . 13.63 109.048 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.848 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 20.3 m -62.72 -22.39 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.579 0.549 . . . . 14.06 110.296 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 61.8 t -58.02 -34.18 48.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.157 -0.929 . . . . 14.08 111.513 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.4 p -59.96 -44.27 94.52 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.445 0.641 . . . . 11.82 110.748 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -83.42 -35.53 16.98 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.231 -0.895 . . . . 10.82 113.006 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 143' ' ' VAL . 39.7 p -66.95 -30.19 70.25 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 117.506 0.653 . . . . 12.55 110.373 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -62.74 -47.64 82.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.676 0.791 . . . . 12.17 108.872 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.11 -42.83 99.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.605 -0.725 . . . . 9.45 110.497 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 24.4 mmt -61.76 -37.51 84.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.607 0.718 . . . . 9.88 109.915 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -69.64 -36.96 76.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.376 -0.829 . . . . 14.43 110.321 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.89 -51.65 38.67 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.671 -0.572 . . . . 10.49 111.671 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.51 -44.05 84.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.289 0.636 . . . . 9.27 111.657 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -60.89 -40.82 94.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.924 0.342 . . . . 11.46 111.924 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -68.41 -47.08 68.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.884 0.373 . . . . 15.5 110.491 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -54.71 -40.08 68.84 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.414 1.086 . . . . 12.39 111.999 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.73 -1.17 26.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.191 0.811 . . . . 11.97 113.191 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t 60.36 47.24 9.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.672 0.789 . . . . 14.37 110.308 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.09 168.83 18.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.527 -0.916 . . . . 13.16 108.527 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -108.08 97.25 6.97 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.44 0.638 . . . . 16.91 109.41 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.6 tp -103.13 123.66 47.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.73 134.29 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.142 -0.688 . . . . 14.37 109.142 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.92 -16.64 59.99 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.204 0.526 . . . . 13.15 111.116 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.37 -6.29 59.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.717 -0.674 . . . . 15.68 111.118 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.11 -10.69 32.68 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.327 -0.397 . . . . 13.1 111.677 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.57 -15.76 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.762 0.791 . . . . 12.16 110.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.848 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 30.9 m-85 -103.85 14.15 31.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.469 -0.787 . . . . 15.41 109.099 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 32.5 m -110.69 -38.31 5.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.474 -0.785 . . . . 15.07 111.269 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -105.97 123.77 38.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.682 -0.407 . . . . 12.68 110.465 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.68 -27.84 4.66 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.972 1.781 . . . . 15.04 111.484 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -105.7 142.53 35.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.995 0.903 . . . . 13.26 111.504 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.14 -37.91 81.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.752 -1.567 . . . . 10.32 112.433 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.34 -18.97 63.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.929 0.714 . . . . 12.75 112.929 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 -17.77 64.86 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.139 0.792 . . . . 11.26 113.139 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.3 tp -70.11 -32.21 70.13 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.087 0.47 . . . . 8.53 110.261 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.49 75.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.467 0.651 . . . . 7.7 109.742 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.83 -21.79 60.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.557 -0.747 . . . . 10.38 110.579 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 9.6 tp10 -80.51 -56.8 3.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.994 -0.548 . . . . 11.97 109.752 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.4 -34.03 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 112.443 0.535 . . . . 9.8 112.443 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.31 -43.01 74.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.996 0.918 . . . . 10.83 110.459 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -83.56 -34.23 25.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.276 -0.874 . . . . 13.85 111.273 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mmm180 -60.7 -58.5 8.19 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.119 -0.491 . . . . 15.46 111.259 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.37 -40.51 56.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.255 -0.578 . . . . 13.35 109.451 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 117.64 -1.171 . . . . 13.51 109.853 178.545 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 . . . . . 0 CA--C 1.507 -0.677 0 N-CA-C 113.866 1.062 . . . . 14.98 113.866 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.02 -27.38 67.37 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.942 -0.703 . . . . 15.79 110.343 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 35.0 m -70.55 -48.73 54.0 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.943 -0.571 . . . . 12.18 109.823 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.67 78.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.084 0.469 . . . . 11.02 110.832 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 29.0 tt0 -67.67 -45.88 73.96 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.028 -0.533 . . . . 16.75 110.255 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.51 -37.76 85.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.072 0.463 . . . . 14.46 110.716 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 -35.49 74.73 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.388 0.514 . . . . 10.71 112.388 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 12.4 ptp180 -69.44 -29.18 66.83 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 119.135 -1.026 . . . . 14.51 109.575 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -67.35 -48.77 66.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.028 -0.533 . . . . 16.85 109.673 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -62.74 -34.56 77.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.408 -0.814 . . . . 13.52 112.377 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.48 -53.15 31.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.358 0.599 . . . . 12.77 110.299 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -29.72 70.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.953 -1.022 . . . . 15.19 112.214 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.08 98.47 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.952 0.406 . . . . 16.26 110.652 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.4 mmt -78.81 -39.51 35.49 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.337 -0.392 . . . . 15.45 112.043 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 mp -90.36 5.69 46.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.749 0.309 . . . . 16.16 111.785 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 54.71 36.88 27.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.421 1.488 . . . . 20.58 112.556 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.89 175.71 6.39 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.377 -1.342 . . . . 17.26 107.377 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.19 115.93 65.19 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.196 -0.668 . . . . 20.19 109.196 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.91 42.93 1.41 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 123.378 2.719 . . . . 17.46 113.218 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -95.86 1.09 Allowed Glycine 0 C--N 1.288 -2.137 0 CA-C-N 114.769 -1.105 . . . . 18.33 111.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.85 66.22 1.53 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.033 0.445 . . . . 20.77 110.231 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 pt -68.42 147.58 12.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.249 -0.432 . . . . 16.1 110.026 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.42 114.12 3.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.064 -0.971 . . . . 19.87 111.002 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.7 m-20 -66.77 -24.76 66.24 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.728 0.811 . . . . 15.1 110.988 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.11 2.33 87.14 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.835 -0.698 . . . . 15.48 113.148 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -73.33 140.49 46.75 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.062 0.458 . . . . 14.88 111.76 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 73.1 ttt180 -76.23 142.04 41.56 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 104.394 -2.447 . . . . 17.38 104.394 166.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 71.3 m-85 -54.68 -25.58 27.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.111 1.152 . . . . 11.99 114.111 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.23 -38.71 92.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.043 0.449 . . . . 14.71 109.832 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.78 -24.28 60.92 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.177 -0.675 . . . . 16.44 109.177 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.19 -15.8 54.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.624 -0.716 . . . . 13.83 110.536 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.26 5.03 53.13 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.999 -0.619 . . . . 14.3 112.749 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.431 HD23 ' HB1' ' A' ' 41' ' ' ALA . 7.1 tt -80.1 140.38 36.46 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.553 -0.536 . . . . 13.04 109.553 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 26.0 t70 -120.98 163.41 18.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 118.184 -0.912 . . . . 15.67 108.837 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 m -57.46 -39.98 77.51 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 118.834 0.743 . . . . 15.49 111.389 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.93 -46.15 85.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 16.98 109.492 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 52.6 mt -60.82 -34.96 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.313 -0.858 . . . . 14.44 110.723 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB1' HD23 ' A' ' 36' ' ' LEU . . . -58.78 -47.27 85.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.417 0.687 . . . . 12.4 111.432 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.71 72.29 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 123.556 0.535 . . . . 14.37 111.148 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -79.07 -49.93 11.87 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.868 -0.606 . . . . 16.05 111.329 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -60.96 -39.34 89.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.4 0.68 . . . . 11.7 112.062 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.3 -28.1 44.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 CA-C-O 121.132 0.491 . . . . 11.48 110.613 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -71.43 -32.03 67.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.982 0.42 . . . . 17.18 109.996 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -69.73 -34.39 73.79 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.84 0.828 . . . . 14.15 108.891 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.6 mt -69.92 -51.88 36.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 114.907 -1.042 . . . . 10.8 109.766 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.23 -28.22 62.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.799 0.84 . . . . 12.98 112.037 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -71.47 -50.78 28.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.531 0.681 . . . . 17.81 109.953 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -70.09 -51.84 28.54 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.71 -1.132 . . . . 15.55 113.303 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.409 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 79.9 m-85 -88.47 -6.67 57.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.869 0.692 . . . . 12.2 112.869 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 55.86 36.08 26.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.58 1.152 . . . . 17.4 112.209 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.68 147.25 32.21 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.958 -1.127 . . . . 12.25 107.958 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -91.22 77.34 5.95 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.762 -0.829 . . . . 16.32 108.762 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 57' ' ' PRO . 29.2 mt -100.35 128.38 30.56 Favored Pre-proline 0 N--CA 1.426 -1.674 0 C-N-CA 120.36 -0.536 . . . . 11.39 111.485 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' O ' HG21 ' A' ' 56' ' ' ILE . 87.0 Cg_endo -78.55 154.79 27.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.468 2.112 . . . . 13.44 108.956 171.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.31 20.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.464 0.706 . . . . 12.81 110.83 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 63' ' ' THR . 7.2 m-20 -62.43 -21.25 65.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.798 -1.092 . . . . 14.14 112.885 176.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.18 -41.33 92.71 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 119.409 -1.377 . . . . 10.76 111.632 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.55 -19.78 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.488 0.661 . . . . 11.0 110.23 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.74 -38.79 17.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 16.59 111.129 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 59' ' ' ASP . 8.5 t -77.66 -41.77 37.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.518 -0.473 . . . . 13.72 110.461 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -119.73 92.35 46.26 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-O 121.378 0.609 . . . . 12.25 109.872 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.509 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 44.8 Cg_endo -93.7 17.15 1.09 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.126 2.551 . . . . 13.57 113.93 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.95 137.94 45.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.08 -1.081 . . . . 13.28 108.08 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.28 -49.08 73.01 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 113.176 0.806 . . . . 11.45 113.176 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 13.9 tppt? -64.8 -35.05 79.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.317 0.58 . . . . 14.64 110.389 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.43 75.7 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.853 -0.612 . . . . 11.34 110.866 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.1 t80 -74.84 -31.97 61.8 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.379 0.609 . . . . 9.05 111.428 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -70.31 -29.18 65.84 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.409 -0.917 . . . . 9.65 110.584 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -75.01 -25.71 59.0 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.569 -0.53 . . . . 12.14 109.569 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 5.6 t90 -61.33 -54.76 39.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.139 -1.43 . . . . 11.26 107.139 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.18 -32.33 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 CA-C-N 115.009 -0.996 . . . . 8.3 109.544 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 -12.97 60.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.864 -0.607 . . . . 9.58 112.388 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.8 m -85.24 -31.28 23.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.627 -0.879 . . . . 10.46 108.627 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -81.18 -44.35 17.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.284 -1.006 . . . . 10.43 108.284 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.311 -1.09 0 N-CA-C 107.587 -1.264 . . . . 10.97 107.587 175.064 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 121.527 0.679 . . . . 10.09 112.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.84 -39.69 39.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.393 1.077 . . . . 11.53 112.581 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.1 tp-100 -62.57 -54.61 37.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.58 -0.526 . . . . 11.91 109.58 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -58.07 -41.29 83.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.942 0.897 . . . . 10.19 111.232 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -48.29 78.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.849 -0.614 . . . . 10.43 110.614 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.6 t -59.61 -37.7 79.28 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 123.699 0.624 . . . . 10.46 109.776 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 106' ' ' GLN . 53.2 mt -58.61 -44.83 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 115.265 -0.879 . . . . 8.37 110.721 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.41 -38.21 86.29 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.152 0.282 . . . . 8.76 111.517 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.2 -45.75 79.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.527 0.203 . . . . 10.86 110.554 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -71.52 -27.56 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.108 -0.637 . . . . 11.62 111.498 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.19 -48.0 83.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.188 -1.041 . . . . 7.62 108.188 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -56.63 -51.89 66.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.453 -1.703 . . . . 11.84 110.712 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -64.92 -39.98 94.36 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.711 0.634 . . . . 12.03 112.711 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 p -67.97 -33.13 74.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.156 0.428 . . . . 9.2 112.156 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -43.0 33.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.492 -0.883 . . . . 10.06 109.204 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.32 82.12 Favored Glycine 0 C--O 1.22 -0.775 0 CA-C-N 115.78 -0.645 . . . . 12.07 112.601 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.14 -28.63 68.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.526 0.679 . . . . 12.38 110.471 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.21 -43.06 10.07 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 11.77 110.127 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.48 -27.07 62.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.448 -0.796 . . . . 13.52 111.789 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 t80 80.27 -36.36 0.14 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.907 1.683 . . . . 17.15 110.742 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.77 172.35 13.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 16.03 110.816 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.83 139.02 76.66 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.988 0.423 . . . . 14.35 111.686 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.17 42.81 0.41 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.997 2.465 . . . . 14.18 111.128 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -101.2 -10.46 42.03 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 115.497 -0.774 . . . . 14.05 111.636 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.64 -13.77 41.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.192 0.52 . . . . 16.88 110.593 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.2 -169.45 2.07 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.124 -0.489 . . . . 12.55 112.119 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 79.68 113.96 0.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.12 1.368 . . . . 14.87 109.797 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 m 61.64 39.17 14.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.361 1.077 . . . . 14.56 109.062 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.69 70.23 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 113.704 -1.589 . . . . 14.2 110.624 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.85 -40.91 46.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.954 0.883 . . . . 13.0 110.247 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 64.03 31.75 13.36 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 113.242 -1.799 . . . . 17.02 112.973 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.75 -18.8 63.2 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.266 0.555 . . . . 13.62 110.788 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.53 -25.39 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.685 -0.689 . . . . 16.54 109.512 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.33 -29.4 10.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.497 -0.774 . . . . 15.87 111.088 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.66 -27.58 58.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.963 0.411 . . . . 13.65 110.725 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -114.82 100.66 1.01 Allowed Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 110.192 -1.163 . . . . 14.16 110.192 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptp -94.2 -15.29 24.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.094 0.473 . . . . 15.81 110.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -122.74 138.26 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.295 -1.002 . . . . 13.63 108.295 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 t -59.36 -16.79 24.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.542 1.137 . . . . 14.06 113.878 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.35 -36.52 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.21 0.529 . . . . 14.08 110.73 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 p -58.81 -44.61 90.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.677 -1.147 . . . . 11.82 112.032 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.96 -46.41 28.94 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.783 -0.722 . . . . 10.82 111.904 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 m -58.71 -52.94 63.55 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 122.859 0.463 . . . . 12.55 110.733 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.09 -44.17 97.77 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.629 -0.714 . . . . 12.17 110.965 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 152' ' ' VAL . 22.1 t90 -67.18 -49.64 63.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.898 -0.592 . . . . 9.45 111.511 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 38.0 ttm -64.7 -33.81 76.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.78 0.659 . . . . 9.88 112.78 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -66.31 -38.18 87.11 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.861 -0.736 . . . . 14.43 109.965 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.1 95.71 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.862 -0.895 . . . . 10.49 110.862 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 148' ' ' TRP . 78.2 t -58.43 -46.97 89.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 123.598 0.759 . . . . 9.27 109.468 174.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.9 m -61.49 -40.43 94.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 11.46 110.135 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -71.36 -53.27 14.72 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.756 -0.656 . . . . 15.5 111.558 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -66.61 -42.62 86.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.798 0.295 . . . . 12.39 111.798 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' A' ' 152' ' ' VAL . 96.7 m-85 -82.37 -8.9 59.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.048 0.451 . . . . 11.97 110.552 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.9 m 61.46 29.84 18.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.645 1.178 . . . . 14.37 111.588 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.4 pt -103.64 150.14 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 13.16 109.057 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -89.02 94.92 10.12 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.537 -1.283 . . . . 16.91 107.537 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.61 120.64 42.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.512 -0.767 . . . . 12.32 109.182 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 134.58 57.18 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.929 -1.032 . . . . 14.37 110.932 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.409 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -69.27 -20.36 63.92 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.67 -0.696 . . . . 13.15 110.715 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.75 -16.87 64.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.966 -0.561 . . . . 15.68 110.348 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.494 ' HB3' ' SD ' ' A' ' 149' ' ' MET . . . -65.71 -14.71 61.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.983 -0.553 . . . . 13.1 112.056 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 162' ' ' ALA . 31.7 pt -68.88 -22.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.521 0.676 . . . . 12.16 109.57 175.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -102.64 -15.52 16.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.661 -0.699 . . . . 15.41 109.157 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 25.9 m -77.16 -46.6 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.819 -0.808 . . . . 15.07 108.819 177.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.46 90.24 0.92 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 121.298 0.571 . . . . 12.68 112.425 -176.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.28 41.9 1.23 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.654 2.236 . . . . 15.04 111.191 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -123.07 142.89 50.38 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-O 122.361 1.077 . . . . 13.26 111.061 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.01 -43.19 93.32 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 113.535 -1.666 . . . . 10.32 110.958 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.74 -37.2 86.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.058 -0.974 . . . . 12.75 111.106 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 m -79.29 -33.0 43.7 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.809 -0.632 . . . . 11.26 110.561 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.05 -43.61 91.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.661 -1.237 . . . . 8.53 107.661 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.66 78.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.698 -0.683 . . . . 7.7 110.907 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -29.97 68.51 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.716 -0.675 . . . . 10.38 110.381 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -78.81 -58.0 3.47 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.65 -0.704 . . . . 11.97 111.696 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.91 -43.75 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.432 0.53 . . . . 9.8 112.432 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.29 -44.67 95.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.143 0.496 . . . . 10.83 110.143 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -72.21 -30.87 65.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.014 -0.994 . . . . 13.85 110.983 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.14 -44.02 85.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.334 -0.617 . . . . 15.46 109.334 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.35 -52.86 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.848 -0.615 . . . . 13.35 110.186 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.308 -1.198 0 N-CA-C 112.432 0.53 . . . . 13.51 112.432 -177.717 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.334 0.588 . . . . 14.98 111.223 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.37 80.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.709 -0.678 . . . . 15.79 111.952 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 p -57.12 -36.04 70.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.517 -0.765 . . . . 12.18 111.445 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.94 76.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.364 -0.606 . . . . 11.02 109.364 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.24 -50.86 72.4 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.591 -0.732 . . . . 16.75 110.57 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -53.94 -47.07 71.65 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.762 0.825 . . . . 14.46 111.954 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -71.68 -36.38 70.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.381 -0.372 . . . . 10.71 111.253 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -67.21 -43.12 82.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.478 0.711 . . . . 14.51 109.841 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -58.59 -45.3 89.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.41 1.084 . . . . 16.85 110.128 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -70.26 -32.88 70.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.263 -0.88 . . . . 13.52 110.761 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.9 -56.66 10.63 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.603 -1.258 . . . . 12.77 107.603 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -36.28 79.33 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.727 -1.124 . . . . 15.19 112.154 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.33 86.99 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.178 0.513 . . . . 16.26 111.405 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.6 mmm -78.01 -38.46 44.78 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.95 -0.568 . . . . 15.45 112.072 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.58 -1.86 58.29 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.422 0.63 . . . . 16.16 112.054 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.0 t80 60.61 56.62 2.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.24 1.416 . . . . 20.58 109.959 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -124.57 166.91 15.24 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.778 -1.564 . . . . 17.26 106.778 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -108.93 119.22 49.57 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-O 121.042 0.448 . . . . 20.19 110.346 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 -23.94 67.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.625 2.883 . . . . 17.46 115.091 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.33 -16.62 71.5 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.036 -0.602 . . . . 18.33 113.391 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -127.16 16.85 7.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.785 0.293 . . . . 20.77 111.043 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.33 139.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 109.709 -0.478 . . . . 16.1 109.709 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' NH2' ' HG2' ' A' ' 183' ' ' GLN . 40.5 ttm180 -78.14 96.71 5.24 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.168 -1.049 . . . . 19.87 108.168 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 11.5 p-10 -67.26 -14.7 63.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.686 -0.688 . . . . 15.1 112.135 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.88 5.85 66.67 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.751 -0.738 . . . . 15.48 112.081 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.6 t -87.51 161.44 17.79 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.623 0.725 . . . . 14.88 109.932 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -101.91 142.88 32.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.129 -0.942 . . . . 17.38 112.72 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -42.71 -60.88 1.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.293 1.437 . . . . 11.99 113.848 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.59 -29.86 70.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 14.71 111.879 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -79.38 -13.47 59.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.98 0.419 . . . . 16.44 111.409 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.36 -22.47 44.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.649 0.738 . . . . 13.83 109.195 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 25.28 6.21 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.964 -1.016 . . . . 14.3 111.107 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -74.0 113.47 11.21 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.08 0.467 . . . . 13.04 109.763 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.34 156.23 24.35 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.19 -0.914 . . . . 15.67 110.909 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 t -56.92 -42.32 79.79 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.062 0.458 . . . . 15.49 109.788 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.62 -48.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.494 -0.776 . . . . 16.98 110.92 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.7 mt -66.05 -38.44 82.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.969 -0.56 . . . . 14.44 110.779 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.57 84.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 12.4 110.334 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.52 -38.23 90.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 14.37 110.842 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -71.35 -42.4 68.54 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.645 0.736 . . . . 16.05 110.974 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -61.33 -47.81 84.22 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 125.531 1.532 . . . . 11.7 111.462 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 tp -63.61 -34.02 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 120.855 0.36 . . . . 11.48 111.722 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 37.6 mmt180 -63.11 -38.32 90.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.717 0.294 . . . . 17.18 111.037 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.03 -39.74 93.81 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.35 0.595 . . . . 14.15 109.624 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.13 -47.66 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.193 -0.912 . . . . 10.8 110.361 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -60.64 -43.2 97.82 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.793 -0.64 . . . . 12.98 111.591 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -72.19 -58.97 2.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.46 -0.791 . . . . 17.81 111.141 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -30.46 69.8 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.012 1.116 . . . . 15.55 114.012 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.22 -2.36 46.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 113.095 0.776 . . . . 12.2 113.095 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 59.01 45.28 15.07 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.344 1.057 . . . . 17.4 110.003 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.49 165.77 22.82 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.536 -0.302 . . . . 12.25 110.204 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.83 71.34 0.74 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.586 -0.894 . . . . 16.32 108.586 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mm -101.31 114.69 65.71 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 116.196 -0.456 . . . . 11.39 110.65 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.79 171.01 16.12 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.346 2.03 . . . . 13.44 110.027 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.33 -1.05 9.35 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.409 0.684 . . . . 12.81 111.699 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.04 -30.62 71.1 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.089 0.956 . . . . 14.14 110.55 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.58 98.35 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.299 -0.477 . . . . 10.76 111.993 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.47 -32.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.763 0.792 . . . . 11.0 110.152 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -80.98 -16.5 53.28 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.982 -0.553 . . . . 16.59 111.097 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -83.57 -48.54 10.13 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.1 -0.704 . . . . 13.72 109.1 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.85 118.96 30.25 Favored Pre-proline 0 C--O 1.215 -0.761 0 CA-C-N 116.229 -0.441 . . . . 12.25 111.324 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.52 -3.99 7.5 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.768 2.312 . . . . 13.57 112.577 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.97 119.58 59.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.99 -1.485 . . . . 13.28 106.99 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.2 p90 -62.12 -33.54 74.66 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.884 0.698 . . . . 11.45 112.884 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -62.72 -38.17 89.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.368 0.604 . . . . 14.64 110.827 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.7 -23.86 36.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.72 0.771 . . . . 11.34 109.649 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 80.9 t80 -81.05 -30.13 34.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 9.05 111.874 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 p -67.61 -33.32 74.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.43 -0.794 . . . . 9.65 109.098 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.99 -29.85 64.64 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.253 -0.885 . . . . 12.14 109.543 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.538 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 82.4 t90 -59.62 -44.34 93.47 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.154 0.982 . . . . 11.26 108.847 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.65 -45.42 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 C-N-CA 123.629 0.772 . . . . 8.3 110.306 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.98 75.63 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 116.162 -0.472 . . . . 9.58 113.569 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -77.18 -22.11 52.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.277 0.561 . . . . 10.46 110.661 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -82.55 -2.64 54.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.342 0.592 . . . . 10.43 111.141 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.428 -1.564 0 N-CA-C 104.946 -2.242 . . . . 10.97 104.946 171.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.9 m . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.803 0.335 . . . . 10.09 111.537 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.26 73.3 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.276 -0.875 . . . . 11.53 111.782 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -72.55 -51.36 20.19 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.161 -0.472 . . . . 11.91 110.261 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -49.94 -51.42 41.32 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.705 0.628 . . . . 10.19 110.897 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 104' ' ' SER . 5.9 mm-40 -63.86 -47.99 78.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 10.43 111.721 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.4 m -66.74 -43.53 83.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.182 -0.463 . . . . 10.46 111.765 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 178' ' ' VAL . 73.3 mt -71.91 -23.64 22.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.0 0 N-CA-C 110.014 -0.365 . . . . 8.37 110.014 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -64.73 -41.84 95.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.232 -0.655 . . . . 8.76 109.232 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.58 -38.98 84.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.15 0.5 . . . . 10.86 109.947 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.17 -49.62 76.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.985 -1.007 . . . . 11.62 109.503 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -50.0 -43.67 50.64 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.135 1.374 . . . . 7.62 112.015 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -60.4 -45.29 94.11 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.817 -1.083 . . . . 11.84 109.715 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -82.0 -22.93 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.61 0.719 . . . . 12.03 110.516 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -73.74 -55.1 6.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.269 -0.878 . . . . 9.2 110.39 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.64 -29.25 33.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.566 -0.531 . . . . 10.06 109.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.2 -19.97 62.36 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.884 -0.487 . . . . 12.07 111.884 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.41 -23.88 61.15 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.449 0.7 . . . . 12.38 109.617 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.53 -23.47 19.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.879 -0.6 . . . . 11.77 110.434 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.91 -26.89 23.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.876 -0.416 . . . . 13.52 109.876 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 73.92 -35.11 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.207 1.403 . . . . 17.15 112.76 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.93 129.92 40.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.087 -1.449 . . . . 16.03 107.087 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -119.45 117.22 33.1 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.839 -0.619 . . . . 14.35 109.642 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -88.02 4.64 5.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.968 2.446 . . . . 14.18 112.816 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.83 -78.79 0.02 OUTLIER Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.779 -1.201 . . . . 14.05 113.106 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 177.88 24.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.336 0.654 . . . . 16.88 109.912 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 mp 47.66 -158.19 0.05 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.251 0.62 . . . . 12.55 111.327 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 76.95 -38.06 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.714 1.206 . . . . 14.87 112.511 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.6 p -69.59 -46.1 67.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.938 -1.134 . . . . 14.56 107.938 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -100.9 89.37 0.8 Allowed Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 107.588 -2.205 . . . . 14.2 107.588 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.58 -14.03 10.87 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 111.545 0.202 . . . . 13.0 111.545 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.99 133.04 47.62 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.824 0.821 . . . . 17.02 110.313 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -65.67 -20.05 66.14 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.829 -1.078 . . . . 13.62 110.035 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.94 -24.9 68.09 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.906 -1.043 . . . . 16.54 111.676 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.13 -34.7 8.31 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.05 -0.66 . . . . 15.87 110.949 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 132' ' ' GLY . 35.3 mt -91.83 -27.17 18.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.638 -0.71 . . . . 13.65 112.721 -171.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -106.96 78.85 0.25 Allowed Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.428 -0.892 . . . . 14.16 113.892 -174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 50.2 tpp -80.87 -40.63 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.157 -1.053 . . . . 15.81 108.157 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -99.59 113.27 25.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.159 -0.928 . . . . 13.63 109.0 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.6 t -72.67 -38.45 67.6 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.244 -0.889 . . . . 14.06 110.449 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.89 -32.05 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.326 0.584 . . . . 14.08 112.02 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.1 t -77.55 -27.15 51.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.104 -1.038 . . . . 11.82 109.726 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.79 -28.58 34.59 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.092 -1.051 . . . . 10.82 111.166 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 162' ' ' ALA . 16.9 p -66.94 -43.24 83.72 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 109.217 -0.66 . . . . 12.55 109.217 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -56.8 -49.75 74.4 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.135 -0.939 . . . . 12.17 109.21 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -55.29 -53.06 60.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.199 -0.91 . . . . 9.45 112.203 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 149' ' ' MET . 4.1 tpt -56.94 -48.84 77.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.436 0.694 . . . . 9.88 110.844 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -64.33 -36.13 83.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.267 -0.424 . . . . 14.43 110.872 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.69 97.64 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.814 -0.515 . . . . 10.49 111.814 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.44 -43.27 98.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.805 -0.442 . . . . 9.27 109.805 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.0 t -59.62 -46.41 89.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.435 -0.802 . . . . 11.46 109.428 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.55 -48.99 78.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.196 0.998 . . . . 15.5 111.025 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -58.53 -27.61 64.69 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.62 0.768 . . . . 12.39 112.779 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -107.46 4.71 26.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.779 0.659 . . . . 11.97 112.779 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m 58.29 32.22 21.79 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.77 0.795 . . . . 14.37 111.315 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.6 pt -107.13 165.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.342 -0.984 . . . . 13.16 108.342 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.97 94.5 5.02 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.335 0.588 . . . . 16.91 112.051 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.69 108.72 10.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.175 -1.046 . . . . 12.32 108.175 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.5 154.75 35.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.194 -0.912 . . . . 14.37 109.835 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 146' ' ' THR . . . -63.72 -16.98 62.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.939 -1.028 . . . . 13.15 113.138 -174.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.93 -6.47 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 116.431 -0.35 . . . . 15.68 111.267 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.96 -11.28 46.43 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.138 0.422 . . . . 13.1 112.138 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.8 pt -64.84 -13.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.253 0.549 . . . . 12.16 111.365 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.59 -1.95 16.63 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.205 -0.452 . . . . 15.41 110.289 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.7 m -84.39 -30.61 25.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.014 -0.539 . . . . 15.07 110.589 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -116.93 108.96 43.52 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.271 -1.011 . . . . 12.68 108.271 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -48.73 -37.73 35.83 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.947 3.098 . . . . 15.04 112.846 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.7 p -125.55 141.01 52.26 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.792 -1.188 . . . . 13.26 107.792 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.61 -1.73 47.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.811 0.671 . . . . 10.32 112.811 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -66.5 -26.08 67.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.162 -1.051 . . . . 12.75 108.162 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 18.1 m -76.1 -18.62 59.09 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.237 -1.347 . . . . 11.26 111.752 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.43 -35.68 76.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.884 0.474 . . . . 8.53 110.286 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.58 -37.64 79.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.142 -0.481 . . . . 7.7 111.567 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.9 -32.6 61.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 10.38 110.349 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 173' ' ' SER . 46.9 mm-40 -70.08 -48.73 56.5 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.619 -0.719 . . . . 11.97 109.998 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 110' ' ' ILE . 12.1 p -66.78 -40.64 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 9.8 111.376 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.99 -37.16 78.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.548 0.689 . . . . 10.83 110.226 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -67.13 -45.85 75.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.982 -1.008 . . . . 13.85 110.106 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -67.99 -48.24 66.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 15.46 111.765 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 90.0 t -64.32 -53.4 43.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 123.48 0.488 . . . . 13.35 109.992 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.457 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 61.7 tt0 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 123.906 0.883 . . . . 13.51 111.62 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.547 0.689 . . . . 14.98 109.404 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.72 -39.4 91.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.397 -0.819 . . . . 15.79 109.887 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.524 ' HG ' ' HH ' ' A' ' 52' ' ' TYR . 49.7 t -58.63 -45.11 89.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.039 -0.726 . . . . 12.18 109.039 176.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.64 94.54 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.994 -0.548 . . . . 11.02 110.891 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -62.63 -37.54 86.73 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.782 0.29 . . . . 16.75 111.782 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.57 -40.49 89.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.53 0.681 . . . . 14.46 110.242 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.57 -33.09 64.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.389 -0.524 . . . . 10.71 111.041 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.26 -50.05 75.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.779 0.432 . . . . 14.51 110.881 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -67.26 -23.85 65.74 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.266 -0.425 . . . . 16.85 111.595 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 m -83.23 -49.4 9.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.994 0.426 . . . . 13.52 110.415 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.1 -52.73 62.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.235 0.614 . . . . 12.77 110.512 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.39 -24.88 64.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.395 0.517 . . . . 15.19 112.395 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.56 85.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.878 0.37 . . . . 16.26 110.147 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.6 mtm -74.01 -27.68 61.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.701 -0.681 . . . . 15.45 111.64 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.04 4.29 54.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.306 -0.406 . . . . 16.16 111.84 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 55.23 39.79 31.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.382 1.073 . . . . 20.58 112.272 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -109.24 155.69 20.8 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.603 -1.258 . . . . 17.26 107.603 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.54 118.84 71.22 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 109.308 -0.627 . . . . 20.19 109.308 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.8 -29.09 12.92 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.395 2.064 . . . . 17.46 114.272 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.79 8.19 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.577 -1.009 . . . . 18.33 110.577 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.49 70.47 8.97 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.268 0.556 . . . . 20.77 111.12 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.62 149.9 13.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.704 -1.221 . . . . 16.1 107.704 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 13.8 ttp180 -82.53 126.08 31.85 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 122.319 0.248 . . . . 19.87 110.406 -177.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.43 -23.62 67.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.606 0.762 . . . . 15.1 112.1 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.429 ' H ' ' HG2' ' A' ' 26' ' ' ARG . . . -96.7 6.76 65.11 Favored Glycine 0 C--N 1.309 -0.929 0 CA-C-N 115.917 -0.583 . . . . 15.48 113.902 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 26' ' ' ARG . 68.8 m -65.14 153.28 41.34 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.932 0.873 . . . . 14.88 112.186 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 8.9 mmm180 -92.15 152.96 19.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.005 -0.998 . . . . 17.38 109.841 -172.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 58.2 m-85 -57.79 -50.29 73.76 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 119.367 0.985 . . . . 11.99 112.836 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.14 -9.37 55.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.415 0.626 . . . . 14.71 111.551 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.27 -37.9 12.39 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.084 -0.71 . . . . 16.44 109.084 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -61.31 -33.85 74.27 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.565 0.746 . . . . 13.83 111.234 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.19 9.75 8.53 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.63 -0.988 . . . . 14.3 110.63 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 41' ' ' ALA . 8.3 tt -91.58 137.1 32.64 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.363 -0.977 . . . . 13.04 108.363 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -132.55 166.93 20.95 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.21 1.004 . . . . 15.67 109.117 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -42.84 -54.62 4.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 15.49 113.437 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.59 -40.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.285 0.564 . . . . 16.98 111.411 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.421 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 67.4 mt -66.41 -36.77 78.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.816 -0.629 . . . . 14.44 110.093 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -58.02 -45.01 87.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.14 -0.936 . . . . 12.4 110.766 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.35 -36.31 75.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.277 -0.874 . . . . 14.37 110.933 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.33 -41.18 57.31 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.49 -0.777 . . . . 16.05 111.507 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -64.84 -41.11 95.98 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.91 -0.586 . . . . 11.7 110.796 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 41' ' ' ALA . 34.3 mm -55.1 -41.6 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.169 -0.469 . . . . 11.48 110.266 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -58.58 -31.71 68.28 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.526 -0.761 . . . . 17.18 110.622 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -80.02 -46.98 15.64 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.603 -0.271 . . . . 14.15 111.288 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 45' ' ' ILE . 22.6 pt -65.74 -32.1 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.539 -0.464 . . . . 10.8 110.41 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.592 ' ND2' HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -60.58 -39.34 87.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.238 0.542 . . . . 12.98 110.19 175.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -73.64 -48.71 30.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.948 -1.024 . . . . 17.81 111.743 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.0 -34.37 64.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.872 -0.731 . . . . 15.55 111.822 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.524 ' HH ' ' HG ' ' A' ' 6' ' ' CYS . 56.7 m-85 -88.87 -6.37 57.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.963 0.727 . . . . 12.2 112.963 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 57.82 41.85 24.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.89 1.276 . . . . 17.4 111.235 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 tp -141.28 136.24 31.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.248 -1.019 . . . . 12.25 108.248 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -84.11 56.0 3.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.833 0.825 . . . . 16.32 109.551 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.592 HG23 ' ND2' ' A' ' 49' ' ' ASN . 10.9 tt -60.24 134.98 90.92 Favored Pre-proline 0 C--O 1.253 1.262 0 CA-C-N 114.139 -1.391 . . . . 11.39 110.2 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -79.07 162.07 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.582 2.188 . . . . 13.44 111.946 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 2.19 26.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.011 -0.995 . . . . 12.81 111.65 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 5.2 m-20 -62.28 -18.26 60.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.961 -0.563 . . . . 14.14 112.37 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 70' ' ' PHE . . . -63.84 -39.34 97.3 Favored Glycine 0 C--O 1.213 -1.183 0 C-N-CA 120.412 -0.899 . . . . 10.76 111.648 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -82.62 -12.84 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 123.025 1.393 . . . . 11.0 108.238 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 52.3 t80 -78.73 -44.91 22.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.174 -1.375 . . . . 16.59 110.058 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.0 t -93.4 -31.98 14.42 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.558 0.577 . . . . 13.72 112.558 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.06 125.67 45.14 Favored Pre-proline 0 CA--C 1.5 -0.964 0 O-C-N 121.785 -0.572 . . . . 12.25 110.805 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 60.4 Cg_endo -87.61 -18.11 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.042 1.828 . . . . 13.57 111.601 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.4 t -108.24 133.38 53.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.195 -1.409 . . . . 13.28 107.195 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 43.6 p90 -72.74 -34.82 67.29 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.375 0.509 . . . . 11.45 112.375 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -71.19 -20.65 62.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.496 0.665 . . . . 14.64 111.005 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.97 -25.86 40.21 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.544 0.688 . . . . 11.34 109.883 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 9.2 t80 -68.04 -30.34 69.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.635 . . . . 9.05 111.325 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -63.87 -22.2 66.81 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.856 0.687 . . . . 9.65 112.856 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.83 -28.03 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.378 0.608 . . . . 12.14 110.07 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -73.81 -45.74 49.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.794 -0.639 . . . . 11.26 109.41 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.57 -42.28 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.661 0 N-CA-C 109.726 -0.472 . . . . 8.3 109.726 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.06 74.31 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.606 -0.725 . . . . 9.58 113.518 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 p -81.21 -38.33 27.16 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.099 -0.64 . . . . 10.46 111.877 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -73.98 -46.65 42.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.959 -0.696 . . . . 10.43 110.025 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 115.907 -0.588 . . . . 10.97 109.667 179.654 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 113.567 0.951 . . . . 10.09 113.567 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.89 -25.25 55.91 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.759 0.281 . . . . 11.53 111.759 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.98 -37.77 88.76 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.45 -0.341 . . . . 11.91 111.762 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -57.34 10.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 10.19 110.737 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -61.72 -44.43 96.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.574 -0.739 . . . . 10.43 109.924 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.8 t -60.39 -43.48 96.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.6 -0.727 . . . . 10.46 110.969 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.6 mt -55.98 -51.41 61.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.36 0.664 . . . . 8.37 110.511 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.58 -39.86 94.49 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 115.201 -0.909 . . . . 8.76 109.869 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.49 -34.82 74.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.957 0.503 . . . . 10.86 111.777 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -68.34 -53.54 23.39 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 110.016 -0.364 . . . . 11.62 110.016 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 171' ' ' LEU . 9.4 tt -63.36 -27.68 69.48 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.306 -0.861 . . . . 7.62 110.401 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.11 -46.19 90.13 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.734 1.214 . . . . 11.84 109.869 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -69.26 -33.8 73.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.048 -0.523 . . . . 12.03 110.91 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -63.48 -42.74 98.55 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.208 -0.451 . . . . 9.2 110.432 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.98 -40.99 68.19 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.622 -0.51 . . . . 10.06 109.622 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.54 -49.79 70.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.852 -0.613 . . . . 12.07 112.424 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.56 -25.84 66.0 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.003 0.521 . . . . 12.38 110.438 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.26 -46.76 60.2 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.06 -0.719 . . . . 11.77 109.06 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.29 -81.03 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.512 -0.767 . . . . 13.52 110.04 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -158.55 -45.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.116 -1.068 . . . . 17.15 108.116 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.7 tp -167.84 157.58 10.13 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.487 -2.412 . . . . 16.03 104.487 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.52 118.01 67.85 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 118.474 0.579 . . . . 14.35 110.733 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.29 -8.21 11.78 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.495 2.13 . . . . 14.18 111.752 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.6 -10.26 74.16 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.246 -0.742 . . . . 14.05 111.246 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -89.66 37.1 0.86 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.24 1.019 . . . . 16.88 110.497 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.21 -5.68 13.02 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.304 -1.316 . . . . 12.55 110.802 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -85.78 121.66 28.75 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.089 -0.505 . . . . 14.87 110.082 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.1 m 69.85 -66.34 0.27 Allowed 'General case' 0 C--O 1.247 0.926 0 C-N-CA 125.082 1.353 . . . . 14.56 112.175 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.5 82.72 1.51 Allowed Glycine 0 C--O 1.239 0.453 0 CA-C-N 116.412 -0.358 . . . . 14.2 113.007 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . -143.49 117.4 9.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.895 -1.15 . . . . 13.0 107.895 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -115.73 164.16 14.76 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.184 -1.413 . . . . 17.02 107.184 -173.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.61 ' H ' ' NE2' ' A' ' 134' ' ' GLN . 40.5 m-85 -42.82 -47.16 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.307 0.854 . . . . 13.62 113.307 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 pp -55.82 -33.85 64.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.679 0.622 . . . . 16.54 112.679 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.68 -1.73 27.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.567 0.58 . . . . 15.87 112.567 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 96.6 mt -93.89 -27.19 16.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.233 0.539 . . . . 13.65 109.775 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 170.67 126.38 0.87 Allowed Glycine 0 N--CA 1.432 -1.594 0 N-CA-C 110.411 -1.076 . . . . 14.16 110.411 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp -70.17 -30.17 67.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.163 0.506 . . . . 15.81 110.904 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -106.92 124.64 49.92 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.743 -0.836 . . . . 13.63 108.743 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 t -61.49 -30.05 70.37 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.422 -0.808 . . . . 14.06 112.473 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 t -76.91 -25.18 15.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 CA-C-O 121.536 0.684 . . . . 14.08 109.99 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -70.65 -28.19 64.61 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.694 -0.803 . . . . 11.82 110.235 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.34 -21.16 59.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.036 -1.225 . . . . 10.82 110.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 m -67.31 -44.77 78.34 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.012 -1.107 . . . . 12.55 108.012 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.26 -46.2 90.65 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.318 -1.31 . . . . 12.17 109.706 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -59.03 -46.72 87.51 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.739 -1.118 . . . . 9.45 111.279 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.441 ' HA ' ' HE3' ' A' ' 149' ' ' MET . 1.1 tpt -53.29 -55.73 22.29 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.558 0.743 . . . . 9.88 112.093 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -63.75 -30.11 71.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.599 -0.44 . . . . 14.43 111.669 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 -50.07 50.33 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.004 -0.839 . . . . 10.49 111.004 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.83 -40.34 86.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.284 0.634 . . . . 9.27 110.25 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.9 t -54.27 -58.83 5.91 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.046 -0.979 . . . . 11.46 110.697 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -71.23 -24.95 62.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.283 -0.417 . . . . 15.5 111.638 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -61.07 -34.93 75.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.689 0.28 . . . . 12.39 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -100.55 6.41 44.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 11.97 111.272 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.3 m 57.42 44.0 22.19 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.284 1.034 . . . . 14.37 111.188 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.5 pt -122.18 146.78 26.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 106.777 -1.564 . . . . 13.16 106.777 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -96.81 96.73 8.76 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.869 -0.732 . . . . 16.91 110.95 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.64 139.48 45.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.555 -0.906 . . . . 12.32 108.555 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.94 44.28 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.426 -0.806 . . . . 14.37 109.201 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.86 -24.04 67.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.593 -0.731 . . . . 13.15 111.616 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.34 2.69 51.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.019 -0.537 . . . . 15.68 111.528 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.55 -14.86 63.07 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.846 -0.534 . . . . 13.1 111.799 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.6 pt -61.37 -18.08 17.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 122.912 0.485 . . . . 12.16 111.478 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -83.47 -6.97 59.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.078 0.466 . . . . 15.41 110.366 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -99.22 -19.51 17.08 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.668 -0.696 . . . . 15.07 110.983 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -116.54 98.74 52.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.332 -0.547 . . . . 12.68 111.554 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.45 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 43.4 Cg_endo -72.22 -29.0 14.8 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.227 1.951 . . . . 15.04 112.408 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 3.3 p -126.71 143.39 51.25 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.378 0.609 . . . . 13.26 110.031 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 114' ' ' LEU . 34.6 tp -56.18 -26.95 52.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.258 1.423 . . . . 10.32 113.045 -174.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.41 -29.72 66.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.844 -0.616 . . . . 12.75 111.125 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -77.54 -30.3 52.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 11.26 109.934 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.47 ' O ' HG21 ' A' ' 178' ' ' VAL . 47.9 tp -75.82 -50.97 13.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.714 -0.675 . . . . 8.53 109.213 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.52 -47.34 48.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.201 0.6 . . . . 7.7 111.817 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 15.2 t70 -65.77 -31.31 72.22 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.773 0.32 . . . . 10.38 111.16 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.31 -40.31 74.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.597 -0.52 . . . . 11.97 109.597 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 174' ' ' LEU . 15.6 t -60.61 -42.24 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.08 -0.711 . . . . 9.8 109.08 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.67 -39.42 65.06 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 123.985 0.803 . . . . 10.83 111.144 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 20.0 mmt180 -73.14 -46.06 53.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.451 -0.574 . . . . 13.85 109.451 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.42 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 2.9 mmp_? -63.63 -39.23 93.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.432 -0.804 . . . . 15.46 112.02 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.12 -34.11 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 13.35 110.213 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.445 1.098 . . . . 13.51 110.749 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 C--O 1.244 0.78 0 N-CA-C 110.376 -0.231 . . . . 18.78 110.376 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 175.15 -175.31 0.09 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.264 1.026 . . . . 16.95 109.16 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.15 -18.69 65.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.844 0.831 . . . . 15.46 109.809 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.79 -11.28 60.55 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.768 -1.105 . . . . 14.98 111.682 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.15 -42.38 80.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 111.749 0.277 . . . . 15.79 111.749 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.3 t -56.34 -44.11 79.74 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.87 -0.605 . . . . 12.18 110.696 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -37.81 50.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.107 -0.497 . . . . 11.02 111.173 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -40.98 98.46 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 122.895 0.478 . . . . 16.75 109.713 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.68 -38.29 84.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.326 0.584 . . . . 14.46 110.175 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.36 -37.56 60.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.529 -0.759 . . . . 10.71 109.913 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -64.18 -32.4 73.96 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.469 -0.787 . . . . 14.51 110.608 175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -61.81 -48.71 79.37 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.693 0.797 . . . . 16.85 110.931 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p -72.52 -30.54 64.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.081 0.467 . . . . 13.52 110.945 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.33 -52.17 49.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.449 -1.315 . . . . 12.77 107.449 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.69 65.88 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.756 -0.656 . . . . 15.19 111.576 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -31.01 69.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.747 0.308 . . . . 16.26 110.676 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.59 -28.37 60.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.168 0.508 . . . . 15.45 110.402 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.36 -8.25 55.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.697 -0.683 . . . . 16.16 111.522 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 56.54 46.91 19.65 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.563 -1.199 . . . . 20.58 110.255 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.2 t -124.39 164.1 20.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.782 -1.554 . . . . 17.26 108.302 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.96 126.65 60.49 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.697 -1.223 . . . . 20.19 107.697 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 -8.4 23.52 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.945 2.43 . . . . 17.46 114.312 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.46 52.72 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.79 -0.719 . . . . 18.33 111.31 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -83.38 84.04 7.65 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.434 -0.95 . . . . 20.77 108.434 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 tp -142.07 149.02 19.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.135 0.493 . . . . 16.1 110.484 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 -101.79 120.21 40.01 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.76 -1.941 . . . . 19.87 105.76 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -67.83 -17.48 64.52 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 120.945 0.403 . . . . 15.1 111.678 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.45 7.42 61.68 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.484 -0.78 . . . . 15.48 112.953 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 p -66.56 133.35 50.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.794 0.807 . . . . 14.88 110.557 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 34.6 mtp85 -82.84 139.12 33.67 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.096 -0.957 . . . . 17.38 111.183 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -47.26 -43.11 21.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.486 0.585 . . . . 11.99 112.538 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.53 -32.24 71.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.227 1.011 . . . . 14.71 111.904 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.6 -41.64 65.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.522 0.677 . . . . 16.44 109.215 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.67 -21.09 61.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.381 -1.282 . . . . 13.83 111.104 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.34 29.12 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.341 -0.933 . . . . 14.3 112.468 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.78 85.41 7.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.329 -1.36 . . . . 13.04 107.329 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -68.72 154.58 41.69 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.872 -1.058 . . . . 15.67 110.576 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 t -49.57 -41.52 41.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.261 0.624 . . . . 15.49 112.311 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -48.52 85.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.214 0.531 . . . . 16.98 110.66 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.3 -36.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.621 -0.718 . . . . 14.44 109.585 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -59.43 -44.34 92.93 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.377 -0.829 . . . . 12.4 110.727 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -59.93 -46.45 89.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 14.37 110.533 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.27 -44.61 92.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.99 -0.55 . . . . 16.05 111.259 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.426 ' O ' HG13 ' A' ' 48' ' ' ILE . 7.5 t90 -60.13 -48.23 82.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.547 1.139 . . . . 11.7 110.051 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 41' ' ' ALA . 30.3 mm -56.94 -45.73 83.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.895 -0.593 . . . . 11.48 111.03 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 18.8 mmm180 -62.82 -31.07 71.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.429 -0.35 . . . . 17.18 110.97 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.13 -38.11 69.33 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 110.026 -0.361 . . . . 14.15 110.026 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 44' ' ' TRP . 68.7 mt -61.68 -50.77 78.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.327 -0.99 . . . . 10.8 108.327 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -54.59 -39.03 67.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.631 -1.168 . . . . 12.98 112.147 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -85.92 -37.32 19.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.73 1.011 . . . . 17.81 113.73 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -87.61 -24.48 23.96 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.508 1.299 . . . . 15.55 114.508 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.93 -10.45 19.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.004 0.742 . . . . 12.2 113.004 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 63.57 70.72 0.52 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 17.4 112.304 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.1 174.72 13.29 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.734 -1.209 . . . . 12.25 107.734 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.74 105.1 9.04 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 118.565 0.62 . . . . 16.32 111.148 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 74' ' ' VAL . 27.3 mm -72.51 124.23 90.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 O-C-N 121.82 -0.55 . . . . 11.39 111.91 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.05 126.48 14.53 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.471 -2.165 . . . . 13.44 106.471 167.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 2.18 0.55 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 115.792 1.775 . . . . 12.81 115.792 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -97.84 10.96 38.86 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.561 -0.712 . . . . 14.14 110.588 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.45 -55.89 27.52 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 121.373 -0.441 . . . . 10.76 112.242 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.42 -29.02 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.798 0.809 . . . . 11.0 110.858 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.41 -36.56 68.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.485 -0.78 . . . . 16.59 110.627 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 m -84.99 -40.96 16.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.154 -0.475 . . . . 13.72 110.7 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' HE1' ' CE3' ' A' ' 73' ' ' TRP . 68.5 m-85 -111.87 102.45 53.65 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.618 -0.882 . . . . 12.25 108.618 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 89.4 Cg_endo -83.5 4.08 7.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.286 1.991 . . . . 13.57 112.46 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.9 t -123.49 120.9 61.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.388 -1.338 . . . . 13.28 107.388 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -59.21 -32.5 70.0 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.335 0.865 . . . . 11.45 113.335 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -62.45 -46.32 89.06 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.994 0.184 . . . . 14.64 110.822 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.01 67.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.406 0.622 . . . . 11.34 110.986 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.76 -24.26 48.91 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.254 1.022 . . . . 9.05 113.095 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.4 p -60.28 -23.93 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.983 -0.448 . . . . 9.65 112.201 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.59 -29.2 69.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.802 0.81 . . . . 12.14 109.621 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.418 ' CE3' ' HE1' ' A' ' 64' ' ' TYR . 43.6 t-105 -87.32 -24.62 24.24 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.34 -0.845 . . . . 11.26 110.46 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 56' ' ' ILE . 42.6 t -84.0 -53.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.188 -0.46 . . . . 8.3 110.916 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.8 66.63 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.866 -0.606 . . . . 9.58 114.097 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 t -75.75 -17.82 59.76 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.282 -0.54 . . . . 10.46 110.77 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -84.76 -7.81 59.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.45 -0.341 . . . . 10.43 111.332 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.24 118.46 8.01 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.806 -0.442 . . . . 10.97 109.806 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.37 126.15 91.59 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.786 -0.643 . . . . 13.77 110.585 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 45.38 1.96 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.732 2.288 . . . . 12.28 111.598 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -152.63 47.25 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.354 -1.35 . . . . 13.71 107.354 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -103.75 -30.19 10.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.388 -0.823 . . . . 13.27 111.066 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.36 -61.62 1.48 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.054 0.454 . . . . 14.77 110.563 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -90.94 89.82 7.62 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.143 -0.688 . . . . 15.24 109.143 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.63 35.77 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.408 -0.36 . . . . 14.58 111.468 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.16 119.98 63.51 Favored Pre-proline 0 C--N 1.314 -0.95 0 C-N-CA 120.918 -0.313 . . . . 12.98 110.455 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.89 -28.83 9.03 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.218 1.945 . . . . 13.66 112.022 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -146.21 139.11 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.456 -0.942 . . . . 12.75 108.456 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.7 -52.06 2.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.002 0.429 . . . . 13.85 110.741 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -129.86 10.86 5.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.056 -1.09 . . . . 14.91 108.056 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -78.42 120.99 83.15 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 114.668 -1.151 . . . . 11.68 110.786 -172.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.25 -1.72 10.4 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.492 2.128 . . . . 11.23 111.975 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.15 126.82 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 121.253 0.549 . . . . 10.77 110.24 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.8 43.64 1.14 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.761 0.791 . . . . 10.76 110.423 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -164.19 167.16 20.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.151 -1.796 . . . . 11.26 106.151 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.23 88.04 13.31 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 111.954 0.353 . . . . 11.01 111.954 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.86 -55.56 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.006 1.804 . . . . 12.86 108.85 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -159.77 128.11 2.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.165 -0.925 . . . . 14.34 108.698 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -96.23 43.18 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.711 2.274 . . . . 12.35 112.35 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.49 -94.14 1.13 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.466 -0.873 . . . . 11.89 111.315 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -15.23 61.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.523 . . . . 11.88 110.415 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -66.79 -33.99 76.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.029 -0.73 . . . . 12.74 109.029 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.12 -55.39 3.35 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.414 -0.812 . . . . 11.49 109.031 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 m -86.01 58.81 5.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.516 0.674 . . . . 10.09 110.913 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.85 -46.2 19.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.317 -0.856 . . . . 11.53 110.412 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -54.01 -44.75 71.19 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.0 -0.545 . . . . 11.91 110.879 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -58.28 -47.37 83.86 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.272 -0.877 . . . . 10.19 112.934 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -35.58 60.47 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.681 -0.807 . . . . 10.43 111.353 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.9 m -58.38 -47.98 82.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.095 -0.502 . . . . 10.46 110.858 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.412 HG12 ' CE1' ' A' ' 156' ' ' PHE . 47.0 mt -63.0 -49.62 82.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 O-C-N 123.353 0.408 . . . . 8.37 110.001 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -51.7 -57.07 10.27 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.953 0.783 . . . . 8.76 112.911 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -67.82 -36.43 80.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.796 0.331 . . . . 10.86 111.471 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.39 -36.26 76.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.617 -0.512 . . . . 11.62 109.617 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.37 -39.08 91.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.629 -0.878 . . . . 7.62 108.629 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.95 -45.98 92.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.138 -0.937 . . . . 11.84 110.438 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.97 -32.56 72.23 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.419 -0.355 . . . . 12.03 111.02 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -65.45 -51.51 59.67 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.892 -0.41 . . . . 9.2 109.892 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.4 tp -64.14 -42.84 96.63 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.451 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.14 91.42 Favored Glycine 0 CA--C 1.518 0.227 0 O-C-N 123.146 0.279 . . . . 12.07 113.099 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.25 -45.35 93.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.862 0.839 . . . . 12.38 109.392 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.432 HD22 ' HB ' ' A' ' 144' ' ' THR . 45.2 tp -70.02 -45.99 66.04 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.525 -1.216 . . . . 11.77 110.739 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.3 tp -72.82 -11.0 60.43 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.934 0.894 . . . . 13.52 110.948 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.0 t80 85.97 -34.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.163 1.785 . . . . 17.15 111.665 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.5 tp -165.12 149.81 9.08 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.963 -1.495 . . . . 16.03 106.963 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -86.99 122.03 71.37 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 105.876 -1.898 . . . . 14.35 105.876 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.38 -3.07 12.25 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 122.65 2.233 . . . . 14.18 111.446 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -162.65 -107.6 0.21 Allowed Glycine 0 C--N 1.291 -1.925 0 CA-C-N 114.773 -1.103 . . . . 14.05 110.701 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -155.87 43.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.199 -2.149 . . . . 16.88 105.199 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.0 mt 62.15 -178.21 0.13 Allowed 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.085 -1.416 . . . . 12.55 111.088 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -148.34 146.51 28.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.736 -1.209 . . . . 14.87 107.736 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.8 t -76.23 91.44 3.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 14.56 109.689 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.37 -92.25 0.15 Allowed Glycine 0 CA--C 1.49 -1.511 0 N-CA-C 108.43 -1.868 . . . . 14.2 108.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 68.23 128.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.336 1.454 . . . . 13.0 112.079 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.54 -176.32 3.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.608 -0.724 . . . . 17.02 109.689 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 66.9 m-85 -63.74 -27.35 69.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.532 0.682 . . . . 13.62 109.652 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.28 -25.24 65.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.736 -1.12 . . . . 16.54 111.216 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.32 -7.33 55.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.419 -0.81 . . . . 15.87 110.23 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.1 mt -106.59 9.3 31.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.473 0.654 . . . . 13.65 110.093 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.64 -175.11 15.94 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.584 -0.734 . . . . 14.16 111.774 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 84.7 mtp -107.09 -9.09 16.27 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.604 0.716 . . . . 15.81 109.979 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -118.58 159.97 22.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.292 -0.867 . . . . 13.63 108.92 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.1 p -81.4 -16.34 52.46 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.776 0.798 . . . . 14.06 109.866 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.41 -36.37 77.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.823 -1.08 . . . . 14.08 111.087 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.432 ' HB ' HD22 ' A' ' 121' ' ' LEU . 7.2 p -63.57 -42.44 98.32 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 116.159 -0.473 . . . . 11.82 110.428 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.08 -41.59 70.19 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.536 -0.756 . . . . 10.82 112.554 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.1 p -65.3 -46.64 79.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 117.082 0.441 . . . . 12.55 111.456 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -59.92 -49.53 77.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 12.17 110.389 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.583 ' O ' HG23 ' A' ' 152' ' ' VAL . 13.9 t90 -62.72 -51.83 65.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.567 -0.742 . . . . 9.45 112.121 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.483 ' SD ' HG13 ' A' ' 165' ' ' ILE . 39.6 ttm -63.79 -37.08 86.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.189 0.44 . . . . 9.88 112.189 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -69.43 -29.07 66.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.493 -0.483 . . . . 14.43 110.533 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.31 -42.47 82.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.688 -0.965 . . . . 10.49 110.688 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 148' ' ' TRP . 22.1 t -58.66 -48.31 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.76 -1.2 . . . . 9.27 107.76 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.8 t -57.71 -52.7 64.39 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.187 -1.37 . . . . 11.46 110.906 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -66.35 -44.14 84.12 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.762 -0.654 . . . . 15.5 111.94 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -65.61 -37.77 87.55 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.039 0.755 . . . . 12.39 113.039 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.412 ' CE1' HG12 ' A' ' 110' ' ' ILE . 97.3 m-85 -93.31 9.91 34.27 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.226 0.536 . . . . 11.97 111.894 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 57.39 43.21 23.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.516 1.126 . . . . 14.37 112.355 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -122.17 155.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.391 -0.596 . . . . 13.16 109.391 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -97.91 97.29 8.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.115 -0.698 . . . . 16.91 109.115 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.17 125.68 54.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.491 -0.929 . . . . 12.32 108.491 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.97 136.01 40.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.263 -0.426 . . . . 14.37 111.106 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.86 -11.46 59.99 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 121.774 0.797 . . . . 13.15 110.421 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.98 -12.03 61.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.139 0.971 . . . . 15.68 109.518 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.2 -10.22 55.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.474 -0.785 . . . . 13.1 109.967 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.483 HG13 ' SD ' ' A' ' 149' ' ' MET . 11.4 mt -56.51 -32.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.81 1.244 . . . . 12.16 109.965 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.29 -6.37 59.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.709 -1.132 . . . . 15.41 109.761 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 88.3 m -94.87 -18.34 21.25 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.052 -0.976 . . . . 15.07 109.582 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.573 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.8 m0 -117.78 98.96 52.09 Favored Pre-proline 0 C--N 1.318 -0.793 0 O-C-N 121.927 -0.483 . . . . 12.68 111.003 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.509 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 83.6 Cg_endo -87.12 3.28 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.556 2.171 . . . . 15.04 112.205 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -139.57 143.9 37.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.88 0.848 . . . . 13.26 111.655 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.36 -28.4 68.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.067 1.747 . . . . 10.32 112.949 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.31 -26.72 60.34 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.047 0.451 . . . . 12.75 110.907 -176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -67.1 -44.98 78.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 113.575 0.954 . . . . 11.26 113.575 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.32 -25.85 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.0 -1.08 . . . . 8.53 110.585 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.36 92.78 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.888 -0.596 . . . . 7.7 111.186 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.56 -26.12 32.68 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.008 -0.677 . . . . 10.38 110.61 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.573 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 9.6 tp10 -68.54 -54.13 18.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.543 -0.298 . . . . 11.97 110.802 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.02 -43.82 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 112.718 0.636 . . . . 9.8 112.718 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 -41.92 92.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.994 0.426 . . . . 10.83 111.399 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -71.87 -29.3 64.22 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.019 -0.537 . . . . 13.85 110.338 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 5.4 mmp_? -65.06 -42.74 93.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.021 -0.536 . . . . 15.46 109.946 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.62 -51.9 23.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.19 -0.459 . . . . 13.35 111.217 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 112.293 0.479 . . . . 13.51 112.293 -178.842 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.24 0.543 . . . . 18.78 111.049 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.32 2.33 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.256 -0.429 . . . . 16.95 111.483 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.19 -17.85 17.94 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.877 0.846 . . . . 15.46 109.973 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.85 -16.64 61.13 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.797 -1.092 . . . . 14.98 110.469 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.75 -42.69 99.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.278 0.473 . . . . 15.79 112.278 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -58.09 -44.43 87.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.018 0.927 . . . . 12.18 110.01 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.32 72.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.786 -0.643 . . . . 11.02 110.887 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 27.2 tt0 -67.36 -43.82 80.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.016 -0.364 . . . . 16.75 110.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.456 ' HA ' HE21 ' A' ' 12' ' ' GLN . 30.2 t80 -53.78 -39.02 65.05 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.409 1.084 . . . . 14.46 110.933 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 mt -82.05 -39.19 23.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.777 -0.647 . . . . 10.71 110.96 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -64.01 -22.66 67.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.379 0.881 . . . . 14.51 113.379 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 45.7 mt-30 -57.3 -48.42 78.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.727 0.298 . . . . 16.85 111.568 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -75.52 -34.2 60.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.097 0.475 . . . . 13.52 110.589 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.89 -43.7 95.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.562 -0.745 . . . . 12.77 109.973 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.69 80.21 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.159 -0.928 . . . . 15.19 111.042 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.91 -44.82 30.21 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.152 -0.476 . . . . 16.26 110.845 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -70.63 -35.0 72.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.001 -0.545 . . . . 15.45 112.382 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.83 -15.68 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.531 0.681 . . . . 16.16 111.655 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 64.28 45.64 3.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.375 -1.284 . . . . 20.58 109.703 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -125.47 165.37 18.58 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.144 -1.058 . . . . 17.26 108.144 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.11 126.85 55.7 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.796 0.332 . . . . 20.19 110.736 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' O ' HG22 ' A' ' 25' ' ' ILE . 38.8 Cg_endo -65.76 -22.52 56.91 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.096 2.531 . . . . 17.46 113.387 -174.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.88 67.97 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 121.001 -0.618 . . . . 18.33 112.632 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -100.96 8.43 43.06 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.253 0.549 . . . . 20.77 111.597 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 22' ' ' PRO . 14.9 tt -85.81 119.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.876 -1.157 . . . . 16.1 107.876 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -74.96 144.17 43.32 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.744 -0.662 . . . . 19.87 110.049 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.53 -16.3 23.81 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.642 1.177 . . . . 15.1 113.914 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.2 6.53 26.95 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 121.032 -0.604 . . . . 15.48 112.264 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -71.01 148.57 47.48 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.473 0.654 . . . . 14.88 110.875 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 99.6 mtt180 -110.68 137.23 48.61 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.02 0.914 . . . . 17.38 111.978 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -47.61 -43.58 25.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.315 -1.766 . . . . 11.99 112.827 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -68.97 -29.54 67.78 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.508 -0.314 . . . . 14.71 111.406 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.72 -23.09 34.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.207 -0.664 . . . . 16.44 109.207 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.88 -39.1 66.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.451 -0.795 . . . . 13.83 109.981 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 14.26 1.05 Allowed Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.266 -0.968 . . . . 14.3 112.824 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 168.8 19.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.345 0.593 . . . . 13.04 110.408 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.4 163.08 40.57 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.234 -2.136 . . . . 15.67 105.234 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -67.03 -31.0 71.24 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 119.579 1.081 . . . . 15.49 109.565 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.36 -43.63 80.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.095 -0.502 . . . . 16.98 109.663 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.17 -33.69 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.672 -0.694 . . . . 14.44 109.944 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.92 95.47 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.814 -0.63 . . . . 12.4 109.776 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.99 -22.54 65.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.703 -0.681 . . . . 14.37 111.369 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.52 -50.83 8.93 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.253 0.549 . . . . 16.05 110.383 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -67.33 -35.68 79.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 C-N-CA 124.417 1.087 . . . . 11.7 111.662 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 48' ' ' ILE . 8.8 tp -58.63 -40.28 78.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-O 120.894 0.378 . . . . 11.48 110.377 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 41.7 ttm180 -69.01 -33.79 74.22 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.304 0.574 . . . . 17.18 110.14 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.36 -27.94 47.06 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 112.495 0.554 . . . . 14.15 112.495 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.426 HD13 HD12 ' A' ' 45' ' ' ILE . 29.7 pt -76.37 -29.54 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 119.219 -0.992 . . . . 10.8 109.032 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.13 -40.03 92.27 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-N 115.377 -0.829 . . . . 12.98 110.372 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 26.3 mtpp -65.22 -49.64 68.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.832 -0.622 . . . . 17.81 110.015 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 44.7 m80 -59.64 -43.86 93.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.551 0.945 . . . . 15.55 113.551 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -92.67 -4.79 52.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.162 1.171 . . . . 12.2 114.162 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.11 45.64 20.47 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.044 1.402 . . . . 17.4 108.891 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.6 tp -119.87 165.92 13.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.206 -1.405 . . . . 12.25 107.206 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -127.33 74.51 1.52 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.139 0.495 . . . . 16.32 109.935 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG12 ' OE1' ' A' ' 77' ' ' GLN . 58.4 mt -89.45 126.36 58.57 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.303 -0.999 . . . . 11.39 108.303 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 56' ' ' ILE . 17.6 Cg_exo -67.2 156.31 66.85 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.002 1.801 . . . . 13.44 109.084 171.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.96 -0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.434 1.272 . . . . 12.81 114.434 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.87 -12.04 60.02 Favored 'General case' 0 C--O 1.24 0.554 0 O-C-N 122.453 -0.154 . . . . 14.14 110.943 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.6 62.69 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 121.304 -0.474 . . . . 10.76 113.079 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.02 35.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.115 0.96 . . . . 11.0 108.716 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -85.42 -44.06 13.08 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.38 -0.825 . . . . 16.59 111.657 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -136.0 25.58 3.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.53 0.681 . . . . 13.72 111.434 -174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -123.34 89.92 50.76 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.73 -1.211 . . . . 12.25 107.73 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.8 Cg_endo -82.99 -3.35 11.07 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.286 1.991 . . . . 13.57 115.697 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.41 120.38 64.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 119.381 0.992 . . . . 13.28 109.347 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -61.37 -35.46 77.52 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.55 -0.75 . . . . 11.45 111.93 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.82 -29.98 69.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.523 . . . . 14.64 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.62 33.78 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.821 0.82 . . . . 11.34 109.423 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 50.7 t80 -87.82 -28.02 21.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.301 -0.863 . . . . 9.05 112.04 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 p -63.4 -36.65 84.43 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.612 -0.68 . . . . 9.65 111.723 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -75.34 -23.69 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 12.14 110.264 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.462 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 49.4 t90 -64.05 -47.89 78.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.053 -1.092 . . . . 11.26 108.053 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 90.9 t -69.22 -43.62 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 CA-C-N 115.594 -0.73 . . . . 8.3 109.235 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.76 -43.9 80.49 Favored Glycine 0 C--O 1.238 0.387 0 CA-C-N 115.491 -0.777 . . . . 9.58 113.319 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -67.58 -33.59 75.33 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.93 0.365 . . . . 10.46 111.183 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.493 ' OE1' HG12 ' A' ' 56' ' ' ILE . 3.7 pt20 -89.67 -2.37 58.27 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.767 -1.173 . . . . 10.43 112.563 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 90.6 mt -70.79 -12.39 61.52 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.243 0.544 . . . . 10.97 110.07 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -78.95 142.92 60.82 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 107.806 -1.183 . . . . 13.77 107.806 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -22.66 -65.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.362 1 C-N-CA 126.61 4.873 . . . . 12.28 117.474 -172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -132.65 48.3 2.42 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.785 0.802 . . . . 13.71 111.444 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.72 9.98 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.903 -0.719 . . . . 13.27 111.413 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.34 8.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.972 0.415 . . . . 14.77 111.277 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -102.49 20.3 17.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.655 1.217 . . . . 15.24 109.196 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.52 76.62 9.56 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.585 -1.189 . . . . 14.58 109.113 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.73 120.79 74.34 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.111 -0.95 . . . . 12.98 108.722 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.51 -24.84 63.19 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.672 2.248 . . . . 13.66 111.935 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.42 72.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.651 -1.24 . . . . 12.75 107.651 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.95 120.24 23.89 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.488 -0.93 . . . . 13.85 108.488 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -135.73 109.05 7.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.951 0.405 . . . . 14.91 110.911 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 92' ' ' PRO . 6.9 tp10 -92.38 114.89 63.67 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 107.258 -1.386 . . . . 11.68 107.258 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HD2' ' OE1' ' A' ' 91' ' ' GLU . 35.8 Cg_endo -65.56 139.15 57.41 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.178 1.919 . . . . 11.23 112.212 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.1 m -84.63 47.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.166 0.984 . . . . 10.77 110.547 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.97 4.43 4.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.194 -0.912 . . . . 10.76 111.282 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 p -76.06 98.15 4.25 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.186 0.517 . . . . 11.26 110.199 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.95 116.37 24.12 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 115.712 -0.676 . . . . 11.01 110.109 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.98 -25.6 27.42 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.612 2.208 . . . . 12.86 112.133 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -142.91 135.73 13.72 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 109.144 -0.687 . . . . 14.34 109.144 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.23 109.11 2.13 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.813 2.342 . . . . 12.35 111.951 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.63 77.11 1.94 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.43 -1.068 . . . . 11.89 110.43 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.15 -40.93 13.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.808 0.337 . . . . 11.88 110.503 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.21 90.62 7.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.857 -0.423 . . . . 12.74 109.857 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.43 -55.43 3.8 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.162 -1.051 . . . . 11.49 108.162 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m -101.29 55.92 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.3 -1.37 . . . . 10.09 107.3 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.44 -46.13 26.32 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.549 1.14 . . . . 11.53 113.555 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.91 -46.64 77.54 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.303 0.483 . . . . 11.91 112.303 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -75.43 -30.23 59.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.195 -0.298 . . . . 10.19 110.195 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.59 -46.08 91.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.003 0.521 . . . . 10.43 111.073 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 m -56.54 -38.44 71.89 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.23 0.538 . . . . 10.46 110.145 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.446 HG23 HG11 ' A' ' 178' ' ' VAL . 66.0 mt -73.59 -52.41 21.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.25 -0.887 . . . . 8.37 109.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -54.88 -43.32 73.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.736 0.814 . . . . 8.76 111.693 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.44 -40.93 93.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.088 -0.506 . . . . 10.86 110.397 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.3 -36.53 66.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.669 . . . . 11.62 109.608 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.48 -45.21 95.2 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.151 0.98 . . . . 7.62 108.406 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.83 -45.3 95.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.385 -0.825 . . . . 11.84 110.385 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -65.31 -39.41 92.45 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.142 -0.481 . . . . 12.03 111.056 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -69.08 -37.88 78.71 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.589 -0.278 . . . . 9.2 111.174 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.1 tp -65.21 -48.48 73.23 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.607 -0.516 . . . . 10.06 109.607 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.89 -49.14 77.31 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.79 -0.641 . . . . 12.07 112.148 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -61.36 -38.85 88.45 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 123.457 0.703 . . . . 12.38 111.322 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.9 tp -67.54 -43.05 81.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.977 -0.556 . . . . 11.77 110.012 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.52 -64.34 0.9 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.293 -0.867 . . . . 13.52 110.252 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.0 t80 168.02 -46.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.301 -2.111 . . . . 17.15 105.301 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -168.38 143.94 3.62 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 103.885 -2.635 . . . . 16.03 103.885 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.61 136.37 20.79 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.065 -0.717 . . . . 14.35 109.065 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.07 6.06 5.56 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.305 2.003 . . . . 14.18 112.378 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 33.76 74.6 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 110.354 -1.098 . . . . 14.05 110.354 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -102.7 20.45 17.24 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.383 1.087 . . . . 16.88 109.259 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -96.64 176.27 6.07 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.158 -0.928 . . . . 12.55 108.981 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 73.1 -58.31 0.6 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.468 1.107 . . . . 14.87 110.547 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -89.64 5.12 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.078 -1.453 . . . . 14.56 107.078 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.99 135.0 5.35 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.405 -1.478 . . . . 14.2 109.405 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' CB ' ' HG3' ' A' ' 172' ' ' LYS . . . -179.66 138.21 0.13 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.988 1.315 . . . . 13.0 107.739 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -170.01 173.9 5.78 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 118.524 -0.751 . . . . 17.02 109.879 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 55.3 m-85 -63.32 -18.87 64.08 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 119.738 1.154 . . . . 13.62 112.534 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.2 -10.08 59.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.06 -0.973 . . . . 16.54 112.373 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.258 14.3 p30 -70.46 -64.95 0.8 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.109 -0.636 . . . . 15.87 112.705 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 pp -87.3 -9.8 53.99 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.687 0.756 . . . . 13.65 109.019 173.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -83.1 70.56 3.17 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.978 -1.01 . . . . 14.16 113.701 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 92.3 mmm -109.06 -65.15 1.17 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.06 -1.459 . . . . 15.81 107.06 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.428 ' CG ' ' HG1' ' A' ' 144' ' ' THR . 5.3 p-10 -139.54 146.01 39.36 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.167 -1.79 . . . . 13.63 106.167 172.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -73.33 -16.56 61.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 113.119 0.785 . . . . 14.06 113.119 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.63 -52.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.021 -0.733 . . . . 14.08 109.021 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.428 ' HG1' ' CG ' ' A' ' 141' ' ' ASP . 40.6 p -63.82 -31.97 73.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.99 -0.55 . . . . 11.82 111.627 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.08 78.27 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.705 -1.236 . . . . 10.82 110.517 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 m -61.39 -45.33 94.82 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.761 -0.829 . . . . 12.55 108.761 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 150' ' ' ARG . 86.1 mm-40 -59.66 -41.16 89.96 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.498 -0.774 . . . . 12.17 111.514 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -65.48 -47.29 76.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.322 -0.854 . . . . 9.45 110.907 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.8 mtp -69.55 -27.35 65.07 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.291 -0.564 . . . . 9.88 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 2.7 tmm_? -59.37 -43.91 92.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.913 -1.144 . . . . 14.43 107.913 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.35 -54.3 20.8 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.364 -0.834 . . . . 10.49 111.474 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.19 -46.85 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.574 0.749 . . . . 9.27 112.385 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 p -64.54 -52.25 58.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.796 0.331 . . . . 11.46 111.864 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -71.95 -38.49 69.77 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.807 0.299 . . . . 15.5 111.807 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -68.75 -31.2 70.07 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.704 0.631 . . . . 12.39 112.704 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -101.38 1.81 38.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.992 0.425 . . . . 11.97 111.845 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 t 60.56 37.2 19.64 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.215 1.006 . . . . 14.37 111.633 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -119.89 138.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.806 -0.813 . . . . 13.16 108.806 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.95 95.66 10.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.607 0.718 . . . . 16.91 110.546 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.64 129.37 54.56 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.928 -1.138 . . . . 12.32 107.928 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.47 56.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.296 -0.631 . . . . 14.37 109.296 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.13 63.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.289 0.566 . . . . 13.15 111.208 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.81 -4.44 58.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.701 -0.682 . . . . 15.68 110.488 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -74.14 0.62 13.33 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.98 0.363 . . . . 13.1 111.98 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.8 pt -64.96 -14.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.885 0.85 . . . . 12.16 109.379 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -103.31 -3.56 25.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.093 -0.958 . . . . 15.41 109.875 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.3 m -99.42 -40.7 7.74 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.236 -0.654 . . . . 15.07 109.236 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -121.37 69.05 20.96 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.663 -0.866 . . . . 12.68 108.663 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' A' ' 135' ' ' PHE . 1.5 Cg_endo -87.12 40.92 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.988 2.458 . . . . 15.04 113.361 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 36.1 p -154.62 143.28 20.74 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 105.227 -2.138 . . . . 13.26 105.227 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.61 -17.02 64.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.356 0.502 . . . . 10.32 112.356 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.449 ' HG3' ' CB ' ' A' ' 133' ' ' ALA . 92.1 mttt -72.41 -44.24 62.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 120.824 -0.351 . . . . 12.75 110.828 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 19.1 m -63.75 -43.93 95.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 123.652 0.595 . . . . 11.26 110.186 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.5 -48.03 71.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.977 -0.556 . . . . 8.53 109.843 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.54 72.81 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.518 0.562 . . . . 7.7 112.518 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 32.8 t70 -83.25 -29.87 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.558 -0.457 . . . . 10.38 111.308 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 173' ' ' SER . 0.2 OUTLIER -57.73 -49.22 77.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.654 0.782 . . . . 11.97 109.906 -177.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.446 HG11 HG23 ' A' ' 110' ' ' ILE . 12.4 p -56.96 -35.95 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.699 -0.682 . . . . 9.8 111.556 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.1 -34.89 79.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.391 0.615 . . . . 10.83 110.314 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 88.8 mtt180 -74.27 -43.72 55.74 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.025 -0.989 . . . . 13.85 108.642 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -64.49 -40.85 96.44 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.396 -1.274 . . . . 15.46 111.192 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 178' ' ' VAL . 34.5 m -84.18 -39.47 14.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 113.196 0.813 . . . . 13.35 113.196 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 120.941 -0.304 . . . . 13.51 111.172 -179.599 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.515 -0.92 . . . . 18.78 108.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.3 66.64 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.267 1.027 . . . . 16.95 112.121 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.53 -53.76 50.11 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 15.46 111.147 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.04 -29.2 55.13 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.608 -0.723 . . . . 14.98 111.89 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.26 -35.88 80.31 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 122.652 0.381 . . . . 15.79 110.423 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.6 m -57.5 -41.57 81.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 120.847 0.356 . . . . 12.18 111.106 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -69.56 -47.39 63.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.049 -0.523 . . . . 11.02 109.633 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.08 -38.33 85.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.739 -0.664 . . . . 16.75 111.85 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.29 -46.2 74.32 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.961 0.41 . . . . 14.46 110.746 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.24 -35.53 78.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.411 -0.359 . . . . 10.71 111.793 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 85.5 mtt180 -61.97 -41.61 98.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 14.51 108.97 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -61.26 -51.18 70.0 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.058 -0.973 . . . . 16.85 110.141 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 t -56.49 -51.48 68.32 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.944 0.778 . . . . 13.52 110.838 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.62 -52.53 65.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 12.77 110.582 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.17 77.3 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.38 0.511 . . . . 15.19 112.38 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.76 78.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.69 0.281 . . . . 16.26 111.026 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 ptm -70.98 -24.5 62.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.5 -0.48 . . . . 15.45 111.865 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.36 0.7 55.69 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.028 0.381 . . . . 16.16 112.028 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 56.73 42.37 26.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.553 1.141 . . . . 20.58 111.813 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.8 m -117.84 174.53 6.13 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.984 -1.007 . . . . 17.26 109.8 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -94.76 124.37 54.95 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.575 -0.739 . . . . 20.19 110.924 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 -17.96 15.91 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.272 2.648 . . . . 17.46 113.501 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.41 43.02 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.143 -1.183 . . . . 18.33 110.143 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.7 69.7 7.73 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.542 0.687 . . . . 20.77 109.395 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.92 153.87 24.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.74 -0.663 . . . . 16.1 109.635 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.63 87.36 2.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 106.762 -1.569 . . . . 19.87 106.762 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.88 -27.57 60.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.399 1.48 . . . . 15.1 113.061 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.96 -11.79 80.77 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.234 -0.984 . . . . 15.48 112.571 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -81.92 144.94 30.59 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.388 0.613 . . . . 14.88 109.723 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 29.5 ptt180 -71.19 146.54 49.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.071 -0.968 . . . . 17.38 110.471 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -48.07 -34.46 9.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.971 1.709 . . . . 11.99 113.144 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.56 -38.24 71.65 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.228 1.011 . . . . 14.71 110.036 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.3 2.41 55.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.565 0.746 . . . . 16.44 110.927 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.6 0.83 56.73 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.113 -0.699 . . . . 13.83 109.113 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.93 11.1 50.92 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.303 -0.862 . . . . 14.3 111.95 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 175.74 5.62 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.084 0.945 . . . . 13.04 111.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -141.51 159.73 41.61 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.984 -1.916 . . . . 15.67 106.828 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -55.9 -42.98 76.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 118.947 0.794 . . . . 15.49 111.111 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.89 -51.42 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.195 -0.911 . . . . 16.98 110.577 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.22 -41.27 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.603 -0.726 . . . . 14.44 110.203 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.44 87.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 12.4 111.174 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.87 -30.42 71.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.191 0.519 . . . . 14.37 111.185 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.6 -43.92 16.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.431 0.634 . . . . 16.05 110.659 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -57.7 -44.04 85.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 124.944 1.298 . . . . 11.7 111.278 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.63 -31.1 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 121.306 -0.158 . . . . 11.48 110.987 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.49 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 1.4 mmp_? -63.1 -39.71 95.51 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.945 -0.391 . . . . 17.18 109.945 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -38.06 79.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.929 0.395 . . . . 14.15 110.356 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.8 -42.33 88.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.966 -0.753 . . . . 10.8 108.966 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' ND2' ' HB ' ' A' ' 56' ' ' ILE . 14.6 m120 -62.01 -36.26 81.0 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.59 -0.732 . . . . 12.98 111.395 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.3 -49.71 13.16 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.738 -0.21 . . . . 17.81 110.725 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -65.27 -42.38 93.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.301 -0.409 . . . . 15.55 111.759 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -85.51 -13.12 50.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.289 0.477 . . . . 12.2 112.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 57.32 38.36 28.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 17.4 109.956 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.6 tp -122.25 138.59 54.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.181 -0.918 . . . . 12.25 110.183 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -70.7 57.67 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.206 1.403 . . . . 16.32 112.573 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' HB ' ' ND2' ' A' ' 49' ' ' ASN . 11.3 mt -88.68 122.85 68.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.583 -0.698 . . . . 11.39 111.43 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -80.38 162.95 22.25 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.138 1.892 . . . . 13.44 108.765 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.31 -6.91 15.68 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.513 0.673 . . . . 12.81 110.617 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 63' ' ' THR . 33.4 t70 -60.99 -27.91 68.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.217 -1.356 . . . . 14.14 111.671 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.86 -48.97 68.97 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 119.945 -1.122 . . . . 10.76 112.776 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -76.01 -28.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.043 0.925 . . . . 11.0 109.422 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 87.3 t80 -64.21 -41.15 97.17 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.809 -1.087 . . . . 16.59 110.832 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 64' ' ' TYR . 11.4 t -94.79 -18.62 21.07 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 120.544 -0.462 . . . . 13.72 111.987 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.52 ' CD2' HG23 ' A' ' 63' ' ' THR . 96.8 m-85 -128.6 96.44 30.12 Favored Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 121.909 -0.494 . . . . 12.25 110.758 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.608 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 86.9 Cg_endo -84.64 4.27 6.97 Favored 'Trans proline' 0 C--O 1.211 -0.831 0 C-N-CA 122.363 2.042 . . . . 13.57 111.922 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.54 122.56 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.917 -1.142 . . . . 13.28 107.917 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -60.92 -40.8 94.58 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.845 0.858 . . . . 11.45 112.345 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.16 -27.4 67.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.933 0.397 . . . . 14.64 111.247 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.25 -31.6 21.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.566 0.698 . . . . 11.34 109.58 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -70.87 -30.69 67.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 9.05 111.794 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -64.09 -28.12 69.56 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.591 -0.693 . . . . 9.65 111.145 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -74.23 -24.98 59.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.709 -0.678 . . . . 12.14 109.83 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.531 ' CZ3' ' HG3' ' A' ' 77' ' ' GLN . 20.6 t90 -64.49 -49.03 72.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.616 -1.253 . . . . 11.26 107.616 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.33 -43.92 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-N 115.079 -0.964 . . . . 8.3 109.536 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.73 -40.63 95.17 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.778 -0.646 . . . . 9.58 112.347 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 24.2 p -77.18 -8.87 58.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.788 0.662 . . . . 10.46 112.788 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.531 ' HG3' ' CZ3' ' A' ' 73' ' ' TRP . 16.8 mm-40 -93.32 -35.35 13.1 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.051 -0.405 . . . . 10.43 110.316 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.48 -41.42 80.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.707 -0.849 . . . . 10.97 108.707 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -128.82 94.55 34.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.181 -0.918 . . . . 13.77 108.592 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 76' ' ' THR . 60.5 Cg_endo -74.32 70.04 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.957 2.438 . . . . 12.28 113.8 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.6 m -75.75 110.9 10.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.88 -0.6 . . . . 13.71 109.827 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -81.55 79.48 8.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.514 -0.55 . . . . 13.27 109.514 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.55 53.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.819 0.819 . . . . 14.77 109.421 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -86.33 46.58 1.36 Allowed 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.043 0.925 . . . . 15.24 109.719 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.97 132.34 36.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.835 -0.62 . . . . 14.58 110.207 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.07 120.75 71.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.813 -0.81 . . . . 12.98 108.813 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.4 -34.92 83.01 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.877 3.051 . . . . 13.66 112.545 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -121.45 111.1 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.504 -1.295 . . . . 12.75 107.504 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -73.76 118.23 16.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.022 0.439 . . . . 13.85 110.28 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -123.83 47.99 1.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.622 -1.251 . . . . 14.91 107.622 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.72 118.62 30.2 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.181 -1.372 . . . . 11.68 111.838 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.27 69.2 5.55 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.651 2.234 . . . . 11.23 110.298 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.69 134.85 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.923 -0.581 . . . . 10.77 109.525 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.65 77.0 9.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.405 0.622 . . . . 10.76 110.714 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 p -88.6 152.4 21.86 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.822 -0.626 . . . . 11.26 111.04 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.97 128.44 25.75 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.827 -0.805 . . . . 11.01 108.827 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.61 -32.78 47.47 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.822 2.348 . . . . 12.86 112.708 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.55 106.97 47.56 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.53 -0.545 . . . . 14.34 109.53 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.48 -4.73 15.37 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.75 2.3 . . . . 12.35 112.476 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.36 -175.42 40.41 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 109.659 -1.377 . . . . 11.89 109.659 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 5.21 51.45 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.973 0.416 . . . . 11.88 110.153 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -65.92 -27.17 67.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.226 -0.443 . . . . 12.74 111.786 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.28 96.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.213 0.53 . . . . 11.49 109.739 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m -75.38 -39.37 59.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.443 -0.799 . . . . 10.09 110.182 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.19 87.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.843 -0.617 . . . . 11.53 110.898 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.437 ' OE1' ' HB ' ' A' ' 182' ' ' VAL . 8.1 tt0 -54.25 -51.84 63.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.664 0.786 . . . . 11.91 109.08 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.35 -45.99 90.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.928 -1.033 . . . . 10.19 111.811 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.63 -39.38 91.1 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.053 0.454 . . . . 10.43 111.591 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -69.33 -51.43 37.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.014 -0.539 . . . . 10.46 110.262 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.467 HG23 HG13 ' A' ' 178' ' ' VAL . 54.6 mt -70.22 -27.02 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 116.267 -0.424 . . . . 8.37 111.456 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.21 -38.78 80.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.559 0.695 . . . . 8.76 109.551 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.76 -31.08 66.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.178 -0.919 . . . . 10.86 110.639 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -77.5 -35.86 53.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.45 -0.341 . . . . 11.62 110.465 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.8 -47.02 83.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.813 -0.81 . . . . 7.62 108.813 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -52.17 -55.22 22.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.879 -1.055 . . . . 11.84 109.835 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.5 -44.08 95.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 12.03 112.581 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 t -63.35 -44.43 94.86 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.058 0.456 . . . . 9.2 110.475 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.05 -42.99 83.86 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.36 -0.607 . . . . 10.06 109.36 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.05 -19.73 68.2 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 116.154 -0.475 . . . . 12.07 112.743 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -78.62 -38.87 38.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.201 -0.666 . . . . 12.38 109.201 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.4 tp -80.83 -45.4 16.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.705 -0.68 . . . . 11.77 110.748 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -83.03 -19.46 36.88 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.196 -0.911 . . . . 13.52 110.223 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.2 t80 73.22 -43.78 0.57 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.855 1.662 . . . . 17.15 112.209 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.5 tp -159.34 142.74 14.57 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.154 -0.684 . . . . 16.03 109.154 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.78 112.08 27.29 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.25 0.344 . . . . 14.35 110.251 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.53 -9.66 20.11 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.888 2.392 . . . . 14.18 112.336 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.13 69.01 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.582 -1.007 . . . . 14.05 110.582 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 78.27 27.17 0.53 Allowed 'General case' 0 C--O 1.247 0.955 0 C-N-CA 125.008 1.323 . . . . 16.88 110.666 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.0 mt 56.85 73.05 0.47 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.647 -1.615 . . . . 12.55 112.267 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -86.33 151.59 23.45 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.116 -1.402 . . . . 14.87 111.39 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -37.33 67.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.83 -1.077 . . . . 14.56 110.262 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.17 62.65 4.53 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 110.771 -0.931 . . . . 14.2 110.771 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.4 143.79 28.48 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.458 -0.571 . . . . 13.0 109.458 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -137.52 139.75 40.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.979 -0.748 . . . . 17.02 108.979 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 12.2 p90 -63.32 -6.87 5.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.733 0.813 . . . . 13.62 112.806 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.84 -61.05 2.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.172 0.511 . . . . 16.54 110.039 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.63 -20.98 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.087 -0.506 . . . . 15.87 110.344 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.02 14.47 15.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.932 -0.577 . . . . 13.65 111.468 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.42 60.02 4.87 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.957 -0.857 . . . . 14.16 110.957 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.03 152.21 51.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.469 -1.308 . . . . 15.81 107.469 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.25 39.87 18.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.192 0.932 . . . . 13.63 111.175 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 p -77.62 -32.81 53.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.219 -0.9 . . . . 14.06 112.138 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.1 -50.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.383 -0.969 . . . . 14.08 108.383 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -72.18 -16.14 61.96 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.34 -0.846 . . . . 11.82 111.303 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.69 -22.09 77.99 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.216 -0.754 . . . . 10.82 111.216 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 82.2 p -66.82 -45.87 76.96 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.182 -1.044 . . . . 12.55 108.182 175.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -61.75 -38.35 87.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.136 -0.938 . . . . 12.17 110.147 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.45 ' O ' HG22 ' A' ' 152' ' ' VAL . 12.4 t90 -56.09 -54.09 49.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 9.45 110.308 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 164' ' ' ALA . 43.6 ttm -66.76 -30.83 71.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.242 0.339 . . . . 9.88 111.543 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 146' ' ' THR . 23.3 mmm180 -58.4 -50.16 74.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 14.43 109.189 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.52 -44.75 96.49 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.654 -0.579 . . . . 10.49 111.654 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 148' ' ' TRP . 80.4 t -57.29 -48.67 81.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 123.208 0.603 . . . . 9.27 111.136 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.2 p -71.19 -31.14 67.27 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.816 0.341 . . . . 11.46 111.526 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.61 -44.91 63.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.027 0.441 . . . . 15.5 110.37 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -66.44 -48.2 70.74 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.791 0.663 . . . . 12.39 112.791 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -84.41 -0.24 52.01 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.171 0.434 . . . . 11.97 112.171 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.5 p 54.43 33.43 18.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.204 1.401 . . . . 14.37 112.482 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.3 pt -109.61 153.55 11.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.541 -0.754 . . . . 13.16 110.308 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.09 95.53 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.185 0.517 . . . . 16.91 110.46 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.98 120.81 26.72 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.006 -0.738 . . . . 12.32 109.006 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 134.74 38.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.903 -0.777 . . . . 14.37 108.903 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.32 -7.86 21.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.749 0.785 . . . . 13.15 111.661 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.3 -19.96 65.96 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.881 0.872 . . . . 15.68 109.711 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 167' ' ' THR . . . -59.8 -19.46 50.85 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.659 0.985 . . . . 13.1 113.659 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.5 pt -70.03 -2.31 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.764 -0.585 . . . . 12.16 111.822 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -122.53 23.69 9.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.743 0.306 . . . . 15.41 110.647 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 164' ' ' ALA . 10.3 t -147.07 20.75 1.24 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.503 -0.479 . . . . 15.07 111.088 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -134.94 103.54 10.79 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 108.552 -0.907 . . . . 12.68 108.552 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.528 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 17.2 Cg_exo -69.19 -33.09 19.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.801 2.334 . . . . 15.04 113.37 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -97.56 155.7 16.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.476 -0.784 . . . . 13.26 110.938 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -81.79 -32.28 31.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.114 -0.948 . . . . 10.32 111.876 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -78.11 -5.6 52.09 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.751 0.649 . . . . 12.75 112.751 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.8 p -54.28 -35.52 62.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.251 1.02 . . . . 11.26 112.46 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 7.3 tt -60.7 -30.79 70.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.184 0.594 . . . . 8.53 110.22 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.48 59.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.259 -0.428 . . . . 7.7 110.369 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.29 -30.22 30.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.845 -0.428 . . . . 10.38 109.845 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 5.3 mm-40 -57.25 -59.97 4.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 11.97 109.309 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.467 HG13 HG23 ' A' ' 110' ' ' ILE . 7.6 p -63.96 -37.16 79.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.595 -1.184 . . . . 9.8 111.843 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.22 -39.32 86.24 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.397 0.617 . . . . 10.83 110.441 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -74.28 -41.09 61.77 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.967 -1.015 . . . . 13.85 110.078 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 181' ' ' ARG . 3.3 mmp_? -69.18 -52.91 23.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.764 -0.653 . . . . 15.46 112.065 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.437 ' HB ' ' OE1' ' A' ' 106' ' ' GLN . 46.6 t -73.9 -65.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 13.35 109.38 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.872 1.269 . . . . 13.51 112.575 175.913 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 4' ' ' ASP . 5.0 m . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 18.78 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 -53.97 2.52 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.137 -0.483 . . . . 16.95 110.53 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.29 -48.14 24.62 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.013 -1.106 . . . . 15.46 108.013 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' A' ' 1' ' ' VAL . 23.6 t70 -69.24 -15.68 63.43 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.84 -1.527 . . . . 14.98 111.122 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.04 -34.38 77.57 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.219 0.533 . . . . 15.79 109.628 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.5 m -60.8 -34.07 73.96 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.182 -0.917 . . . . 12.18 110.229 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.34 -48.46 70.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.702 -0.481 . . . . 11.02 109.702 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.05 -42.52 94.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.467 0.479 . . . . 16.75 111.556 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -63.83 -46.42 85.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 14.46 110.684 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.65 -48.66 59.07 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 111.769 0.285 . . . . 10.71 111.769 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.77 -16.67 63.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.959 -0.696 . . . . 14.51 111.293 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -60.84 -49.2 78.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.342 0.401 . . . . 16.85 109.987 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -79.03 -31.5 44.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.868 -0.333 . . . . 13.52 110.111 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.24 -52.9 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.815 -0.809 . . . . 12.77 108.815 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.79 -25.01 62.68 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.078 -0.51 . . . . 15.19 111.741 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.79 63.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.96 0.41 . . . . 16.26 110.88 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 mmt -85.36 -31.25 23.07 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.898 0.38 . . . . 15.45 110.981 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -96.4 -2.61 45.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.216 0.531 . . . . 16.16 111.505 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 60.16 41.07 17.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.007 1.323 . . . . 20.58 111.795 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 t -107.22 -178.92 3.78 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.032 -0.985 . . . . 17.26 108.586 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -97.72 103.08 15.1 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 123.077 0.551 . . . . 20.19 110.271 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -53.53 -40.55 78.51 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 124.26 3.307 . . . . 17.46 115.258 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.89 -11.65 85.2 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 119.971 -1.109 . . . . 18.33 114.043 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -141.77 58.42 1.49 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.241 0.83 . . . . 20.77 113.241 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.2 pt -97.15 -10.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.18 -0.608 . . . . 16.1 110.408 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 73.85 128.05 0.04 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 125.645 1.578 . . . . 19.87 110.607 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 4.4 p-10 -66.34 -23.83 66.42 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.571 1.323 . . . . 15.1 114.571 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.97 5.89 69.06 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 119.901 -1.142 . . . . 15.48 112.66 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.2 m -70.43 151.54 45.04 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 122.024 0.916 . . . . 14.88 112.951 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 48.1 mtm180 -90.12 132.68 35.3 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.08 -1.418 . . . . 17.38 111.267 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 98.5 m-85 -47.0 -52.69 14.17 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 123.741 0.651 . . . . 11.99 112.638 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' LEU . 19.5 tp -56.1 -37.97 70.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 14.71 111.323 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.73 -23.8 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.799 -0.637 . . . . 16.44 110.885 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.26 -13.42 59.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.296 0.57 . . . . 13.83 110.713 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.21 -8.45 15.9 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.762 -0.732 . . . . 14.3 111.444 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 7.4 tt -69.69 134.23 48.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.461 -0.57 . . . . 13.04 109.461 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 18.5 t70 -114.48 161.33 18.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.233 -1.025 . . . . 15.67 108.233 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 118.829 0.741 . . . . 15.49 111.131 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -70.42 -41.47 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.593 0.711 . . . . 16.98 109.501 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 62.3 mt -67.99 -28.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.001 -1.0 . . . . 14.44 110.177 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' HD22 ' A' ' 36' ' ' LEU . . . -61.14 -48.51 81.3 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.587 -0.733 . . . . 12.4 110.438 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.55 96.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.212 0.529 . . . . 14.37 110.326 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.95 -46.15 88.75 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.912 -1.04 . . . . 16.05 111.618 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -71.92 -41.76 67.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 124.748 1.219 . . . . 11.7 110.437 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mm -51.98 -46.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.634 0.774 . . . . 11.48 112.146 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.9 mtm-85 -58.35 -40.01 81.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.482 0.489 . . . . 17.18 110.617 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 51' ' ' HIS . 22.1 mt-10 -74.19 -34.66 63.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 120.145 -0.622 . . . . 14.15 112.154 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.1 mt -59.93 -46.26 94.21 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 108.866 -0.79 . . . . 10.8 108.866 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -59.84 -39.93 86.8 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 114.972 -1.013 . . . . 12.98 110.535 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -79.2 -43.44 23.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.559 0.578 . . . . 17.81 112.559 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 65.0 m170 -64.86 -44.04 91.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.454 0.538 . . . . 15.55 112.454 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -95.74 -10.77 28.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.35 0.87 . . . . 12.2 113.35 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 59.22 52.06 6.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.313 -1.366 . . . . 17.4 107.313 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.4 tp -127.55 135.96 51.04 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.645 -1.161 . . . . 12.25 110.21 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.02 69.11 3.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 16.32 110.68 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.06 119.24 74.63 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.235 -0.439 . . . . 11.39 110.311 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.45 136.44 31.18 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.103 1.869 . . . . 13.44 109.726 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.88 63.45 Favored 'General case' 0 C--O 1.245 0.868 0 C-N-CA 123.684 0.794 . . . . 12.81 112.036 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.68 -12.36 61.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.205 -0.452 . . . . 14.14 112.066 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.5 -22.87 47.04 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 123.233 0.333 . . . . 10.76 113.663 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -115.94 -1.22 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 122.827 1.299 . . . . 11.0 108.16 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -90.63 -47.74 7.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.398 -0.819 . . . . 16.59 109.541 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 t -96.24 -23.15 16.83 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.792 -0.763 . . . . 13.72 111.493 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -100.57 118.25 61.29 Favored Pre-proline 0 CA--C 1.511 -0.541 0 C-N-CA 120.421 -0.512 . . . . 12.25 109.889 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.656 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.5 Cg_endo -94.53 -1.41 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.363 2.042 . . . . 13.57 114.02 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.31 123.15 68.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.19 0.519 . . . . 13.28 109.925 -174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 89.6 t80 -64.85 -37.12 86.56 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.295 1.038 . . . . 11.45 111.311 -174.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 75.3 tttt -63.34 -39.45 94.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.529 -0.759 . . . . 14.64 111.09 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.47 72.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.135 0.493 . . . . 11.34 110.261 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -67.32 -37.51 83.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.7 -0.682 . . . . 9.05 112.638 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -64.03 -35.31 80.29 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.955 -0.698 . . . . 9.65 112.692 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.158 -0.682 . . . . 12.14 109.158 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -60.66 -38.54 85.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.395 -0.821 . . . . 11.26 109.884 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.18 -48.26 49.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.078 -0.712 . . . . 8.3 109.078 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.49 -43.36 94.09 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.345 -0.843 . . . . 9.58 113.231 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -65.73 -28.5 69.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.794 0.664 . . . . 10.46 112.794 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -85.84 -23.59 27.06 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.433 -0.507 . . . . 10.43 111.022 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.33 124.55 24.79 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.271 0.557 . . . . 10.97 111.592 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -103.86 105.62 49.0 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.855 -1.165 . . . . 13.77 107.855 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.33 123.86 12.1 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.321 2.014 . . . . 12.28 112.565 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -89.69 147.47 23.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.54 -1.282 . . . . 13.71 107.54 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.55 87.54 6.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.97 -0.692 . . . . 13.27 110.472 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.85 -27.22 40.19 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.015 -0.993 . . . . 14.77 109.408 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -83.48 73.26 10.21 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 122.118 0.961 . . . . 15.24 108.747 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.87 -164.78 1.23 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.757 -1.11 . . . . 14.58 109.7 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 131.33 70.6 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 122.999 0.52 . . . . 12.98 110.655 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.81 96.93 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.496 2.131 . . . . 13.66 111.946 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.02 115.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.235 -1.394 . . . . 12.75 107.235 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -85.02 65.48 9.26 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.264 1.031 . . . . 13.85 110.731 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -143.55 136.59 27.71 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 107.003 -1.48 . . . . 14.91 107.003 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.79 125.31 73.54 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 107.964 -1.125 . . . . 11.68 107.964 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 52.13 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.235 2.623 . . . . 11.23 111.869 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.6 p -93.77 -23.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.348 -0.842 . . . . 10.77 110.105 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.67 15.91 22.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.661 -0.416 . . . . 10.76 111.203 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.6 m -71.49 -41.59 69.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.348 -0.612 . . . . 11.26 109.348 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.51 84.55 27.87 Favored Pre-proline 0 N--CA 1.432 -1.333 0 CA-C-N 115.742 -0.663 . . . . 11.01 110.675 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.14 43.14 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 122.434 2.089 . . . . 12.86 112.25 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -176.44 153.24 1.21 Allowed Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 103.371 -2.825 . . . . 14.34 103.371 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.5 124.72 16.76 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.074 1.85 . . . . 12.35 112.094 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.92 -160.36 54.03 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.897 -0.592 . . . . 11.89 112.612 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.467 ' HB2' ' NE2' ' A' ' 183' ' ' GLN . . . -88.33 17.37 5.28 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.821 0.82 . . . . 11.88 110.425 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -73.36 -6.38 45.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.024 -0.989 . . . . 12.74 109.75 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.53 84.64 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.768 -0.651 . . . . 11.49 110.59 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.5 t 55.81 22.82 5.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.736 1.614 . . . . 10.09 111.015 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.57 -49.0 15.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.426 -0.807 . . . . 11.53 109.751 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.47 -43.76 93.17 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.661 -0.866 . . . . 11.91 108.661 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -50.25 -57.64 7.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.186 0.994 . . . . 10.19 111.409 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.14 -40.56 90.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.698 -0.228 . . . . 10.43 111.523 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 t -59.29 -51.06 71.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.661 -0.496 . . . . 10.46 109.661 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.77 -40.46 82.6 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 CA-C-N 116.369 -0.378 . . . . 8.37 110.254 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.04 -44.53 87.44 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.562 0.745 . . . . 8.76 110.602 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.98 -41.87 67.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.725 -0.671 . . . . 10.86 110.783 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -62.68 -40.48 97.22 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.455 -0.339 . . . . 11.62 111.178 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.95 -50.53 66.28 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.871 0.868 . . . . 7.62 109.791 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.8 -46.7 86.99 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.435 -1.257 . . . . 11.84 111.496 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -70.65 -45.91 64.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.184 -0.462 . . . . 12.03 111.195 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.9 t -64.69 -44.03 91.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.809 -0.632 . . . . 9.2 111.065 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.66 -39.94 80.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.127 -0.629 . . . . 10.06 109.903 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.83 -38.94 94.76 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 111.751 -0.54 . . . . 12.07 111.751 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -54.51 -47.2 73.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.335 1.054 . . . . 12.38 110.662 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -86.4 -22.87 26.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.22 0.822 . . . . 11.77 113.22 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.2 tp -84.16 -28.61 27.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.766 0.317 . . . . 13.52 110.614 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 68.69 1.18 2.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.149 1.38 . . . . 17.15 113.803 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -162.92 154.81 18.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.25 -1.389 . . . . 16.03 107.25 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.07 96.49 25.71 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 110.053 -0.351 . . . . 14.35 110.053 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -75.0 -15.61 20.65 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.486 2.124 . . . . 14.18 110.807 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.93 47.69 4.39 Favored Glycine 0 CA--C 1.497 -1.08 0 CA-C-N 114.789 -1.096 . . . . 14.05 112.661 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -121.26 12.51 11.0 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.523 -0.471 . . . . 16.88 111.967 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.4 mt -55.41 -37.11 67.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.42 1.105 . . . . 12.55 111.141 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -98.06 84.68 3.33 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.14 -1.391 . . . . 14.87 111.901 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 m 72.27 -5.22 1.82 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.845 1.424 . . . . 14.56 114.845 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 -34.53 20.68 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 119.496 -1.335 . . . . 14.2 110.559 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.86 95.9 3.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.056 0.942 . . . . 13.0 109.978 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 170' ' ' THR . 46.3 mt-30 -86.89 177.12 7.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.387 -0.968 . . . . 17.02 108.387 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 44.5 p90 -59.98 -23.16 63.4 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.167 0.894 . . . . 13.62 110.111 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.34 -29.91 70.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.888 -1.051 . . . . 16.54 110.35 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.19 -39.19 12.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.84 -0.618 . . . . 15.87 110.08 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.48 -26.86 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 13.65 111.233 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.53 5.08 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.336 -0.459 . . . . 14.16 113.512 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 72.3 mtm -74.81 -29.61 61.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 117.58 0.69 . . . . 15.81 110.594 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.56 ' OD2' HG12 ' A' ' 143' ' ' VAL . 32.6 t70 -149.21 120.5 7.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.25 0.547 . . . . 13.63 111.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 p -75.32 -25.98 58.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.943 1.09 . . . . 14.06 113.943 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 HG12 ' OD2' ' A' ' 141' ' ' ASP . 2.8 p -72.13 -34.98 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.865 -1.161 . . . . 14.08 107.865 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.8 m -60.62 -50.17 74.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.311 -1.313 . . . . 11.82 109.212 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.77 -54.55 27.62 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.613 0.571 . . . . 10.82 113.471 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 6.9 t -62.9 -45.18 93.75 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 112.648 0.61 . . . . 12.55 112.648 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -65.61 -49.31 69.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 12.17 110.951 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -63.72 -42.15 97.96 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.419 -0.809 . . . . 9.45 110.77 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' A' ' 149' ' ' MET . 0.3 OUTLIER -58.81 -54.62 45.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 9.88 111.256 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 146' ' ' THR . 13.5 ptt180 -63.79 -38.66 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.651 -0.25 . . . . 14.43 111.657 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.9 -53.48 44.87 Favored Glycine 0 N--CA 1.443 -0.853 0 O-C-N 123.531 0.519 . . . . 10.49 112.417 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.88 -41.69 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.525 0.203 . . . . 9.27 111.341 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.9 m -60.72 -54.99 38.58 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 116.172 -0.467 . . . . 11.46 111.466 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -69.31 -25.37 64.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.577 -0.738 . . . . 15.5 111.221 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -64.36 -30.77 71.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.872 -0.604 . . . . 12.39 110.878 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' SER . 69.8 m-85 -98.15 -69.69 0.75 Allowed 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.689 -0.804 . . . . 11.97 111.004 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 19.4 t 171.53 17.32 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.278 0.361 . . . . 14.37 110.998 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.5 pt -123.22 168.46 15.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 O-C-N 121.322 -0.861 . . . . 13.16 109.67 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -130.93 118.01 20.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 120.518 -0.473 . . . . 16.91 110.902 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.8 mt -118.71 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.354 -0.839 . . . . 12.32 109.514 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.51 149.28 36.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.115 -0.948 . . . . 14.37 110.147 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.12 0.968 . . . . 13.15 112.695 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.06 1.85 57.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.887 -0.597 . . . . 15.68 111.236 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.437 ' O ' HG21 ' A' ' 167' ' ' THR . . . -66.23 -18.13 65.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.545 0.572 . . . . 13.1 112.545 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . 0.282 2.6 pp -75.93 7.05 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.932 0.716 . . . . 12.16 112.932 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -98.65 -16.03 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.623 -0.717 . . . . 15.41 110.427 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 164' ' ' ALA . 15.2 t -103.34 15.95 27.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.253 -0.579 . . . . 15.07 111.765 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.559 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 13.5 m0 -123.26 119.2 27.58 Favored Pre-proline 0 CA--C 1.501 -0.915 0 O-C-N 121.902 -0.499 . . . . 12.68 110.453 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.424 ' HD2' ' OG ' ' A' ' 173' ' ' SER . 22.7 Cg_exo -63.32 -37.61 49.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.455 2.104 . . . . 15.04 110.261 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 16.5 p -144.24 169.13 18.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.746 -0.661 . . . . 13.26 110.956 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -52.68 -41.31 63.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.166 0.586 . . . . 10.32 111.875 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.86 -22.83 50.11 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.477 0.917 . . . . 12.75 113.477 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 169' ' ' PRO . 14.3 m -69.1 -26.85 65.13 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.033 0.444 . . . . 11.26 110.665 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.483 HD13 ' CH2' ' A' ' 168' ' ' TRP . 23.6 tp -66.82 -46.06 76.35 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.579 -0.897 . . . . 8.53 108.579 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.46 -28.23 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.934 -1.03 . . . . 7.7 111.273 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.72 -40.53 55.46 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.83 -0.348 . . . . 10.38 111.663 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.84 -34.58 66.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.584 0.957 . . . . 11.97 113.584 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.4 -33.66 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.282 -0.567 . . . . 9.8 110.012 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 183' ' ' GLN . 10.6 t70 -60.86 -49.93 75.47 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 109.427 -0.582 . . . . 10.83 109.427 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.6 -29.41 70.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.468 -0.787 . . . . 13.85 112.134 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -85.89 -51.48 6.36 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.193 0.442 . . . . 15.46 112.193 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.92 -36.65 45.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 120.966 0.412 . . . . 13.35 110.913 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 101' ' ' ALA . 23.7 mt-30 . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 118.319 -0.848 . . . . 13.51 109.119 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 107.134 -1.432 . . . . 18.78 107.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.98 -39.56 41.38 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.398 0.888 . . . . 16.95 113.398 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.04 -57.03 13.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 15.46 111.215 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 28.5 t70 -65.65 -32.4 73.94 Favored 'General case' 0 C--O 1.197 -1.703 0 CA-C-N 115.76 -0.654 . . . . 14.98 110.191 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.04 -39.83 93.65 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.286 0.634 . . . . 15.79 111.142 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.6 t -65.1 -35.26 80.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.322 -0.622 . . . . 12.18 109.322 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.25 57.55 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 116.219 -0.446 . . . . 11.02 111.093 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 26.1 mt-30 -51.73 -50.23 60.99 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.767 0.827 . . . . 16.75 111.446 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -42.39 96.13 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.823 -0.351 . . . . 14.46 111.158 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.88 -37.16 70.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.9 0.381 . . . . 10.71 110.505 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -64.84 -47.43 77.98 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.201 1.001 . . . . 14.51 109.041 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.81 -46.89 83.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.064 0.946 . . . . 16.85 111.153 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -72.94 -38.7 66.68 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.228 0.455 . . . . 13.52 112.228 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.92 -46.57 88.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.692 -1.225 . . . . 12.77 107.692 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -61.7 -44.26 97.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 15.19 111.315 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.81 86.39 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.21 0.448 . . . . 16.26 112.21 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.41 -44.63 51.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.039 0.385 . . . . 15.45 112.039 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.47 -9.77 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.228 0.537 . . . . 16.16 111.986 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 t80 65.96 36.97 5.6 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.627 1.203 . . . . 20.58 108.857 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 14.6 p -107.89 163.4 13.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.736 -1.209 . . . . 17.26 107.736 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -90.92 136.58 27.43 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 120.234 -0.586 . . . . 20.19 111.506 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' O ' HG23 ' A' ' 25' ' ' ILE . 81.9 Cg_endo -74.91 6.88 3.09 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.415 2.743 . . . . 17.46 112.671 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.48 -30.51 18.74 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 111.301 -0.719 . . . . 18.33 111.301 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -94.85 47.15 1.15 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.175 0.988 . . . . 20.77 111.674 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 22' ' ' PRO . 9.1 tp -126.8 131.81 70.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.96 -1.496 . . . . 16.1 106.96 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -136.4 174.04 11.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.974 -0.103 . . . . 19.87 111.194 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 2.8 m-20 -67.52 -45.42 75.83 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.623 0.725 . . . . 15.1 111.33 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.44 7.77 74.65 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.002 -0.999 . . . . 15.48 113.998 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.9 m -59.89 144.97 47.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.292 0.567 . . . . 14.88 112.435 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 63.4 mtm180 -82.3 102.33 11.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.548 -2.019 . . . . 17.38 105.548 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' O ' HD22 ' A' ' 36' ' ' LEU . 1.3 t80 -45.55 -58.58 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.798 1.239 . . . . 11.99 114.03 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.34 -29.63 47.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.109 0.481 . . . . 14.71 111.404 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 7.1 mm-40 -68.87 -7.03 30.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 16.44 111.73 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -72.66 -5.96 41.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.233 -0.44 . . . . 13.83 111.239 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.05 11.55 4.74 Favored Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.063 -1.065 . . . . 14.3 114.128 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -115.41 152.17 33.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.898 0.849 . . . . 13.04 112.854 -177.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -126.04 167.59 15.13 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.121 -0.945 . . . . 15.67 109.475 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.3 m -38.72 -52.82 1.69 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.598 1.559 . . . . 15.49 114.71 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.8 -46.19 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.94 0.4 . . . . 16.98 111.317 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -66.16 -38.84 82.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 14.44 109.872 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.16 -42.54 96.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.406 -0.815 . . . . 12.4 110.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.11 96.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.759 . . . . 14.37 110.624 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.85 -40.13 94.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.861 -0.609 . . . . 16.05 111.45 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -67.6 -53.51 27.54 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.034 -0.985 . . . . 11.7 111.53 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 58' ' ' ALA . 7.8 tp -60.49 -29.99 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.421 0.629 . . . . 11.48 110.708 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -62.49 -28.41 69.81 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.06 -0.973 . . . . 17.18 109.417 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -86.61 -33.83 20.05 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.887 -0.597 . . . . 14.15 111.713 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.76 -46.46 96.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.495 -0.557 . . . . 10.8 109.495 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -53.11 -39.27 63.3 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.046 -0.979 . . . . 12.98 111.415 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -77.07 -57.98 3.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.93 -0.577 . . . . 17.81 111.159 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -66.94 -27.99 67.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.284 -0.871 . . . . 15.55 113.219 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -103.85 0.84 30.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.879 -0.728 . . . . 12.2 112.625 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 54.24 47.62 22.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.83 1.252 . . . . 17.4 110.522 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 56' ' ' ILE . 92.8 mt -126.4 142.19 51.62 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.218 -0.901 . . . . 12.25 110.089 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.92 36.34 1.56 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.367 -1.346 . . . . 16.32 107.367 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 54' ' ' LEU . 9.4 tt -56.55 132.69 77.36 Favored Pre-proline 0 C--O 1.244 0.812 0 CA-C-N 112.227 -2.26 . . . . 11.39 110.492 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.38 128.47 30.22 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.143 2.562 . . . . 13.44 111.957 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -71.63 -21.2 61.87 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 121.786 0.803 . . . . 12.81 110.03 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -69.04 -6.87 30.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.102 -0.954 . . . . 14.14 111.52 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' TYR . . . -63.35 -17.67 59.84 Favored Glycine 0 C--N 1.355 1.583 0 N-CA-C 112.019 -0.433 . . . . 10.76 112.019 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -99.16 -43.34 11.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.837 -1.171 . . . . 11.0 107.837 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.71 -48.9 69.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 113.816 -1.538 . . . . 16.59 112.0 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.442 HG21 ' CE2' ' A' ' 64' ' ' TYR . 10.0 t -109.63 13.47 23.82 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.464 -0.494 . . . . 13.72 111.745 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 89.4 m-85 -140.73 75.15 26.08 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 109.339 -0.615 . . . . 12.25 109.339 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.33 38.05 0.7 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.054 2.503 . . . . 13.57 113.253 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.52 120.86 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.645 -1.613 . . . . 13.28 106.645 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -58.03 -42.05 84.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.31 -0.859 . . . . 11.45 112.555 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 83.0 tttt -64.98 -46.09 82.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.764 0.316 . . . . 14.64 110.199 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.85 92.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.975 -0.557 . . . . 11.34 111.551 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.35 -33.93 58.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.183 -0.462 . . . . 9.05 111.633 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -71.2 -33.03 69.56 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.624 -0.83 . . . . 9.65 110.762 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 54.2 mt-30 -69.86 -33.6 72.48 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.888 -0.782 . . . . 12.14 108.888 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.509 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 17.6 t-105 -61.82 -49.63 75.54 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.204 -0.907 . . . . 11.26 110.19 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.2 t -63.2 -45.27 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.259 0 N-CA-C 109.913 -0.403 . . . . 8.3 109.913 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.32 -32.31 80.36 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.667 -0.697 . . . . 9.58 113.398 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 t -87.27 -12.61 46.11 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 122.213 -0.581 . . . . 10.46 110.459 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 86.1 mm-40 -88.45 -47.11 8.59 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 122.308 -0.245 . . . . 10.43 110.366 177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 74' ' ' VAL 0.265 1.2 pp -81.51 80.6 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.846 1.308 . . . . 10.97 112.18 177.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -118.13 92.43 42.54 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.444 -1.253 . . . . 13.77 110.682 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.65 -176.85 2.39 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.954 2.436 . . . . 12.28 109.583 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.88 77.06 9.79 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.509 0.671 . . . . 13.71 109.564 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -97.96 -66.74 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.417 -0.811 . . . . 13.27 110.608 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.53 55.42 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.306 -0.861 . . . . 14.77 109.732 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -85.31 18.93 2.44 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.078 0.942 . . . . 15.24 111.459 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -133.28 109.06 9.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.267 -1.333 . . . . 14.58 108.282 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.87 120.52 81.17 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 109.637 -0.505 . . . . 12.98 109.637 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -77.32 99.26 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.445 2.097 . . . . 13.66 110.858 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.99 145.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.945 -1.131 . . . . 12.75 107.945 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -125.69 169.16 12.82 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.085 0.241 . . . . 13.85 110.352 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -148.82 92.03 1.94 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 123.318 0.386 . . . . 14.91 109.99 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.14 128.52 42.74 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.661 . . . . 11.68 109.214 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.66 55.25 5.12 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.315 2.677 . . . . 11.23 112.477 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.55 141.3 46.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.03 -0.73 . . . . 10.77 109.03 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.2 96.3 10.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.458 0.647 . . . . 10.76 109.304 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.2 m -148.86 147.7 29.02 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.89 -1.522 . . . . 11.26 106.89 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.94 118.43 65.8 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.626 -0.509 . . . . 11.01 109.626 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.35 36.05 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.134 2.556 . . . . 12.86 111.545 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.34 127.09 23.12 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.377 -0.971 . . . . 14.34 108.377 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.48 149.04 18.73 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.231 1.954 . . . . 12.35 111.909 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.93 2.47 86.61 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-N 115.852 -0.613 . . . . 11.89 112.396 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.5 -17.24 59.26 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.097 0.959 . . . . 11.88 111.018 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -69.31 -8.1 43.09 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.818 0.847 . . . . 12.74 112.361 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.08 -14.51 44.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.155 0.503 . . . . 11.49 109.935 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m 61.81 29.7 18.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.949 1.299 . . . . 10.09 112.71 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.67 65.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.818 -0.628 . . . . 11.53 110.813 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -80.15 -40.19 27.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.6 -0.889 . . . . 11.91 108.6 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -55.33 -40.48 71.25 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 114.991 -1.004 . . . . 10.19 111.225 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -60.32 -53.57 56.1 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.041 0.536 . . . . 10.43 110.106 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -56.88 -49.96 73.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.211 -0.904 . . . . 10.46 109.743 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.447 HG12 ' CE1' ' A' ' 156' ' ' PHE . 52.7 mt -53.35 -48.23 56.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.663 -0.699 . . . . 8.37 110.974 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -47.17 -44.36 21.91 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.448 1.099 . . . . 8.76 112.346 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 18.5 t70 -70.28 -50.42 39.68 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.738 -0.385 . . . . 10.86 111.216 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -62.77 -31.7 72.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.356 0.598 . . . . 11.62 111.558 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.5 -40.87 66.53 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.315 1.046 . . . . 7.62 109.326 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.8 -47.15 61.0 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.693 -0.685 . . . . 11.84 111.076 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 10.8 pt20 -65.44 -32.71 74.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 12.03 111.474 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 p -71.65 -35.76 70.47 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.335 -0.546 . . . . 9.2 110.604 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.28 -45.22 70.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.053 -0.721 . . . . 10.06 109.053 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 -34.03 78.85 Favored Glycine 0 C--O 1.237 0.341 0 CA-C-N 116.202 -0.453 . . . . 12.07 111.999 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.13 -50.44 68.22 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.453 0.701 . . . . 12.38 109.516 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.67 -43.61 72.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.159 -0.928 . . . . 11.77 111.638 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.06 -24.3 55.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.358 0.503 . . . . 13.52 112.358 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 67.49 2.27 2.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.208 1.003 . . . . 17.15 111.109 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -156.95 155.91 32.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.278 -0.267 . . . . 16.03 110.278 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.85 114.48 65.24 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.481 -1.303 . . . . 14.35 107.481 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.22 -20.06 21.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.976 1.784 . . . . 14.18 110.782 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.96 -104.05 0.18 Allowed Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 108.482 -1.847 . . . . 14.05 108.482 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.84 11.37 0.75 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.136 0.493 . . . . 16.88 111.799 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp 67.48 119.29 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.59 1.556 . . . . 12.55 114.456 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -162.33 -72.69 0.05 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.525 -1.216 . . . . 14.87 110.556 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -128.58 -35.21 1.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.158 0.429 . . . . 14.56 112.158 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.93 81.07 1.7 Allowed Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.965 -0.854 . . . . 14.2 110.965 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.37 59.03 1.15 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.027 0.441 . . . . 13.0 110.947 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.459 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 17.6 tp60 -72.32 136.2 46.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.734 -1.58 . . . . 17.02 106.734 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.65 -31.02 63.97 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 124.216 1.006 . . . . 13.62 111.831 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.9 -31.24 72.06 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.247 0.546 . . . . 16.54 111.488 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -82.69 -22.11 34.66 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.194 -0.457 . . . . 15.87 110.165 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 31.4 mt -93.11 -28.04 16.57 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.867 -0.606 . . . . 13.65 110.235 -176.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.61 86.41 0.06 OUTLIER Glycine 0 C--N 1.31 -0.883 0 N-CA-C 109.817 -1.313 . . . . 14.16 109.817 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptp -71.22 -18.9 62.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.09 1.144 . . . . 15.81 114.09 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.26 150.61 22.37 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 118.99 -0.529 . . . . 13.63 111.313 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -53.34 -44.66 68.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 117.858 0.299 . . . . 14.06 111.649 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.94 -48.3 88.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 111.295 0.109 . . . . 14.08 111.295 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 p -60.22 -38.51 83.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.466 0.543 . . . . 11.82 112.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.79 22.97 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.783 -1.198 . . . . 10.82 111.897 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.6 m -65.02 -32.6 74.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.374 0.269 . . . . 12.55 110.851 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.97 -49.55 76.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.557 . . . . 12.17 109.926 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -71.76 -34.81 69.79 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.517 -0.765 . . . . 9.45 111.142 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -45.59 92.65 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.469 -1.308 . . . . 9.88 107.469 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 154' ' ' ARG . 69.9 ttt180 -63.82 -43.03 97.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.861 -1.063 . . . . 14.43 109.659 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.09 -49.22 68.79 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 115.638 -0.71 . . . . 10.49 113.296 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.57 -37.45 74.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 117.267 0.534 . . . . 9.27 111.807 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.7 m -59.83 -43.84 94.35 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.955 0.159 . . . . 11.46 110.957 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 28.6 mtm180 -63.38 -45.36 91.45 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.561 -0.291 . . . . 15.5 110.624 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -53.97 -43.12 69.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.595 0.961 . . . . 12.39 113.595 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.447 ' CE1' HG12 ' A' ' 110' ' ' ILE . 79.2 m-85 -102.97 4.89 37.94 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.238 -0.585 . . . . 11.97 111.681 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.5 m 53.95 44.06 29.94 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.237 1.015 . . . . 14.37 111.339 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.95 161.55 15.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.316 -0.856 . . . . 13.16 108.773 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -113.25 96.75 6.08 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.978 0.418 . . . . 16.91 110.34 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.49 149.51 27.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.649 -0.871 . . . . 12.32 108.649 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.33 134.99 42.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.713 -0.676 . . . . 14.37 111.926 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.75 -22.2 62.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 13.15 110.103 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.06 -17.55 61.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.55 -0.75 . . . . 15.68 110.194 175.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.54 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -72.7 -3.2 23.68 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 112.654 0.612 . . . . 13.1 112.654 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.5 pt -68.27 -13.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.748 0.785 . . . . 12.16 109.298 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -111.2 3.79 18.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.29 -0.868 . . . . 15.41 109.357 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 56.9 m -97.25 -38.55 9.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 15.07 108.66 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.5 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.2 m0 -102.32 115.58 64.29 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.784 -0.644 . . . . 12.68 109.631 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.29 -30.36 3.41 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.28 1.987 . . . . 15.04 113.185 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.9 p -128.99 170.89 12.91 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 109.585 -0.524 . . . . 13.26 109.585 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.42 -22.65 66.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.444 -0.344 . . . . 10.32 111.061 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -61.79 -44.47 96.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.158 0.504 . . . . 12.75 110.423 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 5.7 m -61.02 -37.05 81.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.268 -0.878 . . . . 11.26 110.466 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.84 -42.25 58.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.191 -0.459 . . . . 8.53 110.558 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.09 83.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 7.7 111.639 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 20.4 m-20 -79.27 -33.75 43.19 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.411 -0.516 . . . . 10.38 110.653 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.5 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 7.4 tp10 -61.69 -50.45 72.43 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.136 -0.483 . . . . 11.97 111.012 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 -41.69 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.729 -0.669 . . . . 9.8 111.086 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.67 -41.51 97.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.791 0.436 . . . . 10.83 110.478 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 5.0 mmp_? -68.82 -31.33 70.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.638 -0.71 . . . . 13.85 111.089 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -78.09 -37.68 45.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.144 -0.48 . . . . 15.46 109.99 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.71 -59.85 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.931 -0.577 . . . . 13.35 109.661 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.135 0.897 . . . . 13.51 110.998 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.526 0.203 . . . . 18.78 110.729 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 -58.46 0.05 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 122.518 0.327 . . . . 16.95 110.497 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -101.48 -64.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.119 -0.491 . . . . 15.46 111.439 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -53.83 -26.3 23.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.706 1.203 . . . . 14.98 112.987 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.92 -32.71 69.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.369 0.507 . . . . 15.79 112.369 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.487 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 28.9 p -63.83 -37.32 86.94 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 120.103 -0.639 . . . . 12.18 110.441 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 -20.23 61.9 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.088 -0.506 . . . . 11.02 110.259 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.34 -53.08 6.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.995 -0.743 . . . . 16.75 108.995 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.71 -50.18 70.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 115.319 -0.855 . . . . 14.46 112.9 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.6 mt -71.76 -25.7 62.14 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.263 -0.575 . . . . 10.71 111.395 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -70.33 -40.44 74.15 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.041 -0.726 . . . . 14.51 109.041 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -65.63 -44.62 85.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.323 -0.853 . . . . 16.85 109.366 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 t -64.63 -33.77 76.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.742 -0.663 . . . . 13.52 110.693 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.22 -53.31 51.22 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.929 -1.137 . . . . 12.77 107.929 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' CYS . . . -65.37 -33.64 76.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.872 -1.058 . . . . 15.19 111.541 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.84 -33.88 75.64 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.436 0.532 . . . . 16.26 112.436 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' HA ' ' A' ' 44' ' ' TRP . 44.3 mtt -81.27 -21.86 39.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.923 -0.711 . . . . 15.45 111.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 84.2 mt -98.71 -7.34 27.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.175 0.512 . . . . 16.16 110.814 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 64.72 43.67 4.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.224 1.41 . . . . 20.58 111.742 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 6.6 p -126.83 169.91 12.74 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.637 -0.71 . . . . 17.26 111.182 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.09 127.67 78.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 123.061 0.544 . . . . 20.19 111.68 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.5 -9.9 24.19 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.045 2.496 . . . . 17.46 112.314 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.9 -36.18 65.36 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.263 -1.135 . . . . 18.33 110.263 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -83.11 -37.57 23.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.997 -0.742 . . . . 20.77 108.997 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mm -76.38 92.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.828 -1.175 . . . . 16.1 107.828 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.71 155.77 26.59 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.036 -0.984 . . . . 19.87 110.291 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.35 -17.74 64.87 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 114.396 -1.275 . . . . 15.1 111.87 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.52 6.93 39.06 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 120.89 -0.672 . . . . 15.48 112.79 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -68.97 160.81 30.19 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.851 0.834 . . . . 14.88 113.092 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 18.7 ttm180 -97.45 112.46 24.29 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.524 -1.216 . . . . 17.38 109.738 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -39.03 -60.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.831 1.252 . . . . 11.99 113.877 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.63 -32.8 72.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 14.71 111.729 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.64 -17.27 60.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.786 0.803 . . . . 16.44 110.729 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.56 8.31 17.1 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.151 -0.477 . . . . 13.83 111.557 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.21 31.2 12.18 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.813 -0.915 . . . . 14.3 110.813 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.482 HD21 ' HB1' ' A' ' 41' ' ' ALA . 6.5 tt -108.8 135.67 49.64 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.81 -0.811 . . . . 13.04 108.81 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -123.2 164.02 19.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.572 -1.27 . . . . 15.67 107.572 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -49.54 -41.74 42.13 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.609 0.64 . . . . 15.49 111.756 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.57 -49.39 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.928 -0.578 . . . . 16.98 110.675 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.04 -35.72 75.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.996 -0.547 . . . . 14.44 110.438 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -60.38 -46.81 88.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 12.4 111.395 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.16 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.316 0.579 . . . . 14.37 110.999 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.14 -40.02 71.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.745 -0.661 . . . . 16.05 111.076 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.429 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 9.2 t90 -57.78 -45.53 85.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 124.278 1.031 . . . . 11.7 110.09 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 41' ' ' ALA . 40.3 mm -54.96 -39.34 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 114.935 -1.029 . . . . 11.48 110.072 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -57.43 -35.45 70.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.36 -0.836 . . . . 17.18 111.668 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 51' ' ' HIS . 24.5 tt0 -85.09 -35.72 21.63 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.037 -0.665 . . . . 14.15 110.787 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 45' ' ' ILE . 19.5 pt -68.57 -30.28 46.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 119.912 -0.715 . . . . 10.8 110.83 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.597 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 6.1 m-20 -63.69 -27.31 69.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.334 -0.848 . . . . 12.98 110.498 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -79.96 -46.32 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.177 -0.675 . . . . 17.81 109.177 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 20.8 m-70 -51.58 -56.56 12.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.303 -0.862 . . . . 15.55 112.899 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.487 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 97.0 m-85 -107.18 16.51 24.0 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.471 0.545 . . . . 12.2 112.471 -173.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 42.91 42.94 3.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.655 1.182 . . . . 17.4 112.523 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.24 140.57 52.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.831 -0.622 . . . . 12.25 109.325 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -81.19 72.05 8.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.253 -0.43 . . . . 16.32 110.216 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.597 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 18.2 mm -61.47 125.37 84.22 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-N 115.947 -0.57 . . . . 11.39 111.564 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 59.1 Cg_endo -77.27 125.82 8.05 Favored 'Trans proline' 0 N--CA 1.434 -1.985 0 C-N-CA 121.938 1.759 . . . . 13.44 108.671 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.51 -19.79 40.4 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.926 0.713 . . . . 12.81 112.926 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 57' ' ' PRO . 3.0 p30 -62.64 -16.76 58.37 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.171 0.804 . . . . 14.14 113.171 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.23 78.71 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 120.847 -0.692 . . . . 10.76 114.566 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.45 -34.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.496 0.665 . . . . 11.0 111.55 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -73.55 -28.0 61.63 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.202 -0.666 . . . . 16.59 109.202 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 m -83.13 -43.52 16.12 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.229 -0.896 . . . . 13.72 110.078 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.2 94.31 48.04 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.278 -0.419 . . . . 12.25 110.31 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 93.7 Cg_endo -83.65 4.34 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.62 2.214 . . . . 13.57 112.705 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.38 120.61 62.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.642 -1.614 . . . . 13.28 106.642 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -56.09 -44.69 79.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.835 -1.075 . . . . 11.45 113.488 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -71.71 -21.33 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.442 0.639 . . . . 14.64 110.784 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.91 -31.7 22.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.662 0.744 . . . . 11.34 109.348 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 48.3 t80 -71.85 -34.11 68.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.388 -0.824 . . . . 9.05 111.455 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 p -65.03 -24.32 67.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.141 0.496 . . . . 9.65 111.569 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -74.06 -39.76 63.27 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.175 -1.046 . . . . 12.14 108.175 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 59.7 t90 -59.83 -45.91 90.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.583 -1.19 . . . . 11.26 109.246 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.91 -45.38 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 8.3 109.966 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.83 84.96 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.603 -0.726 . . . . 9.58 114.365 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -71.68 -16.4 62.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 10.46 112.452 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -93.29 -26.48 17.3 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.39 -0.368 . . . . 10.43 110.489 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.64 -41.61 87.99 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.943 -0.571 . . . . 10.97 109.915 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -131.76 119.05 16.91 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-N 116.154 -0.476 . . . . 13.77 109.856 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.13 84.74 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.335 2.024 . . . . 12.28 110.021 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.0 t -70.33 -14.84 62.75 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.928 -0.578 . . . . 13.71 110.748 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -94.09 14.48 19.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.187 -0.461 . . . . 13.27 111.764 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.96 -23.1 61.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.528 0.68 . . . . 14.77 109.961 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.413 ' HA ' ' CG ' ' A' ' 91' ' ' GLU . 15.3 t -156.78 157.43 35.02 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.26 -1.756 . . . . 15.24 106.26 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.63 40.75 7.72 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 124.212 0.945 . . . . 14.58 110.692 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 91' ' ' GLU . . . -78.99 131.29 67.25 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.77 -0.826 . . . . 12.98 108.77 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.35 43.76 1.38 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.961 2.441 . . . . 13.66 112.929 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.3 p -146.91 56.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 122.375 1.083 . . . . 12.75 109.586 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 74.66 -59.22 0.56 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.277 1.431 . . . . 13.85 112.008 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -137.09 157.3 47.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.538 -0.912 . . . . 14.91 108.538 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 84' ' ' THR . 1.7 pm0 -83.21 141.22 42.75 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 108.741 -0.837 . . . . 11.68 108.741 172.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.53 68.58 3.57 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.731 2.287 . . . . 11.23 111.268 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.9 124.72 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 CA-C-N 114.776 -1.102 . . . . 10.77 109.488 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.24 60.59 1.22 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.404 -1.332 . . . . 10.76 107.404 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 m 73.77 133.49 0.05 OUTLIER 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.599 -1.637 . . . . 11.26 110.033 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.72 125.92 83.44 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 115.574 -0.739 . . . . 11.01 109.882 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.87 -36.21 97.33 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.46 2.773 . . . . 12.86 110.821 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -124.27 126.98 25.43 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 106.245 -1.761 . . . . 14.34 106.245 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.2 33.07 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.827 2.351 . . . . 12.35 113.555 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 24.91 9.17 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.112 -1.195 . . . . 11.89 110.112 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.73 -25.37 60.16 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.986 0.422 . . . . 11.88 110.655 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.52 116.39 9.87 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.966 -0.753 . . . . 12.74 108.966 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.27 -28.06 56.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.873 -0.603 . . . . 11.49 109.503 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -88.78 81.59 6.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.442 -0.948 . . . . 10.09 108.442 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.72 -28.66 70.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.173 -0.921 . . . . 11.53 112.725 -174.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.475 ' O ' HG13 ' A' ' 110' ' ' ILE . 48.3 tp60 -61.03 -20.92 63.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.027 0.531 . . . . 11.91 111.592 -176.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.489 HH21 ' NE2' ' A' ' 183' ' ' GLN . 10.8 mpt_? -75.05 -31.08 61.2 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.844 0.312 . . . . 10.19 111.844 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 40.1 tt0 -71.88 -43.69 65.0 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.132 0.491 . . . . 10.43 109.984 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -62.48 -21.53 65.54 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.998 -0.546 . . . . 10.46 111.812 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.54 HG12 ' CZ ' ' A' ' 156' ' ' PHE . 55.3 mt -67.07 -54.68 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 108.704 -0.85 . . . . 8.37 108.704 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 13.7 pt20 -64.37 -29.31 70.38 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.937 -0.574 . . . . 8.76 111.751 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.66 -52.2 64.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.618 -0.512 . . . . 10.86 109.618 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -69.41 -37.4 77.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 11.62 110.489 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.28 -42.27 98.36 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.526 -0.916 . . . . 7.62 108.526 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.1 -47.2 87.38 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.596 -0.729 . . . . 11.84 109.404 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.05 -50.37 72.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 12.03 111.705 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.5 m -69.14 -30.45 68.7 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.717 0.266 . . . . 9.2 111.717 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 47.7 tp -68.96 -49.23 59.8 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 108.707 -0.849 . . . . 10.06 108.707 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.32 -22.03 68.93 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.707 -0.759 . . . . 12.07 112.534 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.08 -52.8 8.2 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 122.538 -0.389 . . . . 12.38 110.756 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.56 -18.11 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.732 0.641 . . . . 11.77 112.732 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 118' ' ' LEU . 4.4 mm? -113.42 3.01 15.63 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.035 0.445 . . . . 13.52 110.83 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 70.45 -29.8 0.19 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 17.15 115.596 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.8 tp -136.0 148.76 48.56 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.593 -0.692 . . . . 16.03 111.365 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -84.44 124.25 73.79 Favored Pre-proline 0 CA--C 1.505 -0.784 0 N-CA-C 107.148 -1.427 . . . . 14.35 107.148 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.17 -16.31 12.38 Favored 'Trans proline' 0 C--N 1.33 -0.446 0 C-N-CA 121.848 1.699 . . . . 14.18 113.08 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.15 6.65 87.66 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 110.575 -1.01 . . . . 14.05 110.575 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -99.72 33.22 2.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.666 0.746 . . . . 16.88 110.603 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 68.2 mt -73.34 103.37 4.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.881 -1.054 . . . . 12.55 108.539 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 79.23 1.27 2.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.214 1.406 . . . . 14.87 111.424 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -89.04 -25.35 22.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.604 0.716 . . . . 14.56 109.338 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 157.49 -91.8 0.12 Allowed Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.248 -1.141 . . . . 14.2 110.248 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 63.45 90.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.862 1.265 . . . . 13.0 112.092 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -97.49 136.56 37.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.721 -0.844 . . . . 17.02 108.721 175.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -47.55 -36.45 10.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.21 1.404 . . . . 13.62 114.063 -170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.29 -40.65 96.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.954 0.502 . . . . 16.54 110.926 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.48 -35.27 75.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.009 -0.541 . . . . 15.87 110.434 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.98 -19.52 61.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 13.65 112.076 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.87 20.48 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.439 -1.065 . . . . 14.16 110.439 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.7 ttm -85.98 129.03 34.96 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.547 -0.908 . . . . 15.81 108.547 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.03 176.09 6.93 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.136 -1.061 . . . . 13.63 108.136 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.871 ' HB3' ' HH ' ' A' ' 166' ' ' TYR . 38.6 m -73.73 -48.06 34.72 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.4 -0.92 . . . . 14.06 109.697 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.19 -48.08 88.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 112.012 0.375 . . . . 14.08 112.012 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 p -67.6 -33.93 75.99 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.913 0.387 . . . . 11.82 111.757 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 -25.5 61.86 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 119.971 -1.109 . . . . 10.82 111.116 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.3 m -64.91 -48.34 74.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 12.55 108.705 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -57.13 -53.59 56.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.891 -1.05 . . . . 12.17 109.993 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -53.0 -53.98 42.01 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 9.45 112.743 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.424 ' HA ' ' HE2' ' A' ' 149' ' ' MET . 3.5 tpt -54.76 -54.08 46.66 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.153 0.581 . . . . 9.88 111.425 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -64.62 -37.23 86.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.966 0.413 . . . . 14.43 110.185 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.38 27.89 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.473 -0.785 . . . . 10.49 112.649 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.88 -42.79 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.512 0.325 . . . . 9.27 111.007 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 25.3 m -58.5 -57.15 14.2 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.837 -0.62 . . . . 11.46 110.847 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -64.2 -35.62 81.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.637 -0.71 . . . . 15.5 111.352 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -76.59 -14.84 59.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.036 0.384 . . . . 12.39 112.036 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.54 ' CZ ' HG12 ' A' ' 110' ' ' ILE . 86.1 t80 -95.68 -70.31 0.72 Allowed 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 119.132 -1.027 . . . . 11.97 111.081 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.9 m -178.74 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.79 0.436 . . . . 14.37 112.138 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 27.7 pt -98.84 142.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.268 0.556 . . . . 13.16 111.796 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -91.78 95.75 10.03 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.748 0.785 . . . . 16.91 109.632 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 87.2 mt -101.01 151.23 22.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.288 -0.869 . . . . 12.32 109.25 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.91 45.81 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.393 -1.276 . . . . 14.37 108.763 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.17 -21.18 66.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.444 0.64 . . . . 13.15 110.204 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -82.08 2.94 28.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 15.68 111.009 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.72 61.17 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.905 -0.497 . . . . 13.1 111.685 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.4 pt -67.38 -10.97 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.261 0.553 . . . . 12.16 110.446 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.871 ' HH ' ' HB3' ' A' ' 142' ' ' SER . 27.3 m-85 -106.57 -1.47 22.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 15.41 109.164 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -89.22 -47.0 8.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.106 -0.701 . . . . 15.07 109.106 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.34 141.09 24.79 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 109.223 -0.658 . . . . 12.68 109.223 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 40.5 Cg_endo -97.21 2.26 1.66 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.377 2.051 . . . . 15.04 114.429 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -120.13 144.34 47.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.455 0.909 . . . . 13.26 113.455 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.48 -30.39 71.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.303 -1.317 . . . . 10.32 112.339 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -58.37 -40.1 81.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.534 -0.757 . . . . 12.75 110.674 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -39.59 93.13 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.319 -0.855 . . . . 11.26 110.844 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.55 -50.38 65.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.216 -1.031 . . . . 8.53 108.216 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.04 -32.32 69.65 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.754 0.65 . . . . 7.7 112.754 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.48 -34.2 31.5 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.523 -0.471 . . . . 10.38 111.033 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.98 -47.42 68.61 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.963 0.905 . . . . 11.97 110.118 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.428 HG11 HG23 ' A' ' 110' ' ' ILE . 12.4 p -57.21 -44.29 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.309 -0.86 . . . . 9.8 112.277 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -57.51 -39.45 76.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.023 0.44 . . . . 10.83 111.627 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -80.92 -23.84 38.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.836 -0.62 . . . . 13.85 110.678 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -84.2 -38.67 20.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 15.46 110.276 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.59 -41.78 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.843 -0.617 . . . . 13.35 111.604 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.489 ' NE2' HH21 ' A' ' 107' ' ' ARG . 10.3 pt20 . . . . . 0 N--CA 1.434 -1.229 0 C-N-CA 120.586 -0.446 . . . . 13.51 111.271 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 110.592 -0.151 . . . . 18.78 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.75 -58.19 2.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.013 -0.43 . . . . 16.95 109.906 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -71.38 -49.87 37.77 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.398 0.618 . . . . 15.46 109.669 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -70.25 -19.76 63.11 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.793 -1.094 . . . . 14.98 111.42 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.47 -49.27 62.1 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.021 0.928 . . . . 15.79 112.154 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' A' ' 74' ' ' VAL . 52.6 t -61.46 -48.06 82.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 123.467 0.48 . . . . 12.18 111.535 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.7 92.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.614 -0.267 . . . . 11.02 110.759 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -61.72 -46.52 89.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 123.291 0.369 . . . . 16.75 111.378 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.487 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 77.8 t80 -67.96 -33.52 74.81 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.597 -0.274 . . . . 14.46 110.753 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.93 -40.73 75.36 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 120.354 -0.538 . . . . 10.71 110.229 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -59.4 -45.39 91.61 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.795 -0.446 . . . . 14.51 109.795 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.5 -54.47 46.5 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.488 1.115 . . . . 16.85 111.455 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.7 p -68.18 -35.32 77.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.215 -0.448 . . . . 13.52 111.238 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.13 -52.56 62.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 12.77 108.609 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.04 91.06 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.978 -0.555 . . . . 15.19 111.125 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -49.23 71.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.455 0.539 . . . . 16.26 112.455 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.8 mmm -76.66 -36.79 57.13 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.743 0.646 . . . . 15.45 112.743 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.84 -5.83 58.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.989 0.424 . . . . 16.16 111.71 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 61.04 39.51 16.23 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.767 1.27 . . . . 20.58 110.614 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 t -111.79 -173.56 2.27 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 113.135 -1.848 . . . . 17.26 107.553 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.0 136.92 29.16 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.847 -0.797 . . . . 20.19 108.847 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.1 -19.96 19.65 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.68 2.253 . . . . 17.46 113.182 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.65 -45.42 4.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.704 -0.958 . . . . 18.33 110.704 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.46 75.03 9.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.351 0.596 . . . . 20.77 110.748 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -147.54 144.96 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.744 -0.835 . . . . 16.1 108.744 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -88.42 131.23 34.95 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 107.536 -1.283 . . . . 19.87 107.536 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.58 -15.89 63.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 112.381 0.512 . . . . 15.1 112.381 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.21 7.67 54.67 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-N 116.154 -0.476 . . . . 15.48 112.019 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 p -69.0 133.42 48.11 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.817 0.818 . . . . 14.88 111.324 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 16.5 mtp180 -84.05 140.63 31.71 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.92 -1.037 . . . . 17.38 110.371 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 76.3 m-85 -43.75 -48.35 8.03 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 113.617 0.969 . . . . 11.99 113.617 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.87 -15.15 63.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.217 0.451 . . . . 14.71 112.217 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.1 -39.03 9.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.211 -1.403 . . . . 16.44 107.211 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.2 tp -61.02 -29.17 69.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.058 -1.883 . . . . 13.83 111.581 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.05 6.93 1.39 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.273 -1.441 . . . . 14.3 113.924 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.61 151.42 24.51 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 119.133 -1.027 . . . . 13.04 112.667 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.47 159.89 42.0 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 112.375 -2.193 . . . . 15.67 105.709 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -50.51 -48.52 56.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.821 1.045 . . . . 15.49 113.821 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.29 -46.89 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.479 0.657 . . . . 16.98 110.613 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.35 -37.87 72.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.011 -0.54 . . . . 14.44 110.363 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 -42.19 84.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.607 -0.724 . . . . 12.4 110.19 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.02 84.7 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.247 -0.888 . . . . 14.37 110.93 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.66 -47.74 74.51 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.415 -0.812 . . . . 16.05 110.88 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -66.03 -52.1 52.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.874 1.269 . . . . 11.7 111.818 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.24 -37.16 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.297 0.48 . . . . 11.48 112.297 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -66.39 -40.37 89.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.517 -0.473 . . . . 17.18 110.13 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.48 -24.6 64.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 111.828 0.307 . . . . 14.15 111.828 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.2 -55.72 17.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.29 -0.633 . . . . 10.8 109.29 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 3.3 m-20 -63.31 -34.5 77.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 12.98 112.156 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.43 -47.29 17.83 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.476 -0.329 . . . . 17.81 111.857 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -70.66 -40.29 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 112.822 0.675 . . . . 15.55 112.822 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 9' ' ' PHE . 81.2 m-85 -91.42 -8.13 48.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.786 -0.765 . . . . 12.2 113.02 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 53.98 41.46 32.02 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.959 1.304 . . . . 17.4 109.486 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 tp -115.87 143.47 45.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.737 -0.665 . . . . 12.25 110.942 -170.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -69.76 76.06 0.44 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.491 -0.777 . . . . 16.32 110.861 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.439 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 21.7 mm -98.66 113.86 64.77 Favored Pre-proline 0 C--N 1.316 -0.881 0 O-C-N 121.8 -0.563 . . . . 11.39 110.566 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.6 140.46 93.87 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.478 2.119 . . . . 13.44 109.91 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.89 2.33 1.48 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.289 0.848 . . . . 12.81 113.289 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.4 0.03 41.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 118.961 -0.542 . . . . 14.14 112.163 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.708 ' HA2' ' CZ3' ' A' ' 73' ' ' TRP . . . -43.73 -60.92 3.15 Favored Glycine 0 C--N 1.356 1.667 0 N-CA-C 114.758 0.663 . . . . 10.76 114.758 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.92 -21.7 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.889 1.276 . . . . 11.0 112.019 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -93.33 -40.38 10.44 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.209 -0.451 . . . . 16.59 111.064 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.4 m -73.86 -40.38 63.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.396 -0.366 . . . . 13.72 110.956 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -112.56 103.1 55.35 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.098 -1.075 . . . . 12.25 108.098 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 95.8 Cg_endo -79.55 -0.27 10.58 Favored 'Trans proline' 0 C--O 1.209 -0.949 0 C-N-CA 122.311 2.007 . . . . 13.57 112.529 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.59 119.86 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.757 -1.572 . . . . 13.28 106.757 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 21.9 p90 -57.12 -36.48 70.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.411 0.684 . . . . 11.45 112.529 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -63.77 -31.03 72.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.519 0.727 . . . . 14.64 110.424 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.05 26.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.103 0.478 . . . . 11.34 110.262 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 46.1 t80 -77.39 -30.57 53.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.934 -0.575 . . . . 9.05 111.343 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p -67.26 -24.57 65.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.59 0.71 . . . . 9.65 110.309 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -76.93 -28.66 55.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.608 -0.724 . . . . 12.14 109.404 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.708 ' CZ3' ' HA2' ' A' ' 60' ' ' GLY . 1.6 t90 -56.86 -55.24 36.98 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 108.56 -0.904 . . . . 11.26 108.56 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' SG ' ' A' ' 6' ' ' CYS . 71.5 t -65.8 -43.61 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 CA-C-N 115.132 -0.94 . . . . 8.3 110.188 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.01 -34.67 73.23 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.615 0.572 . . . . 9.58 112.459 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.5 m -72.91 -37.28 67.3 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 122.926 0.49 . . . . 10.46 111.377 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.72 -14.73 60.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.384 . . . . 10.43 112.038 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.43 137.3 32.86 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.943 -1.132 . . . . 10.97 107.943 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.8 139.94 37.63 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 108.991 -0.744 . . . . 13.77 108.991 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -66.87 105.67 0.99 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.549 1.499 . . . . 12.28 108.438 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -80.15 69.87 6.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.059 1.409 . . . . 13.71 111.175 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -85.91 127.95 34.72 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 113.961 -1.472 . . . . 13.27 107.105 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.8 -24.43 63.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.57 0.7 . . . . 14.77 110.058 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 p -97.15 35.68 1.55 Allowed 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.218 -0.901 . . . . 15.24 110.952 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.22 36.98 4.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.885 -0.598 . . . . 14.58 109.749 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.17 138.85 89.71 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.121 -0.945 . . . . 12.98 109.697 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.31 68.15 6.06 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.849 2.366 . . . . 13.66 112.817 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -86.92 94.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 107.812 -1.181 . . . . 12.75 107.812 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -122.26 -175.57 3.16 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.076 -0.965 . . . . 13.85 110.357 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 67.2 94.65 0.07 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.201 1.401 . . . . 14.91 112.039 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -81.73 130.18 62.19 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.743 -1.206 . . . . 11.68 107.743 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.8 133.46 42.04 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.202 1.935 . . . . 11.23 110.924 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.16 127.88 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.036 -0.357 . . . . 10.77 110.036 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.84 60.36 1.2 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.854 0.835 . . . . 10.76 108.851 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.0 m -99.17 146.63 25.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.774 -0.825 . . . . 11.26 108.774 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 73.36 96.67 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 124.997 1.319 . . . . 11.01 111.738 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.36 -44.07 52.32 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.621 2.881 . . . . 12.86 111.568 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -116.46 89.09 26.02 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 107.335 -1.358 . . . . 14.34 107.335 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.1 157.12 23.36 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 121.919 1.746 . . . . 12.35 111.17 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.07 -172.47 17.86 Favored Glycine 0 N--CA 1.424 -2.153 0 C-N-CA 120.924 -0.655 . . . . 11.89 111.617 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.15 -23.47 51.65 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.391 0.615 . . . . 11.88 110.178 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -82.29 82.01 7.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.19 -1.411 . . . . 12.74 107.19 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.84 -5.88 54.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.98 -1.009 . . . . 11.49 111.97 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m -76.91 59.24 1.6 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.525 0.679 . . . . 10.09 109.797 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.56 -49.2 73.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.947 1.299 . . . . 11.53 112.689 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt-30 -58.95 -58.65 7.71 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.24 0.337 . . . . 11.91 110.277 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 60.0 ttp180 -55.76 -50.33 70.71 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.877 0.736 . . . . 10.19 111.71 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.15 -41.06 95.1 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.349 0.406 . . . . 10.43 111.973 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -70.39 -42.54 71.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.323 -0.551 . . . . 10.46 111.185 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 106' ' ' GLN . 92.4 mt -58.76 -52.96 53.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.944 0 N-CA-C 109.322 -0.621 . . . . 8.37 109.322 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -49.31 -49.0 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.353 1.033 . . . . 8.76 112.688 -175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 34.2 t70 -68.0 -44.82 75.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.81 -0.356 . . . . 10.86 111.872 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -70.16 -35.26 73.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.069 0.396 . . . . 11.62 112.069 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.86 -41.34 97.81 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.724 0.809 . . . . 7.62 109.464 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -61.56 -46.43 89.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 11.84 109.219 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 27.7 mt-30 -57.88 -49.88 75.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.02 -0.536 . . . . 12.03 110.8 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -57.24 -45.3 84.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 124.183 0.927 . . . . 9.2 110.97 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.06 -49.9 75.82 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.972 0.17 . . . . 10.06 110.962 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.94 97.83 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 121.252 -0.499 . . . . 12.07 112.129 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.99 -45.94 91.41 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.316 1.046 . . . . 12.38 111.131 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 148' ' ' TRP . 26.9 tp -72.29 -43.93 63.5 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.137 -0.938 . . . . 11.77 111.26 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.9 tp -82.25 -11.72 58.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.792 -0.64 . . . . 13.52 111.619 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 66.89 32.81 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.525 1.13 . . . . 17.15 109.845 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 tp -99.54 140.21 34.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.117 -0.947 . . . . 16.03 108.609 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.11 124.72 86.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 108.744 -0.835 . . . . 14.35 108.744 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.18 -17.91 27.53 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.36 2.707 . . . . 14.18 114.029 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -75.04 -13.71 82.44 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 120.47 -0.872 . . . . 14.05 111.672 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -86.4 -21.56 27.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.312 -0.625 . . . . 16.88 109.312 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.28 69.9 5.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.127 -0.942 . . . . 12.55 110.606 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -160.37 -61.15 0.06 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.312 -1.736 . . . . 14.87 106.312 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.4 m -83.78 -31.84 25.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.974 -0.75 . . . . 14.56 108.974 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.81 1.04 Allowed Glycine 0 C--O 1.215 -1.067 0 N-CA-C 110.786 -0.925 . . . . 14.2 110.786 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.72 34.6 2.93 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.297 -1.371 . . . . 13.0 107.297 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.47 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.5 tt0 -123.25 123.68 41.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.522 -1.672 . . . . 17.02 108.071 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -57.9 -35.72 71.42 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 124.107 0.963 . . . . 13.62 110.344 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.74 -28.61 66.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.103 -0.953 . . . . 16.54 111.277 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -25.66 28.01 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.766 0.793 . . . . 15.87 110.469 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 79.5 mt -79.19 -11.06 59.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.31 -0.859 . . . . 13.65 111.011 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.07 -135.08 9.81 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.918 -1.673 . . . . 14.16 108.918 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.557 ' SD ' HD11 ' A' ' 165' ' ' ILE . 43.3 tpp -176.41 92.08 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.145 -0.687 . . . . 15.81 109.145 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -134.38 126.39 29.5 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.029 0.442 . . . . 13.63 111.211 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.0 m -80.41 -21.84 41.85 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.733 -0.667 . . . . 14.06 111.646 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.0 -58.64 6.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 120.464 0.173 . . . . 14.08 111.124 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.5 t -71.82 -28.96 63.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.414 -0.587 . . . . 11.82 109.414 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.16 -43.95 88.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.427 -0.806 . . . . 10.82 112.601 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -62.81 -45.34 93.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.59 -0.522 . . . . 12.55 109.59 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.91 -49.97 74.07 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.568 -0.742 . . . . 12.17 111.372 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.477 ' O ' HG21 ' A' ' 152' ' ' VAL . 19.4 t90 -63.89 -51.52 64.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.815 -0.63 . . . . 9.45 111.431 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 161' ' ' ALA . 42.0 tpp -63.61 -40.76 97.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.03 0.206 . . . . 9.88 110.959 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -60.45 -41.82 94.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.61 -0.515 . . . . 14.43 109.61 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.83 -45.91 95.23 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.757 -0.656 . . . . 10.49 111.82 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 148' ' ' TRP . 56.0 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.832 -0.433 . . . . 9.27 109.832 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 23.8 m -61.63 -51.68 67.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 11.46 110.8 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -65.01 -40.1 94.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.604 -0.725 . . . . 15.5 111.151 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -55.89 -46.64 78.28 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.424 0.69 . . . . 12.39 111.117 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -101.54 11.58 38.76 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.73 -0.388 . . . . 11.97 111.929 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 p 51.4 50.72 18.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.831 1.252 . . . . 14.37 113.107 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.3 pt -127.62 167.42 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.812 -0.631 . . . . 13.16 109.575 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -102.85 111.83 24.34 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.433 -0.348 . . . . 16.91 110.941 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 85.7 mt -129.98 154.28 47.54 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 106.886 -1.524 . . . . 12.32 106.886 173.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -95.59 138.89 32.63 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.467 0.651 . . . . 14.37 110.825 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.21 -24.09 66.55 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.265 -0.879 . . . . 13.15 111.726 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.59 17.82 6.03 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.007 0.432 . . . . 15.68 110.489 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.93 -3.76 27.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.205 0.817 . . . . 13.1 113.205 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.557 HD11 ' SD ' ' A' ' 140' ' ' MET . 26.0 pt -67.93 -12.34 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.628 0.728 . . . . 12.16 110.211 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -108.39 -2.21 19.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.862 -1.063 . . . . 15.41 108.72 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.9 m -101.97 -45.19 5.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.589 -0.732 . . . . 15.07 110.252 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.547 ' CZ3' HD12 ' A' ' 174' ' ' LEU . 5.3 m0 -111.7 118.24 47.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.433 -0.951 . . . . 12.68 108.433 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.11 -29.86 9.44 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.22 1.947 . . . . 15.04 112.261 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 24.2 p -134.58 153.91 51.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.551 0.691 . . . . 13.26 110.321 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -14.5 51.54 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.078 -0.965 . . . . 10.32 113.233 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -43.39 92.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.171 -0.677 . . . . 12.75 109.171 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.5 m -62.68 -41.73 99.24 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.133 -0.939 . . . . 11.26 110.365 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.547 HD12 ' CZ3' ' A' ' 168' ' ' TRP . 36.3 tp -68.89 -43.94 74.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.313 -0.403 . . . . 8.53 110.823 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 107' ' ' ARG . . . -57.67 -39.67 77.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 7.7 111.459 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 16.8 t70 -79.24 -36.12 40.47 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.675 -0.81 . . . . 10.38 110.546 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 14.0 tp10 -64.27 -44.53 91.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.168 -0.469 . . . . 11.97 111.604 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 182' ' ' VAL . 10.1 p -55.59 -39.77 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.316 0.385 . . . . 9.8 111.282 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 106' ' ' GLN . 33.7 t70 -69.5 -34.48 74.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 10.83 110.55 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 29.9 mmt180 -72.93 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 13.85 109.95 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.8 mmt180 -83.38 -33.59 25.76 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.319 -0.623 . . . . 15.46 109.319 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 178' ' ' VAL . 85.0 t -74.53 -51.17 23.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 116.008 -0.542 . . . . 13.35 111.298 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 119.576 -0.25 . . . . 13.51 111.157 -178.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 120.598 0.237 . . . . 18.78 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.45 -80.29 0.5 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.352 -0.61 . . . . 16.95 109.352 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -73.92 -17.51 61.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.505 0.669 . . . . 15.46 109.6 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.99 -27.45 63.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.477 -0.783 . . . . 14.98 109.808 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.92 -32.15 51.48 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.997 -0.681 . . . . 15.79 109.691 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.41 -35.93 70.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.941 -0.572 . . . . 12.18 109.882 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -62.95 -49.02 76.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.275 -0.639 . . . . 11.02 109.275 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -54.59 -45.6 73.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.893 . . . . 16.75 111.139 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -63.4 -36.22 83.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.69 0.619 . . . . 14.46 110.75 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.18 -38.37 72.13 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.352 -0.385 . . . . 10.71 110.33 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 30.7 mtp180 -63.21 -50.66 69.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.695 -0.483 . . . . 14.51 109.695 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -64.49 -27.43 68.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.93 -0.577 . . . . 16.85 111.829 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.1 m -83.03 -44.27 15.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.241 0.544 . . . . 13.52 110.338 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.36 -41.62 93.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 12.77 111.509 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.947 0.351 . . . . 15.19 111.947 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 -30.04 68.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.529 0.68 . . . . 16.26 109.763 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.7 mtt -83.65 -34.44 25.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 15.45 109.764 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.43 0.44 54.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.735 -0.666 . . . . 16.16 111.217 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.6 t80 59.39 46.74 12.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.462 1.505 . . . . 20.58 110.668 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.63 -176.88 4.92 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.505 -0.77 . . . . 17.26 109.032 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -109.51 140.3 21.98 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.237 -1.023 . . . . 20.19 108.237 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.75 -23.06 70.46 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.729 2.953 . . . . 17.46 113.838 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.74 -6.81 85.56 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.459 -0.877 . . . . 18.33 112.467 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -109.94 16.48 21.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.798 0.666 . . . . 20.77 112.798 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.437 ' HB ' HD22 ' A' ' 34' ' ' LEU . 41.0 pt -106.04 157.37 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 119.366 -0.934 . . . . 16.1 109.904 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 27.2 mmt180 -101.65 94.77 6.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.185 -0.672 . . . . 19.87 109.185 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.81 -22.2 57.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.04 0.936 . . . . 15.1 113.119 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.62 6.51 77.44 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.573 -0.822 . . . . 15.48 112.936 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 57.6 p -115.25 171.03 7.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.337 -0.545 . . . . 14.88 112.38 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 28.7 mtm180 -62.12 147.75 46.51 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.649 0.78 . . . . 17.38 112.277 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -58.44 -32.61 68.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.283 1.033 . . . . 11.99 111.141 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.82 -25.24 67.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.669 -0.696 . . . . 14.71 110.376 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.88 -28.97 27.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.441 -0.577 . . . . 16.44 109.441 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD22 ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -63.23 -31.74 72.97 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 13.83 110.823 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.31 -0.39 4.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.865 -1.16 . . . . 14.3 113.57 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -99.93 168.39 9.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 117.616 0.708 . . . . 13.04 111.438 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -128.07 161.08 30.05 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.095 . . . . 15.67 108.045 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.154 1.168 . . . . 15.49 114.154 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.67 -41.18 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.115 0.483 . . . . 16.98 110.569 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.31 -36.37 74.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.314 0.578 . . . . 14.44 110.258 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.38 72.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.334 -0.848 . . . . 12.4 110.427 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.58 -30.66 71.69 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.314 -0.857 . . . . 14.37 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.99 -40.69 27.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.506 0.669 . . . . 16.05 110.24 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -62.29 -45.74 91.9 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.582 -1.19 . . . . 11.7 111.5 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tp -59.19 -31.92 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 111.863 0.32 . . . . 11.48 111.863 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 34.2 mmt180 -60.96 -50.01 75.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.804 0.335 . . . . 17.18 110.345 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -27.33 64.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.327 -0.549 . . . . 14.15 112.027 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.8 -47.45 92.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.093 -1.077 . . . . 10.8 108.093 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.13 -37.89 75.46 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.092 -0.958 . . . . 12.98 111.196 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -84.63 -47.22 10.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.788 0.328 . . . . 17.81 111.789 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -68.72 -35.43 77.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 116.384 -0.371 . . . . 15.55 111.655 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.04 -2.48 37.09 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.346 0.593 . . . . 12.2 112.179 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 48.6 47.22 20.79 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.502 1.521 . . . . 17.4 110.066 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -124.9 127.29 46.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.893 -1.049 . . . . 12.25 109.15 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.02 53.57 2.48 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 113.579 0.955 . . . . 16.32 113.579 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.0 mm -70.68 117.99 60.74 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.386 -0.598 . . . . 11.39 109.386 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.4 151.84 65.65 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.912 1.741 . . . . 13.44 108.764 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -20.45 21.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.372 1.069 . . . . 12.81 112.894 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.83 -12.64 61.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 14.14 112.33 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.68 -52.84 48.08 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 120.981 -0.628 . . . . 10.76 112.339 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.71 0.767 . . . . 11.0 109.923 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.47 -35.38 73.26 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.564 -0.744 . . . . 16.59 111.081 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.9 m -88.57 -34.32 17.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.746 0.308 . . . . 13.72 110.721 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.95 92.86 48.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.495 -0.557 . . . . 12.25 109.495 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 74.5 Cg_endo -83.76 1.95 8.57 Favored 'Trans proline' 0 C--O 1.205 -1.145 0 C-N-CA 123.192 2.595 . . . . 13.57 114.323 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.55 133.02 39.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.916 -1.142 . . . . 13.28 107.916 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -63.85 -45.45 89.45 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 114.805 -1.088 . . . . 11.45 111.799 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -69.21 -24.58 64.04 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 111.944 0.35 . . . . 14.64 111.944 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.8 -41.04 53.9 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.54 -0.541 . . . . 11.34 109.54 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -75.93 -37.58 58.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.877 -0.601 . . . . 9.05 112.032 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.1 p -60.78 -34.33 74.32 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.702 -0.399 . . . . 9.65 110.893 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -68.53 -44.44 74.6 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.182 -0.673 . . . . 12.14 109.182 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -54.85 -45.9 74.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.351 1.06 . . . . 11.26 110.625 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.52 -45.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.069 -0.514 . . . . 8.3 110.776 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.1 93.88 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.736 -0.665 . . . . 9.58 113.672 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -68.61 -24.73 64.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.46 0.541 . . . . 10.46 112.46 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.02 -2.5 58.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 113.573 0.953 . . . . 10.43 113.573 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.45 -52.7 56.71 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.386 -0.968 . . . . 10.97 108.386 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -142.78 92.03 7.17 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 105.712 -1.959 . . . . 13.77 105.712 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.72 60.19 2.82 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.394 2.729 . . . . 12.28 114.63 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 m -66.39 -36.97 84.19 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.543 -0.54 . . . . 13.71 109.543 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.32 -24.37 65.73 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.764 -0.653 . . . . 13.27 110.324 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.13 -14.87 26.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.066 -0.515 . . . . 14.77 110.704 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -83.58 119.71 25.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.166 -1.05 . . . . 15.24 108.166 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 59.45 49.68 8.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 123.89 0.876 . . . . 14.58 108.65 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.7 87.23 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.572 -1.194 . . . . 12.98 111.592 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.67 8.91 3.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.089 2.526 . . . . 13.66 111.916 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.88 126.98 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 108.297 -1.001 . . . . 12.75 108.297 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.15 75.03 9.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.431 0.634 . . . . 13.85 110.663 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -82.06 -26.88 33.31 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.233 -0.894 . . . . 14.91 108.984 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -78.94 143.26 61.46 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 114.924 -1.035 . . . . 11.68 108.6 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.21 73.94 4.8 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.401 2.067 . . . . 11.23 110.56 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.21 91.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.724 0.773 . . . . 10.77 109.924 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.12 48.78 2.31 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.491 -1.231 . . . . 10.76 108.05 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -63.02 121.67 14.16 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.028 -0.987 . . . . 11.26 110.006 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.74 146.92 32.27 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.785 -0.82 . . . . 11.01 108.785 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.07 0.83 3.38 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.508 2.806 . . . . 12.86 113.131 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -124.06 108.18 30.21 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.529 -1.286 . . . . 14.34 107.529 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.61 -27.2 69.26 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.427 2.085 . . . . 12.35 112.119 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.36 121.84 3.11 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.515 -0.766 . . . . 11.89 111.261 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.88 68.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.134 0.493 . . . . 11.88 110.275 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.57 -33.1 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.655 -0.702 . . . . 12.74 110.595 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.03 70.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.405 0.621 . . . . 11.49 110.559 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.5 m -107.31 43.83 1.14 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.708 -0.678 . . . . 10.09 109.749 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.36 94.17 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.667 -0.697 . . . . 11.53 111.441 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.448 ' O ' HG13 ' A' ' 110' ' ' ILE . 51.8 mt-30 -64.62 -48.35 75.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.999 -0.546 . . . . 11.91 109.796 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.78 -45.43 82.14 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.498 -0.774 . . . . 10.19 110.636 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -56.95 -52.35 65.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.333 0.653 . . . . 10.43 111.149 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 t -58.97 -44.26 91.49 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.635 -0.711 . . . . 10.46 111.163 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 106' ' ' GLN . 83.5 mt -64.08 -49.11 82.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 109.881 -0.415 . . . . 8.37 109.881 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -58.13 -43.69 87.41 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.44 0.696 . . . . 8.76 112.665 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 14.8 t70 -62.59 -43.04 99.79 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.164 0.507 . . . . 10.86 110.099 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.836 ' HH ' ' HD1' ' A' ' 155' ' ' HIS . 65.1 t80 -64.75 -44.1 91.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.639 0.733 . . . . 11.62 110.302 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.99 -33.29 75.26 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.284 -0.871 . . . . 7.62 109.281 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 129' ' ' LEU . 56.6 tttm -62.29 -40.45 96.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.865 0.866 . . . . 11.84 109.802 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 61.1 mm-40 -64.99 -48.6 73.38 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.188 -1.041 . . . . 12.03 108.188 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.4 t -56.58 -52.62 64.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.861 -1.518 . . . . 9.2 111.984 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.538 HD11 ' N ' ' A' ' 119' ' ' GLY . 3.9 pp -68.86 -39.26 79.98 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.377 -0.529 . . . . 10.06 111.746 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.538 ' N ' HD11 ' A' ' 118' ' ' LEU . . . -65.99 -39.44 94.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.126 -0.559 . . . . 12.07 111.778 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.64 -44.74 77.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.869 0.366 . . . . 12.38 110.209 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.0 tp -69.08 -46.08 68.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.334 -0.394 . . . . 11.77 110.953 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -72.72 -20.38 61.22 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.481 0.712 . . . . 13.52 111.327 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.0 t80 83.33 -29.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.005 1.322 . . . . 17.15 112.594 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.8 162.12 36.31 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 122.358 -0.214 . . . . 16.03 110.483 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.0 107.27 42.95 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.005 -0.739 . . . . 14.35 109.005 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -91.87 11.35 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.727 2.285 . . . . 14.18 113.425 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.61 50.69 5.19 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.496 -1.041 . . . . 14.05 110.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -107.48 -15.02 14.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.541 -0.464 . . . . 16.88 112.15 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.417 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 90.3 mt -71.23 97.72 1.6 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.13 0.491 . . . . 12.55 111.746 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 71.07 -20.06 0.23 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.207 1.403 . . . . 14.87 114.558 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -76.73 -28.74 55.91 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.725 0.81 . . . . 14.56 111.137 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.73 102.48 0.21 Allowed Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 110.213 -1.155 . . . . 14.2 110.213 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.86 86.6 2.32 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.99 0.367 . . . . 13.0 111.99 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.42 112.06 23.95 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.15 -0.685 . . . . 17.02 109.15 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -62.55 -20.61 64.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.874 -0.603 . . . . 13.62 111.543 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.14 -29.63 69.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.667 0.787 . . . . 16.54 111.586 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.04 -25.88 39.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.34 0.591 . . . . 15.87 110.901 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.58 2.19 49.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 13.65 111.051 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.01 3.99 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 120.794 -0.717 . . . . 14.16 111.37 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.7 tpp 62.11 86.95 0.1 Allowed 'General case' 0 C--O 1.251 1.153 0 C-N-CA 124.794 1.237 . . . . 15.81 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 44.3 m-20 -57.86 118.73 5.64 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.37 -1.345 . . . . 13.63 107.37 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -56.32 -36.15 68.39 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.126 0.97 . . . . 14.06 111.567 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.01 -44.07 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.369 0.604 . . . . 14.08 110.145 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 141' ' ' ASP . 34.2 m -66.62 -37.96 85.93 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.854 -0.612 . . . . 11.82 110.848 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 -32.86 54.11 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.871 -0.604 . . . . 10.82 112.564 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.6 p -69.7 -39.53 76.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.453 -0.499 . . . . 12.55 110.277 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.84 -46.08 81.96 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.795 0.807 . . . . 12.17 109.699 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -62.18 -54.06 46.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.176 -1.375 . . . . 9.45 111.696 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.428 ' HE3' ' HA ' ' A' ' 149' ' ' MET . 4.0 tpt -58.03 -42.07 84.55 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.947 0.499 . . . . 9.88 110.204 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -58.44 -46.41 86.58 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 115.895 -0.593 . . . . 14.43 110.697 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -45.15 95.89 Favored Glycine 0 C--N 1.321 -0.273 0 O-C-N 123.399 0.437 . . . . 10.49 112.787 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.31 -50.14 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 9.27 110.441 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.1 p -65.5 -38.46 89.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.097 -0.502 . . . . 11.46 111.61 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -63.99 -47.09 81.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 15.5 111.186 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.836 ' HD1' ' HH ' ' A' ' 113' ' ' TYR . 16.0 t-160 -67.48 -31.57 71.81 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.787 -0.365 . . . . 12.39 110.983 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -90.92 6.11 45.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.903 0.705 . . . . 11.97 112.903 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.4 m 59.66 33.51 21.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.777 0.831 . . . . 14.37 112.51 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.44 134.81 58.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.267 -0.642 . . . . 13.16 109.267 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -88.24 94.87 9.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.602 0.715 . . . . 16.91 110.669 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.03 148.73 43.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.026 -1.101 . . . . 12.32 108.026 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.58 143.92 48.08 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.075 -1.083 . . . . 14.37 108.075 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.975 -0.557 . . . . 13.15 109.995 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.32 15.6 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.655 -0.702 . . . . 15.68 110.496 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.99 59.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.053 0.39 . . . . 13.1 112.053 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.64 9.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.434 0.635 . . . . 12.16 112.236 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -110.2 -7.04 14.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.587 -0.733 . . . . 15.41 109.587 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.1 m -79.3 -27.89 42.2 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.281 0.562 . . . . 15.07 110.795 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -113.36 137.83 22.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 116.253 -0.43 . . . . 12.68 110.721 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 -16.93 18.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.063 2.509 . . . . 15.04 111.818 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.9 p -135.65 142.86 45.23 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.489 -1.3 . . . . 13.26 107.489 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.3 -24.9 62.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.742 -0.663 . . . . 10.32 110.983 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -62.34 -21.98 65.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.762 -0.654 . . . . 12.75 110.675 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.6 m -65.7 -18.56 65.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.843 -0.617 . . . . 11.26 111.208 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.94 -46.2 68.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.449 -0.575 . . . . 8.53 109.449 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.16 75.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.494 . . . . 7.7 110.968 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 14.6 t70 -74.99 -31.0 61.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.278 -0.569 . . . . 10.38 110.056 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -76.55 -41.87 45.05 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 123.348 0.659 . . . . 11.97 110.351 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 110' ' ' ILE . 7.2 p -64.67 -30.49 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.744 0.783 . . . . 9.8 110.102 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 183' ' ' GLN . 18.8 t70 -66.59 -28.08 68.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.599 -1.182 . . . . 10.83 110.117 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 85.2 mtt180 -84.22 -42.31 16.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.23 -0.895 . . . . 13.85 109.307 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.04 -51.3 59.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.962 -1.017 . . . . 15.46 111.985 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.25 -35.23 17.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.193 0.52 . . . . 13.35 110.77 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 179' ' ' ASP . 9.0 tt0 . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.246 -0.883 . . . . 13.51 109.212 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 121.392 0.615 . . . . 18.78 111.367 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.82 74.97 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.075 0.55 . . . . 16.95 111.964 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.49 -20.94 64.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.809 0.814 . . . . 15.46 110.292 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.45 -26.99 14.27 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.631 -0.713 . . . . 14.98 110.263 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.66 -47.33 86.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.664 0.385 . . . . 15.79 110.774 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 p -62.63 -36.47 82.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.317 -0.401 . . . . 12.18 111.479 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.56 67.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.445 -0.343 . . . . 11.02 110.235 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.04 -48.59 81.1 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.451 0.701 . . . . 16.75 110.694 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -55.6 -42.25 74.59 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.052 0.845 . . . . 14.46 110.123 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.35 -43.52 63.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.106 -0.497 . . . . 10.71 111.609 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -61.28 -40.0 92.5 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.612 0.244 . . . . 14.51 111.147 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.0 -44.62 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 16.85 110.82 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -71.05 -25.23 62.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.885 0.374 . . . . 13.52 111.415 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.98 -55.96 9.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.72 -1.585 . . . . 12.77 106.72 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.34 65.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.685 -1.143 . . . . 15.19 111.554 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.93 85.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.652 0.263 . . . . 16.26 111.464 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -81.48 -26.09 35.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.018 0.437 . . . . 15.45 111.222 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.57 -4.33 44.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.018 -0.537 . . . . 16.16 112.041 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.97 49.09 3.61 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.955 1.302 . . . . 20.58 112.513 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.15 161.81 22.46 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.781 -1.099 . . . . 17.26 108.757 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -92.9 116.38 66.4 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-O 120.631 0.253 . . . . 20.19 111.124 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 -6.97 19.07 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.388 2.725 . . . . 17.46 113.627 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.76 -20.94 78.96 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.381 -0.688 . . . . 18.33 111.381 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -128.73 71.89 1.43 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 122.167 0.984 . . . . 20.77 109.468 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 tp -127.9 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.612 -0.884 . . . . 16.1 108.612 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -88.67 120.63 30.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.0 -0.741 . . . . 19.87 109.0 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 19.8 m-20 -61.79 -26.44 68.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.46 -0.791 . . . . 15.1 112.174 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.44 4.39 86.16 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.02 -0.61 . . . . 15.48 113.677 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.5 p -79.41 140.36 37.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 117.816 0.808 . . . . 14.88 110.273 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 66.1 mtm180 -75.5 148.24 39.14 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 118.356 -0.831 . . . . 17.38 109.479 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -50.38 -40.19 48.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.905 0.86 . . . . 11.99 110.992 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -23.9 66.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.406 -1.27 . . . . 14.71 112.691 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 30' ' ' ARG . 8.9 mm-40 -76.98 -29.28 55.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.796 0.808 . . . . 16.44 109.074 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.82 -31.94 27.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.16 -0.927 . . . . 13.83 108.808 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.0 32.94 3.63 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 114.787 -1.097 . . . . 14.3 112.174 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.0 tp -81.41 98.9 8.43 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.777 -0.823 . . . . 13.04 108.777 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.91 147.74 45.01 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.707 -1.22 . . . . 15.67 107.707 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 p -58.67 -22.8 57.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.923 0.765 . . . . 15.49 112.178 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.24 -50.93 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.494 -0.558 . . . . 16.98 109.494 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.06 -36.71 76.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.891 -0.781 . . . . 14.44 108.891 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.76 70.98 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.169 -0.923 . . . . 12.4 110.77 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.49 -45.84 85.58 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.066 -0.515 . . . . 14.37 109.967 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -60.79 -45.88 92.68 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.4 0.619 . . . . 16.05 110.712 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -59.34 -52.42 65.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.008 1.723 . . . . 11.7 111.684 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 tp -63.56 -31.61 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.857 0.36 . . . . 11.48 111.403 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' ALA . 99.2 mtt180 -66.35 -35.08 79.45 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 120.972 0.415 . . . . 17.18 110.282 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -73.62 -35.1 65.3 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.22 0.533 . . . . 14.15 110.155 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.01 -50.17 81.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 115.146 -0.934 . . . . 10.8 109.85 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.54 -25.12 59.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.035 -0.984 . . . . 12.98 112.847 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 97.7 mttt -75.82 -61.86 1.78 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 116.296 -0.411 . . . . 17.81 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -74.67 -25.09 58.95 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.958 -0.697 . . . . 15.55 112.008 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -94.96 -6.98 41.22 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.427 0.899 . . . . 12.2 113.427 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 47.92 64.27 1.7 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.877 1.671 . . . . 17.4 112.108 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.48 167.72 21.07 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.94 -1.027 . . . . 12.25 108.312 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.32 70.52 0.76 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.387 -1.338 . . . . 16.32 107.387 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.439 HD12 ' HE1' ' A' ' 73' ' ' TRP . 47.0 mm -92.74 119.93 67.58 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.201 -0.666 . . . . 11.39 109.201 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.65 167.72 7.25 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.056 1.838 . . . . 13.44 108.929 171.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -10.16 3.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.733 1.012 . . . . 12.81 113.733 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.39 -19.57 65.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.26 0.467 . . . . 14.14 112.26 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.77 -44.37 96.36 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.742 -1.218 . . . . 10.76 110.129 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.45 -27.64 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.231 1.012 . . . . 11.0 110.869 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -78.25 -31.5 49.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.734 -0.604 . . . . 16.59 112.175 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t -87.69 -32.28 19.28 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.392 -0.923 . . . . 13.72 110.649 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.474 ' CE2' ' HE3' ' A' ' 73' ' ' TRP . 38.6 m-85 -108.72 100.98 41.73 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 109.526 -0.546 . . . . 12.25 109.526 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.06 -0.45 10.29 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.506 2.137 . . . . 13.57 112.366 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 120.47 61.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.609 -1.626 . . . . 13.28 106.609 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 27' ' ' ASP . 49.2 p90 -58.98 -32.23 69.49 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.024 0.75 . . . . 11.45 113.024 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -60.58 -32.09 71.2 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.919 0.888 . . . . 14.64 111.731 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.5 -30.78 21.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.91 0.862 . . . . 11.34 109.928 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 43.2 t80 -70.63 -31.7 68.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.181 -0.918 . . . . 9.05 111.61 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.1 p -66.18 -28.42 68.75 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.726 -0.609 . . . . 9.65 109.49 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -71.21 -32.76 69.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.481 -0.781 . . . . 12.14 109.634 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.474 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 2.4 t-105 -53.91 -55.8 23.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.413 -0.958 . . . . 11.26 108.413 173.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.13 -44.73 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 C-N-CA 124.031 0.932 . . . . 8.3 110.627 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.6 73.74 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.261 -0.427 . . . . 9.58 113.0 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.2 m -80.36 -31.32 37.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 122.525 -0.397 . . . . 10.46 111.073 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -89.24 -21.41 23.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.051 -0.66 . . . . 10.43 112.073 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -78.94 115.3 18.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.096 -0.335 . . . . 10.97 110.096 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 57.84 62.42 5.21 Favored Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 124.45 1.094 . . . . 13.77 109.825 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.88 154.6 23.06 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.276 1.984 . . . . 12.28 113.117 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.4 p -79.31 49.93 1.03 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.6 0.76 . . . . 13.71 111.094 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -89.62 116.74 27.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.479 -0.934 . . . . 13.27 108.479 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.16 -43.83 8.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.319 -0.4 . . . . 14.77 110.206 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 m 56.12 70.5 0.64 Allowed 'General case' 0 C--O 1.249 1.066 0 CA-C-O 122.059 0.933 . . . . 15.24 109.885 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.09 56.64 4.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.423 -0.808 . . . . 14.58 110.06 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.42 125.97 54.17 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.23 -0.895 . . . . 12.98 109.2 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.37 54.42 4.63 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.894 2.396 . . . . 13.66 111.391 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.45 94.63 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.565 -0.902 . . . . 12.75 108.565 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 73.82 7.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.435 -1.32 . . . . 13.85 107.435 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -148.06 120.36 8.39 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.359 -1.719 . . . . 14.91 106.359 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.83 146.29 38.57 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 123.441 0.463 . . . . 11.68 110.548 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.84 45.97 2.1 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.004 2.469 . . . . 11.23 110.445 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.1 t 57.39 75.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.969 1.308 . . . . 10.77 109.492 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.82 -30.09 11.88 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.916 -1.038 . . . . 10.76 109.987 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -119.37 159.61 23.84 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.329 -0.619 . . . . 11.26 109.329 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.56 69.07 6.51 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.076 -0.511 . . . . 11.01 110.241 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.3 -48.89 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.479 2.12 . . . . 12.86 110.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -112.58 119.94 42.22 Favored Pre-proline 0 N--CA 1.425 -1.714 0 N-CA-C 107.085 -1.45 . . . . 14.34 107.085 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.95 52.68 3.1 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.836 2.357 . . . . 12.35 112.163 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.36 43.77 1.16 Allowed Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.842 -1.303 . . . . 11.89 109.842 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.18 -25.57 55.34 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.606 -0.887 . . . . 11.88 108.606 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -77.28 103.89 7.47 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.827 -1.079 . . . . 12.74 108.456 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.99 -32.64 22.87 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.752 -0.658 . . . . 11.49 109.58 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m 55.45 53.98 9.12 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.813 0.816 . . . . 10.09 110.496 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.25 -35.42 71.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.509 -1.223 . . . . 11.53 109.916 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.17 -44.53 97.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.771 -1.104 . . . . 11.91 109.852 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.442 ' O ' ' HB ' ' A' ' 110' ' ' ILE . 44.1 ttp180 -78.91 -27.46 43.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.875 -0.602 . . . . 10.19 111.17 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.0 -37.05 86.39 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.809 0.337 . . . . 10.43 110.764 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.8 t -64.69 -41.88 95.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.565 -0.902 . . . . 10.46 108.565 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 67.3 mt -57.36 -41.85 79.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 CA-C-N 115.098 -0.956 . . . . 8.37 109.722 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -55.88 -39.64 71.84 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.228 0.611 . . . . 8.76 112.317 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 m-20 -66.83 -40.86 88.13 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.039 0.447 . . . . 10.86 111.129 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -74.57 -35.06 63.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.144 -0.48 . . . . 11.62 111.613 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.72 -43.23 98.12 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.254 -1.387 . . . . 7.62 107.254 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 79.0 tttt -54.66 -48.19 72.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.606 -1.179 . . . . 11.84 110.243 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -70.12 -39.29 75.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.137 -0.483 . . . . 12.03 111.404 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -58.25 -52.8 64.05 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.92 0.888 . . . . 9.2 110.219 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.7 -38.55 58.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.144 -0.48 . . . . 10.06 110.483 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.75 -26.66 67.21 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 116.415 -0.357 . . . . 12.07 112.389 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.92 -32.45 74.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 123.519 0.728 . . . . 12.38 110.296 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.03 -30.95 62.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.577 0.703 . . . . 11.77 109.535 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.87 6.9 46.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.797 -1.092 . . . . 13.52 110.046 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.2 t80 79.96 -48.82 0.35 Allowed 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 127.78 2.432 . . . . 17.15 112.795 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.47 152.62 31.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.904 -0.406 . . . . 16.03 109.904 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.2 112.48 56.47 Favored Pre-proline 0 C--N 1.314 -0.947 0 O-C-N 124.18 0.925 . . . . 14.35 109.401 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -75.91 -37.31 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.223 1.949 . . . . 14.18 112.052 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -116.84 -112.97 2.7 Favored Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 110.118 -1.193 . . . . 14.05 110.118 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -139.29 3.48 2.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.835 -0.215 . . . . 16.88 110.964 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.0 mp 60.65 -177.48 0.11 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.38 1.072 . . . . 12.55 112.588 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -150.37 148.53 28.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.691 -1.596 . . . . 14.87 106.691 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 170' ' ' THR . 25.5 m -74.32 -26.57 60.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.562 -0.744 . . . . 14.56 111.251 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.65 3.53 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 111.123 -0.791 . . . . 14.2 111.123 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.08 107.94 15.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.152 -1.055 . . . . 13.0 108.152 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -73.06 118.04 15.53 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.16 -0.473 . . . . 17.02 110.858 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.53 -27.69 67.96 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.375 -0.83 . . . . 13.62 110.178 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.77 -19.79 65.82 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.408 -0.814 . . . . 16.54 111.629 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.3 -52.39 5.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.496 0.554 . . . . 15.87 112.496 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.82 -10.05 20.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.934 0.716 . . . . 13.65 112.934 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.9 140.19 15.73 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.916 -1.135 . . . . 14.16 112.323 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.2 mtm -133.51 24.6 4.08 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.684 -1.599 . . . . 15.81 106.684 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.41 70.32 1.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.409 -1.723 . . . . 13.63 112.225 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.87 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 45.2 t -68.74 -44.72 73.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.116 0.484 . . . . 14.06 109.919 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.32 -57.25 4.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 122.182 -0.324 . . . . 14.08 110.828 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -69.76 -20.47 63.49 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.64 -0.424 . . . . 11.82 111.927 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -78.86 -24.36 62.26 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.741 -1.218 . . . . 10.82 110.184 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.5 m -72.43 -38.22 68.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.602 -0.888 . . . . 12.55 108.602 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.72 -39.99 86.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.683 -0.69 . . . . 12.17 109.181 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.439 ' O ' HG21 ' A' ' 152' ' ' VAL . 25.1 t90 -65.16 -46.5 80.61 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.188 -0.914 . . . . 9.45 110.711 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.454 ' HA ' ' HE2' ' A' ' 149' ' ' MET . 15.3 mmt -54.35 -47.85 72.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.112 0.482 . . . . 9.88 110.097 176.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 36.6 ttm180 -60.87 -41.02 95.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.247 -0.888 . . . . 14.43 110.232 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.85 -53.57 36.75 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.718 -0.673 . . . . 10.49 111.882 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 148' ' ' TRP . 53.5 t -57.61 -40.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.105 0.479 . . . . 9.27 110.064 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.9 t -61.16 -51.9 67.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.334 -0.848 . . . . 11.46 110.584 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 39.1 ptt180 -75.64 -40.05 56.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.784 0.661 . . . . 15.5 112.784 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -68.98 -33.87 74.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 12.39 111.87 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.97 2.22 43.33 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.737 -0.385 . . . . 11.97 112.025 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 t 60.0 37.57 21.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.972 0.909 . . . . 14.37 111.302 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.12 148.52 19.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.818 -0.438 . . . . 13.16 109.818 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -83.05 95.97 8.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.045 -0.354 . . . . 16.91 110.045 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 tp -109.36 133.99 52.38 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.349 -0.982 . . . . 12.32 108.349 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.46 146.7 29.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.007 -0.542 . . . . 14.37 110.219 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.49 -16.83 62.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 13.15 111.846 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.22 1.87 56.89 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.287 -0.415 . . . . 15.68 110.656 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 168' ' ' TRP . . . -61.83 -22.38 65.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.718 0.636 . . . . 13.1 112.718 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.7 pt -67.44 -12.96 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.235 0.54 . . . . 12.16 111.33 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.87 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 28.8 m-85 -103.75 4.05 34.8 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.038 -0.528 . . . . 15.41 110.477 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.6 t -140.09 14.73 2.44 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 119.392 -0.923 . . . . 15.07 112.931 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.504 ' CD1' ' HB1' ' A' ' 164' ' ' ALA . 25.2 m95 -129.51 114.44 18.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.957 -1.127 . . . . 12.68 107.957 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 58.4 Cg_endo -73.12 -44.13 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.765 2.31 . . . . 15.04 115.491 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 131' ' ' SER . 74.8 p -130.45 -175.56 3.68 Favored 'General case' 0 C--O 1.249 1.058 0 N-CA-C 112.696 0.628 . . . . 13.26 112.696 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 6.7 mp -68.12 -26.5 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.711 -0.477 . . . . 10.32 109.711 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -58.66 -49.96 75.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.45 -0.574 . . . . 12.75 109.45 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.442 ' HB2' ' CE3' ' A' ' 168' ' ' TRP . 3.1 p -67.36 -24.13 65.67 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.884 0.698 . . . . 11.26 112.884 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.12 -47.56 23.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.837 -1.171 . . . . 8.53 107.837 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.22 -30.57 71.69 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.794 -0.639 . . . . 7.7 110.832 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -56.71 -34.97 68.0 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.349 0.66 . . . . 10.38 112.316 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -60.24 -58.27 9.25 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.676 0.75 . . . . 11.97 110.998 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.74 -32.12 51.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.908 -1.042 . . . . 9.8 110.899 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.16 -43.64 92.1 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.31 0.644 . . . . 10.83 110.76 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.4 mtm105 -83.06 -38.07 23.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.198 -0.456 . . . . 13.85 112.038 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -66.26 -46.51 76.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.581 0.585 . . . . 15.46 112.581 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.17 -43.33 17.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.883 0.373 . . . . 13.35 111.828 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.753 -0.462 . . . . 13.51 109.753 -178.638 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 110.109 -0.33 . . . . 18.78 110.109 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.04 -17.12 14.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.496 . . . . 16.95 112.259 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.95 -39.47 9.36 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.598 0.713 . . . . 15.46 109.982 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.59 18.69 8.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.166 -0.924 . . . . 14.98 109.885 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -61.86 -41.68 98.13 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.66 0.985 . . . . 15.79 113.66 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.87 -58.59 5.61 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.754 0.659 . . . . 12.18 110.678 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.12 80.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.625 -0.716 . . . . 11.02 111.333 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -58.16 -47.62 82.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.824 -0.626 . . . . 16.75 111.826 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.02 -34.72 77.02 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 121.099 0.476 . . . . 14.46 110.766 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.88 -36.14 77.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.145 -0.479 . . . . 10.71 110.528 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.91 -48.1 83.37 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.51 -0.552 . . . . 14.51 109.51 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.35 -43.77 88.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.685 . . . . 16.85 111.364 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -72.99 -43.48 62.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.96 -0.563 . . . . 13.52 112.373 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.49 -38.71 90.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.775 -0.454 . . . . 12.77 109.775 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.662 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -63.99 -34.87 78.97 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.738 -0.664 . . . . 15.19 110.792 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.85 61.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.981 -0.554 . . . . 16.26 111.042 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.9 mtt -85.36 -45.56 11.78 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.304 -0.407 . . . . 15.45 111.74 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.65 -5.64 48.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.27 0.841 . . . . 16.16 113.27 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 67.36 28.81 7.73 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.899 0.857 . . . . 20.58 111.93 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 6.9 p -97.45 -174.85 3.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.873 -1.158 . . . . 17.26 107.873 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -104.39 138.99 19.68 Favored Pre-proline 0 C--N 1.305 -1.354 0 C-N-CA 120.302 -0.559 . . . . 20.19 110.33 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.49 -9.09 14.93 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.15 1.9 . . . . 17.46 111.693 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.82 -76.57 0.88 Allowed Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 111.437 -0.665 . . . . 18.33 111.437 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -85.31 55.71 3.62 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.725 0.774 . . . . 20.77 110.372 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.56 140.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.844 -1.169 . . . . 16.1 107.844 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -81.88 100.23 9.5 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.204 0.526 . . . . 19.87 110.045 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 5.8 p-10 -77.16 -20.34 55.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.936 -0.575 . . . . 15.1 112.283 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.85 7.21 64.97 Favored Glycine 0 C--N 1.307 -1.061 0 CA-C-N 116.024 -0.534 . . . . 15.48 112.639 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.3 p -92.15 166.75 12.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.127 0.489 . . . . 14.88 110.597 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 88.5 mtm180 -91.61 141.93 28.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.331 -0.85 . . . . 17.38 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -50.22 -48.81 54.22 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.266 1.21 . . . . 11.99 114.266 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.298 0.57 . . . . 14.71 111.158 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 30' ' ' ARG . 44.1 tt0 -82.2 -20.36 37.95 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 124.078 0.951 . . . . 16.44 109.293 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.4 -0.79 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.347 -0.842 . . . . 13.83 109.43 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.38 74.74 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.562 -0.745 . . . . 14.3 112.341 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.6 tp -81.91 82.31 7.59 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.348 -0.982 . . . . 13.04 108.348 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.503 ' OD2' HG22 ' A' ' 39' ' ' VAL . 17.6 t70 -66.44 165.87 13.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.345 -1.298 . . . . 15.67 109.819 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -56.58 -36.74 69.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 118.44 0.564 . . . . 15.49 111.479 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 HG22 ' OD2' ' A' ' 37' ' ' ASP . 1.5 m -57.41 -51.84 64.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.677 0.751 . . . . 16.98 112.509 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mt -67.87 -46.58 81.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.675 -1.148 . . . . 14.44 110.301 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.36 87.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 12.4 112.458 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.41 93.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.397 0.617 . . . . 14.37 111.034 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.08 -43.3 68.02 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.638 -0.71 . . . . 16.05 110.619 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -57.43 -52.96 63.25 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 125.66 1.584 . . . . 11.7 110.425 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 tp -66.29 -33.03 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.369 -0.378 . . . . 11.48 111.028 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -59.95 -36.23 76.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.368 -0.378 . . . . 17.18 110.628 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.88 -40.37 54.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.299 -0.56 . . . . 14.15 109.69 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.39 -48.44 56.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.007 0.523 . . . . 10.8 110.96 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 16.3 m120 -57.88 -35.91 71.65 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.489 0.551 . . . . 12.98 112.489 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -86.22 -56.11 3.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.061 0.458 . . . . 17.81 110.814 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -61.81 -32.57 72.89 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.073 0.949 . . . . 15.55 111.788 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.15 3.2 25.47 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.473 0.654 . . . . 12.2 111.201 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.251 4.0 pt20 39.82 55.7 2.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.964 2.106 . . . . 17.4 114.308 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.35 159.07 23.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.34 -0.846 . . . . 12.25 110.129 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -94.95 26.82 3.42 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.077 0.551 . . . . 16.32 110.487 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mm -53.71 121.92 30.51 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.346 -0.843 . . . . 11.39 111.027 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.47 137.96 48.61 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.657 1.571 . . . . 13.44 108.555 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.56 -19.99 29.13 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.44 0.696 . . . . 12.81 112.267 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.34 -1.88 57.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.024 -0.534 . . . . 14.14 112.207 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.55 72.0 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 121.481 -0.39 . . . . 10.76 112.368 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.91 -26.22 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.408 0.683 . . . . 11.0 111.522 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -103.76 -2.53 26.26 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.643 -0.423 . . . . 16.59 111.921 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 m -69.52 -57.44 5.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.356 -0.979 . . . . 13.72 108.356 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.23 85.2 50.09 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 105.053 -2.203 . . . . 12.25 105.053 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 71.9 Cg_endo -76.15 54.32 4.14 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.836 2.357 . . . . 13.57 115.175 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.3 126.77 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.277 -1.009 . . . . 13.28 108.277 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -50.54 -54.78 19.8 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.382 0.882 . . . . 11.45 113.382 -171.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 63.1 tttm -65.79 -33.29 75.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.501 . . . . 14.64 111.424 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.94 81.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.104 -0.498 . . . . 11.34 111.04 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.0 t80 -79.06 -32.02 44.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.833 0.349 . . . . 9.05 111.618 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.0 p -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.662 -0.649 . . . . 9.65 110.963 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.16 -27.91 57.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.597 -0.274 . . . . 12.14 110.627 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.526 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 2.2 t90 -53.8 -49.15 68.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.461 1.104 . . . . 11.26 109.277 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 86.8 t -62.83 -41.55 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 123.666 0.786 . . . . 8.3 110.365 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.61 93.22 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.76 -0.654 . . . . 9.58 112.378 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 p -75.22 -22.31 58.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.895 0.379 . . . . 10.46 111.618 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.26 -17.16 57.02 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.957 0.408 . . . . 10.43 110.019 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 97.5 mt -86.01 63.17 7.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.073 0.939 . . . . 10.97 109.383 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -102.15 102.95 27.15 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.216 -1.356 . . . . 13.77 109.418 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.78 79.8 3.21 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.817 2.345 . . . . 12.28 111.713 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -63.16 96.32 0.1 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.856 -1.066 . . . . 13.71 112.56 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -101.23 121.51 41.99 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.421 -0.354 . . . . 13.27 110.057 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.64 -31.34 32.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.727 -0.67 . . . . 14.77 111.235 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 p -97.61 -167.43 1.52 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.293 -0.412 . . . . 15.24 112.001 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 74.58 82.17 0.11 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.241 1.416 . . . . 14.58 110.839 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.07 135.67 62.4 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.234 -0.894 . . . . 12.98 109.244 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.19 39.32 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.991 2.461 . . . . 13.66 113.276 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t 62.3 97.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.582 1.153 . . . . 12.75 111.0 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -97.32 21.52 9.93 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.279 0.561 . . . . 13.85 111.529 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -119.49 134.6 55.14 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.007 0.432 . . . . 14.91 110.036 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.38 134.1 27.35 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 107.895 -1.15 . . . . 11.68 107.895 172.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.78 144.3 77.11 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 122.344 2.029 . . . . 11.23 111.152 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.14 133.83 29.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.265 -0.425 . . . . 10.77 110.908 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.68 83.55 7.18 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.262 0.553 . . . . 10.76 110.29 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 p -64.22 133.27 52.48 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.297 -0.865 . . . . 11.26 109.67 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 128.57 93.92 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.749 -0.205 . . . . 11.01 111.149 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.64 54.68 5.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.039 2.493 . . . . 12.86 111.446 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.72 133.95 22.14 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.454 -0.943 . . . . 14.34 108.454 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.99 126.6 12.66 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.02 1.813 . . . . 12.35 110.483 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.86 165.95 13.25 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.383 -1.087 . . . . 11.89 110.383 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.97 -24.62 58.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 117.062 0.431 . . . . 11.88 111.609 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -84.82 13.34 5.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.285 0.564 . . . . 12.74 111.862 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.05 49.75 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 11.49 109.302 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.4 m -106.28 70.01 0.82 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.441 -0.8 . . . . 10.09 110.079 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.45 69.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.115 -0.493 . . . . 11.53 111.434 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -70.53 -47.28 61.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.806 -0.813 . . . . 11.91 108.806 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -68.98 -40.55 78.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.037 -0.529 . . . . 10.19 110.772 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.8 -41.99 92.42 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.059 -0.519 . . . . 10.43 110.05 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -64.92 -36.53 84.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 120.453 -0.499 . . . . 10.46 111.281 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 178' ' ' VAL . 50.4 mt -59.31 -50.05 81.25 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 109.546 -0.538 . . . . 8.37 109.546 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -60.83 -34.86 75.21 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.536 -0.756 . . . . 8.76 110.114 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 15.0 t70 -63.49 -52.73 60.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.51 -0.768 . . . . 10.86 110.352 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -62.41 -44.72 95.76 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.337 -0.392 . . . . 11.62 109.976 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.91 -47.41 80.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.98 0.912 . . . . 7.62 110.68 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.31 -47.6 85.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.514 -0.766 . . . . 11.84 110.226 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 23.9 mt-30 -66.18 -43.24 87.42 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.879 -0.6 . . . . 12.03 110.717 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.6 t -58.11 -51.81 68.15 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 123.579 0.752 . . . . 9.2 111.803 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.498 HD23 ' CZ2' ' A' ' 148' ' ' TRP . 3.1 tm? -73.46 -40.82 63.87 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.54 -0.541 . . . . 10.06 109.54 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.53 -27.7 72.17 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.074 -0.512 . . . . 12.07 112.47 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.37 -37.94 68.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.369 0.604 . . . . 12.38 109.761 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.545 -0.752 . . . . 11.77 110.033 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.75 -16.68 55.13 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.552 -0.749 . . . . 13.52 110.567 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 72.46 8.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.351 1.46 . . . . 17.15 112.671 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.64 18.39 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.718 0.807 . . . . 16.03 108.99 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.94 126.23 29.48 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.521 -1.288 . . . . 14.35 107.521 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -7.53 21.03 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.76 2.307 . . . . 14.18 112.489 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.01 -73.06 0.39 Allowed Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 120.653 -0.784 . . . . 14.05 112.244 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -124.69 -22.17 4.64 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.821 0.343 . . . . 16.88 111.105 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp 63.5 -154.79 0.32 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 12.55 110.608 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 68.13 -78.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.148 0.979 . . . . 14.87 110.882 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.7 p -97.15 151.25 19.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.544 -0.91 . . . . 14.56 108.544 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.27 64.46 Favored Glycine 0 N--CA 1.47 0.951 0 C-N-CA 119.807 -1.187 . . . . 14.2 110.491 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.5 82.16 1.94 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.181 -1.414 . . . . 13.0 107.181 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.53 124.12 48.72 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.401 -1.272 . . . . 17.02 111.524 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.19 -7.08 51.4 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.086 -0.961 . . . . 13.62 111.372 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.86 -31.64 69.6 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.824 -1.176 . . . . 16.54 107.824 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.91 -51.98 3.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.772 -1.104 . . . . 15.87 110.176 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.18 15.55 2.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.549 0.69 . . . . 13.65 112.113 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.6 61.31 0.41 Allowed Glycine 0 C--N 1.297 -1.591 0 N-CA-C 109.857 -1.297 . . . . 14.16 109.857 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.6 ttm -72.46 -38.5 68.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.201 0.524 . . . . 15.81 110.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.14 143.27 46.63 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.321 -0.854 . . . . 13.63 110.299 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -82.06 -27.34 33.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.431 -0.804 . . . . 14.06 111.945 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.88 -35.96 50.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.204 0.526 . . . . 14.08 109.801 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.1 p -59.15 -48.12 82.77 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.77 -0.65 . . . . 11.82 110.939 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.4 85.14 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 115.499 -0.773 . . . . 10.82 112.726 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.9 t -64.37 -41.84 96.49 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.486 -0.486 . . . . 12.55 111.423 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -66.36 -46.34 77.08 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.891 0.377 . . . . 12.17 111.186 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.498 ' CZ2' HD23 ' A' ' 118' ' ' LEU . 32.8 t90 -64.14 -48.97 73.98 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.878 -0.601 . . . . 9.45 111.789 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 93.6 mmm -60.93 -45.44 94.68 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 123.245 0.34 . . . . 9.88 111.809 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.21 -36.69 80.59 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.026 -0.27 . . . . 14.43 111.187 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.05 -47.97 80.22 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.656 -0.578 . . . . 10.49 111.656 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.26 -42.92 92.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.204 0.526 . . . . 9.27 110.101 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.2 m -62.82 -41.67 99.41 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.342 -0.845 . . . . 11.46 111.23 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -69.71 -41.79 74.9 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.892 -0.595 . . . . 15.5 109.87 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -60.41 -45.14 94.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.856 . . . . 12.39 110.248 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.52 5.9 49.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.473 0.546 . . . . 11.97 112.473 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.2 m 57.26 39.44 28.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.301 1.04 . . . . 14.37 112.887 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.0 149.66 16.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.076 0.465 . . . . 13.16 111.097 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.61 100.04 12.85 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.813 -1.18 . . . . 16.91 107.813 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -103.6 135.44 45.18 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.017 -0.538 . . . . 12.32 109.623 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.34 133.91 39.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.453 0.644 . . . . 14.37 110.573 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.76 64.3 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.683 -0.689 . . . . 13.15 111.487 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.83 -5.17 59.28 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.746 -0.661 . . . . 15.68 111.091 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.21 -8.54 56.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.727 0.775 . . . . 13.1 109.843 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.88 -23.85 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.984 1.314 . . . . 12.16 109.745 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -113.43 16.75 18.8 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.124 -0.944 . . . . 15.41 110.098 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.8 m -101.77 -34.1 9.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.645 -0.707 . . . . 15.07 109.85 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -103.24 107.41 55.48 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.869 -0.419 . . . . 12.68 109.869 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.58 -13.7 9.49 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.155 1.904 . . . . 15.04 113.007 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -129.46 145.29 51.45 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.555 0.693 . . . . 13.26 111.529 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.9 tp -58.17 -35.09 71.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.439 -1.255 . . . . 10.32 111.9 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.84 -25.44 65.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 12.75 111.718 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.4 m -75.88 -20.16 58.28 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.146 0.498 . . . . 11.26 110.5 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.86 -29.75 55.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.578 -0.897 . . . . 8.53 108.578 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.42 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.417 -0.81 . . . . 7.7 109.4 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -62.07 -30.5 71.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 120.804 0.335 . . . . 10.38 111.343 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -59.38 4.58 Favored 'General case' 0 C--O 1.252 1.205 0 N-CA-C 108.583 -0.895 . . . . 11.97 108.583 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.414 ' CG2' HD11 ' A' ' 110' ' ' ILE . 14.9 p -65.49 -35.18 74.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 114.674 -1.148 . . . . 9.8 111.773 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -57.24 -40.9 78.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.59 0.71 . . . . 10.83 110.919 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 34.2 ttp-105 -82.23 -53.22 6.23 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.341 -0.845 . . . . 13.85 111.18 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -75.42 -45.9 36.05 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.895 1.442 . . . . 15.46 114.895 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.98 -31.66 22.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 119.937 -0.705 . . . . 13.35 109.239 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.237 0.41 0 O-C-N 124.9 1.375 . . . . 13.51 111.223 172.776 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.731 ' HB ' ' OD2' ' A' ' 4' ' ' ASP . 44.0 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.145 -1.428 . . . . 18.78 107.145 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.65 70.83 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.657 0.383 . . . . 16.95 111.088 -174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.21 -53.67 47.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.993 0.808 . . . . 15.46 111.039 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.731 ' OD2' ' HB ' ' A' ' 1' ' ' VAL . 3.2 p30 -79.33 -28.01 42.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 14.98 111.078 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.52 -47.16 82.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 121.029 -0.268 . . . . 15.79 110.744 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.7 m -59.68 -42.91 93.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.509 0.195 . . . . 12.18 111.133 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.04 80.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.305 -0.407 . . . . 11.02 110.682 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.81 -39.13 87.61 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.787 -0.642 . . . . 16.75 110.647 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.35 -49.19 78.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.541 0.736 . . . . 14.46 110.289 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.45 -38.08 83.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.422 -0.354 . . . . 10.71 110.683 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -59.74 -43.72 94.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.112 -0.495 . . . . 14.51 109.907 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.25 -41.86 69.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 16.85 110.096 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -57.73 -45.23 86.08 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.098 0.959 . . . . 13.52 111.132 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.48 -48.12 81.83 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.337 -0.616 . . . . 12.77 109.337 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.39 82.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.669 . . . . 15.19 111.831 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.65 86.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.137 0.575 . . . . 16.26 111.725 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.412 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 63.5 mtt -78.11 -42.61 31.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.705 -0.679 . . . . 15.45 111.468 -176.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.16 3.19 52.72 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.869 -0.733 . . . . 16.16 112.083 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 55.56 46.7 22.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.317 1.047 . . . . 20.58 110.187 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.8 m -123.38 -178.47 4.01 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.973 -1.012 . . . . 17.26 109.843 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.0 mp0 -95.64 145.97 30.49 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.462 -1.681 . . . . 20.19 106.462 174.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.01 49.86 3.38 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 121.874 1.716 . . . . 17.46 109.237 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . -51.1 92.54 0.01 OUTLIER Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 127.945 2.688 . . . . 18.33 114.587 -172.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 44.19 29.71 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 127.044 2.138 . . . . 20.77 115.627 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.76 130.31 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.92 -1.141 . . . . 16.1 107.92 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -151.16 0.34 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.243 -1.021 . . . . 19.87 108.243 -173.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.09 -29.63 64.29 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.55 -0.46 . . . . 15.1 111.051 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -53.66 2.45 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.153 -1.022 . . . . 15.48 111.042 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -74.48 108.75 7.45 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.82 -1.178 . . . . 14.88 107.82 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 91.0 mtt180 -89.86 176.43 6.83 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.312 0.856 . . . . 17.38 113.312 -169.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -49.62 -41.17 41.63 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 112.736 0.643 . . . . 11.99 112.736 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.8 mt -60.34 -25.75 66.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 14.71 111.715 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.26 -36.2 79.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.243 0.617 . . . . 16.44 111.213 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.0 mt -88.98 5.22 45.24 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.584 -0.446 . . . . 13.83 112.006 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.79 51.71 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.992 -1.099 . . . . 14.3 112.677 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 41' ' ' ALA . 6.9 tt -75.13 125.12 28.27 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.684 -0.858 . . . . 13.04 108.684 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -117.35 162.18 18.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.953 -1.128 . . . . 15.67 107.953 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 p -48.43 -43.89 34.78 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.401 0.68 . . . . 15.49 112.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.49 -47.66 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.865 -0.607 . . . . 16.98 110.487 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.0 mt -67.16 -34.46 69.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.816 -0.629 . . . . 14.44 110.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB2' HD23 ' A' ' 36' ' ' LEU . . . -59.34 -33.28 70.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 12.4 111.31 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.15 73.52 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.212 -0.449 . . . . 14.37 111.712 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.27 -45.74 14.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.386 0.612 . . . . 16.05 109.711 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.412 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 3.4 t90 -59.34 -40.59 86.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.498 1.119 . . . . 11.7 111.89 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 tp -62.18 -30.64 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.89 0.376 . . . . 11.48 110.872 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -64.96 -41.02 95.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 17.18 109.958 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -31.7 71.67 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 121.191 0.519 . . . . 14.15 111.424 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.409 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 78.5 mt -66.97 -50.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.44 -0.948 . . . . 10.8 108.44 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 90.9 m-20 -62.66 -31.35 72.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.582 -1.19 . . . . 12.98 112.971 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -71.39 -43.13 67.43 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.871 -0.518 . . . . 17.81 110.155 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -74.64 -45.18 46.5 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 113.97 1.1 . . . . 15.55 113.97 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.411 ' O ' HD23 ' A' ' 54' ' ' LEU . 63.9 m-85 -101.64 -1.15 33.36 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.758 -0.777 . . . . 12.2 112.189 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.298 4.0 pt20 48.49 42.71 19.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.242 1.941 . . . . 17.4 116.242 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 52' ' ' TYR . 3.4 mm? -94.51 171.25 8.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.599 -1.259 . . . . 12.25 107.599 171.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -114.12 60.74 0.67 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.506 -0.924 . . . . 16.32 108.506 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 57' ' ' PRO . 62.7 mt -97.4 126.4 41.77 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.35 -0.841 . . . . 11.39 111.0 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.458 ' O ' HG22 ' A' ' 56' ' ' ILE . 74.2 Cg_endo -77.0 169.5 21.51 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.273 1.982 . . . . 13.44 109.186 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.99 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.462 0.648 . . . . 12.81 110.629 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 5.6 m-20 -62.33 -20.09 64.0 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.101 -0.954 . . . . 14.14 112.312 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.07 99.82 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 119.791 -1.195 . . . . 10.76 110.252 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.03 -27.39 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.634 0.73 . . . . 11.0 110.07 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 20.6 m-85 -74.57 -23.47 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.843 -0.536 . . . . 16.59 110.233 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.4 m -87.57 -45.28 10.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.04 -0.527 . . . . 13.72 109.639 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.503 ' HE2' ' CE3' ' A' ' 73' ' ' TRP . 76.0 m-85 -115.74 104.22 53.03 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 120.583 0.23 . . . . 12.25 111.095 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 71.6 Cg_endo -83.13 3.32 7.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.96 1.773 . . . . 13.57 110.842 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -119.97 120.42 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.301 -1.74 . . . . 13.28 106.301 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -63.38 -29.77 71.01 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 113.504 0.927 . . . . 11.45 113.504 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -64.06 -34.25 77.6 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 14.64 111.696 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.16 -29.12 28.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.818 0.818 . . . . 11.34 109.655 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -75.58 -35.85 60.49 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.995 . . . . 9.05 111.377 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -65.02 -30.39 71.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.107 0.48 . . . . 9.65 109.731 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -70.17 -36.75 74.9 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.252 -0.885 . . . . 12.14 109.599 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.503 ' CE3' ' HE2' ' A' ' 64' ' ' TYR . 17.3 t-105 -61.95 -42.29 98.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 11.26 110.606 173.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 79.6 t -68.8 -45.29 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.921 0 N-CA-C 110.087 -0.338 . . . . 8.3 110.087 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.07 87.7 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 116.153 -0.476 . . . . 9.58 113.331 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 p -73.05 -30.18 63.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.053 0.39 . . . . 10.46 112.053 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.48 -19.92 37.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.599 0.714 . . . . 10.43 110.323 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 95.0 mt -79.59 163.72 24.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.185 -0.672 . . . . 10.97 109.185 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.89 100.66 47.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.658 -0.868 . . . . 13.77 108.658 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.28 -178.96 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.003 2.469 . . . . 12.28 112.195 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.7 p 49.42 61.75 2.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.228 1.011 . . . . 13.71 112.687 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -72.06 105.71 4.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.797 -1.092 . . . . 13.27 111.334 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -30.78 39.46 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.503 -0.925 . . . . 14.77 108.503 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.0 m -90.16 123.18 33.77 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.705 -1.591 . . . . 15.24 106.705 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 59.53 74.8 0.43 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 123.895 0.878 . . . . 14.58 111.292 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.87 132.39 73.2 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.836 -1.075 . . . . 12.98 111.095 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.44 68.71 3.49 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.122 2.548 . . . . 13.66 112.525 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.8 136.48 52.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.73 -1.211 . . . . 12.75 107.73 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.21 79.61 9.03 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.574 0.702 . . . . 13.85 110.521 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -122.27 111.12 16.53 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.511 -0.768 . . . . 14.91 109.339 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.02 134.59 77.65 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.915 -0.772 . . . . 11.68 108.915 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.76 43.58 1.27 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.179 2.586 . . . . 11.23 112.265 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.69 134.55 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 10.77 109.365 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.01 50.17 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.366 -0.379 . . . . 10.76 110.492 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 p -86.17 100.7 12.41 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.758 -1.201 . . . . 11.26 107.758 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.44 113.88 62.67 Favored Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.943 -0.571 . . . . 11.01 111.088 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.11 -21.38 13.89 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.308 2.005 . . . . 12.86 110.133 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.408 ' OE1' ' HD2' ' A' ' 99' ' ' PRO . 5.6 tp-100 -130.64 123.13 20.06 Favored Pre-proline 0 N--CA 1.418 -2.062 0 N-CA-C 106.084 -1.821 . . . . 14.34 106.084 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.408 ' HD2' ' OE1' ' A' ' 98' ' ' GLN . 55.9 Cg_endo -72.57 63.26 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.888 2.392 . . . . 12.35 113.337 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 27.41 1.86 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.303 -1.119 . . . . 11.89 110.303 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.4 -43.18 19.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.545 0.688 . . . . 11.88 109.714 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -85.53 138.25 32.33 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.416 -0.811 . . . . 12.74 109.949 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.93 -4.6 57.42 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 11.49 108.562 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.9 p -97.09 32.75 2.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.826 -1.079 . . . . 10.09 109.924 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.08 76.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.435 -0.348 . . . . 11.53 111.8 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -65.47 -40.98 93.81 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.519 0.676 . . . . 11.91 109.659 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -66.22 -36.6 83.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.277 -0.874 . . . . 10.19 112.893 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.68 -38.38 90.14 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 117.921 0.328 . . . . 10.43 110.688 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 t -56.88 -47.72 79.81 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.785 -0.45 . . . . 10.46 109.785 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 110' ' ' ILE . 68.1 mt -68.79 -51.97 39.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.404 -0.591 . . . . 8.37 109.404 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -53.46 -41.38 66.11 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 124.587 1.155 . . . . 8.76 112.126 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 23.8 t70 -63.65 -48.24 78.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.68 0.252 . . . . 10.86 111.68 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.91 -36.06 69.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 11.62 110.413 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.64 -35.99 82.39 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.82 -0.808 . . . . 7.62 108.82 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 25.0 ttpp -61.92 -45.76 92.3 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 11.84 109.472 174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 77.7 mt-30 -56.22 -47.23 78.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.593 -0.73 . . . . 12.03 109.666 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -64.35 -50.98 65.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.111 -0.95 . . . . 9.2 112.124 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 119' ' ' GLY . 3.7 pp -65.09 -34.99 79.71 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.326 -0.549 . . . . 10.06 111.869 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.523 ' N ' HD11 ' A' ' 118' ' ' LEU . . . -66.38 -47.8 68.11 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 111.072 -0.811 . . . . 12.07 111.072 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.37 -38.81 88.34 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.244 1.018 . . . . 12.38 110.624 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 tp -57.39 -44.05 84.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 11.77 110.102 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 86.9 mt -72.96 -63.24 1.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.522 -0.918 . . . . 13.52 108.522 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -179.27 -47.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.654 1.182 . . . . 17.15 109.978 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -162.67 155.3 19.23 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.777 0.322 . . . . 16.03 110.293 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -125.82 127.3 24.82 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.454 -0.794 . . . . 14.35 110.841 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.32 -2.88 12.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.137 2.558 . . . . 14.18 112.213 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.89 41.42 4.38 Favored Glycine 0 CA--C 1.491 -1.469 0 C-N-CA 120.893 -0.67 . . . . 14.05 111.916 173.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -140.34 -72.66 0.36 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.132 -1.027 . . . . 16.88 113.413 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 mp 67.79 141.25 0.03 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.418 1.104 . . . . 12.55 112.044 -166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -83.04 161.91 21.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.879 -1.156 . . . . 14.87 107.879 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.1 m -78.31 17.49 0.64 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.845 0.683 . . . . 14.56 112.845 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.96 -74.83 0.34 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.663 -1.775 . . . . 14.2 108.663 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 62.07 62.43 1.21 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.998 0.919 . . . . 13.0 111.953 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -80.79 104.67 11.46 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.717 -0.674 . . . . 17.02 110.684 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -66.72 -26.81 67.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.255 1.022 . . . . 13.62 109.945 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.16 -24.37 67.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.434 0.635 . . . . 16.54 110.673 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -97.68 -46.27 6.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.157 0.503 . . . . 15.87 109.782 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.03 -26.07 62.94 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 13.65 112.884 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.02 119.68 6.45 Favored Glycine 0 C--N 1.313 -0.729 0 N-CA-C 111.942 -0.463 . . . . 14.16 111.942 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 86.9 mtp -106.18 -23.23 12.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.307 0.575 . . . . 15.81 110.643 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.51 127.44 19.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.344 0.592 . . . . 13.63 110.305 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.716 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 21.7 t -66.87 -37.49 84.53 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.931 -1.031 . . . . 14.06 110.32 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.89 -40.19 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.468 -0.333 . . . . 14.08 111.135 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.7 p -57.56 -35.29 70.16 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.442 . . . . 11.82 111.515 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.36 -32.11 26.19 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.623 -1.275 . . . . 10.82 112.254 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -68.25 -35.6 78.17 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.428 0.614 . . . . 12.55 110.588 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -63.83 -38.72 92.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.116 -0.493 . . . . 12.17 110.334 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -62.4 -44.22 96.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.75 -0.659 . . . . 9.45 110.22 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 149' ' ' MET . 25.8 mmt -60.23 -36.61 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 9.88 110.323 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.614 ' HA ' ' NE ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -67.06 -43.79 81.77 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.946 -0.57 . . . . 14.43 110.426 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.06 71.87 Favored Glycine 0 C--O 1.246 0.873 0 O-C-N 123.692 0.62 . . . . 10.49 112.73 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.34 -33.15 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.45 0.167 . . . . 9.27 110.898 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.4 m -60.58 -47.09 87.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 121.031 0.443 . . . . 11.46 110.124 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -68.83 -50.43 50.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.603 -0.726 . . . . 15.5 111.37 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -66.0 -34.95 79.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.223 0.453 . . . . 12.39 112.223 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.18 5.77 42.81 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.032 -0.667 . . . . 11.97 112.612 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 p 53.16 44.83 29.76 Favored 'General case' 0 C--O 1.247 0.954 0 C-N-CA 124.473 1.109 . . . . 14.37 113.377 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.78 149.07 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.307 -0.861 . . . . 13.16 108.774 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -96.23 95.64 8.25 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.402 -0.962 . . . . 16.91 108.402 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.8 tp -106.12 136.75 45.25 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.943 -0.572 . . . . 12.32 109.7 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.95 134.53 43.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.525 -0.546 . . . . 14.37 109.525 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.5 60.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.734 -0.666 . . . . 13.15 110.763 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.02 -10.85 59.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.436 -0.802 . . . . 15.68 110.573 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 167' ' ' THR . . . -64.61 -11.51 35.76 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.073 -0.512 . . . . 13.1 112.202 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -58.53 -17.61 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 121.445 0.64 . . . . 12.16 111.467 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.716 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 26.7 m-85 -93.38 -6.41 47.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.077 -0.51 . . . . 15.41 112.131 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' ALA . 13.9 t -103.05 8.94 38.76 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.327 -0.949 . . . . 15.07 111.14 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -129.93 99.46 20.12 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 108.98 -0.748 . . . . 12.68 108.98 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.24 -28.78 39.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.742 1.628 . . . . 15.04 110.906 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 27.8 p -121.96 142.4 50.34 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.812 -0.631 . . . . 13.26 109.493 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.16 -30.56 71.69 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.316 1.046 . . . . 10.32 111.622 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -55.23 -27.03 43.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.127 -0.942 . . . . 12.75 111.91 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.7 m -72.16 -19.89 61.69 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.162 -0.472 . . . . 11.26 112.194 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.7 tp -75.68 -29.84 59.18 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.951 -0.7 . . . . 8.53 109.892 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.26 96.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.807 -0.633 . . . . 7.7 111.196 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -82.16 -25.88 33.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.151 -0.62 . . . . 10.38 110.558 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.38 -48.66 69.44 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.163 -0.472 . . . . 11.97 110.408 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 110' ' ' ILE . 9.0 p -59.56 -39.73 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.861 -0.609 . . . . 9.8 110.141 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.88 -44.59 92.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.528 -0.76 . . . . 10.83 111.234 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -70.92 -28.33 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.124 0.488 . . . . 13.85 111.488 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -79.23 -41.98 27.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.624 -0.431 . . . . 15.46 110.806 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.04 -35.25 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.428 -0.509 . . . . 13.35 111.341 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.37 -0.604 . . . . 13.51 109.37 179.198 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.212 -0.888 0 N-CA-C 108.43 -0.952 . . . . 18.78 108.43 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.81 -26.6 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.198 -0.601 . . . . 16.95 112.111 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -49.96 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.003 0.814 . . . . 15.46 112.973 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 22.7 t70 -88.73 -11.21 45.75 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.795 -0.762 . . . . 14.98 110.668 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.8 -38.11 70.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.889 -0.507 . . . . 15.79 111.708 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.0 p -65.7 -35.13 79.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.533 -0.867 . . . . 12.18 109.757 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.52 -35.0 79.53 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.055 -0.52 . . . . 11.02 110.477 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 28.5 mt-30 -53.36 -45.56 69.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 123.622 0.576 . . . . 16.75 110.636 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.45 -46.54 88.04 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.849 -0.614 . . . . 14.46 110.473 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.6 -36.35 73.47 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.01 -0.541 . . . . 10.71 111.075 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.62 -46.47 85.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.841 0.857 . . . . 14.51 109.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.92 -44.63 96.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.389 -0.823 . . . . 16.85 110.289 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -69.07 -40.4 78.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.407 -0.815 . . . . 13.52 110.847 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.77 -51.01 71.79 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.505 -0.924 . . . . 12.77 108.505 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.642 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -62.38 -39.61 93.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.055 . . . . 15.19 111.662 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.34 88.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.326 -0.397 . . . . 16.26 111.351 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.3 mtt -71.93 -36.62 69.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.789 0.328 . . . . 15.45 111.819 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 81.3 mt -94.73 -2.39 51.18 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.673 -0.411 . . . . 16.16 111.73 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 59.15 36.21 23.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.512 1.125 . . . . 20.58 111.104 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 23.5 p -112.27 164.91 12.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.11 -0.95 . . . . 17.26 108.976 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 52.2 mm-40 -91.28 129.29 43.91 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.091 -0.707 . . . . 20.19 109.091 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.93 -14.35 42.75 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.484 2.789 . . . . 17.46 114.317 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.98 -13.43 69.2 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.855 -0.688 . . . . 18.33 112.659 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 10.6 pt20 -79.56 -20.19 47.63 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.278 0.539 . . . . 20.77 110.472 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 pt -92.94 168.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.688 -1.227 . . . . 16.1 107.688 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -134.6 166.17 23.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 119.191 -0.433 . . . . 19.87 111.053 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.5 -51.17 69.52 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.64 0.588 . . . . 15.1 111.167 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.23 6.72 70.5 Favored Glycine 0 C--O 1.244 0.741 0 CA-C-N 115.962 -0.563 . . . . 15.48 113.918 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -76.29 136.84 39.62 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.74 0.781 . . . . 14.88 110.924 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 82.3 mtp180 -77.54 147.08 35.93 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 114.576 -1.193 . . . . 17.38 108.786 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -58.63 -25.45 62.7 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.176 0.806 . . . . 11.99 113.176 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.01 -21.34 59.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.096 -0.502 . . . . 14.71 109.884 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.39 -18.74 18.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.864 0.866 . . . . 16.44 109.006 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.14 -21.63 58.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.702 -0.681 . . . . 13.83 109.792 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 24.56 8.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.45 -0.796 . . . . 14.3 112.543 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.38 163.54 16.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.924 0.869 . . . . 13.04 112.47 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.35 153.46 51.83 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.039 -1.437 . . . . 15.67 107.31 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -49.43 -55.65 12.36 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 123.741 0.65 . . . . 15.49 112.629 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.55 -44.79 99.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.249 -0.432 . . . . 16.98 110.704 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.78 -37.64 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.246 -0.433 . . . . 14.44 110.574 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.68 85.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 12.4 110.176 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.74 90.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.677 -0.692 . . . . 14.37 110.242 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.16 -42.39 90.63 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.461 0.648 . . . . 16.05 110.887 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.531 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 7.4 t90 -61.64 -55.61 28.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.793 1.637 . . . . 11.7 109.17 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 58' ' ' ALA . 16.6 mm -54.32 -39.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.436 0.695 . . . . 11.48 111.583 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 18.4 tpt180 -72.33 -23.32 61.14 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.995 -0.548 . . . . 17.18 111.802 -175.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -86.56 -32.82 20.48 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 120.086 -0.646 . . . . 14.15 109.725 175.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 45' ' ' ILE . 87.9 mt -55.61 -35.8 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.972 0.909 . . . . 10.8 109.05 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' A' ' 46' ' ' ARG . 14.5 m120 -53.62 -39.77 65.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.836 -1.075 . . . . 12.98 112.411 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -84.86 -43.83 13.77 Favored 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 119.977 -0.689 . . . . 17.81 109.885 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -62.3 -37.05 84.07 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.36 0.874 . . . . 15.55 113.36 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -108.06 7.13 27.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.023 0.749 . . . . 12.2 113.023 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 48.17 52.6 13.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.302 1.441 . . . . 17.4 110.392 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 49' ' ' ASN . 33.1 tp -143.24 137.12 28.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.39 -0.967 . . . . 12.25 108.39 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.61 46.54 1.37 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.579 0.704 . . . . 16.32 109.474 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 54' ' ' LEU . 13.1 tt -53.36 128.42 50.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.141 -1.39 . . . . 11.39 110.823 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.2 147.37 12.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.466 2.11 . . . . 13.44 112.179 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.438 ' HA ' HG13 ' A' ' 45' ' ' ILE . . . -68.4 -17.74 64.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.924 -1.034 . . . . 12.81 111.87 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.48 -9.27 56.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 14.14 111.915 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.27 -29.31 72.71 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.081 -0.808 . . . . 10.76 111.081 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.4 mt -76.79 -25.92 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 CA-C-O 121.414 0.626 . . . . 11.0 109.384 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -85.66 -14.03 46.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.297 -0.561 . . . . 16.59 111.526 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 t -97.03 -34.5 11.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.586 -0.446 . . . . 13.72 110.075 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -130.38 79.71 71.89 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.871 0.367 . . . . 12.25 110.273 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.8 Cg_endo -89.18 36.72 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.422 2.748 . . . . 13.57 112.813 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.0 t -124.43 127.31 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.397 -1.705 . . . . 13.28 106.397 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -52.41 -49.16 65.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.807 0.73 . . . . 11.45 112.82 -170.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 17.5 tptm -70.36 -21.33 62.89 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.16 0.505 . . . . 14.64 111.58 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.28 -29.71 24.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.584 0.707 . . . . 11.34 109.875 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -82.55 -28.12 31.2 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.305 -0.861 . . . . 9.05 111.145 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -68.75 -32.36 72.08 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.16 0.505 . . . . 9.65 110.083 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 68' ' ' LYS . 11.2 mm100 -72.23 -29.45 63.95 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 109.24 -0.652 . . . . 12.14 109.24 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.634 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 3.1 t90 -57.99 -53.87 53.33 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.351 -0.981 . . . . 11.26 108.351 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.52 -39.75 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 C-N-CA 124.153 0.981 . . . . 8.3 110.877 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.1 95.11 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.246 -0.433 . . . . 9.58 112.808 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -76.1 -13.42 60.21 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 122.55 -0.382 . . . . 10.46 111.081 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 75.5 mm-40 -83.64 -18.8 36.89 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.638 -0.875 . . . . 10.43 108.638 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.37 66.61 6.98 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.331 -0.989 . . . . 10.97 108.331 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -106.47 114.76 61.75 Favored Pre-proline 0 N--CA 1.419 -1.983 0 CA-C-N 114.379 -1.282 . . . . 13.77 109.716 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.61 135.1 47.37 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.927 2.418 . . . . 12.28 112.426 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 p -79.84 5.74 12.9 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.511 -0.768 . . . . 13.71 111.337 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -84.28 -27.83 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.51 -0.768 . . . . 13.27 109.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.35 -46.09 7.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.733 -0.84 . . . . 14.77 108.733 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.9 m -91.44 97.58 11.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.446 -0.797 . . . . 15.24 110.78 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.91 70.2 0.52 Allowed 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.892 1.277 . . . . 14.58 113.007 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.59 25.44 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 115.671 -0.695 . . . . 12.98 109.718 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.34 48.88 3.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.813 2.342 . . . . 13.66 112.667 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.23 61.55 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.514 -1.662 . . . . 12.75 106.514 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -104.21 -27.8 11.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.269 -0.878 . . . . 13.85 110.652 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 8.2 mpt_? -93.35 88.36 5.95 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.852 -0.613 . . . . 14.91 109.39 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.47 129.71 44.14 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.439 -0.801 . . . . 11.68 109.791 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.82 83.67 1.35 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.844 2.362 . . . . 11.23 110.452 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -82.01 119.54 31.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.191 -0.913 . . . . 10.77 110.726 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.69 139.52 53.87 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.06 -1.459 . . . . 10.76 107.06 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -130.91 161.98 30.68 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.802 -0.814 . . . . 11.26 108.802 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 42.07 83.17 0.21 Allowed Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.624 1.569 . . . . 11.01 113.766 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.88 -34.17 95.55 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.14 1.894 . . . . 12.86 111.446 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -80.08 125.94 80.58 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.455 -0.793 . . . . 14.34 110.838 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.32 103.14 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.534 2.156 . . . . 12.35 110.217 174.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.28 65.78 1.26 Allowed Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.428 -0.892 . . . . 11.89 111.27 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.34 61.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.181 0.515 . . . . 11.88 110.656 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -80.24 78.56 6.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.633 -0.712 . . . . 12.74 110.002 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.95 58.36 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.597 0.713 . . . . 11.49 111.43 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.6 m 61.01 33.35 19.73 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 125.315 1.446 . . . . 10.09 112.772 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.09 -38.86 62.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.599 0.962 . . . . 11.53 113.599 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.01 -41.72 86.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.441 0.638 . . . . 11.91 110.81 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 107' ' ' ARG . 3.5 mpt_? -83.39 -33.71 25.72 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.781 -0.645 . . . . 10.19 110.957 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.155 0.982 . . . . 10.43 110.386 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -60.53 -47.57 85.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.957 -0.565 . . . . 10.46 110.096 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 110' ' ' ILE . 67.1 mt -61.2 -45.53 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.096 -0.705 . . . . 8.37 109.096 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.07 -35.12 68.98 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 114.83 -1.077 . . . . 8.76 111.048 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.87 -37.78 85.81 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.04 0.448 . . . . 10.86 111.47 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -76.37 -44.29 37.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.853 -0.795 . . . . 11.62 108.853 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.8 -41.02 85.77 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.747 -1.115 . . . . 7.62 109.774 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.58 -42.09 74.28 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.318 1.447 . . . . 11.84 110.174 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -81.56 -33.97 31.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 12.03 111.981 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 80.8 p -61.05 -43.92 98.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 121.01 -0.276 . . . . 9.2 111.153 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 119' ' ' GLY . 4.2 pp -75.34 -31.69 60.65 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.531 -0.468 . . . . 10.06 110.659 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 118' ' ' LEU . . . -58.4 -54.94 33.63 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.187 -0.461 . . . . 12.07 111.972 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -60.43 -43.46 96.76 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.825 0.822 . . . . 12.38 110.702 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.59 -45.12 72.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.514 -1.221 . . . . 11.77 111.922 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.1 mt -91.14 -15.33 29.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.341 0.497 . . . . 13.52 112.341 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.1 t80 66.38 33.97 6.63 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.247 -1.39 . . . . 17.15 107.247 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.38 148.73 35.22 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.766 -1.561 . . . . 16.03 108.47 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 12.8 m-20 -67.98 119.91 70.3 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.394 -0.595 . . . . 14.35 109.394 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 16.8 Cg_exo -70.82 32.25 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.858 3.039 . . . . 14.18 114.387 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 125' ' ' ASP . . . -123.13 3.52 9.72 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 108.725 -1.75 . . . . 14.05 108.725 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -106.18 40.59 1.57 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.231 -1.026 . . . . 16.88 108.231 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.88 48.72 0.39 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.612 -1.176 . . . . 12.55 113.168 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -161.51 -44.15 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 125.429 1.492 . . . . 14.87 107.911 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -64.73 -45.42 86.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.265 -0.879 . . . . 14.56 109.023 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.88 30.47 10.35 Favored Glycine 0 C--O 1.214 -1.105 0 CA-C-N 115.387 -0.824 . . . . 14.2 111.047 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.75 -17.99 23.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.487 0.66 . . . . 13.0 109.857 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -87.71 113.63 23.56 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.99 -1.115 . . . . 17.02 107.99 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -64.46 -16.2 62.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.214 0.53 . . . . 13.62 112.218 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.98 -24.51 55.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.118 -0.492 . . . . 16.54 110.618 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -78.22 -27.75 47.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.412 0.625 . . . . 15.87 109.81 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.19 -20.89 66.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.469 -1.241 . . . . 13.65 111.956 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.52 -53.77 4.89 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.843 -0.903 . . . . 14.16 110.843 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.2 mtm -98.1 146.95 25.05 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.305 -1.369 . . . . 15.81 107.305 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -137.39 -68.2 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.776 1.028 . . . . 13.63 113.776 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 t -70.9 -40.19 72.31 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.033 0.382 . . . . 14.06 112.033 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.1 -50.95 53.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.536 0.684 . . . . 14.08 109.733 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -37.97 83.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.036 -0.984 . . . . 11.82 111.143 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.6 98.44 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.653 -0.703 . . . . 10.82 111.522 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.8 m -56.84 -53.26 59.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.682 0.393 . . . . 12.55 110.115 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -64.84 -38.45 91.04 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.316 -0.402 . . . . 12.17 111.894 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.412 ' O ' HG22 ' A' ' 152' ' ' VAL . 10.0 t90 -67.56 -50.9 56.33 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.348 -0.612 . . . . 9.45 109.348 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 mmt -67.63 -26.18 66.11 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.456 -0.793 . . . . 9.88 111.435 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 26.5 tpt180 -62.92 -43.93 97.47 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.405 -0.961 . . . . 14.43 108.405 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.82 91.24 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.144 -0.782 . . . . 10.49 111.144 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 148' ' ' TRP . 97.4 t -61.09 -40.86 87.15 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.465 -0.568 . . . . 9.27 109.465 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 157' ' ' SER . 39.6 m -66.08 -30.13 70.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.751 -0.659 . . . . 11.46 110.821 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 37.6 mmt180 -67.19 -47.74 70.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.56 -0.533 . . . . 15.5 109.56 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -71.53 -55.34 8.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.235 0.828 . . . . 12.39 113.235 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -105.27 -8.35 18.34 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 114.068 1.136 . . . . 11.97 114.068 -170.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 153' ' ' SER . 28.0 m 55.58 38.88 30.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.91 0.884 . . . . 14.37 112.326 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.9 pt -104.23 144.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.333 -0.617 . . . . 13.16 109.333 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -81.98 95.36 7.37 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 123.522 0.514 . . . . 16.91 111.696 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.29 102.39 6.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.577 -0.897 . . . . 12.32 108.577 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.43 175.68 10.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 121.174 -0.21 . . . . 14.37 111.054 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.37 80.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.445 0.641 . . . . 13.15 110.935 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.84 -10.2 45.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.19 -0.914 . . . . 15.68 112.848 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 -13.64 62.33 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 111.675 0.25 . . . . 13.1 111.675 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -66.65 -18.24 23.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 O-C-N 122.107 -0.371 . . . . 12.16 111.729 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -94.02 1.76 56.17 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.933 0.873 . . . . 15.41 110.194 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.5 m -89.32 -9.55 50.1 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.061 -0.972 . . . . 15.07 108.402 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -130.93 149.04 72.58 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.36 -0.978 . . . . 12.68 108.36 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.85 -38.41 2.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.622 2.215 . . . . 15.04 112.317 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.2 p -138.16 162.15 34.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.319 -1.734 . . . . 13.26 106.319 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.17 -1.25 19.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.024 0.44 . . . . 10.32 112.118 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -76.24 -24.34 54.57 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.179 -0.674 . . . . 12.75 109.179 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.2 m -73.88 -2.65 24.69 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.254 -0.885 . . . . 11.26 111.06 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.33 -32.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.464 -0.569 . . . . 8.53 109.464 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.36 68.9 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.299 0.571 . . . . 7.7 111.22 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.37 -24.69 34.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.411 -0.588 . . . . 10.38 109.411 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.63 -60.97 2.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.66 -0.7 . . . . 11.97 110.05 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.2 p -46.14 -52.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 124.053 0.845 . . . . 9.8 113.199 -173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.91 -45.38 93.98 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 111.897 0.332 . . . . 10.83 111.897 -174.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -78.27 -29.76 48.15 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.463 -0.789 . . . . 13.85 110.448 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.25 -39.61 74.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.633 -0.712 . . . . 15.46 109.391 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.0 t -78.39 -60.55 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.692 -0.685 . . . . 13.35 111.658 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 108.664 -0.865 . . . . 13.51 108.664 -173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 109.412 -0.588 . . . . 18.78 109.412 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . 176.26 -177.21 0.13 Allowed 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.544 1.138 . . . . 16.95 108.465 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.24 -24.82 66.65 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.544 0.611 . . . . 15.46 111.164 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.45 -26.7 68.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 14.98 112.058 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 2' ' ' ALA . 10.2 pt-20 -68.89 -27.24 65.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.272 0.558 . . . . 15.79 110.206 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' HB2' ' HH ' ' A' ' 52' ' ' TYR . 35.1 m -66.8 -33.46 75.66 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.459 -0.571 . . . . 12.18 109.459 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 -26.68 32.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.157 -0.474 . . . . 11.02 110.543 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -67.47 -33.97 76.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.175 -0.676 . . . . 16.75 109.175 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -68.5 -28.97 67.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.505 -0.771 . . . . 14.46 109.749 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.81 -44.4 96.25 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.379 -0.6 . . . . 10.71 109.379 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.922 -0.581 . . . . 14.51 109.492 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.75 -46.1 73.07 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.495 -0.775 . . . . 16.85 110.131 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 17' ' ' MET . 48.4 t -59.34 -45.59 90.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.573 -0.74 . . . . 13.52 110.365 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.48 -45.44 93.75 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.273 -0.422 . . . . 12.77 111.449 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.53 -22.95 63.53 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.253 -0.43 . . . . 15.19 111.574 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 -24.36 49.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.426 0.631 . . . . 16.26 109.628 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 13' ' ' SER . 26.5 mmt -78.05 -44.22 27.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.619 -0.719 . . . . 15.45 109.197 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.67 5.49 51.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 16.16 112.607 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 53.41 45.61 27.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.237 1.415 . . . . 20.58 113.107 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -125.33 -173.8 2.91 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.345 -0.983 . . . . 17.26 108.345 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -107.32 134.99 19.72 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 107.976 -1.12 . . . . 20.19 107.976 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -66.04 -11.17 29.93 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.233 2.622 . . . . 17.46 112.859 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.78 -3.41 85.91 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.527 -0.629 . . . . 18.33 111.527 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -102.75 175.41 5.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.677 -1.231 . . . . 20.77 107.677 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.422 HG12 ' HG ' ' A' ' 34' ' ' LEU . 1.9 mp 70.96 140.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 123.883 0.739 . . . . 16.1 110.725 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 6.8 mpt_? -75.25 122.77 24.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.738 -0.601 . . . . 19.87 109.577 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.66 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 p30 -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.83 0.678 . . . . 15.1 112.83 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.37 7.4 68.88 Favored Glycine 0 C--N 1.315 -0.614 0 N-CA-C 110.649 -0.98 . . . . 15.48 110.649 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -99.19 171.34 8.06 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.48 0.657 . . . . 14.88 109.54 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 81.8 mtm180 -92.93 160.3 14.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.163 -0.926 . . . . 17.38 110.38 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -58.26 -18.98 30.66 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.595 -1.184 . . . . 11.99 112.423 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -29.38 70.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.965 -0.561 . . . . 14.71 111.609 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.33 -35.45 80.38 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.361 0.6 . . . . 16.44 109.814 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HG ' HG12 ' A' ' 25' ' ' ILE . 4.1 mp -83.43 -8.92 59.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.772 -0.649 . . . . 13.83 110.248 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.78 35.26 73.08 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 114.83 -1.077 . . . . 14.3 111.373 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.04 114.05 8.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.623 -0.51 . . . . 13.04 109.623 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.22 156.34 23.21 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.481 -0.781 . . . . 15.67 109.784 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 t -56.22 -41.47 75.71 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.271 0.357 . . . . 15.49 111.45 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.23 -47.62 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.912 0.387 . . . . 16.98 110.985 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mt -66.03 -39.68 85.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.026 -0.534 . . . . 14.44 109.683 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.62 99.11 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.588 -0.733 . . . . 12.4 110.444 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.48 85.06 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.564 0.745 . . . . 14.37 111.093 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.84 -47.61 44.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.96 -0.564 . . . . 16.05 111.56 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -61.31 -47.28 86.68 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.088 0.555 . . . . 11.7 111.644 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 tp -59.69 -32.94 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 120.892 0.377 . . . . 11.48 110.571 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -66.86 -32.28 73.45 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.053 -0.522 . . . . 17.18 110.521 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.59 -31.97 60.16 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.564 -0.902 . . . . 14.15 108.564 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.49 -35.12 68.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.566 -0.743 . . . . 10.8 109.783 175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.93 -31.04 70.58 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.475 -0.784 . . . . 12.98 110.042 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -80.45 -43.95 20.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.934 -0.575 . . . . 17.81 110.047 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -65.11 -46.3 81.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.65 0.611 . . . . 15.55 112.65 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.517 ' HH ' ' HB2' ' A' ' 6' ' ' CYS . 55.6 m-85 -100.17 -0.03 39.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 112.787 0.662 . . . . 12.2 112.787 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 53.12 45.17 29.24 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.403 1.481 . . . . 17.4 111.702 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 96.0 mt -134.32 142.87 47.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.579 -1.191 . . . . 12.25 109.485 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -77.51 75.69 4.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.72 -0.844 . . . . 16.32 108.72 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mm -94.18 119.95 66.06 Favored Pre-proline 0 N--CA 1.436 -1.135 0 CA-C-N 116.292 -0.413 . . . . 11.39 111.814 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.15 164.21 13.24 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.869 2.38 . . . . 13.44 110.112 173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -2.92 17.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.634 -0.712 . . . . 12.81 112.518 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.49 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 p30 -68.3 -23.6 64.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.936 -0.306 . . . . 14.14 110.957 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.06 -30.62 70.66 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 119.883 -1.151 . . . . 10.76 111.588 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.94 -21.15 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.723 0.809 . . . . 11.0 110.036 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 16.7 m-85 -85.33 -45.86 11.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.384 -0.598 . . . . 16.59 109.384 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -67.54 -44.6 77.94 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.929 -0.578 . . . . 13.72 110.127 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.05 86.72 14.15 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.873 -0.788 . . . . 12.25 108.873 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 84.1 Cg_endo -83.9 14.87 2.28 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.751 2.301 . . . . 13.57 113.275 -174.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.8 t -124.56 120.29 58.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.118 -1.808 . . . . 13.28 106.118 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.66 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.5 p90 -58.72 -31.6 68.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 11.45 114.313 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -69.36 -24.98 63.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.766 0.654 . . . . 14.64 112.766 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.78 16.97 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.644 -0.873 . . . . 11.34 108.644 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 57.2 t80 -62.15 -28.91 69.98 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.748 -1.114 . . . . 9.05 112.262 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 p -70.0 -26.45 64.08 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.471 -0.768 . . . . 9.65 110.716 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -81.44 -28.94 33.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.746 -0.835 . . . . 12.14 108.746 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 66.1 t90 -58.26 -52.27 66.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.476 1.111 . . . . 11.26 108.094 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 54.4 t -67.88 -39.9 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 CA-C-N 115.266 -0.879 . . . . 8.3 110.781 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.73 97.07 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.192 -0.528 . . . . 9.58 112.3 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.2 m -67.99 -35.97 79.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 111.786 0.291 . . . . 10.46 111.786 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 27.6 pt20 -75.78 -18.77 59.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.363 -0.535 . . . . 10.43 110.517 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.09 -18.09 40.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.141 -0.481 . . . . 10.97 111.039 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -117.52 92.6 41.18 Favored Pre-proline 0 C--O 1.244 0.767 0 N-CA-C 109.879 -0.415 . . . . 13.77 109.879 -176.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -53.27 121.44 9.43 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.434 2.756 . . . . 12.28 112.05 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -65.91 -19.54 65.91 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.479 1.112 . . . . 13.71 113.183 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -105.22 -2.88 23.58 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 121.711 -0.618 . . . . 13.27 111.387 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.5 -18.1 28.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.921 0.391 . . . . 14.77 110.883 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 p -78.57 65.7 3.91 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.707 0.632 . . . . 15.24 112.707 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.62 136.38 38.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.04 -1.096 . . . . 14.58 108.04 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.96 125.36 80.09 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.808 -0.812 . . . . 12.98 108.808 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.95 116.51 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.416 2.077 . . . . 13.66 111.663 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.84 117.95 49.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.423 -0.955 . . . . 12.75 108.423 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.32 125.17 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.986 0.422 . . . . 13.85 110.851 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -127.71 41.15 3.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.636 -0.711 . . . . 14.91 109.517 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -86.87 120.94 71.91 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.138 -0.937 . . . . 11.68 110.022 -178.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 7.1 Cg_exo -72.6 66.47 3.79 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.859 2.372 . . . . 11.23 112.032 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -111.28 123.11 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.941 -0.572 . . . . 10.77 109.587 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.82 18.27 8.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.307 -0.627 . . . . 10.76 109.307 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.1 m 74.77 -48.27 0.64 Allowed 'General case' 0 C--O 1.251 1.179 0 C-N-CA 125.176 1.39 . . . . 11.26 111.325 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.84 141.66 98.4 Favored Pre-proline 0 N--CA 1.446 -0.632 0 C-N-CA 123.62 0.768 . . . . 11.01 109.167 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.18 -12.76 24.65 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.697 2.931 . . . . 12.86 113.768 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -127.67 95.89 34.02 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 108.578 -0.897 . . . . 14.34 108.578 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.01 94.46 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.594 2.196 . . . . 12.35 110.398 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.03 160.98 16.33 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.485 -0.864 . . . . 11.89 112.192 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -60.36 3.55 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.757 0.823 . . . . 11.88 111.148 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -74.31 -10.92 60.06 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.603 0.594 . . . . 12.74 112.603 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.16 68.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.491 0.186 . . . . 11.49 111.347 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.4 m -147.54 -32.68 0.28 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.922 0.712 . . . . 10.09 112.922 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -42.03 80.88 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.414 0.524 . . . . 11.53 112.414 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -51.72 -48.4 63.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.405 0.682 . . . . 11.91 111.573 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -68.92 -42.82 76.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 10.19 109.951 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.32 -44.48 83.25 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.989 -1.005 . . . . 10.43 111.766 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -59.84 -39.09 83.98 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.639 0.257 . . . . 10.46 111.038 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.501 HG22 HG11 ' A' ' 178' ' ' VAL . 59.7 mt -71.29 -50.95 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.921 -0.4 . . . . 8.37 109.921 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -58.84 -39.94 82.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.109 -0.496 . . . . 8.76 111.139 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 31.0 t70 -67.73 -36.98 81.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 10.86 111.007 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -70.05 -42.55 72.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.316 0.579 . . . . 11.62 109.782 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.6 -41.49 94.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.534 1.134 . . . . 7.62 109.033 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 33.9 ttmt -54.47 -54.3 42.74 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.559 1.544 . . . . 11.84 110.254 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -67.34 -42.75 83.04 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.916 -0.583 . . . . 12.03 111.908 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.4 t -56.75 -53.09 61.73 Favored 'General case' 0 C--O 1.248 1.021 0 O-C-N 123.574 0.546 . . . . 9.2 111.79 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.36 -36.77 74.39 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 120.676 -0.409 . . . . 10.06 110.912 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.7 84.95 Favored Glycine 0 C--O 1.223 -0.546 0 N-CA-C 111.24 -0.744 . . . . 12.07 111.24 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 -44.4 91.52 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 124.423 1.089 . . . . 12.38 110.804 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.0 -49.6 67.23 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.96 -1.018 . . . . 11.77 112.145 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 tp -94.02 4.23 54.21 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.703 -0.681 . . . . 13.52 112.358 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.1 t80 59.78 40.65 19.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.197 1.399 . . . . 17.15 110.187 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -111.49 154.86 24.12 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.78 -1.563 . . . . 16.03 106.78 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.8 117.94 63.88 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 107.577 -1.268 . . . . 14.35 107.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.57 107.89 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.921 3.081 . . . . 14.18 113.033 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 130' ' ' ARG . . . 125.46 -36.31 2.82 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.505 -1.225 . . . . 14.05 111.651 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -86.31 42.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.38 1.086 . . . . 16.88 109.366 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 127' ' ' GLY . 3.5 pp -137.65 -7.07 1.69 Allowed 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.584 -1.644 . . . . 12.55 111.199 -178.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 127' ' ' GLY . 38.5 ptt180 -95.91 -5.95 40.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.94 -0.573 . . . . 14.87 110.081 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -70.22 -33.95 72.29 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 14.56 108.797 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.41 -62.67 0.95 Allowed Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 108.84 -1.704 . . . . 14.2 108.84 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 60.07 26.81 16.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.367 1.067 . . . . 13.0 110.992 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -97.68 139.89 32.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.308 -1.315 . . . . 17.02 109.662 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 14.5 p90 -70.19 -12.88 61.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.276 -0.875 . . . . 13.62 109.43 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.65 -32.12 62.16 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.272 -0.876 . . . . 16.54 110.342 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.17 -42.39 6.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.429 0.633 . . . . 15.87 110.852 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.5 mt -79.66 -22.35 43.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.589 -0.732 . . . . 13.65 110.465 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -102.72 43.79 1.62 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.954 -1.259 . . . . 14.16 109.954 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.7 ttp -60.29 -43.41 96.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.655 0.782 . . . . 15.81 110.551 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -127.34 120.21 28.02 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 107.479 -1.304 . . . . 13.63 107.479 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -62.06 -39.33 92.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.877 -1.056 . . . . 14.06 111.972 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.7 t -68.76 -36.83 76.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 110.146 -0.316 . . . . 14.08 110.146 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.5 m -56.9 -46.61 81.8 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.194 -0.457 . . . . 11.82 109.776 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.96 -22.52 76.67 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 119.677 -1.249 . . . . 10.82 111.87 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 92.5 m -63.81 -48.89 75.05 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.64 -0.504 . . . . 12.55 109.64 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -59.6 -40.24 86.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.57 0.7 . . . . 12.17 110.227 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.4 ' O ' HG22 ' A' ' 152' ' ' VAL . 22.4 t90 -68.5 -53.03 25.89 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.927 -1.033 . . . . 9.45 112.318 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.412 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 32.7 ttm -65.96 -35.06 79.56 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 111.915 0.339 . . . . 9.88 111.915 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -66.4 -35.95 81.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.528 . . . . 14.43 109.576 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.06 -43.54 97.14 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.628 -0.989 . . . . 10.49 110.628 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 148' ' ' TRP . 75.9 t -56.55 -45.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.607 0.763 . . . . 9.27 109.253 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.2 m -59.51 -40.15 86.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.377 -0.828 . . . . 11.46 110.994 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -70.72 -46.96 62.1 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.478 -0.328 . . . . 15.5 111.591 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -68.22 -30.61 69.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.293 0.849 . . . . 12.39 113.293 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -101.56 0.16 35.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.075 -0.65 . . . . 11.97 112.123 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.8 m 56.42 45.94 21.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.638 -1.164 . . . . 14.37 112.308 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.5 156.15 41.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 13.16 109.047 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -88.8 106.58 18.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.221 -1.029 . . . . 16.91 108.221 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.41 110.3 11.38 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.782 -0.451 . . . . 12.32 109.782 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.28 135.92 47.67 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.944 -0.571 . . . . 14.37 110.469 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.46 -8.61 9.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.416 1.086 . . . . 13.15 112.834 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -77.42 -10.75 59.65 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.386 -0.598 . . . . 15.68 109.386 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -63.7 -13.13 40.35 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 116.102 -0.499 . . . . 13.1 112.256 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.8 pt -68.64 -12.32 15.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 121.166 0.508 . . . . 12.16 109.937 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.59 19.32 13.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.548 -0.908 . . . . 15.41 108.548 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 88.8 m -108.24 -26.55 10.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.187 -0.915 . . . . 15.07 109.679 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -122.75 143.67 40.76 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 107.978 -1.119 . . . . 12.68 107.978 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.566 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 68.8 Cg_endo -93.02 -5.73 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.902 1.735 . . . . 15.04 111.897 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.756 -0.656 . . . . 13.26 111.134 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.94 -32.92 71.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.904 -1.043 . . . . 10.32 111.988 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -62.71 -20.36 64.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.172 -0.467 . . . . 12.75 111.187 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.8 m -70.88 -17.65 62.71 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.102 -0.499 . . . . 11.26 111.024 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.72 -44.94 61.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.892 -1.151 . . . . 8.53 107.892 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.02 80.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.471 -0.786 . . . . 7.7 111.39 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.99 -19.75 60.55 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.318 0.488 . . . . 10.38 112.318 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -74.75 -52.61 11.05 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.331 -0.618 . . . . 11.97 109.331 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 110' ' ' ILE . 3.3 p -62.46 -42.64 96.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.578 -0.737 . . . . 9.8 110.497 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.43 -41.87 90.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.401 . . . . 10.83 110.655 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -69.07 -53.24 21.43 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.74 0.816 . . . . 13.85 113.071 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -85.01 -32.47 22.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 115.187 1.551 . . . . 15.46 115.187 -173.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.87 -40.75 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.817 -0.753 . . . . 13.35 110.213 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 120.44 -0.504 . . . . 13.51 110.255 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 121.215 0.531 . . . . 18.78 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.87 97.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.015 0.436 . . . . 16.95 112.148 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.98 -23.8 67.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.851 -0.613 . . . . 15.46 111.686 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -98.49 -19.57 17.58 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.921 -0.712 . . . . 14.98 110.008 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.501 ' HA ' HE21 ' A' ' 8' ' ' GLN . 42.9 tt0 -65.92 -37.85 87.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 120.842 0.353 . . . . 15.79 111.295 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 p -63.82 -32.15 73.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.069 0.461 . . . . 12.18 111.016 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -75.14 -40.85 59.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.254 -0.43 . . . . 11.02 109.843 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.501 HE21 ' HA ' ' A' ' 5' ' ' GLU . 50.8 mt-30 -54.47 -43.91 72.13 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.8 0.44 . . . . 16.75 110.616 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.1 -41.41 78.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.771 -0.649 . . . . 14.46 111.006 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.32 -36.29 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.365 -0.38 . . . . 10.71 110.753 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 68.0 mtt180 -60.57 -45.64 93.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.763 -0.829 . . . . 14.51 108.763 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 27.9 mt-30 -59.92 -53.83 53.22 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.558 -0.747 . . . . 16.85 110.244 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 m -56.71 -42.85 79.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.123 -0.944 . . . . 13.52 112.681 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.83 -52.15 22.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.455 0.169 . . . . 12.77 110.687 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.71 71.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.39 0.515 . . . . 15.19 112.39 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.32 84.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.656 0.265 . . . . 16.26 111.544 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.3 mtt -75.81 -32.24 59.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.291 0.567 . . . . 15.45 110.893 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.62 -2.36 41.74 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.877 -0.601 . . . . 16.16 112.199 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 57.54 44.05 21.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.548 1.139 . . . . 20.58 111.589 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.57 177.0 4.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.134 -1.061 . . . . 17.26 108.134 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -96.76 133.72 24.09 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 110.47 -0.196 . . . . 20.19 110.47 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.77 20.66 1.19 Allowed 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 122.89 2.394 . . . . 17.46 111.484 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.16 -104.45 1.2 Allowed Glycine 0 N--CA 1.428 -1.89 0 CA-C-N 114.899 -1.046 . . . . 18.33 113.245 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.42 67.63 9.97 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.299 0.852 . . . . 20.77 113.299 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 pt -90.65 163.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.266 -1.012 . . . . 16.1 108.266 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.511 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 62.0 mtm180 -81.33 132.54 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.382 0.611 . . . . 19.87 109.569 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.01 -39.15 59.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.245 1.818 . . . . 15.1 112.475 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.32 7.48 66.46 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.8 -0.636 . . . . 15.48 114.182 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 74.8 m -68.2 119.16 12.32 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.815 0.817 . . . . 14.88 112.302 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 89.6 mtt180 -70.53 157.92 37.03 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.911 -1.495 . . . . 17.38 110.562 176.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -52.27 -48.6 65.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.951 0.405 . . . . 11.99 111.648 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.27 -41.31 84.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.534 0.734 . . . . 14.71 110.584 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.66 -45.14 84.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.854 -0.612 . . . . 16.44 110.463 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.4 -35.58 74.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.984 -0.553 . . . . 13.83 110.925 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.73 22.06 1.33 Allowed Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.194 -1.003 . . . . 14.3 112.983 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 167.18 20.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.533 0.682 . . . . 13.04 110.681 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -131.41 152.24 50.83 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 117.403 -1.284 . . . . 15.67 107.57 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -55.98 -40.32 73.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 119.495 1.043 . . . . 15.49 111.923 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.21 -51.11 51.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.732 -0.667 . . . . 16.98 110.405 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.64 -35.6 73.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.923 -0.581 . . . . 14.44 112.226 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.97 -30.09 70.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 12.4 110.336 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.47 78.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.512 -0.767 . . . . 14.37 110.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.54 -43.22 66.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 120.473 -0.491 . . . . 16.05 109.762 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -55.76 -54.67 41.62 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.605 -1.18 . . . . 11.7 110.823 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -31.69 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.804 0.335 . . . . 11.48 110.882 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.53 -35.25 75.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.386 0.612 . . . . 17.18 109.509 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -70.21 -21.79 62.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.018 -0.537 . . . . 14.15 112.169 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.9 -46.21 92.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.6 -0.889 . . . . 10.8 108.6 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -62.58 -34.59 77.28 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.321 -0.854 . . . . 12.98 110.952 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -79.12 -39.88 32.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.289 -0.414 . . . . 17.81 110.957 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -79.46 -28.09 41.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.404 -0.362 . . . . 15.55 111.962 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -107.88 -4.84 17.61 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.439 1.274 . . . . 12.2 114.439 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 44.32 47.64 7.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.863 1.665 . . . . 17.4 112.854 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.0 tp -145.33 151.8 38.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.901 -1.148 . . . . 12.25 107.901 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.86 129.41 34.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.911 -0.774 . . . . 16.32 108.911 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.97 153.52 71.12 Favored Pre-proline 0 N--CA 1.42 -1.957 0 C-N-CA 122.76 0.424 . . . . 11.39 110.14 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.18 96.35 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.954 1.769 . . . . 13.44 110.983 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.77 66.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.454 0.645 . . . . 12.81 109.849 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.08 -7.99 14.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 114.632 -1.167 . . . . 14.14 111.735 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.7 -35.49 89.87 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 116.017 -0.538 . . . . 10.76 112.184 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD12 HG22 ' A' ' 61' ' ' ILE . 39.3 mt -73.68 -28.6 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.973 0.892 . . . . 11.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -85.24 -3.09 58.7 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.184 -0.916 . . . . 16.59 112.197 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -111.04 -73.23 0.69 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 116.356 -0.384 . . . . 13.72 110.705 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -136.82 88.51 18.56 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 122.199 1.0 . . . . 12.25 110.106 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.1 Cg_endo -80.91 62.41 8.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.828 3.019 . . . . 13.57 114.063 -172.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.71 129.56 43.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.709 -1.96 . . . . 13.28 105.709 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.37 -37.82 74.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.353 -0.385 . . . . 11.45 111.723 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.33 -31.94 72.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.458 0.647 . . . . 14.64 110.215 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.2 45.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.461 0.648 . . . . 11.34 109.5 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 73' ' ' TRP . 58.1 t80 -72.44 -32.65 66.48 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.499 -0.773 . . . . 9.05 111.364 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -65.2 -23.78 67.18 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.008 -0.677 . . . . 9.65 111.017 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -78.13 -33.73 50.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.23 -0.655 . . . . 12.14 109.23 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -50.2 -59.55 3.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.058 . . . . 11.26 110.411 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.58 -34.48 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 CA-C-N 115.742 -0.663 . . . . 8.3 110.666 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.43 -38.24 93.2 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 116.068 -0.514 . . . . 9.58 113.234 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -81.17 -20.46 41.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.226 0.536 . . . . 10.46 110.12 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 14.5 mm100 -76.8 -23.37 52.83 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.362 0.601 . . . . 10.43 109.906 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.24 61.53 6.88 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.129 0.966 . . . . 10.97 109.385 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -98.79 122.46 52.9 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 106.611 -1.626 . . . . 13.77 106.611 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.64 65.96 7.43 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.189 1.926 . . . . 12.28 113.109 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.0 m -77.65 72.84 4.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.389 1.09 . . . . 13.71 109.221 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -141.92 -51.75 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.555 -1.202 . . . . 13.27 107.932 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.14 -4.98 59.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.134 -0.939 . . . . 14.77 110.82 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -60.74 113.3 2.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 124.234 1.014 . . . . 15.24 111.121 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.43 60.49 0.61 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.185 -1.043 . . . . 14.58 108.185 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.18 123.94 89.33 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.877 -1.056 . . . . 12.98 110.181 -176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.24 110.11 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 13.66 112.287 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.3 77.27 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 121.842 0.829 . . . . 12.75 112.42 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 51.88 63.34 2.28 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.045 1.338 . . . . 13.85 110.683 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -67.64 -71.1 0.22 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.776 -0.647 . . . . 14.91 110.462 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -93.93 107.62 29.28 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 108.724 -0.843 . . . . 11.68 108.724 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.39 -21.01 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.764 1.642 . . . . 11.23 111.435 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.17 128.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 115.356 -0.838 . . . . 10.77 109.702 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.16 -7.31 6.52 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.818 -0.628 . . . . 10.76 110.49 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t 166.3 -29.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 105.142 -2.17 . . . . 11.26 105.142 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.88 166.61 17.49 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 103.147 -2.908 . . . . 11.01 103.147 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.66 42.44 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.057 2.505 . . . . 12.86 113.78 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -131.16 151.27 78.6 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 106.918 -1.512 . . . . 14.34 106.918 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.63 58.39 6.94 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.543 2.162 . . . . 12.35 112.775 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.7 110.67 0.45 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.655 -0.978 . . . . 11.89 110.655 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.67 -34.21 40.55 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.844 0.831 . . . . 11.88 109.957 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -85.16 65.6 9.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 122.408 1.099 . . . . 12.74 109.969 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.14 24.85 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.708 -1.59 . . . . 11.49 106.708 172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 p -98.67 85.88 3.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.776 -1.557 . . . . 10.09 108.256 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.61 -56.77 17.57 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.204 -0.907 . . . . 11.53 112.867 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 110' ' ' ILE . 31.3 mm-40 -59.04 -41.66 88.39 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.409 0.623 . . . . 11.91 110.562 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 37.3 ttt180 -66.24 -36.89 84.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.043 -0.981 . . . . 10.19 111.565 -176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.57 -34.51 70.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.877 -0.729 . . . . 10.43 110.851 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 m -62.28 -41.58 98.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.78 -0.822 . . . . 10.46 108.78 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 51.7 mt -56.68 -44.52 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.165 -0.925 . . . . 8.37 110.932 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 107' ' ' ARG . 15.1 mm100 -53.97 -30.74 48.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.45 0.7 . . . . 8.76 112.431 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -71.14 -46.75 60.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.468 0.652 . . . . 10.86 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 96.0 m-85 -74.79 -27.42 60.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.33 0.586 . . . . 11.62 110.258 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -66.03 -42.3 89.8 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.26 -1.015 . . . . 7.62 108.26 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -60.95 -42.18 97.73 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.001 -0.999 . . . . 11.84 109.78 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.89 -20.01 65.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 12.03 112.382 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.4 m -82.63 -46.02 13.79 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.22 -0.659 . . . . 9.2 109.22 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 59.9 tp -63.13 -41.76 99.38 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.554 0.692 . . . . 10.06 109.633 175.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.82 -49.66 76.16 Favored Glycine 0 C--O 1.2 -2.0 0 CA-C-N 114.935 -1.029 . . . . 12.07 112.454 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -63.48 -28.7 70.14 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.004 0.43 . . . . 12.38 111.094 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 118' ' ' LEU . 26.3 tp -61.3 -42.01 97.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.68 -0.691 . . . . 11.77 110.713 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.13 -76.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.128 -0.693 . . . . 13.52 109.128 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -173.7 -46.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.103 2.561 . . . . 17.15 106.662 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.5 tp -168.21 148.7 4.87 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.252 -2.129 . . . . 16.03 105.252 175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 0.9 OUTLIER -95.82 136.07 22.51 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.29 -1.374 . . . . 14.35 107.29 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 2.7 Cg_endo -86.54 29.86 0.5 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.239 1.959 . . . . 14.18 112.929 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.78 57.61 0.78 Allowed Glycine 0 C--N 1.309 -0.924 0 N-CA-C 110.376 -1.089 . . . . 14.05 110.376 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.58 -18.27 20.72 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.526 0.679 . . . . 16.88 110.689 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.8 113.97 5.99 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.097 -0.956 . . . . 12.55 110.538 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 75.84 10.26 3.3 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.261 . . . . 14.87 112.247 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.3 m -103.66 25.89 9.21 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.68 0.752 . . . . 14.56 110.019 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.39 88.78 1.98 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.68 -0.771 . . . . 14.2 111.99 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.58 95.58 4.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.946 -0.761 . . . . 13.0 108.946 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -118.37 146.69 44.2 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.658 0.742 . . . . 17.02 111.305 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -62.14 -14.63 39.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.819 1.248 . . . . 13.62 112.396 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -69.15 -33.1 72.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.372 0.606 . . . . 16.54 109.905 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.51 -44.74 5.77 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.416 -0.811 . . . . 15.87 110.372 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.06 -23.21 64.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.993 -0.549 . . . . 13.65 111.2 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.06 16.15 30.43 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.557 -0.747 . . . . 14.16 111.626 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.7 ttm -77.85 -24.09 48.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.74 -1.207 . . . . 15.81 107.74 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.08 139.91 52.25 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.669 -1.975 . . . . 13.63 105.669 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.9 m -80.78 -22.73 39.87 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.435 -0.95 . . . . 14.06 108.435 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.878 1.271 . . . . 14.08 111.976 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.37 88.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.882 -0.599 . . . . 11.82 111.572 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.8 44.26 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.782 -0.723 . . . . 10.82 111.354 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.6 m -53.28 -50.87 63.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.346 0.658 . . . . 12.55 110.938 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -76.49 -34.37 58.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.404 0.89 . . . . 12.17 113.404 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -69.9 -52.42 24.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.398 -0.521 . . . . 9.45 109.614 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 165' ' ' ILE . 33.1 ttm -69.66 -31.62 69.8 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.345 0.498 . . . . 9.88 112.345 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -64.57 -35.0 79.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.45 -0.574 . . . . 14.43 109.45 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.71 85.79 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.218 -1.153 . . . . 10.49 110.218 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.05 -49.76 80.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 123.748 0.819 . . . . 9.27 110.036 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.3 t -55.98 -49.55 73.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.813 0.845 . . . . 11.46 110.681 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -66.04 -49.6 67.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.754 0.279 . . . . 15.5 111.754 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -63.06 -34.59 77.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.302 0.853 . . . . 12.39 113.302 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 113' ' ' TYR . 88.5 m-85 -101.06 -3.76 28.67 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.952 0.723 . . . . 11.97 112.952 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t 63.63 34.41 12.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.826 0.85 . . . . 14.37 109.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.5 pt -107.47 155.66 8.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.635 -0.711 . . . . 13.16 109.492 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -99.42 96.75 7.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.791 0.329 . . . . 16.91 111.87 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -124.73 118.59 26.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -108.0 168.4 9.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.423 0.63 . . . . 14.37 111.154 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.13 -6.78 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.505 1.522 . . . . 13.15 114.751 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.91 -23.46 17.43 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.516 -0.474 . . . . 15.68 109.948 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.27 0.52 31.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.786 0.803 . . . . 13.1 109.473 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.489 ' HA ' ' SD ' ' A' ' 149' ' ' MET . 5.9 tt -75.11 -14.41 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.899 -1.046 . . . . 12.16 110.46 -172.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -106.4 6.37 30.32 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.224 -0.898 . . . . 15.41 109.46 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.2 m -87.09 -32.11 20.11 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.796 -0.638 . . . . 15.07 110.092 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.45 74.19 77.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.22 -0.659 . . . . 12.68 109.22 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -94.4 37.22 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.837 2.358 . . . . 15.04 112.115 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 p -140.77 163.2 33.56 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 13.26 109.788 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 49.2 tp -67.21 -55.38 14.3 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.916 0.389 . . . . 10.32 110.518 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -61.27 -44.56 97.03 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.409 -0.814 . . . . 12.75 112.856 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -68.24 -30.66 69.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.754 0.252 . . . . 11.26 110.696 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.59 -45.83 61.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.438 -1.319 . . . . 8.53 107.438 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.87 99.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.605 -0.725 . . . . 7.7 111.243 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 7.0 m-20 -62.94 -33.63 75.76 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.68 0.276 . . . . 10.38 110.679 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 24.7 tp10 -69.22 -57.05 5.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.973 -0.558 . . . . 11.97 110.528 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.93 -36.67 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.136 -0.483 . . . . 9.8 111.518 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.93 -38.36 82.16 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.1 0.476 . . . . 10.83 111.19 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 26.6 mmm180 -77.87 -33.26 52.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 13.85 111.481 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 9.7 mmp_? -73.25 -44.5 59.31 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.745 -0.382 . . . . 15.46 111.555 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.18 -51.73 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.22 0.325 . . . . 13.35 111.761 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.395 -0.812 . . . . 13.51 111.284 -177.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 9.6 p . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 108.336 -0.987 . . . . 18.78 108.336 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . -108.85 -23.63 11.65 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.427 0.528 . . . . 16.95 112.427 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.99 -38.85 12.56 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.758 -0.589 . . . . 15.46 110.882 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -94.46 0.58 55.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.016 -0.538 . . . . 14.98 109.932 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 1' ' ' VAL . 8.6 pt-20 -52.09 -35.44 47.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.901 0.704 . . . . 15.79 112.901 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.74 -43.27 99.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.138 0.495 . . . . 12.18 111.046 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.55 81.78 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.099 -0.501 . . . . 11.02 109.872 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -55.58 -52.31 64.2 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.542 0.526 . . . . 16.75 110.094 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -60.48 -45.72 92.73 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.176 -0.92 . . . . 14.46 111.11 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.89 -36.96 78.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.227 -0.442 . . . . 10.71 111.245 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -62.5 -42.65 99.64 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.032 -0.729 . . . . 14.51 109.032 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.65 -49.62 62.0 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.354 -0.839 . . . . 16.85 110.987 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -62.21 -36.01 80.62 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.041 0.386 . . . . 13.52 112.041 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.47 -55.64 19.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.442 -0.947 . . . . 12.77 108.442 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.87 89.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.131 -0.94 . . . . 15.19 112.016 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.6 77.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.895 0.379 . . . . 16.26 111.479 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.486 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 66.1 mtt -73.76 -21.55 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.677 -0.238 . . . . 15.45 111.511 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.02 11.96 25.52 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.277 0.473 . . . . 16.16 112.277 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 60.84 40.78 15.41 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.419 1.104 . . . . 20.58 110.06 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 68.1 m -121.93 155.28 35.83 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.694 -0.854 . . . . 17.26 108.694 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.42 131.3 31.39 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.74 -0.467 . . . . 20.19 109.74 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.62 -21.5 62.87 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.918 3.079 . . . . 17.46 116.006 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.39 -6.2 84.15 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 119.939 -1.124 . . . . 18.33 111.967 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.96 21.84 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.223 0.535 . . . . 20.77 110.785 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.3 153.4 7.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.79 -1.189 . . . . 16.1 107.79 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -108.22 124.98 51.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.401 0.619 . . . . 19.87 111.085 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -73.0 -21.47 60.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.715 -1.13 . . . . 15.1 111.459 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.92 5.29 79.06 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.303 -0.951 . . . . 15.48 112.906 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -91.68 157.29 17.03 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.521 0.677 . . . . 14.88 110.405 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 22.0 mtp180 -82.49 146.87 29.01 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.988 -1.006 . . . . 17.38 111.347 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -54.64 -43.54 72.39 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 118.52 0.6 . . . . 11.99 112.416 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.11 -31.21 72.3 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.017 -0.538 . . . . 14.71 110.942 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.63 -30.06 46.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.581 0.705 . . . . 16.44 109.266 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.0 -28.92 63.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.675 -0.693 . . . . 13.83 110.572 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.03 4.4 7.87 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.333 -0.937 . . . . 14.3 112.773 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 41' ' ' ALA . 7.3 tt -81.93 131.16 35.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.976 0.417 . . . . 13.04 110.084 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.11 166.42 12.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 117.959 -1.019 . . . . 15.67 109.344 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -55.92 -41.53 74.73 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 119.166 0.894 . . . . 15.49 110.949 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.01 -44.98 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.632 -0.713 . . . . 16.98 110.4 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.14 -38.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.935 -0.575 . . . . 14.44 109.946 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 36' ' ' LEU . . . -58.27 -46.31 86.25 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 123.372 0.669 . . . . 12.4 110.973 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.32 71.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.709 0.766 . . . . 14.37 111.251 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -78.43 -47.91 16.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.328 -0.851 . . . . 16.05 110.931 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 7.6 t90 -60.6 -48.81 80.12 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.323 1.449 . . . . 11.7 111.367 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 tp -62.34 -28.41 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.718 0.77 . . . . 11.48 110.519 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.36 -35.05 54.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.211 -0.904 . . . . 17.18 109.637 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -74.29 -31.88 62.67 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.164 -0.471 . . . . 14.15 111.678 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -69.77 -36.79 71.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.603 -0.839 . . . . 10.8 109.412 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' OD1' HG13 ' A' ' 56' ' ' ILE . 75.1 m-20 -66.73 -27.82 67.92 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.806 0.812 . . . . 12.98 110.417 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.06 -45.54 26.74 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.663 -1.153 . . . . 17.81 110.105 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -70.5 -39.25 74.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.837 0.31 . . . . 15.55 111.837 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.81 -3.9 55.55 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.909 1.077 . . . . 12.2 113.909 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 56.37 47.29 19.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.898 1.332 . . . . 17.4 108.791 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.0 tp -139.0 153.99 48.21 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.46 -1.311 . . . . 12.25 107.46 -173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -114.87 89.17 3.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.874 -0.787 . . . . 16.32 108.874 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.402 HG13 ' OD1' ' A' ' 49' ' ' ASN . 1.5 pp -76.55 147.9 79.22 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 122.243 -0.286 . . . . 11.39 111.717 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -62.65 122.39 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.637 2.225 . . . . 13.44 110.285 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.65 2.34 4.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.798 1.407 . . . . 12.81 114.798 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.43 5.14 46.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.937 -0.477 . . . . 14.14 110.78 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.63 -66.97 2.47 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.088 -0.505 . . . . 10.76 113.871 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.79 -28.08 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 124.436 1.094 . . . . 11.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -75.66 -39.12 58.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.416 -0.811 . . . . 16.59 110.469 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 92.5 m -82.8 -44.0 16.04 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.012 -0.54 . . . . 13.72 110.954 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -113.74 88.36 13.78 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 123.756 0.822 . . . . 12.25 109.093 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.4 Cg_endo -83.56 25.78 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.938 2.425 . . . . 13.57 113.128 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.13 123.69 59.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.614 -1.624 . . . . 13.28 106.614 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.49 -41.32 76.45 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.15 0.98 . . . . 11.45 112.524 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.25 -30.52 71.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.366 0.603 . . . . 14.64 111.081 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.99 -25.01 30.33 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.988 0.423 . . . . 11.34 110.095 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 49.4 t80 -82.58 -31.45 28.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.928 -0.578 . . . . 9.05 110.89 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 p -68.33 -36.97 80.06 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.627 -0.879 . . . . 9.65 108.627 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.6 -41.99 98.28 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.826 -1.079 . . . . 12.14 109.489 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.473 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 63.7 t90 -52.68 -56.01 18.56 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.969 1.308 . . . . 11.26 109.587 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.13 -42.33 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 C-N-CA 123.295 0.638 . . . . 8.3 110.675 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.66 -17.03 66.48 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.343 -0.39 . . . . 9.58 113.454 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.5 m -81.23 -30.12 34.27 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.194 -0.669 . . . . 10.46 109.194 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.85 -43.63 11.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.814 -0.63 . . . . 10.43 110.16 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.52 89.04 4.87 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.837 -0.62 . . . . 10.97 109.86 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -77.32 120.27 80.84 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.045 -0.98 . . . . 13.77 112.606 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.79 156.67 11.81 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.981 2.454 . . . . 12.28 109.559 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -93.37 100.85 13.1 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.207 -0.597 . . . . 13.71 111.495 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.46 137.94 41.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.821 -1.918 . . . . 13.27 105.821 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.03 65.13 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.142 1.377 . . . . 14.77 114.174 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 p -97.87 27.76 4.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.191 0.995 . . . . 15.24 111.374 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.27 42.34 2.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.746 -1.576 . . . . 14.58 106.746 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.03 135.72 96.43 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 114.138 -1.392 . . . . 12.98 109.917 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.09 137.36 81.52 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.477 2.785 . . . . 13.66 112.009 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t 66.62 99.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 124.951 1.3 . . . . 12.75 111.428 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.56 123.25 19.94 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.829 -0.623 . . . . 13.85 110.056 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -96.98 3.64 51.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.844 0.831 . . . . 14.91 109.654 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.89 114.42 52.26 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-N 114.534 -1.212 . . . . 11.68 108.235 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.68 154.73 39.58 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.586 2.191 . . . . 11.23 112.283 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.46 48.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.955 0.883 . . . . 10.77 110.452 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.95 62.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.353 -0.839 . . . . 10.76 111.016 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -81.42 -14.37 57.19 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.256 -0.429 . . . . 11.26 112.107 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.85 23.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 112.733 0.642 . . . . 11.01 112.733 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.22 15.86 1.11 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.002 1.802 . . . . 12.86 113.049 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.6 ' HA ' HE21 ' A' ' 98' ' ' GLN . 0.0 OUTLIER -101.45 111.83 64.29 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 109.59 -0.522 . . . . 14.34 109.59 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.37 112.49 2.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.482 2.121 . . . . 12.35 110.057 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.28 39.21 1.61 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.155 -0.778 . . . . 11.89 111.155 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.21 -12.42 40.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.648 0.261 . . . . 11.88 110.894 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -85.15 170.55 12.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.265 -0.425 . . . . 12.74 110.021 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -3.3 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.775 2.139 . . . . 11.49 116.775 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 22.0 m 78.56 92.57 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.903 1.281 . . . . 10.09 112.403 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.72 -26.41 50.04 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.994 -1.003 . . . . 11.53 111.382 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 8.2 tp-100 -63.9 -48.08 78.06 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.267 -1.383 . . . . 11.91 107.267 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 176' ' ' ASP . 31.9 ttm180 -51.9 -45.62 64.25 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 114.138 -1.392 . . . . 10.19 111.544 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 104' ' ' SER . 52.6 mt-10 -61.3 -44.08 97.82 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 111.905 0.335 . . . . 10.43 111.905 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -65.06 -46.57 80.65 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 120.792 0.329 . . . . 10.46 110.318 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.81 -43.2 96.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.696 -0.684 . . . . 8.37 111.468 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.71 -34.03 72.37 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.496 0.718 . . . . 8.76 111.34 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.73 -30.37 59.22 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.468 -0.493 . . . . 10.86 110.051 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -71.85 -45.92 59.75 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.307 -0.997 . . . . 11.62 108.307 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.84 -40.25 75.73 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.579 -1.192 . . . . 7.62 108.842 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -55.47 -48.73 74.06 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 124.343 1.057 . . . . 11.84 110.601 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -69.31 -38.76 78.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.391 0.615 . . . . 12.03 110.455 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -63.67 -40.45 96.86 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.337 -0.847 . . . . 9.2 110.054 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.11 -38.93 66.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.997 -0.547 . . . . 10.06 109.92 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.93 -27.07 66.36 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-N 115.705 -0.68 . . . . 12.07 112.844 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.23 -29.13 70.24 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.341 0.591 . . . . 12.38 110.041 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.82 -28.93 17.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.988 -0.551 . . . . 11.77 111.067 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.73 -30.14 24.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.91 0.386 . . . . 13.52 110.901 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 74.78 -38.89 0.4 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.545 1.538 . . . . 17.15 111.621 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.23 137.19 52.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.505 -0.924 . . . . 16.03 108.505 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.43 134.77 54.32 Favored Pre-proline 0 CA--C 1.479 -1.755 0 O-C-N 123.688 0.618 . . . . 14.35 109.666 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.35 -26.16 81.21 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.685 2.256 . . . . 14.18 109.911 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.94 -45.96 1.53 Allowed Glycine 0 CA--C 1.493 -1.334 0 CA-C-N 115.175 -0.92 . . . . 14.05 111.84 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -110.31 -48.64 3.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.396 . . . . 16.88 110.324 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp 63.93 -173.08 0.17 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.311 1.044 . . . . 12.55 110.97 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 72.56 -49.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 14.87 111.352 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 m -90.1 114.61 26.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.013 -1.477 . . . . 14.56 107.013 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.18 51.02 3.27 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 108.736 -1.745 . . . . 14.2 108.736 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.02 18.23 17.8 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.081 -0.559 . . . . 13.0 111.334 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.99 83.55 3.68 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.124 -1.065 . . . . 17.02 108.124 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -80.32 -7.12 58.92 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.652 0.739 . . . . 13.62 110.182 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.0 mt -56.46 -24.91 48.78 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.931 1.292 . . . . 16.54 109.368 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.35 -6.13 52.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.944 -1.025 . . . . 15.87 111.799 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.71 9.24 12.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.374 0.607 . . . . 13.65 111.251 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.62 -97.2 2.22 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.944 -0.571 . . . . 14.16 112.562 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.2 ttm -82.05 66.63 7.71 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.945 1.355 . . . . 15.81 110.057 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -92.71 -46.87 7.36 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.819 -1.537 . . . . 13.63 111.996 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.594 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 4.4 m -60.94 -34.63 75.02 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.186 0.517 . . . . 14.06 111.902 -176.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.43 -52.75 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 14.08 110.568 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.2 t -72.14 -28.34 63.19 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 109.81 -0.441 . . . . 11.82 109.81 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.44 -28.77 73.94 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 116.066 -0.515 . . . . 10.82 111.832 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 93.8 m -61.36 -46.97 87.96 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.901 0.382 . . . . 12.55 110.624 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.82 -49.86 71.21 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.447 -0.797 . . . . 12.17 109.608 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.435 ' CZ3' HD13 ' A' ' 171' ' ' LEU . 79.1 t90 -57.76 -49.26 77.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.252 -0.886 . . . . 9.45 111.911 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.439 ' HA ' ' HE3' ' A' ' 149' ' ' MET . 0.7 OUTLIER -57.28 -47.75 80.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 123.378 0.671 . . . . 9.88 111.255 -176.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -69.68 -35.65 75.31 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.744 -0.382 . . . . 14.43 111.603 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.15 -47.58 79.65 Favored Glycine 0 C--O 1.244 0.756 0 C-N-CA 120.798 -0.715 . . . . 10.49 112.148 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.24 -41.17 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 111.839 0.311 . . . . 9.27 111.839 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 158' ' ' ILE . 36.1 p -62.82 -37.88 88.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 111.543 0.201 . . . . 11.46 111.543 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.51 -25.18 65.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 15.5 111.113 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -78.82 -31.54 45.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.919 0.39 . . . . 12.39 110.284 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -94.97 5.69 51.19 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.375 0.607 . . . . 11.97 110.761 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.4 m 57.62 41.04 26.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.901 1.281 . . . . 14.37 111.58 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 153' ' ' SER . 17.8 pt -131.11 156.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.703 -0.681 . . . . 13.16 109.517 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -102.12 108.63 20.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.291 -0.263 . . . . 16.91 110.291 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.87 124.96 42.03 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.612 -0.267 . . . . 12.32 110.804 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.48 143.54 28.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.772 -0.825 . . . . 14.37 108.772 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -70.84 -12.03 61.31 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.345 0.593 . . . . 13.15 112.134 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.51 -12.84 61.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.465 -0.789 . . . . 15.68 109.99 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.71 -15.83 63.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.435 -0.802 . . . . 13.1 112.334 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 162' ' ' ALA . 24.5 pt -71.75 -4.66 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.777 0.799 . . . . 12.16 110.605 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.594 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 38.3 m-85 -110.06 0.83 18.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.571 -0.74 . . . . 15.41 109.498 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.5 m -96.02 -23.27 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.802 -0.814 . . . . 15.07 108.802 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -124.53 138.33 30.93 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.264 -1.013 . . . . 12.68 108.264 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.68 -15.06 27.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.86 2.374 . . . . 15.04 112.389 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.1 p -137.39 143.77 42.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.003 -0.74 . . . . 13.26 109.003 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.435 HD13 ' CZ3' ' A' ' 148' ' ' TRP . 32.4 tp -69.22 -25.16 64.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 10.32 110.979 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.37 -19.64 62.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 12.75 111.634 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.587 ' HA ' ' OD2' ' A' ' 176' ' ' ASP . 16.7 m -71.1 -12.09 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.044 -0.525 . . . . 11.26 112.137 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -64.86 -42.15 95.1 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.298 -1.001 . . . . 8.53 108.298 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 178' ' ' VAL . . . -65.68 -23.42 66.77 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.475 -0.784 . . . . 7.7 110.979 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 173' ' ' SER . 63.4 m-20 -79.39 -25.84 42.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.971 0.415 . . . . 10.38 111.165 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.36 -33.37 16.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.53 0.681 . . . . 11.97 109.463 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 175' ' ' ALA . 7.2 p -53.66 -34.15 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 114.746 1.387 . . . . 9.8 114.746 -170.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 106' ' ' GLN . 7.9 m-20 -57.85 -50.46 73.22 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.217 0.532 . . . . 10.83 109.799 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -71.95 -24.53 61.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.356 -0.838 . . . . 13.85 111.334 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -84.75 -46.26 11.58 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.082 -0.508 . . . . 15.46 111.199 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.67 -41.17 19.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 112.348 0.499 . . . . 13.35 112.348 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 119.156 -0.45 . . . . 13.51 109.812 -179.055 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.752 -0.833 . . . . 18.78 108.752 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.12 -174.5 3.29 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 105.302 -2.11 . . . . 16.95 105.302 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.001 0.905 . . . . 15.46 109.818 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.17 31.81 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.38 -1.282 . . . . 14.98 110.948 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -28.79 70.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.884 -0.598 . . . . 15.79 110.479 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 31.6 m -61.5 -53.7 53.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.305 -0.862 . . . . 12.18 109.877 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.28 -43.08 92.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.286 -0.416 . . . . 11.02 111.3 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -57.12 -50.79 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.405 0.441 . . . . 16.75 111.689 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -63.86 -39.2 93.64 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.956 0.407 . . . . 14.46 111.221 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 88.7 mt -68.02 -40.88 82.84 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.218 -0.447 . . . . 10.71 111.167 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -67.39 -40.22 85.65 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.796 -0.446 . . . . 14.51 109.796 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.78 -54.79 42.2 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.051 0.94 . . . . 16.85 111.506 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 p -65.3 -44.42 87.99 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.994 -0.548 . . . . 13.52 111.951 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.07 -44.63 91.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.934 -0.575 . . . . 12.77 110.815 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.58 97.42 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.562 -0.29 . . . . 15.19 110.698 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.23 -49.08 79.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.96 0.41 . . . . 16.26 111.175 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 ptp -68.6 -26.74 65.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.487 0.551 . . . . 15.45 112.487 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.73 6.5 48.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.795 0.331 . . . . 16.16 111.661 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 59.92 43.13 15.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.403 1.081 . . . . 20.58 111.051 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.1 m -129.94 171.82 12.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 17.26 109.698 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -108.37 135.27 19.99 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.802 -0.814 . . . . 20.19 108.802 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.69 -11.87 33.58 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.007 2.472 . . . . 17.46 112.934 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.22 -14.24 60.68 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.626 -0.59 . . . . 18.33 111.626 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -96.78 -43.78 7.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.123 -0.633 . . . . 20.77 112.138 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.96 138.5 21.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 119.469 -0.892 . . . . 16.1 109.567 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.483 ' HG2' ' OG ' ' A' ' 29' ' ' SER . 4.8 ptm180 -95.1 163.57 13.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.822 0.82 . . . . 19.87 112.785 -165.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.38 -10.88 27.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.564 1.546 . . . . 15.1 111.499 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.57 6.37 29.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.689 -0.687 . . . . 15.48 113.04 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.483 ' OG ' ' HG2' ' A' ' 26' ' ' ARG . 71.4 m -70.64 119.01 14.16 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.928 0.864 . . . . 14.88 111.793 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -87.97 149.3 24.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.543 -0.753 . . . . 17.38 111.375 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -48.37 -42.29 31.21 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.245 0.618 . . . . 11.99 112.402 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.33 -37.89 68.02 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.676 -1.147 . . . . 14.71 111.748 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.22 -7.51 41.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.076 0.465 . . . . 16.44 111.427 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.07 -16.77 34.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.434 0.635 . . . . 13.83 110.309 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.39 27.72 47.02 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.269 -0.878 . . . . 14.3 111.592 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.83 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.955 -1.128 . . . . 13.04 107.955 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' OD2' HG21 ' A' ' 39' ' ' VAL . 18.1 t70 -129.87 168.02 17.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 117.866 -1.064 . . . . 15.67 108.548 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 t -56.57 -44.56 81.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.745 0.702 . . . . 15.49 109.981 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG21 ' OD2' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -58.15 -55.2 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.61 0.719 . . . . 16.98 112.311 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.78 -45.91 87.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.394 -1.275 . . . . 14.44 110.546 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.95 91.56 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.845 -0.616 . . . . 12.4 110.847 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.64 78.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.399 0.68 . . . . 14.37 111.479 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.21 -47.36 65.02 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.187 0.518 . . . . 16.05 111.126 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -64.48 -49.15 72.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.723 1.209 . . . . 11.7 112.338 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.41 -36.93 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.063 0.459 . . . . 11.48 110.503 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -73.64 -26.16 60.64 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.292 -0.413 . . . . 17.18 111.92 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -69.62 -36.69 76.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.937 -1.134 . . . . 14.15 107.937 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.42 -49.58 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.116 -0.947 . . . . 10.8 109.348 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.409 HD22 ' CD1' ' A' ' 56' ' ' ILE . 19.1 m120 -59.84 -37.54 79.54 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.369 0.604 . . . . 12.98 111.153 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -67.29 -58.66 4.41 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.63 1.572 . . . . 17.81 111.665 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -85.35 -27.57 25.78 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.796 -0.762 . . . . 15.55 112.869 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -94.36 -0.93 54.55 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.577 -0.849 . . . . 12.2 112.857 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 44.29 43.56 6.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.056 1.342 . . . . 17.4 112.42 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -117.75 125.83 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.124 -0.943 . . . . 12.25 109.124 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -87.73 96.4 10.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.536 0.522 . . . . 16.32 110.063 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' CD1' HD22 ' A' ' 49' ' ' ASN . 2.4 pp -124.88 153.66 70.82 Favored Pre-proline 0 N--CA 1.426 -1.635 0 O-C-N 121.992 -0.442 . . . . 11.39 110.179 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.43 127.28 17.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.123 1.882 . . . . 13.44 109.867 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.85 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.956 0.903 . . . . 12.81 112.522 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -85.91 -5.47 59.23 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.97 0.414 . . . . 14.14 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.1 -13.17 64.08 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.918 -0.583 . . . . 10.76 112.716 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 tt -58.63 -29.61 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 C-N-CA 123.433 0.693 . . . . 11.0 110.865 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.39 0.8 35.78 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.666 0.617 . . . . 16.59 112.666 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -71.83 -25.89 62.16 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.993 0.901 . . . . 13.72 109.499 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -123.16 100.26 39.68 Favored Pre-proline 0 C--O 1.209 -1.056 0 N-CA-C 106.496 -1.668 . . . . 12.25 106.496 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.14 -1.63 7.46 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.859 2.373 . . . . 13.57 113.819 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.45 120.23 64.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.502 -1.295 . . . . 13.28 107.502 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -54.25 -41.99 69.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.679 1.192 . . . . 11.45 113.067 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -74.1 -29.56 61.91 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.621 -0.263 . . . . 14.64 111.543 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.49 -29.58 46.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 11.34 110.598 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -56.39 -23.98 41.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.936 0.895 . . . . 9.05 113.369 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 p -56.25 -23.58 37.08 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 113.053 0.76 . . . . 9.65 113.053 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.516 ' O ' HG23 ' A' ' 76' ' ' THR . 54.5 tp60 -53.04 -35.88 59.95 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 123.672 0.608 . . . . 12.14 110.332 176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -52.79 -58.76 5.81 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 123.724 0.64 . . . . 11.26 111.402 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.7 t -68.23 -45.8 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 CA-C-N 115.282 -0.872 . . . . 8.3 110.394 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.77 -46.88 81.62 Favored Glycine 0 CA--C 1.518 0.262 0 O-C-N 123.744 0.652 . . . . 9.58 113.543 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' GLN . 14.5 t -79.79 -16.81 54.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 120.321 -0.551 . . . . 10.46 111.488 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -90.63 -13.65 33.92 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 119.708 -0.797 . . . . 10.43 111.593 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 96.8 mt -70.85 -46.76 62.11 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.367 -1.346 . . . . 10.97 107.367 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -160.55 132.08 4.02 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.747 -1.946 . . . . 13.77 105.747 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.59 -43.91 6.23 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 124.047 3.165 . . . . 12.28 113.058 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.4 p 50.02 64.52 1.75 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.861 1.264 . . . . 13.71 113.792 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -95.61 77.55 3.31 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.599 -0.889 . . . . 13.27 108.599 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 -12.28 29.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.794 -0.639 . . . . 14.77 110.077 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -82.2 80.26 8.46 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.845 0.831 . . . . 15.24 109.612 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 130.54 42.67 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.223 -0.898 . . . . 14.58 109.417 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.02 87.7 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.347 -0.983 . . . . 12.98 108.347 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.93 52.72 2.25 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.356 2.704 . . . . 13.66 112.462 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 p -157.94 113.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.28 -0.873 . . . . 12.75 109.145 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.72 14.33 14.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.039 -0.528 . . . . 13.85 111.902 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -155.51 176.74 12.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.06 -1.089 . . . . 14.91 108.06 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.04 135.49 24.62 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 107.464 -1.31 . . . . 11.68 107.464 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 111.04 0.69 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.987 1.791 . . . . 11.23 108.325 173.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t 69.42 79.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.563 -1.273 . . . . 10.77 107.563 -170.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.96 98.46 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.266 -0.879 . . . . 10.76 110.74 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 p -83.78 90.05 7.27 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.94 -0.573 . . . . 11.26 109.458 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.37 111.64 3.23 Favored Pre-proline 0 C--N 1.296 -1.724 0 CA-C-N 115.616 -0.72 . . . . 11.01 110.143 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.47 36.02 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.719 2.28 . . . . 12.86 111.96 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -118.4 116.55 35.22 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.729 -0.669 . . . . 14.34 109.237 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.6 110.72 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.227 2.618 . . . . 12.35 111.753 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.46 10.9 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.922 -0.656 . . . . 11.89 112.242 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -25.13 61.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.974 0.361 . . . . 11.88 111.974 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.69 -26.55 25.87 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 12.74 109.807 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -58.31 3.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.841 -0.618 . . . . 11.49 110.661 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.3 t -146.59 110.53 4.98 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.059 -0.719 . . . . 10.09 109.059 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -35.81 73.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.859 -1.064 . . . . 11.53 113.329 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -60.0 -25.78 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.117 0.414 . . . . 11.91 112.117 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -72.37 -48.54 40.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.919 0.39 . . . . 10.19 110.712 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -65.87 -28.18 68.77 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.524 0.678 . . . . 10.43 110.05 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -64.32 -29.58 70.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.155 -0.93 . . . . 10.46 111.646 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 110' ' ' ILE . 56.1 mt -81.28 -33.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.725 -0.843 . . . . 8.37 108.725 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.05 -53.82 53.8 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.759 -1.109 . . . . 8.76 109.985 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -68.38 -35.56 77.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.333 -0.547 . . . . 10.86 111.114 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.97 -46.57 88.99 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.249 0.343 . . . . 11.62 110.308 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.11 -49.71 76.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.959 -0.564 . . . . 7.62 110.31 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.88 -47.39 85.08 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.681 0.613 . . . . 11.84 111.002 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.81 -34.58 73.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 12.03 112.063 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 -28.97 67.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.824 0.345 . . . . 9.2 110.589 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.5 -44.71 67.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.756 -0.461 . . . . 10.06 109.756 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.36 98.13 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.297 -0.721 . . . . 12.07 111.297 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.35 -42.19 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.369 1.467 . . . . 12.38 110.535 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.63 -34.3 23.12 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.967 -1.015 . . . . 11.77 110.918 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 tp -73.18 -29.29 62.73 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.014 0.746 . . . . 13.52 113.014 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 66.1 13.08 8.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.03 0.932 . . . . 17.15 110.741 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.4 171.34 8.4 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.185 -1.783 . . . . 16.03 106.185 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.89 130.2 91.78 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 109.83 -0.433 . . . . 14.35 109.83 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -69.55 0.73 5.07 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.551 2.168 . . . . 14.18 112.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.87 7.23 57.27 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.402 -0.679 . . . . 14.05 111.402 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -75.3 -16.86 60.39 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.172 0.51 . . . . 16.88 110.372 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.6 165.31 18.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.584 0.707 . . . . 12.55 111.723 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -88.14 77.23 8.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.24 -0.891 . . . . 14.87 109.823 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m 70.91 -48.58 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.814 1.646 . . . . 14.56 111.395 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.12 0.06 OUTLIER Glycine 0 C--N 1.308 -0.99 0 N-CA-C 108.704 -1.758 . . . . 14.2 108.704 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -154.32 93.03 1.56 Allowed 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.499 -0.413 . . . . 13.0 111.902 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 136' ' ' LEU . 28.5 tt0 -168.86 132.35 1.4 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 109.632 -0.507 . . . . 17.02 109.632 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -81.35 -7.46 59.58 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.835 1.05 . . . . 13.62 113.835 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.424 ' H ' ' HG2' ' A' ' 134' ' ' GLN . 83.6 mt -80.15 -35.73 36.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 16.54 112.069 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -37.46 21.24 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.48 0.919 . . . . 15.87 113.48 -173.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.77 -17.54 6.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.243 1.571 . . . . 13.65 115.243 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.36 143.61 4.89 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.226 -0.988 . . . . 14.16 112.289 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -99.49 -7.27 26.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.032 0.444 . . . . 15.81 109.958 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -150.09 149.22 29.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.552 0.691 . . . . 13.63 110.858 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -51.45 -34.99 37.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.699 1.999 . . . . 14.06 114.284 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.3 t -57.5 -47.93 84.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 112.461 0.541 . . . . 14.08 112.461 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.6 p -67.35 -35.54 79.57 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.469 -0.332 . . . . 11.82 110.858 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.01 -47.04 56.88 Favored Glycine 0 C--O 1.219 -0.834 0 N-CA-C 111.285 -0.726 . . . . 10.82 111.285 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 85.9 m -58.25 -46.76 85.39 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.533 0.333 . . . . 12.55 111.009 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.32 -38.15 90.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.259 0.552 . . . . 12.17 111.14 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -67.59 -46.42 72.65 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.477 0.711 . . . . 9.45 110.251 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -49.59 71.2 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.669 0.388 . . . . 9.88 111.192 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 146' ' ' THR . 77.8 mtp180 -58.7 -40.99 85.26 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.641 0.588 . . . . 14.43 110.731 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.07 -44.67 96.94 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.93 -0.577 . . . . 10.49 112.657 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.03 -41.93 84.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-O 121.286 0.565 . . . . 9.27 109.522 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.6 t -59.0 -49.54 77.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.928 -1.033 . . . . 11.46 111.51 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -70.94 -20.87 62.41 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.914 0.388 . . . . 15.5 111.832 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.94 -51.21 7.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.432 -0.507 . . . . 12.39 110.472 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -94.03 -2.05 53.55 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.303 0.853 . . . . 11.97 113.303 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.2 m 62.79 38.99 11.25 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.956 0.884 . . . . 14.37 111.267 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.7 pt -113.66 158.57 13.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.769 -1.105 . . . . 13.16 109.063 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.3 106.04 18.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.728 -0.842 . . . . 16.91 108.728 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.2 mt -121.93 112.32 18.16 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.709 0.766 . . . . 12.32 111.76 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.57 152.06 43.28 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.825 -1.534 . . . . 14.37 108.921 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.87 -13.09 62.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.916 0.865 . . . . 13.15 109.989 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.97 -8.04 45.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.508 1.523 . . . . 15.68 111.804 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.717 ' HA ' ' CZ3' ' A' ' 168' ' ' TRP . . . -59.89 -0.61 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.959 1.837 . . . . 13.1 115.959 -173.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 33.2 pt -96.09 2.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 122.002 -0.436 . . . . 12.16 111.558 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -94.15 -76.18 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.813 1.042 . . . . 15.41 113.813 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -78.64 12.64 1.96 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.3 0.571 . . . . 15.07 111.238 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.717 ' CZ3' ' HA ' ' A' ' 164' ' ' ALA . 18.1 m-90 -120.12 90.68 44.88 Favored Pre-proline 0 N--CA 1.412 -2.363 0 N-CA-C 105.676 -1.972 . . . . 12.68 105.676 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.2 -28.42 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.456 2.104 . . . . 15.04 113.496 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 p -126.06 174.28 8.58 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.526 -0.546 . . . . 13.26 109.526 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.09 -22.09 49.5 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.096 0.951 . . . . 10.32 108.548 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -64.14 -34.42 78.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.807 -1.542 . . . . 12.75 110.477 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -62.23 -45.23 94.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.957 -0.565 . . . . 11.26 110.101 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -70.33 -39.67 74.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.167 -0.47 . . . . 8.53 110.14 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.03 71.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.121 0.486 . . . . 7.7 111.431 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.88 -30.11 40.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.022 0.439 . . . . 10.38 110.212 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -81.84 -37.35 27.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.955 -0.566 . . . . 11.97 112.314 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -56.28 -43.73 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.886 0.374 . . . . 9.8 111.203 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.35 -28.12 62.83 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 121.149 0.5 . . . . 10.83 110.729 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -68.41 -26.69 65.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.474 -0.936 . . . . 13.85 108.474 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -83.98 -48.63 9.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.923 -1.035 . . . . 15.46 110.0 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 86.6 t -70.06 -43.53 79.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 N-CA-C 112.511 0.56 . . . . 13.35 112.511 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.028 -0.73 . . . . 13.51 109.028 -176.529 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.556 1.196 0 N-CA-C 110.186 -0.302 . . . . 18.78 110.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.0 10.98 8.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.584 1.154 . . . . 16.95 113.414 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -102.02 22.45 13.08 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 116.477 -0.329 . . . . 15.46 111.092 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.535 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 30.1 t70 66.7 20.95 10.67 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.644 0.735 . . . . 14.98 110.045 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.04 -40.19 94.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.982 -0.554 . . . . 15.79 111.578 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 57.6 m -60.9 -43.88 97.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.009 -0.541 . . . . 12.18 110.872 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.93 92.83 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 110.09 -0.337 . . . . 11.02 110.09 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 24.7 mt-30 -57.77 -52.99 63.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.168 0.508 . . . . 16.75 110.696 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.98 -46.59 86.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.508 -0.769 . . . . 14.46 111.381 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.84 -35.46 80.74 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.756 0.65 . . . . 10.71 112.756 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtm-85 -62.91 -46.48 87.6 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 120.881 -0.328 . . . . 14.51 110.217 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.09 -41.21 95.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 16.85 110.983 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -58.31 -59.72 4.89 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.206 1.002 . . . . 13.52 111.592 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 17' ' ' MET . 42.3 tp -69.67 -41.63 75.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.471 . . . . 12.77 111.448 -175.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.285 0.476 . . . . 15.19 112.285 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.87 88.96 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.732 -0.387 . . . . 16.26 110.874 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 19.9 ptp -75.06 -31.12 61.19 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.268 -0.423 . . . . 15.45 111.76 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.37 -11.5 37.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.903 0.858 . . . . 16.16 110.934 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.2 t80 64.2 48.62 2.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.968 1.707 . . . . 20.58 109.886 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 21.3 p -119.84 174.82 6.21 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.374 -1.343 . . . . 17.26 107.374 176.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.33 129.91 35.54 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 112.121 0.415 . . . . 20.19 112.121 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.5 -18.91 33.22 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.414 2.742 . . . . 17.46 113.418 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.29 -36.34 7.6 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.318 -1.113 . . . . 18.33 110.318 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -87.45 70.95 9.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.022 -0.732 . . . . 20.77 109.022 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -140.74 151.79 20.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.943 -1.132 . . . . 16.1 107.943 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -114.4 131.33 56.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.804 -0.813 . . . . 19.87 108.804 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 9.3 p-10 -77.12 -21.89 53.54 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.701 0.401 . . . . 15.1 111.48 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.78 5.88 79.59 Favored Glycine 0 C--N 1.312 -0.8 0 N-CA-C 111.025 -0.83 . . . . 15.48 111.025 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -72.33 137.94 46.98 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.261 0.553 . . . . 14.88 109.724 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 49.3 mtp180 -82.55 142.85 31.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.692 -1.225 . . . . 17.38 107.692 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -57.19 -16.47 8.15 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.424 0.898 . . . . 11.99 113.424 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 mt -70.06 -34.6 73.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.972 -0.751 . . . . 14.71 108.972 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -77.42 -24.8 50.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.002 -0.999 . . . . 16.44 109.131 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.0 mt -74.69 -37.22 62.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.855 -0.794 . . . . 13.83 108.855 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.6 26.21 30.61 Favored Glycine 0 CA--C 1.493 -1.288 0 CA-C-N 115.124 -0.944 . . . . 14.3 114.488 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 ' H ' ' A' ' 36' ' ' LEU . 1.5 pt? -85.68 126.37 33.9 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.565 -0.854 . . . . 13.04 110.903 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.83 161.09 27.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.177 -0.919 . . . . 15.67 110.5 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.67 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 4.1 t -54.36 -36.59 64.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.191 0.451 . . . . 15.49 111.026 -175.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -54.54 -56.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.419 0.525 . . . . 16.98 112.419 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.35 -41.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.32 -0.855 . . . . 14.44 110.571 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.94 88.73 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.019 -0.537 . . . . 12.4 110.756 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.43 82.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.469 0.652 . . . . 14.37 110.697 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -67.39 -51.68 49.0 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.618 -0.719 . . . . 16.05 111.259 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -64.64 -45.16 88.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.165 0.986 . . . . 11.7 111.453 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' O ' HG12 ' A' ' 48' ' ' ILE . 10.5 tp -62.5 -35.38 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.5 . . . . 11.48 111.357 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -81.38 -20.27 40.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.732 -0.787 . . . . 17.18 111.546 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -78.36 -31.55 48.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.657 -0.817 . . . . 14.15 111.758 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 45' ' ' ILE . 22.5 pt -67.22 -31.39 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.473 -0.891 . . . . 10.8 108.715 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' ND2' HG13 ' A' ' 56' ' ' ILE . 11.0 m120 -62.14 -42.18 99.0 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 115.196 -0.911 . . . . 12.98 110.422 174.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.33 -47.37 17.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.664 -0.698 . . . . 17.81 110.452 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -66.74 -34.54 78.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.852 -0.613 . . . . 15.55 111.764 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.555 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 69.1 m-85 -101.55 -12.2 18.67 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.626 1.343 . . . . 12.2 114.626 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 57.94 45.85 17.53 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.132 0.968 . . . . 17.4 108.922 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.0 tp -123.37 149.15 45.3 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.879 -1.055 . . . . 12.25 110.719 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -99.64 109.46 21.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.381 -0.97 . . . . 16.32 108.381 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 ' ND2' ' A' ' 49' ' ' ASN . 2.5 pp -124.36 149.63 61.79 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 118.185 0.448 . . . . 11.39 110.765 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.12 105.01 1.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.703 1.602 . . . . 13.44 109.039 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.98 -24.72 25.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.062 1.345 . . . . 12.81 113.145 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.81 -3.26 30.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.428 -0.351 . . . . 14.14 111.453 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.18 -49.3 31.05 Favored Glycine 0 C--O 1.204 -1.756 0 O-C-N 123.656 0.597 . . . . 10.76 113.342 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.53 -31.01 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 11.0 112.209 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.67 ' HH ' ' HG ' ' A' ' 38' ' ' SER . 90.7 m-85 -89.7 -40.11 12.75 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.068 0.396 . . . . 16.59 112.068 -175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -80.36 -35.59 35.21 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.374 0.607 . . . . 13.72 110.457 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -121.64 76.7 36.85 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 124.185 0.994 . . . . 12.25 108.737 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.597 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 4.1 Cg_exo -81.09 37.8 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.165 2.576 . . . . 13.57 113.878 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.53 124.78 60.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.837 -1.542 . . . . 13.28 106.837 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -55.08 -40.36 70.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.167 0.987 . . . . 11.45 113.33 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.4 tttt -64.8 -42.14 95.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 14.64 110.287 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.82 81.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.685 -0.688 . . . . 11.34 110.576 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -71.38 -35.63 71.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.928 0.344 . . . . 9.05 111.928 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 p -65.32 -26.48 68.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.626 -0.83 . . . . 9.65 110.935 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 16.3 mm-40 -77.26 -39.45 48.21 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.022 -0.535 . . . . 12.14 110.051 172.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -62.58 -30.79 71.59 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.54 0.736 . . . . 11.26 111.918 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.75 -44.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.207 -0.664 . . . . 8.3 109.207 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.28 -27.03 73.43 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.417 -0.81 . . . . 9.58 113.991 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -72.9 -16.48 61.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.313 0.557 . . . . 10.46 110.991 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.21 -23.58 32.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.109 -0.701 . . . . 10.43 109.109 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.83 92.63 1.61 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.097 -0.956 . . . . 10.97 110.301 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -116.47 87.59 21.16 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 107.798 -1.186 . . . . 13.77 107.798 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.93 -22.77 26.28 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.105 2.537 . . . . 12.28 112.995 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -87.8 67.08 9.03 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.001 0.905 . . . . 13.71 109.806 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -88.09 -166.77 1.68 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.957 -1.019 . . . . 13.27 108.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.25 -50.06 43.58 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.648 -0.871 . . . . 14.77 108.648 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.2 m -86.44 76.19 9.66 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.284 -0.871 . . . . 15.24 109.459 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -136.38 72.28 1.43 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.473 -0.785 . . . . 14.58 109.45 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 88' ' ' VAL . . . -87.77 123.39 69.28 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.097 -0.501 . . . . 12.98 110.422 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.46 38.63 0.72 Allowed 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 123.005 2.47 . . . . 13.66 111.315 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 86' ' ' ALA . 12.3 p -149.5 17.35 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 122.625 1.202 . . . . 12.75 108.446 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 66.88 9.54 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.781 -1.192 . . . . 13.85 107.781 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -108.59 1.66 21.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.744 -1.116 . . . . 14.91 110.594 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.9 132.94 44.43 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 114.945 -1.025 . . . . 11.68 108.508 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -63.03 127.73 21.09 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.992 1.795 . . . . 11.23 109.633 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.36 136.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.598 -0.728 . . . . 10.77 111.472 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.9 -18.74 36.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.929 . . . . 10.76 108.973 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -86.79 146.58 26.18 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 114.959 -1.019 . . . . 11.26 109.502 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.81 92.16 46.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-O 120.484 0.183 . . . . 11.01 110.612 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.98 -25.29 52.06 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.721 2.28 . . . . 12.86 110.17 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -116.6 85.38 16.61 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 115.049 -0.978 . . . . 14.34 109.088 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -70.5 -12.4 31.43 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.662 2.242 . . . . 12.35 111.176 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.56 43.09 1.63 Allowed Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 110.403 -1.079 . . . . 11.89 110.403 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.58 -37.07 85.61 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.115 -0.698 . . . . 11.88 109.115 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.8 64.74 8.78 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.937 -1.135 . . . . 12.74 107.937 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.36 -61.76 1.5 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.341 0.591 . . . . 11.49 109.804 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 11.3 p -128.89 41.23 3.52 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.755 1.264 . . . . 10.09 108.0 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.84 -24.19 59.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.816 -1.538 . . . . 11.53 110.099 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -66.3 -45.68 79.52 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.822 -1.177 . . . . 11.91 107.822 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.491 ' HB3' ' O ' ' A' ' 104' ' ' SER . 48.0 ttp180 -51.99 -53.01 46.58 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 124.148 0.905 . . . . 10.19 110.219 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.53 -48.27 79.76 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.716 0.635 . . . . 10.43 111.843 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.2 t -60.63 -50.33 73.95 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 10.46 110.971 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.45 -39.54 84.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 CA-C-N 116.469 -0.332 . . . . 8.37 110.929 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -47.48 -42.19 22.27 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 124.742 1.217 . . . . 8.76 112.105 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.0 -29.82 66.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.022 0.439 . . . . 10.86 112.022 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.09 -36.76 16.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.283 0.563 . . . . 11.62 110.186 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.76 -37.36 86.14 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 108.224 -1.028 . . . . 7.62 108.224 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 126' ' ' PRO . 83.6 tttt -51.03 -44.66 61.08 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.248 1.419 . . . . 11.84 110.349 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.69 -44.98 80.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.453 -0.794 . . . . 12.03 110.379 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -66.81 -48.3 69.39 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.557 -0.747 . . . . 9.2 110.968 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 119' ' ' GLY . 4.4 pp -71.38 -34.62 70.58 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.43 0.157 . . . . 10.06 111.147 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.411 ' N ' HD11 ' A' ' 118' ' ' LEU . . . -65.41 -42.64 95.84 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.491 -0.644 . . . . 12.07 111.491 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.17 -44.72 96.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.919 0.866 . . . . 12.38 109.733 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.52 -45.77 78.4 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.509 -1.223 . . . . 11.77 110.956 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.0 tp -76.86 -19.06 57.93 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.518 -0.764 . . . . 13.52 111.073 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.1 t80 62.45 31.71 17.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.862 1.665 . . . . 17.15 109.738 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 125' ' ' ASP . 1.3 tm? -120.27 146.43 46.09 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 105.268 -2.123 . . . . 16.03 105.268 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 16.8 t70 -61.43 122.2 68.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.634 0.584 . . . . 14.35 110.308 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.473 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 15.2 Cg_exo -69.98 6.51 1.36 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.057 2.504 . . . . 14.18 114.787 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.89 1.26 55.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.186 -1.566 . . . . 14.05 109.186 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -125.01 36.8 4.53 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.801 1.286 . . . . 16.88 107.822 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.19 124.04 21.99 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.265 -1.334 . . . . 12.55 110.34 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -63.38 146.32 53.79 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.389 -0.967 . . . . 14.87 108.389 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.5 t -58.3 -61.89 2.24 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 118.765 0.711 . . . . 14.56 111.548 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.12 -57.17 2.71 Favored Glycine 0 C--O 1.247 0.942 0 N-CA-C 110.162 -1.175 . . . . 14.2 110.162 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 71.07 114.57 0.05 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.248 1.419 . . . . 13.0 112.578 176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.82 116.23 6.78 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.542 -0.754 . . . . 17.02 109.555 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.508 ' O ' HD23 ' A' ' 138' ' ' LEU . 17.1 t80 -56.59 -40.07 74.61 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 124.932 1.293 . . . . 13.62 110.961 -177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.0 -2.4 43.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.47 0.915 . . . . 16.54 113.47 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.2 -14.41 61.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.555 0.693 . . . . 15.87 109.993 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -64.77 -14.15 57.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.276 -0.875 . . . . 13.65 112.869 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.81 150.31 6.13 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.295 -0.722 . . . . 14.16 111.295 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.71 -31.49 65.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.806 -0.812 . . . . 15.81 108.806 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.82 125.46 27.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 114.729 -1.123 . . . . 13.63 109.048 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.848 ' HG ' ' HH ' ' A' ' 166' ' ' TYR . 20.3 m -62.72 -22.39 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.579 0.549 . . . . 14.06 110.296 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 61.8 t -58.02 -34.18 48.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.157 -0.929 . . . . 14.08 111.513 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.4 p -59.96 -44.27 94.52 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.445 0.641 . . . . 11.82 110.748 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -83.42 -35.53 16.98 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.231 -0.895 . . . . 10.82 113.006 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 143' ' ' VAL . 39.7 p -66.95 -30.19 70.25 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 117.506 0.653 . . . . 12.55 110.373 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -62.74 -47.64 82.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.676 0.791 . . . . 12.17 108.872 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.11 -42.83 99.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.605 -0.725 . . . . 9.45 110.497 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 24.4 mmt -61.76 -37.51 84.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.607 0.718 . . . . 9.88 109.915 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -69.64 -36.96 76.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.376 -0.829 . . . . 14.43 110.321 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.89 -51.65 38.67 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.671 -0.572 . . . . 10.49 111.671 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.51 -44.05 84.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.289 0.636 . . . . 9.27 111.657 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -60.89 -40.82 94.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.924 0.342 . . . . 11.46 111.924 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -68.41 -47.08 68.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.884 0.373 . . . . 15.5 110.491 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -54.71 -40.08 68.84 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.414 1.086 . . . . 12.39 111.999 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.73 -1.17 26.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.191 0.811 . . . . 11.97 113.191 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t 60.36 47.24 9.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.672 0.789 . . . . 14.37 110.308 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.09 168.83 18.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.527 -0.916 . . . . 13.16 108.527 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -108.08 97.25 6.97 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.44 0.638 . . . . 16.91 109.41 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.6 tp -103.13 123.66 47.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.73 134.29 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.142 -0.688 . . . . 14.37 109.142 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.92 -16.64 59.99 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.204 0.526 . . . . 13.15 111.116 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.37 -6.29 59.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.717 -0.674 . . . . 15.68 111.118 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.11 -10.69 32.68 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.327 -0.397 . . . . 13.1 111.677 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.57 -15.76 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.762 0.791 . . . . 12.16 110.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.848 ' HH ' ' HG ' ' A' ' 142' ' ' SER . 30.9 m-85 -103.85 14.15 31.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.469 -0.787 . . . . 15.41 109.099 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 32.5 m -110.69 -38.31 5.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.474 -0.785 . . . . 15.07 111.269 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -105.97 123.77 38.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.682 -0.407 . . . . 12.68 110.465 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.68 -27.84 4.66 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.972 1.781 . . . . 15.04 111.484 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -105.7 142.53 35.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.995 0.903 . . . . 13.26 111.504 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.14 -37.91 81.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.752 -1.567 . . . . 10.32 112.433 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.34 -18.97 63.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.929 0.714 . . . . 12.75 112.929 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 -17.77 64.86 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.139 0.792 . . . . 11.26 113.139 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.3 tp -70.11 -32.21 70.13 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.087 0.47 . . . . 8.53 110.261 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.49 75.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.467 0.651 . . . . 7.7 109.742 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.83 -21.79 60.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.557 -0.747 . . . . 10.38 110.579 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 9.6 tp10 -80.51 -56.8 3.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.994 -0.548 . . . . 11.97 109.752 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.4 -34.03 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 112.443 0.535 . . . . 9.8 112.443 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.31 -43.01 74.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.996 0.918 . . . . 10.83 110.459 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -83.56 -34.23 25.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.276 -0.874 . . . . 13.85 111.273 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mmm180 -60.7 -58.5 8.19 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.119 -0.491 . . . . 15.46 111.259 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.37 -40.51 56.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.255 -0.578 . . . . 13.35 109.451 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 117.64 -1.171 . . . . 13.51 109.853 178.545 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 110.742 -0.096 . . . . 18.78 110.742 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . 179.76 -174.0 0.23 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.514 -0.921 . . . . 16.95 108.514 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.29 -33.23 73.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.044 0.926 . . . . 15.46 108.804 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -67.46 -8.59 34.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.684 -1.144 . . . . 14.98 113.866 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 2' ' ' ALA . 12.8 pt-20 -67.02 -27.38 67.37 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.942 -0.703 . . . . 15.79 110.343 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 35.0 m -70.55 -48.73 54.0 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.943 -0.571 . . . . 12.18 109.823 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.67 78.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.084 0.469 . . . . 11.02 110.832 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 29.0 tt0 -67.67 -45.88 73.96 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.028 -0.533 . . . . 16.75 110.255 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.51 -37.76 85.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.072 0.463 . . . . 14.46 110.716 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 -35.49 74.73 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.388 0.514 . . . . 10.71 112.388 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 12.4 ptp180 -69.44 -29.18 66.83 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 119.135 -1.026 . . . . 14.51 109.575 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -67.35 -48.77 66.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.028 -0.533 . . . . 16.85 109.673 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -62.74 -34.56 77.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.408 -0.814 . . . . 13.52 112.377 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.48 -53.15 31.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.358 0.599 . . . . 12.77 110.299 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -29.72 70.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.953 -1.022 . . . . 15.19 112.214 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.08 98.47 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.952 0.406 . . . . 16.26 110.652 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.4 mmt -78.81 -39.51 35.49 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.337 -0.392 . . . . 15.45 112.043 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 mp -90.36 5.69 46.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.749 0.309 . . . . 16.16 111.785 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 54.71 36.88 27.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.421 1.488 . . . . 20.58 112.556 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.89 175.71 6.39 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.377 -1.342 . . . . 17.26 107.377 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.19 115.93 65.19 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.196 -0.668 . . . . 20.19 109.196 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.91 42.93 1.41 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 123.378 2.719 . . . . 17.46 113.218 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -95.86 1.09 Allowed Glycine 0 C--N 1.288 -2.137 0 CA-C-N 114.769 -1.105 . . . . 18.33 111.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.85 66.22 1.53 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.033 0.445 . . . . 20.77 110.231 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 pt -68.42 147.58 12.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.249 -0.432 . . . . 16.1 110.026 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.42 114.12 3.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.064 -0.971 . . . . 19.87 111.002 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.7 m-20 -66.77 -24.76 66.24 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.728 0.811 . . . . 15.1 110.988 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.11 2.33 87.14 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.835 -0.698 . . . . 15.48 113.148 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -73.33 140.49 46.75 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.062 0.458 . . . . 14.88 111.76 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 73.1 ttt180 -76.23 142.04 41.56 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 104.394 -2.447 . . . . 17.38 104.394 166.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 71.3 m-85 -54.68 -25.58 27.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.111 1.152 . . . . 11.99 114.111 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.23 -38.71 92.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.043 0.449 . . . . 14.71 109.832 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.78 -24.28 60.92 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.177 -0.675 . . . . 16.44 109.177 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.19 -15.8 54.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.624 -0.716 . . . . 13.83 110.536 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.26 5.03 53.13 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.999 -0.619 . . . . 14.3 112.749 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.431 HD23 ' HB1' ' A' ' 41' ' ' ALA . 7.1 tt -80.1 140.38 36.46 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.553 -0.536 . . . . 13.04 109.553 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 26.0 t70 -120.98 163.41 18.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 118.184 -0.912 . . . . 15.67 108.837 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 m -57.46 -39.98 77.51 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 118.834 0.743 . . . . 15.49 111.389 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.93 -46.15 85.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 16.98 109.492 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 52.6 mt -60.82 -34.96 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.313 -0.858 . . . . 14.44 110.723 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB1' HD23 ' A' ' 36' ' ' LEU . . . -58.78 -47.27 85.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.417 0.687 . . . . 12.4 111.432 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.71 72.29 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 123.556 0.535 . . . . 14.37 111.148 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -79.07 -49.93 11.87 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.868 -0.606 . . . . 16.05 111.329 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -60.96 -39.34 89.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.4 0.68 . . . . 11.7 112.062 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.3 -28.1 44.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 CA-C-O 121.132 0.491 . . . . 11.48 110.613 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -71.43 -32.03 67.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.982 0.42 . . . . 17.18 109.996 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -69.73 -34.39 73.79 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.84 0.828 . . . . 14.15 108.891 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.6 mt -69.92 -51.88 36.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 114.907 -1.042 . . . . 10.8 109.766 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.23 -28.22 62.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.799 0.84 . . . . 12.98 112.037 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -71.47 -50.78 28.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.531 0.681 . . . . 17.81 109.953 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -70.09 -51.84 28.54 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.71 -1.132 . . . . 15.55 113.303 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.409 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 79.9 m-85 -88.47 -6.67 57.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.869 0.692 . . . . 12.2 112.869 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 55.86 36.08 26.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.58 1.152 . . . . 17.4 112.209 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.68 147.25 32.21 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.958 -1.127 . . . . 12.25 107.958 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -91.22 77.34 5.95 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.762 -0.829 . . . . 16.32 108.762 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 57' ' ' PRO . 29.2 mt -100.35 128.38 30.56 Favored Pre-proline 0 N--CA 1.426 -1.674 0 C-N-CA 120.36 -0.536 . . . . 11.39 111.485 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' O ' HG21 ' A' ' 56' ' ' ILE . 87.0 Cg_endo -78.55 154.79 27.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.468 2.112 . . . . 13.44 108.956 171.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.31 20.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.464 0.706 . . . . 12.81 110.83 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 63' ' ' THR . 7.2 m-20 -62.43 -21.25 65.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.798 -1.092 . . . . 14.14 112.885 176.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.18 -41.33 92.71 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 119.409 -1.377 . . . . 10.76 111.632 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.55 -19.78 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.488 0.661 . . . . 11.0 110.23 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.74 -38.79 17.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 16.59 111.129 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 59' ' ' ASP . 8.5 t -77.66 -41.77 37.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.518 -0.473 . . . . 13.72 110.461 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -119.73 92.35 46.26 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-O 121.378 0.609 . . . . 12.25 109.872 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.509 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 44.8 Cg_endo -93.7 17.15 1.09 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.126 2.551 . . . . 13.57 113.93 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.95 137.94 45.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.08 -1.081 . . . . 13.28 108.08 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.28 -49.08 73.01 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 113.176 0.806 . . . . 11.45 113.176 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 13.9 tppt? -64.8 -35.05 79.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.317 0.58 . . . . 14.64 110.389 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.43 75.7 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.853 -0.612 . . . . 11.34 110.866 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.1 t80 -74.84 -31.97 61.8 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.379 0.609 . . . . 9.05 111.428 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -70.31 -29.18 65.84 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.409 -0.917 . . . . 9.65 110.584 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -75.01 -25.71 59.0 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.569 -0.53 . . . . 12.14 109.569 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 5.6 t90 -61.33 -54.76 39.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.139 -1.43 . . . . 11.26 107.139 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.18 -32.33 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 CA-C-N 115.009 -0.996 . . . . 8.3 109.544 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 -12.97 60.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.864 -0.607 . . . . 9.58 112.388 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.8 m -85.24 -31.28 23.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.627 -0.879 . . . . 10.46 108.627 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -81.18 -44.35 17.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.284 -1.006 . . . . 10.43 108.284 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 81.74 8.73 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.587 -1.264 . . . . 10.97 107.587 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.21 127.23 89.29 Favored Pre-proline 0 C--O 1.246 0.899 0 CA-C-N 114.809 -1.087 . . . . 13.77 111.94 -175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.93 108.68 2.36 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.796 2.331 . . . . 12.28 110.586 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -95.89 125.16 40.25 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.492 0.663 . . . . 13.71 111.08 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -98.93 115.46 28.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.576 -1.268 . . . . 13.27 107.576 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.24 -38.15 15.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.469 0.176 . . . . 14.77 111.293 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -74.9 134.31 41.63 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.188 -0.46 . . . . 15.24 109.873 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.52 96.71 2.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.502 -0.555 . . . . 14.58 109.502 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.11 93.34 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.678 -0.692 . . . . 12.98 109.336 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.93 87.55 0.1 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.121 2.547 . . . . 13.66 112.133 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.55 127.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.863 -0.791 . . . . 12.75 108.863 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -99.99 175.71 5.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.765 -0.457 . . . . 13.85 109.765 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 61.38 53.24 3.5 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.245 1.021 . . . . 14.91 110.431 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.86 130.45 86.85 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 114.513 -1.222 . . . . 11.68 108.104 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.12 107.4 0.65 Allowed 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.475 2.117 . . . . 11.23 110.911 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.4 122.75 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.515 0.674 . . . . 10.77 110.834 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.56 54.86 0.88 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.809 -0.812 . . . . 10.76 108.809 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 p -70.32 -44.28 68.59 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.838 -1.073 . . . . 11.26 111.538 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.22 97.51 47.55 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.841 -0.618 . . . . 11.01 109.988 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.34 -45.24 9.91 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.482 2.121 . . . . 12.86 109.872 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -120.51 118.48 30.94 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 107.551 -1.277 . . . . 14.34 107.551 174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.59 44.79 0.41 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.649 2.899 . . . . 12.35 114.163 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.54 2.64 83.02 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 121.14 -0.552 . . . . 11.89 111.945 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.56 -9.48 58.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.17 0.51 . . . . 11.88 110.203 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.36 126.22 30.9 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.346 -0.983 . . . . 12.74 108.346 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.15 99.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.475 -1.239 . . . . 11.49 111.29 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m 55.9 99.09 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.936 0.773 . . . . 10.09 112.126 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.84 -39.69 39.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.393 1.077 . . . . 11.53 112.581 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.1 tp-100 -62.57 -54.61 37.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.58 -0.526 . . . . 11.91 109.58 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -58.07 -41.29 83.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.942 0.897 . . . . 10.19 111.232 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -48.29 78.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.849 -0.614 . . . . 10.43 110.614 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.6 t -59.61 -37.7 79.28 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 123.699 0.624 . . . . 10.46 109.776 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 106' ' ' GLN . 53.2 mt -58.61 -44.83 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 115.265 -0.879 . . . . 8.37 110.721 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.41 -38.21 86.29 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.152 0.282 . . . . 8.76 111.517 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.2 -45.75 79.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.527 0.203 . . . . 10.86 110.554 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -71.52 -27.56 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.108 -0.637 . . . . 11.62 111.498 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.19 -48.0 83.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.188 -1.041 . . . . 7.62 108.188 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -56.63 -51.89 66.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.453 -1.703 . . . . 11.84 110.712 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -64.92 -39.98 94.36 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.711 0.634 . . . . 12.03 112.711 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 p -67.97 -33.13 74.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.156 0.428 . . . . 9.2 112.156 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -43.0 33.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.492 -0.883 . . . . 10.06 109.204 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.32 82.12 Favored Glycine 0 C--O 1.22 -0.775 0 CA-C-N 115.78 -0.645 . . . . 12.07 112.601 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.14 -28.63 68.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.526 0.679 . . . . 12.38 110.471 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.21 -43.06 10.07 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 11.77 110.127 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.48 -27.07 62.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.448 -0.796 . . . . 13.52 111.789 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 t80 80.27 -36.36 0.14 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.907 1.683 . . . . 17.15 110.742 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.77 172.35 13.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 16.03 110.816 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.83 139.02 76.66 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.988 0.423 . . . . 14.35 111.686 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.17 42.81 0.41 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.997 2.465 . . . . 14.18 111.128 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -101.2 -10.46 42.03 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 115.497 -0.774 . . . . 14.05 111.636 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.64 -13.77 41.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.192 0.52 . . . . 16.88 110.593 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.2 -169.45 2.07 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.124 -0.489 . . . . 12.55 112.119 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 79.68 113.96 0.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.12 1.368 . . . . 14.87 109.797 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 m 61.64 39.17 14.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.361 1.077 . . . . 14.56 109.062 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.69 70.23 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 113.704 -1.589 . . . . 14.2 110.624 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.85 -40.91 46.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.954 0.883 . . . . 13.0 110.247 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 64.03 31.75 13.36 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 113.242 -1.799 . . . . 17.02 112.973 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.75 -18.8 63.2 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.266 0.555 . . . . 13.62 110.788 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.53 -25.39 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.685 -0.689 . . . . 16.54 109.512 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.33 -29.4 10.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.497 -0.774 . . . . 15.87 111.088 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.66 -27.58 58.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.963 0.411 . . . . 13.65 110.725 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -114.82 100.66 1.01 Allowed Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 110.192 -1.163 . . . . 14.16 110.192 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptp -94.2 -15.29 24.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.094 0.473 . . . . 15.81 110.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -122.74 138.26 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.295 -1.002 . . . . 13.63 108.295 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 t -59.36 -16.79 24.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.542 1.137 . . . . 14.06 113.878 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.35 -36.52 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.21 0.529 . . . . 14.08 110.73 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 p -58.81 -44.61 90.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.677 -1.147 . . . . 11.82 112.032 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.96 -46.41 28.94 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.783 -0.722 . . . . 10.82 111.904 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 m -58.71 -52.94 63.55 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 122.859 0.463 . . . . 12.55 110.733 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.09 -44.17 97.77 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.629 -0.714 . . . . 12.17 110.965 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 152' ' ' VAL . 22.1 t90 -67.18 -49.64 63.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.898 -0.592 . . . . 9.45 111.511 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 38.0 ttm -64.7 -33.81 76.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.78 0.659 . . . . 9.88 112.78 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -66.31 -38.18 87.11 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.861 -0.736 . . . . 14.43 109.965 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.1 95.71 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.862 -0.895 . . . . 10.49 110.862 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 148' ' ' TRP . 78.2 t -58.43 -46.97 89.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 123.598 0.759 . . . . 9.27 109.468 174.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.9 m -61.49 -40.43 94.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 11.46 110.135 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -71.36 -53.27 14.72 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.756 -0.656 . . . . 15.5 111.558 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -66.61 -42.62 86.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.798 0.295 . . . . 12.39 111.798 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' A' ' 152' ' ' VAL . 96.7 m-85 -82.37 -8.9 59.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.048 0.451 . . . . 11.97 110.552 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.9 m 61.46 29.84 18.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.645 1.178 . . . . 14.37 111.588 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.4 pt -103.64 150.14 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 13.16 109.057 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -89.02 94.92 10.12 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.537 -1.283 . . . . 16.91 107.537 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.61 120.64 42.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.512 -0.767 . . . . 12.32 109.182 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 134.58 57.18 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.929 -1.032 . . . . 14.37 110.932 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.409 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -69.27 -20.36 63.92 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.67 -0.696 . . . . 13.15 110.715 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.75 -16.87 64.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.966 -0.561 . . . . 15.68 110.348 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.494 ' HB3' ' SD ' ' A' ' 149' ' ' MET . . . -65.71 -14.71 61.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.983 -0.553 . . . . 13.1 112.056 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 162' ' ' ALA . 31.7 pt -68.88 -22.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.521 0.676 . . . . 12.16 109.57 175.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -102.64 -15.52 16.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.661 -0.699 . . . . 15.41 109.157 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 25.9 m -77.16 -46.6 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.819 -0.808 . . . . 15.07 108.819 177.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.46 90.24 0.92 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 121.298 0.571 . . . . 12.68 112.425 -176.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.28 41.9 1.23 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.654 2.236 . . . . 15.04 111.191 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -123.07 142.89 50.38 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-O 122.361 1.077 . . . . 13.26 111.061 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.01 -43.19 93.32 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 113.535 -1.666 . . . . 10.32 110.958 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.74 -37.2 86.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.058 -0.974 . . . . 12.75 111.106 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 m -79.29 -33.0 43.7 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.809 -0.632 . . . . 11.26 110.561 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.05 -43.61 91.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.661 -1.237 . . . . 8.53 107.661 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.66 78.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.698 -0.683 . . . . 7.7 110.907 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -29.97 68.51 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.716 -0.675 . . . . 10.38 110.381 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -78.81 -58.0 3.47 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.65 -0.704 . . . . 11.97 111.696 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.91 -43.75 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.432 0.53 . . . . 9.8 112.432 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.29 -44.67 95.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.143 0.496 . . . . 10.83 110.143 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -72.21 -30.87 65.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.014 -0.994 . . . . 13.85 110.983 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.14 -44.02 85.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.334 -0.617 . . . . 15.46 109.334 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.35 -52.86 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.848 -0.615 . . . . 13.35 110.186 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.308 -1.198 0 N-CA-C 112.432 0.53 . . . . 13.51 112.432 -177.717 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 108.978 -0.749 . . . . 18.78 108.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.71 30.73 1.48 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.752 0.787 . . . . 16.95 109.074 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -91.4 -83.68 0.27 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.963 -1.017 . . . . 15.46 111.715 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -109.42 14.42 23.63 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.334 0.588 . . . . 14.98 111.223 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.37 80.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.709 -0.678 . . . . 15.79 111.952 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 p -57.12 -36.04 70.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.517 -0.765 . . . . 12.18 111.445 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.94 76.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.364 -0.606 . . . . 11.02 109.364 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.24 -50.86 72.4 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.591 -0.732 . . . . 16.75 110.57 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -53.94 -47.07 71.65 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.762 0.825 . . . . 14.46 111.954 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -71.68 -36.38 70.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.381 -0.372 . . . . 10.71 111.253 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -67.21 -43.12 82.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.478 0.711 . . . . 14.51 109.841 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -58.59 -45.3 89.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.41 1.084 . . . . 16.85 110.128 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -70.26 -32.88 70.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.263 -0.88 . . . . 13.52 110.761 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.9 -56.66 10.63 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.603 -1.258 . . . . 12.77 107.603 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -36.28 79.33 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.727 -1.124 . . . . 15.19 112.154 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.33 86.99 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.178 0.513 . . . . 16.26 111.405 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.6 mmm -78.01 -38.46 44.78 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.95 -0.568 . . . . 15.45 112.072 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.58 -1.86 58.29 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.422 0.63 . . . . 16.16 112.054 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.0 t80 60.61 56.62 2.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.24 1.416 . . . . 20.58 109.959 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -124.57 166.91 15.24 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.778 -1.564 . . . . 17.26 106.778 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -108.93 119.22 49.57 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-O 121.042 0.448 . . . . 20.19 110.346 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 -23.94 67.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.625 2.883 . . . . 17.46 115.091 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.33 -16.62 71.5 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.036 -0.602 . . . . 18.33 113.391 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -127.16 16.85 7.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.785 0.293 . . . . 20.77 111.043 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.33 139.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 109.709 -0.478 . . . . 16.1 109.709 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' NH2' ' HG2' ' A' ' 183' ' ' GLN . 40.5 ttm180 -78.14 96.71 5.24 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.168 -1.049 . . . . 19.87 108.168 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 11.5 p-10 -67.26 -14.7 63.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.686 -0.688 . . . . 15.1 112.135 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.88 5.85 66.67 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.751 -0.738 . . . . 15.48 112.081 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.6 t -87.51 161.44 17.79 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.623 0.725 . . . . 14.88 109.932 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -101.91 142.88 32.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.129 -0.942 . . . . 17.38 112.72 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -42.71 -60.88 1.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.293 1.437 . . . . 11.99 113.848 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.59 -29.86 70.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 14.71 111.879 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -79.38 -13.47 59.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.98 0.419 . . . . 16.44 111.409 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.36 -22.47 44.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.649 0.738 . . . . 13.83 109.195 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 25.28 6.21 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.964 -1.016 . . . . 14.3 111.107 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -74.0 113.47 11.21 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.08 0.467 . . . . 13.04 109.763 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.34 156.23 24.35 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.19 -0.914 . . . . 15.67 110.909 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 t -56.92 -42.32 79.79 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.062 0.458 . . . . 15.49 109.788 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.62 -48.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.494 -0.776 . . . . 16.98 110.92 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.7 mt -66.05 -38.44 82.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.969 -0.56 . . . . 14.44 110.779 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.57 84.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 12.4 110.334 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.52 -38.23 90.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 14.37 110.842 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -71.35 -42.4 68.54 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.645 0.736 . . . . 16.05 110.974 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -61.33 -47.81 84.22 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 125.531 1.532 . . . . 11.7 111.462 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 tp -63.61 -34.02 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 120.855 0.36 . . . . 11.48 111.722 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 37.6 mmt180 -63.11 -38.32 90.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.717 0.294 . . . . 17.18 111.037 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.03 -39.74 93.81 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.35 0.595 . . . . 14.15 109.624 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.13 -47.66 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.193 -0.912 . . . . 10.8 110.361 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -60.64 -43.2 97.82 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.793 -0.64 . . . . 12.98 111.591 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -72.19 -58.97 2.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.46 -0.791 . . . . 17.81 111.141 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -30.46 69.8 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.012 1.116 . . . . 15.55 114.012 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.22 -2.36 46.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 113.095 0.776 . . . . 12.2 113.095 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 59.01 45.28 15.07 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.344 1.057 . . . . 17.4 110.003 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.49 165.77 22.82 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.536 -0.302 . . . . 12.25 110.204 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.83 71.34 0.74 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.586 -0.894 . . . . 16.32 108.586 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mm -101.31 114.69 65.71 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 116.196 -0.456 . . . . 11.39 110.65 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.79 171.01 16.12 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.346 2.03 . . . . 13.44 110.027 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.33 -1.05 9.35 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.409 0.684 . . . . 12.81 111.699 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.04 -30.62 71.1 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.089 0.956 . . . . 14.14 110.55 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.58 98.35 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.299 -0.477 . . . . 10.76 111.993 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.47 -32.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.763 0.792 . . . . 11.0 110.152 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -80.98 -16.5 53.28 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.982 -0.553 . . . . 16.59 111.097 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -83.57 -48.54 10.13 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.1 -0.704 . . . . 13.72 109.1 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.85 118.96 30.25 Favored Pre-proline 0 C--O 1.215 -0.761 0 CA-C-N 116.229 -0.441 . . . . 12.25 111.324 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.52 -3.99 7.5 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.768 2.312 . . . . 13.57 112.577 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.97 119.58 59.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.99 -1.485 . . . . 13.28 106.99 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.2 p90 -62.12 -33.54 74.66 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.884 0.698 . . . . 11.45 112.884 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -62.72 -38.17 89.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.368 0.604 . . . . 14.64 110.827 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.7 -23.86 36.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.72 0.771 . . . . 11.34 109.649 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 80.9 t80 -81.05 -30.13 34.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 9.05 111.874 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 p -67.61 -33.32 74.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.43 -0.794 . . . . 9.65 109.098 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.99 -29.85 64.64 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.253 -0.885 . . . . 12.14 109.543 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.538 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 82.4 t90 -59.62 -44.34 93.47 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.154 0.982 . . . . 11.26 108.847 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.65 -45.42 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 C-N-CA 123.629 0.772 . . . . 8.3 110.306 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.98 75.63 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 116.162 -0.472 . . . . 9.58 113.569 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -77.18 -22.11 52.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.277 0.561 . . . . 10.46 110.661 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -82.55 -2.64 54.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.342 0.592 . . . . 10.43 111.141 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.6 mt -93.3 105.63 17.69 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.946 -2.242 . . . . 10.97 104.946 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -52.1 115.3 6.54 Favored Pre-proline 0 C--O 1.248 1.002 0 O-C-N 123.765 0.666 . . . . 13.77 112.356 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.91 104.13 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.973 2.448 . . . . 12.28 111.166 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.6 m -95.16 115.19 27.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.812 -0.81 . . . . 13.71 108.812 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -79.93 58.83 3.0 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.598 0.713 . . . . 13.27 111.407 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.66 -3.31 58.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.071 0.939 . . . . 14.77 108.776 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.6 t -148.85 138.66 22.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.164 -1.421 . . . . 15.24 107.164 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 111.18 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.647 -0.501 . . . . 14.58 109.647 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.69 122.67 56.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.934 -0.576 . . . . 12.98 110.404 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.45 11.57 2.63 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.751 2.301 . . . . 13.66 112.053 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.15 56.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.694 1.597 . . . . 12.75 110.957 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -115.51 42.1 2.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.93 0.871 . . . . 13.85 110.65 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -110.87 41.88 1.72 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.814 -1.18 . . . . 14.91 107.814 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.92 117.67 64.47 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 113.953 -1.476 . . . . 11.68 109.706 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.17 158.4 49.1 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.76 2.307 . . . . 11.23 110.771 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.49 137.42 28.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.66 -0.867 . . . . 10.77 108.66 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.84 115.28 27.92 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.657 -1.609 . . . . 10.76 106.657 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 m -81.18 -30.62 34.3 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 120.014 -0.675 . . . . 11.26 109.27 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 107.87 57.0 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.771 -1.196 . . . . 11.01 107.771 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.2 -31.41 55.32 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.707 2.938 . . . . 12.86 112.716 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -77.44 119.95 79.51 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.114 -0.699 . . . . 14.34 109.114 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.61 57.13 6.38 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.676 2.251 . . . . 12.35 111.818 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 142.72 13.37 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.79 -0.924 . . . . 11.89 110.79 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.62 12.61 27.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.896 0.379 . . . . 11.88 111.924 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.02 78.18 5.47 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.131 0.491 . . . . 12.74 110.304 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.38 -24.87 42.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.63 0.729 . . . . 11.49 110.36 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.9 m 57.56 34.42 24.54 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 113.922 -1.49 . . . . 10.09 111.537 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.26 73.3 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.276 -0.875 . . . . 11.53 111.782 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -72.55 -51.36 20.19 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.161 -0.472 . . . . 11.91 110.261 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -49.94 -51.42 41.32 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.705 0.628 . . . . 10.19 110.897 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 104' ' ' SER . 5.9 mm-40 -63.86 -47.99 78.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 10.43 111.721 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.4 m -66.74 -43.53 83.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.182 -0.463 . . . . 10.46 111.765 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 178' ' ' VAL . 73.3 mt -71.91 -23.64 22.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.0 0 N-CA-C 110.014 -0.365 . . . . 8.37 110.014 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -64.73 -41.84 95.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.232 -0.655 . . . . 8.76 109.232 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.58 -38.98 84.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.15 0.5 . . . . 10.86 109.947 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.17 -49.62 76.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.985 -1.007 . . . . 11.62 109.503 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -50.0 -43.67 50.64 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.135 1.374 . . . . 7.62 112.015 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -60.4 -45.29 94.11 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.817 -1.083 . . . . 11.84 109.715 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -82.0 -22.93 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.61 0.719 . . . . 12.03 110.516 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -73.74 -55.1 6.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.269 -0.878 . . . . 9.2 110.39 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.64 -29.25 33.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.566 -0.531 . . . . 10.06 109.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.2 -19.97 62.36 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.884 -0.487 . . . . 12.07 111.884 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.41 -23.88 61.15 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.449 0.7 . . . . 12.38 109.617 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.53 -23.47 19.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.879 -0.6 . . . . 11.77 110.434 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.91 -26.89 23.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.876 -0.416 . . . . 13.52 109.876 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 73.92 -35.11 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.207 1.403 . . . . 17.15 112.76 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.93 129.92 40.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.087 -1.449 . . . . 16.03 107.087 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -119.45 117.22 33.1 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.839 -0.619 . . . . 14.35 109.642 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -88.02 4.64 5.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.968 2.446 . . . . 14.18 112.816 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.83 -78.79 0.02 OUTLIER Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.779 -1.201 . . . . 14.05 113.106 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 177.88 24.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.336 0.654 . . . . 16.88 109.912 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 mp 47.66 -158.19 0.05 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.251 0.62 . . . . 12.55 111.327 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 76.95 -38.06 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.714 1.206 . . . . 14.87 112.511 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.6 p -69.59 -46.1 67.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.938 -1.134 . . . . 14.56 107.938 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -100.9 89.37 0.8 Allowed Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 107.588 -2.205 . . . . 14.2 107.588 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.58 -14.03 10.87 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 111.545 0.202 . . . . 13.0 111.545 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.99 133.04 47.62 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.824 0.821 . . . . 17.02 110.313 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -65.67 -20.05 66.14 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.829 -1.078 . . . . 13.62 110.035 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.94 -24.9 68.09 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.906 -1.043 . . . . 16.54 111.676 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.13 -34.7 8.31 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.05 -0.66 . . . . 15.87 110.949 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 132' ' ' GLY . 35.3 mt -91.83 -27.17 18.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.638 -0.71 . . . . 13.65 112.721 -171.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -106.96 78.85 0.25 Allowed Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.428 -0.892 . . . . 14.16 113.892 -174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 50.2 tpp -80.87 -40.63 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.157 -1.053 . . . . 15.81 108.157 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -99.59 113.27 25.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.159 -0.928 . . . . 13.63 109.0 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.6 t -72.67 -38.45 67.6 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.244 -0.889 . . . . 14.06 110.449 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.89 -32.05 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.326 0.584 . . . . 14.08 112.02 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.1 t -77.55 -27.15 51.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.104 -1.038 . . . . 11.82 109.726 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.79 -28.58 34.59 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.092 -1.051 . . . . 10.82 111.166 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 162' ' ' ALA . 16.9 p -66.94 -43.24 83.72 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 109.217 -0.66 . . . . 12.55 109.217 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -56.8 -49.75 74.4 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.135 -0.939 . . . . 12.17 109.21 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -55.29 -53.06 60.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.199 -0.91 . . . . 9.45 112.203 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 149' ' ' MET . 4.1 tpt -56.94 -48.84 77.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.436 0.694 . . . . 9.88 110.844 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -64.33 -36.13 83.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.267 -0.424 . . . . 14.43 110.872 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.69 97.64 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.814 -0.515 . . . . 10.49 111.814 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.44 -43.27 98.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.805 -0.442 . . . . 9.27 109.805 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.0 t -59.62 -46.41 89.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.435 -0.802 . . . . 11.46 109.428 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.55 -48.99 78.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.196 0.998 . . . . 15.5 111.025 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -58.53 -27.61 64.69 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.62 0.768 . . . . 12.39 112.779 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -107.46 4.71 26.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.779 0.659 . . . . 11.97 112.779 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m 58.29 32.22 21.79 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.77 0.795 . . . . 14.37 111.315 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.6 pt -107.13 165.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.342 -0.984 . . . . 13.16 108.342 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.97 94.5 5.02 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.335 0.588 . . . . 16.91 112.051 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.69 108.72 10.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.175 -1.046 . . . . 12.32 108.175 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.5 154.75 35.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.194 -0.912 . . . . 14.37 109.835 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 146' ' ' THR . . . -63.72 -16.98 62.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.939 -1.028 . . . . 13.15 113.138 -174.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.93 -6.47 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 116.431 -0.35 . . . . 15.68 111.267 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.96 -11.28 46.43 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.138 0.422 . . . . 13.1 112.138 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.8 pt -64.84 -13.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.253 0.549 . . . . 12.16 111.365 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.59 -1.95 16.63 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.205 -0.452 . . . . 15.41 110.289 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.7 m -84.39 -30.61 25.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.014 -0.539 . . . . 15.07 110.589 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -116.93 108.96 43.52 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.271 -1.011 . . . . 12.68 108.271 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -48.73 -37.73 35.83 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.947 3.098 . . . . 15.04 112.846 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.7 p -125.55 141.01 52.26 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.792 -1.188 . . . . 13.26 107.792 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.61 -1.73 47.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.811 0.671 . . . . 10.32 112.811 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -66.5 -26.08 67.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.162 -1.051 . . . . 12.75 108.162 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 18.1 m -76.1 -18.62 59.09 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.237 -1.347 . . . . 11.26 111.752 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.43 -35.68 76.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.884 0.474 . . . . 8.53 110.286 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.58 -37.64 79.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.142 -0.481 . . . . 7.7 111.567 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.9 -32.6 61.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 10.38 110.349 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 173' ' ' SER . 46.9 mm-40 -70.08 -48.73 56.5 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.619 -0.719 . . . . 11.97 109.998 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 110' ' ' ILE . 12.1 p -66.78 -40.64 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 9.8 111.376 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.99 -37.16 78.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.548 0.689 . . . . 10.83 110.226 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -67.13 -45.85 75.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.982 -1.008 . . . . 13.85 110.106 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -67.99 -48.24 66.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 15.46 111.765 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 90.0 t -64.32 -53.4 43.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 123.48 0.488 . . . . 13.35 109.992 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.457 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 61.7 tt0 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 123.906 0.883 . . . . 13.51 111.62 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 121.222 0.534 . . . . 18.78 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.67 -49.11 28.45 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.671 1.36 . . . . 16.95 114.671 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -80.1 -37.37 33.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.161 0.8 . . . . 15.46 113.161 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.62 -37.05 70.96 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.547 0.689 . . . . 14.98 109.404 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.72 -39.4 91.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.397 -0.819 . . . . 15.79 109.887 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.524 ' HG ' ' HH ' ' A' ' 52' ' ' TYR . 49.7 t -58.63 -45.11 89.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.039 -0.726 . . . . 12.18 109.039 176.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.64 94.54 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.994 -0.548 . . . . 11.02 110.891 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -62.63 -37.54 86.73 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.782 0.29 . . . . 16.75 111.782 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.57 -40.49 89.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.53 0.681 . . . . 14.46 110.242 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.57 -33.09 64.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.389 -0.524 . . . . 10.71 111.041 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.26 -50.05 75.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.779 0.432 . . . . 14.51 110.881 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -67.26 -23.85 65.74 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.266 -0.425 . . . . 16.85 111.595 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 m -83.23 -49.4 9.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.994 0.426 . . . . 13.52 110.415 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.1 -52.73 62.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.235 0.614 . . . . 12.77 110.512 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.39 -24.88 64.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.395 0.517 . . . . 15.19 112.395 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.56 85.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.878 0.37 . . . . 16.26 110.147 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.6 mtm -74.01 -27.68 61.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.701 -0.681 . . . . 15.45 111.64 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.04 4.29 54.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.306 -0.406 . . . . 16.16 111.84 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 55.23 39.79 31.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.382 1.073 . . . . 20.58 112.272 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -109.24 155.69 20.8 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.603 -1.258 . . . . 17.26 107.603 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.54 118.84 71.22 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 109.308 -0.627 . . . . 20.19 109.308 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.8 -29.09 12.92 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.395 2.064 . . . . 17.46 114.272 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.79 8.19 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.577 -1.009 . . . . 18.33 110.577 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.49 70.47 8.97 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.268 0.556 . . . . 20.77 111.12 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.62 149.9 13.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.704 -1.221 . . . . 16.1 107.704 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 13.8 ttp180 -82.53 126.08 31.85 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 122.319 0.248 . . . . 19.87 110.406 -177.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.43 -23.62 67.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.606 0.762 . . . . 15.1 112.1 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.429 ' H ' ' HG2' ' A' ' 26' ' ' ARG . . . -96.7 6.76 65.11 Favored Glycine 0 C--N 1.309 -0.929 0 CA-C-N 115.917 -0.583 . . . . 15.48 113.902 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 26' ' ' ARG . 68.8 m -65.14 153.28 41.34 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.932 0.873 . . . . 14.88 112.186 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 8.9 mmm180 -92.15 152.96 19.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.005 -0.998 . . . . 17.38 109.841 -172.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 58.2 m-85 -57.79 -50.29 73.76 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 119.367 0.985 . . . . 11.99 112.836 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.14 -9.37 55.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.415 0.626 . . . . 14.71 111.551 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.27 -37.9 12.39 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.084 -0.71 . . . . 16.44 109.084 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -61.31 -33.85 74.27 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.565 0.746 . . . . 13.83 111.234 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.19 9.75 8.53 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.63 -0.988 . . . . 14.3 110.63 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 41' ' ' ALA . 8.3 tt -91.58 137.1 32.64 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.363 -0.977 . . . . 13.04 108.363 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -132.55 166.93 20.95 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.21 1.004 . . . . 15.67 109.117 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -42.84 -54.62 4.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 15.49 113.437 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.59 -40.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.285 0.564 . . . . 16.98 111.411 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.421 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 67.4 mt -66.41 -36.77 78.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.816 -0.629 . . . . 14.44 110.093 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -58.02 -45.01 87.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.14 -0.936 . . . . 12.4 110.766 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.35 -36.31 75.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.277 -0.874 . . . . 14.37 110.933 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.33 -41.18 57.31 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.49 -0.777 . . . . 16.05 111.507 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -64.84 -41.11 95.98 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.91 -0.586 . . . . 11.7 110.796 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 41' ' ' ALA . 34.3 mm -55.1 -41.6 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.169 -0.469 . . . . 11.48 110.266 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -58.58 -31.71 68.28 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.526 -0.761 . . . . 17.18 110.622 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -80.02 -46.98 15.64 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.603 -0.271 . . . . 14.15 111.288 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 45' ' ' ILE . 22.6 pt -65.74 -32.1 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.539 -0.464 . . . . 10.8 110.41 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.592 ' ND2' HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -60.58 -39.34 87.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.238 0.542 . . . . 12.98 110.19 175.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -73.64 -48.71 30.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.948 -1.024 . . . . 17.81 111.743 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.0 -34.37 64.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.872 -0.731 . . . . 15.55 111.822 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.524 ' HH ' ' HG ' ' A' ' 6' ' ' CYS . 56.7 m-85 -88.87 -6.37 57.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.963 0.727 . . . . 12.2 112.963 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 57.82 41.85 24.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.89 1.276 . . . . 17.4 111.235 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 tp -141.28 136.24 31.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.248 -1.019 . . . . 12.25 108.248 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -84.11 56.0 3.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.833 0.825 . . . . 16.32 109.551 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.592 HG23 ' ND2' ' A' ' 49' ' ' ASN . 10.9 tt -60.24 134.98 90.92 Favored Pre-proline 0 C--O 1.253 1.262 0 CA-C-N 114.139 -1.391 . . . . 11.39 110.2 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -79.07 162.07 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.582 2.188 . . . . 13.44 111.946 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 2.19 26.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.011 -0.995 . . . . 12.81 111.65 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 5.2 m-20 -62.28 -18.26 60.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.961 -0.563 . . . . 14.14 112.37 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 70' ' ' PHE . . . -63.84 -39.34 97.3 Favored Glycine 0 C--O 1.213 -1.183 0 C-N-CA 120.412 -0.899 . . . . 10.76 111.648 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -82.62 -12.84 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 123.025 1.393 . . . . 11.0 108.238 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 52.3 t80 -78.73 -44.91 22.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.174 -1.375 . . . . 16.59 110.058 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.0 t -93.4 -31.98 14.42 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.558 0.577 . . . . 13.72 112.558 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.06 125.67 45.14 Favored Pre-proline 0 CA--C 1.5 -0.964 0 O-C-N 121.785 -0.572 . . . . 12.25 110.805 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 60.4 Cg_endo -87.61 -18.11 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.042 1.828 . . . . 13.57 111.601 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.4 t -108.24 133.38 53.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.195 -1.409 . . . . 13.28 107.195 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 43.6 p90 -72.74 -34.82 67.29 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.375 0.509 . . . . 11.45 112.375 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -71.19 -20.65 62.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.496 0.665 . . . . 14.64 111.005 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.97 -25.86 40.21 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.544 0.688 . . . . 11.34 109.883 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 9.2 t80 -68.04 -30.34 69.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.635 . . . . 9.05 111.325 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -63.87 -22.2 66.81 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.856 0.687 . . . . 9.65 112.856 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.83 -28.03 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.378 0.608 . . . . 12.14 110.07 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -73.81 -45.74 49.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.794 -0.639 . . . . 11.26 109.41 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.57 -42.28 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.661 0 N-CA-C 109.726 -0.472 . . . . 8.3 109.726 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.06 74.31 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.606 -0.725 . . . . 9.58 113.518 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 p -81.21 -38.33 27.16 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.099 -0.64 . . . . 10.46 111.877 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -73.98 -46.65 42.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.959 -0.696 . . . . 10.43 110.025 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.34 84.26 1.9 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.907 -0.588 . . . . 10.97 109.667 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -104.8 100.81 25.5 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.378 -0.971 . . . . 13.77 108.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 150.42 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.361 2.04 . . . . 12.28 111.797 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.4 p -83.14 63.44 7.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.272 1.034 . . . . 13.71 109.75 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -118.11 64.08 0.75 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.802 -1.09 . . . . 13.27 108.788 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.08 -61.61 1.5 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.931 -0.766 . . . . 14.77 108.931 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.7 p -88.19 44.93 1.23 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.2 1.0 . . . . 15.24 109.771 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.52 36.19 0.46 Allowed 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.281 -1.327 . . . . 14.58 108.028 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.88 122.0 85.61 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.064 -0.971 . . . . 12.98 110.265 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.27 143.12 6.47 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.065 1.843 . . . . 13.66 111.817 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.76 96.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 122.076 0.941 . . . . 12.75 108.557 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -110.85 58.79 0.61 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.559 1.171 . . . . 13.85 108.575 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -116.43 102.73 9.77 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.766 -1.561 . . . . 14.91 108.525 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -59.97 124.16 75.59 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.051 -0.722 . . . . 11.68 109.051 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.63 40.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.01 2.474 . . . . 11.23 111.006 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -76.82 94.3 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.214 -0.903 . . . . 10.77 109.866 -178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.98 62.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 10.76 109.798 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -68.32 -15.66 63.65 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.589 -0.732 . . . . 11.26 111.261 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.5 -57.92 0.51 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 112.288 0.477 . . . . 11.01 112.288 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.56 -21.65 19.14 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.512 1.475 . . . . 12.86 111.688 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -119.47 86.57 34.32 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 116.069 -0.514 . . . . 14.34 109.681 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.59 31.55 0.5 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.908 2.405 . . . . 12.35 110.782 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.54 41.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.223 -1.151 . . . . 11.89 110.223 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.43 -28.95 31.01 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.675 0.75 . . . . 11.88 109.061 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.1 133.96 36.14 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.816 -1.084 . . . . 12.74 108.406 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.32 -31.47 18.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.154 0.502 . . . . 11.49 112.005 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.3 m 60.65 26.07 15.81 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.675 -1.148 . . . . 10.09 113.567 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.89 -25.25 55.91 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.759 0.281 . . . . 11.53 111.759 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.98 -37.77 88.76 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.45 -0.341 . . . . 11.91 111.762 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -57.34 10.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 10.19 110.737 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -61.72 -44.43 96.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.574 -0.739 . . . . 10.43 109.924 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.8 t -60.39 -43.48 96.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.6 -0.727 . . . . 10.46 110.969 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.6 mt -55.98 -51.41 61.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.36 0.664 . . . . 8.37 110.511 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.58 -39.86 94.49 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 115.201 -0.909 . . . . 8.76 109.869 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.49 -34.82 74.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.957 0.503 . . . . 10.86 111.777 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -68.34 -53.54 23.39 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 110.016 -0.364 . . . . 11.62 110.016 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 171' ' ' LEU . 9.4 tt -63.36 -27.68 69.48 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.306 -0.861 . . . . 7.62 110.401 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.11 -46.19 90.13 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.734 1.214 . . . . 11.84 109.869 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -69.26 -33.8 73.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.048 -0.523 . . . . 12.03 110.91 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -63.48 -42.74 98.55 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.208 -0.451 . . . . 9.2 110.432 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.98 -40.99 68.19 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.622 -0.51 . . . . 10.06 109.622 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.54 -49.79 70.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.852 -0.613 . . . . 12.07 112.424 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.56 -25.84 66.0 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.003 0.521 . . . . 12.38 110.438 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.26 -46.76 60.2 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.06 -0.719 . . . . 11.77 109.06 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.29 -81.03 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.512 -0.767 . . . . 13.52 110.04 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -158.55 -45.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.116 -1.068 . . . . 17.15 108.116 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.7 tp -167.84 157.58 10.13 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.487 -2.412 . . . . 16.03 104.487 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.52 118.01 67.85 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 118.474 0.579 . . . . 14.35 110.733 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.29 -8.21 11.78 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.495 2.13 . . . . 14.18 111.752 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.6 -10.26 74.16 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.246 -0.742 . . . . 14.05 111.246 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -89.66 37.1 0.86 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.24 1.019 . . . . 16.88 110.497 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.21 -5.68 13.02 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.304 -1.316 . . . . 12.55 110.802 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -85.78 121.66 28.75 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.089 -0.505 . . . . 14.87 110.082 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.1 m 69.85 -66.34 0.27 Allowed 'General case' 0 C--O 1.247 0.926 0 C-N-CA 125.082 1.353 . . . . 14.56 112.175 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.5 82.72 1.51 Allowed Glycine 0 C--O 1.239 0.453 0 CA-C-N 116.412 -0.358 . . . . 14.2 113.007 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . -143.49 117.4 9.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.895 -1.15 . . . . 13.0 107.895 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -115.73 164.16 14.76 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.184 -1.413 . . . . 17.02 107.184 -173.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.61 ' H ' ' NE2' ' A' ' 134' ' ' GLN . 40.5 m-85 -42.82 -47.16 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.307 0.854 . . . . 13.62 113.307 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 pp -55.82 -33.85 64.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.679 0.622 . . . . 16.54 112.679 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.68 -1.73 27.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.567 0.58 . . . . 15.87 112.567 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 96.6 mt -93.89 -27.19 16.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.233 0.539 . . . . 13.65 109.775 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 170.67 126.38 0.87 Allowed Glycine 0 N--CA 1.432 -1.594 0 N-CA-C 110.411 -1.076 . . . . 14.16 110.411 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp -70.17 -30.17 67.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.163 0.506 . . . . 15.81 110.904 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -106.92 124.64 49.92 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.743 -0.836 . . . . 13.63 108.743 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 t -61.49 -30.05 70.37 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.422 -0.808 . . . . 14.06 112.473 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 t -76.91 -25.18 15.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 CA-C-O 121.536 0.684 . . . . 14.08 109.99 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -70.65 -28.19 64.61 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.694 -0.803 . . . . 11.82 110.235 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.34 -21.16 59.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.036 -1.225 . . . . 10.82 110.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 m -67.31 -44.77 78.34 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.012 -1.107 . . . . 12.55 108.012 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.26 -46.2 90.65 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.318 -1.31 . . . . 12.17 109.706 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -59.03 -46.72 87.51 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.739 -1.118 . . . . 9.45 111.279 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.441 ' HA ' ' HE3' ' A' ' 149' ' ' MET . 1.1 tpt -53.29 -55.73 22.29 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.558 0.743 . . . . 9.88 112.093 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -63.75 -30.11 71.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.599 -0.44 . . . . 14.43 111.669 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 -50.07 50.33 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.004 -0.839 . . . . 10.49 111.004 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.83 -40.34 86.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.284 0.634 . . . . 9.27 110.25 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.9 t -54.27 -58.83 5.91 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.046 -0.979 . . . . 11.46 110.697 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -71.23 -24.95 62.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.283 -0.417 . . . . 15.5 111.638 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -61.07 -34.93 75.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.689 0.28 . . . . 12.39 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -100.55 6.41 44.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 11.97 111.272 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.3 m 57.42 44.0 22.19 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.284 1.034 . . . . 14.37 111.188 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.5 pt -122.18 146.78 26.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 106.777 -1.564 . . . . 13.16 106.777 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -96.81 96.73 8.76 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.869 -0.732 . . . . 16.91 110.95 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.64 139.48 45.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.555 -0.906 . . . . 12.32 108.555 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.94 44.28 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.426 -0.806 . . . . 14.37 109.201 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.86 -24.04 67.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.593 -0.731 . . . . 13.15 111.616 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.34 2.69 51.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.019 -0.537 . . . . 15.68 111.528 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.55 -14.86 63.07 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.846 -0.534 . . . . 13.1 111.799 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.6 pt -61.37 -18.08 17.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 122.912 0.485 . . . . 12.16 111.478 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -83.47 -6.97 59.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.078 0.466 . . . . 15.41 110.366 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -99.22 -19.51 17.08 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.668 -0.696 . . . . 15.07 110.983 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -116.54 98.74 52.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.332 -0.547 . . . . 12.68 111.554 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.45 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 43.4 Cg_endo -72.22 -29.0 14.8 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.227 1.951 . . . . 15.04 112.408 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 3.3 p -126.71 143.39 51.25 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.378 0.609 . . . . 13.26 110.031 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 114' ' ' LEU . 34.6 tp -56.18 -26.95 52.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.258 1.423 . . . . 10.32 113.045 -174.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.41 -29.72 66.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.844 -0.616 . . . . 12.75 111.125 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -77.54 -30.3 52.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 11.26 109.934 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.47 ' O ' HG21 ' A' ' 178' ' ' VAL . 47.9 tp -75.82 -50.97 13.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.714 -0.675 . . . . 8.53 109.213 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.52 -47.34 48.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.201 0.6 . . . . 7.7 111.817 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 15.2 t70 -65.77 -31.31 72.22 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.773 0.32 . . . . 10.38 111.16 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.31 -40.31 74.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.597 -0.52 . . . . 11.97 109.597 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 174' ' ' LEU . 15.6 t -60.61 -42.24 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.08 -0.711 . . . . 9.8 109.08 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.67 -39.42 65.06 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 123.985 0.803 . . . . 10.83 111.144 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 20.0 mmt180 -73.14 -46.06 53.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.451 -0.574 . . . . 13.85 109.451 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.42 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 2.9 mmp_? -63.63 -39.23 93.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.432 -0.804 . . . . 15.46 112.02 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.12 -34.11 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 13.35 110.213 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.445 1.098 . . . . 13.51 110.749 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.212 -0.881 0 N-CA-C 111.682 0.253 . . . . 14.98 111.682 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.15 -42.38 80.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 111.749 0.277 . . . . 15.789999999999999 111.749 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.3 t -56.34 -44.11 79.74 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.87 -0.605 . . . . 12.02 110.696 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -37.81 50.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.107 -0.497 . . . . 11.02 111.173 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -62.5 -40.98 98.46 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 122.895 0.478 . . . . 16.07 109.713 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.68 -38.29 84.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.326 0.584 . . . . 13.93 110.175 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.36 -37.56 60.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.529 -0.759 . . . . 10.710000000000001 109.913 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 25' ' ' ILE . 4.9 ttp180 -64.18 -32.4 73.96 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.469 -0.787 . . . . 14.02 110.608 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -61.81 -48.71 79.37 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.693 0.797 . . . . 16.289999999999999 110.931 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p -72.52 -30.54 64.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.081 0.467 . . . . 12.91 110.945 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.33 -52.17 49.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.449 -1.315 . . . . 12.77 107.449 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.69 65.88 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.756 -0.656 . . . . 15.19 111.576 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -31.01 69.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.747 0.308 . . . . 16.260000000000002 110.676 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.59 -28.37 60.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.168 0.508 . . . . 15.449999999999999 110.402 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.36 -8.25 55.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.697 -0.683 . . . . 16.16 111.522 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 56.54 46.91 19.65 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.563 -1.199 . . . . 20.559999999999999 110.255 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.2 t -124.39 164.1 20.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.782 -1.554 . . . . 16.629999999999999 108.302 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.96 126.65 60.49 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.697 -1.223 . . . . 20.190000000000001 107.697 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 -8.4 23.52 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.945 2.43 . . . . 16.600000000000001 114.312 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.46 52.72 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.79 -0.719 . . . . 17.739999999999998 111.31 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -83.38 84.04 7.65 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.434 -0.95 . . . . 20.23 108.434 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.489 HG21 ' HD2' ' A' ' 11' ' ' ARG . 10.8 tp -142.07 149.02 19.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.135 0.493 . . . . 15.98 110.484 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 -101.79 120.21 40.01 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.76 -1.941 . . . . 19.329999999999998 105.76 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -67.83 -17.48 64.52 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 120.945 0.403 . . . . 14.93 111.678 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.45 7.42 61.68 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.484 -0.78 . . . . 14.82 112.953 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 p -66.56 133.35 50.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.794 0.807 . . . . 14.539999999999999 110.557 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 34.6 mtp85 -82.84 139.12 33.67 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.096 -0.957 . . . . 16.75 111.183 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -47.26 -43.11 21.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.486 0.585 . . . . 11.99 112.538 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.53 -32.24 71.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.227 1.011 . . . . 14.449999999999999 111.904 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.6 -41.64 65.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.522 0.677 . . . . 16.440000000000001 109.215 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.67 -21.09 61.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.381 -1.282 . . . . 13.77 111.104 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.34 29.12 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.341 -0.933 . . . . 13.81 112.468 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.78 85.41 7.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.329 -1.36 . . . . 13.039999999999999 107.329 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -68.72 154.58 41.69 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.872 -1.058 . . . . 15.67 110.576 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 t -49.57 -41.52 41.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.261 0.624 . . . . 15.289999999999999 112.311 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -48.52 85.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.214 0.531 . . . . 16.66 110.66 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.3 -36.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.621 -0.718 . . . . 14.140000000000001 109.585 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -59.43 -44.34 92.93 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.377 -0.829 . . . . 12.0 110.727 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -59.93 -46.45 89.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 13.970000000000001 110.533 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -59.27 -44.61 92.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.99 -0.55 . . . . 15.69 111.259 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.432 ' O ' HG13 ' A' ' 48' ' ' ILE . 7.5 t90 -60.13 -48.23 82.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.547 1.139 . . . . 11.69 110.051 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 41' ' ' ALA . 30.3 mm -56.94 -45.73 83.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.895 -0.593 . . . . 11.16 111.03 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 18.8 mmm180 -62.82 -31.07 71.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.429 -0.35 . . . . 16.649999999999999 110.97 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.13 -38.11 69.33 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 110.026 -0.361 . . . . 14.15 110.026 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 44' ' ' TRP . 68.7 mt -61.68 -50.77 78.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.327 -0.99 . . . . 10.800000000000001 108.327 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -54.59 -39.03 67.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.631 -1.168 . . . . 12.98 112.147 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -85.92 -37.32 19.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.73 1.011 . . . . 17.52 113.73 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -87.61 -24.48 23.96 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.508 1.299 . . . . 14.869999999999999 114.508 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.93 -10.45 19.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.004 0.742 . . . . 12.199999999999999 113.004 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 63.57 70.72 0.52 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 16.710000000000001 112.304 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.1 174.72 13.29 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.734 -1.209 . . . . 12.199999999999999 107.734 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.74 105.1 9.04 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 118.565 0.62 . . . . 16.059999999999999 111.148 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 74' ' ' VAL . 27.3 mm -72.51 124.23 90.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 O-C-N 121.82 -0.55 . . . . 11.390000000000001 111.91 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.05 126.48 14.53 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.471 -2.165 . . . . 12.6 106.471 167.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 2.18 0.55 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 115.792 1.775 . . . . 12.52 115.792 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -97.84 10.96 38.86 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.561 -0.712 . . . . 14.140000000000001 110.588 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.45 -55.89 27.52 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 121.373 -0.441 . . . . 10.76 112.242 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.42 -29.02 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.798 0.809 . . . . 11.0 110.858 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.41 -36.56 68.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.485 -0.78 . . . . 16.420000000000002 110.627 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 m -84.99 -40.96 16.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.154 -0.475 . . . . 13.35 110.7 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HE1' ' CE3' ' A' ' 73' ' ' TRP . 68.5 m-85 -111.87 102.45 53.65 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.618 -0.882 . . . . 12.23 108.618 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 89.4 Cg_endo -83.5 4.08 7.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.286 1.991 . . . . 13.06 112.46 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.9 t -123.49 120.9 61.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.388 -1.338 . . . . 12.949999999999999 107.388 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -59.21 -32.5 70.0 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.335 0.865 . . . . 10.92 113.335 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -62.45 -46.32 89.06 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.994 0.184 . . . . 14.32 110.822 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.01 67.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.406 0.622 . . . . 10.93 110.986 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.76 -24.26 48.91 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.254 1.022 . . . . 8.8100000000000005 113.095 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.4 p -60.28 -23.93 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.983 -0.448 . . . . 9.3499999999999996 112.201 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.59 -29.2 69.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.802 0.81 . . . . 11.630000000000001 109.621 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CE3' ' HE1' ' A' ' 64' ' ' TYR . 43.6 t-105 -87.32 -24.62 24.24 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.34 -0.845 . . . . 10.550000000000001 110.46 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' HA ' HD11 ' A' ' 56' ' ' ILE . 42.6 t -84.0 -53.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.188 -0.46 . . . . 8.3000000000000007 110.916 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.8 66.63 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.866 -0.606 . . . . 9.5800000000000001 114.097 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 t -75.75 -17.82 59.76 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.282 -0.54 . . . . 10.23 110.77 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' A' ' 56' ' ' ILE . 69.5 mm-40 -84.76 -7.81 59.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.45 -0.341 . . . . 10.43 111.332 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.806 -0.442 . . . . 10.970000000000001 109.806 178.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 121.516 0.674 . . . . 10.050000000000001 110.913 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.85 -46.2 19.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.317 -0.856 . . . . 11.220000000000001 110.412 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -54.01 -44.75 71.19 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.0 -0.545 . . . . 11.380000000000001 110.879 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -58.28 -47.37 83.86 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.272 -0.877 . . . . 9.6500000000000004 112.934 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -35.58 60.47 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.681 -0.807 . . . . 10.43 111.353 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.9 m -58.38 -47.98 82.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.095 -0.502 . . . . 10.210000000000001 110.858 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.495 HG21 HG11 ' A' ' 178' ' ' VAL . 47.0 mt -63.0 -49.62 82.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 O-C-N 123.353 0.408 . . . . 8.1300000000000008 110.001 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -51.7 -57.07 10.27 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.953 0.783 . . . . 8.4600000000000009 112.911 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -67.82 -36.43 80.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.796 0.331 . . . . 10.859999999999999 111.471 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.39 -36.26 76.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.617 -0.512 . . . . 11.449999999999999 109.617 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.37 -39.08 91.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.629 -0.878 . . . . 7.6200000000000001 108.629 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.95 -45.98 92.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.138 -0.937 . . . . 11.619999999999999 110.438 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.97 -32.56 72.23 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.419 -0.355 . . . . 11.630000000000001 111.02 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -65.45 -51.51 59.67 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.892 -0.41 . . . . 9.1400000000000006 109.892 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.4 tp -64.14 -42.84 96.63 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.451 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.14 91.42 Favored Glycine 0 CA--C 1.518 0.227 0 O-C-N 123.146 0.279 . . . . 12.07 113.099 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.25 -45.35 93.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.862 0.839 . . . . 12.32 109.392 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 144' ' ' THR . 45.2 tp -70.02 -45.99 66.04 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.525 -1.216 . . . . 11.77 110.739 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.3 tp -72.82 -11.0 60.43 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.934 0.894 . . . . 13.52 110.948 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.0 t80 85.97 -34.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.163 1.785 . . . . 16.559999999999999 111.665 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.5 tp -165.12 149.81 9.08 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.963 -1.495 . . . . 15.74 106.963 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -86.99 122.03 71.37 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 105.876 -1.898 . . . . 14.199999999999999 105.876 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.38 -3.07 12.25 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 122.65 2.233 . . . . 14.18 111.446 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -162.65 -107.6 0.21 Allowed Glycine 0 C--N 1.291 -1.925 0 CA-C-N 114.773 -1.103 . . . . 14.029999999999999 110.701 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -155.87 43.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.199 -2.149 . . . . 16.370000000000001 105.199 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.0 mt 62.15 -178.21 0.13 Allowed 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.085 -1.416 . . . . 12.449999999999999 111.088 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -148.34 146.51 28.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.736 -1.209 . . . . 14.43 107.736 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.8 t -76.23 91.44 3.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 14.32 109.689 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.37 -92.25 0.15 Allowed Glycine 0 CA--C 1.49 -1.511 0 N-CA-C 108.43 -1.868 . . . . 13.75 108.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 68.23 128.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.336 1.454 . . . . 12.699999999999999 112.079 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.54 -176.32 3.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.608 -0.724 . . . . 16.379999999999999 109.689 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 66.9 m-85 -63.74 -27.35 69.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.532 0.682 . . . . 13.300000000000001 109.652 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.28 -25.24 65.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.736 -1.12 . . . . 16.25 111.216 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.32 -7.33 55.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.419 -0.81 . . . . 15.869999999999999 110.23 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.1 mt -106.59 9.3 31.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.473 0.654 . . . . 13.65 110.093 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.64 -175.11 15.94 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.584 -0.734 . . . . 14.16 111.774 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 84.7 mtp -107.09 -9.09 16.27 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.604 0.716 . . . . 15.449999999999999 109.979 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -118.58 159.97 22.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.292 -0.867 . . . . 13.630000000000001 108.92 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.1 p -81.4 -16.34 52.46 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.776 0.798 . . . . 13.9 109.866 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.41 -36.37 77.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.823 -1.08 . . . . 13.81 111.087 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 121' ' ' LEU . 7.2 p -63.57 -42.44 98.32 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 116.159 -0.473 . . . . 11.48 110.428 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.08 -41.59 70.19 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.536 -0.756 . . . . 10.35 112.554 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.1 p -65.3 -46.64 79.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 117.082 0.441 . . . . 12.199999999999999 111.456 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -59.92 -49.53 77.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 11.859999999999999 110.389 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.585 ' O ' HG23 ' A' ' 152' ' ' VAL . 13.9 t90 -62.72 -51.83 65.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.567 -0.742 . . . . 9.3200000000000003 112.121 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.478 ' SD ' HG13 ' A' ' 165' ' ' ILE . 39.6 ttm -63.79 -37.08 86.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.189 0.44 . . . . 9.5 112.189 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -69.43 -29.07 66.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.493 -0.483 . . . . 13.91 110.533 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.31 -42.47 82.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.688 -0.965 . . . . 9.8800000000000008 110.688 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 148' ' ' TRP . 22.1 t -58.66 -48.31 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.76 -1.2 . . . . 9.2699999999999996 107.76 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.8 t -57.71 -52.7 64.39 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.187 -1.37 . . . . 11.460000000000001 110.906 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -66.35 -44.14 84.12 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.762 -0.654 . . . . 15.039999999999999 111.94 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -65.61 -37.77 87.55 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.039 0.755 . . . . 11.82 113.039 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 110' ' ' ILE . 97.3 m-85 -93.31 9.91 34.27 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.226 0.536 . . . . 11.970000000000001 111.894 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 57.39 43.21 23.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.516 1.126 . . . . 14.24 112.355 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -122.17 155.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.391 -0.596 . . . . 12.619999999999999 109.391 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -97.91 97.29 8.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.115 -0.698 . . . . 16.390000000000001 109.115 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.17 125.68 54.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.491 -0.929 . . . . 12.32 108.491 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.97 136.01 40.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.263 -0.426 . . . . 14.06 111.106 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.86 -11.46 59.99 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 121.774 0.797 . . . . 12.640000000000001 110.421 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.98 -12.03 61.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.139 0.971 . . . . 15.68 109.518 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.2 -10.22 55.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.474 -0.785 . . . . 12.720000000000001 109.967 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.478 HG13 ' SD ' ' A' ' 149' ' ' MET . 11.4 mt -56.51 -32.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.81 1.244 . . . . 12.16 109.965 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.29 -6.37 59.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.709 -1.132 . . . . 15.08 109.761 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 88.3 m -94.87 -18.34 21.25 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.052 -0.976 . . . . 14.67 109.582 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.586 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.8 m0 -117.78 98.96 52.09 Favored Pre-proline 0 C--N 1.318 -0.793 0 O-C-N 121.927 -0.483 . . . . 12.68 111.003 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 83.6 Cg_endo -87.12 3.28 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.556 2.171 . . . . 14.34 112.205 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -139.57 143.9 37.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.88 0.848 . . . . 12.91 111.655 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.36 -28.4 68.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.067 1.747 . . . . 9.8900000000000006 112.949 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.31 -26.72 60.34 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.047 0.451 . . . . 12.5 110.907 -176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -67.1 -44.98 78.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 113.575 0.954 . . . . 11.039999999999999 113.575 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 174' ' ' LEU . 2.6 pt? -75.32 -25.85 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.0 -1.08 . . . . 8.5 110.585 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.36 92.78 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.888 -0.596 . . . . 7.7000000000000002 111.186 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.56 -26.12 32.68 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.008 -0.677 . . . . 10.380000000000001 110.61 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.586 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 9.6 tp10 -68.54 -54.13 18.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.543 -0.298 . . . . 11.970000000000001 110.802 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -50.02 -43.82 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 112.718 0.636 . . . . 9.8000000000000007 112.718 -176.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 -41.92 92.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.994 0.426 . . . . 10.83 111.399 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -71.87 -29.3 64.22 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.019 -0.537 . . . . 13.5 110.338 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 5.4 mmp_? -65.06 -42.74 93.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.021 -0.536 . . . . 14.84 109.946 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.62 -51.9 23.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.19 -0.459 . . . . 13.35 111.217 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 112.293 0.479 . . . . 13.51 112.293 -178.842 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.719 0.295 . . . . 14.98 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.75 -42.69 99.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.278 0.473 . . . . 15.789999999999999 112.278 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -58.09 -44.43 87.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.018 0.927 . . . . 12.02 110.01 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.32 72.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.786 -0.643 . . . . 11.02 110.887 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 27.2 tt0 -67.36 -43.82 80.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.016 -0.364 . . . . 16.07 110.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 51' ' ' HIS . 30.2 t80 -53.78 -39.02 65.05 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.409 1.084 . . . . 13.93 110.933 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 mt -82.05 -39.19 23.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.777 -0.647 . . . . 10.710000000000001 110.96 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -64.01 -22.66 67.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.379 0.881 . . . . 14.02 113.379 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.58 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 55.3 mt-30 -57.3 -48.42 78.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.727 0.298 . . . . 16.289999999999999 111.568 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -75.52 -34.2 60.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.097 0.475 . . . . 12.91 110.589 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.89 -43.7 95.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.562 -0.745 . . . . 12.77 109.973 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.69 80.21 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.159 -0.928 . . . . 15.19 111.042 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.91 -44.82 30.21 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.152 -0.476 . . . . 16.260000000000002 110.845 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -70.63 -35.0 72.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.001 -0.545 . . . . 15.449999999999999 112.382 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.83 -15.68 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.531 0.681 . . . . 16.16 111.655 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 64.28 45.64 3.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.375 -1.284 . . . . 20.559999999999999 109.703 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -125.47 165.37 18.58 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.144 -1.058 . . . . 16.629999999999999 108.144 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.11 126.85 55.7 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.796 0.332 . . . . 20.190000000000001 110.736 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 38.8 Cg_endo -65.76 -22.52 56.91 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.096 2.531 . . . . 16.600000000000001 113.387 -174.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.88 67.97 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 121.001 -0.618 . . . . 17.739999999999998 112.632 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -100.96 8.43 43.06 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.253 0.549 . . . . 20.23 111.597 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 22' ' ' PRO . 14.9 tt -85.81 119.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.876 -1.157 . . . . 15.98 107.876 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -74.96 144.17 43.32 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.744 -0.662 . . . . 19.329999999999998 110.049 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.53 -16.3 23.81 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.642 1.177 . . . . 14.93 113.914 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.2 6.53 26.95 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 121.032 -0.604 . . . . 14.82 112.264 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -71.01 148.57 47.48 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.473 0.654 . . . . 14.539999999999999 110.875 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 99.6 mtt180 -110.68 137.23 48.61 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.02 0.914 . . . . 16.75 111.978 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -47.61 -43.58 25.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.315 -1.766 . . . . 11.99 112.827 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -68.97 -29.54 67.78 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.508 -0.314 . . . . 14.449999999999999 111.406 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.72 -23.09 34.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.207 -0.664 . . . . 16.440000000000001 109.207 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.88 -39.1 66.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.451 -0.795 . . . . 13.77 109.981 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 14.26 1.05 Allowed Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.266 -0.968 . . . . 13.81 112.824 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 168.8 19.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.345 0.593 . . . . 13.039999999999999 110.408 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.4 163.08 40.57 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.234 -2.136 . . . . 15.67 105.234 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -67.03 -31.0 71.24 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 119.579 1.081 . . . . 15.289999999999999 109.565 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.36 -43.63 80.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.095 -0.502 . . . . 16.66 109.663 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.17 -33.69 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.672 -0.694 . . . . 14.140000000000001 109.944 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.92 95.47 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.814 -0.63 . . . . 12.0 109.776 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.99 -22.54 65.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.703 -0.681 . . . . 13.970000000000001 111.369 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.52 -50.83 8.93 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.253 0.549 . . . . 15.69 110.383 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -67.33 -35.68 79.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 C-N-CA 124.417 1.087 . . . . 11.69 111.662 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 48' ' ' ILE . 8.8 tp -58.63 -40.28 78.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-O 120.894 0.378 . . . . 11.16 110.377 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 41.7 ttm180 -69.01 -33.79 74.22 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.304 0.574 . . . . 16.649999999999999 110.14 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.36 -27.94 47.06 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 112.495 0.554 . . . . 14.15 112.495 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 45' ' ' ILE . 29.7 pt -76.37 -29.54 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 119.219 -0.992 . . . . 10.800000000000001 109.032 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.13 -40.03 92.27 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-N 115.377 -0.829 . . . . 12.98 110.372 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 26.3 mtpp -65.22 -49.64 68.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.832 -0.622 . . . . 17.52 110.015 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 44.7 m80 -59.64 -43.86 93.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.551 0.945 . . . . 14.869999999999999 113.551 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -92.67 -4.79 52.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.162 1.171 . . . . 12.199999999999999 114.162 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.11 45.64 20.47 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.044 1.402 . . . . 16.710000000000001 108.891 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.6 tp -119.87 165.92 13.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.206 -1.405 . . . . 12.199999999999999 107.206 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -127.33 74.51 1.52 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.139 0.495 . . . . 16.059999999999999 109.935 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.483 HG12 ' OE1' ' A' ' 77' ' ' GLN . 58.4 mt -89.45 126.36 58.57 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.303 -0.999 . . . . 11.390000000000001 108.303 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.6 Cg_exo -67.2 156.31 66.85 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.002 1.801 . . . . 12.6 109.084 171.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.96 -0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.434 1.272 . . . . 12.52 114.434 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.87 -12.04 60.02 Favored 'General case' 0 C--O 1.24 0.554 0 O-C-N 122.453 -0.154 . . . . 14.140000000000001 110.943 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.6 62.69 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 121.304 -0.474 . . . . 10.76 113.079 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.02 35.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.115 0.96 . . . . 11.0 108.716 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -85.42 -44.06 13.08 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.38 -0.825 . . . . 16.420000000000002 111.657 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -136.0 25.58 3.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.53 0.681 . . . . 13.35 111.434 -174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -123.34 89.92 50.76 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.73 -1.211 . . . . 12.23 107.73 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.8 Cg_endo -82.99 -3.35 11.07 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.286 1.991 . . . . 13.06 115.697 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.41 120.38 64.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 119.381 0.992 . . . . 12.949999999999999 109.347 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -61.37 -35.46 77.52 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.55 -0.75 . . . . 10.92 111.93 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.82 -29.98 69.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.523 . . . . 14.32 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.62 33.78 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.821 0.82 . . . . 10.93 109.423 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 50.7 t80 -87.82 -28.02 21.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.301 -0.863 . . . . 8.8100000000000005 112.04 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 p -63.4 -36.65 84.43 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.612 -0.68 . . . . 9.3499999999999996 111.723 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -75.34 -23.69 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 11.630000000000001 110.264 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 49.4 t90 -64.05 -47.89 78.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.053 -1.092 . . . . 10.550000000000001 108.053 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 90.9 t -69.22 -43.62 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 CA-C-N 115.594 -0.73 . . . . 8.3000000000000007 109.235 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.76 -43.9 80.49 Favored Glycine 0 C--O 1.238 0.387 0 CA-C-N 115.491 -0.777 . . . . 9.5800000000000001 113.319 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -67.58 -33.59 75.33 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.93 0.365 . . . . 10.23 111.183 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.483 ' OE1' HG12 ' A' ' 56' ' ' ILE . 3.7 pt20 -89.67 -2.37 58.27 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.767 -1.173 . . . . 10.43 112.563 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 90.6 mt . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.243 0.544 . . . . 10.970000000000001 110.07 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 107.3 -1.37 . . . . 10.050000000000001 107.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.44 -46.13 26.32 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.549 1.14 . . . . 11.220000000000001 113.555 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.91 -46.64 77.54 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.303 0.483 . . . . 11.380000000000001 112.303 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -75.43 -30.23 59.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.195 -0.298 . . . . 9.6500000000000004 110.195 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.59 -46.08 91.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.003 0.521 . . . . 10.43 111.073 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 m -56.54 -38.44 71.89 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.23 0.538 . . . . 10.210000000000001 110.145 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.75 HG21 HG11 ' A' ' 178' ' ' VAL . 66.0 mt -73.59 -52.41 21.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.25 -0.887 . . . . 8.1300000000000008 109.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -54.88 -43.32 73.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.736 0.814 . . . . 8.4600000000000009 111.693 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.44 -40.93 93.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.088 -0.506 . . . . 10.859999999999999 110.397 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.3 -36.53 66.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.669 . . . . 11.449999999999999 109.608 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.48 -45.21 95.2 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.151 0.98 . . . . 7.6200000000000001 108.406 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.83 -45.3 95.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.385 -0.825 . . . . 11.619999999999999 110.385 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -65.31 -39.41 92.45 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.142 -0.481 . . . . 11.630000000000001 111.056 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -69.08 -37.88 78.71 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.589 -0.278 . . . . 9.1400000000000006 111.174 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.1 tp -65.21 -48.48 73.23 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.607 -0.516 . . . . 10.06 109.607 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.89 -49.14 77.31 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.79 -0.641 . . . . 12.07 112.148 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -61.36 -38.85 88.45 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 123.457 0.703 . . . . 12.32 111.322 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 148' ' ' TRP . 51.9 tp -67.54 -43.05 81.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.977 -0.556 . . . . 11.77 110.012 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.52 -64.34 0.9 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.293 -0.867 . . . . 13.52 110.252 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.0 t80 168.02 -46.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.301 -2.111 . . . . 16.559999999999999 105.301 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -168.38 143.94 3.62 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 103.885 -2.635 . . . . 15.74 103.885 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.61 136.37 20.79 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.065 -0.717 . . . . 14.199999999999999 109.065 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.07 6.06 5.56 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.305 2.003 . . . . 14.18 112.378 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 33.76 74.6 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 110.354 -1.098 . . . . 14.029999999999999 110.354 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -102.7 20.45 17.24 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.383 1.087 . . . . 16.370000000000001 109.259 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.8 pt? -96.64 176.27 6.07 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.158 -0.928 . . . . 12.449999999999999 108.981 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 73.1 -58.31 0.6 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.468 1.107 . . . . 14.43 110.547 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -89.64 5.12 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.078 -1.453 . . . . 14.32 107.078 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.99 135.0 5.35 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.405 -1.478 . . . . 13.75 109.405 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 172' ' ' LYS . . . -179.66 138.21 0.13 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.988 1.315 . . . . 12.699999999999999 107.739 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' HG22 ' A' ' 170' ' ' THR . 3.9 pt20 -170.01 173.9 5.78 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 118.524 -0.751 . . . . 16.379999999999999 109.879 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 55.3 m-85 -63.32 -18.87 64.08 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 119.738 1.154 . . . . 13.300000000000001 112.534 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.2 -10.08 59.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.06 -0.973 . . . . 16.25 112.373 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.258 14.3 p30 -70.46 -64.95 0.8 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.109 -0.636 . . . . 15.869999999999999 112.705 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 pp -87.3 -9.8 53.99 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.687 0.756 . . . . 13.65 109.019 173.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -83.1 70.56 3.17 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.978 -1.01 . . . . 14.16 113.701 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 92.3 mmm -109.06 -65.15 1.17 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.06 -1.459 . . . . 15.449999999999999 107.06 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.54 146.01 39.36 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.167 -1.79 . . . . 13.630000000000001 106.167 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -73.33 -16.56 61.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 113.119 0.785 . . . . 13.9 113.119 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.63 -52.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.021 -0.733 . . . . 13.81 109.021 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -63.82 -31.97 73.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.99 -0.55 . . . . 11.48 111.627 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.08 78.27 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.705 -1.236 . . . . 10.35 110.517 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 m -61.39 -45.33 94.82 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.761 -0.829 . . . . 12.199999999999999 108.761 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 150' ' ' ARG . 86.1 mm-40 -59.66 -41.16 89.96 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.498 -0.774 . . . . 11.859999999999999 111.514 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.429 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.5 t90 -65.48 -47.29 76.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.322 -0.854 . . . . 9.3200000000000003 110.907 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.8 mtp -69.55 -27.35 65.07 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.291 -0.564 . . . . 9.5 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 2.7 tmm_? -59.37 -43.91 92.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.913 -1.144 . . . . 13.91 107.913 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.35 -54.3 20.8 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.364 -0.834 . . . . 9.8800000000000008 111.474 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.19 -46.85 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.574 0.749 . . . . 9.2699999999999996 112.385 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 p -64.54 -52.25 58.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.796 0.331 . . . . 11.460000000000001 111.864 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -71.95 -38.49 69.77 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.807 0.299 . . . . 15.039999999999999 111.807 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -68.75 -31.2 70.07 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.704 0.631 . . . . 11.82 112.704 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -101.38 1.81 38.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.992 0.425 . . . . 11.970000000000001 111.845 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 t 60.56 37.2 19.64 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.215 1.006 . . . . 14.24 111.633 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -119.89 138.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.806 -0.813 . . . . 12.619999999999999 108.806 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.95 95.66 10.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.607 0.718 . . . . 16.390000000000001 110.546 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.64 129.37 54.56 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.928 -1.138 . . . . 12.32 107.928 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.47 56.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.296 -0.631 . . . . 14.06 109.296 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.13 63.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.289 0.566 . . . . 12.640000000000001 111.208 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.81 -4.44 58.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.701 -0.682 . . . . 15.68 110.488 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -74.14 0.62 13.33 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.98 0.363 . . . . 12.720000000000001 111.98 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.8 pt -64.96 -14.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.885 0.85 . . . . 12.16 109.379 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -103.31 -3.56 25.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.093 -0.958 . . . . 15.08 109.875 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.3 m -99.42 -40.7 7.74 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.236 -0.654 . . . . 14.67 109.236 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.0 m-90 -121.37 69.05 20.96 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.663 -0.866 . . . . 12.68 108.663 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' PHE . 1.5 Cg_endo -87.12 40.92 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.988 2.458 . . . . 14.34 113.361 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.403 HG22 ' C ' ' A' ' 134' ' ' GLN . 36.1 p -154.62 143.28 20.74 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 105.227 -2.138 . . . . 12.91 105.227 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.61 -17.02 64.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.356 0.502 . . . . 9.8900000000000006 112.356 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.455 ' HG3' ' CB ' ' A' ' 133' ' ' ALA . 92.1 mttt -72.41 -44.24 62.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 120.824 -0.351 . . . . 12.5 110.828 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 19.1 m -63.75 -43.93 95.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 123.652 0.595 . . . . 11.039999999999999 110.186 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.5 -48.03 71.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.977 -0.556 . . . . 8.5 109.843 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.54 72.81 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.518 0.562 . . . . 7.7000000000000002 112.518 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 32.8 t70 -83.25 -29.87 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.558 -0.457 . . . . 10.380000000000001 111.308 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 173' ' ' SER . 0.2 OUTLIER -57.73 -49.22 77.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.654 0.782 . . . . 11.970000000000001 109.906 -177.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -56.96 -35.95 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.699 -0.682 . . . . 9.8000000000000007 111.556 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.1 -34.89 79.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.391 0.615 . . . . 10.83 110.314 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 88.8 mtt180 -74.27 -43.72 55.74 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.025 -0.989 . . . . 13.5 108.642 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -64.49 -40.85 96.44 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.396 -1.274 . . . . 14.84 111.192 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 183' ' ' GLN . 34.5 m -84.18 -39.47 14.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 113.196 0.813 . . . . 13.35 113.196 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 182' ' ' VAL . 92.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 120.941 -0.304 . . . . 13.51 111.172 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 111.89 0.33 . . . . 14.98 111.89 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.26 -35.88 80.31 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 122.652 0.381 . . . . 15.789999999999999 110.423 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.6 m -57.5 -41.57 81.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 120.847 0.356 . . . . 12.02 111.106 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -69.56 -47.39 63.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.049 -0.523 . . . . 11.02 109.633 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.08 -38.33 85.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.739 -0.664 . . . . 16.07 111.85 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.29 -46.2 74.32 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.961 0.41 . . . . 13.93 110.746 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.24 -35.53 78.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.411 -0.359 . . . . 10.710000000000001 111.793 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 25' ' ' ILE . 85.5 mtt180 -61.97 -41.61 98.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 14.02 108.97 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -61.26 -51.18 70.0 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.058 -0.973 . . . . 16.289999999999999 110.141 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 t -56.49 -51.48 68.32 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.944 0.778 . . . . 12.91 110.838 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.62 -52.53 65.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 12.77 110.582 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.17 77.3 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.38 0.511 . . . . 15.19 112.38 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.76 78.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.69 0.281 . . . . 16.260000000000002 111.026 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 ptm -70.98 -24.5 62.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.5 -0.48 . . . . 15.449999999999999 111.865 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.36 0.7 55.69 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.028 0.381 . . . . 16.16 112.028 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 56.73 42.37 26.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.553 1.141 . . . . 20.559999999999999 111.813 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.8 m -117.84 174.53 6.13 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.984 -1.007 . . . . 16.629999999999999 109.8 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -94.76 124.37 54.95 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.575 -0.739 . . . . 20.190000000000001 110.924 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 -17.96 15.91 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.272 2.648 . . . . 16.600000000000001 113.501 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.41 43.02 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.143 -1.183 . . . . 17.739999999999998 110.143 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.7 69.7 7.73 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.542 0.687 . . . . 20.23 109.395 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 11' ' ' ARG . 10.0 tp -120.92 153.87 24.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.74 -0.663 . . . . 15.98 109.635 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.63 87.36 2.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 106.762 -1.569 . . . . 19.329999999999998 106.762 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.88 -27.57 60.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.399 1.48 . . . . 14.93 113.061 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.96 -11.79 80.77 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.234 -0.984 . . . . 14.82 112.571 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -81.92 144.94 30.59 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.388 0.613 . . . . 14.539999999999999 109.723 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 29.5 ptt180 -71.19 146.54 49.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.071 -0.968 . . . . 16.75 110.471 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -48.07 -34.46 9.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.971 1.709 . . . . 11.99 113.144 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.56 -38.24 71.65 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.228 1.011 . . . . 14.449999999999999 110.036 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.3 2.41 55.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.565 0.746 . . . . 16.440000000000001 110.927 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.6 0.83 56.73 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.113 -0.699 . . . . 13.77 109.113 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.93 11.1 50.92 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.303 -0.862 . . . . 13.81 111.95 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 175.74 5.62 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.084 0.945 . . . . 13.039999999999999 111.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -141.51 159.73 41.61 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.984 -1.916 . . . . 15.67 106.828 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -55.9 -42.98 76.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 118.947 0.794 . . . . 15.289999999999999 111.111 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.89 -51.42 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.195 -0.911 . . . . 16.66 110.577 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.22 -41.27 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.603 -0.726 . . . . 14.140000000000001 110.203 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.44 87.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 12.0 111.174 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.87 -30.42 71.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.191 0.519 . . . . 13.970000000000001 111.185 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.6 -43.92 16.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.431 0.634 . . . . 15.69 110.659 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -57.7 -44.04 85.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 124.944 1.298 . . . . 11.69 111.278 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.63 -31.1 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 121.306 -0.158 . . . . 11.16 110.987 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 1.4 mmp_? -63.1 -39.71 95.51 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.945 -0.391 . . . . 16.649999999999999 109.945 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -38.06 79.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.929 0.395 . . . . 14.15 110.356 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.8 -42.33 88.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.966 -0.753 . . . . 10.800000000000001 108.966 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.536 ' ND2' ' HB ' ' A' ' 56' ' ' ILE . 14.6 m120 -62.01 -36.26 81.0 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.59 -0.732 . . . . 12.98 111.395 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 46' ' ' ARG . 75.6 mmtt -78.3 -49.71 13.16 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.738 -0.21 . . . . 17.52 110.725 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -65.27 -42.38 93.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.301 -0.409 . . . . 14.869999999999999 111.759 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -85.51 -13.12 50.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.289 0.477 . . . . 12.199999999999999 112.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 57.32 38.36 28.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 16.710000000000001 109.956 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.6 tp -122.25 138.59 54.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.181 -0.918 . . . . 12.199999999999999 110.183 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -70.7 57.67 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.206 1.403 . . . . 16.059999999999999 112.573 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' HB ' ' ND2' ' A' ' 49' ' ' ASN . 11.3 mt -88.68 122.85 68.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.583 -0.698 . . . . 11.390000000000001 111.43 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 5.2 Cg_exo -80.38 162.95 22.25 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.138 1.892 . . . . 12.6 108.765 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.31 -6.91 15.68 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.513 0.673 . . . . 12.52 110.617 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 33.4 t70 -60.99 -27.91 68.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.217 -1.356 . . . . 14.140000000000001 111.671 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' NE1' ' A' ' 73' ' ' TRP . . . -55.86 -48.97 68.97 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 119.945 -1.122 . . . . 10.76 112.776 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -76.01 -28.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.043 0.925 . . . . 11.0 109.422 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 87.3 t80 -64.21 -41.15 97.17 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.809 -1.087 . . . . 16.420000000000002 110.832 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.525 HG23 ' CD2' ' A' ' 64' ' ' TYR . 11.4 t -94.79 -18.62 21.07 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 120.544 -0.462 . . . . 13.35 111.987 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CD2' HG23 ' A' ' 63' ' ' THR . 96.8 m-85 -128.6 96.44 30.12 Favored Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 121.909 -0.494 . . . . 12.23 110.758 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 86.9 Cg_endo -84.64 4.27 6.97 Favored 'Trans proline' 0 C--O 1.211 -0.831 0 C-N-CA 122.363 2.042 . . . . 13.06 111.922 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.54 122.56 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.917 -1.142 . . . . 12.949999999999999 107.917 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -60.92 -40.8 94.58 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.845 0.858 . . . . 10.92 112.345 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.16 -27.4 67.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.933 0.397 . . . . 14.32 111.247 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.25 -31.6 21.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.566 0.698 . . . . 10.93 109.58 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -70.87 -30.69 67.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 8.8100000000000005 111.794 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -64.09 -28.12 69.56 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.591 -0.693 . . . . 9.3499999999999996 111.145 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -74.23 -24.98 59.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.709 -0.678 . . . . 11.630000000000001 109.83 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.542 ' CZ3' ' HG3' ' A' ' 77' ' ' GLN . 20.6 t90 -64.49 -49.03 72.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.616 -1.253 . . . . 10.550000000000001 107.616 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.33 -43.92 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-N 115.079 -0.964 . . . . 8.3000000000000007 109.536 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.73 -40.63 95.17 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.778 -0.646 . . . . 9.5800000000000001 112.347 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.2 p -77.18 -8.87 58.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.788 0.662 . . . . 10.23 112.788 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.542 ' HG3' ' CZ3' ' A' ' 73' ' ' TRP . 16.8 mm-40 -93.32 -35.35 13.1 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.051 -0.405 . . . . 10.43 110.316 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--N 1.325 -0.498 0 N-CA-C 108.707 -0.849 . . . . 10.970000000000001 108.707 175.199 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.444 -0.736 0 CA-C-O 120.999 0.428 . . . . 10.050000000000001 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.19 87.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.843 -0.617 . . . . 11.220000000000001 110.898 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.44 ' OE1' ' HB ' ' A' ' 182' ' ' VAL . 8.1 tt0 -54.25 -51.84 63.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.664 0.786 . . . . 11.380000000000001 109.08 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.35 -45.99 90.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.928 -1.033 . . . . 9.6500000000000004 111.811 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.63 -39.38 91.1 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.053 0.454 . . . . 10.43 111.591 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -69.33 -51.43 37.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.014 -0.539 . . . . 10.210000000000001 110.262 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.823 HG21 HG11 ' A' ' 178' ' ' VAL . 54.6 mt -70.22 -27.02 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 116.267 -0.424 . . . . 8.1300000000000008 111.456 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.21 -38.78 80.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.559 0.695 . . . . 8.4600000000000009 109.551 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.76 -31.08 66.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.178 -0.919 . . . . 10.859999999999999 110.639 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -77.5 -35.86 53.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.45 -0.341 . . . . 11.449999999999999 110.465 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.8 -47.02 83.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.813 -0.81 . . . . 7.6200000000000001 108.813 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -52.17 -55.22 22.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.879 -1.055 . . . . 11.619999999999999 109.835 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.5 -44.08 95.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 11.630000000000001 112.581 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 t -63.35 -44.43 94.86 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.058 0.456 . . . . 9.1400000000000006 110.475 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.05 -42.99 83.86 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.36 -0.607 . . . . 10.06 109.36 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.05 -19.73 68.2 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 116.154 -0.475 . . . . 12.07 112.743 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -78.62 -38.87 38.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.201 -0.666 . . . . 12.32 109.201 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.4 tp -80.83 -45.4 16.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.705 -0.68 . . . . 11.77 110.748 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -83.03 -19.46 36.88 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.196 -0.911 . . . . 13.52 110.223 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.2 t80 73.22 -43.78 0.57 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.855 1.662 . . . . 16.559999999999999 112.209 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.5 tp -159.34 142.74 14.57 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.154 -0.684 . . . . 15.74 109.154 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.78 112.08 27.29 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.25 0.344 . . . . 14.199999999999999 110.251 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.53 -9.66 20.11 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.888 2.392 . . . . 14.18 112.336 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.13 69.01 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.582 -1.007 . . . . 14.029999999999999 110.582 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 78.27 27.17 0.53 Allowed 'General case' 0 C--O 1.247 0.955 0 C-N-CA 125.008 1.323 . . . . 16.370000000000001 110.666 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.0 mt 56.85 73.05 0.47 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.647 -1.615 . . . . 12.449999999999999 112.267 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -86.33 151.59 23.45 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.116 -1.402 . . . . 14.43 111.39 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -37.33 67.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.83 -1.077 . . . . 14.32 110.262 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.17 62.65 4.53 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 110.771 -0.931 . . . . 13.75 110.771 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.4 143.79 28.48 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.458 -0.571 . . . . 12.699999999999999 109.458 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -137.52 139.75 40.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.979 -0.748 . . . . 16.379999999999999 108.979 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 12.2 p90 -63.32 -6.87 5.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.733 0.813 . . . . 13.300000000000001 112.806 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.84 -61.05 2.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.172 0.511 . . . . 16.25 110.039 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.63 -20.98 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.087 -0.506 . . . . 15.869999999999999 110.344 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.02 14.47 15.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.932 -0.577 . . . . 13.65 111.468 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.42 60.02 4.87 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.957 -0.857 . . . . 14.16 110.957 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.03 152.21 51.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.469 -1.308 . . . . 15.449999999999999 107.469 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.25 39.87 18.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.192 0.932 . . . . 13.630000000000001 111.175 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 p -77.62 -32.81 53.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.219 -0.9 . . . . 13.9 112.138 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.1 -50.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.383 -0.969 . . . . 13.81 108.383 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -72.18 -16.14 61.96 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.34 -0.846 . . . . 11.48 111.303 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.69 -22.09 77.99 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.216 -0.754 . . . . 10.35 111.216 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 82.2 p -66.82 -45.87 76.96 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.182 -1.044 . . . . 12.199999999999999 108.182 175.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -61.75 -38.35 87.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.136 -0.938 . . . . 11.859999999999999 110.147 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.459 ' O ' HG23 ' A' ' 152' ' ' VAL . 12.4 t90 -56.09 -54.09 49.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 9.3200000000000003 110.308 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 43.6 ttm -66.76 -30.83 71.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.242 0.339 . . . . 9.5 111.543 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 23.3 mmm180 -58.4 -50.16 74.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 13.91 109.189 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.52 -44.75 96.49 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.654 -0.579 . . . . 9.8800000000000008 111.654 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 148' ' ' TRP . 80.4 t -57.29 -48.67 81.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 123.208 0.603 . . . . 9.2699999999999996 111.136 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.2 p -71.19 -31.14 67.27 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.816 0.341 . . . . 11.460000000000001 111.526 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.61 -44.91 63.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.027 0.441 . . . . 15.039999999999999 110.37 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -66.44 -48.2 70.74 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.791 0.663 . . . . 11.82 112.791 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -84.41 -0.24 52.01 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.171 0.434 . . . . 11.970000000000001 112.171 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.5 p 54.43 33.43 18.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.204 1.401 . . . . 14.24 112.482 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.3 pt -109.61 153.55 11.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.541 -0.754 . . . . 12.619999999999999 110.308 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.09 95.53 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.185 0.517 . . . . 16.390000000000001 110.46 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.98 120.81 26.72 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.006 -0.738 . . . . 12.32 109.006 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 134.74 38.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.903 -0.777 . . . . 14.06 108.903 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.32 -7.86 21.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.749 0.785 . . . . 12.640000000000001 111.661 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.3 -19.96 65.96 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.881 0.872 . . . . 15.68 109.711 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -59.8 -19.46 50.85 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.659 0.985 . . . . 12.720000000000001 113.659 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.5 pt -70.03 -2.31 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.764 -0.585 . . . . 12.16 111.822 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -122.53 23.69 9.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.743 0.306 . . . . 15.08 110.647 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 164' ' ' ALA . 10.3 t -147.07 20.75 1.24 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.503 -0.479 . . . . 14.67 111.088 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -134.94 103.54 10.79 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 108.552 -0.907 . . . . 12.68 108.552 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.524 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 17.2 Cg_exo -69.19 -33.09 19.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.801 2.334 . . . . 14.34 113.37 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -97.56 155.7 16.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.476 -0.784 . . . . 12.91 110.938 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -81.79 -32.28 31.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.114 -0.948 . . . . 9.8900000000000006 111.876 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -78.11 -5.6 52.09 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.751 0.649 . . . . 12.5 112.751 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.8 p -54.28 -35.52 62.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.251 1.02 . . . . 11.039999999999999 112.46 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 7.3 tt -60.7 -30.79 70.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.184 0.594 . . . . 8.5 110.22 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.48 59.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.259 -0.428 . . . . 7.7000000000000002 110.369 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.29 -30.22 30.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.845 -0.428 . . . . 10.380000000000001 109.845 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 5.3 mm-40 -57.25 -59.97 4.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 11.970000000000001 109.309 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 110' ' ' ILE . 7.6 p -63.96 -37.16 79.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.595 -1.184 . . . . 9.8000000000000007 111.843 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.22 -39.32 86.24 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.397 0.617 . . . . 10.83 110.441 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -74.28 -41.09 61.77 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.967 -1.015 . . . . 13.5 110.078 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.51 ' HA ' ' HE ' ' A' ' 181' ' ' ARG . 3.3 mmp_? -69.18 -52.91 23.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.764 -0.653 . . . . 14.84 112.065 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 106' ' ' GLN . 46.6 t -73.9 -65.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 13.35 109.38 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.872 1.269 . . . . 13.51 112.575 175.913 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 121.079 0.466 . . . . 14.98 111.122 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.04 -34.38 77.57 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.219 0.533 . . . . 15.789999999999999 109.628 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.5 m -60.8 -34.07 73.96 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.182 -0.917 . . . . 12.02 110.229 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.34 -48.46 70.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.702 -0.481 . . . . 11.02 109.702 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.05 -42.52 94.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.467 0.479 . . . . 16.07 111.556 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -63.83 -46.42 85.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 13.93 110.684 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.65 -48.66 59.07 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 111.769 0.285 . . . . 10.710000000000001 111.769 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 34.5 ptt180 -68.77 -16.67 63.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.959 -0.696 . . . . 14.02 111.293 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -60.84 -49.2 78.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.342 0.401 . . . . 16.289999999999999 109.987 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -79.03 -31.5 44.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.868 -0.333 . . . . 12.91 110.111 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 8.0 tt -61.24 -52.9 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.815 -0.809 . . . . 12.77 108.815 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.79 -25.01 62.68 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.078 -0.51 . . . . 15.19 111.741 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.79 63.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.96 0.41 . . . . 16.260000000000002 110.88 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 mmt -85.36 -31.25 23.07 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.898 0.38 . . . . 15.449999999999999 110.981 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -96.4 -2.61 45.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.216 0.531 . . . . 16.16 111.505 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 60.16 41.07 17.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.007 1.323 . . . . 20.559999999999999 111.795 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 t -107.22 -178.92 3.78 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.032 -0.985 . . . . 16.629999999999999 108.586 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 mp0 -97.72 103.08 15.1 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 123.077 0.551 . . . . 20.190000000000001 110.271 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 21' ' ' GLU . 12.9 Cg_endo -53.53 -40.55 78.51 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 124.26 3.307 . . . . 16.600000000000001 115.258 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.89 -11.65 85.2 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 119.971 -1.109 . . . . 17.739999999999998 114.043 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -141.77 58.42 1.49 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.241 0.83 . . . . 20.23 113.241 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.2 pt -97.15 -10.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.18 -0.608 . . . . 15.98 110.408 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 73.85 128.05 0.04 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 125.645 1.578 . . . . 19.329999999999998 110.607 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 4.4 p-10 -66.34 -23.83 66.42 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.571 1.323 . . . . 14.93 114.571 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.97 5.89 69.06 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 119.901 -1.142 . . . . 14.82 112.66 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.2 m -70.43 151.54 45.04 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 122.024 0.916 . . . . 14.539999999999999 112.951 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 48.1 mtm180 -90.12 132.68 35.3 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.08 -1.418 . . . . 16.75 111.267 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -47.0 -52.69 14.17 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 123.741 0.651 . . . . 11.99 112.638 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 36' ' ' LEU . 19.5 tp -56.1 -37.97 70.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 14.449999999999999 111.323 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.73 -23.8 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.799 -0.637 . . . . 16.440000000000001 110.885 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.26 -13.42 59.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.296 0.57 . . . . 13.77 110.713 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.21 -8.45 15.9 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.762 -0.732 . . . . 13.81 111.444 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.4 tt -69.69 134.23 48.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.461 -0.57 . . . . 13.039999999999999 109.461 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.471 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 18.5 t70 -114.48 161.33 18.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.233 -1.025 . . . . 15.67 108.233 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 118.829 0.741 . . . . 15.289999999999999 111.131 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -70.42 -41.47 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.593 0.711 . . . . 16.66 109.501 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 62.3 mt -67.99 -28.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.001 -1.0 . . . . 14.140000000000001 110.177 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -61.14 -48.51 81.3 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.587 -0.733 . . . . 12.0 110.438 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.55 96.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.212 0.529 . . . . 13.970000000000001 110.326 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.95 -46.15 88.75 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.912 -1.04 . . . . 15.69 111.618 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.405 ' O ' HG13 ' A' ' 48' ' ' ILE . 6.4 t90 -71.92 -41.76 67.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 124.748 1.219 . . . . 11.69 110.437 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mm -51.98 -46.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.634 0.774 . . . . 11.16 112.146 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.9 mtm-85 -58.35 -40.01 81.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.482 0.489 . . . . 16.649999999999999 110.617 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -74.19 -34.66 63.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 120.145 -0.622 . . . . 14.15 112.154 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 44' ' ' TRP . 74.1 mt -59.93 -46.26 94.21 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 108.866 -0.79 . . . . 10.800000000000001 108.866 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.84 -39.93 86.8 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 114.972 -1.013 . . . . 12.98 110.535 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -79.2 -43.44 23.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.559 0.578 . . . . 17.52 112.559 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -64.86 -44.04 91.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.454 0.538 . . . . 14.869999999999999 112.454 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -95.74 -10.77 28.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.35 0.87 . . . . 12.199999999999999 113.35 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 59.22 52.06 6.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.313 -1.366 . . . . 16.710000000000001 107.313 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.4 tp -127.55 135.96 51.04 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.645 -1.161 . . . . 12.199999999999999 110.21 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.02 69.11 3.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 16.059999999999999 110.68 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mm -82.06 119.24 74.63 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.235 -0.439 . . . . 11.390000000000001 110.311 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.45 136.44 31.18 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.103 1.869 . . . . 12.6 109.726 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.88 63.45 Favored 'General case' 0 C--O 1.245 0.868 0 C-N-CA 123.684 0.794 . . . . 12.52 112.036 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 3.5 p30 -69.68 -12.36 61.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.205 -0.452 . . . . 14.140000000000001 112.066 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.5 -22.87 47.04 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 123.233 0.333 . . . . 10.76 113.663 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -115.94 -1.22 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 122.827 1.299 . . . . 11.0 108.16 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 81.1 t80 -90.63 -47.74 7.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.398 -0.819 . . . . 16.420000000000002 109.541 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 t -96.24 -23.15 16.83 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.792 -0.763 . . . . 13.35 111.493 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -100.57 118.25 61.29 Favored Pre-proline 0 CA--C 1.511 -0.541 0 C-N-CA 120.421 -0.512 . . . . 12.23 109.889 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.5 Cg_endo -94.53 -1.41 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.363 2.042 . . . . 13.06 114.02 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.31 123.15 68.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.19 0.519 . . . . 12.949999999999999 109.925 -174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.85 -37.12 86.56 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.295 1.038 . . . . 10.92 111.311 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 75.3 tttt -63.34 -39.45 94.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.529 -0.759 . . . . 14.32 111.09 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.47 72.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.135 0.493 . . . . 10.93 110.261 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' VAL . 29.1 t80 -67.32 -37.51 83.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.7 -0.682 . . . . 8.8100000000000005 112.638 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -64.03 -35.31 80.29 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.955 -0.698 . . . . 9.3499999999999996 112.692 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.158 -0.682 . . . . 11.630000000000001 109.158 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -60.66 -38.54 85.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.395 -0.821 . . . . 10.550000000000001 109.884 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 70' ' ' PHE . 55.9 t -72.18 -48.26 49.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.078 -0.712 . . . . 8.3000000000000007 109.078 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.49 -43.36 94.09 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.345 -0.843 . . . . 9.5800000000000001 113.231 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -65.73 -28.5 69.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.794 0.664 . . . . 10.23 112.794 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -85.84 -23.59 27.06 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.433 -0.507 . . . . 10.43 111.022 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 CA--C 1.504 -0.821 0 CA-C-O 121.271 0.557 . . . . 10.970000000000001 111.592 178.895 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 121.273 0.559 . . . . 10.050000000000001 111.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.57 -49.0 15.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.426 -0.807 . . . . 11.220000000000001 109.751 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.47 -43.76 93.17 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.661 -0.866 . . . . 11.380000000000001 108.661 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -50.25 -57.64 7.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.186 0.994 . . . . 9.6500000000000004 111.409 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.14 -40.56 90.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.698 -0.228 . . . . 10.43 111.523 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 t -59.29 -51.06 71.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.661 -0.496 . . . . 10.210000000000001 109.661 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.484 HG21 HG11 ' A' ' 178' ' ' VAL . 80.1 mt -59.77 -40.46 82.6 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 CA-C-N 116.369 -0.378 . . . . 8.1300000000000008 110.254 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -58.04 -44.53 87.44 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.562 0.745 . . . . 8.4600000000000009 110.602 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.98 -41.87 67.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.725 -0.671 . . . . 10.859999999999999 110.783 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -62.68 -40.48 97.22 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.455 -0.339 . . . . 11.449999999999999 111.178 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.95 -50.53 66.28 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.871 0.868 . . . . 7.6200000000000001 109.791 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.8 -46.7 86.99 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.435 -1.257 . . . . 11.619999999999999 111.496 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -70.65 -45.91 64.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.184 -0.462 . . . . 11.630000000000001 111.195 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.9 t -64.69 -44.03 91.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.809 -0.632 . . . . 9.1400000000000006 111.065 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.66 -39.94 80.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.127 -0.629 . . . . 10.06 109.903 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.83 -38.94 94.76 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 111.751 -0.54 . . . . 12.07 111.751 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -54.51 -47.2 73.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.335 1.054 . . . . 12.32 110.662 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 144' ' ' THR . 4.6 mm? -86.4 -22.87 26.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.22 0.822 . . . . 11.77 113.22 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.2 tp -84.16 -28.61 27.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.766 0.317 . . . . 13.52 110.614 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 68.69 1.18 2.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.149 1.38 . . . . 16.559999999999999 113.803 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -162.92 154.81 18.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.25 -1.389 . . . . 15.74 107.25 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.07 96.49 25.71 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 110.053 -0.351 . . . . 14.199999999999999 110.053 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -75.0 -15.61 20.65 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.486 2.124 . . . . 14.18 110.807 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.93 47.69 4.39 Favored Glycine 0 CA--C 1.497 -1.08 0 CA-C-N 114.789 -1.096 . . . . 14.029999999999999 112.661 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.26 12.51 11.0 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.523 -0.471 . . . . 16.370000000000001 111.967 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.4 mt -55.41 -37.11 67.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.42 1.105 . . . . 12.449999999999999 111.141 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -98.06 84.68 3.33 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.14 -1.391 . . . . 14.43 111.901 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 m 72.27 -5.22 1.82 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.845 1.424 . . . . 14.32 114.845 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 -34.53 20.68 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 119.496 -1.335 . . . . 13.75 110.559 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.86 95.9 3.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.056 0.942 . . . . 12.699999999999999 109.978 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 170' ' ' THR . 46.3 mt-30 -86.89 177.12 7.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.387 -0.968 . . . . 16.379999999999999 108.387 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 44.5 p90 -59.98 -23.16 63.4 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.167 0.894 . . . . 13.300000000000001 110.111 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.34 -29.91 70.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.888 -1.051 . . . . 16.25 110.35 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.19 -39.19 12.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.84 -0.618 . . . . 15.869999999999999 110.08 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.48 -26.86 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 13.65 111.233 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.53 5.08 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.336 -0.459 . . . . 14.16 113.512 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 72.3 mtm -74.81 -29.61 61.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 117.58 0.69 . . . . 15.449999999999999 110.594 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.563 ' OD2' HG12 ' A' ' 143' ' ' VAL . 32.6 t70 -149.21 120.5 7.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.25 0.547 . . . . 13.630000000000001 111.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 p -75.32 -25.98 58.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.943 1.09 . . . . 13.9 113.943 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.563 HG12 ' OD2' ' A' ' 141' ' ' ASP . 2.8 p -72.13 -34.98 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.865 -1.161 . . . . 13.81 107.865 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 121' ' ' LEU . 37.8 m -60.62 -50.17 74.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.311 -1.313 . . . . 11.48 109.212 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.77 -54.55 27.62 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.613 0.571 . . . . 10.35 113.471 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 6.9 t -62.9 -45.18 93.75 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 112.648 0.61 . . . . 12.199999999999999 112.648 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -65.61 -49.31 69.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 11.859999999999999 110.951 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -63.72 -42.15 97.96 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.419 -0.809 . . . . 9.3200000000000003 110.77 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.466 ' HA ' ' CE ' ' A' ' 149' ' ' MET . 0.3 OUTLIER -58.81 -54.62 45.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 9.5 111.256 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 13.5 ptt180 -63.79 -38.66 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.651 -0.25 . . . . 13.91 111.657 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.9 -53.48 44.87 Favored Glycine 0 N--CA 1.443 -0.853 0 O-C-N 123.531 0.519 . . . . 9.8800000000000008 112.417 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.88 -41.69 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.525 0.203 . . . . 9.2699999999999996 111.341 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.9 m -60.72 -54.99 38.58 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 116.172 -0.467 . . . . 11.460000000000001 111.466 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -69.31 -25.37 64.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.577 -0.738 . . . . 15.039999999999999 111.221 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -64.36 -30.77 71.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.872 -0.604 . . . . 11.82 110.878 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' SER . 69.8 m-85 -98.15 -69.69 0.75 Allowed 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.689 -0.804 . . . . 11.970000000000001 111.004 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 19.4 t 171.53 17.32 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.278 0.361 . . . . 14.24 110.998 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.5 pt -123.22 168.46 15.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 O-C-N 121.322 -0.861 . . . . 12.619999999999999 109.67 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 5.9 tp60 -130.93 118.01 20.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 120.518 -0.473 . . . . 16.390000000000001 110.902 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.8 mt -118.71 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.354 -0.839 . . . . 12.32 109.514 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.51 149.28 36.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.115 -0.948 . . . . 14.06 110.147 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.12 0.968 . . . . 12.640000000000001 112.695 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.06 1.85 57.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.887 -0.597 . . . . 15.68 111.236 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 167' ' ' THR . . . -66.23 -18.13 65.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.545 0.572 . . . . 12.720000000000001 112.545 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . 0.282 2.6 pp -75.93 7.05 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.932 0.716 . . . . 12.16 112.932 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -98.65 -16.03 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.623 -0.717 . . . . 15.08 110.427 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 164' ' ' ALA . 15.2 t -103.34 15.95 27.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.253 -0.579 . . . . 14.67 111.765 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.563 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 13.5 m0 -123.26 119.2 27.58 Favored Pre-proline 0 CA--C 1.501 -0.915 0 O-C-N 121.902 -0.499 . . . . 12.68 110.453 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.43 ' HD2' ' OG ' ' A' ' 173' ' ' SER . 22.7 Cg_exo -63.32 -37.61 49.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.455 2.104 . . . . 14.34 110.261 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 16.5 p -144.24 169.13 18.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.746 -0.661 . . . . 12.91 110.956 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -52.68 -41.31 63.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.166 0.586 . . . . 9.8900000000000006 111.875 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.86 -22.83 50.11 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.477 0.917 . . . . 12.5 113.477 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' HD2' ' A' ' 169' ' ' PRO . 14.3 m -69.1 -26.85 65.13 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.033 0.444 . . . . 11.039999999999999 110.665 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 168' ' ' TRP . 23.6 tp -66.82 -46.06 76.35 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.579 -0.897 . . . . 8.5 108.579 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.46 -28.23 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.934 -1.03 . . . . 7.7000000000000002 111.273 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.72 -40.53 55.46 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.83 -0.348 . . . . 10.380000000000001 111.663 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.84 -34.58 66.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.584 0.957 . . . . 11.970000000000001 113.584 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 110' ' ' ILE . 14.2 p -71.4 -33.66 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.282 -0.567 . . . . 9.8000000000000007 110.012 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 183' ' ' GLN . 10.6 t70 -60.86 -49.93 75.47 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 109.427 -0.582 . . . . 10.83 109.427 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.6 -29.41 70.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.468 -0.787 . . . . 13.5 112.134 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -85.89 -51.48 6.36 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.193 0.442 . . . . 14.84 112.193 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.92 -36.65 45.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 120.966 0.412 . . . . 13.35 110.913 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.7 mt-30 . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 118.319 -0.848 . . . . 13.51 109.119 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.56 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 28.5 t70 . . . . . 0 C--O 1.197 -1.703 0 N-CA-C 110.191 -0.3 . . . . 14.98 110.191 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.04 -39.83 93.65 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.286 0.634 . . . . 15.789999999999999 111.142 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.6 t -65.1 -35.26 80.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.322 -0.622 . . . . 12.02 109.322 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.25 57.55 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 116.219 -0.446 . . . . 11.02 111.093 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 98.9 mt-30 -51.73 -50.23 60.99 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.767 0.827 . . . . 16.07 111.446 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -42.39 96.13 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.823 -0.351 . . . . 13.93 111.158 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.88 -37.16 70.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.9 0.381 . . . . 10.710000000000001 110.505 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -64.84 -47.43 77.98 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.201 1.001 . . . . 14.02 109.041 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.81 -46.89 83.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.064 0.946 . . . . 16.289999999999999 111.153 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -72.94 -38.7 66.68 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.228 0.455 . . . . 12.91 112.228 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.92 -46.57 88.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.692 -1.225 . . . . 12.77 107.692 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -61.7 -44.26 97.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 15.19 111.315 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.81 86.39 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.21 0.448 . . . . 16.260000000000002 112.21 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.41 -44.63 51.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.039 0.385 . . . . 15.449999999999999 112.039 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.47 -9.77 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.228 0.537 . . . . 16.16 111.986 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 t80 65.96 36.97 5.6 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.627 1.203 . . . . 20.559999999999999 108.857 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 14.6 p -107.89 163.4 13.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.736 -1.209 . . . . 16.629999999999999 107.736 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -90.92 136.58 27.43 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 120.234 -0.586 . . . . 20.190000000000001 111.506 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -74.91 6.88 3.09 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.415 2.743 . . . . 16.600000000000001 112.671 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.48 -30.51 18.74 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 111.301 -0.719 . . . . 17.739999999999998 111.301 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -94.85 47.15 1.15 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.175 0.988 . . . . 20.23 111.674 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 tp -126.8 131.81 70.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.96 -1.496 . . . . 15.98 106.96 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -136.4 174.04 11.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.974 -0.103 . . . . 19.329999999999998 111.194 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 2.8 m-20 -67.52 -45.42 75.83 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.623 0.725 . . . . 14.93 111.33 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.44 7.77 74.65 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.002 -0.999 . . . . 14.82 113.998 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.9 m -59.89 144.97 47.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.292 0.567 . . . . 14.539999999999999 112.435 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.4 mtm180 -82.3 102.33 11.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.548 -2.019 . . . . 16.75 105.548 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -45.55 -58.58 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.798 1.239 . . . . 11.99 114.03 -168.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.34 -29.63 47.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.109 0.481 . . . . 14.449999999999999 111.404 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 7.1 mm-40 -68.87 -7.03 30.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 16.440000000000001 111.73 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -72.66 -5.96 41.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.233 -0.44 . . . . 13.77 111.239 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.05 11.55 4.74 Favored Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.063 -1.065 . . . . 13.81 114.128 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -115.41 152.17 33.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.898 0.849 . . . . 13.039999999999999 112.854 -177.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -126.04 167.59 15.13 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.121 -0.945 . . . . 15.67 109.475 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.3 m -38.72 -52.82 1.69 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.598 1.559 . . . . 15.289999999999999 114.71 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.8 -46.19 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.94 0.4 . . . . 16.66 111.317 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -66.16 -38.84 82.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 14.140000000000001 109.872 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.16 -42.54 96.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.406 -0.815 . . . . 12.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.11 96.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.759 . . . . 13.970000000000001 110.624 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.85 -40.13 94.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.861 -0.609 . . . . 15.69 111.45 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -67.6 -53.51 27.54 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.034 -0.985 . . . . 11.69 111.53 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 58' ' ' ALA . 7.8 tp -60.49 -29.99 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.421 0.629 . . . . 11.16 110.708 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -62.49 -28.41 69.81 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.06 -0.973 . . . . 16.649999999999999 109.417 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -86.61 -33.83 20.05 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.887 -0.597 . . . . 14.15 111.713 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.76 -46.46 96.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.495 -0.557 . . . . 10.800000000000001 109.495 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -53.11 -39.27 63.3 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.046 -0.979 . . . . 12.98 111.415 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -77.07 -57.98 3.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.93 -0.577 . . . . 17.52 111.159 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -66.94 -27.99 67.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.284 -0.871 . . . . 14.869999999999999 113.219 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -103.85 0.84 30.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.879 -0.728 . . . . 12.199999999999999 112.625 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 54.24 47.62 22.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.83 1.252 . . . . 16.710000000000001 110.522 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.4 142.19 51.62 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.218 -0.901 . . . . 12.199999999999999 110.089 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.92 36.34 1.56 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.367 -1.346 . . . . 16.059999999999999 107.367 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.616 HD11 ' HD1' ' A' ' 73' ' ' TRP . 9.4 tt -56.55 132.69 77.36 Favored Pre-proline 0 C--O 1.244 0.812 0 CA-C-N 112.227 -2.26 . . . . 11.390000000000001 110.492 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.38 128.47 30.22 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.143 2.562 . . . . 12.6 111.957 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -71.63 -21.2 61.87 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 121.786 0.803 . . . . 12.52 110.03 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -69.04 -6.87 30.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.102 -0.954 . . . . 14.140000000000001 111.52 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 64' ' ' TYR . . . -63.35 -17.67 59.84 Favored Glycine 0 C--N 1.355 1.583 0 N-CA-C 112.019 -0.433 . . . . 10.76 112.019 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -99.16 -43.34 11.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.837 -1.171 . . . . 11.0 107.837 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.71 -48.9 69.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 113.816 -1.538 . . . . 16.420000000000002 112.0 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 64' ' ' TYR . 10.0 t -109.63 13.47 23.82 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.464 -0.494 . . . . 13.35 111.745 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 89.4 m-85 -140.73 75.15 26.08 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 109.339 -0.615 . . . . 12.23 109.339 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.33 38.05 0.7 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.054 2.503 . . . . 13.06 113.253 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 48.2 t -121.52 120.86 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.645 -1.613 . . . . 12.949999999999999 106.645 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -58.03 -42.05 84.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.31 -0.859 . . . . 10.92 112.555 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 83.0 tttt -64.98 -46.09 82.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.764 0.316 . . . . 14.32 110.199 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . . . -60.34 -40.85 92.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.975 -0.557 . . . . 10.93 111.551 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.35 -33.93 58.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.183 -0.462 . . . . 8.8100000000000005 111.633 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -71.2 -33.03 69.56 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.624 -0.83 . . . . 9.3499999999999996 110.762 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 54.2 mt-30 -69.86 -33.6 72.48 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.888 -0.782 . . . . 11.630000000000001 108.888 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.616 ' HD1' HD11 ' A' ' 56' ' ' ILE . 17.6 t-105 -61.82 -49.63 75.54 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.204 -0.907 . . . . 10.550000000000001 110.19 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.2 t -63.2 -45.27 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.259 0 N-CA-C 109.913 -0.403 . . . . 8.3000000000000007 109.913 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.32 -32.31 80.36 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.667 -0.697 . . . . 9.5800000000000001 113.398 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 t -87.27 -12.61 46.11 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 122.213 -0.581 . . . . 10.23 110.459 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 86.1 mm-40 -88.45 -47.11 8.59 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 122.308 -0.245 . . . . 10.43 110.366 177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 74' ' ' VAL 0.265 1.2 pp . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 122.846 1.308 . . . . 10.970000000000001 112.18 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.239 0.533 0 N-CA-C 112.71 0.633 . . . . 10.050000000000001 112.71 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.67 65.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.818 -0.628 . . . . 11.220000000000001 110.813 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 110' ' ' ILE . 12.0 mm-40 -80.15 -40.19 27.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.6 -0.889 . . . . 11.380000000000001 108.6 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -55.33 -40.48 71.25 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 114.991 -1.004 . . . . 9.6500000000000004 111.225 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -60.32 -53.57 56.1 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.041 0.536 . . . . 10.43 110.106 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -56.88 -49.96 73.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.211 -0.904 . . . . 10.210000000000001 109.743 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.462 HG12 ' CE1' ' A' ' 156' ' ' PHE . 52.7 mt -53.35 -48.23 56.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.663 -0.699 . . . . 8.1300000000000008 110.974 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -47.17 -44.36 21.91 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.448 1.099 . . . . 8.4600000000000009 112.346 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 18.5 t70 -70.28 -50.42 39.68 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.738 -0.385 . . . . 10.859999999999999 111.216 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -62.77 -31.7 72.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.356 0.598 . . . . 11.449999999999999 111.558 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.5 -40.87 66.53 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.315 1.046 . . . . 7.6200000000000001 109.326 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.8 -47.15 61.0 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.693 -0.685 . . . . 11.619999999999999 111.076 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 10.8 pt20 -65.44 -32.71 74.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 11.630000000000001 111.474 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 p -71.65 -35.76 70.47 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.335 -0.546 . . . . 9.1400000000000006 110.604 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 138' ' ' LEU . 3.2 tm? -69.28 -45.22 70.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.053 -0.721 . . . . 10.06 109.053 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 -34.03 78.85 Favored Glycine 0 C--O 1.237 0.341 0 CA-C-N 116.202 -0.453 . . . . 12.07 111.999 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.13 -50.44 68.22 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.453 0.701 . . . . 12.32 109.516 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 148' ' ' TRP . 42.5 tp -69.67 -43.61 72.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.159 -0.928 . . . . 11.77 111.638 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 122' ' ' LEU . 10.6 tp -76.06 -24.3 55.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.358 0.503 . . . . 13.52 112.358 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 67.49 2.27 2.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.208 1.003 . . . . 16.559999999999999 111.109 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -156.95 155.91 32.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.278 -0.267 . . . . 15.74 110.278 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.85 114.48 65.24 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.481 -1.303 . . . . 14.199999999999999 107.481 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.22 -20.06 21.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.976 1.784 . . . . 14.18 110.782 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.96 -104.05 0.18 Allowed Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 108.482 -1.847 . . . . 14.029999999999999 108.482 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.84 11.37 0.75 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.136 0.493 . . . . 16.370000000000001 111.799 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp 67.48 119.29 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.59 1.556 . . . . 12.449999999999999 114.456 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -162.33 -72.69 0.05 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.525 -1.216 . . . . 14.43 110.556 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -128.58 -35.21 1.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.158 0.429 . . . . 14.32 112.158 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.93 81.07 1.7 Allowed Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.965 -0.854 . . . . 13.75 110.965 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.37 59.03 1.15 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.027 0.441 . . . . 12.699999999999999 110.947 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.466 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 17.6 tp60 -72.32 136.2 46.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.734 -1.58 . . . . 16.379999999999999 106.734 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.65 -31.02 63.97 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 124.216 1.006 . . . . 13.300000000000001 111.831 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.9 -31.24 72.06 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.247 0.546 . . . . 16.25 111.488 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 134' ' ' GLN . 26.7 m-20 -82.69 -22.11 34.66 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.194 -0.457 . . . . 15.869999999999999 110.165 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 31.4 mt -93.11 -28.04 16.57 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.867 -0.606 . . . . 13.65 110.235 -176.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.61 86.41 0.06 OUTLIER Glycine 0 C--N 1.31 -0.883 0 N-CA-C 109.817 -1.313 . . . . 14.16 109.817 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptp -71.22 -18.9 62.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.09 1.144 . . . . 15.449999999999999 114.09 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.26 150.61 22.37 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 118.99 -0.529 . . . . 13.630000000000001 111.313 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -53.34 -44.66 68.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 117.858 0.299 . . . . 13.9 111.649 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.94 -48.3 88.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 111.295 0.109 . . . . 13.81 111.295 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 p -60.22 -38.51 83.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.466 0.543 . . . . 11.48 112.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.79 22.97 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.783 -1.198 . . . . 10.35 111.897 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.6 m -65.02 -32.6 74.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.374 0.269 . . . . 12.199999999999999 110.851 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.97 -49.55 76.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.557 . . . . 11.859999999999999 109.926 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.444 ' HB2' HD22 ' A' ' 121' ' ' LEU . 19.9 t90 -71.76 -34.81 69.79 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.517 -0.765 . . . . 9.3200000000000003 111.142 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -45.59 92.65 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.469 -1.308 . . . . 9.5 107.469 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 154' ' ' ARG . 69.9 ttt180 -63.82 -43.03 97.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.861 -1.063 . . . . 13.91 109.659 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.09 -49.22 68.79 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 115.638 -0.71 . . . . 9.8800000000000008 113.296 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.57 -37.45 74.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 117.267 0.534 . . . . 9.2699999999999996 111.807 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.7 m -59.83 -43.84 94.35 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.955 0.159 . . . . 11.460000000000001 110.957 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 28.6 mtm180 -63.38 -45.36 91.45 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.561 -0.291 . . . . 15.039999999999999 110.624 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -53.97 -43.12 69.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.595 0.961 . . . . 11.82 113.595 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 110' ' ' ILE . 79.2 m-85 -102.97 4.89 37.94 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.238 -0.585 . . . . 11.970000000000001 111.681 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.5 m 53.95 44.06 29.94 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.237 1.015 . . . . 14.24 111.339 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.95 161.55 15.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.316 -0.856 . . . . 12.619999999999999 108.773 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -113.25 96.75 6.08 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.978 0.418 . . . . 16.390000000000001 110.34 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.49 149.51 27.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.649 -0.871 . . . . 12.32 108.649 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.33 134.99 42.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.713 -0.676 . . . . 14.06 111.926 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.75 -22.2 62.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 12.640000000000001 110.103 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.06 -17.55 61.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.55 -0.75 . . . . 15.68 110.194 175.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.556 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -72.7 -3.2 23.68 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 112.654 0.612 . . . . 12.720000000000001 112.654 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.5 pt -68.27 -13.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.748 0.785 . . . . 12.16 109.298 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -111.2 3.79 18.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.29 -0.868 . . . . 15.08 109.357 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 56.9 m -97.25 -38.55 9.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 14.67 108.66 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.2 m0 -102.32 115.58 64.29 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.784 -0.644 . . . . 12.68 109.631 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.29 -30.36 3.41 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.28 1.987 . . . . 14.34 113.185 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.9 p -128.99 170.89 12.91 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 109.585 -0.524 . . . . 12.91 109.585 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.42 -22.65 66.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.444 -0.344 . . . . 9.8900000000000006 111.061 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -61.79 -44.47 96.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.158 0.504 . . . . 12.5 110.423 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 5.7 m -61.02 -37.05 81.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.268 -0.878 . . . . 11.039999999999999 110.466 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.84 -42.25 58.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.191 -0.459 . . . . 8.5 110.558 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.09 83.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 7.7000000000000002 111.639 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 20.4 m-20 -79.27 -33.75 43.19 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.411 -0.516 . . . . 10.380000000000001 110.653 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.518 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 7.4 tp10 -61.69 -50.45 72.43 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.136 -0.483 . . . . 11.970000000000001 111.012 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 -41.69 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.729 -0.669 . . . . 9.8000000000000007 111.086 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.67 -41.51 97.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.791 0.436 . . . . 10.83 110.478 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 5.0 mmp_? -68.82 -31.33 70.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.638 -0.71 . . . . 13.5 111.089 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -78.09 -37.68 45.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.144 -0.48 . . . . 14.84 109.99 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.71 -59.85 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.931 -0.577 . . . . 13.35 109.661 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.135 0.897 . . . . 13.51 110.998 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 112.987 0.736 . . . . 14.98 112.987 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.92 -32.71 69.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.369 0.507 . . . . 15.789999999999999 112.369 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.507 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 28.9 p -63.83 -37.32 86.94 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 120.103 -0.639 . . . . 12.02 110.441 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 -20.23 61.9 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.088 -0.506 . . . . 11.02 110.259 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.34 -53.08 6.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.995 -0.743 . . . . 16.07 108.995 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.71 -50.18 70.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 115.319 -0.855 . . . . 13.93 112.9 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 48' ' ' ILE . 55.6 mt -71.76 -25.7 62.14 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.263 -0.575 . . . . 10.710000000000001 111.395 -173.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -70.33 -40.44 74.15 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.041 -0.726 . . . . 14.02 109.041 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -65.63 -44.62 85.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.323 -0.853 . . . . 16.289999999999999 109.366 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 t -64.63 -33.77 76.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.742 -0.663 . . . . 12.91 110.693 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.22 -53.31 51.22 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.929 -1.137 . . . . 12.77 107.929 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -65.37 -33.64 76.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.872 -1.058 . . . . 15.19 111.541 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.84 -33.88 75.64 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.436 0.532 . . . . 16.260000000000002 112.436 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 44' ' ' TRP . 44.3 mtt -81.27 -21.86 39.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.923 -0.711 . . . . 15.449999999999999 111.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 84.2 mt -98.71 -7.34 27.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.175 0.512 . . . . 16.16 110.814 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 64.72 43.67 4.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.224 1.41 . . . . 20.559999999999999 111.742 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 6.6 p -126.83 169.91 12.74 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.637 -0.71 . . . . 16.629999999999999 111.182 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.09 127.67 78.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 123.061 0.544 . . . . 20.190000000000001 111.68 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 31.1 Cg_endo -65.5 -9.9 24.19 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.045 2.496 . . . . 16.600000000000001 112.314 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.9 -36.18 65.36 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.263 -1.135 . . . . 17.739999999999998 110.263 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -83.11 -37.57 23.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.997 -0.742 . . . . 20.23 108.997 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 22' ' ' PRO . 50.3 mm -76.38 92.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.828 -1.175 . . . . 15.98 107.828 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.71 155.77 26.59 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.036 -0.984 . . . . 19.329999999999998 110.291 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.35 -17.74 64.87 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 114.396 -1.275 . . . . 14.93 111.87 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.52 6.93 39.06 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 120.89 -0.672 . . . . 14.82 112.79 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 34' ' ' LEU . 66.2 m -68.97 160.81 30.19 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.851 0.834 . . . . 14.539999999999999 113.092 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 18.7 ttm180 -97.45 112.46 24.29 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.524 -1.216 . . . . 16.75 109.738 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -39.03 -60.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.831 1.252 . . . . 11.99 113.877 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 32' ' ' LEU . 2.5 mm? -61.63 -32.8 72.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 14.449999999999999 111.729 -174.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.64 -17.27 60.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.786 0.803 . . . . 16.440000000000001 110.729 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 29' ' ' SER . 94.4 mt -84.56 8.31 17.1 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.151 -0.477 . . . . 13.77 111.557 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.21 31.2 12.18 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.813 -0.915 . . . . 13.81 110.813 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.5 tt -108.8 135.67 49.64 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.81 -0.811 . . . . 13.039999999999999 108.81 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -123.2 164.02 19.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.572 -1.27 . . . . 15.67 107.572 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -49.54 -41.74 42.13 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.609 0.64 . . . . 15.289999999999999 111.756 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.57 -49.39 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.928 -0.578 . . . . 16.66 110.675 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.04 -35.72 75.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.996 -0.547 . . . . 14.140000000000001 110.438 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -60.38 -46.81 88.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 12.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.16 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.316 0.579 . . . . 13.970000000000001 110.999 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.14 -40.02 71.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.745 -0.661 . . . . 15.69 111.076 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 9.2 t90 -57.78 -45.53 85.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 124.278 1.031 . . . . 11.69 110.09 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 41' ' ' ALA . 40.3 mm -54.96 -39.34 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 114.935 -1.029 . . . . 11.16 110.072 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -57.43 -35.45 70.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.36 -0.836 . . . . 16.649999999999999 111.668 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 51' ' ' HIS . 24.5 tt0 -85.09 -35.72 21.63 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.037 -0.665 . . . . 14.15 110.787 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 56' ' ' ILE . 19.5 pt -68.57 -30.28 46.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 119.912 -0.715 . . . . 10.800000000000001 110.83 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.622 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 6.1 m-20 -63.69 -27.31 69.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.334 -0.848 . . . . 12.98 110.498 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -79.96 -46.32 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.177 -0.675 . . . . 17.52 109.177 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 20.8 m-70 -51.58 -56.56 12.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.303 -0.862 . . . . 14.869999999999999 112.899 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 97.0 m-85 -107.18 16.51 24.0 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.471 0.545 . . . . 12.199999999999999 112.471 -173.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 42.91 42.94 3.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.655 1.182 . . . . 16.710000000000001 112.523 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.24 140.57 52.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.831 -0.622 . . . . 12.199999999999999 109.325 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -81.19 72.05 8.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.253 -0.43 . . . . 16.059999999999999 110.216 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.622 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 18.2 mm -61.47 125.37 84.22 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-N 115.947 -0.57 . . . . 11.390000000000001 111.564 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 59.1 Cg_endo -77.27 125.82 8.05 Favored 'Trans proline' 0 N--CA 1.434 -1.985 0 C-N-CA 121.938 1.759 . . . . 12.6 108.671 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.51 -19.79 40.4 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.926 0.713 . . . . 12.52 112.926 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 57' ' ' PRO . 3.0 p30 -62.64 -16.76 58.37 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.171 0.804 . . . . 14.140000000000001 113.171 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.23 78.71 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 120.847 -0.692 . . . . 10.76 114.566 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.45 -34.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.496 0.665 . . . . 11.0 111.55 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -73.55 -28.0 61.63 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.202 -0.666 . . . . 16.420000000000002 109.202 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 m -83.13 -43.52 16.12 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.229 -0.896 . . . . 13.35 110.078 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.2 94.31 48.04 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.278 -0.419 . . . . 12.23 110.31 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 93.7 Cg_endo -83.65 4.34 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.62 2.214 . . . . 13.06 112.705 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.38 120.61 62.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.642 -1.614 . . . . 12.949999999999999 106.642 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -56.09 -44.69 79.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.835 -1.075 . . . . 10.92 113.488 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -71.71 -21.33 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.442 0.639 . . . . 14.32 110.784 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.91 -31.7 22.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.662 0.744 . . . . 10.93 109.348 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.51 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 48.3 t80 -71.85 -34.11 68.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.388 -0.824 . . . . 8.8100000000000005 111.455 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 p -65.03 -24.32 67.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.141 0.496 . . . . 9.3499999999999996 111.569 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -74.06 -39.76 63.27 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.175 -1.046 . . . . 11.630000000000001 108.175 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 59.7 t90 -59.83 -45.91 90.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.583 -1.19 . . . . 10.550000000000001 109.246 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.91 -45.38 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 8.3000000000000007 109.966 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.83 84.96 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.603 -0.726 . . . . 9.5800000000000001 114.365 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -71.68 -16.4 62.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 10.23 112.452 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -93.29 -26.48 17.3 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.39 -0.368 . . . . 10.43 110.489 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.516 -0.363 0 CA-C-N 115.943 -0.571 . . . . 10.970000000000001 109.915 178.086 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.433 -1.31 0 N-CA-C 108.442 -0.948 . . . . 10.050000000000001 108.442 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.72 -28.66 70.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.173 -0.921 . . . . 11.220000000000001 112.725 -174.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.486 ' O ' HG13 ' A' ' 110' ' ' ILE . 48.3 tp60 -61.03 -20.92 63.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.027 0.531 . . . . 11.380000000000001 111.592 -176.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.05 -31.08 61.2 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.844 0.312 . . . . 9.6500000000000004 111.844 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 40.1 tt0 -71.88 -43.69 65.0 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.132 0.491 . . . . 10.43 109.984 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -62.48 -21.53 65.54 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.998 -0.546 . . . . 10.210000000000001 111.812 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.564 HG21 HG11 ' A' ' 178' ' ' VAL . 55.3 mt -67.07 -54.68 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 108.704 -0.85 . . . . 8.1300000000000008 108.704 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 13.7 pt20 -64.37 -29.31 70.38 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.937 -0.574 . . . . 8.4600000000000009 111.751 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.66 -52.2 64.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.618 -0.512 . . . . 10.859999999999999 109.618 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -69.41 -37.4 77.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 11.449999999999999 110.489 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 171' ' ' LEU . 6.3 tt -61.28 -42.27 98.36 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.526 -0.916 . . . . 7.6200000000000001 108.526 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.1 -47.2 87.38 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.596 -0.729 . . . . 11.619999999999999 109.404 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -57.05 -50.37 72.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 11.630000000000001 111.705 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.5 m -69.14 -30.45 68.7 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.717 0.266 . . . . 9.1400000000000006 111.717 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 47.7 tp -68.96 -49.23 59.8 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 108.707 -0.849 . . . . 10.06 108.707 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.32 -22.03 68.93 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.707 -0.759 . . . . 12.07 112.534 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.08 -52.8 8.2 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 122.538 -0.389 . . . . 12.32 110.756 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.56 -18.11 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.732 0.641 . . . . 11.77 112.732 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' LEU . 4.4 mm? -113.42 3.01 15.63 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.035 0.445 . . . . 13.52 110.83 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 70.45 -29.8 0.19 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 16.559999999999999 115.596 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.8 tp -136.0 148.76 48.56 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.593 -0.692 . . . . 15.74 111.365 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -84.44 124.25 73.79 Favored Pre-proline 0 CA--C 1.505 -0.784 0 N-CA-C 107.148 -1.427 . . . . 14.199999999999999 107.148 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB3' HD11 ' A' ' 138' ' ' LEU . 72.9 Cg_endo -79.17 -16.31 12.38 Favored 'Trans proline' 0 C--N 1.33 -0.446 0 C-N-CA 121.848 1.699 . . . . 14.18 113.08 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.15 6.65 87.66 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 110.575 -1.01 . . . . 14.029999999999999 110.575 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 16.1 mm100 -99.72 33.22 2.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.666 0.746 . . . . 16.370000000000001 110.603 -174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 68.2 mt -73.34 103.37 4.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.881 -1.054 . . . . 12.449999999999999 108.539 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 10.2 mmm180 79.23 1.27 2.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.214 1.406 . . . . 14.43 111.424 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -89.04 -25.35 22.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.604 0.716 . . . . 14.32 109.338 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 157.49 -91.8 0.12 Allowed Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.248 -1.141 . . . . 13.75 110.248 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 128' ' ' GLN . . . 63.45 90.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.862 1.265 . . . . 12.699999999999999 112.092 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -97.49 136.56 37.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.721 -0.844 . . . . 16.379999999999999 108.721 175.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 140' ' ' MET . 19.4 p90 -47.55 -36.45 10.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.21 1.404 . . . . 13.300000000000001 114.063 -170.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.29 -40.65 96.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.954 0.502 . . . . 16.25 110.926 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.48 -35.27 75.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.009 -0.541 . . . . 15.869999999999999 110.434 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 126' ' ' PRO . 4.0 mm? -72.98 -19.52 61.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 13.65 112.076 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.87 20.48 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.439 -1.065 . . . . 14.16 110.439 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.438 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . 43.7 ttm -85.98 129.03 34.96 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.547 -0.908 . . . . 15.449999999999999 108.547 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.03 176.09 6.93 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.136 -1.061 . . . . 13.630000000000001 108.136 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' ' OH ' ' A' ' 166' ' ' TYR . 38.6 m -73.73 -48.06 34.72 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.4 -0.92 . . . . 13.9 109.697 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.19 -48.08 88.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 112.012 0.375 . . . . 13.81 112.012 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 p -67.6 -33.93 75.99 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.913 0.387 . . . . 11.48 111.757 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 -25.5 61.86 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 119.971 -1.109 . . . . 10.35 111.116 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.3 m -64.91 -48.34 74.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 12.199999999999999 108.705 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -57.13 -53.59 56.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.891 -1.05 . . . . 11.859999999999999 109.993 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -53.0 -53.98 42.01 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 9.3200000000000003 112.743 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 3.5 tpt -54.76 -54.08 46.66 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.153 0.581 . . . . 9.5 111.425 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . 75.0 ttt180 -64.62 -37.23 86.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.966 0.413 . . . . 13.91 110.185 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.38 27.89 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.473 -0.785 . . . . 9.8800000000000008 112.649 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.88 -42.79 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.512 0.325 . . . . 9.2699999999999996 111.007 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 25.3 m -58.5 -57.15 14.2 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.837 -0.62 . . . . 11.460000000000001 110.847 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -64.2 -35.62 81.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.637 -0.71 . . . . 15.039999999999999 111.352 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -76.59 -14.84 59.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.036 0.384 . . . . 11.82 112.036 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CZ ' HG12 ' A' ' 110' ' ' ILE . 86.1 t80 -95.68 -70.31 0.72 Allowed 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 119.132 -1.027 . . . . 11.970000000000001 111.081 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.9 m -178.74 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.79 0.436 . . . . 14.24 112.138 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 27.7 pt -98.84 142.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.268 0.556 . . . . 12.619999999999999 111.796 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -91.78 95.75 10.03 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.748 0.785 . . . . 16.390000000000001 109.632 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 87.2 mt -101.01 151.23 22.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.288 -0.869 . . . . 12.32 109.25 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.91 45.81 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.393 -1.276 . . . . 14.06 108.763 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 150' ' ' ARG . . . -66.17 -21.18 66.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.444 0.64 . . . . 12.640000000000001 110.204 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -82.08 2.94 28.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 15.68 111.009 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.72 61.17 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.905 -0.497 . . . . 12.720000000000001 111.685 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.4 pt -67.38 -10.97 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.261 0.553 . . . . 12.16 110.446 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 142' ' ' SER . 27.3 m-85 -106.57 -1.47 22.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 15.08 109.164 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -89.22 -47.0 8.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.106 -0.701 . . . . 14.67 109.106 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.34 141.09 24.79 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 109.223 -0.658 . . . . 12.68 109.223 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 40.5 Cg_endo -97.21 2.26 1.66 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.377 2.051 . . . . 14.34 114.429 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -120.13 144.34 47.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.455 0.909 . . . . 12.91 113.455 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 114' ' ' LEU . 4.5 mm? -63.48 -30.39 71.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.303 -1.317 . . . . 9.8900000000000006 112.339 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 56.8 mtpt -58.37 -40.1 81.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.534 -0.757 . . . . 12.5 110.674 176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -39.59 93.13 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.319 -0.855 . . . . 11.039999999999999 110.844 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.55 -50.38 65.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.216 -1.031 . . . . 8.5 108.216 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.04 -32.32 69.65 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.754 0.65 . . . . 7.7000000000000002 112.754 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.48 -34.2 31.5 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.523 -0.471 . . . . 10.380000000000001 111.033 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.98 -47.42 68.61 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.963 0.905 . . . . 11.970000000000001 110.118 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -57.21 -44.29 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.309 -0.86 . . . . 9.8000000000000007 112.277 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -57.51 -39.45 76.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.023 0.44 . . . . 10.83 111.627 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -80.92 -23.84 38.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.836 -0.62 . . . . 13.5 110.678 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -84.2 -38.67 20.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 14.84 110.276 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 178' ' ' VAL . 75.3 t -62.59 -41.78 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.843 -0.617 . . . . 13.35 111.604 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 . . . . . 0 N--CA 1.434 -1.229 0 C-N-CA 120.586 -0.446 . . . . 13.51 111.271 -177.332 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 111.42 0.156 . . . . 14.98 111.42 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.47 -49.27 62.1 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.021 0.928 . . . . 15.789999999999999 112.154 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' HG11 ' A' ' 74' ' ' VAL . 52.6 t -61.46 -48.06 82.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 123.467 0.48 . . . . 12.02 111.535 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.7 92.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.614 -0.267 . . . . 11.02 110.759 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -61.72 -46.52 89.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 123.291 0.369 . . . . 16.07 111.378 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 77.8 t80 -67.96 -33.52 74.81 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.597 -0.274 . . . . 13.93 110.753 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.93 -40.73 75.36 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 120.354 -0.538 . . . . 10.710000000000001 110.229 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -59.4 -45.39 91.61 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.795 -0.446 . . . . 14.02 109.795 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.5 -54.47 46.5 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.488 1.115 . . . . 16.289999999999999 111.455 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.7 p -68.18 -35.32 77.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.215 -0.448 . . . . 12.91 111.238 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.41 HD11 HD21 ' A' ' 34' ' ' LEU . 6.9 tt -63.13 -52.56 62.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 12.77 108.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.04 91.06 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.978 -0.555 . . . . 15.19 111.125 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -49.23 71.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.455 0.539 . . . . 16.260000000000002 112.455 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.8 mmm -76.66 -36.79 57.13 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.743 0.646 . . . . 15.449999999999999 112.743 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.84 -5.83 58.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.989 0.424 . . . . 16.16 111.71 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 61.04 39.51 16.23 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.767 1.27 . . . . 20.559999999999999 110.614 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 t -111.79 -173.56 2.27 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 113.135 -1.848 . . . . 16.629999999999999 107.553 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.0 136.92 29.16 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.847 -0.797 . . . . 20.190000000000001 108.847 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.1 -19.96 19.65 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.68 2.253 . . . . 16.600000000000001 113.182 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.65 -45.42 4.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.704 -0.958 . . . . 17.739999999999998 110.704 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.46 75.03 9.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.351 0.596 . . . . 20.23 110.748 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -147.54 144.96 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.744 -0.835 . . . . 15.98 108.744 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -88.42 131.23 34.95 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 107.536 -1.283 . . . . 19.329999999999998 107.536 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.58 -15.89 63.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 112.381 0.512 . . . . 14.93 112.381 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.21 7.67 54.67 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-N 116.154 -0.476 . . . . 14.82 112.019 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 p -69.0 133.42 48.11 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.817 0.818 . . . . 14.539999999999999 111.324 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 16.5 mtp180 -84.05 140.63 31.71 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.92 -1.037 . . . . 16.75 110.371 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 76.3 m-85 -43.75 -48.35 8.03 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 113.617 0.969 . . . . 11.99 113.617 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.87 -15.15 63.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.217 0.451 . . . . 14.449999999999999 112.217 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.1 -39.03 9.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.211 -1.403 . . . . 16.440000000000001 107.211 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 14' ' ' LEU . 37.2 tp -61.02 -29.17 69.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.058 -1.883 . . . . 13.77 111.581 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.05 6.93 1.39 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.273 -1.441 . . . . 13.81 113.924 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 36' ' ' LEU . 18.9 mt -84.61 151.42 24.51 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 119.133 -1.027 . . . . 13.039999999999999 112.667 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.47 159.89 42.0 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 112.375 -2.193 . . . . 15.67 105.709 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -50.51 -48.52 56.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.821 1.045 . . . . 15.289999999999999 113.821 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.29 -46.89 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.479 0.657 . . . . 16.66 110.613 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.35 -37.87 72.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.011 -0.54 . . . . 14.140000000000001 110.363 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 -42.19 84.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.607 -0.724 . . . . 12.0 110.19 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.02 84.7 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.247 -0.888 . . . . 13.970000000000001 110.93 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -65.66 -47.74 74.51 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.415 -0.812 . . . . 15.69 110.88 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -66.03 -52.1 52.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.874 1.269 . . . . 11.69 111.818 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.24 -37.16 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.297 0.48 . . . . 11.16 112.297 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -66.39 -40.37 89.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.517 -0.473 . . . . 16.649999999999999 110.13 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.48 -24.6 64.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 111.828 0.307 . . . . 14.15 111.828 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.2 -55.72 17.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.29 -0.633 . . . . 10.800000000000001 109.29 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.428 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 3.3 m-20 -63.31 -34.5 77.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 12.98 112.156 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.43 -47.29 17.83 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.476 -0.329 . . . . 17.52 111.857 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -70.66 -40.29 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 112.822 0.675 . . . . 14.869999999999999 112.822 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 9' ' ' PHE . 81.2 m-85 -91.42 -8.13 48.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.786 -0.765 . . . . 12.199999999999999 113.02 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 53.98 41.46 32.02 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.959 1.304 . . . . 16.710000000000001 109.486 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 tp -115.87 143.47 45.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.737 -0.665 . . . . 12.199999999999999 110.942 -170.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -69.76 76.06 0.44 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.491 -0.777 . . . . 16.059999999999999 110.861 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.428 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 21.7 mm -98.66 113.86 64.77 Favored Pre-proline 0 C--N 1.316 -0.881 0 O-C-N 121.8 -0.563 . . . . 11.390000000000001 110.566 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.6 140.46 93.87 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.478 2.119 . . . . 12.6 109.91 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.89 2.33 1.48 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.289 0.848 . . . . 12.52 113.289 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.4 0.03 41.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 118.961 -0.542 . . . . 14.140000000000001 112.163 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.72 ' HA2' ' CZ3' ' A' ' 73' ' ' TRP . . . -43.73 -60.92 3.15 Favored Glycine 0 C--N 1.356 1.667 0 N-CA-C 114.758 0.663 . . . . 10.76 114.758 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.92 -21.7 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.889 1.276 . . . . 11.0 112.019 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -93.33 -40.38 10.44 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.209 -0.451 . . . . 16.420000000000002 111.064 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.4 m -73.86 -40.38 63.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.396 -0.366 . . . . 13.35 110.956 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HE3' ' A' ' 73' ' ' TRP . 96.2 m-85 -112.56 103.1 55.35 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.098 -1.075 . . . . 12.23 108.098 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 95.8 Cg_endo -79.55 -0.27 10.58 Favored 'Trans proline' 0 C--O 1.209 -0.949 0 C-N-CA 122.311 2.007 . . . . 13.06 112.529 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.59 119.86 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.757 -1.572 . . . . 12.949999999999999 106.757 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 21.9 p90 -57.12 -36.48 70.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.411 0.684 . . . . 10.92 112.529 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -63.77 -31.03 72.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.519 0.727 . . . . 14.32 110.424 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.05 26.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.103 0.478 . . . . 10.93 110.262 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 46.1 t80 -77.39 -30.57 53.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.934 -0.575 . . . . 8.8100000000000005 111.343 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p -67.26 -24.57 65.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.59 0.71 . . . . 9.3499999999999996 110.309 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -76.93 -28.66 55.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.608 -0.724 . . . . 11.630000000000001 109.404 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.72 ' CZ3' ' HA2' ' A' ' 60' ' ' GLY . 1.6 t90 -56.86 -55.24 36.98 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 108.56 -0.904 . . . . 10.550000000000001 108.56 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 6' ' ' CYS . 71.5 t -65.8 -43.61 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 CA-C-N 115.132 -0.94 . . . . 8.3000000000000007 110.188 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.01 -34.67 73.23 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.615 0.572 . . . . 9.5800000000000001 112.459 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.5 m -72.91 -37.28 67.3 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 122.926 0.49 . . . . 10.23 111.377 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.72 -14.73 60.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.384 . . . . 10.43 112.038 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.943 -1.132 . . . . 10.970000000000001 107.943 174.298 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 121.525 0.679 . . . . 10.050000000000001 109.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.56 -49.2 73.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.947 1.299 . . . . 11.220000000000001 112.689 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt-30 -58.95 -58.65 7.71 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.24 0.337 . . . . 11.380000000000001 110.277 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 60.0 ttp180 -55.76 -50.33 70.71 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.877 0.736 . . . . 9.6500000000000004 111.71 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.15 -41.06 95.1 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.349 0.406 . . . . 10.43 111.973 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -70.39 -42.54 71.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.323 -0.551 . . . . 10.210000000000001 111.185 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.517 HG21 HG11 ' A' ' 178' ' ' VAL . 92.4 mt -58.76 -52.96 53.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.944 0 N-CA-C 109.322 -0.621 . . . . 8.1300000000000008 109.322 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -49.31 -49.0 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.353 1.033 . . . . 8.4600000000000009 112.688 -175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 34.2 t70 -68.0 -44.82 75.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.81 -0.356 . . . . 10.859999999999999 111.872 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -70.16 -35.26 73.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.069 0.396 . . . . 11.449999999999999 112.069 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.86 -41.34 97.81 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.724 0.809 . . . . 7.6200000000000001 109.464 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -61.56 -46.43 89.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 11.619999999999999 109.219 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 80.1 mt-30 -57.88 -49.88 75.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.02 -0.536 . . . . 11.630000000000001 110.8 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -57.24 -45.3 84.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 124.183 0.927 . . . . 9.1400000000000006 110.97 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.06 -49.9 75.82 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.972 0.17 . . . . 10.06 110.962 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.94 97.83 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 121.252 -0.499 . . . . 12.07 112.129 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.99 -45.94 91.41 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.316 1.046 . . . . 12.32 111.131 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 148' ' ' TRP . 26.9 tp -72.29 -43.93 63.5 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.137 -0.938 . . . . 11.77 111.26 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.9 tp -82.25 -11.72 58.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.792 -0.64 . . . . 13.52 111.619 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 66.89 32.81 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.525 1.13 . . . . 16.559999999999999 109.845 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 tp -99.54 140.21 34.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.117 -0.947 . . . . 15.74 108.609 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 5.8 m-20 -64.11 124.72 86.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 108.744 -0.835 . . . . 14.199999999999999 108.744 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 41.4 Cg_exo -57.18 -17.91 27.53 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.36 2.707 . . . . 14.18 114.029 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -75.04 -13.71 82.44 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 120.47 -0.872 . . . . 14.029999999999999 111.672 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -86.4 -21.56 27.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.312 -0.625 . . . . 16.370000000000001 109.312 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.28 69.9 5.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.127 -0.942 . . . . 12.449999999999999 110.606 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -160.37 -61.15 0.06 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.312 -1.736 . . . . 14.43 106.312 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.4 m -83.78 -31.84 25.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.974 -0.75 . . . . 14.32 108.974 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.81 1.04 Allowed Glycine 0 C--O 1.215 -1.067 0 N-CA-C 110.786 -0.925 . . . . 13.75 110.786 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.72 34.6 2.93 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.297 -1.371 . . . . 12.699999999999999 107.297 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.5 tt0 -123.25 123.68 41.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.522 -1.672 . . . . 16.379999999999999 108.071 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -57.9 -35.72 71.42 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 124.107 0.963 . . . . 13.300000000000001 110.344 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.74 -28.61 66.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.103 -0.953 . . . . 16.25 111.277 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -25.66 28.01 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.766 0.793 . . . . 15.869999999999999 110.469 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 79.5 mt -79.19 -11.06 59.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.31 -0.859 . . . . 13.65 111.011 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.07 -135.08 9.81 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.918 -1.673 . . . . 14.16 108.918 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 165' ' ' ILE . 43.3 tpp -176.41 92.08 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.145 -0.687 . . . . 15.449999999999999 109.145 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -134.38 126.39 29.5 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.029 0.442 . . . . 13.630000000000001 111.211 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.0 m -80.41 -21.84 41.85 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.733 -0.667 . . . . 13.9 111.646 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.0 -58.64 6.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 120.464 0.173 . . . . 13.81 111.124 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.5 t -71.82 -28.96 63.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.414 -0.587 . . . . 11.48 109.414 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.16 -43.95 88.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.427 -0.806 . . . . 10.35 112.601 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -62.81 -45.34 93.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.59 -0.522 . . . . 12.199999999999999 109.59 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.91 -49.97 74.07 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.568 -0.742 . . . . 11.859999999999999 111.372 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.486 ' O ' HG23 ' A' ' 152' ' ' VAL . 19.4 t90 -63.89 -51.52 64.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.815 -0.63 . . . . 9.3200000000000003 111.431 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 161' ' ' ALA . 42.0 tpp -63.61 -40.76 97.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.03 0.206 . . . . 9.5 110.959 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -60.45 -41.82 94.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.61 -0.515 . . . . 13.91 109.61 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.83 -45.91 95.23 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.757 -0.656 . . . . 9.8800000000000008 111.82 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 148' ' ' TRP . 56.0 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.832 -0.433 . . . . 9.2699999999999996 109.832 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 23.8 m -61.63 -51.68 67.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 11.460000000000001 110.8 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -65.01 -40.1 94.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.604 -0.725 . . . . 15.039999999999999 111.151 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -55.89 -46.64 78.28 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.424 0.69 . . . . 11.82 111.117 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -101.54 11.58 38.76 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.73 -0.388 . . . . 11.970000000000001 111.929 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 p 51.4 50.72 18.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.831 1.252 . . . . 14.24 113.107 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.3 pt -127.62 167.42 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.812 -0.631 . . . . 12.619999999999999 109.575 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -102.85 111.83 24.34 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.433 -0.348 . . . . 16.390000000000001 110.941 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 85.7 mt -129.98 154.28 47.54 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 106.886 -1.524 . . . . 12.32 106.886 173.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -95.59 138.89 32.63 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.467 0.651 . . . . 14.06 110.825 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.21 -24.09 66.55 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.265 -0.879 . . . . 12.640000000000001 111.726 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.59 17.82 6.03 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.007 0.432 . . . . 15.68 110.489 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.93 -3.76 27.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.205 0.817 . . . . 12.720000000000001 113.205 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.558 HD12 ' SD ' ' A' ' 140' ' ' MET . 26.0 pt -67.93 -12.34 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.628 0.728 . . . . 12.16 110.211 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -108.39 -2.21 19.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.862 -1.063 . . . . 15.08 108.72 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.9 m -101.97 -45.19 5.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.589 -0.732 . . . . 14.67 110.252 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 174' ' ' LEU . 5.3 m0 -111.7 118.24 47.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.433 -0.951 . . . . 12.68 108.433 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.11 -29.86 9.44 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.22 1.947 . . . . 14.34 112.261 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 24.2 p -134.58 153.91 51.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.551 0.691 . . . . 12.91 110.321 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -14.5 51.54 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.078 -0.965 . . . . 9.8900000000000006 113.233 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -43.39 92.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.171 -0.677 . . . . 12.5 109.171 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.5 m -62.68 -41.73 99.24 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.133 -0.939 . . . . 11.039999999999999 110.365 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.554 HD13 ' CZ3' ' A' ' 168' ' ' TRP . 36.3 tp -68.89 -43.94 74.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.313 -0.403 . . . . 8.5 110.823 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 107' ' ' ARG . . . -57.67 -39.67 77.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 7.7000000000000002 111.459 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 16.8 t70 -79.24 -36.12 40.47 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.675 -0.81 . . . . 10.380000000000001 110.546 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 14.0 tp10 -64.27 -44.53 91.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.168 -0.469 . . . . 11.970000000000001 111.604 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 110' ' ' ILE . 10.1 p -55.59 -39.77 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.316 0.385 . . . . 9.8000000000000007 111.282 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 106' ' ' GLN . 33.7 t70 -69.5 -34.48 74.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 10.83 110.55 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 29.9 mmt180 -72.93 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 13.5 109.95 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.8 mmt180 -83.38 -33.59 25.76 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.319 -0.623 . . . . 14.84 109.319 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 178' ' ' VAL . 85.0 t -74.53 -51.17 23.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 116.008 -0.542 . . . . 13.35 111.298 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 119.576 -0.25 . . . . 13.51 111.157 -178.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 109.808 -0.441 . . . . 14.98 109.808 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.92 -32.15 51.48 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.997 -0.681 . . . . 15.789999999999999 109.691 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.41 -35.93 70.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.941 -0.572 . . . . 12.02 109.882 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.644 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -62.95 -49.02 76.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.275 -0.639 . . . . 11.02 109.275 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -54.59 -45.6 73.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.893 . . . . 16.07 111.139 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . 76.0 t80 -63.4 -36.22 83.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.69 0.619 . . . . 13.93 110.75 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.18 -38.37 72.13 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.352 -0.385 . . . . 10.710000000000001 110.33 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 30.7 mtp180 -63.21 -50.66 69.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.695 -0.483 . . . . 14.02 109.695 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 19.7 pt20 -64.49 -27.43 68.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.93 -0.577 . . . . 16.289999999999999 111.829 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.1 m -83.03 -44.27 15.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.241 0.544 . . . . 12.91 110.338 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.36 -41.62 93.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 12.77 111.509 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.947 0.351 . . . . 15.19 111.947 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 -30.04 68.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.529 0.68 . . . . 16.260000000000002 109.763 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.7 mtt -83.65 -34.44 25.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 15.449999999999999 109.764 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.43 0.44 54.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.735 -0.666 . . . . 16.16 111.217 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.6 t80 59.39 46.74 12.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.462 1.505 . . . . 20.559999999999999 110.668 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.63 -176.88 4.92 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.505 -0.77 . . . . 16.629999999999999 109.032 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -109.51 140.3 21.98 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.237 -1.023 . . . . 20.190000000000001 108.237 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.75 -23.06 70.46 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.729 2.953 . . . . 16.600000000000001 113.838 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.74 -6.81 85.56 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.459 -0.877 . . . . 17.739999999999998 112.467 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -109.94 16.48 21.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.798 0.666 . . . . 20.23 112.798 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.495 ' HB ' HD22 ' A' ' 34' ' ' LEU . 41.0 pt -106.04 157.37 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 119.366 -0.934 . . . . 15.98 109.904 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 27.2 mmt180 -101.65 94.77 6.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.185 -0.672 . . . . 19.329999999999998 109.185 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.81 -22.2 57.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.04 0.936 . . . . 14.93 113.119 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.62 6.51 77.44 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.573 -0.822 . . . . 14.82 112.936 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 57.6 p -115.25 171.03 7.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.337 -0.545 . . . . 14.539999999999999 112.38 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 28.7 mtm180 -62.12 147.75 46.51 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.649 0.78 . . . . 16.75 112.277 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -58.44 -32.61 68.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.283 1.033 . . . . 11.99 111.141 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.82 -25.24 67.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.669 -0.696 . . . . 14.449999999999999 110.376 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.88 -28.97 27.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.441 -0.577 . . . . 16.440000000000001 109.441 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -63.23 -31.74 72.97 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 13.77 110.823 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.31 -0.39 4.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.865 -1.16 . . . . 13.81 113.57 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -99.93 168.39 9.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 117.616 0.708 . . . . 13.039999999999999 111.438 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -128.07 161.08 30.05 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.095 . . . . 15.67 108.045 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.154 1.168 . . . . 15.289999999999999 114.154 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.67 -41.18 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.115 0.483 . . . . 16.66 110.569 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.31 -36.37 74.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.314 0.578 . . . . 14.140000000000001 110.258 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.38 72.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.334 -0.848 . . . . 12.0 110.427 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.58 -30.66 71.69 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.314 -0.857 . . . . 13.970000000000001 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.99 -40.69 27.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.506 0.669 . . . . 15.69 110.24 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -62.29 -45.74 91.9 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.582 -1.19 . . . . 11.69 111.5 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tp -59.19 -31.92 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 111.863 0.32 . . . . 11.16 111.863 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 34.2 mmt180 -60.96 -50.01 75.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.804 0.335 . . . . 16.649999999999999 110.345 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -27.33 64.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.327 -0.549 . . . . 14.15 112.027 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.8 -47.45 92.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.093 -1.077 . . . . 10.800000000000001 108.093 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.13 -37.89 75.46 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.092 -0.958 . . . . 12.98 111.196 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -84.63 -47.22 10.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.788 0.328 . . . . 17.52 111.789 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.72 -35.43 77.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 116.384 -0.371 . . . . 14.869999999999999 111.655 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.04 -2.48 37.09 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.346 0.593 . . . . 12.199999999999999 112.179 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 48.6 47.22 20.79 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.502 1.521 . . . . 16.710000000000001 110.066 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -124.9 127.29 46.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.893 -1.049 . . . . 12.199999999999999 109.15 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.02 53.57 2.48 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 113.579 0.955 . . . . 16.059999999999999 113.579 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.0 mm -70.68 117.99 60.74 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.386 -0.598 . . . . 11.390000000000001 109.386 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.4 151.84 65.65 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.912 1.741 . . . . 12.6 108.764 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -20.45 21.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.372 1.069 . . . . 12.52 112.894 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.83 -12.64 61.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 14.140000000000001 112.33 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.68 -52.84 48.08 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 120.981 -0.628 . . . . 10.76 112.339 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.71 0.767 . . . . 11.0 109.923 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.47 -35.38 73.26 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.564 -0.744 . . . . 16.420000000000002 111.081 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.9 m -88.57 -34.32 17.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.746 0.308 . . . . 13.35 110.721 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.95 92.86 48.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.495 -0.557 . . . . 12.23 109.495 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.698 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 74.5 Cg_endo -83.76 1.95 8.57 Favored 'Trans proline' 0 C--O 1.205 -1.145 0 C-N-CA 123.192 2.595 . . . . 13.06 114.323 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.55 133.02 39.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.916 -1.142 . . . . 12.949999999999999 107.916 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -63.85 -45.45 89.45 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 114.805 -1.088 . . . . 10.92 111.799 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -69.21 -24.58 64.04 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 111.944 0.35 . . . . 14.32 111.944 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.8 -41.04 53.9 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.54 -0.541 . . . . 10.93 109.54 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -75.93 -37.58 58.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.877 -0.601 . . . . 8.8100000000000005 112.032 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.1 p -60.78 -34.33 74.32 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.702 -0.399 . . . . 9.3499999999999996 110.893 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -68.53 -44.44 74.6 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.182 -0.673 . . . . 11.630000000000001 109.182 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -54.85 -45.9 74.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.351 1.06 . . . . 10.550000000000001 110.625 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.52 -45.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.069 -0.514 . . . . 8.3000000000000007 110.776 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.1 93.88 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.736 -0.665 . . . . 9.5800000000000001 113.672 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -68.61 -24.73 64.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.46 0.541 . . . . 10.23 112.46 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.02 -2.5 58.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 113.573 0.953 . . . . 10.43 113.573 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 108.386 -0.968 . . . . 10.970000000000001 108.386 176.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 109.749 -0.463 . . . . 10.050000000000001 109.749 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.36 94.17 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.667 -0.697 . . . . 11.220000000000001 111.441 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' ILE . 51.8 mt-30 -64.62 -48.35 75.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.999 -0.546 . . . . 11.380000000000001 109.796 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.78 -45.43 82.14 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.498 -0.774 . . . . 9.6500000000000004 110.636 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -56.95 -52.35 65.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.333 0.653 . . . . 10.43 111.149 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 t -58.97 -44.26 91.49 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.635 -0.711 . . . . 10.210000000000001 111.163 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.572 HG21 HG11 ' A' ' 178' ' ' VAL . 83.5 mt -64.08 -49.11 82.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 109.881 -0.415 . . . . 8.1300000000000008 109.881 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -58.13 -43.69 87.41 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.44 0.696 . . . . 8.4600000000000009 112.665 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 14.8 t70 -62.59 -43.04 99.79 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.164 0.507 . . . . 10.859999999999999 110.099 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.75 -44.1 91.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.639 0.733 . . . . 11.449999999999999 110.302 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.99 -33.29 75.26 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.284 -0.871 . . . . 7.6200000000000001 109.281 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 129' ' ' LEU . 56.6 tttm -62.29 -40.45 96.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.865 0.866 . . . . 11.619999999999999 109.802 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 61.1 mm-40 -64.99 -48.6 73.38 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.188 -1.041 . . . . 11.630000000000001 108.188 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.4 t -56.58 -52.62 64.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.861 -1.518 . . . . 9.1400000000000006 111.984 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.9 pp -68.86 -39.26 79.98 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.377 -0.529 . . . . 10.06 111.746 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.543 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.99 -39.44 94.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.126 -0.559 . . . . 12.07 111.778 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.64 -44.74 77.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.869 0.366 . . . . 12.32 110.209 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 148' ' ' TRP . 15.0 tp -69.08 -46.08 68.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.334 -0.394 . . . . 11.77 110.953 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -72.72 -20.38 61.22 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.481 0.712 . . . . 13.52 111.327 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.0 t80 83.33 -29.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.005 1.322 . . . . 16.559999999999999 112.594 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.8 162.12 36.31 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 122.358 -0.214 . . . . 15.74 110.483 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.0 107.27 42.95 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.005 -0.739 . . . . 14.199999999999999 109.005 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -91.87 11.35 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.727 2.285 . . . . 14.18 113.425 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.61 50.69 5.19 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.496 -1.041 . . . . 14.029999999999999 110.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -107.48 -15.02 14.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.541 -0.464 . . . . 16.370000000000001 112.15 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.425 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 90.3 mt -71.23 97.72 1.6 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.13 0.491 . . . . 12.449999999999999 111.746 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 71.07 -20.06 0.23 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.207 1.403 . . . . 14.43 114.558 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -76.73 -28.74 55.91 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.725 0.81 . . . . 14.32 111.137 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.73 102.48 0.21 Allowed Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 110.213 -1.155 . . . . 13.75 110.213 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 171' ' ' LEU . . . -108.86 86.6 2.32 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.99 0.367 . . . . 12.699999999999999 111.99 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.42 112.06 23.95 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.15 -0.685 . . . . 16.379999999999999 109.15 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -62.55 -20.61 64.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.874 -0.603 . . . . 13.300000000000001 111.543 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.14 -29.63 69.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.667 0.787 . . . . 16.25 111.586 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.04 -25.88 39.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.34 0.591 . . . . 15.869999999999999 110.901 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.58 2.19 49.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 13.65 111.051 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.01 3.99 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 120.794 -0.717 . . . . 14.16 111.37 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.7 tpp 62.11 86.95 0.1 Allowed 'General case' 0 C--O 1.251 1.153 0 C-N-CA 124.794 1.237 . . . . 15.449999999999999 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 44.3 m-20 -57.86 118.73 5.64 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.37 -1.345 . . . . 13.630000000000001 107.37 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -56.32 -36.15 68.39 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.126 0.97 . . . . 13.9 111.567 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.01 -44.07 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.369 0.604 . . . . 13.81 110.145 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 141' ' ' ASP . 34.2 m -66.62 -37.96 85.93 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.854 -0.612 . . . . 11.48 110.848 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 -32.86 54.11 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.871 -0.604 . . . . 10.35 112.564 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.6 p -69.7 -39.53 76.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.453 -0.499 . . . . 12.199999999999999 110.277 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.84 -46.08 81.96 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.795 0.807 . . . . 11.859999999999999 109.699 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.1 t90 -62.18 -54.06 46.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.176 -1.375 . . . . 9.3200000000000003 111.696 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.0 tpt -58.03 -42.07 84.55 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.947 0.499 . . . . 9.5 110.204 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -58.44 -46.41 86.58 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 115.895 -0.593 . . . . 13.91 110.697 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -45.15 95.89 Favored Glycine 0 C--N 1.321 -0.273 0 O-C-N 123.399 0.437 . . . . 9.8800000000000008 112.787 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.31 -50.14 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 9.2699999999999996 110.441 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.1 p -65.5 -38.46 89.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.097 -0.502 . . . . 11.460000000000001 111.61 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -63.99 -47.09 81.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 15.039999999999999 111.186 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -67.48 -31.57 71.81 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.787 -0.365 . . . . 11.82 110.983 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -90.92 6.11 45.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.903 0.705 . . . . 11.970000000000001 112.903 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.4 m 59.66 33.51 21.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.777 0.831 . . . . 14.24 112.51 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.44 134.81 58.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.267 -0.642 . . . . 12.619999999999999 109.267 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -88.24 94.87 9.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.602 0.715 . . . . 16.390000000000001 110.669 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.03 148.73 43.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.026 -1.101 . . . . 12.32 108.026 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.58 143.92 48.08 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.075 -1.083 . . . . 14.06 108.075 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.975 -0.557 . . . . 12.640000000000001 109.995 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.32 15.6 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.655 -0.702 . . . . 15.68 110.496 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.99 59.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.053 0.39 . . . . 12.720000000000001 112.053 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.64 9.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.434 0.635 . . . . 12.16 112.236 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -110.2 -7.04 14.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.587 -0.733 . . . . 15.08 109.587 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.1 m -79.3 -27.89 42.2 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.281 0.562 . . . . 14.67 110.795 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.7 m-90 -113.36 137.83 22.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 116.253 -0.43 . . . . 12.68 110.721 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 -16.93 18.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.063 2.509 . . . . 14.34 111.818 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.9 p -135.65 142.86 45.23 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.489 -1.3 . . . . 12.91 107.489 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB3' ' HB1' ' A' ' 133' ' ' ALA . 25.8 tp -71.3 -24.9 62.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.742 -0.663 . . . . 9.8900000000000006 110.983 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -62.34 -21.98 65.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.762 -0.654 . . . . 12.5 110.675 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 27.6 m -65.7 -18.56 65.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.843 -0.617 . . . . 11.039999999999999 111.208 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.94 -46.2 68.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.449 -0.575 . . . . 8.5 109.449 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.16 75.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.494 . . . . 7.7000000000000002 110.968 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 14.6 t70 -74.99 -31.0 61.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.278 -0.569 . . . . 10.380000000000001 110.056 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -76.55 -41.87 45.05 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 123.348 0.659 . . . . 11.970000000000001 110.351 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.572 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -64.67 -30.49 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.744 0.783 . . . . 9.8000000000000007 110.102 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 183' ' ' GLN . 18.8 t70 -66.59 -28.08 68.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.599 -1.182 . . . . 10.83 110.117 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 85.2 mtt180 -84.22 -42.31 16.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.23 -0.895 . . . . 13.5 109.307 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.04 -51.3 59.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.962 -1.017 . . . . 14.84 111.985 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.25 -35.23 17.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.193 0.52 . . . . 13.35 110.77 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 179' ' ' ASP . 61.8 tt0 . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.246 -0.883 . . . . 13.51 109.212 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 110.263 -0.273 . . . . 14.98 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.66 -47.33 86.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.664 0.385 . . . . 15.789999999999999 110.774 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 p -62.63 -36.47 82.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.317 -0.401 . . . . 12.02 111.479 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.56 67.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.445 -0.343 . . . . 11.02 110.235 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 64.3 tt0 -60.04 -48.59 81.1 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.451 0.701 . . . . 16.07 110.694 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -55.6 -42.25 74.59 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.052 0.845 . . . . 13.93 110.123 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.35 -43.52 63.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.106 -0.497 . . . . 10.710000000000001 111.609 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 8' ' ' GLN . 30.8 mtm180 -61.28 -40.0 92.5 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.612 0.244 . . . . 14.02 111.147 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.0 -44.62 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 16.289999999999999 110.82 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -71.05 -25.23 62.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.885 0.374 . . . . 12.91 111.415 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.98 -55.96 9.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.72 -1.585 . . . . 12.77 106.72 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.34 65.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.685 -1.143 . . . . 15.19 111.554 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.93 85.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.652 0.263 . . . . 16.260000000000002 111.464 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -81.48 -26.09 35.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.018 0.437 . . . . 15.449999999999999 111.222 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.57 -4.33 44.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.018 -0.537 . . . . 16.16 112.041 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.97 49.09 3.61 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.955 1.302 . . . . 20.559999999999999 112.513 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.15 161.81 22.46 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.781 -1.099 . . . . 16.629999999999999 108.757 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -92.9 116.38 66.4 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-O 120.631 0.253 . . . . 20.190000000000001 111.124 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 -6.97 19.07 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.388 2.725 . . . . 16.600000000000001 113.627 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.76 -20.94 78.96 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.381 -0.688 . . . . 17.739999999999998 111.381 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -128.73 71.89 1.43 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 122.167 0.984 . . . . 20.23 109.468 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 tp -127.9 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.612 -0.884 . . . . 15.98 108.612 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -88.67 120.63 30.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.0 -0.741 . . . . 19.329999999999998 109.0 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 19.8 m-20 -61.79 -26.44 68.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.46 -0.791 . . . . 14.93 112.174 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.44 4.39 86.16 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.02 -0.61 . . . . 14.82 113.677 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.5 p -79.41 140.36 37.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 117.816 0.808 . . . . 14.539999999999999 110.273 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.547 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 66.1 mtm180 -75.5 148.24 39.14 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 118.356 -0.831 . . . . 16.75 109.479 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -50.38 -40.19 48.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.905 0.86 . . . . 11.99 110.992 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -23.9 66.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.406 -1.27 . . . . 14.449999999999999 112.691 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HG2' ' HB2' ' A' ' 30' ' ' ARG . 8.9 mm-40 -76.98 -29.28 55.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.796 0.808 . . . . 16.440000000000001 109.074 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.82 -31.94 27.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.16 -0.927 . . . . 13.77 108.808 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.0 32.94 3.63 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 114.787 -1.097 . . . . 13.81 112.174 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.0 tp -81.41 98.9 8.43 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.777 -0.823 . . . . 13.039999999999999 108.777 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.91 147.74 45.01 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.707 -1.22 . . . . 15.67 107.707 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 19.3 p -58.67 -22.8 57.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.923 0.765 . . . . 15.289999999999999 112.178 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.24 -50.93 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.494 -0.558 . . . . 16.66 109.494 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.06 -36.71 76.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.891 -0.781 . . . . 14.140000000000001 108.891 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 38' ' ' SER . . . -57.09 -36.76 70.98 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.169 -0.923 . . . . 12.0 110.77 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.49 -45.84 85.58 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.066 -0.515 . . . . 13.970000000000001 109.967 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -60.79 -45.88 92.68 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.4 0.619 . . . . 15.69 110.712 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -59.34 -52.42 65.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.008 1.723 . . . . 11.69 111.684 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 tp -63.56 -31.61 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.857 0.36 . . . . 11.16 111.403 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 42' ' ' ALA . 99.2 mtt180 -66.35 -35.08 79.45 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 120.972 0.415 . . . . 16.649999999999999 110.282 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -73.62 -35.1 65.3 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.22 0.533 . . . . 14.15 110.155 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.01 -50.17 81.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 115.146 -0.934 . . . . 10.800000000000001 109.85 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.54 -25.12 59.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.035 -0.984 . . . . 12.98 112.847 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 97.7 mttt -75.82 -61.86 1.78 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 116.296 -0.411 . . . . 17.52 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -74.67 -25.09 58.95 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.958 -0.697 . . . . 14.869999999999999 112.008 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -94.96 -6.98 41.22 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.427 0.899 . . . . 12.199999999999999 113.427 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 47.92 64.27 1.7 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.877 1.671 . . . . 16.710000000000001 112.108 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.48 167.72 21.07 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.94 -1.027 . . . . 12.199999999999999 108.312 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.32 70.52 0.76 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.387 -1.338 . . . . 16.059999999999999 107.387 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.493 HD12 ' HE1' ' A' ' 73' ' ' TRP . 47.0 mm -92.74 119.93 67.58 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.201 -0.666 . . . . 11.390000000000001 109.201 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -87.65 167.72 7.25 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.056 1.838 . . . . 12.6 108.929 171.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -10.16 3.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.733 1.012 . . . . 12.52 113.733 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.39 -19.57 65.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.26 0.467 . . . . 14.140000000000001 112.26 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.77 -44.37 96.36 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.742 -1.218 . . . . 10.76 110.129 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.45 -27.64 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.231 1.012 . . . . 11.0 110.869 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -78.25 -31.5 49.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.734 -0.604 . . . . 16.420000000000002 112.175 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t -87.69 -32.28 19.28 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.392 -0.923 . . . . 13.35 110.649 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.486 ' CE2' ' HE3' ' A' ' 73' ' ' TRP . 38.6 m-85 -108.72 100.98 41.73 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 109.526 -0.546 . . . . 12.23 109.526 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.06 -0.45 10.29 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.506 2.137 . . . . 13.06 112.366 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 120.47 61.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.609 -1.626 . . . . 12.949999999999999 106.609 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 27' ' ' ASP . 49.2 p90 -58.98 -32.23 69.49 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.024 0.75 . . . . 10.92 113.024 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -60.58 -32.09 71.2 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.919 0.888 . . . . 14.32 111.731 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.5 -30.78 21.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.91 0.862 . . . . 10.93 109.928 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 43.2 t80 -70.63 -31.7 68.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.181 -0.918 . . . . 8.8100000000000005 111.61 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.1 p -66.18 -28.42 68.75 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.726 -0.609 . . . . 9.3499999999999996 109.49 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -71.21 -32.76 69.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.481 -0.781 . . . . 11.630000000000001 109.634 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.493 ' HE1' HD12 ' A' ' 56' ' ' ILE . 2.4 t-105 -53.91 -55.8 23.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.413 -0.958 . . . . 10.550000000000001 108.413 173.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.13 -44.73 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 C-N-CA 124.031 0.932 . . . . 8.3000000000000007 110.627 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.6 73.74 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.261 -0.427 . . . . 9.5800000000000001 113.0 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.2 m -80.36 -31.32 37.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 122.525 -0.397 . . . . 10.23 111.073 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -89.24 -21.41 23.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.051 -0.66 . . . . 10.43 112.073 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.316 -0.884 0 N-CA-C 110.096 -0.335 . . . . 10.970000000000001 110.096 174.801 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 121.813 0.816 . . . . 10.050000000000001 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.25 -35.42 71.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.509 -1.223 . . . . 11.220000000000001 109.916 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.17 -44.53 97.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.771 -1.104 . . . . 11.380000000000001 109.852 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.449 ' O ' ' HB ' ' A' ' 110' ' ' ILE . 44.1 ttp180 -78.91 -27.46 43.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.875 -0.602 . . . . 9.6500000000000004 111.17 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.0 -37.05 86.39 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.809 0.337 . . . . 10.43 110.764 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.8 t -64.69 -41.88 95.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.565 -0.902 . . . . 10.210000000000001 108.565 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 178' ' ' VAL . 67.3 mt -57.36 -41.85 79.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 CA-C-N 115.098 -0.956 . . . . 8.1300000000000008 109.722 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -55.88 -39.64 71.84 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.228 0.611 . . . . 8.4600000000000009 112.317 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 m-20 -66.83 -40.86 88.13 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.039 0.447 . . . . 10.859999999999999 111.129 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -74.57 -35.06 63.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.144 -0.48 . . . . 11.449999999999999 111.613 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.72 -43.23 98.12 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.254 -1.387 . . . . 7.6200000000000001 107.254 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 79.0 tttt -54.66 -48.19 72.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.606 -1.179 . . . . 11.619999999999999 110.243 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -70.12 -39.29 75.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.137 -0.483 . . . . 11.630000000000001 111.404 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -58.25 -52.8 64.05 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.92 0.888 . . . . 9.1400000000000006 110.219 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.7 -38.55 58.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.144 -0.48 . . . . 10.06 110.483 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.75 -26.66 67.21 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 116.415 -0.357 . . . . 12.07 112.389 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.92 -32.45 74.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 123.519 0.728 . . . . 12.32 110.296 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.03 -30.95 62.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.577 0.703 . . . . 11.77 109.535 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.87 6.9 46.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.797 -1.092 . . . . 13.52 110.046 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.2 t80 79.96 -48.82 0.35 Allowed 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 127.78 2.432 . . . . 16.559999999999999 112.795 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.47 152.62 31.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.904 -0.406 . . . . 15.74 109.904 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.2 112.48 56.47 Favored Pre-proline 0 C--N 1.314 -0.947 0 O-C-N 124.18 0.925 . . . . 14.199999999999999 109.401 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -75.91 -37.31 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.223 1.949 . . . . 14.18 112.052 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -116.84 -112.97 2.7 Favored Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 110.118 -1.193 . . . . 14.029999999999999 110.118 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -139.29 3.48 2.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.835 -0.215 . . . . 16.370000000000001 110.964 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 115' ' ' LYS . 6.0 mp 60.65 -177.48 0.11 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.38 1.072 . . . . 12.449999999999999 112.588 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -150.37 148.53 28.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.691 -1.596 . . . . 14.43 106.691 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 170' ' ' THR . 25.5 m -74.32 -26.57 60.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.562 -0.744 . . . . 14.32 111.251 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.65 3.53 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 111.123 -0.791 . . . . 13.75 111.123 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.08 107.94 15.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.152 -1.055 . . . . 12.699999999999999 108.152 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -73.06 118.04 15.53 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.16 -0.473 . . . . 16.379999999999999 110.858 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.53 -27.69 67.96 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.375 -0.83 . . . . 13.300000000000001 110.178 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.77 -19.79 65.82 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.408 -0.814 . . . . 16.25 111.629 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.3 -52.39 5.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.496 0.554 . . . . 15.869999999999999 112.496 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.82 -10.05 20.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.934 0.716 . . . . 13.65 112.934 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.9 140.19 15.73 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.916 -1.135 . . . . 14.16 112.323 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.2 mtm -133.51 24.6 4.08 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.684 -1.599 . . . . 15.449999999999999 106.684 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.41 70.32 1.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.409 -1.723 . . . . 13.630000000000001 112.225 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -44.72 73.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.116 0.484 . . . . 13.9 109.919 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.32 -57.25 4.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 122.182 -0.324 . . . . 13.81 110.828 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -69.76 -20.47 63.49 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.64 -0.424 . . . . 11.48 111.927 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -78.86 -24.36 62.26 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.741 -1.218 . . . . 10.35 110.184 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.5 m -72.43 -38.22 68.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.602 -0.888 . . . . 12.199999999999999 108.602 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.72 -39.99 86.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.683 -0.69 . . . . 11.859999999999999 109.181 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 25.1 t90 -65.16 -46.5 80.61 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.188 -0.914 . . . . 9.3200000000000003 110.711 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 15.3 mmt -54.35 -47.85 72.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.112 0.482 . . . . 9.5 110.097 176.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 36.6 ttm180 -60.87 -41.02 95.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.247 -0.888 . . . . 13.91 110.232 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.85 -53.57 36.75 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.718 -0.673 . . . . 9.8800000000000008 111.882 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' TRP . 53.5 t -57.61 -40.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.105 0.479 . . . . 9.2699999999999996 110.064 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.9 t -61.16 -51.9 67.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.334 -0.848 . . . . 11.460000000000001 110.584 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 39.1 ptt180 -75.64 -40.05 56.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.784 0.661 . . . . 15.039999999999999 112.784 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -68.98 -33.87 74.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 11.82 111.87 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.97 2.22 43.33 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.737 -0.385 . . . . 11.970000000000001 112.025 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 t 60.0 37.57 21.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.972 0.909 . . . . 14.24 111.302 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.12 148.52 19.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.818 -0.438 . . . . 12.619999999999999 109.818 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -83.05 95.97 8.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.045 -0.354 . . . . 16.390000000000001 110.045 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 tp -109.36 133.99 52.38 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.349 -0.982 . . . . 12.32 108.349 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.46 146.7 29.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.007 -0.542 . . . . 14.06 110.219 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.49 -16.83 62.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 12.640000000000001 111.846 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.22 1.87 56.89 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.287 -0.415 . . . . 15.68 110.656 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HB1' ' CD1' ' A' ' 168' ' ' TRP . . . -61.83 -22.38 65.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.718 0.636 . . . . 12.720000000000001 112.718 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.7 pt -67.44 -12.96 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.235 0.54 . . . . 12.16 111.33 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -103.75 4.05 34.8 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.038 -0.528 . . . . 15.08 110.477 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.6 t -140.09 14.73 2.44 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 119.392 -0.923 . . . . 14.67 112.931 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.541 ' CD1' ' HB1' ' A' ' 164' ' ' ALA . 25.2 m95 -129.51 114.44 18.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.957 -1.127 . . . . 12.68 107.957 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.487 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 58.4 Cg_endo -73.12 -44.13 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.765 2.31 . . . . 14.34 115.491 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 131' ' ' SER . 74.8 p -130.45 -175.56 3.68 Favored 'General case' 0 C--O 1.249 1.058 0 N-CA-C 112.696 0.628 . . . . 12.91 112.696 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 6.7 mp -68.12 -26.5 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.711 -0.477 . . . . 9.8900000000000006 109.711 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -58.66 -49.96 75.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.45 -0.574 . . . . 12.5 109.45 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB2' ' CE3' ' A' ' 168' ' ' TRP . 3.1 p -67.36 -24.13 65.67 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.884 0.698 . . . . 11.039999999999999 112.884 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.12 -47.56 23.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.837 -1.171 . . . . 8.5 107.837 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.22 -30.57 71.69 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.794 -0.639 . . . . 7.7000000000000002 110.832 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -56.71 -34.97 68.0 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.349 0.66 . . . . 10.380000000000001 112.316 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -60.24 -58.27 9.25 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.676 0.75 . . . . 11.970000000000001 110.998 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 110' ' ' ILE . 9.5 p -69.74 -32.12 51.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.908 -1.042 . . . . 9.8000000000000007 110.899 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.16 -43.64 92.1 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.31 0.644 . . . . 10.83 110.76 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.4 mtm105 -83.06 -38.07 23.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.198 -0.456 . . . . 13.5 112.038 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -66.26 -46.51 76.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.581 0.585 . . . . 14.84 112.581 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.17 -43.33 17.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.883 0.373 . . . . 13.35 111.828 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.753 -0.462 . . . . 13.51 109.753 -178.638 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 121.959 0.885 . . . . 14.98 109.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -61.86 -41.68 98.13 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.66 0.985 . . . . 15.789999999999999 113.66 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.87 -58.59 5.61 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.754 0.659 . . . . 12.02 110.678 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.12 80.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.625 -0.716 . . . . 11.02 111.333 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -58.16 -47.62 82.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.824 -0.626 . . . . 16.07 111.826 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.02 -34.72 77.02 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 121.099 0.476 . . . . 13.93 110.766 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.88 -36.14 77.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.145 -0.479 . . . . 10.710000000000001 110.528 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.91 -48.1 83.37 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.51 -0.552 . . . . 14.02 109.51 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.35 -43.77 88.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.685 . . . . 16.289999999999999 111.364 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -72.99 -43.48 62.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.96 -0.563 . . . . 12.91 112.373 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.49 -38.71 90.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.775 -0.454 . . . . 12.77 109.775 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.67 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -63.99 -34.87 78.97 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.738 -0.664 . . . . 15.19 110.792 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.85 61.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.981 -0.554 . . . . 16.260000000000002 111.042 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.9 mtt -85.36 -45.56 11.78 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.304 -0.407 . . . . 15.449999999999999 111.74 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.65 -5.64 48.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.27 0.841 . . . . 16.16 113.27 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 67.36 28.81 7.73 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.899 0.857 . . . . 20.559999999999999 111.93 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 6.9 p -97.45 -174.85 3.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.873 -1.158 . . . . 16.629999999999999 107.873 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -104.39 138.99 19.68 Favored Pre-proline 0 C--N 1.305 -1.354 0 C-N-CA 120.302 -0.559 . . . . 20.190000000000001 110.33 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.49 -9.09 14.93 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.15 1.9 . . . . 16.600000000000001 111.693 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.82 -76.57 0.88 Allowed Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 111.437 -0.665 . . . . 17.739999999999998 111.437 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -85.31 55.71 3.62 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.725 0.774 . . . . 20.23 110.372 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.56 140.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.844 -1.169 . . . . 15.98 107.844 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -81.88 100.23 9.5 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.204 0.526 . . . . 19.329999999999998 110.045 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 5.8 p-10 -77.16 -20.34 55.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.936 -0.575 . . . . 14.93 112.283 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.85 7.21 64.97 Favored Glycine 0 C--N 1.307 -1.061 0 CA-C-N 116.024 -0.534 . . . . 14.82 112.639 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.3 p -92.15 166.75 12.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.127 0.489 . . . . 14.539999999999999 110.597 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 88.5 mtm180 -91.61 141.93 28.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.331 -0.85 . . . . 16.75 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -50.22 -48.81 54.22 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.266 1.21 . . . . 11.99 114.266 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 36' ' ' LEU . 87.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.298 0.57 . . . . 14.449999999999999 111.158 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 30' ' ' ARG . 44.1 tt0 -82.2 -20.36 37.95 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 124.078 0.951 . . . . 16.440000000000001 109.293 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.4 -0.79 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.347 -0.842 . . . . 13.77 109.43 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.38 74.74 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.562 -0.745 . . . . 13.81 112.341 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 32' ' ' LEU . 20.6 tp -81.91 82.31 7.59 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.348 -0.982 . . . . 13.039999999999999 108.348 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.52 ' OD2' HG22 ' A' ' 39' ' ' VAL . 17.6 t70 -66.44 165.87 13.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.345 -1.298 . . . . 15.67 109.819 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -56.58 -36.74 69.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 118.44 0.564 . . . . 15.289999999999999 111.479 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG22 ' OD2' ' A' ' 37' ' ' ASP . 1.5 m -57.41 -51.84 64.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.677 0.751 . . . . 16.66 112.509 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mt -67.87 -46.58 81.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.675 -1.148 . . . . 14.140000000000001 110.301 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.36 87.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 12.0 112.458 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.41 93.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.397 0.617 . . . . 13.970000000000001 111.034 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.08 -43.3 68.02 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.638 -0.71 . . . . 15.69 110.619 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -57.43 -52.96 63.25 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 125.66 1.584 . . . . 11.69 110.425 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 tp -66.29 -33.03 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.369 -0.378 . . . . 11.16 111.028 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -59.95 -36.23 76.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.368 -0.378 . . . . 16.649999999999999 110.628 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.88 -40.37 54.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.299 -0.56 . . . . 14.15 109.69 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.39 -48.44 56.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.007 0.523 . . . . 10.800000000000001 110.96 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 16.3 m120 -57.88 -35.91 71.65 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.489 0.551 . . . . 12.98 112.489 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -86.22 -56.11 3.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.061 0.458 . . . . 17.52 110.814 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -61.81 -32.57 72.89 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.073 0.949 . . . . 14.869999999999999 111.788 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.15 3.2 25.47 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.473 0.654 . . . . 12.199999999999999 111.201 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.251 13.7 pt20 39.82 55.7 2.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.964 2.106 . . . . 16.710000000000001 114.308 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.35 159.07 23.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.34 -0.846 . . . . 12.199999999999999 110.129 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -94.95 26.82 3.42 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.077 0.551 . . . . 16.059999999999999 110.487 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mm -53.71 121.92 30.51 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.346 -0.843 . . . . 11.390000000000001 111.027 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.47 137.96 48.61 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.657 1.571 . . . . 12.6 108.555 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.56 -19.99 29.13 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.44 0.696 . . . . 12.52 112.267 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.34 -1.88 57.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.024 -0.534 . . . . 14.140000000000001 112.207 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.55 72.0 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 121.481 -0.39 . . . . 10.76 112.368 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.91 -26.22 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.408 0.683 . . . . 11.0 111.522 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -103.76 -2.53 26.26 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.643 -0.423 . . . . 16.420000000000002 111.921 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 m -69.52 -57.44 5.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.356 -0.979 . . . . 13.35 108.356 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.23 85.2 50.09 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 105.053 -2.203 . . . . 12.23 105.053 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 71.9 Cg_endo -76.15 54.32 4.14 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.836 2.357 . . . . 13.06 115.175 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.3 126.77 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.277 -1.009 . . . . 12.949999999999999 108.277 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -50.54 -54.78 19.8 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.382 0.882 . . . . 10.92 113.382 -171.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 63.1 tttm -65.79 -33.29 75.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.501 . . . . 14.32 111.424 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.94 81.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.104 -0.498 . . . . 10.93 111.04 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.0 t80 -79.06 -32.02 44.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.833 0.349 . . . . 8.8100000000000005 111.618 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.0 p -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.662 -0.649 . . . . 9.3499999999999996 110.963 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.16 -27.91 57.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.597 -0.274 . . . . 11.630000000000001 110.627 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.528 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 2.2 t90 -53.8 -49.15 68.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.461 1.104 . . . . 10.550000000000001 109.277 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 86.8 t -62.83 -41.55 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 123.666 0.786 . . . . 8.3000000000000007 110.365 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.61 93.22 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.76 -0.654 . . . . 9.5800000000000001 112.378 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 p -75.22 -22.31 58.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.895 0.379 . . . . 10.23 111.618 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -78.26 -17.16 57.02 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.957 0.408 . . . . 10.43 110.019 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 97.5 mt . . . . . 0 C--N 1.316 -0.882 0 CA-C-O 122.073 0.939 . . . . 10.970000000000001 109.383 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.434 -1.262 0 CA-C-O 120.867 0.365 . . . . 10.050000000000001 110.079 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.45 69.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.115 -0.493 . . . . 11.220000000000001 111.434 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -70.53 -47.28 61.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.806 -0.813 . . . . 11.380000000000001 108.806 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -68.98 -40.55 78.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.037 -0.529 . . . . 9.6500000000000004 110.772 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.8 -41.99 92.42 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.059 -0.519 . . . . 10.43 110.05 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -64.92 -36.53 84.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 120.453 -0.499 . . . . 10.210000000000001 111.281 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.624 HG21 HG11 ' A' ' 178' ' ' VAL . 50.4 mt -59.31 -50.05 81.25 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 109.546 -0.538 . . . . 8.1300000000000008 109.546 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -60.83 -34.86 75.21 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.536 -0.756 . . . . 8.4600000000000009 110.114 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 15.0 t70 -63.49 -52.73 60.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.51 -0.768 . . . . 10.859999999999999 110.352 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -62.41 -44.72 95.76 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.337 -0.392 . . . . 11.449999999999999 109.976 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.91 -47.41 80.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.98 0.912 . . . . 7.6200000000000001 110.68 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.31 -47.6 85.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.514 -0.766 . . . . 11.619999999999999 110.226 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 90.3 mt-30 -66.18 -43.24 87.42 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.879 -0.6 . . . . 11.630000000000001 110.717 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.6 t -58.11 -51.81 68.15 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 123.579 0.752 . . . . 9.1400000000000006 111.803 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.502 HD23 ' CZ2' ' A' ' 148' ' ' TRP . 3.1 tm? -73.46 -40.82 63.87 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.54 -0.541 . . . . 10.06 109.54 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.53 -27.7 72.17 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.074 -0.512 . . . . 12.07 112.47 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.37 -37.94 68.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.369 0.604 . . . . 12.32 109.761 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.545 -0.752 . . . . 11.77 110.033 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.75 -16.68 55.13 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.552 -0.749 . . . . 13.52 110.567 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 72.46 8.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.351 1.46 . . . . 16.559999999999999 112.671 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.64 18.39 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.718 0.807 . . . . 15.74 108.99 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.94 126.23 29.48 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.521 -1.288 . . . . 14.199999999999999 107.521 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -7.53 21.03 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.76 2.307 . . . . 14.18 112.489 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.01 -73.06 0.39 Allowed Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 120.653 -0.784 . . . . 14.029999999999999 112.244 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -124.69 -22.17 4.64 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.821 0.343 . . . . 16.370000000000001 111.105 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp 63.5 -154.79 0.32 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 12.449999999999999 110.608 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.457 ' H ' HD23 ' A' ' 171' ' ' LEU . 67.3 mtp180 68.13 -78.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.148 0.979 . . . . 14.43 110.882 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.7 p -97.15 151.25 19.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.544 -0.91 . . . . 14.32 108.544 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.27 64.46 Favored Glycine 0 N--CA 1.47 0.951 0 C-N-CA 119.807 -1.187 . . . . 13.75 110.491 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.5 82.16 1.94 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.181 -1.414 . . . . 12.699999999999999 107.181 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.53 124.12 48.72 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.401 -1.272 . . . . 16.379999999999999 111.524 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.19 -7.08 51.4 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.086 -0.961 . . . . 13.300000000000001 111.372 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.86 -31.64 69.6 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.824 -1.176 . . . . 16.25 107.824 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.91 -51.98 3.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.772 -1.104 . . . . 15.869999999999999 110.176 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.18 15.55 2.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.549 0.69 . . . . 13.65 112.113 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.6 61.31 0.41 Allowed Glycine 0 C--N 1.297 -1.591 0 N-CA-C 109.857 -1.297 . . . . 14.16 109.857 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.6 ttm -72.46 -38.5 68.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.201 0.524 . . . . 15.449999999999999 110.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.14 143.27 46.63 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.321 -0.854 . . . . 13.630000000000001 110.299 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -82.06 -27.34 33.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.431 -0.804 . . . . 13.9 111.945 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.88 -35.96 50.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.204 0.526 . . . . 13.81 109.801 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.1 p -59.15 -48.12 82.77 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.77 -0.65 . . . . 11.48 110.939 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.4 85.14 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 115.499 -0.773 . . . . 10.35 112.726 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.9 t -64.37 -41.84 96.49 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.486 -0.486 . . . . 12.199999999999999 111.423 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -66.36 -46.34 77.08 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.891 0.377 . . . . 11.859999999999999 111.186 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 118' ' ' LEU . 32.8 t90 -64.14 -48.97 73.98 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.878 -0.601 . . . . 9.3200000000000003 111.789 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.423 ' HG3' HG12 ' A' ' 165' ' ' ILE . 93.6 mmm -60.93 -45.44 94.68 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 123.245 0.34 . . . . 9.5 111.809 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.21 -36.69 80.59 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.026 -0.27 . . . . 13.91 111.187 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.05 -47.97 80.22 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.656 -0.578 . . . . 9.8800000000000008 111.656 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.26 -42.92 92.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.204 0.526 . . . . 9.2699999999999996 110.101 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.2 m -62.82 -41.67 99.41 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.342 -0.845 . . . . 11.460000000000001 111.23 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -69.71 -41.79 74.9 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.892 -0.595 . . . . 15.039999999999999 109.87 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -60.41 -45.14 94.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.856 . . . . 11.82 110.248 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.52 5.9 49.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.473 0.546 . . . . 11.970000000000001 112.473 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.2 m 57.26 39.44 28.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.301 1.04 . . . . 14.24 112.887 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.0 149.66 16.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.076 0.465 . . . . 12.619999999999999 111.097 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.61 100.04 12.85 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.813 -1.18 . . . . 16.390000000000001 107.813 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -103.6 135.44 45.18 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.017 -0.538 . . . . 12.32 109.623 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.34 133.91 39.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.453 0.644 . . . . 14.06 110.573 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.76 64.3 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.683 -0.689 . . . . 12.640000000000001 111.487 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.83 -5.17 59.28 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.746 -0.661 . . . . 15.68 111.091 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.21 -8.54 56.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.727 0.775 . . . . 12.720000000000001 109.843 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.423 HG12 ' HG3' ' A' ' 149' ' ' MET . 10.7 mt -58.88 -23.85 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.984 1.314 . . . . 12.16 109.745 175.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -113.43 16.75 18.8 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.124 -0.944 . . . . 15.08 110.098 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.8 m -101.77 -34.1 9.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.645 -0.707 . . . . 14.67 109.85 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.8 m-90 -103.24 107.41 55.48 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.869 -0.419 . . . . 12.68 109.869 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.58 -13.7 9.49 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.155 1.904 . . . . 14.34 113.007 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -129.46 145.29 51.45 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.555 0.693 . . . . 12.91 111.529 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 130' ' ' ARG . 63.9 tp -58.17 -35.09 71.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.439 -1.255 . . . . 9.8900000000000006 111.9 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.84 -25.44 65.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 12.5 111.718 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 9.4 m -75.88 -20.16 58.28 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.146 0.498 . . . . 11.039999999999999 110.5 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.86 -29.75 55.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.578 -0.897 . . . . 8.5 108.578 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.42 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.417 -0.81 . . . . 7.7000000000000002 109.4 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -62.07 -30.5 71.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 120.804 0.335 . . . . 10.380000000000001 111.343 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -59.38 4.58 Favored 'General case' 0 C--O 1.252 1.205 0 N-CA-C 108.583 -0.895 . . . . 11.970000000000001 108.583 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 110' ' ' ILE . 14.9 p -65.49 -35.18 74.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 114.674 -1.148 . . . . 9.8000000000000007 111.773 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -57.24 -40.9 78.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.59 0.71 . . . . 10.83 110.919 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 34.2 ttp-105 -82.23 -53.22 6.23 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.341 -0.845 . . . . 13.5 111.18 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -75.42 -45.9 36.05 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.895 1.442 . . . . 14.84 114.895 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.98 -31.66 22.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 119.937 -0.705 . . . . 13.35 109.239 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.237 0.41 0 O-C-N 124.9 1.375 . . . . 13.51 111.223 172.776 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 119.721 -0.181 . . . . 14.98 111.078 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.52 -47.16 82.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 121.029 -0.268 . . . . 15.789999999999999 110.744 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 89.7 m -59.68 -42.91 93.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.509 0.195 . . . . 12.02 111.133 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.04 80.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.305 -0.407 . . . . 11.02 110.682 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.81 -39.13 87.61 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.787 -0.642 . . . . 16.07 110.647 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.35 -49.19 78.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.541 0.736 . . . . 13.93 110.289 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 96.0 mt -67.45 -38.08 83.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.422 -0.354 . . . . 10.710000000000001 110.683 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -59.74 -43.72 94.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.112 -0.495 . . . . 14.02 109.907 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.25 -41.86 69.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 16.289999999999999 110.096 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -57.73 -45.23 86.08 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.098 0.959 . . . . 12.91 111.132 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.48 -48.12 81.83 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.337 -0.616 . . . . 12.77 109.337 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.39 82.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.669 . . . . 15.19 111.831 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.65 86.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.137 0.575 . . . . 16.260000000000002 111.725 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.439 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 63.5 mtt -78.11 -42.61 31.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.705 -0.679 . . . . 15.449999999999999 111.468 -176.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.16 3.19 52.72 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.869 -0.733 . . . . 16.16 112.083 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 55.56 46.7 22.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.317 1.047 . . . . 20.559999999999999 110.187 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.8 m -123.38 -178.47 4.01 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.973 -1.012 . . . . 16.629999999999999 109.843 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.64 145.97 30.49 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.462 -1.681 . . . . 20.190000000000001 106.462 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.01 49.86 3.38 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 121.874 1.716 . . . . 16.600000000000001 109.237 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.1 92.54 0.01 OUTLIER Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 127.945 2.688 . . . . 17.739999999999998 114.587 -172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 44.19 29.71 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 127.044 2.138 . . . . 20.23 115.627 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.76 130.31 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.92 -1.141 . . . . 15.98 107.92 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -151.16 0.34 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.243 -1.021 . . . . 19.329999999999998 108.243 -173.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.09 -29.63 64.29 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.55 -0.46 . . . . 14.93 111.051 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -53.66 2.45 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.153 -1.022 . . . . 14.82 111.042 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -74.48 108.75 7.45 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.82 -1.178 . . . . 14.539999999999999 107.82 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 91.0 mtt180 -89.86 176.43 6.83 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.312 0.856 . . . . 16.75 113.312 -169.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -49.62 -41.17 41.63 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 112.736 0.643 . . . . 11.99 112.736 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.8 mt -60.34 -25.75 66.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 14.449999999999999 111.715 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.26 -36.2 79.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.243 0.617 . . . . 16.440000000000001 111.213 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.0 mt -88.98 5.22 45.24 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.584 -0.446 . . . . 13.77 112.006 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.79 51.71 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.992 -1.099 . . . . 13.81 112.677 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.9 tt -75.13 125.12 28.27 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.684 -0.858 . . . . 13.039999999999999 108.684 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -117.35 162.18 18.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.953 -1.128 . . . . 15.67 107.953 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 p -48.43 -43.89 34.78 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.401 0.68 . . . . 15.289999999999999 112.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.49 -47.66 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.865 -0.607 . . . . 16.66 110.487 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.0 mt -67.16 -34.46 69.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.816 -0.629 . . . . 14.140000000000001 110.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -59.34 -33.28 70.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 12.0 111.31 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.15 73.52 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.212 -0.449 . . . . 13.970000000000001 111.712 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.27 -45.74 14.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.386 0.612 . . . . 15.69 109.711 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 3.4 t90 -59.34 -40.59 86.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.498 1.119 . . . . 11.69 111.89 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 tp -62.18 -30.64 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.89 0.376 . . . . 11.16 110.872 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -64.96 -41.02 95.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 16.649999999999999 109.958 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' A' ' 17' ' ' MET . 0.3 OUTLIER -67.89 -31.7 71.67 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 121.191 0.519 . . . . 14.15 111.424 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 78.5 mt -66.97 -50.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.44 -0.948 . . . . 10.800000000000001 108.44 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 90.9 m-20 -62.66 -31.35 72.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.582 -1.19 . . . . 12.98 112.971 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -71.39 -43.13 67.43 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.871 -0.518 . . . . 17.52 110.155 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -74.64 -45.18 46.5 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 113.97 1.1 . . . . 14.869999999999999 113.97 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' HD22 ' A' ' 54' ' ' LEU . 63.9 m-85 -101.64 -1.15 33.36 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.758 -0.777 . . . . 12.199999999999999 112.189 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.298 13.6 pt20 48.49 42.71 19.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.242 1.941 . . . . 16.710000000000001 116.242 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 52' ' ' TYR . 3.4 mm? -94.51 171.25 8.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.599 -1.259 . . . . 12.199999999999999 107.599 171.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -114.12 60.74 0.67 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.506 -0.924 . . . . 16.059999999999999 108.506 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' PRO . 62.7 mt -97.4 126.4 41.77 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.35 -0.841 . . . . 11.390000000000001 111.0 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 56' ' ' ILE . 74.2 Cg_endo -77.0 169.5 21.51 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.273 1.982 . . . . 12.6 109.186 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.99 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.462 0.648 . . . . 12.52 110.629 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 5.6 m-20 -62.33 -20.09 64.0 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.101 -0.954 . . . . 14.140000000000001 112.312 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.07 99.82 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 119.791 -1.195 . . . . 10.76 110.252 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.03 -27.39 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.634 0.73 . . . . 11.0 110.07 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 20.6 m-85 -74.57 -23.47 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.843 -0.536 . . . . 16.420000000000002 110.233 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.4 m -87.57 -45.28 10.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.04 -0.527 . . . . 13.35 109.639 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' HE2' ' CE3' ' A' ' 73' ' ' TRP . 76.0 m-85 -115.74 104.22 53.03 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 120.583 0.23 . . . . 12.23 111.095 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 71.6 Cg_endo -83.13 3.32 7.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.96 1.773 . . . . 13.06 110.842 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -119.97 120.42 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.301 -1.74 . . . . 12.949999999999999 106.301 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -63.38 -29.77 71.01 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 113.504 0.927 . . . . 10.92 113.504 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -64.06 -34.25 77.6 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 14.32 111.696 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.16 -29.12 28.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.818 0.818 . . . . 10.93 109.655 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -75.58 -35.85 60.49 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.995 . . . . 8.8100000000000005 111.377 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -65.02 -30.39 71.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.107 0.48 . . . . 9.3499999999999996 109.731 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -70.17 -36.75 74.9 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.252 -0.885 . . . . 11.630000000000001 109.599 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.504 ' CE3' ' HE2' ' A' ' 64' ' ' TYR . 17.3 t-105 -61.95 -42.29 98.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 10.550000000000001 110.606 173.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 79.6 t -68.8 -45.29 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.921 0 N-CA-C 110.087 -0.338 . . . . 8.3000000000000007 110.087 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.07 87.7 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 116.153 -0.476 . . . . 9.5800000000000001 113.331 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 p -73.05 -30.18 63.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.053 0.39 . . . . 10.23 112.053 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -82.48 -19.92 37.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.599 0.714 . . . . 10.43 110.323 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 95.0 mt . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 109.185 -0.672 . . . . 10.970000000000001 109.185 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.924 -0.398 . . . . 10.050000000000001 109.924 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.08 76.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.435 -0.348 . . . . 11.220000000000001 111.8 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -65.47 -40.98 93.81 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.519 0.676 . . . . 11.380000000000001 109.659 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -66.22 -36.6 83.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.277 -0.874 . . . . 9.6500000000000004 112.893 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.68 -38.38 90.14 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 117.921 0.328 . . . . 10.43 110.688 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 t -56.88 -47.72 79.81 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.785 -0.45 . . . . 10.210000000000001 109.785 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 178' ' ' VAL . 68.1 mt -68.79 -51.97 39.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.404 -0.591 . . . . 8.1300000000000008 109.404 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -53.46 -41.38 66.11 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 124.587 1.155 . . . . 8.4600000000000009 112.126 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 23.8 t70 -63.65 -48.24 78.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.68 0.252 . . . . 10.859999999999999 111.68 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.91 -36.06 69.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 11.449999999999999 110.413 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.64 -35.99 82.39 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.82 -0.808 . . . . 7.6200000000000001 108.82 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 25.0 ttpp -61.92 -45.76 92.3 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 11.619999999999999 109.472 174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 77.7 mt-30 -56.22 -47.23 78.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.593 -0.73 . . . . 11.630000000000001 109.666 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -64.35 -50.98 65.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.111 -0.95 . . . . 9.1400000000000006 112.124 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.7 pp -65.09 -34.99 79.71 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.326 -0.549 . . . . 10.06 111.869 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -66.38 -47.8 68.11 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 111.072 -0.811 . . . . 12.07 111.072 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.37 -38.81 88.34 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.244 1.018 . . . . 12.32 110.624 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 tp -57.39 -44.05 84.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 11.77 110.102 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 86.9 mt -72.96 -63.24 1.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.522 -0.918 . . . . 13.52 108.522 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -179.27 -47.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.654 1.182 . . . . 16.559999999999999 109.978 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -162.67 155.3 19.23 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.777 0.322 . . . . 15.74 110.293 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -125.82 127.3 24.82 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.454 -0.794 . . . . 14.199999999999999 110.841 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.32 -2.88 12.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.137 2.558 . . . . 14.18 112.213 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.89 41.42 4.38 Favored Glycine 0 CA--C 1.491 -1.469 0 C-N-CA 120.893 -0.67 . . . . 14.029999999999999 111.916 173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -140.34 -72.66 0.36 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.132 -1.027 . . . . 16.370000000000001 113.413 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 118' ' ' LEU . 6.2 mp 67.79 141.25 0.03 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.418 1.104 . . . . 12.449999999999999 112.044 -166.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -83.04 161.91 21.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.879 -1.156 . . . . 14.43 107.879 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.1 m -78.31 17.49 0.64 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.845 0.683 . . . . 14.32 112.845 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.96 -74.83 0.34 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.663 -1.775 . . . . 13.75 108.663 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 62.07 62.43 1.21 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.998 0.919 . . . . 12.699999999999999 111.953 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 9.7 tt0 -80.79 104.67 11.46 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.717 -0.674 . . . . 16.379999999999999 110.684 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -66.72 -26.81 67.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.255 1.022 . . . . 13.300000000000001 109.945 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.16 -24.37 67.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.434 0.635 . . . . 16.25 110.673 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -97.68 -46.27 6.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.157 0.503 . . . . 15.869999999999999 109.782 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.03 -26.07 62.94 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 13.65 112.884 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.02 119.68 6.45 Favored Glycine 0 C--N 1.313 -0.729 0 N-CA-C 111.942 -0.463 . . . . 14.16 111.942 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 86.9 mtp -106.18 -23.23 12.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.307 0.575 . . . . 15.449999999999999 110.643 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.51 127.44 19.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.344 0.592 . . . . 13.630000000000001 110.305 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.7 t -66.87 -37.49 84.53 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.931 -1.031 . . . . 13.9 110.32 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.89 -40.19 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.468 -0.333 . . . . 13.81 111.135 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.7 p -57.56 -35.29 70.16 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.442 . . . . 11.48 111.515 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.36 -32.11 26.19 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.623 -1.275 . . . . 10.35 112.254 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -68.25 -35.6 78.17 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.428 0.614 . . . . 12.199999999999999 110.588 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -63.83 -38.72 92.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.116 -0.493 . . . . 11.859999999999999 110.334 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -62.4 -44.22 96.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.75 -0.659 . . . . 9.3200000000000003 110.22 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.8 mmt -60.23 -36.61 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 9.5 110.323 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -67.06 -43.79 81.77 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.946 -0.57 . . . . 13.91 110.426 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.06 71.87 Favored Glycine 0 C--O 1.246 0.873 0 O-C-N 123.692 0.62 . . . . 9.8800000000000008 112.73 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.34 -33.15 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.45 0.167 . . . . 9.2699999999999996 110.898 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.4 m -60.58 -47.09 87.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 121.031 0.443 . . . . 11.460000000000001 110.124 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -68.83 -50.43 50.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.603 -0.726 . . . . 15.039999999999999 111.37 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -66.0 -34.95 79.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.223 0.453 . . . . 11.82 112.223 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.18 5.77 42.81 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.032 -0.667 . . . . 11.970000000000001 112.612 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 p 53.16 44.83 29.76 Favored 'General case' 0 C--O 1.247 0.954 0 C-N-CA 124.473 1.109 . . . . 14.24 113.377 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.78 149.07 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.307 -0.861 . . . . 12.619999999999999 108.774 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -96.23 95.64 8.25 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.402 -0.962 . . . . 16.390000000000001 108.402 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.8 tp -106.12 136.75 45.25 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.943 -0.572 . . . . 12.32 109.7 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.95 134.53 43.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.525 -0.546 . . . . 14.06 109.525 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.5 60.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.734 -0.666 . . . . 12.640000000000001 110.763 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.02 -10.85 59.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.436 -0.802 . . . . 15.68 110.573 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 167' ' ' THR . . . -64.61 -11.51 35.76 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.073 -0.512 . . . . 12.720000000000001 112.202 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -58.53 -17.61 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 121.445 0.64 . . . . 12.16 111.467 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -93.38 -6.41 47.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.077 -0.51 . . . . 15.08 112.131 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 164' ' ' ALA . 13.9 t -103.05 8.94 38.76 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.327 -0.949 . . . . 14.67 111.14 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -129.93 99.46 20.12 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 108.98 -0.748 . . . . 12.68 108.98 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.3 Cg_endo -67.24 -28.78 39.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.742 1.628 . . . . 14.34 110.906 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 27.8 p -121.96 142.4 50.34 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.812 -0.631 . . . . 12.91 109.493 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.16 -30.56 71.69 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.316 1.046 . . . . 9.8900000000000006 111.622 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -55.23 -27.03 43.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.127 -0.942 . . . . 12.5 111.91 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.7 m -72.16 -19.89 61.69 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.162 -0.472 . . . . 11.039999999999999 112.194 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.7 tp -75.68 -29.84 59.18 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.951 -0.7 . . . . 8.5 109.892 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.26 96.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.807 -0.633 . . . . 7.7000000000000002 111.196 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -82.16 -25.88 33.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.151 -0.62 . . . . 10.380000000000001 110.558 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.38 -48.66 69.44 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.163 -0.472 . . . . 11.970000000000001 110.408 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 110' ' ' ILE . 9.0 p -59.56 -39.73 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.861 -0.609 . . . . 9.8000000000000007 110.141 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.88 -44.59 92.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.528 -0.76 . . . . 10.83 111.234 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -70.92 -28.33 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.124 0.488 . . . . 13.5 111.488 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -79.23 -41.98 27.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.624 -0.431 . . . . 14.84 110.806 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.04 -35.25 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.428 -0.509 . . . . 13.35 111.341 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.37 -0.604 . . . . 13.51 109.37 179.198 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 22.7 t70 . . . . . 0 C--O 1.212 -0.891 0 CA-C-O 120.807 0.337 . . . . 14.98 110.668 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.8 -38.11 70.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.889 -0.507 . . . . 15.789999999999999 111.708 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.0 p -65.7 -35.13 79.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.533 -0.867 . . . . 12.02 109.757 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.52 -35.0 79.53 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.055 -0.52 . . . . 11.02 110.477 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 80.3 mt-30 -53.36 -45.56 69.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 123.622 0.576 . . . . 16.07 110.636 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.45 -46.54 88.04 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.849 -0.614 . . . . 13.93 110.473 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.6 -36.35 73.47 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.01 -0.541 . . . . 10.710000000000001 111.075 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.62 -46.47 85.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.841 0.857 . . . . 14.02 109.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.92 -44.63 96.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.389 -0.823 . . . . 16.289999999999999 110.289 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -69.07 -40.4 78.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.407 -0.815 . . . . 12.91 110.847 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.77 -51.01 71.79 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.505 -0.924 . . . . 12.77 108.505 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -62.38 -39.61 93.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.055 . . . . 15.19 111.662 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.34 88.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.326 -0.397 . . . . 16.260000000000002 111.351 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.3 mtt -71.93 -36.62 69.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.789 0.328 . . . . 15.449999999999999 111.819 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 81.3 mt -94.73 -2.39 51.18 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.673 -0.411 . . . . 16.16 111.73 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 59.15 36.21 23.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.512 1.125 . . . . 20.559999999999999 111.104 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 23.5 p -112.27 164.91 12.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.11 -0.95 . . . . 16.629999999999999 108.976 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 52.2 mm-40 -91.28 129.29 43.91 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.091 -0.707 . . . . 20.190000000000001 109.091 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.93 -14.35 42.75 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.484 2.789 . . . . 16.600000000000001 114.317 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.98 -13.43 69.2 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.855 -0.688 . . . . 17.739999999999998 112.659 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 10.6 pt20 -79.56 -20.19 47.63 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.278 0.539 . . . . 20.23 110.472 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 pt -92.94 168.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.688 -1.227 . . . . 15.98 107.688 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -134.6 166.17 23.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 119.191 -0.433 . . . . 19.329999999999998 111.053 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 5.6 m-20 -56.5 -51.17 69.52 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.64 0.588 . . . . 14.93 111.167 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.23 6.72 70.5 Favored Glycine 0 C--O 1.244 0.741 0 CA-C-N 115.962 -0.563 . . . . 14.82 113.918 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -76.29 136.84 39.62 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.74 0.781 . . . . 14.539999999999999 110.924 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 82.3 mtp180 -77.54 147.08 35.93 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 114.576 -1.193 . . . . 16.75 108.786 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -58.63 -25.45 62.7 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.176 0.806 . . . . 11.99 113.176 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.01 -21.34 59.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.096 -0.502 . . . . 14.449999999999999 109.884 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.39 -18.74 18.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.864 0.866 . . . . 16.440000000000001 109.006 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 67' ' ' PHE . 87.6 mt -75.14 -21.63 58.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.702 -0.681 . . . . 13.77 109.792 177.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 24.56 8.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.45 -0.796 . . . . 13.81 112.543 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.38 163.54 16.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.924 0.869 . . . . 13.039999999999999 112.47 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.35 153.46 51.83 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.039 -1.437 . . . . 15.67 107.31 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -49.43 -55.65 12.36 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 123.741 0.65 . . . . 15.289999999999999 112.629 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.55 -44.79 99.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.249 -0.432 . . . . 16.66 110.704 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.78 -37.64 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.246 -0.433 . . . . 14.140000000000001 110.574 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.68 85.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 12.0 110.176 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.74 90.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.677 -0.692 . . . . 13.970000000000001 110.242 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.16 -42.39 90.63 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.461 0.648 . . . . 15.69 110.887 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.546 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 7.4 t90 -61.64 -55.61 28.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.793 1.637 . . . . 11.69 109.17 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.6 mm -54.32 -39.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.436 0.695 . . . . 11.16 111.583 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 18.4 tpt180 -72.33 -23.32 61.14 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.995 -0.548 . . . . 16.649999999999999 111.802 -175.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -86.56 -32.82 20.48 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 120.086 -0.646 . . . . 14.15 109.725 175.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 45' ' ' ILE . 87.9 mt -55.61 -35.8 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.972 0.909 . . . . 10.800000000000001 109.05 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.51 ' OD1' ' HD2' ' A' ' 46' ' ' ARG . 14.5 m120 -53.62 -39.77 65.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.836 -1.075 . . . . 12.98 112.411 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -84.86 -43.83 13.77 Favored 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 119.977 -0.689 . . . . 17.52 109.885 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -62.3 -37.05 84.07 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.36 0.874 . . . . 14.869999999999999 113.36 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -108.06 7.13 27.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.023 0.749 . . . . 12.199999999999999 113.023 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 48.17 52.6 13.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.302 1.441 . . . . 16.710000000000001 110.392 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 49' ' ' ASN . 33.1 tp -143.24 137.12 28.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.39 -0.967 . . . . 12.199999999999999 108.39 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.61 46.54 1.37 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.579 0.704 . . . . 16.059999999999999 109.474 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.1 tt -53.36 128.42 50.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.141 -1.39 . . . . 11.390000000000001 110.823 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 2.2 Cg_endo -83.2 147.37 12.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.466 2.11 . . . . 12.6 112.179 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HA ' HG13 ' A' ' 45' ' ' ILE . . . -68.4 -17.74 64.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.924 -1.034 . . . . 12.52 111.87 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.48 -9.27 56.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 14.140000000000001 111.915 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.27 -29.31 72.71 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.081 -0.808 . . . . 10.76 111.081 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.4 mt -76.79 -25.92 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 CA-C-O 121.414 0.626 . . . . 11.0 109.384 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -85.66 -14.03 46.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.297 -0.561 . . . . 16.420000000000002 111.526 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 t -97.03 -34.5 11.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.586 -0.446 . . . . 13.35 110.075 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -130.38 79.71 71.89 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.871 0.367 . . . . 12.23 110.273 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.8 Cg_endo -89.18 36.72 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.422 2.748 . . . . 13.06 112.813 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.0 t -124.43 127.31 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.397 -1.705 . . . . 12.949999999999999 106.397 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 34' ' ' LEU . 68.2 t80 -52.41 -49.16 65.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.807 0.73 . . . . 10.92 112.82 -170.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 17.5 tptm -70.36 -21.33 62.89 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.16 0.505 . . . . 14.32 111.58 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.28 -29.71 24.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.584 0.707 . . . . 10.93 109.875 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 73' ' ' TRP . 59.3 t80 -82.55 -28.12 31.2 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.305 -0.861 . . . . 8.8100000000000005 111.145 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -68.75 -32.36 72.08 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.16 0.505 . . . . 9.3499999999999996 110.083 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 68' ' ' LYS . 11.2 mm100 -72.23 -29.45 63.95 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 109.24 -0.652 . . . . 11.630000000000001 109.24 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.644 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 3.1 t90 -57.99 -53.87 53.33 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.351 -0.981 . . . . 10.550000000000001 108.351 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.52 -39.75 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 C-N-CA 124.153 0.981 . . . . 8.3000000000000007 110.877 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.1 95.11 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.246 -0.433 . . . . 9.5800000000000001 112.808 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -76.1 -13.42 60.21 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 122.55 -0.382 . . . . 10.23 111.081 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 75.5 mm-40 -83.64 -18.8 36.89 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.638 -0.875 . . . . 10.43 108.638 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.313 -1.01 0 N-CA-C 108.331 -0.989 . . . . 10.970000000000001 108.331 177.178 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.218 -0.578 0 N-CA-C 112.772 0.656 . . . . 10.050000000000001 112.772 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.09 -38.86 62.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.599 0.962 . . . . 11.220000000000001 113.599 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.01 -41.72 86.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.441 0.638 . . . . 11.380000000000001 110.81 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 107' ' ' ARG . 3.5 mpt_? -83.39 -33.71 25.72 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.781 -0.645 . . . . 9.6500000000000004 110.957 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.155 0.982 . . . . 10.43 110.386 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -60.53 -47.57 85.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.957 -0.565 . . . . 10.210000000000001 110.096 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 178' ' ' VAL . 67.1 mt -61.2 -45.53 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.096 -0.705 . . . . 8.1300000000000008 109.096 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.07 -35.12 68.98 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 114.83 -1.077 . . . . 8.4600000000000009 111.048 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.87 -37.78 85.81 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.04 0.448 . . . . 10.859999999999999 111.47 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -76.37 -44.29 37.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.853 -0.795 . . . . 11.449999999999999 108.853 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.8 -41.02 85.77 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.747 -1.115 . . . . 7.6200000000000001 109.774 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.58 -42.09 74.28 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.318 1.447 . . . . 11.619999999999999 110.174 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -81.56 -33.97 31.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 11.630000000000001 111.981 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 80.8 p -61.05 -43.92 98.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 121.01 -0.276 . . . . 9.1400000000000006 111.153 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.2 pp -75.34 -31.69 60.65 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.531 -0.468 . . . . 10.06 110.659 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -58.4 -54.94 33.63 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.187 -0.461 . . . . 12.07 111.972 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -60.43 -43.46 96.76 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.825 0.822 . . . . 12.32 110.702 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.59 -45.12 72.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.514 -1.221 . . . . 11.77 111.922 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.1 mt -91.14 -15.33 29.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.341 0.497 . . . . 13.52 112.341 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.1 t80 66.38 33.97 6.63 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.247 -1.39 . . . . 16.559999999999999 107.247 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.38 148.73 35.22 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.766 -1.561 . . . . 15.74 108.47 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 12.8 m-20 -67.98 119.91 70.3 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.394 -0.595 . . . . 14.199999999999999 109.394 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 16.8 Cg_exo -70.82 32.25 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.858 3.039 . . . . 14.18 114.387 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.13 3.52 9.72 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 108.725 -1.75 . . . . 14.029999999999999 108.725 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -106.18 40.59 1.57 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.231 -1.026 . . . . 16.370000000000001 108.231 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.88 48.72 0.39 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.612 -1.176 . . . . 12.449999999999999 113.168 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -161.51 -44.15 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 125.429 1.492 . . . . 14.43 107.911 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -64.73 -45.42 86.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.265 -0.879 . . . . 14.32 109.023 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.88 30.47 10.35 Favored Glycine 0 C--O 1.214 -1.105 0 CA-C-N 115.387 -0.824 . . . . 13.75 111.047 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB1' ' HG3' ' A' ' 172' ' ' LYS . . . -92.75 -17.99 23.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.487 0.66 . . . . 12.699999999999999 109.857 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -87.71 113.63 23.56 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.99 -1.115 . . . . 16.379999999999999 107.99 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -64.46 -16.2 62.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.214 0.53 . . . . 13.300000000000001 112.218 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.98 -24.51 55.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.118 -0.492 . . . . 16.25 110.618 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -78.22 -27.75 47.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.412 0.625 . . . . 15.869999999999999 109.81 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.19 -20.89 66.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.469 -1.241 . . . . 13.65 111.956 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.52 -53.77 4.89 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.843 -0.903 . . . . 14.16 110.843 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.2 mtm -98.1 146.95 25.05 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.305 -1.369 . . . . 15.449999999999999 107.305 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -137.39 -68.2 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.776 1.028 . . . . 13.630000000000001 113.776 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 t -70.9 -40.19 72.31 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.033 0.382 . . . . 13.9 112.033 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.1 -50.95 53.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.536 0.684 . . . . 13.81 109.733 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -37.97 83.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.036 -0.984 . . . . 11.48 111.143 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.6 98.44 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.653 -0.703 . . . . 10.35 111.522 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.8 m -56.84 -53.26 59.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.682 0.393 . . . . 12.199999999999999 110.115 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -64.84 -38.45 91.04 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.316 -0.402 . . . . 11.859999999999999 111.894 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.0 t90 -67.56 -50.9 56.33 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.348 -0.612 . . . . 9.3200000000000003 109.348 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 mmt -67.63 -26.18 66.11 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.456 -0.793 . . . . 9.5 111.435 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 26.5 tpt180 -62.92 -43.93 97.47 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.405 -0.961 . . . . 13.91 108.405 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.82 91.24 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.144 -0.782 . . . . 9.8800000000000008 111.144 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 148' ' ' TRP . 97.4 t -61.09 -40.86 87.15 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.465 -0.568 . . . . 9.2699999999999996 109.465 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' SER . 39.6 m -66.08 -30.13 70.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.751 -0.659 . . . . 11.460000000000001 110.821 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 37.6 mmt180 -67.19 -47.74 70.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.56 -0.533 . . . . 15.039999999999999 109.56 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -71.53 -55.34 8.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.235 0.828 . . . . 11.82 113.235 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -105.27 -8.35 18.34 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 114.068 1.136 . . . . 11.970000000000001 114.068 -170.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 153' ' ' SER . 28.0 m 55.58 38.88 30.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.91 0.884 . . . . 14.24 112.326 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.9 pt -104.23 144.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.333 -0.617 . . . . 12.619999999999999 109.333 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -81.98 95.36 7.37 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 123.522 0.514 . . . . 16.390000000000001 111.696 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.29 102.39 6.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.577 -0.897 . . . . 12.32 108.577 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.43 175.68 10.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 121.174 -0.21 . . . . 14.06 111.054 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.37 80.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.445 0.641 . . . . 12.640000000000001 110.935 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.84 -10.2 45.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.19 -0.914 . . . . 15.68 112.848 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 -13.64 62.33 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 111.675 0.25 . . . . 12.720000000000001 111.675 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -66.65 -18.24 23.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 O-C-N 122.107 -0.371 . . . . 12.16 111.729 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -94.02 1.76 56.17 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.933 0.873 . . . . 15.08 110.194 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.5 m -89.32 -9.55 50.1 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.061 -0.972 . . . . 14.67 108.402 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -130.93 149.04 72.58 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.36 -0.978 . . . . 12.68 108.36 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.85 -38.41 2.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.622 2.215 . . . . 14.34 112.317 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.2 p -138.16 162.15 34.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.319 -1.734 . . . . 12.91 106.319 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.17 -1.25 19.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.024 0.44 . . . . 9.8900000000000006 112.118 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 133' ' ' ALA . 30.0 mtpp -76.24 -24.34 54.57 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.179 -0.674 . . . . 12.5 109.179 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.2 m -73.88 -2.65 24.69 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.254 -0.885 . . . . 11.039999999999999 111.06 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.33 -32.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.464 -0.569 . . . . 8.5 109.464 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.36 68.9 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.299 0.571 . . . . 7.7000000000000002 111.22 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.37 -24.69 34.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.411 -0.588 . . . . 10.380000000000001 109.411 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.63 -60.97 2.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.66 -0.7 . . . . 11.970000000000001 110.05 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -46.14 -52.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 124.053 0.845 . . . . 9.8000000000000007 113.199 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.428 ' CG ' ' HE ' ' A' ' 107' ' ' ARG . 20.2 t70 -61.91 -45.38 93.98 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 111.897 0.332 . . . . 10.83 111.897 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -78.27 -29.76 48.15 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.463 -0.789 . . . . 13.5 110.448 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.25 -39.61 74.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.633 -0.712 . . . . 14.84 109.391 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.0 t -78.39 -60.55 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.692 -0.685 . . . . 13.35 111.658 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 108.664 -0.865 . . . . 13.51 108.664 -173.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 112.058 0.392 . . . . 14.98 112.058 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.89 -27.24 65.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.272 0.558 . . . . 15.789999999999999 110.206 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.8 -33.46 75.66 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.459 -0.571 . . . . 12.02 109.459 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 -26.68 32.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.157 -0.474 . . . . 11.02 110.543 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -67.47 -33.97 76.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.175 -0.676 . . . . 16.07 109.175 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -68.5 -28.97 67.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.505 -0.771 . . . . 13.93 109.749 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.81 -44.4 96.25 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.379 -0.6 . . . . 10.710000000000001 109.379 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.922 -0.581 . . . . 14.02 109.492 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.75 -46.1 73.07 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.495 -0.775 . . . . 16.289999999999999 110.131 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' MET . 48.4 t -59.34 -45.59 90.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.573 -0.74 . . . . 12.91 110.365 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.48 -45.44 93.75 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.273 -0.422 . . . . 12.77 111.449 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.53 -22.95 63.53 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.253 -0.43 . . . . 15.19 111.574 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 -24.36 49.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.426 0.631 . . . . 16.260000000000002 109.628 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 13' ' ' SER . 26.5 mmt -78.05 -44.22 27.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.619 -0.719 . . . . 15.449999999999999 109.197 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.67 5.49 51.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 16.16 112.607 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 53.41 45.61 27.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.237 1.415 . . . . 20.559999999999999 113.107 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -125.33 -173.8 2.91 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.345 -0.983 . . . . 16.629999999999999 108.345 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -107.32 134.99 19.72 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 107.976 -1.12 . . . . 20.190000000000001 107.976 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -66.04 -11.17 29.93 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.233 2.622 . . . . 16.600000000000001 112.859 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.78 -3.41 85.91 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.527 -0.629 . . . . 17.739999999999998 111.527 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -102.75 175.41 5.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.677 -1.231 . . . . 20.23 107.677 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.485 HG12 ' HG ' ' A' ' 34' ' ' LEU . 1.9 mp 70.96 140.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 123.883 0.739 . . . . 15.98 110.725 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 6.8 mpt_? -75.25 122.77 24.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.738 -0.601 . . . . 19.329999999999998 109.577 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.675 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 p30 -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.83 0.678 . . . . 14.93 112.83 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.37 7.4 68.88 Favored Glycine 0 C--N 1.315 -0.614 0 N-CA-C 110.649 -0.98 . . . . 14.82 110.649 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 26' ' ' ARG . 23.3 t -99.19 171.34 8.06 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.48 0.657 . . . . 14.539999999999999 109.54 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 81.8 mtm180 -92.93 160.3 14.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.163 -0.926 . . . . 16.75 110.38 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -58.26 -18.98 30.66 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.595 -1.184 . . . . 11.99 112.423 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -29.38 70.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.965 -0.561 . . . . 14.449999999999999 111.609 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.33 -35.45 80.38 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.361 0.6 . . . . 16.440000000000001 109.814 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' A' ' 25' ' ' ILE . 4.1 mp -83.43 -8.92 59.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.772 -0.649 . . . . 13.77 110.248 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.78 35.26 73.08 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 114.83 -1.077 . . . . 13.81 111.373 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.04 114.05 8.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.623 -0.51 . . . . 13.039999999999999 109.623 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.22 156.34 23.21 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.481 -0.781 . . . . 15.67 109.784 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 t -56.22 -41.47 75.71 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.271 0.357 . . . . 15.289999999999999 111.45 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.23 -47.62 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.912 0.387 . . . . 16.66 110.985 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mt -66.03 -39.68 85.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.026 -0.534 . . . . 14.140000000000001 109.683 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.62 99.11 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.588 -0.733 . . . . 12.0 110.444 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.48 85.06 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.564 0.745 . . . . 13.970000000000001 111.093 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.84 -47.61 44.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.96 -0.564 . . . . 15.69 111.56 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -61.31 -47.28 86.68 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.088 0.555 . . . . 11.69 111.644 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 48' ' ' ILE . 10.5 tp -59.69 -32.94 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 120.892 0.377 . . . . 11.16 110.571 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -66.86 -32.28 73.45 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.053 -0.522 . . . . 16.649999999999999 110.521 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.59 -31.97 60.16 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.564 -0.902 . . . . 14.15 108.564 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 45' ' ' ILE . 70.4 mt -62.49 -35.12 68.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.566 -0.743 . . . . 10.800000000000001 109.783 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.93 -31.04 70.58 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.475 -0.784 . . . . 12.98 110.042 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -43.95 20.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.934 -0.575 . . . . 17.52 110.047 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -65.11 -46.3 81.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.65 0.611 . . . . 14.869999999999999 112.65 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 55.6 m-85 -100.17 -0.03 39.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 112.787 0.662 . . . . 12.199999999999999 112.787 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 53.12 45.17 29.24 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.403 1.481 . . . . 16.710000000000001 111.702 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 96.0 mt -134.32 142.87 47.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.579 -1.191 . . . . 12.199999999999999 109.485 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -77.51 75.69 4.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.72 -0.844 . . . . 16.059999999999999 108.72 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 25.0 mm -94.18 119.95 66.06 Favored Pre-proline 0 N--CA 1.436 -1.135 0 CA-C-N 116.292 -0.413 . . . . 11.390000000000001 111.814 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -84.15 164.21 13.24 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.869 2.38 . . . . 12.6 110.112 173.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -2.92 17.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.634 -0.712 . . . . 12.52 112.518 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 p30 -68.3 -23.6 64.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.936 -0.306 . . . . 14.140000000000001 110.957 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.06 -30.62 70.66 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 119.883 -1.151 . . . . 10.76 111.588 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.94 -21.15 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.723 0.809 . . . . 11.0 110.036 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 16.7 m-85 -85.33 -45.86 11.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.384 -0.598 . . . . 16.420000000000002 109.384 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -67.54 -44.6 77.94 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.929 -0.578 . . . . 13.35 110.127 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.05 86.72 14.15 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.873 -0.788 . . . . 12.23 108.873 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 84.1 Cg_endo -83.9 14.87 2.28 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.751 2.301 . . . . 13.06 113.275 -174.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.8 t -124.56 120.29 58.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.118 -1.808 . . . . 12.949999999999999 106.118 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.5 p90 -58.72 -31.6 68.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 10.92 114.313 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -69.36 -24.98 63.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.766 0.654 . . . . 14.32 112.766 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.78 16.97 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.644 -0.873 . . . . 10.93 108.644 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 57.2 t80 -62.15 -28.91 69.98 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.748 -1.114 . . . . 8.8100000000000005 112.262 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 p -70.0 -26.45 64.08 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.471 -0.768 . . . . 9.3499999999999996 110.716 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -81.44 -28.94 33.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.746 -0.835 . . . . 11.630000000000001 108.746 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.502 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 66.1 t90 -58.26 -52.27 66.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.476 1.111 . . . . 10.550000000000001 108.094 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 54.4 t -67.88 -39.9 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 CA-C-N 115.266 -0.879 . . . . 8.3000000000000007 110.781 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.73 97.07 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.192 -0.528 . . . . 9.5800000000000001 112.3 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.2 m -67.99 -35.97 79.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 111.786 0.291 . . . . 10.23 111.786 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 27.6 pt20 -75.78 -18.77 59.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.363 -0.535 . . . . 10.43 110.517 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 116.141 -0.481 . . . . 10.970000000000001 111.039 176.799 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 C--O 1.243 0.742 0 N-CA-C 112.922 0.712 . . . . 10.050000000000001 112.922 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -42.03 80.88 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.414 0.524 . . . . 11.220000000000001 112.414 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -51.72 -48.4 63.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.405 0.682 . . . . 11.380000000000001 111.573 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -68.92 -42.82 76.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 9.6500000000000004 109.951 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.32 -44.48 83.25 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.989 -1.005 . . . . 10.43 111.766 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -59.84 -39.09 83.98 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.639 0.257 . . . . 10.210000000000001 111.038 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.66 HG21 HG11 ' A' ' 178' ' ' VAL . 59.7 mt -71.29 -50.95 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.921 -0.4 . . . . 8.1300000000000008 109.921 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -58.84 -39.94 82.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.109 -0.496 . . . . 8.4600000000000009 111.139 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 31.0 t70 -67.73 -36.98 81.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 10.859999999999999 111.007 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -70.05 -42.55 72.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.316 0.579 . . . . 11.449999999999999 109.782 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.6 -41.49 94.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.534 1.134 . . . . 7.6200000000000001 109.033 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 33.9 ttmt -54.47 -54.3 42.74 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.559 1.544 . . . . 11.619999999999999 110.254 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -67.34 -42.75 83.04 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.916 -0.583 . . . . 11.630000000000001 111.908 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.4 t -56.75 -53.09 61.73 Favored 'General case' 0 C--O 1.248 1.021 0 O-C-N 123.574 0.546 . . . . 9.1400000000000006 111.79 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.36 -36.77 74.39 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 120.676 -0.409 . . . . 10.06 110.912 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.7 84.95 Favored Glycine 0 C--O 1.223 -0.546 0 N-CA-C 111.24 -0.744 . . . . 12.07 111.24 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 -44.4 91.52 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 124.423 1.089 . . . . 12.32 110.804 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 148' ' ' TRP . 17.6 tp -66.0 -49.6 67.23 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.96 -1.018 . . . . 11.77 112.145 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 tp -94.02 4.23 54.21 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.703 -0.681 . . . . 13.52 112.358 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.1 t80 59.78 40.65 19.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.197 1.399 . . . . 16.559999999999999 110.187 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -111.49 154.86 24.12 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.78 -1.563 . . . . 15.74 106.78 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.8 117.94 63.88 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 107.577 -1.268 . . . . 14.199999999999999 107.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.57 107.89 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.921 3.081 . . . . 14.18 113.033 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 130' ' ' ARG . . . 125.46 -36.31 2.82 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.505 -1.225 . . . . 14.029999999999999 111.651 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -86.31 42.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.38 1.086 . . . . 16.370000000000001 109.366 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.65 -7.07 1.69 Allowed 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.584 -1.644 . . . . 12.449999999999999 111.199 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 127' ' ' GLY . 38.5 ptt180 -95.91 -5.95 40.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.94 -0.573 . . . . 14.43 110.081 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -70.22 -33.95 72.29 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 14.32 108.797 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.41 -62.67 0.95 Allowed Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 108.84 -1.704 . . . . 13.75 108.84 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 138' ' ' LEU . . . 60.07 26.81 16.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.367 1.067 . . . . 12.699999999999999 110.992 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -97.68 139.89 32.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.308 -1.315 . . . . 16.379999999999999 109.662 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 14.5 p90 -70.19 -12.88 61.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.276 -0.875 . . . . 13.300000000000001 109.43 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.65 -32.12 62.16 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.272 -0.876 . . . . 16.25 110.342 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.17 -42.39 6.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.429 0.633 . . . . 15.869999999999999 110.852 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 133' ' ' ALA . 70.5 mt -79.66 -22.35 43.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.589 -0.732 . . . . 13.65 110.465 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -102.72 43.79 1.62 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.954 -1.259 . . . . 14.16 109.954 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.7 ttp -60.29 -43.41 96.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.655 0.782 . . . . 15.449999999999999 110.551 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -127.34 120.21 28.02 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 107.479 -1.304 . . . . 13.630000000000001 107.479 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -62.06 -39.33 92.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.877 -1.056 . . . . 13.9 111.972 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.7 t -68.76 -36.83 76.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 110.146 -0.316 . . . . 13.81 110.146 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.5 m -56.9 -46.61 81.8 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.194 -0.457 . . . . 11.48 109.776 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.96 -22.52 76.67 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 119.677 -1.249 . . . . 10.35 111.87 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.419 ' HA ' ' HB1' ' A' ' 162' ' ' ALA . 92.5 m -63.81 -48.89 75.05 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.64 -0.504 . . . . 12.199999999999999 109.64 176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -59.6 -40.24 86.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.57 0.7 . . . . 11.859999999999999 110.227 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.484 ' HB2' HD22 ' A' ' 121' ' ' LEU . 22.4 t90 -68.5 -53.03 25.89 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.927 -1.033 . . . . 9.3200000000000003 112.318 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 32.7 ttm -65.96 -35.06 79.56 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 111.915 0.339 . . . . 9.5 111.915 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -66.4 -35.95 81.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.528 . . . . 13.91 109.576 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.06 -43.54 97.14 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.628 -0.989 . . . . 9.8800000000000008 110.628 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' TRP . 75.9 t -56.55 -45.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.607 0.763 . . . . 9.2699999999999996 109.253 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.2 m -59.51 -40.15 86.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.377 -0.828 . . . . 11.460000000000001 110.994 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -70.72 -46.96 62.1 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.478 -0.328 . . . . 15.039999999999999 111.591 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -68.22 -30.61 69.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.293 0.849 . . . . 11.82 113.293 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -101.56 0.16 35.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.075 -0.65 . . . . 11.970000000000001 112.123 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.8 m 56.42 45.94 21.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.638 -1.164 . . . . 14.24 112.308 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.5 156.15 41.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 12.619999999999999 109.047 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -88.8 106.58 18.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.221 -1.029 . . . . 16.390000000000001 108.221 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.41 110.3 11.38 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.782 -0.451 . . . . 12.32 109.782 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.28 135.92 47.67 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.944 -0.571 . . . . 14.06 110.469 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 146' ' ' THR . . . -63.46 -8.61 9.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.416 1.086 . . . . 12.640000000000001 112.834 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -77.42 -10.75 59.65 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.386 -0.598 . . . . 15.68 109.386 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.452 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -63.7 -13.13 40.35 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 116.102 -0.499 . . . . 12.720000000000001 112.256 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.8 pt -68.64 -12.32 15.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 121.166 0.508 . . . . 12.16 109.937 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.59 19.32 13.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.548 -0.908 . . . . 15.08 108.548 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 88.8 m -108.24 -26.55 10.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.187 -0.915 . . . . 14.67 109.679 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -122.75 143.67 40.76 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 107.978 -1.119 . . . . 12.68 107.978 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.572 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 68.8 Cg_endo -93.02 -5.73 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.902 1.735 . . . . 14.34 111.897 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.756 -0.656 . . . . 12.91 111.134 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.94 -32.92 71.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.904 -1.043 . . . . 9.8900000000000006 111.988 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -62.71 -20.36 64.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.172 -0.467 . . . . 12.5 111.187 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.8 m -70.88 -17.65 62.71 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.102 -0.499 . . . . 11.039999999999999 111.024 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.72 -44.94 61.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.892 -1.151 . . . . 8.5 107.892 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.02 80.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.471 -0.786 . . . . 7.7000000000000002 111.39 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.99 -19.75 60.55 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.318 0.488 . . . . 10.380000000000001 112.318 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -74.75 -52.61 11.05 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.331 -0.618 . . . . 11.970000000000001 109.331 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 110' ' ' ILE . 3.3 p -62.46 -42.64 96.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.578 -0.737 . . . . 9.8000000000000007 110.497 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.43 -41.87 90.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.401 . . . . 10.83 110.655 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -69.07 -53.24 21.43 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.74 0.816 . . . . 13.5 113.071 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -85.01 -32.47 22.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 115.187 1.551 . . . . 14.84 115.187 -173.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.87 -40.75 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.817 -0.753 . . . . 13.35 110.213 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 120.44 -0.504 . . . . 13.51 110.255 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 C--O 1.223 -0.29 0 CA-C-O 121.051 0.453 . . . . 14.98 110.008 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.92 -37.85 87.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 120.842 0.353 . . . . 15.789999999999999 111.295 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 p -63.82 -32.15 73.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.069 0.461 . . . . 12.02 111.016 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -75.14 -40.85 59.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.254 -0.43 . . . . 11.02 109.843 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 49.8 mt-30 -54.47 -43.91 72.13 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.8 0.44 . . . . 16.07 110.616 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.1 -41.41 78.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.771 -0.649 . . . . 13.93 111.006 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.32 -36.29 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.365 -0.38 . . . . 10.710000000000001 110.753 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 68.0 mtt180 -60.57 -45.64 93.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.763 -0.829 . . . . 14.02 108.763 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 77.1 mt-30 -59.92 -53.83 53.22 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.558 -0.747 . . . . 16.289999999999999 110.244 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 m -56.71 -42.85 79.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.123 -0.944 . . . . 12.91 112.681 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.83 -52.15 22.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.455 0.169 . . . . 12.77 110.687 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.71 71.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.39 0.515 . . . . 15.19 112.39 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.32 84.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.656 0.265 . . . . 16.260000000000002 111.544 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.3 mtt -75.81 -32.24 59.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.291 0.567 . . . . 15.449999999999999 110.893 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.62 -2.36 41.74 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.877 -0.601 . . . . 16.16 112.199 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 57.54 44.05 21.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.548 1.139 . . . . 20.559999999999999 111.589 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.57 177.0 4.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.134 -1.061 . . . . 16.629999999999999 108.134 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -96.76 133.72 24.09 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 110.47 -0.196 . . . . 20.190000000000001 110.47 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.77 20.66 1.19 Allowed 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 122.89 2.394 . . . . 16.600000000000001 111.484 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.16 -104.45 1.2 Allowed Glycine 0 N--CA 1.428 -1.89 0 CA-C-N 114.899 -1.046 . . . . 17.739999999999998 113.245 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.42 67.63 9.97 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.299 0.852 . . . . 20.23 113.299 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 pt -90.65 163.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.266 -1.012 . . . . 15.98 108.266 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 62.0 mtm180 -81.33 132.54 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.382 0.611 . . . . 19.329999999999998 109.569 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.01 -39.15 59.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.245 1.818 . . . . 14.93 112.475 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.32 7.48 66.46 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.8 -0.636 . . . . 14.82 114.182 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 74.8 m -68.2 119.16 12.32 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.815 0.817 . . . . 14.539999999999999 112.302 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 89.6 mtt180 -70.53 157.92 37.03 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.911 -1.495 . . . . 16.75 110.562 176.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -52.27 -48.6 65.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.951 0.405 . . . . 11.99 111.648 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.27 -41.31 84.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.534 0.734 . . . . 14.449999999999999 110.584 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HH21 ' A' ' 26' ' ' ARG . 6.3 tp10 -65.66 -45.14 84.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.854 -0.612 . . . . 16.440000000000001 110.463 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.4 -35.58 74.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.984 -0.553 . . . . 13.77 110.925 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.73 22.06 1.33 Allowed Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.194 -1.003 . . . . 13.81 112.983 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 167.18 20.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.533 0.682 . . . . 13.039999999999999 110.681 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -131.41 152.24 50.83 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 117.403 -1.284 . . . . 15.67 107.57 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -55.98 -40.32 73.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 119.495 1.043 . . . . 15.289999999999999 111.923 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.21 -51.11 51.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.732 -0.667 . . . . 16.66 110.405 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.64 -35.6 73.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.923 -0.581 . . . . 14.140000000000001 112.226 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.97 -30.09 70.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 12.0 110.336 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.47 78.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.512 -0.767 . . . . 13.970000000000001 110.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.54 -43.22 66.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 120.473 -0.491 . . . . 15.69 109.762 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -55.76 -54.67 41.62 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.605 -1.18 . . . . 11.69 110.823 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 56' ' ' ILE . 10.8 tp -62.51 -31.69 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.804 0.335 . . . . 11.16 110.882 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.53 -35.25 75.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.386 0.612 . . . . 16.649999999999999 109.509 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -70.21 -21.79 62.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.018 -0.537 . . . . 14.15 112.169 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.9 -46.21 92.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.6 -0.889 . . . . 10.800000000000001 108.6 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -62.58 -34.59 77.28 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.321 -0.854 . . . . 12.98 110.952 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -79.12 -39.88 32.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.289 -0.414 . . . . 17.52 110.957 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -79.46 -28.09 41.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.404 -0.362 . . . . 14.869999999999999 111.962 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -107.88 -4.84 17.61 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.439 1.274 . . . . 12.199999999999999 114.439 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 44.32 47.64 7.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.863 1.665 . . . . 16.710000000000001 112.854 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.0 tp -145.33 151.8 38.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.901 -1.148 . . . . 12.199999999999999 107.901 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.86 129.41 34.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.911 -0.774 . . . . 16.059999999999999 108.911 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 HD11 ' A' ' 45' ' ' ILE . 2.3 pp -124.97 153.52 71.12 Favored Pre-proline 0 N--CA 1.42 -1.957 0 C-N-CA 122.76 0.424 . . . . 11.390000000000001 110.14 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.18 96.35 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.954 1.769 . . . . 12.6 110.983 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.77 66.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.454 0.645 . . . . 12.52 109.849 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.08 -7.99 14.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 114.632 -1.167 . . . . 14.140000000000001 111.735 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.7 -35.49 89.87 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 116.017 -0.538 . . . . 10.76 112.184 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -73.68 -28.6 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.973 0.892 . . . . 11.0 109.445 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -85.24 -3.09 58.7 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.184 -0.916 . . . . 16.420000000000002 112.197 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -111.04 -73.23 0.69 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 116.356 -0.384 . . . . 13.35 110.705 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -136.82 88.51 18.56 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 122.199 1.0 . . . . 12.23 110.106 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.1 Cg_endo -80.91 62.41 8.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.828 3.019 . . . . 13.06 114.063 -172.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.71 129.56 43.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.709 -1.96 . . . . 12.949999999999999 105.709 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.37 -37.82 74.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.353 -0.385 . . . . 10.92 111.723 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.33 -31.94 72.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.458 0.647 . . . . 14.32 110.215 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.2 45.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.461 0.648 . . . . 10.93 109.5 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' TRP . 58.1 t80 -72.44 -32.65 66.48 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.499 -0.773 . . . . 8.8100000000000005 111.364 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -65.2 -23.78 67.18 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.008 -0.677 . . . . 9.3499999999999996 111.017 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -78.13 -33.73 50.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.23 -0.655 . . . . 11.630000000000001 109.23 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -50.2 -59.55 3.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.058 . . . . 10.550000000000001 110.411 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.58 -34.48 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 CA-C-N 115.742 -0.663 . . . . 8.3000000000000007 110.666 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.43 -38.24 93.2 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 116.068 -0.514 . . . . 9.5800000000000001 113.234 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -81.17 -20.46 41.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.226 0.536 . . . . 10.23 110.12 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 82.1 mm-40 -76.8 -23.37 52.83 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.362 0.601 . . . . 10.43 109.906 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 122.129 0.966 . . . . 10.970000000000001 109.385 175.642 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 107' ' ' ARG . 9.9 p . . . . . 0 N--CA 1.414 -2.261 0 N-CA-C 108.256 -1.016 . . . . 10.050000000000001 108.256 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.61 -56.77 17.57 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.204 -0.907 . . . . 11.220000000000001 112.867 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 110' ' ' ILE . 31.3 mm-40 -59.04 -41.66 88.39 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.409 0.623 . . . . 11.380000000000001 110.562 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 37.3 ttt180 -66.24 -36.89 84.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.043 -0.981 . . . . 9.6500000000000004 111.565 -176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.57 -34.51 70.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.877 -0.729 . . . . 10.43 110.851 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 m -62.28 -41.58 98.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.78 -0.822 . . . . 10.210000000000001 108.78 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 51.7 mt -56.68 -44.52 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.165 -0.925 . . . . 8.1300000000000008 110.932 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 107' ' ' ARG . 15.1 mm100 -53.97 -30.74 48.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.45 0.7 . . . . 8.4600000000000009 112.431 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -71.14 -46.75 60.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.468 0.652 . . . . 10.859999999999999 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 96.0 m-85 -74.79 -27.42 60.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.33 0.586 . . . . 11.449999999999999 110.258 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -66.03 -42.3 89.8 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.26 -1.015 . . . . 7.6200000000000001 108.26 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -60.95 -42.18 97.73 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.001 -0.999 . . . . 11.619999999999999 109.78 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.89 -20.01 65.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 11.630000000000001 112.382 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.4 m -82.63 -46.02 13.79 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.22 -0.659 . . . . 9.1400000000000006 109.22 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 59.9 tp -63.13 -41.76 99.38 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.554 0.692 . . . . 10.06 109.633 175.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.82 -49.66 76.16 Favored Glycine 0 C--O 1.2 -2.0 0 CA-C-N 114.935 -1.029 . . . . 12.07 112.454 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -63.48 -28.7 70.14 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.004 0.43 . . . . 12.32 111.094 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 147' ' ' GLN . 26.3 tp -61.3 -42.01 97.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.68 -0.691 . . . . 11.77 110.713 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.13 -76.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.128 -0.693 . . . . 13.52 109.128 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -173.7 -46.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.103 2.561 . . . . 16.559999999999999 106.662 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.5 tp -168.21 148.7 4.87 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.252 -2.129 . . . . 15.74 105.252 175.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 0.9 OUTLIER -95.82 136.07 22.51 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.29 -1.374 . . . . 14.199999999999999 107.29 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 2.7 Cg_endo -86.54 29.86 0.5 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.239 1.959 . . . . 14.18 112.929 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.78 57.61 0.78 Allowed Glycine 0 C--N 1.309 -0.924 0 N-CA-C 110.376 -1.089 . . . . 14.029999999999999 110.376 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.58 -18.27 20.72 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.526 0.679 . . . . 16.370000000000001 110.689 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.8 113.97 5.99 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.097 -0.956 . . . . 12.449999999999999 110.538 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 75.84 10.26 3.3 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.261 . . . . 14.43 112.247 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.3 m -103.66 25.89 9.21 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.68 0.752 . . . . 14.32 110.019 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.39 88.78 1.98 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.68 -0.771 . . . . 13.75 111.99 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.58 95.58 4.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.946 -0.761 . . . . 12.699999999999999 108.946 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -118.37 146.69 44.2 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.658 0.742 . . . . 16.379999999999999 111.305 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -62.14 -14.63 39.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.819 1.248 . . . . 13.300000000000001 112.396 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -69.15 -33.1 72.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.372 0.606 . . . . 16.25 109.905 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.51 -44.74 5.77 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.416 -0.811 . . . . 15.869999999999999 110.372 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.06 -23.21 64.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.993 -0.549 . . . . 13.65 111.2 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.06 16.15 30.43 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.557 -0.747 . . . . 14.16 111.626 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.7 ttm -77.85 -24.09 48.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.74 -1.207 . . . . 15.449999999999999 107.74 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.08 139.91 52.25 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.669 -1.975 . . . . 13.630000000000001 105.669 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.9 m -80.78 -22.73 39.87 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.435 -0.95 . . . . 13.9 108.435 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.878 1.271 . . . . 13.81 111.976 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.37 88.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.882 -0.599 . . . . 11.48 111.572 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.8 44.26 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.782 -0.723 . . . . 10.35 111.354 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.6 m -53.28 -50.87 63.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.346 0.658 . . . . 12.199999999999999 110.938 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 121' ' ' LEU . 52.3 mt-30 -76.49 -34.37 58.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.404 0.89 . . . . 11.859999999999999 113.404 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -69.9 -52.42 24.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.398 -0.521 . . . . 9.3200000000000003 109.614 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.494 ' SD ' ' HA ' ' A' ' 165' ' ' ILE . 33.1 ttm -69.66 -31.62 69.8 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.345 0.498 . . . . 9.5 112.345 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -64.57 -35.0 79.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.45 -0.574 . . . . 13.91 109.45 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.71 85.79 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.218 -1.153 . . . . 9.8800000000000008 110.218 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 158' ' ' ILE . 85.2 t -58.05 -49.76 80.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 123.748 0.819 . . . . 9.2699999999999996 110.036 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.3 t -55.98 -49.55 73.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.813 0.845 . . . . 11.460000000000001 110.681 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -66.04 -49.6 67.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.754 0.279 . . . . 15.039999999999999 111.754 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -63.06 -34.59 77.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.302 0.853 . . . . 11.82 113.302 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.441 ' CZ ' HG23 ' A' ' 110' ' ' ILE . 88.5 m-85 -101.06 -3.76 28.67 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.952 0.723 . . . . 11.970000000000001 112.952 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t 63.63 34.41 12.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.826 0.85 . . . . 14.24 109.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 152' ' ' VAL . 33.5 pt -107.47 155.66 8.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.635 -0.711 . . . . 12.619999999999999 109.492 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -99.42 96.75 7.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.791 0.329 . . . . 16.390000000000001 111.87 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -124.73 118.59 26.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -108.0 168.4 9.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.423 0.63 . . . . 14.06 111.154 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.13 -6.78 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.505 1.522 . . . . 12.640000000000001 114.751 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.91 -23.46 17.43 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.516 -0.474 . . . . 15.68 109.948 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.27 0.52 31.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.786 0.803 . . . . 12.720000000000001 109.473 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.494 ' HA ' ' SD ' ' A' ' 149' ' ' MET . 5.9 tt -75.11 -14.41 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.899 -1.046 . . . . 12.16 110.46 -172.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -106.4 6.37 30.32 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.224 -0.898 . . . . 15.08 109.46 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.2 m -87.09 -32.11 20.11 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.796 -0.638 . . . . 14.67 110.092 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.45 74.19 77.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.22 -0.659 . . . . 12.68 109.22 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -94.4 37.22 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.837 2.358 . . . . 14.34 112.115 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 p -140.77 163.2 33.56 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 12.91 109.788 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 49.2 tp -67.21 -55.38 14.3 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.916 0.389 . . . . 9.8900000000000006 110.518 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -61.27 -44.56 97.03 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.409 -0.814 . . . . 12.5 112.856 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -68.24 -30.66 69.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.754 0.252 . . . . 11.039999999999999 110.696 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.59 -45.83 61.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.438 -1.319 . . . . 8.5 107.438 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.87 99.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.605 -0.725 . . . . 7.7000000000000002 111.243 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 7.0 m-20 -62.94 -33.63 75.76 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.68 0.276 . . . . 10.380000000000001 110.679 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 24.7 tp10 -69.22 -57.05 5.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.973 -0.558 . . . . 11.970000000000001 110.528 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.431 HG22 HD13 ' A' ' 110' ' ' ILE . 7.0 p -59.93 -36.67 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.136 -0.483 . . . . 9.8000000000000007 111.518 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.93 -38.36 82.16 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.1 0.476 . . . . 10.83 111.19 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 26.6 mmm180 -77.87 -33.26 52.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 13.5 111.481 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 9.7 mmp_? -73.25 -44.5 59.31 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.745 -0.382 . . . . 14.84 111.555 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.18 -51.73 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.22 0.325 . . . . 13.35 111.761 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.395 -0.812 . . . . 13.51 111.284 -177.156 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 121.219 0.533 . . . . 14.98 109.932 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.09 -35.44 47.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.901 0.704 . . . . 15.789999999999999 112.901 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.74 -43.27 99.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.138 0.495 . . . . 12.02 111.046 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.55 81.78 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.099 -0.501 . . . . 11.02 109.872 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -55.58 -52.31 64.2 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.542 0.526 . . . . 16.07 110.094 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -60.48 -45.72 92.73 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.176 -0.92 . . . . 13.93 111.11 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.89 -36.96 78.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.227 -0.442 . . . . 10.710000000000001 111.245 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -62.5 -42.65 99.64 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.032 -0.729 . . . . 14.02 109.032 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -67.65 -49.62 62.0 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.354 -0.839 . . . . 16.289999999999999 110.987 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -62.21 -36.01 80.62 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.041 0.386 . . . . 12.91 112.041 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.47 -55.64 19.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.442 -0.947 . . . . 12.77 108.442 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.87 89.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.131 -0.94 . . . . 15.19 112.016 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.6 77.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.895 0.379 . . . . 16.260000000000002 111.479 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.497 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 66.1 mtt -73.76 -21.55 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.677 -0.238 . . . . 15.449999999999999 111.511 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.02 11.96 25.52 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.277 0.473 . . . . 16.16 112.277 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 60.84 40.78 15.41 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.419 1.104 . . . . 20.559999999999999 110.06 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 68.1 m -121.93 155.28 35.83 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.694 -0.854 . . . . 16.629999999999999 108.694 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.42 131.3 31.39 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.74 -0.467 . . . . 20.190000000000001 109.74 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.62 -21.5 62.87 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.918 3.079 . . . . 16.600000000000001 116.006 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.39 -6.2 84.15 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 119.939 -1.124 . . . . 17.739999999999998 111.967 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -113.96 21.84 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.223 0.535 . . . . 20.23 110.785 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.3 153.4 7.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.79 -1.189 . . . . 15.98 107.79 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -108.22 124.98 51.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.401 0.619 . . . . 19.329999999999998 111.085 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -73.0 -21.47 60.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.715 -1.13 . . . . 14.93 111.459 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.92 5.29 79.06 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.303 -0.951 . . . . 14.82 112.906 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB2' HD21 ' A' ' 34' ' ' LEU . 54.2 m -91.68 157.29 17.03 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.521 0.677 . . . . 14.539999999999999 110.405 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 22.0 mtp180 -82.49 146.87 29.01 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.988 -1.006 . . . . 16.75 111.347 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -54.64 -43.54 72.39 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 118.52 0.6 . . . . 11.99 112.416 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.11 -31.21 72.3 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.017 -0.538 . . . . 14.449999999999999 110.942 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.63 -30.06 46.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.581 0.705 . . . . 16.440000000000001 109.266 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 29' ' ' SER . 95.8 mt -72.0 -28.92 63.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.675 -0.693 . . . . 13.77 110.572 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.03 4.4 7.87 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.333 -0.937 . . . . 13.81 112.773 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.3 tt -81.93 131.16 35.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.976 0.417 . . . . 13.039999999999999 110.084 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.11 166.42 12.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 117.959 -1.019 . . . . 15.67 109.344 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -55.92 -41.53 74.73 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 119.166 0.894 . . . . 15.289999999999999 110.949 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.01 -44.98 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.632 -0.713 . . . . 16.66 110.4 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.14 -38.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.935 -0.575 . . . . 14.140000000000001 109.946 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.27 -46.31 86.25 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 123.372 0.669 . . . . 12.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.32 71.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.709 0.766 . . . . 13.970000000000001 111.251 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -78.43 -47.91 16.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.328 -0.851 . . . . 15.69 110.931 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 7.6 t90 -60.6 -48.81 80.12 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.323 1.449 . . . . 11.69 111.367 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 tp -62.34 -28.41 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.718 0.77 . . . . 11.16 110.519 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.36 -35.05 54.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.211 -0.904 . . . . 16.649999999999999 109.637 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -74.29 -31.88 62.67 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.164 -0.471 . . . . 14.15 111.678 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -69.77 -36.79 71.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.603 -0.839 . . . . 10.800000000000001 109.412 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.493 ' OD1' HG13 ' A' ' 56' ' ' ILE . 75.1 m-20 -66.73 -27.82 67.92 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.806 0.812 . . . . 12.98 110.417 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.06 -45.54 26.74 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.663 -1.153 . . . . 17.52 110.105 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -70.5 -39.25 74.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.837 0.31 . . . . 14.869999999999999 111.837 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.81 -3.9 55.55 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.909 1.077 . . . . 12.199999999999999 113.909 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 56.37 47.29 19.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.898 1.332 . . . . 16.710000000000001 108.791 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.0 tp -139.0 153.99 48.21 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.46 -1.311 . . . . 12.199999999999999 107.46 -173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -114.87 89.17 3.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.874 -0.787 . . . . 16.059999999999999 108.874 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' OD1' ' A' ' 49' ' ' ASN . 1.5 pp -76.55 147.9 79.22 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 122.243 -0.286 . . . . 11.390000000000001 111.717 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -62.65 122.39 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.637 2.225 . . . . 12.6 110.285 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.65 2.34 4.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.798 1.407 . . . . 12.52 114.798 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.43 5.14 46.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.937 -0.477 . . . . 14.140000000000001 110.78 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.63 -66.97 2.47 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.088 -0.505 . . . . 10.76 113.871 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.79 -28.08 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 124.436 1.094 . . . . 11.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -75.66 -39.12 58.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.416 -0.811 . . . . 16.420000000000002 110.469 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 92.5 m -82.8 -44.0 16.04 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.012 -0.54 . . . . 13.35 110.954 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -113.74 88.36 13.78 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 123.756 0.822 . . . . 12.23 109.093 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.4 Cg_endo -83.56 25.78 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.938 2.425 . . . . 13.06 113.128 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.13 123.69 59.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.614 -1.624 . . . . 12.949999999999999 106.614 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.49 -41.32 76.45 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.15 0.98 . . . . 10.92 112.524 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.25 -30.52 71.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.366 0.603 . . . . 14.32 111.081 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.99 -25.01 30.33 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.988 0.423 . . . . 10.93 110.095 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 49.4 t80 -82.58 -31.45 28.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.928 -0.578 . . . . 8.8100000000000005 110.89 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 p -68.33 -36.97 80.06 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.627 -0.879 . . . . 9.3499999999999996 108.627 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.6 -41.99 98.28 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.826 -1.079 . . . . 11.630000000000001 109.489 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 63.7 t90 -52.68 -56.01 18.56 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.969 1.308 . . . . 10.550000000000001 109.587 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.13 -42.33 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 C-N-CA 123.295 0.638 . . . . 8.3000000000000007 110.675 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.66 -17.03 66.48 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.343 -0.39 . . . . 9.5800000000000001 113.454 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.5 m -81.23 -30.12 34.27 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.194 -0.669 . . . . 10.23 109.194 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.85 -43.63 11.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.814 -0.63 . . . . 10.43 110.16 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.837 -0.62 . . . . 10.970000000000001 109.86 178.636 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 22.0 m . . . . . 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 10.050000000000001 112.403 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.72 -26.41 50.04 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.994 -1.003 . . . . 11.220000000000001 111.382 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.442 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 8.2 tp-100 -63.9 -48.08 78.06 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.267 -1.383 . . . . 11.380000000000001 107.267 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 176' ' ' ASP . 31.9 ttm180 -51.9 -45.62 64.25 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 114.138 -1.392 . . . . 9.6500000000000004 111.544 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 104' ' ' SER . 52.6 mt-10 -61.3 -44.08 97.82 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 111.905 0.335 . . . . 10.43 111.905 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -65.06 -46.57 80.65 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 120.792 0.329 . . . . 10.210000000000001 110.318 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.427 HG21 HG11 ' A' ' 178' ' ' VAL . 81.1 mt -64.81 -43.2 96.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.696 -0.684 . . . . 8.1300000000000008 111.468 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.71 -34.03 72.37 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.496 0.718 . . . . 8.4600000000000009 111.34 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.73 -30.37 59.22 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.468 -0.493 . . . . 10.859999999999999 110.051 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -71.85 -45.92 59.75 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.307 -0.997 . . . . 11.449999999999999 108.307 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.84 -40.25 75.73 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.579 -1.192 . . . . 7.6200000000000001 108.842 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -55.47 -48.73 74.06 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 124.343 1.057 . . . . 11.619999999999999 110.601 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -69.31 -38.76 78.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.391 0.615 . . . . 11.630000000000001 110.455 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -63.67 -40.45 96.86 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.337 -0.847 . . . . 9.1400000000000006 110.054 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.11 -38.93 66.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.997 -0.547 . . . . 10.06 109.92 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.93 -27.07 66.36 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-N 115.705 -0.68 . . . . 12.07 112.844 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.23 -29.13 70.24 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.341 0.591 . . . . 12.32 110.041 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.82 -28.93 17.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.988 -0.551 . . . . 11.77 111.067 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.73 -30.14 24.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.91 0.386 . . . . 13.52 110.901 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 74.78 -38.89 0.4 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.545 1.538 . . . . 16.559999999999999 111.621 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.23 137.19 52.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.505 -0.924 . . . . 15.74 108.505 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.43 134.77 54.32 Favored Pre-proline 0 CA--C 1.479 -1.755 0 O-C-N 123.688 0.618 . . . . 14.199999999999999 109.666 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.35 -26.16 81.21 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.685 2.256 . . . . 14.18 109.911 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.94 -45.96 1.53 Allowed Glycine 0 CA--C 1.493 -1.334 0 CA-C-N 115.175 -0.92 . . . . 14.029999999999999 111.84 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -110.31 -48.64 3.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.396 . . . . 16.370000000000001 110.324 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp 63.93 -173.08 0.17 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.311 1.044 . . . . 12.449999999999999 110.97 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 72.56 -49.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 14.43 111.352 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 m -90.1 114.61 26.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.013 -1.477 . . . . 14.32 107.013 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.18 51.02 3.27 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 108.736 -1.745 . . . . 13.75 108.736 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.02 18.23 17.8 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.081 -0.559 . . . . 12.699999999999999 111.334 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.99 83.55 3.68 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.124 -1.065 . . . . 16.379999999999999 108.124 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -80.32 -7.12 58.92 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.652 0.739 . . . . 13.300000000000001 110.182 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.0 mt -56.46 -24.91 48.78 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.931 1.292 . . . . 16.25 109.368 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.35 -6.13 52.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.944 -1.025 . . . . 15.869999999999999 111.799 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.71 9.24 12.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.374 0.607 . . . . 13.65 111.251 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.62 -97.2 2.22 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.944 -0.571 . . . . 14.16 112.562 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.2 ttm -82.05 66.63 7.71 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.945 1.355 . . . . 15.449999999999999 110.057 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -92.71 -46.87 7.36 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.819 -1.537 . . . . 13.630000000000001 111.996 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 m -60.94 -34.63 75.02 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.186 0.517 . . . . 13.9 111.902 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.43 -52.75 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 13.81 110.568 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.2 t -72.14 -28.34 63.19 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 109.81 -0.441 . . . . 11.48 109.81 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.44 -28.77 73.94 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 116.066 -0.515 . . . . 10.35 111.832 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 162' ' ' ALA . 93.8 m -61.36 -46.97 87.96 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.901 0.382 . . . . 12.199999999999999 110.624 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.82 -49.86 71.21 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.447 -0.797 . . . . 11.859999999999999 109.608 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.45 ' CZ3' HD11 ' A' ' 171' ' ' LEU . 79.1 t90 -57.76 -49.26 77.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.252 -0.886 . . . . 9.3200000000000003 111.911 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -47.75 80.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 123.378 0.671 . . . . 9.5 111.255 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -69.68 -35.65 75.31 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.744 -0.382 . . . . 13.91 111.603 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.15 -47.58 79.65 Favored Glycine 0 C--O 1.244 0.756 0 C-N-CA 120.798 -0.715 . . . . 9.8800000000000008 112.148 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.24 -41.17 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 111.839 0.311 . . . . 9.2699999999999996 111.839 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 158' ' ' ILE . 36.1 p -62.82 -37.88 88.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 111.543 0.201 . . . . 11.460000000000001 111.543 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.51 -25.18 65.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 15.039999999999999 111.113 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -78.82 -31.54 45.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.919 0.39 . . . . 11.82 110.284 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -94.97 5.69 51.19 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.375 0.607 . . . . 11.970000000000001 110.761 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.4 m 57.62 41.04 26.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.901 1.281 . . . . 14.24 111.58 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 153' ' ' SER . 17.8 pt -131.11 156.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.703 -0.681 . . . . 12.619999999999999 109.517 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -102.12 108.63 20.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.291 -0.263 . . . . 16.390000000000001 110.291 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 3.7 mm? -125.87 124.96 42.03 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.612 -0.267 . . . . 12.32 110.804 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.48 143.54 28.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.772 -0.825 . . . . 14.06 108.772 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 146' ' ' THR . . . -70.84 -12.03 61.31 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.345 0.593 . . . . 12.640000000000001 112.134 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.51 -12.84 61.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.465 -0.789 . . . . 15.68 109.99 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.71 -15.83 63.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.435 -0.802 . . . . 12.720000000000001 112.334 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 162' ' ' ALA . 24.5 pt -71.75 -4.66 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.777 0.799 . . . . 12.16 110.605 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -110.06 0.83 18.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.571 -0.74 . . . . 15.08 109.498 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.5 m -96.02 -23.27 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.802 -0.814 . . . . 14.67 108.802 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 169' ' ' PRO . 4.9 m-90 -124.53 138.33 30.93 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.264 -1.013 . . . . 12.68 108.264 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 168' ' ' TRP . 11.5 Cg_exo -72.68 -15.06 27.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.86 2.374 . . . . 14.34 112.389 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.1 p -137.39 143.77 42.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.003 -0.74 . . . . 12.91 109.003 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ3' ' A' ' 148' ' ' TRP . 32.4 tp -69.22 -25.16 64.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 9.8900000000000006 110.979 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.37 -19.64 62.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 12.5 111.634 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.585 ' HA ' ' OD2' ' A' ' 176' ' ' ASP . 16.7 m -71.1 -12.09 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.044 -0.525 . . . . 11.039999999999999 112.137 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -64.86 -42.15 95.1 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.298 -1.001 . . . . 8.5 108.298 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 178' ' ' VAL . . . -65.68 -23.42 66.77 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.475 -0.784 . . . . 7.7000000000000002 110.979 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 173' ' ' SER . 63.4 m-20 -79.39 -25.84 42.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.971 0.415 . . . . 10.380000000000001 111.165 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.36 -33.37 16.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.53 0.681 . . . . 11.970000000000001 109.463 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 175' ' ' ALA . 7.2 p -53.66 -34.15 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 114.746 1.387 . . . . 9.8000000000000007 114.746 -170.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 106' ' ' GLN . 7.9 m-20 -57.85 -50.46 73.22 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.217 0.532 . . . . 10.83 109.799 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -71.95 -24.53 61.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.356 -0.838 . . . . 13.5 111.334 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -84.75 -46.26 11.58 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.082 -0.508 . . . . 14.84 111.199 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.67 -41.17 19.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 112.348 0.499 . . . . 13.35 112.348 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 119.156 -0.45 . . . . 13.51 109.812 -179.055 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.495 0.664 . . . . 14.98 110.948 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -28.79 70.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.884 -0.598 . . . . 15.789999999999999 110.479 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 31.6 m -61.5 -53.7 53.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.305 -0.862 . . . . 12.02 109.877 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.28 -43.08 92.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.286 -0.416 . . . . 11.02 111.3 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -57.12 -50.79 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.405 0.441 . . . . 16.07 111.689 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -63.86 -39.2 93.64 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.956 0.407 . . . . 13.93 111.221 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 88.7 mt -68.02 -40.88 82.84 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.218 -0.447 . . . . 10.710000000000001 111.167 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -67.39 -40.22 85.65 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.796 -0.446 . . . . 14.02 109.796 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.78 -54.79 42.2 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.051 0.94 . . . . 16.289999999999999 111.506 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 p -65.3 -44.42 87.99 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.994 -0.548 . . . . 12.91 111.951 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.07 -44.63 91.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.934 -0.575 . . . . 12.77 110.815 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.58 97.42 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.562 -0.29 . . . . 15.19 110.698 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.23 -49.08 79.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.96 0.41 . . . . 16.260000000000002 111.175 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 ptp -68.6 -26.74 65.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.487 0.551 . . . . 15.449999999999999 112.487 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.73 6.5 48.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.795 0.331 . . . . 16.16 111.661 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 59.92 43.13 15.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.403 1.081 . . . . 20.559999999999999 111.051 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.1 m -129.94 171.82 12.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 16.629999999999999 109.698 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -108.37 135.27 19.99 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.802 -0.814 . . . . 20.190000000000001 108.802 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.69 -11.87 33.58 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.007 2.472 . . . . 16.600000000000001 112.934 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.22 -14.24 60.68 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.626 -0.59 . . . . 17.739999999999998 111.626 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -96.78 -43.78 7.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.123 -0.633 . . . . 20.23 112.138 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.96 138.5 21.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 119.469 -0.892 . . . . 15.98 109.567 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' HG2' ' OG ' ' A' ' 29' ' ' SER . 4.8 ptm180 -95.1 163.57 13.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.822 0.82 . . . . 19.329999999999998 112.785 -165.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' HG11 ' A' ' 66' ' ' VAL . 17.5 t70 -64.38 -10.88 27.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.564 1.546 . . . . 14.93 111.499 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.57 6.37 29.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.689 -0.687 . . . . 14.82 113.04 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.507 ' OG ' ' HG2' ' A' ' 26' ' ' ARG . 71.4 m -70.64 119.01 14.16 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.928 0.864 . . . . 14.539999999999999 111.793 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -87.97 149.3 24.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.543 -0.753 . . . . 16.75 111.375 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -48.37 -42.29 31.21 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.245 0.618 . . . . 11.99 112.402 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.33 -37.89 68.02 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.676 -1.147 . . . . 14.449999999999999 111.748 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.22 -7.51 41.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.076 0.465 . . . . 16.440000000000001 111.427 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.07 -16.77 34.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.434 0.635 . . . . 13.77 110.309 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.39 27.72 47.02 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.269 -0.878 . . . . 13.81 111.592 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.83 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.955 -1.128 . . . . 13.039999999999999 107.955 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD2' HG22 ' A' ' 39' ' ' VAL . 18.1 t70 -129.87 168.02 17.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 117.866 -1.064 . . . . 15.67 108.548 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 t -56.57 -44.56 81.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.745 0.702 . . . . 15.289999999999999 109.981 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.445 HG22 ' OD2' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -58.15 -55.2 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.61 0.719 . . . . 16.66 112.311 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.78 -45.91 87.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.394 -1.275 . . . . 14.140000000000001 110.546 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.95 91.56 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.845 -0.616 . . . . 12.0 110.847 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.64 78.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.399 0.68 . . . . 13.970000000000001 111.479 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.21 -47.36 65.02 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.187 0.518 . . . . 15.69 111.126 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -64.48 -49.15 72.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.723 1.209 . . . . 11.69 112.338 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 48' ' ' ILE . 11.3 tp -61.41 -36.93 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.063 0.459 . . . . 11.16 110.503 -176.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -73.64 -26.16 60.64 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.292 -0.413 . . . . 16.649999999999999 111.92 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -69.62 -36.69 76.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.937 -1.134 . . . . 14.15 107.937 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 45' ' ' ILE . 77.0 mt -60.42 -49.58 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.116 -0.947 . . . . 10.800000000000001 109.348 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.416 HD21 ' CD1' ' A' ' 56' ' ' ILE . 19.1 m120 -59.84 -37.54 79.54 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.369 0.604 . . . . 12.98 111.153 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -67.29 -58.66 4.41 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.63 1.572 . . . . 17.52 111.665 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -85.35 -27.57 25.78 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.796 -0.762 . . . . 14.869999999999999 112.869 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -94.36 -0.93 54.55 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.577 -0.849 . . . . 12.199999999999999 112.857 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 44.29 43.56 6.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.056 1.342 . . . . 16.710000000000001 112.42 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -117.75 125.83 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.124 -0.943 . . . . 12.199999999999999 109.124 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -87.73 96.4 10.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.536 0.522 . . . . 16.059999999999999 110.063 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CD1' HD21 ' A' ' 49' ' ' ASN . 2.4 pp -124.88 153.66 70.82 Favored Pre-proline 0 N--CA 1.426 -1.635 0 O-C-N 121.992 -0.442 . . . . 11.390000000000001 110.179 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.43 127.28 17.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.123 1.882 . . . . 12.6 109.867 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.85 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.956 0.903 . . . . 12.52 112.522 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -85.91 -5.47 59.23 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.97 0.414 . . . . 14.140000000000001 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.1 -13.17 64.08 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.918 -0.583 . . . . 10.76 112.716 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 tt -58.63 -29.61 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 C-N-CA 123.433 0.693 . . . . 11.0 110.865 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.39 0.8 35.78 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.666 0.617 . . . . 16.420000000000002 112.666 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -71.83 -25.89 62.16 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.993 0.901 . . . . 13.35 109.499 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -123.16 100.26 39.68 Favored Pre-proline 0 C--O 1.209 -1.056 0 N-CA-C 106.496 -1.668 . . . . 12.23 106.496 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.14 -1.63 7.46 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.859 2.373 . . . . 13.06 113.819 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 27' ' ' ASP . 60.3 t -116.45 120.23 64.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.502 -1.295 . . . . 12.949999999999999 107.502 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -54.25 -41.99 69.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.679 1.192 . . . . 10.92 113.067 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -74.1 -29.56 61.91 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.621 -0.263 . . . . 14.32 111.543 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.49 -29.58 46.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 10.93 110.598 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -56.39 -23.98 41.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.936 0.895 . . . . 8.8100000000000005 113.369 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 p -56.25 -23.58 37.08 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 113.053 0.76 . . . . 9.3499999999999996 113.053 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 76' ' ' THR . 54.5 tp60 -53.04 -35.88 59.95 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 123.672 0.608 . . . . 11.630000000000001 110.332 176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -52.79 -58.76 5.81 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 123.724 0.64 . . . . 10.550000000000001 111.402 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.7 t -68.23 -45.8 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 CA-C-N 115.282 -0.872 . . . . 8.3000000000000007 110.394 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.77 -46.88 81.62 Favored Glycine 0 CA--C 1.518 0.262 0 O-C-N 123.744 0.652 . . . . 9.5800000000000001 113.543 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 72' ' ' GLN . 14.5 t -79.79 -16.81 54.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 120.321 -0.551 . . . . 10.23 111.488 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -90.63 -13.65 33.92 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 119.708 -0.797 . . . . 10.43 111.593 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 96.8 mt . . . . . 0 C--O 1.243 0.757 0 N-CA-C 107.367 -1.346 . . . . 10.970000000000001 107.367 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 109.059 -0.719 . . . . 10.050000000000001 109.059 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -35.81 73.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.859 -1.064 . . . . 11.220000000000001 113.329 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -60.0 -25.78 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.117 0.414 . . . . 11.380000000000001 112.117 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.412 ' HE ' ' CB ' ' A' ' 179' ' ' ASP . 17.8 ttt180 -72.37 -48.54 40.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.919 0.39 . . . . 9.6500000000000004 110.712 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -65.87 -28.18 68.77 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.524 0.678 . . . . 10.43 110.05 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -64.32 -29.58 70.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.155 -0.93 . . . . 10.210000000000001 111.646 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 178' ' ' VAL . 56.1 mt -81.28 -33.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.725 -0.843 . . . . 8.1300000000000008 108.725 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.05 -53.82 53.8 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.759 -1.109 . . . . 8.4600000000000009 109.985 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -68.38 -35.56 77.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.333 -0.547 . . . . 10.859999999999999 111.114 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.97 -46.57 88.99 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.249 0.343 . . . . 11.449999999999999 110.308 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.11 -49.71 76.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.959 -0.564 . . . . 7.6200000000000001 110.31 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.88 -47.39 85.08 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.681 0.613 . . . . 11.619999999999999 111.002 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.81 -34.58 73.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 11.630000000000001 112.063 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 -28.97 67.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.824 0.345 . . . . 9.1400000000000006 110.589 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.5 -44.71 67.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.756 -0.461 . . . . 10.06 109.756 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.36 98.13 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.297 -0.721 . . . . 12.07 111.297 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.35 -42.19 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.369 1.467 . . . . 12.32 110.535 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD21 ' HB ' ' A' ' 144' ' ' THR . 37.5 tp -84.63 -34.3 23.12 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.967 -1.015 . . . . 11.77 110.918 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 tp -73.18 -29.29 62.73 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.014 0.746 . . . . 13.52 113.014 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 66.1 13.08 8.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.03 0.932 . . . . 16.559999999999999 110.741 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.4 171.34 8.4 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.185 -1.783 . . . . 15.74 106.185 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.89 130.2 91.78 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 109.83 -0.433 . . . . 14.199999999999999 109.83 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -69.55 0.73 5.07 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.551 2.168 . . . . 14.18 112.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.87 7.23 57.27 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.402 -0.679 . . . . 14.029999999999999 111.402 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -75.3 -16.86 60.39 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.172 0.51 . . . . 16.370000000000001 110.372 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.6 165.31 18.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.584 0.707 . . . . 12.449999999999999 111.723 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -88.14 77.23 8.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.24 -0.891 . . . . 14.43 109.823 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m 70.91 -48.58 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.814 1.646 . . . . 14.32 111.395 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.12 0.06 OUTLIER Glycine 0 C--N 1.308 -0.99 0 N-CA-C 108.704 -1.758 . . . . 13.75 108.704 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -154.32 93.03 1.56 Allowed 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.499 -0.413 . . . . 12.699999999999999 111.902 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 136' ' ' LEU . 28.5 tt0 -168.86 132.35 1.4 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 109.632 -0.507 . . . . 16.379999999999999 109.632 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -81.35 -7.46 59.58 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.835 1.05 . . . . 13.300000000000001 113.835 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.512 ' H ' ' HG2' ' A' ' 134' ' ' GLN . 83.6 mt -80.15 -35.73 36.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 16.25 112.069 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -37.46 21.24 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.48 0.919 . . . . 15.869999999999999 113.48 -173.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.77 -17.54 6.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.243 1.571 . . . . 13.65 115.243 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.36 143.61 4.89 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.226 -0.988 . . . . 14.16 112.289 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -99.49 -7.27 26.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.032 0.444 . . . . 15.449999999999999 109.958 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -150.09 149.22 29.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.552 0.691 . . . . 13.630000000000001 110.858 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -51.45 -34.99 37.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.699 1.999 . . . . 13.9 114.284 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.3 t -57.5 -47.93 84.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 112.461 0.541 . . . . 13.81 112.461 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.495 ' HB ' HD21 ' A' ' 121' ' ' LEU . 19.6 p -67.35 -35.54 79.57 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.469 -0.332 . . . . 11.48 110.858 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.01 -47.04 56.88 Favored Glycine 0 C--O 1.219 -0.834 0 N-CA-C 111.285 -0.726 . . . . 10.35 111.285 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 85.9 m -58.25 -46.76 85.39 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.533 0.333 . . . . 12.199999999999999 111.009 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.32 -38.15 90.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.259 0.552 . . . . 11.859999999999999 111.14 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.474 ' HB2' HD22 ' A' ' 121' ' ' LEU . 21.8 t90 -67.59 -46.42 72.65 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.477 0.711 . . . . 9.3200000000000003 110.251 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -49.59 71.2 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.669 0.388 . . . . 9.5 111.192 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 146' ' ' THR . 77.8 mtp180 -58.7 -40.99 85.26 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.641 0.588 . . . . 13.91 110.731 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.07 -44.67 96.94 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.93 -0.577 . . . . 9.8800000000000008 112.657 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.03 -41.93 84.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-O 121.286 0.565 . . . . 9.2699999999999996 109.522 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.6 t -59.0 -49.54 77.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.928 -1.033 . . . . 11.460000000000001 111.51 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -70.94 -20.87 62.41 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.914 0.388 . . . . 15.039999999999999 111.832 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.94 -51.21 7.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.432 -0.507 . . . . 11.82 110.472 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -94.03 -2.05 53.55 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.303 0.853 . . . . 11.970000000000001 113.303 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.2 m 62.79 38.99 11.25 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.956 0.884 . . . . 14.24 111.267 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.7 pt -113.66 158.57 13.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.769 -1.105 . . . . 12.619999999999999 109.063 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.3 106.04 18.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.728 -0.842 . . . . 16.390000000000001 108.728 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 160' ' ' LEU . 45.2 mt -121.93 112.32 18.16 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.709 0.766 . . . . 12.32 111.76 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.57 152.06 43.28 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.825 -1.534 . . . . 14.06 108.921 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.87 -13.09 62.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.916 0.865 . . . . 12.640000000000001 109.989 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.97 -8.04 45.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.508 1.523 . . . . 15.68 111.804 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.735 ' HA ' ' CZ3' ' A' ' 168' ' ' TRP . . . -59.89 -0.61 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.959 1.837 . . . . 12.720000000000001 115.959 -173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 33.2 pt -96.09 2.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 122.002 -0.436 . . . . 12.16 111.558 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -94.15 -76.18 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.813 1.042 . . . . 15.08 113.813 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.417 HG22 ' CZ3' ' A' ' 168' ' ' TRP . 3.5 t -78.64 12.64 1.96 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.3 0.571 . . . . 14.67 111.238 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.735 ' CZ3' ' HA ' ' A' ' 164' ' ' ALA . 18.1 m-90 -120.12 90.68 44.88 Favored Pre-proline 0 N--CA 1.412 -2.363 0 N-CA-C 105.676 -1.972 . . . . 12.68 105.676 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.2 -28.42 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.456 2.104 . . . . 14.34 113.496 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 p -126.06 174.28 8.58 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.526 -0.546 . . . . 12.91 109.526 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.09 -22.09 49.5 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.096 0.951 . . . . 9.8900000000000006 108.548 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -64.14 -34.42 78.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.807 -1.542 . . . . 12.5 110.477 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -62.23 -45.23 94.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.957 -0.565 . . . . 11.039999999999999 110.101 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -70.33 -39.67 74.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.167 -0.47 . . . . 8.5 110.14 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.03 71.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.121 0.486 . . . . 7.7000000000000002 111.431 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.88 -30.11 40.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.022 0.439 . . . . 10.380000000000001 110.212 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -81.84 -37.35 27.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.955 -0.566 . . . . 11.970000000000001 112.314 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -56.28 -43.73 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.886 0.374 . . . . 9.8000000000000007 111.203 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.412 ' CB ' ' HE ' ' A' ' 107' ' ' ARG . 30.2 t70 -72.35 -28.12 62.83 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 121.149 0.5 . . . . 10.83 110.729 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -68.41 -26.69 65.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.474 -0.936 . . . . 13.5 108.474 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -83.98 -48.63 9.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.923 -1.035 . . . . 14.84 110.0 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 86.6 t -70.06 -43.53 79.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 N-CA-C 112.511 0.56 . . . . 13.35 112.511 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.028 -0.73 . . . . 13.51 109.028 -176.529 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 30.1 t70 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.644 0.735 . . . . 14.98 110.045 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.04 -40.19 94.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.982 -0.554 . . . . 15.789999999999999 111.578 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 57.6 m -60.9 -43.88 97.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.009 -0.541 . . . . 12.02 110.872 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.93 92.83 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 110.09 -0.337 . . . . 11.02 110.09 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 97.1 mt-30 -57.77 -52.99 63.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.168 0.508 . . . . 16.07 110.696 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.98 -46.59 86.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.508 -0.769 . . . . 13.93 111.381 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 63.0 mt -65.84 -35.46 80.74 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.756 0.65 . . . . 10.710000000000001 112.756 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtm-85 -62.91 -46.48 87.6 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 120.881 -0.328 . . . . 14.02 110.217 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.09 -41.21 95.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 16.289999999999999 110.983 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -58.31 -59.72 4.89 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.206 1.002 . . . . 12.91 111.592 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 17' ' ' MET . 42.3 tp -69.67 -41.63 75.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.471 . . . . 12.77 111.448 -175.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.285 0.476 . . . . 15.19 112.285 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.87 88.96 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.732 -0.387 . . . . 16.260000000000002 110.874 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 19.9 ptp -75.06 -31.12 61.19 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.268 -0.423 . . . . 15.449999999999999 111.76 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.37 -11.5 37.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.903 0.858 . . . . 16.16 110.934 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.2 t80 64.2 48.62 2.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.968 1.707 . . . . 20.559999999999999 109.886 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 21.3 p -119.84 174.82 6.21 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.374 -1.343 . . . . 16.629999999999999 107.374 176.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.33 129.91 35.54 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 112.121 0.415 . . . . 20.190000000000001 112.121 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.5 -18.91 33.22 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.414 2.742 . . . . 16.600000000000001 113.418 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.29 -36.34 7.6 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.318 -1.113 . . . . 17.739999999999998 110.318 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -87.45 70.95 9.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.022 -0.732 . . . . 20.23 109.022 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -140.74 151.79 20.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.943 -1.132 . . . . 15.98 107.943 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -114.4 131.33 56.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.804 -0.813 . . . . 19.329999999999998 108.804 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 9.3 p-10 -77.12 -21.89 53.54 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.701 0.401 . . . . 14.93 111.48 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.78 5.88 79.59 Favored Glycine 0 C--N 1.312 -0.8 0 N-CA-C 111.025 -0.83 . . . . 14.82 111.025 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -72.33 137.94 46.98 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.261 0.553 . . . . 14.539999999999999 109.724 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 49.3 mtp180 -82.55 142.85 31.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.692 -1.225 . . . . 16.75 107.692 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -57.19 -16.47 8.15 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.424 0.898 . . . . 11.99 113.424 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 mt -70.06 -34.6 73.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.972 -0.751 . . . . 14.449999999999999 108.972 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -77.42 -24.8 50.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.002 -0.999 . . . . 16.440000000000001 109.131 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.0 mt -74.69 -37.22 62.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.855 -0.794 . . . . 13.77 108.855 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.6 26.21 30.61 Favored Glycine 0 CA--C 1.493 -1.288 0 CA-C-N 115.124 -0.944 . . . . 13.81 114.488 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 36' ' ' LEU . 1.5 pt? -85.68 126.37 33.9 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.565 -0.854 . . . . 13.039999999999999 110.903 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.83 161.09 27.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.177 -0.919 . . . . 15.67 110.5 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -54.36 -36.59 64.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.191 0.451 . . . . 15.289999999999999 111.026 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 40' ' ' ILE . 1.4 m -54.54 -56.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.419 0.525 . . . . 16.66 112.419 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' H ' HG23 ' A' ' 39' ' ' VAL . 56.2 mt -59.35 -41.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.32 -0.855 . . . . 14.140000000000001 110.571 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.94 88.73 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.019 -0.537 . . . . 12.0 110.756 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.43 82.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.469 0.652 . . . . 13.970000000000001 110.697 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -67.39 -51.68 49.0 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.618 -0.719 . . . . 15.69 111.259 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -64.64 -45.16 88.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.165 0.986 . . . . 11.69 111.453 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 48' ' ' ILE . 10.5 tp -62.5 -35.38 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.5 . . . . 11.16 111.357 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -81.38 -20.27 40.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.732 -0.787 . . . . 16.649999999999999 111.546 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -78.36 -31.55 48.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.657 -0.817 . . . . 14.15 111.758 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 45' ' ' ILE . 22.5 pt -67.22 -31.39 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.473 -0.891 . . . . 10.800000000000001 108.715 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 56' ' ' ILE . 11.0 m120 -62.14 -42.18 99.0 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 115.196 -0.911 . . . . 12.98 110.422 174.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.33 -47.37 17.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.664 -0.698 . . . . 17.52 110.452 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -66.74 -34.54 78.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.852 -0.613 . . . . 14.869999999999999 111.764 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.569 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 69.1 m-85 -101.55 -12.2 18.67 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.626 1.343 . . . . 12.199999999999999 114.626 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 57.94 45.85 17.53 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.132 0.968 . . . . 16.710000000000001 108.922 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.0 tp -123.37 149.15 45.3 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.879 -1.055 . . . . 12.199999999999999 110.719 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -99.64 109.46 21.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.381 -0.97 . . . . 16.059999999999999 108.381 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.525 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.5 pp -124.36 149.63 61.79 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 118.185 0.448 . . . . 11.390000000000001 110.765 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.12 105.01 1.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.703 1.602 . . . . 12.6 109.039 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.98 -24.72 25.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.062 1.345 . . . . 12.52 113.145 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.81 -3.26 30.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.428 -0.351 . . . . 14.140000000000001 111.453 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.18 -49.3 31.05 Favored Glycine 0 C--O 1.204 -1.756 0 O-C-N 123.656 0.597 . . . . 10.76 113.342 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.53 -31.01 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 11.0 112.209 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.7 -40.11 12.75 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.068 0.396 . . . . 16.420000000000002 112.068 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -80.36 -35.59 35.21 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.374 0.607 . . . . 13.35 110.457 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -121.64 76.7 36.85 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 124.185 0.994 . . . . 12.23 108.737 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 4.1 Cg_exo -81.09 37.8 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.165 2.576 . . . . 13.06 113.878 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.53 124.78 60.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.837 -1.542 . . . . 12.949999999999999 106.837 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -55.08 -40.36 70.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.167 0.987 . . . . 10.92 113.33 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.4 tttt -64.8 -42.14 95.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 14.32 110.287 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.82 81.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.685 -0.688 . . . . 10.93 110.576 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -71.38 -35.63 71.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.928 0.344 . . . . 8.8100000000000005 111.928 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 p -65.32 -26.48 68.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.626 -0.83 . . . . 9.3499999999999996 110.935 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 16.3 mm-40 -77.26 -39.45 48.21 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.022 -0.535 . . . . 11.630000000000001 110.051 172.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -62.58 -30.79 71.59 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.54 0.736 . . . . 10.550000000000001 111.918 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.75 -44.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.207 -0.664 . . . . 8.3000000000000007 109.207 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.28 -27.03 73.43 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.417 -0.81 . . . . 9.5800000000000001 113.991 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -72.9 -16.48 61.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.313 0.557 . . . . 10.23 110.991 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 56' ' ' ILE . 15.1 mm100 -83.21 -23.58 32.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.109 -0.701 . . . . 10.43 109.109 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.502 -0.867 0 CA-C-N 115.097 -0.956 . . . . 10.970000000000001 110.301 178.9 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 11.3 p . . . . . 0 N--CA 1.426 -1.651 0 CA-C-O 122.755 1.264 . . . . 10.050000000000001 108.0 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.84 -24.19 59.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.816 -1.538 . . . . 11.220000000000001 110.099 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -66.3 -45.68 79.52 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.822 -1.177 . . . . 11.380000000000001 107.822 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 104' ' ' SER . 48.0 ttp180 -51.99 -53.01 46.58 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 124.148 0.905 . . . . 9.6500000000000004 110.219 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.53 -48.27 79.76 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.716 0.635 . . . . 10.43 111.843 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.2 t -60.63 -50.33 73.95 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 10.210000000000001 110.971 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 178' ' ' VAL . 97.2 mt -62.45 -39.54 84.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 CA-C-N 116.469 -0.332 . . . . 8.1300000000000008 110.929 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -47.48 -42.19 22.27 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 124.742 1.217 . . . . 8.4600000000000009 112.105 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.0 -29.82 66.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.022 0.439 . . . . 10.859999999999999 112.022 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.09 -36.76 16.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.283 0.563 . . . . 11.449999999999999 110.186 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.76 -37.36 86.14 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 108.224 -1.028 . . . . 7.6200000000000001 108.224 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 126' ' ' PRO . 83.6 tttt -51.03 -44.66 61.08 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.248 1.419 . . . . 11.619999999999999 110.349 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.69 -44.98 80.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.453 -0.794 . . . . 11.630000000000001 110.379 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -66.81 -48.3 69.39 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.557 -0.747 . . . . 9.1400000000000006 110.968 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.4 pp -71.38 -34.62 70.58 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.43 0.157 . . . . 10.06 111.147 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.41 -42.64 95.84 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.491 -0.644 . . . . 12.07 111.491 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.17 -44.72 96.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.919 0.866 . . . . 12.32 109.733 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.52 -45.77 78.4 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.509 -1.223 . . . . 11.77 110.956 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.0 tp -76.86 -19.06 57.93 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.518 -0.764 . . . . 13.52 111.073 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.1 t80 62.45 31.71 17.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.862 1.665 . . . . 16.559999999999999 109.738 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 125' ' ' ASP . 1.3 tm? -120.27 146.43 46.09 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 105.268 -2.123 . . . . 15.74 105.268 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 16.8 t70 -61.43 122.2 68.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.634 0.584 . . . . 14.199999999999999 110.308 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 15.2 Cg_exo -69.98 6.51 1.36 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.057 2.504 . . . . 14.18 114.787 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.89 1.26 55.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.186 -1.566 . . . . 14.029999999999999 109.186 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -125.01 36.8 4.53 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.801 1.286 . . . . 16.370000000000001 107.822 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.19 124.04 21.99 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.265 -1.334 . . . . 12.449999999999999 110.34 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -63.38 146.32 53.79 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.389 -0.967 . . . . 14.43 108.389 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.5 t -58.3 -61.89 2.24 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 118.765 0.711 . . . . 14.32 111.548 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.12 -57.17 2.71 Favored Glycine 0 C--O 1.247 0.942 0 N-CA-C 110.162 -1.175 . . . . 13.75 110.162 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 71.07 114.57 0.05 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.248 1.419 . . . . 12.699999999999999 112.578 176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.82 116.23 6.78 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.542 -0.754 . . . . 16.379999999999999 109.555 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.516 ' O ' HD22 ' A' ' 138' ' ' LEU . 17.1 t80 -56.59 -40.07 74.61 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 124.932 1.293 . . . . 13.300000000000001 110.961 -177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.0 -2.4 43.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.47 0.915 . . . . 16.25 113.47 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.2 -14.41 61.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.555 0.693 . . . . 15.869999999999999 109.993 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -64.77 -14.15 57.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.276 -0.875 . . . . 13.65 112.869 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.81 150.31 6.13 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.295 -0.722 . . . . 14.16 111.295 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.71 -31.49 65.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.806 -0.812 . . . . 15.449999999999999 108.806 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.82 125.46 27.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 114.729 -1.123 . . . . 13.630000000000001 109.048 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -62.72 -22.39 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.579 0.549 . . . . 13.9 110.296 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.443 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 61.8 t -58.02 -34.18 48.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.157 -0.929 . . . . 13.81 111.513 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.4 p -59.96 -44.27 94.52 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.445 0.641 . . . . 11.48 110.748 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -83.42 -35.53 16.98 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.231 -0.895 . . . . 10.35 113.006 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 143' ' ' VAL . 39.7 p -66.95 -30.19 70.25 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 117.506 0.653 . . . . 12.199999999999999 110.373 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -62.74 -47.64 82.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.676 0.791 . . . . 11.859999999999999 108.872 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.11 -42.83 99.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.605 -0.725 . . . . 9.3200000000000003 110.497 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 162' ' ' ALA . 24.4 mmt -61.76 -37.51 84.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.607 0.718 . . . . 9.5 109.915 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -69.64 -36.96 76.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.376 -0.829 . . . . 13.91 110.321 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.89 -51.65 38.67 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.671 -0.572 . . . . 9.8800000000000008 111.671 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.51 -44.05 84.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.289 0.636 . . . . 9.2699999999999996 111.657 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -60.89 -40.82 94.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.924 0.342 . . . . 11.460000000000001 111.924 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -68.41 -47.08 68.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.884 0.373 . . . . 15.039999999999999 110.491 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -54.71 -40.08 68.84 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.414 1.086 . . . . 11.82 111.999 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.73 -1.17 26.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.191 0.811 . . . . 11.970000000000001 113.191 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t 60.36 47.24 9.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.672 0.789 . . . . 14.24 110.308 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.09 168.83 18.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.527 -0.916 . . . . 12.619999999999999 108.527 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -108.08 97.25 6.97 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.44 0.638 . . . . 16.390000000000001 109.41 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.6 tp -103.13 123.66 47.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.73 134.29 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.142 -0.688 . . . . 14.06 109.142 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 149' ' ' MET . . . -75.92 -16.64 59.99 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.204 0.526 . . . . 12.640000000000001 111.116 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.37 -6.29 59.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.717 -0.674 . . . . 15.68 111.118 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.11 -10.69 32.68 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.327 -0.397 . . . . 12.720000000000001 111.677 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.57 -15.76 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.762 0.791 . . . . 12.16 110.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -103.85 14.15 31.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.469 -0.787 . . . . 15.08 109.099 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 32.5 m -110.69 -38.31 5.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.474 -0.785 . . . . 14.67 111.269 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -105.97 123.77 38.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.682 -0.407 . . . . 12.68 110.465 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.68 -27.84 4.66 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.972 1.781 . . . . 14.34 111.484 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -105.7 142.53 35.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.995 0.903 . . . . 12.91 111.504 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.14 -37.91 81.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.752 -1.567 . . . . 9.8900000000000006 112.433 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.34 -18.97 63.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.929 0.714 . . . . 12.5 112.929 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 -17.77 64.86 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.139 0.792 . . . . 11.039999999999999 113.139 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.3 tp -70.11 -32.21 70.13 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.087 0.47 . . . . 8.5 110.261 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.49 75.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.467 0.651 . . . . 7.7000000000000002 109.742 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.83 -21.79 60.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.557 -0.747 . . . . 10.380000000000001 110.579 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 9.6 tp10 -80.51 -56.8 3.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.994 -0.548 . . . . 11.970000000000001 109.752 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 110' ' ' ILE . 10.6 p -55.4 -34.03 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 112.443 0.535 . . . . 9.8000000000000007 112.443 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 107' ' ' ARG . 15.9 t70 -55.31 -43.01 74.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.996 0.918 . . . . 10.83 110.459 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -83.56 -34.23 25.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.276 -0.874 . . . . 13.5 111.273 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mmm180 -60.7 -58.5 8.19 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.119 -0.491 . . . . 14.84 111.259 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.37 -40.51 56.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.255 -0.578 . . . . 13.35 109.451 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 117.64 -1.171 . . . . 13.51 109.853 178.545 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 . . . . . 0 CA--C 1.507 -0.677 0 N-CA-C 113.866 1.062 . . . . 14.98 113.866 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.02 -27.38 67.37 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.942 -0.703 . . . . 15.789999999999999 110.343 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 35.0 m -70.55 -48.73 54.0 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.943 -0.571 . . . . 12.02 109.823 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.67 78.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.084 0.469 . . . . 11.02 110.832 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 29.0 tt0 -67.67 -45.88 73.96 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.028 -0.533 . . . . 16.07 110.255 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.51 -37.76 85.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.072 0.463 . . . . 13.93 110.716 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 -35.49 74.73 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.388 0.514 . . . . 10.710000000000001 112.388 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 12.4 ptp180 -69.44 -29.18 66.83 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 119.135 -1.026 . . . . 14.02 109.575 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -67.35 -48.77 66.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.028 -0.533 . . . . 16.289999999999999 109.673 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -62.74 -34.56 77.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.408 -0.814 . . . . 12.91 112.377 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.48 -53.15 31.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.358 0.599 . . . . 12.77 110.299 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -64.9 -29.72 70.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.953 -1.022 . . . . 15.19 112.214 -176.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.08 98.47 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.952 0.406 . . . . 16.260000000000002 110.652 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.4 mmt -78.81 -39.51 35.49 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.337 -0.392 . . . . 15.449999999999999 112.043 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 mp -90.36 5.69 46.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.749 0.309 . . . . 16.16 111.785 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 54.71 36.88 27.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.421 1.488 . . . . 20.559999999999999 112.556 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 42.4 t -95.89 175.71 6.39 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.377 -1.342 . . . . 16.629999999999999 107.377 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.19 115.93 65.19 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.196 -0.668 . . . . 20.190000000000001 109.196 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.91 42.93 1.41 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 123.378 2.719 . . . . 16.600000000000001 113.218 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -95.86 1.09 Allowed Glycine 0 C--N 1.288 -2.137 0 CA-C-N 114.769 -1.105 . . . . 17.739999999999998 111.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.85 66.22 1.53 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.033 0.445 . . . . 20.23 110.231 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 pt -68.42 147.58 12.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.249 -0.432 . . . . 15.98 110.026 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.42 114.12 3.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.064 -0.971 . . . . 19.329999999999998 111.002 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.7 m-20 -66.77 -24.76 66.24 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.728 0.811 . . . . 14.93 110.988 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.11 2.33 87.14 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.835 -0.698 . . . . 14.82 113.148 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -73.33 140.49 46.75 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.062 0.458 . . . . 14.539999999999999 111.76 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 73.1 ttt180 -76.23 142.04 41.56 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 104.394 -2.447 . . . . 16.75 104.394 166.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 71.3 m-85 -54.68 -25.58 27.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.111 1.152 . . . . 11.99 114.111 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.23 -38.71 92.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.043 0.449 . . . . 14.449999999999999 109.832 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.78 -24.28 60.92 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.177 -0.675 . . . . 16.440000000000001 109.177 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.19 -15.8 54.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.624 -0.716 . . . . 13.77 110.536 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.26 5.03 53.13 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.999 -0.619 . . . . 13.81 112.749 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.1 tt -80.1 140.38 36.46 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.553 -0.536 . . . . 13.039999999999999 109.553 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 26.0 t70 -120.98 163.41 18.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 118.184 -0.912 . . . . 15.67 108.837 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 m -57.46 -39.98 77.51 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 118.834 0.743 . . . . 15.289999999999999 111.389 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.93 -46.15 85.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 16.66 109.492 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 52.6 mt -60.82 -34.96 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.313 -0.858 . . . . 14.140000000000001 110.723 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.78 -47.27 85.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.417 0.687 . . . . 12.0 111.432 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.71 72.29 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 123.556 0.535 . . . . 13.970000000000001 111.148 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -79.07 -49.93 11.87 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.868 -0.606 . . . . 15.69 111.329 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.408 ' CZ3' HD11 ' A' ' 48' ' ' ILE . 7.4 t90 -60.96 -39.34 89.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.4 0.68 . . . . 11.69 112.062 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.3 -28.1 44.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 CA-C-O 121.132 0.491 . . . . 11.16 110.613 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -71.43 -32.03 67.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.982 0.42 . . . . 16.649999999999999 109.996 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -69.73 -34.39 73.79 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.84 0.828 . . . . 14.15 108.891 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.408 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 75.6 mt -69.92 -51.88 36.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 114.907 -1.042 . . . . 10.800000000000001 109.766 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.23 -28.22 62.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.799 0.84 . . . . 12.98 112.037 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -71.47 -50.78 28.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.531 0.681 . . . . 17.52 109.953 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -70.09 -51.84 28.54 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.71 -1.132 . . . . 14.869999999999999 113.303 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 79.9 m-85 -88.47 -6.67 57.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.869 0.692 . . . . 12.199999999999999 112.869 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 55.86 36.08 26.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.58 1.152 . . . . 16.710000000000001 112.209 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.68 147.25 32.21 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.958 -1.127 . . . . 12.199999999999999 107.958 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -91.22 77.34 5.95 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.762 -0.829 . . . . 16.059999999999999 108.762 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.35 128.38 30.56 Favored Pre-proline 0 N--CA 1.426 -1.674 0 C-N-CA 120.36 -0.536 . . . . 11.390000000000001 111.485 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.55 154.79 27.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.468 2.112 . . . . 12.6 108.956 171.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.31 20.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.464 0.706 . . . . 12.52 110.83 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 63' ' ' THR . 7.2 m-20 -62.43 -21.25 65.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.798 -1.092 . . . . 14.140000000000001 112.885 176.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.18 -41.33 92.71 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 119.409 -1.377 . . . . 10.76 111.632 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.55 -19.78 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.488 0.661 . . . . 11.0 110.23 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.74 -38.79 17.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 16.420000000000002 111.129 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 59' ' ' ASP . 8.5 t -77.66 -41.77 37.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.518 -0.473 . . . . 13.35 110.461 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -119.73 92.35 46.26 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-O 121.378 0.609 . . . . 12.23 109.872 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 44.8 Cg_endo -93.7 17.15 1.09 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.126 2.551 . . . . 13.06 113.93 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.95 137.94 45.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.08 -1.081 . . . . 12.949999999999999 108.08 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.28 -49.08 73.01 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 113.176 0.806 . . . . 10.92 113.176 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 13.9 tppt? -64.8 -35.05 79.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.317 0.58 . . . . 14.32 110.389 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.43 75.7 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.853 -0.612 . . . . 10.93 110.866 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.1 t80 -74.84 -31.97 61.8 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.379 0.609 . . . . 8.8100000000000005 111.428 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -70.31 -29.18 65.84 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.409 -0.917 . . . . 9.3499999999999996 110.584 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -75.01 -25.71 59.0 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.569 -0.53 . . . . 11.630000000000001 109.569 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' HZ3' HE21 ' A' ' 77' ' ' GLN . 5.6 t90 -61.33 -54.76 39.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.139 -1.43 . . . . 10.550000000000001 107.139 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.18 -32.33 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 CA-C-N 115.009 -0.996 . . . . 8.3000000000000007 109.544 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 -12.97 60.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.864 -0.607 . . . . 9.5800000000000001 112.388 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.8 m -85.24 -31.28 23.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.627 -0.879 . . . . 10.23 108.627 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.424 HE21 ' HZ3' ' A' ' 73' ' ' TRP . 20.2 mm-40 -81.18 -44.35 17.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.284 -1.006 . . . . 10.43 108.284 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.311 -1.09 0 N-CA-C 107.587 -1.264 . . . . 10.970000000000001 107.587 175.064 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 121.527 0.679 . . . . 10.050000000000001 112.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.84 -39.69 39.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.393 1.077 . . . . 11.220000000000001 112.581 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 60.2 tp60 -62.57 -54.61 37.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.58 -0.526 . . . . 11.380000000000001 109.58 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -58.07 -41.29 83.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.942 0.897 . . . . 9.6500000000000004 111.232 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -48.29 78.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.849 -0.614 . . . . 10.43 110.614 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.6 t -59.61 -37.7 79.28 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 123.699 0.624 . . . . 10.210000000000001 109.776 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 106' ' ' GLN . 53.2 mt -58.61 -44.83 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 115.265 -0.879 . . . . 8.1300000000000008 110.721 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -61.41 -38.21 86.29 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.152 0.282 . . . . 8.4600000000000009 111.517 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.2 -45.75 79.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.527 0.203 . . . . 10.859999999999999 110.554 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -71.52 -27.56 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.108 -0.637 . . . . 11.449999999999999 111.498 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.19 -48.0 83.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.188 -1.041 . . . . 7.6200000000000001 108.188 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -56.63 -51.89 66.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.453 -1.703 . . . . 11.619999999999999 110.712 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -64.92 -39.98 94.36 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.711 0.634 . . . . 11.630000000000001 112.711 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 p -67.97 -33.13 74.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.156 0.428 . . . . 9.1400000000000006 112.156 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -43.0 33.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.492 -0.883 . . . . 10.06 109.204 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.32 82.12 Favored Glycine 0 C--O 1.22 -0.775 0 CA-C-N 115.78 -0.645 . . . . 12.07 112.601 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.14 -28.63 68.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.526 0.679 . . . . 12.32 110.471 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.21 -43.06 10.07 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 11.77 110.127 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.48 -27.07 62.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.448 -0.796 . . . . 13.52 111.789 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 t80 80.27 -36.36 0.14 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.907 1.683 . . . . 16.559999999999999 110.742 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.77 172.35 13.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 15.74 110.816 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.83 139.02 76.66 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.988 0.423 . . . . 14.199999999999999 111.686 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.17 42.81 0.41 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.997 2.465 . . . . 14.18 111.128 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -101.2 -10.46 42.03 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 115.497 -0.774 . . . . 14.029999999999999 111.636 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.64 -13.77 41.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.192 0.52 . . . . 16.370000000000001 110.593 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.2 -169.45 2.07 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.124 -0.489 . . . . 12.449999999999999 112.119 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 79.68 113.96 0.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.12 1.368 . . . . 14.43 109.797 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 m 61.64 39.17 14.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.361 1.077 . . . . 14.32 109.062 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.69 70.23 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 113.704 -1.589 . . . . 13.75 110.624 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.85 -40.91 46.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.954 0.883 . . . . 12.699999999999999 110.247 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 64.03 31.75 13.36 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 113.242 -1.799 . . . . 16.379999999999999 112.973 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.75 -18.8 63.2 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.266 0.555 . . . . 13.300000000000001 110.788 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 136' ' ' LEU . 2.0 mm? -68.53 -25.39 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.685 -0.689 . . . . 16.25 109.512 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.33 -29.4 10.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.497 -0.774 . . . . 15.869999999999999 111.088 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.66 -27.58 58.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.963 0.411 . . . . 13.65 110.725 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -114.82 100.66 1.01 Allowed Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 110.192 -1.163 . . . . 14.16 110.192 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptp -94.2 -15.29 24.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.094 0.473 . . . . 15.449999999999999 110.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -122.74 138.26 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.295 -1.002 . . . . 13.630000000000001 108.295 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 t -59.36 -16.79 24.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.542 1.137 . . . . 13.9 113.878 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.35 -36.52 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.21 0.529 . . . . 13.81 110.73 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 p -58.81 -44.61 90.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.677 -1.147 . . . . 11.48 112.032 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.96 -46.41 28.94 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.783 -0.722 . . . . 10.35 111.904 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 m -58.71 -52.94 63.55 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 122.859 0.463 . . . . 12.199999999999999 110.733 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -61.09 -44.17 97.77 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.629 -0.714 . . . . 11.859999999999999 110.965 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 152' ' ' VAL . 22.1 t90 -67.18 -49.64 63.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.898 -0.592 . . . . 9.3200000000000003 111.511 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 38.0 ttm -64.7 -33.81 76.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.78 0.659 . . . . 9.5 112.78 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -66.31 -38.18 87.11 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.861 -0.736 . . . . 13.91 109.965 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.1 95.71 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.862 -0.895 . . . . 9.8800000000000008 110.862 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 148' ' ' TRP . 78.2 t -58.43 -46.97 89.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 123.598 0.759 . . . . 9.2699999999999996 109.468 174.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.9 m -61.49 -40.43 94.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 11.460000000000001 110.135 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -71.36 -53.27 14.72 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.756 -0.656 . . . . 15.039999999999999 111.558 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -66.61 -42.62 86.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.798 0.295 . . . . 11.82 111.798 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HD1' ' O ' ' A' ' 152' ' ' VAL . 96.7 m-85 -82.37 -8.9 59.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.048 0.451 . . . . 11.970000000000001 110.552 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.9 m 61.46 29.84 18.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.645 1.178 . . . . 14.24 111.588 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 178' ' ' VAL . 28.4 pt -103.64 150.14 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 12.619999999999999 109.057 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -89.02 94.92 10.12 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.537 -1.283 . . . . 16.390000000000001 107.537 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.61 120.64 42.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.512 -0.767 . . . . 12.32 109.182 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 134.58 57.18 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.929 -1.032 . . . . 14.06 110.932 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -69.27 -20.36 63.92 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.67 -0.696 . . . . 12.640000000000001 110.715 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.75 -16.87 64.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.966 -0.561 . . . . 15.68 110.348 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.47 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -65.71 -14.71 61.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.983 -0.553 . . . . 12.720000000000001 112.056 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 162' ' ' ALA . 31.7 pt -68.88 -22.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.521 0.676 . . . . 12.16 109.57 175.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -102.64 -15.52 16.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.661 -0.699 . . . . 15.08 109.157 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 25.9 m -77.16 -46.6 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.819 -0.808 . . . . 14.67 108.819 177.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.46 90.24 0.92 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 121.298 0.571 . . . . 12.68 112.425 -176.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.28 41.9 1.23 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.654 2.236 . . . . 14.34 111.191 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -123.07 142.89 50.38 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-O 122.361 1.077 . . . . 12.91 111.061 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.01 -43.19 93.32 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 113.535 -1.666 . . . . 9.8900000000000006 110.958 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.74 -37.2 86.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.058 -0.974 . . . . 12.5 111.106 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 m -79.29 -33.0 43.7 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.809 -0.632 . . . . 11.039999999999999 110.561 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.05 -43.61 91.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.661 -1.237 . . . . 8.5 107.661 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.66 78.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.698 -0.683 . . . . 7.7000000000000002 110.907 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -29.97 68.51 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.716 -0.675 . . . . 10.380000000000001 110.381 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -78.81 -58.0 3.47 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.65 -0.704 . . . . 11.970000000000001 111.696 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 110' ' ' ILE . 6.7 p -56.91 -43.75 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.432 0.53 . . . . 9.8000000000000007 112.432 -175.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.29 -44.67 95.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.143 0.496 . . . . 10.83 110.143 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -72.21 -30.87 65.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.014 -0.994 . . . . 13.5 110.983 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.14 -44.02 85.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.334 -0.617 . . . . 14.84 109.334 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.35 -52.86 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.848 -0.615 . . . . 13.35 110.186 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.308 -1.198 0 N-CA-C 112.432 0.53 . . . . 13.51 112.432 -177.717 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.334 0.588 . . . . 14.98 111.223 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.37 80.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.709 -0.678 . . . . 15.789999999999999 111.952 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 p -57.12 -36.04 70.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.517 -0.765 . . . . 12.02 111.445 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.94 76.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.364 -0.606 . . . . 11.02 109.364 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -59.24 -50.86 72.4 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.591 -0.732 . . . . 16.07 110.57 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -53.94 -47.07 71.65 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.762 0.825 . . . . 13.93 111.954 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -71.68 -36.38 70.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.381 -0.372 . . . . 10.710000000000001 111.253 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -67.21 -43.12 82.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.478 0.711 . . . . 14.02 109.841 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -58.59 -45.3 89.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.41 1.084 . . . . 16.289999999999999 110.128 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -70.26 -32.88 70.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.263 -0.88 . . . . 12.91 110.761 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.9 -56.66 10.63 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.603 -1.258 . . . . 12.77 107.603 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -61.13 -36.28 79.33 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.727 -1.124 . . . . 15.19 112.154 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.33 86.99 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.178 0.513 . . . . 16.260000000000002 111.405 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.6 mmm -78.01 -38.46 44.78 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.95 -0.568 . . . . 15.449999999999999 112.072 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.58 -1.86 58.29 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.422 0.63 . . . . 16.16 112.054 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.0 t80 60.61 56.62 2.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.24 1.416 . . . . 20.559999999999999 109.959 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 47.6 t -124.57 166.91 15.24 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.778 -1.564 . . . . 16.629999999999999 106.778 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -108.93 119.22 49.57 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-O 121.042 0.448 . . . . 20.190000000000001 110.346 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 -23.94 67.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.625 2.883 . . . . 16.600000000000001 115.091 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.33 -16.62 71.5 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.036 -0.602 . . . . 17.739999999999998 113.391 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.16 16.85 7.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.785 0.293 . . . . 20.23 111.043 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.33 139.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 109.709 -0.478 . . . . 15.98 109.709 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' NH2' ' HG2' ' A' ' 183' ' ' GLN . 40.5 ttm180 -78.14 96.71 5.24 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.168 -1.049 . . . . 19.329999999999998 108.168 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 11.5 p-10 -67.26 -14.7 63.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.686 -0.688 . . . . 14.93 112.135 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.88 5.85 66.67 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.751 -0.738 . . . . 14.82 112.081 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.6 t -87.51 161.44 17.79 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.623 0.725 . . . . 14.539999999999999 109.932 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -101.91 142.88 32.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.129 -0.942 . . . . 16.75 112.72 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -42.71 -60.88 1.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.293 1.437 . . . . 11.99 113.848 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.59 -29.86 70.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 14.449999999999999 111.879 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -79.38 -13.47 59.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.98 0.419 . . . . 16.440000000000001 111.409 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.36 -22.47 44.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.649 0.738 . . . . 13.77 109.195 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 25.28 6.21 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.964 -1.016 . . . . 13.81 111.107 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -74.0 113.47 11.21 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.08 0.467 . . . . 13.039999999999999 109.763 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.34 156.23 24.35 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.19 -0.914 . . . . 15.67 110.909 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 t -56.92 -42.32 79.79 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.062 0.458 . . . . 15.289999999999999 109.788 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.62 -48.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.494 -0.776 . . . . 16.66 110.92 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.7 mt -66.05 -38.44 82.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.969 -0.56 . . . . 14.140000000000001 110.779 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.57 84.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 12.0 110.334 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.52 -38.23 90.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 13.970000000000001 110.842 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -71.35 -42.4 68.54 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.645 0.736 . . . . 15.69 110.974 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -61.33 -47.81 84.22 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 125.531 1.532 . . . . 11.69 111.462 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 56' ' ' ILE . 11.3 tp -63.61 -34.02 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 120.855 0.36 . . . . 11.16 111.722 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 37.6 mmt180 -63.11 -38.32 90.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.717 0.294 . . . . 16.649999999999999 111.037 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.03 -39.74 93.81 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.35 0.595 . . . . 14.15 109.624 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 45' ' ' ILE . 72.9 mt -60.13 -47.66 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.193 -0.912 . . . . 10.800000000000001 110.361 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -60.64 -43.2 97.82 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.793 -0.64 . . . . 12.98 111.591 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -72.19 -58.97 2.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.46 -0.791 . . . . 17.52 111.141 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -30.46 69.8 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.012 1.116 . . . . 14.869999999999999 114.012 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.22 -2.36 46.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 113.095 0.776 . . . . 12.199999999999999 113.095 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 59.01 45.28 15.07 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.344 1.057 . . . . 16.710000000000001 110.003 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.49 165.77 22.82 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.536 -0.302 . . . . 12.199999999999999 110.204 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.83 71.34 0.74 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.586 -0.894 . . . . 16.059999999999999 108.586 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 45' ' ' ILE . 34.7 mm -101.31 114.69 65.71 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 116.196 -0.456 . . . . 11.390000000000001 110.65 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.79 171.01 16.12 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.346 2.03 . . . . 12.6 110.027 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.33 -1.05 9.35 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.409 0.684 . . . . 12.52 111.699 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.04 -30.62 71.1 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.089 0.956 . . . . 14.140000000000001 110.55 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.58 98.35 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.299 -0.477 . . . . 10.76 111.993 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.47 -32.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.763 0.792 . . . . 11.0 110.152 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -80.98 -16.5 53.28 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.982 -0.553 . . . . 16.420000000000002 111.097 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -83.57 -48.54 10.13 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.1 -0.704 . . . . 13.35 109.1 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.85 118.96 30.25 Favored Pre-proline 0 C--O 1.215 -0.761 0 CA-C-N 116.229 -0.441 . . . . 12.23 111.324 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.52 -3.99 7.5 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.768 2.312 . . . . 13.06 112.577 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.97 119.58 59.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.99 -1.485 . . . . 12.949999999999999 106.99 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.2 p90 -62.12 -33.54 74.66 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.884 0.698 . . . . 10.92 112.884 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -62.72 -38.17 89.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.368 0.604 . . . . 14.32 110.827 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.7 -23.86 36.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.72 0.771 . . . . 10.93 109.649 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 80.9 t80 -81.05 -30.13 34.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 8.8100000000000005 111.874 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 p -67.61 -33.32 74.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.43 -0.794 . . . . 9.3499999999999996 109.098 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.99 -29.85 64.64 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.253 -0.885 . . . . 11.630000000000001 109.543 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.543 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 82.4 t90 -59.62 -44.34 93.47 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.154 0.982 . . . . 10.550000000000001 108.847 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.65 -45.42 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 C-N-CA 123.629 0.772 . . . . 8.3000000000000007 110.306 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.98 75.63 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 116.162 -0.472 . . . . 9.5800000000000001 113.569 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -77.18 -22.11 52.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.277 0.561 . . . . 10.23 110.661 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -82.55 -2.64 54.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.342 0.592 . . . . 10.43 111.141 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.428 -1.564 0 N-CA-C 104.946 -2.242 . . . . 10.970000000000001 104.946 171.923 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.9 m . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.803 0.335 . . . . 10.050000000000001 111.537 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.26 73.3 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.276 -0.875 . . . . 11.220000000000001 111.782 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -72.55 -51.36 20.19 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.161 -0.472 . . . . 11.380000000000001 110.261 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -49.94 -51.42 41.32 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.705 0.628 . . . . 9.6500000000000004 110.897 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 104' ' ' SER . 5.9 mm-40 -63.86 -47.99 78.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 10.43 111.721 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.4 m -66.74 -43.53 83.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.182 -0.463 . . . . 10.210000000000001 111.765 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 178' ' ' VAL . 73.3 mt -71.91 -23.64 22.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.0 0 N-CA-C 110.014 -0.365 . . . . 8.1300000000000008 110.014 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -64.73 -41.84 95.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.232 -0.655 . . . . 8.4600000000000009 109.232 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.58 -38.98 84.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.15 0.5 . . . . 10.859999999999999 109.947 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.17 -49.62 76.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.985 -1.007 . . . . 11.449999999999999 109.503 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -50.0 -43.67 50.64 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.135 1.374 . . . . 7.6200000000000001 112.015 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -60.4 -45.29 94.11 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.817 -1.083 . . . . 11.619999999999999 109.715 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -82.0 -22.93 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.61 0.719 . . . . 11.630000000000001 110.516 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -73.74 -55.1 6.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.269 -0.878 . . . . 9.1400000000000006 110.39 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.64 -29.25 33.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.566 -0.531 . . . . 10.06 109.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.2 -19.97 62.36 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.884 -0.487 . . . . 12.07 111.884 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.41 -23.88 61.15 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.449 0.7 . . . . 12.32 109.617 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.53 -23.47 19.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.879 -0.6 . . . . 11.77 110.434 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.91 -26.89 23.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.876 -0.416 . . . . 13.52 109.876 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 73.92 -35.11 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.207 1.403 . . . . 16.559999999999999 112.76 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.93 129.92 40.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.087 -1.449 . . . . 15.74 107.087 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -119.45 117.22 33.1 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.839 -0.619 . . . . 14.199999999999999 109.642 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -88.02 4.64 5.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.968 2.446 . . . . 14.18 112.816 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.83 -78.79 0.02 OUTLIER Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.779 -1.201 . . . . 14.029999999999999 113.106 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 177.88 24.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.336 0.654 . . . . 16.370000000000001 109.912 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 130' ' ' ARG . 6.3 mp 47.66 -158.19 0.05 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.251 0.62 . . . . 12.449999999999999 111.327 -169.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 36.6 mtm-85 76.95 -38.06 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.714 1.206 . . . . 14.43 112.511 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.6 p -69.59 -46.1 67.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.938 -1.134 . . . . 14.32 107.938 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 138' ' ' LEU . . . -100.9 89.37 0.8 Allowed Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 107.588 -2.205 . . . . 13.75 107.588 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.58 -14.03 10.87 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 111.545 0.202 . . . . 12.699999999999999 111.545 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.99 133.04 47.62 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.824 0.821 . . . . 16.379999999999999 110.313 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -65.67 -20.05 66.14 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.829 -1.078 . . . . 13.300000000000001 110.035 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.94 -24.9 68.09 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.906 -1.043 . . . . 16.25 111.676 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.13 -34.7 8.31 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.05 -0.66 . . . . 15.869999999999999 110.949 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 132' ' ' GLY . 35.3 mt -91.83 -27.17 18.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.638 -0.71 . . . . 13.65 112.721 -171.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -106.96 78.85 0.25 Allowed Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.428 -0.892 . . . . 14.16 113.892 -174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 50.2 tpp -80.87 -40.63 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.157 -1.053 . . . . 15.449999999999999 108.157 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -99.59 113.27 25.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.159 -0.928 . . . . 13.630000000000001 109.0 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.6 t -72.67 -38.45 67.6 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.244 -0.889 . . . . 13.9 110.449 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.89 -32.05 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.326 0.584 . . . . 13.81 112.02 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.1 t -77.55 -27.15 51.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.104 -1.038 . . . . 11.48 109.726 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.79 -28.58 34.59 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.092 -1.051 . . . . 10.35 111.166 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.549 ' HB ' ' HB1' ' A' ' 162' ' ' ALA . 16.9 p -66.94 -43.24 83.72 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 109.217 -0.66 . . . . 12.199999999999999 109.217 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -56.8 -49.75 74.4 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.135 -0.939 . . . . 11.859999999999999 109.21 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -55.29 -53.06 60.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.199 -0.91 . . . . 9.3200000000000003 112.203 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.1 tpt -56.94 -48.84 77.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.436 0.694 . . . . 9.5 110.844 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -64.33 -36.13 83.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.267 -0.424 . . . . 13.91 110.872 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.69 97.64 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.814 -0.515 . . . . 9.8800000000000008 111.814 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.44 -43.27 98.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.805 -0.442 . . . . 9.2699999999999996 109.805 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.0 t -59.62 -46.41 89.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.435 -0.802 . . . . 11.460000000000001 109.428 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.55 -48.99 78.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.196 0.998 . . . . 15.039999999999999 111.025 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -58.53 -27.61 64.69 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.62 0.768 . . . . 11.82 112.779 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -107.46 4.71 26.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.779 0.659 . . . . 11.970000000000001 112.779 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m 58.29 32.22 21.79 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.77 0.795 . . . . 14.24 111.315 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.6 pt -107.13 165.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.342 -0.984 . . . . 12.619999999999999 108.342 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -110.97 94.5 5.02 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.335 0.588 . . . . 16.390000000000001 112.051 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.69 108.72 10.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.175 -1.046 . . . . 12.32 108.175 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.5 154.75 35.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.194 -0.912 . . . . 14.06 109.835 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB1' ' HB ' ' A' ' 146' ' ' THR . . . -63.72 -16.98 62.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.939 -1.028 . . . . 12.640000000000001 113.138 -174.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.93 -6.47 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 116.431 -0.35 . . . . 15.68 111.267 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.96 -11.28 46.43 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.138 0.422 . . . . 12.720000000000001 112.138 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.8 pt -64.84 -13.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.253 0.549 . . . . 12.16 111.365 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.59 -1.95 16.63 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.205 -0.452 . . . . 15.08 110.289 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.7 m -84.39 -30.61 25.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.014 -0.539 . . . . 14.67 110.589 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -116.93 108.96 43.52 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.271 -1.011 . . . . 12.68 108.271 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -48.73 -37.73 35.83 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.947 3.098 . . . . 14.34 112.846 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.7 p -125.55 141.01 52.26 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.792 -1.188 . . . . 12.91 107.792 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.61 -1.73 47.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.811 0.671 . . . . 9.8900000000000006 112.811 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -66.5 -26.08 67.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.162 -1.051 . . . . 12.5 108.162 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 18.1 m -76.1 -18.62 59.09 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.237 -1.347 . . . . 11.039999999999999 111.752 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.43 -35.68 76.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.884 0.474 . . . . 8.5 110.286 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.58 -37.64 79.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.142 -0.481 . . . . 7.7000000000000002 111.567 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.9 -32.6 61.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 10.380000000000001 110.349 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 173' ' ' SER . 46.9 mm-40 -70.08 -48.73 56.5 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.619 -0.719 . . . . 11.970000000000001 109.998 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 110' ' ' ILE . 12.1 p -66.78 -40.64 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 9.8000000000000007 111.376 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.99 -37.16 78.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.548 0.689 . . . . 10.83 110.226 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 180' ' ' ARG . 38.6 ttm180 -67.13 -45.85 75.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.982 -1.008 . . . . 13.5 110.106 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -67.99 -48.24 66.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 14.84 111.765 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 90.0 t -64.32 -53.4 43.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 123.48 0.488 . . . . 13.35 109.992 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.468 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 61.7 tt0 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 123.906 0.883 . . . . 13.51 111.62 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.547 0.689 . . . . 14.98 109.404 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.72 -39.4 91.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.397 -0.819 . . . . 15.789999999999999 109.887 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.63 -45.11 89.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.039 -0.726 . . . . 12.02 109.039 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.64 94.54 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.994 -0.548 . . . . 11.02 110.891 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -62.63 -37.54 86.73 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.782 0.29 . . . . 16.07 111.782 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.57 -40.49 89.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.53 0.681 . . . . 13.93 110.242 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.57 -33.09 64.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.389 -0.524 . . . . 10.710000000000001 111.041 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.26 -50.05 75.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.779 0.432 . . . . 14.02 110.881 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 22' ' ' PRO . 10.2 pt20 -67.26 -23.85 65.74 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.266 -0.425 . . . . 16.289999999999999 111.595 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 m -83.23 -49.4 9.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.994 0.426 . . . . 12.91 110.415 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.1 -52.73 62.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.235 0.614 . . . . 12.77 110.512 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.39 -24.88 64.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.395 0.517 . . . . 15.19 112.395 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.56 85.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.878 0.37 . . . . 16.260000000000002 110.147 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.6 mtm -74.01 -27.68 61.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.701 -0.681 . . . . 15.449999999999999 111.64 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.04 4.29 54.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.306 -0.406 . . . . 16.16 111.84 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 55.23 39.79 31.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.382 1.073 . . . . 20.559999999999999 112.272 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -109.24 155.69 20.8 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.603 -1.258 . . . . 16.629999999999999 107.603 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.54 118.84 71.22 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 109.308 -0.627 . . . . 20.190000000000001 109.308 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 5.6 Cg_exo -72.8 -29.09 12.92 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.395 2.064 . . . . 16.600000000000001 114.272 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.79 8.19 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.577 -1.009 . . . . 17.739999999999998 110.577 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.49 70.47 8.97 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.268 0.556 . . . . 20.23 111.12 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.62 149.9 13.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.704 -1.221 . . . . 15.98 107.704 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 28' ' ' GLY . 13.8 ttp180 -82.53 126.08 31.85 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 122.319 0.248 . . . . 19.329999999999998 110.406 -177.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.43 -23.62 67.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.606 0.762 . . . . 14.93 112.1 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 26' ' ' ARG . . . -96.7 6.76 65.11 Favored Glycine 0 C--N 1.309 -0.929 0 CA-C-N 115.917 -0.583 . . . . 14.82 113.902 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 26' ' ' ARG . 68.8 m -65.14 153.28 41.34 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.932 0.873 . . . . 14.539999999999999 112.186 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 8.9 mmm180 -92.15 152.96 19.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.005 -0.998 . . . . 16.75 109.841 -172.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 58.2 m-85 -57.79 -50.29 73.76 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 119.367 0.985 . . . . 11.99 112.836 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 36' ' ' LEU . 3.9 mm? -70.14 -9.37 55.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.415 0.626 . . . . 14.449999999999999 111.551 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.27 -37.9 12.39 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.084 -0.71 . . . . 16.440000000000001 109.084 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -61.31 -33.85 74.27 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.565 0.746 . . . . 13.77 111.234 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.19 9.75 8.53 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.63 -0.988 . . . . 13.81 110.63 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 41' ' ' ALA . 8.3 tt -91.58 137.1 32.64 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.363 -0.977 . . . . 13.039999999999999 108.363 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.486 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -132.55 166.93 20.95 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.21 1.004 . . . . 15.67 109.117 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -42.84 -54.62 4.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 15.289999999999999 113.437 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.59 -40.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.285 0.564 . . . . 16.66 111.411 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 67.4 mt -66.41 -36.77 78.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.816 -0.629 . . . . 14.140000000000001 110.093 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.02 -45.01 87.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.14 -0.936 . . . . 12.0 110.766 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.35 -36.31 75.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.277 -0.874 . . . . 13.970000000000001 110.933 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.33 -41.18 57.31 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.49 -0.777 . . . . 15.69 111.507 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -64.84 -41.11 95.98 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.91 -0.586 . . . . 11.69 110.796 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 41' ' ' ALA . 34.3 mm -55.1 -41.6 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.169 -0.469 . . . . 11.16 110.266 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -58.58 -31.71 68.28 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.526 -0.761 . . . . 16.649999999999999 110.622 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -80.02 -46.98 15.64 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.603 -0.271 . . . . 14.15 111.288 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 45' ' ' ILE . 22.6 pt -65.74 -32.1 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.539 -0.464 . . . . 10.800000000000001 110.41 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' ND2' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -60.58 -39.34 87.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.238 0.542 . . . . 12.98 110.19 175.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -73.64 -48.71 30.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.948 -1.024 . . . . 17.52 111.743 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.0 -34.37 64.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.872 -0.731 . . . . 14.869999999999999 111.822 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -88.87 -6.37 57.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.963 0.727 . . . . 12.199999999999999 112.963 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 57.82 41.85 24.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.89 1.276 . . . . 16.710000000000001 111.235 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 tp -141.28 136.24 31.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.248 -1.019 . . . . 12.199999999999999 108.248 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -84.11 56.0 3.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.833 0.825 . . . . 16.059999999999999 109.551 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.545 HG22 ' ND2' ' A' ' 49' ' ' ASN . 10.9 tt -60.24 134.98 90.92 Favored Pre-proline 0 C--O 1.253 1.262 0 CA-C-N 114.139 -1.391 . . . . 11.390000000000001 110.2 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -79.07 162.07 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.582 2.188 . . . . 12.6 111.946 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 45' ' ' ILE . . . -80.56 2.19 26.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.011 -0.995 . . . . 12.52 111.65 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 5.2 m-20 -62.28 -18.26 60.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.961 -0.563 . . . . 14.140000000000001 112.37 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' A' ' 70' ' ' PHE . . . -63.84 -39.34 97.3 Favored Glycine 0 C--O 1.213 -1.183 0 C-N-CA 120.412 -0.899 . . . . 10.76 111.648 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -82.62 -12.84 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 123.025 1.393 . . . . 11.0 108.238 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 52.3 t80 -78.73 -44.91 22.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.174 -1.375 . . . . 16.420000000000002 110.058 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.0 t -93.4 -31.98 14.42 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.558 0.577 . . . . 13.35 112.558 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.06 125.67 45.14 Favored Pre-proline 0 CA--C 1.5 -0.964 0 O-C-N 121.785 -0.572 . . . . 12.23 110.805 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 60.4 Cg_endo -87.61 -18.11 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.042 1.828 . . . . 13.06 111.601 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.4 t -108.24 133.38 53.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.195 -1.409 . . . . 12.949999999999999 107.195 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 43.6 p90 -72.74 -34.82 67.29 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.375 0.509 . . . . 10.92 112.375 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -71.19 -20.65 62.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.496 0.665 . . . . 14.32 111.005 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.97 -25.86 40.21 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.544 0.688 . . . . 10.93 109.883 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.524 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 9.2 t80 -68.04 -30.34 69.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.635 . . . . 8.8100000000000005 111.325 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -63.87 -22.2 66.81 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.856 0.687 . . . . 9.3499999999999996 112.856 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.83 -28.03 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.378 0.608 . . . . 11.630000000000001 110.07 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -73.81 -45.74 49.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.794 -0.639 . . . . 10.550000000000001 109.41 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.57 -42.28 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.661 0 N-CA-C 109.726 -0.472 . . . . 8.3000000000000007 109.726 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.06 74.31 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.606 -0.725 . . . . 9.5800000000000001 113.518 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 p -81.21 -38.33 27.16 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.099 -0.64 . . . . 10.23 111.877 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -73.98 -46.65 42.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.959 -0.696 . . . . 10.43 110.025 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 115.907 -0.588 . . . . 10.970000000000001 109.667 179.654 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 113.567 0.951 . . . . 10.050000000000001 113.567 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.89 -25.25 55.91 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.759 0.281 . . . . 11.220000000000001 111.759 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.98 -37.77 88.76 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.45 -0.341 . . . . 11.380000000000001 111.762 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -57.34 10.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 9.6500000000000004 110.737 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -61.72 -44.43 96.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.574 -0.739 . . . . 10.43 109.924 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.8 t -60.39 -43.48 96.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.6 -0.727 . . . . 10.210000000000001 110.969 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.6 mt -55.98 -51.41 61.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.36 0.664 . . . . 8.1300000000000008 110.511 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.58 -39.86 94.49 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 115.201 -0.909 . . . . 8.4600000000000009 109.869 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.49 -34.82 74.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.957 0.503 . . . . 10.859999999999999 111.777 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -68.34 -53.54 23.39 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 110.016 -0.364 . . . . 11.449999999999999 110.016 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 171' ' ' LEU . 9.4 tt -63.36 -27.68 69.48 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.306 -0.861 . . . . 7.6200000000000001 110.401 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.11 -46.19 90.13 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.734 1.214 . . . . 11.619999999999999 109.869 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -69.26 -33.8 73.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.048 -0.523 . . . . 11.630000000000001 110.91 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -63.48 -42.74 98.55 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.208 -0.451 . . . . 9.1400000000000006 110.432 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.98 -40.99 68.19 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.622 -0.51 . . . . 10.06 109.622 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.54 -49.79 70.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.852 -0.613 . . . . 12.07 112.424 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.56 -25.84 66.0 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.003 0.521 . . . . 12.32 110.438 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.26 -46.76 60.2 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.06 -0.719 . . . . 11.77 109.06 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.29 -81.03 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.512 -0.767 . . . . 13.52 110.04 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -158.55 -45.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.116 -1.068 . . . . 16.559999999999999 108.116 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.7 tp -167.84 157.58 10.13 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.487 -2.412 . . . . 15.74 104.487 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.52 118.01 67.85 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 118.474 0.579 . . . . 14.199999999999999 110.733 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.29 -8.21 11.78 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.495 2.13 . . . . 14.18 111.752 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.6 -10.26 74.16 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.246 -0.742 . . . . 14.029999999999999 111.246 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -89.66 37.1 0.86 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.24 1.019 . . . . 16.370000000000001 110.497 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.21 -5.68 13.02 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.304 -1.316 . . . . 12.449999999999999 110.802 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -85.78 121.66 28.75 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.089 -0.505 . . . . 14.43 110.082 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.1 m 69.85 -66.34 0.27 Allowed 'General case' 0 C--O 1.247 0.926 0 C-N-CA 125.082 1.353 . . . . 14.32 112.175 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.5 82.72 1.51 Allowed Glycine 0 C--O 1.239 0.453 0 CA-C-N 116.412 -0.358 . . . . 13.75 113.007 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . -143.49 117.4 9.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.895 -1.15 . . . . 12.699999999999999 107.895 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.458 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -115.73 164.16 14.76 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.184 -1.413 . . . . 16.379999999999999 107.184 -173.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 40.5 m-85 -42.82 -47.16 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.307 0.854 . . . . 13.300000000000001 113.307 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 pp -55.82 -33.85 64.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.679 0.622 . . . . 16.25 112.679 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.68 -1.73 27.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.567 0.58 . . . . 15.869999999999999 112.567 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 96.6 mt -93.89 -27.19 16.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.233 0.539 . . . . 13.65 109.775 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 170.67 126.38 0.87 Allowed Glycine 0 N--CA 1.432 -1.594 0 N-CA-C 110.411 -1.076 . . . . 14.16 110.411 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp -70.17 -30.17 67.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.163 0.506 . . . . 15.449999999999999 110.904 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -106.92 124.64 49.92 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.743 -0.836 . . . . 13.630000000000001 108.743 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 t -61.49 -30.05 70.37 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.422 -0.808 . . . . 13.9 112.473 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 t -76.91 -25.18 15.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 CA-C-O 121.536 0.684 . . . . 13.81 109.99 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -70.65 -28.19 64.61 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.694 -0.803 . . . . 11.48 110.235 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.34 -21.16 59.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.036 -1.225 . . . . 10.35 110.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 m -67.31 -44.77 78.34 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.012 -1.107 . . . . 12.199999999999999 108.012 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.26 -46.2 90.65 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.318 -1.31 . . . . 11.859999999999999 109.706 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -59.03 -46.72 87.51 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.739 -1.118 . . . . 9.3200000000000003 111.279 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.1 tpt -53.29 -55.73 22.29 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.558 0.743 . . . . 9.5 112.093 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -63.75 -30.11 71.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.599 -0.44 . . . . 13.91 111.669 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 -50.07 50.33 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.004 -0.839 . . . . 9.8800000000000008 111.004 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.83 -40.34 86.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.284 0.634 . . . . 9.2699999999999996 110.25 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.9 t -54.27 -58.83 5.91 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.046 -0.979 . . . . 11.460000000000001 110.697 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -71.23 -24.95 62.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.283 -0.417 . . . . 15.039999999999999 111.638 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -61.07 -34.93 75.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.689 0.28 . . . . 11.82 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -100.55 6.41 44.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 11.970000000000001 111.272 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.3 m 57.42 44.0 22.19 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.284 1.034 . . . . 14.24 111.188 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.5 pt -122.18 146.78 26.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 106.777 -1.564 . . . . 12.619999999999999 106.777 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -96.81 96.73 8.76 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.869 -0.732 . . . . 16.390000000000001 110.95 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.64 139.48 45.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.555 -0.906 . . . . 12.32 108.555 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.94 44.28 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.426 -0.806 . . . . 14.06 109.201 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.86 -24.04 67.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.593 -0.731 . . . . 12.640000000000001 111.616 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.34 2.69 51.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.019 -0.537 . . . . 15.68 111.528 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.55 -14.86 63.07 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.846 -0.534 . . . . 12.720000000000001 111.799 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.6 pt -61.37 -18.08 17.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 122.912 0.485 . . . . 12.16 111.478 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -83.47 -6.97 59.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.078 0.466 . . . . 15.08 110.366 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -99.22 -19.51 17.08 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.668 -0.696 . . . . 14.67 110.983 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -116.54 98.74 52.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.332 -0.547 . . . . 12.68 111.554 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.434 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 43.4 Cg_endo -72.22 -29.0 14.8 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.227 1.951 . . . . 14.34 112.408 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 3.3 p -126.71 143.39 51.25 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.378 0.609 . . . . 12.91 110.031 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 114' ' ' LEU . 34.6 tp -56.18 -26.95 52.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.258 1.423 . . . . 9.8900000000000006 113.045 -174.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.41 -29.72 66.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.844 -0.616 . . . . 12.5 111.125 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -77.54 -30.3 52.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 11.039999999999999 109.934 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 178' ' ' VAL . 47.9 tp -75.82 -50.97 13.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.714 -0.675 . . . . 8.5 109.213 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.52 -47.34 48.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.201 0.6 . . . . 7.7000000000000002 111.817 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 15.2 t70 -65.77 -31.31 72.22 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.773 0.32 . . . . 10.380000000000001 111.16 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.31 -40.31 74.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.597 -0.52 . . . . 11.970000000000001 109.597 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 174' ' ' LEU . 15.6 t -60.61 -42.24 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.08 -0.711 . . . . 9.8000000000000007 109.08 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.67 -39.42 65.06 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 123.985 0.803 . . . . 10.83 111.144 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 20.0 mmt180 -73.14 -46.06 53.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.451 -0.574 . . . . 13.5 109.451 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 2.9 mmp_? -63.63 -39.23 93.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.432 -0.804 . . . . 14.84 112.02 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.12 -34.11 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 13.35 110.213 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.445 1.098 . . . . 13.51 110.749 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 C--O 1.244 0.78 0 N-CA-C 110.376 -0.231 . . . . 18.510000000000002 110.376 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 175.15 -175.31 0.09 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.264 1.026 . . . . 16.66 109.16 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.15 -18.69 65.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.844 0.831 . . . . 14.84 109.809 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.79 -11.28 60.55 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.768 -1.105 . . . . 14.98 111.682 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.15 -42.38 80.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 111.749 0.277 . . . . 15.789999999999999 111.749 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.3 t -56.34 -44.11 79.74 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.87 -0.605 . . . . 12.02 110.696 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -37.81 50.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.107 -0.497 . . . . 11.02 111.173 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -62.5 -40.98 98.46 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 122.895 0.478 . . . . 16.07 109.713 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.68 -38.29 84.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.326 0.584 . . . . 13.93 110.175 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.36 -37.56 60.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.529 -0.759 . . . . 10.710000000000001 109.913 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 25' ' ' ILE . 4.9 ttp180 -64.18 -32.4 73.96 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.469 -0.787 . . . . 14.02 110.608 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -61.81 -48.71 79.37 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.693 0.797 . . . . 16.289999999999999 110.931 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p -72.52 -30.54 64.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.081 0.467 . . . . 12.91 110.945 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.33 -52.17 49.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.449 -1.315 . . . . 12.77 107.449 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.69 65.88 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.756 -0.656 . . . . 15.19 111.576 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -31.01 69.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.747 0.308 . . . . 16.260000000000002 110.676 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.59 -28.37 60.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.168 0.508 . . . . 15.449999999999999 110.402 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.36 -8.25 55.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.697 -0.683 . . . . 16.16 111.522 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 56.54 46.91 19.65 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.563 -1.199 . . . . 20.559999999999999 110.255 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.2 t -124.39 164.1 20.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.782 -1.554 . . . . 16.629999999999999 108.302 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.96 126.65 60.49 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.697 -1.223 . . . . 20.190000000000001 107.697 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 -8.4 23.52 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.945 2.43 . . . . 16.600000000000001 114.312 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.46 52.72 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.79 -0.719 . . . . 17.739999999999998 111.31 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -83.38 84.04 7.65 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.434 -0.95 . . . . 20.23 108.434 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.489 HG21 ' HD2' ' A' ' 11' ' ' ARG . 10.8 tp -142.07 149.02 19.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.135 0.493 . . . . 15.98 110.484 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 -101.79 120.21 40.01 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.76 -1.941 . . . . 19.329999999999998 105.76 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -67.83 -17.48 64.52 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 120.945 0.403 . . . . 14.93 111.678 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.45 7.42 61.68 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.484 -0.78 . . . . 14.82 112.953 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 p -66.56 133.35 50.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.794 0.807 . . . . 14.539999999999999 110.557 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 34.6 mtp85 -82.84 139.12 33.67 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.096 -0.957 . . . . 16.75 111.183 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -47.26 -43.11 21.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.486 0.585 . . . . 11.99 112.538 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.53 -32.24 71.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.227 1.011 . . . . 14.449999999999999 111.904 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.6 -41.64 65.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.522 0.677 . . . . 16.440000000000001 109.215 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.67 -21.09 61.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.381 -1.282 . . . . 13.77 111.104 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.34 29.12 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.341 -0.933 . . . . 13.81 112.468 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.78 85.41 7.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.329 -1.36 . . . . 13.039999999999999 107.329 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -68.72 154.58 41.69 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.872 -1.058 . . . . 15.67 110.576 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 t -49.57 -41.52 41.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.261 0.624 . . . . 15.289999999999999 112.311 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -48.52 85.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.214 0.531 . . . . 16.66 110.66 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.3 -36.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.621 -0.718 . . . . 14.140000000000001 109.585 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -59.43 -44.34 92.93 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.377 -0.829 . . . . 12.0 110.727 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -59.93 -46.45 89.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 13.970000000000001 110.533 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -59.27 -44.61 92.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.99 -0.55 . . . . 15.69 111.259 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.432 ' O ' HG13 ' A' ' 48' ' ' ILE . 7.5 t90 -60.13 -48.23 82.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.547 1.139 . . . . 11.69 110.051 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 41' ' ' ALA . 30.3 mm -56.94 -45.73 83.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.895 -0.593 . . . . 11.16 111.03 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 18.8 mmm180 -62.82 -31.07 71.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.429 -0.35 . . . . 16.649999999999999 110.97 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.13 -38.11 69.33 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 110.026 -0.361 . . . . 14.15 110.026 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 44' ' ' TRP . 68.7 mt -61.68 -50.77 78.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.327 -0.99 . . . . 10.800000000000001 108.327 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -54.59 -39.03 67.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.631 -1.168 . . . . 12.98 112.147 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -85.92 -37.32 19.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.73 1.011 . . . . 17.52 113.73 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -87.61 -24.48 23.96 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.508 1.299 . . . . 14.869999999999999 114.508 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.93 -10.45 19.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.004 0.742 . . . . 12.199999999999999 113.004 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 63.57 70.72 0.52 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 16.710000000000001 112.304 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.1 174.72 13.29 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.734 -1.209 . . . . 12.199999999999999 107.734 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.74 105.1 9.04 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 118.565 0.62 . . . . 16.059999999999999 111.148 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 74' ' ' VAL . 27.3 mm -72.51 124.23 90.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 O-C-N 121.82 -0.55 . . . . 11.390000000000001 111.91 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.05 126.48 14.53 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.471 -2.165 . . . . 12.6 106.471 167.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 2.18 0.55 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 115.792 1.775 . . . . 12.52 115.792 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -97.84 10.96 38.86 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.561 -0.712 . . . . 14.140000000000001 110.588 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.45 -55.89 27.52 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 121.373 -0.441 . . . . 10.76 112.242 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.42 -29.02 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.798 0.809 . . . . 11.0 110.858 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.41 -36.56 68.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.485 -0.78 . . . . 16.420000000000002 110.627 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 m -84.99 -40.96 16.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.154 -0.475 . . . . 13.35 110.7 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HE1' ' CE3' ' A' ' 73' ' ' TRP . 68.5 m-85 -111.87 102.45 53.65 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.618 -0.882 . . . . 12.23 108.618 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 89.4 Cg_endo -83.5 4.08 7.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.286 1.991 . . . . 13.06 112.46 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.9 t -123.49 120.9 61.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.388 -1.338 . . . . 12.949999999999999 107.388 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -59.21 -32.5 70.0 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.335 0.865 . . . . 10.92 113.335 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -62.45 -46.32 89.06 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.994 0.184 . . . . 14.32 110.822 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.01 67.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.406 0.622 . . . . 10.93 110.986 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.76 -24.26 48.91 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.254 1.022 . . . . 8.8100000000000005 113.095 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.4 p -60.28 -23.93 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.983 -0.448 . . . . 9.3499999999999996 112.201 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.59 -29.2 69.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.802 0.81 . . . . 11.630000000000001 109.621 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CE3' ' HE1' ' A' ' 64' ' ' TYR . 43.6 t-105 -87.32 -24.62 24.24 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.34 -0.845 . . . . 10.550000000000001 110.46 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.465 ' HA ' HD11 ' A' ' 56' ' ' ILE . 42.6 t -84.0 -53.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.188 -0.46 . . . . 8.3000000000000007 110.916 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.8 66.63 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.866 -0.606 . . . . 9.5800000000000001 114.097 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 t -75.75 -17.82 59.76 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.282 -0.54 . . . . 10.23 110.77 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' A' ' 56' ' ' ILE . 69.5 mm-40 -84.76 -7.81 59.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.45 -0.341 . . . . 10.43 111.332 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.24 118.46 8.01 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.806 -0.442 . . . . 10.970000000000001 109.806 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 82' ' ' GLN . 1.6 mp0 -66.37 126.15 91.59 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.786 -0.643 . . . . 13.52 110.585 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 45.38 1.96 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.732 2.288 . . . . 12.279999999999999 111.598 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -152.63 47.25 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.354 -1.35 . . . . 13.44 107.354 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 79' ' ' GLN . 15.3 mm100 -103.75 -30.19 10.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.388 -0.823 . . . . 13.27 111.066 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.36 -61.62 1.48 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.054 0.454 . . . . 14.48 110.563 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -90.94 89.82 7.62 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.143 -0.688 . . . . 14.92 109.143 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.63 35.77 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.408 -0.36 . . . . 14.25 111.468 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.16 119.98 63.51 Favored Pre-proline 0 C--N 1.314 -0.95 0 C-N-CA 120.918 -0.313 . . . . 12.970000000000001 110.455 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.89 -28.83 9.03 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.218 1.945 . . . . 13.4 112.022 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -146.21 139.11 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.456 -0.942 . . . . 12.43 108.456 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.7 -52.06 2.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.002 0.429 . . . . 13.449999999999999 110.741 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -129.86 10.86 5.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.056 -1.09 . . . . 14.41 108.056 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -78.42 120.99 83.15 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 114.668 -1.151 . . . . 11.68 110.786 -172.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.25 -1.72 10.4 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.492 2.128 . . . . 10.84 111.975 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.15 126.82 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 121.253 0.549 . . . . 10.460000000000001 110.24 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.8 43.64 1.14 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.761 0.791 . . . . 10.58 110.423 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -164.19 167.16 20.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.151 -1.796 . . . . 11.039999999999999 106.151 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.23 88.04 13.31 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 111.954 0.353 . . . . 10.880000000000001 111.954 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.86 -55.56 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.006 1.804 . . . . 12.460000000000001 108.85 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -159.77 128.11 2.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.165 -0.925 . . . . 13.779999999999999 108.698 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -96.23 43.18 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.711 2.274 . . . . 11.949999999999999 112.35 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.49 -94.14 1.13 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.466 -0.873 . . . . 11.48 111.315 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -15.23 61.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.523 . . . . 11.550000000000001 110.415 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -66.79 -33.99 76.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.029 -0.73 . . . . 12.59 109.029 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.12 -55.39 3.35 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.414 -0.812 . . . . 11.24 109.031 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 m -86.01 58.81 5.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.516 0.674 . . . . 10.050000000000001 110.913 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.85 -46.2 19.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.317 -0.856 . . . . 11.220000000000001 110.412 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -54.01 -44.75 71.19 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.0 -0.545 . . . . 11.380000000000001 110.879 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -58.28 -47.37 83.86 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.272 -0.877 . . . . 9.6500000000000004 112.934 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -35.58 60.47 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.681 -0.807 . . . . 10.43 111.353 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.9 m -58.38 -47.98 82.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.095 -0.502 . . . . 10.210000000000001 110.858 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.495 HG21 HG11 ' A' ' 178' ' ' VAL . 47.0 mt -63.0 -49.62 82.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 O-C-N 123.353 0.408 . . . . 8.1300000000000008 110.001 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -51.7 -57.07 10.27 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.953 0.783 . . . . 8.4600000000000009 112.911 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -67.82 -36.43 80.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.796 0.331 . . . . 10.859999999999999 111.471 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.39 -36.26 76.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.617 -0.512 . . . . 11.449999999999999 109.617 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.37 -39.08 91.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.629 -0.878 . . . . 7.6200000000000001 108.629 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.95 -45.98 92.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.138 -0.937 . . . . 11.619999999999999 110.438 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.97 -32.56 72.23 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.419 -0.355 . . . . 11.630000000000001 111.02 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -65.45 -51.51 59.67 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.892 -0.41 . . . . 9.1400000000000006 109.892 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.4 tp -64.14 -42.84 96.63 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.451 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.14 91.42 Favored Glycine 0 CA--C 1.518 0.227 0 O-C-N 123.146 0.279 . . . . 12.07 113.099 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.25 -45.35 93.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.862 0.839 . . . . 12.32 109.392 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 144' ' ' THR . 45.2 tp -70.02 -45.99 66.04 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.525 -1.216 . . . . 11.77 110.739 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.3 tp -72.82 -11.0 60.43 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.934 0.894 . . . . 13.52 110.948 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.0 t80 85.97 -34.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.163 1.785 . . . . 16.559999999999999 111.665 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.5 tp -165.12 149.81 9.08 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.963 -1.495 . . . . 15.74 106.963 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -86.99 122.03 71.37 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 105.876 -1.898 . . . . 14.199999999999999 105.876 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.38 -3.07 12.25 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 122.65 2.233 . . . . 14.18 111.446 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -162.65 -107.6 0.21 Allowed Glycine 0 C--N 1.291 -1.925 0 CA-C-N 114.773 -1.103 . . . . 14.029999999999999 110.701 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -155.87 43.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.199 -2.149 . . . . 16.370000000000001 105.199 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.0 mt 62.15 -178.21 0.13 Allowed 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.085 -1.416 . . . . 12.449999999999999 111.088 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -148.34 146.51 28.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.736 -1.209 . . . . 14.43 107.736 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.8 t -76.23 91.44 3.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 14.32 109.689 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.37 -92.25 0.15 Allowed Glycine 0 CA--C 1.49 -1.511 0 N-CA-C 108.43 -1.868 . . . . 13.75 108.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 68.23 128.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.336 1.454 . . . . 12.699999999999999 112.079 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.54 -176.32 3.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.608 -0.724 . . . . 16.379999999999999 109.689 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 66.9 m-85 -63.74 -27.35 69.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.532 0.682 . . . . 13.300000000000001 109.652 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.28 -25.24 65.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.736 -1.12 . . . . 16.25 111.216 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.32 -7.33 55.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.419 -0.81 . . . . 15.869999999999999 110.23 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.1 mt -106.59 9.3 31.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.473 0.654 . . . . 13.65 110.093 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.64 -175.11 15.94 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.584 -0.734 . . . . 14.16 111.774 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 84.7 mtp -107.09 -9.09 16.27 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.604 0.716 . . . . 15.449999999999999 109.979 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -118.58 159.97 22.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.292 -0.867 . . . . 13.630000000000001 108.92 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.1 p -81.4 -16.34 52.46 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.776 0.798 . . . . 13.9 109.866 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.41 -36.37 77.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.823 -1.08 . . . . 13.81 111.087 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 121' ' ' LEU . 7.2 p -63.57 -42.44 98.32 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 116.159 -0.473 . . . . 11.48 110.428 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.08 -41.59 70.19 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.536 -0.756 . . . . 10.35 112.554 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.1 p -65.3 -46.64 79.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 117.082 0.441 . . . . 12.199999999999999 111.456 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -59.92 -49.53 77.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 11.859999999999999 110.389 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.585 ' O ' HG23 ' A' ' 152' ' ' VAL . 13.9 t90 -62.72 -51.83 65.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.567 -0.742 . . . . 9.3200000000000003 112.121 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.478 ' SD ' HG13 ' A' ' 165' ' ' ILE . 39.6 ttm -63.79 -37.08 86.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.189 0.44 . . . . 9.5 112.189 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -69.43 -29.07 66.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.493 -0.483 . . . . 13.91 110.533 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.31 -42.47 82.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.688 -0.965 . . . . 9.8800000000000008 110.688 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 148' ' ' TRP . 22.1 t -58.66 -48.31 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.76 -1.2 . . . . 9.2699999999999996 107.76 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.8 t -57.71 -52.7 64.39 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.187 -1.37 . . . . 11.460000000000001 110.906 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -66.35 -44.14 84.12 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.762 -0.654 . . . . 15.039999999999999 111.94 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -65.61 -37.77 87.55 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.039 0.755 . . . . 11.82 113.039 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 110' ' ' ILE . 97.3 m-85 -93.31 9.91 34.27 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.226 0.536 . . . . 11.970000000000001 111.894 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 57.39 43.21 23.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.516 1.126 . . . . 14.24 112.355 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -122.17 155.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.391 -0.596 . . . . 12.619999999999999 109.391 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -97.91 97.29 8.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.115 -0.698 . . . . 16.390000000000001 109.115 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.17 125.68 54.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.491 -0.929 . . . . 12.32 108.491 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.97 136.01 40.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.263 -0.426 . . . . 14.06 111.106 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.86 -11.46 59.99 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 121.774 0.797 . . . . 12.640000000000001 110.421 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.98 -12.03 61.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.139 0.971 . . . . 15.68 109.518 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.2 -10.22 55.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.474 -0.785 . . . . 12.720000000000001 109.967 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.478 HG13 ' SD ' ' A' ' 149' ' ' MET . 11.4 mt -56.51 -32.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.81 1.244 . . . . 12.16 109.965 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.29 -6.37 59.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.709 -1.132 . . . . 15.08 109.761 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 88.3 m -94.87 -18.34 21.25 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.052 -0.976 . . . . 14.67 109.582 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.586 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.8 m0 -117.78 98.96 52.09 Favored Pre-proline 0 C--N 1.318 -0.793 0 O-C-N 121.927 -0.483 . . . . 12.68 111.003 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 83.6 Cg_endo -87.12 3.28 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.556 2.171 . . . . 14.34 112.205 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -139.57 143.9 37.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.88 0.848 . . . . 12.91 111.655 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.36 -28.4 68.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.067 1.747 . . . . 9.8900000000000006 112.949 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.31 -26.72 60.34 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.047 0.451 . . . . 12.5 110.907 -176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -67.1 -44.98 78.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 113.575 0.954 . . . . 11.039999999999999 113.575 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 174' ' ' LEU . 2.6 pt? -75.32 -25.85 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.0 -1.08 . . . . 8.5 110.585 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.36 92.78 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.888 -0.596 . . . . 7.7000000000000002 111.186 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.56 -26.12 32.68 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.008 -0.677 . . . . 10.380000000000001 110.61 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.586 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 9.6 tp10 -68.54 -54.13 18.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.543 -0.298 . . . . 11.970000000000001 110.802 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -50.02 -43.82 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 112.718 0.636 . . . . 9.8000000000000007 112.718 -176.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 -41.92 92.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.994 0.426 . . . . 10.83 111.399 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -71.87 -29.3 64.22 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.019 -0.537 . . . . 13.5 110.338 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 5.4 mmp_? -65.06 -42.74 93.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.021 -0.536 . . . . 14.84 109.946 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.62 -51.9 23.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.19 -0.459 . . . . 13.35 111.217 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 112.293 0.479 . . . . 13.51 112.293 -178.842 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.24 0.543 . . . . 18.510000000000002 111.049 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.32 2.33 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.256 -0.429 . . . . 16.66 111.483 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.19 -17.85 17.94 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.877 0.846 . . . . 14.84 109.973 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.85 -16.64 61.13 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.797 -1.092 . . . . 14.98 110.469 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.75 -42.69 99.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.278 0.473 . . . . 15.789999999999999 112.278 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -58.09 -44.43 87.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.018 0.927 . . . . 12.02 110.01 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.32 72.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.786 -0.643 . . . . 11.02 110.887 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 27.2 tt0 -67.36 -43.82 80.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.016 -0.364 . . . . 16.07 110.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 51' ' ' HIS . 30.2 t80 -53.78 -39.02 65.05 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.409 1.084 . . . . 13.93 110.933 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 mt -82.05 -39.19 23.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.777 -0.647 . . . . 10.710000000000001 110.96 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -64.01 -22.66 67.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.379 0.881 . . . . 14.02 113.379 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.58 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 55.3 mt-30 -57.3 -48.42 78.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.727 0.298 . . . . 16.289999999999999 111.568 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -75.52 -34.2 60.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.097 0.475 . . . . 12.91 110.589 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.89 -43.7 95.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.562 -0.745 . . . . 12.77 109.973 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.69 80.21 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.159 -0.928 . . . . 15.19 111.042 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.91 -44.82 30.21 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.152 -0.476 . . . . 16.260000000000002 110.845 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -70.63 -35.0 72.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.001 -0.545 . . . . 15.449999999999999 112.382 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.83 -15.68 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.531 0.681 . . . . 16.16 111.655 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 64.28 45.64 3.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.375 -1.284 . . . . 20.559999999999999 109.703 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -125.47 165.37 18.58 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.144 -1.058 . . . . 16.629999999999999 108.144 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.11 126.85 55.7 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.796 0.332 . . . . 20.190000000000001 110.736 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 38.8 Cg_endo -65.76 -22.52 56.91 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.096 2.531 . . . . 16.600000000000001 113.387 -174.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.88 67.97 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 121.001 -0.618 . . . . 17.739999999999998 112.632 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -100.96 8.43 43.06 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.253 0.549 . . . . 20.23 111.597 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 22' ' ' PRO . 14.9 tt -85.81 119.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.876 -1.157 . . . . 15.98 107.876 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -74.96 144.17 43.32 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.744 -0.662 . . . . 19.329999999999998 110.049 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.53 -16.3 23.81 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.642 1.177 . . . . 14.93 113.914 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.2 6.53 26.95 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 121.032 -0.604 . . . . 14.82 112.264 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -71.01 148.57 47.48 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.473 0.654 . . . . 14.539999999999999 110.875 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 99.6 mtt180 -110.68 137.23 48.61 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.02 0.914 . . . . 16.75 111.978 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -47.61 -43.58 25.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.315 -1.766 . . . . 11.99 112.827 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -68.97 -29.54 67.78 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.508 -0.314 . . . . 14.449999999999999 111.406 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.72 -23.09 34.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.207 -0.664 . . . . 16.440000000000001 109.207 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.88 -39.1 66.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.451 -0.795 . . . . 13.77 109.981 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 14.26 1.05 Allowed Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.266 -0.968 . . . . 13.81 112.824 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 168.8 19.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.345 0.593 . . . . 13.039999999999999 110.408 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.4 163.08 40.57 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.234 -2.136 . . . . 15.67 105.234 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -67.03 -31.0 71.24 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 119.579 1.081 . . . . 15.289999999999999 109.565 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.36 -43.63 80.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.095 -0.502 . . . . 16.66 109.663 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.17 -33.69 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.672 -0.694 . . . . 14.140000000000001 109.944 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.92 95.47 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.814 -0.63 . . . . 12.0 109.776 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.99 -22.54 65.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.703 -0.681 . . . . 13.970000000000001 111.369 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.52 -50.83 8.93 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.253 0.549 . . . . 15.69 110.383 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -67.33 -35.68 79.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 C-N-CA 124.417 1.087 . . . . 11.69 111.662 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 48' ' ' ILE . 8.8 tp -58.63 -40.28 78.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-O 120.894 0.378 . . . . 11.16 110.377 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 41.7 ttm180 -69.01 -33.79 74.22 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.304 0.574 . . . . 16.649999999999999 110.14 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.36 -27.94 47.06 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 112.495 0.554 . . . . 14.15 112.495 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 45' ' ' ILE . 29.7 pt -76.37 -29.54 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 119.219 -0.992 . . . . 10.800000000000001 109.032 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.13 -40.03 92.27 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-N 115.377 -0.829 . . . . 12.98 110.372 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 26.3 mtpp -65.22 -49.64 68.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.832 -0.622 . . . . 17.52 110.015 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 44.7 m80 -59.64 -43.86 93.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.551 0.945 . . . . 14.869999999999999 113.551 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -92.67 -4.79 52.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.162 1.171 . . . . 12.199999999999999 114.162 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.11 45.64 20.47 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.044 1.402 . . . . 16.710000000000001 108.891 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.6 tp -119.87 165.92 13.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.206 -1.405 . . . . 12.199999999999999 107.206 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -127.33 74.51 1.52 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.139 0.495 . . . . 16.059999999999999 109.935 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.483 HG12 ' OE1' ' A' ' 77' ' ' GLN . 58.4 mt -89.45 126.36 58.57 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.303 -0.999 . . . . 11.390000000000001 108.303 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.6 Cg_exo -67.2 156.31 66.85 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.002 1.801 . . . . 12.6 109.084 171.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.96 -0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.434 1.272 . . . . 12.52 114.434 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.87 -12.04 60.02 Favored 'General case' 0 C--O 1.24 0.554 0 O-C-N 122.453 -0.154 . . . . 14.140000000000001 110.943 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.6 62.69 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 121.304 -0.474 . . . . 10.76 113.079 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.02 35.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.115 0.96 . . . . 11.0 108.716 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -85.42 -44.06 13.08 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.38 -0.825 . . . . 16.420000000000002 111.657 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -136.0 25.58 3.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.53 0.681 . . . . 13.35 111.434 -174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -123.34 89.92 50.76 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.73 -1.211 . . . . 12.23 107.73 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.8 Cg_endo -82.99 -3.35 11.07 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.286 1.991 . . . . 13.06 115.697 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.41 120.38 64.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 119.381 0.992 . . . . 12.949999999999999 109.347 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -61.37 -35.46 77.52 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.55 -0.75 . . . . 10.92 111.93 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.82 -29.98 69.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.523 . . . . 14.32 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.62 33.78 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.821 0.82 . . . . 10.93 109.423 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 50.7 t80 -87.82 -28.02 21.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.301 -0.863 . . . . 8.8100000000000005 112.04 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 p -63.4 -36.65 84.43 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.612 -0.68 . . . . 9.3499999999999996 111.723 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -75.34 -23.69 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 11.630000000000001 110.264 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 49.4 t90 -64.05 -47.89 78.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.053 -1.092 . . . . 10.550000000000001 108.053 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 90.9 t -69.22 -43.62 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 CA-C-N 115.594 -0.73 . . . . 8.3000000000000007 109.235 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.76 -43.9 80.49 Favored Glycine 0 C--O 1.238 0.387 0 CA-C-N 115.491 -0.777 . . . . 9.5800000000000001 113.319 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -67.58 -33.59 75.33 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.93 0.365 . . . . 10.23 111.183 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.483 ' OE1' HG12 ' A' ' 56' ' ' ILE . 3.7 pt20 -89.67 -2.37 58.27 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.767 -1.173 . . . . 10.43 112.563 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 90.6 mt -70.79 -12.39 61.52 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.243 0.544 . . . . 10.970000000000001 110.07 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -78.95 142.92 60.82 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 107.806 -1.183 . . . . 13.52 107.806 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -22.66 -65.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.362 1 C-N-CA 126.61 4.873 . . . . 12.279999999999999 117.474 -172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -132.65 48.3 2.42 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.785 0.802 . . . . 13.44 111.444 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.72 9.98 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.903 -0.719 . . . . 13.27 111.413 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.34 8.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.972 0.415 . . . . 14.48 111.277 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -102.49 20.3 17.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.655 1.217 . . . . 14.92 109.196 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.52 76.62 9.56 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.585 -1.189 . . . . 14.25 109.113 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.73 120.79 74.34 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.111 -0.95 . . . . 12.970000000000001 108.722 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.51 -24.84 63.19 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.672 2.248 . . . . 13.4 111.935 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.42 72.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.651 -1.24 . . . . 12.43 107.651 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.95 120.24 23.89 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.488 -0.93 . . . . 13.449999999999999 108.488 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -135.73 109.05 7.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.951 0.405 . . . . 14.41 110.911 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 92' ' ' PRO . 6.9 tp10 -92.38 114.89 63.67 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 107.258 -1.386 . . . . 11.68 107.258 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 91' ' ' GLU . 35.8 Cg_endo -65.56 139.15 57.41 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.178 1.919 . . . . 10.84 112.212 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.1 m -84.63 47.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.166 0.984 . . . . 10.460000000000001 110.547 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.97 4.43 4.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.194 -0.912 . . . . 10.58 111.282 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 p -76.06 98.15 4.25 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.186 0.517 . . . . 11.039999999999999 110.199 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.95 116.37 24.12 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 115.712 -0.676 . . . . 10.880000000000001 110.109 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.98 -25.6 27.42 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.612 2.208 . . . . 12.460000000000001 112.133 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.91 135.73 13.72 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 109.144 -0.687 . . . . 13.779999999999999 109.144 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.23 109.11 2.13 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.813 2.342 . . . . 11.949999999999999 111.951 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.63 77.11 1.94 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.43 -1.068 . . . . 11.48 110.43 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.15 -40.93 13.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.808 0.337 . . . . 11.550000000000001 110.503 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 77.3 mt-30 -85.21 90.62 7.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.857 -0.423 . . . . 12.59 109.857 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.43 -55.43 3.8 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.162 -1.051 . . . . 11.24 108.162 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m -101.29 55.92 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.3 -1.37 . . . . 10.050000000000001 107.3 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 102' ' ' GLN . . . -47.44 -46.13 26.32 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.549 1.14 . . . . 11.220000000000001 113.555 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.91 -46.64 77.54 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.303 0.483 . . . . 11.380000000000001 112.303 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -75.43 -30.23 59.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.195 -0.298 . . . . 9.6500000000000004 110.195 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.59 -46.08 91.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.003 0.521 . . . . 10.43 111.073 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 m -56.54 -38.44 71.89 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.23 0.538 . . . . 10.210000000000001 110.145 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.75 HG21 HG11 ' A' ' 178' ' ' VAL . 66.0 mt -73.59 -52.41 21.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.25 -0.887 . . . . 8.1300000000000008 109.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -54.88 -43.32 73.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.736 0.814 . . . . 8.4600000000000009 111.693 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.44 -40.93 93.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.088 -0.506 . . . . 10.859999999999999 110.397 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.3 -36.53 66.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.669 . . . . 11.449999999999999 109.608 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.48 -45.21 95.2 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.151 0.98 . . . . 7.6200000000000001 108.406 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.83 -45.3 95.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.385 -0.825 . . . . 11.619999999999999 110.385 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -65.31 -39.41 92.45 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.142 -0.481 . . . . 11.630000000000001 111.056 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -69.08 -37.88 78.71 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.589 -0.278 . . . . 9.1400000000000006 111.174 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.1 tp -65.21 -48.48 73.23 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.607 -0.516 . . . . 10.06 109.607 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.89 -49.14 77.31 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.79 -0.641 . . . . 12.07 112.148 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -61.36 -38.85 88.45 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 123.457 0.703 . . . . 12.32 111.322 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 148' ' ' TRP . 51.9 tp -67.54 -43.05 81.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.977 -0.556 . . . . 11.77 110.012 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.52 -64.34 0.9 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.293 -0.867 . . . . 13.52 110.252 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.0 t80 168.02 -46.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.301 -2.111 . . . . 16.559999999999999 105.301 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -168.38 143.94 3.62 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 103.885 -2.635 . . . . 15.74 103.885 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.61 136.37 20.79 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.065 -0.717 . . . . 14.199999999999999 109.065 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.07 6.06 5.56 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.305 2.003 . . . . 14.18 112.378 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 33.76 74.6 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 110.354 -1.098 . . . . 14.029999999999999 110.354 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -102.7 20.45 17.24 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.383 1.087 . . . . 16.370000000000001 109.259 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.8 pt? -96.64 176.27 6.07 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.158 -0.928 . . . . 12.449999999999999 108.981 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 73.1 -58.31 0.6 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.468 1.107 . . . . 14.43 110.547 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -89.64 5.12 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.078 -1.453 . . . . 14.32 107.078 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.99 135.0 5.35 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.405 -1.478 . . . . 13.75 109.405 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 172' ' ' LYS . . . -179.66 138.21 0.13 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.988 1.315 . . . . 12.699999999999999 107.739 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' HG22 ' A' ' 170' ' ' THR . 3.9 pt20 -170.01 173.9 5.78 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 118.524 -0.751 . . . . 16.379999999999999 109.879 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 55.3 m-85 -63.32 -18.87 64.08 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 119.738 1.154 . . . . 13.300000000000001 112.534 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.2 -10.08 59.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.06 -0.973 . . . . 16.25 112.373 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.258 14.3 p30 -70.46 -64.95 0.8 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.109 -0.636 . . . . 15.869999999999999 112.705 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 pp -87.3 -9.8 53.99 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.687 0.756 . . . . 13.65 109.019 173.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -83.1 70.56 3.17 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.978 -1.01 . . . . 14.16 113.701 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 92.3 mmm -109.06 -65.15 1.17 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.06 -1.459 . . . . 15.449999999999999 107.06 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.54 146.01 39.36 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.167 -1.79 . . . . 13.630000000000001 106.167 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -73.33 -16.56 61.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 113.119 0.785 . . . . 13.9 113.119 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.63 -52.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.021 -0.733 . . . . 13.81 109.021 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -63.82 -31.97 73.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.99 -0.55 . . . . 11.48 111.627 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.08 78.27 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.705 -1.236 . . . . 10.35 110.517 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 m -61.39 -45.33 94.82 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.761 -0.829 . . . . 12.199999999999999 108.761 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 150' ' ' ARG . 86.1 mm-40 -59.66 -41.16 89.96 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.498 -0.774 . . . . 11.859999999999999 111.514 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.429 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.5 t90 -65.48 -47.29 76.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.322 -0.854 . . . . 9.3200000000000003 110.907 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.8 mtp -69.55 -27.35 65.07 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.291 -0.564 . . . . 9.5 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 2.7 tmm_? -59.37 -43.91 92.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.913 -1.144 . . . . 13.91 107.913 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.35 -54.3 20.8 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.364 -0.834 . . . . 9.8800000000000008 111.474 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.19 -46.85 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.574 0.749 . . . . 9.2699999999999996 112.385 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 p -64.54 -52.25 58.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.796 0.331 . . . . 11.460000000000001 111.864 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -71.95 -38.49 69.77 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.807 0.299 . . . . 15.039999999999999 111.807 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -68.75 -31.2 70.07 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.704 0.631 . . . . 11.82 112.704 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -101.38 1.81 38.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.992 0.425 . . . . 11.970000000000001 111.845 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 t 60.56 37.2 19.64 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.215 1.006 . . . . 14.24 111.633 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -119.89 138.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.806 -0.813 . . . . 12.619999999999999 108.806 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.95 95.66 10.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.607 0.718 . . . . 16.390000000000001 110.546 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.64 129.37 54.56 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.928 -1.138 . . . . 12.32 107.928 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.47 56.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.296 -0.631 . . . . 14.06 109.296 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.13 63.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.289 0.566 . . . . 12.640000000000001 111.208 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.81 -4.44 58.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.701 -0.682 . . . . 15.68 110.488 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -74.14 0.62 13.33 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.98 0.363 . . . . 12.720000000000001 111.98 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.8 pt -64.96 -14.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.885 0.85 . . . . 12.16 109.379 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -103.31 -3.56 25.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.093 -0.958 . . . . 15.08 109.875 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.3 m -99.42 -40.7 7.74 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.236 -0.654 . . . . 14.67 109.236 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.0 m-90 -121.37 69.05 20.96 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.663 -0.866 . . . . 12.68 108.663 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' PHE . 1.5 Cg_endo -87.12 40.92 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.988 2.458 . . . . 14.34 113.361 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.403 HG22 ' C ' ' A' ' 134' ' ' GLN . 36.1 p -154.62 143.28 20.74 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 105.227 -2.138 . . . . 12.91 105.227 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.61 -17.02 64.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.356 0.502 . . . . 9.8900000000000006 112.356 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.455 ' HG3' ' CB ' ' A' ' 133' ' ' ALA . 92.1 mttt -72.41 -44.24 62.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 120.824 -0.351 . . . . 12.5 110.828 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 19.1 m -63.75 -43.93 95.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 123.652 0.595 . . . . 11.039999999999999 110.186 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.5 -48.03 71.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.977 -0.556 . . . . 8.5 109.843 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.54 72.81 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.518 0.562 . . . . 7.7000000000000002 112.518 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 32.8 t70 -83.25 -29.87 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.558 -0.457 . . . . 10.380000000000001 111.308 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 173' ' ' SER . 0.2 OUTLIER -57.73 -49.22 77.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.654 0.782 . . . . 11.970000000000001 109.906 -177.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -56.96 -35.95 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.699 -0.682 . . . . 9.8000000000000007 111.556 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.1 -34.89 79.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.391 0.615 . . . . 10.83 110.314 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 88.8 mtt180 -74.27 -43.72 55.74 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.025 -0.989 . . . . 13.5 108.642 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -64.49 -40.85 96.44 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.396 -1.274 . . . . 14.84 111.192 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 183' ' ' GLN . 34.5 m -84.18 -39.47 14.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 113.196 0.813 . . . . 13.35 113.196 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 182' ' ' VAL . 92.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 120.941 -0.304 . . . . 13.51 111.172 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.515 -0.92 . . . . 18.510000000000002 108.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.3 66.64 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.267 1.027 . . . . 16.66 112.121 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.53 -53.76 50.11 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 14.84 111.147 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.04 -29.2 55.13 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.608 -0.723 . . . . 14.98 111.89 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.26 -35.88 80.31 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 122.652 0.381 . . . . 15.789999999999999 110.423 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.6 m -57.5 -41.57 81.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 120.847 0.356 . . . . 12.02 111.106 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -69.56 -47.39 63.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.049 -0.523 . . . . 11.02 109.633 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.08 -38.33 85.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.739 -0.664 . . . . 16.07 111.85 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.29 -46.2 74.32 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.961 0.41 . . . . 13.93 110.746 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.24 -35.53 78.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.411 -0.359 . . . . 10.710000000000001 111.793 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 25' ' ' ILE . 85.5 mtt180 -61.97 -41.61 98.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 14.02 108.97 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -61.26 -51.18 70.0 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.058 -0.973 . . . . 16.289999999999999 110.141 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 t -56.49 -51.48 68.32 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.944 0.778 . . . . 12.91 110.838 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.62 -52.53 65.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 12.77 110.582 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.17 77.3 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.38 0.511 . . . . 15.19 112.38 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.76 78.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.69 0.281 . . . . 16.260000000000002 111.026 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 ptm -70.98 -24.5 62.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.5 -0.48 . . . . 15.449999999999999 111.865 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.36 0.7 55.69 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.028 0.381 . . . . 16.16 112.028 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 56.73 42.37 26.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.553 1.141 . . . . 20.559999999999999 111.813 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.8 m -117.84 174.53 6.13 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.984 -1.007 . . . . 16.629999999999999 109.8 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -94.76 124.37 54.95 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.575 -0.739 . . . . 20.190000000000001 110.924 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 -17.96 15.91 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.272 2.648 . . . . 16.600000000000001 113.501 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.41 43.02 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.143 -1.183 . . . . 17.739999999999998 110.143 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.7 69.7 7.73 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.542 0.687 . . . . 20.23 109.395 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 11' ' ' ARG . 10.0 tp -120.92 153.87 24.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.74 -0.663 . . . . 15.98 109.635 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.63 87.36 2.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 106.762 -1.569 . . . . 19.329999999999998 106.762 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.88 -27.57 60.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.399 1.48 . . . . 14.93 113.061 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.96 -11.79 80.77 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.234 -0.984 . . . . 14.82 112.571 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -81.92 144.94 30.59 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.388 0.613 . . . . 14.539999999999999 109.723 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 29.5 ptt180 -71.19 146.54 49.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.071 -0.968 . . . . 16.75 110.471 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -48.07 -34.46 9.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.971 1.709 . . . . 11.99 113.144 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.56 -38.24 71.65 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.228 1.011 . . . . 14.449999999999999 110.036 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.3 2.41 55.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.565 0.746 . . . . 16.440000000000001 110.927 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.6 0.83 56.73 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.113 -0.699 . . . . 13.77 109.113 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.93 11.1 50.92 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.303 -0.862 . . . . 13.81 111.95 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 175.74 5.62 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.084 0.945 . . . . 13.039999999999999 111.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -141.51 159.73 41.61 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.984 -1.916 . . . . 15.67 106.828 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -55.9 -42.98 76.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 118.947 0.794 . . . . 15.289999999999999 111.111 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.89 -51.42 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.195 -0.911 . . . . 16.66 110.577 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.22 -41.27 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.603 -0.726 . . . . 14.140000000000001 110.203 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.44 87.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 12.0 111.174 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.87 -30.42 71.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.191 0.519 . . . . 13.970000000000001 111.185 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.6 -43.92 16.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.431 0.634 . . . . 15.69 110.659 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -57.7 -44.04 85.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 124.944 1.298 . . . . 11.69 111.278 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.63 -31.1 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 121.306 -0.158 . . . . 11.16 110.987 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 1.4 mmp_? -63.1 -39.71 95.51 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.945 -0.391 . . . . 16.649999999999999 109.945 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -38.06 79.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.929 0.395 . . . . 14.15 110.356 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.8 -42.33 88.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.966 -0.753 . . . . 10.800000000000001 108.966 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' ND2' ' HB ' ' A' ' 56' ' ' ILE . 14.6 m120 -62.01 -36.26 81.0 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.59 -0.732 . . . . 12.98 111.395 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 46' ' ' ARG . 75.6 mmtt -78.3 -49.71 13.16 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.738 -0.21 . . . . 17.52 110.725 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -65.27 -42.38 93.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.301 -0.409 . . . . 14.869999999999999 111.759 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -85.51 -13.12 50.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.289 0.477 . . . . 12.199999999999999 112.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 57.32 38.36 28.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 16.710000000000001 109.956 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.6 tp -122.25 138.59 54.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.181 -0.918 . . . . 12.199999999999999 110.183 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -70.7 57.67 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.206 1.403 . . . . 16.059999999999999 112.573 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' HB ' ' ND2' ' A' ' 49' ' ' ASN . 11.3 mt -88.68 122.85 68.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.583 -0.698 . . . . 11.390000000000001 111.43 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 5.2 Cg_exo -80.38 162.95 22.25 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.138 1.892 . . . . 12.6 108.765 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.31 -6.91 15.68 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.513 0.673 . . . . 12.52 110.617 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 33.4 t70 -60.99 -27.91 68.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.217 -1.356 . . . . 14.140000000000001 111.671 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' NE1' ' A' ' 73' ' ' TRP . . . -55.86 -48.97 68.97 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 119.945 -1.122 . . . . 10.76 112.776 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -76.01 -28.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.043 0.925 . . . . 11.0 109.422 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 87.3 t80 -64.21 -41.15 97.17 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.809 -1.087 . . . . 16.420000000000002 110.832 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.525 HG23 ' CD2' ' A' ' 64' ' ' TYR . 11.4 t -94.79 -18.62 21.07 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 120.544 -0.462 . . . . 13.35 111.987 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CD2' HG23 ' A' ' 63' ' ' THR . 96.8 m-85 -128.6 96.44 30.12 Favored Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 121.909 -0.494 . . . . 12.23 110.758 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 86.9 Cg_endo -84.64 4.27 6.97 Favored 'Trans proline' 0 C--O 1.211 -0.831 0 C-N-CA 122.363 2.042 . . . . 13.06 111.922 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.54 122.56 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.917 -1.142 . . . . 12.949999999999999 107.917 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -60.92 -40.8 94.58 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.845 0.858 . . . . 10.92 112.345 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.16 -27.4 67.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.933 0.397 . . . . 14.32 111.247 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.25 -31.6 21.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.566 0.698 . . . . 10.93 109.58 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -70.87 -30.69 67.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 8.8100000000000005 111.794 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -64.09 -28.12 69.56 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.591 -0.693 . . . . 9.3499999999999996 111.145 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -74.23 -24.98 59.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.709 -0.678 . . . . 11.630000000000001 109.83 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.542 ' CZ3' ' HG3' ' A' ' 77' ' ' GLN . 20.6 t90 -64.49 -49.03 72.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.616 -1.253 . . . . 10.550000000000001 107.616 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.33 -43.92 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-N 115.079 -0.964 . . . . 8.3000000000000007 109.536 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.73 -40.63 95.17 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.778 -0.646 . . . . 9.5800000000000001 112.347 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.2 p -77.18 -8.87 58.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.788 0.662 . . . . 10.23 112.788 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.542 ' HG3' ' CZ3' ' A' ' 73' ' ' TRP . 16.8 mm-40 -93.32 -35.35 13.1 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.051 -0.405 . . . . 10.43 110.316 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.48 -41.42 80.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.707 -0.849 . . . . 10.970000000000001 108.707 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -128.82 94.55 34.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.181 -0.918 . . . . 13.52 108.592 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.32 70.04 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.957 2.438 . . . . 12.279999999999999 113.8 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.6 m -75.75 110.9 10.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.88 -0.6 . . . . 13.44 109.827 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -81.55 79.48 8.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.514 -0.55 . . . . 13.27 109.514 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.55 53.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.819 0.819 . . . . 14.48 109.421 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -86.33 46.58 1.36 Allowed 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.043 0.925 . . . . 14.92 109.719 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.97 132.34 36.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.835 -0.62 . . . . 14.25 110.207 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.07 120.75 71.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.813 -0.81 . . . . 12.970000000000001 108.813 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.4 -34.92 83.01 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.877 3.051 . . . . 13.4 112.545 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -121.45 111.1 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.504 -1.295 . . . . 12.43 107.504 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -73.76 118.23 16.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.022 0.439 . . . . 13.449999999999999 110.28 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -123.83 47.99 1.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.622 -1.251 . . . . 14.41 107.622 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 41.3 tt0 -58.72 118.62 30.2 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.181 -1.372 . . . . 11.68 111.838 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 1.9 Cg_endo -85.27 69.2 5.55 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.651 2.234 . . . . 10.84 110.298 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.69 134.85 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.923 -0.581 . . . . 10.460000000000001 109.525 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.65 77.0 9.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.405 0.622 . . . . 10.58 110.714 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 p -88.6 152.4 21.86 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.822 -0.626 . . . . 11.039999999999999 111.04 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.97 128.44 25.75 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.827 -0.805 . . . . 10.880000000000001 108.827 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.61 -32.78 47.47 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.822 2.348 . . . . 12.460000000000001 112.708 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -116.55 106.97 47.56 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.53 -0.545 . . . . 13.779999999999999 109.53 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.48 -4.73 15.37 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.75 2.3 . . . . 11.949999999999999 112.476 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.36 -175.42 40.41 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 109.659 -1.377 . . . . 11.48 109.659 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 5.21 51.45 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.973 0.416 . . . . 11.550000000000001 110.153 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -65.92 -27.17 67.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.226 -0.443 . . . . 12.59 111.786 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.28 96.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.213 0.53 . . . . 11.24 109.739 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m -75.38 -39.37 59.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.443 -0.799 . . . . 10.050000000000001 110.182 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.19 87.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.843 -0.617 . . . . 11.220000000000001 110.898 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.44 ' OE1' ' HB ' ' A' ' 182' ' ' VAL . 8.1 tt0 -54.25 -51.84 63.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.664 0.786 . . . . 11.380000000000001 109.08 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.35 -45.99 90.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.928 -1.033 . . . . 9.6500000000000004 111.811 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.63 -39.38 91.1 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.053 0.454 . . . . 10.43 111.591 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -69.33 -51.43 37.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.014 -0.539 . . . . 10.210000000000001 110.262 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.823 HG21 HG11 ' A' ' 178' ' ' VAL . 54.6 mt -70.22 -27.02 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 116.267 -0.424 . . . . 8.1300000000000008 111.456 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.21 -38.78 80.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.559 0.695 . . . . 8.4600000000000009 109.551 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.76 -31.08 66.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.178 -0.919 . . . . 10.859999999999999 110.639 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -77.5 -35.86 53.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.45 -0.341 . . . . 11.449999999999999 110.465 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.8 -47.02 83.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.813 -0.81 . . . . 7.6200000000000001 108.813 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -52.17 -55.22 22.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.879 -1.055 . . . . 11.619999999999999 109.835 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.5 -44.08 95.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 11.630000000000001 112.581 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 t -63.35 -44.43 94.86 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.058 0.456 . . . . 9.1400000000000006 110.475 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.05 -42.99 83.86 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.36 -0.607 . . . . 10.06 109.36 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.05 -19.73 68.2 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 116.154 -0.475 . . . . 12.07 112.743 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -78.62 -38.87 38.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.201 -0.666 . . . . 12.32 109.201 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.4 tp -80.83 -45.4 16.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.705 -0.68 . . . . 11.77 110.748 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -83.03 -19.46 36.88 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.196 -0.911 . . . . 13.52 110.223 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.2 t80 73.22 -43.78 0.57 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.855 1.662 . . . . 16.559999999999999 112.209 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.5 tp -159.34 142.74 14.57 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.154 -0.684 . . . . 15.74 109.154 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.78 112.08 27.29 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.25 0.344 . . . . 14.199999999999999 110.251 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.53 -9.66 20.11 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.888 2.392 . . . . 14.18 112.336 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.13 69.01 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.582 -1.007 . . . . 14.029999999999999 110.582 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 78.27 27.17 0.53 Allowed 'General case' 0 C--O 1.247 0.955 0 C-N-CA 125.008 1.323 . . . . 16.370000000000001 110.666 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.0 mt 56.85 73.05 0.47 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.647 -1.615 . . . . 12.449999999999999 112.267 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -86.33 151.59 23.45 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.116 -1.402 . . . . 14.43 111.39 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -37.33 67.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.83 -1.077 . . . . 14.32 110.262 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.17 62.65 4.53 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 110.771 -0.931 . . . . 13.75 110.771 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.4 143.79 28.48 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.458 -0.571 . . . . 12.699999999999999 109.458 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -137.52 139.75 40.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.979 -0.748 . . . . 16.379999999999999 108.979 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 12.2 p90 -63.32 -6.87 5.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.733 0.813 . . . . 13.300000000000001 112.806 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.84 -61.05 2.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.172 0.511 . . . . 16.25 110.039 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.63 -20.98 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.087 -0.506 . . . . 15.869999999999999 110.344 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.02 14.47 15.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.932 -0.577 . . . . 13.65 111.468 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.42 60.02 4.87 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.957 -0.857 . . . . 14.16 110.957 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.03 152.21 51.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.469 -1.308 . . . . 15.449999999999999 107.469 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.25 39.87 18.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.192 0.932 . . . . 13.630000000000001 111.175 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 p -77.62 -32.81 53.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.219 -0.9 . . . . 13.9 112.138 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.1 -50.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.383 -0.969 . . . . 13.81 108.383 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -72.18 -16.14 61.96 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.34 -0.846 . . . . 11.48 111.303 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.69 -22.09 77.99 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.216 -0.754 . . . . 10.35 111.216 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 82.2 p -66.82 -45.87 76.96 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.182 -1.044 . . . . 12.199999999999999 108.182 175.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -61.75 -38.35 87.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.136 -0.938 . . . . 11.859999999999999 110.147 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.459 ' O ' HG23 ' A' ' 152' ' ' VAL . 12.4 t90 -56.09 -54.09 49.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 9.3200000000000003 110.308 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 43.6 ttm -66.76 -30.83 71.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.242 0.339 . . . . 9.5 111.543 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 23.3 mmm180 -58.4 -50.16 74.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 13.91 109.189 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.52 -44.75 96.49 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.654 -0.579 . . . . 9.8800000000000008 111.654 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 148' ' ' TRP . 80.4 t -57.29 -48.67 81.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 123.208 0.603 . . . . 9.2699999999999996 111.136 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.2 p -71.19 -31.14 67.27 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.816 0.341 . . . . 11.460000000000001 111.526 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.61 -44.91 63.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.027 0.441 . . . . 15.039999999999999 110.37 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -66.44 -48.2 70.74 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.791 0.663 . . . . 11.82 112.791 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -84.41 -0.24 52.01 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.171 0.434 . . . . 11.970000000000001 112.171 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.5 p 54.43 33.43 18.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.204 1.401 . . . . 14.24 112.482 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.3 pt -109.61 153.55 11.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.541 -0.754 . . . . 12.619999999999999 110.308 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.09 95.53 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.185 0.517 . . . . 16.390000000000001 110.46 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.98 120.81 26.72 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.006 -0.738 . . . . 12.32 109.006 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 134.74 38.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.903 -0.777 . . . . 14.06 108.903 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.32 -7.86 21.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.749 0.785 . . . . 12.640000000000001 111.661 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.3 -19.96 65.96 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.881 0.872 . . . . 15.68 109.711 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -59.8 -19.46 50.85 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.659 0.985 . . . . 12.720000000000001 113.659 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.5 pt -70.03 -2.31 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.764 -0.585 . . . . 12.16 111.822 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -122.53 23.69 9.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.743 0.306 . . . . 15.08 110.647 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 164' ' ' ALA . 10.3 t -147.07 20.75 1.24 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.503 -0.479 . . . . 14.67 111.088 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -134.94 103.54 10.79 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 108.552 -0.907 . . . . 12.68 108.552 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.524 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 17.2 Cg_exo -69.19 -33.09 19.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.801 2.334 . . . . 14.34 113.37 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -97.56 155.7 16.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.476 -0.784 . . . . 12.91 110.938 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -81.79 -32.28 31.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.114 -0.948 . . . . 9.8900000000000006 111.876 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -78.11 -5.6 52.09 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.751 0.649 . . . . 12.5 112.751 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.8 p -54.28 -35.52 62.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.251 1.02 . . . . 11.039999999999999 112.46 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 7.3 tt -60.7 -30.79 70.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.184 0.594 . . . . 8.5 110.22 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.48 59.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.259 -0.428 . . . . 7.7000000000000002 110.369 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.29 -30.22 30.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.845 -0.428 . . . . 10.380000000000001 109.845 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 5.3 mm-40 -57.25 -59.97 4.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 11.970000000000001 109.309 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 110' ' ' ILE . 7.6 p -63.96 -37.16 79.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.595 -1.184 . . . . 9.8000000000000007 111.843 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.22 -39.32 86.24 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.397 0.617 . . . . 10.83 110.441 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -74.28 -41.09 61.77 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.967 -1.015 . . . . 13.5 110.078 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.51 ' HA ' ' HE ' ' A' ' 181' ' ' ARG . 3.3 mmp_? -69.18 -52.91 23.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.764 -0.653 . . . . 14.84 112.065 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 106' ' ' GLN . 46.6 t -73.9 -65.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 13.35 109.38 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.872 1.269 . . . . 13.51 112.575 175.913 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 4' ' ' ASP . 5.0 m . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 18.510000000000002 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 -53.97 2.52 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.137 -0.483 . . . . 16.66 110.53 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.29 -48.14 24.62 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.013 -1.106 . . . . 14.84 108.013 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 1' ' ' VAL . 23.6 t70 -69.24 -15.68 63.43 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.84 -1.527 . . . . 14.98 111.122 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.04 -34.38 77.57 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.219 0.533 . . . . 15.789999999999999 109.628 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.5 m -60.8 -34.07 73.96 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.182 -0.917 . . . . 12.02 110.229 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.34 -48.46 70.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.702 -0.481 . . . . 11.02 109.702 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.05 -42.52 94.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.467 0.479 . . . . 16.07 111.556 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -63.83 -46.42 85.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 13.93 110.684 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.65 -48.66 59.07 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 111.769 0.285 . . . . 10.710000000000001 111.769 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 34.5 ptt180 -68.77 -16.67 63.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.959 -0.696 . . . . 14.02 111.293 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -60.84 -49.2 78.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.342 0.401 . . . . 16.289999999999999 109.987 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -79.03 -31.5 44.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.868 -0.333 . . . . 12.91 110.111 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 8.0 tt -61.24 -52.9 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.815 -0.809 . . . . 12.77 108.815 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.79 -25.01 62.68 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.078 -0.51 . . . . 15.19 111.741 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.79 63.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.96 0.41 . . . . 16.260000000000002 110.88 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 mmt -85.36 -31.25 23.07 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.898 0.38 . . . . 15.449999999999999 110.981 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -96.4 -2.61 45.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.216 0.531 . . . . 16.16 111.505 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 60.16 41.07 17.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.007 1.323 . . . . 20.559999999999999 111.795 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 t -107.22 -178.92 3.78 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.032 -0.985 . . . . 16.629999999999999 108.586 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 mp0 -97.72 103.08 15.1 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 123.077 0.551 . . . . 20.190000000000001 110.271 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 21' ' ' GLU . 12.9 Cg_endo -53.53 -40.55 78.51 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 124.26 3.307 . . . . 16.600000000000001 115.258 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.89 -11.65 85.2 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 119.971 -1.109 . . . . 17.739999999999998 114.043 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -141.77 58.42 1.49 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.241 0.83 . . . . 20.23 113.241 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.2 pt -97.15 -10.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.18 -0.608 . . . . 15.98 110.408 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 73.85 128.05 0.04 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 125.645 1.578 . . . . 19.329999999999998 110.607 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 4.4 p-10 -66.34 -23.83 66.42 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.571 1.323 . . . . 14.93 114.571 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.97 5.89 69.06 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 119.901 -1.142 . . . . 14.82 112.66 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.2 m -70.43 151.54 45.04 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 122.024 0.916 . . . . 14.539999999999999 112.951 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 48.1 mtm180 -90.12 132.68 35.3 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.08 -1.418 . . . . 16.75 111.267 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -47.0 -52.69 14.17 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 123.741 0.651 . . . . 11.99 112.638 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 36' ' ' LEU . 19.5 tp -56.1 -37.97 70.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 14.449999999999999 111.323 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.73 -23.8 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.799 -0.637 . . . . 16.440000000000001 110.885 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.26 -13.42 59.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.296 0.57 . . . . 13.77 110.713 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.21 -8.45 15.9 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.762 -0.732 . . . . 13.81 111.444 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.4 tt -69.69 134.23 48.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.461 -0.57 . . . . 13.039999999999999 109.461 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 18.5 t70 -114.48 161.33 18.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.233 -1.025 . . . . 15.67 108.233 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 118.829 0.741 . . . . 15.289999999999999 111.131 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -70.42 -41.47 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.593 0.711 . . . . 16.66 109.501 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 62.3 mt -67.99 -28.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.001 -1.0 . . . . 14.140000000000001 110.177 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -61.14 -48.51 81.3 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.587 -0.733 . . . . 12.0 110.438 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.55 96.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.212 0.529 . . . . 13.970000000000001 110.326 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.95 -46.15 88.75 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.912 -1.04 . . . . 15.69 111.618 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.405 ' O ' HG13 ' A' ' 48' ' ' ILE . 6.4 t90 -71.92 -41.76 67.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 124.748 1.219 . . . . 11.69 110.437 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mm -51.98 -46.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.634 0.774 . . . . 11.16 112.146 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.9 mtm-85 -58.35 -40.01 81.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.482 0.489 . . . . 16.649999999999999 110.617 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -74.19 -34.66 63.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 120.145 -0.622 . . . . 14.15 112.154 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 44' ' ' TRP . 74.1 mt -59.93 -46.26 94.21 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 108.866 -0.79 . . . . 10.800000000000001 108.866 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.84 -39.93 86.8 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 114.972 -1.013 . . . . 12.98 110.535 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -79.2 -43.44 23.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.559 0.578 . . . . 17.52 112.559 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -64.86 -44.04 91.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.454 0.538 . . . . 14.869999999999999 112.454 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -95.74 -10.77 28.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.35 0.87 . . . . 12.199999999999999 113.35 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 59.22 52.06 6.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.313 -1.366 . . . . 16.710000000000001 107.313 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.4 tp -127.55 135.96 51.04 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.645 -1.161 . . . . 12.199999999999999 110.21 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.02 69.11 3.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 16.059999999999999 110.68 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mm -82.06 119.24 74.63 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.235 -0.439 . . . . 11.390000000000001 110.311 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.45 136.44 31.18 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.103 1.869 . . . . 12.6 109.726 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.88 63.45 Favored 'General case' 0 C--O 1.245 0.868 0 C-N-CA 123.684 0.794 . . . . 12.52 112.036 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 3.5 p30 -69.68 -12.36 61.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.205 -0.452 . . . . 14.140000000000001 112.066 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.5 -22.87 47.04 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 123.233 0.333 . . . . 10.76 113.663 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -115.94 -1.22 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 122.827 1.299 . . . . 11.0 108.16 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 81.1 t80 -90.63 -47.74 7.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.398 -0.819 . . . . 16.420000000000002 109.541 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 t -96.24 -23.15 16.83 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.792 -0.763 . . . . 13.35 111.493 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -100.57 118.25 61.29 Favored Pre-proline 0 CA--C 1.511 -0.541 0 C-N-CA 120.421 -0.512 . . . . 12.23 109.889 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.5 Cg_endo -94.53 -1.41 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.363 2.042 . . . . 13.06 114.02 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.31 123.15 68.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.19 0.519 . . . . 12.949999999999999 109.925 -174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.85 -37.12 86.56 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.295 1.038 . . . . 10.92 111.311 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 75.3 tttt -63.34 -39.45 94.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.529 -0.759 . . . . 14.32 111.09 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.47 72.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.135 0.493 . . . . 10.93 110.261 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' VAL . 29.1 t80 -67.32 -37.51 83.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.7 -0.682 . . . . 8.8100000000000005 112.638 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -64.03 -35.31 80.29 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.955 -0.698 . . . . 9.3499999999999996 112.692 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.158 -0.682 . . . . 11.630000000000001 109.158 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -60.66 -38.54 85.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.395 -0.821 . . . . 10.550000000000001 109.884 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 70' ' ' PHE . 55.9 t -72.18 -48.26 49.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.078 -0.712 . . . . 8.3000000000000007 109.078 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.49 -43.36 94.09 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.345 -0.843 . . . . 9.5800000000000001 113.231 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -65.73 -28.5 69.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.794 0.664 . . . . 10.23 112.794 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -85.84 -23.59 27.06 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.433 -0.507 . . . . 10.43 111.022 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.33 124.55 24.79 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.271 0.557 . . . . 10.970000000000001 111.592 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -103.86 105.62 49.0 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.855 -1.165 . . . . 13.52 107.855 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.33 123.86 12.1 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.321 2.014 . . . . 12.279999999999999 112.565 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -89.69 147.47 23.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.54 -1.282 . . . . 13.44 107.54 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.55 87.54 6.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.97 -0.692 . . . . 13.27 110.472 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.85 -27.22 40.19 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.015 -0.993 . . . . 14.48 109.408 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -83.48 73.26 10.21 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 122.118 0.961 . . . . 14.92 108.747 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.87 -164.78 1.23 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.757 -1.11 . . . . 14.25 109.7 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.46 131.33 70.6 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 122.999 0.52 . . . . 12.970000000000001 110.655 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 22.1 Cg_exo -65.81 96.93 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.496 2.131 . . . . 13.4 111.946 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.02 115.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.235 -1.394 . . . . 12.43 107.235 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -85.02 65.48 9.26 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.264 1.031 . . . . 13.449999999999999 110.731 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -143.55 136.59 27.71 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 107.003 -1.48 . . . . 14.41 107.003 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.79 125.31 73.54 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 107.964 -1.125 . . . . 11.68 107.964 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 52.13 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.235 2.623 . . . . 10.84 111.869 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.6 p -93.77 -23.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.348 -0.842 . . . . 10.460000000000001 110.105 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.67 15.91 22.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.661 -0.416 . . . . 10.58 111.203 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.6 m -71.49 -41.59 69.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.348 -0.612 . . . . 11.039999999999999 109.348 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.51 84.55 27.87 Favored Pre-proline 0 N--CA 1.432 -1.333 0 CA-C-N 115.742 -0.663 . . . . 10.880000000000001 110.675 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.14 43.14 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 122.434 2.089 . . . . 12.460000000000001 112.25 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -176.44 153.24 1.21 Allowed Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 103.371 -2.825 . . . . 13.779999999999999 103.371 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.5 124.72 16.76 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.074 1.85 . . . . 11.949999999999999 112.094 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.92 -160.36 54.03 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.897 -0.592 . . . . 11.48 112.612 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.459 ' HB1' ' NE2' ' A' ' 183' ' ' GLN . . . -88.33 17.37 5.28 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.821 0.82 . . . . 11.550000000000001 110.425 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -73.36 -6.38 45.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.024 -0.989 . . . . 12.59 109.75 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.53 84.64 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.768 -0.651 . . . . 11.24 110.59 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.5 t 55.81 22.82 5.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.736 1.614 . . . . 10.050000000000001 111.015 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.57 -49.0 15.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.426 -0.807 . . . . 11.220000000000001 109.751 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.47 -43.76 93.17 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.661 -0.866 . . . . 11.380000000000001 108.661 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -50.25 -57.64 7.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.186 0.994 . . . . 9.6500000000000004 111.409 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.14 -40.56 90.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.698 -0.228 . . . . 10.43 111.523 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 t -59.29 -51.06 71.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.661 -0.496 . . . . 10.210000000000001 109.661 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.484 HG21 HG11 ' A' ' 178' ' ' VAL . 80.1 mt -59.77 -40.46 82.6 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 CA-C-N 116.369 -0.378 . . . . 8.1300000000000008 110.254 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -58.04 -44.53 87.44 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.562 0.745 . . . . 8.4600000000000009 110.602 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.98 -41.87 67.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.725 -0.671 . . . . 10.859999999999999 110.783 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -62.68 -40.48 97.22 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.455 -0.339 . . . . 11.449999999999999 111.178 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.95 -50.53 66.28 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.871 0.868 . . . . 7.6200000000000001 109.791 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.8 -46.7 86.99 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.435 -1.257 . . . . 11.619999999999999 111.496 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -70.65 -45.91 64.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.184 -0.462 . . . . 11.630000000000001 111.195 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.9 t -64.69 -44.03 91.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.809 -0.632 . . . . 9.1400000000000006 111.065 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.66 -39.94 80.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.127 -0.629 . . . . 10.06 109.903 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.83 -38.94 94.76 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 111.751 -0.54 . . . . 12.07 111.751 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -54.51 -47.2 73.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.335 1.054 . . . . 12.32 110.662 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 144' ' ' THR . 4.6 mm? -86.4 -22.87 26.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.22 0.822 . . . . 11.77 113.22 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.2 tp -84.16 -28.61 27.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.766 0.317 . . . . 13.52 110.614 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 68.69 1.18 2.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.149 1.38 . . . . 16.559999999999999 113.803 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -162.92 154.81 18.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.25 -1.389 . . . . 15.74 107.25 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.07 96.49 25.71 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 110.053 -0.351 . . . . 14.199999999999999 110.053 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -75.0 -15.61 20.65 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.486 2.124 . . . . 14.18 110.807 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.93 47.69 4.39 Favored Glycine 0 CA--C 1.497 -1.08 0 CA-C-N 114.789 -1.096 . . . . 14.029999999999999 112.661 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.26 12.51 11.0 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.523 -0.471 . . . . 16.370000000000001 111.967 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.4 mt -55.41 -37.11 67.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.42 1.105 . . . . 12.449999999999999 111.141 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -98.06 84.68 3.33 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.14 -1.391 . . . . 14.43 111.901 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 m 72.27 -5.22 1.82 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.845 1.424 . . . . 14.32 114.845 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 -34.53 20.68 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 119.496 -1.335 . . . . 13.75 110.559 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.86 95.9 3.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.056 0.942 . . . . 12.699999999999999 109.978 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 170' ' ' THR . 46.3 mt-30 -86.89 177.12 7.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.387 -0.968 . . . . 16.379999999999999 108.387 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 44.5 p90 -59.98 -23.16 63.4 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.167 0.894 . . . . 13.300000000000001 110.111 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.34 -29.91 70.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.888 -1.051 . . . . 16.25 110.35 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.19 -39.19 12.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.84 -0.618 . . . . 15.869999999999999 110.08 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.48 -26.86 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 13.65 111.233 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.53 5.08 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.336 -0.459 . . . . 14.16 113.512 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 72.3 mtm -74.81 -29.61 61.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 117.58 0.69 . . . . 15.449999999999999 110.594 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.563 ' OD2' HG12 ' A' ' 143' ' ' VAL . 32.6 t70 -149.21 120.5 7.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.25 0.547 . . . . 13.630000000000001 111.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 p -75.32 -25.98 58.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.943 1.09 . . . . 13.9 113.943 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.563 HG12 ' OD2' ' A' ' 141' ' ' ASP . 2.8 p -72.13 -34.98 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.865 -1.161 . . . . 13.81 107.865 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 121' ' ' LEU . 37.8 m -60.62 -50.17 74.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.311 -1.313 . . . . 11.48 109.212 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.77 -54.55 27.62 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.613 0.571 . . . . 10.35 113.471 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 6.9 t -62.9 -45.18 93.75 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 112.648 0.61 . . . . 12.199999999999999 112.648 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -65.61 -49.31 69.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 11.859999999999999 110.951 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -63.72 -42.15 97.96 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.419 -0.809 . . . . 9.3200000000000003 110.77 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.466 ' HA ' ' CE ' ' A' ' 149' ' ' MET . 0.3 OUTLIER -58.81 -54.62 45.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 9.5 111.256 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 13.5 ptt180 -63.79 -38.66 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.651 -0.25 . . . . 13.91 111.657 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.9 -53.48 44.87 Favored Glycine 0 N--CA 1.443 -0.853 0 O-C-N 123.531 0.519 . . . . 9.8800000000000008 112.417 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.88 -41.69 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.525 0.203 . . . . 9.2699999999999996 111.341 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.9 m -60.72 -54.99 38.58 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 116.172 -0.467 . . . . 11.460000000000001 111.466 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -69.31 -25.37 64.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.577 -0.738 . . . . 15.039999999999999 111.221 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -64.36 -30.77 71.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.872 -0.604 . . . . 11.82 110.878 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' SER . 69.8 m-85 -98.15 -69.69 0.75 Allowed 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.689 -0.804 . . . . 11.970000000000001 111.004 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 19.4 t 171.53 17.32 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.278 0.361 . . . . 14.24 110.998 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.5 pt -123.22 168.46 15.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 O-C-N 121.322 -0.861 . . . . 12.619999999999999 109.67 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 5.9 tp60 -130.93 118.01 20.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 120.518 -0.473 . . . . 16.390000000000001 110.902 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.8 mt -118.71 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.354 -0.839 . . . . 12.32 109.514 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.51 149.28 36.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.115 -0.948 . . . . 14.06 110.147 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.12 0.968 . . . . 12.640000000000001 112.695 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.06 1.85 57.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.887 -0.597 . . . . 15.68 111.236 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 167' ' ' THR . . . -66.23 -18.13 65.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.545 0.572 . . . . 12.720000000000001 112.545 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . 0.282 2.6 pp -75.93 7.05 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.932 0.716 . . . . 12.16 112.932 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -98.65 -16.03 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.623 -0.717 . . . . 15.08 110.427 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 164' ' ' ALA . 15.2 t -103.34 15.95 27.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.253 -0.579 . . . . 14.67 111.765 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.563 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 13.5 m0 -123.26 119.2 27.58 Favored Pre-proline 0 CA--C 1.501 -0.915 0 O-C-N 121.902 -0.499 . . . . 12.68 110.453 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.43 ' HD2' ' OG ' ' A' ' 173' ' ' SER . 22.7 Cg_exo -63.32 -37.61 49.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.455 2.104 . . . . 14.34 110.261 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 16.5 p -144.24 169.13 18.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.746 -0.661 . . . . 12.91 110.956 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -52.68 -41.31 63.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.166 0.586 . . . . 9.8900000000000006 111.875 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.86 -22.83 50.11 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.477 0.917 . . . . 12.5 113.477 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' HD2' ' A' ' 169' ' ' PRO . 14.3 m -69.1 -26.85 65.13 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.033 0.444 . . . . 11.039999999999999 110.665 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 168' ' ' TRP . 23.6 tp -66.82 -46.06 76.35 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.579 -0.897 . . . . 8.5 108.579 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.46 -28.23 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.934 -1.03 . . . . 7.7000000000000002 111.273 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.72 -40.53 55.46 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.83 -0.348 . . . . 10.380000000000001 111.663 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.84 -34.58 66.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.584 0.957 . . . . 11.970000000000001 113.584 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 110' ' ' ILE . 14.2 p -71.4 -33.66 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.282 -0.567 . . . . 9.8000000000000007 110.012 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 183' ' ' GLN . 10.6 t70 -60.86 -49.93 75.47 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 109.427 -0.582 . . . . 10.83 109.427 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.6 -29.41 70.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.468 -0.787 . . . . 13.5 112.134 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -85.89 -51.48 6.36 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.193 0.442 . . . . 14.84 112.193 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.92 -36.65 45.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 120.966 0.412 . . . . 13.35 110.913 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.459 ' NE2' ' HB1' ' A' ' 101' ' ' ALA . 23.7 mt-30 . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 118.319 -0.848 . . . . 13.51 109.119 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 107.134 -1.432 . . . . 18.510000000000002 107.134 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.98 -39.56 41.38 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.398 0.888 . . . . 16.66 113.398 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.04 -57.03 13.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 14.84 111.215 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.56 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 28.5 t70 -65.65 -32.4 73.94 Favored 'General case' 0 C--O 1.197 -1.703 0 CA-C-N 115.76 -0.654 . . . . 14.98 110.191 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.04 -39.83 93.65 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.286 0.634 . . . . 15.789999999999999 111.142 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.6 t -65.1 -35.26 80.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.322 -0.622 . . . . 12.02 109.322 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.25 57.55 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 116.219 -0.446 . . . . 11.02 111.093 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 98.9 mt-30 -51.73 -50.23 60.99 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.767 0.827 . . . . 16.07 111.446 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -42.39 96.13 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.823 -0.351 . . . . 13.93 111.158 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.88 -37.16 70.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.9 0.381 . . . . 10.710000000000001 110.505 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -64.84 -47.43 77.98 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.201 1.001 . . . . 14.02 109.041 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.81 -46.89 83.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.064 0.946 . . . . 16.289999999999999 111.153 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -72.94 -38.7 66.68 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.228 0.455 . . . . 12.91 112.228 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.92 -46.57 88.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.692 -1.225 . . . . 12.77 107.692 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -61.7 -44.26 97.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 15.19 111.315 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.81 86.39 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.21 0.448 . . . . 16.260000000000002 112.21 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.41 -44.63 51.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.039 0.385 . . . . 15.449999999999999 112.039 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.47 -9.77 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.228 0.537 . . . . 16.16 111.986 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 t80 65.96 36.97 5.6 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.627 1.203 . . . . 20.559999999999999 108.857 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 14.6 p -107.89 163.4 13.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.736 -1.209 . . . . 16.629999999999999 107.736 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -90.92 136.58 27.43 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 120.234 -0.586 . . . . 20.190000000000001 111.506 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -74.91 6.88 3.09 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.415 2.743 . . . . 16.600000000000001 112.671 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.48 -30.51 18.74 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 111.301 -0.719 . . . . 17.739999999999998 111.301 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -94.85 47.15 1.15 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.175 0.988 . . . . 20.23 111.674 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 tp -126.8 131.81 70.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.96 -1.496 . . . . 15.98 106.96 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -136.4 174.04 11.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.974 -0.103 . . . . 19.329999999999998 111.194 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 2.8 m-20 -67.52 -45.42 75.83 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.623 0.725 . . . . 14.93 111.33 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.44 7.77 74.65 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.002 -0.999 . . . . 14.82 113.998 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.9 m -59.89 144.97 47.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.292 0.567 . . . . 14.539999999999999 112.435 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.4 mtm180 -82.3 102.33 11.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.548 -2.019 . . . . 16.75 105.548 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -45.55 -58.58 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.798 1.239 . . . . 11.99 114.03 -168.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.34 -29.63 47.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.109 0.481 . . . . 14.449999999999999 111.404 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 7.1 mm-40 -68.87 -7.03 30.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 16.440000000000001 111.73 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -72.66 -5.96 41.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.233 -0.44 . . . . 13.77 111.239 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.05 11.55 4.74 Favored Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.063 -1.065 . . . . 13.81 114.128 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -115.41 152.17 33.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.898 0.849 . . . . 13.039999999999999 112.854 -177.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -126.04 167.59 15.13 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.121 -0.945 . . . . 15.67 109.475 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.3 m -38.72 -52.82 1.69 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.598 1.559 . . . . 15.289999999999999 114.71 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.8 -46.19 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.94 0.4 . . . . 16.66 111.317 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -66.16 -38.84 82.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 14.140000000000001 109.872 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.16 -42.54 96.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.406 -0.815 . . . . 12.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.11 96.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.759 . . . . 13.970000000000001 110.624 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.85 -40.13 94.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.861 -0.609 . . . . 15.69 111.45 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -67.6 -53.51 27.54 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.034 -0.985 . . . . 11.69 111.53 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 58' ' ' ALA . 7.8 tp -60.49 -29.99 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.421 0.629 . . . . 11.16 110.708 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -62.49 -28.41 69.81 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.06 -0.973 . . . . 16.649999999999999 109.417 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -86.61 -33.83 20.05 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.887 -0.597 . . . . 14.15 111.713 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.76 -46.46 96.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.495 -0.557 . . . . 10.800000000000001 109.495 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -53.11 -39.27 63.3 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.046 -0.979 . . . . 12.98 111.415 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -77.07 -57.98 3.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.93 -0.577 . . . . 17.52 111.159 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -66.94 -27.99 67.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.284 -0.871 . . . . 14.869999999999999 113.219 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -103.85 0.84 30.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.879 -0.728 . . . . 12.199999999999999 112.625 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 54.24 47.62 22.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.83 1.252 . . . . 16.710000000000001 110.522 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.4 142.19 51.62 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.218 -0.901 . . . . 12.199999999999999 110.089 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.92 36.34 1.56 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.367 -1.346 . . . . 16.059999999999999 107.367 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.616 HD11 ' HD1' ' A' ' 73' ' ' TRP . 9.4 tt -56.55 132.69 77.36 Favored Pre-proline 0 C--O 1.244 0.812 0 CA-C-N 112.227 -2.26 . . . . 11.390000000000001 110.492 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.38 128.47 30.22 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.143 2.562 . . . . 12.6 111.957 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -71.63 -21.2 61.87 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 121.786 0.803 . . . . 12.52 110.03 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -69.04 -6.87 30.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.102 -0.954 . . . . 14.140000000000001 111.52 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 64' ' ' TYR . . . -63.35 -17.67 59.84 Favored Glycine 0 C--N 1.355 1.583 0 N-CA-C 112.019 -0.433 . . . . 10.76 112.019 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -99.16 -43.34 11.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.837 -1.171 . . . . 11.0 107.837 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.71 -48.9 69.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 113.816 -1.538 . . . . 16.420000000000002 112.0 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 64' ' ' TYR . 10.0 t -109.63 13.47 23.82 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.464 -0.494 . . . . 13.35 111.745 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 89.4 m-85 -140.73 75.15 26.08 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 109.339 -0.615 . . . . 12.23 109.339 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.33 38.05 0.7 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.054 2.503 . . . . 13.06 113.253 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 48.2 t -121.52 120.86 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.645 -1.613 . . . . 12.949999999999999 106.645 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -58.03 -42.05 84.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.31 -0.859 . . . . 10.92 112.555 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 83.0 tttt -64.98 -46.09 82.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.764 0.316 . . . . 14.32 110.199 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . . . -60.34 -40.85 92.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.975 -0.557 . . . . 10.93 111.551 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.35 -33.93 58.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.183 -0.462 . . . . 8.8100000000000005 111.633 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -71.2 -33.03 69.56 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.624 -0.83 . . . . 9.3499999999999996 110.762 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 54.2 mt-30 -69.86 -33.6 72.48 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.888 -0.782 . . . . 11.630000000000001 108.888 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.616 ' HD1' HD11 ' A' ' 56' ' ' ILE . 17.6 t-105 -61.82 -49.63 75.54 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.204 -0.907 . . . . 10.550000000000001 110.19 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.2 t -63.2 -45.27 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.259 0 N-CA-C 109.913 -0.403 . . . . 8.3000000000000007 109.913 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.32 -32.31 80.36 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.667 -0.697 . . . . 9.5800000000000001 113.398 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 t -87.27 -12.61 46.11 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 122.213 -0.581 . . . . 10.23 110.459 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 86.1 mm-40 -88.45 -47.11 8.59 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 122.308 -0.245 . . . . 10.43 110.366 177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 74' ' ' VAL 0.265 1.2 pp -81.51 80.6 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.846 1.308 . . . . 10.970000000000001 112.18 177.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -118.13 92.43 42.54 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.444 -1.253 . . . . 13.52 110.682 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.65 -176.85 2.39 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.954 2.436 . . . . 12.279999999999999 109.583 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 85' ' ' ALA . 24.9 m -85.88 77.06 9.79 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.509 0.671 . . . . 13.44 109.564 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -97.96 -66.74 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.417 -0.811 . . . . 13.27 110.608 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.53 55.42 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.306 -0.861 . . . . 14.48 109.732 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -85.31 18.93 2.44 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.078 0.942 . . . . 14.92 111.459 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -133.28 109.06 9.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.267 -1.333 . . . . 14.25 108.282 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.87 120.52 81.17 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 109.637 -0.505 . . . . 12.970000000000001 109.637 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -77.32 99.26 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.445 2.097 . . . . 13.4 110.858 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.99 145.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.945 -1.131 . . . . 12.43 107.945 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -125.69 169.16 12.82 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.085 0.241 . . . . 13.449999999999999 110.352 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -148.82 92.03 1.94 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 123.318 0.386 . . . . 14.41 109.99 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.14 128.52 42.74 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.661 . . . . 11.68 109.214 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.66 55.25 5.12 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.315 2.677 . . . . 10.84 112.477 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.55 141.3 46.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.03 -0.73 . . . . 10.460000000000001 109.03 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.2 96.3 10.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.458 0.647 . . . . 10.58 109.304 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.2 m -148.86 147.7 29.02 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.89 -1.522 . . . . 11.039999999999999 106.89 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.94 118.43 65.8 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.626 -0.509 . . . . 10.880000000000001 109.626 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.35 36.05 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.134 2.556 . . . . 12.460000000000001 111.545 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.34 127.09 23.12 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.377 -0.971 . . . . 13.779999999999999 108.377 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.48 149.04 18.73 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.231 1.954 . . . . 11.949999999999999 111.909 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.93 2.47 86.61 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-N 115.852 -0.613 . . . . 11.48 112.396 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.5 -17.24 59.26 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.097 0.959 . . . . 11.550000000000001 111.018 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -69.31 -8.1 43.09 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.818 0.847 . . . . 12.59 112.361 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.08 -14.51 44.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.155 0.503 . . . . 11.24 109.935 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m 61.81 29.7 18.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.949 1.299 . . . . 10.050000000000001 112.71 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.67 65.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.818 -0.628 . . . . 11.220000000000001 110.813 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 110' ' ' ILE . 12.0 mm-40 -80.15 -40.19 27.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.6 -0.889 . . . . 11.380000000000001 108.6 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -55.33 -40.48 71.25 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 114.991 -1.004 . . . . 9.6500000000000004 111.225 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -60.32 -53.57 56.1 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.041 0.536 . . . . 10.43 110.106 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -56.88 -49.96 73.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.211 -0.904 . . . . 10.210000000000001 109.743 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.462 HG12 ' CE1' ' A' ' 156' ' ' PHE . 52.7 mt -53.35 -48.23 56.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.663 -0.699 . . . . 8.1300000000000008 110.974 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -47.17 -44.36 21.91 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.448 1.099 . . . . 8.4600000000000009 112.346 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 18.5 t70 -70.28 -50.42 39.68 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.738 -0.385 . . . . 10.859999999999999 111.216 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -62.77 -31.7 72.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.356 0.598 . . . . 11.449999999999999 111.558 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.5 -40.87 66.53 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.315 1.046 . . . . 7.6200000000000001 109.326 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.8 -47.15 61.0 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.693 -0.685 . . . . 11.619999999999999 111.076 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 10.8 pt20 -65.44 -32.71 74.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 11.630000000000001 111.474 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 p -71.65 -35.76 70.47 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.335 -0.546 . . . . 9.1400000000000006 110.604 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 138' ' ' LEU . 3.2 tm? -69.28 -45.22 70.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.053 -0.721 . . . . 10.06 109.053 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 -34.03 78.85 Favored Glycine 0 C--O 1.237 0.341 0 CA-C-N 116.202 -0.453 . . . . 12.07 111.999 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.13 -50.44 68.22 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.453 0.701 . . . . 12.32 109.516 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 148' ' ' TRP . 42.5 tp -69.67 -43.61 72.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.159 -0.928 . . . . 11.77 111.638 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 122' ' ' LEU . 10.6 tp -76.06 -24.3 55.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.358 0.503 . . . . 13.52 112.358 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 67.49 2.27 2.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.208 1.003 . . . . 16.559999999999999 111.109 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -156.95 155.91 32.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.278 -0.267 . . . . 15.74 110.278 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.85 114.48 65.24 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.481 -1.303 . . . . 14.199999999999999 107.481 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.22 -20.06 21.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.976 1.784 . . . . 14.18 110.782 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.96 -104.05 0.18 Allowed Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 108.482 -1.847 . . . . 14.029999999999999 108.482 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.84 11.37 0.75 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.136 0.493 . . . . 16.370000000000001 111.799 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp 67.48 119.29 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.59 1.556 . . . . 12.449999999999999 114.456 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -162.33 -72.69 0.05 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.525 -1.216 . . . . 14.43 110.556 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -128.58 -35.21 1.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.158 0.429 . . . . 14.32 112.158 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.93 81.07 1.7 Allowed Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.965 -0.854 . . . . 13.75 110.965 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.37 59.03 1.15 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.027 0.441 . . . . 12.699999999999999 110.947 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.466 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 17.6 tp60 -72.32 136.2 46.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.734 -1.58 . . . . 16.379999999999999 106.734 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.65 -31.02 63.97 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 124.216 1.006 . . . . 13.300000000000001 111.831 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.9 -31.24 72.06 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.247 0.546 . . . . 16.25 111.488 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 134' ' ' GLN . 26.7 m-20 -82.69 -22.11 34.66 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.194 -0.457 . . . . 15.869999999999999 110.165 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 31.4 mt -93.11 -28.04 16.57 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.867 -0.606 . . . . 13.65 110.235 -176.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.61 86.41 0.06 OUTLIER Glycine 0 C--N 1.31 -0.883 0 N-CA-C 109.817 -1.313 . . . . 14.16 109.817 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptp -71.22 -18.9 62.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.09 1.144 . . . . 15.449999999999999 114.09 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.26 150.61 22.37 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 118.99 -0.529 . . . . 13.630000000000001 111.313 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -53.34 -44.66 68.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 117.858 0.299 . . . . 13.9 111.649 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.94 -48.3 88.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 111.295 0.109 . . . . 13.81 111.295 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 p -60.22 -38.51 83.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.466 0.543 . . . . 11.48 112.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.79 22.97 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.783 -1.198 . . . . 10.35 111.897 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.6 m -65.02 -32.6 74.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.374 0.269 . . . . 12.199999999999999 110.851 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.97 -49.55 76.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.557 . . . . 11.859999999999999 109.926 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.444 ' HB2' HD22 ' A' ' 121' ' ' LEU . 19.9 t90 -71.76 -34.81 69.79 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.517 -0.765 . . . . 9.3200000000000003 111.142 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -45.59 92.65 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.469 -1.308 . . . . 9.5 107.469 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 154' ' ' ARG . 69.9 ttt180 -63.82 -43.03 97.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.861 -1.063 . . . . 13.91 109.659 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.09 -49.22 68.79 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 115.638 -0.71 . . . . 9.8800000000000008 113.296 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.57 -37.45 74.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 117.267 0.534 . . . . 9.2699999999999996 111.807 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.7 m -59.83 -43.84 94.35 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.955 0.159 . . . . 11.460000000000001 110.957 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 28.6 mtm180 -63.38 -45.36 91.45 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.561 -0.291 . . . . 15.039999999999999 110.624 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -53.97 -43.12 69.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.595 0.961 . . . . 11.82 113.595 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 110' ' ' ILE . 79.2 m-85 -102.97 4.89 37.94 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.238 -0.585 . . . . 11.970000000000001 111.681 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.5 m 53.95 44.06 29.94 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.237 1.015 . . . . 14.24 111.339 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.95 161.55 15.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.316 -0.856 . . . . 12.619999999999999 108.773 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -113.25 96.75 6.08 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.978 0.418 . . . . 16.390000000000001 110.34 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.49 149.51 27.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.649 -0.871 . . . . 12.32 108.649 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.33 134.99 42.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.713 -0.676 . . . . 14.06 111.926 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.75 -22.2 62.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 12.640000000000001 110.103 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.06 -17.55 61.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.55 -0.75 . . . . 15.68 110.194 175.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.556 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -72.7 -3.2 23.68 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 112.654 0.612 . . . . 12.720000000000001 112.654 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.5 pt -68.27 -13.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.748 0.785 . . . . 12.16 109.298 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -111.2 3.79 18.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.29 -0.868 . . . . 15.08 109.357 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 56.9 m -97.25 -38.55 9.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 14.67 108.66 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.2 m0 -102.32 115.58 64.29 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.784 -0.644 . . . . 12.68 109.631 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.29 -30.36 3.41 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.28 1.987 . . . . 14.34 113.185 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.9 p -128.99 170.89 12.91 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 109.585 -0.524 . . . . 12.91 109.585 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.42 -22.65 66.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.444 -0.344 . . . . 9.8900000000000006 111.061 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -61.79 -44.47 96.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.158 0.504 . . . . 12.5 110.423 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 5.7 m -61.02 -37.05 81.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.268 -0.878 . . . . 11.039999999999999 110.466 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.84 -42.25 58.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.191 -0.459 . . . . 8.5 110.558 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.09 83.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 7.7000000000000002 111.639 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 20.4 m-20 -79.27 -33.75 43.19 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.411 -0.516 . . . . 10.380000000000001 110.653 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.518 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 7.4 tp10 -61.69 -50.45 72.43 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.136 -0.483 . . . . 11.970000000000001 111.012 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 -41.69 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.729 -0.669 . . . . 9.8000000000000007 111.086 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.67 -41.51 97.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.791 0.436 . . . . 10.83 110.478 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 5.0 mmp_? -68.82 -31.33 70.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.638 -0.71 . . . . 13.5 111.089 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -78.09 -37.68 45.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.144 -0.48 . . . . 14.84 109.99 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.71 -59.85 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.931 -0.577 . . . . 13.35 109.661 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.135 0.897 . . . . 13.51 110.998 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 5' ' ' GLU . 8.8 m . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.526 0.203 . . . . 18.510000000000002 110.729 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 -58.46 0.05 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 122.518 0.327 . . . . 16.66 110.497 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -101.48 -64.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.119 -0.491 . . . . 14.84 111.439 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -53.83 -26.3 23.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.706 1.203 . . . . 14.98 112.987 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 1' ' ' VAL . 13.1 pt-20 -58.92 -32.71 69.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.369 0.507 . . . . 15.789999999999999 112.369 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 28.9 p -63.83 -37.32 86.94 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 120.103 -0.639 . . . . 12.02 110.441 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 -20.23 61.9 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.088 -0.506 . . . . 11.02 110.259 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.34 -53.08 6.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.995 -0.743 . . . . 16.07 108.995 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.71 -50.18 70.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 115.319 -0.855 . . . . 13.93 112.9 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 48' ' ' ILE . 55.6 mt -71.76 -25.7 62.14 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.263 -0.575 . . . . 10.710000000000001 111.395 -173.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -70.33 -40.44 74.15 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.041 -0.726 . . . . 14.02 109.041 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -65.63 -44.62 85.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.323 -0.853 . . . . 16.289999999999999 109.366 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 t -64.63 -33.77 76.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.742 -0.663 . . . . 12.91 110.693 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.22 -53.31 51.22 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.929 -1.137 . . . . 12.77 107.929 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -65.37 -33.64 76.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.872 -1.058 . . . . 15.19 111.541 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.84 -33.88 75.64 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.436 0.532 . . . . 16.260000000000002 112.436 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 44' ' ' TRP . 44.3 mtt -81.27 -21.86 39.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.923 -0.711 . . . . 15.449999999999999 111.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 84.2 mt -98.71 -7.34 27.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.175 0.512 . . . . 16.16 110.814 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 64.72 43.67 4.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.224 1.41 . . . . 20.559999999999999 111.742 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 6.6 p -126.83 169.91 12.74 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.637 -0.71 . . . . 16.629999999999999 111.182 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.09 127.67 78.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 123.061 0.544 . . . . 20.190000000000001 111.68 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 31.1 Cg_endo -65.5 -9.9 24.19 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.045 2.496 . . . . 16.600000000000001 112.314 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.9 -36.18 65.36 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.263 -1.135 . . . . 17.739999999999998 110.263 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -83.11 -37.57 23.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.997 -0.742 . . . . 20.23 108.997 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 22' ' ' PRO . 50.3 mm -76.38 92.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.828 -1.175 . . . . 15.98 107.828 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.71 155.77 26.59 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.036 -0.984 . . . . 19.329999999999998 110.291 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.35 -17.74 64.87 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 114.396 -1.275 . . . . 14.93 111.87 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.52 6.93 39.06 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 120.89 -0.672 . . . . 14.82 112.79 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 34' ' ' LEU . 66.2 m -68.97 160.81 30.19 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.851 0.834 . . . . 14.539999999999999 113.092 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 18.7 ttm180 -97.45 112.46 24.29 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.524 -1.216 . . . . 16.75 109.738 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -39.03 -60.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.831 1.252 . . . . 11.99 113.877 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 32' ' ' LEU . 2.5 mm? -61.63 -32.8 72.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 14.449999999999999 111.729 -174.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.64 -17.27 60.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.786 0.803 . . . . 16.440000000000001 110.729 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 29' ' ' SER . 94.4 mt -84.56 8.31 17.1 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.151 -0.477 . . . . 13.77 111.557 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.21 31.2 12.18 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.813 -0.915 . . . . 13.81 110.813 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.5 tt -108.8 135.67 49.64 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.81 -0.811 . . . . 13.039999999999999 108.81 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -123.2 164.02 19.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.572 -1.27 . . . . 15.67 107.572 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -49.54 -41.74 42.13 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.609 0.64 . . . . 15.289999999999999 111.756 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.57 -49.39 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.928 -0.578 . . . . 16.66 110.675 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.04 -35.72 75.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.996 -0.547 . . . . 14.140000000000001 110.438 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -60.38 -46.81 88.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 12.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.16 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.316 0.579 . . . . 13.970000000000001 110.999 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.14 -40.02 71.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.745 -0.661 . . . . 15.69 111.076 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 9.2 t90 -57.78 -45.53 85.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 124.278 1.031 . . . . 11.69 110.09 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 41' ' ' ALA . 40.3 mm -54.96 -39.34 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 114.935 -1.029 . . . . 11.16 110.072 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -57.43 -35.45 70.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.36 -0.836 . . . . 16.649999999999999 111.668 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 51' ' ' HIS . 24.5 tt0 -85.09 -35.72 21.63 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.037 -0.665 . . . . 14.15 110.787 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 56' ' ' ILE . 19.5 pt -68.57 -30.28 46.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 119.912 -0.715 . . . . 10.800000000000001 110.83 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.622 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 6.1 m-20 -63.69 -27.31 69.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.334 -0.848 . . . . 12.98 110.498 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -79.96 -46.32 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.177 -0.675 . . . . 17.52 109.177 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 20.8 m-70 -51.58 -56.56 12.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.303 -0.862 . . . . 14.869999999999999 112.899 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 97.0 m-85 -107.18 16.51 24.0 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.471 0.545 . . . . 12.199999999999999 112.471 -173.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 42.91 42.94 3.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.655 1.182 . . . . 16.710000000000001 112.523 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.24 140.57 52.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.831 -0.622 . . . . 12.199999999999999 109.325 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -81.19 72.05 8.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.253 -0.43 . . . . 16.059999999999999 110.216 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.622 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 18.2 mm -61.47 125.37 84.22 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-N 115.947 -0.57 . . . . 11.390000000000001 111.564 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 59.1 Cg_endo -77.27 125.82 8.05 Favored 'Trans proline' 0 N--CA 1.434 -1.985 0 C-N-CA 121.938 1.759 . . . . 12.6 108.671 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.51 -19.79 40.4 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.926 0.713 . . . . 12.52 112.926 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 57' ' ' PRO . 3.0 p30 -62.64 -16.76 58.37 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.171 0.804 . . . . 14.140000000000001 113.171 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.23 78.71 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 120.847 -0.692 . . . . 10.76 114.566 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.45 -34.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.496 0.665 . . . . 11.0 111.55 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -73.55 -28.0 61.63 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.202 -0.666 . . . . 16.420000000000002 109.202 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 m -83.13 -43.52 16.12 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.229 -0.896 . . . . 13.35 110.078 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.2 94.31 48.04 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.278 -0.419 . . . . 12.23 110.31 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 93.7 Cg_endo -83.65 4.34 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.62 2.214 . . . . 13.06 112.705 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.38 120.61 62.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.642 -1.614 . . . . 12.949999999999999 106.642 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -56.09 -44.69 79.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.835 -1.075 . . . . 10.92 113.488 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -71.71 -21.33 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.442 0.639 . . . . 14.32 110.784 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.91 -31.7 22.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.662 0.744 . . . . 10.93 109.348 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.51 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 48.3 t80 -71.85 -34.11 68.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.388 -0.824 . . . . 8.8100000000000005 111.455 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 p -65.03 -24.32 67.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.141 0.496 . . . . 9.3499999999999996 111.569 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -74.06 -39.76 63.27 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.175 -1.046 . . . . 11.630000000000001 108.175 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 59.7 t90 -59.83 -45.91 90.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.583 -1.19 . . . . 10.550000000000001 109.246 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.91 -45.38 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 8.3000000000000007 109.966 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.83 84.96 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.603 -0.726 . . . . 9.5800000000000001 114.365 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -71.68 -16.4 62.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 10.23 112.452 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -93.29 -26.48 17.3 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.39 -0.368 . . . . 10.43 110.489 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.64 -41.61 87.99 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.943 -0.571 . . . . 10.970000000000001 109.915 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -131.76 119.05 16.91 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-N 116.154 -0.476 . . . . 13.52 109.856 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.13 84.74 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.335 2.024 . . . . 12.279999999999999 110.021 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.0 t -70.33 -14.84 62.75 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.928 -0.578 . . . . 13.44 110.748 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -94.09 14.48 19.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.187 -0.461 . . . . 13.27 111.764 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.96 -23.1 61.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.528 0.68 . . . . 14.48 109.961 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 91' ' ' GLU . 15.3 t -156.78 157.43 35.02 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.26 -1.756 . . . . 14.92 106.26 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.63 40.75 7.72 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 124.212 0.945 . . . . 14.25 110.692 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 91' ' ' GLU . . . -78.99 131.29 67.25 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.77 -0.826 . . . . 12.970000000000001 108.77 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.35 43.76 1.38 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.961 2.441 . . . . 13.4 112.929 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.3 p -146.91 56.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 122.375 1.083 . . . . 12.43 109.586 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 74.66 -59.22 0.56 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.277 1.431 . . . . 13.449999999999999 112.008 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -137.09 157.3 47.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.538 -0.912 . . . . 14.41 108.538 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . 1.7 pm0 -83.21 141.22 42.75 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 108.741 -0.837 . . . . 11.68 108.741 172.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 8.2 Cg_exo -72.53 68.58 3.57 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.731 2.287 . . . . 10.84 111.268 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.9 124.72 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 CA-C-N 114.776 -1.102 . . . . 10.460000000000001 109.488 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.24 60.59 1.22 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.404 -1.332 . . . . 10.58 107.404 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 m 73.77 133.49 0.05 OUTLIER 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.599 -1.637 . . . . 11.039999999999999 110.033 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.72 125.92 83.44 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 115.574 -0.739 . . . . 10.880000000000001 109.882 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.87 -36.21 97.33 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.46 2.773 . . . . 12.460000000000001 110.821 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 54.0 tt0 -124.27 126.98 25.43 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 106.245 -1.761 . . . . 13.779999999999999 106.245 173.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 2.9 Cg_exo -75.2 33.07 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.827 2.351 . . . . 11.949999999999999 113.555 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 24.91 9.17 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.112 -1.195 . . . . 11.48 110.112 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.73 -25.37 60.16 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.986 0.422 . . . . 11.550000000000001 110.655 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.52 116.39 9.87 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.966 -0.753 . . . . 12.59 108.966 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.27 -28.06 56.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.873 -0.603 . . . . 11.24 109.503 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -88.78 81.59 6.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.442 -0.948 . . . . 10.050000000000001 108.442 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.72 -28.66 70.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.173 -0.921 . . . . 11.220000000000001 112.725 -174.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.486 ' O ' HG13 ' A' ' 110' ' ' ILE . 48.3 tp60 -61.03 -20.92 63.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.027 0.531 . . . . 11.380000000000001 111.592 -176.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.05 -31.08 61.2 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.844 0.312 . . . . 9.6500000000000004 111.844 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 40.1 tt0 -71.88 -43.69 65.0 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.132 0.491 . . . . 10.43 109.984 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -62.48 -21.53 65.54 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.998 -0.546 . . . . 10.210000000000001 111.812 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.564 HG21 HG11 ' A' ' 178' ' ' VAL . 55.3 mt -67.07 -54.68 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 108.704 -0.85 . . . . 8.1300000000000008 108.704 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 13.7 pt20 -64.37 -29.31 70.38 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.937 -0.574 . . . . 8.4600000000000009 111.751 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.66 -52.2 64.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.618 -0.512 . . . . 10.859999999999999 109.618 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -69.41 -37.4 77.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 11.449999999999999 110.489 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 171' ' ' LEU . 6.3 tt -61.28 -42.27 98.36 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.526 -0.916 . . . . 7.6200000000000001 108.526 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.1 -47.2 87.38 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.596 -0.729 . . . . 11.619999999999999 109.404 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -57.05 -50.37 72.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 11.630000000000001 111.705 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.5 m -69.14 -30.45 68.7 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.717 0.266 . . . . 9.1400000000000006 111.717 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 47.7 tp -68.96 -49.23 59.8 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 108.707 -0.849 . . . . 10.06 108.707 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.32 -22.03 68.93 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.707 -0.759 . . . . 12.07 112.534 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.08 -52.8 8.2 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 122.538 -0.389 . . . . 12.32 110.756 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.56 -18.11 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.732 0.641 . . . . 11.77 112.732 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' LEU . 4.4 mm? -113.42 3.01 15.63 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.035 0.445 . . . . 13.52 110.83 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 70.45 -29.8 0.19 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 16.559999999999999 115.596 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.8 tp -136.0 148.76 48.56 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.593 -0.692 . . . . 15.74 111.365 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -84.44 124.25 73.79 Favored Pre-proline 0 CA--C 1.505 -0.784 0 N-CA-C 107.148 -1.427 . . . . 14.199999999999999 107.148 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB3' HD11 ' A' ' 138' ' ' LEU . 72.9 Cg_endo -79.17 -16.31 12.38 Favored 'Trans proline' 0 C--N 1.33 -0.446 0 C-N-CA 121.848 1.699 . . . . 14.18 113.08 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.15 6.65 87.66 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 110.575 -1.01 . . . . 14.029999999999999 110.575 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 16.1 mm100 -99.72 33.22 2.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.666 0.746 . . . . 16.370000000000001 110.603 -174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 68.2 mt -73.34 103.37 4.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.881 -1.054 . . . . 12.449999999999999 108.539 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 10.2 mmm180 79.23 1.27 2.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.214 1.406 . . . . 14.43 111.424 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -89.04 -25.35 22.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.604 0.716 . . . . 14.32 109.338 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 157.49 -91.8 0.12 Allowed Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.248 -1.141 . . . . 13.75 110.248 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 128' ' ' GLN . . . 63.45 90.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.862 1.265 . . . . 12.699999999999999 112.092 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -97.49 136.56 37.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.721 -0.844 . . . . 16.379999999999999 108.721 175.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 140' ' ' MET . 19.4 p90 -47.55 -36.45 10.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.21 1.404 . . . . 13.300000000000001 114.063 -170.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.29 -40.65 96.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.954 0.502 . . . . 16.25 110.926 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.48 -35.27 75.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.009 -0.541 . . . . 15.869999999999999 110.434 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 126' ' ' PRO . 4.0 mm? -72.98 -19.52 61.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 13.65 112.076 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.87 20.48 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.439 -1.065 . . . . 14.16 110.439 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.438 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . 43.7 ttm -85.98 129.03 34.96 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.547 -0.908 . . . . 15.449999999999999 108.547 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.03 176.09 6.93 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.136 -1.061 . . . . 13.630000000000001 108.136 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' ' OH ' ' A' ' 166' ' ' TYR . 38.6 m -73.73 -48.06 34.72 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.4 -0.92 . . . . 13.9 109.697 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.19 -48.08 88.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 112.012 0.375 . . . . 13.81 112.012 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 p -67.6 -33.93 75.99 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.913 0.387 . . . . 11.48 111.757 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 -25.5 61.86 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 119.971 -1.109 . . . . 10.35 111.116 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.3 m -64.91 -48.34 74.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 12.199999999999999 108.705 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -57.13 -53.59 56.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.891 -1.05 . . . . 11.859999999999999 109.993 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -53.0 -53.98 42.01 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 9.3200000000000003 112.743 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 3.5 tpt -54.76 -54.08 46.66 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.153 0.581 . . . . 9.5 111.425 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . 75.0 ttt180 -64.62 -37.23 86.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.966 0.413 . . . . 13.91 110.185 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.38 27.89 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.473 -0.785 . . . . 9.8800000000000008 112.649 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.88 -42.79 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.512 0.325 . . . . 9.2699999999999996 111.007 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 25.3 m -58.5 -57.15 14.2 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.837 -0.62 . . . . 11.460000000000001 110.847 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -64.2 -35.62 81.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.637 -0.71 . . . . 15.039999999999999 111.352 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -76.59 -14.84 59.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.036 0.384 . . . . 11.82 112.036 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CZ ' HG12 ' A' ' 110' ' ' ILE . 86.1 t80 -95.68 -70.31 0.72 Allowed 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 119.132 -1.027 . . . . 11.970000000000001 111.081 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.9 m -178.74 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.79 0.436 . . . . 14.24 112.138 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 27.7 pt -98.84 142.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.268 0.556 . . . . 12.619999999999999 111.796 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -91.78 95.75 10.03 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.748 0.785 . . . . 16.390000000000001 109.632 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 87.2 mt -101.01 151.23 22.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.288 -0.869 . . . . 12.32 109.25 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.91 45.81 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.393 -1.276 . . . . 14.06 108.763 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 150' ' ' ARG . . . -66.17 -21.18 66.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.444 0.64 . . . . 12.640000000000001 110.204 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -82.08 2.94 28.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 15.68 111.009 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.72 61.17 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.905 -0.497 . . . . 12.720000000000001 111.685 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.4 pt -67.38 -10.97 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.261 0.553 . . . . 12.16 110.446 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 142' ' ' SER . 27.3 m-85 -106.57 -1.47 22.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 15.08 109.164 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -89.22 -47.0 8.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.106 -0.701 . . . . 14.67 109.106 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.34 141.09 24.79 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 109.223 -0.658 . . . . 12.68 109.223 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 40.5 Cg_endo -97.21 2.26 1.66 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.377 2.051 . . . . 14.34 114.429 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -120.13 144.34 47.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.455 0.909 . . . . 12.91 113.455 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 114' ' ' LEU . 4.5 mm? -63.48 -30.39 71.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.303 -1.317 . . . . 9.8900000000000006 112.339 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 56.8 mtpt -58.37 -40.1 81.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.534 -0.757 . . . . 12.5 110.674 176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -39.59 93.13 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.319 -0.855 . . . . 11.039999999999999 110.844 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.55 -50.38 65.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.216 -1.031 . . . . 8.5 108.216 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.04 -32.32 69.65 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.754 0.65 . . . . 7.7000000000000002 112.754 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.48 -34.2 31.5 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.523 -0.471 . . . . 10.380000000000001 111.033 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.98 -47.42 68.61 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.963 0.905 . . . . 11.970000000000001 110.118 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -57.21 -44.29 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.309 -0.86 . . . . 9.8000000000000007 112.277 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -57.51 -39.45 76.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.023 0.44 . . . . 10.83 111.627 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -80.92 -23.84 38.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.836 -0.62 . . . . 13.5 110.678 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -84.2 -38.67 20.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 14.84 110.276 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 178' ' ' VAL . 75.3 t -62.59 -41.78 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.843 -0.617 . . . . 13.35 111.604 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 . . . . . 0 N--CA 1.434 -1.229 0 C-N-CA 120.586 -0.446 . . . . 13.51 111.271 -177.332 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 110.592 -0.151 . . . . 18.510000000000002 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.75 -58.19 2.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.013 -0.43 . . . . 16.66 109.906 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -71.38 -49.87 37.77 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.398 0.618 . . . . 14.84 109.669 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -70.25 -19.76 63.11 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.793 -1.094 . . . . 14.98 111.42 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.47 -49.27 62.1 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.021 0.928 . . . . 15.789999999999999 112.154 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' HG11 ' A' ' 74' ' ' VAL . 52.6 t -61.46 -48.06 82.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 123.467 0.48 . . . . 12.02 111.535 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.7 92.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.614 -0.267 . . . . 11.02 110.759 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -61.72 -46.52 89.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 123.291 0.369 . . . . 16.07 111.378 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 77.8 t80 -67.96 -33.52 74.81 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.597 -0.274 . . . . 13.93 110.753 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.93 -40.73 75.36 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 120.354 -0.538 . . . . 10.710000000000001 110.229 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -59.4 -45.39 91.61 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.795 -0.446 . . . . 14.02 109.795 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.5 -54.47 46.5 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.488 1.115 . . . . 16.289999999999999 111.455 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.7 p -68.18 -35.32 77.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.215 -0.448 . . . . 12.91 111.238 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.41 HD11 HD21 ' A' ' 34' ' ' LEU . 6.9 tt -63.13 -52.56 62.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 12.77 108.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.04 91.06 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.978 -0.555 . . . . 15.19 111.125 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -49.23 71.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.455 0.539 . . . . 16.260000000000002 112.455 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.8 mmm -76.66 -36.79 57.13 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.743 0.646 . . . . 15.449999999999999 112.743 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.84 -5.83 58.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.989 0.424 . . . . 16.16 111.71 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 61.04 39.51 16.23 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.767 1.27 . . . . 20.559999999999999 110.614 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 t -111.79 -173.56 2.27 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 113.135 -1.848 . . . . 16.629999999999999 107.553 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.0 136.92 29.16 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.847 -0.797 . . . . 20.190000000000001 108.847 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.1 -19.96 19.65 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.68 2.253 . . . . 16.600000000000001 113.182 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.65 -45.42 4.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.704 -0.958 . . . . 17.739999999999998 110.704 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.46 75.03 9.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.351 0.596 . . . . 20.23 110.748 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -147.54 144.96 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.744 -0.835 . . . . 15.98 108.744 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -88.42 131.23 34.95 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 107.536 -1.283 . . . . 19.329999999999998 107.536 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.58 -15.89 63.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 112.381 0.512 . . . . 14.93 112.381 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.21 7.67 54.67 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-N 116.154 -0.476 . . . . 14.82 112.019 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 p -69.0 133.42 48.11 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.817 0.818 . . . . 14.539999999999999 111.324 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 16.5 mtp180 -84.05 140.63 31.71 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.92 -1.037 . . . . 16.75 110.371 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 76.3 m-85 -43.75 -48.35 8.03 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 113.617 0.969 . . . . 11.99 113.617 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.87 -15.15 63.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.217 0.451 . . . . 14.449999999999999 112.217 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.1 -39.03 9.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.211 -1.403 . . . . 16.440000000000001 107.211 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 14' ' ' LEU . 37.2 tp -61.02 -29.17 69.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.058 -1.883 . . . . 13.77 111.581 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.05 6.93 1.39 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.273 -1.441 . . . . 13.81 113.924 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 36' ' ' LEU . 18.9 mt -84.61 151.42 24.51 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 119.133 -1.027 . . . . 13.039999999999999 112.667 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.47 159.89 42.0 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 112.375 -2.193 . . . . 15.67 105.709 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -50.51 -48.52 56.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.821 1.045 . . . . 15.289999999999999 113.821 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.29 -46.89 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.479 0.657 . . . . 16.66 110.613 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.35 -37.87 72.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.011 -0.54 . . . . 14.140000000000001 110.363 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 -42.19 84.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.607 -0.724 . . . . 12.0 110.19 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.02 84.7 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.247 -0.888 . . . . 13.970000000000001 110.93 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -65.66 -47.74 74.51 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.415 -0.812 . . . . 15.69 110.88 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -66.03 -52.1 52.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.874 1.269 . . . . 11.69 111.818 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.24 -37.16 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.297 0.48 . . . . 11.16 112.297 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -66.39 -40.37 89.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.517 -0.473 . . . . 16.649999999999999 110.13 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.48 -24.6 64.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 111.828 0.307 . . . . 14.15 111.828 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.2 -55.72 17.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.29 -0.633 . . . . 10.800000000000001 109.29 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.428 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 3.3 m-20 -63.31 -34.5 77.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 12.98 112.156 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.43 -47.29 17.83 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.476 -0.329 . . . . 17.52 111.857 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -70.66 -40.29 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 112.822 0.675 . . . . 14.869999999999999 112.822 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 9' ' ' PHE . 81.2 m-85 -91.42 -8.13 48.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.786 -0.765 . . . . 12.199999999999999 113.02 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 53.98 41.46 32.02 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.959 1.304 . . . . 16.710000000000001 109.486 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 tp -115.87 143.47 45.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.737 -0.665 . . . . 12.199999999999999 110.942 -170.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -69.76 76.06 0.44 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.491 -0.777 . . . . 16.059999999999999 110.861 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.428 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 21.7 mm -98.66 113.86 64.77 Favored Pre-proline 0 C--N 1.316 -0.881 0 O-C-N 121.8 -0.563 . . . . 11.390000000000001 110.566 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.6 140.46 93.87 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.478 2.119 . . . . 12.6 109.91 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.89 2.33 1.48 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.289 0.848 . . . . 12.52 113.289 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.4 0.03 41.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 118.961 -0.542 . . . . 14.140000000000001 112.163 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.72 ' HA2' ' CZ3' ' A' ' 73' ' ' TRP . . . -43.73 -60.92 3.15 Favored Glycine 0 C--N 1.356 1.667 0 N-CA-C 114.758 0.663 . . . . 10.76 114.758 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.92 -21.7 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.889 1.276 . . . . 11.0 112.019 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -93.33 -40.38 10.44 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.209 -0.451 . . . . 16.420000000000002 111.064 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.4 m -73.86 -40.38 63.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.396 -0.366 . . . . 13.35 110.956 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HE3' ' A' ' 73' ' ' TRP . 96.2 m-85 -112.56 103.1 55.35 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.098 -1.075 . . . . 12.23 108.098 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 95.8 Cg_endo -79.55 -0.27 10.58 Favored 'Trans proline' 0 C--O 1.209 -0.949 0 C-N-CA 122.311 2.007 . . . . 13.06 112.529 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.59 119.86 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.757 -1.572 . . . . 12.949999999999999 106.757 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 21.9 p90 -57.12 -36.48 70.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.411 0.684 . . . . 10.92 112.529 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -63.77 -31.03 72.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.519 0.727 . . . . 14.32 110.424 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.05 26.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.103 0.478 . . . . 10.93 110.262 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 46.1 t80 -77.39 -30.57 53.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.934 -0.575 . . . . 8.8100000000000005 111.343 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p -67.26 -24.57 65.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.59 0.71 . . . . 9.3499999999999996 110.309 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -76.93 -28.66 55.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.608 -0.724 . . . . 11.630000000000001 109.404 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.72 ' CZ3' ' HA2' ' A' ' 60' ' ' GLY . 1.6 t90 -56.86 -55.24 36.98 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 108.56 -0.904 . . . . 10.550000000000001 108.56 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 6' ' ' CYS . 71.5 t -65.8 -43.61 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 CA-C-N 115.132 -0.94 . . . . 8.3000000000000007 110.188 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.01 -34.67 73.23 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.615 0.572 . . . . 9.5800000000000001 112.459 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.5 m -72.91 -37.28 67.3 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 122.926 0.49 . . . . 10.23 111.377 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.72 -14.73 60.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.384 . . . . 10.43 112.038 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.43 137.3 32.86 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.943 -1.132 . . . . 10.970000000000001 107.943 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.8 139.94 37.63 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 108.991 -0.744 . . . . 13.52 108.991 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -66.87 105.67 0.99 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.549 1.499 . . . . 12.279999999999999 108.438 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -80.15 69.87 6.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.059 1.409 . . . . 13.44 111.175 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -85.91 127.95 34.72 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 113.961 -1.472 . . . . 13.27 107.105 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.8 -24.43 63.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.57 0.7 . . . . 14.48 110.058 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 p -97.15 35.68 1.55 Allowed 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.218 -0.901 . . . . 14.92 110.952 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.22 36.98 4.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.885 -0.598 . . . . 14.25 109.749 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.17 138.85 89.71 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.121 -0.945 . . . . 12.970000000000001 109.697 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.31 68.15 6.06 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.849 2.366 . . . . 13.4 112.817 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -86.92 94.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 107.812 -1.181 . . . . 12.43 107.812 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -122.26 -175.57 3.16 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.076 -0.965 . . . . 13.449999999999999 110.357 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 67.2 94.65 0.07 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.201 1.401 . . . . 14.41 112.039 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -81.73 130.18 62.19 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.743 -1.206 . . . . 11.68 107.743 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.8 133.46 42.04 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.202 1.935 . . . . 10.84 110.924 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.16 127.88 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.036 -0.357 . . . . 10.460000000000001 110.036 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.84 60.36 1.2 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.854 0.835 . . . . 10.58 108.851 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.0 m -99.17 146.63 25.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.774 -0.825 . . . . 11.039999999999999 108.774 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 73.36 96.67 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 124.997 1.319 . . . . 10.880000000000001 111.738 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.36 -44.07 52.32 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.621 2.881 . . . . 12.460000000000001 111.568 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -116.46 89.09 26.02 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 107.335 -1.358 . . . . 13.779999999999999 107.335 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.1 157.12 23.36 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 121.919 1.746 . . . . 11.949999999999999 111.17 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.07 -172.47 17.86 Favored Glycine 0 N--CA 1.424 -2.153 0 C-N-CA 120.924 -0.655 . . . . 11.48 111.617 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.15 -23.47 51.65 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.391 0.615 . . . . 11.550000000000001 110.178 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -82.29 82.01 7.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.19 -1.411 . . . . 12.59 107.19 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.84 -5.88 54.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.98 -1.009 . . . . 11.24 111.97 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m -76.91 59.24 1.6 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.525 0.679 . . . . 10.050000000000001 109.797 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.56 -49.2 73.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.947 1.299 . . . . 11.220000000000001 112.689 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt-30 -58.95 -58.65 7.71 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.24 0.337 . . . . 11.380000000000001 110.277 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 60.0 ttp180 -55.76 -50.33 70.71 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.877 0.736 . . . . 9.6500000000000004 111.71 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.15 -41.06 95.1 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.349 0.406 . . . . 10.43 111.973 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -70.39 -42.54 71.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.323 -0.551 . . . . 10.210000000000001 111.185 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.517 HG21 HG11 ' A' ' 178' ' ' VAL . 92.4 mt -58.76 -52.96 53.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.944 0 N-CA-C 109.322 -0.621 . . . . 8.1300000000000008 109.322 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -49.31 -49.0 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.353 1.033 . . . . 8.4600000000000009 112.688 -175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 34.2 t70 -68.0 -44.82 75.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.81 -0.356 . . . . 10.859999999999999 111.872 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -70.16 -35.26 73.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.069 0.396 . . . . 11.449999999999999 112.069 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.86 -41.34 97.81 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.724 0.809 . . . . 7.6200000000000001 109.464 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -61.56 -46.43 89.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 11.619999999999999 109.219 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 80.1 mt-30 -57.88 -49.88 75.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.02 -0.536 . . . . 11.630000000000001 110.8 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -57.24 -45.3 84.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 124.183 0.927 . . . . 9.1400000000000006 110.97 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.06 -49.9 75.82 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.972 0.17 . . . . 10.06 110.962 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.94 97.83 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 121.252 -0.499 . . . . 12.07 112.129 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.99 -45.94 91.41 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.316 1.046 . . . . 12.32 111.131 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 148' ' ' TRP . 26.9 tp -72.29 -43.93 63.5 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.137 -0.938 . . . . 11.77 111.26 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.9 tp -82.25 -11.72 58.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.792 -0.64 . . . . 13.52 111.619 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 66.89 32.81 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.525 1.13 . . . . 16.559999999999999 109.845 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 tp -99.54 140.21 34.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.117 -0.947 . . . . 15.74 108.609 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 5.8 m-20 -64.11 124.72 86.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 108.744 -0.835 . . . . 14.199999999999999 108.744 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 41.4 Cg_exo -57.18 -17.91 27.53 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.36 2.707 . . . . 14.18 114.029 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -75.04 -13.71 82.44 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 120.47 -0.872 . . . . 14.029999999999999 111.672 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -86.4 -21.56 27.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.312 -0.625 . . . . 16.370000000000001 109.312 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.28 69.9 5.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.127 -0.942 . . . . 12.449999999999999 110.606 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -160.37 -61.15 0.06 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.312 -1.736 . . . . 14.43 106.312 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.4 m -83.78 -31.84 25.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.974 -0.75 . . . . 14.32 108.974 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.81 1.04 Allowed Glycine 0 C--O 1.215 -1.067 0 N-CA-C 110.786 -0.925 . . . . 13.75 110.786 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.72 34.6 2.93 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.297 -1.371 . . . . 12.699999999999999 107.297 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.5 tt0 -123.25 123.68 41.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.522 -1.672 . . . . 16.379999999999999 108.071 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -57.9 -35.72 71.42 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 124.107 0.963 . . . . 13.300000000000001 110.344 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.74 -28.61 66.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.103 -0.953 . . . . 16.25 111.277 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -25.66 28.01 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.766 0.793 . . . . 15.869999999999999 110.469 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 79.5 mt -79.19 -11.06 59.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.31 -0.859 . . . . 13.65 111.011 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.07 -135.08 9.81 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.918 -1.673 . . . . 14.16 108.918 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 165' ' ' ILE . 43.3 tpp -176.41 92.08 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.145 -0.687 . . . . 15.449999999999999 109.145 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -134.38 126.39 29.5 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.029 0.442 . . . . 13.630000000000001 111.211 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.0 m -80.41 -21.84 41.85 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.733 -0.667 . . . . 13.9 111.646 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.0 -58.64 6.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 120.464 0.173 . . . . 13.81 111.124 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.5 t -71.82 -28.96 63.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.414 -0.587 . . . . 11.48 109.414 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.16 -43.95 88.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.427 -0.806 . . . . 10.35 112.601 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -62.81 -45.34 93.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.59 -0.522 . . . . 12.199999999999999 109.59 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.91 -49.97 74.07 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.568 -0.742 . . . . 11.859999999999999 111.372 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.486 ' O ' HG23 ' A' ' 152' ' ' VAL . 19.4 t90 -63.89 -51.52 64.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.815 -0.63 . . . . 9.3200000000000003 111.431 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 161' ' ' ALA . 42.0 tpp -63.61 -40.76 97.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.03 0.206 . . . . 9.5 110.959 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -60.45 -41.82 94.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.61 -0.515 . . . . 13.91 109.61 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.83 -45.91 95.23 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.757 -0.656 . . . . 9.8800000000000008 111.82 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 148' ' ' TRP . 56.0 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.832 -0.433 . . . . 9.2699999999999996 109.832 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 23.8 m -61.63 -51.68 67.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 11.460000000000001 110.8 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -65.01 -40.1 94.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.604 -0.725 . . . . 15.039999999999999 111.151 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -55.89 -46.64 78.28 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.424 0.69 . . . . 11.82 111.117 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -101.54 11.58 38.76 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.73 -0.388 . . . . 11.970000000000001 111.929 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 p 51.4 50.72 18.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.831 1.252 . . . . 14.24 113.107 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.3 pt -127.62 167.42 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.812 -0.631 . . . . 12.619999999999999 109.575 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -102.85 111.83 24.34 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.433 -0.348 . . . . 16.390000000000001 110.941 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 85.7 mt -129.98 154.28 47.54 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 106.886 -1.524 . . . . 12.32 106.886 173.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -95.59 138.89 32.63 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.467 0.651 . . . . 14.06 110.825 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.21 -24.09 66.55 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.265 -0.879 . . . . 12.640000000000001 111.726 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.59 17.82 6.03 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.007 0.432 . . . . 15.68 110.489 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.93 -3.76 27.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.205 0.817 . . . . 12.720000000000001 113.205 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.558 HD12 ' SD ' ' A' ' 140' ' ' MET . 26.0 pt -67.93 -12.34 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.628 0.728 . . . . 12.16 110.211 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -108.39 -2.21 19.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.862 -1.063 . . . . 15.08 108.72 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.9 m -101.97 -45.19 5.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.589 -0.732 . . . . 14.67 110.252 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 174' ' ' LEU . 5.3 m0 -111.7 118.24 47.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.433 -0.951 . . . . 12.68 108.433 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.11 -29.86 9.44 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.22 1.947 . . . . 14.34 112.261 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 24.2 p -134.58 153.91 51.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.551 0.691 . . . . 12.91 110.321 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -14.5 51.54 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.078 -0.965 . . . . 9.8900000000000006 113.233 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -43.39 92.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.171 -0.677 . . . . 12.5 109.171 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.5 m -62.68 -41.73 99.24 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.133 -0.939 . . . . 11.039999999999999 110.365 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.554 HD13 ' CZ3' ' A' ' 168' ' ' TRP . 36.3 tp -68.89 -43.94 74.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.313 -0.403 . . . . 8.5 110.823 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 107' ' ' ARG . . . -57.67 -39.67 77.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 7.7000000000000002 111.459 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 16.8 t70 -79.24 -36.12 40.47 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.675 -0.81 . . . . 10.380000000000001 110.546 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 14.0 tp10 -64.27 -44.53 91.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.168 -0.469 . . . . 11.970000000000001 111.604 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 110' ' ' ILE . 10.1 p -55.59 -39.77 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.316 0.385 . . . . 9.8000000000000007 111.282 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 106' ' ' GLN . 33.7 t70 -69.5 -34.48 74.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 10.83 110.55 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 29.9 mmt180 -72.93 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 13.5 109.95 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.8 mmt180 -83.38 -33.59 25.76 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.319 -0.623 . . . . 14.84 109.319 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 178' ' ' VAL . 85.0 t -74.53 -51.17 23.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 116.008 -0.542 . . . . 13.35 111.298 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 119.576 -0.25 . . . . 13.51 111.157 -178.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 120.598 0.237 . . . . 18.510000000000002 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.45 -80.29 0.5 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.352 -0.61 . . . . 16.66 109.352 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -73.92 -17.51 61.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.505 0.669 . . . . 14.84 109.6 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.99 -27.45 63.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.477 -0.783 . . . . 14.98 109.808 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.92 -32.15 51.48 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.997 -0.681 . . . . 15.789999999999999 109.691 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.41 -35.93 70.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.941 -0.572 . . . . 12.02 109.882 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.644 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -62.95 -49.02 76.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.275 -0.639 . . . . 11.02 109.275 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -54.59 -45.6 73.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.893 . . . . 16.07 111.139 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . 76.0 t80 -63.4 -36.22 83.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.69 0.619 . . . . 13.93 110.75 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.18 -38.37 72.13 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.352 -0.385 . . . . 10.710000000000001 110.33 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 30.7 mtp180 -63.21 -50.66 69.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.695 -0.483 . . . . 14.02 109.695 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 19.7 pt20 -64.49 -27.43 68.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.93 -0.577 . . . . 16.289999999999999 111.829 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.1 m -83.03 -44.27 15.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.241 0.544 . . . . 12.91 110.338 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.36 -41.62 93.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 12.77 111.509 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.947 0.351 . . . . 15.19 111.947 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 -30.04 68.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.529 0.68 . . . . 16.260000000000002 109.763 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.7 mtt -83.65 -34.44 25.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 15.449999999999999 109.764 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.43 0.44 54.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.735 -0.666 . . . . 16.16 111.217 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.6 t80 59.39 46.74 12.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.462 1.505 . . . . 20.559999999999999 110.668 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.63 -176.88 4.92 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.505 -0.77 . . . . 16.629999999999999 109.032 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -109.51 140.3 21.98 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.237 -1.023 . . . . 20.190000000000001 108.237 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.75 -23.06 70.46 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.729 2.953 . . . . 16.600000000000001 113.838 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.74 -6.81 85.56 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.459 -0.877 . . . . 17.739999999999998 112.467 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -109.94 16.48 21.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.798 0.666 . . . . 20.23 112.798 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.495 ' HB ' HD22 ' A' ' 34' ' ' LEU . 41.0 pt -106.04 157.37 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 119.366 -0.934 . . . . 15.98 109.904 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 27.2 mmt180 -101.65 94.77 6.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.185 -0.672 . . . . 19.329999999999998 109.185 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.81 -22.2 57.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.04 0.936 . . . . 14.93 113.119 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.62 6.51 77.44 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.573 -0.822 . . . . 14.82 112.936 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 57.6 p -115.25 171.03 7.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.337 -0.545 . . . . 14.539999999999999 112.38 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 28.7 mtm180 -62.12 147.75 46.51 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.649 0.78 . . . . 16.75 112.277 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -58.44 -32.61 68.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.283 1.033 . . . . 11.99 111.141 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.82 -25.24 67.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.669 -0.696 . . . . 14.449999999999999 110.376 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.88 -28.97 27.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.441 -0.577 . . . . 16.440000000000001 109.441 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -63.23 -31.74 72.97 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 13.77 110.823 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.31 -0.39 4.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.865 -1.16 . . . . 13.81 113.57 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -99.93 168.39 9.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 117.616 0.708 . . . . 13.039999999999999 111.438 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -128.07 161.08 30.05 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.095 . . . . 15.67 108.045 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.154 1.168 . . . . 15.289999999999999 114.154 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.67 -41.18 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.115 0.483 . . . . 16.66 110.569 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.31 -36.37 74.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.314 0.578 . . . . 14.140000000000001 110.258 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.38 72.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.334 -0.848 . . . . 12.0 110.427 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.58 -30.66 71.69 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.314 -0.857 . . . . 13.970000000000001 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.99 -40.69 27.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.506 0.669 . . . . 15.69 110.24 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -62.29 -45.74 91.9 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.582 -1.19 . . . . 11.69 111.5 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tp -59.19 -31.92 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 111.863 0.32 . . . . 11.16 111.863 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 34.2 mmt180 -60.96 -50.01 75.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.804 0.335 . . . . 16.649999999999999 110.345 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -27.33 64.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.327 -0.549 . . . . 14.15 112.027 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.8 -47.45 92.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.093 -1.077 . . . . 10.800000000000001 108.093 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.13 -37.89 75.46 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.092 -0.958 . . . . 12.98 111.196 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -84.63 -47.22 10.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.788 0.328 . . . . 17.52 111.789 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.72 -35.43 77.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 116.384 -0.371 . . . . 14.869999999999999 111.655 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.04 -2.48 37.09 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.346 0.593 . . . . 12.199999999999999 112.179 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 48.6 47.22 20.79 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.502 1.521 . . . . 16.710000000000001 110.066 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -124.9 127.29 46.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.893 -1.049 . . . . 12.199999999999999 109.15 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.02 53.57 2.48 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 113.579 0.955 . . . . 16.059999999999999 113.579 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.0 mm -70.68 117.99 60.74 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.386 -0.598 . . . . 11.390000000000001 109.386 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.4 151.84 65.65 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.912 1.741 . . . . 12.6 108.764 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -20.45 21.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.372 1.069 . . . . 12.52 112.894 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.83 -12.64 61.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 14.140000000000001 112.33 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.68 -52.84 48.08 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 120.981 -0.628 . . . . 10.76 112.339 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.71 0.767 . . . . 11.0 109.923 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.47 -35.38 73.26 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.564 -0.744 . . . . 16.420000000000002 111.081 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.9 m -88.57 -34.32 17.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.746 0.308 . . . . 13.35 110.721 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.95 92.86 48.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.495 -0.557 . . . . 12.23 109.495 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.698 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 74.5 Cg_endo -83.76 1.95 8.57 Favored 'Trans proline' 0 C--O 1.205 -1.145 0 C-N-CA 123.192 2.595 . . . . 13.06 114.323 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.55 133.02 39.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.916 -1.142 . . . . 12.949999999999999 107.916 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -63.85 -45.45 89.45 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 114.805 -1.088 . . . . 10.92 111.799 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -69.21 -24.58 64.04 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 111.944 0.35 . . . . 14.32 111.944 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.8 -41.04 53.9 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.54 -0.541 . . . . 10.93 109.54 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -75.93 -37.58 58.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.877 -0.601 . . . . 8.8100000000000005 112.032 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.1 p -60.78 -34.33 74.32 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.702 -0.399 . . . . 9.3499999999999996 110.893 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -68.53 -44.44 74.6 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.182 -0.673 . . . . 11.630000000000001 109.182 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -54.85 -45.9 74.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.351 1.06 . . . . 10.550000000000001 110.625 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.52 -45.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.069 -0.514 . . . . 8.3000000000000007 110.776 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.1 93.88 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.736 -0.665 . . . . 9.5800000000000001 113.672 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -68.61 -24.73 64.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.46 0.541 . . . . 10.23 112.46 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.02 -2.5 58.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 113.573 0.953 . . . . 10.43 113.573 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.45 -52.7 56.71 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.386 -0.968 . . . . 10.970000000000001 108.386 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -142.78 92.03 7.17 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 105.712 -1.959 . . . . 13.52 105.712 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.72 60.19 2.82 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.394 2.729 . . . . 12.279999999999999 114.63 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 m -66.39 -36.97 84.19 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.543 -0.54 . . . . 13.44 109.543 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.32 -24.37 65.73 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.764 -0.653 . . . . 13.27 110.324 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.13 -14.87 26.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.066 -0.515 . . . . 14.48 110.704 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -83.58 119.71 25.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.166 -1.05 . . . . 14.92 108.166 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 59.45 49.68 8.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 123.89 0.876 . . . . 14.25 108.65 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.7 87.23 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.572 -1.194 . . . . 12.970000000000001 111.592 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.67 8.91 3.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.089 2.526 . . . . 13.4 111.916 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.88 126.98 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 108.297 -1.001 . . . . 12.43 108.297 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.15 75.03 9.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.431 0.634 . . . . 13.449999999999999 110.663 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -82.06 -26.88 33.31 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.233 -0.894 . . . . 14.41 108.984 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -78.94 143.26 61.46 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 114.924 -1.035 . . . . 11.68 108.6 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.21 73.94 4.8 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.401 2.067 . . . . 10.84 110.56 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.21 91.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.724 0.773 . . . . 10.460000000000001 109.924 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.12 48.78 2.31 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.491 -1.231 . . . . 10.58 108.05 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -63.02 121.67 14.16 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.028 -0.987 . . . . 11.039999999999999 110.006 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.74 146.92 32.27 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.785 -0.82 . . . . 10.880000000000001 108.785 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.07 0.83 3.38 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.508 2.806 . . . . 12.460000000000001 113.131 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -124.06 108.18 30.21 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.529 -1.286 . . . . 13.779999999999999 107.529 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.61 -27.2 69.26 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.427 2.085 . . . . 11.949999999999999 112.119 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.36 121.84 3.11 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.515 -0.766 . . . . 11.48 111.261 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.88 68.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.134 0.493 . . . . 11.550000000000001 110.275 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.57 -33.1 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.655 -0.702 . . . . 12.59 110.595 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.03 70.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.405 0.621 . . . . 11.24 110.559 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.5 m -107.31 43.83 1.14 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.708 -0.678 . . . . 10.050000000000001 109.749 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.36 94.17 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.667 -0.697 . . . . 11.220000000000001 111.441 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' ILE . 51.8 mt-30 -64.62 -48.35 75.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.999 -0.546 . . . . 11.380000000000001 109.796 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.78 -45.43 82.14 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.498 -0.774 . . . . 9.6500000000000004 110.636 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -56.95 -52.35 65.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.333 0.653 . . . . 10.43 111.149 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 t -58.97 -44.26 91.49 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.635 -0.711 . . . . 10.210000000000001 111.163 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.572 HG21 HG11 ' A' ' 178' ' ' VAL . 83.5 mt -64.08 -49.11 82.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 109.881 -0.415 . . . . 8.1300000000000008 109.881 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -58.13 -43.69 87.41 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.44 0.696 . . . . 8.4600000000000009 112.665 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 14.8 t70 -62.59 -43.04 99.79 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.164 0.507 . . . . 10.859999999999999 110.099 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.75 -44.1 91.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.639 0.733 . . . . 11.449999999999999 110.302 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.99 -33.29 75.26 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.284 -0.871 . . . . 7.6200000000000001 109.281 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 129' ' ' LEU . 56.6 tttm -62.29 -40.45 96.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.865 0.866 . . . . 11.619999999999999 109.802 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 61.1 mm-40 -64.99 -48.6 73.38 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.188 -1.041 . . . . 11.630000000000001 108.188 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.4 t -56.58 -52.62 64.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.861 -1.518 . . . . 9.1400000000000006 111.984 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.9 pp -68.86 -39.26 79.98 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.377 -0.529 . . . . 10.06 111.746 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.543 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.99 -39.44 94.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.126 -0.559 . . . . 12.07 111.778 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.64 -44.74 77.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.869 0.366 . . . . 12.32 110.209 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 148' ' ' TRP . 15.0 tp -69.08 -46.08 68.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.334 -0.394 . . . . 11.77 110.953 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -72.72 -20.38 61.22 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.481 0.712 . . . . 13.52 111.327 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.0 t80 83.33 -29.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.005 1.322 . . . . 16.559999999999999 112.594 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.8 162.12 36.31 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 122.358 -0.214 . . . . 15.74 110.483 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.0 107.27 42.95 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.005 -0.739 . . . . 14.199999999999999 109.005 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -91.87 11.35 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.727 2.285 . . . . 14.18 113.425 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.61 50.69 5.19 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.496 -1.041 . . . . 14.029999999999999 110.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -107.48 -15.02 14.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.541 -0.464 . . . . 16.370000000000001 112.15 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.425 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 90.3 mt -71.23 97.72 1.6 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.13 0.491 . . . . 12.449999999999999 111.746 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 71.07 -20.06 0.23 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.207 1.403 . . . . 14.43 114.558 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -76.73 -28.74 55.91 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.725 0.81 . . . . 14.32 111.137 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.73 102.48 0.21 Allowed Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 110.213 -1.155 . . . . 13.75 110.213 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 171' ' ' LEU . . . -108.86 86.6 2.32 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.99 0.367 . . . . 12.699999999999999 111.99 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.42 112.06 23.95 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.15 -0.685 . . . . 16.379999999999999 109.15 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -62.55 -20.61 64.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.874 -0.603 . . . . 13.300000000000001 111.543 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.14 -29.63 69.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.667 0.787 . . . . 16.25 111.586 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.04 -25.88 39.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.34 0.591 . . . . 15.869999999999999 110.901 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.58 2.19 49.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 13.65 111.051 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.01 3.99 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 120.794 -0.717 . . . . 14.16 111.37 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.7 tpp 62.11 86.95 0.1 Allowed 'General case' 0 C--O 1.251 1.153 0 C-N-CA 124.794 1.237 . . . . 15.449999999999999 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 44.3 m-20 -57.86 118.73 5.64 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.37 -1.345 . . . . 13.630000000000001 107.37 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -56.32 -36.15 68.39 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.126 0.97 . . . . 13.9 111.567 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.01 -44.07 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.369 0.604 . . . . 13.81 110.145 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 141' ' ' ASP . 34.2 m -66.62 -37.96 85.93 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.854 -0.612 . . . . 11.48 110.848 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 -32.86 54.11 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.871 -0.604 . . . . 10.35 112.564 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.6 p -69.7 -39.53 76.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.453 -0.499 . . . . 12.199999999999999 110.277 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.84 -46.08 81.96 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.795 0.807 . . . . 11.859999999999999 109.699 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.1 t90 -62.18 -54.06 46.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.176 -1.375 . . . . 9.3200000000000003 111.696 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.0 tpt -58.03 -42.07 84.55 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.947 0.499 . . . . 9.5 110.204 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -58.44 -46.41 86.58 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 115.895 -0.593 . . . . 13.91 110.697 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -45.15 95.89 Favored Glycine 0 C--N 1.321 -0.273 0 O-C-N 123.399 0.437 . . . . 9.8800000000000008 112.787 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.31 -50.14 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 9.2699999999999996 110.441 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.1 p -65.5 -38.46 89.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.097 -0.502 . . . . 11.460000000000001 111.61 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -63.99 -47.09 81.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 15.039999999999999 111.186 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -67.48 -31.57 71.81 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.787 -0.365 . . . . 11.82 110.983 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -90.92 6.11 45.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.903 0.705 . . . . 11.970000000000001 112.903 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.4 m 59.66 33.51 21.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.777 0.831 . . . . 14.24 112.51 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.44 134.81 58.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.267 -0.642 . . . . 12.619999999999999 109.267 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -88.24 94.87 9.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.602 0.715 . . . . 16.390000000000001 110.669 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.03 148.73 43.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.026 -1.101 . . . . 12.32 108.026 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.58 143.92 48.08 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.075 -1.083 . . . . 14.06 108.075 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.975 -0.557 . . . . 12.640000000000001 109.995 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.32 15.6 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.655 -0.702 . . . . 15.68 110.496 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.99 59.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.053 0.39 . . . . 12.720000000000001 112.053 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.64 9.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.434 0.635 . . . . 12.16 112.236 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -110.2 -7.04 14.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.587 -0.733 . . . . 15.08 109.587 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.1 m -79.3 -27.89 42.2 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.281 0.562 . . . . 14.67 110.795 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.7 m-90 -113.36 137.83 22.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 116.253 -0.43 . . . . 12.68 110.721 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 -16.93 18.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.063 2.509 . . . . 14.34 111.818 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.9 p -135.65 142.86 45.23 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.489 -1.3 . . . . 12.91 107.489 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB3' ' HB1' ' A' ' 133' ' ' ALA . 25.8 tp -71.3 -24.9 62.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.742 -0.663 . . . . 9.8900000000000006 110.983 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -62.34 -21.98 65.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.762 -0.654 . . . . 12.5 110.675 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 27.6 m -65.7 -18.56 65.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.843 -0.617 . . . . 11.039999999999999 111.208 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.94 -46.2 68.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.449 -0.575 . . . . 8.5 109.449 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.16 75.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.494 . . . . 7.7000000000000002 110.968 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 14.6 t70 -74.99 -31.0 61.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.278 -0.569 . . . . 10.380000000000001 110.056 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -76.55 -41.87 45.05 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 123.348 0.659 . . . . 11.970000000000001 110.351 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.572 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -64.67 -30.49 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.744 0.783 . . . . 9.8000000000000007 110.102 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 183' ' ' GLN . 18.8 t70 -66.59 -28.08 68.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.599 -1.182 . . . . 10.83 110.117 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 85.2 mtt180 -84.22 -42.31 16.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.23 -0.895 . . . . 13.5 109.307 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.04 -51.3 59.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.962 -1.017 . . . . 14.84 111.985 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.25 -35.23 17.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.193 0.52 . . . . 13.35 110.77 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 179' ' ' ASP . 61.8 tt0 . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.246 -0.883 . . . . 13.51 109.212 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 4' ' ' ASP . 10.1 m . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 121.392 0.615 . . . . 18.510000000000002 111.367 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.82 74.97 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.075 0.55 . . . . 16.66 111.964 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.49 -20.94 64.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.809 0.814 . . . . 14.84 110.292 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 1' ' ' VAL . 37.8 t70 -98.45 -26.99 14.27 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.631 -0.713 . . . . 14.98 110.263 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.66 -47.33 86.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.664 0.385 . . . . 15.789999999999999 110.774 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 p -62.63 -36.47 82.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.317 -0.401 . . . . 12.02 111.479 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.56 67.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.445 -0.343 . . . . 11.02 110.235 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 64.3 tt0 -60.04 -48.59 81.1 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.451 0.701 . . . . 16.07 110.694 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -55.6 -42.25 74.59 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.052 0.845 . . . . 13.93 110.123 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.35 -43.52 63.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.106 -0.497 . . . . 10.710000000000001 111.609 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 8' ' ' GLN . 30.8 mtm180 -61.28 -40.0 92.5 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.612 0.244 . . . . 14.02 111.147 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.0 -44.62 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 16.289999999999999 110.82 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -71.05 -25.23 62.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.885 0.374 . . . . 12.91 111.415 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.98 -55.96 9.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.72 -1.585 . . . . 12.77 106.72 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.34 65.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.685 -1.143 . . . . 15.19 111.554 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.93 85.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.652 0.263 . . . . 16.260000000000002 111.464 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -81.48 -26.09 35.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.018 0.437 . . . . 15.449999999999999 111.222 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.57 -4.33 44.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.018 -0.537 . . . . 16.16 112.041 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.97 49.09 3.61 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.955 1.302 . . . . 20.559999999999999 112.513 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.15 161.81 22.46 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.781 -1.099 . . . . 16.629999999999999 108.757 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -92.9 116.38 66.4 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-O 120.631 0.253 . . . . 20.190000000000001 111.124 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 -6.97 19.07 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.388 2.725 . . . . 16.600000000000001 113.627 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.76 -20.94 78.96 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.381 -0.688 . . . . 17.739999999999998 111.381 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -128.73 71.89 1.43 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 122.167 0.984 . . . . 20.23 109.468 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 tp -127.9 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.612 -0.884 . . . . 15.98 108.612 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -88.67 120.63 30.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.0 -0.741 . . . . 19.329999999999998 109.0 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 19.8 m-20 -61.79 -26.44 68.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.46 -0.791 . . . . 14.93 112.174 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.44 4.39 86.16 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.02 -0.61 . . . . 14.82 113.677 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.5 p -79.41 140.36 37.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 117.816 0.808 . . . . 14.539999999999999 110.273 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.547 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 66.1 mtm180 -75.5 148.24 39.14 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 118.356 -0.831 . . . . 16.75 109.479 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -50.38 -40.19 48.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.905 0.86 . . . . 11.99 110.992 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -23.9 66.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.406 -1.27 . . . . 14.449999999999999 112.691 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HG2' ' HB2' ' A' ' 30' ' ' ARG . 8.9 mm-40 -76.98 -29.28 55.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.796 0.808 . . . . 16.440000000000001 109.074 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.82 -31.94 27.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.16 -0.927 . . . . 13.77 108.808 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.0 32.94 3.63 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 114.787 -1.097 . . . . 13.81 112.174 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.0 tp -81.41 98.9 8.43 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.777 -0.823 . . . . 13.039999999999999 108.777 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.91 147.74 45.01 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.707 -1.22 . . . . 15.67 107.707 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 19.3 p -58.67 -22.8 57.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.923 0.765 . . . . 15.289999999999999 112.178 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.24 -50.93 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.494 -0.558 . . . . 16.66 109.494 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.06 -36.71 76.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.891 -0.781 . . . . 14.140000000000001 108.891 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 38' ' ' SER . . . -57.09 -36.76 70.98 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.169 -0.923 . . . . 12.0 110.77 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.49 -45.84 85.58 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.066 -0.515 . . . . 13.970000000000001 109.967 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -60.79 -45.88 92.68 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.4 0.619 . . . . 15.69 110.712 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -59.34 -52.42 65.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.008 1.723 . . . . 11.69 111.684 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 tp -63.56 -31.61 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.857 0.36 . . . . 11.16 111.403 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 42' ' ' ALA . 99.2 mtt180 -66.35 -35.08 79.45 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 120.972 0.415 . . . . 16.649999999999999 110.282 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -73.62 -35.1 65.3 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.22 0.533 . . . . 14.15 110.155 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.01 -50.17 81.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 115.146 -0.934 . . . . 10.800000000000001 109.85 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.54 -25.12 59.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.035 -0.984 . . . . 12.98 112.847 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 97.7 mttt -75.82 -61.86 1.78 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 116.296 -0.411 . . . . 17.52 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -74.67 -25.09 58.95 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.958 -0.697 . . . . 14.869999999999999 112.008 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -94.96 -6.98 41.22 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.427 0.899 . . . . 12.199999999999999 113.427 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 47.92 64.27 1.7 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.877 1.671 . . . . 16.710000000000001 112.108 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.48 167.72 21.07 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.94 -1.027 . . . . 12.199999999999999 108.312 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.32 70.52 0.76 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.387 -1.338 . . . . 16.059999999999999 107.387 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.493 HD12 ' HE1' ' A' ' 73' ' ' TRP . 47.0 mm -92.74 119.93 67.58 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.201 -0.666 . . . . 11.390000000000001 109.201 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -87.65 167.72 7.25 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.056 1.838 . . . . 12.6 108.929 171.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -10.16 3.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.733 1.012 . . . . 12.52 113.733 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.39 -19.57 65.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.26 0.467 . . . . 14.140000000000001 112.26 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.77 -44.37 96.36 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.742 -1.218 . . . . 10.76 110.129 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.45 -27.64 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.231 1.012 . . . . 11.0 110.869 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -78.25 -31.5 49.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.734 -0.604 . . . . 16.420000000000002 112.175 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t -87.69 -32.28 19.28 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.392 -0.923 . . . . 13.35 110.649 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.486 ' CE2' ' HE3' ' A' ' 73' ' ' TRP . 38.6 m-85 -108.72 100.98 41.73 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 109.526 -0.546 . . . . 12.23 109.526 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.06 -0.45 10.29 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.506 2.137 . . . . 13.06 112.366 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 120.47 61.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.609 -1.626 . . . . 12.949999999999999 106.609 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 27' ' ' ASP . 49.2 p90 -58.98 -32.23 69.49 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.024 0.75 . . . . 10.92 113.024 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -60.58 -32.09 71.2 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.919 0.888 . . . . 14.32 111.731 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.5 -30.78 21.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.91 0.862 . . . . 10.93 109.928 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 43.2 t80 -70.63 -31.7 68.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.181 -0.918 . . . . 8.8100000000000005 111.61 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.1 p -66.18 -28.42 68.75 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.726 -0.609 . . . . 9.3499999999999996 109.49 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -71.21 -32.76 69.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.481 -0.781 . . . . 11.630000000000001 109.634 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.493 ' HE1' HD12 ' A' ' 56' ' ' ILE . 2.4 t-105 -53.91 -55.8 23.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.413 -0.958 . . . . 10.550000000000001 108.413 173.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.13 -44.73 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 C-N-CA 124.031 0.932 . . . . 8.3000000000000007 110.627 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.6 73.74 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.261 -0.427 . . . . 9.5800000000000001 113.0 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.2 m -80.36 -31.32 37.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 122.525 -0.397 . . . . 10.23 111.073 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -89.24 -21.41 23.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.051 -0.66 . . . . 10.43 112.073 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -78.94 115.3 18.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.096 -0.335 . . . . 10.970000000000001 110.096 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 57.84 62.42 5.21 Favored Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 124.45 1.094 . . . . 13.52 109.825 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.88 154.6 23.06 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.276 1.984 . . . . 12.279999999999999 113.117 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.4 p -79.31 49.93 1.03 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.6 0.76 . . . . 13.44 111.094 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -89.62 116.74 27.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.479 -0.934 . . . . 13.27 108.479 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.16 -43.83 8.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.319 -0.4 . . . . 14.48 110.206 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 m 56.12 70.5 0.64 Allowed 'General case' 0 C--O 1.249 1.066 0 CA-C-O 122.059 0.933 . . . . 14.92 109.885 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.09 56.64 4.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.423 -0.808 . . . . 14.25 110.06 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.42 125.97 54.17 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.23 -0.895 . . . . 12.970000000000001 109.2 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.37 54.42 4.63 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.894 2.396 . . . . 13.4 111.391 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.45 94.63 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.565 -0.902 . . . . 12.43 108.565 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 73.82 7.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.435 -1.32 . . . . 13.449999999999999 107.435 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -148.06 120.36 8.39 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.359 -1.719 . . . . 14.41 106.359 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.83 146.29 38.57 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 123.441 0.463 . . . . 11.68 110.548 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.84 45.97 2.1 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.004 2.469 . . . . 10.84 110.445 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.1 t 57.39 75.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.969 1.308 . . . . 10.460000000000001 109.492 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.82 -30.09 11.88 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.916 -1.038 . . . . 10.58 109.987 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -119.37 159.61 23.84 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.329 -0.619 . . . . 11.039999999999999 109.329 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.56 69.07 6.51 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.076 -0.511 . . . . 10.880000000000001 110.241 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.3 -48.89 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.479 2.12 . . . . 12.460000000000001 110.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -112.58 119.94 42.22 Favored Pre-proline 0 N--CA 1.425 -1.714 0 N-CA-C 107.085 -1.45 . . . . 13.779999999999999 107.085 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.95 52.68 3.1 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.836 2.357 . . . . 11.949999999999999 112.163 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.36 43.77 1.16 Allowed Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.842 -1.303 . . . . 11.48 109.842 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.18 -25.57 55.34 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.606 -0.887 . . . . 11.550000000000001 108.606 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -77.28 103.89 7.47 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.827 -1.079 . . . . 12.59 108.456 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.99 -32.64 22.87 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.752 -0.658 . . . . 11.24 109.58 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m 55.45 53.98 9.12 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.813 0.816 . . . . 10.050000000000001 110.496 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.25 -35.42 71.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.509 -1.223 . . . . 11.220000000000001 109.916 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.17 -44.53 97.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.771 -1.104 . . . . 11.380000000000001 109.852 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.449 ' O ' ' HB ' ' A' ' 110' ' ' ILE . 44.1 ttp180 -78.91 -27.46 43.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.875 -0.602 . . . . 9.6500000000000004 111.17 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.0 -37.05 86.39 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.809 0.337 . . . . 10.43 110.764 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.8 t -64.69 -41.88 95.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.565 -0.902 . . . . 10.210000000000001 108.565 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 178' ' ' VAL . 67.3 mt -57.36 -41.85 79.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 CA-C-N 115.098 -0.956 . . . . 8.1300000000000008 109.722 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -55.88 -39.64 71.84 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.228 0.611 . . . . 8.4600000000000009 112.317 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 m-20 -66.83 -40.86 88.13 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.039 0.447 . . . . 10.859999999999999 111.129 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -74.57 -35.06 63.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.144 -0.48 . . . . 11.449999999999999 111.613 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.72 -43.23 98.12 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.254 -1.387 . . . . 7.6200000000000001 107.254 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 79.0 tttt -54.66 -48.19 72.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.606 -1.179 . . . . 11.619999999999999 110.243 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -70.12 -39.29 75.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.137 -0.483 . . . . 11.630000000000001 111.404 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -58.25 -52.8 64.05 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.92 0.888 . . . . 9.1400000000000006 110.219 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.7 -38.55 58.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.144 -0.48 . . . . 10.06 110.483 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.75 -26.66 67.21 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 116.415 -0.357 . . . . 12.07 112.389 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.92 -32.45 74.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 123.519 0.728 . . . . 12.32 110.296 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.03 -30.95 62.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.577 0.703 . . . . 11.77 109.535 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.87 6.9 46.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.797 -1.092 . . . . 13.52 110.046 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.2 t80 79.96 -48.82 0.35 Allowed 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 127.78 2.432 . . . . 16.559999999999999 112.795 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.47 152.62 31.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.904 -0.406 . . . . 15.74 109.904 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.2 112.48 56.47 Favored Pre-proline 0 C--N 1.314 -0.947 0 O-C-N 124.18 0.925 . . . . 14.199999999999999 109.401 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -75.91 -37.31 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.223 1.949 . . . . 14.18 112.052 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -116.84 -112.97 2.7 Favored Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 110.118 -1.193 . . . . 14.029999999999999 110.118 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -139.29 3.48 2.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.835 -0.215 . . . . 16.370000000000001 110.964 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 115' ' ' LYS . 6.0 mp 60.65 -177.48 0.11 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.38 1.072 . . . . 12.449999999999999 112.588 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -150.37 148.53 28.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.691 -1.596 . . . . 14.43 106.691 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 170' ' ' THR . 25.5 m -74.32 -26.57 60.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.562 -0.744 . . . . 14.32 111.251 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.65 3.53 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 111.123 -0.791 . . . . 13.75 111.123 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.08 107.94 15.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.152 -1.055 . . . . 12.699999999999999 108.152 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -73.06 118.04 15.53 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.16 -0.473 . . . . 16.379999999999999 110.858 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.53 -27.69 67.96 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.375 -0.83 . . . . 13.300000000000001 110.178 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.77 -19.79 65.82 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.408 -0.814 . . . . 16.25 111.629 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.3 -52.39 5.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.496 0.554 . . . . 15.869999999999999 112.496 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.82 -10.05 20.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.934 0.716 . . . . 13.65 112.934 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.9 140.19 15.73 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.916 -1.135 . . . . 14.16 112.323 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.2 mtm -133.51 24.6 4.08 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.684 -1.599 . . . . 15.449999999999999 106.684 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.41 70.32 1.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.409 -1.723 . . . . 13.630000000000001 112.225 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -44.72 73.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.116 0.484 . . . . 13.9 109.919 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.32 -57.25 4.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 122.182 -0.324 . . . . 13.81 110.828 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -69.76 -20.47 63.49 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.64 -0.424 . . . . 11.48 111.927 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -78.86 -24.36 62.26 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.741 -1.218 . . . . 10.35 110.184 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.5 m -72.43 -38.22 68.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.602 -0.888 . . . . 12.199999999999999 108.602 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.72 -39.99 86.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.683 -0.69 . . . . 11.859999999999999 109.181 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 25.1 t90 -65.16 -46.5 80.61 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.188 -0.914 . . . . 9.3200000000000003 110.711 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 15.3 mmt -54.35 -47.85 72.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.112 0.482 . . . . 9.5 110.097 176.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 36.6 ttm180 -60.87 -41.02 95.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.247 -0.888 . . . . 13.91 110.232 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.85 -53.57 36.75 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.718 -0.673 . . . . 9.8800000000000008 111.882 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' TRP . 53.5 t -57.61 -40.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.105 0.479 . . . . 9.2699999999999996 110.064 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.9 t -61.16 -51.9 67.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.334 -0.848 . . . . 11.460000000000001 110.584 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 39.1 ptt180 -75.64 -40.05 56.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.784 0.661 . . . . 15.039999999999999 112.784 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -68.98 -33.87 74.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 11.82 111.87 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.97 2.22 43.33 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.737 -0.385 . . . . 11.970000000000001 112.025 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 t 60.0 37.57 21.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.972 0.909 . . . . 14.24 111.302 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.12 148.52 19.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.818 -0.438 . . . . 12.619999999999999 109.818 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -83.05 95.97 8.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.045 -0.354 . . . . 16.390000000000001 110.045 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 tp -109.36 133.99 52.38 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.349 -0.982 . . . . 12.32 108.349 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.46 146.7 29.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.007 -0.542 . . . . 14.06 110.219 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.49 -16.83 62.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 12.640000000000001 111.846 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.22 1.87 56.89 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.287 -0.415 . . . . 15.68 110.656 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HB1' ' CD1' ' A' ' 168' ' ' TRP . . . -61.83 -22.38 65.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.718 0.636 . . . . 12.720000000000001 112.718 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.7 pt -67.44 -12.96 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.235 0.54 . . . . 12.16 111.33 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -103.75 4.05 34.8 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.038 -0.528 . . . . 15.08 110.477 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.6 t -140.09 14.73 2.44 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 119.392 -0.923 . . . . 14.67 112.931 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.541 ' CD1' ' HB1' ' A' ' 164' ' ' ALA . 25.2 m95 -129.51 114.44 18.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.957 -1.127 . . . . 12.68 107.957 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.487 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 58.4 Cg_endo -73.12 -44.13 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.765 2.31 . . . . 14.34 115.491 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 131' ' ' SER . 74.8 p -130.45 -175.56 3.68 Favored 'General case' 0 C--O 1.249 1.058 0 N-CA-C 112.696 0.628 . . . . 12.91 112.696 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 6.7 mp -68.12 -26.5 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.711 -0.477 . . . . 9.8900000000000006 109.711 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -58.66 -49.96 75.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.45 -0.574 . . . . 12.5 109.45 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB2' ' CE3' ' A' ' 168' ' ' TRP . 3.1 p -67.36 -24.13 65.67 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.884 0.698 . . . . 11.039999999999999 112.884 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.12 -47.56 23.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.837 -1.171 . . . . 8.5 107.837 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.22 -30.57 71.69 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.794 -0.639 . . . . 7.7000000000000002 110.832 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -56.71 -34.97 68.0 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.349 0.66 . . . . 10.380000000000001 112.316 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -60.24 -58.27 9.25 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.676 0.75 . . . . 11.970000000000001 110.998 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 110' ' ' ILE . 9.5 p -69.74 -32.12 51.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.908 -1.042 . . . . 9.8000000000000007 110.899 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.16 -43.64 92.1 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.31 0.644 . . . . 10.83 110.76 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.4 mtm105 -83.06 -38.07 23.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.198 -0.456 . . . . 13.5 112.038 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -66.26 -46.51 76.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.581 0.585 . . . . 14.84 112.581 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.17 -43.33 17.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.883 0.373 . . . . 13.35 111.828 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.753 -0.462 . . . . 13.51 109.753 -178.638 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 110.109 -0.33 . . . . 18.510000000000002 110.109 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.04 -17.12 14.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.496 . . . . 16.66 112.259 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.95 -39.47 9.36 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.598 0.713 . . . . 14.84 109.982 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.59 18.69 8.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.166 -0.924 . . . . 14.98 109.885 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -61.86 -41.68 98.13 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.66 0.985 . . . . 15.789999999999999 113.66 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.87 -58.59 5.61 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.754 0.659 . . . . 12.02 110.678 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.12 80.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.625 -0.716 . . . . 11.02 111.333 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -58.16 -47.62 82.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.824 -0.626 . . . . 16.07 111.826 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.02 -34.72 77.02 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 121.099 0.476 . . . . 13.93 110.766 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.88 -36.14 77.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.145 -0.479 . . . . 10.710000000000001 110.528 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.91 -48.1 83.37 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.51 -0.552 . . . . 14.02 109.51 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.35 -43.77 88.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.685 . . . . 16.289999999999999 111.364 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -72.99 -43.48 62.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.96 -0.563 . . . . 12.91 112.373 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.49 -38.71 90.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.775 -0.454 . . . . 12.77 109.775 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.67 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -63.99 -34.87 78.97 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.738 -0.664 . . . . 15.19 110.792 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.85 61.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.981 -0.554 . . . . 16.260000000000002 111.042 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.9 mtt -85.36 -45.56 11.78 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.304 -0.407 . . . . 15.449999999999999 111.74 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.65 -5.64 48.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.27 0.841 . . . . 16.16 113.27 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 67.36 28.81 7.73 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.899 0.857 . . . . 20.559999999999999 111.93 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 6.9 p -97.45 -174.85 3.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.873 -1.158 . . . . 16.629999999999999 107.873 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -104.39 138.99 19.68 Favored Pre-proline 0 C--N 1.305 -1.354 0 C-N-CA 120.302 -0.559 . . . . 20.190000000000001 110.33 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.49 -9.09 14.93 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.15 1.9 . . . . 16.600000000000001 111.693 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.82 -76.57 0.88 Allowed Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 111.437 -0.665 . . . . 17.739999999999998 111.437 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -85.31 55.71 3.62 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.725 0.774 . . . . 20.23 110.372 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.56 140.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.844 -1.169 . . . . 15.98 107.844 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -81.88 100.23 9.5 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.204 0.526 . . . . 19.329999999999998 110.045 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 5.8 p-10 -77.16 -20.34 55.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.936 -0.575 . . . . 14.93 112.283 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.85 7.21 64.97 Favored Glycine 0 C--N 1.307 -1.061 0 CA-C-N 116.024 -0.534 . . . . 14.82 112.639 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.3 p -92.15 166.75 12.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.127 0.489 . . . . 14.539999999999999 110.597 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 88.5 mtm180 -91.61 141.93 28.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.331 -0.85 . . . . 16.75 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -50.22 -48.81 54.22 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.266 1.21 . . . . 11.99 114.266 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 36' ' ' LEU . 87.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.298 0.57 . . . . 14.449999999999999 111.158 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 30' ' ' ARG . 44.1 tt0 -82.2 -20.36 37.95 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 124.078 0.951 . . . . 16.440000000000001 109.293 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.4 -0.79 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.347 -0.842 . . . . 13.77 109.43 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.38 74.74 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.562 -0.745 . . . . 13.81 112.341 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 32' ' ' LEU . 20.6 tp -81.91 82.31 7.59 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.348 -0.982 . . . . 13.039999999999999 108.348 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.52 ' OD2' HG22 ' A' ' 39' ' ' VAL . 17.6 t70 -66.44 165.87 13.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.345 -1.298 . . . . 15.67 109.819 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -56.58 -36.74 69.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 118.44 0.564 . . . . 15.289999999999999 111.479 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG22 ' OD2' ' A' ' 37' ' ' ASP . 1.5 m -57.41 -51.84 64.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.677 0.751 . . . . 16.66 112.509 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mt -67.87 -46.58 81.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.675 -1.148 . . . . 14.140000000000001 110.301 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.36 87.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 12.0 112.458 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.41 93.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.397 0.617 . . . . 13.970000000000001 111.034 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.08 -43.3 68.02 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.638 -0.71 . . . . 15.69 110.619 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -57.43 -52.96 63.25 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 125.66 1.584 . . . . 11.69 110.425 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 tp -66.29 -33.03 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.369 -0.378 . . . . 11.16 111.028 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -59.95 -36.23 76.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.368 -0.378 . . . . 16.649999999999999 110.628 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.88 -40.37 54.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.299 -0.56 . . . . 14.15 109.69 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.39 -48.44 56.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.007 0.523 . . . . 10.800000000000001 110.96 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 16.3 m120 -57.88 -35.91 71.65 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.489 0.551 . . . . 12.98 112.489 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -86.22 -56.11 3.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.061 0.458 . . . . 17.52 110.814 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -61.81 -32.57 72.89 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.073 0.949 . . . . 14.869999999999999 111.788 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.15 3.2 25.47 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.473 0.654 . . . . 12.199999999999999 111.201 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.251 13.7 pt20 39.82 55.7 2.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.964 2.106 . . . . 16.710000000000001 114.308 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.35 159.07 23.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.34 -0.846 . . . . 12.199999999999999 110.129 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -94.95 26.82 3.42 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.077 0.551 . . . . 16.059999999999999 110.487 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mm -53.71 121.92 30.51 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.346 -0.843 . . . . 11.390000000000001 111.027 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.47 137.96 48.61 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.657 1.571 . . . . 12.6 108.555 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.56 -19.99 29.13 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.44 0.696 . . . . 12.52 112.267 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.34 -1.88 57.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.024 -0.534 . . . . 14.140000000000001 112.207 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.55 72.0 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 121.481 -0.39 . . . . 10.76 112.368 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.91 -26.22 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.408 0.683 . . . . 11.0 111.522 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -103.76 -2.53 26.26 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.643 -0.423 . . . . 16.420000000000002 111.921 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 m -69.52 -57.44 5.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.356 -0.979 . . . . 13.35 108.356 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.23 85.2 50.09 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 105.053 -2.203 . . . . 12.23 105.053 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 71.9 Cg_endo -76.15 54.32 4.14 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.836 2.357 . . . . 13.06 115.175 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.3 126.77 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.277 -1.009 . . . . 12.949999999999999 108.277 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -50.54 -54.78 19.8 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.382 0.882 . . . . 10.92 113.382 -171.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 63.1 tttm -65.79 -33.29 75.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.501 . . . . 14.32 111.424 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.94 81.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.104 -0.498 . . . . 10.93 111.04 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.0 t80 -79.06 -32.02 44.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.833 0.349 . . . . 8.8100000000000005 111.618 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.0 p -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.662 -0.649 . . . . 9.3499999999999996 110.963 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.16 -27.91 57.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.597 -0.274 . . . . 11.630000000000001 110.627 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.528 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 2.2 t90 -53.8 -49.15 68.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.461 1.104 . . . . 10.550000000000001 109.277 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 86.8 t -62.83 -41.55 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 123.666 0.786 . . . . 8.3000000000000007 110.365 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.61 93.22 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.76 -0.654 . . . . 9.5800000000000001 112.378 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 p -75.22 -22.31 58.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.895 0.379 . . . . 10.23 111.618 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -78.26 -17.16 57.02 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.957 0.408 . . . . 10.43 110.019 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 97.5 mt -86.01 63.17 7.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.073 0.939 . . . . 10.970000000000001 109.383 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -102.15 102.95 27.15 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.216 -1.356 . . . . 13.52 109.418 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.78 79.8 3.21 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.817 2.345 . . . . 12.279999999999999 111.713 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -63.16 96.32 0.1 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.856 -1.066 . . . . 13.44 112.56 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -101.23 121.51 41.99 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.421 -0.354 . . . . 13.27 110.057 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.64 -31.34 32.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.727 -0.67 . . . . 14.48 111.235 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 p -97.61 -167.43 1.52 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.293 -0.412 . . . . 14.92 112.001 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 74.58 82.17 0.11 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.241 1.416 . . . . 14.25 110.839 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.07 135.67 62.4 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.234 -0.894 . . . . 12.970000000000001 109.244 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.19 39.32 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.991 2.461 . . . . 13.4 113.276 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t 62.3 97.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.582 1.153 . . . . 12.43 111.0 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -97.32 21.52 9.93 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.279 0.561 . . . . 13.449999999999999 111.529 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -119.49 134.6 55.14 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.007 0.432 . . . . 14.41 110.036 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.38 134.1 27.35 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 107.895 -1.15 . . . . 11.68 107.895 172.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.78 144.3 77.11 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 122.344 2.029 . . . . 10.84 111.152 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.14 133.83 29.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.265 -0.425 . . . . 10.460000000000001 110.908 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.68 83.55 7.18 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.262 0.553 . . . . 10.58 110.29 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 p -64.22 133.27 52.48 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.297 -0.865 . . . . 11.039999999999999 109.67 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 128.57 93.92 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.749 -0.205 . . . . 10.880000000000001 111.149 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.64 54.68 5.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.039 2.493 . . . . 12.460000000000001 111.446 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 98.2 mt-30 -113.72 133.95 22.14 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.454 -0.943 . . . . 13.779999999999999 108.454 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 13.6 Cg_exo -70.99 126.6 12.66 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.02 1.813 . . . . 11.949999999999999 110.483 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.86 165.95 13.25 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.383 -1.087 . . . . 11.48 110.383 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.97 -24.62 58.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 117.062 0.431 . . . . 11.550000000000001 111.609 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -84.82 13.34 5.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.285 0.564 . . . . 12.59 111.862 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.05 49.75 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 11.24 109.302 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.4 m -106.28 70.01 0.82 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.441 -0.8 . . . . 10.050000000000001 110.079 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.45 69.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.115 -0.493 . . . . 11.220000000000001 111.434 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -70.53 -47.28 61.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.806 -0.813 . . . . 11.380000000000001 108.806 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -68.98 -40.55 78.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.037 -0.529 . . . . 9.6500000000000004 110.772 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.8 -41.99 92.42 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.059 -0.519 . . . . 10.43 110.05 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -64.92 -36.53 84.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 120.453 -0.499 . . . . 10.210000000000001 111.281 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.624 HG21 HG11 ' A' ' 178' ' ' VAL . 50.4 mt -59.31 -50.05 81.25 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 109.546 -0.538 . . . . 8.1300000000000008 109.546 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -60.83 -34.86 75.21 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.536 -0.756 . . . . 8.4600000000000009 110.114 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 15.0 t70 -63.49 -52.73 60.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.51 -0.768 . . . . 10.859999999999999 110.352 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -62.41 -44.72 95.76 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.337 -0.392 . . . . 11.449999999999999 109.976 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.91 -47.41 80.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.98 0.912 . . . . 7.6200000000000001 110.68 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.31 -47.6 85.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.514 -0.766 . . . . 11.619999999999999 110.226 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 90.3 mt-30 -66.18 -43.24 87.42 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.879 -0.6 . . . . 11.630000000000001 110.717 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.6 t -58.11 -51.81 68.15 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 123.579 0.752 . . . . 9.1400000000000006 111.803 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.502 HD23 ' CZ2' ' A' ' 148' ' ' TRP . 3.1 tm? -73.46 -40.82 63.87 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.54 -0.541 . . . . 10.06 109.54 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.53 -27.7 72.17 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.074 -0.512 . . . . 12.07 112.47 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.37 -37.94 68.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.369 0.604 . . . . 12.32 109.761 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.545 -0.752 . . . . 11.77 110.033 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.75 -16.68 55.13 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.552 -0.749 . . . . 13.52 110.567 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 72.46 8.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.351 1.46 . . . . 16.559999999999999 112.671 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.64 18.39 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.718 0.807 . . . . 15.74 108.99 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.94 126.23 29.48 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.521 -1.288 . . . . 14.199999999999999 107.521 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -7.53 21.03 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.76 2.307 . . . . 14.18 112.489 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.01 -73.06 0.39 Allowed Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 120.653 -0.784 . . . . 14.029999999999999 112.244 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -124.69 -22.17 4.64 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.821 0.343 . . . . 16.370000000000001 111.105 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp 63.5 -154.79 0.32 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 12.449999999999999 110.608 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.457 ' H ' HD23 ' A' ' 171' ' ' LEU . 67.3 mtp180 68.13 -78.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.148 0.979 . . . . 14.43 110.882 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.7 p -97.15 151.25 19.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.544 -0.91 . . . . 14.32 108.544 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.27 64.46 Favored Glycine 0 N--CA 1.47 0.951 0 C-N-CA 119.807 -1.187 . . . . 13.75 110.491 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.5 82.16 1.94 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.181 -1.414 . . . . 12.699999999999999 107.181 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.53 124.12 48.72 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.401 -1.272 . . . . 16.379999999999999 111.524 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.19 -7.08 51.4 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.086 -0.961 . . . . 13.300000000000001 111.372 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.86 -31.64 69.6 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.824 -1.176 . . . . 16.25 107.824 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.91 -51.98 3.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.772 -1.104 . . . . 15.869999999999999 110.176 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.18 15.55 2.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.549 0.69 . . . . 13.65 112.113 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.6 61.31 0.41 Allowed Glycine 0 C--N 1.297 -1.591 0 N-CA-C 109.857 -1.297 . . . . 14.16 109.857 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.6 ttm -72.46 -38.5 68.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.201 0.524 . . . . 15.449999999999999 110.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.14 143.27 46.63 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.321 -0.854 . . . . 13.630000000000001 110.299 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -82.06 -27.34 33.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.431 -0.804 . . . . 13.9 111.945 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.88 -35.96 50.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.204 0.526 . . . . 13.81 109.801 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.1 p -59.15 -48.12 82.77 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.77 -0.65 . . . . 11.48 110.939 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.4 85.14 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 115.499 -0.773 . . . . 10.35 112.726 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.9 t -64.37 -41.84 96.49 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.486 -0.486 . . . . 12.199999999999999 111.423 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -66.36 -46.34 77.08 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.891 0.377 . . . . 11.859999999999999 111.186 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 118' ' ' LEU . 32.8 t90 -64.14 -48.97 73.98 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.878 -0.601 . . . . 9.3200000000000003 111.789 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.423 ' HG3' HG12 ' A' ' 165' ' ' ILE . 93.6 mmm -60.93 -45.44 94.68 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 123.245 0.34 . . . . 9.5 111.809 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.21 -36.69 80.59 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.026 -0.27 . . . . 13.91 111.187 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.05 -47.97 80.22 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.656 -0.578 . . . . 9.8800000000000008 111.656 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.26 -42.92 92.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.204 0.526 . . . . 9.2699999999999996 110.101 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.2 m -62.82 -41.67 99.41 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.342 -0.845 . . . . 11.460000000000001 111.23 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -69.71 -41.79 74.9 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.892 -0.595 . . . . 15.039999999999999 109.87 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -60.41 -45.14 94.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.856 . . . . 11.82 110.248 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.52 5.9 49.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.473 0.546 . . . . 11.970000000000001 112.473 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.2 m 57.26 39.44 28.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.301 1.04 . . . . 14.24 112.887 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.0 149.66 16.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.076 0.465 . . . . 12.619999999999999 111.097 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.61 100.04 12.85 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.813 -1.18 . . . . 16.390000000000001 107.813 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -103.6 135.44 45.18 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.017 -0.538 . . . . 12.32 109.623 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.34 133.91 39.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.453 0.644 . . . . 14.06 110.573 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.76 64.3 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.683 -0.689 . . . . 12.640000000000001 111.487 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.83 -5.17 59.28 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.746 -0.661 . . . . 15.68 111.091 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.21 -8.54 56.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.727 0.775 . . . . 12.720000000000001 109.843 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.423 HG12 ' HG3' ' A' ' 149' ' ' MET . 10.7 mt -58.88 -23.85 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.984 1.314 . . . . 12.16 109.745 175.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -113.43 16.75 18.8 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.124 -0.944 . . . . 15.08 110.098 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.8 m -101.77 -34.1 9.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.645 -0.707 . . . . 14.67 109.85 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.8 m-90 -103.24 107.41 55.48 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.869 -0.419 . . . . 12.68 109.869 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.58 -13.7 9.49 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.155 1.904 . . . . 14.34 113.007 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -129.46 145.29 51.45 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.555 0.693 . . . . 12.91 111.529 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 130' ' ' ARG . 63.9 tp -58.17 -35.09 71.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.439 -1.255 . . . . 9.8900000000000006 111.9 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.84 -25.44 65.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 12.5 111.718 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 9.4 m -75.88 -20.16 58.28 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.146 0.498 . . . . 11.039999999999999 110.5 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.86 -29.75 55.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.578 -0.897 . . . . 8.5 108.578 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.42 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.417 -0.81 . . . . 7.7000000000000002 109.4 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -62.07 -30.5 71.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 120.804 0.335 . . . . 10.380000000000001 111.343 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -59.38 4.58 Favored 'General case' 0 C--O 1.252 1.205 0 N-CA-C 108.583 -0.895 . . . . 11.970000000000001 108.583 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 110' ' ' ILE . 14.9 p -65.49 -35.18 74.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 114.674 -1.148 . . . . 9.8000000000000007 111.773 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -57.24 -40.9 78.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.59 0.71 . . . . 10.83 110.919 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 34.2 ttp-105 -82.23 -53.22 6.23 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.341 -0.845 . . . . 13.5 111.18 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -75.42 -45.9 36.05 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.895 1.442 . . . . 14.84 114.895 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.98 -31.66 22.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 119.937 -0.705 . . . . 13.35 109.239 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.237 0.41 0 O-C-N 124.9 1.375 . . . . 13.51 111.223 172.776 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.742 ' HB ' ' OD2' ' A' ' 4' ' ' ASP . 44.0 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.145 -1.428 . . . . 18.510000000000002 107.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.65 70.83 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.657 0.383 . . . . 16.66 111.088 -174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.21 -53.67 47.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.993 0.808 . . . . 14.84 111.039 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.742 ' OD2' ' HB ' ' A' ' 1' ' ' VAL . 3.2 p30 -79.33 -28.01 42.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 14.98 111.078 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.52 -47.16 82.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 121.029 -0.268 . . . . 15.789999999999999 110.744 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 89.7 m -59.68 -42.91 93.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.509 0.195 . . . . 12.02 111.133 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.04 80.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.305 -0.407 . . . . 11.02 110.682 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.81 -39.13 87.61 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.787 -0.642 . . . . 16.07 110.647 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.35 -49.19 78.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.541 0.736 . . . . 13.93 110.289 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 96.0 mt -67.45 -38.08 83.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.422 -0.354 . . . . 10.710000000000001 110.683 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -59.74 -43.72 94.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.112 -0.495 . . . . 14.02 109.907 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.25 -41.86 69.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 16.289999999999999 110.096 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -57.73 -45.23 86.08 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.098 0.959 . . . . 12.91 111.132 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.48 -48.12 81.83 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.337 -0.616 . . . . 12.77 109.337 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.39 82.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.669 . . . . 15.19 111.831 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.65 86.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.137 0.575 . . . . 16.260000000000002 111.725 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.439 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 63.5 mtt -78.11 -42.61 31.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.705 -0.679 . . . . 15.449999999999999 111.468 -176.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.16 3.19 52.72 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.869 -0.733 . . . . 16.16 112.083 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 55.56 46.7 22.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.317 1.047 . . . . 20.559999999999999 110.187 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.8 m -123.38 -178.47 4.01 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.973 -1.012 . . . . 16.629999999999999 109.843 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.64 145.97 30.49 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.462 -1.681 . . . . 20.190000000000001 106.462 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.01 49.86 3.38 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 121.874 1.716 . . . . 16.600000000000001 109.237 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.1 92.54 0.01 OUTLIER Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 127.945 2.688 . . . . 17.739999999999998 114.587 -172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 44.19 29.71 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 127.044 2.138 . . . . 20.23 115.627 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.76 130.31 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.92 -1.141 . . . . 15.98 107.92 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -151.16 0.34 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.243 -1.021 . . . . 19.329999999999998 108.243 -173.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.09 -29.63 64.29 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.55 -0.46 . . . . 14.93 111.051 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -53.66 2.45 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.153 -1.022 . . . . 14.82 111.042 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -74.48 108.75 7.45 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.82 -1.178 . . . . 14.539999999999999 107.82 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 91.0 mtt180 -89.86 176.43 6.83 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.312 0.856 . . . . 16.75 113.312 -169.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -49.62 -41.17 41.63 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 112.736 0.643 . . . . 11.99 112.736 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.8 mt -60.34 -25.75 66.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 14.449999999999999 111.715 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.26 -36.2 79.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.243 0.617 . . . . 16.440000000000001 111.213 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.0 mt -88.98 5.22 45.24 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.584 -0.446 . . . . 13.77 112.006 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.79 51.71 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.992 -1.099 . . . . 13.81 112.677 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.9 tt -75.13 125.12 28.27 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.684 -0.858 . . . . 13.039999999999999 108.684 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -117.35 162.18 18.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.953 -1.128 . . . . 15.67 107.953 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 p -48.43 -43.89 34.78 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.401 0.68 . . . . 15.289999999999999 112.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.49 -47.66 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.865 -0.607 . . . . 16.66 110.487 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.0 mt -67.16 -34.46 69.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.816 -0.629 . . . . 14.140000000000001 110.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -59.34 -33.28 70.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 12.0 111.31 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.15 73.52 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.212 -0.449 . . . . 13.970000000000001 111.712 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.27 -45.74 14.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.386 0.612 . . . . 15.69 109.711 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 3.4 t90 -59.34 -40.59 86.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.498 1.119 . . . . 11.69 111.89 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 tp -62.18 -30.64 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.89 0.376 . . . . 11.16 110.872 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -64.96 -41.02 95.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 16.649999999999999 109.958 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' A' ' 17' ' ' MET . 0.3 OUTLIER -67.89 -31.7 71.67 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 121.191 0.519 . . . . 14.15 111.424 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 78.5 mt -66.97 -50.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.44 -0.948 . . . . 10.800000000000001 108.44 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 90.9 m-20 -62.66 -31.35 72.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.582 -1.19 . . . . 12.98 112.971 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -71.39 -43.13 67.43 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.871 -0.518 . . . . 17.52 110.155 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -74.64 -45.18 46.5 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 113.97 1.1 . . . . 14.869999999999999 113.97 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' HD22 ' A' ' 54' ' ' LEU . 63.9 m-85 -101.64 -1.15 33.36 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.758 -0.777 . . . . 12.199999999999999 112.189 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.298 13.6 pt20 48.49 42.71 19.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.242 1.941 . . . . 16.710000000000001 116.242 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 52' ' ' TYR . 3.4 mm? -94.51 171.25 8.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.599 -1.259 . . . . 12.199999999999999 107.599 171.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -114.12 60.74 0.67 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.506 -0.924 . . . . 16.059999999999999 108.506 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' PRO . 62.7 mt -97.4 126.4 41.77 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.35 -0.841 . . . . 11.390000000000001 111.0 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 56' ' ' ILE . 74.2 Cg_endo -77.0 169.5 21.51 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.273 1.982 . . . . 12.6 109.186 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.99 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.462 0.648 . . . . 12.52 110.629 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 5.6 m-20 -62.33 -20.09 64.0 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.101 -0.954 . . . . 14.140000000000001 112.312 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.07 99.82 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 119.791 -1.195 . . . . 10.76 110.252 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.03 -27.39 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.634 0.73 . . . . 11.0 110.07 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 20.6 m-85 -74.57 -23.47 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.843 -0.536 . . . . 16.420000000000002 110.233 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.4 m -87.57 -45.28 10.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.04 -0.527 . . . . 13.35 109.639 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' HE2' ' CE3' ' A' ' 73' ' ' TRP . 76.0 m-85 -115.74 104.22 53.03 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 120.583 0.23 . . . . 12.23 111.095 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 71.6 Cg_endo -83.13 3.32 7.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.96 1.773 . . . . 13.06 110.842 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -119.97 120.42 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.301 -1.74 . . . . 12.949999999999999 106.301 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -63.38 -29.77 71.01 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 113.504 0.927 . . . . 10.92 113.504 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -64.06 -34.25 77.6 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 14.32 111.696 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.16 -29.12 28.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.818 0.818 . . . . 10.93 109.655 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -75.58 -35.85 60.49 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.995 . . . . 8.8100000000000005 111.377 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -65.02 -30.39 71.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.107 0.48 . . . . 9.3499999999999996 109.731 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -70.17 -36.75 74.9 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.252 -0.885 . . . . 11.630000000000001 109.599 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.504 ' CE3' ' HE2' ' A' ' 64' ' ' TYR . 17.3 t-105 -61.95 -42.29 98.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 10.550000000000001 110.606 173.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 79.6 t -68.8 -45.29 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.921 0 N-CA-C 110.087 -0.338 . . . . 8.3000000000000007 110.087 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.07 87.7 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 116.153 -0.476 . . . . 9.5800000000000001 113.331 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 p -73.05 -30.18 63.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.053 0.39 . . . . 10.23 112.053 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -82.48 -19.92 37.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.599 0.714 . . . . 10.43 110.323 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 95.0 mt -79.59 163.72 24.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.185 -0.672 . . . . 10.970000000000001 109.185 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.89 100.66 47.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.658 -0.868 . . . . 13.52 108.658 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.28 -178.96 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.003 2.469 . . . . 12.279999999999999 112.195 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.7 p 49.42 61.75 2.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.228 1.011 . . . . 13.44 112.687 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -72.06 105.71 4.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.797 -1.092 . . . . 13.27 111.334 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -30.78 39.46 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.503 -0.925 . . . . 14.48 108.503 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.0 m -90.16 123.18 33.77 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.705 -1.591 . . . . 14.92 106.705 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 59.53 74.8 0.43 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 123.895 0.878 . . . . 14.25 111.292 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.87 132.39 73.2 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.836 -1.075 . . . . 12.970000000000001 111.095 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 12.7 Cg_exo -72.44 68.71 3.49 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.122 2.548 . . . . 13.4 112.525 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.8 136.48 52.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.73 -1.211 . . . . 12.43 107.73 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.21 79.61 9.03 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.574 0.702 . . . . 13.449999999999999 110.521 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -122.27 111.12 16.53 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.511 -0.768 . . . . 14.41 109.339 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.02 134.59 77.65 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.915 -0.772 . . . . 11.68 108.915 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.76 43.58 1.27 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.179 2.586 . . . . 10.84 112.265 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.69 134.55 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 10.460000000000001 109.365 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.01 50.17 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.366 -0.379 . . . . 10.58 110.492 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 p -86.17 100.7 12.41 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.758 -1.201 . . . . 11.039999999999999 107.758 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.44 113.88 62.67 Favored Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.943 -0.571 . . . . 10.880000000000001 111.088 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.11 -21.38 13.89 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.308 2.005 . . . . 12.460000000000001 110.133 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 99' ' ' PRO . 5.6 tp-100 -130.64 123.13 20.06 Favored Pre-proline 0 N--CA 1.418 -2.062 0 N-CA-C 106.084 -1.821 . . . . 13.779999999999999 106.084 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD2' ' OE1' ' A' ' 98' ' ' GLN . 55.9 Cg_endo -72.57 63.26 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.888 2.392 . . . . 11.949999999999999 113.337 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 27.41 1.86 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.303 -1.119 . . . . 11.48 110.303 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.4 -43.18 19.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.545 0.688 . . . . 11.550000000000001 109.714 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -85.53 138.25 32.33 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.416 -0.811 . . . . 12.59 109.949 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.93 -4.6 57.42 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 11.24 108.562 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.9 p -97.09 32.75 2.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.826 -1.079 . . . . 10.050000000000001 109.924 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.08 76.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.435 -0.348 . . . . 11.220000000000001 111.8 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -65.47 -40.98 93.81 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.519 0.676 . . . . 11.380000000000001 109.659 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -66.22 -36.6 83.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.277 -0.874 . . . . 9.6500000000000004 112.893 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.68 -38.38 90.14 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 117.921 0.328 . . . . 10.43 110.688 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 t -56.88 -47.72 79.81 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.785 -0.45 . . . . 10.210000000000001 109.785 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 178' ' ' VAL . 68.1 mt -68.79 -51.97 39.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.404 -0.591 . . . . 8.1300000000000008 109.404 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -53.46 -41.38 66.11 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 124.587 1.155 . . . . 8.4600000000000009 112.126 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 23.8 t70 -63.65 -48.24 78.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.68 0.252 . . . . 10.859999999999999 111.68 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.91 -36.06 69.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 11.449999999999999 110.413 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.64 -35.99 82.39 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.82 -0.808 . . . . 7.6200000000000001 108.82 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 25.0 ttpp -61.92 -45.76 92.3 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 11.619999999999999 109.472 174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 77.7 mt-30 -56.22 -47.23 78.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.593 -0.73 . . . . 11.630000000000001 109.666 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -64.35 -50.98 65.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.111 -0.95 . . . . 9.1400000000000006 112.124 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.7 pp -65.09 -34.99 79.71 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.326 -0.549 . . . . 10.06 111.869 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -66.38 -47.8 68.11 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 111.072 -0.811 . . . . 12.07 111.072 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.37 -38.81 88.34 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.244 1.018 . . . . 12.32 110.624 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 tp -57.39 -44.05 84.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 11.77 110.102 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 86.9 mt -72.96 -63.24 1.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.522 -0.918 . . . . 13.52 108.522 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -179.27 -47.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.654 1.182 . . . . 16.559999999999999 109.978 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -162.67 155.3 19.23 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.777 0.322 . . . . 15.74 110.293 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -125.82 127.3 24.82 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.454 -0.794 . . . . 14.199999999999999 110.841 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.32 -2.88 12.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.137 2.558 . . . . 14.18 112.213 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.89 41.42 4.38 Favored Glycine 0 CA--C 1.491 -1.469 0 C-N-CA 120.893 -0.67 . . . . 14.029999999999999 111.916 173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -140.34 -72.66 0.36 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.132 -1.027 . . . . 16.370000000000001 113.413 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 118' ' ' LEU . 6.2 mp 67.79 141.25 0.03 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.418 1.104 . . . . 12.449999999999999 112.044 -166.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -83.04 161.91 21.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.879 -1.156 . . . . 14.43 107.879 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.1 m -78.31 17.49 0.64 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.845 0.683 . . . . 14.32 112.845 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.96 -74.83 0.34 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.663 -1.775 . . . . 13.75 108.663 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 62.07 62.43 1.21 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.998 0.919 . . . . 12.699999999999999 111.953 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 9.7 tt0 -80.79 104.67 11.46 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.717 -0.674 . . . . 16.379999999999999 110.684 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -66.72 -26.81 67.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.255 1.022 . . . . 13.300000000000001 109.945 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.16 -24.37 67.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.434 0.635 . . . . 16.25 110.673 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -97.68 -46.27 6.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.157 0.503 . . . . 15.869999999999999 109.782 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.03 -26.07 62.94 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 13.65 112.884 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.02 119.68 6.45 Favored Glycine 0 C--N 1.313 -0.729 0 N-CA-C 111.942 -0.463 . . . . 14.16 111.942 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 86.9 mtp -106.18 -23.23 12.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.307 0.575 . . . . 15.449999999999999 110.643 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.51 127.44 19.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.344 0.592 . . . . 13.630000000000001 110.305 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.7 t -66.87 -37.49 84.53 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.931 -1.031 . . . . 13.9 110.32 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.89 -40.19 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.468 -0.333 . . . . 13.81 111.135 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.7 p -57.56 -35.29 70.16 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.442 . . . . 11.48 111.515 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.36 -32.11 26.19 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.623 -1.275 . . . . 10.35 112.254 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -68.25 -35.6 78.17 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.428 0.614 . . . . 12.199999999999999 110.588 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -63.83 -38.72 92.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.116 -0.493 . . . . 11.859999999999999 110.334 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -62.4 -44.22 96.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.75 -0.659 . . . . 9.3200000000000003 110.22 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.8 mmt -60.23 -36.61 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 9.5 110.323 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -67.06 -43.79 81.77 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.946 -0.57 . . . . 13.91 110.426 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.06 71.87 Favored Glycine 0 C--O 1.246 0.873 0 O-C-N 123.692 0.62 . . . . 9.8800000000000008 112.73 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.34 -33.15 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.45 0.167 . . . . 9.2699999999999996 110.898 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.4 m -60.58 -47.09 87.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 121.031 0.443 . . . . 11.460000000000001 110.124 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -68.83 -50.43 50.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.603 -0.726 . . . . 15.039999999999999 111.37 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -66.0 -34.95 79.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.223 0.453 . . . . 11.82 112.223 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.18 5.77 42.81 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.032 -0.667 . . . . 11.970000000000001 112.612 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 p 53.16 44.83 29.76 Favored 'General case' 0 C--O 1.247 0.954 0 C-N-CA 124.473 1.109 . . . . 14.24 113.377 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.78 149.07 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.307 -0.861 . . . . 12.619999999999999 108.774 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -96.23 95.64 8.25 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.402 -0.962 . . . . 16.390000000000001 108.402 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.8 tp -106.12 136.75 45.25 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.943 -0.572 . . . . 12.32 109.7 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.95 134.53 43.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.525 -0.546 . . . . 14.06 109.525 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.5 60.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.734 -0.666 . . . . 12.640000000000001 110.763 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.02 -10.85 59.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.436 -0.802 . . . . 15.68 110.573 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 167' ' ' THR . . . -64.61 -11.51 35.76 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.073 -0.512 . . . . 12.720000000000001 112.202 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -58.53 -17.61 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 121.445 0.64 . . . . 12.16 111.467 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -93.38 -6.41 47.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.077 -0.51 . . . . 15.08 112.131 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 164' ' ' ALA . 13.9 t -103.05 8.94 38.76 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.327 -0.949 . . . . 14.67 111.14 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -129.93 99.46 20.12 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 108.98 -0.748 . . . . 12.68 108.98 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.3 Cg_endo -67.24 -28.78 39.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.742 1.628 . . . . 14.34 110.906 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 27.8 p -121.96 142.4 50.34 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.812 -0.631 . . . . 12.91 109.493 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.16 -30.56 71.69 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.316 1.046 . . . . 9.8900000000000006 111.622 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -55.23 -27.03 43.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.127 -0.942 . . . . 12.5 111.91 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.7 m -72.16 -19.89 61.69 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.162 -0.472 . . . . 11.039999999999999 112.194 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.7 tp -75.68 -29.84 59.18 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.951 -0.7 . . . . 8.5 109.892 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.26 96.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.807 -0.633 . . . . 7.7000000000000002 111.196 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -82.16 -25.88 33.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.151 -0.62 . . . . 10.380000000000001 110.558 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.38 -48.66 69.44 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.163 -0.472 . . . . 11.970000000000001 110.408 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 110' ' ' ILE . 9.0 p -59.56 -39.73 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.861 -0.609 . . . . 9.8000000000000007 110.141 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.88 -44.59 92.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.528 -0.76 . . . . 10.83 111.234 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -70.92 -28.33 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.124 0.488 . . . . 13.5 111.488 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -79.23 -41.98 27.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.624 -0.431 . . . . 14.84 110.806 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.04 -35.25 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.428 -0.509 . . . . 13.35 111.341 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.37 -0.604 . . . . 13.51 109.37 179.198 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.212 -0.888 0 N-CA-C 108.43 -0.952 . . . . 18.510000000000002 108.43 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.81 -26.6 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.198 -0.601 . . . . 16.66 112.111 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -49.96 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.003 0.814 . . . . 14.84 112.973 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 22.7 t70 -88.73 -11.21 45.75 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.795 -0.762 . . . . 14.98 110.668 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.8 -38.11 70.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.889 -0.507 . . . . 15.789999999999999 111.708 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.0 p -65.7 -35.13 79.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.533 -0.867 . . . . 12.02 109.757 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.52 -35.0 79.53 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.055 -0.52 . . . . 11.02 110.477 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 80.3 mt-30 -53.36 -45.56 69.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 123.622 0.576 . . . . 16.07 110.636 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.45 -46.54 88.04 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.849 -0.614 . . . . 13.93 110.473 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.6 -36.35 73.47 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.01 -0.541 . . . . 10.710000000000001 111.075 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.62 -46.47 85.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.841 0.857 . . . . 14.02 109.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.92 -44.63 96.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.389 -0.823 . . . . 16.289999999999999 110.289 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -69.07 -40.4 78.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.407 -0.815 . . . . 12.91 110.847 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.77 -51.01 71.79 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.505 -0.924 . . . . 12.77 108.505 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -62.38 -39.61 93.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.055 . . . . 15.19 111.662 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.34 88.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.326 -0.397 . . . . 16.260000000000002 111.351 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.3 mtt -71.93 -36.62 69.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.789 0.328 . . . . 15.449999999999999 111.819 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 81.3 mt -94.73 -2.39 51.18 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.673 -0.411 . . . . 16.16 111.73 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 59.15 36.21 23.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.512 1.125 . . . . 20.559999999999999 111.104 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.653 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 23.5 p -112.27 164.91 12.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.11 -0.95 . . . . 16.629999999999999 108.976 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 52.2 mm-40 -91.28 129.29 43.91 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.091 -0.707 . . . . 20.190000000000001 109.091 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.93 -14.35 42.75 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.484 2.789 . . . . 16.600000000000001 114.317 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.98 -13.43 69.2 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.855 -0.688 . . . . 17.739999999999998 112.659 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 10.6 pt20 -79.56 -20.19 47.63 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.278 0.539 . . . . 20.23 110.472 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 pt -92.94 168.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.688 -1.227 . . . . 15.98 107.688 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -134.6 166.17 23.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 119.191 -0.433 . . . . 19.329999999999998 111.053 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 5.6 m-20 -56.5 -51.17 69.52 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.64 0.588 . . . . 14.93 111.167 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.23 6.72 70.5 Favored Glycine 0 C--O 1.244 0.741 0 CA-C-N 115.962 -0.563 . . . . 14.82 113.918 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -76.29 136.84 39.62 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.74 0.781 . . . . 14.539999999999999 110.924 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 82.3 mtp180 -77.54 147.08 35.93 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 114.576 -1.193 . . . . 16.75 108.786 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -58.63 -25.45 62.7 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.176 0.806 . . . . 11.99 113.176 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.01 -21.34 59.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.096 -0.502 . . . . 14.449999999999999 109.884 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.39 -18.74 18.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.864 0.866 . . . . 16.440000000000001 109.006 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 67' ' ' PHE . 87.6 mt -75.14 -21.63 58.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.702 -0.681 . . . . 13.77 109.792 177.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 24.56 8.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.45 -0.796 . . . . 13.81 112.543 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.38 163.54 16.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.924 0.869 . . . . 13.039999999999999 112.47 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.35 153.46 51.83 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.039 -1.437 . . . . 15.67 107.31 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -49.43 -55.65 12.36 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 123.741 0.65 . . . . 15.289999999999999 112.629 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.55 -44.79 99.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.249 -0.432 . . . . 16.66 110.704 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.78 -37.64 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.246 -0.433 . . . . 14.140000000000001 110.574 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.68 85.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 12.0 110.176 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.74 90.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.677 -0.692 . . . . 13.970000000000001 110.242 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.16 -42.39 90.63 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.461 0.648 . . . . 15.69 110.887 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.546 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 7.4 t90 -61.64 -55.61 28.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.793 1.637 . . . . 11.69 109.17 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.6 mm -54.32 -39.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.436 0.695 . . . . 11.16 111.583 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 18.4 tpt180 -72.33 -23.32 61.14 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.995 -0.548 . . . . 16.649999999999999 111.802 -175.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -86.56 -32.82 20.48 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 120.086 -0.646 . . . . 14.15 109.725 175.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 45' ' ' ILE . 87.9 mt -55.61 -35.8 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.972 0.909 . . . . 10.800000000000001 109.05 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' OD1' ' HD2' ' A' ' 46' ' ' ARG . 14.5 m120 -53.62 -39.77 65.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.836 -1.075 . . . . 12.98 112.411 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -84.86 -43.83 13.77 Favored 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 119.977 -0.689 . . . . 17.52 109.885 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -62.3 -37.05 84.07 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.36 0.874 . . . . 14.869999999999999 113.36 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -108.06 7.13 27.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.023 0.749 . . . . 12.199999999999999 113.023 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 48.17 52.6 13.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.302 1.441 . . . . 16.710000000000001 110.392 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 49' ' ' ASN . 33.1 tp -143.24 137.12 28.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.39 -0.967 . . . . 12.199999999999999 108.39 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.61 46.54 1.37 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.579 0.704 . . . . 16.059999999999999 109.474 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.1 tt -53.36 128.42 50.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.141 -1.39 . . . . 11.390000000000001 110.823 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 2.2 Cg_endo -83.2 147.37 12.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.466 2.11 . . . . 12.6 112.179 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HA ' HG13 ' A' ' 45' ' ' ILE . . . -68.4 -17.74 64.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.924 -1.034 . . . . 12.52 111.87 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.48 -9.27 56.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 14.140000000000001 111.915 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.27 -29.31 72.71 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.081 -0.808 . . . . 10.76 111.081 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.4 mt -76.79 -25.92 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 CA-C-O 121.414 0.626 . . . . 11.0 109.384 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -85.66 -14.03 46.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.297 -0.561 . . . . 16.420000000000002 111.526 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 t -97.03 -34.5 11.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.586 -0.446 . . . . 13.35 110.075 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -130.38 79.71 71.89 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.871 0.367 . . . . 12.23 110.273 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.8 Cg_endo -89.18 36.72 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.422 2.748 . . . . 13.06 112.813 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.0 t -124.43 127.31 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.397 -1.705 . . . . 12.949999999999999 106.397 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 34' ' ' LEU . 68.2 t80 -52.41 -49.16 65.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.807 0.73 . . . . 10.92 112.82 -170.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 17.5 tptm -70.36 -21.33 62.89 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.16 0.505 . . . . 14.32 111.58 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.28 -29.71 24.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.584 0.707 . . . . 10.93 109.875 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 73' ' ' TRP . 59.3 t80 -82.55 -28.12 31.2 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.305 -0.861 . . . . 8.8100000000000005 111.145 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -68.75 -32.36 72.08 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.16 0.505 . . . . 9.3499999999999996 110.083 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 68' ' ' LYS . 11.2 mm100 -72.23 -29.45 63.95 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 109.24 -0.652 . . . . 11.630000000000001 109.24 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.644 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 3.1 t90 -57.99 -53.87 53.33 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.351 -0.981 . . . . 10.550000000000001 108.351 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.52 -39.75 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 C-N-CA 124.153 0.981 . . . . 8.3000000000000007 110.877 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.1 95.11 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.246 -0.433 . . . . 9.5800000000000001 112.808 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -76.1 -13.42 60.21 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 122.55 -0.382 . . . . 10.23 111.081 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 75.5 mm-40 -83.64 -18.8 36.89 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.638 -0.875 . . . . 10.43 108.638 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.37 66.61 6.98 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.331 -0.989 . . . . 10.970000000000001 108.331 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 49.3 tp60 -106.47 114.76 61.75 Favored Pre-proline 0 N--CA 1.419 -1.983 0 CA-C-N 114.379 -1.282 . . . . 13.52 109.716 -177.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' GLN . 26.9 Cg_exo -63.61 135.1 47.37 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.927 2.418 . . . . 12.279999999999999 112.426 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 p -79.84 5.74 12.9 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.511 -0.768 . . . . 13.44 111.337 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -84.28 -27.83 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.51 -0.768 . . . . 13.27 109.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.35 -46.09 7.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.733 -0.84 . . . . 14.48 108.733 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.9 m -91.44 97.58 11.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.446 -0.797 . . . . 14.92 110.78 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.91 70.2 0.52 Allowed 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.892 1.277 . . . . 14.25 113.007 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.59 25.44 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 115.671 -0.695 . . . . 12.970000000000001 109.718 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.34 48.88 3.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.813 2.342 . . . . 13.4 112.667 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.23 61.55 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.514 -1.662 . . . . 12.43 106.514 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -104.21 -27.8 11.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.269 -0.878 . . . . 13.449999999999999 110.652 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 8.2 mpt_? -93.35 88.36 5.95 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.852 -0.613 . . . . 14.41 109.39 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.47 129.71 44.14 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.439 -0.801 . . . . 11.68 109.791 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.82 83.67 1.35 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.844 2.362 . . . . 10.84 110.452 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -82.01 119.54 31.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.191 -0.913 . . . . 10.460000000000001 110.726 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.69 139.52 53.87 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.06 -1.459 . . . . 10.58 107.06 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -130.91 161.98 30.68 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.802 -0.814 . . . . 11.039999999999999 108.802 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 42.07 83.17 0.21 Allowed Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.624 1.569 . . . . 10.880000000000001 113.766 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.88 -34.17 95.55 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.14 1.894 . . . . 12.460000000000001 111.446 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 59.0 tt0 -80.08 125.94 80.58 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.455 -0.793 . . . . 13.779999999999999 110.838 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 16.2 Cg_exo -70.32 103.14 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.534 2.156 . . . . 11.949999999999999 110.217 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.28 65.78 1.26 Allowed Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.428 -0.892 . . . . 11.48 111.27 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.34 61.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.181 0.515 . . . . 11.550000000000001 110.656 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -80.24 78.56 6.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.633 -0.712 . . . . 12.59 110.002 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.95 58.36 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.597 0.713 . . . . 11.24 111.43 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.6 m 61.01 33.35 19.73 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 125.315 1.446 . . . . 10.050000000000001 112.772 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.09 -38.86 62.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.599 0.962 . . . . 11.220000000000001 113.599 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.01 -41.72 86.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.441 0.638 . . . . 11.380000000000001 110.81 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 107' ' ' ARG . 3.5 mpt_? -83.39 -33.71 25.72 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.781 -0.645 . . . . 9.6500000000000004 110.957 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.155 0.982 . . . . 10.43 110.386 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -60.53 -47.57 85.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.957 -0.565 . . . . 10.210000000000001 110.096 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 178' ' ' VAL . 67.1 mt -61.2 -45.53 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.096 -0.705 . . . . 8.1300000000000008 109.096 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.07 -35.12 68.98 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 114.83 -1.077 . . . . 8.4600000000000009 111.048 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.87 -37.78 85.81 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.04 0.448 . . . . 10.859999999999999 111.47 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -76.37 -44.29 37.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.853 -0.795 . . . . 11.449999999999999 108.853 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.8 -41.02 85.77 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.747 -1.115 . . . . 7.6200000000000001 109.774 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.58 -42.09 74.28 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.318 1.447 . . . . 11.619999999999999 110.174 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -81.56 -33.97 31.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 11.630000000000001 111.981 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 80.8 p -61.05 -43.92 98.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 121.01 -0.276 . . . . 9.1400000000000006 111.153 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.2 pp -75.34 -31.69 60.65 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.531 -0.468 . . . . 10.06 110.659 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -58.4 -54.94 33.63 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.187 -0.461 . . . . 12.07 111.972 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -60.43 -43.46 96.76 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.825 0.822 . . . . 12.32 110.702 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.59 -45.12 72.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.514 -1.221 . . . . 11.77 111.922 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.1 mt -91.14 -15.33 29.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.341 0.497 . . . . 13.52 112.341 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.1 t80 66.38 33.97 6.63 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.247 -1.39 . . . . 16.559999999999999 107.247 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.38 148.73 35.22 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.766 -1.561 . . . . 15.74 108.47 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 12.8 m-20 -67.98 119.91 70.3 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.394 -0.595 . . . . 14.199999999999999 109.394 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 16.8 Cg_exo -70.82 32.25 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.858 3.039 . . . . 14.18 114.387 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.13 3.52 9.72 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 108.725 -1.75 . . . . 14.029999999999999 108.725 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -106.18 40.59 1.57 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.231 -1.026 . . . . 16.370000000000001 108.231 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.88 48.72 0.39 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.612 -1.176 . . . . 12.449999999999999 113.168 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -161.51 -44.15 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 125.429 1.492 . . . . 14.43 107.911 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -64.73 -45.42 86.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.265 -0.879 . . . . 14.32 109.023 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.88 30.47 10.35 Favored Glycine 0 C--O 1.214 -1.105 0 CA-C-N 115.387 -0.824 . . . . 13.75 111.047 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB1' ' HG3' ' A' ' 172' ' ' LYS . . . -92.75 -17.99 23.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.487 0.66 . . . . 12.699999999999999 109.857 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -87.71 113.63 23.56 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.99 -1.115 . . . . 16.379999999999999 107.99 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -64.46 -16.2 62.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.214 0.53 . . . . 13.300000000000001 112.218 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.98 -24.51 55.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.118 -0.492 . . . . 16.25 110.618 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -78.22 -27.75 47.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.412 0.625 . . . . 15.869999999999999 109.81 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.19 -20.89 66.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.469 -1.241 . . . . 13.65 111.956 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.52 -53.77 4.89 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.843 -0.903 . . . . 14.16 110.843 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.2 mtm -98.1 146.95 25.05 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.305 -1.369 . . . . 15.449999999999999 107.305 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -137.39 -68.2 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.776 1.028 . . . . 13.630000000000001 113.776 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 t -70.9 -40.19 72.31 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.033 0.382 . . . . 13.9 112.033 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.1 -50.95 53.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.536 0.684 . . . . 13.81 109.733 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -37.97 83.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.036 -0.984 . . . . 11.48 111.143 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.6 98.44 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.653 -0.703 . . . . 10.35 111.522 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.8 m -56.84 -53.26 59.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.682 0.393 . . . . 12.199999999999999 110.115 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -64.84 -38.45 91.04 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.316 -0.402 . . . . 11.859999999999999 111.894 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.0 t90 -67.56 -50.9 56.33 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.348 -0.612 . . . . 9.3200000000000003 109.348 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 mmt -67.63 -26.18 66.11 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.456 -0.793 . . . . 9.5 111.435 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 26.5 tpt180 -62.92 -43.93 97.47 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.405 -0.961 . . . . 13.91 108.405 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.82 91.24 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.144 -0.782 . . . . 9.8800000000000008 111.144 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 148' ' ' TRP . 97.4 t -61.09 -40.86 87.15 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.465 -0.568 . . . . 9.2699999999999996 109.465 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' SER . 39.6 m -66.08 -30.13 70.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.751 -0.659 . . . . 11.460000000000001 110.821 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 37.6 mmt180 -67.19 -47.74 70.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.56 -0.533 . . . . 15.039999999999999 109.56 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -71.53 -55.34 8.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.235 0.828 . . . . 11.82 113.235 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -105.27 -8.35 18.34 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 114.068 1.136 . . . . 11.970000000000001 114.068 -170.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 153' ' ' SER . 28.0 m 55.58 38.88 30.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.91 0.884 . . . . 14.24 112.326 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.9 pt -104.23 144.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.333 -0.617 . . . . 12.619999999999999 109.333 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -81.98 95.36 7.37 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 123.522 0.514 . . . . 16.390000000000001 111.696 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.29 102.39 6.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.577 -0.897 . . . . 12.32 108.577 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.43 175.68 10.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 121.174 -0.21 . . . . 14.06 111.054 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.37 80.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.445 0.641 . . . . 12.640000000000001 110.935 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.84 -10.2 45.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.19 -0.914 . . . . 15.68 112.848 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 -13.64 62.33 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 111.675 0.25 . . . . 12.720000000000001 111.675 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -66.65 -18.24 23.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 O-C-N 122.107 -0.371 . . . . 12.16 111.729 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -94.02 1.76 56.17 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.933 0.873 . . . . 15.08 110.194 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.5 m -89.32 -9.55 50.1 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.061 -0.972 . . . . 14.67 108.402 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -130.93 149.04 72.58 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.36 -0.978 . . . . 12.68 108.36 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.85 -38.41 2.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.622 2.215 . . . . 14.34 112.317 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.2 p -138.16 162.15 34.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.319 -1.734 . . . . 12.91 106.319 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.17 -1.25 19.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.024 0.44 . . . . 9.8900000000000006 112.118 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 133' ' ' ALA . 30.0 mtpp -76.24 -24.34 54.57 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.179 -0.674 . . . . 12.5 109.179 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.2 m -73.88 -2.65 24.69 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.254 -0.885 . . . . 11.039999999999999 111.06 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.33 -32.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.464 -0.569 . . . . 8.5 109.464 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.36 68.9 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.299 0.571 . . . . 7.7000000000000002 111.22 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.37 -24.69 34.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.411 -0.588 . . . . 10.380000000000001 109.411 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.63 -60.97 2.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.66 -0.7 . . . . 11.970000000000001 110.05 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -46.14 -52.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 124.053 0.845 . . . . 9.8000000000000007 113.199 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.428 ' CG ' ' HE ' ' A' ' 107' ' ' ARG . 20.2 t70 -61.91 -45.38 93.98 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 111.897 0.332 . . . . 10.83 111.897 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -78.27 -29.76 48.15 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.463 -0.789 . . . . 13.5 110.448 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.25 -39.61 74.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.633 -0.712 . . . . 14.84 109.391 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.0 t -78.39 -60.55 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.692 -0.685 . . . . 13.35 111.658 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 108.664 -0.865 . . . . 13.51 108.664 -173.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 109.412 -0.588 . . . . 18.510000000000002 109.412 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . 176.26 -177.21 0.13 Allowed 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.544 1.138 . . . . 16.66 108.465 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.24 -24.82 66.65 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.544 0.611 . . . . 14.84 111.164 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.45 -26.7 68.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 14.98 112.058 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 2' ' ' ALA . 10.2 pt-20 -68.89 -27.24 65.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.272 0.558 . . . . 15.789999999999999 110.206 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.8 -33.46 75.66 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.459 -0.571 . . . . 12.02 109.459 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 -26.68 32.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.157 -0.474 . . . . 11.02 110.543 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -67.47 -33.97 76.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.175 -0.676 . . . . 16.07 109.175 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -68.5 -28.97 67.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.505 -0.771 . . . . 13.93 109.749 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.81 -44.4 96.25 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.379 -0.6 . . . . 10.710000000000001 109.379 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.922 -0.581 . . . . 14.02 109.492 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.75 -46.1 73.07 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.495 -0.775 . . . . 16.289999999999999 110.131 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' MET . 48.4 t -59.34 -45.59 90.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.573 -0.74 . . . . 12.91 110.365 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.48 -45.44 93.75 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.273 -0.422 . . . . 12.77 111.449 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.53 -22.95 63.53 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.253 -0.43 . . . . 15.19 111.574 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 -24.36 49.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.426 0.631 . . . . 16.260000000000002 109.628 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 13' ' ' SER . 26.5 mmt -78.05 -44.22 27.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.619 -0.719 . . . . 15.449999999999999 109.197 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.67 5.49 51.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 16.16 112.607 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 53.41 45.61 27.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.237 1.415 . . . . 20.559999999999999 113.107 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -125.33 -173.8 2.91 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.345 -0.983 . . . . 16.629999999999999 108.345 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -107.32 134.99 19.72 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 107.976 -1.12 . . . . 20.190000000000001 107.976 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -66.04 -11.17 29.93 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.233 2.622 . . . . 16.600000000000001 112.859 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.78 -3.41 85.91 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.527 -0.629 . . . . 17.739999999999998 111.527 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -102.75 175.41 5.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.677 -1.231 . . . . 20.23 107.677 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.485 HG12 ' HG ' ' A' ' 34' ' ' LEU . 1.9 mp 70.96 140.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 123.883 0.739 . . . . 15.98 110.725 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 6.8 mpt_? -75.25 122.77 24.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.738 -0.601 . . . . 19.329999999999998 109.577 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.675 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 p30 -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.83 0.678 . . . . 14.93 112.83 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.37 7.4 68.88 Favored Glycine 0 C--N 1.315 -0.614 0 N-CA-C 110.649 -0.98 . . . . 14.82 110.649 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 26' ' ' ARG . 23.3 t -99.19 171.34 8.06 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.48 0.657 . . . . 14.539999999999999 109.54 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 81.8 mtm180 -92.93 160.3 14.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.163 -0.926 . . . . 16.75 110.38 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -58.26 -18.98 30.66 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.595 -1.184 . . . . 11.99 112.423 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -29.38 70.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.965 -0.561 . . . . 14.449999999999999 111.609 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.33 -35.45 80.38 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.361 0.6 . . . . 16.440000000000001 109.814 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' A' ' 25' ' ' ILE . 4.1 mp -83.43 -8.92 59.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.772 -0.649 . . . . 13.77 110.248 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.78 35.26 73.08 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 114.83 -1.077 . . . . 13.81 111.373 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.04 114.05 8.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.623 -0.51 . . . . 13.039999999999999 109.623 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.22 156.34 23.21 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.481 -0.781 . . . . 15.67 109.784 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 t -56.22 -41.47 75.71 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.271 0.357 . . . . 15.289999999999999 111.45 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.23 -47.62 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.912 0.387 . . . . 16.66 110.985 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mt -66.03 -39.68 85.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.026 -0.534 . . . . 14.140000000000001 109.683 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.62 99.11 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.588 -0.733 . . . . 12.0 110.444 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.48 85.06 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.564 0.745 . . . . 13.970000000000001 111.093 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.84 -47.61 44.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.96 -0.564 . . . . 15.69 111.56 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -61.31 -47.28 86.68 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.088 0.555 . . . . 11.69 111.644 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 48' ' ' ILE . 10.5 tp -59.69 -32.94 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 120.892 0.377 . . . . 11.16 110.571 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -66.86 -32.28 73.45 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.053 -0.522 . . . . 16.649999999999999 110.521 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.59 -31.97 60.16 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.564 -0.902 . . . . 14.15 108.564 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 45' ' ' ILE . 70.4 mt -62.49 -35.12 68.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.566 -0.743 . . . . 10.800000000000001 109.783 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.93 -31.04 70.58 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.475 -0.784 . . . . 12.98 110.042 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -43.95 20.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.934 -0.575 . . . . 17.52 110.047 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -65.11 -46.3 81.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.65 0.611 . . . . 14.869999999999999 112.65 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 55.6 m-85 -100.17 -0.03 39.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 112.787 0.662 . . . . 12.199999999999999 112.787 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 53.12 45.17 29.24 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.403 1.481 . . . . 16.710000000000001 111.702 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 96.0 mt -134.32 142.87 47.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.579 -1.191 . . . . 12.199999999999999 109.485 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -77.51 75.69 4.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.72 -0.844 . . . . 16.059999999999999 108.72 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 25.0 mm -94.18 119.95 66.06 Favored Pre-proline 0 N--CA 1.436 -1.135 0 CA-C-N 116.292 -0.413 . . . . 11.390000000000001 111.814 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -84.15 164.21 13.24 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.869 2.38 . . . . 12.6 110.112 173.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -2.92 17.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.634 -0.712 . . . . 12.52 112.518 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 p30 -68.3 -23.6 64.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.936 -0.306 . . . . 14.140000000000001 110.957 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.06 -30.62 70.66 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 119.883 -1.151 . . . . 10.76 111.588 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.94 -21.15 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.723 0.809 . . . . 11.0 110.036 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 16.7 m-85 -85.33 -45.86 11.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.384 -0.598 . . . . 16.420000000000002 109.384 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -67.54 -44.6 77.94 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.929 -0.578 . . . . 13.35 110.127 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.05 86.72 14.15 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.873 -0.788 . . . . 12.23 108.873 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 84.1 Cg_endo -83.9 14.87 2.28 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.751 2.301 . . . . 13.06 113.275 -174.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.8 t -124.56 120.29 58.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.118 -1.808 . . . . 12.949999999999999 106.118 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.5 p90 -58.72 -31.6 68.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 10.92 114.313 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -69.36 -24.98 63.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.766 0.654 . . . . 14.32 112.766 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.78 16.97 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.644 -0.873 . . . . 10.93 108.644 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 57.2 t80 -62.15 -28.91 69.98 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.748 -1.114 . . . . 8.8100000000000005 112.262 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 p -70.0 -26.45 64.08 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.471 -0.768 . . . . 9.3499999999999996 110.716 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -81.44 -28.94 33.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.746 -0.835 . . . . 11.630000000000001 108.746 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.502 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 66.1 t90 -58.26 -52.27 66.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.476 1.111 . . . . 10.550000000000001 108.094 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 54.4 t -67.88 -39.9 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 CA-C-N 115.266 -0.879 . . . . 8.3000000000000007 110.781 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.73 97.07 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.192 -0.528 . . . . 9.5800000000000001 112.3 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.2 m -67.99 -35.97 79.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 111.786 0.291 . . . . 10.23 111.786 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 27.6 pt20 -75.78 -18.77 59.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.363 -0.535 . . . . 10.43 110.517 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.09 -18.09 40.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.141 -0.481 . . . . 10.970000000000001 111.039 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -117.52 92.6 41.18 Favored Pre-proline 0 C--O 1.244 0.767 0 N-CA-C 109.879 -0.415 . . . . 13.52 109.879 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -53.27 121.44 9.43 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.434 2.756 . . . . 12.279999999999999 112.05 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -65.91 -19.54 65.91 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.479 1.112 . . . . 13.44 113.183 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.22 -2.88 23.58 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 121.711 -0.618 . . . . 13.27 111.387 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.5 -18.1 28.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.921 0.391 . . . . 14.48 110.883 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 p -78.57 65.7 3.91 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.707 0.632 . . . . 14.92 112.707 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.62 136.38 38.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.04 -1.096 . . . . 14.25 108.04 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.96 125.36 80.09 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.808 -0.812 . . . . 12.970000000000001 108.808 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.95 116.51 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.416 2.077 . . . . 13.4 111.663 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.84 117.95 49.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.423 -0.955 . . . . 12.43 108.423 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -73.32 125.17 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.986 0.422 . . . . 13.449999999999999 110.851 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -127.71 41.15 3.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.636 -0.711 . . . . 14.41 109.517 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -86.87 120.94 71.91 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.138 -0.937 . . . . 11.68 110.022 -178.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 7.1 Cg_exo -72.6 66.47 3.79 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.859 2.372 . . . . 10.84 112.032 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -111.28 123.11 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.941 -0.572 . . . . 10.460000000000001 109.587 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.82 18.27 8.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.307 -0.627 . . . . 10.58 109.307 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.1 m 74.77 -48.27 0.64 Allowed 'General case' 0 C--O 1.251 1.179 0 C-N-CA 125.176 1.39 . . . . 11.039999999999999 111.325 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.84 141.66 98.4 Favored Pre-proline 0 N--CA 1.446 -0.632 0 C-N-CA 123.62 0.768 . . . . 10.880000000000001 109.167 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.18 -12.76 24.65 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.697 2.931 . . . . 12.460000000000001 113.768 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -127.67 95.89 34.02 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 108.578 -0.897 . . . . 13.779999999999999 108.578 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.01 94.46 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.594 2.196 . . . . 11.949999999999999 110.398 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.03 160.98 16.33 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.485 -0.864 . . . . 11.48 112.192 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -60.36 3.55 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.757 0.823 . . . . 11.550000000000001 111.148 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -74.31 -10.92 60.06 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.603 0.594 . . . . 12.59 112.603 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.16 68.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.491 0.186 . . . . 11.24 111.347 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.4 m -147.54 -32.68 0.28 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.922 0.712 . . . . 10.050000000000001 112.922 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -42.03 80.88 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.414 0.524 . . . . 11.220000000000001 112.414 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -51.72 -48.4 63.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.405 0.682 . . . . 11.380000000000001 111.573 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -68.92 -42.82 76.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 9.6500000000000004 109.951 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.32 -44.48 83.25 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.989 -1.005 . . . . 10.43 111.766 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -59.84 -39.09 83.98 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.639 0.257 . . . . 10.210000000000001 111.038 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.66 HG21 HG11 ' A' ' 178' ' ' VAL . 59.7 mt -71.29 -50.95 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.921 -0.4 . . . . 8.1300000000000008 109.921 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -58.84 -39.94 82.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.109 -0.496 . . . . 8.4600000000000009 111.139 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 31.0 t70 -67.73 -36.98 81.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 10.859999999999999 111.007 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -70.05 -42.55 72.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.316 0.579 . . . . 11.449999999999999 109.782 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.6 -41.49 94.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.534 1.134 . . . . 7.6200000000000001 109.033 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 33.9 ttmt -54.47 -54.3 42.74 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.559 1.544 . . . . 11.619999999999999 110.254 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -67.34 -42.75 83.04 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.916 -0.583 . . . . 11.630000000000001 111.908 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.4 t -56.75 -53.09 61.73 Favored 'General case' 0 C--O 1.248 1.021 0 O-C-N 123.574 0.546 . . . . 9.1400000000000006 111.79 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.36 -36.77 74.39 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 120.676 -0.409 . . . . 10.06 110.912 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.7 84.95 Favored Glycine 0 C--O 1.223 -0.546 0 N-CA-C 111.24 -0.744 . . . . 12.07 111.24 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 -44.4 91.52 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 124.423 1.089 . . . . 12.32 110.804 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 148' ' ' TRP . 17.6 tp -66.0 -49.6 67.23 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.96 -1.018 . . . . 11.77 112.145 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 tp -94.02 4.23 54.21 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.703 -0.681 . . . . 13.52 112.358 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.1 t80 59.78 40.65 19.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.197 1.399 . . . . 16.559999999999999 110.187 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -111.49 154.86 24.12 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.78 -1.563 . . . . 15.74 106.78 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.8 117.94 63.88 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 107.577 -1.268 . . . . 14.199999999999999 107.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.57 107.89 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.921 3.081 . . . . 14.18 113.033 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 130' ' ' ARG . . . 125.46 -36.31 2.82 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.505 -1.225 . . . . 14.029999999999999 111.651 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -86.31 42.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.38 1.086 . . . . 16.370000000000001 109.366 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.65 -7.07 1.69 Allowed 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.584 -1.644 . . . . 12.449999999999999 111.199 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 127' ' ' GLY . 38.5 ptt180 -95.91 -5.95 40.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.94 -0.573 . . . . 14.43 110.081 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -70.22 -33.95 72.29 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 14.32 108.797 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.41 -62.67 0.95 Allowed Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 108.84 -1.704 . . . . 13.75 108.84 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 138' ' ' LEU . . . 60.07 26.81 16.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.367 1.067 . . . . 12.699999999999999 110.992 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -97.68 139.89 32.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.308 -1.315 . . . . 16.379999999999999 109.662 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 14.5 p90 -70.19 -12.88 61.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.276 -0.875 . . . . 13.300000000000001 109.43 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.65 -32.12 62.16 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.272 -0.876 . . . . 16.25 110.342 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.17 -42.39 6.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.429 0.633 . . . . 15.869999999999999 110.852 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 133' ' ' ALA . 70.5 mt -79.66 -22.35 43.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.589 -0.732 . . . . 13.65 110.465 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -102.72 43.79 1.62 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.954 -1.259 . . . . 14.16 109.954 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.7 ttp -60.29 -43.41 96.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.655 0.782 . . . . 15.449999999999999 110.551 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -127.34 120.21 28.02 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 107.479 -1.304 . . . . 13.630000000000001 107.479 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -62.06 -39.33 92.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.877 -1.056 . . . . 13.9 111.972 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.7 t -68.76 -36.83 76.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 110.146 -0.316 . . . . 13.81 110.146 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.5 m -56.9 -46.61 81.8 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.194 -0.457 . . . . 11.48 109.776 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.96 -22.52 76.67 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 119.677 -1.249 . . . . 10.35 111.87 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.419 ' HA ' ' HB1' ' A' ' 162' ' ' ALA . 92.5 m -63.81 -48.89 75.05 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.64 -0.504 . . . . 12.199999999999999 109.64 176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -59.6 -40.24 86.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.57 0.7 . . . . 11.859999999999999 110.227 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.484 ' HB2' HD22 ' A' ' 121' ' ' LEU . 22.4 t90 -68.5 -53.03 25.89 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.927 -1.033 . . . . 9.3200000000000003 112.318 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 32.7 ttm -65.96 -35.06 79.56 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 111.915 0.339 . . . . 9.5 111.915 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -66.4 -35.95 81.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.528 . . . . 13.91 109.576 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.06 -43.54 97.14 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.628 -0.989 . . . . 9.8800000000000008 110.628 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' TRP . 75.9 t -56.55 -45.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.607 0.763 . . . . 9.2699999999999996 109.253 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.2 m -59.51 -40.15 86.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.377 -0.828 . . . . 11.460000000000001 110.994 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -70.72 -46.96 62.1 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.478 -0.328 . . . . 15.039999999999999 111.591 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -68.22 -30.61 69.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.293 0.849 . . . . 11.82 113.293 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -101.56 0.16 35.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.075 -0.65 . . . . 11.970000000000001 112.123 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.8 m 56.42 45.94 21.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.638 -1.164 . . . . 14.24 112.308 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.5 156.15 41.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 12.619999999999999 109.047 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -88.8 106.58 18.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.221 -1.029 . . . . 16.390000000000001 108.221 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.41 110.3 11.38 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.782 -0.451 . . . . 12.32 109.782 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.28 135.92 47.67 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.944 -0.571 . . . . 14.06 110.469 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 146' ' ' THR . . . -63.46 -8.61 9.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.416 1.086 . . . . 12.640000000000001 112.834 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -77.42 -10.75 59.65 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.386 -0.598 . . . . 15.68 109.386 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.452 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -63.7 -13.13 40.35 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 116.102 -0.499 . . . . 12.720000000000001 112.256 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.8 pt -68.64 -12.32 15.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 121.166 0.508 . . . . 12.16 109.937 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.59 19.32 13.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.548 -0.908 . . . . 15.08 108.548 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 88.8 m -108.24 -26.55 10.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.187 -0.915 . . . . 14.67 109.679 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -122.75 143.67 40.76 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 107.978 -1.119 . . . . 12.68 107.978 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.572 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 68.8 Cg_endo -93.02 -5.73 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.902 1.735 . . . . 14.34 111.897 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.756 -0.656 . . . . 12.91 111.134 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.94 -32.92 71.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.904 -1.043 . . . . 9.8900000000000006 111.988 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -62.71 -20.36 64.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.172 -0.467 . . . . 12.5 111.187 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.8 m -70.88 -17.65 62.71 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.102 -0.499 . . . . 11.039999999999999 111.024 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.72 -44.94 61.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.892 -1.151 . . . . 8.5 107.892 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.02 80.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.471 -0.786 . . . . 7.7000000000000002 111.39 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.99 -19.75 60.55 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.318 0.488 . . . . 10.380000000000001 112.318 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -74.75 -52.61 11.05 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.331 -0.618 . . . . 11.970000000000001 109.331 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 110' ' ' ILE . 3.3 p -62.46 -42.64 96.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.578 -0.737 . . . . 9.8000000000000007 110.497 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.43 -41.87 90.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.401 . . . . 10.83 110.655 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -69.07 -53.24 21.43 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.74 0.816 . . . . 13.5 113.071 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -85.01 -32.47 22.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 115.187 1.551 . . . . 14.84 115.187 -173.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.87 -40.75 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.817 -0.753 . . . . 13.35 110.213 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 120.44 -0.504 . . . . 13.51 110.255 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 121.215 0.531 . . . . 18.510000000000002 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.87 97.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.015 0.436 . . . . 16.66 112.148 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.98 -23.8 67.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.851 -0.613 . . . . 14.84 111.686 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -98.49 -19.57 17.58 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.921 -0.712 . . . . 14.98 110.008 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.92 -37.85 87.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 120.842 0.353 . . . . 15.789999999999999 111.295 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 p -63.82 -32.15 73.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.069 0.461 . . . . 12.02 111.016 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -75.14 -40.85 59.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.254 -0.43 . . . . 11.02 109.843 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 49.8 mt-30 -54.47 -43.91 72.13 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.8 0.44 . . . . 16.07 110.616 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.1 -41.41 78.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.771 -0.649 . . . . 13.93 111.006 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.32 -36.29 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.365 -0.38 . . . . 10.710000000000001 110.753 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 68.0 mtt180 -60.57 -45.64 93.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.763 -0.829 . . . . 14.02 108.763 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 77.1 mt-30 -59.92 -53.83 53.22 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.558 -0.747 . . . . 16.289999999999999 110.244 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 m -56.71 -42.85 79.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.123 -0.944 . . . . 12.91 112.681 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.83 -52.15 22.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.455 0.169 . . . . 12.77 110.687 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.71 71.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.39 0.515 . . . . 15.19 112.39 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.32 84.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.656 0.265 . . . . 16.260000000000002 111.544 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.3 mtt -75.81 -32.24 59.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.291 0.567 . . . . 15.449999999999999 110.893 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.62 -2.36 41.74 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.877 -0.601 . . . . 16.16 112.199 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 57.54 44.05 21.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.548 1.139 . . . . 20.559999999999999 111.589 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.57 177.0 4.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.134 -1.061 . . . . 16.629999999999999 108.134 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -96.76 133.72 24.09 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 110.47 -0.196 . . . . 20.190000000000001 110.47 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.77 20.66 1.19 Allowed 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 122.89 2.394 . . . . 16.600000000000001 111.484 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.16 -104.45 1.2 Allowed Glycine 0 N--CA 1.428 -1.89 0 CA-C-N 114.899 -1.046 . . . . 17.739999999999998 113.245 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.42 67.63 9.97 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.299 0.852 . . . . 20.23 113.299 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 pt -90.65 163.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.266 -1.012 . . . . 15.98 108.266 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 62.0 mtm180 -81.33 132.54 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.382 0.611 . . . . 19.329999999999998 109.569 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.01 -39.15 59.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.245 1.818 . . . . 14.93 112.475 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.32 7.48 66.46 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.8 -0.636 . . . . 14.82 114.182 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 74.8 m -68.2 119.16 12.32 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.815 0.817 . . . . 14.539999999999999 112.302 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 89.6 mtt180 -70.53 157.92 37.03 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.911 -1.495 . . . . 16.75 110.562 176.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -52.27 -48.6 65.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.951 0.405 . . . . 11.99 111.648 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.27 -41.31 84.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.534 0.734 . . . . 14.449999999999999 110.584 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HH21 ' A' ' 26' ' ' ARG . 6.3 tp10 -65.66 -45.14 84.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.854 -0.612 . . . . 16.440000000000001 110.463 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.4 -35.58 74.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.984 -0.553 . . . . 13.77 110.925 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.73 22.06 1.33 Allowed Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.194 -1.003 . . . . 13.81 112.983 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 167.18 20.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.533 0.682 . . . . 13.039999999999999 110.681 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -131.41 152.24 50.83 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 117.403 -1.284 . . . . 15.67 107.57 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -55.98 -40.32 73.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 119.495 1.043 . . . . 15.289999999999999 111.923 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.21 -51.11 51.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.732 -0.667 . . . . 16.66 110.405 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.64 -35.6 73.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.923 -0.581 . . . . 14.140000000000001 112.226 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.97 -30.09 70.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 12.0 110.336 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.47 78.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.512 -0.767 . . . . 13.970000000000001 110.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.54 -43.22 66.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 120.473 -0.491 . . . . 15.69 109.762 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -55.76 -54.67 41.62 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.605 -1.18 . . . . 11.69 110.823 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 56' ' ' ILE . 10.8 tp -62.51 -31.69 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.804 0.335 . . . . 11.16 110.882 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.53 -35.25 75.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.386 0.612 . . . . 16.649999999999999 109.509 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -70.21 -21.79 62.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.018 -0.537 . . . . 14.15 112.169 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.9 -46.21 92.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.6 -0.889 . . . . 10.800000000000001 108.6 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -62.58 -34.59 77.28 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.321 -0.854 . . . . 12.98 110.952 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -79.12 -39.88 32.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.289 -0.414 . . . . 17.52 110.957 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -79.46 -28.09 41.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.404 -0.362 . . . . 14.869999999999999 111.962 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -107.88 -4.84 17.61 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.439 1.274 . . . . 12.199999999999999 114.439 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 44.32 47.64 7.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.863 1.665 . . . . 16.710000000000001 112.854 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.0 tp -145.33 151.8 38.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.901 -1.148 . . . . 12.199999999999999 107.901 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.86 129.41 34.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.911 -0.774 . . . . 16.059999999999999 108.911 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 HD11 ' A' ' 45' ' ' ILE . 2.3 pp -124.97 153.52 71.12 Favored Pre-proline 0 N--CA 1.42 -1.957 0 C-N-CA 122.76 0.424 . . . . 11.390000000000001 110.14 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.18 96.35 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.954 1.769 . . . . 12.6 110.983 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.77 66.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.454 0.645 . . . . 12.52 109.849 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.08 -7.99 14.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 114.632 -1.167 . . . . 14.140000000000001 111.735 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.7 -35.49 89.87 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 116.017 -0.538 . . . . 10.76 112.184 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -73.68 -28.6 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.973 0.892 . . . . 11.0 109.445 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -85.24 -3.09 58.7 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.184 -0.916 . . . . 16.420000000000002 112.197 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -111.04 -73.23 0.69 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 116.356 -0.384 . . . . 13.35 110.705 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -136.82 88.51 18.56 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 122.199 1.0 . . . . 12.23 110.106 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.1 Cg_endo -80.91 62.41 8.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.828 3.019 . . . . 13.06 114.063 -172.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.71 129.56 43.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.709 -1.96 . . . . 12.949999999999999 105.709 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.37 -37.82 74.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.353 -0.385 . . . . 10.92 111.723 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.33 -31.94 72.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.458 0.647 . . . . 14.32 110.215 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.2 45.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.461 0.648 . . . . 10.93 109.5 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' TRP . 58.1 t80 -72.44 -32.65 66.48 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.499 -0.773 . . . . 8.8100000000000005 111.364 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -65.2 -23.78 67.18 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.008 -0.677 . . . . 9.3499999999999996 111.017 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -78.13 -33.73 50.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.23 -0.655 . . . . 11.630000000000001 109.23 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -50.2 -59.55 3.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.058 . . . . 10.550000000000001 110.411 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.58 -34.48 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 CA-C-N 115.742 -0.663 . . . . 8.3000000000000007 110.666 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.43 -38.24 93.2 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 116.068 -0.514 . . . . 9.5800000000000001 113.234 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -81.17 -20.46 41.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.226 0.536 . . . . 10.23 110.12 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 82.1 mm-40 -76.8 -23.37 52.83 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.362 0.601 . . . . 10.43 109.906 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.24 61.53 6.88 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.129 0.966 . . . . 10.970000000000001 109.385 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -98.79 122.46 52.9 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 106.611 -1.626 . . . . 13.52 106.611 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.64 65.96 7.43 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.189 1.926 . . . . 12.279999999999999 113.109 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.0 m -77.65 72.84 4.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.389 1.09 . . . . 13.44 109.221 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -141.92 -51.75 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.555 -1.202 . . . . 13.27 107.932 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.14 -4.98 59.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.134 -0.939 . . . . 14.48 110.82 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -60.74 113.3 2.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 124.234 1.014 . . . . 14.92 111.121 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.43 60.49 0.61 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.185 -1.043 . . . . 14.25 108.185 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.18 123.94 89.33 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.877 -1.056 . . . . 12.970000000000001 110.181 -176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.24 110.11 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 13.4 112.287 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.3 77.27 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 121.842 0.829 . . . . 12.43 112.42 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 51.88 63.34 2.28 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.045 1.338 . . . . 13.449999999999999 110.683 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -67.64 -71.1 0.22 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.776 -0.647 . . . . 14.41 110.462 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -93.93 107.62 29.28 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 108.724 -0.843 . . . . 11.68 108.724 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.39 -21.01 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.764 1.642 . . . . 10.84 111.435 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.17 128.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 115.356 -0.838 . . . . 10.460000000000001 109.702 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.16 -7.31 6.52 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.818 -0.628 . . . . 10.58 110.49 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t 166.3 -29.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 105.142 -2.17 . . . . 11.039999999999999 105.142 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.88 166.61 17.49 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 103.147 -2.908 . . . . 10.880000000000001 103.147 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.66 42.44 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.057 2.505 . . . . 12.460000000000001 113.78 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -131.16 151.27 78.6 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 106.918 -1.512 . . . . 13.779999999999999 106.918 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.63 58.39 6.94 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.543 2.162 . . . . 11.949999999999999 112.775 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.7 110.67 0.45 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.655 -0.978 . . . . 11.48 110.655 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.67 -34.21 40.55 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.844 0.831 . . . . 11.550000000000001 109.957 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -85.16 65.6 9.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 122.408 1.099 . . . . 12.59 109.969 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.14 24.85 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.708 -1.59 . . . . 11.24 106.708 172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 107' ' ' ARG . 9.9 p -98.67 85.88 3.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.776 -1.557 . . . . 10.050000000000001 108.256 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.61 -56.77 17.57 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.204 -0.907 . . . . 11.220000000000001 112.867 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 110' ' ' ILE . 31.3 mm-40 -59.04 -41.66 88.39 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.409 0.623 . . . . 11.380000000000001 110.562 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 37.3 ttt180 -66.24 -36.89 84.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.043 -0.981 . . . . 9.6500000000000004 111.565 -176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.57 -34.51 70.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.877 -0.729 . . . . 10.43 110.851 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 m -62.28 -41.58 98.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.78 -0.822 . . . . 10.210000000000001 108.78 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 51.7 mt -56.68 -44.52 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.165 -0.925 . . . . 8.1300000000000008 110.932 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 107' ' ' ARG . 15.1 mm100 -53.97 -30.74 48.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.45 0.7 . . . . 8.4600000000000009 112.431 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -71.14 -46.75 60.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.468 0.652 . . . . 10.859999999999999 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 96.0 m-85 -74.79 -27.42 60.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.33 0.586 . . . . 11.449999999999999 110.258 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -66.03 -42.3 89.8 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.26 -1.015 . . . . 7.6200000000000001 108.26 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -60.95 -42.18 97.73 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.001 -0.999 . . . . 11.619999999999999 109.78 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.89 -20.01 65.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 11.630000000000001 112.382 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.4 m -82.63 -46.02 13.79 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.22 -0.659 . . . . 9.1400000000000006 109.22 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 59.9 tp -63.13 -41.76 99.38 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.554 0.692 . . . . 10.06 109.633 175.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.82 -49.66 76.16 Favored Glycine 0 C--O 1.2 -2.0 0 CA-C-N 114.935 -1.029 . . . . 12.07 112.454 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -63.48 -28.7 70.14 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.004 0.43 . . . . 12.32 111.094 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 147' ' ' GLN . 26.3 tp -61.3 -42.01 97.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.68 -0.691 . . . . 11.77 110.713 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.13 -76.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.128 -0.693 . . . . 13.52 109.128 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -173.7 -46.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.103 2.561 . . . . 16.559999999999999 106.662 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.5 tp -168.21 148.7 4.87 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.252 -2.129 . . . . 15.74 105.252 175.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 0.9 OUTLIER -95.82 136.07 22.51 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.29 -1.374 . . . . 14.199999999999999 107.29 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 2.7 Cg_endo -86.54 29.86 0.5 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.239 1.959 . . . . 14.18 112.929 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.78 57.61 0.78 Allowed Glycine 0 C--N 1.309 -0.924 0 N-CA-C 110.376 -1.089 . . . . 14.029999999999999 110.376 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.58 -18.27 20.72 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.526 0.679 . . . . 16.370000000000001 110.689 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.8 113.97 5.99 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.097 -0.956 . . . . 12.449999999999999 110.538 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 75.84 10.26 3.3 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.261 . . . . 14.43 112.247 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.3 m -103.66 25.89 9.21 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.68 0.752 . . . . 14.32 110.019 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.39 88.78 1.98 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.68 -0.771 . . . . 13.75 111.99 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.58 95.58 4.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.946 -0.761 . . . . 12.699999999999999 108.946 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -118.37 146.69 44.2 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.658 0.742 . . . . 16.379999999999999 111.305 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -62.14 -14.63 39.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.819 1.248 . . . . 13.300000000000001 112.396 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -69.15 -33.1 72.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.372 0.606 . . . . 16.25 109.905 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.51 -44.74 5.77 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.416 -0.811 . . . . 15.869999999999999 110.372 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.06 -23.21 64.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.993 -0.549 . . . . 13.65 111.2 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.06 16.15 30.43 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.557 -0.747 . . . . 14.16 111.626 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.7 ttm -77.85 -24.09 48.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.74 -1.207 . . . . 15.449999999999999 107.74 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.08 139.91 52.25 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.669 -1.975 . . . . 13.630000000000001 105.669 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.9 m -80.78 -22.73 39.87 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.435 -0.95 . . . . 13.9 108.435 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.878 1.271 . . . . 13.81 111.976 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.37 88.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.882 -0.599 . . . . 11.48 111.572 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.8 44.26 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.782 -0.723 . . . . 10.35 111.354 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.6 m -53.28 -50.87 63.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.346 0.658 . . . . 12.199999999999999 110.938 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 121' ' ' LEU . 52.3 mt-30 -76.49 -34.37 58.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.404 0.89 . . . . 11.859999999999999 113.404 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -69.9 -52.42 24.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.398 -0.521 . . . . 9.3200000000000003 109.614 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.494 ' SD ' ' HA ' ' A' ' 165' ' ' ILE . 33.1 ttm -69.66 -31.62 69.8 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.345 0.498 . . . . 9.5 112.345 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -64.57 -35.0 79.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.45 -0.574 . . . . 13.91 109.45 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.71 85.79 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.218 -1.153 . . . . 9.8800000000000008 110.218 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 158' ' ' ILE . 85.2 t -58.05 -49.76 80.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 123.748 0.819 . . . . 9.2699999999999996 110.036 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.3 t -55.98 -49.55 73.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.813 0.845 . . . . 11.460000000000001 110.681 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -66.04 -49.6 67.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.754 0.279 . . . . 15.039999999999999 111.754 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -63.06 -34.59 77.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.302 0.853 . . . . 11.82 113.302 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.441 ' CZ ' HG23 ' A' ' 110' ' ' ILE . 88.5 m-85 -101.06 -3.76 28.67 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.952 0.723 . . . . 11.970000000000001 112.952 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t 63.63 34.41 12.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.826 0.85 . . . . 14.24 109.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 152' ' ' VAL . 33.5 pt -107.47 155.66 8.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.635 -0.711 . . . . 12.619999999999999 109.492 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -99.42 96.75 7.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.791 0.329 . . . . 16.390000000000001 111.87 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -124.73 118.59 26.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -108.0 168.4 9.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.423 0.63 . . . . 14.06 111.154 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.13 -6.78 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.505 1.522 . . . . 12.640000000000001 114.751 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.91 -23.46 17.43 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.516 -0.474 . . . . 15.68 109.948 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.27 0.52 31.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.786 0.803 . . . . 12.720000000000001 109.473 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.494 ' HA ' ' SD ' ' A' ' 149' ' ' MET . 5.9 tt -75.11 -14.41 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.899 -1.046 . . . . 12.16 110.46 -172.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -106.4 6.37 30.32 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.224 -0.898 . . . . 15.08 109.46 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.2 m -87.09 -32.11 20.11 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.796 -0.638 . . . . 14.67 110.092 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.45 74.19 77.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.22 -0.659 . . . . 12.68 109.22 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -94.4 37.22 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.837 2.358 . . . . 14.34 112.115 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 p -140.77 163.2 33.56 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 12.91 109.788 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 49.2 tp -67.21 -55.38 14.3 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.916 0.389 . . . . 9.8900000000000006 110.518 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -61.27 -44.56 97.03 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.409 -0.814 . . . . 12.5 112.856 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -68.24 -30.66 69.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.754 0.252 . . . . 11.039999999999999 110.696 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.59 -45.83 61.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.438 -1.319 . . . . 8.5 107.438 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.87 99.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.605 -0.725 . . . . 7.7000000000000002 111.243 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 7.0 m-20 -62.94 -33.63 75.76 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.68 0.276 . . . . 10.380000000000001 110.679 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 24.7 tp10 -69.22 -57.05 5.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.973 -0.558 . . . . 11.970000000000001 110.528 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.431 HG22 HD13 ' A' ' 110' ' ' ILE . 7.0 p -59.93 -36.67 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.136 -0.483 . . . . 9.8000000000000007 111.518 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.93 -38.36 82.16 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.1 0.476 . . . . 10.83 111.19 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 26.6 mmm180 -77.87 -33.26 52.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 13.5 111.481 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 9.7 mmp_? -73.25 -44.5 59.31 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.745 -0.382 . . . . 14.84 111.555 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.18 -51.73 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.22 0.325 . . . . 13.35 111.761 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.395 -0.812 . . . . 13.51 111.284 -177.156 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 9.6 p . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 108.336 -0.987 . . . . 18.510000000000002 108.336 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . -108.85 -23.63 11.65 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.427 0.528 . . . . 16.66 112.427 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.99 -38.85 12.56 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.758 -0.589 . . . . 14.84 110.882 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -94.46 0.58 55.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.016 -0.538 . . . . 14.98 109.932 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 1' ' ' VAL . 8.6 pt-20 -52.09 -35.44 47.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.901 0.704 . . . . 15.789999999999999 112.901 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.74 -43.27 99.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.138 0.495 . . . . 12.02 111.046 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.55 81.78 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.099 -0.501 . . . . 11.02 109.872 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -55.58 -52.31 64.2 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.542 0.526 . . . . 16.07 110.094 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -60.48 -45.72 92.73 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.176 -0.92 . . . . 13.93 111.11 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.89 -36.96 78.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.227 -0.442 . . . . 10.710000000000001 111.245 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -62.5 -42.65 99.64 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.032 -0.729 . . . . 14.02 109.032 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -67.65 -49.62 62.0 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.354 -0.839 . . . . 16.289999999999999 110.987 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -62.21 -36.01 80.62 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.041 0.386 . . . . 12.91 112.041 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.47 -55.64 19.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.442 -0.947 . . . . 12.77 108.442 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.87 89.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.131 -0.94 . . . . 15.19 112.016 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.6 77.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.895 0.379 . . . . 16.260000000000002 111.479 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.497 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 66.1 mtt -73.76 -21.55 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.677 -0.238 . . . . 15.449999999999999 111.511 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.02 11.96 25.52 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.277 0.473 . . . . 16.16 112.277 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 60.84 40.78 15.41 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.419 1.104 . . . . 20.559999999999999 110.06 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 68.1 m -121.93 155.28 35.83 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.694 -0.854 . . . . 16.629999999999999 108.694 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.42 131.3 31.39 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.74 -0.467 . . . . 20.190000000000001 109.74 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.62 -21.5 62.87 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.918 3.079 . . . . 16.600000000000001 116.006 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.39 -6.2 84.15 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 119.939 -1.124 . . . . 17.739999999999998 111.967 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -113.96 21.84 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.223 0.535 . . . . 20.23 110.785 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.3 153.4 7.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.79 -1.189 . . . . 15.98 107.79 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -108.22 124.98 51.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.401 0.619 . . . . 19.329999999999998 111.085 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -73.0 -21.47 60.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.715 -1.13 . . . . 14.93 111.459 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.92 5.29 79.06 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.303 -0.951 . . . . 14.82 112.906 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB2' HD21 ' A' ' 34' ' ' LEU . 54.2 m -91.68 157.29 17.03 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.521 0.677 . . . . 14.539999999999999 110.405 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 22.0 mtp180 -82.49 146.87 29.01 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.988 -1.006 . . . . 16.75 111.347 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -54.64 -43.54 72.39 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 118.52 0.6 . . . . 11.99 112.416 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.11 -31.21 72.3 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.017 -0.538 . . . . 14.449999999999999 110.942 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.63 -30.06 46.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.581 0.705 . . . . 16.440000000000001 109.266 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 29' ' ' SER . 95.8 mt -72.0 -28.92 63.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.675 -0.693 . . . . 13.77 110.572 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.03 4.4 7.87 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.333 -0.937 . . . . 13.81 112.773 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.3 tt -81.93 131.16 35.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.976 0.417 . . . . 13.039999999999999 110.084 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.11 166.42 12.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 117.959 -1.019 . . . . 15.67 109.344 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -55.92 -41.53 74.73 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 119.166 0.894 . . . . 15.289999999999999 110.949 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.01 -44.98 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.632 -0.713 . . . . 16.66 110.4 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.14 -38.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.935 -0.575 . . . . 14.140000000000001 109.946 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.27 -46.31 86.25 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 123.372 0.669 . . . . 12.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.32 71.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.709 0.766 . . . . 13.970000000000001 111.251 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -78.43 -47.91 16.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.328 -0.851 . . . . 15.69 110.931 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 7.6 t90 -60.6 -48.81 80.12 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.323 1.449 . . . . 11.69 111.367 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 tp -62.34 -28.41 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.718 0.77 . . . . 11.16 110.519 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.36 -35.05 54.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.211 -0.904 . . . . 16.649999999999999 109.637 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -74.29 -31.88 62.67 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.164 -0.471 . . . . 14.15 111.678 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -69.77 -36.79 71.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.603 -0.839 . . . . 10.800000000000001 109.412 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.493 ' OD1' HG13 ' A' ' 56' ' ' ILE . 75.1 m-20 -66.73 -27.82 67.92 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.806 0.812 . . . . 12.98 110.417 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.06 -45.54 26.74 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.663 -1.153 . . . . 17.52 110.105 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -70.5 -39.25 74.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.837 0.31 . . . . 14.869999999999999 111.837 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.81 -3.9 55.55 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.909 1.077 . . . . 12.199999999999999 113.909 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 56.37 47.29 19.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.898 1.332 . . . . 16.710000000000001 108.791 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.0 tp -139.0 153.99 48.21 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.46 -1.311 . . . . 12.199999999999999 107.46 -173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -114.87 89.17 3.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.874 -0.787 . . . . 16.059999999999999 108.874 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' OD1' ' A' ' 49' ' ' ASN . 1.5 pp -76.55 147.9 79.22 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 122.243 -0.286 . . . . 11.390000000000001 111.717 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -62.65 122.39 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.637 2.225 . . . . 12.6 110.285 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.65 2.34 4.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.798 1.407 . . . . 12.52 114.798 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.43 5.14 46.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.937 -0.477 . . . . 14.140000000000001 110.78 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.63 -66.97 2.47 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.088 -0.505 . . . . 10.76 113.871 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.79 -28.08 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 124.436 1.094 . . . . 11.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -75.66 -39.12 58.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.416 -0.811 . . . . 16.420000000000002 110.469 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 92.5 m -82.8 -44.0 16.04 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.012 -0.54 . . . . 13.35 110.954 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -113.74 88.36 13.78 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 123.756 0.822 . . . . 12.23 109.093 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.4 Cg_endo -83.56 25.78 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.938 2.425 . . . . 13.06 113.128 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.13 123.69 59.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.614 -1.624 . . . . 12.949999999999999 106.614 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.49 -41.32 76.45 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.15 0.98 . . . . 10.92 112.524 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.25 -30.52 71.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.366 0.603 . . . . 14.32 111.081 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.99 -25.01 30.33 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.988 0.423 . . . . 10.93 110.095 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 49.4 t80 -82.58 -31.45 28.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.928 -0.578 . . . . 8.8100000000000005 110.89 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 p -68.33 -36.97 80.06 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.627 -0.879 . . . . 9.3499999999999996 108.627 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.6 -41.99 98.28 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.826 -1.079 . . . . 11.630000000000001 109.489 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 63.7 t90 -52.68 -56.01 18.56 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.969 1.308 . . . . 10.550000000000001 109.587 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.13 -42.33 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 C-N-CA 123.295 0.638 . . . . 8.3000000000000007 110.675 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.66 -17.03 66.48 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.343 -0.39 . . . . 9.5800000000000001 113.454 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.5 m -81.23 -30.12 34.27 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.194 -0.669 . . . . 10.23 109.194 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.85 -43.63 11.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.814 -0.63 . . . . 10.43 110.16 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.52 89.04 4.87 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.837 -0.62 . . . . 10.970000000000001 109.86 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 93.1 mt-30 -77.32 120.27 80.84 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.045 -0.98 . . . . 13.52 112.606 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -84.79 156.67 11.81 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.981 2.454 . . . . 12.279999999999999 109.559 171.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -93.37 100.85 13.1 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.207 -0.597 . . . . 13.44 111.495 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.46 137.94 41.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.821 -1.918 . . . . 13.27 105.821 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.03 65.13 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.142 1.377 . . . . 14.48 114.174 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 p -97.87 27.76 4.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.191 0.995 . . . . 14.92 111.374 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.27 42.34 2.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.746 -1.576 . . . . 14.25 106.746 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -64.03 135.72 96.43 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 114.138 -1.392 . . . . 12.970000000000001 109.917 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 49.7 Cg_exo -57.09 137.36 81.52 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.477 2.785 . . . . 13.4 112.009 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t 66.62 99.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 124.951 1.3 . . . . 12.43 111.428 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.56 123.25 19.94 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.829 -0.623 . . . . 13.449999999999999 110.056 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -96.98 3.64 51.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.844 0.831 . . . . 14.41 109.654 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.89 114.42 52.26 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-N 114.534 -1.212 . . . . 11.68 108.235 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.68 154.73 39.58 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.586 2.191 . . . . 10.84 112.283 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.46 48.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.955 0.883 . . . . 10.460000000000001 110.452 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.95 62.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.353 -0.839 . . . . 10.58 111.016 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -81.42 -14.37 57.19 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.256 -0.429 . . . . 11.039999999999999 112.107 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.85 23.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 112.733 0.642 . . . . 10.880000000000001 112.733 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.22 15.86 1.11 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.002 1.802 . . . . 12.460000000000001 113.049 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -101.45 111.83 64.29 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 109.59 -0.522 . . . . 13.779999999999999 109.59 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.37 112.49 2.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.482 2.121 . . . . 11.949999999999999 110.057 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.28 39.21 1.61 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.155 -0.778 . . . . 11.48 111.155 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.21 -12.42 40.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.648 0.261 . . . . 11.550000000000001 110.894 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 14.5 mm-40 -85.15 170.55 12.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.265 -0.425 . . . . 12.59 110.021 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -3.3 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.775 2.139 . . . . 11.24 116.775 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 22.0 m 78.56 92.57 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.903 1.281 . . . . 10.050000000000001 112.403 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.72 -26.41 50.04 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.994 -1.003 . . . . 11.220000000000001 111.382 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.442 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 8.2 tp-100 -63.9 -48.08 78.06 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.267 -1.383 . . . . 11.380000000000001 107.267 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 176' ' ' ASP . 31.9 ttm180 -51.9 -45.62 64.25 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 114.138 -1.392 . . . . 9.6500000000000004 111.544 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 104' ' ' SER . 52.6 mt-10 -61.3 -44.08 97.82 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 111.905 0.335 . . . . 10.43 111.905 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -65.06 -46.57 80.65 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 120.792 0.329 . . . . 10.210000000000001 110.318 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.427 HG21 HG11 ' A' ' 178' ' ' VAL . 81.1 mt -64.81 -43.2 96.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.696 -0.684 . . . . 8.1300000000000008 111.468 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.71 -34.03 72.37 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.496 0.718 . . . . 8.4600000000000009 111.34 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.73 -30.37 59.22 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.468 -0.493 . . . . 10.859999999999999 110.051 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -71.85 -45.92 59.75 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.307 -0.997 . . . . 11.449999999999999 108.307 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.84 -40.25 75.73 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.579 -1.192 . . . . 7.6200000000000001 108.842 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -55.47 -48.73 74.06 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 124.343 1.057 . . . . 11.619999999999999 110.601 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -69.31 -38.76 78.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.391 0.615 . . . . 11.630000000000001 110.455 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -63.67 -40.45 96.86 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.337 -0.847 . . . . 9.1400000000000006 110.054 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.11 -38.93 66.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.997 -0.547 . . . . 10.06 109.92 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.93 -27.07 66.36 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-N 115.705 -0.68 . . . . 12.07 112.844 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.23 -29.13 70.24 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.341 0.591 . . . . 12.32 110.041 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.82 -28.93 17.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.988 -0.551 . . . . 11.77 111.067 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.73 -30.14 24.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.91 0.386 . . . . 13.52 110.901 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 74.78 -38.89 0.4 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.545 1.538 . . . . 16.559999999999999 111.621 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.23 137.19 52.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.505 -0.924 . . . . 15.74 108.505 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.43 134.77 54.32 Favored Pre-proline 0 CA--C 1.479 -1.755 0 O-C-N 123.688 0.618 . . . . 14.199999999999999 109.666 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.35 -26.16 81.21 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.685 2.256 . . . . 14.18 109.911 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.94 -45.96 1.53 Allowed Glycine 0 CA--C 1.493 -1.334 0 CA-C-N 115.175 -0.92 . . . . 14.029999999999999 111.84 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -110.31 -48.64 3.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.396 . . . . 16.370000000000001 110.324 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp 63.93 -173.08 0.17 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.311 1.044 . . . . 12.449999999999999 110.97 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 72.56 -49.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 14.43 111.352 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 m -90.1 114.61 26.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.013 -1.477 . . . . 14.32 107.013 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.18 51.02 3.27 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 108.736 -1.745 . . . . 13.75 108.736 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.02 18.23 17.8 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.081 -0.559 . . . . 12.699999999999999 111.334 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.99 83.55 3.68 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.124 -1.065 . . . . 16.379999999999999 108.124 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -80.32 -7.12 58.92 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.652 0.739 . . . . 13.300000000000001 110.182 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.0 mt -56.46 -24.91 48.78 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.931 1.292 . . . . 16.25 109.368 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.35 -6.13 52.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.944 -1.025 . . . . 15.869999999999999 111.799 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.71 9.24 12.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.374 0.607 . . . . 13.65 111.251 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.62 -97.2 2.22 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.944 -0.571 . . . . 14.16 112.562 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.2 ttm -82.05 66.63 7.71 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.945 1.355 . . . . 15.449999999999999 110.057 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -92.71 -46.87 7.36 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.819 -1.537 . . . . 13.630000000000001 111.996 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 m -60.94 -34.63 75.02 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.186 0.517 . . . . 13.9 111.902 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.43 -52.75 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 13.81 110.568 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.2 t -72.14 -28.34 63.19 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 109.81 -0.441 . . . . 11.48 109.81 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.44 -28.77 73.94 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 116.066 -0.515 . . . . 10.35 111.832 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 162' ' ' ALA . 93.8 m -61.36 -46.97 87.96 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.901 0.382 . . . . 12.199999999999999 110.624 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.82 -49.86 71.21 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.447 -0.797 . . . . 11.859999999999999 109.608 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.45 ' CZ3' HD11 ' A' ' 171' ' ' LEU . 79.1 t90 -57.76 -49.26 77.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.252 -0.886 . . . . 9.3200000000000003 111.911 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -47.75 80.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 123.378 0.671 . . . . 9.5 111.255 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -69.68 -35.65 75.31 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.744 -0.382 . . . . 13.91 111.603 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.15 -47.58 79.65 Favored Glycine 0 C--O 1.244 0.756 0 C-N-CA 120.798 -0.715 . . . . 9.8800000000000008 112.148 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.24 -41.17 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 111.839 0.311 . . . . 9.2699999999999996 111.839 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 158' ' ' ILE . 36.1 p -62.82 -37.88 88.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 111.543 0.201 . . . . 11.460000000000001 111.543 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.51 -25.18 65.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 15.039999999999999 111.113 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -78.82 -31.54 45.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.919 0.39 . . . . 11.82 110.284 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -94.97 5.69 51.19 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.375 0.607 . . . . 11.970000000000001 110.761 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.4 m 57.62 41.04 26.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.901 1.281 . . . . 14.24 111.58 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 153' ' ' SER . 17.8 pt -131.11 156.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.703 -0.681 . . . . 12.619999999999999 109.517 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -102.12 108.63 20.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.291 -0.263 . . . . 16.390000000000001 110.291 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 3.7 mm? -125.87 124.96 42.03 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.612 -0.267 . . . . 12.32 110.804 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.48 143.54 28.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.772 -0.825 . . . . 14.06 108.772 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 146' ' ' THR . . . -70.84 -12.03 61.31 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.345 0.593 . . . . 12.640000000000001 112.134 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.51 -12.84 61.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.465 -0.789 . . . . 15.68 109.99 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.71 -15.83 63.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.435 -0.802 . . . . 12.720000000000001 112.334 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 162' ' ' ALA . 24.5 pt -71.75 -4.66 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.777 0.799 . . . . 12.16 110.605 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -110.06 0.83 18.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.571 -0.74 . . . . 15.08 109.498 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.5 m -96.02 -23.27 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.802 -0.814 . . . . 14.67 108.802 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 169' ' ' PRO . 4.9 m-90 -124.53 138.33 30.93 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.264 -1.013 . . . . 12.68 108.264 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 168' ' ' TRP . 11.5 Cg_exo -72.68 -15.06 27.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.86 2.374 . . . . 14.34 112.389 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.1 p -137.39 143.77 42.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.003 -0.74 . . . . 12.91 109.003 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ3' ' A' ' 148' ' ' TRP . 32.4 tp -69.22 -25.16 64.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 9.8900000000000006 110.979 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.37 -19.64 62.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 12.5 111.634 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.585 ' HA ' ' OD2' ' A' ' 176' ' ' ASP . 16.7 m -71.1 -12.09 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.044 -0.525 . . . . 11.039999999999999 112.137 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -64.86 -42.15 95.1 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.298 -1.001 . . . . 8.5 108.298 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 178' ' ' VAL . . . -65.68 -23.42 66.77 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.475 -0.784 . . . . 7.7000000000000002 110.979 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 173' ' ' SER . 63.4 m-20 -79.39 -25.84 42.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.971 0.415 . . . . 10.380000000000001 111.165 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.36 -33.37 16.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.53 0.681 . . . . 11.970000000000001 109.463 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 175' ' ' ALA . 7.2 p -53.66 -34.15 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 114.746 1.387 . . . . 9.8000000000000007 114.746 -170.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 106' ' ' GLN . 7.9 m-20 -57.85 -50.46 73.22 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.217 0.532 . . . . 10.83 109.799 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -71.95 -24.53 61.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.356 -0.838 . . . . 13.5 111.334 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -84.75 -46.26 11.58 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.082 -0.508 . . . . 14.84 111.199 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.67 -41.17 19.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 112.348 0.499 . . . . 13.35 112.348 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 119.156 -0.45 . . . . 13.51 109.812 -179.055 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.752 -0.833 . . . . 18.510000000000002 108.752 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.12 -174.5 3.29 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 105.302 -2.11 . . . . 16.66 105.302 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.001 0.905 . . . . 14.84 109.818 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.17 31.81 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.38 -1.282 . . . . 14.98 110.948 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -28.79 70.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.884 -0.598 . . . . 15.789999999999999 110.479 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 31.6 m -61.5 -53.7 53.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.305 -0.862 . . . . 12.02 109.877 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.28 -43.08 92.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.286 -0.416 . . . . 11.02 111.3 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -57.12 -50.79 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.405 0.441 . . . . 16.07 111.689 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -63.86 -39.2 93.64 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.956 0.407 . . . . 13.93 111.221 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 88.7 mt -68.02 -40.88 82.84 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.218 -0.447 . . . . 10.710000000000001 111.167 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -67.39 -40.22 85.65 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.796 -0.446 . . . . 14.02 109.796 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.78 -54.79 42.2 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.051 0.94 . . . . 16.289999999999999 111.506 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 p -65.3 -44.42 87.99 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.994 -0.548 . . . . 12.91 111.951 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.07 -44.63 91.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.934 -0.575 . . . . 12.77 110.815 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.58 97.42 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.562 -0.29 . . . . 15.19 110.698 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.23 -49.08 79.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.96 0.41 . . . . 16.260000000000002 111.175 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 ptp -68.6 -26.74 65.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.487 0.551 . . . . 15.449999999999999 112.487 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.73 6.5 48.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.795 0.331 . . . . 16.16 111.661 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 59.92 43.13 15.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.403 1.081 . . . . 20.559999999999999 111.051 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.1 m -129.94 171.82 12.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 16.629999999999999 109.698 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -108.37 135.27 19.99 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.802 -0.814 . . . . 20.190000000000001 108.802 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.69 -11.87 33.58 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.007 2.472 . . . . 16.600000000000001 112.934 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.22 -14.24 60.68 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.626 -0.59 . . . . 17.739999999999998 111.626 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -96.78 -43.78 7.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.123 -0.633 . . . . 20.23 112.138 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.96 138.5 21.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 119.469 -0.892 . . . . 15.98 109.567 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' HG2' ' OG ' ' A' ' 29' ' ' SER . 4.8 ptm180 -95.1 163.57 13.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.822 0.82 . . . . 19.329999999999998 112.785 -165.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' HG11 ' A' ' 66' ' ' VAL . 17.5 t70 -64.38 -10.88 27.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.564 1.546 . . . . 14.93 111.499 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.57 6.37 29.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.689 -0.687 . . . . 14.82 113.04 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.507 ' OG ' ' HG2' ' A' ' 26' ' ' ARG . 71.4 m -70.64 119.01 14.16 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.928 0.864 . . . . 14.539999999999999 111.793 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -87.97 149.3 24.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.543 -0.753 . . . . 16.75 111.375 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -48.37 -42.29 31.21 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.245 0.618 . . . . 11.99 112.402 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.33 -37.89 68.02 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.676 -1.147 . . . . 14.449999999999999 111.748 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.22 -7.51 41.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.076 0.465 . . . . 16.440000000000001 111.427 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.07 -16.77 34.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.434 0.635 . . . . 13.77 110.309 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.39 27.72 47.02 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.269 -0.878 . . . . 13.81 111.592 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.83 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.955 -1.128 . . . . 13.039999999999999 107.955 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD2' HG22 ' A' ' 39' ' ' VAL . 18.1 t70 -129.87 168.02 17.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 117.866 -1.064 . . . . 15.67 108.548 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 t -56.57 -44.56 81.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.745 0.702 . . . . 15.289999999999999 109.981 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.445 HG22 ' OD2' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -58.15 -55.2 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.61 0.719 . . . . 16.66 112.311 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.78 -45.91 87.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.394 -1.275 . . . . 14.140000000000001 110.546 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.95 91.56 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.845 -0.616 . . . . 12.0 110.847 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.64 78.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.399 0.68 . . . . 13.970000000000001 111.479 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.21 -47.36 65.02 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.187 0.518 . . . . 15.69 111.126 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -64.48 -49.15 72.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.723 1.209 . . . . 11.69 112.338 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 48' ' ' ILE . 11.3 tp -61.41 -36.93 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.063 0.459 . . . . 11.16 110.503 -176.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -73.64 -26.16 60.64 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.292 -0.413 . . . . 16.649999999999999 111.92 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -69.62 -36.69 76.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.937 -1.134 . . . . 14.15 107.937 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 45' ' ' ILE . 77.0 mt -60.42 -49.58 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.116 -0.947 . . . . 10.800000000000001 109.348 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.416 HD21 ' CD1' ' A' ' 56' ' ' ILE . 19.1 m120 -59.84 -37.54 79.54 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.369 0.604 . . . . 12.98 111.153 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -67.29 -58.66 4.41 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.63 1.572 . . . . 17.52 111.665 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -85.35 -27.57 25.78 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.796 -0.762 . . . . 14.869999999999999 112.869 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -94.36 -0.93 54.55 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.577 -0.849 . . . . 12.199999999999999 112.857 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 44.29 43.56 6.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.056 1.342 . . . . 16.710000000000001 112.42 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -117.75 125.83 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.124 -0.943 . . . . 12.199999999999999 109.124 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -87.73 96.4 10.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.536 0.522 . . . . 16.059999999999999 110.063 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CD1' HD21 ' A' ' 49' ' ' ASN . 2.4 pp -124.88 153.66 70.82 Favored Pre-proline 0 N--CA 1.426 -1.635 0 O-C-N 121.992 -0.442 . . . . 11.390000000000001 110.179 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.43 127.28 17.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.123 1.882 . . . . 12.6 109.867 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.85 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.956 0.903 . . . . 12.52 112.522 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -85.91 -5.47 59.23 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.97 0.414 . . . . 14.140000000000001 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.1 -13.17 64.08 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.918 -0.583 . . . . 10.76 112.716 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 tt -58.63 -29.61 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 C-N-CA 123.433 0.693 . . . . 11.0 110.865 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.39 0.8 35.78 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.666 0.617 . . . . 16.420000000000002 112.666 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -71.83 -25.89 62.16 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.993 0.901 . . . . 13.35 109.499 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -123.16 100.26 39.68 Favored Pre-proline 0 C--O 1.209 -1.056 0 N-CA-C 106.496 -1.668 . . . . 12.23 106.496 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.14 -1.63 7.46 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.859 2.373 . . . . 13.06 113.819 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 27' ' ' ASP . 60.3 t -116.45 120.23 64.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.502 -1.295 . . . . 12.949999999999999 107.502 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -54.25 -41.99 69.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.679 1.192 . . . . 10.92 113.067 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -74.1 -29.56 61.91 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.621 -0.263 . . . . 14.32 111.543 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.49 -29.58 46.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 10.93 110.598 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -56.39 -23.98 41.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.936 0.895 . . . . 8.8100000000000005 113.369 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 p -56.25 -23.58 37.08 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 113.053 0.76 . . . . 9.3499999999999996 113.053 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 76' ' ' THR . 54.5 tp60 -53.04 -35.88 59.95 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 123.672 0.608 . . . . 11.630000000000001 110.332 176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -52.79 -58.76 5.81 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 123.724 0.64 . . . . 10.550000000000001 111.402 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.7 t -68.23 -45.8 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 CA-C-N 115.282 -0.872 . . . . 8.3000000000000007 110.394 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.77 -46.88 81.62 Favored Glycine 0 CA--C 1.518 0.262 0 O-C-N 123.744 0.652 . . . . 9.5800000000000001 113.543 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 72' ' ' GLN . 14.5 t -79.79 -16.81 54.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 120.321 -0.551 . . . . 10.23 111.488 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -90.63 -13.65 33.92 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 119.708 -0.797 . . . . 10.43 111.593 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 96.8 mt -70.85 -46.76 62.11 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.367 -1.346 . . . . 10.970000000000001 107.367 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -160.55 132.08 4.02 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.747 -1.946 . . . . 13.52 105.747 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.59 -43.91 6.23 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 124.047 3.165 . . . . 12.279999999999999 113.058 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.4 p 50.02 64.52 1.75 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.861 1.264 . . . . 13.44 113.792 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -95.61 77.55 3.31 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.599 -0.889 . . . . 13.27 108.599 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 -12.28 29.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.794 -0.639 . . . . 14.48 110.077 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -82.2 80.26 8.46 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.845 0.831 . . . . 14.92 109.612 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 130.54 42.67 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.223 -0.898 . . . . 14.25 109.417 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.02 87.7 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.347 -0.983 . . . . 12.970000000000001 108.347 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.93 52.72 2.25 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.356 2.704 . . . . 13.4 112.462 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 p -157.94 113.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.28 -0.873 . . . . 12.43 109.145 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -117.72 14.33 14.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.039 -0.528 . . . . 13.449999999999999 111.902 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -155.51 176.74 12.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.06 -1.089 . . . . 14.41 108.06 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.04 135.49 24.62 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 107.464 -1.31 . . . . 11.68 107.464 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 111.04 0.69 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.987 1.791 . . . . 10.84 108.325 173.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t 69.42 79.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.563 -1.273 . . . . 10.460000000000001 107.563 -170.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.96 98.46 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.266 -0.879 . . . . 10.58 110.74 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 p -83.78 90.05 7.27 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.94 -0.573 . . . . 11.039999999999999 109.458 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.37 111.64 3.23 Favored Pre-proline 0 C--N 1.296 -1.724 0 CA-C-N 115.616 -0.72 . . . . 10.880000000000001 110.143 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.47 36.02 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.719 2.28 . . . . 12.460000000000001 111.96 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -118.4 116.55 35.22 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.729 -0.669 . . . . 13.779999999999999 109.237 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.6 110.72 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.227 2.618 . . . . 11.949999999999999 111.753 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.46 10.9 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.922 -0.656 . . . . 11.48 112.242 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -25.13 61.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.974 0.361 . . . . 11.550000000000001 111.974 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -85.69 -26.55 25.87 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 12.59 109.807 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -58.31 3.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.841 -0.618 . . . . 11.24 110.661 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.3 t -146.59 110.53 4.98 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.059 -0.719 . . . . 10.050000000000001 109.059 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -35.81 73.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.859 -1.064 . . . . 11.220000000000001 113.329 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -60.0 -25.78 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.117 0.414 . . . . 11.380000000000001 112.117 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.412 ' HE ' ' CB ' ' A' ' 179' ' ' ASP . 17.8 ttt180 -72.37 -48.54 40.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.919 0.39 . . . . 9.6500000000000004 110.712 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -65.87 -28.18 68.77 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.524 0.678 . . . . 10.43 110.05 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -64.32 -29.58 70.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.155 -0.93 . . . . 10.210000000000001 111.646 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 178' ' ' VAL . 56.1 mt -81.28 -33.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.725 -0.843 . . . . 8.1300000000000008 108.725 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.05 -53.82 53.8 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.759 -1.109 . . . . 8.4600000000000009 109.985 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -68.38 -35.56 77.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.333 -0.547 . . . . 10.859999999999999 111.114 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.97 -46.57 88.99 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.249 0.343 . . . . 11.449999999999999 110.308 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.11 -49.71 76.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.959 -0.564 . . . . 7.6200000000000001 110.31 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.88 -47.39 85.08 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.681 0.613 . . . . 11.619999999999999 111.002 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.81 -34.58 73.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 11.630000000000001 112.063 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 -28.97 67.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.824 0.345 . . . . 9.1400000000000006 110.589 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.5 -44.71 67.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.756 -0.461 . . . . 10.06 109.756 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.36 98.13 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.297 -0.721 . . . . 12.07 111.297 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.35 -42.19 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.369 1.467 . . . . 12.32 110.535 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD21 ' HB ' ' A' ' 144' ' ' THR . 37.5 tp -84.63 -34.3 23.12 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.967 -1.015 . . . . 11.77 110.918 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 tp -73.18 -29.29 62.73 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.014 0.746 . . . . 13.52 113.014 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 66.1 13.08 8.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.03 0.932 . . . . 16.559999999999999 110.741 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.4 171.34 8.4 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.185 -1.783 . . . . 15.74 106.185 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.89 130.2 91.78 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 109.83 -0.433 . . . . 14.199999999999999 109.83 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -69.55 0.73 5.07 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.551 2.168 . . . . 14.18 112.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.87 7.23 57.27 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.402 -0.679 . . . . 14.029999999999999 111.402 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -75.3 -16.86 60.39 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.172 0.51 . . . . 16.370000000000001 110.372 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.6 165.31 18.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.584 0.707 . . . . 12.449999999999999 111.723 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -88.14 77.23 8.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.24 -0.891 . . . . 14.43 109.823 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m 70.91 -48.58 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.814 1.646 . . . . 14.32 111.395 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.12 0.06 OUTLIER Glycine 0 C--N 1.308 -0.99 0 N-CA-C 108.704 -1.758 . . . . 13.75 108.704 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -154.32 93.03 1.56 Allowed 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.499 -0.413 . . . . 12.699999999999999 111.902 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 136' ' ' LEU . 28.5 tt0 -168.86 132.35 1.4 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 109.632 -0.507 . . . . 16.379999999999999 109.632 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -81.35 -7.46 59.58 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.835 1.05 . . . . 13.300000000000001 113.835 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.512 ' H ' ' HG2' ' A' ' 134' ' ' GLN . 83.6 mt -80.15 -35.73 36.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 16.25 112.069 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -37.46 21.24 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.48 0.919 . . . . 15.869999999999999 113.48 -173.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.77 -17.54 6.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.243 1.571 . . . . 13.65 115.243 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.36 143.61 4.89 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.226 -0.988 . . . . 14.16 112.289 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -99.49 -7.27 26.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.032 0.444 . . . . 15.449999999999999 109.958 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -150.09 149.22 29.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.552 0.691 . . . . 13.630000000000001 110.858 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -51.45 -34.99 37.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.699 1.999 . . . . 13.9 114.284 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.3 t -57.5 -47.93 84.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 112.461 0.541 . . . . 13.81 112.461 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.495 ' HB ' HD21 ' A' ' 121' ' ' LEU . 19.6 p -67.35 -35.54 79.57 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.469 -0.332 . . . . 11.48 110.858 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.01 -47.04 56.88 Favored Glycine 0 C--O 1.219 -0.834 0 N-CA-C 111.285 -0.726 . . . . 10.35 111.285 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 85.9 m -58.25 -46.76 85.39 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.533 0.333 . . . . 12.199999999999999 111.009 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.32 -38.15 90.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.259 0.552 . . . . 11.859999999999999 111.14 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.474 ' HB2' HD22 ' A' ' 121' ' ' LEU . 21.8 t90 -67.59 -46.42 72.65 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.477 0.711 . . . . 9.3200000000000003 110.251 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -49.59 71.2 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.669 0.388 . . . . 9.5 111.192 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 146' ' ' THR . 77.8 mtp180 -58.7 -40.99 85.26 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.641 0.588 . . . . 13.91 110.731 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.07 -44.67 96.94 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.93 -0.577 . . . . 9.8800000000000008 112.657 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.03 -41.93 84.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-O 121.286 0.565 . . . . 9.2699999999999996 109.522 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.6 t -59.0 -49.54 77.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.928 -1.033 . . . . 11.460000000000001 111.51 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -70.94 -20.87 62.41 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.914 0.388 . . . . 15.039999999999999 111.832 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.94 -51.21 7.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.432 -0.507 . . . . 11.82 110.472 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -94.03 -2.05 53.55 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.303 0.853 . . . . 11.970000000000001 113.303 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.2 m 62.79 38.99 11.25 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.956 0.884 . . . . 14.24 111.267 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.7 pt -113.66 158.57 13.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.769 -1.105 . . . . 12.619999999999999 109.063 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.3 106.04 18.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.728 -0.842 . . . . 16.390000000000001 108.728 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 160' ' ' LEU . 45.2 mt -121.93 112.32 18.16 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.709 0.766 . . . . 12.32 111.76 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.57 152.06 43.28 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.825 -1.534 . . . . 14.06 108.921 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.87 -13.09 62.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.916 0.865 . . . . 12.640000000000001 109.989 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.97 -8.04 45.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.508 1.523 . . . . 15.68 111.804 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.735 ' HA ' ' CZ3' ' A' ' 168' ' ' TRP . . . -59.89 -0.61 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.959 1.837 . . . . 12.720000000000001 115.959 -173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 33.2 pt -96.09 2.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 122.002 -0.436 . . . . 12.16 111.558 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -94.15 -76.18 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.813 1.042 . . . . 15.08 113.813 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.417 HG22 ' CZ3' ' A' ' 168' ' ' TRP . 3.5 t -78.64 12.64 1.96 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.3 0.571 . . . . 14.67 111.238 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.735 ' CZ3' ' HA ' ' A' ' 164' ' ' ALA . 18.1 m-90 -120.12 90.68 44.88 Favored Pre-proline 0 N--CA 1.412 -2.363 0 N-CA-C 105.676 -1.972 . . . . 12.68 105.676 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.2 -28.42 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.456 2.104 . . . . 14.34 113.496 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 p -126.06 174.28 8.58 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.526 -0.546 . . . . 12.91 109.526 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.09 -22.09 49.5 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.096 0.951 . . . . 9.8900000000000006 108.548 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -64.14 -34.42 78.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.807 -1.542 . . . . 12.5 110.477 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -62.23 -45.23 94.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.957 -0.565 . . . . 11.039999999999999 110.101 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -70.33 -39.67 74.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.167 -0.47 . . . . 8.5 110.14 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.03 71.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.121 0.486 . . . . 7.7000000000000002 111.431 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.88 -30.11 40.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.022 0.439 . . . . 10.380000000000001 110.212 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -81.84 -37.35 27.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.955 -0.566 . . . . 11.970000000000001 112.314 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -56.28 -43.73 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.886 0.374 . . . . 9.8000000000000007 111.203 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.412 ' CB ' ' HE ' ' A' ' 107' ' ' ARG . 30.2 t70 -72.35 -28.12 62.83 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 121.149 0.5 . . . . 10.83 110.729 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -68.41 -26.69 65.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.474 -0.936 . . . . 13.5 108.474 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -83.98 -48.63 9.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.923 -1.035 . . . . 14.84 110.0 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 86.6 t -70.06 -43.53 79.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 N-CA-C 112.511 0.56 . . . . 13.35 112.511 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.028 -0.73 . . . . 13.51 109.028 -176.529 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 3' ' ' ASP . 1.6 p . . . . . 0 CA--C 1.556 1.196 0 N-CA-C 110.186 -0.302 . . . . 18.510000000000002 110.186 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.0 10.98 8.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.584 1.154 . . . . 16.66 113.414 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' H ' HG13 ' A' ' 1' ' ' VAL . 57.5 m-20 -102.02 22.45 13.08 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 116.477 -0.329 . . . . 14.84 111.092 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 30.1 t70 66.7 20.95 10.67 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.644 0.735 . . . . 14.98 110.045 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.04 -40.19 94.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.982 -0.554 . . . . 15.789999999999999 111.578 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 57.6 m -60.9 -43.88 97.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.009 -0.541 . . . . 12.02 110.872 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.93 92.83 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 110.09 -0.337 . . . . 11.02 110.09 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 97.1 mt-30 -57.77 -52.99 63.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.168 0.508 . . . . 16.07 110.696 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.98 -46.59 86.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.508 -0.769 . . . . 13.93 111.381 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 63.0 mt -65.84 -35.46 80.74 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.756 0.65 . . . . 10.710000000000001 112.756 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtm-85 -62.91 -46.48 87.6 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 120.881 -0.328 . . . . 14.02 110.217 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.09 -41.21 95.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 16.289999999999999 110.983 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -58.31 -59.72 4.89 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.206 1.002 . . . . 12.91 111.592 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 17' ' ' MET . 42.3 tp -69.67 -41.63 75.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.471 . . . . 12.77 111.448 -175.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.285 0.476 . . . . 15.19 112.285 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.87 88.96 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.732 -0.387 . . . . 16.260000000000002 110.874 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 19.9 ptp -75.06 -31.12 61.19 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.268 -0.423 . . . . 15.449999999999999 111.76 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.37 -11.5 37.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.903 0.858 . . . . 16.16 110.934 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.2 t80 64.2 48.62 2.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.968 1.707 . . . . 20.559999999999999 109.886 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 21.3 p -119.84 174.82 6.21 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.374 -1.343 . . . . 16.629999999999999 107.374 176.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.33 129.91 35.54 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 112.121 0.415 . . . . 20.190000000000001 112.121 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.5 -18.91 33.22 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.414 2.742 . . . . 16.600000000000001 113.418 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.29 -36.34 7.6 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.318 -1.113 . . . . 17.739999999999998 110.318 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -87.45 70.95 9.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.022 -0.732 . . . . 20.23 109.022 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -140.74 151.79 20.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.943 -1.132 . . . . 15.98 107.943 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -114.4 131.33 56.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.804 -0.813 . . . . 19.329999999999998 108.804 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 9.3 p-10 -77.12 -21.89 53.54 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.701 0.401 . . . . 14.93 111.48 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.78 5.88 79.59 Favored Glycine 0 C--N 1.312 -0.8 0 N-CA-C 111.025 -0.83 . . . . 14.82 111.025 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -72.33 137.94 46.98 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.261 0.553 . . . . 14.539999999999999 109.724 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 49.3 mtp180 -82.55 142.85 31.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.692 -1.225 . . . . 16.75 107.692 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -57.19 -16.47 8.15 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.424 0.898 . . . . 11.99 113.424 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 mt -70.06 -34.6 73.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.972 -0.751 . . . . 14.449999999999999 108.972 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -77.42 -24.8 50.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.002 -0.999 . . . . 16.440000000000001 109.131 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.0 mt -74.69 -37.22 62.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.855 -0.794 . . . . 13.77 108.855 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.6 26.21 30.61 Favored Glycine 0 CA--C 1.493 -1.288 0 CA-C-N 115.124 -0.944 . . . . 13.81 114.488 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 36' ' ' LEU . 1.5 pt? -85.68 126.37 33.9 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.565 -0.854 . . . . 13.039999999999999 110.903 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.83 161.09 27.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.177 -0.919 . . . . 15.67 110.5 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -54.36 -36.59 64.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.191 0.451 . . . . 15.289999999999999 111.026 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 40' ' ' ILE . 1.4 m -54.54 -56.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.419 0.525 . . . . 16.66 112.419 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' H ' HG23 ' A' ' 39' ' ' VAL . 56.2 mt -59.35 -41.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.32 -0.855 . . . . 14.140000000000001 110.571 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.94 88.73 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.019 -0.537 . . . . 12.0 110.756 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.43 82.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.469 0.652 . . . . 13.970000000000001 110.697 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -67.39 -51.68 49.0 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.618 -0.719 . . . . 15.69 111.259 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -64.64 -45.16 88.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.165 0.986 . . . . 11.69 111.453 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 48' ' ' ILE . 10.5 tp -62.5 -35.38 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.5 . . . . 11.16 111.357 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -81.38 -20.27 40.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.732 -0.787 . . . . 16.649999999999999 111.546 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -78.36 -31.55 48.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.657 -0.817 . . . . 14.15 111.758 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 45' ' ' ILE . 22.5 pt -67.22 -31.39 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.473 -0.891 . . . . 10.800000000000001 108.715 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 56' ' ' ILE . 11.0 m120 -62.14 -42.18 99.0 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 115.196 -0.911 . . . . 12.98 110.422 174.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.33 -47.37 17.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.664 -0.698 . . . . 17.52 110.452 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -66.74 -34.54 78.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.852 -0.613 . . . . 14.869999999999999 111.764 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 69.1 m-85 -101.55 -12.2 18.67 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.626 1.343 . . . . 12.199999999999999 114.626 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 57.94 45.85 17.53 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.132 0.968 . . . . 16.710000000000001 108.922 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.0 tp -123.37 149.15 45.3 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.879 -1.055 . . . . 12.199999999999999 110.719 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -99.64 109.46 21.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.381 -0.97 . . . . 16.059999999999999 108.381 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.525 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.5 pp -124.36 149.63 61.79 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 118.185 0.448 . . . . 11.390000000000001 110.765 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.12 105.01 1.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.703 1.602 . . . . 12.6 109.039 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.98 -24.72 25.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.062 1.345 . . . . 12.52 113.145 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.81 -3.26 30.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.428 -0.351 . . . . 14.140000000000001 111.453 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.18 -49.3 31.05 Favored Glycine 0 C--O 1.204 -1.756 0 O-C-N 123.656 0.597 . . . . 10.76 113.342 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.53 -31.01 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 11.0 112.209 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.7 -40.11 12.75 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.068 0.396 . . . . 16.420000000000002 112.068 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -80.36 -35.59 35.21 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.374 0.607 . . . . 13.35 110.457 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -121.64 76.7 36.85 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 124.185 0.994 . . . . 12.23 108.737 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 4.1 Cg_exo -81.09 37.8 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.165 2.576 . . . . 13.06 113.878 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.53 124.78 60.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.837 -1.542 . . . . 12.949999999999999 106.837 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -55.08 -40.36 70.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.167 0.987 . . . . 10.92 113.33 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.4 tttt -64.8 -42.14 95.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 14.32 110.287 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.82 81.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.685 -0.688 . . . . 10.93 110.576 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -71.38 -35.63 71.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.928 0.344 . . . . 8.8100000000000005 111.928 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 p -65.32 -26.48 68.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.626 -0.83 . . . . 9.3499999999999996 110.935 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 16.3 mm-40 -77.26 -39.45 48.21 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.022 -0.535 . . . . 11.630000000000001 110.051 172.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -62.58 -30.79 71.59 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.54 0.736 . . . . 10.550000000000001 111.918 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.75 -44.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.207 -0.664 . . . . 8.3000000000000007 109.207 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.28 -27.03 73.43 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.417 -0.81 . . . . 9.5800000000000001 113.991 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -72.9 -16.48 61.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.313 0.557 . . . . 10.23 110.991 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 56' ' ' ILE . 15.1 mm100 -83.21 -23.58 32.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.109 -0.701 . . . . 10.43 109.109 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.83 92.63 1.61 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.097 -0.956 . . . . 10.970000000000001 110.301 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -116.47 87.59 21.16 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 107.798 -1.186 . . . . 13.52 107.798 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.93 -22.77 26.28 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.105 2.537 . . . . 12.279999999999999 112.995 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -87.8 67.08 9.03 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.001 0.905 . . . . 13.44 109.806 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -88.09 -166.77 1.68 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.957 -1.019 . . . . 13.27 108.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.25 -50.06 43.58 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.648 -0.871 . . . . 14.48 108.648 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.2 m -86.44 76.19 9.66 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.284 -0.871 . . . . 14.92 109.459 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -136.38 72.28 1.43 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.473 -0.785 . . . . 14.25 109.45 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -87.77 123.39 69.28 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.097 -0.501 . . . . 12.970000000000001 110.422 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 3.1 Cg_exo -78.46 38.63 0.72 Allowed 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 123.005 2.47 . . . . 13.4 111.315 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.5 17.35 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 122.625 1.202 . . . . 12.43 108.446 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 66.88 9.54 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.781 -1.192 . . . . 13.449999999999999 107.781 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -108.59 1.66 21.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.744 -1.116 . . . . 14.41 110.594 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.9 132.94 44.43 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 114.945 -1.025 . . . . 11.68 108.508 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -63.03 127.73 21.09 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.992 1.795 . . . . 10.84 109.633 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.36 136.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.598 -0.728 . . . . 10.460000000000001 111.472 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.9 -18.74 36.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.929 . . . . 10.58 108.973 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -86.79 146.58 26.18 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 114.959 -1.019 . . . . 11.039999999999999 109.502 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.81 92.16 46.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-O 120.484 0.183 . . . . 10.880000000000001 110.612 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.98 -25.29 52.06 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.721 2.28 . . . . 12.460000000000001 110.17 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -116.6 85.38 16.61 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 115.049 -0.978 . . . . 13.779999999999999 109.088 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -70.5 -12.4 31.43 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.662 2.242 . . . . 11.949999999999999 111.176 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.56 43.09 1.63 Allowed Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 110.403 -1.079 . . . . 11.48 110.403 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.58 -37.07 85.61 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.115 -0.698 . . . . 11.550000000000001 109.115 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -85.8 64.74 8.78 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.937 -1.135 . . . . 12.59 107.937 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.36 -61.76 1.5 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.341 0.591 . . . . 11.24 109.804 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 11.3 p -128.89 41.23 3.52 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.755 1.264 . . . . 10.050000000000001 108.0 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.84 -24.19 59.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.816 -1.538 . . . . 11.220000000000001 110.099 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -66.3 -45.68 79.52 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.822 -1.177 . . . . 11.380000000000001 107.822 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 104' ' ' SER . 48.0 ttp180 -51.99 -53.01 46.58 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 124.148 0.905 . . . . 9.6500000000000004 110.219 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.53 -48.27 79.76 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.716 0.635 . . . . 10.43 111.843 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.2 t -60.63 -50.33 73.95 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 10.210000000000001 110.971 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 178' ' ' VAL . 97.2 mt -62.45 -39.54 84.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 CA-C-N 116.469 -0.332 . . . . 8.1300000000000008 110.929 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -47.48 -42.19 22.27 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 124.742 1.217 . . . . 8.4600000000000009 112.105 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.0 -29.82 66.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.022 0.439 . . . . 10.859999999999999 112.022 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.09 -36.76 16.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.283 0.563 . . . . 11.449999999999999 110.186 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.76 -37.36 86.14 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 108.224 -1.028 . . . . 7.6200000000000001 108.224 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 126' ' ' PRO . 83.6 tttt -51.03 -44.66 61.08 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.248 1.419 . . . . 11.619999999999999 110.349 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.69 -44.98 80.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.453 -0.794 . . . . 11.630000000000001 110.379 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -66.81 -48.3 69.39 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.557 -0.747 . . . . 9.1400000000000006 110.968 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.4 pp -71.38 -34.62 70.58 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.43 0.157 . . . . 10.06 111.147 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.41 -42.64 95.84 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.491 -0.644 . . . . 12.07 111.491 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.17 -44.72 96.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.919 0.866 . . . . 12.32 109.733 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.52 -45.77 78.4 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.509 -1.223 . . . . 11.77 110.956 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.0 tp -76.86 -19.06 57.93 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.518 -0.764 . . . . 13.52 111.073 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.1 t80 62.45 31.71 17.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.862 1.665 . . . . 16.559999999999999 109.738 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 125' ' ' ASP . 1.3 tm? -120.27 146.43 46.09 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 105.268 -2.123 . . . . 15.74 105.268 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 16.8 t70 -61.43 122.2 68.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.634 0.584 . . . . 14.199999999999999 110.308 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 15.2 Cg_exo -69.98 6.51 1.36 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.057 2.504 . . . . 14.18 114.787 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.89 1.26 55.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.186 -1.566 . . . . 14.029999999999999 109.186 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -125.01 36.8 4.53 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.801 1.286 . . . . 16.370000000000001 107.822 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.19 124.04 21.99 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.265 -1.334 . . . . 12.449999999999999 110.34 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -63.38 146.32 53.79 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.389 -0.967 . . . . 14.43 108.389 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.5 t -58.3 -61.89 2.24 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 118.765 0.711 . . . . 14.32 111.548 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.12 -57.17 2.71 Favored Glycine 0 C--O 1.247 0.942 0 N-CA-C 110.162 -1.175 . . . . 13.75 110.162 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 71.07 114.57 0.05 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.248 1.419 . . . . 12.699999999999999 112.578 176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.82 116.23 6.78 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.542 -0.754 . . . . 16.379999999999999 109.555 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.516 ' O ' HD22 ' A' ' 138' ' ' LEU . 17.1 t80 -56.59 -40.07 74.61 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 124.932 1.293 . . . . 13.300000000000001 110.961 -177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.0 -2.4 43.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.47 0.915 . . . . 16.25 113.47 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.2 -14.41 61.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.555 0.693 . . . . 15.869999999999999 109.993 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -64.77 -14.15 57.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.276 -0.875 . . . . 13.65 112.869 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.81 150.31 6.13 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.295 -0.722 . . . . 14.16 111.295 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.71 -31.49 65.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.806 -0.812 . . . . 15.449999999999999 108.806 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.82 125.46 27.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 114.729 -1.123 . . . . 13.630000000000001 109.048 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -62.72 -22.39 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.579 0.549 . . . . 13.9 110.296 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.443 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 61.8 t -58.02 -34.18 48.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.157 -0.929 . . . . 13.81 111.513 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.4 p -59.96 -44.27 94.52 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.445 0.641 . . . . 11.48 110.748 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -83.42 -35.53 16.98 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.231 -0.895 . . . . 10.35 113.006 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 143' ' ' VAL . 39.7 p -66.95 -30.19 70.25 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 117.506 0.653 . . . . 12.199999999999999 110.373 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -62.74 -47.64 82.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.676 0.791 . . . . 11.859999999999999 108.872 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.11 -42.83 99.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.605 -0.725 . . . . 9.3200000000000003 110.497 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 162' ' ' ALA . 24.4 mmt -61.76 -37.51 84.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.607 0.718 . . . . 9.5 109.915 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -69.64 -36.96 76.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.376 -0.829 . . . . 13.91 110.321 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.89 -51.65 38.67 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.671 -0.572 . . . . 9.8800000000000008 111.671 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.51 -44.05 84.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.289 0.636 . . . . 9.2699999999999996 111.657 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -60.89 -40.82 94.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.924 0.342 . . . . 11.460000000000001 111.924 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -68.41 -47.08 68.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.884 0.373 . . . . 15.039999999999999 110.491 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -54.71 -40.08 68.84 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.414 1.086 . . . . 11.82 111.999 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.73 -1.17 26.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.191 0.811 . . . . 11.970000000000001 113.191 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t 60.36 47.24 9.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.672 0.789 . . . . 14.24 110.308 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.09 168.83 18.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.527 -0.916 . . . . 12.619999999999999 108.527 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -108.08 97.25 6.97 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.44 0.638 . . . . 16.390000000000001 109.41 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.6 tp -103.13 123.66 47.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.73 134.29 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.142 -0.688 . . . . 14.06 109.142 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 149' ' ' MET . . . -75.92 -16.64 59.99 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.204 0.526 . . . . 12.640000000000001 111.116 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.37 -6.29 59.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.717 -0.674 . . . . 15.68 111.118 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.11 -10.69 32.68 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.327 -0.397 . . . . 12.720000000000001 111.677 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.57 -15.76 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.762 0.791 . . . . 12.16 110.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -103.85 14.15 31.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.469 -0.787 . . . . 15.08 109.099 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 32.5 m -110.69 -38.31 5.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.474 -0.785 . . . . 14.67 111.269 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -105.97 123.77 38.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.682 -0.407 . . . . 12.68 110.465 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.68 -27.84 4.66 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.972 1.781 . . . . 14.34 111.484 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -105.7 142.53 35.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.995 0.903 . . . . 12.91 111.504 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.14 -37.91 81.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.752 -1.567 . . . . 9.8900000000000006 112.433 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.34 -18.97 63.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.929 0.714 . . . . 12.5 112.929 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 -17.77 64.86 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.139 0.792 . . . . 11.039999999999999 113.139 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.3 tp -70.11 -32.21 70.13 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.087 0.47 . . . . 8.5 110.261 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.49 75.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.467 0.651 . . . . 7.7000000000000002 109.742 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.83 -21.79 60.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.557 -0.747 . . . . 10.380000000000001 110.579 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 9.6 tp10 -80.51 -56.8 3.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.994 -0.548 . . . . 11.970000000000001 109.752 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 110' ' ' ILE . 10.6 p -55.4 -34.03 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 112.443 0.535 . . . . 9.8000000000000007 112.443 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 107' ' ' ARG . 15.9 t70 -55.31 -43.01 74.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.996 0.918 . . . . 10.83 110.459 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -83.56 -34.23 25.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.276 -0.874 . . . . 13.5 111.273 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mmm180 -60.7 -58.5 8.19 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.119 -0.491 . . . . 14.84 111.259 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.37 -40.51 56.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.255 -0.578 . . . . 13.35 109.451 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 117.64 -1.171 . . . . 13.51 109.853 178.545 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 5' ' ' GLU . 56.9 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 110.742 -0.096 . . . . 18.510000000000002 110.742 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . 179.76 -174.0 0.23 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.514 -0.921 . . . . 16.66 108.514 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.29 -33.23 73.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.044 0.926 . . . . 14.84 108.804 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -67.46 -8.59 34.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.684 -1.144 . . . . 14.98 113.866 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 2' ' ' ALA . 12.8 pt-20 -67.02 -27.38 67.37 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.942 -0.703 . . . . 15.789999999999999 110.343 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 35.0 m -70.55 -48.73 54.0 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.943 -0.571 . . . . 12.02 109.823 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.67 78.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.084 0.469 . . . . 11.02 110.832 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 29.0 tt0 -67.67 -45.88 73.96 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.028 -0.533 . . . . 16.07 110.255 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.51 -37.76 85.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.072 0.463 . . . . 13.93 110.716 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 -35.49 74.73 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.388 0.514 . . . . 10.710000000000001 112.388 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 12.4 ptp180 -69.44 -29.18 66.83 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 119.135 -1.026 . . . . 14.02 109.575 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -67.35 -48.77 66.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.028 -0.533 . . . . 16.289999999999999 109.673 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -62.74 -34.56 77.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.408 -0.814 . . . . 12.91 112.377 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.48 -53.15 31.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.358 0.599 . . . . 12.77 110.299 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -64.9 -29.72 70.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.953 -1.022 . . . . 15.19 112.214 -176.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.08 98.47 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.952 0.406 . . . . 16.260000000000002 110.652 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.4 mmt -78.81 -39.51 35.49 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.337 -0.392 . . . . 15.449999999999999 112.043 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 mp -90.36 5.69 46.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.749 0.309 . . . . 16.16 111.785 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 54.71 36.88 27.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.421 1.488 . . . . 20.559999999999999 112.556 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 42.4 t -95.89 175.71 6.39 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.377 -1.342 . . . . 16.629999999999999 107.377 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.19 115.93 65.19 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.196 -0.668 . . . . 20.190000000000001 109.196 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.91 42.93 1.41 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 123.378 2.719 . . . . 16.600000000000001 113.218 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -95.86 1.09 Allowed Glycine 0 C--N 1.288 -2.137 0 CA-C-N 114.769 -1.105 . . . . 17.739999999999998 111.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.85 66.22 1.53 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.033 0.445 . . . . 20.23 110.231 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 pt -68.42 147.58 12.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.249 -0.432 . . . . 15.98 110.026 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.42 114.12 3.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.064 -0.971 . . . . 19.329999999999998 111.002 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.7 m-20 -66.77 -24.76 66.24 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.728 0.811 . . . . 14.93 110.988 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.11 2.33 87.14 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.835 -0.698 . . . . 14.82 113.148 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -73.33 140.49 46.75 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.062 0.458 . . . . 14.539999999999999 111.76 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 73.1 ttt180 -76.23 142.04 41.56 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 104.394 -2.447 . . . . 16.75 104.394 166.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 71.3 m-85 -54.68 -25.58 27.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.111 1.152 . . . . 11.99 114.111 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.23 -38.71 92.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.043 0.449 . . . . 14.449999999999999 109.832 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.78 -24.28 60.92 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.177 -0.675 . . . . 16.440000000000001 109.177 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.19 -15.8 54.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.624 -0.716 . . . . 13.77 110.536 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.26 5.03 53.13 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.999 -0.619 . . . . 13.81 112.749 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.1 tt -80.1 140.38 36.46 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.553 -0.536 . . . . 13.039999999999999 109.553 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 26.0 t70 -120.98 163.41 18.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 118.184 -0.912 . . . . 15.67 108.837 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 m -57.46 -39.98 77.51 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 118.834 0.743 . . . . 15.289999999999999 111.389 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.93 -46.15 85.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 16.66 109.492 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 52.6 mt -60.82 -34.96 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.313 -0.858 . . . . 14.140000000000001 110.723 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.78 -47.27 85.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.417 0.687 . . . . 12.0 111.432 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.71 72.29 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 123.556 0.535 . . . . 13.970000000000001 111.148 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -79.07 -49.93 11.87 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.868 -0.606 . . . . 15.69 111.329 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.408 ' CZ3' HD11 ' A' ' 48' ' ' ILE . 7.4 t90 -60.96 -39.34 89.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.4 0.68 . . . . 11.69 112.062 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.3 -28.1 44.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 CA-C-O 121.132 0.491 . . . . 11.16 110.613 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -71.43 -32.03 67.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.982 0.42 . . . . 16.649999999999999 109.996 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -69.73 -34.39 73.79 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.84 0.828 . . . . 14.15 108.891 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.408 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 75.6 mt -69.92 -51.88 36.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 114.907 -1.042 . . . . 10.800000000000001 109.766 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.23 -28.22 62.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.799 0.84 . . . . 12.98 112.037 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -71.47 -50.78 28.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.531 0.681 . . . . 17.52 109.953 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -70.09 -51.84 28.54 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.71 -1.132 . . . . 14.869999999999999 113.303 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 79.9 m-85 -88.47 -6.67 57.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.869 0.692 . . . . 12.199999999999999 112.869 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 55.86 36.08 26.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.58 1.152 . . . . 16.710000000000001 112.209 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.68 147.25 32.21 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.958 -1.127 . . . . 12.199999999999999 107.958 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -91.22 77.34 5.95 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.762 -0.829 . . . . 16.059999999999999 108.762 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.35 128.38 30.56 Favored Pre-proline 0 N--CA 1.426 -1.674 0 C-N-CA 120.36 -0.536 . . . . 11.390000000000001 111.485 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.55 154.79 27.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.468 2.112 . . . . 12.6 108.956 171.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.31 20.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.464 0.706 . . . . 12.52 110.83 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 63' ' ' THR . 7.2 m-20 -62.43 -21.25 65.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.798 -1.092 . . . . 14.140000000000001 112.885 176.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.18 -41.33 92.71 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 119.409 -1.377 . . . . 10.76 111.632 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.55 -19.78 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.488 0.661 . . . . 11.0 110.23 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.74 -38.79 17.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 16.420000000000002 111.129 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 59' ' ' ASP . 8.5 t -77.66 -41.77 37.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.518 -0.473 . . . . 13.35 110.461 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -119.73 92.35 46.26 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-O 121.378 0.609 . . . . 12.23 109.872 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 44.8 Cg_endo -93.7 17.15 1.09 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.126 2.551 . . . . 13.06 113.93 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.95 137.94 45.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.08 -1.081 . . . . 12.949999999999999 108.08 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.28 -49.08 73.01 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 113.176 0.806 . . . . 10.92 113.176 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 13.9 tppt? -64.8 -35.05 79.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.317 0.58 . . . . 14.32 110.389 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.43 75.7 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.853 -0.612 . . . . 10.93 110.866 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.1 t80 -74.84 -31.97 61.8 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.379 0.609 . . . . 8.8100000000000005 111.428 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -70.31 -29.18 65.84 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.409 -0.917 . . . . 9.3499999999999996 110.584 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -75.01 -25.71 59.0 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.569 -0.53 . . . . 11.630000000000001 109.569 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' HZ3' HE21 ' A' ' 77' ' ' GLN . 5.6 t90 -61.33 -54.76 39.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.139 -1.43 . . . . 10.550000000000001 107.139 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.18 -32.33 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 CA-C-N 115.009 -0.996 . . . . 8.3000000000000007 109.544 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 -12.97 60.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.864 -0.607 . . . . 9.5800000000000001 112.388 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.8 m -85.24 -31.28 23.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.627 -0.879 . . . . 10.23 108.627 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.424 HE21 ' HZ3' ' A' ' 73' ' ' TRP . 20.2 mm-40 -81.18 -44.35 17.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.284 -1.006 . . . . 10.43 108.284 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 81.74 8.73 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.587 -1.264 . . . . 10.970000000000001 107.587 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.21 127.23 89.29 Favored Pre-proline 0 C--O 1.246 0.899 0 CA-C-N 114.809 -1.087 . . . . 13.52 111.94 -175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.93 108.68 2.36 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.796 2.331 . . . . 12.279999999999999 110.586 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -95.89 125.16 40.25 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.492 0.663 . . . . 13.44 111.08 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -98.93 115.46 28.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.576 -1.268 . . . . 13.27 107.576 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.24 -38.15 15.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.469 0.176 . . . . 14.48 111.293 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -74.9 134.31 41.63 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.188 -0.46 . . . . 14.92 109.873 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.52 96.71 2.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.502 -0.555 . . . . 14.25 109.502 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.11 93.34 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.678 -0.692 . . . . 12.970000000000001 109.336 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.93 87.55 0.1 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.121 2.547 . . . . 13.4 112.133 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.55 127.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.863 -0.791 . . . . 12.43 108.863 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -99.99 175.71 5.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.765 -0.457 . . . . 13.449999999999999 109.765 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 61.38 53.24 3.5 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.245 1.021 . . . . 14.41 110.431 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.86 130.45 86.85 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 114.513 -1.222 . . . . 11.68 108.104 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.12 107.4 0.65 Allowed 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.475 2.117 . . . . 10.84 110.911 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.4 122.75 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.515 0.674 . . . . 10.460000000000001 110.834 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.56 54.86 0.88 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.809 -0.812 . . . . 10.58 108.809 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 p -70.32 -44.28 68.59 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.838 -1.073 . . . . 11.039999999999999 111.538 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.22 97.51 47.55 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.841 -0.618 . . . . 10.880000000000001 109.988 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.34 -45.24 9.91 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.482 2.121 . . . . 12.460000000000001 109.872 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 88.9 mm-40 -120.51 118.48 30.94 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 107.551 -1.277 . . . . 13.779999999999999 107.551 174.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 17.3 Cg_exo -69.59 44.79 0.41 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.649 2.899 . . . . 11.949999999999999 114.163 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.54 2.64 83.02 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 121.14 -0.552 . . . . 11.48 111.945 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.56 -9.48 58.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.17 0.51 . . . . 11.550000000000001 110.203 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.36 126.22 30.9 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.346 -0.983 . . . . 12.59 108.346 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.15 99.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.475 -1.239 . . . . 11.24 111.29 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m 55.9 99.09 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.936 0.773 . . . . 10.050000000000001 112.126 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.84 -39.69 39.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.393 1.077 . . . . 11.220000000000001 112.581 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 60.2 tp60 -62.57 -54.61 37.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.58 -0.526 . . . . 11.380000000000001 109.58 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -58.07 -41.29 83.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.942 0.897 . . . . 9.6500000000000004 111.232 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -48.29 78.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.849 -0.614 . . . . 10.43 110.614 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.6 t -59.61 -37.7 79.28 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 123.699 0.624 . . . . 10.210000000000001 109.776 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 106' ' ' GLN . 53.2 mt -58.61 -44.83 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 115.265 -0.879 . . . . 8.1300000000000008 110.721 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -61.41 -38.21 86.29 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.152 0.282 . . . . 8.4600000000000009 111.517 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.2 -45.75 79.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.527 0.203 . . . . 10.859999999999999 110.554 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -71.52 -27.56 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.108 -0.637 . . . . 11.449999999999999 111.498 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.19 -48.0 83.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.188 -1.041 . . . . 7.6200000000000001 108.188 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -56.63 -51.89 66.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.453 -1.703 . . . . 11.619999999999999 110.712 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -64.92 -39.98 94.36 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.711 0.634 . . . . 11.630000000000001 112.711 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 p -67.97 -33.13 74.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.156 0.428 . . . . 9.1400000000000006 112.156 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -43.0 33.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.492 -0.883 . . . . 10.06 109.204 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.32 82.12 Favored Glycine 0 C--O 1.22 -0.775 0 CA-C-N 115.78 -0.645 . . . . 12.07 112.601 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.14 -28.63 68.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.526 0.679 . . . . 12.32 110.471 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.21 -43.06 10.07 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 11.77 110.127 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.48 -27.07 62.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.448 -0.796 . . . . 13.52 111.789 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 t80 80.27 -36.36 0.14 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.907 1.683 . . . . 16.559999999999999 110.742 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.77 172.35 13.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 15.74 110.816 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.83 139.02 76.66 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.988 0.423 . . . . 14.199999999999999 111.686 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.17 42.81 0.41 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.997 2.465 . . . . 14.18 111.128 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -101.2 -10.46 42.03 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 115.497 -0.774 . . . . 14.029999999999999 111.636 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.64 -13.77 41.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.192 0.52 . . . . 16.370000000000001 110.593 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.2 -169.45 2.07 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.124 -0.489 . . . . 12.449999999999999 112.119 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 79.68 113.96 0.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.12 1.368 . . . . 14.43 109.797 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 m 61.64 39.17 14.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.361 1.077 . . . . 14.32 109.062 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.69 70.23 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 113.704 -1.589 . . . . 13.75 110.624 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.85 -40.91 46.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.954 0.883 . . . . 12.699999999999999 110.247 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 64.03 31.75 13.36 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 113.242 -1.799 . . . . 16.379999999999999 112.973 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.75 -18.8 63.2 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.266 0.555 . . . . 13.300000000000001 110.788 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 136' ' ' LEU . 2.0 mm? -68.53 -25.39 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.685 -0.689 . . . . 16.25 109.512 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.33 -29.4 10.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.497 -0.774 . . . . 15.869999999999999 111.088 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.66 -27.58 58.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.963 0.411 . . . . 13.65 110.725 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -114.82 100.66 1.01 Allowed Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 110.192 -1.163 . . . . 14.16 110.192 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptp -94.2 -15.29 24.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.094 0.473 . . . . 15.449999999999999 110.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -122.74 138.26 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.295 -1.002 . . . . 13.630000000000001 108.295 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 t -59.36 -16.79 24.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.542 1.137 . . . . 13.9 113.878 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.35 -36.52 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.21 0.529 . . . . 13.81 110.73 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 p -58.81 -44.61 90.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.677 -1.147 . . . . 11.48 112.032 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.96 -46.41 28.94 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.783 -0.722 . . . . 10.35 111.904 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 m -58.71 -52.94 63.55 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 122.859 0.463 . . . . 12.199999999999999 110.733 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -61.09 -44.17 97.77 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.629 -0.714 . . . . 11.859999999999999 110.965 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 152' ' ' VAL . 22.1 t90 -67.18 -49.64 63.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.898 -0.592 . . . . 9.3200000000000003 111.511 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 38.0 ttm -64.7 -33.81 76.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.78 0.659 . . . . 9.5 112.78 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -66.31 -38.18 87.11 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.861 -0.736 . . . . 13.91 109.965 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.1 95.71 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.862 -0.895 . . . . 9.8800000000000008 110.862 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 148' ' ' TRP . 78.2 t -58.43 -46.97 89.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 123.598 0.759 . . . . 9.2699999999999996 109.468 174.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.9 m -61.49 -40.43 94.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 11.460000000000001 110.135 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -71.36 -53.27 14.72 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.756 -0.656 . . . . 15.039999999999999 111.558 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -66.61 -42.62 86.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.798 0.295 . . . . 11.82 111.798 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HD1' ' O ' ' A' ' 152' ' ' VAL . 96.7 m-85 -82.37 -8.9 59.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.048 0.451 . . . . 11.970000000000001 110.552 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.9 m 61.46 29.84 18.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.645 1.178 . . . . 14.24 111.588 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 178' ' ' VAL . 28.4 pt -103.64 150.14 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 12.619999999999999 109.057 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -89.02 94.92 10.12 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.537 -1.283 . . . . 16.390000000000001 107.537 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.61 120.64 42.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.512 -0.767 . . . . 12.32 109.182 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 134.58 57.18 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.929 -1.032 . . . . 14.06 110.932 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -69.27 -20.36 63.92 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.67 -0.696 . . . . 12.640000000000001 110.715 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.75 -16.87 64.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.966 -0.561 . . . . 15.68 110.348 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.47 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -65.71 -14.71 61.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.983 -0.553 . . . . 12.720000000000001 112.056 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 162' ' ' ALA . 31.7 pt -68.88 -22.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.521 0.676 . . . . 12.16 109.57 175.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -102.64 -15.52 16.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.661 -0.699 . . . . 15.08 109.157 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 25.9 m -77.16 -46.6 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.819 -0.808 . . . . 14.67 108.819 177.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.46 90.24 0.92 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 121.298 0.571 . . . . 12.68 112.425 -176.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.28 41.9 1.23 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.654 2.236 . . . . 14.34 111.191 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -123.07 142.89 50.38 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-O 122.361 1.077 . . . . 12.91 111.061 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.01 -43.19 93.32 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 113.535 -1.666 . . . . 9.8900000000000006 110.958 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.74 -37.2 86.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.058 -0.974 . . . . 12.5 111.106 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 m -79.29 -33.0 43.7 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.809 -0.632 . . . . 11.039999999999999 110.561 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.05 -43.61 91.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.661 -1.237 . . . . 8.5 107.661 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.66 78.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.698 -0.683 . . . . 7.7000000000000002 110.907 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -29.97 68.51 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.716 -0.675 . . . . 10.380000000000001 110.381 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -78.81 -58.0 3.47 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.65 -0.704 . . . . 11.970000000000001 111.696 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 110' ' ' ILE . 6.7 p -56.91 -43.75 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.432 0.53 . . . . 9.8000000000000007 112.432 -175.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.29 -44.67 95.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.143 0.496 . . . . 10.83 110.143 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -72.21 -30.87 65.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.014 -0.994 . . . . 13.5 110.983 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.14 -44.02 85.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.334 -0.617 . . . . 14.84 109.334 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.35 -52.86 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.848 -0.615 . . . . 13.35 110.186 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.308 -1.198 0 N-CA-C 112.432 0.53 . . . . 13.51 112.432 -177.717 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 108.978 -0.749 . . . . 18.510000000000002 108.978 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.71 30.73 1.48 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.752 0.787 . . . . 16.66 109.074 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -91.4 -83.68 0.27 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.963 -1.017 . . . . 14.84 111.715 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -109.42 14.42 23.63 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.334 0.588 . . . . 14.98 111.223 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.37 80.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.709 -0.678 . . . . 15.789999999999999 111.952 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 p -57.12 -36.04 70.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.517 -0.765 . . . . 12.02 111.445 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.94 76.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.364 -0.606 . . . . 11.02 109.364 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -59.24 -50.86 72.4 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.591 -0.732 . . . . 16.07 110.57 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -53.94 -47.07 71.65 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.762 0.825 . . . . 13.93 111.954 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -71.68 -36.38 70.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.381 -0.372 . . . . 10.710000000000001 111.253 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -67.21 -43.12 82.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.478 0.711 . . . . 14.02 109.841 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -58.59 -45.3 89.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.41 1.084 . . . . 16.289999999999999 110.128 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -70.26 -32.88 70.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.263 -0.88 . . . . 12.91 110.761 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.9 -56.66 10.63 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.603 -1.258 . . . . 12.77 107.603 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -61.13 -36.28 79.33 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.727 -1.124 . . . . 15.19 112.154 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.33 86.99 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.178 0.513 . . . . 16.260000000000002 111.405 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.6 mmm -78.01 -38.46 44.78 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.95 -0.568 . . . . 15.449999999999999 112.072 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.58 -1.86 58.29 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.422 0.63 . . . . 16.16 112.054 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.0 t80 60.61 56.62 2.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.24 1.416 . . . . 20.559999999999999 109.959 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 47.6 t -124.57 166.91 15.24 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.778 -1.564 . . . . 16.629999999999999 106.778 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -108.93 119.22 49.57 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-O 121.042 0.448 . . . . 20.190000000000001 110.346 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 -23.94 67.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.625 2.883 . . . . 16.600000000000001 115.091 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.33 -16.62 71.5 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.036 -0.602 . . . . 17.739999999999998 113.391 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.16 16.85 7.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.785 0.293 . . . . 20.23 111.043 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.33 139.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 109.709 -0.478 . . . . 15.98 109.709 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' NH2' ' HG2' ' A' ' 183' ' ' GLN . 40.5 ttm180 -78.14 96.71 5.24 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.168 -1.049 . . . . 19.329999999999998 108.168 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 11.5 p-10 -67.26 -14.7 63.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.686 -0.688 . . . . 14.93 112.135 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.88 5.85 66.67 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.751 -0.738 . . . . 14.82 112.081 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.6 t -87.51 161.44 17.79 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.623 0.725 . . . . 14.539999999999999 109.932 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -101.91 142.88 32.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.129 -0.942 . . . . 16.75 112.72 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -42.71 -60.88 1.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.293 1.437 . . . . 11.99 113.848 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.59 -29.86 70.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 14.449999999999999 111.879 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -79.38 -13.47 59.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.98 0.419 . . . . 16.440000000000001 111.409 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.36 -22.47 44.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.649 0.738 . . . . 13.77 109.195 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 25.28 6.21 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.964 -1.016 . . . . 13.81 111.107 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -74.0 113.47 11.21 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.08 0.467 . . . . 13.039999999999999 109.763 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.34 156.23 24.35 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.19 -0.914 . . . . 15.67 110.909 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 t -56.92 -42.32 79.79 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.062 0.458 . . . . 15.289999999999999 109.788 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.62 -48.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.494 -0.776 . . . . 16.66 110.92 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.7 mt -66.05 -38.44 82.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.969 -0.56 . . . . 14.140000000000001 110.779 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.57 84.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 12.0 110.334 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.52 -38.23 90.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 13.970000000000001 110.842 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -71.35 -42.4 68.54 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.645 0.736 . . . . 15.69 110.974 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -61.33 -47.81 84.22 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 125.531 1.532 . . . . 11.69 111.462 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 56' ' ' ILE . 11.3 tp -63.61 -34.02 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 120.855 0.36 . . . . 11.16 111.722 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 37.6 mmt180 -63.11 -38.32 90.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.717 0.294 . . . . 16.649999999999999 111.037 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.03 -39.74 93.81 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.35 0.595 . . . . 14.15 109.624 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 45' ' ' ILE . 72.9 mt -60.13 -47.66 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.193 -0.912 . . . . 10.800000000000001 110.361 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -60.64 -43.2 97.82 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.793 -0.64 . . . . 12.98 111.591 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -72.19 -58.97 2.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.46 -0.791 . . . . 17.52 111.141 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -30.46 69.8 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.012 1.116 . . . . 14.869999999999999 114.012 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.22 -2.36 46.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 113.095 0.776 . . . . 12.199999999999999 113.095 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 59.01 45.28 15.07 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.344 1.057 . . . . 16.710000000000001 110.003 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.49 165.77 22.82 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.536 -0.302 . . . . 12.199999999999999 110.204 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.83 71.34 0.74 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.586 -0.894 . . . . 16.059999999999999 108.586 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 45' ' ' ILE . 34.7 mm -101.31 114.69 65.71 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 116.196 -0.456 . . . . 11.390000000000001 110.65 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.79 171.01 16.12 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.346 2.03 . . . . 12.6 110.027 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.33 -1.05 9.35 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.409 0.684 . . . . 12.52 111.699 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.04 -30.62 71.1 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.089 0.956 . . . . 14.140000000000001 110.55 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.58 98.35 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.299 -0.477 . . . . 10.76 111.993 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.47 -32.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.763 0.792 . . . . 11.0 110.152 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -80.98 -16.5 53.28 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.982 -0.553 . . . . 16.420000000000002 111.097 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -83.57 -48.54 10.13 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.1 -0.704 . . . . 13.35 109.1 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.85 118.96 30.25 Favored Pre-proline 0 C--O 1.215 -0.761 0 CA-C-N 116.229 -0.441 . . . . 12.23 111.324 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.52 -3.99 7.5 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.768 2.312 . . . . 13.06 112.577 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.97 119.58 59.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.99 -1.485 . . . . 12.949999999999999 106.99 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.2 p90 -62.12 -33.54 74.66 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.884 0.698 . . . . 10.92 112.884 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -62.72 -38.17 89.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.368 0.604 . . . . 14.32 110.827 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.7 -23.86 36.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.72 0.771 . . . . 10.93 109.649 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 80.9 t80 -81.05 -30.13 34.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 8.8100000000000005 111.874 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 p -67.61 -33.32 74.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.43 -0.794 . . . . 9.3499999999999996 109.098 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.99 -29.85 64.64 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.253 -0.885 . . . . 11.630000000000001 109.543 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.543 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 82.4 t90 -59.62 -44.34 93.47 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.154 0.982 . . . . 10.550000000000001 108.847 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.65 -45.42 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 C-N-CA 123.629 0.772 . . . . 8.3000000000000007 110.306 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.98 75.63 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 116.162 -0.472 . . . . 9.5800000000000001 113.569 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -77.18 -22.11 52.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.277 0.561 . . . . 10.23 110.661 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -82.55 -2.64 54.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.342 0.592 . . . . 10.43 111.141 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.6 mt -93.3 105.63 17.69 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.946 -2.242 . . . . 10.970000000000001 104.946 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -52.1 115.3 6.54 Favored Pre-proline 0 C--O 1.248 1.002 0 O-C-N 123.765 0.666 . . . . 13.52 112.356 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.91 104.13 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.973 2.448 . . . . 12.279999999999999 111.166 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.6 m -95.16 115.19 27.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.812 -0.81 . . . . 13.44 108.812 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -79.93 58.83 3.0 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.598 0.713 . . . . 13.27 111.407 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.66 -3.31 58.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.071 0.939 . . . . 14.48 108.776 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.6 t -148.85 138.66 22.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.164 -1.421 . . . . 14.92 107.164 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 111.18 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.647 -0.501 . . . . 14.25 109.647 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.69 122.67 56.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.934 -0.576 . . . . 12.970000000000001 110.404 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.45 11.57 2.63 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.751 2.301 . . . . 13.4 112.053 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.15 56.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.694 1.597 . . . . 12.43 110.957 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -115.51 42.1 2.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.93 0.871 . . . . 13.449999999999999 110.65 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -110.87 41.88 1.72 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.814 -1.18 . . . . 14.41 107.814 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 33.9 tt0 -74.92 117.67 64.47 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 113.953 -1.476 . . . . 11.68 109.706 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 12.2 Cg_exo -73.17 158.4 49.1 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.76 2.307 . . . . 10.84 110.771 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.49 137.42 28.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.66 -0.867 . . . . 10.460000000000001 108.66 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.84 115.28 27.92 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.657 -1.609 . . . . 10.58 106.657 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 m -81.18 -30.62 34.3 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 120.014 -0.675 . . . . 11.039999999999999 109.27 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 107.87 57.0 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.771 -1.196 . . . . 10.880000000000001 107.771 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.2 -31.41 55.32 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.707 2.938 . . . . 12.460000000000001 112.716 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -77.44 119.95 79.51 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.114 -0.699 . . . . 13.779999999999999 109.114 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.61 57.13 6.38 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.676 2.251 . . . . 11.949999999999999 111.818 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 142.72 13.37 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.79 -0.924 . . . . 11.48 110.79 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.62 12.61 27.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.896 0.379 . . . . 11.550000000000001 111.924 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.02 78.18 5.47 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.131 0.491 . . . . 12.59 110.304 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.38 -24.87 42.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.63 0.729 . . . . 11.24 110.36 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.9 m 57.56 34.42 24.54 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 113.922 -1.49 . . . . 10.050000000000001 111.537 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.26 73.3 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.276 -0.875 . . . . 11.220000000000001 111.782 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -72.55 -51.36 20.19 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.161 -0.472 . . . . 11.380000000000001 110.261 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -49.94 -51.42 41.32 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.705 0.628 . . . . 9.6500000000000004 110.897 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 104' ' ' SER . 5.9 mm-40 -63.86 -47.99 78.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 10.43 111.721 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.4 m -66.74 -43.53 83.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.182 -0.463 . . . . 10.210000000000001 111.765 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 178' ' ' VAL . 73.3 mt -71.91 -23.64 22.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.0 0 N-CA-C 110.014 -0.365 . . . . 8.1300000000000008 110.014 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -64.73 -41.84 95.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.232 -0.655 . . . . 8.4600000000000009 109.232 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.58 -38.98 84.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.15 0.5 . . . . 10.859999999999999 109.947 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.17 -49.62 76.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.985 -1.007 . . . . 11.449999999999999 109.503 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -50.0 -43.67 50.64 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.135 1.374 . . . . 7.6200000000000001 112.015 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -60.4 -45.29 94.11 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.817 -1.083 . . . . 11.619999999999999 109.715 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -82.0 -22.93 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.61 0.719 . . . . 11.630000000000001 110.516 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -73.74 -55.1 6.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.269 -0.878 . . . . 9.1400000000000006 110.39 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.64 -29.25 33.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.566 -0.531 . . . . 10.06 109.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.2 -19.97 62.36 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.884 -0.487 . . . . 12.07 111.884 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.41 -23.88 61.15 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.449 0.7 . . . . 12.32 109.617 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.53 -23.47 19.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.879 -0.6 . . . . 11.77 110.434 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.91 -26.89 23.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.876 -0.416 . . . . 13.52 109.876 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 73.92 -35.11 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.207 1.403 . . . . 16.559999999999999 112.76 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.93 129.92 40.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.087 -1.449 . . . . 15.74 107.087 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -119.45 117.22 33.1 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.839 -0.619 . . . . 14.199999999999999 109.642 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -88.02 4.64 5.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.968 2.446 . . . . 14.18 112.816 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.83 -78.79 0.02 OUTLIER Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.779 -1.201 . . . . 14.029999999999999 113.106 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 177.88 24.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.336 0.654 . . . . 16.370000000000001 109.912 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 130' ' ' ARG . 6.3 mp 47.66 -158.19 0.05 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.251 0.62 . . . . 12.449999999999999 111.327 -169.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 36.6 mtm-85 76.95 -38.06 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.714 1.206 . . . . 14.43 112.511 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.6 p -69.59 -46.1 67.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.938 -1.134 . . . . 14.32 107.938 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 138' ' ' LEU . . . -100.9 89.37 0.8 Allowed Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 107.588 -2.205 . . . . 13.75 107.588 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.58 -14.03 10.87 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 111.545 0.202 . . . . 12.699999999999999 111.545 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.99 133.04 47.62 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.824 0.821 . . . . 16.379999999999999 110.313 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -65.67 -20.05 66.14 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.829 -1.078 . . . . 13.300000000000001 110.035 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.94 -24.9 68.09 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.906 -1.043 . . . . 16.25 111.676 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.13 -34.7 8.31 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.05 -0.66 . . . . 15.869999999999999 110.949 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 132' ' ' GLY . 35.3 mt -91.83 -27.17 18.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.638 -0.71 . . . . 13.65 112.721 -171.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -106.96 78.85 0.25 Allowed Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.428 -0.892 . . . . 14.16 113.892 -174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 50.2 tpp -80.87 -40.63 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.157 -1.053 . . . . 15.449999999999999 108.157 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -99.59 113.27 25.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.159 -0.928 . . . . 13.630000000000001 109.0 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.6 t -72.67 -38.45 67.6 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.244 -0.889 . . . . 13.9 110.449 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.89 -32.05 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.326 0.584 . . . . 13.81 112.02 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.1 t -77.55 -27.15 51.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.104 -1.038 . . . . 11.48 109.726 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.79 -28.58 34.59 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.092 -1.051 . . . . 10.35 111.166 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.549 ' HB ' ' HB1' ' A' ' 162' ' ' ALA . 16.9 p -66.94 -43.24 83.72 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 109.217 -0.66 . . . . 12.199999999999999 109.217 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -56.8 -49.75 74.4 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.135 -0.939 . . . . 11.859999999999999 109.21 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -55.29 -53.06 60.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.199 -0.91 . . . . 9.3200000000000003 112.203 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.1 tpt -56.94 -48.84 77.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.436 0.694 . . . . 9.5 110.844 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -64.33 -36.13 83.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.267 -0.424 . . . . 13.91 110.872 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.69 97.64 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.814 -0.515 . . . . 9.8800000000000008 111.814 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.44 -43.27 98.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.805 -0.442 . . . . 9.2699999999999996 109.805 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.0 t -59.62 -46.41 89.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.435 -0.802 . . . . 11.460000000000001 109.428 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.55 -48.99 78.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.196 0.998 . . . . 15.039999999999999 111.025 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -58.53 -27.61 64.69 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.62 0.768 . . . . 11.82 112.779 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -107.46 4.71 26.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.779 0.659 . . . . 11.970000000000001 112.779 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m 58.29 32.22 21.79 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.77 0.795 . . . . 14.24 111.315 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.6 pt -107.13 165.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.342 -0.984 . . . . 12.619999999999999 108.342 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -110.97 94.5 5.02 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.335 0.588 . . . . 16.390000000000001 112.051 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.69 108.72 10.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.175 -1.046 . . . . 12.32 108.175 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.5 154.75 35.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.194 -0.912 . . . . 14.06 109.835 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB1' ' HB ' ' A' ' 146' ' ' THR . . . -63.72 -16.98 62.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.939 -1.028 . . . . 12.640000000000001 113.138 -174.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.93 -6.47 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 116.431 -0.35 . . . . 15.68 111.267 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.96 -11.28 46.43 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.138 0.422 . . . . 12.720000000000001 112.138 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.8 pt -64.84 -13.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.253 0.549 . . . . 12.16 111.365 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.59 -1.95 16.63 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.205 -0.452 . . . . 15.08 110.289 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.7 m -84.39 -30.61 25.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.014 -0.539 . . . . 14.67 110.589 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -116.93 108.96 43.52 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.271 -1.011 . . . . 12.68 108.271 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -48.73 -37.73 35.83 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.947 3.098 . . . . 14.34 112.846 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.7 p -125.55 141.01 52.26 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.792 -1.188 . . . . 12.91 107.792 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.61 -1.73 47.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.811 0.671 . . . . 9.8900000000000006 112.811 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -66.5 -26.08 67.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.162 -1.051 . . . . 12.5 108.162 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 18.1 m -76.1 -18.62 59.09 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.237 -1.347 . . . . 11.039999999999999 111.752 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.43 -35.68 76.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.884 0.474 . . . . 8.5 110.286 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.58 -37.64 79.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.142 -0.481 . . . . 7.7000000000000002 111.567 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.9 -32.6 61.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 10.380000000000001 110.349 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 173' ' ' SER . 46.9 mm-40 -70.08 -48.73 56.5 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.619 -0.719 . . . . 11.970000000000001 109.998 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 110' ' ' ILE . 12.1 p -66.78 -40.64 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 9.8000000000000007 111.376 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.99 -37.16 78.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.548 0.689 . . . . 10.83 110.226 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 180' ' ' ARG . 38.6 ttm180 -67.13 -45.85 75.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.982 -1.008 . . . . 13.5 110.106 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -67.99 -48.24 66.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 14.84 111.765 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 90.0 t -64.32 -53.4 43.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 123.48 0.488 . . . . 13.35 109.992 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.468 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 61.7 tt0 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 123.906 0.883 . . . . 13.51 111.62 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 121.222 0.534 . . . . 18.510000000000002 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.67 -49.11 28.45 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.671 1.36 . . . . 16.66 114.671 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -80.1 -37.37 33.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.161 0.8 . . . . 14.84 113.161 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.62 -37.05 70.96 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.547 0.689 . . . . 14.98 109.404 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.72 -39.4 91.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.397 -0.819 . . . . 15.789999999999999 109.887 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.63 -45.11 89.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.039 -0.726 . . . . 12.02 109.039 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.64 94.54 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.994 -0.548 . . . . 11.02 110.891 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -62.63 -37.54 86.73 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.782 0.29 . . . . 16.07 111.782 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.57 -40.49 89.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.53 0.681 . . . . 13.93 110.242 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.57 -33.09 64.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.389 -0.524 . . . . 10.710000000000001 111.041 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.26 -50.05 75.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.779 0.432 . . . . 14.02 110.881 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 22' ' ' PRO . 10.2 pt20 -67.26 -23.85 65.74 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.266 -0.425 . . . . 16.289999999999999 111.595 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 m -83.23 -49.4 9.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.994 0.426 . . . . 12.91 110.415 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.1 -52.73 62.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.235 0.614 . . . . 12.77 110.512 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.39 -24.88 64.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.395 0.517 . . . . 15.19 112.395 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.56 85.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.878 0.37 . . . . 16.260000000000002 110.147 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.6 mtm -74.01 -27.68 61.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.701 -0.681 . . . . 15.449999999999999 111.64 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.04 4.29 54.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.306 -0.406 . . . . 16.16 111.84 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 55.23 39.79 31.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.382 1.073 . . . . 20.559999999999999 112.272 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -109.24 155.69 20.8 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.603 -1.258 . . . . 16.629999999999999 107.603 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.54 118.84 71.22 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 109.308 -0.627 . . . . 20.190000000000001 109.308 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 5.6 Cg_exo -72.8 -29.09 12.92 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.395 2.064 . . . . 16.600000000000001 114.272 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.79 8.19 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.577 -1.009 . . . . 17.739999999999998 110.577 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.49 70.47 8.97 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.268 0.556 . . . . 20.23 111.12 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.62 149.9 13.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.704 -1.221 . . . . 15.98 107.704 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 28' ' ' GLY . 13.8 ttp180 -82.53 126.08 31.85 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 122.319 0.248 . . . . 19.329999999999998 110.406 -177.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.43 -23.62 67.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.606 0.762 . . . . 14.93 112.1 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 26' ' ' ARG . . . -96.7 6.76 65.11 Favored Glycine 0 C--N 1.309 -0.929 0 CA-C-N 115.917 -0.583 . . . . 14.82 113.902 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 26' ' ' ARG . 68.8 m -65.14 153.28 41.34 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.932 0.873 . . . . 14.539999999999999 112.186 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 8.9 mmm180 -92.15 152.96 19.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.005 -0.998 . . . . 16.75 109.841 -172.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 58.2 m-85 -57.79 -50.29 73.76 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 119.367 0.985 . . . . 11.99 112.836 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 36' ' ' LEU . 3.9 mm? -70.14 -9.37 55.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.415 0.626 . . . . 14.449999999999999 111.551 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.27 -37.9 12.39 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.084 -0.71 . . . . 16.440000000000001 109.084 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -61.31 -33.85 74.27 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.565 0.746 . . . . 13.77 111.234 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.19 9.75 8.53 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.63 -0.988 . . . . 13.81 110.63 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 41' ' ' ALA . 8.3 tt -91.58 137.1 32.64 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.363 -0.977 . . . . 13.039999999999999 108.363 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.486 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -132.55 166.93 20.95 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.21 1.004 . . . . 15.67 109.117 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -42.84 -54.62 4.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 15.289999999999999 113.437 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.59 -40.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.285 0.564 . . . . 16.66 111.411 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 67.4 mt -66.41 -36.77 78.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.816 -0.629 . . . . 14.140000000000001 110.093 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.02 -45.01 87.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.14 -0.936 . . . . 12.0 110.766 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.35 -36.31 75.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.277 -0.874 . . . . 13.970000000000001 110.933 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.33 -41.18 57.31 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.49 -0.777 . . . . 15.69 111.507 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -64.84 -41.11 95.98 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.91 -0.586 . . . . 11.69 110.796 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 41' ' ' ALA . 34.3 mm -55.1 -41.6 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.169 -0.469 . . . . 11.16 110.266 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -58.58 -31.71 68.28 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.526 -0.761 . . . . 16.649999999999999 110.622 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -80.02 -46.98 15.64 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.603 -0.271 . . . . 14.15 111.288 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 45' ' ' ILE . 22.6 pt -65.74 -32.1 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.539 -0.464 . . . . 10.800000000000001 110.41 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' ND2' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -60.58 -39.34 87.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.238 0.542 . . . . 12.98 110.19 175.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -73.64 -48.71 30.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.948 -1.024 . . . . 17.52 111.743 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.0 -34.37 64.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.872 -0.731 . . . . 14.869999999999999 111.822 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -88.87 -6.37 57.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.963 0.727 . . . . 12.199999999999999 112.963 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 57.82 41.85 24.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.89 1.276 . . . . 16.710000000000001 111.235 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 tp -141.28 136.24 31.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.248 -1.019 . . . . 12.199999999999999 108.248 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -84.11 56.0 3.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.833 0.825 . . . . 16.059999999999999 109.551 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.545 HG22 ' ND2' ' A' ' 49' ' ' ASN . 10.9 tt -60.24 134.98 90.92 Favored Pre-proline 0 C--O 1.253 1.262 0 CA-C-N 114.139 -1.391 . . . . 11.390000000000001 110.2 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -79.07 162.07 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.582 2.188 . . . . 12.6 111.946 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 45' ' ' ILE . . . -80.56 2.19 26.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.011 -0.995 . . . . 12.52 111.65 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 5.2 m-20 -62.28 -18.26 60.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.961 -0.563 . . . . 14.140000000000001 112.37 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' A' ' 70' ' ' PHE . . . -63.84 -39.34 97.3 Favored Glycine 0 C--O 1.213 -1.183 0 C-N-CA 120.412 -0.899 . . . . 10.76 111.648 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -82.62 -12.84 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 123.025 1.393 . . . . 11.0 108.238 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 52.3 t80 -78.73 -44.91 22.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.174 -1.375 . . . . 16.420000000000002 110.058 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.0 t -93.4 -31.98 14.42 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.558 0.577 . . . . 13.35 112.558 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.06 125.67 45.14 Favored Pre-proline 0 CA--C 1.5 -0.964 0 O-C-N 121.785 -0.572 . . . . 12.23 110.805 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 60.4 Cg_endo -87.61 -18.11 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.042 1.828 . . . . 13.06 111.601 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.4 t -108.24 133.38 53.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.195 -1.409 . . . . 12.949999999999999 107.195 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 43.6 p90 -72.74 -34.82 67.29 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.375 0.509 . . . . 10.92 112.375 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -71.19 -20.65 62.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.496 0.665 . . . . 14.32 111.005 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.97 -25.86 40.21 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.544 0.688 . . . . 10.93 109.883 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.524 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 9.2 t80 -68.04 -30.34 69.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.635 . . . . 8.8100000000000005 111.325 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -63.87 -22.2 66.81 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.856 0.687 . . . . 9.3499999999999996 112.856 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.83 -28.03 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.378 0.608 . . . . 11.630000000000001 110.07 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -73.81 -45.74 49.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.794 -0.639 . . . . 10.550000000000001 109.41 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.57 -42.28 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.661 0 N-CA-C 109.726 -0.472 . . . . 8.3000000000000007 109.726 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.06 74.31 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.606 -0.725 . . . . 9.5800000000000001 113.518 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 p -81.21 -38.33 27.16 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.099 -0.64 . . . . 10.23 111.877 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -73.98 -46.65 42.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.959 -0.696 . . . . 10.43 110.025 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.34 84.26 1.9 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.907 -0.588 . . . . 10.970000000000001 109.667 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -104.8 100.81 25.5 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.378 -0.971 . . . . 13.52 108.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 150.42 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.361 2.04 . . . . 12.279999999999999 111.797 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.4 p -83.14 63.44 7.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.272 1.034 . . . . 13.44 109.75 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -118.11 64.08 0.75 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.802 -1.09 . . . . 13.27 108.788 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.08 -61.61 1.5 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.931 -0.766 . . . . 14.48 108.931 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.7 p -88.19 44.93 1.23 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.2 1.0 . . . . 14.92 109.771 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.52 36.19 0.46 Allowed 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.281 -1.327 . . . . 14.25 108.028 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.88 122.0 85.61 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.064 -0.971 . . . . 12.970000000000001 110.265 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.27 143.12 6.47 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.065 1.843 . . . . 13.4 111.817 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.76 96.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 122.076 0.941 . . . . 12.43 108.557 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -110.85 58.79 0.61 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.559 1.171 . . . . 13.449999999999999 108.575 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -116.43 102.73 9.77 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.766 -1.561 . . . . 14.41 108.525 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -59.97 124.16 75.59 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.051 -0.722 . . . . 11.68 109.051 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.63 40.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.01 2.474 . . . . 10.84 111.006 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -76.82 94.3 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.214 -0.903 . . . . 10.460000000000001 109.866 -178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 98' ' ' GLN . . . -70.71 -22.98 62.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 10.58 109.798 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -68.32 -15.66 63.65 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.589 -0.732 . . . . 11.039999999999999 111.261 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.5 -57.92 0.51 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 112.288 0.477 . . . . 10.880000000000001 112.288 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.56 -21.65 19.14 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.512 1.475 . . . . 12.460000000000001 111.688 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 55.2 tt0 -119.47 86.57 34.32 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 116.069 -0.514 . . . . 13.779999999999999 109.681 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.59 31.55 0.5 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.908 2.405 . . . . 11.949999999999999 110.782 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.54 41.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.223 -1.151 . . . . 11.48 110.223 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.43 -28.95 31.01 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.675 0.75 . . . . 11.550000000000001 109.061 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -80.1 133.96 36.14 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.816 -1.084 . . . . 12.59 108.406 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.32 -31.47 18.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.154 0.502 . . . . 11.24 112.005 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.3 m 60.65 26.07 15.81 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.675 -1.148 . . . . 10.050000000000001 113.567 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.89 -25.25 55.91 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.759 0.281 . . . . 11.220000000000001 111.759 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.98 -37.77 88.76 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.45 -0.341 . . . . 11.380000000000001 111.762 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -57.34 10.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 9.6500000000000004 110.737 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -61.72 -44.43 96.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.574 -0.739 . . . . 10.43 109.924 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.8 t -60.39 -43.48 96.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.6 -0.727 . . . . 10.210000000000001 110.969 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.6 mt -55.98 -51.41 61.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.36 0.664 . . . . 8.1300000000000008 110.511 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.58 -39.86 94.49 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 115.201 -0.909 . . . . 8.4600000000000009 109.869 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.49 -34.82 74.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.957 0.503 . . . . 10.859999999999999 111.777 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -68.34 -53.54 23.39 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 110.016 -0.364 . . . . 11.449999999999999 110.016 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 171' ' ' LEU . 9.4 tt -63.36 -27.68 69.48 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.306 -0.861 . . . . 7.6200000000000001 110.401 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.11 -46.19 90.13 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.734 1.214 . . . . 11.619999999999999 109.869 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -69.26 -33.8 73.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.048 -0.523 . . . . 11.630000000000001 110.91 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -63.48 -42.74 98.55 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.208 -0.451 . . . . 9.1400000000000006 110.432 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.98 -40.99 68.19 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.622 -0.51 . . . . 10.06 109.622 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.54 -49.79 70.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.852 -0.613 . . . . 12.07 112.424 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.56 -25.84 66.0 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.003 0.521 . . . . 12.32 110.438 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.26 -46.76 60.2 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.06 -0.719 . . . . 11.77 109.06 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.29 -81.03 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.512 -0.767 . . . . 13.52 110.04 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -158.55 -45.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.116 -1.068 . . . . 16.559999999999999 108.116 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.7 tp -167.84 157.58 10.13 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.487 -2.412 . . . . 15.74 104.487 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.52 118.01 67.85 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 118.474 0.579 . . . . 14.199999999999999 110.733 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.29 -8.21 11.78 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.495 2.13 . . . . 14.18 111.752 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.6 -10.26 74.16 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.246 -0.742 . . . . 14.029999999999999 111.246 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -89.66 37.1 0.86 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.24 1.019 . . . . 16.370000000000001 110.497 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.21 -5.68 13.02 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.304 -1.316 . . . . 12.449999999999999 110.802 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -85.78 121.66 28.75 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.089 -0.505 . . . . 14.43 110.082 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.1 m 69.85 -66.34 0.27 Allowed 'General case' 0 C--O 1.247 0.926 0 C-N-CA 125.082 1.353 . . . . 14.32 112.175 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.5 82.72 1.51 Allowed Glycine 0 C--O 1.239 0.453 0 CA-C-N 116.412 -0.358 . . . . 13.75 113.007 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . -143.49 117.4 9.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.895 -1.15 . . . . 12.699999999999999 107.895 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.458 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -115.73 164.16 14.76 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.184 -1.413 . . . . 16.379999999999999 107.184 -173.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 40.5 m-85 -42.82 -47.16 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.307 0.854 . . . . 13.300000000000001 113.307 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 pp -55.82 -33.85 64.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.679 0.622 . . . . 16.25 112.679 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.68 -1.73 27.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.567 0.58 . . . . 15.869999999999999 112.567 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 96.6 mt -93.89 -27.19 16.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.233 0.539 . . . . 13.65 109.775 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 170.67 126.38 0.87 Allowed Glycine 0 N--CA 1.432 -1.594 0 N-CA-C 110.411 -1.076 . . . . 14.16 110.411 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp -70.17 -30.17 67.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.163 0.506 . . . . 15.449999999999999 110.904 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -106.92 124.64 49.92 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.743 -0.836 . . . . 13.630000000000001 108.743 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 t -61.49 -30.05 70.37 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.422 -0.808 . . . . 13.9 112.473 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 t -76.91 -25.18 15.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 CA-C-O 121.536 0.684 . . . . 13.81 109.99 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -70.65 -28.19 64.61 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.694 -0.803 . . . . 11.48 110.235 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.34 -21.16 59.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.036 -1.225 . . . . 10.35 110.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 m -67.31 -44.77 78.34 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.012 -1.107 . . . . 12.199999999999999 108.012 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.26 -46.2 90.65 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.318 -1.31 . . . . 11.859999999999999 109.706 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -59.03 -46.72 87.51 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.739 -1.118 . . . . 9.3200000000000003 111.279 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.1 tpt -53.29 -55.73 22.29 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.558 0.743 . . . . 9.5 112.093 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -63.75 -30.11 71.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.599 -0.44 . . . . 13.91 111.669 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 -50.07 50.33 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.004 -0.839 . . . . 9.8800000000000008 111.004 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.83 -40.34 86.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.284 0.634 . . . . 9.2699999999999996 110.25 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.9 t -54.27 -58.83 5.91 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.046 -0.979 . . . . 11.460000000000001 110.697 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -71.23 -24.95 62.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.283 -0.417 . . . . 15.039999999999999 111.638 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -61.07 -34.93 75.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.689 0.28 . . . . 11.82 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -100.55 6.41 44.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 11.970000000000001 111.272 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.3 m 57.42 44.0 22.19 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.284 1.034 . . . . 14.24 111.188 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.5 pt -122.18 146.78 26.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 106.777 -1.564 . . . . 12.619999999999999 106.777 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -96.81 96.73 8.76 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.869 -0.732 . . . . 16.390000000000001 110.95 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.64 139.48 45.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.555 -0.906 . . . . 12.32 108.555 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.94 44.28 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.426 -0.806 . . . . 14.06 109.201 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.86 -24.04 67.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.593 -0.731 . . . . 12.640000000000001 111.616 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.34 2.69 51.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.019 -0.537 . . . . 15.68 111.528 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.55 -14.86 63.07 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.846 -0.534 . . . . 12.720000000000001 111.799 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.6 pt -61.37 -18.08 17.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 122.912 0.485 . . . . 12.16 111.478 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -83.47 -6.97 59.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.078 0.466 . . . . 15.08 110.366 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -99.22 -19.51 17.08 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.668 -0.696 . . . . 14.67 110.983 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -116.54 98.74 52.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.332 -0.547 . . . . 12.68 111.554 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.434 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 43.4 Cg_endo -72.22 -29.0 14.8 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.227 1.951 . . . . 14.34 112.408 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 3.3 p -126.71 143.39 51.25 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.378 0.609 . . . . 12.91 110.031 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 114' ' ' LEU . 34.6 tp -56.18 -26.95 52.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.258 1.423 . . . . 9.8900000000000006 113.045 -174.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.41 -29.72 66.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.844 -0.616 . . . . 12.5 111.125 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -77.54 -30.3 52.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 11.039999999999999 109.934 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 178' ' ' VAL . 47.9 tp -75.82 -50.97 13.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.714 -0.675 . . . . 8.5 109.213 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.52 -47.34 48.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.201 0.6 . . . . 7.7000000000000002 111.817 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 15.2 t70 -65.77 -31.31 72.22 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.773 0.32 . . . . 10.380000000000001 111.16 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.31 -40.31 74.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.597 -0.52 . . . . 11.970000000000001 109.597 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 174' ' ' LEU . 15.6 t -60.61 -42.24 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.08 -0.711 . . . . 9.8000000000000007 109.08 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.67 -39.42 65.06 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 123.985 0.803 . . . . 10.83 111.144 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 20.0 mmt180 -73.14 -46.06 53.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.451 -0.574 . . . . 13.5 109.451 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 181' ' ' ARG . 2.9 mmp_? -63.63 -39.23 93.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.432 -0.804 . . . . 14.84 112.02 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.12 -34.11 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 13.35 110.213 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.445 1.098 . . . . 13.51 110.749 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.212 -0.881 0 N-CA-C 111.682 0.253 . . . . 14.98 111.682 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.15 -42.38 80.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 111.749 0.277 . . . . 15.79 111.749 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.3 t -56.34 -44.11 79.74 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.87 -0.605 . . . . 12.02 110.696 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -37.81 50.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.107 -0.497 . . . . 11.02 111.173 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -40.98 98.46 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 122.895 0.478 . . . . 16.07 109.713 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.68 -38.29 84.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.326 0.584 . . . . 13.93 110.175 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.36 -37.56 60.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.529 -0.759 . . . . 10.71 109.913 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 25' ' ' ILE . 4.9 ttp180 -64.18 -32.4 73.96 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.469 -0.787 . . . . 14.02 110.608 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -61.81 -48.71 79.37 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.693 0.797 . . . . 16.29 110.931 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p -72.52 -30.54 64.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.081 0.467 . . . . 12.91 110.945 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.33 -52.17 49.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.449 -1.315 . . . . 12.77 107.449 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.69 65.88 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.756 -0.656 . . . . 15.19 111.576 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -31.01 69.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.747 0.308 . . . . 16.26 110.676 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.59 -28.37 60.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.168 0.508 . . . . 15.45 110.402 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.36 -8.25 55.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.697 -0.683 . . . . 16.16 111.522 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 56.54 46.91 19.65 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.563 -1.199 . . . . 20.56 110.255 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.2 t -124.39 164.1 20.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.782 -1.554 . . . . 16.63 108.302 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.96 126.65 60.49 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.697 -1.223 . . . . 20.19 107.697 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 -8.4 23.52 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.945 2.43 . . . . 16.6 114.312 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.46 52.72 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.79 -0.719 . . . . 17.74 111.31 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -83.38 84.04 7.65 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.434 -0.95 . . . . 20.23 108.434 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.489 HG21 ' HD2' ' A' ' 11' ' ' ARG . 10.8 tp -142.07 149.02 19.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.135 0.493 . . . . 15.98 110.484 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 -101.79 120.21 40.01 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.76 -1.941 . . . . 19.33 105.76 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -67.83 -17.48 64.52 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 120.945 0.403 . . . . 14.93 111.678 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.45 7.42 61.68 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.484 -0.78 . . . . 14.82 112.953 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 p -66.56 133.35 50.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.794 0.807 . . . . 14.54 110.557 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 34.6 mtp85 -82.84 139.12 33.67 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.096 -0.957 . . . . 16.75 111.183 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -47.26 -43.11 21.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.486 0.585 . . . . 11.99 112.538 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.53 -32.24 71.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.227 1.011 . . . . 14.45 111.904 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.6 -41.64 65.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.522 0.677 . . . . 16.44 109.215 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.67 -21.09 61.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.381 -1.282 . . . . 13.77 111.104 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.34 29.12 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.341 -0.933 . . . . 13.81 112.468 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.78 85.41 7.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.329 -1.36 . . . . 13.04 107.329 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -68.72 154.58 41.69 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.872 -1.058 . . . . 15.67 110.576 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 t -49.57 -41.52 41.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.261 0.624 . . . . 15.29 112.311 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -48.52 85.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.214 0.531 . . . . 16.66 110.66 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.3 -36.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.621 -0.718 . . . . 14.14 109.585 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -59.43 -44.34 92.93 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.377 -0.829 . . . . 12.0 110.727 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -59.93 -46.45 89.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 13.97 110.533 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.27 -44.61 92.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.99 -0.55 . . . . 15.69 111.259 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.432 ' O ' HG13 ' A' ' 48' ' ' ILE . 7.5 t90 -60.13 -48.23 82.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.547 1.139 . . . . 11.69 110.051 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 41' ' ' ALA . 30.3 mm -56.94 -45.73 83.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.895 -0.593 . . . . 11.16 111.03 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 18.8 mmm180 -62.82 -31.07 71.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.429 -0.35 . . . . 16.65 110.97 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.13 -38.11 69.33 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 110.026 -0.361 . . . . 14.15 110.026 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 44' ' ' TRP . 68.7 mt -61.68 -50.77 78.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.327 -0.99 . . . . 10.8 108.327 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -54.59 -39.03 67.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.631 -1.168 . . . . 12.98 112.147 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -85.92 -37.32 19.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.73 1.011 . . . . 17.52 113.73 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -87.61 -24.48 23.96 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.508 1.299 . . . . 14.87 114.508 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.93 -10.45 19.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.004 0.742 . . . . 12.2 113.004 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 63.57 70.72 0.52 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 16.71 112.304 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.1 174.72 13.29 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.734 -1.209 . . . . 12.2 107.734 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.74 105.1 9.04 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 118.565 0.62 . . . . 16.06 111.148 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 74' ' ' VAL . 27.3 mm -72.51 124.23 90.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 O-C-N 121.82 -0.55 . . . . 11.39 111.91 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.05 126.48 14.53 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.471 -2.165 . . . . 12.6 106.471 167.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 2.18 0.55 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 115.792 1.775 . . . . 12.52 115.792 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -97.84 10.96 38.86 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.561 -0.712 . . . . 14.14 110.588 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.45 -55.89 27.52 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 121.373 -0.441 . . . . 10.76 112.242 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.42 -29.02 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.798 0.809 . . . . 11.0 110.858 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.41 -36.56 68.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.485 -0.78 . . . . 16.42 110.627 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 m -84.99 -40.96 16.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.154 -0.475 . . . . 13.35 110.7 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HE1' ' CE3' ' A' ' 73' ' ' TRP . 68.5 m-85 -111.87 102.45 53.65 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.618 -0.882 . . . . 12.23 108.618 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 89.4 Cg_endo -83.5 4.08 7.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.286 1.991 . . . . 13.06 112.46 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.9 t -123.49 120.9 61.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.388 -1.338 . . . . 12.95 107.388 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -59.21 -32.5 70.0 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.335 0.865 . . . . 10.92 113.335 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -62.45 -46.32 89.06 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.994 0.184 . . . . 14.32 110.822 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.01 67.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.406 0.622 . . . . 10.93 110.986 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.76 -24.26 48.91 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.254 1.022 . . . . 8.81 113.095 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.4 p -60.28 -23.93 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.983 -0.448 . . . . 9.35 112.201 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.59 -29.2 69.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.802 0.81 . . . . 11.63 109.621 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CE3' ' HE1' ' A' ' 64' ' ' TYR . 43.6 t-105 -87.32 -24.62 24.24 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.34 -0.845 . . . . 10.55 110.46 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' HA ' HD11 ' A' ' 56' ' ' ILE . 42.6 t -84.0 -53.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.188 -0.46 . . . . 8.3 110.916 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.8 66.63 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.866 -0.606 . . . . 9.58 114.097 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 t -75.75 -17.82 59.76 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.282 -0.54 . . . . 10.23 110.77 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' A' ' 56' ' ' ILE . 69.5 mm-40 -84.76 -7.81 59.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.45 -0.341 . . . . 10.43 111.332 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.806 -0.442 . . . . 10.97 109.806 178.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 121.516 0.674 . . . . 10.05 110.913 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.85 -46.2 19.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.317 -0.856 . . . . 11.22 110.412 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -54.01 -44.75 71.19 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.0 -0.545 . . . . 11.38 110.879 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -58.28 -47.37 83.86 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.272 -0.877 . . . . 9.65 112.934 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -35.58 60.47 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.681 -0.807 . . . . 10.43 111.353 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.9 m -58.38 -47.98 82.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.095 -0.502 . . . . 10.21 110.858 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.495 HG21 HG11 ' A' ' 178' ' ' VAL . 47.0 mt -63.0 -49.62 82.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 O-C-N 123.353 0.408 . . . . 8.13 110.001 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -51.7 -57.07 10.27 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.953 0.783 . . . . 8.46 112.911 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -67.82 -36.43 80.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.796 0.331 . . . . 10.86 111.471 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.39 -36.26 76.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.617 -0.512 . . . . 11.45 109.617 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.37 -39.08 91.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.629 -0.878 . . . . 7.62 108.629 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.95 -45.98 92.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.138 -0.937 . . . . 11.62 110.438 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.97 -32.56 72.23 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.419 -0.355 . . . . 11.63 111.02 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -65.45 -51.51 59.67 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.892 -0.41 . . . . 9.14 109.892 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.4 tp -64.14 -42.84 96.63 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.451 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.14 91.42 Favored Glycine 0 CA--C 1.518 0.227 0 O-C-N 123.146 0.279 . . . . 12.07 113.099 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.25 -45.35 93.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.862 0.839 . . . . 12.32 109.392 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 144' ' ' THR . 45.2 tp -70.02 -45.99 66.04 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.525 -1.216 . . . . 11.77 110.739 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.3 tp -72.82 -11.0 60.43 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.934 0.894 . . . . 13.52 110.948 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.0 t80 85.97 -34.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.163 1.785 . . . . 16.56 111.665 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.5 tp -165.12 149.81 9.08 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.963 -1.495 . . . . 15.74 106.963 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -86.99 122.03 71.37 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 105.876 -1.898 . . . . 14.2 105.876 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.38 -3.07 12.25 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 122.65 2.233 . . . . 14.18 111.446 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -162.65 -107.6 0.21 Allowed Glycine 0 C--N 1.291 -1.925 0 CA-C-N 114.773 -1.103 . . . . 14.03 110.701 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -155.87 43.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.199 -2.149 . . . . 16.37 105.199 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.0 mt 62.15 -178.21 0.13 Allowed 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.085 -1.416 . . . . 12.45 111.088 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -148.34 146.51 28.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.736 -1.209 . . . . 14.43 107.736 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.8 t -76.23 91.44 3.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 14.32 109.689 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.37 -92.25 0.15 Allowed Glycine 0 CA--C 1.49 -1.511 0 N-CA-C 108.43 -1.868 . . . . 13.75 108.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 68.23 128.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.336 1.454 . . . . 12.7 112.079 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.54 -176.32 3.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.608 -0.724 . . . . 16.38 109.689 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 66.9 m-85 -63.74 -27.35 69.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.532 0.682 . . . . 13.3 109.652 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.28 -25.24 65.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.736 -1.12 . . . . 16.25 111.216 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.32 -7.33 55.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.419 -0.81 . . . . 15.87 110.23 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.1 mt -106.59 9.3 31.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.473 0.654 . . . . 13.65 110.093 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.64 -175.11 15.94 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.584 -0.734 . . . . 14.16 111.774 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 84.7 mtp -107.09 -9.09 16.27 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.604 0.716 . . . . 15.45 109.979 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -118.58 159.97 22.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.292 -0.867 . . . . 13.63 108.92 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.1 p -81.4 -16.34 52.46 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.776 0.798 . . . . 13.9 109.866 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.41 -36.37 77.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.823 -1.08 . . . . 13.81 111.087 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 121' ' ' LEU . 7.2 p -63.57 -42.44 98.32 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 116.159 -0.473 . . . . 11.48 110.428 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.08 -41.59 70.19 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.536 -0.756 . . . . 10.35 112.554 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.1 p -65.3 -46.64 79.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 117.082 0.441 . . . . 12.2 111.456 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -59.92 -49.53 77.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 11.86 110.389 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.585 ' O ' HG23 ' A' ' 152' ' ' VAL . 13.9 t90 -62.72 -51.83 65.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.567 -0.742 . . . . 9.32 112.121 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.478 ' SD ' HG13 ' A' ' 165' ' ' ILE . 39.6 ttm -63.79 -37.08 86.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.189 0.44 . . . . 9.5 112.189 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -69.43 -29.07 66.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.493 -0.483 . . . . 13.91 110.533 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.31 -42.47 82.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.688 -0.965 . . . . 9.88 110.688 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 148' ' ' TRP . 22.1 t -58.66 -48.31 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.76 -1.2 . . . . 9.27 107.76 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.8 t -57.71 -52.7 64.39 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.187 -1.37 . . . . 11.46 110.906 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -66.35 -44.14 84.12 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.762 -0.654 . . . . 15.04 111.94 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -65.61 -37.77 87.55 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.039 0.755 . . . . 11.82 113.039 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 110' ' ' ILE . 97.3 m-85 -93.31 9.91 34.27 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.226 0.536 . . . . 11.97 111.894 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 57.39 43.21 23.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.516 1.126 . . . . 14.24 112.355 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -122.17 155.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.391 -0.596 . . . . 12.62 109.391 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -97.91 97.29 8.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.115 -0.698 . . . . 16.39 109.115 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.17 125.68 54.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.491 -0.929 . . . . 12.32 108.491 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.97 136.01 40.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.263 -0.426 . . . . 14.06 111.106 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.86 -11.46 59.99 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 121.774 0.797 . . . . 12.64 110.421 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.98 -12.03 61.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.139 0.971 . . . . 15.68 109.518 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.2 -10.22 55.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.474 -0.785 . . . . 12.72 109.967 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.478 HG13 ' SD ' ' A' ' 149' ' ' MET . 11.4 mt -56.51 -32.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.81 1.244 . . . . 12.16 109.965 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.29 -6.37 59.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.709 -1.132 . . . . 15.08 109.761 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 88.3 m -94.87 -18.34 21.25 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.052 -0.976 . . . . 14.67 109.582 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.586 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.8 m0 -117.78 98.96 52.09 Favored Pre-proline 0 C--N 1.318 -0.793 0 O-C-N 121.927 -0.483 . . . . 12.68 111.003 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 83.6 Cg_endo -87.12 3.28 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.556 2.171 . . . . 14.34 112.205 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -139.57 143.9 37.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.88 0.848 . . . . 12.91 111.655 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.36 -28.4 68.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.067 1.747 . . . . 9.89 112.949 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.31 -26.72 60.34 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.047 0.451 . . . . 12.5 110.907 -176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -67.1 -44.98 78.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 113.575 0.954 . . . . 11.04 113.575 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 174' ' ' LEU . 2.6 pt? -75.32 -25.85 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.0 -1.08 . . . . 8.5 110.585 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.36 92.78 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.888 -0.596 . . . . 7.7 111.186 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.56 -26.12 32.68 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.008 -0.677 . . . . 10.38 110.61 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.586 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 9.6 tp10 -68.54 -54.13 18.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.543 -0.298 . . . . 11.97 110.802 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -50.02 -43.82 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 112.718 0.636 . . . . 9.8 112.718 -176.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 -41.92 92.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.994 0.426 . . . . 10.83 111.399 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -71.87 -29.3 64.22 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.019 -0.537 . . . . 13.5 110.338 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 5.4 mmp_? -65.06 -42.74 93.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.021 -0.536 . . . . 14.84 109.946 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.62 -51.9 23.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.19 -0.459 . . . . 13.35 111.217 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 112.293 0.479 . . . . 13.51 112.293 -178.842 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.719 0.295 . . . . 14.98 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.75 -42.69 99.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.278 0.473 . . . . 15.79 112.278 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -58.09 -44.43 87.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.018 0.927 . . . . 12.02 110.01 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.32 72.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.786 -0.643 . . . . 11.02 110.887 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 27.2 tt0 -67.36 -43.82 80.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.016 -0.364 . . . . 16.07 110.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.547 ' HA ' HE21 ' A' ' 12' ' ' GLN . 30.2 t80 -53.78 -39.02 65.05 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.409 1.084 . . . . 13.93 110.933 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 mt -82.05 -39.19 23.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.777 -0.647 . . . . 10.71 110.96 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -64.01 -22.66 67.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.379 0.881 . . . . 14.02 113.379 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.58 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 45.7 mt-30 -57.3 -48.42 78.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.727 0.298 . . . . 16.29 111.568 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -75.52 -34.2 60.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.097 0.475 . . . . 12.91 110.589 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.89 -43.7 95.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.562 -0.745 . . . . 12.77 109.973 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.69 80.21 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.159 -0.928 . . . . 15.19 111.042 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.91 -44.82 30.21 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.152 -0.476 . . . . 16.26 110.845 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -70.63 -35.0 72.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.001 -0.545 . . . . 15.45 112.382 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.83 -15.68 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.531 0.681 . . . . 16.16 111.655 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 64.28 45.64 3.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.375 -1.284 . . . . 20.56 109.703 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -125.47 165.37 18.58 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.144 -1.058 . . . . 16.63 108.144 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.11 126.85 55.7 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.796 0.332 . . . . 20.19 110.736 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 38.8 Cg_endo -65.76 -22.52 56.91 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.096 2.531 . . . . 16.6 113.387 -174.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.88 67.97 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 121.001 -0.618 . . . . 17.74 112.632 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -100.96 8.43 43.06 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.253 0.549 . . . . 20.23 111.597 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 22' ' ' PRO . 14.9 tt -85.81 119.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.876 -1.157 . . . . 15.98 107.876 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -74.96 144.17 43.32 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.744 -0.662 . . . . 19.33 110.049 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.53 -16.3 23.81 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.642 1.177 . . . . 14.93 113.914 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.2 6.53 26.95 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 121.032 -0.604 . . . . 14.82 112.264 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -71.01 148.57 47.48 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.473 0.654 . . . . 14.54 110.875 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 99.6 mtt180 -110.68 137.23 48.61 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.02 0.914 . . . . 16.75 111.978 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -47.61 -43.58 25.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.315 -1.766 . . . . 11.99 112.827 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -68.97 -29.54 67.78 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.508 -0.314 . . . . 14.45 111.406 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.72 -23.09 34.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.207 -0.664 . . . . 16.44 109.207 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.88 -39.1 66.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.451 -0.795 . . . . 13.77 109.981 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 14.26 1.05 Allowed Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.266 -0.968 . . . . 13.81 112.824 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 168.8 19.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.345 0.593 . . . . 13.04 110.408 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.4 163.08 40.57 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.234 -2.136 . . . . 15.67 105.234 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -67.03 -31.0 71.24 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 119.579 1.081 . . . . 15.29 109.565 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.36 -43.63 80.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.095 -0.502 . . . . 16.66 109.663 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.17 -33.69 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.672 -0.694 . . . . 14.14 109.944 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.92 95.47 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.814 -0.63 . . . . 12.0 109.776 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.99 -22.54 65.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.703 -0.681 . . . . 13.97 111.369 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.52 -50.83 8.93 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.253 0.549 . . . . 15.69 110.383 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -67.33 -35.68 79.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 C-N-CA 124.417 1.087 . . . . 11.69 111.662 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 48' ' ' ILE . 8.8 tp -58.63 -40.28 78.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-O 120.894 0.378 . . . . 11.16 110.377 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 41.7 ttm180 -69.01 -33.79 74.22 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.304 0.574 . . . . 16.65 110.14 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.36 -27.94 47.06 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 112.495 0.554 . . . . 14.15 112.495 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 45' ' ' ILE . 29.7 pt -76.37 -29.54 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 119.219 -0.992 . . . . 10.8 109.032 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.13 -40.03 92.27 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-N 115.377 -0.829 . . . . 12.98 110.372 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 26.3 mtpp -65.22 -49.64 68.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.832 -0.622 . . . . 17.52 110.015 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 44.7 m80 -59.64 -43.86 93.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.551 0.945 . . . . 14.87 113.551 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -92.67 -4.79 52.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.162 1.171 . . . . 12.2 114.162 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.11 45.64 20.47 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.044 1.402 . . . . 16.71 108.891 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.6 tp -119.87 165.92 13.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.206 -1.405 . . . . 12.2 107.206 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -127.33 74.51 1.52 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.139 0.495 . . . . 16.06 109.935 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.483 HG12 ' OE1' ' A' ' 77' ' ' GLN . 58.4 mt -89.45 126.36 58.57 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.303 -0.999 . . . . 11.39 108.303 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.6 Cg_exo -67.2 156.31 66.85 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.002 1.801 . . . . 12.6 109.084 171.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.96 -0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.434 1.272 . . . . 12.52 114.434 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.87 -12.04 60.02 Favored 'General case' 0 C--O 1.24 0.554 0 O-C-N 122.453 -0.154 . . . . 14.14 110.943 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.6 62.69 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 121.304 -0.474 . . . . 10.76 113.079 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.02 35.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.115 0.96 . . . . 11.0 108.716 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -85.42 -44.06 13.08 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.38 -0.825 . . . . 16.42 111.657 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -136.0 25.58 3.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.53 0.681 . . . . 13.35 111.434 -174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -123.34 89.92 50.76 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.73 -1.211 . . . . 12.23 107.73 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.8 Cg_endo -82.99 -3.35 11.07 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.286 1.991 . . . . 13.06 115.697 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.41 120.38 64.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 119.381 0.992 . . . . 12.95 109.347 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -61.37 -35.46 77.52 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.55 -0.75 . . . . 10.92 111.93 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.82 -29.98 69.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.523 . . . . 14.32 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.62 33.78 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.821 0.82 . . . . 10.93 109.423 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 50.7 t80 -87.82 -28.02 21.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.301 -0.863 . . . . 8.81 112.04 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 p -63.4 -36.65 84.43 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.612 -0.68 . . . . 9.35 111.723 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -75.34 -23.69 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 11.63 110.264 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 49.4 t90 -64.05 -47.89 78.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.053 -1.092 . . . . 10.55 108.053 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 90.9 t -69.22 -43.62 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 CA-C-N 115.594 -0.73 . . . . 8.3 109.235 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.76 -43.9 80.49 Favored Glycine 0 C--O 1.238 0.387 0 CA-C-N 115.491 -0.777 . . . . 9.58 113.319 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -67.58 -33.59 75.33 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.93 0.365 . . . . 10.23 111.183 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.483 ' OE1' HG12 ' A' ' 56' ' ' ILE . 3.7 pt20 -89.67 -2.37 58.27 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.767 -1.173 . . . . 10.43 112.563 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 90.6 mt . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.243 0.544 . . . . 10.97 110.07 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 107.3 -1.37 . . . . 10.05 107.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.44 -46.13 26.32 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.549 1.14 . . . . 11.22 113.555 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.91 -46.64 77.54 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.303 0.483 . . . . 11.38 112.303 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -75.43 -30.23 59.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.195 -0.298 . . . . 9.65 110.195 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.59 -46.08 91.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.003 0.521 . . . . 10.43 111.073 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 m -56.54 -38.44 71.89 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.23 0.538 . . . . 10.21 110.145 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.75 HG21 HG11 ' A' ' 178' ' ' VAL . 66.0 mt -73.59 -52.41 21.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.25 -0.887 . . . . 8.13 109.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -54.88 -43.32 73.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.736 0.814 . . . . 8.46 111.693 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.44 -40.93 93.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.088 -0.506 . . . . 10.86 110.397 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.3 -36.53 66.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.669 . . . . 11.45 109.608 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.48 -45.21 95.2 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.151 0.98 . . . . 7.62 108.406 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.83 -45.3 95.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.385 -0.825 . . . . 11.62 110.385 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -65.31 -39.41 92.45 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.142 -0.481 . . . . 11.63 111.056 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -69.08 -37.88 78.71 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.589 -0.278 . . . . 9.14 111.174 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.1 tp -65.21 -48.48 73.23 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.607 -0.516 . . . . 10.06 109.607 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.89 -49.14 77.31 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.79 -0.641 . . . . 12.07 112.148 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -61.36 -38.85 88.45 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 123.457 0.703 . . . . 12.32 111.322 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 148' ' ' TRP . 51.9 tp -67.54 -43.05 81.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.977 -0.556 . . . . 11.77 110.012 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.52 -64.34 0.9 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.293 -0.867 . . . . 13.52 110.252 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.0 t80 168.02 -46.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.301 -2.111 . . . . 16.56 105.301 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -168.38 143.94 3.62 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 103.885 -2.635 . . . . 15.74 103.885 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.61 136.37 20.79 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.065 -0.717 . . . . 14.2 109.065 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.07 6.06 5.56 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.305 2.003 . . . . 14.18 112.378 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 33.76 74.6 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 110.354 -1.098 . . . . 14.03 110.354 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -102.7 20.45 17.24 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.383 1.087 . . . . 16.37 109.259 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.8 pt? -96.64 176.27 6.07 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.158 -0.928 . . . . 12.45 108.981 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 73.1 -58.31 0.6 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.468 1.107 . . . . 14.43 110.547 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -89.64 5.12 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.078 -1.453 . . . . 14.32 107.078 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.99 135.0 5.35 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.405 -1.478 . . . . 13.75 109.405 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 172' ' ' LYS . . . -179.66 138.21 0.13 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.988 1.315 . . . . 12.7 107.739 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' HG22 ' A' ' 170' ' ' THR . 3.9 pt20 -170.01 173.9 5.78 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 118.524 -0.751 . . . . 16.38 109.879 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 55.3 m-85 -63.32 -18.87 64.08 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 119.738 1.154 . . . . 13.3 112.534 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.2 -10.08 59.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.06 -0.973 . . . . 16.25 112.373 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.258 14.3 p30 -70.46 -64.95 0.8 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.109 -0.636 . . . . 15.87 112.705 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 pp -87.3 -9.8 53.99 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.687 0.756 . . . . 13.65 109.019 173.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -83.1 70.56 3.17 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.978 -1.01 . . . . 14.16 113.701 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 92.3 mmm -109.06 -65.15 1.17 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.06 -1.459 . . . . 15.45 107.06 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.54 146.01 39.36 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.167 -1.79 . . . . 13.63 106.167 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -73.33 -16.56 61.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 113.119 0.785 . . . . 13.9 113.119 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.63 -52.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.021 -0.733 . . . . 13.81 109.021 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -63.82 -31.97 73.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.99 -0.55 . . . . 11.48 111.627 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.08 78.27 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.705 -1.236 . . . . 10.35 110.517 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 m -61.39 -45.33 94.82 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.761 -0.829 . . . . 12.2 108.761 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 150' ' ' ARG . 86.1 mm-40 -59.66 -41.16 89.96 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.498 -0.774 . . . . 11.86 111.514 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.429 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.5 t90 -65.48 -47.29 76.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.322 -0.854 . . . . 9.32 110.907 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.8 mtp -69.55 -27.35 65.07 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.291 -0.564 . . . . 9.5 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 2.7 tmm_? -59.37 -43.91 92.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.913 -1.144 . . . . 13.91 107.913 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.35 -54.3 20.8 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.364 -0.834 . . . . 9.88 111.474 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.19 -46.85 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.574 0.749 . . . . 9.27 112.385 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 p -64.54 -52.25 58.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.796 0.331 . . . . 11.46 111.864 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -71.95 -38.49 69.77 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.807 0.299 . . . . 15.04 111.807 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -68.75 -31.2 70.07 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.704 0.631 . . . . 11.82 112.704 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -101.38 1.81 38.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.992 0.425 . . . . 11.97 111.845 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 t 60.56 37.2 19.64 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.215 1.006 . . . . 14.24 111.633 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -119.89 138.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.806 -0.813 . . . . 12.62 108.806 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.95 95.66 10.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.607 0.718 . . . . 16.39 110.546 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.64 129.37 54.56 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.928 -1.138 . . . . 12.32 107.928 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.47 56.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.296 -0.631 . . . . 14.06 109.296 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.13 63.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.289 0.566 . . . . 12.64 111.208 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.81 -4.44 58.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.701 -0.682 . . . . 15.68 110.488 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -74.14 0.62 13.33 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.98 0.363 . . . . 12.72 111.98 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.8 pt -64.96 -14.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.885 0.85 . . . . 12.16 109.379 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -103.31 -3.56 25.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.093 -0.958 . . . . 15.08 109.875 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.3 m -99.42 -40.7 7.74 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.236 -0.654 . . . . 14.67 109.236 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.0 m-90 -121.37 69.05 20.96 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.663 -0.866 . . . . 12.68 108.663 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' PHE . 1.5 Cg_endo -87.12 40.92 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.988 2.458 . . . . 14.34 113.361 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.403 HG22 ' C ' ' A' ' 134' ' ' GLN . 36.1 p -154.62 143.28 20.74 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 105.227 -2.138 . . . . 12.91 105.227 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.61 -17.02 64.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.356 0.502 . . . . 9.89 112.356 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.455 ' HG3' ' CB ' ' A' ' 133' ' ' ALA . 92.1 mttt -72.41 -44.24 62.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 120.824 -0.351 . . . . 12.5 110.828 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 19.1 m -63.75 -43.93 95.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 123.652 0.595 . . . . 11.04 110.186 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.5 -48.03 71.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.977 -0.556 . . . . 8.5 109.843 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.54 72.81 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.518 0.562 . . . . 7.7 112.518 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 32.8 t70 -83.25 -29.87 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.558 -0.457 . . . . 10.38 111.308 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 173' ' ' SER . 0.2 OUTLIER -57.73 -49.22 77.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.654 0.782 . . . . 11.97 109.906 -177.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -56.96 -35.95 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.699 -0.682 . . . . 9.8 111.556 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.1 -34.89 79.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.391 0.615 . . . . 10.83 110.314 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 88.8 mtt180 -74.27 -43.72 55.74 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.025 -0.989 . . . . 13.5 108.642 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -64.49 -40.85 96.44 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.396 -1.274 . . . . 14.84 111.192 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 183' ' ' GLN . 34.5 m -84.18 -39.47 14.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 113.196 0.813 . . . . 13.35 113.196 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 182' ' ' VAL . 92.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 120.941 -0.304 . . . . 13.51 111.172 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 111.89 0.33 . . . . 14.98 111.89 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.26 -35.88 80.31 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 122.652 0.381 . . . . 15.79 110.423 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.6 m -57.5 -41.57 81.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 120.847 0.356 . . . . 12.02 111.106 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -69.56 -47.39 63.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.049 -0.523 . . . . 11.02 109.633 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.08 -38.33 85.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.739 -0.664 . . . . 16.07 111.85 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.29 -46.2 74.32 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.961 0.41 . . . . 13.93 110.746 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.24 -35.53 78.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.411 -0.359 . . . . 10.71 111.793 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 25' ' ' ILE . 85.5 mtt180 -61.97 -41.61 98.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 14.02 108.97 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -61.26 -51.18 70.0 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.058 -0.973 . . . . 16.29 110.141 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 t -56.49 -51.48 68.32 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.944 0.778 . . . . 12.91 110.838 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.62 -52.53 65.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 12.77 110.582 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.17 77.3 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.38 0.511 . . . . 15.19 112.38 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.76 78.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.69 0.281 . . . . 16.26 111.026 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 ptm -70.98 -24.5 62.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.5 -0.48 . . . . 15.45 111.865 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.36 0.7 55.69 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.028 0.381 . . . . 16.16 112.028 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 56.73 42.37 26.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.553 1.141 . . . . 20.56 111.813 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.8 m -117.84 174.53 6.13 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.984 -1.007 . . . . 16.63 109.8 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -94.76 124.37 54.95 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.575 -0.739 . . . . 20.19 110.924 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 -17.96 15.91 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.272 2.648 . . . . 16.6 113.501 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.41 43.02 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.143 -1.183 . . . . 17.74 110.143 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.7 69.7 7.73 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.542 0.687 . . . . 20.23 109.395 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 11' ' ' ARG . 10.0 tp -120.92 153.87 24.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.74 -0.663 . . . . 15.98 109.635 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.63 87.36 2.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 106.762 -1.569 . . . . 19.33 106.762 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.88 -27.57 60.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.399 1.48 . . . . 14.93 113.061 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.96 -11.79 80.77 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.234 -0.984 . . . . 14.82 112.571 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -81.92 144.94 30.59 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.388 0.613 . . . . 14.54 109.723 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 29.5 ptt180 -71.19 146.54 49.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.071 -0.968 . . . . 16.75 110.471 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -48.07 -34.46 9.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.971 1.709 . . . . 11.99 113.144 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.56 -38.24 71.65 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.228 1.011 . . . . 14.45 110.036 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.3 2.41 55.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.565 0.746 . . . . 16.44 110.927 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.6 0.83 56.73 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.113 -0.699 . . . . 13.77 109.113 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.93 11.1 50.92 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.303 -0.862 . . . . 13.81 111.95 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 175.74 5.62 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.084 0.945 . . . . 13.04 111.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -141.51 159.73 41.61 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.984 -1.916 . . . . 15.67 106.828 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -55.9 -42.98 76.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 118.947 0.794 . . . . 15.29 111.111 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.89 -51.42 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.195 -0.911 . . . . 16.66 110.577 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.22 -41.27 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.603 -0.726 . . . . 14.14 110.203 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.44 87.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 12.0 111.174 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.87 -30.42 71.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.191 0.519 . . . . 13.97 111.185 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.6 -43.92 16.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.431 0.634 . . . . 15.69 110.659 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -57.7 -44.04 85.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 124.944 1.298 . . . . 11.69 111.278 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.63 -31.1 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 121.306 -0.158 . . . . 11.16 110.987 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 1.4 mmp_? -63.1 -39.71 95.51 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.945 -0.391 . . . . 16.65 109.945 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -38.06 79.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.929 0.395 . . . . 14.15 110.356 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.8 -42.33 88.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.966 -0.753 . . . . 10.8 108.966 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.536 ' ND2' ' HB ' ' A' ' 56' ' ' ILE . 14.6 m120 -62.01 -36.26 81.0 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.59 -0.732 . . . . 12.98 111.395 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 46' ' ' ARG . 75.6 mmtt -78.3 -49.71 13.16 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.738 -0.21 . . . . 17.52 110.725 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -65.27 -42.38 93.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.301 -0.409 . . . . 14.87 111.759 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -85.51 -13.12 50.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.289 0.477 . . . . 12.2 112.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 57.32 38.36 28.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 16.71 109.956 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.6 tp -122.25 138.59 54.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.181 -0.918 . . . . 12.2 110.183 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -70.7 57.67 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.206 1.403 . . . . 16.06 112.573 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' HB ' ' ND2' ' A' ' 49' ' ' ASN . 11.3 mt -88.68 122.85 68.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.583 -0.698 . . . . 11.39 111.43 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 5.2 Cg_exo -80.38 162.95 22.25 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.138 1.892 . . . . 12.6 108.765 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.31 -6.91 15.68 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.513 0.673 . . . . 12.52 110.617 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 33.4 t70 -60.99 -27.91 68.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.217 -1.356 . . . . 14.14 111.671 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' NE1' ' A' ' 73' ' ' TRP . . . -55.86 -48.97 68.97 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 119.945 -1.122 . . . . 10.76 112.776 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -76.01 -28.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.043 0.925 . . . . 11.0 109.422 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 87.3 t80 -64.21 -41.15 97.17 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.809 -1.087 . . . . 16.42 110.832 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.525 HG23 ' CD2' ' A' ' 64' ' ' TYR . 11.4 t -94.79 -18.62 21.07 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 120.544 -0.462 . . . . 13.35 111.987 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CD2' HG23 ' A' ' 63' ' ' THR . 96.8 m-85 -128.6 96.44 30.12 Favored Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 121.909 -0.494 . . . . 12.23 110.758 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 86.9 Cg_endo -84.64 4.27 6.97 Favored 'Trans proline' 0 C--O 1.211 -0.831 0 C-N-CA 122.363 2.042 . . . . 13.06 111.922 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.54 122.56 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.917 -1.142 . . . . 12.95 107.917 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -60.92 -40.8 94.58 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.845 0.858 . . . . 10.92 112.345 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.16 -27.4 67.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.933 0.397 . . . . 14.32 111.247 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.25 -31.6 21.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.566 0.698 . . . . 10.93 109.58 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -70.87 -30.69 67.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 8.81 111.794 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -64.09 -28.12 69.56 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.591 -0.693 . . . . 9.35 111.145 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -74.23 -24.98 59.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.709 -0.678 . . . . 11.63 109.83 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.542 ' CZ3' ' HG3' ' A' ' 77' ' ' GLN . 20.6 t90 -64.49 -49.03 72.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.616 -1.253 . . . . 10.55 107.616 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.33 -43.92 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-N 115.079 -0.964 . . . . 8.3 109.536 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.73 -40.63 95.17 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.778 -0.646 . . . . 9.58 112.347 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.2 p -77.18 -8.87 58.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.788 0.662 . . . . 10.23 112.788 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.542 ' HG3' ' CZ3' ' A' ' 73' ' ' TRP . 16.8 mm-40 -93.32 -35.35 13.1 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.051 -0.405 . . . . 10.43 110.316 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--N 1.325 -0.498 0 N-CA-C 108.707 -0.849 . . . . 10.97 108.707 175.199 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.444 -0.736 0 CA-C-O 120.999 0.428 . . . . 10.05 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.19 87.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.843 -0.617 . . . . 11.22 110.898 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.44 ' OE1' ' HB ' ' A' ' 182' ' ' VAL . 8.1 tt0 -54.25 -51.84 63.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.664 0.786 . . . . 11.38 109.08 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.35 -45.99 90.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.928 -1.033 . . . . 9.65 111.811 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.63 -39.38 91.1 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.053 0.454 . . . . 10.43 111.591 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -69.33 -51.43 37.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.014 -0.539 . . . . 10.21 110.262 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.823 HG21 HG11 ' A' ' 178' ' ' VAL . 54.6 mt -70.22 -27.02 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 116.267 -0.424 . . . . 8.13 111.456 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.21 -38.78 80.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.559 0.695 . . . . 8.46 109.551 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.76 -31.08 66.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.178 -0.919 . . . . 10.86 110.639 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -77.5 -35.86 53.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.45 -0.341 . . . . 11.45 110.465 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.8 -47.02 83.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.813 -0.81 . . . . 7.62 108.813 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -52.17 -55.22 22.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.879 -1.055 . . . . 11.62 109.835 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.5 -44.08 95.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 11.63 112.581 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 t -63.35 -44.43 94.86 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.058 0.456 . . . . 9.14 110.475 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.05 -42.99 83.86 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.36 -0.607 . . . . 10.06 109.36 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.05 -19.73 68.2 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 116.154 -0.475 . . . . 12.07 112.743 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -78.62 -38.87 38.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.201 -0.666 . . . . 12.32 109.201 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.4 tp -80.83 -45.4 16.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.705 -0.68 . . . . 11.77 110.748 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -83.03 -19.46 36.88 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.196 -0.911 . . . . 13.52 110.223 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.2 t80 73.22 -43.78 0.57 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.855 1.662 . . . . 16.56 112.209 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.5 tp -159.34 142.74 14.57 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.154 -0.684 . . . . 15.74 109.154 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.78 112.08 27.29 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.25 0.344 . . . . 14.2 110.251 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.53 -9.66 20.11 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.888 2.392 . . . . 14.18 112.336 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.13 69.01 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.582 -1.007 . . . . 14.03 110.582 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 78.27 27.17 0.53 Allowed 'General case' 0 C--O 1.247 0.955 0 C-N-CA 125.008 1.323 . . . . 16.37 110.666 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.0 mt 56.85 73.05 0.47 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.647 -1.615 . . . . 12.45 112.267 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -86.33 151.59 23.45 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.116 -1.402 . . . . 14.43 111.39 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -37.33 67.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.83 -1.077 . . . . 14.32 110.262 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.17 62.65 4.53 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 110.771 -0.931 . . . . 13.75 110.771 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.4 143.79 28.48 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.458 -0.571 . . . . 12.7 109.458 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -137.52 139.75 40.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.979 -0.748 . . . . 16.38 108.979 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 12.2 p90 -63.32 -6.87 5.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.733 0.813 . . . . 13.3 112.806 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.84 -61.05 2.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.172 0.511 . . . . 16.25 110.039 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.63 -20.98 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.087 -0.506 . . . . 15.87 110.344 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.02 14.47 15.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.932 -0.577 . . . . 13.65 111.468 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.42 60.02 4.87 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.957 -0.857 . . . . 14.16 110.957 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.03 152.21 51.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.469 -1.308 . . . . 15.45 107.469 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.25 39.87 18.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.192 0.932 . . . . 13.63 111.175 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 p -77.62 -32.81 53.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.219 -0.9 . . . . 13.9 112.138 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.1 -50.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.383 -0.969 . . . . 13.81 108.383 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -72.18 -16.14 61.96 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.34 -0.846 . . . . 11.48 111.303 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.69 -22.09 77.99 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.216 -0.754 . . . . 10.35 111.216 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 82.2 p -66.82 -45.87 76.96 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.182 -1.044 . . . . 12.2 108.182 175.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -61.75 -38.35 87.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.136 -0.938 . . . . 11.86 110.147 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.459 ' O ' HG23 ' A' ' 152' ' ' VAL . 12.4 t90 -56.09 -54.09 49.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 9.32 110.308 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 43.6 ttm -66.76 -30.83 71.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.242 0.339 . . . . 9.5 111.543 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 23.3 mmm180 -58.4 -50.16 74.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 13.91 109.189 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.52 -44.75 96.49 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.654 -0.579 . . . . 9.88 111.654 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 148' ' ' TRP . 80.4 t -57.29 -48.67 81.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 123.208 0.603 . . . . 9.27 111.136 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.2 p -71.19 -31.14 67.27 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.816 0.341 . . . . 11.46 111.526 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.61 -44.91 63.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.027 0.441 . . . . 15.04 110.37 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -66.44 -48.2 70.74 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.791 0.663 . . . . 11.82 112.791 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -84.41 -0.24 52.01 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.171 0.434 . . . . 11.97 112.171 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.5 p 54.43 33.43 18.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.204 1.401 . . . . 14.24 112.482 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.3 pt -109.61 153.55 11.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.541 -0.754 . . . . 12.62 110.308 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.09 95.53 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.185 0.517 . . . . 16.39 110.46 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.98 120.81 26.72 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.006 -0.738 . . . . 12.32 109.006 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 134.74 38.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.903 -0.777 . . . . 14.06 108.903 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.32 -7.86 21.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.749 0.785 . . . . 12.64 111.661 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.3 -19.96 65.96 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.881 0.872 . . . . 15.68 109.711 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -59.8 -19.46 50.85 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.659 0.985 . . . . 12.72 113.659 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.5 pt -70.03 -2.31 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.764 -0.585 . . . . 12.16 111.822 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -122.53 23.69 9.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.743 0.306 . . . . 15.08 110.647 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 164' ' ' ALA . 10.3 t -147.07 20.75 1.24 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.503 -0.479 . . . . 14.67 111.088 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -134.94 103.54 10.79 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 108.552 -0.907 . . . . 12.68 108.552 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.524 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 17.2 Cg_exo -69.19 -33.09 19.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.801 2.334 . . . . 14.34 113.37 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -97.56 155.7 16.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.476 -0.784 . . . . 12.91 110.938 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -81.79 -32.28 31.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.114 -0.948 . . . . 9.89 111.876 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -78.11 -5.6 52.09 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.751 0.649 . . . . 12.5 112.751 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.8 p -54.28 -35.52 62.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.251 1.02 . . . . 11.04 112.46 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 7.3 tt -60.7 -30.79 70.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.184 0.594 . . . . 8.5 110.22 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.48 59.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.259 -0.428 . . . . 7.7 110.369 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.29 -30.22 30.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.845 -0.428 . . . . 10.38 109.845 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 5.3 mm-40 -57.25 -59.97 4.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 11.97 109.309 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 110' ' ' ILE . 7.6 p -63.96 -37.16 79.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.595 -1.184 . . . . 9.8 111.843 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.22 -39.32 86.24 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.397 0.617 . . . . 10.83 110.441 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -74.28 -41.09 61.77 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.967 -1.015 . . . . 13.5 110.078 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.51 ' HA ' ' HE ' ' A' ' 181' ' ' ARG . 3.3 mmp_? -69.18 -52.91 23.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.764 -0.653 . . . . 14.84 112.065 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 106' ' ' GLN . 46.6 t -73.9 -65.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 13.35 109.38 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.872 1.269 . . . . 13.51 112.575 175.913 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 121.079 0.466 . . . . 14.98 111.122 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.04 -34.38 77.57 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.219 0.533 . . . . 15.79 109.628 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.5 m -60.8 -34.07 73.96 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.182 -0.917 . . . . 12.02 110.229 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.34 -48.46 70.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.702 -0.481 . . . . 11.02 109.702 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.05 -42.52 94.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.467 0.479 . . . . 16.07 111.556 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -63.83 -46.42 85.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 13.93 110.684 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.65 -48.66 59.07 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 111.769 0.285 . . . . 10.71 111.769 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 34.5 ptt180 -68.77 -16.67 63.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.959 -0.696 . . . . 14.02 111.293 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -60.84 -49.2 78.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.342 0.401 . . . . 16.29 109.987 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -79.03 -31.5 44.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.868 -0.333 . . . . 12.91 110.111 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 8.0 tt -61.24 -52.9 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.815 -0.809 . . . . 12.77 108.815 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.79 -25.01 62.68 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.078 -0.51 . . . . 15.19 111.741 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.79 63.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.96 0.41 . . . . 16.26 110.88 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 mmt -85.36 -31.25 23.07 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.898 0.38 . . . . 15.45 110.981 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -96.4 -2.61 45.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.216 0.531 . . . . 16.16 111.505 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 60.16 41.07 17.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.007 1.323 . . . . 20.56 111.795 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 t -107.22 -178.92 3.78 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.032 -0.985 . . . . 16.63 108.586 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 mp0 -97.72 103.08 15.1 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 123.077 0.551 . . . . 20.19 110.271 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 21' ' ' GLU . 12.9 Cg_endo -53.53 -40.55 78.51 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 124.26 3.307 . . . . 16.6 115.258 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.89 -11.65 85.2 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 119.971 -1.109 . . . . 17.74 114.043 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -141.77 58.42 1.49 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.241 0.83 . . . . 20.23 113.241 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.2 pt -97.15 -10.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.18 -0.608 . . . . 15.98 110.408 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 73.85 128.05 0.04 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 125.645 1.578 . . . . 19.33 110.607 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 4.4 p-10 -66.34 -23.83 66.42 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.571 1.323 . . . . 14.93 114.571 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.97 5.89 69.06 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 119.901 -1.142 . . . . 14.82 112.66 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.2 m -70.43 151.54 45.04 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 122.024 0.916 . . . . 14.54 112.951 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 48.1 mtm180 -90.12 132.68 35.3 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.08 -1.418 . . . . 16.75 111.267 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -47.0 -52.69 14.17 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 123.741 0.651 . . . . 11.99 112.638 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 36' ' ' LEU . 19.5 tp -56.1 -37.97 70.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 14.45 111.323 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.73 -23.8 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.799 -0.637 . . . . 16.44 110.885 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.26 -13.42 59.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.296 0.57 . . . . 13.77 110.713 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.21 -8.45 15.9 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.762 -0.732 . . . . 13.81 111.444 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.4 tt -69.69 134.23 48.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.461 -0.57 . . . . 13.04 109.461 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.471 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 18.5 t70 -114.48 161.33 18.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.233 -1.025 . . . . 15.67 108.233 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 118.829 0.741 . . . . 15.29 111.131 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -70.42 -41.47 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.593 0.711 . . . . 16.66 109.501 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 62.3 mt -67.99 -28.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.001 -1.0 . . . . 14.14 110.177 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -61.14 -48.51 81.3 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.587 -0.733 . . . . 12.0 110.438 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.55 96.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.212 0.529 . . . . 13.97 110.326 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.95 -46.15 88.75 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.912 -1.04 . . . . 15.69 111.618 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.405 ' O ' HG13 ' A' ' 48' ' ' ILE . 6.4 t90 -71.92 -41.76 67.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 124.748 1.219 . . . . 11.69 110.437 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mm -51.98 -46.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.634 0.774 . . . . 11.16 112.146 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.9 mtm-85 -58.35 -40.01 81.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.482 0.489 . . . . 16.65 110.617 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 51' ' ' HIS . 22.1 mt-10 -74.19 -34.66 63.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 120.145 -0.622 . . . . 14.15 112.154 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 44' ' ' TRP . 74.1 mt -59.93 -46.26 94.21 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 108.866 -0.79 . . . . 10.8 108.866 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -59.84 -39.93 86.8 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 114.972 -1.013 . . . . 12.98 110.535 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -79.2 -43.44 23.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.559 0.578 . . . . 17.52 112.559 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 65.0 m170 -64.86 -44.04 91.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.454 0.538 . . . . 14.87 112.454 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -95.74 -10.77 28.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.35 0.87 . . . . 12.2 113.35 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 59.22 52.06 6.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.313 -1.366 . . . . 16.71 107.313 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.4 tp -127.55 135.96 51.04 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.645 -1.161 . . . . 12.2 110.21 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.02 69.11 3.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 16.06 110.68 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mm -82.06 119.24 74.63 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.235 -0.439 . . . . 11.39 110.311 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.45 136.44 31.18 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.103 1.869 . . . . 12.6 109.726 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.88 63.45 Favored 'General case' 0 C--O 1.245 0.868 0 C-N-CA 123.684 0.794 . . . . 12.52 112.036 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 3.5 p30 -69.68 -12.36 61.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.205 -0.452 . . . . 14.14 112.066 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.5 -22.87 47.04 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 123.233 0.333 . . . . 10.76 113.663 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -115.94 -1.22 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 122.827 1.299 . . . . 11.0 108.16 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 81.1 t80 -90.63 -47.74 7.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.398 -0.819 . . . . 16.42 109.541 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 t -96.24 -23.15 16.83 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.792 -0.763 . . . . 13.35 111.493 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -100.57 118.25 61.29 Favored Pre-proline 0 CA--C 1.511 -0.541 0 C-N-CA 120.421 -0.512 . . . . 12.23 109.889 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.5 Cg_endo -94.53 -1.41 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.363 2.042 . . . . 13.06 114.02 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.31 123.15 68.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.19 0.519 . . . . 12.95 109.925 -174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.85 -37.12 86.56 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.295 1.038 . . . . 10.92 111.311 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 75.3 tttt -63.34 -39.45 94.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.529 -0.759 . . . . 14.32 111.09 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.47 72.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.135 0.493 . . . . 10.93 110.261 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' VAL . 29.1 t80 -67.32 -37.51 83.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.7 -0.682 . . . . 8.81 112.638 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -64.03 -35.31 80.29 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.955 -0.698 . . . . 9.35 112.692 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.158 -0.682 . . . . 11.63 109.158 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -60.66 -38.54 85.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.395 -0.821 . . . . 10.55 109.884 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 70' ' ' PHE . 55.9 t -72.18 -48.26 49.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.078 -0.712 . . . . 8.3 109.078 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.49 -43.36 94.09 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.345 -0.843 . . . . 9.58 113.231 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -65.73 -28.5 69.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.794 0.664 . . . . 10.23 112.794 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -85.84 -23.59 27.06 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.433 -0.507 . . . . 10.43 111.022 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 CA--C 1.504 -0.821 0 CA-C-O 121.271 0.557 . . . . 10.97 111.592 178.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 121.273 0.559 . . . . 10.05 111.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.57 -49.0 15.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.426 -0.807 . . . . 11.22 109.751 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.47 -43.76 93.17 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.661 -0.866 . . . . 11.38 108.661 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -50.25 -57.64 7.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.186 0.994 . . . . 9.65 111.409 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.14 -40.56 90.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.698 -0.228 . . . . 10.43 111.523 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 t -59.29 -51.06 71.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.661 -0.496 . . . . 10.21 109.661 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.484 HG21 HG11 ' A' ' 178' ' ' VAL . 80.1 mt -59.77 -40.46 82.6 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 CA-C-N 116.369 -0.378 . . . . 8.13 110.254 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.04 -44.53 87.44 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.562 0.745 . . . . 8.46 110.602 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.98 -41.87 67.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.725 -0.671 . . . . 10.86 110.783 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -62.68 -40.48 97.22 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.455 -0.339 . . . . 11.45 111.178 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.95 -50.53 66.28 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.871 0.868 . . . . 7.62 109.791 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.8 -46.7 86.99 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.435 -1.257 . . . . 11.62 111.496 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -70.65 -45.91 64.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.184 -0.462 . . . . 11.63 111.195 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.9 t -64.69 -44.03 91.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.809 -0.632 . . . . 9.14 111.065 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.66 -39.94 80.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.127 -0.629 . . . . 10.06 109.903 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.83 -38.94 94.76 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 111.751 -0.54 . . . . 12.07 111.751 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -54.51 -47.2 73.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.335 1.054 . . . . 12.32 110.662 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 144' ' ' THR . 4.6 mm? -86.4 -22.87 26.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.22 0.822 . . . . 11.77 113.22 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.2 tp -84.16 -28.61 27.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.766 0.317 . . . . 13.52 110.614 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 68.69 1.18 2.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.149 1.38 . . . . 16.56 113.803 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -162.92 154.81 18.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.25 -1.389 . . . . 15.74 107.25 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.07 96.49 25.71 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 110.053 -0.351 . . . . 14.2 110.053 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -75.0 -15.61 20.65 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.486 2.124 . . . . 14.18 110.807 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.93 47.69 4.39 Favored Glycine 0 CA--C 1.497 -1.08 0 CA-C-N 114.789 -1.096 . . . . 14.03 112.661 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -121.26 12.51 11.0 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.523 -0.471 . . . . 16.37 111.967 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.4 mt -55.41 -37.11 67.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.42 1.105 . . . . 12.45 111.141 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -98.06 84.68 3.33 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.14 -1.391 . . . . 14.43 111.901 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 m 72.27 -5.22 1.82 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.845 1.424 . . . . 14.32 114.845 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 -34.53 20.68 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 119.496 -1.335 . . . . 13.75 110.559 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.86 95.9 3.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.056 0.942 . . . . 12.7 109.978 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 170' ' ' THR . 46.3 mt-30 -86.89 177.12 7.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.387 -0.968 . . . . 16.38 108.387 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 44.5 p90 -59.98 -23.16 63.4 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.167 0.894 . . . . 13.3 110.111 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.34 -29.91 70.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.888 -1.051 . . . . 16.25 110.35 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.19 -39.19 12.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.84 -0.618 . . . . 15.87 110.08 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.48 -26.86 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 13.65 111.233 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.53 5.08 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.336 -0.459 . . . . 14.16 113.512 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 72.3 mtm -74.81 -29.61 61.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 117.58 0.69 . . . . 15.45 110.594 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.563 ' OD2' HG12 ' A' ' 143' ' ' VAL . 32.6 t70 -149.21 120.5 7.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.25 0.547 . . . . 13.63 111.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 p -75.32 -25.98 58.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.943 1.09 . . . . 13.9 113.943 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.563 HG12 ' OD2' ' A' ' 141' ' ' ASP . 2.8 p -72.13 -34.98 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.865 -1.161 . . . . 13.81 107.865 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 121' ' ' LEU . 37.8 m -60.62 -50.17 74.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.311 -1.313 . . . . 11.48 109.212 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.77 -54.55 27.62 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.613 0.571 . . . . 10.35 113.471 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 6.9 t -62.9 -45.18 93.75 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 112.648 0.61 . . . . 12.2 112.648 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -65.61 -49.31 69.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 11.86 110.951 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -63.72 -42.15 97.96 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.419 -0.809 . . . . 9.32 110.77 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.466 ' HA ' ' CE ' ' A' ' 149' ' ' MET . 0.3 OUTLIER -58.81 -54.62 45.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 9.5 111.256 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 13.5 ptt180 -63.79 -38.66 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.651 -0.25 . . . . 13.91 111.657 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.9 -53.48 44.87 Favored Glycine 0 N--CA 1.443 -0.853 0 O-C-N 123.531 0.519 . . . . 9.88 112.417 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.88 -41.69 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.525 0.203 . . . . 9.27 111.341 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.9 m -60.72 -54.99 38.58 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 116.172 -0.467 . . . . 11.46 111.466 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -69.31 -25.37 64.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.577 -0.738 . . . . 15.04 111.221 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -64.36 -30.77 71.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.872 -0.604 . . . . 11.82 110.878 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' SER . 69.8 m-85 -98.15 -69.69 0.75 Allowed 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.689 -0.804 . . . . 11.97 111.004 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 19.4 t 171.53 17.32 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.278 0.361 . . . . 14.24 110.998 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.5 pt -123.22 168.46 15.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 O-C-N 121.322 -0.861 . . . . 12.62 109.67 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 5.9 tp60 -130.93 118.01 20.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 120.518 -0.473 . . . . 16.39 110.902 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.8 mt -118.71 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.354 -0.839 . . . . 12.32 109.514 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.51 149.28 36.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.115 -0.948 . . . . 14.06 110.147 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.12 0.968 . . . . 12.64 112.695 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.06 1.85 57.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.887 -0.597 . . . . 15.68 111.236 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 167' ' ' THR . . . -66.23 -18.13 65.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.545 0.572 . . . . 12.72 112.545 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . 0.282 2.6 pp -75.93 7.05 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.932 0.716 . . . . 12.16 112.932 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -98.65 -16.03 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.623 -0.717 . . . . 15.08 110.427 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 164' ' ' ALA . 15.2 t -103.34 15.95 27.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.253 -0.579 . . . . 14.67 111.765 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.563 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 13.5 m0 -123.26 119.2 27.58 Favored Pre-proline 0 CA--C 1.501 -0.915 0 O-C-N 121.902 -0.499 . . . . 12.68 110.453 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.43 ' HD2' ' OG ' ' A' ' 173' ' ' SER . 22.7 Cg_exo -63.32 -37.61 49.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.455 2.104 . . . . 14.34 110.261 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 16.5 p -144.24 169.13 18.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.746 -0.661 . . . . 12.91 110.956 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -52.68 -41.31 63.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.166 0.586 . . . . 9.89 111.875 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.86 -22.83 50.11 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.477 0.917 . . . . 12.5 113.477 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' HD2' ' A' ' 169' ' ' PRO . 14.3 m -69.1 -26.85 65.13 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.033 0.444 . . . . 11.04 110.665 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 168' ' ' TRP . 23.6 tp -66.82 -46.06 76.35 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.579 -0.897 . . . . 8.5 108.579 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.46 -28.23 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.934 -1.03 . . . . 7.7 111.273 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.72 -40.53 55.46 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.83 -0.348 . . . . 10.38 111.663 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.84 -34.58 66.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.584 0.957 . . . . 11.97 113.584 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 110' ' ' ILE . 14.2 p -71.4 -33.66 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.282 -0.567 . . . . 9.8 110.012 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 183' ' ' GLN . 10.6 t70 -60.86 -49.93 75.47 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 109.427 -0.582 . . . . 10.83 109.427 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.6 -29.41 70.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.468 -0.787 . . . . 13.5 112.134 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -85.89 -51.48 6.36 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.193 0.442 . . . . 14.84 112.193 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.92 -36.65 45.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 120.966 0.412 . . . . 13.35 110.913 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.7 mt-30 . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 118.319 -0.848 . . . . 13.51 109.119 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.56 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 28.5 t70 . . . . . 0 C--O 1.197 -1.703 0 N-CA-C 110.191 -0.3 . . . . 14.98 110.191 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.04 -39.83 93.65 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.286 0.634 . . . . 15.79 111.142 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.6 t -65.1 -35.26 80.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.322 -0.622 . . . . 12.02 109.322 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.25 57.55 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 116.219 -0.446 . . . . 11.02 111.093 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 26.1 mt-30 -51.73 -50.23 60.99 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.767 0.827 . . . . 16.07 111.446 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -42.39 96.13 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.823 -0.351 . . . . 13.93 111.158 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.88 -37.16 70.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.9 0.381 . . . . 10.71 110.505 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -64.84 -47.43 77.98 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.201 1.001 . . . . 14.02 109.041 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.81 -46.89 83.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.064 0.946 . . . . 16.29 111.153 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -72.94 -38.7 66.68 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.228 0.455 . . . . 12.91 112.228 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.92 -46.57 88.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.692 -1.225 . . . . 12.77 107.692 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -61.7 -44.26 97.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 15.19 111.315 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.81 86.39 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.21 0.448 . . . . 16.26 112.21 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.41 -44.63 51.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.039 0.385 . . . . 15.45 112.039 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.47 -9.77 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.228 0.537 . . . . 16.16 111.986 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 t80 65.96 36.97 5.6 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.627 1.203 . . . . 20.56 108.857 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 14.6 p -107.89 163.4 13.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.736 -1.209 . . . . 16.63 107.736 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -90.92 136.58 27.43 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 120.234 -0.586 . . . . 20.19 111.506 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -74.91 6.88 3.09 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.415 2.743 . . . . 16.6 112.671 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.48 -30.51 18.74 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 111.301 -0.719 . . . . 17.74 111.301 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -94.85 47.15 1.15 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.175 0.988 . . . . 20.23 111.674 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 tp -126.8 131.81 70.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.96 -1.496 . . . . 15.98 106.96 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -136.4 174.04 11.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.974 -0.103 . . . . 19.33 111.194 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 2.8 m-20 -67.52 -45.42 75.83 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.623 0.725 . . . . 14.93 111.33 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.44 7.77 74.65 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.002 -0.999 . . . . 14.82 113.998 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.9 m -59.89 144.97 47.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.292 0.567 . . . . 14.54 112.435 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.4 mtm180 -82.3 102.33 11.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.548 -2.019 . . . . 16.75 105.548 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -45.55 -58.58 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.798 1.239 . . . . 11.99 114.03 -168.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.34 -29.63 47.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.109 0.481 . . . . 14.45 111.404 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 7.1 mm-40 -68.87 -7.03 30.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 16.44 111.73 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -72.66 -5.96 41.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.233 -0.44 . . . . 13.77 111.239 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.05 11.55 4.74 Favored Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.063 -1.065 . . . . 13.81 114.128 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -115.41 152.17 33.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.898 0.849 . . . . 13.04 112.854 -177.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -126.04 167.59 15.13 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.121 -0.945 . . . . 15.67 109.475 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.3 m -38.72 -52.82 1.69 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.598 1.559 . . . . 15.29 114.71 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.8 -46.19 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.94 0.4 . . . . 16.66 111.317 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -66.16 -38.84 82.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 14.14 109.872 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.16 -42.54 96.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.406 -0.815 . . . . 12.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.11 96.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.759 . . . . 13.97 110.624 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.85 -40.13 94.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.861 -0.609 . . . . 15.69 111.45 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -67.6 -53.51 27.54 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.034 -0.985 . . . . 11.69 111.53 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 58' ' ' ALA . 7.8 tp -60.49 -29.99 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.421 0.629 . . . . 11.16 110.708 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -62.49 -28.41 69.81 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.06 -0.973 . . . . 16.65 109.417 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -86.61 -33.83 20.05 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.887 -0.597 . . . . 14.15 111.713 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.76 -46.46 96.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.495 -0.557 . . . . 10.8 109.495 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -53.11 -39.27 63.3 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.046 -0.979 . . . . 12.98 111.415 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -77.07 -57.98 3.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.93 -0.577 . . . . 17.52 111.159 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -66.94 -27.99 67.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.284 -0.871 . . . . 14.87 113.219 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -103.85 0.84 30.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.879 -0.728 . . . . 12.2 112.625 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 54.24 47.62 22.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.83 1.252 . . . . 16.71 110.522 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.4 142.19 51.62 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.218 -0.901 . . . . 12.2 110.089 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.92 36.34 1.56 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.367 -1.346 . . . . 16.06 107.367 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.616 HD11 ' HD1' ' A' ' 73' ' ' TRP . 9.4 tt -56.55 132.69 77.36 Favored Pre-proline 0 C--O 1.244 0.812 0 CA-C-N 112.227 -2.26 . . . . 11.39 110.492 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.38 128.47 30.22 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.143 2.562 . . . . 12.6 111.957 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -71.63 -21.2 61.87 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 121.786 0.803 . . . . 12.52 110.03 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -69.04 -6.87 30.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.102 -0.954 . . . . 14.14 111.52 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 64' ' ' TYR . . . -63.35 -17.67 59.84 Favored Glycine 0 C--N 1.355 1.583 0 N-CA-C 112.019 -0.433 . . . . 10.76 112.019 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -99.16 -43.34 11.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.837 -1.171 . . . . 11.0 107.837 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.71 -48.9 69.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 113.816 -1.538 . . . . 16.42 112.0 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 64' ' ' TYR . 10.0 t -109.63 13.47 23.82 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.464 -0.494 . . . . 13.35 111.745 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 89.4 m-85 -140.73 75.15 26.08 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 109.339 -0.615 . . . . 12.23 109.339 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.33 38.05 0.7 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.054 2.503 . . . . 13.06 113.253 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 48.2 t -121.52 120.86 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.645 -1.613 . . . . 12.95 106.645 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -58.03 -42.05 84.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.31 -0.859 . . . . 10.92 112.555 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 83.0 tttt -64.98 -46.09 82.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.764 0.316 . . . . 14.32 110.199 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . . . -60.34 -40.85 92.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.975 -0.557 . . . . 10.93 111.551 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.35 -33.93 58.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.183 -0.462 . . . . 8.81 111.633 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -71.2 -33.03 69.56 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.624 -0.83 . . . . 9.35 110.762 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 54.2 mt-30 -69.86 -33.6 72.48 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.888 -0.782 . . . . 11.63 108.888 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.616 ' HD1' HD11 ' A' ' 56' ' ' ILE . 17.6 t-105 -61.82 -49.63 75.54 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.204 -0.907 . . . . 10.55 110.19 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.2 t -63.2 -45.27 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.259 0 N-CA-C 109.913 -0.403 . . . . 8.3 109.913 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.32 -32.31 80.36 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.667 -0.697 . . . . 9.58 113.398 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 t -87.27 -12.61 46.11 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 122.213 -0.581 . . . . 10.23 110.459 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 86.1 mm-40 -88.45 -47.11 8.59 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 122.308 -0.245 . . . . 10.43 110.366 177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 74' ' ' VAL 0.265 1.2 pp . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 122.846 1.308 . . . . 10.97 112.18 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.239 0.533 0 N-CA-C 112.71 0.633 . . . . 10.05 112.71 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.67 65.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.818 -0.628 . . . . 11.22 110.813 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 110' ' ' ILE . 12.0 mm-40 -80.15 -40.19 27.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.6 -0.889 . . . . 11.38 108.6 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -55.33 -40.48 71.25 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 114.991 -1.004 . . . . 9.65 111.225 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -60.32 -53.57 56.1 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.041 0.536 . . . . 10.43 110.106 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -56.88 -49.96 73.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.211 -0.904 . . . . 10.21 109.743 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.462 HG12 ' CE1' ' A' ' 156' ' ' PHE . 52.7 mt -53.35 -48.23 56.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.663 -0.699 . . . . 8.13 110.974 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -47.17 -44.36 21.91 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.448 1.099 . . . . 8.46 112.346 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 18.5 t70 -70.28 -50.42 39.68 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.738 -0.385 . . . . 10.86 111.216 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -62.77 -31.7 72.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.356 0.598 . . . . 11.45 111.558 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.5 -40.87 66.53 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.315 1.046 . . . . 7.62 109.326 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.8 -47.15 61.0 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.693 -0.685 . . . . 11.62 111.076 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 10.8 pt20 -65.44 -32.71 74.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 11.63 111.474 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 p -71.65 -35.76 70.47 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.335 -0.546 . . . . 9.14 110.604 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 138' ' ' LEU . 3.2 tm? -69.28 -45.22 70.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.053 -0.721 . . . . 10.06 109.053 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 -34.03 78.85 Favored Glycine 0 C--O 1.237 0.341 0 CA-C-N 116.202 -0.453 . . . . 12.07 111.999 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.13 -50.44 68.22 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.453 0.701 . . . . 12.32 109.516 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 148' ' ' TRP . 42.5 tp -69.67 -43.61 72.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.159 -0.928 . . . . 11.77 111.638 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 122' ' ' LEU . 10.6 tp -76.06 -24.3 55.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.358 0.503 . . . . 13.52 112.358 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 67.49 2.27 2.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.208 1.003 . . . . 16.56 111.109 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -156.95 155.91 32.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.278 -0.267 . . . . 15.74 110.278 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.85 114.48 65.24 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.481 -1.303 . . . . 14.2 107.481 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.22 -20.06 21.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.976 1.784 . . . . 14.18 110.782 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.96 -104.05 0.18 Allowed Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 108.482 -1.847 . . . . 14.03 108.482 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.84 11.37 0.75 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.136 0.493 . . . . 16.37 111.799 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp 67.48 119.29 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.59 1.556 . . . . 12.45 114.456 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -162.33 -72.69 0.05 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.525 -1.216 . . . . 14.43 110.556 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -128.58 -35.21 1.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.158 0.429 . . . . 14.32 112.158 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.93 81.07 1.7 Allowed Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.965 -0.854 . . . . 13.75 110.965 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.37 59.03 1.15 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.027 0.441 . . . . 12.7 110.947 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.466 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 17.6 tp60 -72.32 136.2 46.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.734 -1.58 . . . . 16.38 106.734 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.65 -31.02 63.97 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 124.216 1.006 . . . . 13.3 111.831 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.9 -31.24 72.06 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.247 0.546 . . . . 16.25 111.488 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 134' ' ' GLN . 26.7 m-20 -82.69 -22.11 34.66 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.194 -0.457 . . . . 15.87 110.165 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 31.4 mt -93.11 -28.04 16.57 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.867 -0.606 . . . . 13.65 110.235 -176.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.61 86.41 0.06 OUTLIER Glycine 0 C--N 1.31 -0.883 0 N-CA-C 109.817 -1.313 . . . . 14.16 109.817 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptp -71.22 -18.9 62.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.09 1.144 . . . . 15.45 114.09 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.26 150.61 22.37 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 118.99 -0.529 . . . . 13.63 111.313 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -53.34 -44.66 68.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 117.858 0.299 . . . . 13.9 111.649 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.94 -48.3 88.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 111.295 0.109 . . . . 13.81 111.295 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 p -60.22 -38.51 83.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.466 0.543 . . . . 11.48 112.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.79 22.97 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.783 -1.198 . . . . 10.35 111.897 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.6 m -65.02 -32.6 74.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.374 0.269 . . . . 12.2 110.851 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.97 -49.55 76.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.557 . . . . 11.86 109.926 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.444 ' HB2' HD22 ' A' ' 121' ' ' LEU . 19.9 t90 -71.76 -34.81 69.79 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.517 -0.765 . . . . 9.32 111.142 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -45.59 92.65 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.469 -1.308 . . . . 9.5 107.469 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 154' ' ' ARG . 69.9 ttt180 -63.82 -43.03 97.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.861 -1.063 . . . . 13.91 109.659 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.09 -49.22 68.79 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 115.638 -0.71 . . . . 9.88 113.296 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.57 -37.45 74.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 117.267 0.534 . . . . 9.27 111.807 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.7 m -59.83 -43.84 94.35 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.955 0.159 . . . . 11.46 110.957 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 28.6 mtm180 -63.38 -45.36 91.45 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.561 -0.291 . . . . 15.04 110.624 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -53.97 -43.12 69.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.595 0.961 . . . . 11.82 113.595 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 110' ' ' ILE . 79.2 m-85 -102.97 4.89 37.94 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.238 -0.585 . . . . 11.97 111.681 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.5 m 53.95 44.06 29.94 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.237 1.015 . . . . 14.24 111.339 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.95 161.55 15.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.316 -0.856 . . . . 12.62 108.773 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -113.25 96.75 6.08 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.978 0.418 . . . . 16.39 110.34 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.49 149.51 27.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.649 -0.871 . . . . 12.32 108.649 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.33 134.99 42.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.713 -0.676 . . . . 14.06 111.926 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.75 -22.2 62.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 12.64 110.103 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.06 -17.55 61.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.55 -0.75 . . . . 15.68 110.194 175.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.556 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -72.7 -3.2 23.68 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 112.654 0.612 . . . . 12.72 112.654 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.5 pt -68.27 -13.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.748 0.785 . . . . 12.16 109.298 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -111.2 3.79 18.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.29 -0.868 . . . . 15.08 109.357 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 56.9 m -97.25 -38.55 9.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 14.67 108.66 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.2 m0 -102.32 115.58 64.29 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.784 -0.644 . . . . 12.68 109.631 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.29 -30.36 3.41 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.28 1.987 . . . . 14.34 113.185 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.9 p -128.99 170.89 12.91 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 109.585 -0.524 . . . . 12.91 109.585 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.42 -22.65 66.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.444 -0.344 . . . . 9.89 111.061 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -61.79 -44.47 96.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.158 0.504 . . . . 12.5 110.423 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 5.7 m -61.02 -37.05 81.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.268 -0.878 . . . . 11.04 110.466 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.84 -42.25 58.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.191 -0.459 . . . . 8.5 110.558 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.09 83.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 7.7 111.639 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 20.4 m-20 -79.27 -33.75 43.19 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.411 -0.516 . . . . 10.38 110.653 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.518 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 7.4 tp10 -61.69 -50.45 72.43 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.136 -0.483 . . . . 11.97 111.012 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 -41.69 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.729 -0.669 . . . . 9.8 111.086 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.67 -41.51 97.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.791 0.436 . . . . 10.83 110.478 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 5.0 mmp_? -68.82 -31.33 70.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.638 -0.71 . . . . 13.5 111.089 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -78.09 -37.68 45.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.144 -0.48 . . . . 14.84 109.99 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.71 -59.85 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.931 -0.577 . . . . 13.35 109.661 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.135 0.897 . . . . 13.51 110.998 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 112.987 0.736 . . . . 14.98 112.987 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -58.92 -32.71 69.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.369 0.507 . . . . 15.79 112.369 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.507 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 28.9 p -63.83 -37.32 86.94 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 120.103 -0.639 . . . . 12.02 110.441 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 -20.23 61.9 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.088 -0.506 . . . . 11.02 110.259 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.34 -53.08 6.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.995 -0.743 . . . . 16.07 108.995 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.71 -50.18 70.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 115.319 -0.855 . . . . 13.93 112.9 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 48' ' ' ILE . 55.6 mt -71.76 -25.7 62.14 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.263 -0.575 . . . . 10.71 111.395 -173.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -70.33 -40.44 74.15 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.041 -0.726 . . . . 14.02 109.041 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -65.63 -44.62 85.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.323 -0.853 . . . . 16.29 109.366 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 t -64.63 -33.77 76.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.742 -0.663 . . . . 12.91 110.693 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.22 -53.31 51.22 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.929 -1.137 . . . . 12.77 107.929 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -65.37 -33.64 76.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.872 -1.058 . . . . 15.19 111.541 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.84 -33.88 75.64 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.436 0.532 . . . . 16.26 112.436 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 44' ' ' TRP . 44.3 mtt -81.27 -21.86 39.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.923 -0.711 . . . . 15.45 111.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 84.2 mt -98.71 -7.34 27.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.175 0.512 . . . . 16.16 110.814 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 64.72 43.67 4.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.224 1.41 . . . . 20.56 111.742 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 6.6 p -126.83 169.91 12.74 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.637 -0.71 . . . . 16.63 111.182 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.09 127.67 78.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 123.061 0.544 . . . . 20.19 111.68 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 31.1 Cg_endo -65.5 -9.9 24.19 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.045 2.496 . . . . 16.6 112.314 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.9 -36.18 65.36 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.263 -1.135 . . . . 17.74 110.263 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -83.11 -37.57 23.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.997 -0.742 . . . . 20.23 108.997 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 22' ' ' PRO . 50.3 mm -76.38 92.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.828 -1.175 . . . . 15.98 107.828 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.71 155.77 26.59 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.036 -0.984 . . . . 19.33 110.291 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.35 -17.74 64.87 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 114.396 -1.275 . . . . 14.93 111.87 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.52 6.93 39.06 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 120.89 -0.672 . . . . 14.82 112.79 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 34' ' ' LEU . 66.2 m -68.97 160.81 30.19 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.851 0.834 . . . . 14.54 113.092 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 18.7 ttm180 -97.45 112.46 24.29 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.524 -1.216 . . . . 16.75 109.738 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -39.03 -60.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.831 1.252 . . . . 11.99 113.877 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD22 ' H ' ' A' ' 32' ' ' LEU . 2.5 mm? -61.63 -32.8 72.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 14.45 111.729 -174.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.64 -17.27 60.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.786 0.803 . . . . 16.44 110.729 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 29' ' ' SER . 94.4 mt -84.56 8.31 17.1 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.151 -0.477 . . . . 13.77 111.557 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.21 31.2 12.18 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.813 -0.915 . . . . 13.81 110.813 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.5 tt -108.8 135.67 49.64 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.81 -0.811 . . . . 13.04 108.81 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -123.2 164.02 19.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.572 -1.27 . . . . 15.67 107.572 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -49.54 -41.74 42.13 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.609 0.64 . . . . 15.29 111.756 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.57 -49.39 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.928 -0.578 . . . . 16.66 110.675 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.04 -35.72 75.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.996 -0.547 . . . . 14.14 110.438 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -60.38 -46.81 88.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 12.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.16 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.316 0.579 . . . . 13.97 110.999 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.14 -40.02 71.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.745 -0.661 . . . . 15.69 111.076 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 9.2 t90 -57.78 -45.53 85.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 124.278 1.031 . . . . 11.69 110.09 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 41' ' ' ALA . 40.3 mm -54.96 -39.34 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 114.935 -1.029 . . . . 11.16 110.072 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -57.43 -35.45 70.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.36 -0.836 . . . . 16.65 111.668 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 51' ' ' HIS . 24.5 tt0 -85.09 -35.72 21.63 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.037 -0.665 . . . . 14.15 110.787 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 56' ' ' ILE . 19.5 pt -68.57 -30.28 46.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 119.912 -0.715 . . . . 10.8 110.83 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.622 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 6.1 m-20 -63.69 -27.31 69.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.334 -0.848 . . . . 12.98 110.498 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -79.96 -46.32 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.177 -0.675 . . . . 17.52 109.177 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 20.8 m-70 -51.58 -56.56 12.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.303 -0.862 . . . . 14.87 112.899 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 97.0 m-85 -107.18 16.51 24.0 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.471 0.545 . . . . 12.2 112.471 -173.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 42.91 42.94 3.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.655 1.182 . . . . 16.71 112.523 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.24 140.57 52.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.831 -0.622 . . . . 12.2 109.325 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -81.19 72.05 8.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.253 -0.43 . . . . 16.06 110.216 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.622 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 18.2 mm -61.47 125.37 84.22 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-N 115.947 -0.57 . . . . 11.39 111.564 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 59.1 Cg_endo -77.27 125.82 8.05 Favored 'Trans proline' 0 N--CA 1.434 -1.985 0 C-N-CA 121.938 1.759 . . . . 12.6 108.671 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.51 -19.79 40.4 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.926 0.713 . . . . 12.52 112.926 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 57' ' ' PRO . 3.0 p30 -62.64 -16.76 58.37 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.171 0.804 . . . . 14.14 113.171 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.23 78.71 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 120.847 -0.692 . . . . 10.76 114.566 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.45 -34.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.496 0.665 . . . . 11.0 111.55 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -73.55 -28.0 61.63 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.202 -0.666 . . . . 16.42 109.202 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 m -83.13 -43.52 16.12 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.229 -0.896 . . . . 13.35 110.078 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.2 94.31 48.04 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.278 -0.419 . . . . 12.23 110.31 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 93.7 Cg_endo -83.65 4.34 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.62 2.214 . . . . 13.06 112.705 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.38 120.61 62.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.642 -1.614 . . . . 12.95 106.642 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -56.09 -44.69 79.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.835 -1.075 . . . . 10.92 113.488 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -71.71 -21.33 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.442 0.639 . . . . 14.32 110.784 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.91 -31.7 22.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.662 0.744 . . . . 10.93 109.348 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.51 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 48.3 t80 -71.85 -34.11 68.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.388 -0.824 . . . . 8.81 111.455 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 p -65.03 -24.32 67.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.141 0.496 . . . . 9.35 111.569 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -74.06 -39.76 63.27 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.175 -1.046 . . . . 11.63 108.175 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 59.7 t90 -59.83 -45.91 90.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.583 -1.19 . . . . 10.55 109.246 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.91 -45.38 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 8.3 109.966 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.83 84.96 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.603 -0.726 . . . . 9.58 114.365 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -71.68 -16.4 62.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 10.23 112.452 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -93.29 -26.48 17.3 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.39 -0.368 . . . . 10.43 110.489 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.516 -0.363 0 CA-C-N 115.943 -0.571 . . . . 10.97 109.915 178.086 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.433 -1.31 0 N-CA-C 108.442 -0.948 . . . . 10.05 108.442 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.72 -28.66 70.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.173 -0.921 . . . . 11.22 112.725 -174.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.486 ' O ' HG13 ' A' ' 110' ' ' ILE . 48.3 tp60 -61.03 -20.92 63.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.027 0.531 . . . . 11.38 111.592 -176.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.492 HH21 ' NE2' ' A' ' 183' ' ' GLN . 10.8 mpt_? -75.05 -31.08 61.2 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.844 0.312 . . . . 9.65 111.844 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 40.1 tt0 -71.88 -43.69 65.0 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.132 0.491 . . . . 10.43 109.984 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -62.48 -21.53 65.54 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.998 -0.546 . . . . 10.21 111.812 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.564 HG21 HG11 ' A' ' 178' ' ' VAL . 55.3 mt -67.07 -54.68 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 108.704 -0.85 . . . . 8.13 108.704 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 13.7 pt20 -64.37 -29.31 70.38 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.937 -0.574 . . . . 8.46 111.751 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.66 -52.2 64.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.618 -0.512 . . . . 10.86 109.618 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -69.41 -37.4 77.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 11.45 110.489 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 171' ' ' LEU . 6.3 tt -61.28 -42.27 98.36 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.526 -0.916 . . . . 7.62 108.526 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.1 -47.2 87.38 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.596 -0.729 . . . . 11.62 109.404 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.05 -50.37 72.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 11.63 111.705 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.5 m -69.14 -30.45 68.7 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.717 0.266 . . . . 9.14 111.717 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 47.7 tp -68.96 -49.23 59.8 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 108.707 -0.849 . . . . 10.06 108.707 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.32 -22.03 68.93 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.707 -0.759 . . . . 12.07 112.534 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.08 -52.8 8.2 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 122.538 -0.389 . . . . 12.32 110.756 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.56 -18.11 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.732 0.641 . . . . 11.77 112.732 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' LEU . 4.4 mm? -113.42 3.01 15.63 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.035 0.445 . . . . 13.52 110.83 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 70.45 -29.8 0.19 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 16.56 115.596 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.8 tp -136.0 148.76 48.56 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.593 -0.692 . . . . 15.74 111.365 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -84.44 124.25 73.79 Favored Pre-proline 0 CA--C 1.505 -0.784 0 N-CA-C 107.148 -1.427 . . . . 14.2 107.148 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB3' HD11 ' A' ' 138' ' ' LEU . 72.9 Cg_endo -79.17 -16.31 12.38 Favored 'Trans proline' 0 C--N 1.33 -0.446 0 C-N-CA 121.848 1.699 . . . . 14.18 113.08 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.15 6.65 87.66 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 110.575 -1.01 . . . . 14.03 110.575 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 16.1 mm100 -99.72 33.22 2.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.666 0.746 . . . . 16.37 110.603 -174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 68.2 mt -73.34 103.37 4.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.881 -1.054 . . . . 12.45 108.539 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 10.2 mmm180 79.23 1.27 2.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.214 1.406 . . . . 14.43 111.424 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -89.04 -25.35 22.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.604 0.716 . . . . 14.32 109.338 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 157.49 -91.8 0.12 Allowed Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.248 -1.141 . . . . 13.75 110.248 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 128' ' ' GLN . . . 63.45 90.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.862 1.265 . . . . 12.7 112.092 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -97.49 136.56 37.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.721 -0.844 . . . . 16.38 108.721 175.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 140' ' ' MET . 19.4 p90 -47.55 -36.45 10.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.21 1.404 . . . . 13.3 114.063 -170.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.29 -40.65 96.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.954 0.502 . . . . 16.25 110.926 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.48 -35.27 75.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.009 -0.541 . . . . 15.87 110.434 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 126' ' ' PRO . 4.0 mm? -72.98 -19.52 61.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 13.65 112.076 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.87 20.48 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.439 -1.065 . . . . 14.16 110.439 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.438 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . 43.7 ttm -85.98 129.03 34.96 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.547 -0.908 . . . . 15.45 108.547 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.03 176.09 6.93 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.136 -1.061 . . . . 13.63 108.136 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' ' OH ' ' A' ' 166' ' ' TYR . 38.6 m -73.73 -48.06 34.72 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.4 -0.92 . . . . 13.9 109.697 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.19 -48.08 88.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 112.012 0.375 . . . . 13.81 112.012 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 p -67.6 -33.93 75.99 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.913 0.387 . . . . 11.48 111.757 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 -25.5 61.86 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 119.971 -1.109 . . . . 10.35 111.116 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.3 m -64.91 -48.34 74.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 12.2 108.705 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -57.13 -53.59 56.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.891 -1.05 . . . . 11.86 109.993 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -53.0 -53.98 42.01 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 9.32 112.743 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 3.5 tpt -54.76 -54.08 46.66 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.153 0.581 . . . . 9.5 111.425 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . 75.0 ttt180 -64.62 -37.23 86.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.966 0.413 . . . . 13.91 110.185 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.38 27.89 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.473 -0.785 . . . . 9.88 112.649 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.88 -42.79 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.512 0.325 . . . . 9.27 111.007 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 25.3 m -58.5 -57.15 14.2 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.837 -0.62 . . . . 11.46 110.847 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -64.2 -35.62 81.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.637 -0.71 . . . . 15.04 111.352 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -76.59 -14.84 59.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.036 0.384 . . . . 11.82 112.036 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CZ ' HG12 ' A' ' 110' ' ' ILE . 86.1 t80 -95.68 -70.31 0.72 Allowed 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 119.132 -1.027 . . . . 11.97 111.081 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.9 m -178.74 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.79 0.436 . . . . 14.24 112.138 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 27.7 pt -98.84 142.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.268 0.556 . . . . 12.62 111.796 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -91.78 95.75 10.03 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.748 0.785 . . . . 16.39 109.632 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 87.2 mt -101.01 151.23 22.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.288 -0.869 . . . . 12.32 109.25 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.91 45.81 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.393 -1.276 . . . . 14.06 108.763 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 150' ' ' ARG . . . -66.17 -21.18 66.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.444 0.64 . . . . 12.64 110.204 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -82.08 2.94 28.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 15.68 111.009 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.72 61.17 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.905 -0.497 . . . . 12.72 111.685 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.4 pt -67.38 -10.97 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.261 0.553 . . . . 12.16 110.446 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 142' ' ' SER . 27.3 m-85 -106.57 -1.47 22.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 15.08 109.164 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -89.22 -47.0 8.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.106 -0.701 . . . . 14.67 109.106 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.34 141.09 24.79 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 109.223 -0.658 . . . . 12.68 109.223 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 40.5 Cg_endo -97.21 2.26 1.66 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.377 2.051 . . . . 14.34 114.429 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -120.13 144.34 47.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.455 0.909 . . . . 12.91 113.455 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 114' ' ' LEU . 4.5 mm? -63.48 -30.39 71.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.303 -1.317 . . . . 9.89 112.339 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 56.8 mtpt -58.37 -40.1 81.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.534 -0.757 . . . . 12.5 110.674 176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -39.59 93.13 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.319 -0.855 . . . . 11.04 110.844 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.55 -50.38 65.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.216 -1.031 . . . . 8.5 108.216 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.04 -32.32 69.65 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.754 0.65 . . . . 7.7 112.754 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.48 -34.2 31.5 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.523 -0.471 . . . . 10.38 111.033 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.98 -47.42 68.61 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.963 0.905 . . . . 11.97 110.118 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -57.21 -44.29 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.309 -0.86 . . . . 9.8 112.277 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -57.51 -39.45 76.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.023 0.44 . . . . 10.83 111.627 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -80.92 -23.84 38.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.836 -0.62 . . . . 13.5 110.678 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -84.2 -38.67 20.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 14.84 110.276 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 178' ' ' VAL . 75.3 t -62.59 -41.78 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.843 -0.617 . . . . 13.35 111.604 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.492 ' NE2' HH21 ' A' ' 107' ' ' ARG . 10.3 pt20 . . . . . 0 N--CA 1.434 -1.229 0 C-N-CA 120.586 -0.446 . . . . 13.51 111.271 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 111.42 0.156 . . . . 14.98 111.42 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.47 -49.27 62.1 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.021 0.928 . . . . 15.79 112.154 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' HG11 ' A' ' 74' ' ' VAL . 52.6 t -61.46 -48.06 82.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 123.467 0.48 . . . . 12.02 111.535 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.7 92.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.614 -0.267 . . . . 11.02 110.759 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -61.72 -46.52 89.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 123.291 0.369 . . . . 16.07 111.378 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 77.8 t80 -67.96 -33.52 74.81 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.597 -0.274 . . . . 13.93 110.753 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.93 -40.73 75.36 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 120.354 -0.538 . . . . 10.71 110.229 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -59.4 -45.39 91.61 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.795 -0.446 . . . . 14.02 109.795 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.5 -54.47 46.5 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.488 1.115 . . . . 16.29 111.455 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.7 p -68.18 -35.32 77.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.215 -0.448 . . . . 12.91 111.238 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.41 HD11 HD21 ' A' ' 34' ' ' LEU . 6.9 tt -63.13 -52.56 62.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 12.77 108.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.04 91.06 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.978 -0.555 . . . . 15.19 111.125 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -49.23 71.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.455 0.539 . . . . 16.26 112.455 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.8 mmm -76.66 -36.79 57.13 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.743 0.646 . . . . 15.45 112.743 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.84 -5.83 58.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.989 0.424 . . . . 16.16 111.71 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 61.04 39.51 16.23 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.767 1.27 . . . . 20.56 110.614 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 t -111.79 -173.56 2.27 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 113.135 -1.848 . . . . 16.63 107.553 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.0 136.92 29.16 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.847 -0.797 . . . . 20.19 108.847 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.1 -19.96 19.65 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.68 2.253 . . . . 16.6 113.182 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.65 -45.42 4.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.704 -0.958 . . . . 17.74 110.704 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.46 75.03 9.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.351 0.596 . . . . 20.23 110.748 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -147.54 144.96 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.744 -0.835 . . . . 15.98 108.744 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -88.42 131.23 34.95 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 107.536 -1.283 . . . . 19.33 107.536 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.58 -15.89 63.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 112.381 0.512 . . . . 14.93 112.381 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.21 7.67 54.67 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-N 116.154 -0.476 . . . . 14.82 112.019 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 p -69.0 133.42 48.11 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.817 0.818 . . . . 14.54 111.324 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 16.5 mtp180 -84.05 140.63 31.71 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.92 -1.037 . . . . 16.75 110.371 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 76.3 m-85 -43.75 -48.35 8.03 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 113.617 0.969 . . . . 11.99 113.617 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.87 -15.15 63.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.217 0.451 . . . . 14.45 112.217 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.1 -39.03 9.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.211 -1.403 . . . . 16.44 107.211 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 14' ' ' LEU . 37.2 tp -61.02 -29.17 69.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.058 -1.883 . . . . 13.77 111.581 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.05 6.93 1.39 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.273 -1.441 . . . . 13.81 113.924 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 36' ' ' LEU . 18.9 mt -84.61 151.42 24.51 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 119.133 -1.027 . . . . 13.04 112.667 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.47 159.89 42.0 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 112.375 -2.193 . . . . 15.67 105.709 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -50.51 -48.52 56.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.821 1.045 . . . . 15.29 113.821 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.29 -46.89 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.479 0.657 . . . . 16.66 110.613 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.35 -37.87 72.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.011 -0.54 . . . . 14.14 110.363 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 -42.19 84.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.607 -0.724 . . . . 12.0 110.19 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.02 84.7 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.247 -0.888 . . . . 13.97 110.93 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.66 -47.74 74.51 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.415 -0.812 . . . . 15.69 110.88 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -66.03 -52.1 52.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.874 1.269 . . . . 11.69 111.818 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.24 -37.16 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.297 0.48 . . . . 11.16 112.297 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -66.39 -40.37 89.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.517 -0.473 . . . . 16.65 110.13 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.48 -24.6 64.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 111.828 0.307 . . . . 14.15 111.828 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.2 -55.72 17.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.29 -0.633 . . . . 10.8 109.29 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.428 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 3.3 m-20 -63.31 -34.5 77.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 12.98 112.156 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.43 -47.29 17.83 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.476 -0.329 . . . . 17.52 111.857 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -70.66 -40.29 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 112.822 0.675 . . . . 14.87 112.822 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 9' ' ' PHE . 81.2 m-85 -91.42 -8.13 48.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.786 -0.765 . . . . 12.2 113.02 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 53.98 41.46 32.02 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.959 1.304 . . . . 16.71 109.486 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 tp -115.87 143.47 45.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.737 -0.665 . . . . 12.2 110.942 -170.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -69.76 76.06 0.44 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.491 -0.777 . . . . 16.06 110.861 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.428 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 21.7 mm -98.66 113.86 64.77 Favored Pre-proline 0 C--N 1.316 -0.881 0 O-C-N 121.8 -0.563 . . . . 11.39 110.566 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.6 140.46 93.87 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.478 2.119 . . . . 12.6 109.91 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.89 2.33 1.48 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.289 0.848 . . . . 12.52 113.289 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.4 0.03 41.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 118.961 -0.542 . . . . 14.14 112.163 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.72 ' HA2' ' CZ3' ' A' ' 73' ' ' TRP . . . -43.73 -60.92 3.15 Favored Glycine 0 C--N 1.356 1.667 0 N-CA-C 114.758 0.663 . . . . 10.76 114.758 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.92 -21.7 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.889 1.276 . . . . 11.0 112.019 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -93.33 -40.38 10.44 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.209 -0.451 . . . . 16.42 111.064 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.4 m -73.86 -40.38 63.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.396 -0.366 . . . . 13.35 110.956 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HE3' ' A' ' 73' ' ' TRP . 96.2 m-85 -112.56 103.1 55.35 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.098 -1.075 . . . . 12.23 108.098 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 95.8 Cg_endo -79.55 -0.27 10.58 Favored 'Trans proline' 0 C--O 1.209 -0.949 0 C-N-CA 122.311 2.007 . . . . 13.06 112.529 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.59 119.86 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.757 -1.572 . . . . 12.95 106.757 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 21.9 p90 -57.12 -36.48 70.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.411 0.684 . . . . 10.92 112.529 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -63.77 -31.03 72.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.519 0.727 . . . . 14.32 110.424 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.05 26.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.103 0.478 . . . . 10.93 110.262 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 46.1 t80 -77.39 -30.57 53.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.934 -0.575 . . . . 8.81 111.343 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p -67.26 -24.57 65.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.59 0.71 . . . . 9.35 110.309 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -76.93 -28.66 55.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.608 -0.724 . . . . 11.63 109.404 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.72 ' CZ3' ' HA2' ' A' ' 60' ' ' GLY . 1.6 t90 -56.86 -55.24 36.98 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 108.56 -0.904 . . . . 10.55 108.56 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 6' ' ' CYS . 71.5 t -65.8 -43.61 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 CA-C-N 115.132 -0.94 . . . . 8.3 110.188 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.01 -34.67 73.23 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.615 0.572 . . . . 9.58 112.459 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.5 m -72.91 -37.28 67.3 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 122.926 0.49 . . . . 10.23 111.377 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.72 -14.73 60.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.384 . . . . 10.43 112.038 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.943 -1.132 . . . . 10.97 107.943 174.298 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 121.525 0.679 . . . . 10.05 109.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.56 -49.2 73.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.947 1.299 . . . . 11.22 112.689 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt-30 -58.95 -58.65 7.71 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.24 0.337 . . . . 11.38 110.277 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 60.0 ttp180 -55.76 -50.33 70.71 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.877 0.736 . . . . 9.65 111.71 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.15 -41.06 95.1 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.349 0.406 . . . . 10.43 111.973 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -70.39 -42.54 71.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.323 -0.551 . . . . 10.21 111.185 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.517 HG21 HG11 ' A' ' 178' ' ' VAL . 92.4 mt -58.76 -52.96 53.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.944 0 N-CA-C 109.322 -0.621 . . . . 8.13 109.322 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -49.31 -49.0 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.353 1.033 . . . . 8.46 112.688 -175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 34.2 t70 -68.0 -44.82 75.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.81 -0.356 . . . . 10.86 111.872 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -70.16 -35.26 73.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.069 0.396 . . . . 11.45 112.069 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.86 -41.34 97.81 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.724 0.809 . . . . 7.62 109.464 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -61.56 -46.43 89.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 11.62 109.219 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 27.7 mt-30 -57.88 -49.88 75.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.02 -0.536 . . . . 11.63 110.8 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -57.24 -45.3 84.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 124.183 0.927 . . . . 9.14 110.97 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.06 -49.9 75.82 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.972 0.17 . . . . 10.06 110.962 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.94 97.83 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 121.252 -0.499 . . . . 12.07 112.129 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.99 -45.94 91.41 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.316 1.046 . . . . 12.32 111.131 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 148' ' ' TRP . 26.9 tp -72.29 -43.93 63.5 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.137 -0.938 . . . . 11.77 111.26 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.9 tp -82.25 -11.72 58.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.792 -0.64 . . . . 13.52 111.619 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 66.89 32.81 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.525 1.13 . . . . 16.56 109.845 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 tp -99.54 140.21 34.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.117 -0.947 . . . . 15.74 108.609 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 5.8 m-20 -64.11 124.72 86.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 108.744 -0.835 . . . . 14.2 108.744 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 41.4 Cg_exo -57.18 -17.91 27.53 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.36 2.707 . . . . 14.18 114.029 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -75.04 -13.71 82.44 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 120.47 -0.872 . . . . 14.03 111.672 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -86.4 -21.56 27.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.312 -0.625 . . . . 16.37 109.312 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.28 69.9 5.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.127 -0.942 . . . . 12.45 110.606 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -160.37 -61.15 0.06 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.312 -1.736 . . . . 14.43 106.312 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.4 m -83.78 -31.84 25.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.974 -0.75 . . . . 14.32 108.974 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.81 1.04 Allowed Glycine 0 C--O 1.215 -1.067 0 N-CA-C 110.786 -0.925 . . . . 13.75 110.786 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.72 34.6 2.93 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.297 -1.371 . . . . 12.7 107.297 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.5 tt0 -123.25 123.68 41.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.522 -1.672 . . . . 16.38 108.071 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -57.9 -35.72 71.42 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 124.107 0.963 . . . . 13.3 110.344 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.74 -28.61 66.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.103 -0.953 . . . . 16.25 111.277 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -25.66 28.01 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.766 0.793 . . . . 15.87 110.469 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 79.5 mt -79.19 -11.06 59.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.31 -0.859 . . . . 13.65 111.011 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.07 -135.08 9.81 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.918 -1.673 . . . . 14.16 108.918 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 165' ' ' ILE . 43.3 tpp -176.41 92.08 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.145 -0.687 . . . . 15.45 109.145 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -134.38 126.39 29.5 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.029 0.442 . . . . 13.63 111.211 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.0 m -80.41 -21.84 41.85 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.733 -0.667 . . . . 13.9 111.646 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.0 -58.64 6.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 120.464 0.173 . . . . 13.81 111.124 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.5 t -71.82 -28.96 63.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.414 -0.587 . . . . 11.48 109.414 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.16 -43.95 88.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.427 -0.806 . . . . 10.35 112.601 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -62.81 -45.34 93.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.59 -0.522 . . . . 12.2 109.59 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.91 -49.97 74.07 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.568 -0.742 . . . . 11.86 111.372 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.486 ' O ' HG23 ' A' ' 152' ' ' VAL . 19.4 t90 -63.89 -51.52 64.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.815 -0.63 . . . . 9.32 111.431 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 161' ' ' ALA . 42.0 tpp -63.61 -40.76 97.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.03 0.206 . . . . 9.5 110.959 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -60.45 -41.82 94.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.61 -0.515 . . . . 13.91 109.61 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.83 -45.91 95.23 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.757 -0.656 . . . . 9.88 111.82 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 148' ' ' TRP . 56.0 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.832 -0.433 . . . . 9.27 109.832 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 23.8 m -61.63 -51.68 67.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 11.46 110.8 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -65.01 -40.1 94.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.604 -0.725 . . . . 15.04 111.151 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -55.89 -46.64 78.28 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.424 0.69 . . . . 11.82 111.117 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -101.54 11.58 38.76 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.73 -0.388 . . . . 11.97 111.929 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 p 51.4 50.72 18.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.831 1.252 . . . . 14.24 113.107 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.3 pt -127.62 167.42 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.812 -0.631 . . . . 12.62 109.575 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -102.85 111.83 24.34 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.433 -0.348 . . . . 16.39 110.941 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 85.7 mt -129.98 154.28 47.54 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 106.886 -1.524 . . . . 12.32 106.886 173.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -95.59 138.89 32.63 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.467 0.651 . . . . 14.06 110.825 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.21 -24.09 66.55 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.265 -0.879 . . . . 12.64 111.726 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.59 17.82 6.03 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.007 0.432 . . . . 15.68 110.489 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.93 -3.76 27.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.205 0.817 . . . . 12.72 113.205 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.558 HD12 ' SD ' ' A' ' 140' ' ' MET . 26.0 pt -67.93 -12.34 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.628 0.728 . . . . 12.16 110.211 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -108.39 -2.21 19.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.862 -1.063 . . . . 15.08 108.72 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.9 m -101.97 -45.19 5.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.589 -0.732 . . . . 14.67 110.252 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 174' ' ' LEU . 5.3 m0 -111.7 118.24 47.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.433 -0.951 . . . . 12.68 108.433 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.11 -29.86 9.44 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.22 1.947 . . . . 14.34 112.261 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 24.2 p -134.58 153.91 51.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.551 0.691 . . . . 12.91 110.321 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -14.5 51.54 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.078 -0.965 . . . . 9.89 113.233 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -43.39 92.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.171 -0.677 . . . . 12.5 109.171 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.5 m -62.68 -41.73 99.24 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.133 -0.939 . . . . 11.04 110.365 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.554 HD13 ' CZ3' ' A' ' 168' ' ' TRP . 36.3 tp -68.89 -43.94 74.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.313 -0.403 . . . . 8.5 110.823 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 107' ' ' ARG . . . -57.67 -39.67 77.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 7.7 111.459 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 16.8 t70 -79.24 -36.12 40.47 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.675 -0.81 . . . . 10.38 110.546 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 14.0 tp10 -64.27 -44.53 91.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.168 -0.469 . . . . 11.97 111.604 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 110' ' ' ILE . 10.1 p -55.59 -39.77 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.316 0.385 . . . . 9.8 111.282 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 106' ' ' GLN . 33.7 t70 -69.5 -34.48 74.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 10.83 110.55 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 29.9 mmt180 -72.93 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 13.5 109.95 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.8 mmt180 -83.38 -33.59 25.76 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.319 -0.623 . . . . 14.84 109.319 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 178' ' ' VAL . 85.0 t -74.53 -51.17 23.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 116.008 -0.542 . . . . 13.35 111.298 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 119.576 -0.25 . . . . 13.51 111.157 -178.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 109.808 -0.441 . . . . 14.98 109.808 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.92 -32.15 51.48 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.997 -0.681 . . . . 15.79 109.691 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.41 -35.93 70.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.941 -0.572 . . . . 12.02 109.882 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.644 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -62.95 -49.02 76.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.275 -0.639 . . . . 11.02 109.275 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -54.59 -45.6 73.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.893 . . . . 16.07 111.139 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . 76.0 t80 -63.4 -36.22 83.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.69 0.619 . . . . 13.93 110.75 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.18 -38.37 72.13 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.352 -0.385 . . . . 10.71 110.33 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 30.7 mtp180 -63.21 -50.66 69.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.695 -0.483 . . . . 14.02 109.695 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 19.7 pt20 -64.49 -27.43 68.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.93 -0.577 . . . . 16.29 111.829 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.1 m -83.03 -44.27 15.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.241 0.544 . . . . 12.91 110.338 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.36 -41.62 93.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 12.77 111.509 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.947 0.351 . . . . 15.19 111.947 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 -30.04 68.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.529 0.68 . . . . 16.26 109.763 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.7 mtt -83.65 -34.44 25.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 15.45 109.764 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.43 0.44 54.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.735 -0.666 . . . . 16.16 111.217 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.6 t80 59.39 46.74 12.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.462 1.505 . . . . 20.56 110.668 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.63 -176.88 4.92 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.505 -0.77 . . . . 16.63 109.032 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -109.51 140.3 21.98 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.237 -1.023 . . . . 20.19 108.237 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.75 -23.06 70.46 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.729 2.953 . . . . 16.6 113.838 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.74 -6.81 85.56 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.459 -0.877 . . . . 17.74 112.467 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -109.94 16.48 21.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.798 0.666 . . . . 20.23 112.798 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.495 ' HB ' HD22 ' A' ' 34' ' ' LEU . 41.0 pt -106.04 157.37 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 119.366 -0.934 . . . . 15.98 109.904 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 27.2 mmt180 -101.65 94.77 6.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.185 -0.672 . . . . 19.33 109.185 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.81 -22.2 57.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.04 0.936 . . . . 14.93 113.119 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.62 6.51 77.44 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.573 -0.822 . . . . 14.82 112.936 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 57.6 p -115.25 171.03 7.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.337 -0.545 . . . . 14.54 112.38 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 28.7 mtm180 -62.12 147.75 46.51 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.649 0.78 . . . . 16.75 112.277 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -58.44 -32.61 68.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.283 1.033 . . . . 11.99 111.141 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.82 -25.24 67.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.669 -0.696 . . . . 14.45 110.376 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.88 -28.97 27.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.441 -0.577 . . . . 16.44 109.441 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -63.23 -31.74 72.97 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 13.77 110.823 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.31 -0.39 4.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.865 -1.16 . . . . 13.81 113.57 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -99.93 168.39 9.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 117.616 0.708 . . . . 13.04 111.438 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -128.07 161.08 30.05 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.095 . . . . 15.67 108.045 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.154 1.168 . . . . 15.29 114.154 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.67 -41.18 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.115 0.483 . . . . 16.66 110.569 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.31 -36.37 74.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.314 0.578 . . . . 14.14 110.258 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.38 72.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.334 -0.848 . . . . 12.0 110.427 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.58 -30.66 71.69 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.314 -0.857 . . . . 13.97 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.99 -40.69 27.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.506 0.669 . . . . 15.69 110.24 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -62.29 -45.74 91.9 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.582 -1.19 . . . . 11.69 111.5 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tp -59.19 -31.92 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 111.863 0.32 . . . . 11.16 111.863 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 34.2 mmt180 -60.96 -50.01 75.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.804 0.335 . . . . 16.65 110.345 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -27.33 64.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.327 -0.549 . . . . 14.15 112.027 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.8 -47.45 92.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.093 -1.077 . . . . 10.8 108.093 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.13 -37.89 75.46 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.092 -0.958 . . . . 12.98 111.196 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -84.63 -47.22 10.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.788 0.328 . . . . 17.52 111.789 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -68.72 -35.43 77.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 116.384 -0.371 . . . . 14.87 111.655 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.04 -2.48 37.09 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.346 0.593 . . . . 12.2 112.179 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 48.6 47.22 20.79 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.502 1.521 . . . . 16.71 110.066 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -124.9 127.29 46.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.893 -1.049 . . . . 12.2 109.15 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.02 53.57 2.48 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 113.579 0.955 . . . . 16.06 113.579 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.0 mm -70.68 117.99 60.74 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.386 -0.598 . . . . 11.39 109.386 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.4 151.84 65.65 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.912 1.741 . . . . 12.6 108.764 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -20.45 21.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.372 1.069 . . . . 12.52 112.894 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.83 -12.64 61.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 14.14 112.33 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.68 -52.84 48.08 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 120.981 -0.628 . . . . 10.76 112.339 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.71 0.767 . . . . 11.0 109.923 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.47 -35.38 73.26 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.564 -0.744 . . . . 16.42 111.081 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.9 m -88.57 -34.32 17.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.746 0.308 . . . . 13.35 110.721 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.95 92.86 48.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.495 -0.557 . . . . 12.23 109.495 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.698 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 74.5 Cg_endo -83.76 1.95 8.57 Favored 'Trans proline' 0 C--O 1.205 -1.145 0 C-N-CA 123.192 2.595 . . . . 13.06 114.323 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.55 133.02 39.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.916 -1.142 . . . . 12.95 107.916 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -63.85 -45.45 89.45 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 114.805 -1.088 . . . . 10.92 111.799 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -69.21 -24.58 64.04 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 111.944 0.35 . . . . 14.32 111.944 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.8 -41.04 53.9 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.54 -0.541 . . . . 10.93 109.54 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -75.93 -37.58 58.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.877 -0.601 . . . . 8.81 112.032 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.1 p -60.78 -34.33 74.32 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.702 -0.399 . . . . 9.35 110.893 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -68.53 -44.44 74.6 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.182 -0.673 . . . . 11.63 109.182 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -54.85 -45.9 74.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.351 1.06 . . . . 10.55 110.625 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.52 -45.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.069 -0.514 . . . . 8.3 110.776 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.1 93.88 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.736 -0.665 . . . . 9.58 113.672 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -68.61 -24.73 64.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.46 0.541 . . . . 10.23 112.46 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.02 -2.5 58.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 113.573 0.953 . . . . 10.43 113.573 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 108.386 -0.968 . . . . 10.97 108.386 176.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 109.749 -0.463 . . . . 10.05 109.749 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.36 94.17 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.667 -0.697 . . . . 11.22 111.441 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' ILE . 51.8 mt-30 -64.62 -48.35 75.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.999 -0.546 . . . . 11.38 109.796 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.78 -45.43 82.14 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.498 -0.774 . . . . 9.65 110.636 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -56.95 -52.35 65.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.333 0.653 . . . . 10.43 111.149 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 t -58.97 -44.26 91.49 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.635 -0.711 . . . . 10.21 111.163 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.572 HG21 HG11 ' A' ' 178' ' ' VAL . 83.5 mt -64.08 -49.11 82.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 109.881 -0.415 . . . . 8.13 109.881 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -58.13 -43.69 87.41 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.44 0.696 . . . . 8.46 112.665 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 14.8 t70 -62.59 -43.04 99.79 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.164 0.507 . . . . 10.86 110.099 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.75 -44.1 91.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.639 0.733 . . . . 11.45 110.302 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.99 -33.29 75.26 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.284 -0.871 . . . . 7.62 109.281 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 129' ' ' LEU . 56.6 tttm -62.29 -40.45 96.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.865 0.866 . . . . 11.62 109.802 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 61.1 mm-40 -64.99 -48.6 73.38 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.188 -1.041 . . . . 11.63 108.188 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.4 t -56.58 -52.62 64.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.861 -1.518 . . . . 9.14 111.984 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.9 pp -68.86 -39.26 79.98 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.377 -0.529 . . . . 10.06 111.746 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.543 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.99 -39.44 94.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.126 -0.559 . . . . 12.07 111.778 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.64 -44.74 77.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.869 0.366 . . . . 12.32 110.209 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 148' ' ' TRP . 15.0 tp -69.08 -46.08 68.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.334 -0.394 . . . . 11.77 110.953 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -72.72 -20.38 61.22 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.481 0.712 . . . . 13.52 111.327 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.0 t80 83.33 -29.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.005 1.322 . . . . 16.56 112.594 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.8 162.12 36.31 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 122.358 -0.214 . . . . 15.74 110.483 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.0 107.27 42.95 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.005 -0.739 . . . . 14.2 109.005 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -91.87 11.35 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.727 2.285 . . . . 14.18 113.425 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.61 50.69 5.19 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.496 -1.041 . . . . 14.03 110.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -107.48 -15.02 14.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.541 -0.464 . . . . 16.37 112.15 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.425 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 90.3 mt -71.23 97.72 1.6 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.13 0.491 . . . . 12.45 111.746 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 71.07 -20.06 0.23 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.207 1.403 . . . . 14.43 114.558 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -76.73 -28.74 55.91 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.725 0.81 . . . . 14.32 111.137 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.73 102.48 0.21 Allowed Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 110.213 -1.155 . . . . 13.75 110.213 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 171' ' ' LEU . . . -108.86 86.6 2.32 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.99 0.367 . . . . 12.7 111.99 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.42 112.06 23.95 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.15 -0.685 . . . . 16.38 109.15 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -62.55 -20.61 64.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.874 -0.603 . . . . 13.3 111.543 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.14 -29.63 69.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.667 0.787 . . . . 16.25 111.586 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.04 -25.88 39.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.34 0.591 . . . . 15.87 110.901 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.58 2.19 49.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 13.65 111.051 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.01 3.99 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 120.794 -0.717 . . . . 14.16 111.37 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.7 tpp 62.11 86.95 0.1 Allowed 'General case' 0 C--O 1.251 1.153 0 C-N-CA 124.794 1.237 . . . . 15.45 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 44.3 m-20 -57.86 118.73 5.64 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.37 -1.345 . . . . 13.63 107.37 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -56.32 -36.15 68.39 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.126 0.97 . . . . 13.9 111.567 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.01 -44.07 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.369 0.604 . . . . 13.81 110.145 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 141' ' ' ASP . 34.2 m -66.62 -37.96 85.93 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.854 -0.612 . . . . 11.48 110.848 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 -32.86 54.11 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.871 -0.604 . . . . 10.35 112.564 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.6 p -69.7 -39.53 76.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.453 -0.499 . . . . 12.2 110.277 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.84 -46.08 81.96 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.795 0.807 . . . . 11.86 109.699 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.1 t90 -62.18 -54.06 46.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.176 -1.375 . . . . 9.32 111.696 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.0 tpt -58.03 -42.07 84.55 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.947 0.499 . . . . 9.5 110.204 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -58.44 -46.41 86.58 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 115.895 -0.593 . . . . 13.91 110.697 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -45.15 95.89 Favored Glycine 0 C--N 1.321 -0.273 0 O-C-N 123.399 0.437 . . . . 9.88 112.787 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.31 -50.14 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 9.27 110.441 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.1 p -65.5 -38.46 89.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.097 -0.502 . . . . 11.46 111.61 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -63.99 -47.09 81.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 15.04 111.186 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -67.48 -31.57 71.81 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.787 -0.365 . . . . 11.82 110.983 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -90.92 6.11 45.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.903 0.705 . . . . 11.97 112.903 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.4 m 59.66 33.51 21.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.777 0.831 . . . . 14.24 112.51 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.44 134.81 58.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.267 -0.642 . . . . 12.62 109.267 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -88.24 94.87 9.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.602 0.715 . . . . 16.39 110.669 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.03 148.73 43.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.026 -1.101 . . . . 12.32 108.026 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.58 143.92 48.08 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.075 -1.083 . . . . 14.06 108.075 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.975 -0.557 . . . . 12.64 109.995 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.32 15.6 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.655 -0.702 . . . . 15.68 110.496 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.99 59.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.053 0.39 . . . . 12.72 112.053 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.64 9.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.434 0.635 . . . . 12.16 112.236 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -110.2 -7.04 14.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.587 -0.733 . . . . 15.08 109.587 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.1 m -79.3 -27.89 42.2 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.281 0.562 . . . . 14.67 110.795 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.7 m-90 -113.36 137.83 22.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 116.253 -0.43 . . . . 12.68 110.721 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 -16.93 18.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.063 2.509 . . . . 14.34 111.818 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.9 p -135.65 142.86 45.23 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.489 -1.3 . . . . 12.91 107.489 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB3' ' HB1' ' A' ' 133' ' ' ALA . 25.8 tp -71.3 -24.9 62.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.742 -0.663 . . . . 9.89 110.983 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -62.34 -21.98 65.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.762 -0.654 . . . . 12.5 110.675 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 27.6 m -65.7 -18.56 65.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.843 -0.617 . . . . 11.04 111.208 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.94 -46.2 68.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.449 -0.575 . . . . 8.5 109.449 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.16 75.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.494 . . . . 7.7 110.968 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 14.6 t70 -74.99 -31.0 61.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.278 -0.569 . . . . 10.38 110.056 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -76.55 -41.87 45.05 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 123.348 0.659 . . . . 11.97 110.351 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.572 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -64.67 -30.49 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.744 0.783 . . . . 9.8 110.102 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 183' ' ' GLN . 18.8 t70 -66.59 -28.08 68.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.599 -1.182 . . . . 10.83 110.117 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 85.2 mtt180 -84.22 -42.31 16.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.23 -0.895 . . . . 13.5 109.307 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.04 -51.3 59.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.962 -1.017 . . . . 14.84 111.985 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.25 -35.23 17.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.193 0.52 . . . . 13.35 110.77 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 179' ' ' ASP . 9.0 tt0 . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.246 -0.883 . . . . 13.51 109.212 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 110.263 -0.273 . . . . 14.98 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.66 -47.33 86.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.664 0.385 . . . . 15.79 110.774 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 p -62.63 -36.47 82.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.317 -0.401 . . . . 12.02 111.479 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.56 67.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.445 -0.343 . . . . 11.02 110.235 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 64.3 tt0 -60.04 -48.59 81.1 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.451 0.701 . . . . 16.07 110.694 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -55.6 -42.25 74.59 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.052 0.845 . . . . 13.93 110.123 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.35 -43.52 63.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.106 -0.497 . . . . 10.71 111.609 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 8' ' ' GLN . 30.8 mtm180 -61.28 -40.0 92.5 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.612 0.244 . . . . 14.02 111.147 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.0 -44.62 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 16.29 110.82 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -71.05 -25.23 62.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.885 0.374 . . . . 12.91 111.415 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.98 -55.96 9.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.72 -1.585 . . . . 12.77 106.72 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.34 65.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.685 -1.143 . . . . 15.19 111.554 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.93 85.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.652 0.263 . . . . 16.26 111.464 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -81.48 -26.09 35.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.018 0.437 . . . . 15.45 111.222 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.57 -4.33 44.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.018 -0.537 . . . . 16.16 112.041 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.97 49.09 3.61 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.955 1.302 . . . . 20.56 112.513 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.15 161.81 22.46 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.781 -1.099 . . . . 16.63 108.757 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -92.9 116.38 66.4 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-O 120.631 0.253 . . . . 20.19 111.124 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 -6.97 19.07 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.388 2.725 . . . . 16.6 113.627 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.76 -20.94 78.96 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.381 -0.688 . . . . 17.74 111.381 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -128.73 71.89 1.43 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 122.167 0.984 . . . . 20.23 109.468 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 tp -127.9 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.612 -0.884 . . . . 15.98 108.612 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -88.67 120.63 30.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.0 -0.741 . . . . 19.33 109.0 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 19.8 m-20 -61.79 -26.44 68.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.46 -0.791 . . . . 14.93 112.174 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.44 4.39 86.16 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.02 -0.61 . . . . 14.82 113.677 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.5 p -79.41 140.36 37.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 117.816 0.808 . . . . 14.54 110.273 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.547 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 66.1 mtm180 -75.5 148.24 39.14 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 118.356 -0.831 . . . . 16.75 109.479 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -50.38 -40.19 48.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.905 0.86 . . . . 11.99 110.992 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -23.9 66.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.406 -1.27 . . . . 14.45 112.691 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HG2' ' HB2' ' A' ' 30' ' ' ARG . 8.9 mm-40 -76.98 -29.28 55.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.796 0.808 . . . . 16.44 109.074 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.82 -31.94 27.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.16 -0.927 . . . . 13.77 108.808 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.0 32.94 3.63 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 114.787 -1.097 . . . . 13.81 112.174 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.0 tp -81.41 98.9 8.43 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.777 -0.823 . . . . 13.04 108.777 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.91 147.74 45.01 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.707 -1.22 . . . . 15.67 107.707 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 19.3 p -58.67 -22.8 57.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.923 0.765 . . . . 15.29 112.178 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.24 -50.93 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.494 -0.558 . . . . 16.66 109.494 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.06 -36.71 76.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.891 -0.781 . . . . 14.14 108.891 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 38' ' ' SER . . . -57.09 -36.76 70.98 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.169 -0.923 . . . . 12.0 110.77 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.49 -45.84 85.58 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.066 -0.515 . . . . 13.97 109.967 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -60.79 -45.88 92.68 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.4 0.619 . . . . 15.69 110.712 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -59.34 -52.42 65.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.008 1.723 . . . . 11.69 111.684 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 tp -63.56 -31.61 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.857 0.36 . . . . 11.16 111.403 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 42' ' ' ALA . 99.2 mtt180 -66.35 -35.08 79.45 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 120.972 0.415 . . . . 16.65 110.282 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -73.62 -35.1 65.3 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.22 0.533 . . . . 14.15 110.155 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.01 -50.17 81.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 115.146 -0.934 . . . . 10.8 109.85 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.54 -25.12 59.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.035 -0.984 . . . . 12.98 112.847 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 97.7 mttt -75.82 -61.86 1.78 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 116.296 -0.411 . . . . 17.52 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -74.67 -25.09 58.95 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.958 -0.697 . . . . 14.87 112.008 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -94.96 -6.98 41.22 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.427 0.899 . . . . 12.2 113.427 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 47.92 64.27 1.7 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.877 1.671 . . . . 16.71 112.108 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.48 167.72 21.07 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.94 -1.027 . . . . 12.2 108.312 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.32 70.52 0.76 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.387 -1.338 . . . . 16.06 107.387 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.493 HD12 ' HE1' ' A' ' 73' ' ' TRP . 47.0 mm -92.74 119.93 67.58 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.201 -0.666 . . . . 11.39 109.201 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -87.65 167.72 7.25 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.056 1.838 . . . . 12.6 108.929 171.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -10.16 3.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.733 1.012 . . . . 12.52 113.733 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.39 -19.57 65.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.26 0.467 . . . . 14.14 112.26 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.77 -44.37 96.36 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.742 -1.218 . . . . 10.76 110.129 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.45 -27.64 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.231 1.012 . . . . 11.0 110.869 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -78.25 -31.5 49.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.734 -0.604 . . . . 16.42 112.175 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t -87.69 -32.28 19.28 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.392 -0.923 . . . . 13.35 110.649 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.486 ' CE2' ' HE3' ' A' ' 73' ' ' TRP . 38.6 m-85 -108.72 100.98 41.73 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 109.526 -0.546 . . . . 12.23 109.526 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.06 -0.45 10.29 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.506 2.137 . . . . 13.06 112.366 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 120.47 61.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.609 -1.626 . . . . 12.95 106.609 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 27' ' ' ASP . 49.2 p90 -58.98 -32.23 69.49 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.024 0.75 . . . . 10.92 113.024 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -60.58 -32.09 71.2 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.919 0.888 . . . . 14.32 111.731 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.5 -30.78 21.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.91 0.862 . . . . 10.93 109.928 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 43.2 t80 -70.63 -31.7 68.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.181 -0.918 . . . . 8.81 111.61 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.1 p -66.18 -28.42 68.75 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.726 -0.609 . . . . 9.35 109.49 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -71.21 -32.76 69.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.481 -0.781 . . . . 11.63 109.634 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.493 ' HE1' HD12 ' A' ' 56' ' ' ILE . 2.4 t-105 -53.91 -55.8 23.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.413 -0.958 . . . . 10.55 108.413 173.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.13 -44.73 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 C-N-CA 124.031 0.932 . . . . 8.3 110.627 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.6 73.74 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.261 -0.427 . . . . 9.58 113.0 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.2 m -80.36 -31.32 37.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 122.525 -0.397 . . . . 10.23 111.073 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -89.24 -21.41 23.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.051 -0.66 . . . . 10.43 112.073 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.316 -0.884 0 N-CA-C 110.096 -0.335 . . . . 10.97 110.096 174.801 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 121.813 0.816 . . . . 10.05 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.25 -35.42 71.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.509 -1.223 . . . . 11.22 109.916 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.17 -44.53 97.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.771 -1.104 . . . . 11.38 109.852 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.449 ' O ' ' HB ' ' A' ' 110' ' ' ILE . 44.1 ttp180 -78.91 -27.46 43.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.875 -0.602 . . . . 9.65 111.17 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.0 -37.05 86.39 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.809 0.337 . . . . 10.43 110.764 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.8 t -64.69 -41.88 95.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.565 -0.902 . . . . 10.21 108.565 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 178' ' ' VAL . 67.3 mt -57.36 -41.85 79.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 CA-C-N 115.098 -0.956 . . . . 8.13 109.722 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -55.88 -39.64 71.84 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.228 0.611 . . . . 8.46 112.317 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 m-20 -66.83 -40.86 88.13 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.039 0.447 . . . . 10.86 111.129 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -74.57 -35.06 63.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.144 -0.48 . . . . 11.45 111.613 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.72 -43.23 98.12 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.254 -1.387 . . . . 7.62 107.254 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 79.0 tttt -54.66 -48.19 72.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.606 -1.179 . . . . 11.62 110.243 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -70.12 -39.29 75.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.137 -0.483 . . . . 11.63 111.404 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -58.25 -52.8 64.05 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.92 0.888 . . . . 9.14 110.219 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.7 -38.55 58.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.144 -0.48 . . . . 10.06 110.483 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.75 -26.66 67.21 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 116.415 -0.357 . . . . 12.07 112.389 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.92 -32.45 74.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 123.519 0.728 . . . . 12.32 110.296 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.03 -30.95 62.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.577 0.703 . . . . 11.77 109.535 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.87 6.9 46.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.797 -1.092 . . . . 13.52 110.046 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.2 t80 79.96 -48.82 0.35 Allowed 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 127.78 2.432 . . . . 16.56 112.795 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.47 152.62 31.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.904 -0.406 . . . . 15.74 109.904 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.2 112.48 56.47 Favored Pre-proline 0 C--N 1.314 -0.947 0 O-C-N 124.18 0.925 . . . . 14.2 109.401 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -75.91 -37.31 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.223 1.949 . . . . 14.18 112.052 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -116.84 -112.97 2.7 Favored Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 110.118 -1.193 . . . . 14.03 110.118 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -139.29 3.48 2.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.835 -0.215 . . . . 16.37 110.964 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 115' ' ' LYS . 6.0 mp 60.65 -177.48 0.11 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.38 1.072 . . . . 12.45 112.588 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -150.37 148.53 28.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.691 -1.596 . . . . 14.43 106.691 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 170' ' ' THR . 25.5 m -74.32 -26.57 60.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.562 -0.744 . . . . 14.32 111.251 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.65 3.53 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 111.123 -0.791 . . . . 13.75 111.123 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.08 107.94 15.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.152 -1.055 . . . . 12.7 108.152 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -73.06 118.04 15.53 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.16 -0.473 . . . . 16.38 110.858 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.53 -27.69 67.96 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.375 -0.83 . . . . 13.3 110.178 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.77 -19.79 65.82 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.408 -0.814 . . . . 16.25 111.629 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.3 -52.39 5.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.496 0.554 . . . . 15.87 112.496 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.82 -10.05 20.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.934 0.716 . . . . 13.65 112.934 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.9 140.19 15.73 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.916 -1.135 . . . . 14.16 112.323 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.2 mtm -133.51 24.6 4.08 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.684 -1.599 . . . . 15.45 106.684 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.41 70.32 1.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.409 -1.723 . . . . 13.63 112.225 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -44.72 73.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.116 0.484 . . . . 13.9 109.919 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.32 -57.25 4.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 122.182 -0.324 . . . . 13.81 110.828 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -69.76 -20.47 63.49 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.64 -0.424 . . . . 11.48 111.927 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -78.86 -24.36 62.26 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.741 -1.218 . . . . 10.35 110.184 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.5 m -72.43 -38.22 68.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.602 -0.888 . . . . 12.2 108.602 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.72 -39.99 86.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.683 -0.69 . . . . 11.86 109.181 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 25.1 t90 -65.16 -46.5 80.61 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.188 -0.914 . . . . 9.32 110.711 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 15.3 mmt -54.35 -47.85 72.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.112 0.482 . . . . 9.5 110.097 176.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 36.6 ttm180 -60.87 -41.02 95.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.247 -0.888 . . . . 13.91 110.232 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.85 -53.57 36.75 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.718 -0.673 . . . . 9.88 111.882 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' TRP . 53.5 t -57.61 -40.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.105 0.479 . . . . 9.27 110.064 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.9 t -61.16 -51.9 67.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.334 -0.848 . . . . 11.46 110.584 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 39.1 ptt180 -75.64 -40.05 56.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.784 0.661 . . . . 15.04 112.784 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -68.98 -33.87 74.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 11.82 111.87 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.97 2.22 43.33 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.737 -0.385 . . . . 11.97 112.025 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 t 60.0 37.57 21.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.972 0.909 . . . . 14.24 111.302 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.12 148.52 19.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.818 -0.438 . . . . 12.62 109.818 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -83.05 95.97 8.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.045 -0.354 . . . . 16.39 110.045 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 tp -109.36 133.99 52.38 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.349 -0.982 . . . . 12.32 108.349 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.46 146.7 29.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.007 -0.542 . . . . 14.06 110.219 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.49 -16.83 62.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 12.64 111.846 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.22 1.87 56.89 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.287 -0.415 . . . . 15.68 110.656 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HB1' ' CD1' ' A' ' 168' ' ' TRP . . . -61.83 -22.38 65.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.718 0.636 . . . . 12.72 112.718 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.7 pt -67.44 -12.96 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.235 0.54 . . . . 12.16 111.33 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -103.75 4.05 34.8 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.038 -0.528 . . . . 15.08 110.477 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.6 t -140.09 14.73 2.44 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 119.392 -0.923 . . . . 14.67 112.931 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.541 ' CD1' ' HB1' ' A' ' 164' ' ' ALA . 25.2 m95 -129.51 114.44 18.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.957 -1.127 . . . . 12.68 107.957 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.487 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 58.4 Cg_endo -73.12 -44.13 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.765 2.31 . . . . 14.34 115.491 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 131' ' ' SER . 74.8 p -130.45 -175.56 3.68 Favored 'General case' 0 C--O 1.249 1.058 0 N-CA-C 112.696 0.628 . . . . 12.91 112.696 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 6.7 mp -68.12 -26.5 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.711 -0.477 . . . . 9.89 109.711 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -58.66 -49.96 75.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.45 -0.574 . . . . 12.5 109.45 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB2' ' CE3' ' A' ' 168' ' ' TRP . 3.1 p -67.36 -24.13 65.67 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.884 0.698 . . . . 11.04 112.884 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.12 -47.56 23.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.837 -1.171 . . . . 8.5 107.837 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.22 -30.57 71.69 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.794 -0.639 . . . . 7.7 110.832 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -56.71 -34.97 68.0 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.349 0.66 . . . . 10.38 112.316 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -60.24 -58.27 9.25 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.676 0.75 . . . . 11.97 110.998 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 110' ' ' ILE . 9.5 p -69.74 -32.12 51.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.908 -1.042 . . . . 9.8 110.899 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.16 -43.64 92.1 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.31 0.644 . . . . 10.83 110.76 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.4 mtm105 -83.06 -38.07 23.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.198 -0.456 . . . . 13.5 112.038 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -66.26 -46.51 76.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.581 0.585 . . . . 14.84 112.581 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.17 -43.33 17.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.883 0.373 . . . . 13.35 111.828 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.753 -0.462 . . . . 13.51 109.753 -178.638 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 121.959 0.885 . . . . 14.98 109.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -61.86 -41.68 98.13 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.66 0.985 . . . . 15.79 113.66 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.87 -58.59 5.61 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.754 0.659 . . . . 12.02 110.678 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.12 80.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.625 -0.716 . . . . 11.02 111.333 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -58.16 -47.62 82.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.824 -0.626 . . . . 16.07 111.826 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.02 -34.72 77.02 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 121.099 0.476 . . . . 13.93 110.766 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.88 -36.14 77.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.145 -0.479 . . . . 10.71 110.528 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.91 -48.1 83.37 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.51 -0.552 . . . . 14.02 109.51 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.35 -43.77 88.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.685 . . . . 16.29 111.364 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -72.99 -43.48 62.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.96 -0.563 . . . . 12.91 112.373 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.49 -38.71 90.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.775 -0.454 . . . . 12.77 109.775 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.67 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -63.99 -34.87 78.97 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.738 -0.664 . . . . 15.19 110.792 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.85 61.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.981 -0.554 . . . . 16.26 111.042 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.9 mtt -85.36 -45.56 11.78 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.304 -0.407 . . . . 15.45 111.74 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.65 -5.64 48.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.27 0.841 . . . . 16.16 113.27 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 67.36 28.81 7.73 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.899 0.857 . . . . 20.56 111.93 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 6.9 p -97.45 -174.85 3.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.873 -1.158 . . . . 16.63 107.873 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -104.39 138.99 19.68 Favored Pre-proline 0 C--N 1.305 -1.354 0 C-N-CA 120.302 -0.559 . . . . 20.19 110.33 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.49 -9.09 14.93 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.15 1.9 . . . . 16.6 111.693 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.82 -76.57 0.88 Allowed Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 111.437 -0.665 . . . . 17.74 111.437 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -85.31 55.71 3.62 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.725 0.774 . . . . 20.23 110.372 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.56 140.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.844 -1.169 . . . . 15.98 107.844 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -81.88 100.23 9.5 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.204 0.526 . . . . 19.33 110.045 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 5.8 p-10 -77.16 -20.34 55.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.936 -0.575 . . . . 14.93 112.283 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.85 7.21 64.97 Favored Glycine 0 C--N 1.307 -1.061 0 CA-C-N 116.024 -0.534 . . . . 14.82 112.639 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.3 p -92.15 166.75 12.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.127 0.489 . . . . 14.54 110.597 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 88.5 mtm180 -91.61 141.93 28.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.331 -0.85 . . . . 16.75 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -50.22 -48.81 54.22 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.266 1.21 . . . . 11.99 114.266 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 36' ' ' LEU . 87.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.298 0.57 . . . . 14.45 111.158 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 30' ' ' ARG . 44.1 tt0 -82.2 -20.36 37.95 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 124.078 0.951 . . . . 16.44 109.293 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.4 -0.79 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.347 -0.842 . . . . 13.77 109.43 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.38 74.74 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.562 -0.745 . . . . 13.81 112.341 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 32' ' ' LEU . 20.6 tp -81.91 82.31 7.59 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.348 -0.982 . . . . 13.04 108.348 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.52 ' OD2' HG22 ' A' ' 39' ' ' VAL . 17.6 t70 -66.44 165.87 13.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.345 -1.298 . . . . 15.67 109.819 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -56.58 -36.74 69.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 118.44 0.564 . . . . 15.29 111.479 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG22 ' OD2' ' A' ' 37' ' ' ASP . 1.5 m -57.41 -51.84 64.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.677 0.751 . . . . 16.66 112.509 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mt -67.87 -46.58 81.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.675 -1.148 . . . . 14.14 110.301 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.36 87.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 12.0 112.458 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.41 93.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.397 0.617 . . . . 13.97 111.034 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.08 -43.3 68.02 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.638 -0.71 . . . . 15.69 110.619 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -57.43 -52.96 63.25 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 125.66 1.584 . . . . 11.69 110.425 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 tp -66.29 -33.03 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.369 -0.378 . . . . 11.16 111.028 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -59.95 -36.23 76.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.368 -0.378 . . . . 16.65 110.628 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.88 -40.37 54.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.299 -0.56 . . . . 14.15 109.69 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.39 -48.44 56.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.007 0.523 . . . . 10.8 110.96 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 16.3 m120 -57.88 -35.91 71.65 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.489 0.551 . . . . 12.98 112.489 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -86.22 -56.11 3.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.061 0.458 . . . . 17.52 110.814 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -61.81 -32.57 72.89 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.073 0.949 . . . . 14.87 111.788 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.15 3.2 25.47 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.473 0.654 . . . . 12.2 111.201 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.251 4.0 pt20 39.82 55.7 2.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.964 2.106 . . . . 16.71 114.308 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.35 159.07 23.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.34 -0.846 . . . . 12.2 110.129 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -94.95 26.82 3.42 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.077 0.551 . . . . 16.06 110.487 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mm -53.71 121.92 30.51 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.346 -0.843 . . . . 11.39 111.027 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.47 137.96 48.61 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.657 1.571 . . . . 12.6 108.555 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.56 -19.99 29.13 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.44 0.696 . . . . 12.52 112.267 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.34 -1.88 57.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.024 -0.534 . . . . 14.14 112.207 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.55 72.0 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 121.481 -0.39 . . . . 10.76 112.368 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.91 -26.22 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.408 0.683 . . . . 11.0 111.522 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -103.76 -2.53 26.26 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.643 -0.423 . . . . 16.42 111.921 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 m -69.52 -57.44 5.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.356 -0.979 . . . . 13.35 108.356 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.23 85.2 50.09 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 105.053 -2.203 . . . . 12.23 105.053 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 71.9 Cg_endo -76.15 54.32 4.14 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.836 2.357 . . . . 13.06 115.175 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.3 126.77 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.277 -1.009 . . . . 12.95 108.277 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -50.54 -54.78 19.8 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.382 0.882 . . . . 10.92 113.382 -171.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 63.1 tttm -65.79 -33.29 75.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.501 . . . . 14.32 111.424 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.94 81.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.104 -0.498 . . . . 10.93 111.04 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.0 t80 -79.06 -32.02 44.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.833 0.349 . . . . 8.81 111.618 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.0 p -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.662 -0.649 . . . . 9.35 110.963 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.16 -27.91 57.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.597 -0.274 . . . . 11.63 110.627 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.528 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 2.2 t90 -53.8 -49.15 68.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.461 1.104 . . . . 10.55 109.277 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 86.8 t -62.83 -41.55 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 123.666 0.786 . . . . 8.3 110.365 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.61 93.22 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.76 -0.654 . . . . 9.58 112.378 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 p -75.22 -22.31 58.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.895 0.379 . . . . 10.23 111.618 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.26 -17.16 57.02 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.957 0.408 . . . . 10.43 110.019 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 97.5 mt . . . . . 0 C--N 1.316 -0.882 0 CA-C-O 122.073 0.939 . . . . 10.97 109.383 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.434 -1.262 0 CA-C-O 120.867 0.365 . . . . 10.05 110.079 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.45 69.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.115 -0.493 . . . . 11.22 111.434 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -70.53 -47.28 61.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.806 -0.813 . . . . 11.38 108.806 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -68.98 -40.55 78.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.037 -0.529 . . . . 9.65 110.772 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.8 -41.99 92.42 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.059 -0.519 . . . . 10.43 110.05 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -64.92 -36.53 84.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 120.453 -0.499 . . . . 10.21 111.281 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.624 HG21 HG11 ' A' ' 178' ' ' VAL . 50.4 mt -59.31 -50.05 81.25 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 109.546 -0.538 . . . . 8.13 109.546 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -60.83 -34.86 75.21 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.536 -0.756 . . . . 8.46 110.114 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 15.0 t70 -63.49 -52.73 60.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.51 -0.768 . . . . 10.86 110.352 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -62.41 -44.72 95.76 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.337 -0.392 . . . . 11.45 109.976 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.91 -47.41 80.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.98 0.912 . . . . 7.62 110.68 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.31 -47.6 85.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.514 -0.766 . . . . 11.62 110.226 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 23.9 mt-30 -66.18 -43.24 87.42 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.879 -0.6 . . . . 11.63 110.717 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.6 t -58.11 -51.81 68.15 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 123.579 0.752 . . . . 9.14 111.803 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.502 HD23 ' CZ2' ' A' ' 148' ' ' TRP . 3.1 tm? -73.46 -40.82 63.87 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.54 -0.541 . . . . 10.06 109.54 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.53 -27.7 72.17 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.074 -0.512 . . . . 12.07 112.47 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.37 -37.94 68.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.369 0.604 . . . . 12.32 109.761 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.545 -0.752 . . . . 11.77 110.033 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.75 -16.68 55.13 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.552 -0.749 . . . . 13.52 110.567 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 72.46 8.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.351 1.46 . . . . 16.56 112.671 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.64 18.39 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.718 0.807 . . . . 15.74 108.99 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.94 126.23 29.48 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.521 -1.288 . . . . 14.2 107.521 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -7.53 21.03 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.76 2.307 . . . . 14.18 112.489 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.01 -73.06 0.39 Allowed Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 120.653 -0.784 . . . . 14.03 112.244 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -124.69 -22.17 4.64 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.821 0.343 . . . . 16.37 111.105 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp 63.5 -154.79 0.32 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 12.45 110.608 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.457 ' H ' HD23 ' A' ' 171' ' ' LEU . 67.3 mtp180 68.13 -78.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.148 0.979 . . . . 14.43 110.882 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.7 p -97.15 151.25 19.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.544 -0.91 . . . . 14.32 108.544 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.27 64.46 Favored Glycine 0 N--CA 1.47 0.951 0 C-N-CA 119.807 -1.187 . . . . 13.75 110.491 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.5 82.16 1.94 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.181 -1.414 . . . . 12.7 107.181 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.53 124.12 48.72 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.401 -1.272 . . . . 16.38 111.524 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.19 -7.08 51.4 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.086 -0.961 . . . . 13.3 111.372 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.86 -31.64 69.6 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.824 -1.176 . . . . 16.25 107.824 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.91 -51.98 3.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.772 -1.104 . . . . 15.87 110.176 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.18 15.55 2.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.549 0.69 . . . . 13.65 112.113 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.6 61.31 0.41 Allowed Glycine 0 C--N 1.297 -1.591 0 N-CA-C 109.857 -1.297 . . . . 14.16 109.857 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.6 ttm -72.46 -38.5 68.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.201 0.524 . . . . 15.45 110.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.14 143.27 46.63 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.321 -0.854 . . . . 13.63 110.299 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -82.06 -27.34 33.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.431 -0.804 . . . . 13.9 111.945 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.88 -35.96 50.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.204 0.526 . . . . 13.81 109.801 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.1 p -59.15 -48.12 82.77 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.77 -0.65 . . . . 11.48 110.939 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.4 85.14 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 115.499 -0.773 . . . . 10.35 112.726 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.9 t -64.37 -41.84 96.49 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.486 -0.486 . . . . 12.2 111.423 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -66.36 -46.34 77.08 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.891 0.377 . . . . 11.86 111.186 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 118' ' ' LEU . 32.8 t90 -64.14 -48.97 73.98 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.878 -0.601 . . . . 9.32 111.789 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.423 ' HG3' HG12 ' A' ' 165' ' ' ILE . 93.6 mmm -60.93 -45.44 94.68 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 123.245 0.34 . . . . 9.5 111.809 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.21 -36.69 80.59 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.026 -0.27 . . . . 13.91 111.187 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.05 -47.97 80.22 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.656 -0.578 . . . . 9.88 111.656 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.26 -42.92 92.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.204 0.526 . . . . 9.27 110.101 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.2 m -62.82 -41.67 99.41 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.342 -0.845 . . . . 11.46 111.23 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -69.71 -41.79 74.9 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.892 -0.595 . . . . 15.04 109.87 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -60.41 -45.14 94.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.856 . . . . 11.82 110.248 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.52 5.9 49.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.473 0.546 . . . . 11.97 112.473 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.2 m 57.26 39.44 28.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.301 1.04 . . . . 14.24 112.887 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.0 149.66 16.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.076 0.465 . . . . 12.62 111.097 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.61 100.04 12.85 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.813 -1.18 . . . . 16.39 107.813 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -103.6 135.44 45.18 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.017 -0.538 . . . . 12.32 109.623 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.34 133.91 39.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.453 0.644 . . . . 14.06 110.573 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.76 64.3 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.683 -0.689 . . . . 12.64 111.487 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.83 -5.17 59.28 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.746 -0.661 . . . . 15.68 111.091 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.21 -8.54 56.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.727 0.775 . . . . 12.72 109.843 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.423 HG12 ' HG3' ' A' ' 149' ' ' MET . 10.7 mt -58.88 -23.85 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.984 1.314 . . . . 12.16 109.745 175.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -113.43 16.75 18.8 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.124 -0.944 . . . . 15.08 110.098 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.8 m -101.77 -34.1 9.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.645 -0.707 . . . . 14.67 109.85 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.8 m-90 -103.24 107.41 55.48 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.869 -0.419 . . . . 12.68 109.869 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.58 -13.7 9.49 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.155 1.904 . . . . 14.34 113.007 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -129.46 145.29 51.45 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.555 0.693 . . . . 12.91 111.529 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 130' ' ' ARG . 63.9 tp -58.17 -35.09 71.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.439 -1.255 . . . . 9.89 111.9 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.84 -25.44 65.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 12.5 111.718 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 9.4 m -75.88 -20.16 58.28 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.146 0.498 . . . . 11.04 110.5 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.86 -29.75 55.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.578 -0.897 . . . . 8.5 108.578 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.42 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.417 -0.81 . . . . 7.7 109.4 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -62.07 -30.5 71.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 120.804 0.335 . . . . 10.38 111.343 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -59.38 4.58 Favored 'General case' 0 C--O 1.252 1.205 0 N-CA-C 108.583 -0.895 . . . . 11.97 108.583 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 110' ' ' ILE . 14.9 p -65.49 -35.18 74.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 114.674 -1.148 . . . . 9.8 111.773 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -57.24 -40.9 78.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.59 0.71 . . . . 10.83 110.919 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 34.2 ttp-105 -82.23 -53.22 6.23 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.341 -0.845 . . . . 13.5 111.18 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -75.42 -45.9 36.05 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.895 1.442 . . . . 14.84 114.895 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.98 -31.66 22.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 119.937 -0.705 . . . . 13.35 109.239 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.237 0.41 0 O-C-N 124.9 1.375 . . . . 13.51 111.223 172.776 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 119.721 -0.181 . . . . 14.98 111.078 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.52 -47.16 82.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 121.029 -0.268 . . . . 15.79 110.744 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 89.7 m -59.68 -42.91 93.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.509 0.195 . . . . 12.02 111.133 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.04 80.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.305 -0.407 . . . . 11.02 110.682 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.81 -39.13 87.61 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.787 -0.642 . . . . 16.07 110.647 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.35 -49.19 78.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.541 0.736 . . . . 13.93 110.289 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 96.0 mt -67.45 -38.08 83.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.422 -0.354 . . . . 10.71 110.683 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -59.74 -43.72 94.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.112 -0.495 . . . . 14.02 109.907 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.25 -41.86 69.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 16.29 110.096 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -57.73 -45.23 86.08 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.098 0.959 . . . . 12.91 111.132 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.48 -48.12 81.83 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.337 -0.616 . . . . 12.77 109.337 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.39 82.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.669 . . . . 15.19 111.831 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.65 86.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.137 0.575 . . . . 16.26 111.725 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.439 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 63.5 mtt -78.11 -42.61 31.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.705 -0.679 . . . . 15.45 111.468 -176.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.16 3.19 52.72 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.869 -0.733 . . . . 16.16 112.083 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 55.56 46.7 22.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.317 1.047 . . . . 20.56 110.187 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.8 m -123.38 -178.47 4.01 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.973 -1.012 . . . . 16.63 109.843 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.64 145.97 30.49 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.462 -1.681 . . . . 20.19 106.462 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.01 49.86 3.38 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 121.874 1.716 . . . . 16.6 109.237 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.1 92.54 0.01 OUTLIER Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 127.945 2.688 . . . . 17.74 114.587 -172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 44.19 29.71 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 127.044 2.138 . . . . 20.23 115.627 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.76 130.31 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.92 -1.141 . . . . 15.98 107.92 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -151.16 0.34 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.243 -1.021 . . . . 19.33 108.243 -173.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.09 -29.63 64.29 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.55 -0.46 . . . . 14.93 111.051 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -53.66 2.45 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.153 -1.022 . . . . 14.82 111.042 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -74.48 108.75 7.45 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.82 -1.178 . . . . 14.54 107.82 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 91.0 mtt180 -89.86 176.43 6.83 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.312 0.856 . . . . 16.75 113.312 -169.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -49.62 -41.17 41.63 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 112.736 0.643 . . . . 11.99 112.736 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.8 mt -60.34 -25.75 66.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 14.45 111.715 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.26 -36.2 79.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.243 0.617 . . . . 16.44 111.213 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.0 mt -88.98 5.22 45.24 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.584 -0.446 . . . . 13.77 112.006 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.79 51.71 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.992 -1.099 . . . . 13.81 112.677 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.9 tt -75.13 125.12 28.27 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.684 -0.858 . . . . 13.04 108.684 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -117.35 162.18 18.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.953 -1.128 . . . . 15.67 107.953 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 p -48.43 -43.89 34.78 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.401 0.68 . . . . 15.29 112.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.49 -47.66 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.865 -0.607 . . . . 16.66 110.487 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.0 mt -67.16 -34.46 69.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.816 -0.629 . . . . 14.14 110.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -59.34 -33.28 70.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 12.0 111.31 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.15 73.52 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.212 -0.449 . . . . 13.97 111.712 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.27 -45.74 14.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.386 0.612 . . . . 15.69 109.711 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 3.4 t90 -59.34 -40.59 86.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.498 1.119 . . . . 11.69 111.89 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 tp -62.18 -30.64 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.89 0.376 . . . . 11.16 110.872 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -64.96 -41.02 95.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 16.65 109.958 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' A' ' 17' ' ' MET . 0.3 OUTLIER -67.89 -31.7 71.67 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 121.191 0.519 . . . . 14.15 111.424 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 78.5 mt -66.97 -50.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.44 -0.948 . . . . 10.8 108.44 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 90.9 m-20 -62.66 -31.35 72.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.582 -1.19 . . . . 12.98 112.971 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -71.39 -43.13 67.43 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.871 -0.518 . . . . 17.52 110.155 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -74.64 -45.18 46.5 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 113.97 1.1 . . . . 14.87 113.97 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' HD22 ' A' ' 54' ' ' LEU . 63.9 m-85 -101.64 -1.15 33.36 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.758 -0.777 . . . . 12.2 112.189 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.298 4.0 pt20 48.49 42.71 19.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.242 1.941 . . . . 16.71 116.242 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 52' ' ' TYR . 3.4 mm? -94.51 171.25 8.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.599 -1.259 . . . . 12.2 107.599 171.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -114.12 60.74 0.67 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.506 -0.924 . . . . 16.06 108.506 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' PRO . 62.7 mt -97.4 126.4 41.77 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.35 -0.841 . . . . 11.39 111.0 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 56' ' ' ILE . 74.2 Cg_endo -77.0 169.5 21.51 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.273 1.982 . . . . 12.6 109.186 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.99 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.462 0.648 . . . . 12.52 110.629 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 5.6 m-20 -62.33 -20.09 64.0 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.101 -0.954 . . . . 14.14 112.312 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.07 99.82 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 119.791 -1.195 . . . . 10.76 110.252 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.03 -27.39 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.634 0.73 . . . . 11.0 110.07 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 20.6 m-85 -74.57 -23.47 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.843 -0.536 . . . . 16.42 110.233 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.4 m -87.57 -45.28 10.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.04 -0.527 . . . . 13.35 109.639 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' HE2' ' CE3' ' A' ' 73' ' ' TRP . 76.0 m-85 -115.74 104.22 53.03 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 120.583 0.23 . . . . 12.23 111.095 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 71.6 Cg_endo -83.13 3.32 7.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.96 1.773 . . . . 13.06 110.842 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -119.97 120.42 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.301 -1.74 . . . . 12.95 106.301 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -63.38 -29.77 71.01 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 113.504 0.927 . . . . 10.92 113.504 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -64.06 -34.25 77.6 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 14.32 111.696 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.16 -29.12 28.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.818 0.818 . . . . 10.93 109.655 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -75.58 -35.85 60.49 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.995 . . . . 8.81 111.377 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -65.02 -30.39 71.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.107 0.48 . . . . 9.35 109.731 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -70.17 -36.75 74.9 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.252 -0.885 . . . . 11.63 109.599 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.504 ' CE3' ' HE2' ' A' ' 64' ' ' TYR . 17.3 t-105 -61.95 -42.29 98.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 10.55 110.606 173.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 79.6 t -68.8 -45.29 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.921 0 N-CA-C 110.087 -0.338 . . . . 8.3 110.087 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.07 87.7 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 116.153 -0.476 . . . . 9.58 113.331 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 p -73.05 -30.18 63.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.053 0.39 . . . . 10.23 112.053 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.48 -19.92 37.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.599 0.714 . . . . 10.43 110.323 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 95.0 mt . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 109.185 -0.672 . . . . 10.97 109.185 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.924 -0.398 . . . . 10.05 109.924 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.08 76.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.435 -0.348 . . . . 11.22 111.8 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -65.47 -40.98 93.81 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.519 0.676 . . . . 11.38 109.659 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -66.22 -36.6 83.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.277 -0.874 . . . . 9.65 112.893 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.68 -38.38 90.14 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 117.921 0.328 . . . . 10.43 110.688 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 t -56.88 -47.72 79.81 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.785 -0.45 . . . . 10.21 109.785 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 178' ' ' VAL . 68.1 mt -68.79 -51.97 39.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.404 -0.591 . . . . 8.13 109.404 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -53.46 -41.38 66.11 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 124.587 1.155 . . . . 8.46 112.126 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 23.8 t70 -63.65 -48.24 78.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.68 0.252 . . . . 10.86 111.68 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.91 -36.06 69.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 11.45 110.413 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.64 -35.99 82.39 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.82 -0.808 . . . . 7.62 108.82 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 25.0 ttpp -61.92 -45.76 92.3 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 11.62 109.472 174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 77.7 mt-30 -56.22 -47.23 78.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.593 -0.73 . . . . 11.63 109.666 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -64.35 -50.98 65.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.111 -0.95 . . . . 9.14 112.124 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.7 pp -65.09 -34.99 79.71 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.326 -0.549 . . . . 10.06 111.869 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -66.38 -47.8 68.11 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 111.072 -0.811 . . . . 12.07 111.072 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.37 -38.81 88.34 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.244 1.018 . . . . 12.32 110.624 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 tp -57.39 -44.05 84.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 11.77 110.102 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 86.9 mt -72.96 -63.24 1.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.522 -0.918 . . . . 13.52 108.522 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -179.27 -47.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.654 1.182 . . . . 16.56 109.978 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -162.67 155.3 19.23 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.777 0.322 . . . . 15.74 110.293 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -125.82 127.3 24.82 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.454 -0.794 . . . . 14.2 110.841 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.32 -2.88 12.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.137 2.558 . . . . 14.18 112.213 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.89 41.42 4.38 Favored Glycine 0 CA--C 1.491 -1.469 0 C-N-CA 120.893 -0.67 . . . . 14.03 111.916 173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -140.34 -72.66 0.36 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.132 -1.027 . . . . 16.37 113.413 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 118' ' ' LEU . 6.2 mp 67.79 141.25 0.03 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.418 1.104 . . . . 12.45 112.044 -166.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -83.04 161.91 21.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.879 -1.156 . . . . 14.43 107.879 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.1 m -78.31 17.49 0.64 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.845 0.683 . . . . 14.32 112.845 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.96 -74.83 0.34 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.663 -1.775 . . . . 13.75 108.663 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 62.07 62.43 1.21 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.998 0.919 . . . . 12.7 111.953 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 9.7 tt0 -80.79 104.67 11.46 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.717 -0.674 . . . . 16.38 110.684 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -66.72 -26.81 67.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.255 1.022 . . . . 13.3 109.945 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.16 -24.37 67.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.434 0.635 . . . . 16.25 110.673 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -97.68 -46.27 6.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.157 0.503 . . . . 15.87 109.782 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.03 -26.07 62.94 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 13.65 112.884 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.02 119.68 6.45 Favored Glycine 0 C--N 1.313 -0.729 0 N-CA-C 111.942 -0.463 . . . . 14.16 111.942 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 86.9 mtp -106.18 -23.23 12.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.307 0.575 . . . . 15.45 110.643 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.51 127.44 19.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.344 0.592 . . . . 13.63 110.305 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.7 t -66.87 -37.49 84.53 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.931 -1.031 . . . . 13.9 110.32 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.89 -40.19 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.468 -0.333 . . . . 13.81 111.135 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.7 p -57.56 -35.29 70.16 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.442 . . . . 11.48 111.515 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.36 -32.11 26.19 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.623 -1.275 . . . . 10.35 112.254 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -68.25 -35.6 78.17 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.428 0.614 . . . . 12.2 110.588 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -63.83 -38.72 92.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.116 -0.493 . . . . 11.86 110.334 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -62.4 -44.22 96.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.75 -0.659 . . . . 9.32 110.22 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.8 mmt -60.23 -36.61 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 9.5 110.323 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' NE ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -67.06 -43.79 81.77 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.946 -0.57 . . . . 13.91 110.426 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.06 71.87 Favored Glycine 0 C--O 1.246 0.873 0 O-C-N 123.692 0.62 . . . . 9.88 112.73 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.34 -33.15 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.45 0.167 . . . . 9.27 110.898 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.4 m -60.58 -47.09 87.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 121.031 0.443 . . . . 11.46 110.124 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -68.83 -50.43 50.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.603 -0.726 . . . . 15.04 111.37 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -66.0 -34.95 79.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.223 0.453 . . . . 11.82 112.223 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.18 5.77 42.81 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.032 -0.667 . . . . 11.97 112.612 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 p 53.16 44.83 29.76 Favored 'General case' 0 C--O 1.247 0.954 0 C-N-CA 124.473 1.109 . . . . 14.24 113.377 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.78 149.07 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.307 -0.861 . . . . 12.62 108.774 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -96.23 95.64 8.25 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.402 -0.962 . . . . 16.39 108.402 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.8 tp -106.12 136.75 45.25 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.943 -0.572 . . . . 12.32 109.7 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.95 134.53 43.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.525 -0.546 . . . . 14.06 109.525 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.5 60.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.734 -0.666 . . . . 12.64 110.763 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.02 -10.85 59.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.436 -0.802 . . . . 15.68 110.573 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 167' ' ' THR . . . -64.61 -11.51 35.76 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.073 -0.512 . . . . 12.72 112.202 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -58.53 -17.61 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 121.445 0.64 . . . . 12.16 111.467 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -93.38 -6.41 47.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.077 -0.51 . . . . 15.08 112.131 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 164' ' ' ALA . 13.9 t -103.05 8.94 38.76 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.327 -0.949 . . . . 14.67 111.14 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -129.93 99.46 20.12 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 108.98 -0.748 . . . . 12.68 108.98 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.3 Cg_endo -67.24 -28.78 39.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.742 1.628 . . . . 14.34 110.906 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 27.8 p -121.96 142.4 50.34 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.812 -0.631 . . . . 12.91 109.493 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.16 -30.56 71.69 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.316 1.046 . . . . 9.89 111.622 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -55.23 -27.03 43.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.127 -0.942 . . . . 12.5 111.91 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.7 m -72.16 -19.89 61.69 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.162 -0.472 . . . . 11.04 112.194 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.7 tp -75.68 -29.84 59.18 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.951 -0.7 . . . . 8.5 109.892 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.26 96.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.807 -0.633 . . . . 7.7 111.196 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -82.16 -25.88 33.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.151 -0.62 . . . . 10.38 110.558 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.38 -48.66 69.44 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.163 -0.472 . . . . 11.97 110.408 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 110' ' ' ILE . 9.0 p -59.56 -39.73 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.861 -0.609 . . . . 9.8 110.141 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.88 -44.59 92.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.528 -0.76 . . . . 10.83 111.234 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -70.92 -28.33 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.124 0.488 . . . . 13.5 111.488 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -79.23 -41.98 27.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.624 -0.431 . . . . 14.84 110.806 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.04 -35.25 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.428 -0.509 . . . . 13.35 111.341 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.37 -0.604 . . . . 13.51 109.37 179.198 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 22.7 t70 . . . . . 0 C--O 1.212 -0.891 0 CA-C-O 120.807 0.337 . . . . 14.98 110.668 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.8 -38.11 70.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.889 -0.507 . . . . 15.79 111.708 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.0 p -65.7 -35.13 79.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.533 -0.867 . . . . 12.02 109.757 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.52 -35.0 79.53 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.055 -0.52 . . . . 11.02 110.477 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 28.5 mt-30 -53.36 -45.56 69.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 123.622 0.576 . . . . 16.07 110.636 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.45 -46.54 88.04 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.849 -0.614 . . . . 13.93 110.473 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.6 -36.35 73.47 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.01 -0.541 . . . . 10.71 111.075 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.62 -46.47 85.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.841 0.857 . . . . 14.02 109.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.92 -44.63 96.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.389 -0.823 . . . . 16.29 110.289 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -69.07 -40.4 78.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.407 -0.815 . . . . 12.91 110.847 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.77 -51.01 71.79 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.505 -0.924 . . . . 12.77 108.505 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -62.38 -39.61 93.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.055 . . . . 15.19 111.662 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.34 88.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.326 -0.397 . . . . 16.26 111.351 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.3 mtt -71.93 -36.62 69.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.789 0.328 . . . . 15.45 111.819 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 81.3 mt -94.73 -2.39 51.18 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.673 -0.411 . . . . 16.16 111.73 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 59.15 36.21 23.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.512 1.125 . . . . 20.56 111.104 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 23.5 p -112.27 164.91 12.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.11 -0.95 . . . . 16.63 108.976 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 52.2 mm-40 -91.28 129.29 43.91 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.091 -0.707 . . . . 20.19 109.091 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.93 -14.35 42.75 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.484 2.789 . . . . 16.6 114.317 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.98 -13.43 69.2 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.855 -0.688 . . . . 17.74 112.659 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 10.6 pt20 -79.56 -20.19 47.63 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.278 0.539 . . . . 20.23 110.472 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 pt -92.94 168.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.688 -1.227 . . . . 15.98 107.688 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -134.6 166.17 23.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 119.191 -0.433 . . . . 19.33 111.053 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 5.6 m-20 -56.5 -51.17 69.52 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.64 0.588 . . . . 14.93 111.167 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.23 6.72 70.5 Favored Glycine 0 C--O 1.244 0.741 0 CA-C-N 115.962 -0.563 . . . . 14.82 113.918 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -76.29 136.84 39.62 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.74 0.781 . . . . 14.54 110.924 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 82.3 mtp180 -77.54 147.08 35.93 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 114.576 -1.193 . . . . 16.75 108.786 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -58.63 -25.45 62.7 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.176 0.806 . . . . 11.99 113.176 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.01 -21.34 59.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.096 -0.502 . . . . 14.45 109.884 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.39 -18.74 18.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.864 0.866 . . . . 16.44 109.006 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 67' ' ' PHE . 87.6 mt -75.14 -21.63 58.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.702 -0.681 . . . . 13.77 109.792 177.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 24.56 8.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.45 -0.796 . . . . 13.81 112.543 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.38 163.54 16.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.924 0.869 . . . . 13.04 112.47 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.35 153.46 51.83 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.039 -1.437 . . . . 15.67 107.31 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -49.43 -55.65 12.36 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 123.741 0.65 . . . . 15.29 112.629 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.55 -44.79 99.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.249 -0.432 . . . . 16.66 110.704 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.78 -37.64 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.246 -0.433 . . . . 14.14 110.574 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.68 85.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 12.0 110.176 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.74 90.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.677 -0.692 . . . . 13.97 110.242 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.16 -42.39 90.63 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.461 0.648 . . . . 15.69 110.887 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.546 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 7.4 t90 -61.64 -55.61 28.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.793 1.637 . . . . 11.69 109.17 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.6 mm -54.32 -39.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.436 0.695 . . . . 11.16 111.583 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 18.4 tpt180 -72.33 -23.32 61.14 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.995 -0.548 . . . . 16.65 111.802 -175.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -86.56 -32.82 20.48 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 120.086 -0.646 . . . . 14.15 109.725 175.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 45' ' ' ILE . 87.9 mt -55.61 -35.8 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.972 0.909 . . . . 10.8 109.05 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.51 ' OD1' ' HD2' ' A' ' 46' ' ' ARG . 14.5 m120 -53.62 -39.77 65.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.836 -1.075 . . . . 12.98 112.411 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -84.86 -43.83 13.77 Favored 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 119.977 -0.689 . . . . 17.52 109.885 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -62.3 -37.05 84.07 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.36 0.874 . . . . 14.87 113.36 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -108.06 7.13 27.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.023 0.749 . . . . 12.2 113.023 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 48.17 52.6 13.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.302 1.441 . . . . 16.71 110.392 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 49' ' ' ASN . 33.1 tp -143.24 137.12 28.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.39 -0.967 . . . . 12.2 108.39 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.61 46.54 1.37 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.579 0.704 . . . . 16.06 109.474 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.1 tt -53.36 128.42 50.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.141 -1.39 . . . . 11.39 110.823 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 2.2 Cg_endo -83.2 147.37 12.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.466 2.11 . . . . 12.6 112.179 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HA ' HG13 ' A' ' 45' ' ' ILE . . . -68.4 -17.74 64.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.924 -1.034 . . . . 12.52 111.87 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.48 -9.27 56.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 14.14 111.915 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.27 -29.31 72.71 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.081 -0.808 . . . . 10.76 111.081 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.4 mt -76.79 -25.92 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 CA-C-O 121.414 0.626 . . . . 11.0 109.384 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -85.66 -14.03 46.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.297 -0.561 . . . . 16.42 111.526 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 t -97.03 -34.5 11.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.586 -0.446 . . . . 13.35 110.075 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -130.38 79.71 71.89 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.871 0.367 . . . . 12.23 110.273 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.8 Cg_endo -89.18 36.72 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.422 2.748 . . . . 13.06 112.813 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.0 t -124.43 127.31 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.397 -1.705 . . . . 12.95 106.397 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 34' ' ' LEU . 68.2 t80 -52.41 -49.16 65.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.807 0.73 . . . . 10.92 112.82 -170.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 17.5 tptm -70.36 -21.33 62.89 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.16 0.505 . . . . 14.32 111.58 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.28 -29.71 24.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.584 0.707 . . . . 10.93 109.875 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 73' ' ' TRP . 59.3 t80 -82.55 -28.12 31.2 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.305 -0.861 . . . . 8.81 111.145 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -68.75 -32.36 72.08 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.16 0.505 . . . . 9.35 110.083 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 68' ' ' LYS . 11.2 mm100 -72.23 -29.45 63.95 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 109.24 -0.652 . . . . 11.63 109.24 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.644 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 3.1 t90 -57.99 -53.87 53.33 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.351 -0.981 . . . . 10.55 108.351 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.52 -39.75 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 C-N-CA 124.153 0.981 . . . . 8.3 110.877 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.1 95.11 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.246 -0.433 . . . . 9.58 112.808 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -76.1 -13.42 60.21 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 122.55 -0.382 . . . . 10.23 111.081 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 75.5 mm-40 -83.64 -18.8 36.89 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.638 -0.875 . . . . 10.43 108.638 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.313 -1.01 0 N-CA-C 108.331 -0.989 . . . . 10.97 108.331 177.178 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.218 -0.578 0 N-CA-C 112.772 0.656 . . . . 10.05 112.772 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.09 -38.86 62.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.599 0.962 . . . . 11.22 113.599 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.01 -41.72 86.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.441 0.638 . . . . 11.38 110.81 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 107' ' ' ARG . 3.5 mpt_? -83.39 -33.71 25.72 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.781 -0.645 . . . . 9.65 110.957 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.155 0.982 . . . . 10.43 110.386 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -60.53 -47.57 85.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.957 -0.565 . . . . 10.21 110.096 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 178' ' ' VAL . 67.1 mt -61.2 -45.53 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.096 -0.705 . . . . 8.13 109.096 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.07 -35.12 68.98 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 114.83 -1.077 . . . . 8.46 111.048 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.87 -37.78 85.81 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.04 0.448 . . . . 10.86 111.47 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -76.37 -44.29 37.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.853 -0.795 . . . . 11.45 108.853 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.8 -41.02 85.77 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.747 -1.115 . . . . 7.62 109.774 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.58 -42.09 74.28 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.318 1.447 . . . . 11.62 110.174 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -81.56 -33.97 31.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 11.63 111.981 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 80.8 p -61.05 -43.92 98.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 121.01 -0.276 . . . . 9.14 111.153 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.2 pp -75.34 -31.69 60.65 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.531 -0.468 . . . . 10.06 110.659 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -58.4 -54.94 33.63 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.187 -0.461 . . . . 12.07 111.972 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -60.43 -43.46 96.76 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.825 0.822 . . . . 12.32 110.702 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.59 -45.12 72.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.514 -1.221 . . . . 11.77 111.922 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.1 mt -91.14 -15.33 29.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.341 0.497 . . . . 13.52 112.341 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.1 t80 66.38 33.97 6.63 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.247 -1.39 . . . . 16.56 107.247 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.38 148.73 35.22 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.766 -1.561 . . . . 15.74 108.47 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 12.8 m-20 -67.98 119.91 70.3 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.394 -0.595 . . . . 14.2 109.394 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 16.8 Cg_exo -70.82 32.25 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.858 3.039 . . . . 14.18 114.387 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.13 3.52 9.72 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 108.725 -1.75 . . . . 14.03 108.725 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -106.18 40.59 1.57 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.231 -1.026 . . . . 16.37 108.231 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.88 48.72 0.39 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.612 -1.176 . . . . 12.45 113.168 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -161.51 -44.15 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 125.429 1.492 . . . . 14.43 107.911 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -64.73 -45.42 86.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.265 -0.879 . . . . 14.32 109.023 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.88 30.47 10.35 Favored Glycine 0 C--O 1.214 -1.105 0 CA-C-N 115.387 -0.824 . . . . 13.75 111.047 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB1' ' HG3' ' A' ' 172' ' ' LYS . . . -92.75 -17.99 23.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.487 0.66 . . . . 12.7 109.857 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -87.71 113.63 23.56 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.99 -1.115 . . . . 16.38 107.99 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -64.46 -16.2 62.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.214 0.53 . . . . 13.3 112.218 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.98 -24.51 55.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.118 -0.492 . . . . 16.25 110.618 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -78.22 -27.75 47.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.412 0.625 . . . . 15.87 109.81 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.19 -20.89 66.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.469 -1.241 . . . . 13.65 111.956 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.52 -53.77 4.89 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.843 -0.903 . . . . 14.16 110.843 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.2 mtm -98.1 146.95 25.05 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.305 -1.369 . . . . 15.45 107.305 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -137.39 -68.2 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.776 1.028 . . . . 13.63 113.776 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 t -70.9 -40.19 72.31 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.033 0.382 . . . . 13.9 112.033 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.1 -50.95 53.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.536 0.684 . . . . 13.81 109.733 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -37.97 83.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.036 -0.984 . . . . 11.48 111.143 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.6 98.44 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.653 -0.703 . . . . 10.35 111.522 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.8 m -56.84 -53.26 59.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.682 0.393 . . . . 12.2 110.115 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -64.84 -38.45 91.04 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.316 -0.402 . . . . 11.86 111.894 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.0 t90 -67.56 -50.9 56.33 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.348 -0.612 . . . . 9.32 109.348 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 mmt -67.63 -26.18 66.11 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.456 -0.793 . . . . 9.5 111.435 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 26.5 tpt180 -62.92 -43.93 97.47 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.405 -0.961 . . . . 13.91 108.405 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.82 91.24 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.144 -0.782 . . . . 9.88 111.144 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 148' ' ' TRP . 97.4 t -61.09 -40.86 87.15 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.465 -0.568 . . . . 9.27 109.465 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' SER . 39.6 m -66.08 -30.13 70.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.751 -0.659 . . . . 11.46 110.821 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 37.6 mmt180 -67.19 -47.74 70.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.56 -0.533 . . . . 15.04 109.56 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -71.53 -55.34 8.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.235 0.828 . . . . 11.82 113.235 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -105.27 -8.35 18.34 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 114.068 1.136 . . . . 11.97 114.068 -170.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 153' ' ' SER . 28.0 m 55.58 38.88 30.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.91 0.884 . . . . 14.24 112.326 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.9 pt -104.23 144.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.333 -0.617 . . . . 12.62 109.333 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -81.98 95.36 7.37 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 123.522 0.514 . . . . 16.39 111.696 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.29 102.39 6.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.577 -0.897 . . . . 12.32 108.577 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.43 175.68 10.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 121.174 -0.21 . . . . 14.06 111.054 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.37 80.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.445 0.641 . . . . 12.64 110.935 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.84 -10.2 45.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.19 -0.914 . . . . 15.68 112.848 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 -13.64 62.33 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 111.675 0.25 . . . . 12.72 111.675 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -66.65 -18.24 23.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 O-C-N 122.107 -0.371 . . . . 12.16 111.729 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -94.02 1.76 56.17 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.933 0.873 . . . . 15.08 110.194 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.5 m -89.32 -9.55 50.1 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.061 -0.972 . . . . 14.67 108.402 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -130.93 149.04 72.58 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.36 -0.978 . . . . 12.68 108.36 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.85 -38.41 2.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.622 2.215 . . . . 14.34 112.317 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.2 p -138.16 162.15 34.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.319 -1.734 . . . . 12.91 106.319 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.17 -1.25 19.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.024 0.44 . . . . 9.89 112.118 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 133' ' ' ALA . 30.0 mtpp -76.24 -24.34 54.57 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.179 -0.674 . . . . 12.5 109.179 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.2 m -73.88 -2.65 24.69 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.254 -0.885 . . . . 11.04 111.06 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.33 -32.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.464 -0.569 . . . . 8.5 109.464 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.36 68.9 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.299 0.571 . . . . 7.7 111.22 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.37 -24.69 34.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.411 -0.588 . . . . 10.38 109.411 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.63 -60.97 2.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.66 -0.7 . . . . 11.97 110.05 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -46.14 -52.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 124.053 0.845 . . . . 9.8 113.199 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.428 ' CG ' ' HE ' ' A' ' 107' ' ' ARG . 20.2 t70 -61.91 -45.38 93.98 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 111.897 0.332 . . . . 10.83 111.897 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -78.27 -29.76 48.15 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.463 -0.789 . . . . 13.5 110.448 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.25 -39.61 74.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.633 -0.712 . . . . 14.84 109.391 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.0 t -78.39 -60.55 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.692 -0.685 . . . . 13.35 111.658 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 108.664 -0.865 . . . . 13.51 108.664 -173.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 112.058 0.392 . . . . 14.98 112.058 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.89 -27.24 65.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.272 0.558 . . . . 15.79 110.206 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.8 -33.46 75.66 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.459 -0.571 . . . . 12.02 109.459 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 -26.68 32.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.157 -0.474 . . . . 11.02 110.543 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -67.47 -33.97 76.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.175 -0.676 . . . . 16.07 109.175 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -68.5 -28.97 67.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.505 -0.771 . . . . 13.93 109.749 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.81 -44.4 96.25 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.379 -0.6 . . . . 10.71 109.379 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.922 -0.581 . . . . 14.02 109.492 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.75 -46.1 73.07 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.495 -0.775 . . . . 16.29 110.131 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' MET . 48.4 t -59.34 -45.59 90.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.573 -0.74 . . . . 12.91 110.365 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.48 -45.44 93.75 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.273 -0.422 . . . . 12.77 111.449 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.53 -22.95 63.53 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.253 -0.43 . . . . 15.19 111.574 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 -24.36 49.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.426 0.631 . . . . 16.26 109.628 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 13' ' ' SER . 26.5 mmt -78.05 -44.22 27.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.619 -0.719 . . . . 15.45 109.197 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.67 5.49 51.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 16.16 112.607 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 53.41 45.61 27.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.237 1.415 . . . . 20.56 113.107 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -125.33 -173.8 2.91 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.345 -0.983 . . . . 16.63 108.345 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -107.32 134.99 19.72 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 107.976 -1.12 . . . . 20.19 107.976 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -66.04 -11.17 29.93 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.233 2.622 . . . . 16.6 112.859 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.78 -3.41 85.91 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.527 -0.629 . . . . 17.74 111.527 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -102.75 175.41 5.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.677 -1.231 . . . . 20.23 107.677 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.485 HG12 ' HG ' ' A' ' 34' ' ' LEU . 1.9 mp 70.96 140.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 123.883 0.739 . . . . 15.98 110.725 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 6.8 mpt_? -75.25 122.77 24.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.738 -0.601 . . . . 19.33 109.577 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.675 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 p30 -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.83 0.678 . . . . 14.93 112.83 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.37 7.4 68.88 Favored Glycine 0 C--N 1.315 -0.614 0 N-CA-C 110.649 -0.98 . . . . 14.82 110.649 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 26' ' ' ARG . 23.3 t -99.19 171.34 8.06 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.48 0.657 . . . . 14.54 109.54 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 81.8 mtm180 -92.93 160.3 14.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.163 -0.926 . . . . 16.75 110.38 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -58.26 -18.98 30.66 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.595 -1.184 . . . . 11.99 112.423 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -29.38 70.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.965 -0.561 . . . . 14.45 111.609 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.33 -35.45 80.38 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.361 0.6 . . . . 16.44 109.814 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' A' ' 25' ' ' ILE . 4.1 mp -83.43 -8.92 59.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.772 -0.649 . . . . 13.77 110.248 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.78 35.26 73.08 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 114.83 -1.077 . . . . 13.81 111.373 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.04 114.05 8.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.623 -0.51 . . . . 13.04 109.623 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.22 156.34 23.21 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.481 -0.781 . . . . 15.67 109.784 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 t -56.22 -41.47 75.71 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.271 0.357 . . . . 15.29 111.45 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.23 -47.62 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.912 0.387 . . . . 16.66 110.985 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mt -66.03 -39.68 85.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.026 -0.534 . . . . 14.14 109.683 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.62 99.11 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.588 -0.733 . . . . 12.0 110.444 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.48 85.06 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.564 0.745 . . . . 13.97 111.093 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.84 -47.61 44.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.96 -0.564 . . . . 15.69 111.56 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -61.31 -47.28 86.68 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.088 0.555 . . . . 11.69 111.644 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 48' ' ' ILE . 10.5 tp -59.69 -32.94 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 120.892 0.377 . . . . 11.16 110.571 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -66.86 -32.28 73.45 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.053 -0.522 . . . . 16.65 110.521 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.59 -31.97 60.16 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.564 -0.902 . . . . 14.15 108.564 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 45' ' ' ILE . 70.4 mt -62.49 -35.12 68.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.566 -0.743 . . . . 10.8 109.783 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.93 -31.04 70.58 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.475 -0.784 . . . . 12.98 110.042 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -43.95 20.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.934 -0.575 . . . . 17.52 110.047 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -65.11 -46.3 81.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.65 0.611 . . . . 14.87 112.65 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 55.6 m-85 -100.17 -0.03 39.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 112.787 0.662 . . . . 12.2 112.787 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 53.12 45.17 29.24 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.403 1.481 . . . . 16.71 111.702 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 96.0 mt -134.32 142.87 47.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.579 -1.191 . . . . 12.2 109.485 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -77.51 75.69 4.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.72 -0.844 . . . . 16.06 108.72 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 25.0 mm -94.18 119.95 66.06 Favored Pre-proline 0 N--CA 1.436 -1.135 0 CA-C-N 116.292 -0.413 . . . . 11.39 111.814 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -84.15 164.21 13.24 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.869 2.38 . . . . 12.6 110.112 173.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -2.92 17.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.634 -0.712 . . . . 12.52 112.518 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 p30 -68.3 -23.6 64.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.936 -0.306 . . . . 14.14 110.957 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.06 -30.62 70.66 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 119.883 -1.151 . . . . 10.76 111.588 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.94 -21.15 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.723 0.809 . . . . 11.0 110.036 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 16.7 m-85 -85.33 -45.86 11.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.384 -0.598 . . . . 16.42 109.384 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -67.54 -44.6 77.94 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.929 -0.578 . . . . 13.35 110.127 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.05 86.72 14.15 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.873 -0.788 . . . . 12.23 108.873 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 84.1 Cg_endo -83.9 14.87 2.28 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.751 2.301 . . . . 13.06 113.275 -174.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.8 t -124.56 120.29 58.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.118 -1.808 . . . . 12.95 106.118 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.5 p90 -58.72 -31.6 68.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 10.92 114.313 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -69.36 -24.98 63.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.766 0.654 . . . . 14.32 112.766 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.78 16.97 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.644 -0.873 . . . . 10.93 108.644 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 57.2 t80 -62.15 -28.91 69.98 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.748 -1.114 . . . . 8.81 112.262 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 p -70.0 -26.45 64.08 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.471 -0.768 . . . . 9.35 110.716 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -81.44 -28.94 33.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.746 -0.835 . . . . 11.63 108.746 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.502 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 66.1 t90 -58.26 -52.27 66.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.476 1.111 . . . . 10.55 108.094 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 54.4 t -67.88 -39.9 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 CA-C-N 115.266 -0.879 . . . . 8.3 110.781 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.73 97.07 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.192 -0.528 . . . . 9.58 112.3 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.2 m -67.99 -35.97 79.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 111.786 0.291 . . . . 10.23 111.786 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 27.6 pt20 -75.78 -18.77 59.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.363 -0.535 . . . . 10.43 110.517 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 116.141 -0.481 . . . . 10.97 111.039 176.799 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 C--O 1.243 0.742 0 N-CA-C 112.922 0.712 . . . . 10.05 112.922 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -42.03 80.88 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.414 0.524 . . . . 11.22 112.414 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -51.72 -48.4 63.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.405 0.682 . . . . 11.38 111.573 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -68.92 -42.82 76.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 9.65 109.951 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.32 -44.48 83.25 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.989 -1.005 . . . . 10.43 111.766 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -59.84 -39.09 83.98 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.639 0.257 . . . . 10.21 111.038 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.66 HG21 HG11 ' A' ' 178' ' ' VAL . 59.7 mt -71.29 -50.95 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.921 -0.4 . . . . 8.13 109.921 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -58.84 -39.94 82.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.109 -0.496 . . . . 8.46 111.139 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 31.0 t70 -67.73 -36.98 81.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 10.86 111.007 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -70.05 -42.55 72.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.316 0.579 . . . . 11.45 109.782 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.6 -41.49 94.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.534 1.134 . . . . 7.62 109.033 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 33.9 ttmt -54.47 -54.3 42.74 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.559 1.544 . . . . 11.62 110.254 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -67.34 -42.75 83.04 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.916 -0.583 . . . . 11.63 111.908 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.4 t -56.75 -53.09 61.73 Favored 'General case' 0 C--O 1.248 1.021 0 O-C-N 123.574 0.546 . . . . 9.14 111.79 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.36 -36.77 74.39 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 120.676 -0.409 . . . . 10.06 110.912 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.7 84.95 Favored Glycine 0 C--O 1.223 -0.546 0 N-CA-C 111.24 -0.744 . . . . 12.07 111.24 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 -44.4 91.52 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 124.423 1.089 . . . . 12.32 110.804 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 148' ' ' TRP . 17.6 tp -66.0 -49.6 67.23 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.96 -1.018 . . . . 11.77 112.145 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 tp -94.02 4.23 54.21 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.703 -0.681 . . . . 13.52 112.358 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.1 t80 59.78 40.65 19.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.197 1.399 . . . . 16.56 110.187 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -111.49 154.86 24.12 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.78 -1.563 . . . . 15.74 106.78 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.8 117.94 63.88 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 107.577 -1.268 . . . . 14.2 107.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.57 107.89 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.921 3.081 . . . . 14.18 113.033 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 130' ' ' ARG . . . 125.46 -36.31 2.82 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.505 -1.225 . . . . 14.03 111.651 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -86.31 42.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.38 1.086 . . . . 16.37 109.366 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.65 -7.07 1.69 Allowed 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.584 -1.644 . . . . 12.45 111.199 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 127' ' ' GLY . 38.5 ptt180 -95.91 -5.95 40.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.94 -0.573 . . . . 14.43 110.081 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -70.22 -33.95 72.29 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 14.32 108.797 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.41 -62.67 0.95 Allowed Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 108.84 -1.704 . . . . 13.75 108.84 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 138' ' ' LEU . . . 60.07 26.81 16.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.367 1.067 . . . . 12.7 110.992 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -97.68 139.89 32.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.308 -1.315 . . . . 16.38 109.662 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 14.5 p90 -70.19 -12.88 61.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.276 -0.875 . . . . 13.3 109.43 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.65 -32.12 62.16 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.272 -0.876 . . . . 16.25 110.342 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.17 -42.39 6.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.429 0.633 . . . . 15.87 110.852 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 133' ' ' ALA . 70.5 mt -79.66 -22.35 43.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.589 -0.732 . . . . 13.65 110.465 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -102.72 43.79 1.62 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.954 -1.259 . . . . 14.16 109.954 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.7 ttp -60.29 -43.41 96.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.655 0.782 . . . . 15.45 110.551 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -127.34 120.21 28.02 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 107.479 -1.304 . . . . 13.63 107.479 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -62.06 -39.33 92.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.877 -1.056 . . . . 13.9 111.972 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.7 t -68.76 -36.83 76.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 110.146 -0.316 . . . . 13.81 110.146 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.5 m -56.9 -46.61 81.8 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.194 -0.457 . . . . 11.48 109.776 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.96 -22.52 76.67 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 119.677 -1.249 . . . . 10.35 111.87 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.419 ' HA ' ' HB1' ' A' ' 162' ' ' ALA . 92.5 m -63.81 -48.89 75.05 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.64 -0.504 . . . . 12.2 109.64 176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -59.6 -40.24 86.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.57 0.7 . . . . 11.86 110.227 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.484 ' HB2' HD22 ' A' ' 121' ' ' LEU . 22.4 t90 -68.5 -53.03 25.89 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.927 -1.033 . . . . 9.32 112.318 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 32.7 ttm -65.96 -35.06 79.56 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 111.915 0.339 . . . . 9.5 111.915 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -66.4 -35.95 81.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.528 . . . . 13.91 109.576 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.06 -43.54 97.14 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.628 -0.989 . . . . 9.88 110.628 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' TRP . 75.9 t -56.55 -45.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.607 0.763 . . . . 9.27 109.253 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.2 m -59.51 -40.15 86.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.377 -0.828 . . . . 11.46 110.994 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -70.72 -46.96 62.1 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.478 -0.328 . . . . 15.04 111.591 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -68.22 -30.61 69.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.293 0.849 . . . . 11.82 113.293 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -101.56 0.16 35.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.075 -0.65 . . . . 11.97 112.123 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.8 m 56.42 45.94 21.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.638 -1.164 . . . . 14.24 112.308 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.5 156.15 41.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 12.62 109.047 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -88.8 106.58 18.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.221 -1.029 . . . . 16.39 108.221 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.41 110.3 11.38 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.782 -0.451 . . . . 12.32 109.782 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.28 135.92 47.67 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.944 -0.571 . . . . 14.06 110.469 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 146' ' ' THR . . . -63.46 -8.61 9.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.416 1.086 . . . . 12.64 112.834 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -77.42 -10.75 59.65 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.386 -0.598 . . . . 15.68 109.386 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.452 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -63.7 -13.13 40.35 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 116.102 -0.499 . . . . 12.72 112.256 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.8 pt -68.64 -12.32 15.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 121.166 0.508 . . . . 12.16 109.937 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.59 19.32 13.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.548 -0.908 . . . . 15.08 108.548 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 88.8 m -108.24 -26.55 10.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.187 -0.915 . . . . 14.67 109.679 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -122.75 143.67 40.76 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 107.978 -1.119 . . . . 12.68 107.978 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.572 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 68.8 Cg_endo -93.02 -5.73 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.902 1.735 . . . . 14.34 111.897 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.756 -0.656 . . . . 12.91 111.134 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.94 -32.92 71.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.904 -1.043 . . . . 9.89 111.988 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -62.71 -20.36 64.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.172 -0.467 . . . . 12.5 111.187 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.8 m -70.88 -17.65 62.71 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.102 -0.499 . . . . 11.04 111.024 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.72 -44.94 61.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.892 -1.151 . . . . 8.5 107.892 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.02 80.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.471 -0.786 . . . . 7.7 111.39 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.99 -19.75 60.55 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.318 0.488 . . . . 10.38 112.318 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -74.75 -52.61 11.05 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.331 -0.618 . . . . 11.97 109.331 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 110' ' ' ILE . 3.3 p -62.46 -42.64 96.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.578 -0.737 . . . . 9.8 110.497 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.43 -41.87 90.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.401 . . . . 10.83 110.655 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -69.07 -53.24 21.43 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.74 0.816 . . . . 13.5 113.071 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -85.01 -32.47 22.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 115.187 1.551 . . . . 14.84 115.187 -173.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.87 -40.75 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.817 -0.753 . . . . 13.35 110.213 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 120.44 -0.504 . . . . 13.51 110.255 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 C--O 1.223 -0.29 0 CA-C-O 121.051 0.453 . . . . 14.98 110.008 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' HA ' HE21 ' A' ' 8' ' ' GLN . 42.9 tt0 -65.92 -37.85 87.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 120.842 0.353 . . . . 15.79 111.295 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 p -63.82 -32.15 73.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.069 0.461 . . . . 12.02 111.016 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -75.14 -40.85 59.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.254 -0.43 . . . . 11.02 109.843 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 5' ' ' GLU . 50.8 mt-30 -54.47 -43.91 72.13 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.8 0.44 . . . . 16.07 110.616 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.1 -41.41 78.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.771 -0.649 . . . . 13.93 111.006 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.32 -36.29 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.365 -0.38 . . . . 10.71 110.753 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 68.0 mtt180 -60.57 -45.64 93.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.763 -0.829 . . . . 14.02 108.763 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 27.9 mt-30 -59.92 -53.83 53.22 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.558 -0.747 . . . . 16.29 110.244 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 m -56.71 -42.85 79.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.123 -0.944 . . . . 12.91 112.681 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.83 -52.15 22.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.455 0.169 . . . . 12.77 110.687 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.71 71.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.39 0.515 . . . . 15.19 112.39 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.32 84.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.656 0.265 . . . . 16.26 111.544 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.3 mtt -75.81 -32.24 59.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.291 0.567 . . . . 15.45 110.893 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.62 -2.36 41.74 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.877 -0.601 . . . . 16.16 112.199 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 57.54 44.05 21.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.548 1.139 . . . . 20.56 111.589 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.57 177.0 4.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.134 -1.061 . . . . 16.63 108.134 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -96.76 133.72 24.09 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 110.47 -0.196 . . . . 20.19 110.47 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.77 20.66 1.19 Allowed 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 122.89 2.394 . . . . 16.6 111.484 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.16 -104.45 1.2 Allowed Glycine 0 N--CA 1.428 -1.89 0 CA-C-N 114.899 -1.046 . . . . 17.74 113.245 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.42 67.63 9.97 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.299 0.852 . . . . 20.23 113.299 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 pt -90.65 163.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.266 -1.012 . . . . 15.98 108.266 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 62.0 mtm180 -81.33 132.54 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.382 0.611 . . . . 19.33 109.569 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.01 -39.15 59.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.245 1.818 . . . . 14.93 112.475 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.32 7.48 66.46 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.8 -0.636 . . . . 14.82 114.182 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 74.8 m -68.2 119.16 12.32 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.815 0.817 . . . . 14.54 112.302 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 89.6 mtt180 -70.53 157.92 37.03 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.911 -1.495 . . . . 16.75 110.562 176.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -52.27 -48.6 65.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.951 0.405 . . . . 11.99 111.648 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.27 -41.31 84.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.534 0.734 . . . . 14.45 110.584 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HH21 ' A' ' 26' ' ' ARG . 6.3 tp10 -65.66 -45.14 84.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.854 -0.612 . . . . 16.44 110.463 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.4 -35.58 74.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.984 -0.553 . . . . 13.77 110.925 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.73 22.06 1.33 Allowed Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.194 -1.003 . . . . 13.81 112.983 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 167.18 20.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.533 0.682 . . . . 13.04 110.681 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -131.41 152.24 50.83 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 117.403 -1.284 . . . . 15.67 107.57 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -55.98 -40.32 73.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 119.495 1.043 . . . . 15.29 111.923 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.21 -51.11 51.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.732 -0.667 . . . . 16.66 110.405 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.64 -35.6 73.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.923 -0.581 . . . . 14.14 112.226 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.97 -30.09 70.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 12.0 110.336 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.47 78.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.512 -0.767 . . . . 13.97 110.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.54 -43.22 66.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 120.473 -0.491 . . . . 15.69 109.762 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -55.76 -54.67 41.62 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.605 -1.18 . . . . 11.69 110.823 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 56' ' ' ILE . 10.8 tp -62.51 -31.69 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.804 0.335 . . . . 11.16 110.882 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.53 -35.25 75.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.386 0.612 . . . . 16.65 109.509 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -70.21 -21.79 62.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.018 -0.537 . . . . 14.15 112.169 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.9 -46.21 92.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.6 -0.889 . . . . 10.8 108.6 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -62.58 -34.59 77.28 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.321 -0.854 . . . . 12.98 110.952 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -79.12 -39.88 32.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.289 -0.414 . . . . 17.52 110.957 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -79.46 -28.09 41.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.404 -0.362 . . . . 14.87 111.962 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -107.88 -4.84 17.61 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.439 1.274 . . . . 12.2 114.439 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 44.32 47.64 7.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.863 1.665 . . . . 16.71 112.854 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.0 tp -145.33 151.8 38.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.901 -1.148 . . . . 12.2 107.901 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.86 129.41 34.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.911 -0.774 . . . . 16.06 108.911 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 HD11 ' A' ' 45' ' ' ILE . 2.3 pp -124.97 153.52 71.12 Favored Pre-proline 0 N--CA 1.42 -1.957 0 C-N-CA 122.76 0.424 . . . . 11.39 110.14 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.18 96.35 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.954 1.769 . . . . 12.6 110.983 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.77 66.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.454 0.645 . . . . 12.52 109.849 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.08 -7.99 14.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 114.632 -1.167 . . . . 14.14 111.735 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.7 -35.49 89.87 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 116.017 -0.538 . . . . 10.76 112.184 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -73.68 -28.6 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.973 0.892 . . . . 11.0 109.445 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -85.24 -3.09 58.7 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.184 -0.916 . . . . 16.42 112.197 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -111.04 -73.23 0.69 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 116.356 -0.384 . . . . 13.35 110.705 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -136.82 88.51 18.56 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 122.199 1.0 . . . . 12.23 110.106 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.1 Cg_endo -80.91 62.41 8.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.828 3.019 . . . . 13.06 114.063 -172.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.71 129.56 43.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.709 -1.96 . . . . 12.95 105.709 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.37 -37.82 74.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.353 -0.385 . . . . 10.92 111.723 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.33 -31.94 72.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.458 0.647 . . . . 14.32 110.215 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.2 45.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.461 0.648 . . . . 10.93 109.5 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' TRP . 58.1 t80 -72.44 -32.65 66.48 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.499 -0.773 . . . . 8.81 111.364 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -65.2 -23.78 67.18 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.008 -0.677 . . . . 9.35 111.017 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -78.13 -33.73 50.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.23 -0.655 . . . . 11.63 109.23 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -50.2 -59.55 3.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.058 . . . . 10.55 110.411 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.58 -34.48 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 CA-C-N 115.742 -0.663 . . . . 8.3 110.666 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.43 -38.24 93.2 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 116.068 -0.514 . . . . 9.58 113.234 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -81.17 -20.46 41.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.226 0.536 . . . . 10.23 110.12 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 14.5 mm100 -76.8 -23.37 52.83 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.362 0.601 . . . . 10.43 109.906 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 122.129 0.966 . . . . 10.97 109.385 175.642 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 107' ' ' ARG . 9.9 p . . . . . 0 N--CA 1.414 -2.261 0 N-CA-C 108.256 -1.016 . . . . 10.05 108.256 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.61 -56.77 17.57 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.204 -0.907 . . . . 11.22 112.867 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 110' ' ' ILE . 31.3 mm-40 -59.04 -41.66 88.39 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.409 0.623 . . . . 11.38 110.562 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 37.3 ttt180 -66.24 -36.89 84.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.043 -0.981 . . . . 9.65 111.565 -176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.57 -34.51 70.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.877 -0.729 . . . . 10.43 110.851 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 m -62.28 -41.58 98.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.78 -0.822 . . . . 10.21 108.78 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 51.7 mt -56.68 -44.52 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.165 -0.925 . . . . 8.13 110.932 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 107' ' ' ARG . 15.1 mm100 -53.97 -30.74 48.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.45 0.7 . . . . 8.46 112.431 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -71.14 -46.75 60.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.468 0.652 . . . . 10.86 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 96.0 m-85 -74.79 -27.42 60.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.33 0.586 . . . . 11.45 110.258 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -66.03 -42.3 89.8 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.26 -1.015 . . . . 7.62 108.26 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -60.95 -42.18 97.73 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.001 -0.999 . . . . 11.62 109.78 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.89 -20.01 65.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 11.63 112.382 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.4 m -82.63 -46.02 13.79 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.22 -0.659 . . . . 9.14 109.22 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 59.9 tp -63.13 -41.76 99.38 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.554 0.692 . . . . 10.06 109.633 175.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.82 -49.66 76.16 Favored Glycine 0 C--O 1.2 -2.0 0 CA-C-N 114.935 -1.029 . . . . 12.07 112.454 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -63.48 -28.7 70.14 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.004 0.43 . . . . 12.32 111.094 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 147' ' ' GLN . 26.3 tp -61.3 -42.01 97.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.68 -0.691 . . . . 11.77 110.713 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.13 -76.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.128 -0.693 . . . . 13.52 109.128 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -173.7 -46.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.103 2.561 . . . . 16.56 106.662 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.5 tp -168.21 148.7 4.87 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.252 -2.129 . . . . 15.74 105.252 175.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 0.9 OUTLIER -95.82 136.07 22.51 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.29 -1.374 . . . . 14.2 107.29 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 2.7 Cg_endo -86.54 29.86 0.5 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.239 1.959 . . . . 14.18 112.929 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.78 57.61 0.78 Allowed Glycine 0 C--N 1.309 -0.924 0 N-CA-C 110.376 -1.089 . . . . 14.03 110.376 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.58 -18.27 20.72 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.526 0.679 . . . . 16.37 110.689 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.8 113.97 5.99 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.097 -0.956 . . . . 12.45 110.538 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 75.84 10.26 3.3 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.261 . . . . 14.43 112.247 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.3 m -103.66 25.89 9.21 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.68 0.752 . . . . 14.32 110.019 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.39 88.78 1.98 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.68 -0.771 . . . . 13.75 111.99 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.58 95.58 4.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.946 -0.761 . . . . 12.7 108.946 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -118.37 146.69 44.2 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.658 0.742 . . . . 16.38 111.305 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -62.14 -14.63 39.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.819 1.248 . . . . 13.3 112.396 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -69.15 -33.1 72.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.372 0.606 . . . . 16.25 109.905 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.51 -44.74 5.77 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.416 -0.811 . . . . 15.87 110.372 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.06 -23.21 64.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.993 -0.549 . . . . 13.65 111.2 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.06 16.15 30.43 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.557 -0.747 . . . . 14.16 111.626 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.7 ttm -77.85 -24.09 48.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.74 -1.207 . . . . 15.45 107.74 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.08 139.91 52.25 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.669 -1.975 . . . . 13.63 105.669 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.9 m -80.78 -22.73 39.87 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.435 -0.95 . . . . 13.9 108.435 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.878 1.271 . . . . 13.81 111.976 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.37 88.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.882 -0.599 . . . . 11.48 111.572 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.8 44.26 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.782 -0.723 . . . . 10.35 111.354 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.6 m -53.28 -50.87 63.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.346 0.658 . . . . 12.2 110.938 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 121' ' ' LEU . 46.9 mt-30 -76.49 -34.37 58.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.404 0.89 . . . . 11.86 113.404 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -69.9 -52.42 24.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.398 -0.521 . . . . 9.32 109.614 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.494 ' SD ' ' HA ' ' A' ' 165' ' ' ILE . 33.1 ttm -69.66 -31.62 69.8 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.345 0.498 . . . . 9.5 112.345 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -64.57 -35.0 79.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.45 -0.574 . . . . 13.91 109.45 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.71 85.79 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.218 -1.153 . . . . 9.88 110.218 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 158' ' ' ILE . 85.2 t -58.05 -49.76 80.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 123.748 0.819 . . . . 9.27 110.036 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.3 t -55.98 -49.55 73.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.813 0.845 . . . . 11.46 110.681 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -66.04 -49.6 67.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.754 0.279 . . . . 15.04 111.754 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -63.06 -34.59 77.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.302 0.853 . . . . 11.82 113.302 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.441 ' CZ ' HG23 ' A' ' 110' ' ' ILE . 88.5 m-85 -101.06 -3.76 28.67 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.952 0.723 . . . . 11.97 112.952 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t 63.63 34.41 12.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.826 0.85 . . . . 14.24 109.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 152' ' ' VAL . 33.5 pt -107.47 155.66 8.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.635 -0.711 . . . . 12.62 109.492 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -99.42 96.75 7.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.791 0.329 . . . . 16.39 111.87 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -124.73 118.59 26.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -108.0 168.4 9.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.423 0.63 . . . . 14.06 111.154 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.13 -6.78 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.505 1.522 . . . . 12.64 114.751 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.91 -23.46 17.43 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.516 -0.474 . . . . 15.68 109.948 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.27 0.52 31.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.786 0.803 . . . . 12.72 109.473 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.494 ' HA ' ' SD ' ' A' ' 149' ' ' MET . 5.9 tt -75.11 -14.41 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.899 -1.046 . . . . 12.16 110.46 -172.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -106.4 6.37 30.32 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.224 -0.898 . . . . 15.08 109.46 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.2 m -87.09 -32.11 20.11 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.796 -0.638 . . . . 14.67 110.092 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.45 74.19 77.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.22 -0.659 . . . . 12.68 109.22 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -94.4 37.22 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.837 2.358 . . . . 14.34 112.115 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 p -140.77 163.2 33.56 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 12.91 109.788 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 49.2 tp -67.21 -55.38 14.3 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.916 0.389 . . . . 9.89 110.518 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -61.27 -44.56 97.03 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.409 -0.814 . . . . 12.5 112.856 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -68.24 -30.66 69.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.754 0.252 . . . . 11.04 110.696 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.59 -45.83 61.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.438 -1.319 . . . . 8.5 107.438 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.87 99.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.605 -0.725 . . . . 7.7 111.243 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 7.0 m-20 -62.94 -33.63 75.76 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.68 0.276 . . . . 10.38 110.679 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 24.7 tp10 -69.22 -57.05 5.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.973 -0.558 . . . . 11.97 110.528 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.431 HG22 HD13 ' A' ' 110' ' ' ILE . 7.0 p -59.93 -36.67 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.136 -0.483 . . . . 9.8 111.518 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.93 -38.36 82.16 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.1 0.476 . . . . 10.83 111.19 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 26.6 mmm180 -77.87 -33.26 52.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 13.5 111.481 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 9.7 mmp_? -73.25 -44.5 59.31 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.745 -0.382 . . . . 14.84 111.555 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.18 -51.73 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.22 0.325 . . . . 13.35 111.761 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.395 -0.812 . . . . 13.51 111.284 -177.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 121.219 0.533 . . . . 14.98 109.932 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.09 -35.44 47.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.901 0.704 . . . . 15.79 112.901 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.74 -43.27 99.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.138 0.495 . . . . 12.02 111.046 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.55 81.78 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.099 -0.501 . . . . 11.02 109.872 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -55.58 -52.31 64.2 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.542 0.526 . . . . 16.07 110.094 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -60.48 -45.72 92.73 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.176 -0.92 . . . . 13.93 111.11 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.89 -36.96 78.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.227 -0.442 . . . . 10.71 111.245 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -62.5 -42.65 99.64 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.032 -0.729 . . . . 14.02 109.032 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.65 -49.62 62.0 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.354 -0.839 . . . . 16.29 110.987 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -62.21 -36.01 80.62 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.041 0.386 . . . . 12.91 112.041 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.47 -55.64 19.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.442 -0.947 . . . . 12.77 108.442 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.87 89.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.131 -0.94 . . . . 15.19 112.016 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.6 77.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.895 0.379 . . . . 16.26 111.479 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.497 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 66.1 mtt -73.76 -21.55 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.677 -0.238 . . . . 15.45 111.511 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.02 11.96 25.52 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.277 0.473 . . . . 16.16 112.277 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 60.84 40.78 15.41 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.419 1.104 . . . . 20.56 110.06 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 68.1 m -121.93 155.28 35.83 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.694 -0.854 . . . . 16.63 108.694 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.42 131.3 31.39 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.74 -0.467 . . . . 20.19 109.74 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.62 -21.5 62.87 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.918 3.079 . . . . 16.6 116.006 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.39 -6.2 84.15 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 119.939 -1.124 . . . . 17.74 111.967 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.96 21.84 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.223 0.535 . . . . 20.23 110.785 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.3 153.4 7.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.79 -1.189 . . . . 15.98 107.79 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -108.22 124.98 51.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.401 0.619 . . . . 19.33 111.085 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -73.0 -21.47 60.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.715 -1.13 . . . . 14.93 111.459 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.92 5.29 79.06 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.303 -0.951 . . . . 14.82 112.906 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB2' HD21 ' A' ' 34' ' ' LEU . 54.2 m -91.68 157.29 17.03 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.521 0.677 . . . . 14.54 110.405 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 22.0 mtp180 -82.49 146.87 29.01 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.988 -1.006 . . . . 16.75 111.347 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -54.64 -43.54 72.39 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 118.52 0.6 . . . . 11.99 112.416 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.11 -31.21 72.3 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.017 -0.538 . . . . 14.45 110.942 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.63 -30.06 46.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.581 0.705 . . . . 16.44 109.266 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 29' ' ' SER . 95.8 mt -72.0 -28.92 63.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.675 -0.693 . . . . 13.77 110.572 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.03 4.4 7.87 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.333 -0.937 . . . . 13.81 112.773 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.3 tt -81.93 131.16 35.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.976 0.417 . . . . 13.04 110.084 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.11 166.42 12.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 117.959 -1.019 . . . . 15.67 109.344 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -55.92 -41.53 74.73 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 119.166 0.894 . . . . 15.29 110.949 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.01 -44.98 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.632 -0.713 . . . . 16.66 110.4 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.14 -38.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.935 -0.575 . . . . 14.14 109.946 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.27 -46.31 86.25 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 123.372 0.669 . . . . 12.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.32 71.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.709 0.766 . . . . 13.97 111.251 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -78.43 -47.91 16.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.328 -0.851 . . . . 15.69 110.931 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 7.6 t90 -60.6 -48.81 80.12 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.323 1.449 . . . . 11.69 111.367 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 tp -62.34 -28.41 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.718 0.77 . . . . 11.16 110.519 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.36 -35.05 54.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.211 -0.904 . . . . 16.65 109.637 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -74.29 -31.88 62.67 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.164 -0.471 . . . . 14.15 111.678 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -69.77 -36.79 71.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.603 -0.839 . . . . 10.8 109.412 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.493 ' OD1' HG13 ' A' ' 56' ' ' ILE . 75.1 m-20 -66.73 -27.82 67.92 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.806 0.812 . . . . 12.98 110.417 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.06 -45.54 26.74 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.663 -1.153 . . . . 17.52 110.105 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -70.5 -39.25 74.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.837 0.31 . . . . 14.87 111.837 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.81 -3.9 55.55 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.909 1.077 . . . . 12.2 113.909 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 56.37 47.29 19.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.898 1.332 . . . . 16.71 108.791 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.0 tp -139.0 153.99 48.21 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.46 -1.311 . . . . 12.2 107.46 -173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -114.87 89.17 3.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.874 -0.787 . . . . 16.06 108.874 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' OD1' ' A' ' 49' ' ' ASN . 1.5 pp -76.55 147.9 79.22 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 122.243 -0.286 . . . . 11.39 111.717 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -62.65 122.39 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.637 2.225 . . . . 12.6 110.285 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.65 2.34 4.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.798 1.407 . . . . 12.52 114.798 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.43 5.14 46.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.937 -0.477 . . . . 14.14 110.78 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.63 -66.97 2.47 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.088 -0.505 . . . . 10.76 113.871 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.79 -28.08 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 124.436 1.094 . . . . 11.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -75.66 -39.12 58.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.416 -0.811 . . . . 16.42 110.469 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 92.5 m -82.8 -44.0 16.04 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.012 -0.54 . . . . 13.35 110.954 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -113.74 88.36 13.78 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 123.756 0.822 . . . . 12.23 109.093 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.4 Cg_endo -83.56 25.78 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.938 2.425 . . . . 13.06 113.128 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.13 123.69 59.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.614 -1.624 . . . . 12.95 106.614 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.49 -41.32 76.45 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.15 0.98 . . . . 10.92 112.524 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.25 -30.52 71.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.366 0.603 . . . . 14.32 111.081 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.99 -25.01 30.33 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.988 0.423 . . . . 10.93 110.095 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 49.4 t80 -82.58 -31.45 28.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.928 -0.578 . . . . 8.81 110.89 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 p -68.33 -36.97 80.06 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.627 -0.879 . . . . 9.35 108.627 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.6 -41.99 98.28 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.826 -1.079 . . . . 11.63 109.489 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 63.7 t90 -52.68 -56.01 18.56 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.969 1.308 . . . . 10.55 109.587 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.13 -42.33 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 C-N-CA 123.295 0.638 . . . . 8.3 110.675 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.66 -17.03 66.48 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.343 -0.39 . . . . 9.58 113.454 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.5 m -81.23 -30.12 34.27 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.194 -0.669 . . . . 10.23 109.194 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.85 -43.63 11.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.814 -0.63 . . . . 10.43 110.16 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.837 -0.62 . . . . 10.97 109.86 178.636 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 22.0 m . . . . . 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 10.05 112.403 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.72 -26.41 50.04 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.994 -1.003 . . . . 11.22 111.382 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.442 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 8.2 tp-100 -63.9 -48.08 78.06 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.267 -1.383 . . . . 11.38 107.267 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 176' ' ' ASP . 31.9 ttm180 -51.9 -45.62 64.25 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 114.138 -1.392 . . . . 9.65 111.544 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 104' ' ' SER . 52.6 mt-10 -61.3 -44.08 97.82 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 111.905 0.335 . . . . 10.43 111.905 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -65.06 -46.57 80.65 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 120.792 0.329 . . . . 10.21 110.318 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.427 HG21 HG11 ' A' ' 178' ' ' VAL . 81.1 mt -64.81 -43.2 96.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.696 -0.684 . . . . 8.13 111.468 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.71 -34.03 72.37 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.496 0.718 . . . . 8.46 111.34 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.73 -30.37 59.22 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.468 -0.493 . . . . 10.86 110.051 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -71.85 -45.92 59.75 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.307 -0.997 . . . . 11.45 108.307 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.84 -40.25 75.73 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.579 -1.192 . . . . 7.62 108.842 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -55.47 -48.73 74.06 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 124.343 1.057 . . . . 11.62 110.601 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -69.31 -38.76 78.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.391 0.615 . . . . 11.63 110.455 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -63.67 -40.45 96.86 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.337 -0.847 . . . . 9.14 110.054 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.11 -38.93 66.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.997 -0.547 . . . . 10.06 109.92 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.93 -27.07 66.36 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-N 115.705 -0.68 . . . . 12.07 112.844 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.23 -29.13 70.24 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.341 0.591 . . . . 12.32 110.041 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.82 -28.93 17.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.988 -0.551 . . . . 11.77 111.067 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.73 -30.14 24.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.91 0.386 . . . . 13.52 110.901 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 74.78 -38.89 0.4 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.545 1.538 . . . . 16.56 111.621 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.23 137.19 52.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.505 -0.924 . . . . 15.74 108.505 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.43 134.77 54.32 Favored Pre-proline 0 CA--C 1.479 -1.755 0 O-C-N 123.688 0.618 . . . . 14.2 109.666 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.35 -26.16 81.21 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.685 2.256 . . . . 14.18 109.911 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.94 -45.96 1.53 Allowed Glycine 0 CA--C 1.493 -1.334 0 CA-C-N 115.175 -0.92 . . . . 14.03 111.84 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -110.31 -48.64 3.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.396 . . . . 16.37 110.324 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp 63.93 -173.08 0.17 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.311 1.044 . . . . 12.45 110.97 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 72.56 -49.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 14.43 111.352 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 m -90.1 114.61 26.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.013 -1.477 . . . . 14.32 107.013 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.18 51.02 3.27 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 108.736 -1.745 . . . . 13.75 108.736 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.02 18.23 17.8 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.081 -0.559 . . . . 12.7 111.334 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.99 83.55 3.68 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.124 -1.065 . . . . 16.38 108.124 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -80.32 -7.12 58.92 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.652 0.739 . . . . 13.3 110.182 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.0 mt -56.46 -24.91 48.78 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.931 1.292 . . . . 16.25 109.368 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.35 -6.13 52.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.944 -1.025 . . . . 15.87 111.799 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.71 9.24 12.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.374 0.607 . . . . 13.65 111.251 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.62 -97.2 2.22 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.944 -0.571 . . . . 14.16 112.562 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.2 ttm -82.05 66.63 7.71 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.945 1.355 . . . . 15.45 110.057 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -92.71 -46.87 7.36 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.819 -1.537 . . . . 13.63 111.996 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 m -60.94 -34.63 75.02 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.186 0.517 . . . . 13.9 111.902 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.43 -52.75 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 13.81 110.568 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.2 t -72.14 -28.34 63.19 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 109.81 -0.441 . . . . 11.48 109.81 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.44 -28.77 73.94 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 116.066 -0.515 . . . . 10.35 111.832 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 162' ' ' ALA . 93.8 m -61.36 -46.97 87.96 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.901 0.382 . . . . 12.2 110.624 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.82 -49.86 71.21 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.447 -0.797 . . . . 11.86 109.608 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.45 ' CZ3' HD11 ' A' ' 171' ' ' LEU . 79.1 t90 -57.76 -49.26 77.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.252 -0.886 . . . . 9.32 111.911 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -47.75 80.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 123.378 0.671 . . . . 9.5 111.255 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -69.68 -35.65 75.31 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.744 -0.382 . . . . 13.91 111.603 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.15 -47.58 79.65 Favored Glycine 0 C--O 1.244 0.756 0 C-N-CA 120.798 -0.715 . . . . 9.88 112.148 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.24 -41.17 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 111.839 0.311 . . . . 9.27 111.839 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 158' ' ' ILE . 36.1 p -62.82 -37.88 88.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 111.543 0.201 . . . . 11.46 111.543 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.51 -25.18 65.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 15.04 111.113 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -78.82 -31.54 45.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.919 0.39 . . . . 11.82 110.284 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -94.97 5.69 51.19 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.375 0.607 . . . . 11.97 110.761 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.4 m 57.62 41.04 26.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.901 1.281 . . . . 14.24 111.58 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 153' ' ' SER . 17.8 pt -131.11 156.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.703 -0.681 . . . . 12.62 109.517 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -102.12 108.63 20.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.291 -0.263 . . . . 16.39 110.291 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 3.7 mm? -125.87 124.96 42.03 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.612 -0.267 . . . . 12.32 110.804 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.48 143.54 28.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.772 -0.825 . . . . 14.06 108.772 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 146' ' ' THR . . . -70.84 -12.03 61.31 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.345 0.593 . . . . 12.64 112.134 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.51 -12.84 61.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.465 -0.789 . . . . 15.68 109.99 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.71 -15.83 63.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.435 -0.802 . . . . 12.72 112.334 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 162' ' ' ALA . 24.5 pt -71.75 -4.66 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.777 0.799 . . . . 12.16 110.605 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -110.06 0.83 18.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.571 -0.74 . . . . 15.08 109.498 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.5 m -96.02 -23.27 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.802 -0.814 . . . . 14.67 108.802 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 169' ' ' PRO . 4.9 m-90 -124.53 138.33 30.93 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.264 -1.013 . . . . 12.68 108.264 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 168' ' ' TRP . 11.5 Cg_exo -72.68 -15.06 27.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.86 2.374 . . . . 14.34 112.389 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.1 p -137.39 143.77 42.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.003 -0.74 . . . . 12.91 109.003 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ3' ' A' ' 148' ' ' TRP . 32.4 tp -69.22 -25.16 64.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 9.89 110.979 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.37 -19.64 62.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 12.5 111.634 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.585 ' HA ' ' OD2' ' A' ' 176' ' ' ASP . 16.7 m -71.1 -12.09 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.044 -0.525 . . . . 11.04 112.137 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -64.86 -42.15 95.1 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.298 -1.001 . . . . 8.5 108.298 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 178' ' ' VAL . . . -65.68 -23.42 66.77 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.475 -0.784 . . . . 7.7 110.979 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 173' ' ' SER . 63.4 m-20 -79.39 -25.84 42.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.971 0.415 . . . . 10.38 111.165 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.36 -33.37 16.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.53 0.681 . . . . 11.97 109.463 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 175' ' ' ALA . 7.2 p -53.66 -34.15 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 114.746 1.387 . . . . 9.8 114.746 -170.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 106' ' ' GLN . 7.9 m-20 -57.85 -50.46 73.22 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.217 0.532 . . . . 10.83 109.799 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -71.95 -24.53 61.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.356 -0.838 . . . . 13.5 111.334 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -84.75 -46.26 11.58 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.082 -0.508 . . . . 14.84 111.199 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.67 -41.17 19.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 112.348 0.499 . . . . 13.35 112.348 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 119.156 -0.45 . . . . 13.51 109.812 -179.055 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.495 0.664 . . . . 14.98 110.948 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -28.79 70.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.884 -0.598 . . . . 15.79 110.479 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 31.6 m -61.5 -53.7 53.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.305 -0.862 . . . . 12.02 109.877 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.28 -43.08 92.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.286 -0.416 . . . . 11.02 111.3 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -57.12 -50.79 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.405 0.441 . . . . 16.07 111.689 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -63.86 -39.2 93.64 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.956 0.407 . . . . 13.93 111.221 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 88.7 mt -68.02 -40.88 82.84 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.218 -0.447 . . . . 10.71 111.167 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -67.39 -40.22 85.65 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.796 -0.446 . . . . 14.02 109.796 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.78 -54.79 42.2 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.051 0.94 . . . . 16.29 111.506 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 p -65.3 -44.42 87.99 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.994 -0.548 . . . . 12.91 111.951 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.07 -44.63 91.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.934 -0.575 . . . . 12.77 110.815 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.58 97.42 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.562 -0.29 . . . . 15.19 110.698 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.23 -49.08 79.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.96 0.41 . . . . 16.26 111.175 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 ptp -68.6 -26.74 65.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.487 0.551 . . . . 15.45 112.487 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.73 6.5 48.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.795 0.331 . . . . 16.16 111.661 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 59.92 43.13 15.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.403 1.081 . . . . 20.56 111.051 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.1 m -129.94 171.82 12.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 16.63 109.698 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -108.37 135.27 19.99 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.802 -0.814 . . . . 20.19 108.802 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.69 -11.87 33.58 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.007 2.472 . . . . 16.6 112.934 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.22 -14.24 60.68 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.626 -0.59 . . . . 17.74 111.626 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -96.78 -43.78 7.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.123 -0.633 . . . . 20.23 112.138 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.96 138.5 21.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 119.469 -0.892 . . . . 15.98 109.567 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' HG2' ' OG ' ' A' ' 29' ' ' SER . 4.8 ptm180 -95.1 163.57 13.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.822 0.82 . . . . 19.33 112.785 -165.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' HG11 ' A' ' 66' ' ' VAL . 17.5 t70 -64.38 -10.88 27.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.564 1.546 . . . . 14.93 111.499 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.57 6.37 29.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.689 -0.687 . . . . 14.82 113.04 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.507 ' OG ' ' HG2' ' A' ' 26' ' ' ARG . 71.4 m -70.64 119.01 14.16 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.928 0.864 . . . . 14.54 111.793 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -87.97 149.3 24.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.543 -0.753 . . . . 16.75 111.375 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -48.37 -42.29 31.21 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.245 0.618 . . . . 11.99 112.402 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.33 -37.89 68.02 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.676 -1.147 . . . . 14.45 111.748 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.22 -7.51 41.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.076 0.465 . . . . 16.44 111.427 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.07 -16.77 34.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.434 0.635 . . . . 13.77 110.309 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.39 27.72 47.02 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.269 -0.878 . . . . 13.81 111.592 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.83 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.955 -1.128 . . . . 13.04 107.955 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD2' HG22 ' A' ' 39' ' ' VAL . 18.1 t70 -129.87 168.02 17.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 117.866 -1.064 . . . . 15.67 108.548 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 t -56.57 -44.56 81.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.745 0.702 . . . . 15.29 109.981 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.445 HG22 ' OD2' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -58.15 -55.2 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.61 0.719 . . . . 16.66 112.311 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.78 -45.91 87.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.394 -1.275 . . . . 14.14 110.546 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.95 91.56 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.845 -0.616 . . . . 12.0 110.847 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.64 78.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.399 0.68 . . . . 13.97 111.479 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.21 -47.36 65.02 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.187 0.518 . . . . 15.69 111.126 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -64.48 -49.15 72.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.723 1.209 . . . . 11.69 112.338 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 48' ' ' ILE . 11.3 tp -61.41 -36.93 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.063 0.459 . . . . 11.16 110.503 -176.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -73.64 -26.16 60.64 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.292 -0.413 . . . . 16.65 111.92 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -69.62 -36.69 76.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.937 -1.134 . . . . 14.15 107.937 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 45' ' ' ILE . 77.0 mt -60.42 -49.58 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.116 -0.947 . . . . 10.8 109.348 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.416 HD21 ' CD1' ' A' ' 56' ' ' ILE . 19.1 m120 -59.84 -37.54 79.54 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.369 0.604 . . . . 12.98 111.153 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -67.29 -58.66 4.41 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.63 1.572 . . . . 17.52 111.665 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -85.35 -27.57 25.78 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.796 -0.762 . . . . 14.87 112.869 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -94.36 -0.93 54.55 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.577 -0.849 . . . . 12.2 112.857 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 44.29 43.56 6.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.056 1.342 . . . . 16.71 112.42 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -117.75 125.83 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.124 -0.943 . . . . 12.2 109.124 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -87.73 96.4 10.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.536 0.522 . . . . 16.06 110.063 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CD1' HD21 ' A' ' 49' ' ' ASN . 2.4 pp -124.88 153.66 70.82 Favored Pre-proline 0 N--CA 1.426 -1.635 0 O-C-N 121.992 -0.442 . . . . 11.39 110.179 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.43 127.28 17.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.123 1.882 . . . . 12.6 109.867 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.85 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.956 0.903 . . . . 12.52 112.522 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -85.91 -5.47 59.23 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.97 0.414 . . . . 14.14 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.1 -13.17 64.08 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.918 -0.583 . . . . 10.76 112.716 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 tt -58.63 -29.61 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 C-N-CA 123.433 0.693 . . . . 11.0 110.865 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.39 0.8 35.78 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.666 0.617 . . . . 16.42 112.666 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -71.83 -25.89 62.16 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.993 0.901 . . . . 13.35 109.499 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -123.16 100.26 39.68 Favored Pre-proline 0 C--O 1.209 -1.056 0 N-CA-C 106.496 -1.668 . . . . 12.23 106.496 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.14 -1.63 7.46 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.859 2.373 . . . . 13.06 113.819 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 27' ' ' ASP . 60.3 t -116.45 120.23 64.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.502 -1.295 . . . . 12.95 107.502 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -54.25 -41.99 69.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.679 1.192 . . . . 10.92 113.067 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -74.1 -29.56 61.91 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.621 -0.263 . . . . 14.32 111.543 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.49 -29.58 46.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 10.93 110.598 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -56.39 -23.98 41.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.936 0.895 . . . . 8.81 113.369 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 p -56.25 -23.58 37.08 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 113.053 0.76 . . . . 9.35 113.053 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 76' ' ' THR . 54.5 tp60 -53.04 -35.88 59.95 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 123.672 0.608 . . . . 11.63 110.332 176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -52.79 -58.76 5.81 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 123.724 0.64 . . . . 10.55 111.402 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.7 t -68.23 -45.8 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 CA-C-N 115.282 -0.872 . . . . 8.3 110.394 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.77 -46.88 81.62 Favored Glycine 0 CA--C 1.518 0.262 0 O-C-N 123.744 0.652 . . . . 9.58 113.543 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 72' ' ' GLN . 14.5 t -79.79 -16.81 54.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 120.321 -0.551 . . . . 10.23 111.488 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -90.63 -13.65 33.92 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 119.708 -0.797 . . . . 10.43 111.593 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 96.8 mt . . . . . 0 C--O 1.243 0.757 0 N-CA-C 107.367 -1.346 . . . . 10.97 107.367 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 109.059 -0.719 . . . . 10.05 109.059 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -35.81 73.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.859 -1.064 . . . . 11.22 113.329 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -60.0 -25.78 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.117 0.414 . . . . 11.38 112.117 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.412 ' HE ' ' CB ' ' A' ' 179' ' ' ASP . 17.8 ttt180 -72.37 -48.54 40.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.919 0.39 . . . . 9.65 110.712 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -65.87 -28.18 68.77 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.524 0.678 . . . . 10.43 110.05 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -64.32 -29.58 70.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.155 -0.93 . . . . 10.21 111.646 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 178' ' ' VAL . 56.1 mt -81.28 -33.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.725 -0.843 . . . . 8.13 108.725 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.05 -53.82 53.8 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.759 -1.109 . . . . 8.46 109.985 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -68.38 -35.56 77.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.333 -0.547 . . . . 10.86 111.114 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.97 -46.57 88.99 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.249 0.343 . . . . 11.45 110.308 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.11 -49.71 76.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.959 -0.564 . . . . 7.62 110.31 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.88 -47.39 85.08 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.681 0.613 . . . . 11.62 111.002 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.81 -34.58 73.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 11.63 112.063 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 -28.97 67.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.824 0.345 . . . . 9.14 110.589 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.5 -44.71 67.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.756 -0.461 . . . . 10.06 109.756 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.36 98.13 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.297 -0.721 . . . . 12.07 111.297 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.35 -42.19 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.369 1.467 . . . . 12.32 110.535 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD21 ' HB ' ' A' ' 144' ' ' THR . 37.5 tp -84.63 -34.3 23.12 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.967 -1.015 . . . . 11.77 110.918 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 tp -73.18 -29.29 62.73 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.014 0.746 . . . . 13.52 113.014 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 66.1 13.08 8.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.03 0.932 . . . . 16.56 110.741 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.4 171.34 8.4 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.185 -1.783 . . . . 15.74 106.185 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.89 130.2 91.78 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 109.83 -0.433 . . . . 14.2 109.83 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -69.55 0.73 5.07 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.551 2.168 . . . . 14.18 112.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.87 7.23 57.27 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.402 -0.679 . . . . 14.03 111.402 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -75.3 -16.86 60.39 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.172 0.51 . . . . 16.37 110.372 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.6 165.31 18.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.584 0.707 . . . . 12.45 111.723 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -88.14 77.23 8.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.24 -0.891 . . . . 14.43 109.823 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m 70.91 -48.58 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.814 1.646 . . . . 14.32 111.395 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.12 0.06 OUTLIER Glycine 0 C--N 1.308 -0.99 0 N-CA-C 108.704 -1.758 . . . . 13.75 108.704 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -154.32 93.03 1.56 Allowed 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.499 -0.413 . . . . 12.7 111.902 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 136' ' ' LEU . 28.5 tt0 -168.86 132.35 1.4 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 109.632 -0.507 . . . . 16.38 109.632 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -81.35 -7.46 59.58 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.835 1.05 . . . . 13.3 113.835 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.512 ' H ' ' HG2' ' A' ' 134' ' ' GLN . 83.6 mt -80.15 -35.73 36.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 16.25 112.069 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -37.46 21.24 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.48 0.919 . . . . 15.87 113.48 -173.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.77 -17.54 6.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.243 1.571 . . . . 13.65 115.243 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.36 143.61 4.89 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.226 -0.988 . . . . 14.16 112.289 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -99.49 -7.27 26.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.032 0.444 . . . . 15.45 109.958 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -150.09 149.22 29.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.552 0.691 . . . . 13.63 110.858 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -51.45 -34.99 37.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.699 1.999 . . . . 13.9 114.284 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.3 t -57.5 -47.93 84.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 112.461 0.541 . . . . 13.81 112.461 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.495 ' HB ' HD21 ' A' ' 121' ' ' LEU . 19.6 p -67.35 -35.54 79.57 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.469 -0.332 . . . . 11.48 110.858 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.01 -47.04 56.88 Favored Glycine 0 C--O 1.219 -0.834 0 N-CA-C 111.285 -0.726 . . . . 10.35 111.285 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 85.9 m -58.25 -46.76 85.39 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.533 0.333 . . . . 12.2 111.009 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.32 -38.15 90.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.259 0.552 . . . . 11.86 111.14 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.474 ' HB2' HD22 ' A' ' 121' ' ' LEU . 21.8 t90 -67.59 -46.42 72.65 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.477 0.711 . . . . 9.32 110.251 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -49.59 71.2 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.669 0.388 . . . . 9.5 111.192 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 146' ' ' THR . 77.8 mtp180 -58.7 -40.99 85.26 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.641 0.588 . . . . 13.91 110.731 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.07 -44.67 96.94 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.93 -0.577 . . . . 9.88 112.657 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.03 -41.93 84.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-O 121.286 0.565 . . . . 9.27 109.522 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.6 t -59.0 -49.54 77.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.928 -1.033 . . . . 11.46 111.51 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -70.94 -20.87 62.41 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.914 0.388 . . . . 15.04 111.832 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.94 -51.21 7.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.432 -0.507 . . . . 11.82 110.472 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -94.03 -2.05 53.55 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.303 0.853 . . . . 11.97 113.303 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.2 m 62.79 38.99 11.25 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.956 0.884 . . . . 14.24 111.267 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.7 pt -113.66 158.57 13.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.769 -1.105 . . . . 12.62 109.063 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.3 106.04 18.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.728 -0.842 . . . . 16.39 108.728 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 160' ' ' LEU . 45.2 mt -121.93 112.32 18.16 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.709 0.766 . . . . 12.32 111.76 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.57 152.06 43.28 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.825 -1.534 . . . . 14.06 108.921 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.87 -13.09 62.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.916 0.865 . . . . 12.64 109.989 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.97 -8.04 45.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.508 1.523 . . . . 15.68 111.804 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.735 ' HA ' ' CZ3' ' A' ' 168' ' ' TRP . . . -59.89 -0.61 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.959 1.837 . . . . 12.72 115.959 -173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 33.2 pt -96.09 2.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 122.002 -0.436 . . . . 12.16 111.558 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -94.15 -76.18 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.813 1.042 . . . . 15.08 113.813 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.417 HG22 ' CZ3' ' A' ' 168' ' ' TRP . 3.5 t -78.64 12.64 1.96 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.3 0.571 . . . . 14.67 111.238 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.735 ' CZ3' ' HA ' ' A' ' 164' ' ' ALA . 18.1 m-90 -120.12 90.68 44.88 Favored Pre-proline 0 N--CA 1.412 -2.363 0 N-CA-C 105.676 -1.972 . . . . 12.68 105.676 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.2 -28.42 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.456 2.104 . . . . 14.34 113.496 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 p -126.06 174.28 8.58 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.526 -0.546 . . . . 12.91 109.526 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.09 -22.09 49.5 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.096 0.951 . . . . 9.89 108.548 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -64.14 -34.42 78.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.807 -1.542 . . . . 12.5 110.477 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -62.23 -45.23 94.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.957 -0.565 . . . . 11.04 110.101 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -70.33 -39.67 74.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.167 -0.47 . . . . 8.5 110.14 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.03 71.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.121 0.486 . . . . 7.7 111.431 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.88 -30.11 40.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.022 0.439 . . . . 10.38 110.212 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -81.84 -37.35 27.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.955 -0.566 . . . . 11.97 112.314 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -56.28 -43.73 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.886 0.374 . . . . 9.8 111.203 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.412 ' CB ' ' HE ' ' A' ' 107' ' ' ARG . 30.2 t70 -72.35 -28.12 62.83 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 121.149 0.5 . . . . 10.83 110.729 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -68.41 -26.69 65.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.474 -0.936 . . . . 13.5 108.474 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -83.98 -48.63 9.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.923 -1.035 . . . . 14.84 110.0 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 86.6 t -70.06 -43.53 79.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 N-CA-C 112.511 0.56 . . . . 13.35 112.511 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.028 -0.73 . . . . 13.51 109.028 -176.529 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 30.1 t70 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.644 0.735 . . . . 14.98 110.045 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.04 -40.19 94.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.982 -0.554 . . . . 15.79 111.578 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 57.6 m -60.9 -43.88 97.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.009 -0.541 . . . . 12.02 110.872 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.93 92.83 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 110.09 -0.337 . . . . 11.02 110.09 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 24.7 mt-30 -57.77 -52.99 63.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.168 0.508 . . . . 16.07 110.696 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.98 -46.59 86.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.508 -0.769 . . . . 13.93 111.381 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 63.0 mt -65.84 -35.46 80.74 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.756 0.65 . . . . 10.71 112.756 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtm-85 -62.91 -46.48 87.6 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 120.881 -0.328 . . . . 14.02 110.217 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.09 -41.21 95.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 16.29 110.983 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -58.31 -59.72 4.89 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.206 1.002 . . . . 12.91 111.592 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 17' ' ' MET . 42.3 tp -69.67 -41.63 75.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.471 . . . . 12.77 111.448 -175.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.285 0.476 . . . . 15.19 112.285 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.87 88.96 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.732 -0.387 . . . . 16.26 110.874 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 19.9 ptp -75.06 -31.12 61.19 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.268 -0.423 . . . . 15.45 111.76 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.37 -11.5 37.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.903 0.858 . . . . 16.16 110.934 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.2 t80 64.2 48.62 2.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.968 1.707 . . . . 20.56 109.886 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 21.3 p -119.84 174.82 6.21 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.374 -1.343 . . . . 16.63 107.374 176.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.33 129.91 35.54 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 112.121 0.415 . . . . 20.19 112.121 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.5 -18.91 33.22 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.414 2.742 . . . . 16.6 113.418 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.29 -36.34 7.6 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.318 -1.113 . . . . 17.74 110.318 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -87.45 70.95 9.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.022 -0.732 . . . . 20.23 109.022 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -140.74 151.79 20.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.943 -1.132 . . . . 15.98 107.943 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -114.4 131.33 56.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.804 -0.813 . . . . 19.33 108.804 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 9.3 p-10 -77.12 -21.89 53.54 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.701 0.401 . . . . 14.93 111.48 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.78 5.88 79.59 Favored Glycine 0 C--N 1.312 -0.8 0 N-CA-C 111.025 -0.83 . . . . 14.82 111.025 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -72.33 137.94 46.98 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.261 0.553 . . . . 14.54 109.724 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 49.3 mtp180 -82.55 142.85 31.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.692 -1.225 . . . . 16.75 107.692 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -57.19 -16.47 8.15 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.424 0.898 . . . . 11.99 113.424 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 mt -70.06 -34.6 73.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.972 -0.751 . . . . 14.45 108.972 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -77.42 -24.8 50.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.002 -0.999 . . . . 16.44 109.131 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.0 mt -74.69 -37.22 62.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.855 -0.794 . . . . 13.77 108.855 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.6 26.21 30.61 Favored Glycine 0 CA--C 1.493 -1.288 0 CA-C-N 115.124 -0.944 . . . . 13.81 114.488 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.5 pt? -85.68 126.37 33.9 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.565 -0.854 . . . . 13.04 110.903 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.83 161.09 27.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.177 -0.919 . . . . 15.67 110.5 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -54.36 -36.59 64.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.191 0.451 . . . . 15.29 111.026 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 40' ' ' ILE . 1.4 m -54.54 -56.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.419 0.525 . . . . 16.66 112.419 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' H ' HG23 ' A' ' 39' ' ' VAL . 56.2 mt -59.35 -41.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.32 -0.855 . . . . 14.14 110.571 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.94 88.73 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.019 -0.537 . . . . 12.0 110.756 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.43 82.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.469 0.652 . . . . 13.97 110.697 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -67.39 -51.68 49.0 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.618 -0.719 . . . . 15.69 111.259 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -64.64 -45.16 88.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.165 0.986 . . . . 11.69 111.453 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 48' ' ' ILE . 10.5 tp -62.5 -35.38 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.5 . . . . 11.16 111.357 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -81.38 -20.27 40.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.732 -0.787 . . . . 16.65 111.546 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -78.36 -31.55 48.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.657 -0.817 . . . . 14.15 111.758 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 45' ' ' ILE . 22.5 pt -67.22 -31.39 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.473 -0.891 . . . . 10.8 108.715 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 56' ' ' ILE . 11.0 m120 -62.14 -42.18 99.0 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 115.196 -0.911 . . . . 12.98 110.422 174.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.33 -47.37 17.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.664 -0.698 . . . . 17.52 110.452 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -66.74 -34.54 78.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.852 -0.613 . . . . 14.87 111.764 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.569 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 69.1 m-85 -101.55 -12.2 18.67 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.626 1.343 . . . . 12.2 114.626 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 57.94 45.85 17.53 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.132 0.968 . . . . 16.71 108.922 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.0 tp -123.37 149.15 45.3 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.879 -1.055 . . . . 12.2 110.719 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -99.64 109.46 21.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.381 -0.97 . . . . 16.06 108.381 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.525 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.5 pp -124.36 149.63 61.79 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 118.185 0.448 . . . . 11.39 110.765 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.12 105.01 1.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.703 1.602 . . . . 12.6 109.039 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.98 -24.72 25.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.062 1.345 . . . . 12.52 113.145 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.81 -3.26 30.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.428 -0.351 . . . . 14.14 111.453 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.18 -49.3 31.05 Favored Glycine 0 C--O 1.204 -1.756 0 O-C-N 123.656 0.597 . . . . 10.76 113.342 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.53 -31.01 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 11.0 112.209 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.7 -40.11 12.75 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.068 0.396 . . . . 16.42 112.068 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -80.36 -35.59 35.21 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.374 0.607 . . . . 13.35 110.457 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -121.64 76.7 36.85 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 124.185 0.994 . . . . 12.23 108.737 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 4.1 Cg_exo -81.09 37.8 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.165 2.576 . . . . 13.06 113.878 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.53 124.78 60.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.837 -1.542 . . . . 12.95 106.837 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -55.08 -40.36 70.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.167 0.987 . . . . 10.92 113.33 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.4 tttt -64.8 -42.14 95.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 14.32 110.287 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.82 81.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.685 -0.688 . . . . 10.93 110.576 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -71.38 -35.63 71.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.928 0.344 . . . . 8.81 111.928 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 p -65.32 -26.48 68.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.626 -0.83 . . . . 9.35 110.935 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 16.3 mm-40 -77.26 -39.45 48.21 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.022 -0.535 . . . . 11.63 110.051 172.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -62.58 -30.79 71.59 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.54 0.736 . . . . 10.55 111.918 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.75 -44.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.207 -0.664 . . . . 8.3 109.207 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.28 -27.03 73.43 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.417 -0.81 . . . . 9.58 113.991 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -72.9 -16.48 61.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.313 0.557 . . . . 10.23 110.991 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 56' ' ' ILE . 15.1 mm100 -83.21 -23.58 32.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.109 -0.701 . . . . 10.43 109.109 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.502 -0.867 0 CA-C-N 115.097 -0.956 . . . . 10.97 110.301 178.9 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 11.3 p . . . . . 0 N--CA 1.426 -1.651 0 CA-C-O 122.755 1.264 . . . . 10.05 108.0 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.84 -24.19 59.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.816 -1.538 . . . . 11.22 110.099 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -66.3 -45.68 79.52 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.822 -1.177 . . . . 11.38 107.822 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 104' ' ' SER . 48.0 ttp180 -51.99 -53.01 46.58 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 124.148 0.905 . . . . 9.65 110.219 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.53 -48.27 79.76 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.716 0.635 . . . . 10.43 111.843 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.2 t -60.63 -50.33 73.95 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 10.21 110.971 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 178' ' ' VAL . 97.2 mt -62.45 -39.54 84.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 CA-C-N 116.469 -0.332 . . . . 8.13 110.929 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -47.48 -42.19 22.27 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 124.742 1.217 . . . . 8.46 112.105 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.0 -29.82 66.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.022 0.439 . . . . 10.86 112.022 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.09 -36.76 16.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.283 0.563 . . . . 11.45 110.186 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.76 -37.36 86.14 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 108.224 -1.028 . . . . 7.62 108.224 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 126' ' ' PRO . 83.6 tttt -51.03 -44.66 61.08 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.248 1.419 . . . . 11.62 110.349 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.69 -44.98 80.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.453 -0.794 . . . . 11.63 110.379 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -66.81 -48.3 69.39 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.557 -0.747 . . . . 9.14 110.968 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.4 pp -71.38 -34.62 70.58 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.43 0.157 . . . . 10.06 111.147 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.41 -42.64 95.84 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.491 -0.644 . . . . 12.07 111.491 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.17 -44.72 96.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.919 0.866 . . . . 12.32 109.733 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.52 -45.77 78.4 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.509 -1.223 . . . . 11.77 110.956 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.0 tp -76.86 -19.06 57.93 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.518 -0.764 . . . . 13.52 111.073 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.1 t80 62.45 31.71 17.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.862 1.665 . . . . 16.56 109.738 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 125' ' ' ASP . 1.3 tm? -120.27 146.43 46.09 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 105.268 -2.123 . . . . 15.74 105.268 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 16.8 t70 -61.43 122.2 68.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.634 0.584 . . . . 14.2 110.308 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 15.2 Cg_exo -69.98 6.51 1.36 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.057 2.504 . . . . 14.18 114.787 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.89 1.26 55.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.186 -1.566 . . . . 14.03 109.186 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -125.01 36.8 4.53 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.801 1.286 . . . . 16.37 107.822 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.19 124.04 21.99 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.265 -1.334 . . . . 12.45 110.34 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -63.38 146.32 53.79 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.389 -0.967 . . . . 14.43 108.389 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.5 t -58.3 -61.89 2.24 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 118.765 0.711 . . . . 14.32 111.548 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.12 -57.17 2.71 Favored Glycine 0 C--O 1.247 0.942 0 N-CA-C 110.162 -1.175 . . . . 13.75 110.162 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 71.07 114.57 0.05 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.248 1.419 . . . . 12.7 112.578 176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.82 116.23 6.78 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.542 -0.754 . . . . 16.38 109.555 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.516 ' O ' HD22 ' A' ' 138' ' ' LEU . 17.1 t80 -56.59 -40.07 74.61 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 124.932 1.293 . . . . 13.3 110.961 -177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.0 -2.4 43.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.47 0.915 . . . . 16.25 113.47 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.2 -14.41 61.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.555 0.693 . . . . 15.87 109.993 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -64.77 -14.15 57.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.276 -0.875 . . . . 13.65 112.869 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.81 150.31 6.13 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.295 -0.722 . . . . 14.16 111.295 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.71 -31.49 65.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.806 -0.812 . . . . 15.45 108.806 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.82 125.46 27.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 114.729 -1.123 . . . . 13.63 109.048 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -62.72 -22.39 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.579 0.549 . . . . 13.9 110.296 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.443 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 61.8 t -58.02 -34.18 48.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.157 -0.929 . . . . 13.81 111.513 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.4 p -59.96 -44.27 94.52 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.445 0.641 . . . . 11.48 110.748 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -83.42 -35.53 16.98 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.231 -0.895 . . . . 10.35 113.006 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 143' ' ' VAL . 39.7 p -66.95 -30.19 70.25 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 117.506 0.653 . . . . 12.2 110.373 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -62.74 -47.64 82.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.676 0.791 . . . . 11.86 108.872 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.11 -42.83 99.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.605 -0.725 . . . . 9.32 110.497 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 162' ' ' ALA . 24.4 mmt -61.76 -37.51 84.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.607 0.718 . . . . 9.5 109.915 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -69.64 -36.96 76.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.376 -0.829 . . . . 13.91 110.321 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.89 -51.65 38.67 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.671 -0.572 . . . . 9.88 111.671 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.51 -44.05 84.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.289 0.636 . . . . 9.27 111.657 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -60.89 -40.82 94.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.924 0.342 . . . . 11.46 111.924 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -68.41 -47.08 68.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.884 0.373 . . . . 15.04 110.491 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -54.71 -40.08 68.84 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.414 1.086 . . . . 11.82 111.999 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.73 -1.17 26.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.191 0.811 . . . . 11.97 113.191 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t 60.36 47.24 9.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.672 0.789 . . . . 14.24 110.308 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.09 168.83 18.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.527 -0.916 . . . . 12.62 108.527 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -108.08 97.25 6.97 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.44 0.638 . . . . 16.39 109.41 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.6 tp -103.13 123.66 47.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.73 134.29 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.142 -0.688 . . . . 14.06 109.142 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 149' ' ' MET . . . -75.92 -16.64 59.99 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.204 0.526 . . . . 12.64 111.116 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.37 -6.29 59.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.717 -0.674 . . . . 15.68 111.118 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.11 -10.69 32.68 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.327 -0.397 . . . . 12.72 111.677 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.57 -15.76 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.762 0.791 . . . . 12.16 110.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -103.85 14.15 31.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.469 -0.787 . . . . 15.08 109.099 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 32.5 m -110.69 -38.31 5.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.474 -0.785 . . . . 14.67 111.269 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -105.97 123.77 38.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.682 -0.407 . . . . 12.68 110.465 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.68 -27.84 4.66 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.972 1.781 . . . . 14.34 111.484 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -105.7 142.53 35.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.995 0.903 . . . . 12.91 111.504 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.14 -37.91 81.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.752 -1.567 . . . . 9.89 112.433 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.34 -18.97 63.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.929 0.714 . . . . 12.5 112.929 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 -17.77 64.86 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.139 0.792 . . . . 11.04 113.139 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.3 tp -70.11 -32.21 70.13 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.087 0.47 . . . . 8.5 110.261 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.49 75.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.467 0.651 . . . . 7.7 109.742 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.83 -21.79 60.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.557 -0.747 . . . . 10.38 110.579 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 9.6 tp10 -80.51 -56.8 3.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.994 -0.548 . . . . 11.97 109.752 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 110' ' ' ILE . 10.6 p -55.4 -34.03 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 112.443 0.535 . . . . 9.8 112.443 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 107' ' ' ARG . 15.9 t70 -55.31 -43.01 74.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.996 0.918 . . . . 10.83 110.459 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -83.56 -34.23 25.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.276 -0.874 . . . . 13.5 111.273 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mmm180 -60.7 -58.5 8.19 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.119 -0.491 . . . . 14.84 111.259 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.37 -40.51 56.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.255 -0.578 . . . . 13.35 109.451 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 117.64 -1.171 . . . . 13.51 109.853 178.545 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 . . . . . 0 CA--C 1.507 -0.677 0 N-CA-C 113.866 1.062 . . . . 14.98 113.866 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.02 -27.38 67.37 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.942 -0.703 . . . . 15.79 110.343 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 35.0 m -70.55 -48.73 54.0 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.943 -0.571 . . . . 12.02 109.823 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.67 78.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.084 0.469 . . . . 11.02 110.832 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 29.0 tt0 -67.67 -45.88 73.96 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.028 -0.533 . . . . 16.07 110.255 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.51 -37.76 85.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.072 0.463 . . . . 13.93 110.716 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 -35.49 74.73 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.388 0.514 . . . . 10.71 112.388 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 12.4 ptp180 -69.44 -29.18 66.83 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 119.135 -1.026 . . . . 14.02 109.575 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -67.35 -48.77 66.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.028 -0.533 . . . . 16.29 109.673 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -62.74 -34.56 77.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.408 -0.814 . . . . 12.91 112.377 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.48 -53.15 31.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.358 0.599 . . . . 12.77 110.299 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -64.9 -29.72 70.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.953 -1.022 . . . . 15.19 112.214 -176.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.08 98.47 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.952 0.406 . . . . 16.26 110.652 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.4 mmt -78.81 -39.51 35.49 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.337 -0.392 . . . . 15.45 112.043 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 mp -90.36 5.69 46.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.749 0.309 . . . . 16.16 111.785 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 54.71 36.88 27.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.421 1.488 . . . . 20.56 112.556 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 42.4 t -95.89 175.71 6.39 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.377 -1.342 . . . . 16.63 107.377 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.19 115.93 65.19 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.196 -0.668 . . . . 20.19 109.196 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.91 42.93 1.41 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 123.378 2.719 . . . . 16.6 113.218 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -95.86 1.09 Allowed Glycine 0 C--N 1.288 -2.137 0 CA-C-N 114.769 -1.105 . . . . 17.74 111.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.85 66.22 1.53 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.033 0.445 . . . . 20.23 110.231 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 pt -68.42 147.58 12.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.249 -0.432 . . . . 15.98 110.026 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.42 114.12 3.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.064 -0.971 . . . . 19.33 111.002 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.7 m-20 -66.77 -24.76 66.24 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.728 0.811 . . . . 14.93 110.988 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.11 2.33 87.14 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.835 -0.698 . . . . 14.82 113.148 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -73.33 140.49 46.75 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.062 0.458 . . . . 14.54 111.76 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 73.1 ttt180 -76.23 142.04 41.56 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 104.394 -2.447 . . . . 16.75 104.394 166.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 71.3 m-85 -54.68 -25.58 27.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.111 1.152 . . . . 11.99 114.111 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.23 -38.71 92.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.043 0.449 . . . . 14.45 109.832 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.78 -24.28 60.92 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.177 -0.675 . . . . 16.44 109.177 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.19 -15.8 54.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.624 -0.716 . . . . 13.77 110.536 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.26 5.03 53.13 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.999 -0.619 . . . . 13.81 112.749 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.1 tt -80.1 140.38 36.46 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.553 -0.536 . . . . 13.04 109.553 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 26.0 t70 -120.98 163.41 18.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 118.184 -0.912 . . . . 15.67 108.837 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 m -57.46 -39.98 77.51 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 118.834 0.743 . . . . 15.29 111.389 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.93 -46.15 85.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 16.66 109.492 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 52.6 mt -60.82 -34.96 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.313 -0.858 . . . . 14.14 110.723 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.78 -47.27 85.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.417 0.687 . . . . 12.0 111.432 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.71 72.29 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 123.556 0.535 . . . . 13.97 111.148 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -79.07 -49.93 11.87 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.868 -0.606 . . . . 15.69 111.329 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.408 ' CZ3' HD11 ' A' ' 48' ' ' ILE . 7.4 t90 -60.96 -39.34 89.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.4 0.68 . . . . 11.69 112.062 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.3 -28.1 44.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 CA-C-O 121.132 0.491 . . . . 11.16 110.613 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -71.43 -32.03 67.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.982 0.42 . . . . 16.65 109.996 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -69.73 -34.39 73.79 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.84 0.828 . . . . 14.15 108.891 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.408 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 75.6 mt -69.92 -51.88 36.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 114.907 -1.042 . . . . 10.8 109.766 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.23 -28.22 62.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.799 0.84 . . . . 12.98 112.037 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -71.47 -50.78 28.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.531 0.681 . . . . 17.52 109.953 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -70.09 -51.84 28.54 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.71 -1.132 . . . . 14.87 113.303 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 79.9 m-85 -88.47 -6.67 57.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.869 0.692 . . . . 12.2 112.869 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 55.86 36.08 26.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.58 1.152 . . . . 16.71 112.209 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.68 147.25 32.21 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.958 -1.127 . . . . 12.2 107.958 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -91.22 77.34 5.95 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.762 -0.829 . . . . 16.06 108.762 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.35 128.38 30.56 Favored Pre-proline 0 N--CA 1.426 -1.674 0 C-N-CA 120.36 -0.536 . . . . 11.39 111.485 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.55 154.79 27.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.468 2.112 . . . . 12.6 108.956 171.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.31 20.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.464 0.706 . . . . 12.52 110.83 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 63' ' ' THR . 7.2 m-20 -62.43 -21.25 65.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.798 -1.092 . . . . 14.14 112.885 176.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.18 -41.33 92.71 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 119.409 -1.377 . . . . 10.76 111.632 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.55 -19.78 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.488 0.661 . . . . 11.0 110.23 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.74 -38.79 17.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 16.42 111.129 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 59' ' ' ASP . 8.5 t -77.66 -41.77 37.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.518 -0.473 . . . . 13.35 110.461 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -119.73 92.35 46.26 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-O 121.378 0.609 . . . . 12.23 109.872 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 44.8 Cg_endo -93.7 17.15 1.09 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.126 2.551 . . . . 13.06 113.93 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.95 137.94 45.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.08 -1.081 . . . . 12.95 108.08 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.28 -49.08 73.01 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 113.176 0.806 . . . . 10.92 113.176 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 13.9 tppt? -64.8 -35.05 79.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.317 0.58 . . . . 14.32 110.389 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.43 75.7 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.853 -0.612 . . . . 10.93 110.866 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.1 t80 -74.84 -31.97 61.8 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.379 0.609 . . . . 8.81 111.428 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -70.31 -29.18 65.84 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.409 -0.917 . . . . 9.35 110.584 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -75.01 -25.71 59.0 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.569 -0.53 . . . . 11.63 109.569 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 5.6 t90 -61.33 -54.76 39.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.139 -1.43 . . . . 10.55 107.139 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.18 -32.33 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 CA-C-N 115.009 -0.996 . . . . 8.3 109.544 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 -12.97 60.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.864 -0.607 . . . . 9.58 112.388 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.8 m -85.24 -31.28 23.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.627 -0.879 . . . . 10.23 108.627 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -81.18 -44.35 17.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.284 -1.006 . . . . 10.43 108.284 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.311 -1.09 0 N-CA-C 107.587 -1.264 . . . . 10.97 107.587 175.064 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 121.527 0.679 . . . . 10.05 112.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.84 -39.69 39.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.393 1.077 . . . . 11.22 112.581 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.1 tp-100 -62.57 -54.61 37.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.58 -0.526 . . . . 11.38 109.58 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -58.07 -41.29 83.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.942 0.897 . . . . 9.65 111.232 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -48.29 78.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.849 -0.614 . . . . 10.43 110.614 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.6 t -59.61 -37.7 79.28 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 123.699 0.624 . . . . 10.21 109.776 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 106' ' ' GLN . 53.2 mt -58.61 -44.83 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 115.265 -0.879 . . . . 8.13 110.721 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.41 -38.21 86.29 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.152 0.282 . . . . 8.46 111.517 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.2 -45.75 79.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.527 0.203 . . . . 10.86 110.554 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -71.52 -27.56 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.108 -0.637 . . . . 11.45 111.498 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.19 -48.0 83.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.188 -1.041 . . . . 7.62 108.188 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -56.63 -51.89 66.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.453 -1.703 . . . . 11.62 110.712 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -64.92 -39.98 94.36 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.711 0.634 . . . . 11.63 112.711 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 p -67.97 -33.13 74.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.156 0.428 . . . . 9.14 112.156 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -43.0 33.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.492 -0.883 . . . . 10.06 109.204 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.32 82.12 Favored Glycine 0 C--O 1.22 -0.775 0 CA-C-N 115.78 -0.645 . . . . 12.07 112.601 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.14 -28.63 68.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.526 0.679 . . . . 12.32 110.471 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.21 -43.06 10.07 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 11.77 110.127 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.48 -27.07 62.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.448 -0.796 . . . . 13.52 111.789 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 t80 80.27 -36.36 0.14 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.907 1.683 . . . . 16.56 110.742 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.77 172.35 13.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 15.74 110.816 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.83 139.02 76.66 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.988 0.423 . . . . 14.2 111.686 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.17 42.81 0.41 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.997 2.465 . . . . 14.18 111.128 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -101.2 -10.46 42.03 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 115.497 -0.774 . . . . 14.03 111.636 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.64 -13.77 41.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.192 0.52 . . . . 16.37 110.593 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.2 -169.45 2.07 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.124 -0.489 . . . . 12.45 112.119 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 79.68 113.96 0.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.12 1.368 . . . . 14.43 109.797 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 m 61.64 39.17 14.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.361 1.077 . . . . 14.32 109.062 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.69 70.23 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 113.704 -1.589 . . . . 13.75 110.624 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.85 -40.91 46.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.954 0.883 . . . . 12.7 110.247 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 64.03 31.75 13.36 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 113.242 -1.799 . . . . 16.38 112.973 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.75 -18.8 63.2 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.266 0.555 . . . . 13.3 110.788 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 136' ' ' LEU . 2.0 mm? -68.53 -25.39 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.685 -0.689 . . . . 16.25 109.512 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.33 -29.4 10.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.497 -0.774 . . . . 15.87 111.088 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.66 -27.58 58.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.963 0.411 . . . . 13.65 110.725 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -114.82 100.66 1.01 Allowed Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 110.192 -1.163 . . . . 14.16 110.192 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptp -94.2 -15.29 24.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.094 0.473 . . . . 15.45 110.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -122.74 138.26 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.295 -1.002 . . . . 13.63 108.295 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 t -59.36 -16.79 24.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.542 1.137 . . . . 13.9 113.878 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.35 -36.52 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.21 0.529 . . . . 13.81 110.73 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 p -58.81 -44.61 90.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.677 -1.147 . . . . 11.48 112.032 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.96 -46.41 28.94 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.783 -0.722 . . . . 10.35 111.904 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 m -58.71 -52.94 63.55 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 122.859 0.463 . . . . 12.2 110.733 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.09 -44.17 97.77 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.629 -0.714 . . . . 11.86 110.965 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 152' ' ' VAL . 22.1 t90 -67.18 -49.64 63.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.898 -0.592 . . . . 9.32 111.511 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 38.0 ttm -64.7 -33.81 76.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.78 0.659 . . . . 9.5 112.78 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -66.31 -38.18 87.11 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.861 -0.736 . . . . 13.91 109.965 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.1 95.71 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.862 -0.895 . . . . 9.88 110.862 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 148' ' ' TRP . 78.2 t -58.43 -46.97 89.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 123.598 0.759 . . . . 9.27 109.468 174.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.9 m -61.49 -40.43 94.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 11.46 110.135 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -71.36 -53.27 14.72 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.756 -0.656 . . . . 15.04 111.558 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -66.61 -42.62 86.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.798 0.295 . . . . 11.82 111.798 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HD1' ' O ' ' A' ' 152' ' ' VAL . 96.7 m-85 -82.37 -8.9 59.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.048 0.451 . . . . 11.97 110.552 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.9 m 61.46 29.84 18.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.645 1.178 . . . . 14.24 111.588 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 178' ' ' VAL . 28.4 pt -103.64 150.14 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 12.62 109.057 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -89.02 94.92 10.12 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.537 -1.283 . . . . 16.39 107.537 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.61 120.64 42.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.512 -0.767 . . . . 12.32 109.182 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 134.58 57.18 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.929 -1.032 . . . . 14.06 110.932 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -69.27 -20.36 63.92 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.67 -0.696 . . . . 12.64 110.715 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.75 -16.87 64.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.966 -0.561 . . . . 15.68 110.348 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.47 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -65.71 -14.71 61.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.983 -0.553 . . . . 12.72 112.056 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 162' ' ' ALA . 31.7 pt -68.88 -22.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.521 0.676 . . . . 12.16 109.57 175.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -102.64 -15.52 16.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.661 -0.699 . . . . 15.08 109.157 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 25.9 m -77.16 -46.6 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.819 -0.808 . . . . 14.67 108.819 177.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.46 90.24 0.92 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 121.298 0.571 . . . . 12.68 112.425 -176.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.28 41.9 1.23 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.654 2.236 . . . . 14.34 111.191 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -123.07 142.89 50.38 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-O 122.361 1.077 . . . . 12.91 111.061 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.01 -43.19 93.32 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 113.535 -1.666 . . . . 9.89 110.958 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.74 -37.2 86.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.058 -0.974 . . . . 12.5 111.106 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 m -79.29 -33.0 43.7 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.809 -0.632 . . . . 11.04 110.561 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.05 -43.61 91.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.661 -1.237 . . . . 8.5 107.661 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.66 78.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.698 -0.683 . . . . 7.7 110.907 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -29.97 68.51 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.716 -0.675 . . . . 10.38 110.381 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -78.81 -58.0 3.47 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.65 -0.704 . . . . 11.97 111.696 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 110' ' ' ILE . 6.7 p -56.91 -43.75 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.432 0.53 . . . . 9.8 112.432 -175.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.29 -44.67 95.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.143 0.496 . . . . 10.83 110.143 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -72.21 -30.87 65.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.014 -0.994 . . . . 13.5 110.983 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.14 -44.02 85.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.334 -0.617 . . . . 14.84 109.334 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.35 -52.86 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.848 -0.615 . . . . 13.35 110.186 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.308 -1.198 0 N-CA-C 112.432 0.53 . . . . 13.51 112.432 -177.717 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.334 0.588 . . . . 14.98 111.223 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.37 80.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.709 -0.678 . . . . 15.79 111.952 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 p -57.12 -36.04 70.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.517 -0.765 . . . . 12.02 111.445 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.94 76.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.364 -0.606 . . . . 11.02 109.364 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.24 -50.86 72.4 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.591 -0.732 . . . . 16.07 110.57 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -53.94 -47.07 71.65 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.762 0.825 . . . . 13.93 111.954 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -71.68 -36.38 70.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.381 -0.372 . . . . 10.71 111.253 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -67.21 -43.12 82.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.478 0.711 . . . . 14.02 109.841 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -58.59 -45.3 89.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.41 1.084 . . . . 16.29 110.128 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -70.26 -32.88 70.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.263 -0.88 . . . . 12.91 110.761 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.9 -56.66 10.63 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.603 -1.258 . . . . 12.77 107.603 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -61.13 -36.28 79.33 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.727 -1.124 . . . . 15.19 112.154 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.33 86.99 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.178 0.513 . . . . 16.26 111.405 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.6 mmm -78.01 -38.46 44.78 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.95 -0.568 . . . . 15.45 112.072 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.58 -1.86 58.29 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.422 0.63 . . . . 16.16 112.054 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.0 t80 60.61 56.62 2.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.24 1.416 . . . . 20.56 109.959 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 47.6 t -124.57 166.91 15.24 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.778 -1.564 . . . . 16.63 106.778 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -108.93 119.22 49.57 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-O 121.042 0.448 . . . . 20.19 110.346 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 -23.94 67.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.625 2.883 . . . . 16.6 115.091 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.33 -16.62 71.5 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.036 -0.602 . . . . 17.74 113.391 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -127.16 16.85 7.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.785 0.293 . . . . 20.23 111.043 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.33 139.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 109.709 -0.478 . . . . 15.98 109.709 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' NH2' ' HG2' ' A' ' 183' ' ' GLN . 40.5 ttm180 -78.14 96.71 5.24 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.168 -1.049 . . . . 19.33 108.168 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 11.5 p-10 -67.26 -14.7 63.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.686 -0.688 . . . . 14.93 112.135 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.88 5.85 66.67 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.751 -0.738 . . . . 14.82 112.081 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.6 t -87.51 161.44 17.79 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.623 0.725 . . . . 14.54 109.932 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -101.91 142.88 32.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.129 -0.942 . . . . 16.75 112.72 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -42.71 -60.88 1.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.293 1.437 . . . . 11.99 113.848 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.59 -29.86 70.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 14.45 111.879 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -79.38 -13.47 59.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.98 0.419 . . . . 16.44 111.409 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.36 -22.47 44.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.649 0.738 . . . . 13.77 109.195 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 25.28 6.21 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.964 -1.016 . . . . 13.81 111.107 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -74.0 113.47 11.21 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.08 0.467 . . . . 13.04 109.763 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.34 156.23 24.35 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.19 -0.914 . . . . 15.67 110.909 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 t -56.92 -42.32 79.79 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.062 0.458 . . . . 15.29 109.788 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.62 -48.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.494 -0.776 . . . . 16.66 110.92 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.7 mt -66.05 -38.44 82.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.969 -0.56 . . . . 14.14 110.779 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.57 84.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 12.0 110.334 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.52 -38.23 90.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 13.97 110.842 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -71.35 -42.4 68.54 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.645 0.736 . . . . 15.69 110.974 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -61.33 -47.81 84.22 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 125.531 1.532 . . . . 11.69 111.462 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 56' ' ' ILE . 11.3 tp -63.61 -34.02 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 120.855 0.36 . . . . 11.16 111.722 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 37.6 mmt180 -63.11 -38.32 90.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.717 0.294 . . . . 16.65 111.037 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.03 -39.74 93.81 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.35 0.595 . . . . 14.15 109.624 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 45' ' ' ILE . 72.9 mt -60.13 -47.66 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.193 -0.912 . . . . 10.8 110.361 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -60.64 -43.2 97.82 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.793 -0.64 . . . . 12.98 111.591 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -72.19 -58.97 2.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.46 -0.791 . . . . 17.52 111.141 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -30.46 69.8 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.012 1.116 . . . . 14.87 114.012 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.22 -2.36 46.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 113.095 0.776 . . . . 12.2 113.095 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 59.01 45.28 15.07 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.344 1.057 . . . . 16.71 110.003 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.49 165.77 22.82 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.536 -0.302 . . . . 12.2 110.204 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.83 71.34 0.74 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.586 -0.894 . . . . 16.06 108.586 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 45' ' ' ILE . 34.7 mm -101.31 114.69 65.71 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 116.196 -0.456 . . . . 11.39 110.65 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.79 171.01 16.12 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.346 2.03 . . . . 12.6 110.027 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.33 -1.05 9.35 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.409 0.684 . . . . 12.52 111.699 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.04 -30.62 71.1 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.089 0.956 . . . . 14.14 110.55 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.58 98.35 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.299 -0.477 . . . . 10.76 111.993 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.47 -32.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.763 0.792 . . . . 11.0 110.152 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -80.98 -16.5 53.28 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.982 -0.553 . . . . 16.42 111.097 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -83.57 -48.54 10.13 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.1 -0.704 . . . . 13.35 109.1 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.85 118.96 30.25 Favored Pre-proline 0 C--O 1.215 -0.761 0 CA-C-N 116.229 -0.441 . . . . 12.23 111.324 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.52 -3.99 7.5 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.768 2.312 . . . . 13.06 112.577 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.97 119.58 59.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.99 -1.485 . . . . 12.95 106.99 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.2 p90 -62.12 -33.54 74.66 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.884 0.698 . . . . 10.92 112.884 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -62.72 -38.17 89.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.368 0.604 . . . . 14.32 110.827 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.7 -23.86 36.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.72 0.771 . . . . 10.93 109.649 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 80.9 t80 -81.05 -30.13 34.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 8.81 111.874 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 p -67.61 -33.32 74.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.43 -0.794 . . . . 9.35 109.098 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.99 -29.85 64.64 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.253 -0.885 . . . . 11.63 109.543 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.543 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 82.4 t90 -59.62 -44.34 93.47 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.154 0.982 . . . . 10.55 108.847 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.65 -45.42 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 C-N-CA 123.629 0.772 . . . . 8.3 110.306 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.98 75.63 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 116.162 -0.472 . . . . 9.58 113.569 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -77.18 -22.11 52.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.277 0.561 . . . . 10.23 110.661 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -82.55 -2.64 54.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.342 0.592 . . . . 10.43 111.141 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.428 -1.564 0 N-CA-C 104.946 -2.242 . . . . 10.97 104.946 171.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.9 m . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.803 0.335 . . . . 10.05 111.537 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.26 73.3 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.276 -0.875 . . . . 11.22 111.782 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -72.55 -51.36 20.19 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.161 -0.472 . . . . 11.38 110.261 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -49.94 -51.42 41.32 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.705 0.628 . . . . 9.65 110.897 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 104' ' ' SER . 5.9 mm-40 -63.86 -47.99 78.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 10.43 111.721 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.4 m -66.74 -43.53 83.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.182 -0.463 . . . . 10.21 111.765 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 178' ' ' VAL . 73.3 mt -71.91 -23.64 22.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.0 0 N-CA-C 110.014 -0.365 . . . . 8.13 110.014 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -64.73 -41.84 95.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.232 -0.655 . . . . 8.46 109.232 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.58 -38.98 84.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.15 0.5 . . . . 10.86 109.947 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.17 -49.62 76.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.985 -1.007 . . . . 11.45 109.503 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -50.0 -43.67 50.64 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.135 1.374 . . . . 7.62 112.015 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -60.4 -45.29 94.11 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.817 -1.083 . . . . 11.62 109.715 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -82.0 -22.93 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.61 0.719 . . . . 11.63 110.516 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -73.74 -55.1 6.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.269 -0.878 . . . . 9.14 110.39 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.64 -29.25 33.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.566 -0.531 . . . . 10.06 109.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.2 -19.97 62.36 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.884 -0.487 . . . . 12.07 111.884 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.41 -23.88 61.15 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.449 0.7 . . . . 12.32 109.617 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.53 -23.47 19.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.879 -0.6 . . . . 11.77 110.434 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.91 -26.89 23.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.876 -0.416 . . . . 13.52 109.876 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 73.92 -35.11 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.207 1.403 . . . . 16.56 112.76 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.93 129.92 40.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.087 -1.449 . . . . 15.74 107.087 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -119.45 117.22 33.1 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.839 -0.619 . . . . 14.2 109.642 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -88.02 4.64 5.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.968 2.446 . . . . 14.18 112.816 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.83 -78.79 0.02 OUTLIER Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.779 -1.201 . . . . 14.03 113.106 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 177.88 24.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.336 0.654 . . . . 16.37 109.912 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 130' ' ' ARG . 6.3 mp 47.66 -158.19 0.05 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.251 0.62 . . . . 12.45 111.327 -169.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 36.6 mtm-85 76.95 -38.06 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.714 1.206 . . . . 14.43 112.511 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.6 p -69.59 -46.1 67.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.938 -1.134 . . . . 14.32 107.938 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 138' ' ' LEU . . . -100.9 89.37 0.8 Allowed Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 107.588 -2.205 . . . . 13.75 107.588 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.58 -14.03 10.87 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 111.545 0.202 . . . . 12.7 111.545 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.99 133.04 47.62 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.824 0.821 . . . . 16.38 110.313 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -65.67 -20.05 66.14 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.829 -1.078 . . . . 13.3 110.035 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.94 -24.9 68.09 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.906 -1.043 . . . . 16.25 111.676 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.13 -34.7 8.31 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.05 -0.66 . . . . 15.87 110.949 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 132' ' ' GLY . 35.3 mt -91.83 -27.17 18.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.638 -0.71 . . . . 13.65 112.721 -171.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -106.96 78.85 0.25 Allowed Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.428 -0.892 . . . . 14.16 113.892 -174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 50.2 tpp -80.87 -40.63 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.157 -1.053 . . . . 15.45 108.157 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -99.59 113.27 25.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.159 -0.928 . . . . 13.63 109.0 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.6 t -72.67 -38.45 67.6 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.244 -0.889 . . . . 13.9 110.449 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.89 -32.05 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.326 0.584 . . . . 13.81 112.02 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.1 t -77.55 -27.15 51.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.104 -1.038 . . . . 11.48 109.726 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.79 -28.58 34.59 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.092 -1.051 . . . . 10.35 111.166 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.549 ' HB ' ' HB1' ' A' ' 162' ' ' ALA . 16.9 p -66.94 -43.24 83.72 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 109.217 -0.66 . . . . 12.2 109.217 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -56.8 -49.75 74.4 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.135 -0.939 . . . . 11.86 109.21 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -55.29 -53.06 60.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.199 -0.91 . . . . 9.32 112.203 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.1 tpt -56.94 -48.84 77.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.436 0.694 . . . . 9.5 110.844 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -64.33 -36.13 83.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.267 -0.424 . . . . 13.91 110.872 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.69 97.64 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.814 -0.515 . . . . 9.88 111.814 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.44 -43.27 98.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.805 -0.442 . . . . 9.27 109.805 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.0 t -59.62 -46.41 89.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.435 -0.802 . . . . 11.46 109.428 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.55 -48.99 78.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.196 0.998 . . . . 15.04 111.025 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -58.53 -27.61 64.69 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.62 0.768 . . . . 11.82 112.779 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -107.46 4.71 26.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.779 0.659 . . . . 11.97 112.779 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m 58.29 32.22 21.79 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.77 0.795 . . . . 14.24 111.315 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.6 pt -107.13 165.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.342 -0.984 . . . . 12.62 108.342 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.97 94.5 5.02 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.335 0.588 . . . . 16.39 112.051 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.69 108.72 10.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.175 -1.046 . . . . 12.32 108.175 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.5 154.75 35.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.194 -0.912 . . . . 14.06 109.835 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB1' ' HB ' ' A' ' 146' ' ' THR . . . -63.72 -16.98 62.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.939 -1.028 . . . . 12.64 113.138 -174.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.93 -6.47 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 116.431 -0.35 . . . . 15.68 111.267 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.96 -11.28 46.43 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.138 0.422 . . . . 12.72 112.138 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.8 pt -64.84 -13.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.253 0.549 . . . . 12.16 111.365 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.59 -1.95 16.63 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.205 -0.452 . . . . 15.08 110.289 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.7 m -84.39 -30.61 25.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.014 -0.539 . . . . 14.67 110.589 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -116.93 108.96 43.52 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.271 -1.011 . . . . 12.68 108.271 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -48.73 -37.73 35.83 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.947 3.098 . . . . 14.34 112.846 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.7 p -125.55 141.01 52.26 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.792 -1.188 . . . . 12.91 107.792 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.61 -1.73 47.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.811 0.671 . . . . 9.89 112.811 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -66.5 -26.08 67.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.162 -1.051 . . . . 12.5 108.162 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 18.1 m -76.1 -18.62 59.09 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.237 -1.347 . . . . 11.04 111.752 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.43 -35.68 76.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.884 0.474 . . . . 8.5 110.286 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.58 -37.64 79.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.142 -0.481 . . . . 7.7 111.567 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.9 -32.6 61.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 10.38 110.349 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 173' ' ' SER . 46.9 mm-40 -70.08 -48.73 56.5 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.619 -0.719 . . . . 11.97 109.998 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 110' ' ' ILE . 12.1 p -66.78 -40.64 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 9.8 111.376 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.99 -37.16 78.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.548 0.689 . . . . 10.83 110.226 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 180' ' ' ARG . 38.6 ttm180 -67.13 -45.85 75.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.982 -1.008 . . . . 13.5 110.106 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -67.99 -48.24 66.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 14.84 111.765 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 90.0 t -64.32 -53.4 43.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 123.48 0.488 . . . . 13.35 109.992 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.468 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 61.7 tt0 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 123.906 0.883 . . . . 13.51 111.62 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.547 0.689 . . . . 14.98 109.404 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.72 -39.4 91.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.397 -0.819 . . . . 15.79 109.887 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.63 -45.11 89.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.039 -0.726 . . . . 12.02 109.039 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.64 94.54 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.994 -0.548 . . . . 11.02 110.891 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -62.63 -37.54 86.73 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.782 0.29 . . . . 16.07 111.782 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.57 -40.49 89.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.53 0.681 . . . . 13.93 110.242 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.57 -33.09 64.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.389 -0.524 . . . . 10.71 111.041 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.26 -50.05 75.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.779 0.432 . . . . 14.02 110.881 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 22' ' ' PRO . 10.2 pt20 -67.26 -23.85 65.74 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.266 -0.425 . . . . 16.29 111.595 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 m -83.23 -49.4 9.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.994 0.426 . . . . 12.91 110.415 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.1 -52.73 62.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.235 0.614 . . . . 12.77 110.512 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.39 -24.88 64.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.395 0.517 . . . . 15.19 112.395 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.56 85.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.878 0.37 . . . . 16.26 110.147 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.6 mtm -74.01 -27.68 61.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.701 -0.681 . . . . 15.45 111.64 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.04 4.29 54.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.306 -0.406 . . . . 16.16 111.84 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 55.23 39.79 31.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.382 1.073 . . . . 20.56 112.272 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -109.24 155.69 20.8 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.603 -1.258 . . . . 16.63 107.603 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.54 118.84 71.22 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 109.308 -0.627 . . . . 20.19 109.308 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 5.6 Cg_exo -72.8 -29.09 12.92 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.395 2.064 . . . . 16.6 114.272 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.79 8.19 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.577 -1.009 . . . . 17.74 110.577 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.49 70.47 8.97 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.268 0.556 . . . . 20.23 111.12 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.62 149.9 13.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.704 -1.221 . . . . 15.98 107.704 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 28' ' ' GLY . 13.8 ttp180 -82.53 126.08 31.85 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 122.319 0.248 . . . . 19.33 110.406 -177.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.43 -23.62 67.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.606 0.762 . . . . 14.93 112.1 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 26' ' ' ARG . . . -96.7 6.76 65.11 Favored Glycine 0 C--N 1.309 -0.929 0 CA-C-N 115.917 -0.583 . . . . 14.82 113.902 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 26' ' ' ARG . 68.8 m -65.14 153.28 41.34 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.932 0.873 . . . . 14.54 112.186 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 8.9 mmm180 -92.15 152.96 19.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.005 -0.998 . . . . 16.75 109.841 -172.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 58.2 m-85 -57.79 -50.29 73.76 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 119.367 0.985 . . . . 11.99 112.836 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 36' ' ' LEU . 3.9 mm? -70.14 -9.37 55.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.415 0.626 . . . . 14.45 111.551 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.27 -37.9 12.39 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.084 -0.71 . . . . 16.44 109.084 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -61.31 -33.85 74.27 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.565 0.746 . . . . 13.77 111.234 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.19 9.75 8.53 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.63 -0.988 . . . . 13.81 110.63 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 41' ' ' ALA . 8.3 tt -91.58 137.1 32.64 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.363 -0.977 . . . . 13.04 108.363 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.486 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -132.55 166.93 20.95 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.21 1.004 . . . . 15.67 109.117 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -42.84 -54.62 4.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 15.29 113.437 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.59 -40.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.285 0.564 . . . . 16.66 111.411 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 67.4 mt -66.41 -36.77 78.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.816 -0.629 . . . . 14.14 110.093 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.02 -45.01 87.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.14 -0.936 . . . . 12.0 110.766 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.35 -36.31 75.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.277 -0.874 . . . . 13.97 110.933 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.33 -41.18 57.31 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.49 -0.777 . . . . 15.69 111.507 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -64.84 -41.11 95.98 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.91 -0.586 . . . . 11.69 110.796 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 41' ' ' ALA . 34.3 mm -55.1 -41.6 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.169 -0.469 . . . . 11.16 110.266 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -58.58 -31.71 68.28 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.526 -0.761 . . . . 16.65 110.622 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -80.02 -46.98 15.64 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.603 -0.271 . . . . 14.15 111.288 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 45' ' ' ILE . 22.6 pt -65.74 -32.1 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.539 -0.464 . . . . 10.8 110.41 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' ND2' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -60.58 -39.34 87.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.238 0.542 . . . . 12.98 110.19 175.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -73.64 -48.71 30.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.948 -1.024 . . . . 17.52 111.743 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.0 -34.37 64.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.872 -0.731 . . . . 14.87 111.822 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -88.87 -6.37 57.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.963 0.727 . . . . 12.2 112.963 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 57.82 41.85 24.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.89 1.276 . . . . 16.71 111.235 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 tp -141.28 136.24 31.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.248 -1.019 . . . . 12.2 108.248 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -84.11 56.0 3.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.833 0.825 . . . . 16.06 109.551 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.545 HG22 ' ND2' ' A' ' 49' ' ' ASN . 10.9 tt -60.24 134.98 90.92 Favored Pre-proline 0 C--O 1.253 1.262 0 CA-C-N 114.139 -1.391 . . . . 11.39 110.2 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -79.07 162.07 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.582 2.188 . . . . 12.6 111.946 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 45' ' ' ILE . . . -80.56 2.19 26.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.011 -0.995 . . . . 12.52 111.65 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 5.2 m-20 -62.28 -18.26 60.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.961 -0.563 . . . . 14.14 112.37 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' A' ' 70' ' ' PHE . . . -63.84 -39.34 97.3 Favored Glycine 0 C--O 1.213 -1.183 0 C-N-CA 120.412 -0.899 . . . . 10.76 111.648 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -82.62 -12.84 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 123.025 1.393 . . . . 11.0 108.238 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 52.3 t80 -78.73 -44.91 22.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.174 -1.375 . . . . 16.42 110.058 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.0 t -93.4 -31.98 14.42 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.558 0.577 . . . . 13.35 112.558 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.06 125.67 45.14 Favored Pre-proline 0 CA--C 1.5 -0.964 0 O-C-N 121.785 -0.572 . . . . 12.23 110.805 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 60.4 Cg_endo -87.61 -18.11 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.042 1.828 . . . . 13.06 111.601 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.4 t -108.24 133.38 53.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.195 -1.409 . . . . 12.95 107.195 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 43.6 p90 -72.74 -34.82 67.29 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.375 0.509 . . . . 10.92 112.375 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -71.19 -20.65 62.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.496 0.665 . . . . 14.32 111.005 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.97 -25.86 40.21 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.544 0.688 . . . . 10.93 109.883 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.524 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 9.2 t80 -68.04 -30.34 69.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.635 . . . . 8.81 111.325 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -63.87 -22.2 66.81 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.856 0.687 . . . . 9.35 112.856 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.83 -28.03 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.378 0.608 . . . . 11.63 110.07 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -73.81 -45.74 49.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.794 -0.639 . . . . 10.55 109.41 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.57 -42.28 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.661 0 N-CA-C 109.726 -0.472 . . . . 8.3 109.726 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.06 74.31 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.606 -0.725 . . . . 9.58 113.518 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 p -81.21 -38.33 27.16 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.099 -0.64 . . . . 10.23 111.877 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -73.98 -46.65 42.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.959 -0.696 . . . . 10.43 110.025 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 115.907 -0.588 . . . . 10.97 109.667 179.654 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 113.567 0.951 . . . . 10.05 113.567 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.89 -25.25 55.91 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.759 0.281 . . . . 11.22 111.759 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.98 -37.77 88.76 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.45 -0.341 . . . . 11.38 111.762 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -57.34 10.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 9.65 110.737 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -61.72 -44.43 96.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.574 -0.739 . . . . 10.43 109.924 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.8 t -60.39 -43.48 96.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.6 -0.727 . . . . 10.21 110.969 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.6 mt -55.98 -51.41 61.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.36 0.664 . . . . 8.13 110.511 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.58 -39.86 94.49 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 115.201 -0.909 . . . . 8.46 109.869 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.49 -34.82 74.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.957 0.503 . . . . 10.86 111.777 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -68.34 -53.54 23.39 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 110.016 -0.364 . . . . 11.45 110.016 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 171' ' ' LEU . 9.4 tt -63.36 -27.68 69.48 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.306 -0.861 . . . . 7.62 110.401 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.11 -46.19 90.13 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.734 1.214 . . . . 11.62 109.869 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -69.26 -33.8 73.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.048 -0.523 . . . . 11.63 110.91 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -63.48 -42.74 98.55 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.208 -0.451 . . . . 9.14 110.432 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.98 -40.99 68.19 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.622 -0.51 . . . . 10.06 109.622 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.54 -49.79 70.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.852 -0.613 . . . . 12.07 112.424 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.56 -25.84 66.0 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.003 0.521 . . . . 12.32 110.438 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.26 -46.76 60.2 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.06 -0.719 . . . . 11.77 109.06 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.29 -81.03 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.512 -0.767 . . . . 13.52 110.04 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -158.55 -45.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.116 -1.068 . . . . 16.56 108.116 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.7 tp -167.84 157.58 10.13 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.487 -2.412 . . . . 15.74 104.487 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.52 118.01 67.85 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 118.474 0.579 . . . . 14.2 110.733 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.29 -8.21 11.78 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.495 2.13 . . . . 14.18 111.752 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.6 -10.26 74.16 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.246 -0.742 . . . . 14.03 111.246 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -89.66 37.1 0.86 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.24 1.019 . . . . 16.37 110.497 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.21 -5.68 13.02 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.304 -1.316 . . . . 12.45 110.802 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -85.78 121.66 28.75 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.089 -0.505 . . . . 14.43 110.082 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.1 m 69.85 -66.34 0.27 Allowed 'General case' 0 C--O 1.247 0.926 0 C-N-CA 125.082 1.353 . . . . 14.32 112.175 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.5 82.72 1.51 Allowed Glycine 0 C--O 1.239 0.453 0 CA-C-N 116.412 -0.358 . . . . 13.75 113.007 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . -143.49 117.4 9.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.895 -1.15 . . . . 12.7 107.895 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -115.73 164.16 14.76 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.184 -1.413 . . . . 16.38 107.184 -173.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.631 ' H ' ' NE2' ' A' ' 134' ' ' GLN . 40.5 m-85 -42.82 -47.16 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.307 0.854 . . . . 13.3 113.307 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 pp -55.82 -33.85 64.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.679 0.622 . . . . 16.25 112.679 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.68 -1.73 27.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.567 0.58 . . . . 15.87 112.567 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 96.6 mt -93.89 -27.19 16.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.233 0.539 . . . . 13.65 109.775 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 170.67 126.38 0.87 Allowed Glycine 0 N--CA 1.432 -1.594 0 N-CA-C 110.411 -1.076 . . . . 14.16 110.411 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp -70.17 -30.17 67.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.163 0.506 . . . . 15.45 110.904 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -106.92 124.64 49.92 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.743 -0.836 . . . . 13.63 108.743 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 t -61.49 -30.05 70.37 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.422 -0.808 . . . . 13.9 112.473 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 t -76.91 -25.18 15.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 CA-C-O 121.536 0.684 . . . . 13.81 109.99 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -70.65 -28.19 64.61 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.694 -0.803 . . . . 11.48 110.235 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.34 -21.16 59.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.036 -1.225 . . . . 10.35 110.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 m -67.31 -44.77 78.34 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.012 -1.107 . . . . 12.2 108.012 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.26 -46.2 90.65 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.318 -1.31 . . . . 11.86 109.706 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -59.03 -46.72 87.51 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.739 -1.118 . . . . 9.32 111.279 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.1 tpt -53.29 -55.73 22.29 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.558 0.743 . . . . 9.5 112.093 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -63.75 -30.11 71.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.599 -0.44 . . . . 13.91 111.669 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 -50.07 50.33 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.004 -0.839 . . . . 9.88 111.004 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.83 -40.34 86.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.284 0.634 . . . . 9.27 110.25 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.9 t -54.27 -58.83 5.91 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.046 -0.979 . . . . 11.46 110.697 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -71.23 -24.95 62.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.283 -0.417 . . . . 15.04 111.638 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -61.07 -34.93 75.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.689 0.28 . . . . 11.82 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -100.55 6.41 44.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 11.97 111.272 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.3 m 57.42 44.0 22.19 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.284 1.034 . . . . 14.24 111.188 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.5 pt -122.18 146.78 26.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 106.777 -1.564 . . . . 12.62 106.777 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -96.81 96.73 8.76 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.869 -0.732 . . . . 16.39 110.95 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.64 139.48 45.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.555 -0.906 . . . . 12.32 108.555 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.94 44.28 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.426 -0.806 . . . . 14.06 109.201 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.86 -24.04 67.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.593 -0.731 . . . . 12.64 111.616 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.34 2.69 51.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.019 -0.537 . . . . 15.68 111.528 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.55 -14.86 63.07 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.846 -0.534 . . . . 12.72 111.799 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.6 pt -61.37 -18.08 17.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 122.912 0.485 . . . . 12.16 111.478 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -83.47 -6.97 59.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.078 0.466 . . . . 15.08 110.366 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -99.22 -19.51 17.08 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.668 -0.696 . . . . 14.67 110.983 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -116.54 98.74 52.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.332 -0.547 . . . . 12.68 111.554 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.434 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 43.4 Cg_endo -72.22 -29.0 14.8 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.227 1.951 . . . . 14.34 112.408 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 3.3 p -126.71 143.39 51.25 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.378 0.609 . . . . 12.91 110.031 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 114' ' ' LEU . 34.6 tp -56.18 -26.95 52.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.258 1.423 . . . . 9.89 113.045 -174.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.41 -29.72 66.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.844 -0.616 . . . . 12.5 111.125 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -77.54 -30.3 52.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 11.04 109.934 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 178' ' ' VAL . 47.9 tp -75.82 -50.97 13.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.714 -0.675 . . . . 8.5 109.213 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.52 -47.34 48.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.201 0.6 . . . . 7.7 111.817 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 15.2 t70 -65.77 -31.31 72.22 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.773 0.32 . . . . 10.38 111.16 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.31 -40.31 74.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.597 -0.52 . . . . 11.97 109.597 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 174' ' ' LEU . 15.6 t -60.61 -42.24 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.08 -0.711 . . . . 9.8 109.08 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.67 -39.42 65.06 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 123.985 0.803 . . . . 10.83 111.144 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 20.0 mmt180 -73.14 -46.06 53.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.451 -0.574 . . . . 13.5 109.451 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 2.9 mmp_? -63.63 -39.23 93.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.432 -0.804 . . . . 14.84 112.02 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.12 -34.11 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 13.35 110.213 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.445 1.098 . . . . 13.51 110.749 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 C--O 1.244 0.78 0 N-CA-C 110.376 -0.231 . . . . 18.51 110.376 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 175.15 -175.31 0.09 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.264 1.026 . . . . 16.66 109.16 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.15 -18.69 65.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.844 0.831 . . . . 14.84 109.809 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.79 -11.28 60.55 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.768 -1.105 . . . . 14.98 111.682 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.15 -42.38 80.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 111.749 0.277 . . . . 15.79 111.749 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.3 t -56.34 -44.11 79.74 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.87 -0.605 . . . . 12.02 110.696 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -37.81 50.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.107 -0.497 . . . . 11.02 111.173 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -40.98 98.46 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 122.895 0.478 . . . . 16.07 109.713 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.68 -38.29 84.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.326 0.584 . . . . 13.93 110.175 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.36 -37.56 60.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.529 -0.759 . . . . 10.71 109.913 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 25' ' ' ILE . 4.9 ttp180 -64.18 -32.4 73.96 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.469 -0.787 . . . . 14.02 110.608 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -61.81 -48.71 79.37 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.693 0.797 . . . . 16.29 110.931 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p -72.52 -30.54 64.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.081 0.467 . . . . 12.91 110.945 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.33 -52.17 49.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.449 -1.315 . . . . 12.77 107.449 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.69 65.88 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.756 -0.656 . . . . 15.19 111.576 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -31.01 69.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.747 0.308 . . . . 16.26 110.676 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.59 -28.37 60.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.168 0.508 . . . . 15.45 110.402 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.36 -8.25 55.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.697 -0.683 . . . . 16.16 111.522 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 56.54 46.91 19.65 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.563 -1.199 . . . . 20.56 110.255 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.2 t -124.39 164.1 20.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.782 -1.554 . . . . 16.63 108.302 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.96 126.65 60.49 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.697 -1.223 . . . . 20.19 107.697 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 -8.4 23.52 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.945 2.43 . . . . 16.6 114.312 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.46 52.72 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.79 -0.719 . . . . 17.74 111.31 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -83.38 84.04 7.65 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.434 -0.95 . . . . 20.23 108.434 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.489 HG21 ' HD2' ' A' ' 11' ' ' ARG . 10.8 tp -142.07 149.02 19.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.135 0.493 . . . . 15.98 110.484 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 -101.79 120.21 40.01 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.76 -1.941 . . . . 19.33 105.76 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -67.83 -17.48 64.52 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 120.945 0.403 . . . . 14.93 111.678 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.45 7.42 61.68 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.484 -0.78 . . . . 14.82 112.953 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 p -66.56 133.35 50.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.794 0.807 . . . . 14.54 110.557 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 34.6 mtp85 -82.84 139.12 33.67 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.096 -0.957 . . . . 16.75 111.183 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -47.26 -43.11 21.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.486 0.585 . . . . 11.99 112.538 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.53 -32.24 71.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.227 1.011 . . . . 14.45 111.904 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.6 -41.64 65.41 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.522 0.677 . . . . 16.44 109.215 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.67 -21.09 61.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.381 -1.282 . . . . 13.77 111.104 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.34 29.12 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.341 -0.933 . . . . 13.81 112.468 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.78 85.41 7.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.329 -1.36 . . . . 13.04 107.329 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -68.72 154.58 41.69 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.872 -1.058 . . . . 15.67 110.576 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 t -49.57 -41.52 41.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.261 0.624 . . . . 15.29 112.311 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -48.52 85.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.214 0.531 . . . . 16.66 110.66 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.3 -36.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.621 -0.718 . . . . 14.14 109.585 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 45' ' ' ILE . . . -59.43 -44.34 92.93 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.377 -0.829 . . . . 12.0 110.727 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -59.93 -46.45 89.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 13.97 110.533 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -59.27 -44.61 92.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.99 -0.55 . . . . 15.69 111.259 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.432 ' O ' HG13 ' A' ' 48' ' ' ILE . 7.5 t90 -60.13 -48.23 82.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 124.547 1.139 . . . . 11.69 110.051 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 41' ' ' ALA . 30.3 mm -56.94 -45.73 83.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.895 -0.593 . . . . 11.16 111.03 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 18.8 mmm180 -62.82 -31.07 71.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.429 -0.35 . . . . 16.65 110.97 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.13 -38.11 69.33 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 110.026 -0.361 . . . . 14.15 110.026 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 44' ' ' TRP . 68.7 mt -61.68 -50.77 78.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.327 -0.99 . . . . 10.8 108.327 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -54.59 -39.03 67.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.631 -1.168 . . . . 12.98 112.147 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -85.92 -37.32 19.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.73 1.011 . . . . 17.52 113.73 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -87.61 -24.48 23.96 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.508 1.299 . . . . 14.87 114.508 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.93 -10.45 19.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.004 0.742 . . . . 12.2 113.004 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 63.57 70.72 0.52 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 16.71 112.304 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.1 174.72 13.29 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.734 -1.209 . . . . 12.2 107.734 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.74 105.1 9.04 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 118.565 0.62 . . . . 16.06 111.148 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 74' ' ' VAL . 27.3 mm -72.51 124.23 90.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 O-C-N 121.82 -0.55 . . . . 11.39 111.91 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.05 126.48 14.53 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.471 -2.165 . . . . 12.6 106.471 167.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 2.18 0.55 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 115.792 1.775 . . . . 12.52 115.792 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -97.84 10.96 38.86 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.561 -0.712 . . . . 14.14 110.588 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.45 -55.89 27.52 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 121.373 -0.441 . . . . 10.76 112.242 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.42 -29.02 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.798 0.809 . . . . 11.0 110.858 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.41 -36.56 68.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.485 -0.78 . . . . 16.42 110.627 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 m -84.99 -40.96 16.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.154 -0.475 . . . . 13.35 110.7 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HE1' ' CE3' ' A' ' 73' ' ' TRP . 68.5 m-85 -111.87 102.45 53.65 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.618 -0.882 . . . . 12.23 108.618 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 89.4 Cg_endo -83.5 4.08 7.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.286 1.991 . . . . 13.06 112.46 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.9 t -123.49 120.9 61.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.388 -1.338 . . . . 12.95 107.388 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -59.21 -32.5 70.0 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.335 0.865 . . . . 10.92 113.335 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -62.45 -46.32 89.06 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.994 0.184 . . . . 14.32 110.822 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.01 67.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.406 0.622 . . . . 10.93 110.986 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.76 -24.26 48.91 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.254 1.022 . . . . 8.81 113.095 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.4 p -60.28 -23.93 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.983 -0.448 . . . . 9.35 112.201 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.59 -29.2 69.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.802 0.81 . . . . 11.63 109.621 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CE3' ' HE1' ' A' ' 64' ' ' TYR . 43.6 t-105 -87.32 -24.62 24.24 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.34 -0.845 . . . . 10.55 110.46 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.465 ' HA ' HD11 ' A' ' 56' ' ' ILE . 42.6 t -84.0 -53.97 9.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.188 -0.46 . . . . 8.3 110.916 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.8 66.63 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.866 -0.606 . . . . 9.58 114.097 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.1 t -75.75 -17.82 59.76 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.282 -0.54 . . . . 10.23 110.77 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' A' ' 56' ' ' ILE . 69.5 mm-40 -84.76 -7.81 59.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.45 -0.341 . . . . 10.43 111.332 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.24 118.46 8.01 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.806 -0.442 . . . . 10.97 109.806 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 82' ' ' GLN . 1.6 mp0 -66.37 126.15 91.59 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.786 -0.643 . . . . 13.52 110.585 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 45.38 1.96 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.732 2.288 . . . . 12.28 111.598 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -152.63 47.25 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.354 -1.35 . . . . 13.44 107.354 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 79' ' ' GLN . 15.3 mm100 -103.75 -30.19 10.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.388 -0.823 . . . . 13.27 111.066 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.36 -61.62 1.48 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.054 0.454 . . . . 14.48 110.563 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -90.94 89.82 7.62 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.143 -0.688 . . . . 14.92 109.143 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.63 35.77 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.408 -0.36 . . . . 14.25 111.468 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.16 119.98 63.51 Favored Pre-proline 0 C--N 1.314 -0.95 0 C-N-CA 120.918 -0.313 . . . . 12.97 110.455 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.89 -28.83 9.03 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.218 1.945 . . . . 13.4 112.022 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -146.21 139.11 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.456 -0.942 . . . . 12.43 108.456 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.7 -52.06 2.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.002 0.429 . . . . 13.45 110.741 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -129.86 10.86 5.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.056 -1.09 . . . . 14.41 108.056 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -78.42 120.99 83.15 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 114.668 -1.151 . . . . 11.68 110.786 -172.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.25 -1.72 10.4 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.492 2.128 . . . . 10.84 111.975 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.15 126.82 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 121.253 0.549 . . . . 10.46 110.24 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.8 43.64 1.14 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.761 0.791 . . . . 10.58 110.423 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -164.19 167.16 20.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.151 -1.796 . . . . 11.04 106.151 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.23 88.04 13.31 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 111.954 0.353 . . . . 10.88 111.954 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.86 -55.56 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.006 1.804 . . . . 12.46 108.85 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -159.77 128.11 2.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.165 -0.925 . . . . 13.78 108.698 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -96.23 43.18 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.711 2.274 . . . . 11.95 112.35 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.49 -94.14 1.13 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.466 -0.873 . . . . 11.48 111.315 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.12 -15.23 61.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.523 . . . . 11.55 110.415 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -66.79 -33.99 76.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.029 -0.73 . . . . 12.59 109.029 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.12 -55.39 3.35 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.414 -0.812 . . . . 11.24 109.031 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 m -86.01 58.81 5.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.516 0.674 . . . . 10.05 110.913 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.85 -46.2 19.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.317 -0.856 . . . . 11.22 110.412 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -54.01 -44.75 71.19 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.0 -0.545 . . . . 11.38 110.879 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -58.28 -47.37 83.86 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.272 -0.877 . . . . 9.65 112.934 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -35.58 60.47 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.681 -0.807 . . . . 10.43 111.353 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.9 m -58.38 -47.98 82.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.095 -0.502 . . . . 10.21 110.858 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.495 HG21 HG11 ' A' ' 178' ' ' VAL . 47.0 mt -63.0 -49.62 82.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 O-C-N 123.353 0.408 . . . . 8.13 110.001 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -51.7 -57.07 10.27 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.953 0.783 . . . . 8.46 112.911 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -67.82 -36.43 80.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.796 0.331 . . . . 10.86 111.471 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.39 -36.26 76.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.617 -0.512 . . . . 11.45 109.617 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.37 -39.08 91.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.629 -0.878 . . . . 7.62 108.629 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.95 -45.98 92.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.138 -0.937 . . . . 11.62 110.438 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.97 -32.56 72.23 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.419 -0.355 . . . . 11.63 111.02 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -65.45 -51.51 59.67 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.892 -0.41 . . . . 9.14 109.892 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.4 tp -64.14 -42.84 96.63 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.451 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.14 91.42 Favored Glycine 0 CA--C 1.518 0.227 0 O-C-N 123.146 0.279 . . . . 12.07 113.099 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.25 -45.35 93.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.862 0.839 . . . . 12.32 109.392 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 144' ' ' THR . 45.2 tp -70.02 -45.99 66.04 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.525 -1.216 . . . . 11.77 110.739 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.3 tp -72.82 -11.0 60.43 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.934 0.894 . . . . 13.52 110.948 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.0 t80 85.97 -34.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.163 1.785 . . . . 16.56 111.665 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.5 tp -165.12 149.81 9.08 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.963 -1.495 . . . . 15.74 106.963 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -86.99 122.03 71.37 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 105.876 -1.898 . . . . 14.2 105.876 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.38 -3.07 12.25 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 122.65 2.233 . . . . 14.18 111.446 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -162.65 -107.6 0.21 Allowed Glycine 0 C--N 1.291 -1.925 0 CA-C-N 114.773 -1.103 . . . . 14.03 110.701 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -155.87 43.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.199 -2.149 . . . . 16.37 105.199 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.0 mt 62.15 -178.21 0.13 Allowed 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.085 -1.416 . . . . 12.45 111.088 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -148.34 146.51 28.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.736 -1.209 . . . . 14.43 107.736 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.8 t -76.23 91.44 3.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 14.32 109.689 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.37 -92.25 0.15 Allowed Glycine 0 CA--C 1.49 -1.511 0 N-CA-C 108.43 -1.868 . . . . 13.75 108.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 68.23 128.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.336 1.454 . . . . 12.7 112.079 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.54 -176.32 3.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.608 -0.724 . . . . 16.38 109.689 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 169' ' ' PRO . 66.9 m-85 -63.74 -27.35 69.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.532 0.682 . . . . 13.3 109.652 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.28 -25.24 65.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.736 -1.12 . . . . 16.25 111.216 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.32 -7.33 55.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.419 -0.81 . . . . 15.87 110.23 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.1 mt -106.59 9.3 31.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.473 0.654 . . . . 13.65 110.093 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.64 -175.11 15.94 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.584 -0.734 . . . . 14.16 111.774 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 84.7 mtp -107.09 -9.09 16.27 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.604 0.716 . . . . 15.45 109.979 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -118.58 159.97 22.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.292 -0.867 . . . . 13.63 108.92 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.1 p -81.4 -16.34 52.46 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.776 0.798 . . . . 13.9 109.866 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.41 -36.37 77.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.823 -1.08 . . . . 13.81 111.087 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 121' ' ' LEU . 7.2 p -63.57 -42.44 98.32 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 116.159 -0.473 . . . . 11.48 110.428 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.08 -41.59 70.19 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.536 -0.756 . . . . 10.35 112.554 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.1 p -65.3 -46.64 79.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 117.082 0.441 . . . . 12.2 111.456 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -59.92 -49.53 77.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 11.86 110.389 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.585 ' O ' HG23 ' A' ' 152' ' ' VAL . 13.9 t90 -62.72 -51.83 65.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.567 -0.742 . . . . 9.32 112.121 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.478 ' SD ' HG13 ' A' ' 165' ' ' ILE . 39.6 ttm -63.79 -37.08 86.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.189 0.44 . . . . 9.5 112.189 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -69.43 -29.07 66.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.493 -0.483 . . . . 13.91 110.533 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.31 -42.47 82.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.688 -0.965 . . . . 9.88 110.688 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 148' ' ' TRP . 22.1 t -58.66 -48.31 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.76 -1.2 . . . . 9.27 107.76 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.8 t -57.71 -52.7 64.39 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.187 -1.37 . . . . 11.46 110.906 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -66.35 -44.14 84.12 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.762 -0.654 . . . . 15.04 111.94 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -65.61 -37.77 87.55 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.039 0.755 . . . . 11.82 113.039 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 110' ' ' ILE . 97.3 m-85 -93.31 9.91 34.27 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.226 0.536 . . . . 11.97 111.894 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 57.39 43.21 23.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.516 1.126 . . . . 14.24 112.355 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -122.17 155.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.391 -0.596 . . . . 12.62 109.391 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -97.91 97.29 8.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.115 -0.698 . . . . 16.39 109.115 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.17 125.68 54.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.491 -0.929 . . . . 12.32 108.491 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.97 136.01 40.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.263 -0.426 . . . . 14.06 111.106 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.86 -11.46 59.99 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 121.774 0.797 . . . . 12.64 110.421 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.98 -12.03 61.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.139 0.971 . . . . 15.68 109.518 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.2 -10.22 55.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.474 -0.785 . . . . 12.72 109.967 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.478 HG13 ' SD ' ' A' ' 149' ' ' MET . 11.4 mt -56.51 -32.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.81 1.244 . . . . 12.16 109.965 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.29 -6.37 59.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.709 -1.132 . . . . 15.08 109.761 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 88.3 m -94.87 -18.34 21.25 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.052 -0.976 . . . . 14.67 109.582 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.586 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.8 m0 -117.78 98.96 52.09 Favored Pre-proline 0 C--N 1.318 -0.793 0 O-C-N 121.927 -0.483 . . . . 12.68 111.003 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 83.6 Cg_endo -87.12 3.28 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.556 2.171 . . . . 14.34 112.205 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -139.57 143.9 37.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.88 0.848 . . . . 12.91 111.655 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.36 -28.4 68.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.067 1.747 . . . . 9.89 112.949 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.31 -26.72 60.34 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.047 0.451 . . . . 12.5 110.907 -176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -67.1 -44.98 78.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 113.575 0.954 . . . . 11.04 113.575 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 174' ' ' LEU . 2.6 pt? -75.32 -25.85 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.0 -1.08 . . . . 8.5 110.585 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.36 92.78 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.888 -0.596 . . . . 7.7 111.186 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.56 -26.12 32.68 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.008 -0.677 . . . . 10.38 110.61 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.586 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 9.6 tp10 -68.54 -54.13 18.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.543 -0.298 . . . . 11.97 110.802 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -50.02 -43.82 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 112.718 0.636 . . . . 9.8 112.718 -176.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 -41.92 92.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.994 0.426 . . . . 10.83 111.399 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -71.87 -29.3 64.22 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.019 -0.537 . . . . 13.5 110.338 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 5.4 mmp_? -65.06 -42.74 93.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.021 -0.536 . . . . 14.84 109.946 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.62 -51.9 23.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.19 -0.459 . . . . 13.35 111.217 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 112.293 0.479 . . . . 13.51 112.293 -178.842 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.24 0.543 . . . . 18.51 111.049 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.32 2.33 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.256 -0.429 . . . . 16.66 111.483 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.19 -17.85 17.94 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.877 0.846 . . . . 14.84 109.973 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.85 -16.64 61.13 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.797 -1.092 . . . . 14.98 110.469 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.75 -42.69 99.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.278 0.473 . . . . 15.79 112.278 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -58.09 -44.43 87.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.018 0.927 . . . . 12.02 110.01 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.32 72.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.786 -0.643 . . . . 11.02 110.887 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 27.2 tt0 -67.36 -43.82 80.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.016 -0.364 . . . . 16.07 110.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.547 ' HA ' HE21 ' A' ' 12' ' ' GLN . 30.2 t80 -53.78 -39.02 65.05 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.409 1.084 . . . . 13.93 110.933 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 mt -82.05 -39.19 23.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.777 -0.647 . . . . 10.71 110.96 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -64.01 -22.66 67.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.379 0.881 . . . . 14.02 113.379 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.58 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 45.7 mt-30 -57.3 -48.42 78.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.727 0.298 . . . . 16.29 111.568 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -75.52 -34.2 60.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.097 0.475 . . . . 12.91 110.589 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.89 -43.7 95.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.562 -0.745 . . . . 12.77 109.973 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.69 80.21 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.159 -0.928 . . . . 15.19 111.042 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.91 -44.82 30.21 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.152 -0.476 . . . . 16.26 110.845 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -70.63 -35.0 72.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.001 -0.545 . . . . 15.45 112.382 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.83 -15.68 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.531 0.681 . . . . 16.16 111.655 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 64.28 45.64 3.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.375 -1.284 . . . . 20.56 109.703 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -125.47 165.37 18.58 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.144 -1.058 . . . . 16.63 108.144 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.11 126.85 55.7 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-O 120.796 0.332 . . . . 20.19 110.736 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 38.8 Cg_endo -65.76 -22.52 56.91 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.096 2.531 . . . . 16.6 113.387 -174.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.88 67.97 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 121.001 -0.618 . . . . 17.74 112.632 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -100.96 8.43 43.06 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.253 0.549 . . . . 20.23 111.597 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 22' ' ' PRO . 14.9 tt -85.81 119.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.876 -1.157 . . . . 15.98 107.876 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -74.96 144.17 43.32 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.744 -0.662 . . . . 19.33 110.049 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.53 -16.3 23.81 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.642 1.177 . . . . 14.93 113.914 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.2 6.53 26.95 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 121.032 -0.604 . . . . 14.82 112.264 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -71.01 148.57 47.48 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.473 0.654 . . . . 14.54 110.875 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 99.6 mtt180 -110.68 137.23 48.61 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.02 0.914 . . . . 16.75 111.978 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -47.61 -43.58 25.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.315 -1.766 . . . . 11.99 112.827 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -68.97 -29.54 67.78 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.508 -0.314 . . . . 14.45 111.406 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.72 -23.09 34.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.207 -0.664 . . . . 16.44 109.207 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.88 -39.1 66.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.451 -0.795 . . . . 13.77 109.981 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.57 14.26 1.05 Allowed Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.266 -0.968 . . . . 13.81 112.824 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 168.8 19.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.345 0.593 . . . . 13.04 110.408 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.4 163.08 40.57 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.234 -2.136 . . . . 15.67 105.234 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -67.03 -31.0 71.24 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 119.579 1.081 . . . . 15.29 109.565 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.36 -43.63 80.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.095 -0.502 . . . . 16.66 109.663 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.17 -33.69 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.672 -0.694 . . . . 14.14 109.944 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.92 95.47 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.814 -0.63 . . . . 12.0 109.776 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.99 -22.54 65.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.703 -0.681 . . . . 13.97 111.369 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.52 -50.83 8.93 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.253 0.549 . . . . 15.69 110.383 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -67.33 -35.68 79.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 C-N-CA 124.417 1.087 . . . . 11.69 111.662 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 48' ' ' ILE . 8.8 tp -58.63 -40.28 78.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-O 120.894 0.378 . . . . 11.16 110.377 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 41.7 ttm180 -69.01 -33.79 74.22 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.304 0.574 . . . . 16.65 110.14 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.36 -27.94 47.06 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 112.495 0.554 . . . . 14.15 112.495 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 45' ' ' ILE . 29.7 pt -76.37 -29.54 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 119.219 -0.992 . . . . 10.8 109.032 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.13 -40.03 92.27 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-N 115.377 -0.829 . . . . 12.98 110.372 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 26.3 mtpp -65.22 -49.64 68.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.832 -0.622 . . . . 17.52 110.015 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 44.7 m80 -59.64 -43.86 93.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.551 0.945 . . . . 14.87 113.551 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -92.67 -4.79 52.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.162 1.171 . . . . 12.2 114.162 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.11 45.64 20.47 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.044 1.402 . . . . 16.71 108.891 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.6 tp -119.87 165.92 13.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.206 -1.405 . . . . 12.2 107.206 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -127.33 74.51 1.52 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.139 0.495 . . . . 16.06 109.935 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.483 HG12 ' OE1' ' A' ' 77' ' ' GLN . 58.4 mt -89.45 126.36 58.57 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.303 -0.999 . . . . 11.39 108.303 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.6 Cg_exo -67.2 156.31 66.85 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.002 1.801 . . . . 12.6 109.084 171.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.96 -0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.434 1.272 . . . . 12.52 114.434 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.87 -12.04 60.02 Favored 'General case' 0 C--O 1.24 0.554 0 O-C-N 122.453 -0.154 . . . . 14.14 110.943 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.6 62.69 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 121.304 -0.474 . . . . 10.76 113.079 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.02 35.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.115 0.96 . . . . 11.0 108.716 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -85.42 -44.06 13.08 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.38 -0.825 . . . . 16.42 111.657 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -136.0 25.58 3.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.53 0.681 . . . . 13.35 111.434 -174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -123.34 89.92 50.76 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.73 -1.211 . . . . 12.23 107.73 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.8 Cg_endo -82.99 -3.35 11.07 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.286 1.991 . . . . 13.06 115.697 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.41 120.38 64.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 119.381 0.992 . . . . 12.95 109.347 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -61.37 -35.46 77.52 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.55 -0.75 . . . . 10.92 111.93 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.82 -29.98 69.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.523 . . . . 14.32 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.62 33.78 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.821 0.82 . . . . 10.93 109.423 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 50.7 t80 -87.82 -28.02 21.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.301 -0.863 . . . . 8.81 112.04 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 p -63.4 -36.65 84.43 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.612 -0.68 . . . . 9.35 111.723 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -75.34 -23.69 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 11.63 110.264 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 49.4 t90 -64.05 -47.89 78.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.053 -1.092 . . . . 10.55 108.053 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 90.9 t -69.22 -43.62 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 CA-C-N 115.594 -0.73 . . . . 8.3 109.235 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.76 -43.9 80.49 Favored Glycine 0 C--O 1.238 0.387 0 CA-C-N 115.491 -0.777 . . . . 9.58 113.319 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -67.58 -33.59 75.33 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.93 0.365 . . . . 10.23 111.183 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.483 ' OE1' HG12 ' A' ' 56' ' ' ILE . 3.7 pt20 -89.67 -2.37 58.27 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.767 -1.173 . . . . 10.43 112.563 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 90.6 mt -70.79 -12.39 61.52 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.243 0.544 . . . . 10.97 110.07 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -78.95 142.92 60.82 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 107.806 -1.183 . . . . 13.52 107.806 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -22.66 -65.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.362 1 C-N-CA 126.61 4.873 . . . . 12.28 117.474 -172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -132.65 48.3 2.42 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.785 0.802 . . . . 13.44 111.444 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.72 9.98 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.903 -0.719 . . . . 13.27 111.413 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.34 8.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.972 0.415 . . . . 14.48 111.277 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -102.49 20.3 17.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.655 1.217 . . . . 14.92 109.196 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.52 76.62 9.56 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.585 -1.189 . . . . 14.25 109.113 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.73 120.79 74.34 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.111 -0.95 . . . . 12.97 108.722 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.51 -24.84 63.19 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.672 2.248 . . . . 13.4 111.935 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.42 72.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.651 -1.24 . . . . 12.43 107.651 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.95 120.24 23.89 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.488 -0.93 . . . . 13.45 108.488 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -135.73 109.05 7.81 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.951 0.405 . . . . 14.41 110.911 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 92' ' ' PRO . 6.9 tp10 -92.38 114.89 63.67 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 107.258 -1.386 . . . . 11.68 107.258 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 91' ' ' GLU . 35.8 Cg_endo -65.56 139.15 57.41 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.178 1.919 . . . . 10.84 112.212 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.1 m -84.63 47.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.166 0.984 . . . . 10.46 110.547 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.97 4.43 4.91 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.194 -0.912 . . . . 10.58 111.282 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 p -76.06 98.15 4.25 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.186 0.517 . . . . 11.04 110.199 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.95 116.37 24.12 Favored Pre-proline 0 N--CA 1.426 -1.654 0 CA-C-N 115.712 -0.676 . . . . 10.88 110.109 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.98 -25.6 27.42 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.612 2.208 . . . . 12.46 112.133 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -142.91 135.73 13.72 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 109.144 -0.687 . . . . 13.78 109.144 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.23 109.11 2.13 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.813 2.342 . . . . 11.95 111.951 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.63 77.11 1.94 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.43 -1.068 . . . . 11.48 110.43 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.15 -40.93 13.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.808 0.337 . . . . 11.55 110.503 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 77.3 mt-30 -85.21 90.62 7.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.857 -0.423 . . . . 12.59 109.857 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.43 -55.43 3.8 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.162 -1.051 . . . . 11.24 108.162 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m -101.29 55.92 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.3 -1.37 . . . . 10.05 107.3 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 102' ' ' GLN . . . -47.44 -46.13 26.32 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.549 1.14 . . . . 11.22 113.555 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.91 -46.64 77.54 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.303 0.483 . . . . 11.38 112.303 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -75.43 -30.23 59.95 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 110.195 -0.298 . . . . 9.65 110.195 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.59 -46.08 91.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.003 0.521 . . . . 10.43 111.073 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 m -56.54 -38.44 71.89 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.23 0.538 . . . . 10.21 110.145 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.75 HG21 HG11 ' A' ' 178' ' ' VAL . 66.0 mt -73.59 -52.41 21.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.25 -0.887 . . . . 8.13 109.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -54.88 -43.32 73.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.736 0.814 . . . . 8.46 111.693 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.44 -40.93 93.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.088 -0.506 . . . . 10.86 110.397 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.3 -36.53 66.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.669 . . . . 11.45 109.608 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.48 -45.21 95.2 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.151 0.98 . . . . 7.62 108.406 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.83 -45.3 95.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.385 -0.825 . . . . 11.62 110.385 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -65.31 -39.41 92.45 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.142 -0.481 . . . . 11.63 111.056 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -69.08 -37.88 78.71 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.589 -0.278 . . . . 9.14 111.174 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.1 tp -65.21 -48.48 73.23 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.607 -0.516 . . . . 10.06 109.607 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.89 -49.14 77.31 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.79 -0.641 . . . . 12.07 112.148 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -61.36 -38.85 88.45 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 123.457 0.703 . . . . 12.32 111.322 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 148' ' ' TRP . 51.9 tp -67.54 -43.05 81.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.977 -0.556 . . . . 11.77 110.012 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.52 -64.34 0.9 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.293 -0.867 . . . . 13.52 110.252 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.0 t80 168.02 -46.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.301 -2.111 . . . . 16.56 105.301 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -168.38 143.94 3.62 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 103.885 -2.635 . . . . 15.74 103.885 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.61 136.37 20.79 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.065 -0.717 . . . . 14.2 109.065 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.07 6.06 5.56 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.305 2.003 . . . . 14.18 112.378 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 33.76 74.6 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 110.354 -1.098 . . . . 14.03 110.354 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -102.7 20.45 17.24 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.383 1.087 . . . . 16.37 109.259 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.8 pt? -96.64 176.27 6.07 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.158 -0.928 . . . . 12.45 108.981 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 73.1 -58.31 0.6 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.468 1.107 . . . . 14.43 110.547 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -89.64 5.12 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.078 -1.453 . . . . 14.32 107.078 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.99 135.0 5.35 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.405 -1.478 . . . . 13.75 109.405 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 172' ' ' LYS . . . -179.66 138.21 0.13 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.988 1.315 . . . . 12.7 107.739 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' HG22 ' A' ' 170' ' ' THR . 3.9 pt20 -170.01 173.9 5.78 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 118.524 -0.751 . . . . 16.38 109.879 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 55.3 m-85 -63.32 -18.87 64.08 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 119.738 1.154 . . . . 13.3 112.534 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.2 -10.08 59.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.06 -0.973 . . . . 16.25 112.373 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.258 14.3 p30 -70.46 -64.95 0.8 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.109 -0.636 . . . . 15.87 112.705 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 pp -87.3 -9.8 53.99 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.687 0.756 . . . . 13.65 109.019 173.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -83.1 70.56 3.17 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.978 -1.01 . . . . 14.16 113.701 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 92.3 mmm -109.06 -65.15 1.17 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.06 -1.459 . . . . 15.45 107.06 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.54 146.01 39.36 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.167 -1.79 . . . . 13.63 106.167 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -73.33 -16.56 61.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 113.119 0.785 . . . . 13.9 113.119 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.63 -52.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.021 -0.733 . . . . 13.81 109.021 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.6 p -63.82 -31.97 73.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.99 -0.55 . . . . 11.48 111.627 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.49 -37.08 78.27 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.705 -1.236 . . . . 10.35 110.517 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 m -61.39 -45.33 94.82 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.761 -0.829 . . . . 12.2 108.761 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 150' ' ' ARG . 86.1 mm-40 -59.66 -41.16 89.96 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.498 -0.774 . . . . 11.86 111.514 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.429 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.5 t90 -65.48 -47.29 76.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.322 -0.854 . . . . 9.32 110.907 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.8 mtp -69.55 -27.35 65.07 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.291 -0.564 . . . . 9.5 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 2.7 tmm_? -59.37 -43.91 92.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.913 -1.144 . . . . 13.91 107.913 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.35 -54.3 20.8 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.364 -0.834 . . . . 9.88 111.474 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.19 -46.85 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.574 0.749 . . . . 9.27 112.385 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 p -64.54 -52.25 58.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.796 0.331 . . . . 11.46 111.864 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -71.95 -38.49 69.77 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.807 0.299 . . . . 15.04 111.807 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -68.75 -31.2 70.07 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.704 0.631 . . . . 11.82 112.704 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -101.38 1.81 38.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.992 0.425 . . . . 11.97 111.845 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 t 60.56 37.2 19.64 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.215 1.006 . . . . 14.24 111.633 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -119.89 138.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.806 -0.813 . . . . 12.62 108.806 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.95 95.66 10.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.607 0.718 . . . . 16.39 110.546 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.64 129.37 54.56 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.928 -1.138 . . . . 12.32 107.928 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.47 56.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.296 -0.631 . . . . 14.06 109.296 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.13 63.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.289 0.566 . . . . 12.64 111.208 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.81 -4.44 58.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.701 -0.682 . . . . 15.68 110.488 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -74.14 0.62 13.33 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.98 0.363 . . . . 12.72 111.98 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.8 pt -64.96 -14.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.885 0.85 . . . . 12.16 109.379 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -103.31 -3.56 25.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.093 -0.958 . . . . 15.08 109.875 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.3 m -99.42 -40.7 7.74 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.236 -0.654 . . . . 14.67 109.236 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.0 m-90 -121.37 69.05 20.96 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.663 -0.866 . . . . 12.68 108.663 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' PHE . 1.5 Cg_endo -87.12 40.92 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.988 2.458 . . . . 14.34 113.361 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.403 HG22 ' C ' ' A' ' 134' ' ' GLN . 36.1 p -154.62 143.28 20.74 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 105.227 -2.138 . . . . 12.91 105.227 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.61 -17.02 64.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.356 0.502 . . . . 9.89 112.356 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.455 ' HG3' ' CB ' ' A' ' 133' ' ' ALA . 92.1 mttt -72.41 -44.24 62.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 120.824 -0.351 . . . . 12.5 110.828 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 19.1 m -63.75 -43.93 95.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 123.652 0.595 . . . . 11.04 110.186 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.5 -48.03 71.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.977 -0.556 . . . . 8.5 109.843 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.54 72.81 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.518 0.562 . . . . 7.7 112.518 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 32.8 t70 -83.25 -29.87 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.558 -0.457 . . . . 10.38 111.308 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 173' ' ' SER . 0.2 OUTLIER -57.73 -49.22 77.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.654 0.782 . . . . 11.97 109.906 -177.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -56.96 -35.95 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.699 -0.682 . . . . 9.8 111.556 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.1 -34.89 79.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.391 0.615 . . . . 10.83 110.314 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 88.8 mtt180 -74.27 -43.72 55.74 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.025 -0.989 . . . . 13.5 108.642 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -64.49 -40.85 96.44 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.396 -1.274 . . . . 14.84 111.192 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 183' ' ' GLN . 34.5 m -84.18 -39.47 14.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 113.196 0.813 . . . . 13.35 113.196 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 182' ' ' VAL . 92.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 120.941 -0.304 . . . . 13.51 111.172 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.515 -0.92 . . . . 18.51 108.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.3 66.64 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.267 1.027 . . . . 16.66 112.121 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.53 -53.76 50.11 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 14.84 111.147 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.04 -29.2 55.13 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.608 -0.723 . . . . 14.98 111.89 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.26 -35.88 80.31 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 122.652 0.381 . . . . 15.79 110.423 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.6 m -57.5 -41.57 81.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 120.847 0.356 . . . . 12.02 111.106 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -69.56 -47.39 63.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.049 -0.523 . . . . 11.02 109.633 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.08 -38.33 85.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.739 -0.664 . . . . 16.07 111.85 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.29 -46.2 74.32 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.961 0.41 . . . . 13.93 110.746 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.24 -35.53 78.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.411 -0.359 . . . . 10.71 111.793 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 25' ' ' ILE . 85.5 mtt180 -61.97 -41.61 98.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 14.02 108.97 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -61.26 -51.18 70.0 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.058 -0.973 . . . . 16.29 110.141 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.4 t -56.49 -51.48 68.32 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.944 0.778 . . . . 12.91 110.838 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.62 -52.53 65.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.087 -0.961 . . . . 12.77 110.582 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.17 77.3 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.38 0.511 . . . . 15.19 112.38 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.76 78.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.69 0.281 . . . . 16.26 111.026 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 ptm -70.98 -24.5 62.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.5 -0.48 . . . . 15.45 111.865 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.36 0.7 55.69 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.028 0.381 . . . . 16.16 112.028 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 56.73 42.37 26.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.553 1.141 . . . . 20.56 111.813 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.8 m -117.84 174.53 6.13 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.984 -1.007 . . . . 16.63 109.8 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -94.76 124.37 54.95 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.575 -0.739 . . . . 20.19 110.924 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 -17.96 15.91 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.272 2.648 . . . . 16.6 113.501 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.41 43.02 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.143 -1.183 . . . . 17.74 110.143 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.7 69.7 7.73 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.542 0.687 . . . . 20.23 109.395 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 11' ' ' ARG . 10.0 tp -120.92 153.87 24.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.74 -0.663 . . . . 15.98 109.635 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.63 87.36 2.72 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 106.762 -1.569 . . . . 19.33 106.762 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.88 -27.57 60.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.399 1.48 . . . . 14.93 113.061 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.96 -11.79 80.77 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.234 -0.984 . . . . 14.82 112.571 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -81.92 144.94 30.59 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.388 0.613 . . . . 14.54 109.723 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 29.5 ptt180 -71.19 146.54 49.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.071 -0.968 . . . . 16.75 110.471 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -48.07 -34.46 9.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.971 1.709 . . . . 11.99 113.144 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.56 -38.24 71.65 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.228 1.011 . . . . 14.45 110.036 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.3 2.41 55.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.565 0.746 . . . . 16.44 110.927 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.6 0.83 56.73 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.113 -0.699 . . . . 13.77 109.113 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.93 11.1 50.92 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.303 -0.862 . . . . 13.81 111.95 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 175.74 5.62 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.084 0.945 . . . . 13.04 111.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -141.51 159.73 41.61 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.984 -1.916 . . . . 15.67 106.828 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -55.9 -42.98 76.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 118.947 0.794 . . . . 15.29 111.111 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.89 -51.42 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.195 -0.911 . . . . 16.66 110.577 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.22 -41.27 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.603 -0.726 . . . . 14.14 110.203 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.44 87.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 12.0 111.174 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.87 -30.42 71.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.191 0.519 . . . . 13.97 111.185 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.6 -43.92 16.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.431 0.634 . . . . 15.69 110.659 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -57.7 -44.04 85.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 124.944 1.298 . . . . 11.69 111.278 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.63 -31.1 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 121.306 -0.158 . . . . 11.16 110.987 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 1.4 mmp_? -63.1 -39.71 95.51 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.945 -0.391 . . . . 16.65 109.945 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -38.06 79.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.929 0.395 . . . . 14.15 110.356 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.8 -42.33 88.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.966 -0.753 . . . . 10.8 108.966 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' ND2' ' HB ' ' A' ' 56' ' ' ILE . 14.6 m120 -62.01 -36.26 81.0 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.59 -0.732 . . . . 12.98 111.395 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 46' ' ' ARG . 75.6 mmtt -78.3 -49.71 13.16 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.738 -0.21 . . . . 17.52 110.725 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -65.27 -42.38 93.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.301 -0.409 . . . . 14.87 111.759 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -85.51 -13.12 50.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.289 0.477 . . . . 12.2 112.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 57.32 38.36 28.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 16.71 109.956 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.6 tp -122.25 138.59 54.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.181 -0.918 . . . . 12.2 110.183 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -70.7 57.67 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.206 1.403 . . . . 16.06 112.573 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' HB ' ' ND2' ' A' ' 49' ' ' ASN . 11.3 mt -88.68 122.85 68.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.583 -0.698 . . . . 11.39 111.43 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 5.2 Cg_exo -80.38 162.95 22.25 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.138 1.892 . . . . 12.6 108.765 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.31 -6.91 15.68 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.513 0.673 . . . . 12.52 110.617 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 33.4 t70 -60.99 -27.91 68.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.217 -1.356 . . . . 14.14 111.671 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' NE1' ' A' ' 73' ' ' TRP . . . -55.86 -48.97 68.97 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 119.945 -1.122 . . . . 10.76 112.776 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -76.01 -28.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.043 0.925 . . . . 11.0 109.422 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 87.3 t80 -64.21 -41.15 97.17 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.809 -1.087 . . . . 16.42 110.832 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.525 HG23 ' CD2' ' A' ' 64' ' ' TYR . 11.4 t -94.79 -18.62 21.07 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 120.544 -0.462 . . . . 13.35 111.987 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CD2' HG23 ' A' ' 63' ' ' THR . 96.8 m-85 -128.6 96.44 30.12 Favored Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 121.909 -0.494 . . . . 12.23 110.758 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 86.9 Cg_endo -84.64 4.27 6.97 Favored 'Trans proline' 0 C--O 1.211 -0.831 0 C-N-CA 122.363 2.042 . . . . 13.06 111.922 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.54 122.56 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.917 -1.142 . . . . 12.95 107.917 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -60.92 -40.8 94.58 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.845 0.858 . . . . 10.92 112.345 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.16 -27.4 67.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.933 0.397 . . . . 14.32 111.247 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.25 -31.6 21.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.566 0.698 . . . . 10.93 109.58 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -70.87 -30.69 67.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 8.81 111.794 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -64.09 -28.12 69.56 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.591 -0.693 . . . . 9.35 111.145 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -74.23 -24.98 59.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.709 -0.678 . . . . 11.63 109.83 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.542 ' CZ3' ' HG3' ' A' ' 77' ' ' GLN . 20.6 t90 -64.49 -49.03 72.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.616 -1.253 . . . . 10.55 107.616 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.33 -43.92 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-N 115.079 -0.964 . . . . 8.3 109.536 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.73 -40.63 95.17 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.778 -0.646 . . . . 9.58 112.347 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.2 p -77.18 -8.87 58.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.788 0.662 . . . . 10.23 112.788 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.542 ' HG3' ' CZ3' ' A' ' 73' ' ' TRP . 16.8 mm-40 -93.32 -35.35 13.1 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 122.051 -0.405 . . . . 10.43 110.316 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.48 -41.42 80.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.707 -0.849 . . . . 10.97 108.707 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -128.82 94.55 34.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.181 -0.918 . . . . 13.52 108.592 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.32 70.04 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.957 2.438 . . . . 12.28 113.8 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.6 m -75.75 110.9 10.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.88 -0.6 . . . . 13.44 109.827 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -81.55 79.48 8.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.514 -0.55 . . . . 13.27 109.514 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.55 53.17 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.819 0.819 . . . . 14.48 109.421 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -86.33 46.58 1.36 Allowed 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.043 0.925 . . . . 14.92 109.719 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.97 132.34 36.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.835 -0.62 . . . . 14.25 110.207 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.07 120.75 71.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.813 -0.81 . . . . 12.97 108.813 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.4 -34.92 83.01 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.877 3.051 . . . . 13.4 112.545 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.2 t -121.45 111.1 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.504 -1.295 . . . . 12.43 107.504 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -73.76 118.23 16.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.022 0.439 . . . . 13.45 110.28 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -123.83 47.99 1.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.622 -1.251 . . . . 14.41 107.622 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 41.3 tt0 -58.72 118.62 30.2 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.181 -1.372 . . . . 11.68 111.838 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 1.9 Cg_endo -85.27 69.2 5.55 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.651 2.234 . . . . 10.84 110.298 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.69 134.85 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.923 -0.581 . . . . 10.46 109.525 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.65 77.0 9.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.405 0.622 . . . . 10.58 110.714 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 p -88.6 152.4 21.86 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.822 -0.626 . . . . 11.04 111.04 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.97 128.44 25.75 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.827 -0.805 . . . . 10.88 108.827 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.61 -32.78 47.47 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.822 2.348 . . . . 12.46 112.708 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.55 106.97 47.56 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.53 -0.545 . . . . 13.78 109.53 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.48 -4.73 15.37 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.75 2.3 . . . . 11.95 112.476 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.36 -175.42 40.41 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 109.659 -1.377 . . . . 11.48 109.659 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 5.21 51.45 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.973 0.416 . . . . 11.55 110.153 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -65.92 -27.17 67.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.226 -0.443 . . . . 12.59 111.786 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.28 96.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.213 0.53 . . . . 11.24 109.739 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m -75.38 -39.37 59.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.443 -0.799 . . . . 10.05 110.182 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.19 87.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.843 -0.617 . . . . 11.22 110.898 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.44 ' OE1' ' HB ' ' A' ' 182' ' ' VAL . 8.1 tt0 -54.25 -51.84 63.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.664 0.786 . . . . 11.38 109.08 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.35 -45.99 90.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.928 -1.033 . . . . 9.65 111.811 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.63 -39.38 91.1 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 121.053 0.454 . . . . 10.43 111.591 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -69.33 -51.43 37.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.014 -0.539 . . . . 10.21 110.262 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.823 HG21 HG11 ' A' ' 178' ' ' VAL . 54.6 mt -70.22 -27.02 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 116.267 -0.424 . . . . 8.13 111.456 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.21 -38.78 80.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.559 0.695 . . . . 8.46 109.551 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.76 -31.08 66.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.178 -0.919 . . . . 10.86 110.639 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -77.5 -35.86 53.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.45 -0.341 . . . . 11.45 110.465 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.8 -47.02 83.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.813 -0.81 . . . . 7.62 108.813 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -52.17 -55.22 22.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.879 -1.055 . . . . 11.62 109.835 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.5 -44.08 95.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 11.63 112.581 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 t -63.35 -44.43 94.86 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.058 0.456 . . . . 9.14 110.475 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.05 -42.99 83.86 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.36 -0.607 . . . . 10.06 109.36 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.05 -19.73 68.2 Favored Glycine 0 C--O 1.216 -1.022 0 CA-C-N 116.154 -0.475 . . . . 12.07 112.743 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -78.62 -38.87 38.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.201 -0.666 . . . . 12.32 109.201 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.4 tp -80.83 -45.4 16.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.705 -0.68 . . . . 11.77 110.748 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -83.03 -19.46 36.88 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.196 -0.911 . . . . 13.52 110.223 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.2 t80 73.22 -43.78 0.57 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.855 1.662 . . . . 16.56 112.209 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.5 tp -159.34 142.74 14.57 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.154 -0.684 . . . . 15.74 109.154 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.78 112.08 27.29 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 123.25 0.344 . . . . 14.2 110.251 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.53 -9.66 20.11 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.888 2.392 . . . . 14.18 112.336 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.13 69.01 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.582 -1.007 . . . . 14.03 110.582 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 78.27 27.17 0.53 Allowed 'General case' 0 C--O 1.247 0.955 0 C-N-CA 125.008 1.323 . . . . 16.37 110.666 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.0 mt 56.85 73.05 0.47 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.647 -1.615 . . . . 12.45 112.267 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -86.33 151.59 23.45 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.116 -1.402 . . . . 14.43 111.39 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -37.33 67.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.83 -1.077 . . . . 14.32 110.262 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.17 62.65 4.53 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 110.771 -0.931 . . . . 13.75 110.771 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.4 143.79 28.48 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.458 -0.571 . . . . 12.7 109.458 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -137.52 139.75 40.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.979 -0.748 . . . . 16.38 108.979 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 12.2 p90 -63.32 -6.87 5.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.733 0.813 . . . . 13.3 112.806 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.84 -61.05 2.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.172 0.511 . . . . 16.25 110.039 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.63 -20.98 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.087 -0.506 . . . . 15.87 110.344 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.02 14.47 15.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.932 -0.577 . . . . 13.65 111.468 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.42 60.02 4.87 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.957 -0.857 . . . . 14.16 110.957 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.03 152.21 51.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.469 -1.308 . . . . 15.45 107.469 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.25 39.87 18.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.192 0.932 . . . . 13.63 111.175 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.7 p -77.62 -32.81 53.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.219 -0.9 . . . . 13.9 112.138 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.1 -50.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.383 -0.969 . . . . 13.81 108.383 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -72.18 -16.14 61.96 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.34 -0.846 . . . . 11.48 111.303 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.69 -22.09 77.99 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.216 -0.754 . . . . 10.35 111.216 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 82.2 p -66.82 -45.87 76.96 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.182 -1.044 . . . . 12.2 108.182 175.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -61.75 -38.35 87.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.136 -0.938 . . . . 11.86 110.147 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.459 ' O ' HG23 ' A' ' 152' ' ' VAL . 12.4 t90 -56.09 -54.09 49.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 9.32 110.308 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 43.6 ttm -66.76 -30.83 71.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.242 0.339 . . . . 9.5 111.543 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 23.3 mmm180 -58.4 -50.16 74.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 13.91 109.189 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.52 -44.75 96.49 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.654 -0.579 . . . . 9.88 111.654 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 148' ' ' TRP . 80.4 t -57.29 -48.67 81.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 123.208 0.603 . . . . 9.27 111.136 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.2 p -71.19 -31.14 67.27 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.816 0.341 . . . . 11.46 111.526 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -71.61 -44.91 63.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.027 0.441 . . . . 15.04 110.37 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -66.44 -48.2 70.74 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.791 0.663 . . . . 11.82 112.791 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -84.41 -0.24 52.01 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.171 0.434 . . . . 11.97 112.171 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.5 p 54.43 33.43 18.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.204 1.401 . . . . 14.24 112.482 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.3 pt -109.61 153.55 11.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.541 -0.754 . . . . 12.62 110.308 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -91.09 95.53 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.185 0.517 . . . . 16.39 110.46 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.98 120.81 26.72 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.006 -0.738 . . . . 12.32 109.006 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 134.74 38.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.903 -0.777 . . . . 14.06 108.903 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.32 -7.86 21.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.749 0.785 . . . . 12.64 111.661 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.3 -19.96 65.96 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.881 0.872 . . . . 15.68 109.711 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -59.8 -19.46 50.85 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.659 0.985 . . . . 12.72 113.659 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.5 pt -70.03 -2.31 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.764 -0.585 . . . . 12.16 111.822 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -122.53 23.69 9.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.743 0.306 . . . . 15.08 110.647 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 164' ' ' ALA . 10.3 t -147.07 20.75 1.24 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.503 -0.479 . . . . 14.67 111.088 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -134.94 103.54 10.79 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 108.552 -0.907 . . . . 12.68 108.552 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.524 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 17.2 Cg_exo -69.19 -33.09 19.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.801 2.334 . . . . 14.34 113.37 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -97.56 155.7 16.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.476 -0.784 . . . . 12.91 110.938 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -81.79 -32.28 31.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.114 -0.948 . . . . 9.89 111.876 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -78.11 -5.6 52.09 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.751 0.649 . . . . 12.5 112.751 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.8 p -54.28 -35.52 62.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.251 1.02 . . . . 11.04 112.46 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 7.3 tt -60.7 -30.79 70.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.184 0.594 . . . . 8.5 110.22 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.48 59.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.259 -0.428 . . . . 7.7 110.369 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.29 -30.22 30.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.845 -0.428 . . . . 10.38 109.845 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 5.3 mm-40 -57.25 -59.97 4.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.744 0.783 . . . . 11.97 109.309 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 110' ' ' ILE . 7.6 p -63.96 -37.16 79.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.595 -1.184 . . . . 9.8 111.843 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.22 -39.32 86.24 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.397 0.617 . . . . 10.83 110.441 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -74.28 -41.09 61.77 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.967 -1.015 . . . . 13.5 110.078 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.51 ' HA ' ' HE ' ' A' ' 181' ' ' ARG . 3.3 mmp_? -69.18 -52.91 23.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.764 -0.653 . . . . 14.84 112.065 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 106' ' ' GLN . 46.6 t -73.9 -65.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 13.35 109.38 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.872 1.269 . . . . 13.51 112.575 175.913 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 4' ' ' ASP . 5.0 m . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 18.51 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 -53.97 2.52 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.137 -0.483 . . . . 16.66 110.53 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.29 -48.14 24.62 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.013 -1.106 . . . . 14.84 108.013 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 1' ' ' VAL . 23.6 t70 -69.24 -15.68 63.43 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.84 -1.527 . . . . 14.98 111.122 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.04 -34.38 77.57 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 121.219 0.533 . . . . 15.79 109.628 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.5 m -60.8 -34.07 73.96 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.182 -0.917 . . . . 12.02 110.229 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.34 -48.46 70.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.702 -0.481 . . . . 11.02 109.702 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.05 -42.52 94.65 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.467 0.479 . . . . 16.07 111.556 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -63.83 -46.42 85.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 13.93 110.684 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.65 -48.66 59.07 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 111.769 0.285 . . . . 10.71 111.769 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 34.5 ptt180 -68.77 -16.67 63.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.959 -0.696 . . . . 14.02 111.293 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -60.84 -49.2 78.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.342 0.401 . . . . 16.29 109.987 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -79.03 -31.5 44.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.868 -0.333 . . . . 12.91 110.111 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 8.0 tt -61.24 -52.9 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.815 -0.809 . . . . 12.77 108.815 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.79 -25.01 62.68 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.078 -0.51 . . . . 15.19 111.741 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.79 63.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.96 0.41 . . . . 16.26 110.88 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 mmt -85.36 -31.25 23.07 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.898 0.38 . . . . 15.45 110.981 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -96.4 -2.61 45.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.216 0.531 . . . . 16.16 111.505 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 60.16 41.07 17.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.007 1.323 . . . . 20.56 111.795 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 t -107.22 -178.92 3.78 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.032 -0.985 . . . . 16.63 108.586 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 mp0 -97.72 103.08 15.1 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 123.077 0.551 . . . . 20.19 110.271 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 21' ' ' GLU . 12.9 Cg_endo -53.53 -40.55 78.51 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 124.26 3.307 . . . . 16.6 115.258 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.89 -11.65 85.2 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 119.971 -1.109 . . . . 17.74 114.043 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -141.77 58.42 1.49 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.241 0.83 . . . . 20.23 113.241 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.2 pt -97.15 -10.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.18 -0.608 . . . . 15.98 110.408 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 73.85 128.05 0.04 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 125.645 1.578 . . . . 19.33 110.607 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 4.4 p-10 -66.34 -23.83 66.42 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.571 1.323 . . . . 14.93 114.571 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.97 5.89 69.06 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 119.901 -1.142 . . . . 14.82 112.66 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.2 m -70.43 151.54 45.04 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 122.024 0.916 . . . . 14.54 112.951 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 48.1 mtm180 -90.12 132.68 35.3 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.08 -1.418 . . . . 16.75 111.267 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -47.0 -52.69 14.17 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 123.741 0.651 . . . . 11.99 112.638 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 36' ' ' LEU . 19.5 tp -56.1 -37.97 70.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 14.45 111.323 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.73 -23.8 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.799 -0.637 . . . . 16.44 110.885 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.26 -13.42 59.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.296 0.57 . . . . 13.77 110.713 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.21 -8.45 15.9 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.762 -0.732 . . . . 13.81 111.444 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.4 tt -69.69 134.23 48.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.461 -0.57 . . . . 13.04 109.461 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 18.5 t70 -114.48 161.33 18.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.233 -1.025 . . . . 15.67 108.233 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -59.25 -34.51 72.32 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 118.829 0.741 . . . . 15.29 111.131 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -70.42 -41.47 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.593 0.711 . . . . 16.66 109.501 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 62.3 mt -67.99 -28.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.001 -1.0 . . . . 14.14 110.177 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -61.14 -48.51 81.3 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.587 -0.733 . . . . 12.0 110.438 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.55 96.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.212 0.529 . . . . 13.97 110.326 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.95 -46.15 88.75 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.912 -1.04 . . . . 15.69 111.618 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.405 ' O ' HG13 ' A' ' 48' ' ' ILE . 6.4 t90 -71.92 -41.76 67.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 124.748 1.219 . . . . 11.69 110.437 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mm -51.98 -46.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.634 0.774 . . . . 11.16 112.146 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.9 mtm-85 -58.35 -40.01 81.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.482 0.489 . . . . 16.65 110.617 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 51' ' ' HIS . 22.1 mt-10 -74.19 -34.66 63.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 120.145 -0.622 . . . . 14.15 112.154 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 44' ' ' TRP . 74.1 mt -59.93 -46.26 94.21 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 108.866 -0.79 . . . . 10.8 108.866 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -59.84 -39.93 86.8 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 114.972 -1.013 . . . . 12.98 110.535 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -79.2 -43.44 23.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.559 0.578 . . . . 17.52 112.559 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 65.0 m170 -64.86 -44.04 91.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.454 0.538 . . . . 14.87 112.454 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -95.74 -10.77 28.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.35 0.87 . . . . 12.2 113.35 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 59.22 52.06 6.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.313 -1.366 . . . . 16.71 107.313 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.4 tp -127.55 135.96 51.04 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.645 -1.161 . . . . 12.2 110.21 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.02 69.11 3.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 16.06 110.68 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mm -82.06 119.24 74.63 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.235 -0.439 . . . . 11.39 110.311 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.45 136.44 31.18 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.103 1.869 . . . . 12.6 109.726 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.88 63.45 Favored 'General case' 0 C--O 1.245 0.868 0 C-N-CA 123.684 0.794 . . . . 12.52 112.036 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 3.5 p30 -69.68 -12.36 61.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.205 -0.452 . . . . 14.14 112.066 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.5 -22.87 47.04 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 123.233 0.333 . . . . 10.76 113.663 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -115.94 -1.22 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 122.827 1.299 . . . . 11.0 108.16 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 81.1 t80 -90.63 -47.74 7.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.398 -0.819 . . . . 16.42 109.541 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 t -96.24 -23.15 16.83 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.792 -0.763 . . . . 13.35 111.493 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -100.57 118.25 61.29 Favored Pre-proline 0 CA--C 1.511 -0.541 0 C-N-CA 120.421 -0.512 . . . . 12.23 109.889 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.5 Cg_endo -94.53 -1.41 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.363 2.042 . . . . 13.06 114.02 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.31 123.15 68.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.19 0.519 . . . . 12.95 109.925 -174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.85 -37.12 86.56 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.295 1.038 . . . . 10.92 111.311 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 75.3 tttt -63.34 -39.45 94.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.529 -0.759 . . . . 14.32 111.09 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.47 72.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.135 0.493 . . . . 10.93 110.261 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' VAL . 29.1 t80 -67.32 -37.51 83.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.7 -0.682 . . . . 8.81 112.638 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -64.03 -35.31 80.29 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.955 -0.698 . . . . 9.35 112.692 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.158 -0.682 . . . . 11.63 109.158 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -60.66 -38.54 85.25 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.395 -0.821 . . . . 10.55 109.884 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 70' ' ' PHE . 55.9 t -72.18 -48.26 49.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.078 -0.712 . . . . 8.3 109.078 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.49 -43.36 94.09 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.345 -0.843 . . . . 9.58 113.231 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -65.73 -28.5 69.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.794 0.664 . . . . 10.23 112.794 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -85.84 -23.59 27.06 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.433 -0.507 . . . . 10.43 111.022 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.33 124.55 24.79 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.271 0.557 . . . . 10.97 111.592 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -103.86 105.62 49.0 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.855 -1.165 . . . . 13.52 107.855 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.33 123.86 12.1 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.321 2.014 . . . . 12.28 112.565 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -89.69 147.47 23.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.54 -1.282 . . . . 13.44 107.54 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.55 87.54 6.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.97 -0.692 . . . . 13.27 110.472 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.85 -27.22 40.19 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.015 -0.993 . . . . 14.48 109.408 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -83.48 73.26 10.21 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 122.118 0.961 . . . . 14.92 108.747 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.87 -164.78 1.23 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.757 -1.11 . . . . 14.25 109.7 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.46 131.33 70.6 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 122.999 0.52 . . . . 12.97 110.655 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 22.1 Cg_exo -65.81 96.93 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.496 2.131 . . . . 13.4 111.946 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.02 115.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.235 -1.394 . . . . 12.43 107.235 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -85.02 65.48 9.26 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.264 1.031 . . . . 13.45 110.731 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -143.55 136.59 27.71 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 107.003 -1.48 . . . . 14.41 107.003 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.79 125.31 73.54 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 107.964 -1.125 . . . . 11.68 107.964 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 52.13 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.235 2.623 . . . . 10.84 111.869 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.6 p -93.77 -23.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.348 -0.842 . . . . 10.46 110.105 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.67 15.91 22.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.661 -0.416 . . . . 10.58 111.203 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.6 m -71.49 -41.59 69.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.348 -0.612 . . . . 11.04 109.348 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.51 84.55 27.87 Favored Pre-proline 0 N--CA 1.432 -1.333 0 CA-C-N 115.742 -0.663 . . . . 10.88 110.675 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.14 43.14 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 122.434 2.089 . . . . 12.46 112.25 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -176.44 153.24 1.21 Allowed Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 103.371 -2.825 . . . . 13.78 103.371 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.5 124.72 16.76 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.074 1.85 . . . . 11.95 112.094 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.92 -160.36 54.03 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.897 -0.592 . . . . 11.48 112.612 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.459 ' HB1' ' NE2' ' A' ' 183' ' ' GLN . . . -88.33 17.37 5.28 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.821 0.82 . . . . 11.55 110.425 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -73.36 -6.38 45.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.024 -0.989 . . . . 12.59 109.75 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.53 84.64 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.768 -0.651 . . . . 11.24 110.59 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.5 t 55.81 22.82 5.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.736 1.614 . . . . 10.05 111.015 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.57 -49.0 15.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.426 -0.807 . . . . 11.22 109.751 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -64.47 -43.76 93.17 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.661 -0.866 . . . . 11.38 108.661 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -50.25 -57.64 7.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.186 0.994 . . . . 9.65 111.409 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.14 -40.56 90.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.698 -0.228 . . . . 10.43 111.523 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 t -59.29 -51.06 71.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.661 -0.496 . . . . 10.21 109.661 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.484 HG21 HG11 ' A' ' 178' ' ' VAL . 80.1 mt -59.77 -40.46 82.6 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 CA-C-N 116.369 -0.378 . . . . 8.13 110.254 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.04 -44.53 87.44 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.562 0.745 . . . . 8.46 110.602 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.98 -41.87 67.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.725 -0.671 . . . . 10.86 110.783 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -62.68 -40.48 97.22 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.455 -0.339 . . . . 11.45 111.178 175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.95 -50.53 66.28 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.871 0.868 . . . . 7.62 109.791 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.8 -46.7 86.99 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.435 -1.257 . . . . 11.62 111.496 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -70.65 -45.91 64.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.184 -0.462 . . . . 11.63 111.195 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.9 t -64.69 -44.03 91.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.809 -0.632 . . . . 9.14 111.065 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.66 -39.94 80.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.127 -0.629 . . . . 10.06 109.903 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.83 -38.94 94.76 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 111.751 -0.54 . . . . 12.07 111.751 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -54.51 -47.2 73.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.335 1.054 . . . . 12.32 110.662 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 144' ' ' THR . 4.6 mm? -86.4 -22.87 26.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.22 0.822 . . . . 11.77 113.22 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.2 tp -84.16 -28.61 27.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.766 0.317 . . . . 13.52 110.614 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 68.69 1.18 2.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.149 1.38 . . . . 16.56 113.803 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -162.92 154.81 18.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.25 -1.389 . . . . 15.74 107.25 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.07 96.49 25.71 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 110.053 -0.351 . . . . 14.2 110.053 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -75.0 -15.61 20.65 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.486 2.124 . . . . 14.18 110.807 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.93 47.69 4.39 Favored Glycine 0 CA--C 1.497 -1.08 0 CA-C-N 114.789 -1.096 . . . . 14.03 112.661 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -121.26 12.51 11.0 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.523 -0.471 . . . . 16.37 111.967 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.4 mt -55.41 -37.11 67.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.42 1.105 . . . . 12.45 111.141 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -98.06 84.68 3.33 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 114.14 -1.391 . . . . 14.43 111.901 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 m 72.27 -5.22 1.82 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.845 1.424 . . . . 14.32 114.845 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 -34.53 20.68 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 119.496 -1.335 . . . . 13.75 110.559 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.86 95.9 3.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 124.056 0.942 . . . . 12.7 109.978 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 170' ' ' THR . 46.3 mt-30 -86.89 177.12 7.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.387 -0.968 . . . . 16.38 108.387 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 44.5 p90 -59.98 -23.16 63.4 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.167 0.894 . . . . 13.3 110.111 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.34 -29.91 70.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.888 -1.051 . . . . 16.25 110.35 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.19 -39.19 12.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.84 -0.618 . . . . 15.87 110.08 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.48 -26.86 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 13.65 111.233 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.53 5.08 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.336 -0.459 . . . . 14.16 113.512 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 72.3 mtm -74.81 -29.61 61.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 117.58 0.69 . . . . 15.45 110.594 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.563 ' OD2' HG12 ' A' ' 143' ' ' VAL . 32.6 t70 -149.21 120.5 7.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.25 0.547 . . . . 13.63 111.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 p -75.32 -25.98 58.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.943 1.09 . . . . 13.9 113.943 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.563 HG12 ' OD2' ' A' ' 141' ' ' ASP . 2.8 p -72.13 -34.98 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 107.865 -1.161 . . . . 13.81 107.865 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 121' ' ' LEU . 37.8 m -60.62 -50.17 74.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.311 -1.313 . . . . 11.48 109.212 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.77 -54.55 27.62 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.613 0.571 . . . . 10.35 113.471 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 6.9 t -62.9 -45.18 93.75 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 112.648 0.61 . . . . 12.2 112.648 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -65.61 -49.31 69.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 11.86 110.951 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -63.72 -42.15 97.96 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.419 -0.809 . . . . 9.32 110.77 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.466 ' HA ' ' CE ' ' A' ' 149' ' ' MET . 0.3 OUTLIER -58.81 -54.62 45.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 9.5 111.256 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 146' ' ' THR . 13.5 ptt180 -63.79 -38.66 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.651 -0.25 . . . . 13.91 111.657 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.9 -53.48 44.87 Favored Glycine 0 N--CA 1.443 -0.853 0 O-C-N 123.531 0.519 . . . . 9.88 112.417 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.88 -41.69 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.525 0.203 . . . . 9.27 111.341 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.9 m -60.72 -54.99 38.58 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 116.172 -0.467 . . . . 11.46 111.466 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -69.31 -25.37 64.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.577 -0.738 . . . . 15.04 111.221 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -64.36 -30.77 71.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.872 -0.604 . . . . 11.82 110.878 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' SER . 69.8 m-85 -98.15 -69.69 0.75 Allowed 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.689 -0.804 . . . . 11.97 111.004 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 19.4 t 171.53 17.32 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.278 0.361 . . . . 14.24 110.998 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.5 pt -123.22 168.46 15.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 O-C-N 121.322 -0.861 . . . . 12.62 109.67 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 5.9 tp60 -130.93 118.01 20.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 120.518 -0.473 . . . . 16.39 110.902 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 93.8 mt -118.71 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.354 -0.839 . . . . 12.32 109.514 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.51 149.28 36.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.115 -0.948 . . . . 14.06 110.147 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.12 0.968 . . . . 12.64 112.695 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.06 1.85 57.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.887 -0.597 . . . . 15.68 111.236 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 167' ' ' THR . . . -66.23 -18.13 65.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.545 0.572 . . . . 12.72 112.545 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . 0.282 2.6 pp -75.93 7.05 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.932 0.716 . . . . 12.16 112.932 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -98.65 -16.03 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.623 -0.717 . . . . 15.08 110.427 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 164' ' ' ALA . 15.2 t -103.34 15.95 27.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.253 -0.579 . . . . 14.67 111.765 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.563 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 13.5 m0 -123.26 119.2 27.58 Favored Pre-proline 0 CA--C 1.501 -0.915 0 O-C-N 121.902 -0.499 . . . . 12.68 110.453 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.43 ' HD2' ' OG ' ' A' ' 173' ' ' SER . 22.7 Cg_exo -63.32 -37.61 49.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.455 2.104 . . . . 14.34 110.261 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 16.5 p -144.24 169.13 18.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.746 -0.661 . . . . 12.91 110.956 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -52.68 -41.31 63.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.166 0.586 . . . . 9.89 111.875 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.86 -22.83 50.11 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.477 0.917 . . . . 12.5 113.477 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' HD2' ' A' ' 169' ' ' PRO . 14.3 m -69.1 -26.85 65.13 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.033 0.444 . . . . 11.04 110.665 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 168' ' ' TRP . 23.6 tp -66.82 -46.06 76.35 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.579 -0.897 . . . . 8.5 108.579 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.46 -28.23 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.934 -1.03 . . . . 7.7 111.273 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.72 -40.53 55.46 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.83 -0.348 . . . . 10.38 111.663 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.84 -34.58 66.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.584 0.957 . . . . 11.97 113.584 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 110' ' ' ILE . 14.2 p -71.4 -33.66 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.282 -0.567 . . . . 9.8 110.012 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 183' ' ' GLN . 10.6 t70 -60.86 -49.93 75.47 Favored 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 109.427 -0.582 . . . . 10.83 109.427 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.6 -29.41 70.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.468 -0.787 . . . . 13.5 112.134 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -85.89 -51.48 6.36 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.193 0.442 . . . . 14.84 112.193 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.92 -36.65 45.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 120.966 0.412 . . . . 13.35 110.913 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.459 ' NE2' ' HB1' ' A' ' 101' ' ' ALA . 23.7 mt-30 . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 118.319 -0.848 . . . . 13.51 109.119 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 107.134 -1.432 . . . . 18.51 107.134 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.98 -39.56 41.38 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.398 0.888 . . . . 16.66 113.398 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.04 -57.03 13.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 14.84 111.215 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.56 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 28.5 t70 -65.65 -32.4 73.94 Favored 'General case' 0 C--O 1.197 -1.703 0 CA-C-N 115.76 -0.654 . . . . 14.98 110.191 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.04 -39.83 93.65 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.286 0.634 . . . . 15.79 111.142 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.6 t -65.1 -35.26 80.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.322 -0.622 . . . . 12.02 109.322 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.25 57.55 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 116.219 -0.446 . . . . 11.02 111.093 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 26.1 mt-30 -51.73 -50.23 60.99 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.767 0.827 . . . . 16.07 111.446 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -42.39 96.13 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.823 -0.351 . . . . 13.93 111.158 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.88 -37.16 70.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.9 0.381 . . . . 10.71 110.505 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -64.84 -47.43 77.98 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.201 1.001 . . . . 14.02 109.041 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.81 -46.89 83.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.064 0.946 . . . . 16.29 111.153 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -72.94 -38.7 66.68 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.228 0.455 . . . . 12.91 112.228 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.92 -46.57 88.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.692 -1.225 . . . . 12.77 107.692 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -61.7 -44.26 97.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 15.19 111.315 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.81 86.39 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.21 0.448 . . . . 16.26 112.21 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.41 -44.63 51.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.039 0.385 . . . . 15.45 112.039 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.47 -9.77 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.228 0.537 . . . . 16.16 111.986 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 t80 65.96 36.97 5.6 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.627 1.203 . . . . 20.56 108.857 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 14.6 p -107.89 163.4 13.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.736 -1.209 . . . . 16.63 107.736 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -90.92 136.58 27.43 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 120.234 -0.586 . . . . 20.19 111.506 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -74.91 6.88 3.09 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.415 2.743 . . . . 16.6 112.671 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.48 -30.51 18.74 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 111.301 -0.719 . . . . 17.74 111.301 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -94.85 47.15 1.15 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.175 0.988 . . . . 20.23 111.674 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 tp -126.8 131.81 70.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.96 -1.496 . . . . 15.98 106.96 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -136.4 174.04 11.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.974 -0.103 . . . . 19.33 111.194 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 2.8 m-20 -67.52 -45.42 75.83 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.623 0.725 . . . . 14.93 111.33 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.44 7.77 74.65 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.002 -0.999 . . . . 14.82 113.998 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.9 m -59.89 144.97 47.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.292 0.567 . . . . 14.54 112.435 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.4 mtm180 -82.3 102.33 11.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.548 -2.019 . . . . 16.75 105.548 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -45.55 -58.58 3.28 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.798 1.239 . . . . 11.99 114.03 -168.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.34 -29.63 47.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.109 0.481 . . . . 14.45 111.404 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 7.1 mm-40 -68.87 -7.03 30.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 16.44 111.73 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -72.66 -5.96 41.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.233 -0.44 . . . . 13.77 111.239 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.05 11.55 4.74 Favored Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.063 -1.065 . . . . 13.81 114.128 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -115.41 152.17 33.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.898 0.849 . . . . 13.04 112.854 -177.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -126.04 167.59 15.13 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.121 -0.945 . . . . 15.67 109.475 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.3 m -38.72 -52.82 1.69 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.598 1.559 . . . . 15.29 114.71 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.8 -46.19 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.94 0.4 . . . . 16.66 111.317 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -66.16 -38.84 82.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 14.14 109.872 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.16 -42.54 96.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.406 -0.815 . . . . 12.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.11 96.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.529 -0.759 . . . . 13.97 110.624 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.85 -40.13 94.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.861 -0.609 . . . . 15.69 111.45 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -67.6 -53.51 27.54 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.034 -0.985 . . . . 11.69 111.53 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 58' ' ' ALA . 7.8 tp -60.49 -29.99 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.421 0.629 . . . . 11.16 110.708 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -62.49 -28.41 69.81 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.06 -0.973 . . . . 16.65 109.417 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -86.61 -33.83 20.05 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.887 -0.597 . . . . 14.15 111.713 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.76 -46.46 96.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.495 -0.557 . . . . 10.8 109.495 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -53.11 -39.27 63.3 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.046 -0.979 . . . . 12.98 111.415 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -77.07 -57.98 3.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.93 -0.577 . . . . 17.52 111.159 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -66.94 -27.99 67.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.284 -0.871 . . . . 14.87 113.219 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -103.85 0.84 30.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.879 -0.728 . . . . 12.2 112.625 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 54.24 47.62 22.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.83 1.252 . . . . 16.71 110.522 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.4 142.19 51.62 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.218 -0.901 . . . . 12.2 110.089 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -97.92 36.34 1.56 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.367 -1.346 . . . . 16.06 107.367 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.616 HD11 ' HD1' ' A' ' 73' ' ' TRP . 9.4 tt -56.55 132.69 77.36 Favored Pre-proline 0 C--O 1.244 0.812 0 CA-C-N 112.227 -2.26 . . . . 11.39 110.492 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.38 128.47 30.22 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.143 2.562 . . . . 12.6 111.957 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -71.63 -21.2 61.87 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-O 121.786 0.803 . . . . 12.52 110.03 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -69.04 -6.87 30.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.102 -0.954 . . . . 14.14 111.52 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 64' ' ' TYR . . . -63.35 -17.67 59.84 Favored Glycine 0 C--N 1.355 1.583 0 N-CA-C 112.019 -0.433 . . . . 10.76 112.019 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -99.16 -43.34 11.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.837 -1.171 . . . . 11.0 107.837 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -53.71 -48.9 69.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 113.816 -1.538 . . . . 16.42 112.0 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 64' ' ' TYR . 10.0 t -109.63 13.47 23.82 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.464 -0.494 . . . . 13.35 111.745 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 89.4 m-85 -140.73 75.15 26.08 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 109.339 -0.615 . . . . 12.23 109.339 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.33 38.05 0.7 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.054 2.503 . . . . 13.06 113.253 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 48.2 t -121.52 120.86 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.645 -1.613 . . . . 12.95 106.645 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -58.03 -42.05 84.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.31 -0.859 . . . . 10.92 112.555 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 83.0 tttt -64.98 -46.09 82.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.764 0.316 . . . . 14.32 110.199 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . . . -60.34 -40.85 92.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.975 -0.557 . . . . 10.93 111.551 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.35 -33.93 58.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.183 -0.462 . . . . 8.81 111.633 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -71.2 -33.03 69.56 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.624 -0.83 . . . . 9.35 110.762 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 54.2 mt-30 -69.86 -33.6 72.48 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.888 -0.782 . . . . 11.63 108.888 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.616 ' HD1' HD11 ' A' ' 56' ' ' ILE . 17.6 t-105 -61.82 -49.63 75.54 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.204 -0.907 . . . . 10.55 110.19 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.2 t -63.2 -45.27 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.259 0 N-CA-C 109.913 -0.403 . . . . 8.3 109.913 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.32 -32.31 80.36 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.667 -0.697 . . . . 9.58 113.398 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 t -87.27 -12.61 46.11 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 122.213 -0.581 . . . . 10.23 110.459 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 86.1 mm-40 -88.45 -47.11 8.59 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 122.308 -0.245 . . . . 10.43 110.366 177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 74' ' ' VAL 0.265 1.2 pp -81.51 80.6 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.846 1.308 . . . . 10.97 112.18 177.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -118.13 92.43 42.54 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.444 -1.253 . . . . 13.52 110.682 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.65 -176.85 2.39 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.954 2.436 . . . . 12.28 109.583 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 85' ' ' ALA . 24.9 m -85.88 77.06 9.79 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.509 0.671 . . . . 13.44 109.564 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -97.96 -66.74 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.417 -0.811 . . . . 13.27 110.608 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.53 55.42 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.306 -0.861 . . . . 14.48 109.732 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -85.31 18.93 2.44 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.078 0.942 . . . . 14.92 111.459 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -133.28 109.06 9.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.267 -1.333 . . . . 14.25 108.282 178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.87 120.52 81.17 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 109.637 -0.505 . . . . 12.97 109.637 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -77.32 99.26 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.445 2.097 . . . . 13.4 110.858 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.99 145.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.945 -1.131 . . . . 12.43 107.945 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -125.69 169.16 12.82 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.085 0.241 . . . . 13.45 110.352 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -148.82 92.03 1.94 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 123.318 0.386 . . . . 14.41 109.99 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.14 128.52 42.74 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.661 . . . . 11.68 109.214 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.66 55.25 5.12 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.315 2.677 . . . . 10.84 112.477 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.55 141.3 46.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.03 -0.73 . . . . 10.46 109.03 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.2 96.3 10.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.458 0.647 . . . . 10.58 109.304 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.2 m -148.86 147.7 29.02 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.89 -1.522 . . . . 11.04 106.89 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.94 118.43 65.8 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.626 -0.509 . . . . 10.88 109.626 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.35 36.05 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.134 2.556 . . . . 12.46 111.545 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.34 127.09 23.12 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.377 -0.971 . . . . 13.78 108.377 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.48 149.04 18.73 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.231 1.954 . . . . 11.95 111.909 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.93 2.47 86.61 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-N 115.852 -0.613 . . . . 11.48 112.396 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.5 -17.24 59.26 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.097 0.959 . . . . 11.55 111.018 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -69.31 -8.1 43.09 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.818 0.847 . . . . 12.59 112.361 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.08 -14.51 44.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.155 0.503 . . . . 11.24 109.935 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m 61.81 29.7 18.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.949 1.299 . . . . 10.05 112.71 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.67 65.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.818 -0.628 . . . . 11.22 110.813 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 110' ' ' ILE . 12.0 mm-40 -80.15 -40.19 27.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.6 -0.889 . . . . 11.38 108.6 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -55.33 -40.48 71.25 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 114.991 -1.004 . . . . 9.65 111.225 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -60.32 -53.57 56.1 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.041 0.536 . . . . 10.43 110.106 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -56.88 -49.96 73.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.211 -0.904 . . . . 10.21 109.743 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.462 HG12 ' CE1' ' A' ' 156' ' ' PHE . 52.7 mt -53.35 -48.23 56.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.867 0 CA-C-N 115.663 -0.699 . . . . 8.13 110.974 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -47.17 -44.36 21.91 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.448 1.099 . . . . 8.46 112.346 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 18.5 t70 -70.28 -50.42 39.68 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.738 -0.385 . . . . 10.86 111.216 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -62.77 -31.7 72.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.356 0.598 . . . . 11.45 111.558 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.5 -40.87 66.53 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 124.315 1.046 . . . . 7.62 109.326 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.8 -47.15 61.0 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.693 -0.685 . . . . 11.62 111.076 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 10.8 pt20 -65.44 -32.71 74.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 11.63 111.474 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 p -71.65 -35.76 70.47 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.335 -0.546 . . . . 9.14 110.604 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 138' ' ' LEU . 3.2 tm? -69.28 -45.22 70.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.053 -0.721 . . . . 10.06 109.053 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 -34.03 78.85 Favored Glycine 0 C--O 1.237 0.341 0 CA-C-N 116.202 -0.453 . . . . 12.07 111.999 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.13 -50.44 68.22 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.453 0.701 . . . . 12.32 109.516 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 148' ' ' TRP . 42.5 tp -69.67 -43.61 72.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.159 -0.928 . . . . 11.77 111.638 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 122' ' ' LEU . 10.6 tp -76.06 -24.3 55.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.358 0.503 . . . . 13.52 112.358 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 67.49 2.27 2.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.208 1.003 . . . . 16.56 111.109 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -156.95 155.91 32.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.278 -0.267 . . . . 15.74 110.278 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.85 114.48 65.24 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.481 -1.303 . . . . 14.2 107.481 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.22 -20.06 21.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.976 1.784 . . . . 14.18 110.782 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.96 -104.05 0.18 Allowed Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 108.482 -1.847 . . . . 14.03 108.482 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.84 11.37 0.75 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.136 0.493 . . . . 16.37 111.799 176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp 67.48 119.29 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.59 1.556 . . . . 12.45 114.456 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -162.33 -72.69 0.05 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.525 -1.216 . . . . 14.43 110.556 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -128.58 -35.21 1.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.158 0.429 . . . . 14.32 112.158 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.93 81.07 1.7 Allowed Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.965 -0.854 . . . . 13.75 110.965 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.37 59.03 1.15 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.027 0.441 . . . . 12.7 110.947 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.466 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 17.6 tp60 -72.32 136.2 46.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.734 -1.58 . . . . 16.38 106.734 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.65 -31.02 63.97 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 124.216 1.006 . . . . 13.3 111.831 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.9 -31.24 72.06 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.247 0.546 . . . . 16.25 111.488 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 134' ' ' GLN . 26.7 m-20 -82.69 -22.11 34.66 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.194 -0.457 . . . . 15.87 110.165 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 31.4 mt -93.11 -28.04 16.57 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.867 -0.606 . . . . 13.65 110.235 -176.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 174.61 86.41 0.06 OUTLIER Glycine 0 C--N 1.31 -0.883 0 N-CA-C 109.817 -1.313 . . . . 14.16 109.817 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptp -71.22 -18.9 62.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.09 1.144 . . . . 15.45 114.09 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.26 150.61 22.37 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 118.99 -0.529 . . . . 13.63 111.313 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -53.34 -44.66 68.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 117.858 0.299 . . . . 13.9 111.649 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.94 -48.3 88.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 111.295 0.109 . . . . 13.81 111.295 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 p -60.22 -38.51 83.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.466 0.543 . . . . 11.48 112.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.79 22.97 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.783 -1.198 . . . . 10.35 111.897 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.6 m -65.02 -32.6 74.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.374 0.269 . . . . 12.2 110.851 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.97 -49.55 76.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.557 . . . . 11.86 109.926 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.444 ' HB2' HD22 ' A' ' 121' ' ' LEU . 19.9 t90 -71.76 -34.81 69.79 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.517 -0.765 . . . . 9.32 111.142 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -45.59 92.65 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.469 -1.308 . . . . 9.5 107.469 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 154' ' ' ARG . 69.9 ttt180 -63.82 -43.03 97.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.861 -1.063 . . . . 13.91 109.659 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.09 -49.22 68.79 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 115.638 -0.71 . . . . 9.88 113.296 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.57 -37.45 74.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 117.267 0.534 . . . . 9.27 111.807 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.7 m -59.83 -43.84 94.35 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.955 0.159 . . . . 11.46 110.957 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 28.6 mtm180 -63.38 -45.36 91.45 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.561 -0.291 . . . . 15.04 110.624 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -53.97 -43.12 69.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.595 0.961 . . . . 11.82 113.595 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 110' ' ' ILE . 79.2 m-85 -102.97 4.89 37.94 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.238 -0.585 . . . . 11.97 111.681 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.5 m 53.95 44.06 29.94 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.237 1.015 . . . . 14.24 111.339 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.3 pt -116.95 161.55 15.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.316 -0.856 . . . . 12.62 108.773 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -113.25 96.75 6.08 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.978 0.418 . . . . 16.39 110.34 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.49 149.51 27.01 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.649 -0.871 . . . . 12.32 108.649 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.33 134.99 42.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.713 -0.676 . . . . 14.06 111.926 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.75 -22.2 62.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 12.64 110.103 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.06 -17.55 61.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.55 -0.75 . . . . 15.68 110.194 175.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.556 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -72.7 -3.2 23.68 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 112.654 0.612 . . . . 12.72 112.654 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.5 pt -68.27 -13.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.748 0.785 . . . . 12.16 109.298 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -111.2 3.79 18.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.29 -0.868 . . . . 15.08 109.357 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 56.9 m -97.25 -38.55 9.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 14.67 108.66 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CZ2' ' HG2' ' A' ' 177' ' ' GLU . 6.2 m0 -102.32 115.58 64.29 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.784 -0.644 . . . . 12.68 109.631 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.29 -30.36 3.41 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.28 1.987 . . . . 14.34 113.185 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.9 p -128.99 170.89 12.91 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 109.585 -0.524 . . . . 12.91 109.585 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.42 -22.65 66.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.444 -0.344 . . . . 9.89 111.061 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -61.79 -44.47 96.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.158 0.504 . . . . 12.5 110.423 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 5.7 m -61.02 -37.05 81.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.268 -0.878 . . . . 11.04 110.466 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.84 -42.25 58.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.191 -0.459 . . . . 8.5 110.558 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.09 83.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 7.7 111.639 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 20.4 m-20 -79.27 -33.75 43.19 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.411 -0.516 . . . . 10.38 110.653 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.518 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 7.4 tp10 -61.69 -50.45 72.43 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.136 -0.483 . . . . 11.97 111.012 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 -41.69 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.729 -0.669 . . . . 9.8 111.086 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.67 -41.51 97.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.791 0.436 . . . . 10.83 110.478 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 5.0 mmp_? -68.82 -31.33 70.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.638 -0.71 . . . . 13.5 111.089 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -78.09 -37.68 45.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.144 -0.48 . . . . 14.84 109.99 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.71 -59.85 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.931 -0.577 . . . . 13.35 109.661 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.135 0.897 . . . . 13.51 110.998 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 5' ' ' GLU . 8.8 m . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.526 0.203 . . . . 18.51 110.729 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 -58.46 0.05 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 122.518 0.327 . . . . 16.66 110.497 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -101.48 -64.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.119 -0.491 . . . . 14.84 111.439 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -53.83 -26.3 23.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.706 1.203 . . . . 14.98 112.987 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 1' ' ' VAL . 13.1 pt-20 -58.92 -32.71 69.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.369 0.507 . . . . 15.79 112.369 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 28.9 p -63.83 -37.32 86.94 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 120.103 -0.639 . . . . 12.02 110.441 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 -20.23 61.9 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 116.088 -0.506 . . . . 11.02 110.259 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.34 -53.08 6.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.995 -0.743 . . . . 16.07 108.995 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.71 -50.18 70.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 115.319 -0.855 . . . . 13.93 112.9 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 48' ' ' ILE . 55.6 mt -71.76 -25.7 62.14 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.263 -0.575 . . . . 10.71 111.395 -173.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -70.33 -40.44 74.15 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.041 -0.726 . . . . 14.02 109.041 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -65.63 -44.62 85.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.323 -0.853 . . . . 16.29 109.366 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 t -64.63 -33.77 76.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.742 -0.663 . . . . 12.91 110.693 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.22 -53.31 51.22 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.929 -1.137 . . . . 12.77 107.929 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -65.37 -33.64 76.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.872 -1.058 . . . . 15.19 111.541 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.84 -33.88 75.64 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.436 0.532 . . . . 16.26 112.436 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 44' ' ' TRP . 44.3 mtt -81.27 -21.86 39.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.923 -0.711 . . . . 15.45 111.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 84.2 mt -98.71 -7.34 27.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.175 0.512 . . . . 16.16 110.814 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 64.72 43.67 4.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.224 1.41 . . . . 20.56 111.742 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 6.6 p -126.83 169.91 12.74 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.637 -0.71 . . . . 16.63 111.182 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.09 127.67 78.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 123.061 0.544 . . . . 20.19 111.68 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' A' ' 25' ' ' ILE . 31.1 Cg_endo -65.5 -9.9 24.19 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.045 2.496 . . . . 16.6 112.314 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.9 -36.18 65.36 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.263 -1.135 . . . . 17.74 110.263 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -83.11 -37.57 23.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.997 -0.742 . . . . 20.23 108.997 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 22' ' ' PRO . 50.3 mm -76.38 92.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.828 -1.175 . . . . 15.98 107.828 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.71 155.77 26.59 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.036 -0.984 . . . . 19.33 110.291 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.35 -17.74 64.87 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 114.396 -1.275 . . . . 14.93 111.87 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.52 6.93 39.06 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 120.89 -0.672 . . . . 14.82 112.79 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 34' ' ' LEU . 66.2 m -68.97 160.81 30.19 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.851 0.834 . . . . 14.54 113.092 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 18.7 ttm180 -97.45 112.46 24.29 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.524 -1.216 . . . . 16.75 109.738 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -39.03 -60.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.831 1.252 . . . . 11.99 113.877 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD22 ' H ' ' A' ' 32' ' ' LEU . 2.5 mm? -61.63 -32.8 72.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 14.45 111.729 -174.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.64 -17.27 60.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.786 0.803 . . . . 16.44 110.729 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 29' ' ' SER . 94.4 mt -84.56 8.31 17.1 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.151 -0.477 . . . . 13.77 111.557 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.21 31.2 12.18 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.813 -0.915 . . . . 13.81 110.813 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.5 tt -108.8 135.67 49.64 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.81 -0.811 . . . . 13.04 108.81 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -123.2 164.02 19.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.572 -1.27 . . . . 15.67 107.572 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -49.54 -41.74 42.13 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.609 0.64 . . . . 15.29 111.756 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.57 -49.39 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.928 -0.578 . . . . 16.66 110.675 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.04 -35.72 75.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.996 -0.547 . . . . 14.14 110.438 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -60.38 -46.81 88.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 12.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.16 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.316 0.579 . . . . 13.97 110.999 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.14 -40.02 71.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.745 -0.661 . . . . 15.69 111.076 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 9.2 t90 -57.78 -45.53 85.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 124.278 1.031 . . . . 11.69 110.09 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 41' ' ' ALA . 40.3 mm -54.96 -39.34 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 114.935 -1.029 . . . . 11.16 110.072 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -57.43 -35.45 70.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.36 -0.836 . . . . 16.65 111.668 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 51' ' ' HIS . 24.5 tt0 -85.09 -35.72 21.63 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.037 -0.665 . . . . 14.15 110.787 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 56' ' ' ILE . 19.5 pt -68.57 -30.28 46.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 119.912 -0.715 . . . . 10.8 110.83 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.622 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 6.1 m-20 -63.69 -27.31 69.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.334 -0.848 . . . . 12.98 110.498 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -79.96 -46.32 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.177 -0.675 . . . . 17.52 109.177 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 20.8 m-70 -51.58 -56.56 12.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.303 -0.862 . . . . 14.87 112.899 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 97.0 m-85 -107.18 16.51 24.0 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.471 0.545 . . . . 12.2 112.471 -173.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 42.91 42.94 3.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.655 1.182 . . . . 16.71 112.523 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.24 140.57 52.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.831 -0.622 . . . . 12.2 109.325 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -81.19 72.05 8.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.253 -0.43 . . . . 16.06 110.216 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.622 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 18.2 mm -61.47 125.37 84.22 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-N 115.947 -0.57 . . . . 11.39 111.564 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 59.1 Cg_endo -77.27 125.82 8.05 Favored 'Trans proline' 0 N--CA 1.434 -1.985 0 C-N-CA 121.938 1.759 . . . . 12.6 108.671 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.51 -19.79 40.4 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.926 0.713 . . . . 12.52 112.926 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 57' ' ' PRO . 3.0 p30 -62.64 -16.76 58.37 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.171 0.804 . . . . 14.14 113.171 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.23 78.71 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 120.847 -0.692 . . . . 10.76 114.566 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.45 -34.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.496 0.665 . . . . 11.0 111.55 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -73.55 -28.0 61.63 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.202 -0.666 . . . . 16.42 109.202 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 m -83.13 -43.52 16.12 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.229 -0.896 . . . . 13.35 110.078 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.2 94.31 48.04 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.278 -0.419 . . . . 12.23 110.31 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 93.7 Cg_endo -83.65 4.34 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.62 2.214 . . . . 13.06 112.705 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.38 120.61 62.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.642 -1.614 . . . . 12.95 106.642 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -56.09 -44.69 79.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.835 -1.075 . . . . 10.92 113.488 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -71.71 -21.33 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.442 0.639 . . . . 14.32 110.784 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.91 -31.7 22.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.662 0.744 . . . . 10.93 109.348 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.51 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 48.3 t80 -71.85 -34.11 68.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.388 -0.824 . . . . 8.81 111.455 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 p -65.03 -24.32 67.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.141 0.496 . . . . 9.35 111.569 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -74.06 -39.76 63.27 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.175 -1.046 . . . . 11.63 108.175 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 59.7 t90 -59.83 -45.91 90.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.583 -1.19 . . . . 10.55 109.246 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.91 -45.38 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 8.3 109.966 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.83 84.96 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.603 -0.726 . . . . 9.58 114.365 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -71.68 -16.4 62.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 10.23 112.452 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -93.29 -26.48 17.3 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.39 -0.368 . . . . 10.43 110.489 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.64 -41.61 87.99 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.943 -0.571 . . . . 10.97 109.915 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -131.76 119.05 16.91 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-N 116.154 -0.476 . . . . 13.52 109.856 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.13 84.74 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.335 2.024 . . . . 12.28 110.021 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.0 t -70.33 -14.84 62.75 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.928 -0.578 . . . . 13.44 110.748 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -94.09 14.48 19.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.187 -0.461 . . . . 13.27 111.764 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.96 -23.1 61.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.528 0.68 . . . . 14.48 109.961 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 91' ' ' GLU . 15.3 t -156.78 157.43 35.02 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.26 -1.756 . . . . 14.92 106.26 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.63 40.75 7.72 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 124.212 0.945 . . . . 14.25 110.692 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 91' ' ' GLU . . . -78.99 131.29 67.25 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.77 -0.826 . . . . 12.97 108.77 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.35 43.76 1.38 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.961 2.441 . . . . 13.4 112.929 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.3 p -146.91 56.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 122.375 1.083 . . . . 12.43 109.586 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 74.66 -59.22 0.56 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.277 1.431 . . . . 13.45 112.008 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -137.09 157.3 47.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.538 -0.912 . . . . 14.41 108.538 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . 1.7 pm0 -83.21 141.22 42.75 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 108.741 -0.837 . . . . 11.68 108.741 172.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 8.2 Cg_exo -72.53 68.58 3.57 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.731 2.287 . . . . 10.84 111.268 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.9 124.72 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 CA-C-N 114.776 -1.102 . . . . 10.46 109.488 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.24 60.59 1.22 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.404 -1.332 . . . . 10.58 107.404 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 m 73.77 133.49 0.05 OUTLIER 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.599 -1.637 . . . . 11.04 110.033 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.72 125.92 83.44 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 115.574 -0.739 . . . . 10.88 109.882 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.87 -36.21 97.33 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.46 2.773 . . . . 12.46 110.821 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.5 tt0 -124.27 126.98 25.43 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 106.245 -1.761 . . . . 13.78 106.245 173.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 2.9 Cg_exo -75.2 33.07 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.827 2.351 . . . . 11.95 113.555 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 24.91 9.17 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.112 -1.195 . . . . 11.48 110.112 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.73 -25.37 60.16 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.986 0.422 . . . . 11.55 110.655 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.52 116.39 9.87 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.966 -0.753 . . . . 12.59 108.966 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.27 -28.06 56.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.873 -0.603 . . . . 11.24 109.503 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.3 m -88.78 81.59 6.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.442 -0.948 . . . . 10.05 108.442 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.72 -28.66 70.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.173 -0.921 . . . . 11.22 112.725 -174.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.486 ' O ' HG13 ' A' ' 110' ' ' ILE . 48.3 tp60 -61.03 -20.92 63.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.027 0.531 . . . . 11.38 111.592 -176.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.492 HH21 ' NE2' ' A' ' 183' ' ' GLN . 10.8 mpt_? -75.05 -31.08 61.2 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.844 0.312 . . . . 9.65 111.844 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 40.1 tt0 -71.88 -43.69 65.0 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.132 0.491 . . . . 10.43 109.984 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -62.48 -21.53 65.54 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.998 -0.546 . . . . 10.21 111.812 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.564 HG21 HG11 ' A' ' 178' ' ' VAL . 55.3 mt -67.07 -54.68 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 108.704 -0.85 . . . . 8.13 108.704 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 13.7 pt20 -64.37 -29.31 70.38 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.937 -0.574 . . . . 8.46 111.751 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.66 -52.2 64.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.618 -0.512 . . . . 10.86 109.618 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -69.41 -37.4 77.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 11.45 110.489 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 171' ' ' LEU . 6.3 tt -61.28 -42.27 98.36 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.526 -0.916 . . . . 7.62 108.526 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.1 -47.2 87.38 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.596 -0.729 . . . . 11.62 109.404 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.05 -50.37 72.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 11.63 111.705 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.5 m -69.14 -30.45 68.7 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.717 0.266 . . . . 9.14 111.717 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 47.7 tp -68.96 -49.23 59.8 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 108.707 -0.849 . . . . 10.06 108.707 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.32 -22.03 68.93 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.707 -0.759 . . . . 12.07 112.534 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.08 -52.8 8.2 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 122.538 -0.389 . . . . 12.32 110.756 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.56 -18.11 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.732 0.641 . . . . 11.77 112.732 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' LEU . 4.4 mm? -113.42 3.01 15.63 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.035 0.445 . . . . 13.52 110.83 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 70.45 -29.8 0.19 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 16.56 115.596 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.8 tp -136.0 148.76 48.56 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.593 -0.692 . . . . 15.74 111.365 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -84.44 124.25 73.79 Favored Pre-proline 0 CA--C 1.505 -0.784 0 N-CA-C 107.148 -1.427 . . . . 14.2 107.148 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB3' HD11 ' A' ' 138' ' ' LEU . 72.9 Cg_endo -79.17 -16.31 12.38 Favored 'Trans proline' 0 C--N 1.33 -0.446 0 C-N-CA 121.848 1.699 . . . . 14.18 113.08 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.15 6.65 87.66 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 110.575 -1.01 . . . . 14.03 110.575 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 16.1 mm100 -99.72 33.22 2.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.666 0.746 . . . . 16.37 110.603 -174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 68.2 mt -73.34 103.37 4.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.881 -1.054 . . . . 12.45 108.539 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 10.2 mmm180 79.23 1.27 2.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.214 1.406 . . . . 14.43 111.424 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -89.04 -25.35 22.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.604 0.716 . . . . 14.32 109.338 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 157.49 -91.8 0.12 Allowed Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.248 -1.141 . . . . 13.75 110.248 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 128' ' ' GLN . . . 63.45 90.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.862 1.265 . . . . 12.7 112.092 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -97.49 136.56 37.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.721 -0.844 . . . . 16.38 108.721 175.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 140' ' ' MET . 19.4 p90 -47.55 -36.45 10.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.21 1.404 . . . . 13.3 114.063 -170.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.29 -40.65 96.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.954 0.502 . . . . 16.25 110.926 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.48 -35.27 75.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.009 -0.541 . . . . 15.87 110.434 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 126' ' ' PRO . 4.0 mm? -72.98 -19.52 61.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 13.65 112.076 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.87 20.48 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.439 -1.065 . . . . 14.16 110.439 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.438 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . 43.7 ttm -85.98 129.03 34.96 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.547 -0.908 . . . . 15.45 108.547 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.03 176.09 6.93 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.136 -1.061 . . . . 13.63 108.136 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' ' OH ' ' A' ' 166' ' ' TYR . 38.6 m -73.73 -48.06 34.72 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.4 -0.92 . . . . 13.9 109.697 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.19 -48.08 88.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 112.012 0.375 . . . . 13.81 112.012 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 p -67.6 -33.93 75.99 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.913 0.387 . . . . 11.48 111.757 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 -25.5 61.86 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 119.971 -1.109 . . . . 10.35 111.116 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.3 m -64.91 -48.34 74.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 12.2 108.705 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -57.13 -53.59 56.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.891 -1.05 . . . . 11.86 109.993 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -53.0 -53.98 42.01 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.37 -0.832 . . . . 9.32 112.743 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 3.5 tpt -54.76 -54.08 46.66 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.153 0.581 . . . . 9.5 111.425 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . 75.0 ttt180 -64.62 -37.23 86.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.966 0.413 . . . . 13.91 110.185 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.38 27.89 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.473 -0.785 . . . . 9.88 112.649 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.88 -42.79 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.512 0.325 . . . . 9.27 111.007 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 25.3 m -58.5 -57.15 14.2 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.837 -0.62 . . . . 11.46 110.847 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -64.2 -35.62 81.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.637 -0.71 . . . . 15.04 111.352 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -76.59 -14.84 59.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.036 0.384 . . . . 11.82 112.036 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CZ ' HG12 ' A' ' 110' ' ' ILE . 86.1 t80 -95.68 -70.31 0.72 Allowed 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 119.132 -1.027 . . . . 11.97 111.081 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.9 m -178.74 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.79 0.436 . . . . 14.24 112.138 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 27.7 pt -98.84 142.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.268 0.556 . . . . 12.62 111.796 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -91.78 95.75 10.03 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.748 0.785 . . . . 16.39 109.632 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 87.2 mt -101.01 151.23 22.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.288 -0.869 . . . . 12.32 109.25 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.91 45.81 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.393 -1.276 . . . . 14.06 108.763 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 150' ' ' ARG . . . -66.17 -21.18 66.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.444 0.64 . . . . 12.64 110.204 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -82.08 2.94 28.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 15.68 111.009 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.72 61.17 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.905 -0.497 . . . . 12.72 111.685 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.4 pt -67.38 -10.97 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.261 0.553 . . . . 12.16 110.446 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 142' ' ' SER . 27.3 m-85 -106.57 -1.47 22.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 15.08 109.164 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -89.22 -47.0 8.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.106 -0.701 . . . . 14.67 109.106 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.34 141.09 24.79 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 109.223 -0.658 . . . . 12.68 109.223 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 40.5 Cg_endo -97.21 2.26 1.66 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.377 2.051 . . . . 14.34 114.429 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 1.3 p -120.13 144.34 47.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.455 0.909 . . . . 12.91 113.455 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 114' ' ' LEU . 4.5 mm? -63.48 -30.39 71.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.303 -1.317 . . . . 9.89 112.339 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 56.8 mtpt -58.37 -40.1 81.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.534 -0.757 . . . . 12.5 110.674 176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -39.59 93.13 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.319 -0.855 . . . . 11.04 110.844 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.55 -50.38 65.38 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.216 -1.031 . . . . 8.5 108.216 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.04 -32.32 69.65 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.754 0.65 . . . . 7.7 112.754 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.48 -34.2 31.5 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.523 -0.471 . . . . 10.38 111.033 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.98 -47.42 68.61 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.963 0.905 . . . . 11.97 110.118 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 110' ' ' ILE . 12.4 p -57.21 -44.29 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.309 -0.86 . . . . 9.8 112.277 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -57.51 -39.45 76.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.023 0.44 . . . . 10.83 111.627 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -80.92 -23.84 38.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.836 -0.62 . . . . 13.5 110.678 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -84.2 -38.67 20.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 14.84 110.276 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 178' ' ' VAL . 75.3 t -62.59 -41.78 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.843 -0.617 . . . . 13.35 111.604 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.492 ' NE2' HH21 ' A' ' 107' ' ' ARG . 10.3 pt20 . . . . . 0 N--CA 1.434 -1.229 0 C-N-CA 120.586 -0.446 . . . . 13.51 111.271 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 110.592 -0.151 . . . . 18.51 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.75 -58.19 2.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.013 -0.43 . . . . 16.66 109.906 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -71.38 -49.87 37.77 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.398 0.618 . . . . 14.84 109.669 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -70.25 -19.76 63.11 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.793 -1.094 . . . . 14.98 111.42 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.47 -49.27 62.1 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.021 0.928 . . . . 15.79 112.154 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' HG11 ' A' ' 74' ' ' VAL . 52.6 t -61.46 -48.06 82.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 123.467 0.48 . . . . 12.02 111.535 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.7 92.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.614 -0.267 . . . . 11.02 110.759 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -61.72 -46.52 89.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 123.291 0.369 . . . . 16.07 111.378 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HB3' ' OH ' ' A' ' 52' ' ' TYR . 77.8 t80 -67.96 -33.52 74.81 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.597 -0.274 . . . . 13.93 110.753 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.93 -40.73 75.36 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 120.354 -0.538 . . . . 10.71 110.229 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -59.4 -45.39 91.61 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.795 -0.446 . . . . 14.02 109.795 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.5 -54.47 46.5 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.488 1.115 . . . . 16.29 111.455 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.7 p -68.18 -35.32 77.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.215 -0.448 . . . . 12.91 111.238 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.41 HD11 HD21 ' A' ' 34' ' ' LEU . 6.9 tt -63.13 -52.56 62.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 12.77 108.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.04 91.06 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.978 -0.555 . . . . 15.19 111.125 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -49.23 71.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.455 0.539 . . . . 16.26 112.455 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.8 mmm -76.66 -36.79 57.13 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.743 0.646 . . . . 15.45 112.743 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.84 -5.83 58.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.989 0.424 . . . . 16.16 111.71 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 61.04 39.51 16.23 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.767 1.27 . . . . 20.56 110.614 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.5 t -111.79 -173.56 2.27 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 113.135 -1.848 . . . . 16.63 107.553 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.0 136.92 29.16 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.847 -0.797 . . . . 20.19 108.847 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.1 -19.96 19.65 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.68 2.253 . . . . 16.6 113.182 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.65 -45.42 4.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.704 -0.958 . . . . 17.74 110.704 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.46 75.03 9.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.351 0.596 . . . . 20.23 110.748 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -147.54 144.96 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.744 -0.835 . . . . 15.98 108.744 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -88.42 131.23 34.95 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 107.536 -1.283 . . . . 19.33 107.536 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.58 -15.89 63.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 112.381 0.512 . . . . 14.93 112.381 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.21 7.67 54.67 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-N 116.154 -0.476 . . . . 14.82 112.019 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 p -69.0 133.42 48.11 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.817 0.818 . . . . 14.54 111.324 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 16.5 mtp180 -84.05 140.63 31.71 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.92 -1.037 . . . . 16.75 110.371 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 76.3 m-85 -43.75 -48.35 8.03 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 113.617 0.969 . . . . 11.99 113.617 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.87 -15.15 63.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.217 0.451 . . . . 14.45 112.217 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.1 -39.03 9.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.211 -1.403 . . . . 16.44 107.211 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 14' ' ' LEU . 37.2 tp -61.02 -29.17 69.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.058 -1.883 . . . . 13.77 111.581 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.05 6.93 1.39 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.273 -1.441 . . . . 13.81 113.924 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 36' ' ' LEU . 18.9 mt -84.61 151.42 24.51 Favored 'General case' 0 CA--C 1.477 -1.849 0 C-N-CA 119.133 -1.027 . . . . 13.04 112.667 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.47 159.89 42.0 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 112.375 -2.193 . . . . 15.67 105.709 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -50.51 -48.52 56.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.821 1.045 . . . . 15.29 113.821 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.29 -46.89 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.479 0.657 . . . . 16.66 110.613 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.35 -37.87 72.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.011 -0.54 . . . . 14.14 110.363 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 -42.19 84.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.607 -0.724 . . . . 12.0 110.19 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.02 84.7 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.247 -0.888 . . . . 13.97 110.93 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.66 -47.74 74.51 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.415 -0.812 . . . . 15.69 110.88 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -66.03 -52.1 52.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.874 1.269 . . . . 11.69 111.818 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.24 -37.16 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.297 0.48 . . . . 11.16 112.297 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -66.39 -40.37 89.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.517 -0.473 . . . . 16.65 110.13 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.48 -24.6 64.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 111.828 0.307 . . . . 14.15 111.828 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.2 -55.72 17.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.29 -0.633 . . . . 10.8 109.29 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.428 ' OD1' ' HB ' ' A' ' 56' ' ' ILE . 3.3 m-20 -63.31 -34.5 77.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 12.98 112.156 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.43 -47.29 17.83 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.476 -0.329 . . . . 17.52 111.857 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -70.66 -40.29 73.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 112.822 0.675 . . . . 14.87 112.822 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 9' ' ' PHE . 81.2 m-85 -91.42 -8.13 48.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.786 -0.765 . . . . 12.2 113.02 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 53.98 41.46 32.02 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.959 1.304 . . . . 16.71 109.486 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 tp -115.87 143.47 45.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.737 -0.665 . . . . 12.2 110.942 -170.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -69.76 76.06 0.44 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.491 -0.777 . . . . 16.06 110.861 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.428 ' HB ' ' OD1' ' A' ' 49' ' ' ASN . 21.7 mm -98.66 113.86 64.77 Favored Pre-proline 0 C--N 1.316 -0.881 0 O-C-N 121.8 -0.563 . . . . 11.39 110.566 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.6 140.46 93.87 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.478 2.119 . . . . 12.6 109.91 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.89 2.33 1.48 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.289 0.848 . . . . 12.52 113.289 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.4 0.03 41.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 118.961 -0.542 . . . . 14.14 112.163 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.72 ' HA2' ' CZ3' ' A' ' 73' ' ' TRP . . . -43.73 -60.92 3.15 Favored Glycine 0 C--N 1.356 1.667 0 N-CA-C 114.758 0.663 . . . . 10.76 114.758 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.92 -21.7 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.889 1.276 . . . . 11.0 112.019 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -93.33 -40.38 10.44 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.209 -0.451 . . . . 16.42 111.064 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.4 m -73.86 -40.38 63.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.396 -0.366 . . . . 13.35 110.956 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HE3' ' A' ' 73' ' ' TRP . 96.2 m-85 -112.56 103.1 55.35 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.098 -1.075 . . . . 12.23 108.098 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 95.8 Cg_endo -79.55 -0.27 10.58 Favored 'Trans proline' 0 C--O 1.209 -0.949 0 C-N-CA 122.311 2.007 . . . . 13.06 112.529 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.59 119.86 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.757 -1.572 . . . . 12.95 106.757 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 21.9 p90 -57.12 -36.48 70.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.411 0.684 . . . . 10.92 112.529 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -63.77 -31.03 72.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.519 0.727 . . . . 14.32 110.424 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.05 26.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.103 0.478 . . . . 10.93 110.262 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 46.1 t80 -77.39 -30.57 53.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.934 -0.575 . . . . 8.81 111.343 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p -67.26 -24.57 65.81 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.59 0.71 . . . . 9.35 110.309 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -76.93 -28.66 55.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.608 -0.724 . . . . 11.63 109.404 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.72 ' CZ3' ' HA2' ' A' ' 60' ' ' GLY . 1.6 t90 -56.86 -55.24 36.98 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 108.56 -0.904 . . . . 10.55 108.56 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 6' ' ' CYS . 71.5 t -65.8 -43.61 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 CA-C-N 115.132 -0.94 . . . . 8.3 110.188 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.01 -34.67 73.23 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.615 0.572 . . . . 9.58 112.459 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.5 m -72.91 -37.28 67.3 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 122.926 0.49 . . . . 10.23 111.377 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.72 -14.73 60.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.384 . . . . 10.43 112.038 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.43 137.3 32.86 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.943 -1.132 . . . . 10.97 107.943 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.8 139.94 37.63 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 108.991 -0.744 . . . . 13.52 108.991 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -66.87 105.67 0.99 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.549 1.499 . . . . 12.28 108.438 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -80.15 69.87 6.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.059 1.409 . . . . 13.44 111.175 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -85.91 127.95 34.72 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 113.961 -1.472 . . . . 13.27 107.105 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.8 -24.43 63.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.57 0.7 . . . . 14.48 110.058 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 p -97.15 35.68 1.55 Allowed 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.218 -0.901 . . . . 14.92 110.952 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.22 36.98 4.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.885 -0.598 . . . . 14.25 109.749 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.17 138.85 89.71 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.121 -0.945 . . . . 12.97 109.697 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.31 68.15 6.06 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.849 2.366 . . . . 13.4 112.817 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -86.92 94.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 107.812 -1.181 . . . . 12.43 107.812 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -122.26 -175.57 3.16 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.076 -0.965 . . . . 13.45 110.357 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 67.2 94.65 0.07 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.201 1.401 . . . . 14.41 112.039 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -81.73 130.18 62.19 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.743 -1.206 . . . . 11.68 107.743 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.8 133.46 42.04 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.202 1.935 . . . . 10.84 110.924 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.16 127.88 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.036 -0.357 . . . . 10.46 110.036 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.84 60.36 1.2 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.854 0.835 . . . . 10.58 108.851 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.0 m -99.17 146.63 25.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.774 -0.825 . . . . 11.04 108.774 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 73.36 96.67 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 124.997 1.319 . . . . 10.88 111.738 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.36 -44.07 52.32 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.621 2.881 . . . . 12.46 111.568 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -116.46 89.09 26.02 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 107.335 -1.358 . . . . 13.78 107.335 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.1 157.12 23.36 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 121.919 1.746 . . . . 11.95 111.17 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.07 -172.47 17.86 Favored Glycine 0 N--CA 1.424 -2.153 0 C-N-CA 120.924 -0.655 . . . . 11.48 111.617 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.15 -23.47 51.65 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.391 0.615 . . . . 11.55 110.178 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -82.29 82.01 7.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.19 -1.411 . . . . 12.59 107.19 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.84 -5.88 54.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.98 -1.009 . . . . 11.24 111.97 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m -76.91 59.24 1.6 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.525 0.679 . . . . 10.05 109.797 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.56 -49.2 73.33 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 124.947 1.299 . . . . 11.22 112.689 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt-30 -58.95 -58.65 7.71 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.24 0.337 . . . . 11.38 110.277 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 60.0 ttp180 -55.76 -50.33 70.71 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.877 0.736 . . . . 9.65 111.71 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.15 -41.06 95.1 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.349 0.406 . . . . 10.43 111.973 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -70.39 -42.54 71.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.323 -0.551 . . . . 10.21 111.185 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.517 HG21 HG11 ' A' ' 178' ' ' VAL . 92.4 mt -58.76 -52.96 53.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.944 0 N-CA-C 109.322 -0.621 . . . . 8.13 109.322 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -49.31 -49.0 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.353 1.033 . . . . 8.46 112.688 -175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 34.2 t70 -68.0 -44.82 75.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.81 -0.356 . . . . 10.86 111.872 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -70.16 -35.26 73.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.069 0.396 . . . . 11.45 112.069 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.86 -41.34 97.81 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.724 0.809 . . . . 7.62 109.464 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -61.56 -46.43 89.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 11.62 109.219 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 27.7 mt-30 -57.88 -49.88 75.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.02 -0.536 . . . . 11.63 110.8 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -57.24 -45.3 84.04 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 124.183 0.927 . . . . 9.14 110.97 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.06 -49.9 75.82 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.972 0.17 . . . . 10.06 110.962 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.94 97.83 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 121.252 -0.499 . . . . 12.07 112.129 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.99 -45.94 91.41 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.316 1.046 . . . . 12.32 111.131 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 148' ' ' TRP . 26.9 tp -72.29 -43.93 63.5 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.137 -0.938 . . . . 11.77 111.26 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.9 tp -82.25 -11.72 58.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.792 -0.64 . . . . 13.52 111.619 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 66.89 32.81 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.525 1.13 . . . . 16.56 109.845 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 tp -99.54 140.21 34.07 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.117 -0.947 . . . . 15.74 108.609 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 5.8 m-20 -64.11 124.72 86.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 108.744 -0.835 . . . . 14.2 108.744 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 41.4 Cg_exo -57.18 -17.91 27.53 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.36 2.707 . . . . 14.18 114.029 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -75.04 -13.71 82.44 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 120.47 -0.872 . . . . 14.03 111.672 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -86.4 -21.56 27.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.312 -0.625 . . . . 16.37 109.312 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.28 69.9 5.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.127 -0.942 . . . . 12.45 110.606 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -160.37 -61.15 0.06 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.312 -1.736 . . . . 14.43 106.312 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.4 m -83.78 -31.84 25.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.974 -0.75 . . . . 14.32 108.974 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.81 1.04 Allowed Glycine 0 C--O 1.215 -1.067 0 N-CA-C 110.786 -0.925 . . . . 13.75 110.786 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.72 34.6 2.93 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.297 -1.371 . . . . 12.7 107.297 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.5 tt0 -123.25 123.68 41.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.522 -1.672 . . . . 16.38 108.071 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -57.9 -35.72 71.42 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 124.107 0.963 . . . . 13.3 110.344 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.74 -28.61 66.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.103 -0.953 . . . . 16.25 111.277 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -25.66 28.01 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.766 0.793 . . . . 15.87 110.469 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 79.5 mt -79.19 -11.06 59.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.31 -0.859 . . . . 13.65 111.011 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.07 -135.08 9.81 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.918 -1.673 . . . . 14.16 108.918 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 165' ' ' ILE . 43.3 tpp -176.41 92.08 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.145 -0.687 . . . . 15.45 109.145 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -134.38 126.39 29.5 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.029 0.442 . . . . 13.63 111.211 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.0 m -80.41 -21.84 41.85 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.733 -0.667 . . . . 13.9 111.646 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.0 -58.64 6.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 120.464 0.173 . . . . 13.81 111.124 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.5 t -71.82 -28.96 63.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.414 -0.587 . . . . 11.48 109.414 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.16 -43.95 88.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.427 -0.806 . . . . 10.35 112.601 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -62.81 -45.34 93.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.59 -0.522 . . . . 12.2 109.59 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.91 -49.97 74.07 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.568 -0.742 . . . . 11.86 111.372 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.486 ' O ' HG23 ' A' ' 152' ' ' VAL . 19.4 t90 -63.89 -51.52 64.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.815 -0.63 . . . . 9.32 111.431 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 161' ' ' ALA . 42.0 tpp -63.61 -40.76 97.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.03 0.206 . . . . 9.5 110.959 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -60.45 -41.82 94.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.61 -0.515 . . . . 13.91 109.61 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.83 -45.91 95.23 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.757 -0.656 . . . . 9.88 111.82 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 148' ' ' TRP . 56.0 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.832 -0.433 . . . . 9.27 109.832 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 160' ' ' LEU . 23.8 m -61.63 -51.68 67.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 11.46 110.8 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -65.01 -40.1 94.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.604 -0.725 . . . . 15.04 111.151 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -55.89 -46.64 78.28 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.424 0.69 . . . . 11.82 111.117 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -101.54 11.58 38.76 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.73 -0.388 . . . . 11.97 111.929 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.9 p 51.4 50.72 18.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.831 1.252 . . . . 14.24 113.107 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.3 pt -127.62 167.42 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.812 -0.631 . . . . 12.62 109.575 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -102.85 111.83 24.34 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.433 -0.348 . . . . 16.39 110.941 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 85.7 mt -129.98 154.28 47.54 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 106.886 -1.524 . . . . 12.32 106.886 173.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -95.59 138.89 32.63 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.467 0.651 . . . . 14.06 110.825 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.21 -24.09 66.55 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.265 -0.879 . . . . 12.64 111.726 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.59 17.82 6.03 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.007 0.432 . . . . 15.68 110.489 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.93 -3.76 27.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.205 0.817 . . . . 12.72 113.205 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.558 HD12 ' SD ' ' A' ' 140' ' ' MET . 26.0 pt -67.93 -12.34 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.628 0.728 . . . . 12.16 110.211 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -108.39 -2.21 19.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.862 -1.063 . . . . 15.08 108.72 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.9 m -101.97 -45.19 5.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.589 -0.732 . . . . 14.67 110.252 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 174' ' ' LEU . 5.3 m0 -111.7 118.24 47.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.433 -0.951 . . . . 12.68 108.433 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.11 -29.86 9.44 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.22 1.947 . . . . 14.34 112.261 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . 24.2 p -134.58 153.91 51.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.551 0.691 . . . . 12.91 110.321 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -14.5 51.54 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.078 -0.965 . . . . 9.89 113.233 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -43.39 92.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.171 -0.677 . . . . 12.5 109.171 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.5 m -62.68 -41.73 99.24 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.133 -0.939 . . . . 11.04 110.365 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.554 HD13 ' CZ3' ' A' ' 168' ' ' TRP . 36.3 tp -68.89 -43.94 74.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.313 -0.403 . . . . 8.5 110.823 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 107' ' ' ARG . . . -57.67 -39.67 77.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 7.7 111.459 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 16.8 t70 -79.24 -36.12 40.47 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.675 -0.81 . . . . 10.38 110.546 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 14.0 tp10 -64.27 -44.53 91.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.168 -0.469 . . . . 11.97 111.604 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 110' ' ' ILE . 10.1 p -55.59 -39.77 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.316 0.385 . . . . 9.8 111.282 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 106' ' ' GLN . 33.7 t70 -69.5 -34.48 74.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 10.83 110.55 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 29.9 mmt180 -72.93 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 13.5 109.95 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.8 mmt180 -83.38 -33.59 25.76 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.319 -0.623 . . . . 14.84 109.319 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 178' ' ' VAL . 85.0 t -74.53 -51.17 23.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 116.008 -0.542 . . . . 13.35 111.298 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 119.576 -0.25 . . . . 13.51 111.157 -178.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 120.598 0.237 . . . . 18.51 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.45 -80.29 0.5 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.352 -0.61 . . . . 16.66 109.352 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -73.92 -17.51 61.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.505 0.669 . . . . 14.84 109.6 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.99 -27.45 63.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.477 -0.783 . . . . 14.98 109.808 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.92 -32.15 51.48 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.997 -0.681 . . . . 15.79 109.691 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.41 -35.93 70.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.941 -0.572 . . . . 12.02 109.882 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.644 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -62.95 -49.02 76.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.275 -0.639 . . . . 11.02 109.275 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -54.59 -45.6 73.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.893 . . . . 16.07 111.139 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . 76.0 t80 -63.4 -36.22 83.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.69 0.619 . . . . 13.93 110.75 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.18 -38.37 72.13 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.352 -0.385 . . . . 10.71 110.33 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 30.7 mtp180 -63.21 -50.66 69.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.695 -0.483 . . . . 14.02 109.695 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 19.7 pt20 -64.49 -27.43 68.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.93 -0.577 . . . . 16.29 111.829 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.1 m -83.03 -44.27 15.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.241 0.544 . . . . 12.91 110.338 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.36 -41.62 93.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 12.77 111.509 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.947 0.351 . . . . 15.19 111.947 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 -30.04 68.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.529 0.68 . . . . 16.26 109.763 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.7 mtt -83.65 -34.44 25.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 15.45 109.764 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.43 0.44 54.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.735 -0.666 . . . . 16.16 111.217 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.6 t80 59.39 46.74 12.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.462 1.505 . . . . 20.56 110.668 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.63 -176.88 4.92 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.505 -0.77 . . . . 16.63 109.032 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -109.51 140.3 21.98 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.237 -1.023 . . . . 20.19 108.237 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.75 -23.06 70.46 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.729 2.953 . . . . 16.6 113.838 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.74 -6.81 85.56 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.459 -0.877 . . . . 17.74 112.467 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -109.94 16.48 21.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.798 0.666 . . . . 20.23 112.798 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.495 ' HB ' HD22 ' A' ' 34' ' ' LEU . 41.0 pt -106.04 157.37 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 119.366 -0.934 . . . . 15.98 109.904 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 27.2 mmt180 -101.65 94.77 6.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.185 -0.672 . . . . 19.33 109.185 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.81 -22.2 57.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.04 0.936 . . . . 14.93 113.119 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.62 6.51 77.44 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.573 -0.822 . . . . 14.82 112.936 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 57.6 p -115.25 171.03 7.94 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.337 -0.545 . . . . 14.54 112.38 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 28.7 mtm180 -62.12 147.75 46.51 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.649 0.78 . . . . 16.75 112.277 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -58.44 -32.61 68.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.283 1.033 . . . . 11.99 111.141 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.82 -25.24 67.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.669 -0.696 . . . . 14.45 110.376 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.88 -28.97 27.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.441 -0.577 . . . . 16.44 109.441 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -63.23 -31.74 72.97 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 13.77 110.823 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.31 -0.39 4.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.865 -1.16 . . . . 13.81 113.57 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -99.93 168.39 9.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 117.616 0.708 . . . . 13.04 111.438 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -128.07 161.08 30.05 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.095 . . . . 15.67 108.045 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 p -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.154 1.168 . . . . 15.29 114.154 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.67 -41.18 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.115 0.483 . . . . 16.66 110.569 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.31 -36.37 74.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.314 0.578 . . . . 14.14 110.258 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.38 72.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.334 -0.848 . . . . 12.0 110.427 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.58 -30.66 71.69 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.314 -0.857 . . . . 13.97 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.99 -40.69 27.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.506 0.669 . . . . 15.69 110.24 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -62.29 -45.74 91.9 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.582 -1.19 . . . . 11.69 111.5 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 tp -59.19 -31.92 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 111.863 0.32 . . . . 11.16 111.863 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 34.2 mmt180 -60.96 -50.01 75.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.804 0.335 . . . . 16.65 110.345 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -27.33 64.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.327 -0.549 . . . . 14.15 112.027 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.8 -47.45 92.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.093 -1.077 . . . . 10.8 108.093 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.13 -37.89 75.46 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.092 -0.958 . . . . 12.98 111.196 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -84.63 -47.22 10.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.788 0.328 . . . . 17.52 111.789 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -68.72 -35.43 77.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 116.384 -0.371 . . . . 14.87 111.655 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.04 -2.48 37.09 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.346 0.593 . . . . 12.2 112.179 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 48.6 47.22 20.79 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.502 1.521 . . . . 16.71 110.066 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -124.9 127.29 46.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.893 -1.049 . . . . 12.2 109.15 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.02 53.57 2.48 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 113.579 0.955 . . . . 16.06 113.579 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.0 mm -70.68 117.99 60.74 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.386 -0.598 . . . . 11.39 109.386 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.4 151.84 65.65 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.912 1.741 . . . . 12.6 108.764 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.61 -20.45 21.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.372 1.069 . . . . 12.52 112.894 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -71.83 -12.64 61.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 14.14 112.33 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.68 -52.84 48.08 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 120.981 -0.628 . . . . 10.76 112.339 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.71 0.767 . . . . 11.0 109.923 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.47 -35.38 73.26 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.564 -0.744 . . . . 16.42 111.081 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.9 m -88.57 -34.32 17.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.746 0.308 . . . . 13.35 110.721 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.95 92.86 48.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.495 -0.557 . . . . 12.23 109.495 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.698 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 74.5 Cg_endo -83.76 1.95 8.57 Favored 'Trans proline' 0 C--O 1.205 -1.145 0 C-N-CA 123.192 2.595 . . . . 13.06 114.323 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.55 133.02 39.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.916 -1.142 . . . . 12.95 107.916 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -63.85 -45.45 89.45 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 114.805 -1.088 . . . . 10.92 111.799 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -69.21 -24.58 64.04 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 111.944 0.35 . . . . 14.32 111.944 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.8 -41.04 53.9 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.54 -0.541 . . . . 10.93 109.54 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -75.93 -37.58 58.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.877 -0.601 . . . . 8.81 112.032 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.1 p -60.78 -34.33 74.32 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.702 -0.399 . . . . 9.35 110.893 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -68.53 -44.44 74.6 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.182 -0.673 . . . . 11.63 109.182 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -54.85 -45.9 74.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.351 1.06 . . . . 10.55 110.625 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.52 -45.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.069 -0.514 . . . . 8.3 110.776 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.1 93.88 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.736 -0.665 . . . . 9.58 113.672 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -68.61 -24.73 64.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.46 0.541 . . . . 10.23 112.46 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.02 -2.5 58.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 113.573 0.953 . . . . 10.43 113.573 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.45 -52.7 56.71 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.386 -0.968 . . . . 10.97 108.386 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -142.78 92.03 7.17 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 105.712 -1.959 . . . . 13.52 105.712 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.72 60.19 2.82 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.394 2.729 . . . . 12.28 114.63 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 m -66.39 -36.97 84.19 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.543 -0.54 . . . . 13.44 109.543 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.32 -24.37 65.73 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.764 -0.653 . . . . 13.27 110.324 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.13 -14.87 26.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.066 -0.515 . . . . 14.48 110.704 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -83.58 119.71 25.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.166 -1.05 . . . . 14.92 108.166 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 59.45 49.68 8.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 123.89 0.876 . . . . 14.25 108.65 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.7 87.23 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.572 -1.194 . . . . 12.97 111.592 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.67 8.91 3.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.089 2.526 . . . . 13.4 111.916 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.88 126.98 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 108.297 -1.001 . . . . 12.43 108.297 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.15 75.03 9.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.431 0.634 . . . . 13.45 110.663 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -82.06 -26.88 33.31 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.233 -0.894 . . . . 14.41 108.984 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -78.94 143.26 61.46 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 114.924 -1.035 . . . . 11.68 108.6 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.21 73.94 4.8 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.401 2.067 . . . . 10.84 110.56 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.21 91.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.724 0.773 . . . . 10.46 109.924 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.12 48.78 2.31 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.491 -1.231 . . . . 10.58 108.05 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 m -63.02 121.67 14.16 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.028 -0.987 . . . . 11.04 110.006 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.74 146.92 32.27 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.785 -0.82 . . . . 10.88 108.785 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.07 0.83 3.38 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.508 2.806 . . . . 12.46 113.131 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -124.06 108.18 30.21 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.529 -1.286 . . . . 13.78 107.529 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.61 -27.2 69.26 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.427 2.085 . . . . 11.95 112.119 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.36 121.84 3.11 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.515 -0.766 . . . . 11.48 111.261 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.88 68.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.134 0.493 . . . . 11.55 110.275 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.57 -33.1 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.655 -0.702 . . . . 12.59 110.595 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.37 -43.03 70.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.405 0.621 . . . . 11.24 110.559 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.5 m -107.31 43.83 1.14 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.708 -0.678 . . . . 10.05 109.749 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.36 94.17 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.667 -0.697 . . . . 11.22 111.441 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' ILE . 51.8 mt-30 -64.62 -48.35 75.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.999 -0.546 . . . . 11.38 109.796 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.78 -45.43 82.14 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.498 -0.774 . . . . 9.65 110.636 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -56.95 -52.35 65.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.333 0.653 . . . . 10.43 111.149 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 t -58.97 -44.26 91.49 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.635 -0.711 . . . . 10.21 111.163 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.572 HG21 HG11 ' A' ' 178' ' ' VAL . 83.5 mt -64.08 -49.11 82.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 N-CA-C 109.881 -0.415 . . . . 8.13 109.881 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -58.13 -43.69 87.41 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.44 0.696 . . . . 8.46 112.665 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 14.8 t70 -62.59 -43.04 99.79 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.164 0.507 . . . . 10.86 110.099 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.75 -44.1 91.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.639 0.733 . . . . 11.45 110.302 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.99 -33.29 75.26 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.284 -0.871 . . . . 7.62 109.281 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 129' ' ' LEU . 56.6 tttm -62.29 -40.45 96.31 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.865 0.866 . . . . 11.62 109.802 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 61.1 mm-40 -64.99 -48.6 73.38 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.188 -1.041 . . . . 11.63 108.188 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.4 t -56.58 -52.62 64.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.861 -1.518 . . . . 9.14 111.984 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.9 pp -68.86 -39.26 79.98 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.377 -0.529 . . . . 10.06 111.746 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.543 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.99 -39.44 94.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.126 -0.559 . . . . 12.07 111.778 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.64 -44.74 77.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.869 0.366 . . . . 12.32 110.209 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 148' ' ' TRP . 15.0 tp -69.08 -46.08 68.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.334 -0.394 . . . . 11.77 110.953 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -72.72 -20.38 61.22 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.481 0.712 . . . . 13.52 111.327 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.0 t80 83.33 -29.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.005 1.322 . . . . 16.56 112.594 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.8 162.12 36.31 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 122.358 -0.214 . . . . 15.74 110.483 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.0 107.27 42.95 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.005 -0.739 . . . . 14.2 109.005 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -91.87 11.35 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.727 2.285 . . . . 14.18 113.425 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.61 50.69 5.19 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.496 -1.041 . . . . 14.03 110.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -107.48 -15.02 14.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.541 -0.464 . . . . 16.37 112.15 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.425 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 90.3 mt -71.23 97.72 1.6 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.13 0.491 . . . . 12.45 111.746 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 71.07 -20.06 0.23 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.207 1.403 . . . . 14.43 114.558 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -76.73 -28.74 55.91 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.725 0.81 . . . . 14.32 111.137 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.73 102.48 0.21 Allowed Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 110.213 -1.155 . . . . 13.75 110.213 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 171' ' ' LEU . . . -108.86 86.6 2.32 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.99 0.367 . . . . 12.7 111.99 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.42 112.06 23.95 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.15 -0.685 . . . . 16.38 109.15 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -62.55 -20.61 64.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.874 -0.603 . . . . 13.3 111.543 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.14 -29.63 69.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.667 0.787 . . . . 16.25 111.586 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.04 -25.88 39.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.34 0.591 . . . . 15.87 110.901 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.58 2.19 49.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 13.65 111.051 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.01 3.99 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 120.794 -0.717 . . . . 14.16 111.37 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.7 tpp 62.11 86.95 0.1 Allowed 'General case' 0 C--O 1.251 1.153 0 C-N-CA 124.794 1.237 . . . . 15.45 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 44.3 m-20 -57.86 118.73 5.64 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.37 -1.345 . . . . 13.63 107.37 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -56.32 -36.15 68.39 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.126 0.97 . . . . 13.9 111.567 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.01 -44.07 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.369 0.604 . . . . 13.81 110.145 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 141' ' ' ASP . 34.2 m -66.62 -37.96 85.93 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.854 -0.612 . . . . 11.48 110.848 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 -32.86 54.11 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.871 -0.604 . . . . 10.35 112.564 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.6 p -69.7 -39.53 76.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.453 -0.499 . . . . 12.2 110.277 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.84 -46.08 81.96 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.795 0.807 . . . . 11.86 109.699 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 121' ' ' LEU . 27.1 t90 -62.18 -54.06 46.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.176 -1.375 . . . . 9.32 111.696 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.0 tpt -58.03 -42.07 84.55 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.947 0.499 . . . . 9.5 110.204 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -58.44 -46.41 86.58 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 115.895 -0.593 . . . . 13.91 110.697 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -45.15 95.89 Favored Glycine 0 C--N 1.321 -0.273 0 O-C-N 123.399 0.437 . . . . 9.88 112.787 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.31 -50.14 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 9.27 110.441 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.1 p -65.5 -38.46 89.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.097 -0.502 . . . . 11.46 111.61 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -63.99 -47.09 81.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 15.04 111.186 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -67.48 -31.57 71.81 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.787 -0.365 . . . . 11.82 110.983 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -90.92 6.11 45.9 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.903 0.705 . . . . 11.97 112.903 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.4 m 59.66 33.51 21.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.777 0.831 . . . . 14.24 112.51 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.44 134.81 58.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.267 -0.642 . . . . 12.62 109.267 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -88.24 94.87 9.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.602 0.715 . . . . 16.39 110.669 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.03 148.73 43.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.026 -1.101 . . . . 12.32 108.026 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.58 143.92 48.08 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.075 -1.083 . . . . 14.06 108.075 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.975 -0.557 . . . . 12.64 109.995 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.32 15.6 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.655 -0.702 . . . . 15.68 110.496 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.99 59.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.053 0.39 . . . . 12.72 112.053 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.64 9.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.434 0.635 . . . . 12.16 112.236 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -110.2 -7.04 14.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.587 -0.733 . . . . 15.08 109.587 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.1 m -79.3 -27.89 42.2 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.281 0.562 . . . . 14.67 110.795 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.7 m-90 -113.36 137.83 22.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 116.253 -0.43 . . . . 12.68 110.721 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 -16.93 18.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.063 2.509 . . . . 14.34 111.818 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.9 p -135.65 142.86 45.23 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.489 -1.3 . . . . 12.91 107.489 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB3' ' HB1' ' A' ' 133' ' ' ALA . 25.8 tp -71.3 -24.9 62.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.742 -0.663 . . . . 9.89 110.983 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -62.34 -21.98 65.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.762 -0.654 . . . . 12.5 110.675 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 27.6 m -65.7 -18.56 65.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.843 -0.617 . . . . 11.04 111.208 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.94 -46.2 68.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.449 -0.575 . . . . 8.5 109.449 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.16 75.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.494 . . . . 7.7 110.968 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 14.6 t70 -74.99 -31.0 61.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.278 -0.569 . . . . 10.38 110.056 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -76.55 -41.87 45.05 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 123.348 0.659 . . . . 11.97 110.351 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.572 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -64.67 -30.49 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.744 0.783 . . . . 9.8 110.102 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 183' ' ' GLN . 18.8 t70 -66.59 -28.08 68.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.599 -1.182 . . . . 10.83 110.117 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 176' ' ' ASP . 85.2 mtt180 -84.22 -42.31 16.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.23 -0.895 . . . . 13.5 109.307 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.04 -51.3 59.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.962 -1.017 . . . . 14.84 111.985 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.25 -35.23 17.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.193 0.52 . . . . 13.35 110.77 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 179' ' ' ASP . 9.0 tt0 . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.246 -0.883 . . . . 13.51 109.212 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 4' ' ' ASP . 10.1 m . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 121.392 0.615 . . . . 18.51 111.367 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.82 74.97 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.075 0.55 . . . . 16.66 111.964 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.49 -20.94 64.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.809 0.814 . . . . 14.84 110.292 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 1' ' ' VAL . 37.8 t70 -98.45 -26.99 14.27 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.631 -0.713 . . . . 14.98 110.263 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.66 -47.33 86.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.664 0.385 . . . . 15.79 110.774 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 p -62.63 -36.47 82.9 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.317 -0.401 . . . . 12.02 111.479 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.09 -43.56 67.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.445 -0.343 . . . . 11.02 110.235 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 64.3 tt0 -60.04 -48.59 81.1 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.451 0.701 . . . . 16.07 110.694 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -55.6 -42.25 74.59 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.052 0.845 . . . . 13.93 110.123 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.35 -43.52 63.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.106 -0.497 . . . . 10.71 111.609 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 8' ' ' GLN . 30.8 mtm180 -61.28 -40.0 92.5 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.612 0.244 . . . . 14.02 111.147 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.0 -44.62 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 16.29 110.82 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -71.05 -25.23 62.55 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.885 0.374 . . . . 12.91 111.415 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.98 -55.96 9.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.72 -1.585 . . . . 12.77 106.72 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.34 65.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.685 -1.143 . . . . 15.19 111.554 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.93 85.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.652 0.263 . . . . 16.26 111.464 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.5 mtt -81.48 -26.09 35.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.018 0.437 . . . . 15.45 111.222 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.57 -4.33 44.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.018 -0.537 . . . . 16.16 112.041 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.97 49.09 3.61 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.955 1.302 . . . . 20.56 112.513 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.15 161.81 22.46 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.781 -1.099 . . . . 16.63 108.757 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -92.9 116.38 66.4 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-O 120.631 0.253 . . . . 20.19 111.124 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 -6.97 19.07 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.388 2.725 . . . . 16.6 113.627 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.76 -20.94 78.96 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.381 -0.688 . . . . 17.74 111.381 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -128.73 71.89 1.43 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 122.167 0.984 . . . . 20.23 109.468 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 tp -127.9 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.612 -0.884 . . . . 15.98 108.612 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -88.67 120.63 30.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.0 -0.741 . . . . 19.33 109.0 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 19.8 m-20 -61.79 -26.44 68.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.46 -0.791 . . . . 14.93 112.174 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.44 4.39 86.16 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.02 -0.61 . . . . 14.82 113.677 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.5 p -79.41 140.36 37.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 117.816 0.808 . . . . 14.54 110.273 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.547 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 66.1 mtm180 -75.5 148.24 39.14 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 118.356 -0.831 . . . . 16.75 109.479 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -50.38 -40.19 48.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.905 0.86 . . . . 11.99 110.992 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -23.9 66.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.406 -1.27 . . . . 14.45 112.691 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HG2' ' HB2' ' A' ' 30' ' ' ARG . 8.9 mm-40 -76.98 -29.28 55.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.796 0.808 . . . . 16.44 109.074 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.82 -31.94 27.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.16 -0.927 . . . . 13.77 108.808 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.0 32.94 3.63 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 114.787 -1.097 . . . . 13.81 112.174 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.0 tp -81.41 98.9 8.43 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.777 -0.823 . . . . 13.04 108.777 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.91 147.74 45.01 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.707 -1.22 . . . . 15.67 107.707 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 19.3 p -58.67 -22.8 57.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.923 0.765 . . . . 15.29 112.178 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.24 -50.93 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.494 -0.558 . . . . 16.66 109.494 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.06 -36.71 76.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.891 -0.781 . . . . 14.14 108.891 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 38' ' ' SER . . . -57.09 -36.76 70.98 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.169 -0.923 . . . . 12.0 110.77 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 46' ' ' ARG . . . -64.49 -45.84 85.58 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.066 -0.515 . . . . 13.97 109.967 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -60.79 -45.88 92.68 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.4 0.619 . . . . 15.69 110.712 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -59.34 -52.42 65.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 126.008 1.723 . . . . 11.69 111.684 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 tp -63.56 -31.61 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.857 0.36 . . . . 11.16 111.403 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 42' ' ' ALA . 99.2 mtt180 -66.35 -35.08 79.45 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 120.972 0.415 . . . . 16.65 110.282 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -73.62 -35.1 65.3 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.22 0.533 . . . . 14.15 110.155 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.01 -50.17 81.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 115.146 -0.934 . . . . 10.8 109.85 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.54 -25.12 59.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.035 -0.984 . . . . 12.98 112.847 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 97.7 mttt -75.82 -61.86 1.78 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 116.296 -0.411 . . . . 17.52 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -74.67 -25.09 58.95 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.958 -0.697 . . . . 14.87 112.008 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -94.96 -6.98 41.22 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.427 0.899 . . . . 12.2 113.427 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 47.92 64.27 1.7 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.877 1.671 . . . . 16.71 112.108 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.48 167.72 21.07 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.94 -1.027 . . . . 12.2 108.312 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -116.32 70.52 0.76 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.387 -1.338 . . . . 16.06 107.387 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.493 HD12 ' HE1' ' A' ' 73' ' ' TRP . 47.0 mm -92.74 119.93 67.58 Favored Pre-proline 0 N--CA 1.427 -1.603 0 N-CA-C 109.201 -0.666 . . . . 11.39 109.201 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -87.65 167.72 7.25 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.056 1.838 . . . . 12.6 108.929 171.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -10.16 3.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.733 1.012 . . . . 12.52 113.733 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.39 -19.57 65.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.26 0.467 . . . . 14.14 112.26 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.77 -44.37 96.36 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.742 -1.218 . . . . 10.76 110.129 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.45 -27.64 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.231 1.012 . . . . 11.0 110.869 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -78.25 -31.5 49.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.734 -0.604 . . . . 16.42 112.175 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t -87.69 -32.28 19.28 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.392 -0.923 . . . . 13.35 110.649 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.486 ' CE2' ' HE3' ' A' ' 73' ' ' TRP . 38.6 m-85 -108.72 100.98 41.73 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 109.526 -0.546 . . . . 12.23 109.526 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.06 -0.45 10.29 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.506 2.137 . . . . 13.06 112.366 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 120.47 61.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.609 -1.626 . . . . 12.95 106.609 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 27' ' ' ASP . 49.2 p90 -58.98 -32.23 69.49 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.024 0.75 . . . . 10.92 113.024 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -60.58 -32.09 71.2 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.919 0.888 . . . . 14.32 111.731 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.5 -30.78 21.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.91 0.862 . . . . 10.93 109.928 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 43.2 t80 -70.63 -31.7 68.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.181 -0.918 . . . . 8.81 111.61 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.1 p -66.18 -28.42 68.75 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.726 -0.609 . . . . 9.35 109.49 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -71.21 -32.76 69.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.481 -0.781 . . . . 11.63 109.634 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.493 ' HE1' HD12 ' A' ' 56' ' ' ILE . 2.4 t-105 -53.91 -55.8 23.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.413 -0.958 . . . . 10.55 108.413 173.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.13 -44.73 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 C-N-CA 124.031 0.932 . . . . 8.3 110.627 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.6 73.74 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.261 -0.427 . . . . 9.58 113.0 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.2 m -80.36 -31.32 37.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 122.525 -0.397 . . . . 10.23 111.073 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -89.24 -21.41 23.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.051 -0.66 . . . . 10.43 112.073 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -78.94 115.3 18.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.096 -0.335 . . . . 10.97 110.096 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 57.84 62.42 5.21 Favored Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 124.45 1.094 . . . . 13.52 109.825 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.88 154.6 23.06 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.276 1.984 . . . . 12.28 113.117 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.4 p -79.31 49.93 1.03 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.6 0.76 . . . . 13.44 111.094 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -89.62 116.74 27.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.479 -0.934 . . . . 13.27 108.479 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.16 -43.83 8.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.319 -0.4 . . . . 14.48 110.206 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 m 56.12 70.5 0.64 Allowed 'General case' 0 C--O 1.249 1.066 0 CA-C-O 122.059 0.933 . . . . 14.92 109.885 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.09 56.64 4.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.423 -0.808 . . . . 14.25 110.06 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.42 125.97 54.17 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.23 -0.895 . . . . 12.97 109.2 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.37 54.42 4.63 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.894 2.396 . . . . 13.4 111.391 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.45 94.63 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.565 -0.902 . . . . 12.43 108.565 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 73.82 7.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.435 -1.32 . . . . 13.45 107.435 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -148.06 120.36 8.39 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.359 -1.719 . . . . 14.41 106.359 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.83 146.29 38.57 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 123.441 0.463 . . . . 11.68 110.548 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.84 45.97 2.1 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.004 2.469 . . . . 10.84 110.445 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.1 t 57.39 75.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.969 1.308 . . . . 10.46 109.492 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.82 -30.09 11.88 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.916 -1.038 . . . . 10.58 109.987 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -119.37 159.61 23.84 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.329 -0.619 . . . . 11.04 109.329 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.56 69.07 6.51 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.076 -0.511 . . . . 10.88 110.241 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.3 -48.89 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.479 2.12 . . . . 12.46 110.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -112.58 119.94 42.22 Favored Pre-proline 0 N--CA 1.425 -1.714 0 N-CA-C 107.085 -1.45 . . . . 13.78 107.085 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.95 52.68 3.1 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.836 2.357 . . . . 11.95 112.163 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.36 43.77 1.16 Allowed Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.842 -1.303 . . . . 11.48 109.842 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.18 -25.57 55.34 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.606 -0.887 . . . . 11.55 108.606 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -77.28 103.89 7.47 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.827 -1.079 . . . . 12.59 108.456 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.99 -32.64 22.87 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.752 -0.658 . . . . 11.24 109.58 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m 55.45 53.98 9.12 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.813 0.816 . . . . 10.05 110.496 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.25 -35.42 71.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.509 -1.223 . . . . 11.22 109.916 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.17 -44.53 97.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.771 -1.104 . . . . 11.38 109.852 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.449 ' O ' ' HB ' ' A' ' 110' ' ' ILE . 44.1 ttp180 -78.91 -27.46 43.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.875 -0.602 . . . . 9.65 111.17 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.0 -37.05 86.39 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.809 0.337 . . . . 10.43 110.764 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.8 t -64.69 -41.88 95.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.565 -0.902 . . . . 10.21 108.565 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 178' ' ' VAL . 67.3 mt -57.36 -41.85 79.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 CA-C-N 115.098 -0.956 . . . . 8.13 109.722 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -55.88 -39.64 71.84 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.228 0.611 . . . . 8.46 112.317 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 m-20 -66.83 -40.86 88.13 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.039 0.447 . . . . 10.86 111.129 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -74.57 -35.06 63.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.144 -0.48 . . . . 11.45 111.613 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.72 -43.23 98.12 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.254 -1.387 . . . . 7.62 107.254 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 79.0 tttt -54.66 -48.19 72.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.606 -1.179 . . . . 11.62 110.243 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -70.12 -39.29 75.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.137 -0.483 . . . . 11.63 111.404 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -58.25 -52.8 64.05 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.92 0.888 . . . . 9.14 110.219 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.7 -38.55 58.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.144 -0.48 . . . . 10.06 110.483 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.75 -26.66 67.21 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 116.415 -0.357 . . . . 12.07 112.389 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.92 -32.45 74.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 123.519 0.728 . . . . 12.32 110.296 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.03 -30.95 62.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.577 0.703 . . . . 11.77 109.535 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.87 6.9 46.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.797 -1.092 . . . . 13.52 110.046 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.2 t80 79.96 -48.82 0.35 Allowed 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 127.78 2.432 . . . . 16.56 112.795 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.47 152.62 31.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.904 -0.406 . . . . 15.74 109.904 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.2 112.48 56.47 Favored Pre-proline 0 C--N 1.314 -0.947 0 O-C-N 124.18 0.925 . . . . 14.2 109.401 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -75.91 -37.31 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.223 1.949 . . . . 14.18 112.052 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -116.84 -112.97 2.7 Favored Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 110.118 -1.193 . . . . 14.03 110.118 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -139.29 3.48 2.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.835 -0.215 . . . . 16.37 110.964 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 115' ' ' LYS . 6.0 mp 60.65 -177.48 0.11 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.38 1.072 . . . . 12.45 112.588 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -150.37 148.53 28.91 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.691 -1.596 . . . . 14.43 106.691 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 170' ' ' THR . 25.5 m -74.32 -26.57 60.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.562 -0.744 . . . . 14.32 111.251 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.65 3.53 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 111.123 -0.791 . . . . 13.75 111.123 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.08 107.94 15.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.152 -1.055 . . . . 12.7 108.152 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -73.06 118.04 15.53 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.16 -0.473 . . . . 16.38 110.858 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.53 -27.69 67.96 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.375 -0.83 . . . . 13.3 110.178 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.77 -19.79 65.82 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.408 -0.814 . . . . 16.25 111.629 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.3 -52.39 5.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.496 0.554 . . . . 15.87 112.496 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.82 -10.05 20.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.934 0.716 . . . . 13.65 112.934 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.9 140.19 15.73 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.916 -1.135 . . . . 14.16 112.323 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.2 mtm -133.51 24.6 4.08 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.684 -1.599 . . . . 15.45 106.684 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.41 70.32 1.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.409 -1.723 . . . . 13.63 112.225 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -44.72 73.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.116 0.484 . . . . 13.9 109.919 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.32 -57.25 4.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 122.182 -0.324 . . . . 13.81 110.828 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -69.76 -20.47 63.49 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.64 -0.424 . . . . 11.48 111.927 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -78.86 -24.36 62.26 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.741 -1.218 . . . . 10.35 110.184 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.5 m -72.43 -38.22 68.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.602 -0.888 . . . . 12.2 108.602 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.72 -39.99 86.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.683 -0.69 . . . . 11.86 109.181 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 25.1 t90 -65.16 -46.5 80.61 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.188 -0.914 . . . . 9.32 110.711 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 15.3 mmt -54.35 -47.85 72.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.112 0.482 . . . . 9.5 110.097 176.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 36.6 ttm180 -60.87 -41.02 95.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.247 -0.888 . . . . 13.91 110.232 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.85 -53.57 36.75 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.718 -0.673 . . . . 9.88 111.882 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' TRP . 53.5 t -57.61 -40.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.105 0.479 . . . . 9.27 110.064 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.9 t -61.16 -51.9 67.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.334 -0.848 . . . . 11.46 110.584 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 39.1 ptt180 -75.64 -40.05 56.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.784 0.661 . . . . 15.04 112.784 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -68.98 -33.87 74.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 11.82 111.87 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.97 2.22 43.33 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.737 -0.385 . . . . 11.97 112.025 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 t 60.0 37.57 21.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.972 0.909 . . . . 14.24 111.302 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.12 148.52 19.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.818 -0.438 . . . . 12.62 109.818 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -83.05 95.97 8.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.045 -0.354 . . . . 16.39 110.045 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 tp -109.36 133.99 52.38 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.349 -0.982 . . . . 12.32 108.349 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.46 146.7 29.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.007 -0.542 . . . . 14.06 110.219 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.49 -16.83 62.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 12.64 111.846 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.22 1.87 56.89 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.287 -0.415 . . . . 15.68 110.656 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HB1' ' CD1' ' A' ' 168' ' ' TRP . . . -61.83 -22.38 65.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.718 0.636 . . . . 12.72 112.718 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.7 pt -67.44 -12.96 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.235 0.54 . . . . 12.16 111.33 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -103.75 4.05 34.8 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.038 -0.528 . . . . 15.08 110.477 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.6 t -140.09 14.73 2.44 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 119.392 -0.923 . . . . 14.67 112.931 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.541 ' CD1' ' HB1' ' A' ' 164' ' ' ALA . 25.2 m95 -129.51 114.44 18.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.957 -1.127 . . . . 12.68 107.957 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.487 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 58.4 Cg_endo -73.12 -44.13 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.765 2.31 . . . . 14.34 115.491 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 131' ' ' SER . 74.8 p -130.45 -175.56 3.68 Favored 'General case' 0 C--O 1.249 1.058 0 N-CA-C 112.696 0.628 . . . . 12.91 112.696 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 131' ' ' SER . 6.7 mp -68.12 -26.5 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.711 -0.477 . . . . 9.89 109.711 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -58.66 -49.96 75.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.45 -0.574 . . . . 12.5 109.45 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB2' ' CE3' ' A' ' 168' ' ' TRP . 3.1 p -67.36 -24.13 65.67 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.884 0.698 . . . . 11.04 112.884 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.12 -47.56 23.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.837 -1.171 . . . . 8.5 107.837 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.22 -30.57 71.69 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.794 -0.639 . . . . 7.7 110.832 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -56.71 -34.97 68.0 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.349 0.66 . . . . 10.38 112.316 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -60.24 -58.27 9.25 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.676 0.75 . . . . 11.97 110.998 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 110' ' ' ILE . 9.5 p -69.74 -32.12 51.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.908 -1.042 . . . . 9.8 110.899 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.16 -43.64 92.1 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.31 0.644 . . . . 10.83 110.76 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.4 mtm105 -83.06 -38.07 23.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.198 -0.456 . . . . 13.5 112.038 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -66.26 -46.51 76.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.581 0.585 . . . . 14.84 112.581 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.17 -43.33 17.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.883 0.373 . . . . 13.35 111.828 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.753 -0.462 . . . . 13.51 109.753 -178.638 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 110.109 -0.33 . . . . 18.51 110.109 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.04 -17.12 14.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.496 . . . . 16.66 112.259 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.95 -39.47 9.36 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.598 0.713 . . . . 14.84 109.982 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.59 18.69 8.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.166 -0.924 . . . . 14.98 109.885 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -61.86 -41.68 98.13 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.66 0.985 . . . . 15.79 113.66 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.87 -58.59 5.61 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.754 0.659 . . . . 12.02 110.678 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.12 80.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.625 -0.716 . . . . 11.02 111.333 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -58.16 -47.62 82.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.824 -0.626 . . . . 16.07 111.826 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.02 -34.72 77.02 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 121.099 0.476 . . . . 13.93 110.766 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.88 -36.14 77.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.145 -0.479 . . . . 10.71 110.528 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.91 -48.1 83.37 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.51 -0.552 . . . . 14.02 109.51 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.35 -43.77 88.47 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.685 . . . . 16.29 111.364 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -72.99 -43.48 62.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.96 -0.563 . . . . 12.91 112.373 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.49 -38.71 90.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.775 -0.454 . . . . 12.77 109.775 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.67 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -63.99 -34.87 78.97 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.738 -0.664 . . . . 15.19 110.792 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.85 61.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.981 -0.554 . . . . 16.26 111.042 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.9 mtt -85.36 -45.56 11.78 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.304 -0.407 . . . . 15.45 111.74 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.65 -5.64 48.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.27 0.841 . . . . 16.16 113.27 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 67.36 28.81 7.73 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.899 0.857 . . . . 20.56 111.93 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 6.9 p -97.45 -174.85 3.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.873 -1.158 . . . . 16.63 107.873 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -104.39 138.99 19.68 Favored Pre-proline 0 C--N 1.305 -1.354 0 C-N-CA 120.302 -0.559 . . . . 20.19 110.33 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.49 -9.09 14.93 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.15 1.9 . . . . 16.6 111.693 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.82 -76.57 0.88 Allowed Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 111.437 -0.665 . . . . 17.74 111.437 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -85.31 55.71 3.62 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.725 0.774 . . . . 20.23 110.372 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.56 140.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.844 -1.169 . . . . 15.98 107.844 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -81.88 100.23 9.5 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.204 0.526 . . . . 19.33 110.045 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 5.8 p-10 -77.16 -20.34 55.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.936 -0.575 . . . . 14.93 112.283 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.85 7.21 64.97 Favored Glycine 0 C--N 1.307 -1.061 0 CA-C-N 116.024 -0.534 . . . . 14.82 112.639 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.3 p -92.15 166.75 12.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.127 0.489 . . . . 14.54 110.597 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 88.5 mtm180 -91.61 141.93 28.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.331 -0.85 . . . . 16.75 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -50.22 -48.81 54.22 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.266 1.21 . . . . 11.99 114.266 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 36' ' ' LEU . 87.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.298 0.57 . . . . 14.45 111.158 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 30' ' ' ARG . 44.1 tt0 -82.2 -20.36 37.95 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 124.078 0.951 . . . . 16.44 109.293 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.4 -0.79 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.347 -0.842 . . . . 13.77 109.43 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.38 74.74 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.562 -0.745 . . . . 13.81 112.341 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 32' ' ' LEU . 20.6 tp -81.91 82.31 7.59 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.348 -0.982 . . . . 13.04 108.348 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.52 ' OD2' HG22 ' A' ' 39' ' ' VAL . 17.6 t70 -66.44 165.87 13.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.345 -1.298 . . . . 15.67 109.819 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -56.58 -36.74 69.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 118.44 0.564 . . . . 15.29 111.479 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG22 ' OD2' ' A' ' 37' ' ' ASP . 1.5 m -57.41 -51.84 64.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.677 0.751 . . . . 16.66 112.509 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mt -67.87 -46.58 81.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.675 -1.148 . . . . 14.14 110.301 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.36 87.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 12.0 112.458 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.41 93.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.397 0.617 . . . . 13.97 111.034 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.08 -43.3 68.02 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.638 -0.71 . . . . 15.69 110.619 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -57.43 -52.96 63.25 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 125.66 1.584 . . . . 11.69 110.425 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 tp -66.29 -33.03 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.369 -0.378 . . . . 11.16 111.028 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -59.95 -36.23 76.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.368 -0.378 . . . . 16.65 110.628 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.88 -40.37 54.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.299 -0.56 . . . . 14.15 109.69 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.39 -48.44 56.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.007 0.523 . . . . 10.8 110.96 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 16.3 m120 -57.88 -35.91 71.65 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.489 0.551 . . . . 12.98 112.489 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -86.22 -56.11 3.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.061 0.458 . . . . 17.52 110.814 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -61.81 -32.57 72.89 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.073 0.949 . . . . 14.87 111.788 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.15 3.2 25.47 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.473 0.654 . . . . 12.2 111.201 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.251 4.0 pt20 39.82 55.7 2.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.964 2.106 . . . . 16.71 114.308 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.35 159.07 23.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.34 -0.846 . . . . 12.2 110.129 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -94.95 26.82 3.42 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.077 0.551 . . . . 16.06 110.487 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mm -53.71 121.92 30.51 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.346 -0.843 . . . . 11.39 111.027 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.47 137.96 48.61 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.657 1.571 . . . . 12.6 108.555 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.56 -19.99 29.13 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.44 0.696 . . . . 12.52 112.267 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.34 -1.88 57.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.024 -0.534 . . . . 14.14 112.207 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.55 72.0 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 121.481 -0.39 . . . . 10.76 112.368 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.91 -26.22 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.408 0.683 . . . . 11.0 111.522 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -103.76 -2.53 26.26 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.643 -0.423 . . . . 16.42 111.921 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 m -69.52 -57.44 5.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.356 -0.979 . . . . 13.35 108.356 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.23 85.2 50.09 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 105.053 -2.203 . . . . 12.23 105.053 172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 71.9 Cg_endo -76.15 54.32 4.14 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.836 2.357 . . . . 13.06 115.175 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.3 126.77 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.277 -1.009 . . . . 12.95 108.277 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -50.54 -54.78 19.8 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.382 0.882 . . . . 10.92 113.382 -171.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 63.1 tttm -65.79 -33.29 75.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.501 . . . . 14.32 111.424 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.94 81.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.104 -0.498 . . . . 10.93 111.04 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.0 t80 -79.06 -32.02 44.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.833 0.349 . . . . 8.81 111.618 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.0 p -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.662 -0.649 . . . . 9.35 110.963 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.16 -27.91 57.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.597 -0.274 . . . . 11.63 110.627 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.528 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 2.2 t90 -53.8 -49.15 68.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.461 1.104 . . . . 10.55 109.277 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 86.8 t -62.83 -41.55 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 123.666 0.786 . . . . 8.3 110.365 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.61 93.22 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.76 -0.654 . . . . 9.58 112.378 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 p -75.22 -22.31 58.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.895 0.379 . . . . 10.23 111.618 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.26 -17.16 57.02 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.957 0.408 . . . . 10.43 110.019 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 97.5 mt -86.01 63.17 7.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.073 0.939 . . . . 10.97 109.383 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -102.15 102.95 27.15 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.216 -1.356 . . . . 13.52 109.418 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.78 79.8 3.21 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.817 2.345 . . . . 12.28 111.713 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -63.16 96.32 0.1 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.856 -1.066 . . . . 13.44 112.56 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -101.23 121.51 41.99 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.421 -0.354 . . . . 13.27 110.057 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.64 -31.34 32.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.727 -0.67 . . . . 14.48 111.235 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 p -97.61 -167.43 1.52 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.293 -0.412 . . . . 14.92 112.001 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 74.58 82.17 0.11 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.241 1.416 . . . . 14.25 110.839 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.07 135.67 62.4 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.234 -0.894 . . . . 12.97 109.244 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.19 39.32 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.991 2.461 . . . . 13.4 113.276 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t 62.3 97.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.582 1.153 . . . . 12.43 111.0 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -97.32 21.52 9.93 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.279 0.561 . . . . 13.45 111.529 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -119.49 134.6 55.14 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.007 0.432 . . . . 14.41 110.036 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.38 134.1 27.35 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 107.895 -1.15 . . . . 11.68 107.895 172.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.78 144.3 77.11 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 122.344 2.029 . . . . 10.84 111.152 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.14 133.83 29.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.265 -0.425 . . . . 10.46 110.908 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.68 83.55 7.18 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.262 0.553 . . . . 10.58 110.29 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 p -64.22 133.27 52.48 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.297 -0.865 . . . . 11.04 109.67 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 128.57 93.92 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.749 -0.205 . . . . 10.88 111.149 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.64 54.68 5.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.039 2.493 . . . . 12.46 111.446 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 26.3 mt-30 -113.72 133.95 22.14 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.454 -0.943 . . . . 13.78 108.454 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 13.6 Cg_exo -70.99 126.6 12.66 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.02 1.813 . . . . 11.95 110.483 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.86 165.95 13.25 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.383 -1.087 . . . . 11.48 110.383 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.97 -24.62 58.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 117.062 0.431 . . . . 11.55 111.609 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -84.82 13.34 5.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.285 0.564 . . . . 12.59 111.862 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.05 49.75 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 11.24 109.302 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.4 m -106.28 70.01 0.82 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.441 -0.8 . . . . 10.05 110.079 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.45 69.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.115 -0.493 . . . . 11.22 111.434 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -70.53 -47.28 61.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.806 -0.813 . . . . 11.38 108.806 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -68.98 -40.55 78.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.037 -0.529 . . . . 9.65 110.772 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.8 -41.99 92.42 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.059 -0.519 . . . . 10.43 110.05 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 p -64.92 -36.53 84.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 120.453 -0.499 . . . . 10.21 111.281 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.624 HG21 HG11 ' A' ' 178' ' ' VAL . 50.4 mt -59.31 -50.05 81.25 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 109.546 -0.538 . . . . 8.13 109.546 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -60.83 -34.86 75.21 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.536 -0.756 . . . . 8.46 110.114 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 15.0 t70 -63.49 -52.73 60.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.51 -0.768 . . . . 10.86 110.352 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -62.41 -44.72 95.76 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.337 -0.392 . . . . 11.45 109.976 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.91 -47.41 80.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.98 0.912 . . . . 7.62 110.68 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.31 -47.6 85.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.514 -0.766 . . . . 11.62 110.226 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 23.9 mt-30 -66.18 -43.24 87.42 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.879 -0.6 . . . . 11.63 110.717 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.6 t -58.11 -51.81 68.15 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 123.579 0.752 . . . . 9.14 111.803 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.502 HD23 ' CZ2' ' A' ' 148' ' ' TRP . 3.1 tm? -73.46 -40.82 63.87 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.54 -0.541 . . . . 10.06 109.54 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.53 -27.7 72.17 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.074 -0.512 . . . . 12.07 112.47 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.37 -37.94 68.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.369 0.604 . . . . 12.32 109.761 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.545 -0.752 . . . . 11.77 110.033 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.75 -16.68 55.13 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.552 -0.749 . . . . 13.52 110.567 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 72.46 8.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.351 1.46 . . . . 16.56 112.671 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.64 18.39 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.718 0.807 . . . . 15.74 108.99 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.94 126.23 29.48 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.521 -1.288 . . . . 14.2 107.521 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -7.53 21.03 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.76 2.307 . . . . 14.18 112.489 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.01 -73.06 0.39 Allowed Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 120.653 -0.784 . . . . 14.03 112.244 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -124.69 -22.17 4.64 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.821 0.343 . . . . 16.37 111.105 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp 63.5 -154.79 0.32 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 12.45 110.608 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.457 ' H ' HD23 ' A' ' 171' ' ' LEU . 67.3 mtp180 68.13 -78.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.148 0.979 . . . . 14.43 110.882 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.7 p -97.15 151.25 19.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.544 -0.91 . . . . 14.32 108.544 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.16 26.27 64.46 Favored Glycine 0 N--CA 1.47 0.951 0 C-N-CA 119.807 -1.187 . . . . 13.75 110.491 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.5 82.16 1.94 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.181 -1.414 . . . . 12.7 107.181 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.53 124.12 48.72 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.401 -1.272 . . . . 16.38 111.524 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.19 -7.08 51.4 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.086 -0.961 . . . . 13.3 111.372 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.86 -31.64 69.6 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.824 -1.176 . . . . 16.25 107.824 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.91 -51.98 3.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.772 -1.104 . . . . 15.87 110.176 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.18 15.55 2.83 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.549 0.69 . . . . 13.65 112.113 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -116.6 61.31 0.41 Allowed Glycine 0 C--N 1.297 -1.591 0 N-CA-C 109.857 -1.297 . . . . 14.16 109.857 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.6 ttm -72.46 -38.5 68.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.201 0.524 . . . . 15.45 110.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.14 143.27 46.63 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.321 -0.854 . . . . 13.63 110.299 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -82.06 -27.34 33.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.431 -0.804 . . . . 13.9 111.945 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.88 -35.96 50.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.204 0.526 . . . . 13.81 109.801 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.1 p -59.15 -48.12 82.77 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.77 -0.65 . . . . 11.48 110.939 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.4 85.14 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 115.499 -0.773 . . . . 10.35 112.726 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.9 t -64.37 -41.84 96.49 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.486 -0.486 . . . . 12.2 111.423 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -66.36 -46.34 77.08 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.891 0.377 . . . . 11.86 111.186 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 118' ' ' LEU . 32.8 t90 -64.14 -48.97 73.98 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.878 -0.601 . . . . 9.32 111.789 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.423 ' HG3' HG12 ' A' ' 165' ' ' ILE . 93.6 mmm -60.93 -45.44 94.68 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 123.245 0.34 . . . . 9.5 111.809 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -61.21 -36.69 80.59 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.026 -0.27 . . . . 13.91 111.187 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.05 -47.97 80.22 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.656 -0.578 . . . . 9.88 111.656 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.26 -42.92 92.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.204 0.526 . . . . 9.27 110.101 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.2 m -62.82 -41.67 99.41 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.342 -0.845 . . . . 11.46 111.23 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -69.71 -41.79 74.9 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.892 -0.595 . . . . 15.04 109.87 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -60.41 -45.14 94.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.856 . . . . 11.82 110.248 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.52 5.9 49.14 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.473 0.546 . . . . 11.97 112.473 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.2 m 57.26 39.44 28.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.301 1.04 . . . . 14.24 112.887 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.0 149.66 16.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.076 0.465 . . . . 12.62 111.097 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.61 100.04 12.85 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.813 -1.18 . . . . 16.39 107.813 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -103.6 135.44 45.18 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.017 -0.538 . . . . 12.32 109.623 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.34 133.91 39.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.453 0.644 . . . . 14.06 110.573 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.76 64.3 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.683 -0.689 . . . . 12.64 111.487 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.83 -5.17 59.28 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.746 -0.661 . . . . 15.68 111.091 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.21 -8.54 56.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.727 0.775 . . . . 12.72 109.843 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.423 HG12 ' HG3' ' A' ' 149' ' ' MET . 10.7 mt -58.88 -23.85 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.984 1.314 . . . . 12.16 109.745 175.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -113.43 16.75 18.8 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.124 -0.944 . . . . 15.08 110.098 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.8 m -101.77 -34.1 9.57 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.645 -0.707 . . . . 14.67 109.85 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 4.8 m-90 -103.24 107.41 55.48 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.869 -0.419 . . . . 12.68 109.869 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.58 -13.7 9.49 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.155 1.904 . . . . 14.34 113.007 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -129.46 145.29 51.45 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.555 0.693 . . . . 12.91 111.529 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 130' ' ' ARG . 63.9 tp -58.17 -35.09 71.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.439 -1.255 . . . . 9.89 111.9 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.84 -25.44 65.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 12.5 111.718 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 168' ' ' TRP . 9.4 m -75.88 -20.16 58.28 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.146 0.498 . . . . 11.04 110.5 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.86 -29.75 55.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.578 -0.897 . . . . 8.5 108.578 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.42 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.417 -0.81 . . . . 7.7 109.4 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -62.07 -30.5 71.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 120.804 0.335 . . . . 10.38 111.343 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -59.38 4.58 Favored 'General case' 0 C--O 1.252 1.205 0 N-CA-C 108.583 -0.895 . . . . 11.97 108.583 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 110' ' ' ILE . 14.9 p -65.49 -35.18 74.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 114.674 -1.148 . . . . 9.8 111.773 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -57.24 -40.9 78.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.59 0.71 . . . . 10.83 110.919 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 34.2 ttp-105 -82.23 -53.22 6.23 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.341 -0.845 . . . . 13.5 111.18 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -75.42 -45.9 36.05 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.895 1.442 . . . . 14.84 114.895 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.98 -31.66 22.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 119.937 -0.705 . . . . 13.35 109.239 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.237 0.41 0 O-C-N 124.9 1.375 . . . . 13.51 111.223 172.776 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.742 ' HB ' ' OD2' ' A' ' 4' ' ' ASP . 44.0 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.145 -1.428 . . . . 18.51 107.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.65 70.83 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 122.657 0.383 . . . . 16.66 111.088 -174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.21 -53.67 47.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.993 0.808 . . . . 14.84 111.039 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.742 ' OD2' ' HB ' ' A' ' 1' ' ' VAL . 3.2 p30 -79.33 -28.01 42.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 14.98 111.078 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.52 -47.16 82.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 121.029 -0.268 . . . . 15.79 110.744 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 89.7 m -59.68 -42.91 93.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.509 0.195 . . . . 12.02 111.133 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.04 80.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.305 -0.407 . . . . 11.02 110.682 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.81 -39.13 87.61 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.787 -0.642 . . . . 16.07 110.647 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.35 -49.19 78.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.541 0.736 . . . . 13.93 110.289 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 96.0 mt -67.45 -38.08 83.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.422 -0.354 . . . . 10.71 110.683 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -59.74 -43.72 94.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.112 -0.495 . . . . 14.02 109.907 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.25 -41.86 69.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 16.29 110.096 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -57.73 -45.23 86.08 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.098 0.959 . . . . 12.91 111.132 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.48 -48.12 81.83 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.337 -0.616 . . . . 12.77 109.337 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.39 82.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.669 . . . . 15.19 111.831 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.65 86.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.137 0.575 . . . . 16.26 111.725 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.439 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 63.5 mtt -78.11 -42.61 31.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.705 -0.679 . . . . 15.45 111.468 -176.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -89.16 3.19 52.72 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.869 -0.733 . . . . 16.16 112.083 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 55.56 46.7 22.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.317 1.047 . . . . 20.56 110.187 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.8 m -123.38 -178.47 4.01 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.973 -1.012 . . . . 16.63 109.843 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.64 145.97 30.49 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.462 -1.681 . . . . 20.19 106.462 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.01 49.86 3.38 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 121.874 1.716 . . . . 16.6 109.237 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.1 92.54 0.01 OUTLIER Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 127.945 2.688 . . . . 17.74 114.587 -172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 44.19 29.71 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 127.044 2.138 . . . . 20.23 115.627 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -67.76 130.31 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.92 -1.141 . . . . 15.98 107.92 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -151.16 0.34 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.243 -1.021 . . . . 19.33 108.243 -173.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.09 -29.63 64.29 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.55 -0.46 . . . . 14.93 111.051 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -53.66 2.45 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.153 -1.022 . . . . 14.82 111.042 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -74.48 108.75 7.45 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.82 -1.178 . . . . 14.54 107.82 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 91.0 mtt180 -89.86 176.43 6.83 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.312 0.856 . . . . 16.75 113.312 -169.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -49.62 -41.17 41.63 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 112.736 0.643 . . . . 11.99 112.736 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.8 mt -60.34 -25.75 66.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 14.45 111.715 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.26 -36.2 79.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.243 0.617 . . . . 16.44 111.213 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.0 mt -88.98 5.22 45.24 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.584 -0.446 . . . . 13.77 112.006 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.79 51.71 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.992 -1.099 . . . . 13.81 112.677 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 41' ' ' ALA . 6.9 tt -75.13 125.12 28.27 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.684 -0.858 . . . . 13.04 108.684 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -117.35 162.18 18.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.953 -1.128 . . . . 15.67 107.953 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 p -48.43 -43.89 34.78 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.401 0.68 . . . . 15.29 112.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.49 -47.66 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.865 -0.607 . . . . 16.66 110.487 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.0 mt -67.16 -34.46 69.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.816 -0.629 . . . . 14.14 110.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -59.34 -33.28 70.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 12.0 111.31 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.15 73.52 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.212 -0.449 . . . . 13.97 111.712 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.27 -45.74 14.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.386 0.612 . . . . 15.69 109.711 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 3.4 t90 -59.34 -40.59 86.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.498 1.119 . . . . 11.69 111.89 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 tp -62.18 -30.64 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.89 0.376 . . . . 11.16 110.872 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -64.96 -41.02 95.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 16.65 109.958 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' A' ' 17' ' ' MET . 0.3 OUTLIER -67.89 -31.7 71.67 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 121.191 0.519 . . . . 14.15 111.424 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 78.5 mt -66.97 -50.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.44 -0.948 . . . . 10.8 108.44 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 90.9 m-20 -62.66 -31.35 72.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.582 -1.19 . . . . 12.98 112.971 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -71.39 -43.13 67.43 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.871 -0.518 . . . . 17.52 110.155 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -74.64 -45.18 46.5 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 113.97 1.1 . . . . 14.87 113.97 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' HD22 ' A' ' 54' ' ' LEU . 63.9 m-85 -101.64 -1.15 33.36 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.758 -0.777 . . . . 12.2 112.189 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.298 4.0 pt20 48.49 42.71 19.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.242 1.941 . . . . 16.71 116.242 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 52' ' ' TYR . 3.4 mm? -94.51 171.25 8.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.599 -1.259 . . . . 12.2 107.599 171.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -114.12 60.74 0.67 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.506 -0.924 . . . . 16.06 108.506 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' PRO . 62.7 mt -97.4 126.4 41.77 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.35 -0.841 . . . . 11.39 111.0 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 56' ' ' ILE . 74.2 Cg_endo -77.0 169.5 21.51 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.273 1.982 . . . . 12.6 109.186 172.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.99 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.462 0.648 . . . . 12.52 110.629 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 5.6 m-20 -62.33 -20.09 64.0 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.101 -0.954 . . . . 14.14 112.312 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.07 99.82 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 119.791 -1.195 . . . . 10.76 110.252 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.03 -27.39 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.634 0.73 . . . . 11.0 110.07 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 20.6 m-85 -74.57 -23.47 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.843 -0.536 . . . . 16.42 110.233 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.4 m -87.57 -45.28 10.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.04 -0.527 . . . . 13.35 109.639 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' HE2' ' CE3' ' A' ' 73' ' ' TRP . 76.0 m-85 -115.74 104.22 53.03 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 120.583 0.23 . . . . 12.23 111.095 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 71.6 Cg_endo -83.13 3.32 7.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.96 1.773 . . . . 13.06 110.842 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -119.97 120.42 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.301 -1.74 . . . . 12.95 106.301 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -63.38 -29.77 71.01 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 113.504 0.927 . . . . 10.92 113.504 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -64.06 -34.25 77.6 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 14.32 111.696 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.16 -29.12 28.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.818 0.818 . . . . 10.93 109.655 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -75.58 -35.85 60.49 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.012 -0.995 . . . . 8.81 111.377 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -65.02 -30.39 71.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.107 0.48 . . . . 9.35 109.731 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -70.17 -36.75 74.9 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.252 -0.885 . . . . 11.63 109.599 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.504 ' CE3' ' HE2' ' A' ' 64' ' ' TYR . 17.3 t-105 -61.95 -42.29 98.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 10.55 110.606 173.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 79.6 t -68.8 -45.29 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.921 0 N-CA-C 110.087 -0.338 . . . . 8.3 110.087 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.07 87.7 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 116.153 -0.476 . . . . 9.58 113.331 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 p -73.05 -30.18 63.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.053 0.39 . . . . 10.23 112.053 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.48 -19.92 37.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.599 0.714 . . . . 10.43 110.323 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 95.0 mt -79.59 163.72 24.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.185 -0.672 . . . . 10.97 109.185 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.89 100.66 47.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.658 -0.868 . . . . 13.52 108.658 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.28 -178.96 2.61 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.003 2.469 . . . . 12.28 112.195 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.7 p 49.42 61.75 2.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.228 1.011 . . . . 13.44 112.687 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -72.06 105.71 4.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.797 -1.092 . . . . 13.27 111.334 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -30.78 39.46 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.503 -0.925 . . . . 14.48 108.503 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.0 m -90.16 123.18 33.77 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.705 -1.591 . . . . 14.92 106.705 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 59.53 74.8 0.43 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 123.895 0.878 . . . . 14.25 111.292 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.87 132.39 73.2 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.836 -1.075 . . . . 12.97 111.095 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 12.7 Cg_exo -72.44 68.71 3.49 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.122 2.548 . . . . 13.4 112.525 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.8 136.48 52.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.73 -1.211 . . . . 12.43 107.73 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.21 79.61 9.03 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.574 0.702 . . . . 13.45 110.521 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -122.27 111.12 16.53 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.511 -0.768 . . . . 14.41 109.339 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -74.02 134.59 77.65 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.915 -0.772 . . . . 11.68 108.915 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.76 43.58 1.27 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.179 2.586 . . . . 10.84 112.265 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.69 134.55 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 10.46 109.365 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.01 50.17 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.366 -0.379 . . . . 10.58 110.492 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 p -86.17 100.7 12.41 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.758 -1.201 . . . . 11.04 107.758 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.44 113.88 62.67 Favored Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.943 -0.571 . . . . 10.88 111.088 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.11 -21.38 13.89 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.308 2.005 . . . . 12.46 110.133 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 99' ' ' PRO . 5.6 tp-100 -130.64 123.13 20.06 Favored Pre-proline 0 N--CA 1.418 -2.062 0 N-CA-C 106.084 -1.821 . . . . 13.78 106.084 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD2' ' OE1' ' A' ' 98' ' ' GLN . 55.9 Cg_endo -72.57 63.26 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.888 2.392 . . . . 11.95 113.337 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 27.41 1.86 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.303 -1.119 . . . . 11.48 110.303 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.4 -43.18 19.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.545 0.688 . . . . 11.55 109.714 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -85.53 138.25 32.33 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.416 -0.811 . . . . 12.59 109.949 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.93 -4.6 57.42 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 11.24 108.562 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.9 p -97.09 32.75 2.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.826 -1.079 . . . . 10.05 109.924 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.08 76.97 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.435 -0.348 . . . . 11.22 111.8 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -65.47 -40.98 93.81 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.519 0.676 . . . . 11.38 109.659 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -66.22 -36.6 83.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.277 -0.874 . . . . 9.65 112.893 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.68 -38.38 90.14 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 117.921 0.328 . . . . 10.43 110.688 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 t -56.88 -47.72 79.81 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.785 -0.45 . . . . 10.21 109.785 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 178' ' ' VAL . 68.1 mt -68.79 -51.97 39.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.404 -0.591 . . . . 8.13 109.404 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -53.46 -41.38 66.11 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 124.587 1.155 . . . . 8.46 112.126 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 23.8 t70 -63.65 -48.24 78.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.68 0.252 . . . . 10.86 111.68 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.91 -36.06 69.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 11.45 110.413 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.64 -35.99 82.39 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.82 -0.808 . . . . 7.62 108.82 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 25.0 ttpp -61.92 -45.76 92.3 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 11.62 109.472 174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 77.7 mt-30 -56.22 -47.23 78.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.593 -0.73 . . . . 11.63 109.666 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -64.35 -50.98 65.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.111 -0.95 . . . . 9.14 112.124 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 119' ' ' GLY . 3.7 pp -65.09 -34.99 79.71 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.326 -0.549 . . . . 10.06 111.869 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -66.38 -47.8 68.11 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 111.072 -0.811 . . . . 12.07 111.072 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.37 -38.81 88.34 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.244 1.018 . . . . 12.32 110.624 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 tp -57.39 -44.05 84.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 11.77 110.102 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 86.9 mt -72.96 -63.24 1.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.522 -0.918 . . . . 13.52 108.522 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -179.27 -47.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.654 1.182 . . . . 16.56 109.978 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -162.67 155.3 19.23 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.777 0.322 . . . . 15.74 110.293 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -125.82 127.3 24.82 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.454 -0.794 . . . . 14.2 110.841 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.32 -2.88 12.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.137 2.558 . . . . 14.18 112.213 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.89 41.42 4.38 Favored Glycine 0 CA--C 1.491 -1.469 0 C-N-CA 120.893 -0.67 . . . . 14.03 111.916 173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -140.34 -72.66 0.36 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.132 -1.027 . . . . 16.37 113.413 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 118' ' ' LEU . 6.2 mp 67.79 141.25 0.03 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-O 122.418 1.104 . . . . 12.45 112.044 -166.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -83.04 161.91 21.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.879 -1.156 . . . . 14.43 107.879 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.1 m -78.31 17.49 0.64 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.845 0.683 . . . . 14.32 112.845 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.96 -74.83 0.34 Allowed Glycine 0 CA--C 1.494 -1.226 0 N-CA-C 108.663 -1.775 . . . . 13.75 108.663 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 62.07 62.43 1.21 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.998 0.919 . . . . 12.7 111.953 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' PRO . 9.7 tt0 -80.79 104.67 11.46 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.717 -0.674 . . . . 16.38 110.684 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -66.72 -26.81 67.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.255 1.022 . . . . 13.3 109.945 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.16 -24.37 67.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.434 0.635 . . . . 16.25 110.673 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -97.68 -46.27 6.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.157 0.503 . . . . 15.87 109.782 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.03 -26.07 62.94 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 13.65 112.884 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.02 119.68 6.45 Favored Glycine 0 C--N 1.313 -0.729 0 N-CA-C 111.942 -0.463 . . . . 14.16 111.942 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 86.9 mtp -106.18 -23.23 12.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.307 0.575 . . . . 15.45 110.643 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.51 127.44 19.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.344 0.592 . . . . 13.63 110.305 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.7 t -66.87 -37.49 84.53 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.931 -1.031 . . . . 13.9 110.32 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.89 -40.19 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.468 -0.333 . . . . 13.81 111.135 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.7 p -57.56 -35.29 70.16 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.442 . . . . 11.48 111.515 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.36 -32.11 26.19 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.623 -1.275 . . . . 10.35 112.254 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -68.25 -35.6 78.17 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.428 0.614 . . . . 12.2 110.588 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -63.83 -38.72 92.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.116 -0.493 . . . . 11.86 110.334 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -62.4 -44.22 96.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.75 -0.659 . . . . 9.32 110.22 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.8 mmt -60.23 -36.61 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 9.5 110.323 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' NE ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -67.06 -43.79 81.77 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.946 -0.57 . . . . 13.91 110.426 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.06 71.87 Favored Glycine 0 C--O 1.246 0.873 0 O-C-N 123.692 0.62 . . . . 9.88 112.73 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.34 -33.15 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.45 0.167 . . . . 9.27 110.898 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.4 m -60.58 -47.09 87.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 121.031 0.443 . . . . 11.46 110.124 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -68.83 -50.43 50.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.603 -0.726 . . . . 15.04 111.37 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -66.0 -34.95 79.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.223 0.453 . . . . 11.82 112.223 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -101.18 5.77 42.81 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.032 -0.667 . . . . 11.97 112.612 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 p 53.16 44.83 29.76 Favored 'General case' 0 C--O 1.247 0.954 0 C-N-CA 124.473 1.109 . . . . 14.24 113.377 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.78 149.07 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.307 -0.861 . . . . 12.62 108.774 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -96.23 95.64 8.25 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.402 -0.962 . . . . 16.39 108.402 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.8 tp -106.12 136.75 45.25 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.943 -0.572 . . . . 12.32 109.7 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.95 134.53 43.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.525 -0.546 . . . . 14.06 109.525 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.5 60.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.734 -0.666 . . . . 12.64 110.763 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.02 -10.85 59.86 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.436 -0.802 . . . . 15.68 110.573 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 167' ' ' THR . . . -64.61 -11.51 35.76 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.073 -0.512 . . . . 12.72 112.202 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -58.53 -17.61 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 121.445 0.64 . . . . 12.16 111.467 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -93.38 -6.41 47.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.077 -0.51 . . . . 15.08 112.131 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 164' ' ' ALA . 13.9 t -103.05 8.94 38.76 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.327 -0.949 . . . . 14.67 111.14 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -129.93 99.46 20.12 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 108.98 -0.748 . . . . 12.68 108.98 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.3 Cg_endo -67.24 -28.78 39.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.742 1.628 . . . . 14.34 110.906 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 27.8 p -121.96 142.4 50.34 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.812 -0.631 . . . . 12.91 109.493 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.16 -30.56 71.69 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.316 1.046 . . . . 9.89 111.622 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -55.23 -27.03 43.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.127 -0.942 . . . . 12.5 111.91 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.7 m -72.16 -19.89 61.69 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.162 -0.472 . . . . 11.04 112.194 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.7 tp -75.68 -29.84 59.18 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.951 -0.7 . . . . 8.5 109.892 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.26 96.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.807 -0.633 . . . . 7.7 111.196 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -82.16 -25.88 33.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.151 -0.62 . . . . 10.38 110.558 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -66.38 -48.66 69.44 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.163 -0.472 . . . . 11.97 110.408 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 110' ' ' ILE . 9.0 p -59.56 -39.73 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.861 -0.609 . . . . 9.8 110.141 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.88 -44.59 92.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.528 -0.76 . . . . 10.83 111.234 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -70.92 -28.33 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.124 0.488 . . . . 13.5 111.488 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -79.23 -41.98 27.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.624 -0.431 . . . . 14.84 110.806 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.04 -35.25 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.428 -0.509 . . . . 13.35 111.341 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.37 -0.604 . . . . 13.51 109.37 179.198 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.212 -0.888 0 N-CA-C 108.43 -0.952 . . . . 18.51 108.43 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.81 -26.6 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.198 -0.601 . . . . 16.66 112.111 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -49.96 -74.73 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.003 0.814 . . . . 14.84 112.973 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 22.7 t70 -88.73 -11.21 45.75 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.795 -0.762 . . . . 14.98 110.668 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.8 -38.11 70.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.889 -0.507 . . . . 15.79 111.708 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.0 p -65.7 -35.13 79.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.533 -0.867 . . . . 12.02 109.757 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.52 -35.0 79.53 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.055 -0.52 . . . . 11.02 110.477 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 28.5 mt-30 -53.36 -45.56 69.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 123.622 0.576 . . . . 16.07 110.636 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.45 -46.54 88.04 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.849 -0.614 . . . . 13.93 110.473 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.6 -36.35 73.47 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.01 -0.541 . . . . 10.71 111.075 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.62 -46.47 85.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.841 0.857 . . . . 14.02 109.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.92 -44.63 96.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.389 -0.823 . . . . 16.29 110.289 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -69.07 -40.4 78.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.407 -0.815 . . . . 12.91 110.847 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.77 -51.01 71.79 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.505 -0.924 . . . . 12.77 108.505 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.653 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -62.38 -39.61 93.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.055 . . . . 15.19 111.662 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.89 -38.34 88.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.326 -0.397 . . . . 16.26 111.351 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.3 mtt -71.93 -36.62 69.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.789 0.328 . . . . 15.45 111.819 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 81.3 mt -94.73 -2.39 51.18 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.673 -0.411 . . . . 16.16 111.73 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 59.15 36.21 23.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.512 1.125 . . . . 20.56 111.104 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.653 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 23.5 p -112.27 164.91 12.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.11 -0.95 . . . . 16.63 108.976 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 52.2 mm-40 -91.28 129.29 43.91 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.091 -0.707 . . . . 20.19 109.091 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.93 -14.35 42.75 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.484 2.789 . . . . 16.6 114.317 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.98 -13.43 69.2 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.855 -0.688 . . . . 17.74 112.659 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 10.6 pt20 -79.56 -20.19 47.63 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.278 0.539 . . . . 20.23 110.472 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 pt -92.94 168.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.688 -1.227 . . . . 15.98 107.688 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -134.6 166.17 23.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 119.191 -0.433 . . . . 19.33 111.053 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 5.6 m-20 -56.5 -51.17 69.52 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.64 0.588 . . . . 14.93 111.167 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.23 6.72 70.5 Favored Glycine 0 C--O 1.244 0.741 0 CA-C-N 115.962 -0.563 . . . . 14.82 113.918 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -76.29 136.84 39.62 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.74 0.781 . . . . 14.54 110.924 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 82.3 mtp180 -77.54 147.08 35.93 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 114.576 -1.193 . . . . 16.75 108.786 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -58.63 -25.45 62.7 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.176 0.806 . . . . 11.99 113.176 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.01 -21.34 59.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.096 -0.502 . . . . 14.45 109.884 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.39 -18.74 18.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.864 0.866 . . . . 16.44 109.006 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 67' ' ' PHE . 87.6 mt -75.14 -21.63 58.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.702 -0.681 . . . . 13.77 109.792 177.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 24.56 8.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.45 -0.796 . . . . 13.81 112.543 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.38 163.54 16.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.924 0.869 . . . . 13.04 112.47 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.35 153.46 51.83 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.039 -1.437 . . . . 15.67 107.31 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -49.43 -55.65 12.36 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 123.741 0.65 . . . . 15.29 112.629 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.55 -44.79 99.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.249 -0.432 . . . . 16.66 110.704 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.78 -37.64 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.246 -0.433 . . . . 14.14 110.574 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.68 85.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 12.0 110.176 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.74 90.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.677 -0.692 . . . . 13.97 110.242 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.16 -42.39 90.63 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.461 0.648 . . . . 15.69 110.887 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.546 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 7.4 t90 -61.64 -55.61 28.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.793 1.637 . . . . 11.69 109.17 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.6 mm -54.32 -39.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.436 0.695 . . . . 11.16 111.583 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 18.4 tpt180 -72.33 -23.32 61.14 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.995 -0.548 . . . . 16.65 111.802 -175.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -86.56 -32.82 20.48 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 120.086 -0.646 . . . . 14.15 109.725 175.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 45' ' ' ILE . 87.9 mt -55.61 -35.8 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.972 0.909 . . . . 10.8 109.05 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' OD1' ' HD2' ' A' ' 46' ' ' ARG . 14.5 m120 -53.62 -39.77 65.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.836 -1.075 . . . . 12.98 112.411 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -84.86 -43.83 13.77 Favored 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 119.977 -0.689 . . . . 17.52 109.885 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -62.3 -37.05 84.07 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.36 0.874 . . . . 14.87 113.36 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -108.06 7.13 27.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.023 0.749 . . . . 12.2 113.023 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 48.17 52.6 13.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.302 1.441 . . . . 16.71 110.392 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 49' ' ' ASN . 33.1 tp -143.24 137.12 28.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.39 -0.967 . . . . 12.2 108.39 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.61 46.54 1.37 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.579 0.704 . . . . 16.06 109.474 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.1 tt -53.36 128.42 50.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.141 -1.39 . . . . 11.39 110.823 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 2.2 Cg_endo -83.2 147.37 12.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.466 2.11 . . . . 12.6 112.179 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HA ' HG13 ' A' ' 45' ' ' ILE . . . -68.4 -17.74 64.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.924 -1.034 . . . . 12.52 111.87 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.48 -9.27 56.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 14.14 111.915 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.27 -29.31 72.71 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.081 -0.808 . . . . 10.76 111.081 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.4 mt -76.79 -25.92 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 CA-C-O 121.414 0.626 . . . . 11.0 109.384 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -85.66 -14.03 46.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.297 -0.561 . . . . 16.42 111.526 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 t -97.03 -34.5 11.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.586 -0.446 . . . . 13.35 110.075 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -130.38 79.71 71.89 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.871 0.367 . . . . 12.23 110.273 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.8 Cg_endo -89.18 36.72 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.422 2.748 . . . . 13.06 112.813 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.0 t -124.43 127.31 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.397 -1.705 . . . . 12.95 106.397 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 34' ' ' LEU . 68.2 t80 -52.41 -49.16 65.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.807 0.73 . . . . 10.92 112.82 -170.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 17.5 tptm -70.36 -21.33 62.89 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.16 0.505 . . . . 14.32 111.58 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.28 -29.71 24.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.584 0.707 . . . . 10.93 109.875 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 73' ' ' TRP . 59.3 t80 -82.55 -28.12 31.2 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.305 -0.861 . . . . 8.81 111.145 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -68.75 -32.36 72.08 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.16 0.505 . . . . 9.35 110.083 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 68' ' ' LYS . 11.2 mm100 -72.23 -29.45 63.95 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 109.24 -0.652 . . . . 11.63 109.24 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.644 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 3.1 t90 -57.99 -53.87 53.33 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.351 -0.981 . . . . 10.55 108.351 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.52 -39.75 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 C-N-CA 124.153 0.981 . . . . 8.3 110.877 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.1 95.11 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.246 -0.433 . . . . 9.58 112.808 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -76.1 -13.42 60.21 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 122.55 -0.382 . . . . 10.23 111.081 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 75.5 mm-40 -83.64 -18.8 36.89 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.638 -0.875 . . . . 10.43 108.638 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.37 66.61 6.98 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.331 -0.989 . . . . 10.97 108.331 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 49.3 tp60 -106.47 114.76 61.75 Favored Pre-proline 0 N--CA 1.419 -1.983 0 CA-C-N 114.379 -1.282 . . . . 13.52 109.716 -177.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' GLN . 26.9 Cg_exo -63.61 135.1 47.37 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.927 2.418 . . . . 12.28 112.426 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 p -79.84 5.74 12.9 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.511 -0.768 . . . . 13.44 111.337 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -84.28 -27.83 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.51 -0.768 . . . . 13.27 109.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.35 -46.09 7.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.733 -0.84 . . . . 14.48 108.733 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.9 m -91.44 97.58 11.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.446 -0.797 . . . . 14.92 110.78 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.91 70.2 0.52 Allowed 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.892 1.277 . . . . 14.25 113.007 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.59 25.44 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 115.671 -0.695 . . . . 12.97 109.718 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.34 48.88 3.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.813 2.342 . . . . 13.4 112.667 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.23 61.55 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.514 -1.662 . . . . 12.43 106.514 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -104.21 -27.8 11.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.269 -0.878 . . . . 13.45 110.652 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 8.2 mpt_? -93.35 88.36 5.95 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.852 -0.613 . . . . 14.41 109.39 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.47 129.71 44.14 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 115.439 -0.801 . . . . 11.68 109.791 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.82 83.67 1.35 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.844 2.362 . . . . 10.84 110.452 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -82.01 119.54 31.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.191 -0.913 . . . . 10.46 110.726 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.69 139.52 53.87 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.06 -1.459 . . . . 10.58 107.06 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -130.91 161.98 30.68 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.802 -0.814 . . . . 11.04 108.802 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 42.07 83.17 0.21 Allowed Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.624 1.569 . . . . 10.88 113.766 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.88 -34.17 95.55 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.14 1.894 . . . . 12.46 111.446 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.8 tt0 -80.08 125.94 80.58 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.455 -0.793 . . . . 13.78 110.838 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 16.2 Cg_exo -70.32 103.14 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.534 2.156 . . . . 11.95 110.217 174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.28 65.78 1.26 Allowed Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.428 -0.892 . . . . 11.48 111.27 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.34 61.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.181 0.515 . . . . 11.55 110.656 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -80.24 78.56 6.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.633 -0.712 . . . . 12.59 110.002 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.95 58.36 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.597 0.713 . . . . 11.24 111.43 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.6 m 61.01 33.35 19.73 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 125.315 1.446 . . . . 10.05 112.772 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.09 -38.86 62.92 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.599 0.962 . . . . 11.22 113.599 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.01 -41.72 86.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.441 0.638 . . . . 11.38 110.81 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 107' ' ' ARG . 3.5 mpt_? -83.39 -33.71 25.72 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.781 -0.645 . . . . 9.65 110.957 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.56 -34.06 76.2 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.155 0.982 . . . . 10.43 110.386 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -60.53 -47.57 85.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.957 -0.565 . . . . 10.21 110.096 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 178' ' ' VAL . 67.1 mt -61.2 -45.53 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.096 -0.705 . . . . 8.13 109.096 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.07 -35.12 68.98 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 114.83 -1.077 . . . . 8.46 111.048 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.87 -37.78 85.81 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.04 0.448 . . . . 10.86 111.47 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -76.37 -44.29 37.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.853 -0.795 . . . . 11.45 108.853 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.8 -41.02 85.77 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.747 -1.115 . . . . 7.62 109.774 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.58 -42.09 74.28 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.318 1.447 . . . . 11.62 110.174 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -81.56 -33.97 31.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 11.63 111.981 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 80.8 p -61.05 -43.92 98.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 121.01 -0.276 . . . . 9.14 111.153 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.2 pp -75.34 -31.69 60.65 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.531 -0.468 . . . . 10.06 110.659 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -58.4 -54.94 33.63 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.187 -0.461 . . . . 12.07 111.972 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -60.43 -43.46 96.76 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.825 0.822 . . . . 12.32 110.702 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.59 -45.12 72.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.514 -1.221 . . . . 11.77 111.922 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.1 mt -91.14 -15.33 29.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.341 0.497 . . . . 13.52 112.341 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.1 t80 66.38 33.97 6.63 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.247 -1.39 . . . . 16.56 107.247 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.38 148.73 35.22 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.766 -1.561 . . . . 15.74 108.47 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 12.8 m-20 -67.98 119.91 70.3 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.394 -0.595 . . . . 14.2 109.394 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 16.8 Cg_exo -70.82 32.25 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.858 3.039 . . . . 14.18 114.387 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.13 3.52 9.72 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 108.725 -1.75 . . . . 14.03 108.725 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -106.18 40.59 1.57 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.231 -1.026 . . . . 16.37 108.231 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.88 48.72 0.39 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.612 -1.176 . . . . 12.45 113.168 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -161.51 -44.15 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 125.429 1.492 . . . . 14.43 107.911 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -64.73 -45.42 86.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.265 -0.879 . . . . 14.32 109.023 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.88 30.47 10.35 Favored Glycine 0 C--O 1.214 -1.105 0 CA-C-N 115.387 -0.824 . . . . 13.75 111.047 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB1' ' HG3' ' A' ' 172' ' ' LYS . . . -92.75 -17.99 23.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.487 0.66 . . . . 12.7 109.857 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -87.71 113.63 23.56 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.99 -1.115 . . . . 16.38 107.99 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -64.46 -16.2 62.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.214 0.53 . . . . 13.3 112.218 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.98 -24.51 55.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.118 -0.492 . . . . 16.25 110.618 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -78.22 -27.75 47.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.412 0.625 . . . . 15.87 109.81 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.19 -20.89 66.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.469 -1.241 . . . . 13.65 111.956 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.52 -53.77 4.89 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.843 -0.903 . . . . 14.16 110.843 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.2 mtm -98.1 146.95 25.05 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.305 -1.369 . . . . 15.45 107.305 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -137.39 -68.2 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.776 1.028 . . . . 13.63 113.776 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.2 t -70.9 -40.19 72.31 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.033 0.382 . . . . 13.9 112.033 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.1 -50.95 53.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.536 0.684 . . . . 13.81 109.733 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -37.97 83.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.036 -0.984 . . . . 11.48 111.143 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.6 98.44 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.653 -0.703 . . . . 10.35 111.522 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.8 m -56.84 -53.26 59.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.682 0.393 . . . . 12.2 110.115 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -64.84 -38.45 91.04 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.316 -0.402 . . . . 11.86 111.894 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.0 t90 -67.56 -50.9 56.33 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.348 -0.612 . . . . 9.32 109.348 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 mmt -67.63 -26.18 66.11 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.456 -0.793 . . . . 9.5 111.435 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 154' ' ' ARG . 26.5 tpt180 -62.92 -43.93 97.47 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.405 -0.961 . . . . 13.91 108.405 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.82 91.24 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.144 -0.782 . . . . 9.88 111.144 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 148' ' ' TRP . 97.4 t -61.09 -40.86 87.15 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.465 -0.568 . . . . 9.27 109.465 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' SER . 39.6 m -66.08 -30.13 70.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.751 -0.659 . . . . 11.46 110.821 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 150' ' ' ARG . 37.6 mmt180 -67.19 -47.74 70.02 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.56 -0.533 . . . . 15.04 109.56 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -71.53 -55.34 8.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.235 0.828 . . . . 11.82 113.235 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -105.27 -8.35 18.34 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 114.068 1.136 . . . . 11.97 114.068 -170.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 153' ' ' SER . 28.0 m 55.58 38.88 30.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.91 0.884 . . . . 14.24 112.326 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.9 pt -104.23 144.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.333 -0.617 . . . . 12.62 109.333 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -81.98 95.36 7.37 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 123.522 0.514 . . . . 16.39 111.696 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.29 102.39 6.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.577 -0.897 . . . . 12.32 108.577 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.43 175.68 10.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 121.174 -0.21 . . . . 14.06 111.054 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.37 80.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.445 0.641 . . . . 12.64 110.935 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.84 -10.2 45.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.19 -0.914 . . . . 15.68 112.848 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.99 -13.64 62.33 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 111.675 0.25 . . . . 12.72 111.675 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.4 pt -66.65 -18.24 23.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 O-C-N 122.107 -0.371 . . . . 12.16 111.729 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -94.02 1.76 56.17 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.933 0.873 . . . . 15.08 110.194 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.5 m -89.32 -9.55 50.1 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.061 -0.972 . . . . 14.67 108.402 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -130.93 149.04 72.58 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.36 -0.978 . . . . 12.68 108.36 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.85 -38.41 2.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.622 2.215 . . . . 14.34 112.317 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.2 p -138.16 162.15 34.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.319 -1.734 . . . . 12.91 106.319 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.17 -1.25 19.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.024 0.44 . . . . 9.89 112.118 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 133' ' ' ALA . 30.0 mtpp -76.24 -24.34 54.57 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.179 -0.674 . . . . 12.5 109.179 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.2 m -73.88 -2.65 24.69 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.254 -0.885 . . . . 11.04 111.06 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.33 -32.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.464 -0.569 . . . . 8.5 109.464 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.36 68.9 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.299 0.571 . . . . 7.7 111.22 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.37 -24.69 34.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.411 -0.588 . . . . 10.38 109.411 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.63 -60.97 2.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.66 -0.7 . . . . 11.97 110.05 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 110' ' ' ILE . 7.2 p -46.14 -52.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 124.053 0.845 . . . . 9.8 113.199 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.428 ' CG ' ' HE ' ' A' ' 107' ' ' ARG . 20.2 t70 -61.91 -45.38 93.98 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 111.897 0.332 . . . . 10.83 111.897 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -78.27 -29.76 48.15 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.463 -0.789 . . . . 13.5 110.448 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.25 -39.61 74.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.633 -0.712 . . . . 14.84 109.391 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.0 t -78.39 -60.55 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.692 -0.685 . . . . 13.35 111.658 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 108.664 -0.865 . . . . 13.51 108.664 -173.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 109.412 -0.588 . . . . 18.51 109.412 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . 176.26 -177.21 0.13 Allowed 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.544 1.138 . . . . 16.66 108.465 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.24 -24.82 66.65 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.544 0.611 . . . . 14.84 111.164 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.45 -26.7 68.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.973 -0.558 . . . . 14.98 112.058 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 2' ' ' ALA . 10.2 pt-20 -68.89 -27.24 65.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.272 0.558 . . . . 15.79 110.206 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.8 -33.46 75.66 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.459 -0.571 . . . . 12.02 109.459 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 -26.68 32.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.157 -0.474 . . . . 11.02 110.543 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -67.47 -33.97 76.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.175 -0.676 . . . . 16.07 109.175 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -68.5 -28.97 67.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.505 -0.771 . . . . 13.93 109.749 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.81 -44.4 96.25 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.379 -0.6 . . . . 10.71 109.379 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.922 -0.581 . . . . 14.02 109.492 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.75 -46.1 73.07 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.495 -0.775 . . . . 16.29 110.131 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' MET . 48.4 t -59.34 -45.59 90.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.573 -0.74 . . . . 12.91 110.365 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.48 -45.44 93.75 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.273 -0.422 . . . . 12.77 111.449 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.53 -22.95 63.53 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.253 -0.43 . . . . 15.19 111.574 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 -24.36 49.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.426 0.631 . . . . 16.26 109.628 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 13' ' ' SER . 26.5 mmt -78.05 -44.22 27.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.619 -0.719 . . . . 15.45 109.197 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.67 5.49 51.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 16.16 112.607 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 53.41 45.61 27.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.237 1.415 . . . . 20.56 113.107 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -125.33 -173.8 2.91 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.345 -0.983 . . . . 16.63 108.345 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -107.32 134.99 19.72 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 107.976 -1.12 . . . . 20.19 107.976 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -66.04 -11.17 29.93 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 123.233 2.622 . . . . 16.6 112.859 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.78 -3.41 85.91 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.527 -0.629 . . . . 17.74 111.527 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -102.75 175.41 5.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.677 -1.231 . . . . 20.23 107.677 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.485 HG12 ' HG ' ' A' ' 34' ' ' LEU . 1.9 mp 70.96 140.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 123.883 0.739 . . . . 15.98 110.725 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 6.8 mpt_? -75.25 122.77 24.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.738 -0.601 . . . . 19.33 109.577 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.675 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 p30 -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.83 0.678 . . . . 14.93 112.83 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.37 7.4 68.88 Favored Glycine 0 C--N 1.315 -0.614 0 N-CA-C 110.649 -0.98 . . . . 14.82 110.649 177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 26' ' ' ARG . 23.3 t -99.19 171.34 8.06 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.48 0.657 . . . . 14.54 109.54 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 81.8 mtm180 -92.93 160.3 14.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.163 -0.926 . . . . 16.75 110.38 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -58.26 -18.98 30.66 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.595 -1.184 . . . . 11.99 112.423 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -29.38 70.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.965 -0.561 . . . . 14.45 111.609 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.33 -35.45 80.38 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.361 0.6 . . . . 16.44 109.814 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' A' ' 25' ' ' ILE . 4.1 mp -83.43 -8.92 59.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.772 -0.649 . . . . 13.77 110.248 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.78 35.26 73.08 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 114.83 -1.077 . . . . 13.81 111.373 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.04 114.05 8.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.623 -0.51 . . . . 13.04 109.623 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.22 156.34 23.21 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.481 -0.781 . . . . 15.67 109.784 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 t -56.22 -41.47 75.71 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 123.271 0.357 . . . . 15.29 111.45 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.23 -47.62 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.912 0.387 . . . . 16.66 110.985 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mt -66.03 -39.68 85.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.026 -0.534 . . . . 14.14 109.683 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.62 99.11 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.588 -0.733 . . . . 12.0 110.444 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.48 85.06 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.564 0.745 . . . . 13.97 111.093 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.84 -47.61 44.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.96 -0.564 . . . . 15.69 111.56 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -61.31 -47.28 86.68 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.088 0.555 . . . . 11.69 111.644 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 48' ' ' ILE . 10.5 tp -59.69 -32.94 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 120.892 0.377 . . . . 11.16 110.571 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -66.86 -32.28 73.45 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.053 -0.522 . . . . 16.65 110.521 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.59 -31.97 60.16 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.564 -0.902 . . . . 14.15 108.564 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 45' ' ' ILE . 70.4 mt -62.49 -35.12 68.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.566 -0.743 . . . . 10.8 109.783 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.93 -31.04 70.58 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.475 -0.784 . . . . 12.98 110.042 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -43.95 20.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.934 -0.575 . . . . 17.52 110.047 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -65.11 -46.3 81.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.65 0.611 . . . . 14.87 112.65 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 55.6 m-85 -100.17 -0.03 39.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 112.787 0.662 . . . . 12.2 112.787 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 53.12 45.17 29.24 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 125.403 1.481 . . . . 16.71 111.702 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 96.0 mt -134.32 142.87 47.4 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.579 -1.191 . . . . 12.2 109.485 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -77.51 75.69 4.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.72 -0.844 . . . . 16.06 108.72 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 25.0 mm -94.18 119.95 66.06 Favored Pre-proline 0 N--CA 1.436 -1.135 0 CA-C-N 116.292 -0.413 . . . . 11.39 111.814 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -84.15 164.21 13.24 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.869 2.38 . . . . 12.6 110.112 173.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -2.92 17.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.634 -0.712 . . . . 12.52 112.518 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 p30 -68.3 -23.6 64.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.936 -0.306 . . . . 14.14 110.957 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.06 -30.62 70.66 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 119.883 -1.151 . . . . 10.76 111.588 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.94 -21.15 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.723 0.809 . . . . 11.0 110.036 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 59' ' ' ASP . 16.7 m-85 -85.33 -45.86 11.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.384 -0.598 . . . . 16.42 109.384 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -67.54 -44.6 77.94 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.929 -0.578 . . . . 13.35 110.127 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.05 86.72 14.15 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 108.873 -0.788 . . . . 12.23 108.873 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 84.1 Cg_endo -83.9 14.87 2.28 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.751 2.301 . . . . 13.06 113.275 -174.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.8 t -124.56 120.29 58.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.118 -1.808 . . . . 12.95 106.118 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.5 p90 -58.72 -31.6 68.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 10.92 114.313 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -69.36 -24.98 63.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.766 0.654 . . . . 14.32 112.766 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.78 16.97 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.644 -0.873 . . . . 10.93 108.644 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 57.2 t80 -62.15 -28.91 69.98 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.748 -1.114 . . . . 8.81 112.262 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 p -70.0 -26.45 64.08 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.471 -0.768 . . . . 9.35 110.716 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -81.44 -28.94 33.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.746 -0.835 . . . . 11.63 108.746 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.502 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 66.1 t90 -58.26 -52.27 66.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.476 1.111 . . . . 10.55 108.094 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 54.4 t -67.88 -39.9 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 CA-C-N 115.266 -0.879 . . . . 8.3 110.781 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.73 97.07 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.192 -0.528 . . . . 9.58 112.3 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.2 m -67.99 -35.97 79.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 111.786 0.291 . . . . 10.23 111.786 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 27.6 pt20 -75.78 -18.77 59.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.363 -0.535 . . . . 10.43 110.517 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.09 -18.09 40.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.141 -0.481 . . . . 10.97 111.039 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HA ' HE21 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -117.52 92.6 41.18 Favored Pre-proline 0 C--O 1.244 0.767 0 N-CA-C 109.879 -0.415 . . . . 13.52 109.879 -176.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -53.27 121.44 9.43 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.434 2.756 . . . . 12.28 112.05 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.1 m -65.91 -19.54 65.91 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.479 1.112 . . . . 13.44 113.183 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -105.22 -2.88 23.58 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 121.711 -0.618 . . . . 13.27 111.387 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.5 -18.1 28.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.921 0.391 . . . . 14.48 110.883 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 p -78.57 65.7 3.91 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.707 0.632 . . . . 14.92 112.707 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.62 136.38 38.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.04 -1.096 . . . . 14.25 108.04 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.96 125.36 80.09 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.808 -0.812 . . . . 12.97 108.808 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.95 116.51 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.416 2.077 . . . . 13.4 111.663 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.84 117.95 49.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.423 -0.955 . . . . 12.43 108.423 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.32 125.17 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.986 0.422 . . . . 13.45 110.851 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -127.71 41.15 3.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.636 -0.711 . . . . 14.41 109.517 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -86.87 120.94 71.91 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.138 -0.937 . . . . 11.68 110.022 -178.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 7.1 Cg_exo -72.6 66.47 3.79 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.859 2.372 . . . . 10.84 112.032 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -111.28 123.11 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.941 -0.572 . . . . 10.46 109.587 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.82 18.27 8.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.307 -0.627 . . . . 10.58 109.307 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.1 m 74.77 -48.27 0.64 Allowed 'General case' 0 C--O 1.251 1.179 0 C-N-CA 125.176 1.39 . . . . 11.04 111.325 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.84 141.66 98.4 Favored Pre-proline 0 N--CA 1.446 -0.632 0 C-N-CA 123.62 0.768 . . . . 10.88 109.167 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.18 -12.76 24.65 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.697 2.931 . . . . 12.46 113.768 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -127.67 95.89 34.02 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 108.578 -0.897 . . . . 13.78 108.578 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.01 94.46 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.594 2.196 . . . . 11.95 110.398 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.03 160.98 16.33 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.485 -0.864 . . . . 11.48 112.192 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -60.36 3.55 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.757 0.823 . . . . 11.55 111.148 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -74.31 -10.92 60.06 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.603 0.594 . . . . 12.59 112.603 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.16 68.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.491 0.186 . . . . 11.24 111.347 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.4 m -147.54 -32.68 0.28 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.922 0.712 . . . . 10.05 112.922 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -42.03 80.88 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.414 0.524 . . . . 11.22 112.414 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -51.72 -48.4 63.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.405 0.682 . . . . 11.38 111.573 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -68.92 -42.82 76.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 9.65 109.951 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.32 -44.48 83.25 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.989 -1.005 . . . . 10.43 111.766 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -59.84 -39.09 83.98 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.639 0.257 . . . . 10.21 111.038 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.66 HG21 HG11 ' A' ' 178' ' ' VAL . 59.7 mt -71.29 -50.95 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.921 -0.4 . . . . 8.13 109.921 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -58.84 -39.94 82.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.109 -0.496 . . . . 8.46 111.139 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 31.0 t70 -67.73 -36.98 81.56 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 10.86 111.007 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -70.05 -42.55 72.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.316 0.579 . . . . 11.45 109.782 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.6 -41.49 94.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.534 1.134 . . . . 7.62 109.033 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 112' ' ' ASP . 33.9 ttmt -54.47 -54.3 42.74 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.559 1.544 . . . . 11.62 110.254 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -67.34 -42.75 83.04 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.916 -0.583 . . . . 11.63 111.908 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.4 t -56.75 -53.09 61.73 Favored 'General case' 0 C--O 1.248 1.021 0 O-C-N 123.574 0.546 . . . . 9.14 111.79 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.36 -36.77 74.39 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 120.676 -0.409 . . . . 10.06 110.912 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.7 84.95 Favored Glycine 0 C--O 1.223 -0.546 0 N-CA-C 111.24 -0.744 . . . . 12.07 111.24 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 -44.4 91.52 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 124.423 1.089 . . . . 12.32 110.804 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 148' ' ' TRP . 17.6 tp -66.0 -49.6 67.23 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.96 -1.018 . . . . 11.77 112.145 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 tp -94.02 4.23 54.21 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.703 -0.681 . . . . 13.52 112.358 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.1 t80 59.78 40.65 19.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.197 1.399 . . . . 16.56 110.187 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -111.49 154.86 24.12 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.78 -1.563 . . . . 15.74 106.78 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.8 117.94 63.88 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 107.577 -1.268 . . . . 14.2 107.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.57 107.89 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.921 3.081 . . . . 14.18 113.033 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 130' ' ' ARG . . . 125.46 -36.31 2.82 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.505 -1.225 . . . . 14.03 111.651 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -86.31 42.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.38 1.086 . . . . 16.37 109.366 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.65 -7.07 1.69 Allowed 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.584 -1.644 . . . . 12.45 111.199 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 127' ' ' GLY . 38.5 ptt180 -95.91 -5.95 40.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.94 -0.573 . . . . 14.43 110.081 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -70.22 -33.95 72.29 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 14.32 108.797 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.41 -62.67 0.95 Allowed Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 108.84 -1.704 . . . . 13.75 108.84 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 138' ' ' LEU . . . 60.07 26.81 16.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.367 1.067 . . . . 12.7 110.992 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -97.68 139.89 32.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.308 -1.315 . . . . 16.38 109.662 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 169' ' ' PRO . 14.5 p90 -70.19 -12.88 61.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.276 -0.875 . . . . 13.3 109.43 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.65 -32.12 62.16 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.272 -0.876 . . . . 16.25 110.342 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.17 -42.39 6.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.429 0.633 . . . . 15.87 110.852 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 133' ' ' ALA . 70.5 mt -79.66 -22.35 43.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.589 -0.732 . . . . 13.65 110.465 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -102.72 43.79 1.62 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.954 -1.259 . . . . 14.16 109.954 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.7 ttp -60.29 -43.41 96.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.655 0.782 . . . . 15.45 110.551 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -127.34 120.21 28.02 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 107.479 -1.304 . . . . 13.63 107.479 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -62.06 -39.33 92.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.877 -1.056 . . . . 13.9 111.972 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.7 t -68.76 -36.83 76.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 110.146 -0.316 . . . . 13.81 110.146 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.5 m -56.9 -46.61 81.8 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.194 -0.457 . . . . 11.48 109.776 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.96 -22.52 76.67 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 119.677 -1.249 . . . . 10.35 111.87 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.419 ' HA ' ' HB1' ' A' ' 162' ' ' ALA . 92.5 m -63.81 -48.89 75.05 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.64 -0.504 . . . . 12.2 109.64 176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -59.6 -40.24 86.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.57 0.7 . . . . 11.86 110.227 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.484 ' HB2' HD22 ' A' ' 121' ' ' LEU . 22.4 t90 -68.5 -53.03 25.89 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.927 -1.033 . . . . 9.32 112.318 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 32.7 ttm -65.96 -35.06 79.56 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 111.915 0.339 . . . . 9.5 111.915 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -66.4 -35.95 81.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.528 . . . . 13.91 109.576 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.06 -43.54 97.14 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.628 -0.989 . . . . 9.88 110.628 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' TRP . 75.9 t -56.55 -45.92 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.607 0.763 . . . . 9.27 109.253 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.2 m -59.51 -40.15 86.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.377 -0.828 . . . . 11.46 110.994 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -70.72 -46.96 62.1 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.478 -0.328 . . . . 15.04 111.591 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -68.22 -30.61 69.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 113.293 0.849 . . . . 11.82 113.293 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -101.56 0.16 35.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.075 -0.65 . . . . 11.97 112.123 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.8 m 56.42 45.94 21.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.638 -1.164 . . . . 14.24 112.308 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.5 156.15 41.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 12.62 109.047 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -88.8 106.58 18.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.221 -1.029 . . . . 16.39 108.221 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.41 110.3 11.38 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.782 -0.451 . . . . 12.32 109.782 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.28 135.92 47.67 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.944 -0.571 . . . . 14.06 110.469 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 146' ' ' THR . . . -63.46 -8.61 9.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.416 1.086 . . . . 12.64 112.834 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -77.42 -10.75 59.65 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.386 -0.598 . . . . 15.68 109.386 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.452 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -63.7 -13.13 40.35 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 116.102 -0.499 . . . . 12.72 112.256 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.8 pt -68.64 -12.32 15.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 121.166 0.508 . . . . 12.16 109.937 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -118.59 19.32 13.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.548 -0.908 . . . . 15.08 108.548 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 88.8 m -108.24 -26.55 10.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.187 -0.915 . . . . 14.67 109.679 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -122.75 143.67 40.76 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 107.978 -1.119 . . . . 12.68 107.978 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.572 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 68.8 Cg_endo -93.02 -5.73 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.902 1.735 . . . . 14.34 111.897 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.756 -0.656 . . . . 12.91 111.134 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.94 -32.92 71.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.904 -1.043 . . . . 9.89 111.988 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -62.71 -20.36 64.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.172 -0.467 . . . . 12.5 111.187 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.8 m -70.88 -17.65 62.71 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.102 -0.499 . . . . 11.04 111.024 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.72 -44.94 61.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.892 -1.151 . . . . 8.5 107.892 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.02 80.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.471 -0.786 . . . . 7.7 111.39 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.99 -19.75 60.55 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.318 0.488 . . . . 10.38 112.318 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -74.75 -52.61 11.05 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.331 -0.618 . . . . 11.97 109.331 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 110' ' ' ILE . 3.3 p -62.46 -42.64 96.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.578 -0.737 . . . . 9.8 110.497 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.43 -41.87 90.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.401 . . . . 10.83 110.655 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -69.07 -53.24 21.43 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.74 0.816 . . . . 13.5 113.071 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -85.01 -32.47 22.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 115.187 1.551 . . . . 14.84 115.187 -173.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.87 -40.75 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.817 -0.753 . . . . 13.35 110.213 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 120.44 -0.504 . . . . 13.51 110.255 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 121.215 0.531 . . . . 18.51 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.87 97.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.015 0.436 . . . . 16.66 112.148 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.98 -23.8 67.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.851 -0.613 . . . . 14.84 111.686 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -98.49 -19.57 17.58 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.921 -0.712 . . . . 14.98 110.008 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' HA ' HE21 ' A' ' 8' ' ' GLN . 42.9 tt0 -65.92 -37.85 87.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 120.842 0.353 . . . . 15.79 111.295 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.8 p -63.82 -32.15 73.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.069 0.461 . . . . 12.02 111.016 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 11' ' ' ARG . . . -75.14 -40.85 59.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.254 -0.43 . . . . 11.02 109.843 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 5' ' ' GLU . 50.8 mt-30 -54.47 -43.91 72.13 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.8 0.44 . . . . 16.07 110.616 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.1 -41.41 78.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.771 -0.649 . . . . 13.93 111.006 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.32 -36.29 66.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.365 -0.38 . . . . 10.71 110.753 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 7' ' ' ALA . 68.0 mtt180 -60.57 -45.64 93.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.763 -0.829 . . . . 14.02 108.763 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 27.9 mt-30 -59.92 -53.83 53.22 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.558 -0.747 . . . . 16.29 110.244 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 m -56.71 -42.85 79.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.123 -0.944 . . . . 12.91 112.681 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.83 -52.15 22.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.455 0.169 . . . . 12.77 110.687 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.71 71.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.39 0.515 . . . . 15.19 112.39 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.32 84.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.656 0.265 . . . . 16.26 111.544 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.3 mtt -75.81 -32.24 59.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.291 0.567 . . . . 15.45 110.893 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.62 -2.36 41.74 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.877 -0.601 . . . . 16.16 112.199 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 57.54 44.05 21.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.548 1.139 . . . . 20.56 111.589 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.57 177.0 4.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.134 -1.061 . . . . 16.63 108.134 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -96.76 133.72 24.09 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 110.47 -0.196 . . . . 20.19 110.47 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.77 20.66 1.19 Allowed 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 122.89 2.394 . . . . 16.6 111.484 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.16 -104.45 1.2 Allowed Glycine 0 N--CA 1.428 -1.89 0 CA-C-N 114.899 -1.046 . . . . 17.74 113.245 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.42 67.63 9.97 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.299 0.852 . . . . 20.23 113.299 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 pt -90.65 163.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.266 -1.012 . . . . 15.98 108.266 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 62.0 mtm180 -81.33 132.54 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.382 0.611 . . . . 19.33 109.569 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.01 -39.15 59.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.245 1.818 . . . . 14.93 112.475 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.32 7.48 66.46 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.8 -0.636 . . . . 14.82 114.182 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' A' ' 26' ' ' ARG . 74.8 m -68.2 119.16 12.32 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.815 0.817 . . . . 14.54 112.302 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 89.6 mtt180 -70.53 157.92 37.03 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.911 -1.495 . . . . 16.75 110.562 176.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -52.27 -48.6 65.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.951 0.405 . . . . 11.99 111.648 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.27 -41.31 84.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.534 0.734 . . . . 14.45 110.584 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HH21 ' A' ' 26' ' ' ARG . 6.3 tp10 -65.66 -45.14 84.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.854 -0.612 . . . . 16.44 110.463 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.4 -35.58 74.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.984 -0.553 . . . . 13.77 110.925 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.73 22.06 1.33 Allowed Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.194 -1.003 . . . . 13.81 112.983 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 167.18 20.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.533 0.682 . . . . 13.04 110.681 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -131.41 152.24 50.83 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 117.403 -1.284 . . . . 15.67 107.57 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -55.98 -40.32 73.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 119.495 1.043 . . . . 15.29 111.923 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.21 -51.11 51.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.732 -0.667 . . . . 16.66 110.405 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.64 -35.6 73.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.923 -0.581 . . . . 14.14 112.226 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.97 -30.09 70.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 12.0 110.336 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.47 78.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.512 -0.767 . . . . 13.97 110.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.54 -43.22 66.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 120.473 -0.491 . . . . 15.69 109.762 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -55.76 -54.67 41.62 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.605 -1.18 . . . . 11.69 110.823 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 56' ' ' ILE . 10.8 tp -62.51 -31.69 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.804 0.335 . . . . 11.16 110.882 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.53 -35.25 75.29 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.386 0.612 . . . . 16.65 109.509 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -70.21 -21.79 62.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.018 -0.537 . . . . 14.15 112.169 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.9 -46.21 92.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.6 -0.889 . . . . 10.8 108.6 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -62.58 -34.59 77.28 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.321 -0.854 . . . . 12.98 110.952 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -79.12 -39.88 32.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.289 -0.414 . . . . 17.52 110.957 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -79.46 -28.09 41.6 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.404 -0.362 . . . . 14.87 111.962 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -107.88 -4.84 17.61 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.439 1.274 . . . . 12.2 114.439 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 44.32 47.64 7.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.863 1.665 . . . . 16.71 112.854 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.0 tp -145.33 151.8 38.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.901 -1.148 . . . . 12.2 107.901 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.86 129.41 34.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.911 -0.774 . . . . 16.06 108.911 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 HD11 ' A' ' 45' ' ' ILE . 2.3 pp -124.97 153.52 71.12 Favored Pre-proline 0 N--CA 1.42 -1.957 0 C-N-CA 122.76 0.424 . . . . 11.39 110.14 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.18 96.35 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.954 1.769 . . . . 12.6 110.983 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.77 66.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.454 0.645 . . . . 12.52 109.849 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.08 -7.99 14.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 114.632 -1.167 . . . . 14.14 111.735 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.7 -35.49 89.87 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 116.017 -0.538 . . . . 10.76 112.184 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -73.68 -28.6 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.973 0.892 . . . . 11.0 109.445 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -85.24 -3.09 58.7 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.184 -0.916 . . . . 16.42 112.197 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -111.04 -73.23 0.69 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 116.356 -0.384 . . . . 13.35 110.705 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -136.82 88.51 18.56 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-O 122.199 1.0 . . . . 12.23 110.106 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 94.1 Cg_endo -80.91 62.41 8.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.828 3.019 . . . . 13.06 114.063 -172.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.71 129.56 43.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.709 -1.96 . . . . 12.95 105.709 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.37 -37.82 74.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.353 -0.385 . . . . 10.92 111.723 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.33 -31.94 72.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.458 0.647 . . . . 14.32 110.215 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.2 45.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.461 0.648 . . . . 10.93 109.5 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' TRP . 58.1 t80 -72.44 -32.65 66.48 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.499 -0.773 . . . . 8.81 111.364 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -65.2 -23.78 67.18 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.008 -0.677 . . . . 9.35 111.017 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -78.13 -33.73 50.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.23 -0.655 . . . . 11.63 109.23 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -50.2 -59.55 3.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.058 . . . . 10.55 110.411 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.58 -34.48 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 CA-C-N 115.742 -0.663 . . . . 8.3 110.666 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.43 -38.24 93.2 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 116.068 -0.514 . . . . 9.58 113.234 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -81.17 -20.46 41.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.226 0.536 . . . . 10.23 110.12 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 73' ' ' TRP . 14.5 mm100 -76.8 -23.37 52.83 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.362 0.601 . . . . 10.43 109.906 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.24 61.53 6.88 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.129 0.966 . . . . 10.97 109.385 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -98.79 122.46 52.9 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 106.611 -1.626 . . . . 13.52 106.611 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.64 65.96 7.43 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.189 1.926 . . . . 12.28 113.109 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.0 m -77.65 72.84 4.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.389 1.09 . . . . 13.44 109.221 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -141.92 -51.75 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.555 -1.202 . . . . 13.27 107.932 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.14 -4.98 59.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.134 -0.939 . . . . 14.48 110.82 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -60.74 113.3 2.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 124.234 1.014 . . . . 14.92 111.121 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.43 60.49 0.61 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.185 -1.043 . . . . 14.25 108.185 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.18 123.94 89.33 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.877 -1.056 . . . . 12.97 110.181 -176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.24 110.11 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 13.4 112.287 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.3 77.27 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 121.842 0.829 . . . . 12.43 112.42 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 51.88 63.34 2.28 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.045 1.338 . . . . 13.45 110.683 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -67.64 -71.1 0.22 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.776 -0.647 . . . . 14.41 110.462 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -93.93 107.62 29.28 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 108.724 -0.843 . . . . 11.68 108.724 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.39 -21.01 17.8 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.764 1.642 . . . . 10.84 111.435 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.17 128.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 115.356 -0.838 . . . . 10.46 109.702 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.16 -7.31 6.52 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.818 -0.628 . . . . 10.58 110.49 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t 166.3 -29.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 105.142 -2.17 . . . . 11.04 105.142 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.88 166.61 17.49 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 103.147 -2.908 . . . . 10.88 103.147 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.66 42.44 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.057 2.505 . . . . 12.46 113.78 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -131.16 151.27 78.6 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 106.918 -1.512 . . . . 13.78 106.918 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.63 58.39 6.94 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.543 2.162 . . . . 11.95 112.775 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.7 110.67 0.45 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.655 -0.978 . . . . 11.48 110.655 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.67 -34.21 40.55 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.844 0.831 . . . . 11.55 109.957 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -85.16 65.6 9.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 122.408 1.099 . . . . 12.59 109.969 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.14 24.85 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.708 -1.59 . . . . 11.24 106.708 172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 107' ' ' ARG . 9.9 p -98.67 85.88 3.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.776 -1.557 . . . . 10.05 108.256 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.61 -56.77 17.57 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.204 -0.907 . . . . 11.22 112.867 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 110' ' ' ILE . 31.3 mm-40 -59.04 -41.66 88.39 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.409 0.623 . . . . 11.38 110.562 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 37.3 ttt180 -66.24 -36.89 84.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.043 -0.981 . . . . 9.65 111.565 -176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.57 -34.51 70.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.877 -0.729 . . . . 10.43 110.851 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 m -62.28 -41.58 98.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.78 -0.822 . . . . 10.21 108.78 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 107' ' ' ARG . 51.7 mt -56.68 -44.52 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.165 -0.925 . . . . 8.13 110.932 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 107' ' ' ARG . 15.1 mm100 -53.97 -30.74 48.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.45 0.7 . . . . 8.46 112.431 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -71.14 -46.75 60.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.468 0.652 . . . . 10.86 110.39 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 96.0 m-85 -74.79 -27.42 60.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.33 0.586 . . . . 11.45 110.258 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -66.03 -42.3 89.8 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.26 -1.015 . . . . 7.62 108.26 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -60.95 -42.18 97.73 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.001 -0.999 . . . . 11.62 109.78 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.89 -20.01 65.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 11.63 112.382 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.4 m -82.63 -46.02 13.79 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.22 -0.659 . . . . 9.14 109.22 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 59.9 tp -63.13 -41.76 99.38 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.554 0.692 . . . . 10.06 109.633 175.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.82 -49.66 76.16 Favored Glycine 0 C--O 1.2 -2.0 0 CA-C-N 114.935 -1.029 . . . . 12.07 112.454 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -63.48 -28.7 70.14 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.004 0.43 . . . . 12.32 111.094 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 147' ' ' GLN . 26.3 tp -61.3 -42.01 97.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.68 -0.691 . . . . 11.77 110.713 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.13 -76.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.128 -0.693 . . . . 13.52 109.128 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -173.7 -46.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.103 2.561 . . . . 16.56 106.662 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.5 tp -168.21 148.7 4.87 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 105.252 -2.129 . . . . 15.74 105.252 175.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 0.9 OUTLIER -95.82 136.07 22.51 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.29 -1.374 . . . . 14.2 107.29 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 125' ' ' ASP . 2.7 Cg_endo -86.54 29.86 0.5 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.239 1.959 . . . . 14.18 112.929 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.78 57.61 0.78 Allowed Glycine 0 C--N 1.309 -0.924 0 N-CA-C 110.376 -1.089 . . . . 14.03 110.376 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.58 -18.27 20.72 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.526 0.679 . . . . 16.37 110.689 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.8 113.97 5.99 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.097 -0.956 . . . . 12.45 110.538 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 75.84 10.26 3.3 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.261 . . . . 14.43 112.247 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.3 m -103.66 25.89 9.21 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.68 0.752 . . . . 14.32 110.019 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.39 88.78 1.98 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.68 -0.771 . . . . 13.75 111.99 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.58 95.58 4.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.946 -0.761 . . . . 12.7 108.946 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -118.37 146.69 44.2 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.658 0.742 . . . . 16.38 111.305 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -62.14 -14.63 39.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.819 1.248 . . . . 13.3 112.396 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -69.15 -33.1 72.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.372 0.606 . . . . 16.25 109.905 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.51 -44.74 5.77 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.416 -0.811 . . . . 15.87 110.372 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.06 -23.21 64.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.993 -0.549 . . . . 13.65 111.2 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.06 16.15 30.43 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.557 -0.747 . . . . 14.16 111.626 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.7 ttm -77.85 -24.09 48.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.74 -1.207 . . . . 15.45 107.74 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.08 139.91 52.25 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.669 -1.975 . . . . 13.63 105.669 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.9 m -80.78 -22.73 39.87 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.435 -0.95 . . . . 13.9 108.435 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.878 1.271 . . . . 13.81 111.976 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.37 88.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.882 -0.599 . . . . 11.48 111.572 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.8 44.26 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.782 -0.723 . . . . 10.35 111.354 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.6 m -53.28 -50.87 63.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.346 0.658 . . . . 12.2 110.938 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 121' ' ' LEU . 46.9 mt-30 -76.49 -34.37 58.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.404 0.89 . . . . 11.86 113.404 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -69.9 -52.42 24.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.398 -0.521 . . . . 9.32 109.614 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.494 ' SD ' ' HA ' ' A' ' 165' ' ' ILE . 33.1 ttm -69.66 -31.62 69.8 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.345 0.498 . . . . 9.5 112.345 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -64.57 -35.0 79.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.45 -0.574 . . . . 13.91 109.45 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.71 85.79 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.218 -1.153 . . . . 9.88 110.218 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 158' ' ' ILE . 85.2 t -58.05 -49.76 80.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 123.748 0.819 . . . . 9.27 110.036 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.3 t -55.98 -49.55 73.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.813 0.845 . . . . 11.46 110.681 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -66.04 -49.6 67.13 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.754 0.279 . . . . 15.04 111.754 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -63.06 -34.59 77.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.302 0.853 . . . . 11.82 113.302 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.441 ' CZ ' HG23 ' A' ' 110' ' ' ILE . 88.5 m-85 -101.06 -3.76 28.67 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.952 0.723 . . . . 11.97 112.952 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t 63.63 34.41 12.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.826 0.85 . . . . 14.24 109.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 152' ' ' VAL . 33.5 pt -107.47 155.66 8.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.635 -0.711 . . . . 12.62 109.492 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -99.42 96.75 7.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.791 0.329 . . . . 16.39 111.87 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -124.73 118.59 26.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -108.0 168.4 9.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.423 0.63 . . . . 14.06 111.154 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.13 -6.78 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.505 1.522 . . . . 12.64 114.751 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.91 -23.46 17.43 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.516 -0.474 . . . . 15.68 109.948 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -103.27 0.52 31.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.786 0.803 . . . . 12.72 109.473 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.494 ' HA ' ' SD ' ' A' ' 149' ' ' MET . 5.9 tt -75.11 -14.41 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.899 -1.046 . . . . 12.16 110.46 -172.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -106.4 6.37 30.32 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.224 -0.898 . . . . 15.08 109.46 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.2 m -87.09 -32.11 20.11 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.796 -0.638 . . . . 14.67 110.092 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.45 74.19 77.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.22 -0.659 . . . . 12.68 109.22 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -94.4 37.22 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.837 2.358 . . . . 14.34 112.115 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 p -140.77 163.2 33.56 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 12.91 109.788 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 49.2 tp -67.21 -55.38 14.3 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.916 0.389 . . . . 9.89 110.518 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -61.27 -44.56 97.03 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.409 -0.814 . . . . 12.5 112.856 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -68.24 -30.66 69.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.754 0.252 . . . . 11.04 110.696 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.59 -45.83 61.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.438 -1.319 . . . . 8.5 107.438 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.87 99.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.605 -0.725 . . . . 7.7 111.243 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 7.0 m-20 -62.94 -33.63 75.76 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.68 0.276 . . . . 10.38 110.679 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 24.7 tp10 -69.22 -57.05 5.86 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.973 -0.558 . . . . 11.97 110.528 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.431 HG22 HD13 ' A' ' 110' ' ' ILE . 7.0 p -59.93 -36.67 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.136 -0.483 . . . . 9.8 111.518 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.93 -38.36 82.16 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.1 0.476 . . . . 10.83 111.19 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 26.6 mmm180 -77.87 -33.26 52.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 13.5 111.481 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 9.7 mmp_? -73.25 -44.5 59.31 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.745 -0.382 . . . . 14.84 111.555 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.18 -51.73 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.22 0.325 . . . . 13.35 111.761 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.395 -0.812 . . . . 13.51 111.284 -177.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 9.6 p . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 108.336 -0.987 . . . . 18.51 108.336 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . -108.85 -23.63 11.65 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.427 0.528 . . . . 16.66 112.427 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.99 -38.85 12.56 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.758 -0.589 . . . . 14.84 110.882 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -94.46 0.58 55.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.016 -0.538 . . . . 14.98 109.932 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 1' ' ' VAL . 8.6 pt-20 -52.09 -35.44 47.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.901 0.704 . . . . 15.79 112.901 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.74 -43.27 99.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.138 0.495 . . . . 12.02 111.046 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.55 81.78 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.099 -0.501 . . . . 11.02 109.872 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -55.58 -52.31 64.2 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.542 0.526 . . . . 16.07 110.094 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -60.48 -45.72 92.73 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.176 -0.92 . . . . 13.93 111.11 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.89 -36.96 78.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.227 -0.442 . . . . 10.71 111.245 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -62.5 -42.65 99.64 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.032 -0.729 . . . . 14.02 109.032 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.65 -49.62 62.0 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.354 -0.839 . . . . 16.29 110.987 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -62.21 -36.01 80.62 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.041 0.386 . . . . 12.91 112.041 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.47 -55.64 19.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.442 -0.947 . . . . 12.77 108.442 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.87 89.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.131 -0.94 . . . . 15.19 112.016 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.6 77.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.895 0.379 . . . . 16.26 111.479 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.497 ' SD ' ' HD1' ' A' ' 44' ' ' TRP . 66.1 mtt -73.76 -21.55 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.677 -0.238 . . . . 15.45 111.511 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.4 mt -109.02 11.96 25.52 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.277 0.473 . . . . 16.16 112.277 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 60.84 40.78 15.41 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.419 1.104 . . . . 20.56 110.06 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 68.1 m -121.93 155.28 35.83 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.694 -0.854 . . . . 16.63 108.694 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.42 131.3 31.39 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.74 -0.467 . . . . 20.19 109.74 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.62 -21.5 62.87 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.918 3.079 . . . . 16.6 116.006 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.39 -6.2 84.15 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 119.939 -1.124 . . . . 17.74 111.967 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.96 21.84 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.223 0.535 . . . . 20.23 110.785 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -106.3 153.4 7.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.79 -1.189 . . . . 15.98 107.79 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -108.22 124.98 51.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.401 0.619 . . . . 19.33 111.085 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -73.0 -21.47 60.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.715 -1.13 . . . . 14.93 111.459 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.92 5.29 79.06 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.303 -0.951 . . . . 14.82 112.906 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB2' HD21 ' A' ' 34' ' ' LEU . 54.2 m -91.68 157.29 17.03 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.521 0.677 . . . . 14.54 110.405 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 22.0 mtp180 -82.49 146.87 29.01 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.988 -1.006 . . . . 16.75 111.347 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -54.64 -43.54 72.39 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 118.52 0.6 . . . . 11.99 112.416 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.11 -31.21 72.3 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.017 -0.538 . . . . 14.45 110.942 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.63 -30.06 46.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.581 0.705 . . . . 16.44 109.266 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 29' ' ' SER . 95.8 mt -72.0 -28.92 63.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.675 -0.693 . . . . 13.77 110.572 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.03 4.4 7.87 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.333 -0.937 . . . . 13.81 112.773 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.3 tt -81.93 131.16 35.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.976 0.417 . . . . 13.04 110.084 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.11 166.42 12.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 117.959 -1.019 . . . . 15.67 109.344 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -55.92 -41.53 74.73 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 119.166 0.894 . . . . 15.29 110.949 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.01 -44.98 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.632 -0.713 . . . . 16.66 110.4 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.14 -38.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.935 -0.575 . . . . 14.14 109.946 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.27 -46.31 86.25 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 123.372 0.669 . . . . 12.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.32 71.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.709 0.766 . . . . 13.97 111.251 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -78.43 -47.91 16.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.328 -0.851 . . . . 15.69 110.931 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HD1' ' SD ' ' A' ' 17' ' ' MET . 7.6 t90 -60.6 -48.81 80.12 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.323 1.449 . . . . 11.69 111.367 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 tp -62.34 -28.41 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.718 0.77 . . . . 11.16 110.519 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.36 -35.05 54.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.211 -0.904 . . . . 16.65 109.637 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -74.29 -31.88 62.67 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.164 -0.471 . . . . 14.15 111.678 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -69.77 -36.79 71.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.603 -0.839 . . . . 10.8 109.412 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.493 ' OD1' HG13 ' A' ' 56' ' ' ILE . 75.1 m-20 -66.73 -27.82 67.92 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.806 0.812 . . . . 12.98 110.417 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.06 -45.54 26.74 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.663 -1.153 . . . . 17.52 110.105 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -70.5 -39.25 74.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.837 0.31 . . . . 14.87 111.837 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.81 -3.9 55.55 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.909 1.077 . . . . 12.2 113.909 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 56.37 47.29 19.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.898 1.332 . . . . 16.71 108.791 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.0 tp -139.0 153.99 48.21 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.46 -1.311 . . . . 12.2 107.46 -173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -114.87 89.17 3.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.874 -0.787 . . . . 16.06 108.874 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' OD1' ' A' ' 49' ' ' ASN . 1.5 pp -76.55 147.9 79.22 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 122.243 -0.286 . . . . 11.39 111.717 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -62.65 122.39 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.637 2.225 . . . . 12.6 110.285 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.65 2.34 4.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.798 1.407 . . . . 12.52 114.798 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.43 5.14 46.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.937 -0.477 . . . . 14.14 110.78 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.63 -66.97 2.47 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.088 -0.505 . . . . 10.76 113.871 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.79 -28.08 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 124.436 1.094 . . . . 11.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -75.66 -39.12 58.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.416 -0.811 . . . . 16.42 110.469 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 92.5 m -82.8 -44.0 16.04 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.012 -0.54 . . . . 13.35 110.954 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -113.74 88.36 13.78 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 123.756 0.822 . . . . 12.23 109.093 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 2.4 Cg_endo -83.56 25.78 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.938 2.425 . . . . 13.06 113.128 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.13 123.69 59.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.614 -1.624 . . . . 12.95 106.614 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.49 -41.32 76.45 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.15 0.98 . . . . 10.92 112.524 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.25 -30.52 71.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.366 0.603 . . . . 14.32 111.081 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.99 -25.01 30.33 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.988 0.423 . . . . 10.93 110.095 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 49.4 t80 -82.58 -31.45 28.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.928 -0.578 . . . . 8.81 110.89 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 p -68.33 -36.97 80.06 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.627 -0.879 . . . . 9.35 108.627 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.6 -41.99 98.28 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.826 -1.079 . . . . 11.63 109.489 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 63.7 t90 -52.68 -56.01 18.56 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.969 1.308 . . . . 10.55 109.587 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.13 -42.33 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 C-N-CA 123.295 0.638 . . . . 8.3 110.675 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.66 -17.03 66.48 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.343 -0.39 . . . . 9.58 113.454 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.5 m -81.23 -30.12 34.27 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.194 -0.669 . . . . 10.23 109.194 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.85 -43.63 11.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.814 -0.63 . . . . 10.43 110.16 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.52 89.04 4.87 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.837 -0.62 . . . . 10.97 109.86 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 93.1 mt-30 -77.32 120.27 80.84 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.045 -0.98 . . . . 13.52 112.606 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -84.79 156.67 11.81 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.981 2.454 . . . . 12.28 109.559 171.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -93.37 100.85 13.1 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.207 -0.597 . . . . 13.44 111.495 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.46 137.94 41.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.821 -1.918 . . . . 13.27 105.821 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.03 65.13 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.142 1.377 . . . . 14.48 114.174 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 p -97.87 27.76 4.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.191 0.995 . . . . 14.92 111.374 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.27 42.34 2.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.746 -1.576 . . . . 14.25 106.746 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -64.03 135.72 96.43 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 114.138 -1.392 . . . . 12.97 109.917 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 49.7 Cg_exo -57.09 137.36 81.52 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.477 2.785 . . . . 13.4 112.009 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t 66.62 99.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 124.951 1.3 . . . . 12.43 111.428 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.56 123.25 19.94 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.829 -0.623 . . . . 13.45 110.056 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -96.98 3.64 51.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.844 0.831 . . . . 14.41 109.654 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.89 114.42 52.26 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-N 114.534 -1.212 . . . . 11.68 108.235 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.68 154.73 39.58 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.586 2.191 . . . . 10.84 112.283 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.46 48.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.955 0.883 . . . . 10.46 110.452 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.37 -14.95 62.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.353 -0.839 . . . . 10.58 111.016 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -81.42 -14.37 57.19 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.256 -0.429 . . . . 11.04 112.107 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.85 23.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 112.733 0.642 . . . . 10.88 112.733 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.22 15.86 1.11 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.002 1.802 . . . . 12.46 113.049 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.683 ' HA ' HE21 ' A' ' 98' ' ' GLN . 0.0 OUTLIER -101.45 111.83 64.29 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 109.59 -0.522 . . . . 13.78 109.59 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.37 112.49 2.36 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.482 2.121 . . . . 11.95 110.057 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.28 39.21 1.61 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.155 -0.778 . . . . 11.48 111.155 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.21 -12.42 40.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.648 0.261 . . . . 11.55 110.894 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 14.5 mm-40 -85.15 170.55 12.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.265 -0.425 . . . . 12.59 110.021 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -3.3 0.64 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.775 2.139 . . . . 11.24 116.775 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 22.0 m 78.56 92.57 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.903 1.281 . . . . 10.05 112.403 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.72 -26.41 50.04 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.994 -1.003 . . . . 11.22 111.382 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.442 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 8.2 tp-100 -63.9 -48.08 78.06 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.267 -1.383 . . . . 11.38 107.267 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 176' ' ' ASP . 31.9 ttm180 -51.9 -45.62 64.25 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 114.138 -1.392 . . . . 9.65 111.544 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 104' ' ' SER . 52.6 mt-10 -61.3 -44.08 97.82 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 111.905 0.335 . . . . 10.43 111.905 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -65.06 -46.57 80.65 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 120.792 0.329 . . . . 10.21 110.318 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.427 HG21 HG11 ' A' ' 178' ' ' VAL . 81.1 mt -64.81 -43.2 96.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.696 -0.684 . . . . 8.13 111.468 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.71 -34.03 72.37 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.496 0.718 . . . . 8.46 111.34 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.73 -30.37 59.22 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.468 -0.493 . . . . 10.86 110.051 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -71.85 -45.92 59.75 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.307 -0.997 . . . . 11.45 108.307 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.84 -40.25 75.73 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.579 -1.192 . . . . 7.62 108.842 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -55.47 -48.73 74.06 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 124.343 1.057 . . . . 11.62 110.601 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -69.31 -38.76 78.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.391 0.615 . . . . 11.63 110.455 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -63.67 -40.45 96.86 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.337 -0.847 . . . . 9.14 110.054 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.11 -38.93 66.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.997 -0.547 . . . . 10.06 109.92 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.93 -27.07 66.36 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-N 115.705 -0.68 . . . . 12.07 112.844 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.23 -29.13 70.24 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.341 0.591 . . . . 12.32 110.041 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.82 -28.93 17.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.988 -0.551 . . . . 11.77 111.067 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.73 -30.14 24.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.91 0.386 . . . . 13.52 110.901 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 74.78 -38.89 0.4 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.545 1.538 . . . . 16.56 111.621 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.23 137.19 52.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.505 -0.924 . . . . 15.74 108.505 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.43 134.77 54.32 Favored Pre-proline 0 CA--C 1.479 -1.755 0 O-C-N 123.688 0.618 . . . . 14.2 109.666 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.35 -26.16 81.21 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.685 2.256 . . . . 14.18 109.911 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.94 -45.96 1.53 Allowed Glycine 0 CA--C 1.493 -1.334 0 CA-C-N 115.175 -0.92 . . . . 14.03 111.84 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -110.31 -48.64 3.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.396 . . . . 16.37 110.324 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp 63.93 -173.08 0.17 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.311 1.044 . . . . 12.45 110.97 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 72.56 -49.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 14.43 111.352 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 m -90.1 114.61 26.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.013 -1.477 . . . . 14.32 107.013 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.18 51.02 3.27 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 108.736 -1.745 . . . . 13.75 108.736 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.02 18.23 17.8 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.081 -0.559 . . . . 12.7 111.334 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.99 83.55 3.68 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.124 -1.065 . . . . 16.38 108.124 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -80.32 -7.12 58.92 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.652 0.739 . . . . 13.3 110.182 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.0 mt -56.46 -24.91 48.78 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.931 1.292 . . . . 16.25 109.368 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.35 -6.13 52.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.944 -1.025 . . . . 15.87 111.799 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.71 9.24 12.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.374 0.607 . . . . 13.65 111.251 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.62 -97.2 2.22 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.944 -0.571 . . . . 14.16 112.562 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.2 ttm -82.05 66.63 7.71 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.945 1.355 . . . . 15.45 110.057 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -92.71 -46.87 7.36 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.819 -1.537 . . . . 13.63 111.996 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 m -60.94 -34.63 75.02 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.186 0.517 . . . . 13.9 111.902 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.43 -52.75 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 13.81 110.568 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.2 t -72.14 -28.34 63.19 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 109.81 -0.441 . . . . 11.48 109.81 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.44 -28.77 73.94 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 116.066 -0.515 . . . . 10.35 111.832 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 162' ' ' ALA . 93.8 m -61.36 -46.97 87.96 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.901 0.382 . . . . 12.2 110.624 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.82 -49.86 71.21 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.447 -0.797 . . . . 11.86 109.608 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.45 ' CZ3' HD11 ' A' ' 171' ' ' LEU . 79.1 t90 -57.76 -49.26 77.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.252 -0.886 . . . . 9.32 111.911 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -47.75 80.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 123.378 0.671 . . . . 9.5 111.255 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -69.68 -35.65 75.31 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.744 -0.382 . . . . 13.91 111.603 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.15 -47.58 79.65 Favored Glycine 0 C--O 1.244 0.756 0 C-N-CA 120.798 -0.715 . . . . 9.88 112.148 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.24 -41.17 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 111.839 0.311 . . . . 9.27 111.839 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 158' ' ' ILE . 36.1 p -62.82 -37.88 88.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 111.543 0.201 . . . . 11.46 111.543 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.51 -25.18 65.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 15.04 111.113 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -78.82 -31.54 45.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.919 0.39 . . . . 11.82 110.284 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -94.97 5.69 51.19 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.375 0.607 . . . . 11.97 110.761 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.4 m 57.62 41.04 26.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.901 1.281 . . . . 14.24 111.58 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 153' ' ' SER . 17.8 pt -131.11 156.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.703 -0.681 . . . . 12.62 109.517 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -102.12 108.63 20.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.291 -0.263 . . . . 16.39 110.291 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 3.7 mm? -125.87 124.96 42.03 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.612 -0.267 . . . . 12.32 110.804 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.48 143.54 28.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.772 -0.825 . . . . 14.06 108.772 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 146' ' ' THR . . . -70.84 -12.03 61.31 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.345 0.593 . . . . 12.64 112.134 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.51 -12.84 61.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.465 -0.789 . . . . 15.68 109.99 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.71 -15.83 63.79 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.435 -0.802 . . . . 12.72 112.334 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 162' ' ' ALA . 24.5 pt -71.75 -4.66 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.777 0.799 . . . . 12.16 110.605 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -110.06 0.83 18.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.571 -0.74 . . . . 15.08 109.498 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.5 m -96.02 -23.27 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.802 -0.814 . . . . 14.67 108.802 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 169' ' ' PRO . 4.9 m-90 -124.53 138.33 30.93 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.264 -1.013 . . . . 12.68 108.264 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 168' ' ' TRP . 11.5 Cg_exo -72.68 -15.06 27.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.86 2.374 . . . . 14.34 112.389 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.1 p -137.39 143.77 42.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.003 -0.74 . . . . 12.91 109.003 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ3' ' A' ' 148' ' ' TRP . 32.4 tp -69.22 -25.16 64.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 9.89 110.979 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.37 -19.64 62.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 12.5 111.634 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.585 ' HA ' ' OD2' ' A' ' 176' ' ' ASP . 16.7 m -71.1 -12.09 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.044 -0.525 . . . . 11.04 112.137 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -64.86 -42.15 95.1 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.298 -1.001 . . . . 8.5 108.298 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 178' ' ' VAL . . . -65.68 -23.42 66.77 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.475 -0.784 . . . . 7.7 110.979 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 173' ' ' SER . 63.4 m-20 -79.39 -25.84 42.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.971 0.415 . . . . 10.38 111.165 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.36 -33.37 16.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.53 0.681 . . . . 11.97 109.463 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 175' ' ' ALA . 7.2 p -53.66 -34.15 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 114.746 1.387 . . . . 9.8 114.746 -170.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 106' ' ' GLN . 7.9 m-20 -57.85 -50.46 73.22 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.217 0.532 . . . . 10.83 109.799 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -71.95 -24.53 61.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.356 -0.838 . . . . 13.5 111.334 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -84.75 -46.26 11.58 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.082 -0.508 . . . . 14.84 111.199 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.5 t -80.67 -41.17 19.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 112.348 0.499 . . . . 13.35 112.348 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 119.156 -0.45 . . . . 13.51 109.812 -179.055 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.752 -0.833 . . . . 18.51 108.752 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.12 -174.5 3.29 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 105.302 -2.11 . . . . 16.66 105.302 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.001 0.905 . . . . 14.84 109.818 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.17 31.81 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.38 -1.282 . . . . 14.98 110.948 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -28.79 70.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.884 -0.598 . . . . 15.79 110.479 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 31.6 m -61.5 -53.7 53.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.305 -0.862 . . . . 12.02 109.877 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.28 -43.08 92.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.286 -0.416 . . . . 11.02 111.3 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -57.12 -50.79 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.405 0.441 . . . . 16.07 111.689 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -63.86 -39.2 93.64 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.956 0.407 . . . . 13.93 111.221 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 88.7 mt -68.02 -40.88 82.84 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.218 -0.447 . . . . 10.71 111.167 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -67.39 -40.22 85.65 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.796 -0.446 . . . . 14.02 109.796 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.78 -54.79 42.2 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.051 0.94 . . . . 16.29 111.506 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 p -65.3 -44.42 87.99 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.994 -0.548 . . . . 12.91 111.951 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.07 -44.63 91.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.934 -0.575 . . . . 12.77 110.815 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.58 97.42 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.562 -0.29 . . . . 15.19 110.698 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.23 -49.08 79.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.96 0.41 . . . . 16.26 111.175 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 ptp -68.6 -26.74 65.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.487 0.551 . . . . 15.45 112.487 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.73 6.5 48.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.795 0.331 . . . . 16.16 111.661 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 59.92 43.13 15.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.403 1.081 . . . . 20.56 111.051 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.1 m -129.94 171.82 12.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 16.63 109.698 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -108.37 135.27 19.99 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.802 -0.814 . . . . 20.19 108.802 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.69 -11.87 33.58 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.007 2.472 . . . . 16.6 112.934 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.22 -14.24 60.68 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.626 -0.59 . . . . 17.74 111.626 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -96.78 -43.78 7.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.123 -0.633 . . . . 20.23 112.138 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.96 138.5 21.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 119.469 -0.892 . . . . 15.98 109.567 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' HG2' ' OG ' ' A' ' 29' ' ' SER . 4.8 ptm180 -95.1 163.57 13.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.822 0.82 . . . . 19.33 112.785 -165.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' HG11 ' A' ' 66' ' ' VAL . 17.5 t70 -64.38 -10.88 27.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.564 1.546 . . . . 14.93 111.499 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.57 6.37 29.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.689 -0.687 . . . . 14.82 113.04 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.507 ' OG ' ' HG2' ' A' ' 26' ' ' ARG . 71.4 m -70.64 119.01 14.16 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 117.928 0.864 . . . . 14.54 111.793 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -87.97 149.3 24.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.543 -0.753 . . . . 16.75 111.375 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -48.37 -42.29 31.21 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.245 0.618 . . . . 11.99 112.402 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.33 -37.89 68.02 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.676 -1.147 . . . . 14.45 111.748 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.22 -7.51 41.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.076 0.465 . . . . 16.44 111.427 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.07 -16.77 34.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.434 0.635 . . . . 13.77 110.309 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.39 27.72 47.02 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.269 -0.878 . . . . 13.81 111.592 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.83 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.955 -1.128 . . . . 13.04 107.955 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD2' HG22 ' A' ' 39' ' ' VAL . 18.1 t70 -129.87 168.02 17.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 117.866 -1.064 . . . . 15.67 108.548 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 t -56.57 -44.56 81.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.745 0.702 . . . . 15.29 109.981 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.445 HG22 ' OD2' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -58.15 -55.2 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.61 0.719 . . . . 16.66 112.311 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.78 -45.91 87.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.394 -1.275 . . . . 14.14 110.546 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.95 91.56 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.845 -0.616 . . . . 12.0 110.847 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.64 78.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.399 0.68 . . . . 13.97 111.479 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.21 -47.36 65.02 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.187 0.518 . . . . 15.69 111.126 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -64.48 -49.15 72.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.723 1.209 . . . . 11.69 112.338 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 48' ' ' ILE . 11.3 tp -61.41 -36.93 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.063 0.459 . . . . 11.16 110.503 -176.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -73.64 -26.16 60.64 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.292 -0.413 . . . . 16.65 111.92 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -69.62 -36.69 76.39 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.937 -1.134 . . . . 14.15 107.937 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 45' ' ' ILE . 77.0 mt -60.42 -49.58 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.116 -0.947 . . . . 10.8 109.348 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.416 HD21 ' CD1' ' A' ' 56' ' ' ILE . 19.1 m120 -59.84 -37.54 79.54 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.369 0.604 . . . . 12.98 111.153 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -67.29 -58.66 4.41 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.63 1.572 . . . . 17.52 111.665 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -85.35 -27.57 25.78 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.796 -0.762 . . . . 14.87 112.869 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -94.36 -0.93 54.55 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.577 -0.849 . . . . 12.2 112.857 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 44.29 43.56 6.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.056 1.342 . . . . 16.71 112.42 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -117.75 125.83 51.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.124 -0.943 . . . . 12.2 109.124 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -87.73 96.4 10.43 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.536 0.522 . . . . 16.06 110.063 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CD1' HD21 ' A' ' 49' ' ' ASN . 2.4 pp -124.88 153.66 70.82 Favored Pre-proline 0 N--CA 1.426 -1.635 0 O-C-N 121.992 -0.442 . . . . 11.39 110.179 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.43 127.28 17.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.123 1.882 . . . . 12.6 109.867 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.85 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.956 0.903 . . . . 12.52 112.522 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -85.91 -5.47 59.23 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.97 0.414 . . . . 14.14 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.1 -13.17 64.08 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.918 -0.583 . . . . 10.76 112.716 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 tt -58.63 -29.61 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 C-N-CA 123.433 0.693 . . . . 11.0 110.865 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.39 0.8 35.78 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.666 0.617 . . . . 16.42 112.666 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -71.83 -25.89 62.16 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.993 0.901 . . . . 13.35 109.499 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -123.16 100.26 39.68 Favored Pre-proline 0 C--O 1.209 -1.056 0 N-CA-C 106.496 -1.668 . . . . 12.23 106.496 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.14 -1.63 7.46 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.859 2.373 . . . . 13.06 113.819 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 27' ' ' ASP . 60.3 t -116.45 120.23 64.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.502 -1.295 . . . . 12.95 107.502 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -54.25 -41.99 69.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.679 1.192 . . . . 10.92 113.067 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -74.1 -29.56 61.91 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 116.621 -0.263 . . . . 14.32 111.543 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.49 -29.58 46.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 10.93 110.598 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -56.39 -23.98 41.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.936 0.895 . . . . 8.81 113.369 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 p -56.25 -23.58 37.08 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 113.053 0.76 . . . . 9.35 113.053 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 76' ' ' THR . 54.5 tp60 -53.04 -35.88 59.95 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 123.672 0.608 . . . . 11.63 110.332 176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -52.79 -58.76 5.81 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 123.724 0.64 . . . . 10.55 111.402 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 84.7 t -68.23 -45.8 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 CA-C-N 115.282 -0.872 . . . . 8.3 110.394 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.77 -46.88 81.62 Favored Glycine 0 CA--C 1.518 0.262 0 O-C-N 123.744 0.652 . . . . 9.58 113.543 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 72' ' ' GLN . 14.5 t -79.79 -16.81 54.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 120.321 -0.551 . . . . 10.23 111.488 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -90.63 -13.65 33.92 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 119.708 -0.797 . . . . 10.43 111.593 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 96.8 mt -70.85 -46.76 62.11 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.367 -1.346 . . . . 10.97 107.367 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -160.55 132.08 4.02 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.747 -1.946 . . . . 13.52 105.747 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.59 -43.91 6.23 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 124.047 3.165 . . . . 12.28 113.058 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.4 p 50.02 64.52 1.75 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.861 1.264 . . . . 13.44 113.792 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -95.61 77.55 3.31 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.599 -0.889 . . . . 13.27 108.599 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 -12.28 29.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.794 -0.639 . . . . 14.48 110.077 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -82.2 80.26 8.46 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.845 0.831 . . . . 14.92 109.612 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 130.54 42.67 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.223 -0.898 . . . . 14.25 109.417 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.02 87.7 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.347 -0.983 . . . . 12.97 108.347 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.93 52.72 2.25 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.356 2.704 . . . . 13.4 112.462 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 p -157.94 113.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.28 -0.873 . . . . 12.43 109.145 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.72 14.33 14.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.039 -0.528 . . . . 13.45 111.902 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -155.51 176.74 12.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.06 -1.089 . . . . 14.41 108.06 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.04 135.49 24.62 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 107.464 -1.31 . . . . 11.68 107.464 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 111.04 0.69 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 121.987 1.791 . . . . 10.84 108.325 173.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t 69.42 79.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.563 -1.273 . . . . 10.46 107.563 -170.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.96 98.46 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.266 -0.879 . . . . 10.58 110.74 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 p -83.78 90.05 7.27 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.94 -0.573 . . . . 11.04 109.458 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.37 111.64 3.23 Favored Pre-proline 0 C--N 1.296 -1.724 0 CA-C-N 115.616 -0.72 . . . . 10.88 110.143 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.47 36.02 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.719 2.28 . . . . 12.46 111.96 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -118.4 116.55 35.22 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.729 -0.669 . . . . 13.78 109.237 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.6 110.72 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.227 2.618 . . . . 11.95 111.753 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.46 10.9 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.922 -0.656 . . . . 11.48 112.242 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -25.13 61.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.974 0.361 . . . . 11.55 111.974 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.69 -26.55 25.87 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 12.59 109.807 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -58.31 3.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.841 -0.618 . . . . 11.24 110.661 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.3 t -146.59 110.53 4.98 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.059 -0.719 . . . . 10.05 109.059 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -35.81 73.95 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.859 -1.064 . . . . 11.22 113.329 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -60.0 -25.78 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.117 0.414 . . . . 11.38 112.117 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.412 ' HE ' ' CB ' ' A' ' 179' ' ' ASP . 17.8 ttt180 -72.37 -48.54 40.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.919 0.39 . . . . 9.65 110.712 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -65.87 -28.18 68.77 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.524 0.678 . . . . 10.43 110.05 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -64.32 -29.58 70.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.155 -0.93 . . . . 10.21 111.646 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 178' ' ' VAL . 56.1 mt -81.28 -33.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.725 -0.843 . . . . 8.13 108.725 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.05 -53.82 53.8 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.759 -1.109 . . . . 8.46 109.985 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -68.38 -35.56 77.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.333 -0.547 . . . . 10.86 111.114 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.97 -46.57 88.99 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.249 0.343 . . . . 11.45 110.308 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.11 -49.71 76.21 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.959 -0.564 . . . . 7.62 110.31 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.88 -47.39 85.08 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.681 0.613 . . . . 11.62 111.002 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.81 -34.58 73.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 11.63 112.063 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.0 m -68.76 -28.97 67.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.824 0.345 . . . . 9.14 110.589 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.5 -44.71 67.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.756 -0.461 . . . . 10.06 109.756 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.36 98.13 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.297 -0.721 . . . . 12.07 111.297 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -51.35 -42.19 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.369 1.467 . . . . 12.32 110.535 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD21 ' HB ' ' A' ' 144' ' ' THR . 37.5 tp -84.63 -34.3 23.12 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.967 -1.015 . . . . 11.77 110.918 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 tp -73.18 -29.29 62.73 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 113.014 0.746 . . . . 13.52 113.014 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 66.1 13.08 8.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.03 0.932 . . . . 16.56 110.741 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.4 171.34 8.4 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.185 -1.783 . . . . 15.74 106.185 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.89 130.2 91.78 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 109.83 -0.433 . . . . 14.2 109.83 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -69.55 0.73 5.07 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.551 2.168 . . . . 14.18 112.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.87 7.23 57.27 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.402 -0.679 . . . . 14.03 111.402 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -75.3 -16.86 60.39 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.172 0.51 . . . . 16.37 110.372 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.6 165.31 18.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.584 0.707 . . . . 12.45 111.723 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -88.14 77.23 8.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.24 -0.891 . . . . 14.43 109.823 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m 70.91 -48.58 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.814 1.646 . . . . 14.32 111.395 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.12 0.06 OUTLIER Glycine 0 C--N 1.308 -0.99 0 N-CA-C 108.704 -1.758 . . . . 13.75 108.704 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -154.32 93.03 1.56 Allowed 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.499 -0.413 . . . . 12.7 111.902 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 136' ' ' LEU . 28.5 tt0 -168.86 132.35 1.4 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 109.632 -0.507 . . . . 16.38 109.632 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -81.35 -7.46 59.58 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.835 1.05 . . . . 13.3 113.835 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.512 ' H ' ' HG2' ' A' ' 134' ' ' GLN . 83.6 mt -80.15 -35.73 36.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 16.25 112.069 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -37.46 21.24 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.48 0.919 . . . . 15.87 113.48 -173.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.77 -17.54 6.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.243 1.571 . . . . 13.65 115.243 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.36 143.61 4.89 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.226 -0.988 . . . . 14.16 112.289 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -99.49 -7.27 26.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.032 0.444 . . . . 15.45 109.958 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -150.09 149.22 29.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.552 0.691 . . . . 13.63 110.858 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 m -51.45 -34.99 37.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.699 1.999 . . . . 13.9 114.284 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 66.3 t -57.5 -47.93 84.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 112.461 0.541 . . . . 13.81 112.461 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.495 ' HB ' HD21 ' A' ' 121' ' ' LEU . 19.6 p -67.35 -35.54 79.57 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.469 -0.332 . . . . 11.48 110.858 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.01 -47.04 56.88 Favored Glycine 0 C--O 1.219 -0.834 0 N-CA-C 111.285 -0.726 . . . . 10.35 111.285 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 85.9 m -58.25 -46.76 85.39 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.533 0.333 . . . . 12.2 111.009 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -63.32 -38.15 90.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.259 0.552 . . . . 11.86 111.14 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.474 ' HB2' HD22 ' A' ' 121' ' ' LEU . 21.8 t90 -67.59 -46.42 72.65 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.477 0.711 . . . . 9.32 110.251 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -49.59 71.2 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.669 0.388 . . . . 9.5 111.192 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 146' ' ' THR . 77.8 mtp180 -58.7 -40.99 85.26 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.641 0.588 . . . . 13.91 110.731 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.07 -44.67 96.94 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.93 -0.577 . . . . 9.88 112.657 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.03 -41.93 84.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-O 121.286 0.565 . . . . 9.27 109.522 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.6 t -59.0 -49.54 77.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.928 -1.033 . . . . 11.46 111.51 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -70.94 -20.87 62.41 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.914 0.388 . . . . 15.04 111.832 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.94 -51.21 7.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.432 -0.507 . . . . 11.82 110.472 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -94.03 -2.05 53.55 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.303 0.853 . . . . 11.97 113.303 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.2 m 62.79 38.99 11.25 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.956 0.884 . . . . 14.24 111.267 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.7 pt -113.66 158.57 13.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.769 -1.105 . . . . 12.62 109.063 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.3 106.04 18.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.728 -0.842 . . . . 16.39 108.728 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 160' ' ' LEU . 45.2 mt -121.93 112.32 18.16 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.709 0.766 . . . . 12.32 111.76 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.57 152.06 43.28 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.825 -1.534 . . . . 14.06 108.921 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.87 -13.09 62.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.916 0.865 . . . . 12.64 109.989 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.97 -8.04 45.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.508 1.523 . . . . 15.68 111.804 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.735 ' HA ' ' CZ3' ' A' ' 168' ' ' TRP . . . -59.89 -0.61 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.959 1.837 . . . . 12.72 115.959 -173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 33.2 pt -96.09 2.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 122.002 -0.436 . . . . 12.16 111.558 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -94.15 -76.18 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.813 1.042 . . . . 15.08 113.813 -174.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.417 HG22 ' CZ3' ' A' ' 168' ' ' TRP . 3.5 t -78.64 12.64 1.96 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.3 0.571 . . . . 14.67 111.238 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.735 ' CZ3' ' HA ' ' A' ' 164' ' ' ALA . 18.1 m-90 -120.12 90.68 44.88 Favored Pre-proline 0 N--CA 1.412 -2.363 0 N-CA-C 105.676 -1.972 . . . . 12.68 105.676 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.2 -28.42 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.456 2.104 . . . . 14.34 113.496 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 p -126.06 174.28 8.58 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.526 -0.546 . . . . 12.91 109.526 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.09 -22.09 49.5 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.096 0.951 . . . . 9.89 108.548 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -64.14 -34.42 78.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.807 -1.542 . . . . 12.5 110.477 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -62.23 -45.23 94.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.957 -0.565 . . . . 11.04 110.101 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -70.33 -39.67 74.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.167 -0.47 . . . . 8.5 110.14 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.03 71.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.121 0.486 . . . . 7.7 111.431 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.88 -30.11 40.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.022 0.439 . . . . 10.38 110.212 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -81.84 -37.35 27.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.955 -0.566 . . . . 11.97 112.314 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 110' ' ' ILE . 7.3 p -56.28 -43.73 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.886 0.374 . . . . 9.8 111.203 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.412 ' CB ' ' HE ' ' A' ' 107' ' ' ARG . 30.2 t70 -72.35 -28.12 62.83 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 121.149 0.5 . . . . 10.83 110.729 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -68.41 -26.69 65.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.474 -0.936 . . . . 13.5 108.474 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -83.98 -48.63 9.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.923 -1.035 . . . . 14.84 110.0 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 86.6 t -70.06 -43.53 79.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 N-CA-C 112.511 0.56 . . . . 13.35 112.511 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.028 -0.73 . . . . 13.51 109.028 -176.529 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 3' ' ' ASP . 1.6 p . . . . . 0 CA--C 1.556 1.196 0 N-CA-C 110.186 -0.302 . . . . 18.51 110.186 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.0 10.98 8.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.584 1.154 . . . . 16.66 113.414 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' H ' HG13 ' A' ' 1' ' ' VAL . 57.5 m-20 -102.02 22.45 13.08 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 116.477 -0.329 . . . . 14.84 111.092 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 30.1 t70 66.7 20.95 10.67 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.644 0.735 . . . . 14.98 110.045 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.04 -40.19 94.42 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.982 -0.554 . . . . 15.79 111.578 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 57.6 m -60.9 -43.88 97.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.009 -0.541 . . . . 12.02 110.872 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.93 92.83 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 110.09 -0.337 . . . . 11.02 110.09 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 4' ' ' ASP . 24.7 mt-30 -57.77 -52.99 63.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.168 0.508 . . . . 16.07 110.696 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.98 -46.59 86.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.508 -0.769 . . . . 13.93 111.381 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' CYS . 63.0 mt -65.84 -35.46 80.74 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.756 0.65 . . . . 10.71 112.756 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtm-85 -62.91 -46.48 87.6 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 120.881 -0.328 . . . . 14.02 110.217 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.09 -41.21 95.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 16.29 110.983 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -58.31 -59.72 4.89 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.206 1.002 . . . . 12.91 111.592 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 17' ' ' MET . 42.3 tp -69.67 -41.63 75.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.471 . . . . 12.77 111.448 -175.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.285 0.476 . . . . 15.19 112.285 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.87 88.96 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.732 -0.387 . . . . 16.26 110.874 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 19.9 ptp -75.06 -31.12 61.19 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.268 -0.423 . . . . 15.45 111.76 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.37 -11.5 37.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.903 0.858 . . . . 16.16 110.934 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.2 t80 64.2 48.62 2.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.968 1.707 . . . . 20.56 109.886 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 15' ' ' ALA . 21.3 p -119.84 174.82 6.21 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.374 -1.343 . . . . 16.63 107.374 176.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.33 129.91 35.54 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 112.121 0.415 . . . . 20.19 112.121 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.5 -18.91 33.22 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 123.414 2.742 . . . . 16.6 113.418 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.29 -36.34 7.6 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.318 -1.113 . . . . 17.74 110.318 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -87.45 70.95 9.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.022 -0.732 . . . . 20.23 109.022 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -140.74 151.79 20.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.943 -1.132 . . . . 15.98 107.943 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -114.4 131.33 56.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.804 -0.813 . . . . 19.33 108.804 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 9.3 p-10 -77.12 -21.89 53.54 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.701 0.401 . . . . 14.93 111.48 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.78 5.88 79.59 Favored Glycine 0 C--N 1.312 -0.8 0 N-CA-C 111.025 -0.83 . . . . 14.82 111.025 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -72.33 137.94 46.98 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.261 0.553 . . . . 14.54 109.724 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 49.3 mtp180 -82.55 142.85 31.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.692 -1.225 . . . . 16.75 107.692 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -57.19 -16.47 8.15 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.424 0.898 . . . . 11.99 113.424 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 mt -70.06 -34.6 73.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.972 -0.751 . . . . 14.45 108.972 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -77.42 -24.8 50.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.002 -0.999 . . . . 16.44 109.131 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.0 mt -74.69 -37.22 62.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.855 -0.794 . . . . 13.77 108.855 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.6 26.21 30.61 Favored Glycine 0 CA--C 1.493 -1.288 0 CA-C-N 115.124 -0.944 . . . . 13.81 114.488 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.5 pt? -85.68 126.37 33.9 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.565 -0.854 . . . . 13.04 110.903 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.83 161.09 27.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.177 -0.919 . . . . 15.67 110.5 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 t -54.36 -36.59 64.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.191 0.451 . . . . 15.29 111.026 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 40' ' ' ILE . 1.4 m -54.54 -56.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.419 0.525 . . . . 16.66 112.419 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' H ' HG23 ' A' ' 39' ' ' VAL . 56.2 mt -59.35 -41.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.32 -0.855 . . . . 14.14 110.571 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.94 88.73 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.019 -0.537 . . . . 12.0 110.756 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.43 82.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.469 0.652 . . . . 13.97 110.697 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -67.39 -51.68 49.0 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.618 -0.719 . . . . 15.69 111.259 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -64.64 -45.16 88.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.165 0.986 . . . . 11.69 111.453 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 48' ' ' ILE . 10.5 tp -62.5 -35.38 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.5 . . . . 11.16 111.357 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -81.38 -20.27 40.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.732 -0.787 . . . . 16.65 111.546 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -78.36 -31.55 48.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.657 -0.817 . . . . 14.15 111.758 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 45' ' ' ILE . 22.5 pt -67.22 -31.39 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.473 -0.891 . . . . 10.8 108.715 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 56' ' ' ILE . 11.0 m120 -62.14 -42.18 99.0 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 115.196 -0.911 . . . . 12.98 110.422 174.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.33 -47.37 17.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.664 -0.698 . . . . 17.52 110.452 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -66.74 -34.54 78.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.852 -0.613 . . . . 14.87 111.764 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 69.1 m-85 -101.55 -12.2 18.67 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.626 1.343 . . . . 12.2 114.626 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 57.94 45.85 17.53 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.132 0.968 . . . . 16.71 108.922 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.0 tp -123.37 149.15 45.3 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.879 -1.055 . . . . 12.2 110.719 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -99.64 109.46 21.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.381 -0.97 . . . . 16.06 108.381 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.525 HG22 ' HG3' ' A' ' 77' ' ' GLN . 2.5 pp -124.36 149.63 61.79 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 118.185 0.448 . . . . 11.39 110.765 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.12 105.01 1.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.703 1.602 . . . . 12.6 109.039 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.98 -24.72 25.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.062 1.345 . . . . 12.52 113.145 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.81 -3.26 30.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.428 -0.351 . . . . 14.14 111.453 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.18 -49.3 31.05 Favored Glycine 0 C--O 1.204 -1.756 0 O-C-N 123.656 0.597 . . . . 10.76 113.342 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.53 -31.01 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 11.0 112.209 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.7 -40.11 12.75 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.068 0.396 . . . . 16.42 112.068 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -80.36 -35.59 35.21 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.374 0.607 . . . . 13.35 110.457 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -121.64 76.7 36.85 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 124.185 0.994 . . . . 12.23 108.737 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 4.1 Cg_exo -81.09 37.8 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.165 2.576 . . . . 13.06 113.878 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.53 124.78 60.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.837 -1.542 . . . . 12.95 106.837 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -55.08 -40.36 70.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.167 0.987 . . . . 10.92 113.33 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.4 tttt -64.8 -42.14 95.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 14.32 110.287 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.82 81.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.685 -0.688 . . . . 10.93 110.576 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -71.38 -35.63 71.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.928 0.344 . . . . 8.81 111.928 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 p -65.32 -26.48 68.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.626 -0.83 . . . . 9.35 110.935 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 16.3 mm-40 -77.26 -39.45 48.21 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.022 -0.535 . . . . 11.63 110.051 172.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -62.58 -30.79 71.59 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.54 0.736 . . . . 10.55 111.918 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.75 -44.11 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.207 -0.664 . . . . 8.3 109.207 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.28 -27.03 73.43 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.417 -0.81 . . . . 9.58 113.991 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -72.9 -16.48 61.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.313 0.557 . . . . 10.23 110.991 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 56' ' ' ILE . 15.1 mm100 -83.21 -23.58 32.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.109 -0.701 . . . . 10.43 109.109 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.83 92.63 1.61 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.097 -0.956 . . . . 10.97 110.301 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -116.47 87.59 21.16 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 107.798 -1.186 . . . . 13.52 107.798 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.93 -22.77 26.28 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.105 2.537 . . . . 12.28 112.995 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -87.8 67.08 9.03 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.001 0.905 . . . . 13.44 109.806 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -88.09 -166.77 1.68 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.957 -1.019 . . . . 13.27 108.787 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.25 -50.06 43.58 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.648 -0.871 . . . . 14.48 108.648 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.2 m -86.44 76.19 9.66 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.284 -0.871 . . . . 14.92 109.459 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -136.38 72.28 1.43 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.473 -0.785 . . . . 14.25 109.45 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . . . -87.77 123.39 69.28 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.097 -0.501 . . . . 12.97 110.422 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 86' ' ' ALA . 3.1 Cg_exo -78.46 38.63 0.72 Allowed 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 123.005 2.47 . . . . 13.4 111.315 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.5 17.35 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 122.625 1.202 . . . . 12.43 108.446 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 66.88 9.54 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.781 -1.192 . . . . 13.45 107.781 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -108.59 1.66 21.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.744 -1.116 . . . . 14.41 110.594 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.9 132.94 44.43 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 114.945 -1.025 . . . . 11.68 108.508 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -63.03 127.73 21.09 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.992 1.795 . . . . 10.84 109.633 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.36 136.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.598 -0.728 . . . . 10.46 111.472 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.9 -18.74 36.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.929 . . . . 10.58 108.973 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -86.79 146.58 26.18 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 114.959 -1.019 . . . . 11.04 109.502 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.81 92.16 46.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-O 120.484 0.183 . . . . 10.88 110.612 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.98 -25.29 52.06 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.721 2.28 . . . . 12.46 110.17 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -116.6 85.38 16.61 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 115.049 -0.978 . . . . 13.78 109.088 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -70.5 -12.4 31.43 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.662 2.242 . . . . 11.95 111.176 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.56 43.09 1.63 Allowed Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 110.403 -1.079 . . . . 11.48 110.403 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.58 -37.07 85.61 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.115 -0.698 . . . . 11.55 109.115 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.8 64.74 8.78 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.937 -1.135 . . . . 12.59 107.937 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.36 -61.76 1.5 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.341 0.591 . . . . 11.24 109.804 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 11.3 p -128.89 41.23 3.52 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.755 1.264 . . . . 10.05 108.0 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.84 -24.19 59.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.816 -1.538 . . . . 11.22 110.099 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -66.3 -45.68 79.52 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.822 -1.177 . . . . 11.38 107.822 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 104' ' ' SER . 48.0 ttp180 -51.99 -53.01 46.58 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 124.148 0.905 . . . . 9.65 110.219 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.53 -48.27 79.76 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.716 0.635 . . . . 10.43 111.843 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.2 t -60.63 -50.33 73.95 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 10.21 110.971 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 178' ' ' VAL . 97.2 mt -62.45 -39.54 84.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 CA-C-N 116.469 -0.332 . . . . 8.13 110.929 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -47.48 -42.19 22.27 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 124.742 1.217 . . . . 8.46 112.105 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.0 -29.82 66.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.022 0.439 . . . . 10.86 112.022 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.09 -36.76 16.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.283 0.563 . . . . 11.45 110.186 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.76 -37.36 86.14 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 108.224 -1.028 . . . . 7.62 108.224 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 126' ' ' PRO . 83.6 tttt -51.03 -44.66 61.08 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.248 1.419 . . . . 11.62 110.349 175.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.69 -44.98 80.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.453 -0.794 . . . . 11.63 110.379 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -66.81 -48.3 69.39 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.557 -0.747 . . . . 9.14 110.968 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 119' ' ' GLY . 4.4 pp -71.38 -34.62 70.58 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.43 0.157 . . . . 10.06 111.147 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 118' ' ' LEU . . . -65.41 -42.64 95.84 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.491 -0.644 . . . . 12.07 111.491 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.17 -44.72 96.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.919 0.866 . . . . 12.32 109.733 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.52 -45.77 78.4 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.509 -1.223 . . . . 11.77 110.956 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.0 tp -76.86 -19.06 57.93 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.518 -0.764 . . . . 13.52 111.073 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.1 t80 62.45 31.71 17.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.862 1.665 . . . . 16.56 109.738 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 125' ' ' ASP . 1.3 tm? -120.27 146.43 46.09 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 105.268 -2.123 . . . . 15.74 105.268 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 16.8 t70 -61.43 122.2 68.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.634 0.584 . . . . 14.2 110.308 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 15.2 Cg_exo -69.98 6.51 1.36 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.057 2.504 . . . . 14.18 114.787 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.89 1.26 55.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.186 -1.566 . . . . 14.03 109.186 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -125.01 36.8 4.53 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.801 1.286 . . . . 16.37 107.822 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.19 124.04 21.99 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.265 -1.334 . . . . 12.45 110.34 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -63.38 146.32 53.79 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.389 -0.967 . . . . 14.43 108.389 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.5 t -58.3 -61.89 2.24 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 118.765 0.711 . . . . 14.32 111.548 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.12 -57.17 2.71 Favored Glycine 0 C--O 1.247 0.942 0 N-CA-C 110.162 -1.175 . . . . 13.75 110.162 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . 71.07 114.57 0.05 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.248 1.419 . . . . 12.7 112.578 176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.82 116.23 6.78 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.542 -0.754 . . . . 16.38 109.555 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.516 ' O ' HD22 ' A' ' 138' ' ' LEU . 17.1 t80 -56.59 -40.07 74.61 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 124.932 1.293 . . . . 13.3 110.961 -177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.0 -2.4 43.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.47 0.915 . . . . 16.25 113.47 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.2 -14.41 61.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.555 0.693 . . . . 15.87 109.993 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -64.77 -14.15 57.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.276 -0.875 . . . . 13.65 112.869 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.81 150.31 6.13 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 111.295 -0.722 . . . . 14.16 111.295 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.71 -31.49 65.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.806 -0.812 . . . . 15.45 108.806 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.82 125.46 27.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 114.729 -1.123 . . . . 13.63 109.048 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -62.72 -22.39 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.579 0.549 . . . . 13.9 110.296 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.443 ' HA ' ' OG1' ' A' ' 146' ' ' THR . 61.8 t -58.02 -34.18 48.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.157 -0.929 . . . . 13.81 111.513 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.4 p -59.96 -44.27 94.52 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.445 0.641 . . . . 11.48 110.748 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . . . -83.42 -35.53 16.98 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.231 -0.895 . . . . 10.35 113.006 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 143' ' ' VAL . 39.7 p -66.95 -30.19 70.25 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 117.506 0.653 . . . . 12.2 110.373 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -62.74 -47.64 82.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.676 0.791 . . . . 11.86 108.872 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.11 -42.83 99.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.605 -0.725 . . . . 9.32 110.497 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 162' ' ' ALA . 24.4 mmt -61.76 -37.51 84.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.607 0.718 . . . . 9.5 109.915 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -69.64 -36.96 76.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.376 -0.829 . . . . 13.91 110.321 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.89 -51.65 38.67 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.671 -0.572 . . . . 9.88 111.671 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.51 -44.05 84.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.289 0.636 . . . . 9.27 111.657 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -60.89 -40.82 94.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.924 0.342 . . . . 11.46 111.924 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -68.41 -47.08 68.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.884 0.373 . . . . 15.04 110.491 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -54.71 -40.08 68.84 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.414 1.086 . . . . 11.82 111.999 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.73 -1.17 26.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.191 0.811 . . . . 11.97 113.191 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t 60.36 47.24 9.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.672 0.789 . . . . 14.24 110.308 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.09 168.83 18.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.527 -0.916 . . . . 12.62 108.527 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -108.08 97.25 6.97 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.44 0.638 . . . . 16.39 109.41 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.6 tp -103.13 123.66 47.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.046 -1.094 . . . . 12.32 108.046 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.73 134.29 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.142 -0.688 . . . . 14.06 109.142 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 149' ' ' MET . . . -75.92 -16.64 59.99 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.204 0.526 . . . . 12.64 111.116 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.37 -6.29 59.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.717 -0.674 . . . . 15.68 111.118 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.11 -10.69 32.68 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.327 -0.397 . . . . 12.72 111.677 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.57 -15.76 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.762 0.791 . . . . 12.16 110.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -103.85 14.15 31.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.469 -0.787 . . . . 15.08 109.099 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 32.5 m -110.69 -38.31 5.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.474 -0.785 . . . . 14.67 111.269 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -105.97 123.77 38.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.682 -0.407 . . . . 12.68 110.465 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.68 -27.84 4.66 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.972 1.781 . . . . 14.34 111.484 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -105.7 142.53 35.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.995 0.903 . . . . 12.91 111.504 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.14 -37.91 81.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.752 -1.567 . . . . 9.89 112.433 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.34 -18.97 63.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.929 0.714 . . . . 12.5 112.929 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 -17.77 64.86 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.139 0.792 . . . . 11.04 113.139 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.3 tp -70.11 -32.21 70.13 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.087 0.47 . . . . 8.5 110.261 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.49 75.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.467 0.651 . . . . 7.7 109.742 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.83 -21.79 60.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.557 -0.747 . . . . 10.38 110.579 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 9.6 tp10 -80.51 -56.8 3.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.994 -0.548 . . . . 11.97 109.752 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 110' ' ' ILE . 10.6 p -55.4 -34.03 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 112.443 0.535 . . . . 9.8 112.443 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 107' ' ' ARG . 15.9 t70 -55.31 -43.01 74.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.996 0.918 . . . . 10.83 110.459 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -83.56 -34.23 25.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.276 -0.874 . . . . 13.5 111.273 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mmm180 -60.7 -58.5 8.19 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.119 -0.491 . . . . 14.84 111.259 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.37 -40.51 56.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.255 -0.578 . . . . 13.35 109.451 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 117.64 -1.171 . . . . 13.51 109.853 178.545 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 5' ' ' GLU . 56.9 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 110.742 -0.096 . . . . 18.51 110.742 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . 179.76 -174.0 0.23 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.514 -0.921 . . . . 16.66 108.514 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.29 -33.23 73.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.044 0.926 . . . . 14.84 108.804 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -67.46 -8.59 34.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.684 -1.144 . . . . 14.98 113.866 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 2' ' ' ALA . 12.8 pt-20 -67.02 -27.38 67.37 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.942 -0.703 . . . . 15.79 110.343 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' HA ' ' OH ' ' A' ' 52' ' ' TYR . 35.0 m -70.55 -48.73 54.0 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.943 -0.571 . . . . 12.02 109.823 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.67 78.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.084 0.469 . . . . 11.02 110.832 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 29.0 tt0 -67.67 -45.88 73.96 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.028 -0.533 . . . . 16.07 110.255 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -66.51 -37.76 85.75 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.072 0.463 . . . . 13.93 110.716 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 -35.49 74.73 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.388 0.514 . . . . 10.71 112.388 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 12.4 ptp180 -69.44 -29.18 66.83 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 119.135 -1.026 . . . . 14.02 109.575 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -67.35 -48.77 66.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.028 -0.533 . . . . 16.29 109.673 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -62.74 -34.56 77.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.408 -0.814 . . . . 12.91 112.377 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.48 -53.15 31.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.358 0.599 . . . . 12.77 110.299 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -64.9 -29.72 70.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.953 -1.022 . . . . 15.19 112.214 -176.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.08 98.47 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.952 0.406 . . . . 16.26 110.652 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.4 mmt -78.81 -39.51 35.49 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.337 -0.392 . . . . 15.45 112.043 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 mp -90.36 5.69 46.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.749 0.309 . . . . 16.16 111.785 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 54.71 36.88 27.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.421 1.488 . . . . 20.56 112.556 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 42.4 t -95.89 175.71 6.39 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.377 -1.342 . . . . 16.63 107.377 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.19 115.93 65.19 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.196 -0.668 . . . . 20.19 109.196 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.91 42.93 1.41 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 123.378 2.719 . . . . 16.6 113.218 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.37 -95.86 1.09 Allowed Glycine 0 C--N 1.288 -2.137 0 CA-C-N 114.769 -1.105 . . . . 17.74 111.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.85 66.22 1.53 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.033 0.445 . . . . 20.23 110.231 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 pt -68.42 147.58 12.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.249 -0.432 . . . . 15.98 110.026 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.42 114.12 3.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.064 -0.971 . . . . 19.33 111.002 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.7 m-20 -66.77 -24.76 66.24 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.728 0.811 . . . . 14.93 110.988 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.11 2.33 87.14 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.835 -0.698 . . . . 14.82 113.148 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -73.33 140.49 46.75 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.062 0.458 . . . . 14.54 111.76 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 73.1 ttt180 -76.23 142.04 41.56 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 104.394 -2.447 . . . . 16.75 104.394 166.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 71.3 m-85 -54.68 -25.58 27.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.111 1.152 . . . . 11.99 114.111 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.23 -38.71 92.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.043 0.449 . . . . 14.45 109.832 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.78 -24.28 60.92 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.177 -0.675 . . . . 16.44 109.177 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.19 -15.8 54.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.624 -0.716 . . . . 13.77 110.536 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.26 5.03 53.13 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.999 -0.619 . . . . 13.81 112.749 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 41' ' ' ALA . 7.1 tt -80.1 140.38 36.46 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.553 -0.536 . . . . 13.04 109.553 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 26.0 t70 -120.98 163.41 18.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 118.184 -0.912 . . . . 15.67 108.837 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 m -57.46 -39.98 77.51 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 118.834 0.743 . . . . 15.29 111.389 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.93 -46.15 85.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 16.66 109.492 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 52.6 mt -60.82 -34.96 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.313 -0.858 . . . . 14.14 110.723 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.78 -47.27 85.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.417 0.687 . . . . 12.0 111.432 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.71 72.29 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 123.556 0.535 . . . . 13.97 111.148 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -79.07 -49.93 11.87 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.868 -0.606 . . . . 15.69 111.329 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.408 ' CZ3' HD11 ' A' ' 48' ' ' ILE . 7.4 t90 -60.96 -39.34 89.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.4 0.68 . . . . 11.69 112.062 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.3 -28.1 44.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 CA-C-O 121.132 0.491 . . . . 11.16 110.613 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -71.43 -32.03 67.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.982 0.42 . . . . 16.65 109.996 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -69.73 -34.39 73.79 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.84 0.828 . . . . 14.15 108.891 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.408 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 75.6 mt -69.92 -51.88 36.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 114.907 -1.042 . . . . 10.8 109.766 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.23 -28.22 62.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.799 0.84 . . . . 12.98 112.037 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -71.47 -50.78 28.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.531 0.681 . . . . 17.52 109.953 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -70.09 -51.84 28.54 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.71 -1.132 . . . . 14.87 113.303 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' A' ' 6' ' ' CYS . 79.9 m-85 -88.47 -6.67 57.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.869 0.692 . . . . 12.2 112.869 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 55.86 36.08 26.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.58 1.152 . . . . 16.71 112.209 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.68 147.25 32.21 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.958 -1.127 . . . . 12.2 107.958 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -91.22 77.34 5.95 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.762 -0.829 . . . . 16.06 108.762 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.35 128.38 30.56 Favored Pre-proline 0 N--CA 1.426 -1.674 0 C-N-CA 120.36 -0.536 . . . . 11.39 111.485 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.55 154.79 27.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.468 2.112 . . . . 12.6 108.956 171.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.31 20.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.464 0.706 . . . . 12.52 110.83 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 63' ' ' THR . 7.2 m-20 -62.43 -21.25 65.27 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.798 -1.092 . . . . 14.14 112.885 176.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.18 -41.33 92.71 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 119.409 -1.377 . . . . 10.76 111.632 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.55 -19.78 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.488 0.661 . . . . 11.0 110.23 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.74 -38.79 17.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 16.42 111.129 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 59' ' ' ASP . 8.5 t -77.66 -41.77 37.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.518 -0.473 . . . . 13.35 110.461 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -119.73 92.35 46.26 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-O 121.378 0.609 . . . . 12.23 109.872 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 44.8 Cg_endo -93.7 17.15 1.09 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.126 2.551 . . . . 13.06 113.93 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.95 137.94 45.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.08 -1.081 . . . . 12.95 108.08 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.28 -49.08 73.01 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 113.176 0.806 . . . . 10.92 113.176 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 13.9 tppt? -64.8 -35.05 79.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.317 0.58 . . . . 14.32 110.389 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.43 75.7 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.853 -0.612 . . . . 10.93 110.866 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 66.1 t80 -74.84 -31.97 61.8 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.379 0.609 . . . . 8.81 111.428 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -70.31 -29.18 65.84 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.409 -0.917 . . . . 9.35 110.584 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -75.01 -25.71 59.0 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.569 -0.53 . . . . 11.63 109.569 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 5.6 t90 -61.33 -54.76 39.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.139 -1.43 . . . . 10.55 107.139 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.18 -32.33 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 CA-C-N 115.009 -0.996 . . . . 8.3 109.544 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 -12.97 60.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.864 -0.607 . . . . 9.58 112.388 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.8 m -85.24 -31.28 23.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.627 -0.879 . . . . 10.23 108.627 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -81.18 -44.35 17.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.284 -1.006 . . . . 10.43 108.284 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 81.74 8.73 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.587 -1.264 . . . . 10.97 107.587 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.21 127.23 89.29 Favored Pre-proline 0 C--O 1.246 0.899 0 CA-C-N 114.809 -1.087 . . . . 13.52 111.94 -175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.93 108.68 2.36 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.796 2.331 . . . . 12.28 110.586 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -95.89 125.16 40.25 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.492 0.663 . . . . 13.44 111.08 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -98.93 115.46 28.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.576 -1.268 . . . . 13.27 107.576 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.24 -38.15 15.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.469 0.176 . . . . 14.48 111.293 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -74.9 134.31 41.63 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.188 -0.46 . . . . 14.92 109.873 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.52 96.71 2.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.502 -0.555 . . . . 14.25 109.502 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.11 93.34 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.678 -0.692 . . . . 12.97 109.336 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.93 87.55 0.1 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.121 2.547 . . . . 13.4 112.133 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.55 127.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.863 -0.791 . . . . 12.43 108.863 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -99.99 175.71 5.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.765 -0.457 . . . . 13.45 109.765 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 61.38 53.24 3.5 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.245 1.021 . . . . 14.41 110.431 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.86 130.45 86.85 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 114.513 -1.222 . . . . 11.68 108.104 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.12 107.4 0.65 Allowed 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.475 2.117 . . . . 10.84 110.911 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.4 122.75 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.515 0.674 . . . . 10.46 110.834 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.56 54.86 0.88 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.809 -0.812 . . . . 10.58 108.809 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 p -70.32 -44.28 68.59 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.838 -1.073 . . . . 11.04 111.538 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.22 97.51 47.55 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.841 -0.618 . . . . 10.88 109.988 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.34 -45.24 9.91 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.482 2.121 . . . . 12.46 109.872 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 16.4 mm100 -120.51 118.48 30.94 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 107.551 -1.277 . . . . 13.78 107.551 174.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 98' ' ' GLN . 17.3 Cg_exo -69.59 44.79 0.41 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.649 2.899 . . . . 11.95 114.163 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.54 2.64 83.02 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 121.14 -0.552 . . . . 11.48 111.945 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.56 -9.48 58.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.17 0.51 . . . . 11.55 110.203 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.36 126.22 30.9 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.346 -0.983 . . . . 12.59 108.346 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.15 99.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.475 -1.239 . . . . 11.24 111.29 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m 55.9 99.09 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.936 0.773 . . . . 10.05 112.126 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.84 -39.69 39.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.393 1.077 . . . . 11.22 112.581 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.1 tp-100 -62.57 -54.61 37.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.58 -0.526 . . . . 11.38 109.58 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -58.07 -41.29 83.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.942 0.897 . . . . 9.65 111.232 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -48.29 78.1 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.849 -0.614 . . . . 10.43 110.614 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.6 t -59.61 -37.7 79.28 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 123.699 0.624 . . . . 10.21 109.776 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 106' ' ' GLN . 53.2 mt -58.61 -44.83 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 115.265 -0.879 . . . . 8.13 110.721 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.41 -38.21 86.29 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.152 0.282 . . . . 8.46 111.517 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.2 -45.75 79.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.527 0.203 . . . . 10.86 110.554 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -71.52 -27.56 63.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.108 -0.637 . . . . 11.45 111.498 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.19 -48.0 83.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.188 -1.041 . . . . 7.62 108.188 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -56.63 -51.89 66.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.453 -1.703 . . . . 11.62 110.712 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -64.92 -39.98 94.36 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.711 0.634 . . . . 11.63 112.711 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 p -67.97 -33.13 74.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.156 0.428 . . . . 9.14 112.156 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -43.0 33.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.492 -0.883 . . . . 10.06 109.204 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.32 82.12 Favored Glycine 0 C--O 1.22 -0.775 0 CA-C-N 115.78 -0.645 . . . . 12.07 112.601 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.14 -28.63 68.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.526 0.679 . . . . 12.32 110.471 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.21 -43.06 10.07 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 11.77 110.127 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.48 -27.07 62.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.448 -0.796 . . . . 13.52 111.789 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 t80 80.27 -36.36 0.14 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.907 1.683 . . . . 16.56 110.742 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.77 172.35 13.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 15.74 110.816 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.83 139.02 76.66 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.988 0.423 . . . . 14.2 111.686 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.17 42.81 0.41 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.997 2.465 . . . . 14.18 111.128 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -101.2 -10.46 42.03 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 115.497 -0.774 . . . . 14.03 111.636 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.64 -13.77 41.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.192 0.52 . . . . 16.37 110.593 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.2 -169.45 2.07 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.124 -0.489 . . . . 12.45 112.119 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 79.68 113.96 0.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.12 1.368 . . . . 14.43 109.797 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 m 61.64 39.17 14.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.361 1.077 . . . . 14.32 109.062 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.69 70.23 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.65 0 CA-C-N 113.704 -1.589 . . . . 13.75 110.624 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.85 -40.91 46.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.954 0.883 . . . . 12.7 110.247 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 64.03 31.75 13.36 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 113.242 -1.799 . . . . 16.38 112.973 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.75 -18.8 63.2 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.266 0.555 . . . . 13.3 110.788 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 136' ' ' LEU . 2.0 mm? -68.53 -25.39 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.685 -0.689 . . . . 16.25 109.512 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.33 -29.4 10.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.497 -0.774 . . . . 15.87 111.088 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.66 -27.58 58.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.963 0.411 . . . . 13.65 110.725 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -114.82 100.66 1.01 Allowed Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 110.192 -1.163 . . . . 14.16 110.192 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptp -94.2 -15.29 24.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.094 0.473 . . . . 15.45 110.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -122.74 138.26 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.295 -1.002 . . . . 13.63 108.295 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.5 t -59.36 -16.79 24.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.542 1.137 . . . . 13.9 113.878 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.35 -36.52 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.21 0.529 . . . . 13.81 110.73 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 p -58.81 -44.61 90.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.677 -1.147 . . . . 11.48 112.032 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.96 -46.41 28.94 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.783 -0.722 . . . . 10.35 111.904 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 m -58.71 -52.94 63.55 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 122.859 0.463 . . . . 12.2 110.733 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.09 -44.17 97.77 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-N 115.629 -0.714 . . . . 11.86 110.965 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 152' ' ' VAL . 22.1 t90 -67.18 -49.64 63.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.898 -0.592 . . . . 9.32 111.511 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 164' ' ' ALA . 38.0 ttm -64.7 -33.81 76.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.78 0.659 . . . . 9.5 112.78 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -66.31 -38.18 87.11 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.861 -0.736 . . . . 13.91 109.965 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.33 -39.1 95.71 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.862 -0.895 . . . . 9.88 110.862 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 148' ' ' TRP . 78.2 t -58.43 -46.97 89.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 123.598 0.759 . . . . 9.27 109.468 174.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.9 m -61.49 -40.43 94.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 11.46 110.135 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -71.36 -53.27 14.72 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.756 -0.656 . . . . 15.04 111.558 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -66.61 -42.62 86.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.798 0.295 . . . . 11.82 111.798 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HD1' ' O ' ' A' ' 152' ' ' VAL . 96.7 m-85 -82.37 -8.9 59.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.048 0.451 . . . . 11.97 110.552 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.9 m 61.46 29.84 18.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.645 1.178 . . . . 14.24 111.588 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 178' ' ' VAL . 28.4 pt -103.64 150.14 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 12.62 109.057 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -89.02 94.92 10.12 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.537 -1.283 . . . . 16.39 107.537 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.61 120.64 42.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.512 -0.767 . . . . 12.32 109.182 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 134.58 57.18 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.929 -1.032 . . . . 14.06 110.932 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 165' ' ' ILE . . . -69.27 -20.36 63.92 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.67 -0.696 . . . . 12.64 110.715 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.75 -16.87 64.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.966 -0.561 . . . . 15.68 110.348 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.47 ' HA ' ' OG1' ' A' ' 167' ' ' THR . . . -65.71 -14.71 61.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.983 -0.553 . . . . 12.72 112.056 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 162' ' ' ALA . 31.7 pt -68.88 -22.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.521 0.676 . . . . 12.16 109.57 175.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -102.64 -15.52 16.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.661 -0.699 . . . . 15.08 109.157 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 164' ' ' ALA . 25.9 m -77.16 -46.6 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.819 -0.808 . . . . 14.67 108.819 177.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.46 90.24 0.92 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-O 121.298 0.571 . . . . 12.68 112.425 -176.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.28 41.9 1.23 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.654 2.236 . . . . 14.34 111.191 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 p -123.07 142.89 50.38 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-O 122.361 1.077 . . . . 12.91 111.061 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.01 -43.19 93.32 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 113.535 -1.666 . . . . 9.89 110.958 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.74 -37.2 86.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.058 -0.974 . . . . 12.5 111.106 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 m -79.29 -33.0 43.7 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.809 -0.632 . . . . 11.04 110.561 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.05 -43.61 91.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.661 -1.237 . . . . 8.5 107.661 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.66 78.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.698 -0.683 . . . . 7.7 110.907 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -29.97 68.51 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.716 -0.675 . . . . 10.38 110.381 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -78.81 -58.0 3.47 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.65 -0.704 . . . . 11.97 111.696 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 110' ' ' ILE . 6.7 p -56.91 -43.75 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.432 0.53 . . . . 9.8 112.432 -175.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.29 -44.67 95.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.143 0.496 . . . . 10.83 110.143 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -72.21 -30.87 65.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.014 -0.994 . . . . 13.5 110.983 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.14 -44.02 85.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.334 -0.617 . . . . 14.84 109.334 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.35 -52.86 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.848 -0.615 . . . . 13.35 110.186 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.308 -1.198 0 N-CA-C 112.432 0.53 . . . . 13.51 112.432 -177.717 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 108.978 -0.749 . . . . 18.51 108.978 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.71 30.73 1.48 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.752 0.787 . . . . 16.66 109.074 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -91.4 -83.68 0.27 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.963 -1.017 . . . . 14.84 111.715 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -109.42 14.42 23.63 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.334 0.588 . . . . 14.98 111.223 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.37 80.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.709 -0.678 . . . . 15.79 111.952 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 p -57.12 -36.04 70.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.517 -0.765 . . . . 12.02 111.445 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.94 76.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.364 -0.606 . . . . 11.02 109.364 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.24 -50.86 72.4 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.591 -0.732 . . . . 16.07 110.57 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -53.94 -47.07 71.65 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.762 0.825 . . . . 13.93 111.954 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -71.68 -36.38 70.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.381 -0.372 . . . . 10.71 111.253 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -67.21 -43.12 82.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.478 0.711 . . . . 14.02 109.841 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -58.59 -45.3 89.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.41 1.084 . . . . 16.29 110.128 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -70.26 -32.88 70.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.263 -0.88 . . . . 12.91 110.761 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.9 -56.66 10.63 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.603 -1.258 . . . . 12.77 107.603 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -61.13 -36.28 79.33 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.727 -1.124 . . . . 15.19 112.154 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.33 86.99 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.178 0.513 . . . . 16.26 111.405 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.6 mmm -78.01 -38.46 44.78 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.95 -0.568 . . . . 15.45 112.072 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.58 -1.86 58.29 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.422 0.63 . . . . 16.16 112.054 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.0 t80 60.61 56.62 2.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.24 1.416 . . . . 20.56 109.959 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 47.6 t -124.57 166.91 15.24 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.778 -1.564 . . . . 16.63 106.778 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -108.93 119.22 49.57 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-O 121.042 0.448 . . . . 20.19 110.346 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 -23.94 67.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.625 2.883 . . . . 16.6 115.091 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.33 -16.62 71.5 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.036 -0.602 . . . . 17.74 113.391 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -127.16 16.85 7.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.785 0.293 . . . . 20.23 111.043 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.33 139.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 109.709 -0.478 . . . . 15.98 109.709 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' NH2' ' HG2' ' A' ' 183' ' ' GLN . 40.5 ttm180 -78.14 96.71 5.24 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.168 -1.049 . . . . 19.33 108.168 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . 11.5 p-10 -67.26 -14.7 63.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.686 -0.688 . . . . 14.93 112.135 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.88 5.85 66.67 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.751 -0.738 . . . . 14.82 112.081 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.6 t -87.51 161.44 17.79 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.623 0.725 . . . . 14.54 109.932 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -101.91 142.88 32.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.129 -0.942 . . . . 16.75 112.72 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -42.71 -60.88 1.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.293 1.437 . . . . 11.99 113.848 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.59 -29.86 70.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 14.45 111.879 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -79.38 -13.47 59.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.98 0.419 . . . . 16.44 111.409 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.36 -22.47 44.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.649 0.738 . . . . 13.77 109.195 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 25.28 6.21 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.964 -1.016 . . . . 13.81 111.107 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -74.0 113.47 11.21 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.08 0.467 . . . . 13.04 109.763 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.34 156.23 24.35 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.19 -0.914 . . . . 15.67 110.909 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 t -56.92 -42.32 79.79 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.062 0.458 . . . . 15.29 109.788 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.62 -48.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.494 -0.776 . . . . 16.66 110.92 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.7 mt -66.05 -38.44 82.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.969 -0.56 . . . . 14.14 110.779 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.57 84.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 12.0 110.334 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -64.52 -38.23 90.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 13.97 110.842 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -71.35 -42.4 68.54 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.645 0.736 . . . . 15.69 110.974 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -61.33 -47.81 84.22 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 125.531 1.532 . . . . 11.69 111.462 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 56' ' ' ILE . 11.3 tp -63.61 -34.02 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 120.855 0.36 . . . . 11.16 111.722 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 37.6 mmt180 -63.11 -38.32 90.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.717 0.294 . . . . 16.65 111.037 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.03 -39.74 93.81 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.35 0.595 . . . . 14.15 109.624 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 45' ' ' ILE . 72.9 mt -60.13 -47.66 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.193 -0.912 . . . . 10.8 110.361 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -60.64 -43.2 97.82 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.793 -0.64 . . . . 12.98 111.591 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -72.19 -58.97 2.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.46 -0.791 . . . . 17.52 111.141 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -30.46 69.8 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.012 1.116 . . . . 14.87 114.012 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.22 -2.36 46.32 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 113.095 0.776 . . . . 12.2 113.095 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 59.01 45.28 15.07 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.344 1.057 . . . . 16.71 110.003 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.49 165.77 22.82 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.536 -0.302 . . . . 12.2 110.204 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.83 71.34 0.74 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.586 -0.894 . . . . 16.06 108.586 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 45' ' ' ILE . 34.7 mm -101.31 114.69 65.71 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 116.196 -0.456 . . . . 11.39 110.65 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.79 171.01 16.12 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.346 2.03 . . . . 12.6 110.027 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.33 -1.05 9.35 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.409 0.684 . . . . 12.52 111.699 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.04 -30.62 71.1 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.089 0.956 . . . . 14.14 110.55 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.96 -42.58 98.35 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.299 -0.477 . . . . 10.76 111.993 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.47 -32.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.763 0.792 . . . . 11.0 110.152 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -80.98 -16.5 53.28 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.982 -0.553 . . . . 16.42 111.097 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -83.57 -48.54 10.13 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.1 -0.704 . . . . 13.35 109.1 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.85 118.96 30.25 Favored Pre-proline 0 C--O 1.215 -0.761 0 CA-C-N 116.229 -0.441 . . . . 12.23 111.324 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.52 -3.99 7.5 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.768 2.312 . . . . 13.06 112.577 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.97 119.58 59.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.99 -1.485 . . . . 12.95 106.99 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 27' ' ' ASP . 43.2 p90 -62.12 -33.54 74.66 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 112.884 0.698 . . . . 10.92 112.884 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -62.72 -38.17 89.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.368 0.604 . . . . 14.32 110.827 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.7 -23.86 36.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.72 0.771 . . . . 10.93 109.649 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 73' ' ' TRP . 80.9 t80 -81.05 -30.13 34.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 8.81 111.874 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 p -67.61 -33.32 74.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.43 -0.794 . . . . 9.35 109.098 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.99 -29.85 64.64 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.253 -0.885 . . . . 11.63 109.543 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.543 ' HB3' ' O ' ' A' ' 70' ' ' PHE . 82.4 t90 -59.62 -44.34 93.47 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.154 0.982 . . . . 10.55 108.847 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.4 t -76.65 -45.42 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 C-N-CA 123.629 0.772 . . . . 8.3 110.306 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.98 75.63 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 116.162 -0.472 . . . . 9.58 113.569 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -77.18 -22.11 52.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.277 0.561 . . . . 10.23 110.661 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -82.55 -2.64 54.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.342 0.592 . . . . 10.43 111.141 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.6 mt -93.3 105.63 17.69 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 104.946 -2.242 . . . . 10.97 104.946 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -52.1 115.3 6.54 Favored Pre-proline 0 C--O 1.248 1.002 0 O-C-N 123.765 0.666 . . . . 13.52 112.356 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.91 104.13 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.973 2.448 . . . . 12.28 111.166 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.6 m -95.16 115.19 27.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.812 -0.81 . . . . 13.44 108.812 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -79.93 58.83 3.0 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.598 0.713 . . . . 13.27 111.407 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.66 -3.31 58.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.071 0.939 . . . . 14.48 108.776 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.6 t -148.85 138.66 22.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.164 -1.421 . . . . 14.92 107.164 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 111.18 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.647 -0.501 . . . . 14.25 109.647 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.69 122.67 56.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.934 -0.576 . . . . 12.97 110.404 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.45 11.57 2.63 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.751 2.301 . . . . 13.4 112.053 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.15 56.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.694 1.597 . . . . 12.43 110.957 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -115.51 42.1 2.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.93 0.871 . . . . 13.45 110.65 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -110.87 41.88 1.72 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.814 -1.18 . . . . 14.41 107.814 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 33.9 tt0 -74.92 117.67 64.47 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 113.953 -1.476 . . . . 11.68 109.706 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 12.2 Cg_exo -73.17 158.4 49.1 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.76 2.307 . . . . 10.84 110.771 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.49 137.42 28.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.66 -0.867 . . . . 10.46 108.66 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.84 115.28 27.92 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.657 -1.609 . . . . 10.58 106.657 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 m -81.18 -30.62 34.3 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 120.014 -0.675 . . . . 11.04 109.27 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 107.87 57.0 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.771 -1.196 . . . . 10.88 107.771 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.2 -31.41 55.32 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.707 2.938 . . . . 12.46 112.716 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -77.44 119.95 79.51 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.114 -0.699 . . . . 13.78 109.114 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.61 57.13 6.38 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.676 2.251 . . . . 11.95 111.818 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 142.72 13.37 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.79 -0.924 . . . . 11.48 110.79 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.62 12.61 27.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.896 0.379 . . . . 11.55 111.924 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.02 78.18 5.47 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.131 0.491 . . . . 12.59 110.304 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.38 -24.87 42.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.63 0.729 . . . . 11.24 110.36 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.9 m 57.56 34.42 24.54 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 113.922 -1.49 . . . . 10.05 111.537 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.26 73.3 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.276 -0.875 . . . . 11.22 111.782 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -72.55 -51.36 20.19 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.161 -0.472 . . . . 11.38 110.261 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -49.94 -51.42 41.32 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.705 0.628 . . . . 9.65 110.897 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 104' ' ' SER . 5.9 mm-40 -63.86 -47.99 78.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 10.43 111.721 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.4 m -66.74 -43.53 83.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.182 -0.463 . . . . 10.21 111.765 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 178' ' ' VAL . 73.3 mt -71.91 -23.64 22.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.0 0 N-CA-C 110.014 -0.365 . . . . 8.13 110.014 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -64.73 -41.84 95.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.232 -0.655 . . . . 8.46 109.232 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.58 -38.98 84.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.15 0.5 . . . . 10.86 109.947 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.17 -49.62 76.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.985 -1.007 . . . . 11.45 109.503 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -50.0 -43.67 50.64 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.135 1.374 . . . . 7.62 112.015 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -60.4 -45.29 94.11 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.817 -1.083 . . . . 11.62 109.715 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -82.0 -22.93 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.61 0.719 . . . . 11.63 110.516 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -73.74 -55.1 6.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.269 -0.878 . . . . 9.14 110.39 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.64 -29.25 33.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.566 -0.531 . . . . 10.06 109.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.2 -19.97 62.36 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.884 -0.487 . . . . 12.07 111.884 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.41 -23.88 61.15 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.449 0.7 . . . . 12.32 109.617 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.53 -23.47 19.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.879 -0.6 . . . . 11.77 110.434 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.91 -26.89 23.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.876 -0.416 . . . . 13.52 109.876 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 73.92 -35.11 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.207 1.403 . . . . 16.56 112.76 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.93 129.92 40.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.087 -1.449 . . . . 15.74 107.087 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -119.45 117.22 33.1 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.839 -0.619 . . . . 14.2 109.642 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -88.02 4.64 5.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.968 2.446 . . . . 14.18 112.816 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.83 -78.79 0.02 OUTLIER Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.779 -1.201 . . . . 14.03 113.106 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 177.88 24.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.336 0.654 . . . . 16.37 109.912 -174.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 130' ' ' ARG . 6.3 mp 47.66 -158.19 0.05 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.251 0.62 . . . . 12.45 111.327 -169.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 36.6 mtm-85 76.95 -38.06 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.714 1.206 . . . . 14.43 112.511 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.6 p -69.59 -46.1 67.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.938 -1.134 . . . . 14.32 107.938 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 138' ' ' LEU . . . -100.9 89.37 0.8 Allowed Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 107.588 -2.205 . . . . 13.75 107.588 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.58 -14.03 10.87 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 111.545 0.202 . . . . 12.7 111.545 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.99 133.04 47.62 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.824 0.821 . . . . 16.38 110.313 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -65.67 -20.05 66.14 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.829 -1.078 . . . . 13.3 110.035 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.94 -24.9 68.09 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.906 -1.043 . . . . 16.25 111.676 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.13 -34.7 8.31 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.05 -0.66 . . . . 15.87 110.949 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 132' ' ' GLY . 35.3 mt -91.83 -27.17 18.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.638 -0.71 . . . . 13.65 112.721 -171.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -106.96 78.85 0.25 Allowed Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.428 -0.892 . . . . 14.16 113.892 -174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 50.2 tpp -80.87 -40.63 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.157 -1.053 . . . . 15.45 108.157 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -99.59 113.27 25.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.159 -0.928 . . . . 13.63 109.0 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.6 t -72.67 -38.45 67.6 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.244 -0.889 . . . . 13.9 110.449 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.89 -32.05 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.326 0.584 . . . . 13.81 112.02 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.1 t -77.55 -27.15 51.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.104 -1.038 . . . . 11.48 109.726 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.79 -28.58 34.59 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.092 -1.051 . . . . 10.35 111.166 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.549 ' HB ' ' HB1' ' A' ' 162' ' ' ALA . 16.9 p -66.94 -43.24 83.72 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 109.217 -0.66 . . . . 12.2 109.217 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -56.8 -49.75 74.4 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.135 -0.939 . . . . 11.86 109.21 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -55.29 -53.06 60.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.199 -0.91 . . . . 9.32 112.203 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 4.1 tpt -56.94 -48.84 77.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.436 0.694 . . . . 9.5 110.844 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -64.33 -36.13 83.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.267 -0.424 . . . . 13.91 110.872 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.69 97.64 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.814 -0.515 . . . . 9.88 111.814 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.44 -43.27 98.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.805 -0.442 . . . . 9.27 109.805 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.0 t -59.62 -46.41 89.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.435 -0.802 . . . . 11.46 109.428 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.55 -48.99 78.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.196 0.998 . . . . 15.04 111.025 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -58.53 -27.61 64.69 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.62 0.768 . . . . 11.82 112.779 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -107.46 4.71 26.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.779 0.659 . . . . 11.97 112.779 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m 58.29 32.22 21.79 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.77 0.795 . . . . 14.24 111.315 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.6 pt -107.13 165.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.342 -0.984 . . . . 12.62 108.342 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.97 94.5 5.02 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.335 0.588 . . . . 16.39 112.051 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.69 108.72 10.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.175 -1.046 . . . . 12.32 108.175 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.5 154.75 35.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.194 -0.912 . . . . 14.06 109.835 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB1' ' HB ' ' A' ' 146' ' ' THR . . . -63.72 -16.98 62.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.939 -1.028 . . . . 12.64 113.138 -174.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.93 -6.47 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 116.431 -0.35 . . . . 15.68 111.267 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.96 -11.28 46.43 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.138 0.422 . . . . 12.72 112.138 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.8 pt -64.84 -13.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.253 0.549 . . . . 12.16 111.365 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.59 -1.95 16.63 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.205 -0.452 . . . . 15.08 110.289 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.7 m -84.39 -30.61 25.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.014 -0.539 . . . . 14.67 110.589 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -116.93 108.96 43.52 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.271 -1.011 . . . . 12.68 108.271 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -48.73 -37.73 35.83 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.947 3.098 . . . . 14.34 112.846 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.7 p -125.55 141.01 52.26 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.792 -1.188 . . . . 12.91 107.792 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.61 -1.73 47.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.811 0.671 . . . . 9.89 112.811 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -66.5 -26.08 67.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.162 -1.051 . . . . 12.5 108.162 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 18.1 m -76.1 -18.62 59.09 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.237 -1.347 . . . . 11.04 111.752 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.0 tt -60.43 -35.68 76.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.884 0.474 . . . . 8.5 110.286 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.58 -37.64 79.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.142 -0.481 . . . . 7.7 111.567 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.9 -32.6 61.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 10.38 110.349 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 173' ' ' SER . 46.9 mm-40 -70.08 -48.73 56.5 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.619 -0.719 . . . . 11.97 109.998 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 110' ' ' ILE . 12.1 p -66.78 -40.64 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 9.8 111.376 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.99 -37.16 78.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.548 0.689 . . . . 10.83 110.226 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 180' ' ' ARG . 38.6 ttm180 -67.13 -45.85 75.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.982 -1.008 . . . . 13.5 110.106 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -67.99 -48.24 66.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 14.84 111.765 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 90.0 t -64.32 -53.4 43.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 123.48 0.488 . . . . 13.35 109.992 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.468 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 61.7 tt0 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 123.906 0.883 . . . . 13.51 111.62 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 121.222 0.534 . . . . 18.51 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.67 -49.11 28.45 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.671 1.36 . . . . 16.66 114.671 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -80.1 -37.37 33.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.161 0.8 . . . . 14.84 113.161 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.62 -37.05 70.96 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.547 0.689 . . . . 14.98 109.404 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.72 -39.4 91.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.397 -0.819 . . . . 15.79 109.887 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.63 -45.11 89.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.039 -0.726 . . . . 12.02 109.039 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.64 94.54 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.994 -0.548 . . . . 11.02 110.891 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -62.63 -37.54 86.73 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 111.782 0.29 . . . . 16.07 111.782 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.57 -40.49 89.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.53 0.681 . . . . 13.93 110.242 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.57 -33.09 64.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.389 -0.524 . . . . 10.71 111.041 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.26 -50.05 75.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.779 0.432 . . . . 14.02 110.881 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 22' ' ' PRO . 10.2 pt20 -67.26 -23.85 65.74 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.266 -0.425 . . . . 16.29 111.595 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 m -83.23 -49.4 9.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.994 0.426 . . . . 12.91 110.415 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.1 -52.73 62.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.235 0.614 . . . . 12.77 110.512 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.39 -24.88 64.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.395 0.517 . . . . 15.19 112.395 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.56 85.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.878 0.37 . . . . 16.26 110.147 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.6 mtm -74.01 -27.68 61.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.701 -0.681 . . . . 15.45 111.64 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.04 4.29 54.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.306 -0.406 . . . . 16.16 111.84 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 55.23 39.79 31.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.382 1.073 . . . . 20.56 112.272 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -109.24 155.69 20.8 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.603 -1.258 . . . . 16.63 107.603 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.54 118.84 71.22 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 109.308 -0.627 . . . . 20.19 109.308 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 5.6 Cg_exo -72.8 -29.09 12.92 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.395 2.064 . . . . 16.6 114.272 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.79 8.19 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.577 -1.009 . . . . 17.74 110.577 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.49 70.47 8.97 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.268 0.556 . . . . 20.23 111.12 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.62 149.9 13.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.704 -1.221 . . . . 15.98 107.704 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 28' ' ' GLY . 13.8 ttp180 -82.53 126.08 31.85 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 122.319 0.248 . . . . 19.33 110.406 -177.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.43 -23.62 67.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.606 0.762 . . . . 14.93 112.1 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 26' ' ' ARG . . . -96.7 6.76 65.11 Favored Glycine 0 C--N 1.309 -0.929 0 CA-C-N 115.917 -0.583 . . . . 14.82 113.902 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 26' ' ' ARG . 68.8 m -65.14 153.28 41.34 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.932 0.873 . . . . 14.54 112.186 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 8.9 mmm180 -92.15 152.96 19.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.005 -0.998 . . . . 16.75 109.841 -172.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 67' ' ' PHE . 58.2 m-85 -57.79 -50.29 73.76 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 119.367 0.985 . . . . 11.99 112.836 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 36' ' ' LEU . 3.9 mm? -70.14 -9.37 55.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.415 0.626 . . . . 14.45 111.551 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.27 -37.9 12.39 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.084 -0.71 . . . . 16.44 109.084 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 30' ' ' ARG . 96.0 mt -61.31 -33.85 74.27 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.565 0.746 . . . . 13.77 111.234 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.19 9.75 8.53 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.63 -0.988 . . . . 13.81 110.63 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 41' ' ' ALA . 8.3 tt -91.58 137.1 32.64 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.363 -0.977 . . . . 13.04 108.363 177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.486 ' H ' ' HB ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -132.55 166.93 20.95 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.21 1.004 . . . . 15.67 109.117 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -42.84 -54.62 4.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 15.29 113.437 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.59 -40.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.285 0.564 . . . . 16.66 111.411 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 37' ' ' ASP . 67.4 mt -66.41 -36.77 78.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.816 -0.629 . . . . 14.14 110.093 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 36' ' ' LEU . . . -58.02 -45.01 87.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.14 -0.936 . . . . 12.0 110.766 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.35 -36.31 75.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.277 -0.874 . . . . 13.97 110.933 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.33 -41.18 57.31 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.49 -0.777 . . . . 15.69 111.507 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -64.84 -41.11 95.98 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.91 -0.586 . . . . 11.69 110.796 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 41' ' ' ALA . 34.3 mm -55.1 -41.6 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.169 -0.469 . . . . 11.16 110.266 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -58.58 -31.71 68.28 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.526 -0.761 . . . . 16.65 110.622 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -80.02 -46.98 15.64 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.603 -0.271 . . . . 14.15 111.288 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 45' ' ' ILE . 22.6 pt -65.74 -32.1 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.539 -0.464 . . . . 10.8 110.41 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' ND2' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -60.58 -39.34 87.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.238 0.542 . . . . 12.98 110.19 175.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -73.64 -48.71 30.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.948 -1.024 . . . . 17.52 111.743 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.0 -34.37 64.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.872 -0.731 . . . . 14.87 111.822 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -88.87 -6.37 57.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.963 0.727 . . . . 12.2 112.963 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 57.82 41.85 24.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.89 1.276 . . . . 16.71 111.235 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 tp -141.28 136.24 31.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.248 -1.019 . . . . 12.2 108.248 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -84.11 56.0 3.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.833 0.825 . . . . 16.06 109.551 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.545 HG22 ' ND2' ' A' ' 49' ' ' ASN . 10.9 tt -60.24 134.98 90.92 Favored Pre-proline 0 C--O 1.253 1.262 0 CA-C-N 114.139 -1.391 . . . . 11.39 110.2 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 56' ' ' ILE . 4.9 Cg_exo -79.07 162.07 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.582 2.188 . . . . 12.6 111.946 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 45' ' ' ILE . . . -80.56 2.19 26.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.011 -0.995 . . . . 12.52 111.65 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 5.2 m-20 -62.28 -18.26 60.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.961 -0.563 . . . . 14.14 112.37 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' A' ' 70' ' ' PHE . . . -63.84 -39.34 97.3 Favored Glycine 0 C--O 1.213 -1.183 0 C-N-CA 120.412 -0.899 . . . . 10.76 111.648 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.4 mt -82.62 -12.84 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 123.025 1.393 . . . . 11.0 108.238 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 59' ' ' ASP . 52.3 t80 -78.73 -44.91 22.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.174 -1.375 . . . . 16.42 110.058 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.0 t -93.4 -31.98 14.42 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.558 0.577 . . . . 13.35 112.558 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.06 125.67 45.14 Favored Pre-proline 0 CA--C 1.5 -0.964 0 O-C-N 121.785 -0.572 . . . . 12.23 110.805 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 60.4 Cg_endo -87.61 -18.11 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.042 1.828 . . . . 13.06 111.601 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.4 t -108.24 133.38 53.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.195 -1.409 . . . . 12.95 107.195 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 31' ' ' PHE . 43.6 p90 -72.74 -34.82 67.29 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.375 0.509 . . . . 10.92 112.375 -172.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -71.19 -20.65 62.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.496 0.665 . . . . 14.32 111.005 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.97 -25.86 40.21 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.544 0.688 . . . . 10.93 109.883 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.524 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 9.2 t80 -68.04 -30.34 69.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.635 . . . . 8.81 111.325 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -63.87 -22.2 66.81 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.856 0.687 . . . . 9.35 112.856 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.83 -28.03 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.378 0.608 . . . . 11.63 110.07 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -73.81 -45.74 49.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.794 -0.639 . . . . 10.55 109.41 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.57 -42.28 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.661 0 N-CA-C 109.726 -0.472 . . . . 8.3 109.726 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.06 74.31 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.606 -0.725 . . . . 9.58 113.518 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 p -81.21 -38.33 27.16 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.099 -0.64 . . . . 10.23 111.877 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -73.98 -46.65 42.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.959 -0.696 . . . . 10.43 110.025 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.34 84.26 1.9 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.907 -0.588 . . . . 10.97 109.667 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -104.8 100.81 25.5 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.378 -0.971 . . . . 13.52 108.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 150.42 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.361 2.04 . . . . 12.28 111.797 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.4 p -83.14 63.44 7.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.272 1.034 . . . . 13.44 109.75 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -118.11 64.08 0.75 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.802 -1.09 . . . . 13.27 108.788 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.08 -61.61 1.5 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.931 -0.766 . . . . 14.48 108.931 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.7 p -88.19 44.93 1.23 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.2 1.0 . . . . 14.92 109.771 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.52 36.19 0.46 Allowed 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.281 -1.327 . . . . 14.25 108.028 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.88 122.0 85.61 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.064 -0.971 . . . . 12.97 110.265 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.27 143.12 6.47 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.065 1.843 . . . . 13.4 111.817 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.76 96.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 122.076 0.941 . . . . 12.43 108.557 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -110.85 58.79 0.61 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.559 1.171 . . . . 13.45 108.575 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -116.43 102.73 9.77 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.766 -1.561 . . . . 14.41 108.525 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -59.97 124.16 75.59 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.051 -0.722 . . . . 11.68 109.051 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.63 40.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.01 2.474 . . . . 10.84 111.006 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -76.82 94.3 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.214 -0.903 . . . . 10.46 109.866 -178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 98' ' ' GLN . . . -70.71 -22.98 62.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.244 -0.889 . . . . 10.58 109.798 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -68.32 -15.66 63.65 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.589 -0.732 . . . . 11.04 111.261 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.5 -57.92 0.51 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 112.288 0.477 . . . . 10.88 112.288 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.56 -21.65 19.14 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.512 1.475 . . . . 12.46 111.688 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 7.3 tt0 -119.47 86.57 34.32 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 116.069 -0.514 . . . . 13.78 109.681 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.59 31.55 0.5 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.908 2.405 . . . . 11.95 110.782 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.54 41.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.223 -1.151 . . . . 11.48 110.223 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.43 -28.95 31.01 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.675 0.75 . . . . 11.55 109.061 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.1 133.96 36.14 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.816 -1.084 . . . . 12.59 108.406 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.32 -31.47 18.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.154 0.502 . . . . 11.24 112.005 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.3 m 60.65 26.07 15.81 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.675 -1.148 . . . . 10.05 113.567 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.89 -25.25 55.91 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.759 0.281 . . . . 11.22 111.759 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.98 -37.77 88.76 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.45 -0.341 . . . . 11.38 111.762 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -57.34 10.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 9.65 110.737 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -61.72 -44.43 96.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.574 -0.739 . . . . 10.43 109.924 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.8 t -60.39 -43.48 96.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.6 -0.727 . . . . 10.21 110.969 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.6 mt -55.98 -51.41 61.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.36 0.664 . . . . 8.13 110.511 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.58 -39.86 94.49 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 115.201 -0.909 . . . . 8.46 109.869 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.49 -34.82 74.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.957 0.503 . . . . 10.86 111.777 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -68.34 -53.54 23.39 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 110.016 -0.364 . . . . 11.45 110.016 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 171' ' ' LEU . 9.4 tt -63.36 -27.68 69.48 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.306 -0.861 . . . . 7.62 110.401 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.11 -46.19 90.13 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.734 1.214 . . . . 11.62 109.869 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -69.26 -33.8 73.8 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.048 -0.523 . . . . 11.63 110.91 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -63.48 -42.74 98.55 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.208 -0.451 . . . . 9.14 110.432 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.98 -40.99 68.19 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.622 -0.51 . . . . 10.06 109.622 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.54 -49.79 70.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.852 -0.613 . . . . 12.07 112.424 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.56 -25.84 66.0 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.003 0.521 . . . . 12.32 110.438 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.26 -46.76 60.2 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.06 -0.719 . . . . 11.77 109.06 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -75.29 -81.03 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.512 -0.767 . . . . 13.52 110.04 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -158.55 -45.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.116 -1.068 . . . . 16.56 108.116 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.7 tp -167.84 157.58 10.13 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.487 -2.412 . . . . 15.74 104.487 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -92.52 118.01 67.85 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 118.474 0.579 . . . . 14.2 110.733 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.29 -8.21 11.78 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.495 2.13 . . . . 14.18 111.752 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.6 -10.26 74.16 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.246 -0.742 . . . . 14.03 111.246 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -89.66 37.1 0.86 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.24 1.019 . . . . 16.37 110.497 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.21 -5.68 13.02 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.304 -1.316 . . . . 12.45 110.802 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -85.78 121.66 28.75 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.089 -0.505 . . . . 14.43 110.082 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.1 m 69.85 -66.34 0.27 Allowed 'General case' 0 C--O 1.247 0.926 0 C-N-CA 125.082 1.353 . . . . 14.32 112.175 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.5 82.72 1.51 Allowed Glycine 0 C--O 1.239 0.453 0 CA-C-N 116.412 -0.358 . . . . 13.75 113.007 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 170' ' ' THR . . . -143.49 117.4 9.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.895 -1.15 . . . . 12.7 107.895 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -115.73 164.16 14.76 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.184 -1.413 . . . . 16.38 107.184 -173.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.631 ' H ' ' NE2' ' A' ' 134' ' ' GLN . 40.5 m-85 -42.82 -47.16 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.307 0.854 . . . . 13.3 113.307 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 pp -55.82 -33.85 64.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.679 0.622 . . . . 16.25 112.679 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.68 -1.73 27.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.567 0.58 . . . . 15.87 112.567 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 96.6 mt -93.89 -27.19 16.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.233 0.539 . . . . 13.65 109.775 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 170.67 126.38 0.87 Allowed Glycine 0 N--CA 1.432 -1.594 0 N-CA-C 110.411 -1.076 . . . . 14.16 110.411 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp -70.17 -30.17 67.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.163 0.506 . . . . 15.45 110.904 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -106.92 124.64 49.92 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.743 -0.836 . . . . 13.63 108.743 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 t -61.49 -30.05 70.37 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.422 -0.808 . . . . 13.9 112.473 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 t -76.91 -25.18 15.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 CA-C-O 121.536 0.684 . . . . 13.81 109.99 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -70.65 -28.19 64.61 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.694 -0.803 . . . . 11.48 110.235 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.34 -21.16 59.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.036 -1.225 . . . . 10.35 110.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 m -67.31 -44.77 78.34 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.012 -1.107 . . . . 12.2 108.012 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.26 -46.2 90.65 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.318 -1.31 . . . . 11.86 109.706 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -59.03 -46.72 87.51 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.739 -1.118 . . . . 9.32 111.279 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.1 tpt -53.29 -55.73 22.29 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.558 0.743 . . . . 9.5 112.093 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -63.75 -30.11 71.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.599 -0.44 . . . . 13.91 111.669 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 -50.07 50.33 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.004 -0.839 . . . . 9.88 111.004 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.83 -40.34 86.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.284 0.634 . . . . 9.27 110.25 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.9 t -54.27 -58.83 5.91 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.046 -0.979 . . . . 11.46 110.697 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -71.23 -24.95 62.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.283 -0.417 . . . . 15.04 111.638 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -61.07 -34.93 75.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.689 0.28 . . . . 11.82 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -100.55 6.41 44.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 11.97 111.272 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.3 m 57.42 44.0 22.19 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.284 1.034 . . . . 14.24 111.188 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.5 pt -122.18 146.78 26.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 106.777 -1.564 . . . . 12.62 106.777 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -96.81 96.73 8.76 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.869 -0.732 . . . . 16.39 110.95 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.64 139.48 45.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.555 -0.906 . . . . 12.32 108.555 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.94 44.28 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.426 -0.806 . . . . 14.06 109.201 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.86 -24.04 67.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.593 -0.731 . . . . 12.64 111.616 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.34 2.69 51.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.019 -0.537 . . . . 15.68 111.528 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.55 -14.86 63.07 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.846 -0.534 . . . . 12.72 111.799 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.6 pt -61.37 -18.08 17.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 122.912 0.485 . . . . 12.16 111.478 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -83.47 -6.97 59.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.078 0.466 . . . . 15.08 110.366 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -99.22 -19.51 17.08 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.668 -0.696 . . . . 14.67 110.983 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -116.54 98.74 52.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.332 -0.547 . . . . 12.68 111.554 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.434 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 43.4 Cg_endo -72.22 -29.0 14.8 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.227 1.951 . . . . 14.34 112.408 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 133' ' ' ALA . 3.3 p -126.71 143.39 51.25 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.378 0.609 . . . . 12.91 110.031 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 114' ' ' LEU . 34.6 tp -56.18 -26.95 52.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.258 1.423 . . . . 9.89 113.045 -174.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.41 -29.72 66.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.844 -0.616 . . . . 12.5 111.125 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -77.54 -30.3 52.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 11.04 109.934 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 178' ' ' VAL . 47.9 tp -75.82 -50.97 13.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.714 -0.675 . . . . 8.5 109.213 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.52 -47.34 48.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.201 0.6 . . . . 7.7 111.817 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 180' ' ' ARG . 15.2 t70 -65.77 -31.31 72.22 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.773 0.32 . . . . 10.38 111.16 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.31 -40.31 74.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.597 -0.52 . . . . 11.97 109.597 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 174' ' ' LEU . 15.6 t -60.61 -42.24 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.08 -0.711 . . . . 9.8 109.08 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.67 -39.42 65.06 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 123.985 0.803 . . . . 10.83 111.144 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 176' ' ' ASP . 20.0 mmt180 -73.14 -46.06 53.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.451 -0.574 . . . . 13.5 109.451 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 181' ' ' ARG . 2.9 mmp_? -63.63 -39.23 93.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.432 -0.804 . . . . 14.84 112.02 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.12 -34.11 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 13.35 110.213 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.445 1.098 . . . . 13.51 110.749 179.928 . . . . . . . . 0 0 . 1 stop_ save_